PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Heinritz, SN; Weiss, E; Eklund, M; Aumiller, T; Louis, S; Rings, A; Messner, S; Camarinha-Silva, A; Seifert, J; Bischoff, SC; Mosenthin, R				Heinritz, Sonja N.; Weiss, Eva; Eklund, Meike; Aumiller, Tobias; Louis, Sandrine; Rings, Andreas; Messner, Sabine; Camarinha-Silva, Amelia; Seifert, Jana; Bischoff, Stephan C.; Mosenthin, Rainer			Intestinal Microbiota and Microbial Metabolites Are Changed in a Pig Model Fed a High-Fat/Low-Fiber or a Low-Fat/High-Fiber Diet	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GUT MICROBIOTA; HEALTH-BENEFITS; WEIGHT-GAIN; DIVERSITY; BIFIDOBACTERIA; FERMENTATION; PREDICTION; CHILDREN; BACTERIA	The intestinal microbiota and its metabolites appear to be an important factor for gastrointestinal function and health. However, research is still needed to further elaborate potential relationships between nutrition, gut microbiota and host's health by means of a suitable animal model. The present study examined the effect of two different diets on microbial composition and activity by using the pig as a model for humans. Eight pigs were equally allotted to two treatments, either fed a low-fat/high-fiber (LF), or a high-fat/low-fiber (HF) diet for 7 weeks. Feces were sampled at day 7 of every experimental week. Diet effects on fecal microbiota were assessed using quantitative real-time PCR, DNA fingerprinting and meta-proteomics. Furthermore, fecal short-chain fatty acid (SCFA) profiles and ammonia concentrations were determined. Gene copy numbers of lactobacilli, bifidobacteria (P<0.001) and Faecalibacterium prausnitzii (P<0.05) were higher in the LF pigs, while Enterobacteriaceae were more abundant in the HF pigs (P<0.001). Higher numbers of proteins affiliated to Enterobacteriaceae were also present in the HF samples. Proteins for polysaccharide breakdown did almost exclusively originate from Prevotellaceae. Total and individual fecal SCFA concentrations were higher for pigs of the LF treatment (P<0.05), whereas fecal ammonia concentrations did not differ between treatments (P>0.05). Results provide evidence that beginning from the start of the experiment, the LF diet stimulated beneficial bacteria and SCFA production, especially butyrate (P<0.05), while the HF diet fostered those bacterial groups which have been associated with a negative impact on health conditions. These findings correspond to results in humans and might strengthen the hypothesis that the response of the porcine gut microbiota to a specific dietary modulation is in support of using the pig as suitable animal model for humans to assess diet-gut-microbiota interactions.	[Heinritz, Sonja N.; Weiss, Eva; Eklund, Meike; Aumiller, Tobias; Messner, Sabine; Camarinha-Silva, Amelia; Seifert, Jana; Mosenthin, Rainer] Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany; [Louis, Sandrine; Rings, Andreas; Bischoff, Stephan C.] Univ Hohenheim, Dept Nutr Med, Stuttgart, Germany	University Hohenheim; University Hohenheim	Mosenthin, R (corresponding author), Univ Hohenheim, Inst Anim Sci, Stuttgart, Germany.	rainer.mosenthin@uni-hohenheim.de	Silva, Amélia Camarinha/AAB-5584-2019	Camarinha Silva, Amelia/0000-0001-7814-6569; Aumiller, Tobias/0000-0001-6836-0297; Seifert, Jana/0000-0002-7690-8539	University of Hohenheim	University of Hohenheim	The work was supported by a grant of the University of Hohenheim. There is no specific grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Bublitz DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101456; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Damms-Machado A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/806248; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Drissi F, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.6; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33; FRASER J. R., 1959, Journal of the Science of Food and Agriculture, V10, P506, DOI 10.1002/jsfa.2740100910; Frese SA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0091-8; Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948; Gonzalez LM, 2015, TRANSL RES, V166, P12, DOI 10.1016/j.trsl.2015.01.004; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Haange SB, 2012, J PROTEOME RES, V11, P5406, DOI 10.1021/pr3006364; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hermes RG, 2009, J ANIM SCI, V87, P3569, DOI 10.2527/jas.2008-1241; Jehmlich N, 2008, RAPID COMMUN MASS SP, V22, P2889, DOI 10.1002/rcm.3684; Kaczmarczyk MM, 2012, METABOLISM, V61, P1058, DOI 10.1016/j.metabol.2012.01.017; Kadooka Y, 2010, EUR J CLIN NUTR, V64, P636, DOI 10.1038/ejcn.2010.19; Kailasapathy K, 2000, IMMUNOL CELL BIOL, V78, P80, DOI 10.1046/j.1440-1711.2000.00886.x; Kalliomaki M, 2008, AM J CLIN NUTR, V87, P534, DOI 10.1093/ajcn/87.3.534; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kim HB, 2011, VET MICROBIOL, V153, P124, DOI 10.1016/j.vetmic.2011.05.021; Leser TD, 2002, APPL ENVIRON MICROB, V68, P673, DOI 10.1128/AEM.68.2.673-690.2002; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Loh G, 2006, J NUTR, V136, P1198, DOI 10.1093/jn/136.5.1198; Looft T, 2014, ISME J, V8, P1566, DOI 10.1038/ismej.2014.12; Luoto R, 2010, BRIT J NUTR, V103, P1792, DOI 10.1017/S0007114509993898; Matise I, 2000, VET PATHOL, V37, P318, DOI 10.1354/vp.37-4-318; Mikkelsen LL, 2003, APPL ENVIRON MICROB, V69, P654, DOI 10.1128/AEM.69.1.654-658.2003; Millet S, 2010, CRIT REV FOOD SCI, V50, P605, DOI 10.1080/10408390802565939; Million M, 2013, INT J OBESITY, V37, P1460, DOI 10.1038/ijo.2013.20; Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Naumann C., 1997, VDLUFA METHODENBUCH, VIII; NOBLET J, 1994, J ANIM SCI, V72, P344, DOI 10.2527/1994.722344x; PALMQUIST DL, 1994, J NUTR, V124, pS1377; Pang XY, 2007, ISME J, V1, P156, DOI 10.1038/ismej.2007.23; Pedersen R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056612; Pettigrew J. E., 1991, Swine Nutrition., P133; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; Piepho HP, 2004, J COMPUT GRAPH STAT, V13, P456, DOI 10.1198/1061860043515; Pluske JR, 2002, NUTR RES REV, V15, P333, DOI 10.1079/NRR200242; Purushe J, 2010, MICROB ECOL, V60, P721, DOI 10.1007/s00248-010-9692-8; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Remely M, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000253; Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shen JA, 2010, ARCH MICROBIOL, V192, P959, DOI 10.1007/s00203-010-0628-y; Simpson PJ, 2003, J BACTERIOL, V185, P2571, DOI 10.1128/JB.185.8.2571-2581.2003; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Smith AG, 2010, LIVEST SCI, V133, P148, DOI 10.1016/j.livsci.2010.06.049; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wagnerberger S, 2012, BRIT J NUTR, V107, P1727, DOI 10.1017/S0007114511004983; Wang J, 2010, CARBOHYD POLYM, V82, P419, DOI 10.1016/j.carbpol.2010.04.082; Wang M, 2015, ILAR J, V56, P63, DOI 10.1093/ilar/ilv006; Weiss E, 2016, J SCI FOOD AGR, V96, P2230, DOI 10.1002/jsfa.7340; Winer BJ, 1991, STATISTICAL PRINCIPL; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu ST, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-444; Yan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059581; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; ZIJLSTRA JB, 1977, CLIN CHIM ACTA, V78, P243, DOI 10.1016/0009-8981(77)90312-6; Zumbrun SD, 2013, P NATL ACAD SCI USA, V110, pE2126, DOI 10.1073/pnas.1222014110	71	95	100	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154329	10.1371/journal.pone.0154329	http://dx.doi.org/10.1371/journal.pone.0154329			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100182	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500183
J	Al Toma, V; Farcas, AD; Roman, I; Sevastre, B; Hathazi, D; Scurtu, F; Damian, G; Silaghi-Dumitrescu, R				Al Toma, Vlad; Farcas, Anca D.; Roman, Ioana; Sevastre, Bogdan; Hathazi, Denisa; Scurtu, Florina; Damian, Grigore; Silaghi-Dumitrescu, Radu			Comparative In Vivo Effects of HemoglobinBased Oxygen Carriers (HBOC) with Varying Prooxidant and Physiological Reactivity	PLOS ONE			English	Article							HUMAN POLYMERIZED HEMOGLOBIN; BLOOD SUBSTITUTES; CROSS-LINKING; HEMORRHAGIC-SHOCK; NITRIC-OXIDE; BOVINE; GLUTARALDEHYDE; THERAPEUTICS; TRANSFUSION; HEMERYTHRIN	A series of hemoglobin-based oxygen carrier candidates (HBOC), previously noted for their differences in prooxidative and physiological reactivity, were compared in terms of the negative effects displayed upon injection in Wistar rats. At the concentrations tested, antioxidant strategies based on albumin as well as based on rubrerythrin appear to offer observable physiological advantages.	[Al Toma, Vlad; Farcas, Anca D.; Roman, Ioana] Biol Res Inst, Cluj Napoca 400113, Romania; [Al Toma, Vlad; Farcas, Anca D.; Hathazi, Denisa; Scurtu, Florina; Silaghi-Dumitrescu, Radu] Univ Babes Bolyai, Dept Chem & Chem Engn, Cluj Napoca 400028, Romania; [Al Toma, Vlad; Farcas, Anca D.; Hathazi, Denisa] Natl Inst Res & Dev Isotop & Mol Technol, Cluj Napoca 400293, Romania; [Sevastre, Bogdan] Univ Agr Sci & Vet Med, Dept Pathophysiol, Cluj Napoca 400372, Romania; [Damian, Grigore] Univ Babes Bolyai, Dept Phys, Cluj Napoca 400028, Romania	Babes Bolyai University from Cluj; National Institute for Research & Development of Isotopic & Molecular Technologies Cluj-Napoca; University of Agricultural Sciences & Veterinary Medicine Cluj Napoca; Babes Bolyai University from Cluj	Silaghi-Dumitrescu, R (corresponding author), Univ Babes Bolyai, Dept Chem & Chem Engn, Cluj Napoca 400028, Romania.	rsilaghi@chem.ubbcluj.ro	Ioana, Roman/AAX-9721-2021; Scurtu, Florina/P-4602-2014; Sevastre, Bogdan/AAP-5221-2020; Silaghi-Dumitrescu, Radu/A-2883-2008; DAMIAN, Grigore/B-6010-2011; Stoica, Anca-Daniela/Y-6506-2018; Toma, Vlad-Alexandru/S-1514-2019	Sevastre, Bogdan/0000-0002-6168-3429; Silaghi-Dumitrescu, Radu/0000-0003-3038-7747; DAMIAN, Grigore/0000-0003-4127-8140; Stoica, Anca-Daniela/0000-0002-7510-5793; Toma, Vlad-Alexandru/0000-0002-1141-2559; Hathazi, Denisa/0000-0002-0683-7552; Scurtu, Florina/0000-0002-2406-9163	Romanian Ministry of Education and Research [PN09-440213]; "Babes-Bolyai" University via the Sectoral Operational Programme for Human Resources Development - European Social Fund [POSDRU/159/1.5/S/132400]	Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); "Babes-Bolyai" University via the Sectoral Operational Programme for Human Resources Development - European Social Fund	Funding from the The Romanian Ministry of Education and Research (http://www.research.ro/, grant PN09-440213) is gratefully acknowledged by VAT, ADF, IR, DH. FS thanks the "Babes-Bolyai" University for financial support via the Sectoral Operational Programme for Human Resources Development 2007-2013, co-financed by the European Social Fund, under the project POSDRU/159/1.5/S/132400 with the title "Young successful researchers - professional development in an international and interdisciplinary environment."	Alayash AI, 2014, TRENDS BIOTECHNOL, V32, P177, DOI 10.1016/j.tibtech.2014.02.006; Alayash AI, 2001, ARCH BIOCHEM BIOPHYS, V391, P225, DOI 10.1006/abbi.2001.2426; Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; ALAYASH AI, 1994, ANN NY ACAD SCI, V738, P378; AMBERSON WR, 1949, J APPL PHYSIOL, V1, P469, DOI 10.1152/jappl.1949.1.7.469; Amberson WR, 1933, SCIENCE, V78, P106, DOI 10.1126/science.78.2014.106; Arnaud F, 2012, RESUSCITATION, V83, P1038, DOI 10.1016/j.resuscitation.2012.01.018; Baek JH, 2012, TOXICOL SCI, V127, P567, DOI 10.1093/toxsci/kfs109; Bian YZ, 2011, ARTIF CELL BLOOD SUB, V39, P127, DOI 10.3109/10731199.2011.581052; Buehler PW, 2010, TRENDS MOL MED, V16, P447, DOI 10.1016/j.molmed.2010.07.006; CHANG TMS, 1988, BIOMATER ARTIF CELL, V16, P1; Chang WH, 2004, ARTIF CELL BLOOD SUB, V32, P243, DOI 10.1081/BIO-120037830; Deac F, 2011, J BIOCHEM, V149, P75, DOI 10.1093/jb/mvq123; Doherty DH, 1998, NAT BIOTECHNOL, V16, P672, DOI 10.1038/nbt0798-672; Dunne J, 2006, BIOCHEM J, V399, P513, DOI 10.1042/BJ20060341; Elmer J, 2012, J FUNCT BIOMATER, V3, P49, DOI 10.3390/jfb3010049; Fernandes Marilia Sabo, 2014, World J Exp Med, V4, P38, DOI 10.5493/wjem.v4.i3.38; Fischer-Fodor E, 2011, J BIOSCIENCES, V36, P215, DOI 10.1007/s12038-011-9066-5; Gould SA, 1998, J AM COLL SURGEONS, V187, P113, DOI 10.1016/S1072-7515(98)00095-7; Gulati A, 1998, SHOCK, V9, P65, DOI 10.1097/00024382-199801000-00010; Hathazi D, 2014, BIOMACROMOLECULES, V15, P1920, DOI 10.1021/bm5004256; Iacob B, 2011, ARTIF CELL BLOOD SUB, V39, P293, DOI 10.3109/10731199.2011.563362; Jahr JS, 2008, EXPERT OPIN BIOL TH, V8, P1425, DOI 10.1517/14712598.8.9.1425 ; Jahr JS, 2008, J TRAUMA, V64, P1484, DOI 10.1097/TA.0b013e318173a93f; Jain NC, 1993, ESSENTIALS VET HEMAT; Jin S, 2002, J AM CHEM SOC, V124, P9845, DOI 10.1021/ja026587u; Katz LM, 2002, RESUSCITATION, V54, P77, DOI 10.1016/S0300-9572(02)00053-9; Krieter H, 1997, J CARDIOTHOR VASC AN, V11, P3, DOI 10.1016/S1053-0770(97)90243-3; Matheson B, 2002, J APPL PHYSIOL, V93, P1479, DOI 10.1152/japplphysiol.00191.2002; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Olofsson C, 2006, ANESTHESIOLOGY, V105, P1153, DOI 10.1097/00000542-200612000-00015; Prange HD, 2001, J APPL PHYSIOL, V91, P33, DOI 10.1152/jappl.2001.91.1.33; Proctor KG, 2003, J TRAUMA, V54, pS106, DOI 10.1097/01.TA.0000047222.96258.0D; Reeder BJ, 2008, J BIOL CHEM, V283, P30780, DOI 10.1074/jbc.M804709200; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; Scurtu F, 2014, ARTIF CELL NANOMED B, V42, P13, DOI 10.3109/21691401.2012.762652; Scurtu VF, 2013, PHARMACEUTICALS, V6, P867, DOI 10.3390/ph6070867; Standl T, 2003, J VASC SURG, V37, P859, DOI 10.1067/mva.2003.127; Tsuchida E, 2006, ARTIF CELL BLOOD SUB, V34, P581, DOI 10.1080/10731190600973907; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Winslow RM, 2000, BRIT J HAEMATOL, V111, P387, DOI 10.1046/j.1365-2141.2000.02326.x; Winslow Robert M, 2003, Curr Hematol Rep, V2, P503; Wong NSW, 2007, ARTIF CELL BLOOD SUB, V35, P481, DOI 10.1080/10731190701586210; Yeaman MR, 2014, NAT REV MICROBIOL, V12, P426, DOI 10.1038/nrmicro3269; Zolog O, 2011, PROTEIN J, V30, P27, DOI 10.1007/s10930-010-9298-5	48	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153909	10.1371/journal.pone.0153909	http://dx.doi.org/10.1371/journal.pone.0153909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097326	gold, Green Submitted, Green Published			2022-12-27	WOS:000374543600069
J	Das, JR; Gutkind, JS; Ray, PE				Das, Jharna R.; Gutkind, J. Silvio; Ray, Patricio E.			Circulating Fibroblast Growth Factor-2, HIV-Tat, and Vascular Endothelial Cell Growth Factor-A in HIV-Infected Children with Renal Disease Activate Rho-A and Src in Cultured Renal Endothelial Cells	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; FACTOR-BINDING-PROTEIN; KAPOSIS-SARCOMA; HIV-1-ASSOCIATED NEPHROPATHY; INFLAMMATORY CYTOKINES; BARRIER PROPERTIES; EPITHELIAL-CELLS; TRANSGENIC RAT; FACTOR VEGF; HEPARIN	Renal endothelial cells (REc) are the first target of HIV-1 in the kidney. The integrity of REc is maintained at least partially by heparin binding growth factors that bind to heparan sulfate proteoglycans located on their cell surface. However, previous studies showed that the accumulation of two heparin-binding growth factors, Vascular Endothelial Cell Growth Factor-A (VEGF-A) and Fibroblast Growth Factor-2 (FGF-2), in combination with the viral protein Tat, can precipitate the progression of HIV-renal diseases. Nonetheless, very little is known about how these factors affect the behavior of REc in HIV+ children. We carried out this study to determine how VEGF-A, FGF-2, and HIV-Tat, modulate the cytoskeletal structure and permeability of cultured REc, identify key signaling pathways involved in this process, and develop a functional REc assay to detect HIV+ children affected by these changes. We found that VEGF-A and FGF-2, acting in synergy with HIV-Tat and heparin, affected the cytoskeletal structure and permeability of REc through changes in Rho-A, Src, and Rac-1 activity. Furthermore, urine samples from HIV+ children with renal diseases, showed high levels of VEGF-A and FGF-2, and induced similar changes in cultured REc and podocytes. These findings suggest that FGF-2, VEGF-A, and HIV-Tat, may affect the glomerular filtration barrier in HIV+ children through the induction of synergistic changes in Rho-A and Src activity. Further studies are needed to define the clinical value of the REc assay described in this study to identify HIV+ children exposed to circulating factors that may induce glomerular injury through similar mechanisms.	[Das, Jharna R.; Ray, Patricio E.] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Gutkind, J. Silvio] Univ Calif San Diego, Dept Pharmacol, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ray, Patricio E.] Childrens Natl Hlth Syst, Div Nephrol, Washington, DC USA; [Ray, Patricio E.] George Washington Univ, Dept Pediat, Washington, DC 20052 USA	Children's National Health System; University of California System; University of California San Diego; Children's National Health System; George Washington University	Ray, PE (corresponding author), Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA.; Ray, PE (corresponding author), Childrens Natl Hlth Syst, Div Nephrol, Washington, DC USA.; Ray, PE (corresponding author), George Washington Univ, Dept Pediat, Washington, DC 20052 USA.	Pray@childrensnational.org	Gutkind, J. Silvio/J-1201-2016	Gutkind, J. Silvio/0000-0002-5150-4482	National Institutes of Health [R01-HL102497, R01-DK 49419, R01 DK103564, R01 DK108368]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102497] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049419, R01DK108368, R01DK103564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health grants R01-HL102497, R01-DK 49419, R01 DK103564, and R01 DK108368. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 1996, ONCOGENE, V12, P289; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; AVIEZER D, 1994, CELL, V79, P1005, DOI 10.1016/0092-8674(94)90031-0; Babelova A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080328; Barillari G, 1999, J IMMUNOL, V163, P1929; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; Blattner SM, 2013, KIDNEY INT, V84, P920, DOI 10.1038/ki.2013.175; Bruggeman LA, 2000, J AM SOC NEPHROL, V11, P2079, DOI 10.1681/ASN.V11112079; COHEN T, 1995, J BIOL CHEM, V270, P11322, DOI 10.1074/jbc.270.19.11322; Conaldi PG, 2002, AM J PATHOL, V161, P53, DOI 10.1016/S0002-9440(10)64156-9; Cornali E, 1996, AM J PATHOL, V149, P1851; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Crublet E, 2008, J BIOL CHEM, V283, P15193, DOI 10.1074/jbc.M800066200; DAGATI V, 1989, KIDNEY INT, V35, P1358, DOI 10.1038/ki.1989.135; de Paz JL, 2007, CHEM BIOL, V14, P879, DOI 10.1016/j.chembiol.2007.07.007; Doublier S, 2007, AIDS, V21, P423, DOI 10.1097/QAD.0b013e328012c522; DUTT K, 1990, ONCOGENE, V5, P195; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Funderburg NT, 2014, THROMB RES, V133, pS21, DOI 10.1016/j.thromres.2014.03.012; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; Huveneers S, 2009, J CELL SCI, V122, P1059, DOI 10.1242/jcs.039446; Jerebtsova M, 2015, AM J PHYSIOL-HEART C, V309, pH314, DOI 10.1152/ajpheart.00373.2015; Kim NH, 2005, KIDNEY INT, V67, P167, DOI 10.1111/j.1523-1755.2005.00067.x; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kistler AD, 2012, KIDNEY INT, V81, P1053, DOI 10.1038/ki.2012.12; Korgaonkar SN, 2008, J AM SOC NEPHROL, V19, P877, DOI 10.1681/ASN.2007050629; Liu XH, 2001, KIDNEY INT, V59, P1717, DOI 10.1046/j.1523-1755.2001.0590051717.x; Lucas GM, 2014, CLIN INFECT DIS, V59, pE96, DOI 10.1093/cid/ciu617; Mammoto T, 2007, J BIOL CHEM, V282, P23910, DOI 10.1074/jbc.M702169200; MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; McCulloch MI, 2008, SEMIN NEPHROL, V28, P585, DOI 10.1016/j.semnephrol.2008.09.001; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Murakami M, 2011, J CLIN INVEST, V121, P2668, DOI 10.1172/JCI44762; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; Persidsky Y, 2006, BLOOD, V107, P4770, DOI 10.1182/blood-2005-11-4721; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ray P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133699; Ray PE, 2006, AM J PHYSIOL-REG I, V290, pR105, DOI 10.1152/ajpregu.00492.2005; Ray PE, 2005, PEDIATR NEPHROL, V20, P1401, DOI 10.1007/s00467-005-1950-5; Ray PE, 1998, KIDNEY INT, V53, P1217, DOI 10.1046/j.1523-1755.1998.00900.x; RAY PE, 1994, KIDNEY INT, V46, P759, DOI 10.1038/ki.1994.331; Ray PE, 2003, KIDNEY INT, V63, P2242, DOI 10.1046/j.1523-1755.2003.00028.x; Ray PE, 1999, PEDIATR NEPHROL, V13, P586, DOI 10.1007/s004670050749; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rosenfeldt Hans, 2006, J Mol Signal, V1, P8, DOI 10.1186/1750-2187-1-8; Rostgaard J, 1997, MICROVASC RES, V53, P1, DOI 10.1006/mvre.1996.1987; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Samaniego F, 1998, AM J PATHOL, V152, P1433; Satchell SC, 2006, KIDNEY INT, V69, P1633, DOI 10.1038/sj.ki.5000277; Satchell SC, 2004, J AM SOC NEPHROL, V15, P566, DOI 10.1097/01.ASN.0000115397.22519.03; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; SEILER MW, 1977, LAB INVEST, V36, P48; Soler-Garcia AA, 2009, KIDNEY INT, V76, P207, DOI 10.1038/ki.2009.115; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Urbinati C, 2009, BLOOD, V114, P3335, DOI 10.1182/blood-2009-01-198945; Urbinati C, 2008, MOLECULES, V13, P2758, DOI 10.3390/molecules13112758; VEHASKARI VM, 1982, KIDNEY INT, V22, P127, DOI 10.1038/ki.1982.144; Wang LM, 2012, KIDNEY INT, V81, P1075, DOI 10.1038/ki.2011.472; Waschke J, 2006, HISTOCHEM CELL BIOL, V125, P397, DOI 10.1007/s00418-005-0080-2; Waschke J, 2005, AM J PHYSIOL-HEART C, V288, pH1296, DOI 10.1152/ajpheart.00687.2004; Waschke J, 2004, AM J PHYSIOL-HEART C, V286, pH394, DOI 10.1152/ajpheart.00221.2003; Xie XF, 2014, J AM SOC NEPHROL, V25, P1800, DOI 10.1681/ASN.2013070710; Yu HY, 2013, MOL CELL BIOL, V33, P4755, DOI 10.1128/MCB.00730-13; Zakrzewska M, 2009, J BIOL CHEM, V284, P25388, DOI 10.1074/jbc.M109.001289	72	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153837	10.1371/journal.pone.0153837	http://dx.doi.org/10.1371/journal.pone.0153837			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097314	gold, Green Submitted, Green Published			2022-12-27	WOS:000374543600061
J	Quitmann, JH; Bullinger, M; Sommer, R; Rohenkohl, AC; Da Silva, NMB				Quitmann, Julia Hannah; Bullinger, Monika; Sommer, Rachel; Rohenkohl, Anja Christine; Bernardino Da Silva, Neuza Maria			Associations between Psychological Problems and Quality of Life in Pediatric Short Stature from Patients' and Parents' Perspectives	PLOS ONE			English	Article							IDIOPATHIC SHORT STATURE; GROWTH-HORMONE DEFICIENCY; CHRONIC HEALTH CONDITIONS; DIFFICULTIES QUESTIONNAIRE; SELF-ESTEEM; PART 2; CHILDREN; ADOLESCENTS; STRENGTHS; HEIGHT	Short stature has been associated with psychosocial impairments, but whether treatments and achieved height impact on health-related quality of life (HrQoL) and psychological functioning of children/adolescents is still controversial. This study aimed to examine the effects of height deviation and treatment status on psychosocial adaptation outcomes and to identify clinical and psychosocial determinants of internalizing/externalizing problems in a large cohort of short statured children/adolescents from seven European countries. Participants were 345 children aged 8-18 years with a clinical diagnosis of short stature and 421 parents of 4-18 year-old patients. Children and parents reported on psychological problems (Strengths and Difficulties Questionnaire), generic (KIDSCREEN) and condition-specific HrQoL (QoLISSY). According to analyses of covariance, children/adolescents with current short stature presented more parent-reported internalizing problems and lower self-and parent-reported condition-specific HrQoL, compared to patients with an achieved height above -2SD. Treated children self-reported better HrQoL than the untreated group. Hierarchical regression analysis showed that, rather than height-related clinical variables, children's sex, younger age and poorer HrQoL were the best predictors of psychological problems, explaining 39% of the variance in patient-and 42% in parent-reported internalizing problems, and 22% of the variance in patient-and 24% in parent-reported externalizing problems. Treatment status also moderated the negative links between patient-reported HrQoL and internalizing problems, explaining 2% of additional variance. These results suggest that children with current short stature are at greater risk for internalizing problems. Routine assessment of HrQoL in pediatric healthcare may help identify children for referral to specialized psychological assessment and intervention.	[Quitmann, Julia Hannah; Bullinger, Monika; Sommer, Rachel; Rohenkohl, Anja Christine; Bernardino Da Silva, Neuza Maria] Univ Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Bernardino Da Silva, Neuza Maria] Univ Coimbra, Cognit & Behav Ctr Res & Intervent, Coimbra, Portugal	University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidade de Coimbra	Quitmann, JH (corresponding author), Univ Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	j.quitmann@uke.de	da Silva, Neuza/A-9883-2013	da Silva, Neuza/0000-0003-4110-9961; Bullinger, Monika/0000-0001-8876-0159	Pfizer Ltd.	Pfizer Ltd.(Pfizer)	The project was funded by Pfizer Ltd. and the authors were provided funding for its conduct. No funding was received for the writing of this paper. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2009, J PAEDIATR CHILD H, V45, P636, DOI 10.1111/j.1440-1754.2009.01586.x; Aiken L. S., 1991, MULTIPLE REGRESSION; Annett RD, 2003, J ASTHMA, V40, P577, DOI 10.1081/JAS-120019030; [Anonymous], 2010, Am Psychol, V65, P493, DOI 10.1037/a0020168; Barlow JH, 2006, CHILD CARE HLTH DEV, V32, P19, DOI 10.1111/j.1365-2214.2006.00591.x; Batty GD, 2009, ECON HUM BIOL, V7, P137, DOI 10.1016/j.ehb.2009.06.004; Becker A, 2004, EUR CHILD ADOLES PSY, V13, P11, DOI 10.1007/s00787-004-2003-5; Bryant J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004440.pub2; Bullinger M, 2006, J PUBLIC HEALTH-HEID, V14, P343, DOI 10.1007/s10389-006-0066-0; Bullinger M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0236-2; Bullinger M, 2014, HORM RES PAEDIAT, V82, P18, DOI 10.1159/000358832; Bullinger M, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-76; Bullinger M, 2009, HORM RES, V72, P74, DOI 10.1159/000232159; Bullinger-Naber M., 2013, QUALITY LIFE SHORT S, V1; Chaplin JE, 2011, HORM RES PAEDIAT, V75, P291, DOI 10.1159/000322937; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen P., 2008, J CLIN ENDOCRINOLOGY, V93; Coste J, 2012, J CLIN ENDOCR METAB, V97, P3231, DOI 10.1210/jc.2012-1543; DeKlyen M, 1998, Clin Child Fam Psychol Rev, V1, P3, DOI 10.1023/A:1021844214633; Downie AB, 1997, BMJ-BRIT MED J, V314, P97, DOI 10.1136/bmj.314.7074.97; Drotar D, 1997, J PEDIATR PSYCHOL, V22, P149; Flouri E, 2008, CHILD CARE HLTH DEV, V34, P152, DOI 10.1111/j.1365-2214.2007.00752.x; Frazier PA, 2004, J COUNS PSYCHOL, V51, P115, DOI 10.1037/0022-0167.51.1.115; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; GORDON M, 1982, J PEDIATR-US, V101, P477, DOI 10.1016/S0022-3476(82)80093-0; HARPER DC, 1991, J PEDIATR PSYCHOL, V16, P533, DOI 10.1093/jpepsy/16.5.533; Hauffa B.P., 2008, NORMALES WACHSTUM WA; Hayes A. F., 2013, INTRO MEDIATION MODE, DOI DOI 10.1111/JEDM.12050; HOLMES CS, 1985, J DEV BEHAV PEDIATR, V6, P263; Hwang Jun-Won, 2015, Ann Pediatr Endocrinol Metab, V20, P79, DOI 10.6065/apem.2015.20.2.79; Jose P.E., 2013, MODGRAPH 1 PROGRAMME; Keselman A, 2000, J PEDIATR ENDOCR MET, V13, P409; LAW CM, 1987, ARCH DIS CHILD, V62, P855, DOI 10.1136/adc.62.8.855; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lee JM, 2009, PEDIATRICS, V124, P903, DOI 10.1542/peds.2008-0085; Lee MM, 2006, NEW ENGL J MED, V354, P2576, DOI 10.1056/NEJMcp060828; MacKinnon DP, 2008, HEALTH PSYCHOL, V27, pS99, DOI 10.1037/0278-6133.27.2(Suppl.).S99; Meltzer H, 2003, INT REV PSYCHIATR, V15, P185, DOI 10.1080/0954026021000046155; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; PECK MN, 1995, SOC SCI MED, V41, P733, DOI 10.1016/0277-9536(94)00379-8; Quitmann J., 2014, WIE ERLEBEN BETROFFE; Quitmann J, 2015, J CHILD FAM STUD, V24, P703, DOI 10.1007/s10826-013-9880-5; Ranke MB, 1996, HORM RES, V45, P64, DOI 10.1159/000184851; Ranke MB, 2001, HORM RES, V55, P115, DOI 10.1159/000049982; Ravens-Sieberer U, 2010, QUAL LIFE RES, V19, P1487, DOI 10.1007/s11136-010-9706-5; Ravens-Sieberer Ulrike, 2007, Psychosoc Med, V4, pDoc08; Rekers-Mombarg LTM, 1998, ACTA PAEDIATR, V87, P865, DOI 10.1080/080352598750013653; Richmond EJ, 2008, PITUITARY, V11, P115, DOI 10.1007/s11102-008-0105-7; Rohenkohl A., 2015, EUROPEAN J PEDIAT, P1; Rohenkohl A., 2015, BRIEF VERSION QUALIT; Rohenkohl AC, 2014, ACTA CLIN BELG, V69, P177, DOI 10.1179/2295333714Y.0000000024; Ross JL, 2004, J CLIN ENDOCR METAB, V89, P4873, DOI 10.1210/jc.2004-0791; Rush KS, 2004, BEHAV MODIF, V28, P621, DOI 10.1177/0145445503259830; Sandberg DE, 2015, PEDIATR CLIN N AM, V62, P963, DOI 10.1016/j.pcl.2015.04.009; Sandberg DE, 2005, HORM RES, V63, P275, DOI 10.1159/000086593; Sandberg DE, 2002, BEST PRACT RES CL EN, V16, P449, DOI 10.1053/beem.2002.0211; Savage MO, 2009, NAT CLIN PRACT ENDOC, V5, P148, DOI 10.1038/ncpendmet1074; Sheppard L, 2006, HORM RES, V65, P243, DOI 10.1159/000092455; Silva N, 2015, CHILD CARE HLTH DEV, V41, P112, DOI 10.1111/cch.12147; Silver EJ, 1998, J PEDIATR PSYCHOL, V23, P5, DOI 10.1093/jpepsy/23.1.5; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Sommer R, 2015, EUR J PEDIATR, V174, P875, DOI 10.1007/s00431-014-2480-6; Stabler B., 1998, J PEDIAT, V133; Steinhausen HC, 2000, J DEV BEHAV PEDIATR, V21, P423, DOI 10.1097/00004703-200012000-00004; Tanaka T, 2002, GROWTH HORM IGF RES, V12, P323, DOI 10.1016/S1096-6374(02)00045-X; Theunissen NCM, 2002, J PEDIATR-US, V140, P507, DOI 10.1067/mpd.2002.123766; Ulph F, 2004, ARCH DIS CHILD, V89, P17, DOI 10.1136/adc.2002.010694; Varni James W, 2005, Health Qual Life Outcomes, V3, P34, DOI 10.1186/1477-7525-3-34; Versteegh MM, 2012, VALUE HEALTH, V15, P504, DOI 10.1016/j.jval.2011.12.003; Visser-van Balen H, 2006, ARCH DIS CHILD, V91, P433, DOI 10.1136/adc.2005.086942; Voss LD, 2006, EUR J ENDOCRINOL, V155, pS39, DOI 10.1530/eje.1.02262; Wheeler PG, 2004, ARCH PEDIAT ADOL MED, V158, P236, DOI 10.1001/archpedi.158.3.236; White-Koning M, 2007, PEDIATRICS, V120, pE804, DOI 10.1542/peds.2006-3272; Wit JM, 2008, GROWTH HORM IGF RES, V18, P111, DOI 10.1016/j.ghir.2007.11.003; Wit JM, 2008, GROWTH HORM IGF RES, V18, P89, DOI 10.1016/j.ghir.2007.11.004; Woerner W, 2002, Z KINDER JUG-PSYCH, V30, P105, DOI 10.1024//1422-4917.30.2.105	79	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153953	10.1371/journal.pone.0153953	http://dx.doi.org/10.1371/journal.pone.0153953			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097033	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600075
J	Teki, S; Kumar, S; Griffiths, TD				Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.			Large-Scale Analysis of Auditory Segregation Behavior Crowdsourced via a Smartphone App	PLOS ONE			English	Article							STREAM SEGREGATION; SCENE ANALYSIS; INFORMATIONAL MASKING; PATTERNS; HEARING; RECOGNITION; PERCEPTION; COHERENCE; AWARENESS; CORTEX	The human auditory system is adept at detecting sound sources of interest from a complex mixture of several other simultaneous sounds. The ability to selectively attend to the speech of one speaker whilst ignoring other speakers and background noise is of vital biological significance-the capacity to make sense of complex 'auditory scenes' is significantly impaired in aging populations as well as those with hearing loss. We investigated this problem by designing a synthetic signal, termed the 'stochastic figure-ground' stimulus that captures essential aspects of complex sounds in the natural environment. Previously, we showed that under controlled laboratory conditions, young listeners sampled from the university subject pool (n = 10) performed very well in detecting targets embedded in the stochastic figure- ground signal. Here, we presented a modified version of this cocktail party paradigm as a 'game' featured in a smartphone app (The Great Brain Experiment) and obtained data from a large population with diverse demographical patterns (n = 5148). Despite differences in paradigms and experimental settings, the observed target-detection performance by users of the app was robust and consistent with our previous results from the psychophysical study. Our results highlight the potential use of smartphone apps in capturing robust large-scale auditory behavioral data from normal healthy volunteers, which can also be extended to study auditory deficits in clinical populations with hearing impairments and central auditory disorders.	[Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Teki, Sundeep; Kumar, Sukhbinder; Griffiths, Timothy D.] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Teki, Sundeep] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England	University of London; University College London; Newcastle University - UK; University of Oxford	Teki, S (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, London, England.; Teki, S (corresponding author), Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.; Teki, S (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	sundeep.teki@gmail.com	Teki, Sundeep/H-2756-2019	Teki, Sundeep/0000-0002-7951-6581; Griffiths, Timothy/0000-0001-8066-4381; Kumar, Sukhbinder/0000-0003-3025-9040	Wellcome Trust [WT091681MA, WT106084/Z/14/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by a Wellcome Trust grant (WT091681MA) awarded to Timothy D. Griffiths. Sundeep Teki is supported by the Wellcome Trust (WT106084/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel SM, 2000, SCAND AUDIOL, V29, P131, DOI 10.1080/010503900750042699; ABEL SM, 1990, SCAND AUDIOL, V19, P43, DOI 10.3109/01050399009070751; Akram S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114427; Bregman A.S., 1990, AUDITORY SCENE ANAL; Brown HR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100662; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Crump MJC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057410; DUQUESNOY AJ, 1983, J ACOUST SOC AM, V74, P739, DOI 10.1121/1.389859; Dykstra AR, 2013, ELIFE, V2, DOI 10.7554/eLife.01136; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Fishman Y. I., 2010, OXFORD HDB AUDITORY; Fishman YI, 2004, J ACOUST SOC AM, V116, P1656, DOI 10.1121/1.1778903; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gutschalk A, 2014, HEARING RES, V307, P98, DOI 10.1016/j.heares.2013.08.003; Gutschalk A, 2008, PLOS BIOL, V6, P1156, DOI 10.1371/journal.pbio.0060138; HUMES LE, 1994, J SPEECH HEAR RES, V37, P465, DOI 10.1044/jshr.3702.465; Khatib F, 2011, P NATL ACAD SCI USA, V108, P18949, DOI 10.1073/pnas.1115898108; KIDD G, 1995, J ACOUST SOC AM, V97, P3782, DOI 10.1121/1.413107; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Krishnan L, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003985; LYNCH MP, 1994, J GERONTOL, V49, pP165, DOI 10.1093/geronj/49.4.P165; McDermott JH, 2009, CURR BIOL, V19, pR1024, DOI 10.1016/j.cub.2009.09.005; Mcnab F, 2014, J EXP PSYCHOL HUMAN, V40, P960, DOI 10.1037/a0036013; Micheyl C, 2013, J EXP PSYCHOL HUMAN, V39, P1568, DOI 10.1037/a0032241; Micheyl C, 2013, J ACOUST SOC AM, V133, pEL188, DOI 10.1121/1.4789866; Morrell CH, 1996, J ACOUST SOC AM, V100, P1949, DOI 10.1121/1.417906; Nelken I, 2014, J NEUROSCI, V34, P15135, DOI 10.1523/JNEUROSCI.2989-14.2014; Perez P, 2011, AGING DIS, V2, P231; Rimmele J, 2012, HEARING RES, V289, P98, DOI 10.1016/j.heares.2012.04.006; Rimmele JM, 2015, INT J PSYCHOPHYSIOL, V95, P175, DOI 10.1016/j.ijpsycho.2014.06.010; Rutledge RB, 2014, P NATL ACAD SCI USA, V111, P12252, DOI 10.1073/pnas.1407535111; Shamma SA, 2011, TRENDS NEUROSCI, V34, P114, DOI 10.1016/j.tins.2010.11.002; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Teki S, 2013, ELIFE, V2, DOI 10.7554/eLife.00699; Teki S, 2011, J NEUROSCI, V31, P164, DOI 10.1523/JNEUROSCI.3788-10.2011; TRAINOR LJ, 1989, PERCEPT PSYCHOPHYS, V45, P417, DOI 10.3758/BF03210715; van Noorden LPAS, 1975, TEMPORAL COHERENCE P; von Ahn L, 2008, SCIENCE, V321, P1465, DOI 10.1126/science.1160379; Zekveld AA, 2011, EAR HEARING, V32, P498, DOI 10.1097/AUD.0b013e31820512bb	39	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153916	10.1371/journal.pone.0153916	http://dx.doi.org/10.1371/journal.pone.0153916			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096165	Green Published, gold			2022-12-27	WOS:000374543600070
J	Tourret, J; Willing, BP; Croxen, MA; Dufour, N; Dion, S; Wachtel, S; Denamur, E; Finlay, BB				Tourret, Jerome; Willing, Benjamin P.; Croxen, Matthew A.; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick; Finlay, B. Brett			Small Intestine Early Innate Immunity Response during Intestinal Colonization by Escherichia coli Depends on Its Extra-Intestinal Virulence Status	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; PATHOGENICITY ISLAND; CLONAL GROUP; EPITHELIAL-CELLS; GENOMIC ISLANDS; P-FIMBRIAE; STRAINS; MICROBIOTA; HOST; HEMOLYSIN	Uropathogenic Escherichia coli (UPEC) strains live as commensals in the digestive tract of the host, but they can also initiate urinary tract infections. The aim of this work was to determine how a host detects the presence of a new UPEC strain in the digestive tract. Mice were orally challenged with UPEC strains 536 and CFT073, non-pathogenic strain K12 MG1655, and.PAI-536, an isogenic mutant of strain 536 lacking all 7 pathogenicity islands whose virulence is drastically attenuated. Intestinal colonization was measured, and cytokine expression was determined in various organs recovered from mice after oral challenge. UPEC strain 536 efficiently colonized the mouse digestive tract, and prior Enterobacteriaceae colonization was found to impact strain 536 colonization efficiency. An innate immune response, detected as the production of TNF alpha, IL-6 and IL-10 cytokines, was activated in the ileum 48 hours after oral challenge with strain 536, and returned to baseline within 8 days, without a drop in fecal pathogen load. Although inflammation was detected in the ileum, histology was normal at the time of cytokine peak. Comparison of cytokine secretion 48h after oral gavage with E. coli strain 536, CFT073, MG1655 or.PAI-536 showed that inflammation was more pronounced with UPECs than with non-pathogenic or attenuated strains. Pathogenicity islands also seemed to be involved in host detection, as IL-6 intestinal secretion was increased after administration of E. coli strain 536, but not after administration of Delta PAI-536. In conclusion, UPEC colonization of the mouse digestive tract activates acute phase inflammatory cytokine secretion but does not trigger any pathological changes, illustrating the opportunistic nature of UPECs. This digestive tract colonization model will be useful for studying the factors controlling the switch from commensalism to pathogenicity.	[Tourret, Jerome; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick] INSERM, UMR 1137, IAME, Paris, France; [Tourret, Jerome; Dufour, Nicolas; Dion, Sara; Wachtel, Sarah; Denamur, Erick] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Tourret, Jerome] Grp Hosp Univ Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France; [Tourret, Jerome] Univ Paris 06, Sorbonne Univ, Paris, France; [Willing, Benjamin P.; Croxen, Matthew A.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Willing, Benjamin P.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Croxen, Matthew A.] British Columbia Ctr Dis Control, Publ Hlth Lab, Vancouver, BC, Canada; [Wachtel, Sarah] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Lurie Childrens Hosp,Chicago Res Ctr, Chicago, IL 60611 USA; [Dufour, Nicolas] Inst Pasteur, Mol Biol Gene Extremophiles, Dept Microbiol, Paris, France; [Dufour, Nicolas] Hop Louis Mourier, AP HP, Serv Reanimat Medicochirurg, F-92701 Colombes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of British Columbia; University of Alberta; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite	Tourret, J (corresponding author), INSERM, UMR 1137, IAME, Paris, France.; Tourret, J (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Tourret, J (corresponding author), Grp Hosp Univ Pitie Salpetriere Charles Foix, AP HP, Dept Urol Nephrol & Transplantat, Paris, France.; Tourret, J (corresponding author), Univ Paris 06, Sorbonne Univ, Paris, France.	jerome.tourret@psl.aphp.fr	DUFOUR, Nicolas N/U-4634-2018; Willing, Benjamin/AAA-9650-2019	DUFOUR, Nicolas N/0000-0002-1359-6689; Croxen, Matthew/0000-0002-9564-7952; Tourret, Jerome/0000-0003-2998-6531	"Fondation Recherche Medicale"; "Societe de Nephrologie"; Novartis pharma(R); Canada Research Chairs program; Canadian Institutes of Health Research (CIHR)	"Fondation Recherche Medicale"; "Societe de Nephrologie"; Novartis pharma(R); Canada Research Chairs program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	J.T. received funding from "Fondation Recherche Medicale", "Societe de Nephrologie", and Novartis pharma (R). B.P.W. is supported by the Canada Research Chairs program. Work in BBF's laboratory is funded by the Canadian Institutes of Health Research (CIHR). BBF is the University of British Columbia Peter Wall Distinguished Professor. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERBERTH I, 1995, MICROB PATHOGENESIS, V18, P373, DOI 10.1006/mpat.1995.0034; BERGER H, 1982, J BACTERIOL, V152, P1241; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chiurchiu C, 2003, AM J KIDNEY DIS, V41, DOI 10.1053/ajkd.2003.50022; Clermont O, 2014, J MICROBIOL METH, V101, P24, DOI 10.1016/j.mimet.2014.03.008; Clermont O, 2013, ENV MICROBIOL REP, V5, P58, DOI 10.1111/1758-2229.12019; Croxen MA, 2013, CLIN MICROBIOL REV, V26, P822, DOI 10.1128/CMR.00022-13; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Foxman B, 2010, NAT REV UROL, V7, P653, DOI 10.1038/nrurol.2010.190; Gadea MD, 2012, REV ARGENT MICROBIOL, V44, P94; Giamarellos-Bourboulis EJ, 2010, INT J ANTIMICROB AG, V36, pS2, DOI 10.1016/j.ijantimicag.2010.11.003; GRUNEBERG RN, 1969, LANCET, V2, P766; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Herias MV, 1997, INFECT IMMUN, V65, P531; HERIAS MV, 1995, INFECT IMMUN, V63, P4781; Johnson JR, 2011, EMERG INFECT DIS, V17, P2001, DOI 10.3201/eid1711.110488; Johnson JR, 2002, LANCET, V359, P2249, DOI 10.1016/S0140-6736(02)09264-4; Kaiser P, 2012, IMMUNOL REV, V245, P56, DOI 10.1111/j.1600-065X.2011.01070.x; KALLENIUS G, 1981, LANCET, V2, P1369; Kao JS, 1997, INFECT IMMUN, V65, P2812, DOI 10.1128/IAI.65.7.2812-2820.1997; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Le Gall T, 2007, MOL BIOL EVOL, V24, P2373, DOI 10.1093/molbev/msm172; Lefort A, 2011, J CLIN MICROBIOL, V49, P777, DOI 10.1128/JCM.01902-10; Lloyd AL, 2007, J BACTERIOL, V189, P3532, DOI 10.1128/JB.01744-06; Lloyd AL, 2009, J BACTERIOL, V191, P3469, DOI 10.1128/JB.01717-08; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016/S0140-6736(98)01267-7; MOBLEY HLT, 1990, INFECT IMMUN, V58, P1281, DOI 10.1128/IAI.58.5.1281-1289.1990; Moreno E, 2008, J CLIN MICROBIOL, V46, P2529, DOI 10.1128/JCM.00813-08; Myhal M L, 1982, Eur J Clin Microbiol, V1, P186, DOI 10.1007/BF02019621; Nowrouzian F, 2001, EPIDEMIOL INFECT, V126, P19, DOI 10.1017/S095026880100512X; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Payros D, 2014, GUT MICROBES, V5, P313, DOI 10.4161/gmic.28932; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; Rasko DA, 2001, J INFECT DIS, V184, P1041, DOI 10.1086/323602; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Sansonetti PJ, 2011, MUCOSAL IMMUNOL, V4, P8, DOI 10.1038/mi.2010.77; Sansonetti PJ, 2009, CELL, V138, P416, DOI 10.1016/j.cell.2009.07.024; Schneider G, 2004, INFECT IMMUN, V72, P5993, DOI 10.1128/IAI.72.10.5993-6001.2004; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Skjot-Rasmussen L, 2013, CLIN MICROBIOL INFEC, V19, P656, DOI 10.1111/j.1469-0691.2012.03961.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tenaillon O, 2010, NAT REV MICROBIOL, V8, P207, DOI 10.1038/nrmicro2298; Tourret J, 2010, INT J MED MICROBIOL, V300, P435, DOI 10.1016/j.ijmm.2010.04.013; van der Woude MW, 2008, ANNU REV MICROBIOL, V62, P153, DOI 10.1146/annurev.micro.62.081307.162938; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135	51	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153034	10.1371/journal.pone.0153034	http://dx.doi.org/10.1371/journal.pone.0153034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096607	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600024
J	Goldstein, M; Uchida, S				Goldstein, Markus; Uchida, Seiichi			A Comparative Evaluation of Unsupervised Anomaly Detection Algorithms for Multivariate Data	PLOS ONE			English	Article							NOVELTY DETECTION	Anomaly detection is the process of identifying unexpected items or events in datasets, which differ from the norm. In contrast to standard classification tasks, anomaly detection is often applied on unlabeled data, taking only the internal structure of the dataset into account. This challenge is known as unsupervised anomaly detection and is addressed in many practical applications, for example in network intrusion detection, fraud detection as well as in the life science and medical domain. Dozens of algorithms have been proposed in this area, but unfortunately the research community still lacks a comparative universal evaluation as well as common publicly available datasets. These shortcomings are addressed in this study, where 19 different unsupervised anomaly detection algorithms are evaluated on 10 different datasets from multiple application domains. By publishing the source code and the datasets, this paper aims to be a new well-funded basis for unsupervised anomaly detection research. Additionally, this evaluation reveals the strengths and weaknesses of the different approaches for the first time. Besides the anomaly detection performance, computational effort, the impact of parameter settings as well as the global/local anomaly detection behavior is outlined. As a conclusion, we give an advise on algorithm selection for typical real-world tasks.	[Goldstein, Markus] Kyushu Univ, Ctr Coevolut Social Syst Innovat, Fukuoka 812, Japan; [Uchida, Seiichi] Kyushu Univ, Dept Adv Informat Technol, Fukuoka 812, Japan	Kyushu University; Kyushu University	Goldstein, M (corresponding author), Kyushu Univ, Ctr Coevolut Social Syst Innovat, Fukuoka 812, Japan.	goldstein@ait.kyushu-u.ac.jp	Goldstein, Markus/ABH-3405-2021	Goldstein, Markus/0000-0003-2631-6882; Uchida, Seiichi/0000-0001-8592-7566	Japan Science and Technology Agency (JST); Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program); Japan Science and Technology Agency (JST) through "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)"	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program); Japan Science and Technology Agency (JST) through "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)"	The authors are thankful for the support of the Japan Science and Technology Agency (JST) and its "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)," http://www.jst.go.jp/tt/EN/platform/coi.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research is supported by The Japan Science and Technology Agency (JST) through its "Center of Innovation Science and Technology based Radical Innovation and Entrepreneurship Program (COI Program)".	Abe N., 2006, P 12 ACM SIGKDD INT, P504, DOI [10.1145/1150402.1150459, DOI 10.1145/1150402.1150459]; Aggarwal, 2015, OUTLIER ANAL, DOI [DOI 10.1007/978-1-4614-6396-2, 10.1007/978-1-4614-6396-2]; Akoglu L, 2015, DATA MIN KNOWL DISC, V29, P626, DOI 10.1007/s10618-014-0365-y; Amer M., 2013, P ACM SIGKDD WORKSHO, P8, DOI [10.1145/2500853.2500857, DOI 10.1145/2500853.2500857]; Amer M., 2012, PROC 3 RAPIDMINER CO, P1; Angiulli F, 2002, FAST OUTLIER DETECTI, V2431, P43; Auslander B, 2011, P SPIE; Bache Kevin, 2013, UCI MACHINE LEARNING; Basharat A, 2008, PROC CVPR IEEE, P1301; Bolton RJ, 2002, STAT SCI, V17, P235; Breunig M. M., 2000, SIGMOD Record, V29, P93, DOI 10.1145/335191.335388; Carrasquilla U, 2011, CMG J; Chhabra P, 2008, INFOCOM 2008 27 C CO; Dehak N, 2011, IEEE T AUDIO SPEECH, V19, P788, DOI 10.1109/TASL.2010.2064307; Ding XM, 2014, NEUROCOMPUTING, V135, P313, DOI 10.1016/j.neucom.2013.12.002; Eskin E., 2002, APPL DATA MINING COM, P77, DOI DOI 10.1007/978-1-4615-0953-0_4; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; Garcia-Teodoro P, 2009, COMPUT SECUR, V28, P18, DOI 10.1016/j.cose.2008.08.003; Gebhardt J, 2013, PROC INT CONF DOC, P479, DOI 10.1109/ICDAR.2013.102; Goldstein Markus, 2013, Proceedings of the 2nd International Conference on Pattern Recognition Applications and Methods. ICPRAM 2013, P530; Goldstein M., 2012, KI 2012 POSTER, P59, DOI DOI 10.1007/978-3-642-21329-8_4; Goldstein M, 2013, ANOMALY DETECTION DA, P367; Goldstein M., 2014, 10 JOINT WORKSH MACH; Goldstein M, 2014, THESIS U KAISERSLAUT; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hawkins S., 2000, P 4 INT C DAT WAR KN, P170; He ZY, 2003, PATTERN RECOGN LETT, V24, P1641, DOI 10.1016/S0167-8655(03)00003-5; Hodge VJ, 2004, ARTIF INTELL REV, V22, P85, DOI 10.1023/B:AIRE.0000045502.10941.a9; Jin W, 2006, LECT NOTES ARTIF INT, V3918, P577; Kim Y, 2004, IEEE INFOCOM SER, P2594; Kriegel H.P., 2009, P 18 ACM C INF KNOWL, P1649, DOI [DOI 10.1145/1645953.1646195, 10.1145/1645953.1646195]; Kwitt R., 2007, 2007 INT MULTICONFER, P37, DOI DOI 10.1109/ICCGI.2007.62; Lazarevic A, 2003, SIAM PROC S, P25; Leung K., 2005, P 28 AUSTR C COMP SC, V38, P333; Lin J, 2005, 18 IEEE S COMP BAS M, P23; Lindsay, 1995, NSF CBMS REGIONAL C, V51; Mahalanobis P.C., 1936, P NATL I SCI INDIA, V2, P49, DOI DOI 10.1145/1390156.1390302; Mangasarian OL, 1990, SIAM NEWS, V23, P1; Markou M, 2003, SIGNAL PROCESS, V83, P2481, DOI 10.1016/j.sigpro.2003.07.018; Martin RA, 2007, P JOINT ARM NAV NASA; Mehrotra K., 1997, ELEMENTS ARTIFICIAL; MicenkovuY B., 2014, P ACM SIGKDD 2014 WO, P51; Moya MM, 1996, NEURAL NETWORKS, V9, P463, DOI 10.1016/0893-6080(95)00120-4; Papadimitriou S, 2003, PROC INT CONF DATA, P315, DOI 10.1109/ICDE.2003.1260802; Papadimitriou S, 2002, 559 CMU COMP SCI DEP; Pawling Alec, 2007, Computational & Mathematical Organization Theory, V13, P407, DOI 10.1007/s10588-007-9018-7; Phua C., 2005, COMPREHENSIVE SURVEY; Pimentel MAF, 2014, SIGNAL PROCESS, V99, P215, DOI 10.1016/j.sigpro.2013.12.026; Portnoy L., 2001, P ACM CSS WORKSH DAT, P5; Prasad NR, 2009, CMC-COMPUT MATER CON, V14, P1, DOI 10.1145/1541880.1541882; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ramaswamy S, 2000, SIGMOD REC, V29, P427, DOI 10.1145/335191.335437; Reif M, 2008, 19 INT C PATT REC IC; ROSENBLATT M, 1956, ANN MATH STAT, V27, P832, DOI 10.1214/aoms/1177728190; Rousseeuw PJ, 1999, TECHNOMETRICS, V41, P212, DOI 10.2307/1270566; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Schiffmann W, 1992, SYNTHESIS PERFORMANC; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Scholkopf B., 2002, LEARNING KERNELS; Scholz M., 2006, P 12 ACM SIGKDD INT, P935, DOI [10.1145/1150402.1150531, DOI 10.1145/1150402.1150531]; Schubert E., 2012, SDM, P1047, DOI DOI 10.1137/1.9781611972825.90; Shyu ML, 2003, 2003 INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO, VOL III, PROCEEDINGS, P353; Sigholm J, 2012, IEEE MILIT COMMUN C; Tang J., 2002, PACIFIC ASIA C KNOWL, V2336, P535, DOI DOI 10.1007/3-540-47887-6_53; Thiprungsri S., 2011, INT J DIGITAL ACCOUN, V11, DOI [10.4192/1577-8517-v11_4, DOI 10.4192/1577-8517-V11_4]; Vert R, 2006, J MACH LEARN RES, V7, P817; Yeung DY, 2003, PATTERN RECOGN, V36, P229, DOI 10.1016/S0031-3203(02)00026-2; Zimek A., 2014, ACM SIGKDD EXPLORATI, V15, P11, DOI [10.1145/2594473.2594476, DOI 10.1145/2594473.2594476]	70	372	381	10	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152173	10.1371/journal.pone.0152173	http://dx.doi.org/10.1371/journal.pone.0152173			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093601	Green Published, gold			2022-12-27	WOS:000374541200004
J	Hodge, RJ; Paulik, MA; Walker, A; Boucheron, JA; McMullen, SL; Gillmor, DS; Nunez, DJ				Hodge, Rebecca J.; Paulik, Mark A.; Walker, Ann; Boucheron, Joyce A.; McMullen, Susan L.; Gillmor, Dawn S.; Nunez, Derek J.			Weight and Glucose Reduction Observed with a Combination of Nutritional Agents in Rodent Models Does Not Translate to Humans in a Randomized Clinical Trial with Healthy Volunteers and Subjects with Type 2 Diabetes	PLOS ONE			English	Article							GUT MICROBIOTA; INSULIN-RESISTANCE; OLIGOFRUCTOSE; OBESITY; MICE; DIET; FAT; INFLAMMATION; MANAGEMENT; INGESTION	Background Nutritional agents have modest efficacy in reducing weight and blood glucose in animal models and humans, but combinations are less well characterized. GSK2890457 (GSK457) is a combination of 4 nutritional agents, discovered by the systematic assessment of 16 potential components using the diet-induced obese mouse model, which was subsequently evaluated in a human study. Nonclinical Results In the diet-induced obese mouse model, GSK457 (15% w/w in chow) given with a long-acting glucagon-like peptide -1 receptor agonist, exendin-4 AlbudAb, produced weight loss of 30.8% after 28 days of treatment. In db/db mice, a model of diabetes, GSK457 (10% w/w) combined with the exendin-4 AlbudAb reduced glucose by 217 mg/dL and HbA1c by 1.2% after 14 days. Clinical Results GSK457 was evaluated in a 6 week randomized, placebo-controlled study that enrolled healthy subjects and subjects with type 2 diabetes to investigate changes in weight and glucose. In healthy subjects, GSK457 well tolerated when titrated up to 40 g/day, and it reduced systemic exposure of metformin by similar to 30%. In subjects with diabetes taking liraglutide 1.8 mg/day, GSK457 did not reduce weight, but it slightly decreased mean glucose by 0.356 mmol/L (95% CI: -1.409, 0.698) and HbAlc by 0.065% (95% CI: -0.495, 0.365), compared to placebo. In subjects with diabetes taking metformin, weight increased in the GSK457-treated group [adjusted mean % increase from baseline: 1.26% (95% CI: -0.24, 2.75)], and mean glucose and HbA1c were decreased slightly compared to placebo [adjusted mean glucose change from baseline: -1.22 mmol/L (95% CI: -2.45, 0.01); adjusted mean HbA1c change from baseline: -0.219% (95% CI: -0.910, 0.472)]. Conclusions Our data demonstrate remarkable effects of GSK457 in rodent models of obesity and diabetes, but a marked lack of translation to humans. Caution should be exercised with nutritional agents when predicting human efficacy from rodent models of obesity and diabetes.	[Hodge, Rebecca J.; Nunez, Derek J.] GlaxoSmithKline, Metab Pathways Cardiovasc Unit, Discovery Med, Res Triangle Pk, NC USA; [Paulik, Mark A.; Boucheron, Joyce A.] GlaxoSmithKline, Metab Pathways Cardiovasc Unit, Biol, Res Triangle Pk, NC USA; [Walker, Ann] GlaxoSmithKline, Quantitat Sci Clin Stat, R&D Projects Clin Platforms & Sci, Res Triangle Pk, NC USA; [McMullen, Susan L.; Gillmor, Dawn S.] GlaxoSmithKline, Clin Pharmacol Sci & Study Operat, Res Triangle Pk, NC USA; [Paulik, Mark A.] Intarcia Therapeut, Res Triangle Pk, NC USA; [McMullen, Susan L.] PAREXEL Int, Durham, NC USA; [Gillmor, Dawn S.] PPD Inc, Morrisville, NC USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Parexel International	Hodge, RJ (corresponding author), GlaxoSmithKline, Metab Pathways Cardiovasc Unit, Discovery Med, Res Triangle Pk, NC USA.	rhodge.dvm@gmail.com			GlaxoSmithKline plc	GlaxoSmithKline plc(GlaxoSmithKline)	The funder (GlaxoSmithKline plc) provided support in the form of salaries for authors RJH, MAP, AW, JAB, SLM, DSG, and DJN and provided general feedback on study design. The authors were solely responsible for data collection and analysis and preparation of the manuscript. It is current GlaxoSmithKline policy that all clinical studies be published. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1996, ICH HARM TRIP GUID G; [Anonymous], 1998, NIH PUBLICATION, P12; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008; Carr RD, 2008, AM J PHYSIOL-ENDOC M, V295, pE779, DOI 10.1152/ajpendo.90233.2008; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; DILORENZO C, 1988, GASTROENTEROLOGY, V95, P1211, DOI 10.1016/0016-5085(88)90352-6; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2; Godlewski G, 2009, PROSTAG OTH LIPID M, V89, P105, DOI 10.1016/j.prostaglandins.2009.07.001; Guo HH, 2012, J NUTR BIOCHEM, V23, P349, DOI 10.1016/j.jnutbio.2010.12.013; HOWARD MD, 1995, J NUTR, V125, P2604; Inzucchi SE, 2015, DIABETES CARE, V38, P140, DOI 10.2337/dc14-2441; Janssen S, 2013, TRENDS ENDOCRIN MET, V24, P92, DOI 10.1016/j.tem.2012.11.006; Karra E, 2010, MOL CELL ENDOCRINOL, V316, P120, DOI 10.1016/j.mce.2009.06.010; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Moran TH, 2009, INT J OBESITY, V33, pS7, DOI 10.1038/ijo.2009.9; Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, pE679, DOI 10.1152/ajpendo.00377.2013; Napolitano A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100778; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Puddu Alessandra, 2014, Mediators Inflamm, V2014, P162021, DOI 10.1155/2014/162021; Rie S, 2007, BIOCHEM PHARMACOL, V74, P1619, DOI 10.1016/j.bcp.2007.08.008; SCHWARTZ SE, 1988, AM J CLIN NUTR, V48, P1413, DOI 10.1093/ajcn/48.6.1413; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; Teres S, 2008, P NATL ACAD SCI USA, V105, P13811, DOI 10.1073/pnas.0807500105; Tharakan G, 2011, TRENDS PHARMACOL SCI, V32, P8, DOI 10.1016/j.tips.2010.10.003; Tsuda T, 2008, J AGR FOOD CHEM, V56, P642, DOI 10.1021/jf073113b; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhang D, 2014, DRUG DES DEV THER, V8, P1013, DOI 10.2147/DDDT.S53892	36	6	6	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153151	10.1371/journal.pone.0153151	http://dx.doi.org/10.1371/journal.pone.0153151			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093610	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200014
J	Alsalman, O; Ost, J; Vanspauwen, R; Blaivie, C; De Ridder, D; Vanneste, S				Alsalman, Ola; Ost, Jan; Vanspauwen, Robby; Blaivie, Catherine; De Ridder, Dirk; Vanneste, Sven			The Neural Correlates of Chronic Symptoms of Vertigo Proneness in Humans	PLOS ONE			English	Article							PARIETOINSULAR VESTIBULAR CORTEX; POSITRON-EMISSION-TOMOGRAPHY; FRONTAL EYE FIELD; FUNCTIONAL CONNECTIVITY; ALPHA-OSCILLATIONS; ORBITOFRONTAL CORTEX; CALORIC STIMULATION; GAMMA OSCILLATIONS; ANALOG SCALE; BRAIN-STEM	Vestibular signals are of significant importance for variable functions including gaze stabilization, spatial perception, navigation, cognition, and bodily self-consciousness. The vestibular network governs functions that might be impaired in patients affected with vestibular dysfunction. It is currently unclear how different brain regions/networks process vestibular information and integrate the information into a unified spatial percept related to somatosensory awareness and whether people with recurrent balance complaints have a neural signature as a trait affecting their development of chronic symptoms of vertigo. Pivotal evidence points to a vestibular-related brain network in humans that is widely distributed in nature. By using resting state source localized electroencephalography in non-vertiginous state, electrophysiological changes in activity and functional connectivity of 23 patients with balance complaints where chronic symptoms of vertigo and dizziness are among the most common reported complaints are analyzed and compared to healthy subjects. The analyses showed increased alpha2 activity within the posterior cingulate cortex and the precuneues/ cuneus and reduced beta3 and gamma activity within the pregenual and subgenual anterior cingulate cortex for the subjects with balance complaints. These electrophysiological variations were correlated with reported chronic symptoms of vertigo intensity. A region of interest analysis found reduced functional connectivity for gamma activity within the vestibular cortex, precuneus, frontal eye field, intra-parietal sulcus, orbitofrontal cortex, and the dorsal anterior cingulate cortex. In addition, there was a positive correlation between chronic symptoms of vertigo intensity and increased alpha-gamma nesting in the left frontal eye field. When compared to healthy subjects, there is evidence of electrophysiological changes in the brain of patients with balance complaints even outside chronic symptoms of vertigo episodes. This suggests that these patients have a neural signature or trait that makes them prone to developing chronic balance problems.	[Alsalman, Ola; Vanneste, Sven] Univ Texas Dallas, Lab Clin & Integrat Neurosci, Sch Behav & Brain Sci, Dallas, TX 75230 USA; [Ost, Jan] Sint Augustinus Hosp Antwerp, BRAI2N, Antwerp, Belgium; [Vanspauwen, Robby; Blaivie, Catherine] Sint Augustinus Hosp Antwerp, European Inst ORL HNS, ENT Dept, Antwerp, Belgium; [De Ridder, Dirk] Univ Otago, Dept Surg Sci, Sect Neurosurg, Dunedin Sch Med, Dunedin, New Zealand	University of Texas System; University of Texas Dallas; University of Otago	Vanneste, S (corresponding author), Univ Texas Dallas, Lab Clin & Integrat Neurosci, Sch Behav & Brain Sci, Dallas, TX 75230 USA.	sven.vanneste@utdallas.edu		Vanspauwen, Robby/0000-0001-8044-9358; Vanneste, Sven/0000-0003-1513-5752				Adamchic I, 2012, AM J AUDIOL, V21, P215, DOI 10.1044/1059-0889(2012/12-0010); Agrawal Y, 2009, ARCH INTERN MED, V169, P938, DOI 10.1001/archinternmed.2009.66; Angelaki DE, 2008, ANNU REV NEUROSCI, V31, P125, DOI 10.1146/annurev.neuro.31.060407.125555; Arnal LH, 2012, TRENDS COGN SCI, V16, P390, DOI 10.1016/j.tics.2012.05.003; Augustine J R, 1985, Neurol Res, V7, P2; Baier B, 2013, BRAIN BEHAV, V3, P519, DOI 10.1002/brb3.155; Balabann CD, 2011, EXPERT REV NEUROTHER, V11, P379, DOI [10.1586/ern.11.19, 10.1586/ERN.11.19]; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; Berlin HA, 2004, BRAIN, V127, P1108, DOI 10.1093/brain/awh135; BOTTINI G, 1994, EXP BRAIN RES, V99, P164; BRANDT T, 1994, ANN NEUROL, V36, P337, DOI 10.1002/ana.410360304; BRANDT T, 1994, ANN NEUROL, V35, P403, DOI 10.1002/ana.410350406; Brandt T, 2014, J NEUROL, V261, P229, DOI 10.1007/s00415-013-7190-x; Buckholtz JW, 2008, TRENDS NEUROSCI, V31, P120, DOI 10.1016/j.tins.2007.12.006; Buffalo EA, 2011, P NATL ACAD SCI USA, V108, P11262, DOI 10.1073/pnas.1011284108; Buttner-Ennever JA, 1999, ANN NY ACAD SCI, V871, P51, DOI 10.1111/j.1749-6632.1999.tb09175.x; BUTTNERENNEVER JA, 1992, ANN NY ACAD SCI, V656, P363, DOI 10.1111/j.1749-6632.1992.tb25222.x; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Capotosto P, 2009, J NEUROSCI, V29, P5863, DOI 10.1523/JNEUROSCI.0539-09.2009; Cohen MX, 2009, J COGNITIVE NEUROSCI, V21, P875, DOI 10.1162/jocn.2009.21062; Compston A, 2010, BRAIN, V133, P1, DOI 10.1093/brain/awp330; Congedo M, 2002, VERSION 3 O COMPUTER; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dannenbaum E, 2011, J VESTIBUL RES-EQUIL, V21, P153, DOI 10.3233/VES-2011-0412; De Ridder D, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00124; De Ridder D, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.331; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; De Ridder D, 2011, P NATL ACAD SCI USA, V108, P8075, DOI 10.1073/pnas.1018466108; de Waele C, 2001, EXP BRAIN RES, V141, P541, DOI 10.1007/s00221-001-0894-7; Demertzi A, 2016, BRAIN STRUCT FUNCT, V221, P2873, DOI 10.1007/s00429-015-1054-3; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Dieterich M, 2001, NEUROIMAG CLIN N AM, V11, P263; Dieterich M, 2008, BRAIN, V131, P2538, DOI 10.1093/brain/awn042; Dieterich M, 2007, CURR OPIN NEUROL, V20, P12, DOI 10.1097/WCO.0b013e328013f854; Dieterich M, 2015, ANN NY ACAD SCI, V1343, P10, DOI 10.1111/nyas.12585; Eickhoff SB, 2006, HUM BRAIN MAPP, V27, P611, DOI 10.1002/hbm.20205; Emri M, 2003, J NEUROPHYSIOL, V89, P2639, DOI 10.1152/jn.00599.2002; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Fasold O, 2002, NEUROIMAGE, V17, P1384, DOI 10.1006/nimg.2002.1241; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Fife TD, 2008, NEUROLOGY, V70, P2067, DOI 10.1212/01.wnl.0000313378.77444.ac; Fong E, 2015, ARCH PHYS MED REHAB, V96, P357, DOI 10.1016/j.apmr.2014.09.017; Foxe JJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00154; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; Gottlich M, 2014, NEUROIMAGE-CLIN, V4, P488, DOI 10.1016/j.nicl.2014.03.003; Grosbras MH, 2002, J COGNITIVE NEUROSCI, V14, P1109, DOI 10.1162/089892902320474553; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P559; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hannaford PC, 2005, FAM PRACT, V22, P227, DOI 10.1093/fampra/cmi004; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen O, 2012, TRENDS COGN SCI, V16, P200, DOI 10.1016/j.tics.2012.03.002; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Kelly SP, 2006, J NEUROPHYSIOL, V95, P3844, DOI 10.1152/jn.01234.2005; Kirsch V, 2016, BRAIN STRUCT FUNCT, V221, P1291, DOI 10.1007/s00429-014-0971-x; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klingner CM, 2014, NEUROIMAGE-CLIN, V6, P109, DOI 10.1016/j.nicl.2014.08.022; Kluge M, 2000, NEUROLOGY, V55, P1906, DOI 10.1212/WNL.55.12.1906; Kong J, 2010, PAIN, V148, P257, DOI 10.1016/j.pain.2009.11.008; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; KROENKE K, 1993, ARCH INTERN MED, V153, P2474, DOI 10.1001/archinte.153.21.2474; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Marshall TR, 2015, J NEUROSCI, V35, P1638, DOI 10.1523/JNEUROSCI.3116-14.2015; Meli A, 2006, ACTA OTO-LARYNGOL, V126, P259, DOI 10.1080/00016480500388885; Mirz F, 1999, HEARING RES, V134, P133, DOI 10.1016/S0378-5955(99)00075-1; Miyamoto T, 2007, NEUROSCI LETT, V423, P68, DOI 10.1016/j.neulet.2007.06.036; Neuhauser HK, 2008, ARCH INTERN MED, V168, P2118, DOI 10.1001/archinte.168.19.2118; Neuhauser HK, 2007, CURR OPIN NEUROL, V20, P40, DOI 10.1097/WCO.0b013e328013f432; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nunez PL, 2001, HUM BRAIN MAPP, V13, P125, DOI 10.1002/hbm.1030; Obermann M, 2015, J NEUROL, V262, P2083, DOI 10.1007/s00415-015-7803-7; Osipova D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003990; Papathanasiou ES, 2014, CLIN NEUROPHYSIOL, V125, P658, DOI 10.1016/j.clinph.2013.11.042; Pascual-Marqui R. D., 2007, ARXIV07111455; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Pascual-Marqui RD, 2007, 07103341 ARXIV; Perez N, 2001, ACTA OTO-LARYNGOL, P145; Piker EG, 2014, OTOL NEUROTOL, V35, P873, DOI 10.1097/MAO.0000000000000391; Ray S, 2015, TRENDS COGN SCI, V19, P78, DOI 10.1016/j.tics.2014.12.002; Schlindwein P, 2008, NEUROIMAGE, V39, P19, DOI 10.1016/j.neuroimage.2007.08.016; Shany-Ur T, 2014, BRAIN, V137, P2368, DOI 10.1093/brain/awu161; Stewart MG, 1999, LARYNGOSCOPE, V109, P600, DOI 10.1097/00005537-199904000-00015; Suzuki M, 2001, COGNITIVE BRAIN RES, V12, P441, DOI 10.1016/S0926-6410(01)00080-5; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Thut G, 2012, CURR BIOL, V22, pR658, DOI 10.1016/j.cub.2012.06.061; Tuunainen E, 2012, AURIS NASUS LARYNX, V39, P577, DOI 10.1016/j.anl.2011.12.004; VANDOORN P, 1982, B EUR PHYSIOPATH RES, V18, P829; Vanneste S, 2015, BRAIN CONNECT, V5, P371, DOI 10.1089/brain.2014.0255; Vanneste S, 2012, BRAIN TOPOGR, V25, P97, DOI 10.1007/s10548-011-0191-0; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2011, CLIN NEUROPHYSIOL, V122, P578, DOI 10.1016/j.clinph.2010.07.022; Vanneste S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013618; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029; Vanni S, 2001, P NATL ACAD SCI USA, V98, P2776, DOI 10.1073/pnas.041600898; VanRullen R, 2005, P NATL ACAD SCI USA, V102, P5291, DOI 10.1073/pnas.0409172102; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Voytek B, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00191; Worden MS, 2000, J NEUROSCI, V20; Wu Q, 2015, HUM BRAIN MAPP, V36, P4317, DOI 10.1002/hbm.22919; Wuyts FL, 2007, CURR OPIN NEUROL, V20, P19, DOI 10.1097/WCO.0b013e3280140808; Yamagishi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074962; Zanto TP, 2011, NAT NEUROSCI, V14, P656, DOI 10.1038/nn.2773; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	112	10	12	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152309	10.1371/journal.pone.0152309	http://dx.doi.org/10.1371/journal.pone.0152309			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089185	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000005
J	Grimes, DR; Kannan, P; McIntyre, A; Kavanagh, A; Siddiky, A; Wigfield, S; Harris, A; Partridge, M				Grimes, David Robert; Kannan, Pavitra; McIntyre, Alan; Kavanagh, Anthony; Siddiky, Abul; Wigfield, Simon; Harris, Adrian; Partridge, Mike			The Role of Oxygen in Avascular Tumor Growth	PLOS ONE			English	Article							MATHEMATICAL-MODEL; SPHEROIDS; CELLS; RADIOSENSITIZATION; GEMCITABINE; DELIVERY; CULTURE	We oxygen status of a tumor has significant clinical implications for treatment prognosis, with well-oxygenated subvolumes responding markedly better to radiotherapy than poorly supplied regions. Oxygen is essential for tumor growth, yet estimation of local oxygen distribution can be difficult to ascertain in situ, due to chaotic patterns of vasculature. It is possible to avoid this confounding influence by using avascular tumor models, such as tumor spheroids, a much better approximation of realistic tumor dynamics than monolayers, where oxygen supply can be described by diffusion alone. Similar to in situ tumours, spheroids exhibit an approximately sigmoidal growth curve, often approximated and fitted by logistic and Gompertzian sigmoid functions. These describe the basic rate of growth well, but do not offer an explicitly mechanistic explanation. This work examines the oxygen dynamics of spheroids and demonstrates that this growth can be derived mechanistically with cellular doubling time and oxygen consumption rate (OCR) being key parameters. The model is fitted to growth curves for a range of cell lines and derived values of OCR are validated using clinical measurement. Finally, we illustrate how changes in OCR due to gemcitabine treatment can be directly inferred using this model.	[Grimes, David Robert; Kannan, Pavitra; Siddiky, Abul; Partridge, Mike] Univ Oxford, Gray Labs, Canc Res UK MRC Oxford Inst Radiat Oncol, Old Rd Campus, Oxford OX3 7DQ, England; [McIntyre, Alan; Wigfield, Simon; Harris, Adrian] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Headley Way, Oxford OX3 9DS, England; [Kavanagh, Anthony] Univ Oxford, Dept Oncol, Adv Technol Dev Grp, Old Rd Campus Res Bldg, Oxford OX3 7DQ, England	University of Oxford; University of Oxford; University of Oxford	Grimes, DR (corresponding author), Univ Oxford, Gray Labs, Canc Res UK MRC Oxford Inst Radiat Oncol, Old Rd Campus, Oxford OX3 7DQ, England.	davidrobert.grimes@oncology.ox.ac.uk	Grimes, David Robert/J-7384-2013; Harris, Adrian L/ABA-3343-2020; Kannan, Pavitra/I-2796-2019	Grimes, David Robert/0000-0003-3140-3278; Harris, Adrian L/0000-0003-1376-8409; Kannan, Pavitra/0000-0002-9170-6062; McIntyre, Alan/0000-0002-4791-7292	Cancer Research UK [C5255/A15935, C53469/A19834]; Cancer Research UK [16049, 19834, 18974, 11359, 16466] Funding Source: researchfish; Medical Research Council [G0300648] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10163] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The authors gratefully acknowledge funding from Cancer Research UK, grant references C5255/A15935 and C53469/A19834.	CONGER AD, 1983, CANCER RES, V43, P556; Dubessy C, 2000, CRIT REV ONCOL HEMAT, V36, P179, DOI 10.1016/S1040-8428(00)00085-8; Dufau I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-15; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; FELLER W., 1940, ACTA BIOTHEORETICA, V5, P51, DOI 10.1007/BF01602862; FREYER JP, 1988, CANCER RES, V48, P2432; FUKAMACHI H, 1987, J CELL SCI, V87, P615; Gerlee P., 2013, CANC RES; Grimes DR, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0070; Grimes DR, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140080; Grimes DR, 2015, BIOMED PHYS ENG EXPR, V1, DOI 10.1088/2057-1976/1/4/045209; Grimes DR, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1124; Gyllenberg M, 1989, RES REPORTS HELSINKI; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Ivascu A, 2006, J BIOMOL SCREEN, V11, P922, DOI 10.1177/1087057106292763; Jones AF, 2000, J MATH BIOL, V40, P473, DOI 10.1007/s002850000033; Kal HB, 2006, ANTICANCER RES, V26, P139; Kelly CJ, 2012, NUCL MED BIOL, V39, P986, DOI 10.1016/j.nucmedbio.2012.04.006; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Kim TH, 2010, BIOMATERIALS, V31, P7386, DOI 10.1016/j.biomaterials.2010.06.004; Kunz-Schughart L, 2000, AM J PHYSIOL-CELL PH, V278, pC765, DOI 10.1152/ajpcell.2000.278.4.C765; Lawrence TS, 1999, ONCOLOGY-NY, V13, P55; Madsen SJ, 2006, LASER SURG MED, V38, P555, DOI 10.1002/lsm.20350; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; MARUSIC M, 1994, CELL PROLIFERAT, V27, P73, DOI 10.1111/j.1365-2184.1994.tb01407.x; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Park K, 2008, LAB CHIP, V8, P1034, DOI 10.1039/b803601b; Roose T, 2007, SIAM REV, V49, P179, DOI 10.1137/S0036144504446291; Santini MT IP, MULTICELLULAR TUMOUR; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shewach DS, 1996, INVEST NEW DRUG, V14, P257, DOI 10.1007/BF00194528; Steel GG, 1977, GROWTH KINETICS TUMO; SUTHERLAND RM, 1971, JNCI-J NATL CANCER I, V46, P113; SWAN GW, 1990, MATH BIOSCI, V101, P237, DOI 10.1016/0025-5564(90)90021-P; TEICHER BA, 1987, CANCER RES, V47, P388; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Ward JP, 1997, IMA J MATH APPL MED, V14, P39; Wheldon T. E., 1988, MED SCI SERIES; WOLFF DA, 1972, J CELL BIOL, V55, P579, DOI 10.1083/jcb.55.3.579; Wrzesinski K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106973	41	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153692	10.1371/journal.pone.0153692	http://dx.doi.org/10.1371/journal.pone.0153692			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088720	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000042
J	Hu, NP; Duan, JL; Li, HH; Wang, YH; Wang, F; Chu, JJ; Sun, J; Liu, MY; Wang, C; Lu, CT; Wen, AD				Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Yanhua; Wang, Fang; Chu, Jianjie; Sun, Jin; Liu, Meiyou; Wang, Chao; Lu, Chengtao; Wen, Aidong			Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-beta 1-Induced Epithelial-to-Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TGF-BETA; OBSTRUCTIVE NEPHROPATHY; IN-VITRO; CARTHAMUS-TINCTORIUS; FIBROBLASTS; DIFFERENTIATION; MYOFIBROBLASTS; PROGRESSION; ACTIVATION	Objective Renal fibrosis is the common pathological foundation of many chronic kidney diseases (CKDs). The aim of this study was to investigate whether Hydroxysafflor yellow A (HSYA) can preserve renal function by inhibiting the progression of renal fibrosis and the potential mechanisms. Methods Renal fibrosis was induced by unilateral ureteral obstruction (UUO) performed on 7-week-old C57BL/6 mice. HSYA (10, 50 and 100 mg/kg) were intragastrically administered. Sham group and model group were administered with the same volume of vehicle. Serum and kidney samples were collected 14 days after the UUO surgery. Serum biochemical indicators were measured by automatic biochemical analyzer. Histological changes were evaluated by HE and Masson staining. In vitro, the anti-fibrotic effect of HSYA was tested on human recombinant transforming growth factor-beta 1 (TGF-beta 1) stimulated HK-2 cells. The protein levels of alpha-SMA, collagen-I and fibronectin in kidney tissue andHK-2 cells were measured by immunohistochemistry and immunofluorescence. The protein levels of apoptosis-relative and TGF-beta 1/Smad3 signaling were detected by western blot. Results HSYA slowed the development of renal fibrosis both in vivo and in vitro. In UUO rats, renal function index suggested that HSYA treatment decreased the level of serum creatinine (Scr) and blood urea nitrogen (BUN) rose by UUO (P< 0.05). HE staining and Masson staining demonstrated that kidney interstitial fibrosis, tubular atrophy, and inflammatory cell infiltration were notably attenuated in the high-dose HSYA group compared with the model group. The expressions of alpha-SMA, collagen-I and fibronectin were decreased in the UUO kidney and HK-2 cells of the HSYA-treatment group. Moreover, HSYA reduced the apoptotic rate of HK-2 cells stimulated by TGF-beta 1. Further study revealed that HSYA regulated the TGF-beta 1/Smads signaling pathway both in kidney tissue and HK-2 cells. Conclusions These results suggested that HSYA had a protective effect against fibrosis in renal cells, at least partly, through inhibiting TGF-beta 1/smad3-mediated Epithelial-mesenchymal transition signaling pathway.	[Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Fang; Chu, Jianjie; Sun, Jin; Liu, Meiyou; Wang, Chao; Lu, Chengtao; Wen, Aidong] Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China; [Hu, Naping; Duan, Jialin; Li, Huihui; Wang, Yanhua; Wang, Fang; Chu, Jianjie; Sun, Jin; Wen, Aidong] Shaanxi Univ Chinese Med, Coll Pharm, Xianyang 712046, Peoples R China	Air Force Military Medical University; Shaanxi University of Chinese Medicine	Lu, CT; Wen, AD (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Pharm, Xian 710032, Peoples R China.; Wen, AD (corresponding author), Shaanxi Univ Chinese Med, Coll Pharm, Xianyang 712046, Peoples R China.	lu-009@163.com; 18991397171@163.com	wang, yi/GVT-8516-2022; Wang, Yuan/HHC-1520-2022; Wang, Yanbo/HFZ-8018-2022; Duan, Jialin/N-1630-2017; Wen, Aidong/P-2654-2019; wang, yan/GSE-6489-2022	Wen, Aidong/0000-0002-4535-0501; 	National Natural Science Foundation of China [81373947, 81302695]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Natural Science Foundation of China, Grant Nos. 81373947 (to ADW) and 81302695 (CTL). They all played a role in the study design, data collection and analysis.	Badid C, 2002, NEPHROL DIAL TRANSPL, V17, P1993, DOI 10.1093/ndt/17.11.1993; Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Becker GJ, 2000, CURR OPIN NEPHROL HY, V9, P133, DOI 10.1097/00041552-200003000-00006; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Burns WC, 2007, CELLS TISSUES ORGANS, V185, P222, DOI 10.1159/000101323; Chen HY, 2011, DIABETES, V60, P590, DOI 10.2337/db10-0403; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docherty NG, 2006, AM J PHYSIOL-RENAL, V290, pF1202, DOI 10.1152/ajprenal.00406.2005; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2964, DOI 10.1681/ASN.2006070704; Feng ZM, 2013, J NAT PROD, V76, P270, DOI 10.1021/np300814k; Hu Q, 2009, NEPHROL DIAL TRANSPL, V24, P3033, DOI 10.1093/ndt/gfp245; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Jia LN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117757; Kohan DE, 2014, KIDNEY INT, V86, P896, DOI 10.1038/ki.2014.143; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Li R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058848; Liu GX, 2014, CLIN SCI, V127, P195, DOI 10.1042/CS20130706; Liu N, 2011, J PHARMACOL EXP THER, V338, P758, DOI 10.1124/jpet.111.181727; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Meng XM, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6100; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Shi YL, 2013, MOL MED REP, V7, P419, DOI 10.3892/mmr.2012.1213; Wang CY, 2013, PHYTOMEDICINE, V20, P592, DOI 10.1016/j.phymed.2013.02.001; Wang L, 2011, BIOL PHARM BULL, V34, P511, DOI 10.1248/bpb.34.511; Wang QL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-31; Xu WJ, 2014, J PHARMACOL EXP THER, V350, P552, DOI 10.1124/jpet.114.214205; Yang FY, 2010, J PATHOL, V221, P390, DOI 10.1002/path.2721; Yang JW, 2003, AM J PHYSIOL-RENAL, V284, pF349, DOI 10.1152/ajprenal.00154.2002; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3; Yang Y, 2008, J ETHNOPHARMACOL, V118, P264, DOI 10.1016/j.jep.2008.04.012; Yang YL, 2008, J CELL BIOCHEM, V104, P908, DOI 10.1002/jcb.21676; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1254, DOI 10.1097/01.ASN.0000064292.37793.FB; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhang YB, 2011, EUR J PHARMACOL, V660, P438, DOI 10.1016/j.ejphar.2011.04.015; Zhao TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090807; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zhou Y, 2010, J AM SOC NEPHROL, V21, P598, DOI 10.1681/ASN.2009050552	44	25	28	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153409	10.1371/journal.pone.0153409	http://dx.doi.org/10.1371/journal.pone.0153409			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088510	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000020
J	Singh, A; Ubaid-Ullah, S; Ramteke, AK; Batra, JK				Singh, Alla; Ubaid-Ullah, Shah; Ramteke, Anup K.; Batra, Janendra K.			Influence of Conformation of M. tuberculosis RNase P Protein Subunit on Its Function	PLOS ONE			English	Article							EUKARYOTIC RIBONUCLEASE-P; PRECURSOR-TRANSFER-RNA; MYCOBACTERIUM-TUBERCULOSIS; SUBSTRATE RECOGNITION; MESSENGER-RNA; COMPONENT; CLEAVAGE; ENZYME; MECHANISM; EVOLUTION	RNase P is an essential enzyme that processes 5' end leader sequence of pre-tRNA to generate mature tRNA. The bacterial RNase Ps contain a RNA subunit and one protein subunit, where the RNA subunit contains the catalytic activity. The protein subunit which lacks any catalytic activity, relaxes the ionic requirements for holoenzyme reaction and is indispensable for pre-tRNA cleavage in vivo. In the current study, we reconstituted the M. tuberculosis RNase P holoenzyme in vitro. We prepared the RNase P protein through two different strategies that differ in the conditions under which the recombinant M. tuberculosis protein, expressed in E. coli was purified. The mycobacterial RNase P protein which was purified under native conditions subsequent to isolation from inclusion bodies and in vitro renaturation, was capable of cleaving pre-tRNA specifically without the requirement of RNase P RNA. However, the preparation that was purified under denaturing conditions and refolded subsequently lacked any inherent pre-tRNA processing activity and cleaved the substrate only as a component of the holoenzyme with the RNA subunit. We found that the two RNase P protein preparations attained alternative conformations and differed with respect to their stability as well.	[Singh, Alla; Ubaid-Ullah, Shah; Ramteke, Anup K.; Batra, Janendra K.] Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India; [Ubaid-Ullah, Shah] Cent Univ Kashmir CUK, Sch Life Sci, Dept Biotechnol, Transit Campus Sonwar, Srinagar 190004, Jammu & Kashmir, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Central University of Kashmir	Batra, JK (corresponding author), Natl Inst Immunol, Immunochem Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	janendra@nii.res.in	SHAH, UBAID Ullah/C-4193-2018; Batra, Janendra/GWQ-8031-2022	SHAH, UBAID Ullah/0000-0002-6546-301X; Batra, Janendra/0000-0003-2206-3398	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was supported by grants to the National Institute of Immunology from the Department of Biotechnology, Government of India.	Behr MA, 2013, ADV EXP MED BIOL, V783, P81, DOI 10.1007/978-1-4614-6111-1_4; BERNHARDT D, 1969, J MOL BIOL, V42, P43, DOI 10.1016/0022-2836(69)90485-9; BLANK A, 1982, ANAL BIOCHEM, V120, P267, DOI 10.1016/0003-2697(82)90347-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crary SM, 1998, BIOCHEMISTRY-US, V37, P9409, DOI 10.1021/bi980613c; Demeshkina N, 2010, CURR OPIN STRUC BIOL, V20, P325, DOI 10.1016/j.sbi.2010.03.002; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; Evans D, 2006, TRENDS BIOCHEM SCI, V31, P333, DOI 10.1016/j.tibs.2006.04.007; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Goldfarb KC, 2012, GENE DEV, V26, P1005, DOI 10.1101/gad.193581.112; Gossringer Markus, 2012, Methods Mol Biol, V848, P61, DOI 10.1007/978-1-61779-545-9_5; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hall TA, 2002, RNA, V8, P296, DOI 10.1017/S1355838202028492; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Hu YM, 1998, FEMS MICROBIOL LETT, V158, P139; Kazantsev AV, 2006, NAT REV MICROBIOL, V4, P729, DOI 10.1038/nrmicro1491; Kikovska E, 2007, P NATL ACAD SCI USA, V104, P2062, DOI 10.1073/pnas.0607326104; Kirsebom LA, 2007, BIOCHIMIE, V89, P1183, DOI 10.1016/j.biochi.2007.05.009; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; Kurz JC, 2002, BIOCHEMISTRY-US, V41, P9545, DOI 10.1021/bi025553w; Kurz JC, 1998, BIOCHEMISTRY-US, V37, P2393, DOI 10.1021/bi972530m; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Maraia RJ, 2011, WIRES RNA, V2, P362, DOI 10.1002/wrna.64; Morl M, 2001, EMBO REP, V2, P17, DOI 10.1093/embo-reports/kve006; Niranjanakumari S, 1998, P NATL ACAD SCI USA, V95, P15212, DOI 10.1073/pnas.95.26.15212; O'Brien RJ, 2001, AM J RESP CRIT CARE, V163, P1055, DOI 10.1164/ajrccm.163.5.2007122; OCONNOR JP, 1991, MOL CELL BIOL, V11, P425, DOI 10.1128/MCB.11.1.425; Pannucci JA, 1999, P NATL ACAD SCI USA, V96, P7803, DOI 10.1073/pnas.96.14.7803; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rossmanith W, 1998, BIOCHEM BIOPH RES CO, V247, P234, DOI 10.1006/bbrc.1998.8766; Singh A, 2016, IUBMB LIFE, V68, P178, DOI 10.1002/iub.1472; SMITH D, 1993, BIOCHEMISTRY-US, V32, P5273, DOI 10.1021/bi00071a001; True HL, 1998, J BIOL CHEM, V273, P7193, DOI 10.1074/jbc.273.13.7193; Turrini PCG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032456; WANG MJ, 1988, EMBO J, V7, P1567, DOI 10.1002/j.1460-2075.1988.tb02981.x; Westhof E, 1996, J MOL BIOL, V258, P600, DOI 10.1006/jmbi.1996.0272; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Zhang YJJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002946	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153798	10.1371/journal.pone.0153798	http://dx.doi.org/10.1371/journal.pone.0153798			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088505	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000050
J	Assega, FM; Birindelli, JLO; Bialetzki, A; Shibatta, OA				Assega, Fernando Massayuki; Olivan Birindelli, Jose Luis; Bialetzki, Andrea; Shibatta, Oscar Akio			External Morphology of Lophiosilurus alexandri Steindachner, 1876 during Early Stages of Development, and Its Implications for the Evolution of Pseudopimelodidae (Siluriformes)	PLOS ONE			English	Article							OSTARIOPHYSI; PHYLOGENY; ONTOGENY	Pseudopimelodidae are Neotropical catfishes characterized by having slightly to strongly depressed body in fully developed specimens. The largest species of the family with 500 mm SL, Lophiosilurus alexandri, experiences impressive changes in body shape during development, becoming extremely depressed when fully developed. Accordingly, Lophiosilurus alexandri is an ideal species to observe the morphological changes during ontogeny, and to seek solid interpretations on the polarity of characters. Specimens of distinct larval periods (yolk sac, flexion and postflexion; n = 186 specimens) and juvenile stages (n = 20) were analyzed. Changes in body shape, position of mouth and eye, morphology of fins and pigmentation were observed during the development of Lophiosilurus. Larvae (5.7-11.2 mm standard length) had pigmentation concentrated on the head and parts of body, eyes small and pigmented, short barbels, and well-developed finfold. Juveniles (15.9-28.1 mm standard length) had body shape similar to adult, with head depressed and bearing bony ridges, large mouth, dorsally-oriented eyes, small barbels and well-developed shoulder bulges (cleithral width). The greatest morphological changes in the development of L. alexandri occurred during the postflexion larval stage. Relative to standard length, measurements of snout length, head depth and body depth are smaller in juveniles than in larvae, but body width is larger. New interpretations on the phylogenetic characters related to these changes are provided in view of the two alternative hypotheses of the evolution of Pseudopimelodidae.	[Assega, Fernando Massayuki; Olivan Birindelli, Jose Luis; Shibatta, Oscar Akio] Univ Estadual Londrina, Ctr Ciencias Biol, Programa Posgrad Ciencias Biol, Dept Biol Anim & Vegetal, BR-86051980 Londrina, PR, Brazil; [Bialetzki, Andrea] Univ Estadual Maringa, Dept Biol, Programa Posgrad Ecol Ambientes Aquat Continentai, Maringa, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Maringa	Shibatta, OA (corresponding author), Univ Estadual Londrina, Ctr Ciencias Biol, Programa Posgrad Ciencias Biol, Dept Biol Anim & Vegetal, BR-86051980 Londrina, PR, Brazil.	shibatta@uel.br	Birindelli, Jose LO/F-4991-2015; Shibatta, Oscar A/I-1392-2012; Birindelli, José L.O./AAS-7096-2020; Fapesp, Biota/F-8655-2017; Bialetzki, Andrea/D-5883-2013	Shibatta, Oscar A/0000-0003-2883-5934; Birindelli, José L.O./0000-0001-9646-9636; Fapesp, Biota/0000-0002-9887-8449; Bialetzki, Andrea/0000-0002-8048-5049	CNPq; Fundacao Araucaria; CAPES	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The work was supported by CNPq (to AB), Fundacao Araucaria (to OAS and JLOB) and fellowship grants from CAPES (to FMA). This is part of author FMA's Msc thesis, developed under the Programa de Pos-Graduacao em Ciencias Biologicas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom E. H., 1954, Fishery Bulletin United States, V56, P209; ALEXANDER RM, 1966, J ZOOL, V148, P88; [Anonymous], 1991, HETEROCHRONY EVOLUTI; Arratia F. G., 1984, Museo Nacional de Historia Natural Boletin (Santiago), P49; Arratia G, 2003, CATFISHES, VOLS 1-2, P121; ARRATIA G, 1992, J MORPHOL, V214, P187, DOI 10.1002/jmor.1052140209; Balon E. K., 1984, EARLY LIFE HIST FISH, P13; Bialetzki Andrea, 2008, Acta Scientiarum Biological Sciences, V30, P141; Birindelli JLO, 2014, NEOTROP ICHTHYOL, V12, P451, DOI 10.1590/1982-0224-20120027; Birindelli JLO, 2011, J MORPHOL, V272, P890, DOI 10.1002/jmor.10961; Blaxter J.H.S., 1988, P1; BRITSKI H.A., 1986, MANUAL IDENTIFICACAO; Collette BB, 1977, S ZOOL SOC LOND, V39, P25; de Pinna M.C.C., 1996, FIELDIANA ZOOLOGY, V84, P1, DOI DOI 10.5962/BHL.TITLE.5359; DEQUEIROZ K, 1985, SYST ZOOL, V34, P280, DOI 10.1093/sysbio/34.3.280; de Mello GCG, 2015, NEOTROP ICHTHYOL, V13, P677, DOI 10.1590/1982-0224-20140161; Guimaraes-Cruz RJ, 2009, J APPL ICHTHYOL, V25, P321, DOI 10.1111/j.1439-0426.2008.01153.x; Haeckel Ernst, 1866, GENERELLE MORPHOLOGI, V2; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kendall A.W. Jr, 1984, American Society of Ichthyologists and Herpetologists Special Publication, P11; Lovejoy NR, 2004, INTEGR COMP BIOL, V44, P366, DOI 10.1093/icb/44.5.366; Lundberg J.G., 1969, American Museum Novitates, VNo. 2398, P1; Nakatani K, 2001, OVOS LARVAS PEIXES A; Nakatani K., 1997, PLAN CO INUNDA O ALT, P281; NELSON G, 1978, SYST ZOOL, V27, P324, DOI 10.2307/2412883; Ortega-Lara A, 2006, NEOTROP ICHTHYOL, V4, P147, DOI 10.1590/S1679-62252006000200002; Ponton D, 2001, FOLIA ZOOL, V50, P2; ROBERTS TR, 1982, ZOOL SCR, V11, P55, DOI 10.1111/j.1463-6409.1982.tb00518.x; Sabaj Perez M. H., 2014, STANDARD SYMBOLIC CO; Sato Y., 2003, AGUAS PEIXES PESCADO, V1st edition, P229; Sato Y, 1999, ESTUDOS ECOLOGICOS C, P401; SATO Y, 2006, GUIA ILUSTRADO PEIXE, P69; Schultze Hans-Peter, 2013, P187; Shibatta O. A., 1998, THESIS U FEDERAL SAO; Shibatta OA, 2005, ZOOTAXA, P21; Sullivan JP, 2006, MOL PHYLOGENET EVOL, V41, P636, DOI 10.1016/j.ympev.2006.05.044; Taguti TL, 1903, BIOTA NEOTROP, V9; Tenorio RA, 2003, ASPECTOS BIOL REPROD; WAYNE RK, 1986, EVOLUTION, V40, P243, DOI 10.1111/j.1558-5646.1986.tb00467.x; Wiley ML., 1970, B AM MUS NAT HIST, V143, P145	40	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153123	10.1371/journal.pone.0153123	http://dx.doi.org/10.1371/journal.pone.0153123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082430	Green Published, gold			2022-12-27	WOS:000374291800012
J	Mao, A; Mason, W; Suri, S; Watts, DJ				Mao, Andrew; Mason, Winter; Suri, Siddharth; Watts, Duncan J.			An Experimental Study of Team Size and Performance on a Complex Task	PLOS ONE			English	Article							COMMUNICATION NETS; NETWORK STRUCTURE; COORDINATION; INDIVIDUALS; KNOWLEDGE; DYNAMICS; MODEL	The relationship between team size and productivity is a question of broad relevance across economics, psychology, and management science. For complex tasks, however, where both the potential benefits and costs of coordinated work increase with the number of workers, neither theoretical arguments nor empirical evidence consistently favor larger vs. smaller teams. Experimental findings, meanwhile, have relied on small groups and highly stylized tasks, hence are hard to generalize to realistic settings. Here we narrow the gap between real-world task complexity and experimental control, reporting results from an online experiment in which 47 teams of size ranging from n = 1 to 32 collaborated on a realistic crisis mapping task. We find that individuals in teams exerted lower overall effort than independent workers, in part by allocating their effort to less demanding (and less productive) sub-tasks; however, we also find that individuals in teams collaborated more with increasing team size. Directly comparing these competing effects, we find that the largest teams outperformed an equivalent number of independent workers, suggesting that gains to collaboration dominated losses to effort. Importantly, these teams also performed comparably to a field deployment of crisis mappers, suggesting that experiments of the type described here can help solve practical problems as well as advancing the science of collective intelligence.	[Mao, Andrew; Suri, Siddharth; Watts, Duncan J.] Microsoft Res, 641 Ave Amer, New York, NY 10011 USA; [Mason, Winter] Facebook Inc, 1299 Penn Ave NW, Washington, DC 20004 USA	Microsoft; Facebook Inc	Mao, A (corresponding author), Microsoft Res, 641 Ave Amer, New York, NY 10011 USA.	mao@microsoft.com			Facebook Inc.; Microsoft Research	Facebook Inc.(Facebook Inc); Microsoft Research(Microsoft)	The authors received no specific funding for this work. Facebook Inc. and Microsoft Research provided support in the form of salaries for authors WM and AM, SS, DJW respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; BECKER SW, 1969, ADMIN SCI QUART, V14, P260, DOI 10.2307/2391104; Bettencourt LMA, 2009, TOP COGN SCI, V1, P598, DOI 10.1111/j.1756-8765.2009.01047.x; Brooks F. P., 1975, MYTHICAL MAN MONTH; Carzo Jr R, 1969, ADM SCI Q, P178, DOI [10.2307/2391096, DOI 10.2307/2391096]; Carzo Jr R, 1963, ADMIN SCI QUART, P393, DOI 10.2307/2390959; COHEN AM, 1969, ADMIN SCI QUART, V14, P208, DOI 10.2307/2391099; Gooding R. Z., 1985, ADM SCI Q, V30, P462, DOI [DOI 10.2307/2392692, 10.2307/2392692]; Guetzkow H, 1955, MANAGE SCI, V1, P233, DOI 10.1287/mnsc.1.3-4.233; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; HOLMSTROM B, 1982, BELL J ECON, V13, P324, DOI 10.2307/3003457; INGHAM AG, 1974, J EXP SOC PSYCHOL, V10, P371, DOI 10.1016/0022-1031(74)90033-X; Janis IL, 1972, VICTIMS GROUPTHINK P; Judd S, 2010, P NATL ACAD SCI USA, V107, P14978, DOI 10.1073/pnas.1001280107; KARAU SJ, 1993, J PERS SOC PSYCHOL, V65, P681, DOI 10.1037/0022-3514.65.4.681; Kearns M, 2006, SCIENCE, V313, P824, DOI 10.1126/science.1127207; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; LATANE B, 1979, J PERS SOC PSYCHOL, V37, P822, DOI 10.1037//0022-3514.37.6.822; Laughlin PR, 2006, J PERS SOC PSYCHOL, V90, P644, DOI 10.1037/0022-3514.90.4.644; Lazer D, 2007, ADMIN SCI QUART, V52, P667, DOI 10.2189/asqu.52.4.667; LITTLEPAGE GE, 1991, PERS SOC PSYCHOL B, V17, P449, DOI 10.1177/0146167291174014; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; MALONE TW, 1994, ACM COMPUT SURV, V26, P87, DOI 10.1145/174666.174668; Mao A, 2012, P 4 WORKSH HUM COMP; Marschak J, 1972, EC THEORY TEAMS; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; Mason W, 2012, P NATL ACAD SCI USA, V109, P764, DOI 10.1073/pnas.1110069108; Meier P., 2012, SUMMARY DIGITAL DISA; Meier Patrick, 2015, DIGITAL HUMANITARIAN; MULDER M, 1960, SOCIOMETRY, V23, P1, DOI 10.2307/2786133; Page SE, 2008, DIFFERENCE POWER DIV; Shaw ME, 1932, AM J PSYCHOL, V44, P491, DOI 10.2307/1415351; SHAW ME, 1954, J EXP PSYCHOL, V48, P211, DOI 10.1037/h0054191; Shore J, 2015, ORGAN SCI, V26, P1432, DOI 10.1287/orsc.2015.0980; Standby Task Force, 2012, COP BOPH SBTF ACT; Standby Task Force, 2012, UN US SOC MED RESP T; Steiner I. D, 1972, GROUP PROCESSES PROD; TETLOCK PE, 1992, J PERS SOC PSYCHOL, V63, P403, DOI 10.1037/0022-3514.63.3.403; Ungar L, 2012, P AAAI FALL S MACH A; Wheelan SA, 2009, SMALL GROUP RES; Woolley AW, 2010, SCIENCE, V330, P686, DOI 10.1126/science.1193147; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	42	50	50	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153048	10.1371/journal.pone.0153048	http://dx.doi.org/10.1371/journal.pone.0153048			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082239	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800011
J	Lai, MC; Chang, CM; Sun, HS				Lai, Ming-Chih; Chang, Chiao-May; Sun, H. Sunny			Hypoxia Induces Autophagy through Translational Up-Regulation of Lysosomal Proteins in Human Colon Cancer Cells	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; INTERNAL RIBOSOME ENTRY; INDUCIBLE FACTOR-I; GENE-EXPRESSION; COLORECTAL TUMORIGENESIS; CYCLE ARREST; STRESS; MTOR; PHOSPHORYLATION; ANGIOGENESIS	Hypoxia occurs in a wide variety of physiological and pathological conditions, including tumorigenesis. Tumor cells have to adapt to hypoxia by altering their gene expression and protein synthesis. Here, we showed that hypoxia inhibits translation through activation of PERK and inactivation of mTOR in human colon cancer HCT116 cells. Prolonged hypoxia (1% O-2, 16 h) dramatically inhibits general translation in HCT116 cells, yet selected mRNAs remain efficiently translated under such a condition. Using microarray analysis of polysome-associated mRNAs, we identified a large number of hypoxia-regulated genes at the translational level. Efficiently translated mRNAs during hypoxia were validated by polysome profiling and quantitative real-time RT-PCR. Pathway enrichment analysis showed that many of the up-regulated genes are involved in lysosome, glycan and lipid metabolism, antigen presentation, cell adhesion, and remodeling of the extracellular matrix and cytoskeleton. The majority of down-regulated genes are involved in apoptosis, ubiquitin-mediated proteolysis, and oxidative phosphorylation. Further investigation showed that hypoxia induces lysosomal autophagy and mitochondrial dysfunction through translational regulation in HCT116 cells. The abundance of several translation factors and the mTOR kinase activity are involved in hypoxia-induced mitochondrial autophagy in HCT116 cells. Our studies highlight the importance of translational regulation for tumor cell adaptation to hypoxia.	[Lai, Ming-Chih] Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan; [Lai, Ming-Chih] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Taoyuan, Taiwan; [Chang, Chiao-May; Sun, H. Sunny] Natl Cheng Kung Univ, Bioinformat Ctr, Tainan 701, Taiwan; [Sun, H. Sunny] Natl Cheng Kung Univ, Inst Mol Med, Tainan 701, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; National Cheng Kung University; National Cheng Kung University	Sun, HS (corresponding author), Chang Gung Univ, Dept Biomed Sci, Taoyuan, Taiwan.	mclai@mail.cgu.edu.tw; hssun@mail.ncku.edu.tw		Hung, Li-Man/0000-0002-6032-7668; Sun, Sunny/0000-0002-3661-4448	Ministry of Science and Technology, Taiwan [NSC100-2320-B-006-021-MY3, NSC101-2627-B-006-005]; Chang Gung Memorial Hospital, Taiwan [CMRPD3E0012]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants from Ministry of Science and Technology, Taiwan (NSC100-2320-B-006-021-MY3 to MCL and NSC101-2627-B-006-005 to HSS) and Chang Gung Memorial Hospital, Taiwan (CMRPD3E0012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Blais JD, 2006, MOL CELL BIOL, V26, P9517, DOI 10.1128/MCB.01145-06; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Brown JM, 2002, INT J RADIAT ONCOL, V54, P1299, DOI 10.1016/S0360-3016(02)03936-6; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Chen TM, 2014, NUCLEIC ACIDS RES, V42, P2932, DOI 10.1093/nar/gkt1286; Connolly E, 2006, MOL CELL BIOL, V26, P3955, DOI 10.1128/MCB.26.10.3955-3965.2006; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Eskelinen EL, 2002, MOL BIOL CELL, V13, P3355, DOI 10.1091/mbc.E02-02-0114; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flamant L, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-191; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He MF, 2010, INT J CANCER, V126, P266, DOI 10.1002/ijc.24694; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Koritzinsky M, 2005, RADIOTHER ONCOL, V76, P177, DOI 10.1016/j.radonc.2005.06.036; Koritzinsky M, 2007, METHOD ENZYMOL, V435, P247, DOI 10.1016/S0076-6879(07)35013-1; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Koumenis C, 2002, MOL CELL BIOL, V22, P7405, DOI 10.1128/MCB.22.21.7405-7416.2002; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kuballa P, 2012, ANNU REV IMMUNOL, V30, P611, DOI 10.1146/annurev-immunol-020711-074948; Kunz Manfred, 2003, Mol Cancer, V2, P23, DOI 10.1186/1476-4598-2-23; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobo MR, 2013, NEURO-ONCOLOGY, V15, P1673, DOI 10.1093/neuonc/not119; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; PETTERSEN EO, 1986, CANCER RES, V46, P4346; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Ruan K, 2009, J CELL BIOCHEM, V107, P1053, DOI 10.1002/jcb.22214; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Sun Y, 2013, AUTOPHAGY, V9, P1115, DOI 10.4161/auto.24919; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Thomas JD, 2007, RNA, V13, P1116, DOI 10.1261/rna.534807; van den Beucken T, 2011, RADIOTHER ONCOL, V99, P379, DOI 10.1016/j.radonc.2011.05.058; Vaupel P, 2004, ONCOLOGIST, V9, P10, DOI 10.1634/theoncologist.9-90005-10; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Waldner MJ, 2010, MOL ASPECTS MED, V31, P171, DOI 10.1016/j.mam.2010.02.005; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Zavoral M, 2014, WORLD J GASTROENTERO, V20, P3825, DOI 10.3748/wjg.v20.i14.3825; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	60	28	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153627	10.1371/journal.pone.0153627	http://dx.doi.org/10.1371/journal.pone.0153627			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078027	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700097
J	Li, ZY; Ji, XM; Wang, WC; Liu, JJ; Liang, XF; Wu, H; Liu, J; Eggert, US; Liu, QS; Zhang, X				Li, Zhiyuan; Ji, Xinmiao; Wang, Wenchao; Liu, Juanjuan; Liang, Xiaofei; Wu, Hong; Liu, Jing; Eggert, Ulrike S.; Liu, Qingsong; Zhang, Xin			Ammonia Induces Autophagy through Dopamine Receptor D3 and MTOR	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; LIVER-FAILURE; HUMAN-DISEASE; BRAIN; ANTAGONIST; INHIBITOR; CANCER; ROLES; CELLS; HYPERAMMONEMIA	Hyperammonemia is frequently seen in tumor microenvironments as well as in liver diseases where it can lead to severe brain damage or death. Ammonia induces autophagy, a mechanism that tumor cells may use to protect themselves from external stresses. However, how cells sense ammonia has been unclear. Here we show that culture medium alone containing Glutamine can generate milimolar of ammonia at 37 degrees in the absence of cells. In addition, we reveal that ammonia acts through the G protein-coupled receptor DRD3 (Dopamine receptor D3) to induce autophagy. At the same time, ammonia induces DRD3 degradation, which involves PIK3C3/VPS34-dependent pathways. Ammonia inhibits MTOR (mechanistic target of Rapamycin) activity and localization in cells, which is mediated by DRD3. Therefore, ammonia has dual roles in autophagy: one to induce autophagy through DRD3 and MTOR, the other to increase autophagosomal pH to inhibit autophagic flux. Our study not only adds a new sensing and output pathway for DRD3 that bridges ammonia sensing and autophagy induction, but also provides potential mechanisms for the clinical consequences of hyperammonemia in brain damage, neurodegenerative diseases and tumors.	[Li, Zhiyuan; Ji, Xinmiao; Wang, Wenchao; Liu, Juanjuan; Liang, Xiaofei; Wu, Hong; Liu, Jing; Liu, Qingsong; Zhang, Xin] Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China; [Liu, Juanjuan; Wu, Hong; Liu, Qingsong] Univ Sci & Technol China, Hefei 230026, Anhui, Peoples R China; [Eggert, Ulrike S.] Kings Coll London, Dept Chem, London WC2R 2LS, England; [Eggert, Ulrike S.] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of London; King's College London; University of London; King's College London	Zhang, X (corresponding author), Chinese Acad Sci, High Field Magnet Lab, Hefei, Anhui, Peoples R China.	xinzhang@hmfl.ac.cn	Liu, Jing/C-9666-2014; li, zhiyuan/M-5096-2015; Zhang, Xin/AAB-9359-2020	Liu, Jing/0000-0001-9513-3591; li, zhiyuan/0000-0003-1496-3521; Zhang, Xin/0000-0002-3499-2189; Eggert, Ulrike/0000-0003-0932-5525; Liang, Xiaofei/0000-0001-8722-694X	Chinese Academy of Sciences "Hundred Talent program"; National Natural Science Foundation of China [31301112]	Chinese Academy of Sciences "Hundred Talent program"(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences "Hundred Talent program" and National Natural Science Foundation of China (Project No. 31301112) to Xin Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; BARTON AC, 1991, BRAIN RES, V547, P199, DOI 10.1016/0006-8993(91)90963-V; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Bouschet T, 2005, CR BIOL, V328, P691, DOI 10.1016/j.crvi.2004.10.006; Broadbridge V, 2010, J CLIN GASTROENTEROL, V44, pE186, DOI 10.1097/MCG.0b013e3181d96aad; CHANCE WT, 1988, LIFE SCI, V43, P67, DOI 10.1016/0024-3205(88)90238-X; CHANCE WT, 1991, LIFE SCI, V48, P425, DOI 10.1016/0024-3205(91)90498-Z; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cuervo AM, 2012, MOL ASPECTS MED, V33, P2, DOI 10.1016/j.mam.2011.09.001; Damink SWMO, 2009, METAB BRAIN DIS, V24, P169, DOI 10.1007/s11011-008-9122-5; Elphick GF, 2004, SCIENCE, V306, P1380, DOI 10.1126/science.1103492; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Flombaum CD, 2000, SEMIN ONCOL, V27, P322; Gimenez-Xavier P, 2009, NEUROTOXICOLOGY, V30, P658, DOI 10.1016/j.neuro.2009.04.007; Harder LM, 2014, AUTOPHAGY, V10, P339, DOI 10.4161/auto.26863; Heng BC, 2013, BIOTECHNOL ADV, V31, P1676, DOI 10.1016/j.biotechadv.2013.08.017; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Kossaify A, 2013, BIOMARK INSIGHTS, V8, P115, DOI 10.4137/BMI.S12703; Lim J, 2011, AUTOPHAGY, V7, P51, DOI 10.4161/auto.7.1.13909; Liu QS, 2013, CANCER RES, V73, P2574, DOI 10.1158/0008-5472.CAN-12-1702; Macintosh RL, 2013, SEMIN CANCER BIOL, V23, P344, DOI 10.1016/j.semcancer.2013.05.006; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mouille B, 2003, BBA-GEN SUBJECTS, V1624, P88, DOI 10.1016/j.bbagen.2003.09.014; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ott P, 2004, NEUROCHEM INT, V44, P185, DOI 10.1016/S0197-0186(03)00153-0; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2013, ANNU REV NEUROSCI, V36, P139, DOI 10.1146/annurev-neuro-062012-170313; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Polletta L, 2015, AUTOPHAGY, V11, P253, DOI 10.1080/15548627.2015.1009778; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Rose C, 2005, METAB BRAIN DIS, V20, P275, DOI 10.1007/s11011-005-7906-4; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schneider JL, 2014, CURR OPIN GENET DEV, V26, P16, DOI 10.1016/j.gde.2014.04.003; Shin JH, 2012, BIOL PHARM BULL, V35, P1069, DOI 10.1248/bpb.b12-00009; Takei N, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00028; Wauson EM, 2014, TRENDS ENDOCRIN MET, V25, P274, DOI 10.1016/j.tem.2014.03.006; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Yan H, 2013, J CELL BIOCHEM, V114, P103, DOI 10.1002/jcb.24306; Yang YP, 2005, ACTA PHARMACOL SIN, V26, P1421, DOI 10.1111/j.1745-7254.2005.00235.x; Zhang X, 2013, MOL BIOSYST, V9, P586, DOI 10.1039/c2mb25429h; Zhang X, 2012, CYTOSKELETON, V69, P810, DOI 10.1002/cm.21055; Zhang X, 2012, P NATL ACAD SCI USA, V109, P12485, DOI 10.1073/pnas.1207821109	49	20	23	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153526	10.1371/journal.pone.0153526	http://dx.doi.org/10.1371/journal.pone.0153526			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077655	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700074
J	Martinuzzi, A; Montanaro, D; Vavla, M; Paparella, G; Bonanni, P; Musumeci, O; Brighina, E; Hlavata, H; Rossi, G; Aghakhanyan, G; Martino, N; Baratto, A; D'Angelo, MG; Peruch, F; Fantin, M; Arnoldi, A; Citterio, A; Vantaggiato, C; Rizzo, V; Toscano, A; Bresolin, N; Bassi, MT				Martinuzzi, Andrea; Montanaro, Domenico; Vavla, Marinela; Paparella, Gabriella; Bonanni, Paolo; Musumeci, Olimpia; Brighina, Erika; Hlavata, Hana; Rossi, Giuseppe; Aghakhanyan, Gayane; Martino, Nicola; Baratto, Alessandra; D'Angelo, Maria Grazia; Peruch, Francesca; Fantin, Marianna; Arnoldi, Alessia; Citterio, Andrea; Vantaggiato, Chiara; Rizzo, Vincenzo; Toscano, Antonio; Bresolin, Nereo; Bassi, Maria Teresa			Clinical and Paraclinical Indicators of Motor System Impairment in Hereditary Spastic Paraplegia: A Pilot Study	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT; MUTATIONS; WHITE; PARAPARESIS; SPECTRUM; FEATURES; SPG11; PHENOTYPE; FREQUENT; PROTEIN	Background Hereditary spastic paraplegias (HSP) are a composite and genetically heterogeneous group of conditions mainly expressed by the impairment of the central motor system ("pure" forms). The involvement of other components of the central nervous system or of other systems is described in the "complicate" forms. The definition of an investigation protocol capable, by assembling clinical and paraclinical indicators to fully represent the extent of the motor system impairment, would help both the clinical handling of these conditions and contribute to our understanding of their pathogenesis. Methods We applied a clinical and paraclinical protocol which included tools exploring motor and non motor functioning, neurophysiology and MRI to a composite cohort of 70 molecularly defined HSP patients aged 3 to 65, to define for each indicator its significance in detailing the presence and the severity of the pathology. Results Clinically increased deep tendon reflexes and lower limb (LL) weakness are constant findings in all patients. The "complicated" forms are characterized by peripheral motor impairment, cognitive and cerebellar involvement. The Spastic Paraplegia Rating Scale efficiently reflects the severity of functional problems and correlates with disease duration. Neurophysiology consistently documents the impairment of the central motor pathway to the LLs. Nevertheless, the upper extremities and sensory system involvement is a frequent finding. MRI diffusion tensor imaging (DTI) highlighted a significant alteration of FA and MD. Combining the sampling of the various portion of the cortico-spinal tract (CST) DTI consistently discriminated patients from controls. Conclusion We propose a graded clinical and paraclinical protocol for HSP phenotype definition, indicating for each tool the discriminative and descriptive capacity. Our protocol applied to 9 different forms of HSP showed that the functional impairment often extends beyond the CST. The novel DTI approach may add significant elements in disease recognition, staging and mapping.	[Martinuzzi, Andrea; Vavla, Marinela; Paparella, Gabriella; Bonanni, Paolo; Peruch, Francesca; Fantin, Marianna] IRCCS E Medea, Polo Reg Conegliano, Conegliano, TV, Italy; [Montanaro, Domenico; Hlavata, Hana; Aghakhanyan, Gayane] Fdn CNR Reg Toscana G Monasterio, Unit Neuroradiol, Pisa, Italy; [Musumeci, Olimpia; Rizzo, Vincenzo; Toscano, Antonio] Univ Messina, Dept Neurosci, Messina, Italy; [Brighina, Erika; D'Angelo, Maria Grazia] IRCCS E Medea, Neurorehabil Dept, Bosisio Parini, LC, Italy; [Rossi, Giuseppe] CNR, Inst Clin Physiol, Unit Epidemiol & Biostat, Pisa, Italy; [Martino, Nicola; Baratto, Alessandra] ULSS 7 Pieve Soligo, Dept Imaging, Conegliano, TV, Italy; [Arnoldi, Alessia; Citterio, Andrea; Vantaggiato, Chiara; Bassi, Maria Teresa] IRCCS E Medea, Mol Biol Lab, Bosisio Parini, LC, Italy; [Bresolin, Nereo] Univ Milan, Dept Neurosci, IRCCS Fdn Policlin, Milan, Italy	IRCCS Eugenio Medea; University of Messina; IRCCS Eugenio Medea; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); IRCCS Eugenio Medea; University of Milan	Martinuzzi, A (corresponding author), IRCCS E Medea, Polo Reg Conegliano, Conegliano, TV, Italy.	andrea.martinuzzi@lanostrafamiglia.it	Rizzo, Vincenzo/K-8989-2016; Citterio, Andrea/K-4379-2016; D'Angelo, Maria Grazia/K-4685-2016; Martinuzzi, Andrea/K-3887-2016; Vantaggiato, Chiara/AAH-5702-2019; Paparella, Gabriella/AAA-6540-2020; Bassi, Maria Teresa T/A-3517-2014; Montanaro, Domenico/K-5938-2016; Martinuzzi, Andrea/AAC-3127-2022; Toscano, Antonio/AHE-4657-2022; Martino, Nicola/AAP-9891-2020; Aghakhanyan, Gayane/AAC-7691-2022; bonanni, paolo/T-7360-2017; Montanaro, Domenico/AAB-9718-2022; Vavla, Marinela/J-7312-2016	Citterio, Andrea/0000-0003-4462-5646; D'Angelo, Maria Grazia/0000-0003-1241-4350; Martinuzzi, Andrea/0000-0002-0319-3579; Vantaggiato, Chiara/0000-0002-3910-6836; Paparella, Gabriella/0000-0002-9986-9907; Bassi, Maria Teresa T/0000-0002-8236-1197; Aghakhanyan, Gayane/0000-0001-5152-497X; bonanni, paolo/0000-0002-9448-9059; Montanaro, Domenico/0000-0002-9895-7016; Fantin, Marianna/0000-0002-5746-5453; Vavla, Marinela/0000-0002-3598-2978; Bresolin, Nereo/0000-0001-6694-3595	Italian Ministry of health; ERA-Net for Research on Rare Diseases grant NEUROLIPID;  [RF-IEM-2006-365041]	Italian Ministry of health(Ministry of Health, Italy); ERA-Net for Research on Rare Diseases grant NEUROLIPID; 	This work was supported by the Italian Ministry of health under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases grant NEUROLIPID and grant n. RF-IEM-2006-365041, RC 2009 (1.6); 2010 (10.4); 2011 (10.3); 2012(10.2) and RC 2013 (4.7) to AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghakhanyan G, 2014, AM J NEURORADIOL, V35, P1533, DOI 10.3174/ajnr.A3897; Agosta F, 2015, RADIOLOGY; Agosta F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042816; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026; Blackstone C, 2012, ANNU REV NEUROSCI, V35, P25, DOI 10.1146/annurev-neuro-062111-150400; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Chen Q, 2008, NEUROSCI LETT, V441, P21, DOI 10.1016/j.neulet.2008.05.114; Chetta A, 2006, RESP MED, V100, P1573, DOI 10.1016/j.rmed.2006.01.001; Compston A, 2010, BRAIN, V133, P2835, DOI 10.1093/brain/awq274; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; de Bot ST, 2010, J NEUROL NEUROSUR PS, V81, P1073, DOI 10.1136/jnnp.2009.201103; DeLuca GC, 2004, NEUROPATH APPL NEURO, V30, P576, DOI 10.1111/j.1365-2990.2004.00587.x; Depienne C, 2006, J MED GENET, V43, P259, DOI 10.1136/jmg.2005.035311; Dini Leandro I, 2013, Surg Neurol Int, V4, P51, DOI 10.4103/2152-7806.110508; Duning T, 2010, MOVEMENT DISORD, V25, P1986, DOI 10.1002/mds.23211; Faber I, 2014, ARQ NEURO-PSIQUIAT, V72, P219, DOI 10.1590/0004-282X20130248; Fink JK, 2013, ACTA NEUROPATHOL, V126, P307, DOI 10.1007/s00401-013-1115-8; Finsterer J, 2012, J NEUROL SCI, V318, P1, DOI 10.1016/j.jns.2012.03.025; Franca MC, 2012, J NEUROL NEUROSUR PS, V83, P828, DOI 10.1136/jnnp-2011-300129; Goizet C, 2011, HUM MUTAT, V32, P1118, DOI 10.1002/humu.21542; HARDING AE, 1983, LANCET, V1, P1151; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hewamadduma C, 2009, NEUROGENETICS, V10, P105, DOI 10.1007/s10048-008-0163-z; Hopkins HG, 2006, NEW VIEW STAT EFFECT; Karle KN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-158; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lindig T, 2015, J NEUROL, V262, P1961, DOI 10.1007/s00415-015-7791-7; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Loureiro JL, 2013, JAMA NEUROL, V70, P481, DOI 10.1001/jamaneurol.2013.1956; Manganelli F, 2011, CLIN NEUROPHYSIOL, V122, P819, DOI 10.1016/j.clinph.2010.10.025; McDermott CJ, 2006, NEUROLOGY, V67, P45, DOI 10.1212/01.wnl.0000223315.62404.00; Mondini S., 2011, ESAME NEUROPSICOLOGI; MSALL ME, 1994, CLIN PEDIATR, V33, P421, DOI 10.1177/000992289403300708; Musumeci O, 2011, NEUROL SCI, V32, P665, DOI 10.1007/s10072-010-0445-8; Novarino G, 2014, SCIENCE, V343, P506, DOI 10.1126/science.1247363; Oguz KK, 2013, DIAGN INTERV RADIOL, V19, P181, DOI 10.5152/dir.2013.046; Pacheco FT, 2014, J NEUROIMAGING, V24, P205, DOI 10.1111/j.1552-6569.2012.00714.x; Pensato V, 2014, BRAIN, V137, P1907, DOI 10.1093/brain/awu121; Proukakis C, 2011, J NEUROL SCI, V306, P62, DOI 10.1016/j.jns.2011.03.043; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; Sartucci F, 2007, BRAIN RES BULL, V74, P243, DOI 10.1016/j.brainresbull.2007.06.018; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Stevanin G, 2007, NAT GENET, V39, P366, DOI 10.1038/ng1980; Svenson IK, 2004, NEUROGENETICS, V5, P157, DOI 10.1007/s10048-004-0186-z; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; Tsaousidou MK, 2008, AM J HUM GENET, V82, P510, DOI 10.1016/j.ajhg.2007.10.001; van Gassen KLI, 2012, BRAIN, V135, P2994, DOI 10.1093/brain/aws224; Wechsler D., 2008, WECHSLER ADULT INTEL, V4th ed; Wechsler DW., 1999, INTELLIGENCE SCALE C; White KD, 2000, NEUROLOGY, V55, P89, DOI 10.1212/WNL.55.1.89; Windpassinger C, 2004, NAT GENET, V36, P271, DOI 10.1038/ng1313; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zuchner S, 2006, AM J HUM GENET, V79, P365, DOI 10.1086/505361	55	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153283	10.1371/journal.pone.0153283	http://dx.doi.org/10.1371/journal.pone.0153283			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077743	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700035
J	Matsuu, A; Kobayashi, T; Patchimasiri, T; Shiina, T; Suzuki, S; Chaichoune, K; Ratanakorn, P; Hiromoto, Y; Abe, H; Parchariyanon, S; Saito, T				Matsuu, Aya; Kobayashi, Tomoko; Patchimasiri, Tuangthong; Shiina, Takashi; Suzuki, Shingo; Chaichoune, Kridsada; Ratanakorn, Parntep; Hiromoto, Yasuaki; Abe, Haruka; Parchariyanon, Sujira; Saito, Takehiko			Pathogenicity of Genetically Similar, H5N1 Highly Pathogenic Avian Influenza Virus Strains in Chicken and the Differences in Sensitivity among Different Chicken Breeds	PLOS ONE			English	Article							A VIRUS; MX PROTEIN; PA-X; ANTIVIRAL ACTIVITY; IMMUNE-RESPONSES; HOST RESPONSE; HONG-KONG; GENE; REPLICATION; RESISTANCE	Differences in the pathogenicity of genetically closely related H5N1 highly pathogenic avian influenza viruses (HPAIVs) were evaluated in White Leghorn chickens. These viruses varied in the clinical symptoms they induced, including lethality, virus shedding, and replication in host tissues. A comparison of the host responses in the lung, brain, and spleen suggested that the differences in viral replication efficiency were related to the host cytokine response at the early phase of infection, especially variations in the proinflammatory cytokine IL-6. Based on these findings, we inoculated the virus that showed the mildest pathogenicity among the five tested, A/pigeon/Thailand/VSMU-7-NPT/2004, into four breeds of Thai indigenous chicken, Phadu-Hung-Dang (PHD), Chee, Dang, and Luang-Hung-Khao (LHK), to explore effects of genetic background on host response. Among these breeds, Chee, Dang, and LHK showed significantly longer survival times than White Leghorns. Virus shedding from dead Thai indigenous chickens was significantly lower than that from White Leghorns. Although polymorphisms were observed in the Mx and MHC class I genes, there was no significant association between the polymorphisms in these loci and resistance to HPAIV.	[Matsuu, Aya; Kobayashi, Tomoko; Hiromoto, Yasuaki; Abe, Haruka; Saito, Takehiko] Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand; [Matsuu, Aya; Kobayashi, Tomoko; Hiromoto, Yasuaki; Abe, Haruka; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan; [Matsuu, Aya] Kagoshima Univ, Joint Fac Vet, Transboundary Anim Dis Res Ctr, Kagoshima 890, Japan; [Shiina, Takashi; Suzuki, Shingo] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa 25911, Japan; [Chaichoune, Kridsada; Ratanakorn, Parntep] Mahidol Univ, Fac Vet Sci, Monitoring & Surveillance Ctr Zoonot Dis Wildlife, Phuttamonthon, Nakhon Pathom, Thailand; [Patchimasiri, Tuangthong; Parchariyanon, Sujira] Natl Inst Anim Hlth, Bangkok, Thailand; [Abe, Haruka; Saito, Takehiko] Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kagoshima University; Tokai University; Mahidol University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Saito, T (corresponding author), Thailand Japan Zoonot Dis Collaborating Ctr ZDCC, Bangkok, Thailand.; Saito, T (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Res Team Zoonot Dis, Tsukuba, Ibaraki, Japan.; Saito, T (corresponding author), Natl Agr & Food Res Org NARO, Natl Inst Anim Hlth, Influenza & Prion Dis Res Ctr, Tsukuba, Ibaraki, Japan.	taksaito@affrc.go.jp	Saito, Takehiko/AFM-3038-2022	Suzuki, Shingo/0000-0003-1880-582X; Abe, Haruka/0000-0003-0141-5059; Shiina, Takashi/0000-0002-2067-6708	Founding Research Center for Emerging and Reemerging Infectious Diseases	Founding Research Center for Emerging and Reemerging Infectious Diseases	This work was supported by a program of the Founding Research Center for Emerging and Reemerging Infectious Diseases, which was launched via a project commissioned by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant number: not applicable, http://www.amed.go.jp/program/list/01/06/jgrid02.html; in Japanese) to T. Saito. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNHEITER H, 1990, New Biologist, V2, P851; Banat GR, 2013, DEV COMP IMMUNOL, V39, P430, DOI 10.1016/j.dci.2012.10.006; Benfield CTO, 2008, J VIROL, V82, P7533, DOI 10.1128/JVI.00185-08; BRILES WE, 1977, SCIENCE, V195, P193, DOI 10.1126/science.831269; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Ewald SJ, 2011, IMMUNOGENETICS, V63, P363, DOI 10.1007/s00251-010-0509-1; Feng X, 2015, J VIROL; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Gao HJ, 2015, J GEN VIROL, V96, P2036, DOI 10.1099/vir.0.000143; Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104; Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076; Hayashi T, 2015, J VIROL, V89, P6442, DOI 10.1128/JVI.00319-15; Hayashi T, 2011, VIROLOGY, V412, P9, DOI 10.1016/j.virol.2010.12.040; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hosomichi K, 2008, J IMMUNOL, V181, P3393, DOI 10.4049/jimmunol.181.5.3393; Hovanessian AG, 2007, CYTOKINE GROWTH F R, V18, P351, DOI 10.1016/j.cytogfr.2007.06.003; Hu J, 2015, J VIROL, V89, P4126, DOI 10.1128/JVI.02132-14; Hui RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0111771; Hunt HD, 2010, AVIAN DIS, V54, P572, DOI 10.1637/8888-042409-ResNote.1; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jiao PR, 2008, J VIROL, V82, P1146, DOI 10.1128/JVI.01698-07; Kalaya B, 2006, J POULT SCI, V43, P120; Kamal RP, 2015, J VIROL, V89, P5835, DOI 10.1128/JVI.03137-14; Karpala AJ, 2011, J INTERF CYTOK RES, V31, P393, DOI 10.1089/jir.2010.0069; Ko JH, 2004, JPN J VET RES, V51, P123; Ko JH, 2004, ANIM GENET, V35, P119, DOI 10.1111/j.1365-2052.2004.01096.x; Ko JH, 2002, GENOME RES, V12, P595, DOI 10.1101/gr.210702. Article published online before print in March ; Kuchipudi SV, 2014, VET RES, V45, DOI 10.1186/s13567-014-0118-3; Lamont SJ, 1998, POULTRY SCI, V77, P1111, DOI 10.1093/ps/77.8.1111; Lee SH, 2002, GENOME RES, V12, P527, DOI 10.1101/gr.20102; Lima-Rosa CAV, 2004, ANIM GENET, V35, P278, DOI 10.1111/j.1365-2052.2004.01160.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long JS, 2013, J VIROL, V87, P9983, DOI 10.1128/JVI.01399-13; Medina RA, 2011, NAT REV MICROBIOL, V9, P590, DOI 10.1038/nrmicro2613; Nao N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137989; OIE, UPD HIGHL PATH AV IN; Rajagopal R, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-25; REED L. J., 1938, AMER JOUR HYG, V27, P493; SCHUMACHER B, 1994, VIROLOGY, V203, P144, DOI 10.1006/viro.1994.1464; Silva MC, 2009, J MOL EVOL, V68, P279, DOI 10.1007/s00239-009-9200-2; Sironi L, 2008, VIROLOGY, V380, P152, DOI 10.1016/j.virol.2008.07.022; Sironi Laura, 2011, BMC Proc, V5 Suppl 4, pS25, DOI 10.1186/1753-6561-5-S4-S25; Spickler AR, 2008, AVIAN PATHOL, V37, P555, DOI 10.1080/03079450802499118; STAEHELI P, 1986, CELL, V44, P147, DOI 10.1016/0092-8674(86)90493-9; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Suzuki K, 2009, J VIROL, V83, P7475, DOI 10.1128/JVI.01434-08; Suzuki Y, 2014, J VIROL, V88, P11130, DOI 10.1128/JVI.01564-14; Uchida Y, 2008, VIRUS RES, V138, P70, DOI 10.1016/j.virusres.2008.08.007; Wallny HJ, 2006, P NATL ACAD SCI USA, V103, P1434, DOI 10.1073/pnas.0507386103; Wasilenko JL, 2009, ARCH VIROL, V154, P969, DOI 10.1007/s00705-009-0399-4; Watanabe C, 2011, VET IMMUNOL IMMUNOP, V144, P187, DOI 10.1016/j.vetimm.2011.10.002; Watanabe T, 2007, CYTOGENET GENOME RES, V117, P370, DOI 10.1159/000103200; Xu XY, 1999, VIROLOGY, V261, P15, DOI 10.1006/viro.1999.9820; Zhu WF, 2015, SCI REP-UK, V5, DOI 10.1038/srep14170	54	22	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153649	10.1371/journal.pone.0153649	http://dx.doi.org/10.1371/journal.pone.0153649			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078641	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700100
J	Norton, N; Advani, PP; Serie, DJ; Geiger, XJ; Necela, BM; Axenfeld, BC; Kachergus, JM; Feathers, RW; Carr, JM; Crook, JE; Moreno-Aspitia, A; Anastasiadis, PZ; Perez, EA; Thompson, EA				Norton, Nadine; Advani, Pooja P.; Serie, Daniel J.; Geiger, Xochiquetzal J.; Necela, Brian M.; Axenfeld, Bianca C.; Kachergus, Jennifer M.; Feathers, Ryan W.; Carr, Jennifer M.; Crook, Julia E.; Moreno-Aspitia, Alvaro; Anastasiadis, Panos Z.; Perez, Edith A.; Thompson, E. Aubrey			Assessment of Tumor Heterogeneity, as Evidenced by Gene Expression Profiles, Pathway Activation, and Gene Copy Number, in Patients with Multifocal Invasive Lobular Breast Tumors	PLOS ONE			English	Article							E-CADHERIN; CONSERVING THERAPY; DUCTAL CARCINOMA; CANCER SUBTYPES; RECEPTOR; METASTASIS; RECURRENCE; DISCRIMINATION; SUPPRESSION; PROGRESSION	Background Invasive lobular carcinoma (ILC) comprises approximately similar to 10-20% of breast cancers. In general, multifocal/multicentric (MF/MC) breast cancer has been associated with an increased rate of regional lymph node metastases. Tumor heterogeneity between foci represents a largely unstudied source of genomic variation in those rare patients with MF/MC ILC. Methods We characterized gene expression and copy number in 2 or more foci from 11 patients with MF/MC ILC (all ER+, HER2-) and adjacent normal tissue. RNA and DNA were extracted from 3x1.5mm cores from all foci. Gene expression (730 genes) and copy number (80 genes) were measured using Nanostring PanCancer and Cancer CNV panels. Linear mixed models were employed to compare expression in tumor versus normal samples from the same patient, and to assess heterogeneity (variability) in expression among multiple ILC within an individual. Results 35 and 34 genes were upregulated (FC>2) and down-regulated (FC<0.5) respectively in ILC tumor relative to adjacent normal tissue, q<0.05. 9/34 down-regulated genes (FIGF, RELN, PROM1, SFRP1, MMP7, NTRK2, LAMB3, SPRY2, KIT) had changes larger than CDH1, a hallmark of ILC. Copy number changes in these patients were relatively few but consistent across foci within each patient. Amplification of three genes (CCND1, FADD, ORAOV1) at 11q13.3 was present in 2/11 patients in both foci. We observed significant evidence of within-patient between-foci variability (heterogeneity) in gene expression for 466 genes (p<0.05 with FDR 8%), including CDH1, FIGF, RELN, SFRP1, MMP7, NTRK2, LAMB3, SPRY2 and KIT. Conclusions There was substantial variation in gene expression between ILC foci within patients, including known markers of ILC, suggesting an additional level of complexity that should be addressed.	[Norton, Nadine; Necela, Brian M.; Axenfeld, Bianca C.; Kachergus, Jennifer M.; Feathers, Ryan W.; Carr, Jennifer M.; Anastasiadis, Panos Z.; Thompson, E. Aubrey] Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA; [Advani, Pooja P.; Moreno-Aspitia, Alvaro; Perez, Edith A.] Mayo Clin, Div Hematol Oncol, Jacksonville, FL 32224 USA; [Serie, Daniel J.; Crook, Julia E.] Mayo Clin, Dept Hlth Sci Res, Jacksonville, FL 32224 USA; [Geiger, Xochiquetzal J.] Mayo Clin, Dept Lab Med & Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Thompson, EA (corresponding author), Mayo Clin, Dept Canc Biol, Jacksonville, FL 32224 USA.	Thompson.aubrey@mayo.edu			Mayo Clinic Cancer Focus Research Team; 26.2 with Donna Foundation; Serene M. and Frances C. Durling endowment	Mayo Clinic Cancer Focus Research Team; 26.2 with Donna Foundation; Serene M. and Frances C. Durling endowment	This study was funded by Mayo Clinic Cancer Focus Research Team (AMA), the 26.2 with Donna Foundation (EAP) and the Serene M. and Frances C. Durling endowment (EAP).; This study was funded by Mayo Clinic Cancer Focus Research Team, the 26.2 with Donna Foundation and the Serene M. and Frances C. Durling endowment.	Acerbi I, 2015, INTEGR BIOL-UK, V7, P1120, DOI 10.1039/c5ib00040h; Alizadeh AA, 2015, NAT MED, V21, P846, DOI 10.1038/nm.3915; Andl CD, 2005, CANCER BIOL THER, V4, P28, DOI 10.4161/cbt.4.1.1431; Arpino G, 2004, BREAST CANCER RES, V6, pR149, DOI 10.1186/bcr767; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cabioglu N, 2009, J AM COLL SURGEONS, V208, P67, DOI 10.1016/j.jamcollsurg.2008.09.001; Choi EJ, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-137; Choi Y, 2012, HUM PATHOL, V43, P48, DOI 10.1016/j.humpath.2010.08.026; Chua B, 2001, ANZ J SURG, V71, P723, DOI 10.1046/j.1445-1433.2001.02266.x; Chung AP, 2012, J AM COLL SURGEONS, V215, P137, DOI 10.1016/j.jamcollsurg.2012.05.006; Coombs NJ, 2005, J CLIN ONCOL, V23, P7497, DOI 10.1200/JCO.2005.02.1147; Courjal F, 1997, CANCER RES, V57, P4360; Dabbs DJ, 2013, AM J SURG PATHOL, V37, pE1, DOI 10.1097/PAS.0b013e3182918a2b; Desmedt C, 2015, J PATHOL, V236, P457, DOI 10.1002/path.4540; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Geiger TR, 2007, CANCER RES, V67, P6221, DOI 10.1158/0008-5472.CAN-07-0121; Ghazani AA, 2007, NEOPLASIA, V9, P511, DOI 10.1593/neo.07301; Gruel N, 2010, EUR J CANCER, V46, P2399, DOI 10.1016/j.ejca.2010.05.013; Hirsch E, 2014, ONCOGENE, V33, P3083, DOI 10.1038/onc.2013.265; HOLM S, 1979, SCAND J STAT, V6, P65; Iyengar P, 2005, J CLIN INVEST, V115, P1163, DOI 10.1172/JCI200523424; Korkola JE, 2003, CANCER RES, V63, P7167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo TL, 2004, CANCER RES, V64, P6127, DOI 10.1158/0008-5472.CAN-04-1207; Metzger O, 2013, J CLIN ONCOL, V31, P3083, DOI 10.1200/JCO.2012.46.1574; NOGUCHI S, 1994, CANCER, V74, P872, DOI 10.1002/1097-0142(19940801)74:3<872::AID-CNCR2820740313>3.0.CO;2-P; Noorlag R, 2015, VIRCHOWS ARCH, V466, P363, DOI 10.1007/s00428-015-1719-6; Norton N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081925; Oyama T, 1998, CANCER RES, V58, P2876; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pekar G, 2013, CANCER-AM CANCER SOC, V119, P1132, DOI 10.1002/cncr.27877; PETERS G, 1995, BREAST CANCER RES TR, V33, P125, DOI 10.1007/BF00682720; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Reed AEM, 2013, VIRCHOWS ARCH, V463, P535, DOI 10.1007/s00428-013-1468-3; Rezo A, 2011, BREAST, V20, P259, DOI 10.1016/j.breast.2011.01.005; Shields MA, 2011, J BIOL CHEM, V286, P10495, DOI 10.1074/jbc.M110.195628; TEIXEIRA MR, 1994, BRIT J CANCER, V70, P922, DOI 10.1038/bjc.1994.421; Teixeira MR, 1997, GENE CHROMOSOME CANC, V18, P170, DOI 10.1002/(SICI)1098-2264(199703)18:3<170::AID-GCC3>3.0.CO;2-Z; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viale G, 2009, BREAST CANCER RES TR, V117, P211, DOI 10.1007/s10549-008-0112-4; Voduc KD, 2010, J CLIN ONCOL, V28, P1684, DOI 10.1200/JCO.2009.24.9284; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weigelt B, 2008, J PATHOL, V216, P141, DOI 10.1002/path.2407; Wolters R, 2013, BREAST CANCER RES TR, V142, P579, DOI 10.1007/s10549-013-2772-y; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	48	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153411	10.1371/journal.pone.0153411	http://dx.doi.org/10.1371/journal.pone.0153411			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078887	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700052
J	Wu, CH; Tung, YC; Lin, TK; Chai, CY; Su, YF; Tsai, TH; Tsai, CY; Lu, YY; Lin, CL				Wu, Chieh-Hsin; Tung, Yi-Ching; Lin, Tzu-Kang; Chai, Chee-Yin; Su, Yu-Feng; Tsai, Tai-Hsin; Tsai, Cheng-Yu; Lu, Ying-Yi; Lin, Chih-Lung			Hip Fracture in People with Erectile Dysfunction: A Nationwide Population-Based Cohort Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; INCREASED RISK; CARDIOVASCULAR-DISEASES; COGNITIVE FUNCTION; MEN; DEPRESSION; PREVALENCE; TESTOSTERONE; METAANALYSIS; ASSOCIATION	The aims of this study were to investigate the risk of hip fracture and contributing factors in patients with erectile dysfunction(ED). This population-based study was performed using the Taiwan National Health Insurance Research Database. The analysis included4636 patients aged >= 40 years who had been diagnosed with ED (International Classification of Diseases, Ninth Revision, Clinical Modification codes 302.72, 607.84) during 1996-2010. The control group included 18,544 randomly selected age-matched patients without ED (1: 4 ratio). The association between ED and hip fracture risk was estimated using a Cox proportional hazard regression model. During the follow-up period, 59 (1.27%) patients in the ED group and 140 (0.75%) patients in the non-ED group developed hip fracture. After adjusting for covariates, the overall incidence of hip fracture was 3.74-times higher in the ED group than in the non-ED group (2.03 vs. 0.50 per 1000 person-years, respectively). The difference in the overall incidence of hip fracture was largest during the 3-year follow-up period (hazard ratio = 7.85; 95% confidence interval = 2.94-20.96; P < 0.0001). To the best of our knowledge, this nationwide population-based study is the first to investigate the relationship between ED and subsequent hip fracture in an Asian population. The results showed that ED patients had a higher risk of developing hip fracture. Patients with ED, particularly those aged 40-59 years, should undergo bone mineral density examinations as early as possible and should take measures to reduce the risk of falls.	[Wu, Chieh-Hsin; Chai, Chee-Yin; Lu, Ying-Yi; Lin, Chih-Lung] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Wu, Chieh-Hsin; Su, Yu-Feng; Tsai, Tai-Hsin; Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Tung, Yi-Ching] Kaohsiung Med Univ, Dept Publ Hlth & Environm Med, Coll Med, Kaohsiung, Taiwan; [Lin, Tzu-Kang] Chang Gung Univ, Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Chai, Chee-Yin] Kaohsiung Med Univ, Dept Pathol, Coll Med, Fac Med, Kaohsiung, Taiwan; [Chai, Chee-Yin] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan; [Lu, Ying-Yi] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan; [Lu, Ying-Yi] Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Dept Neurosurg, Coll Med, Fac Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung Memorial Hospital; Chang Gung University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Medical University	Lu, YY; Lin, CL (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan.; Lu, YY (corresponding author), Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung, Taiwan.; Lu, YY (corresponding author), Yuh Ing Jr Coll Hlth Care & Management, Cosmet Applicat & Management Dept, Kaohsiung, Taiwan.; Lin, CL (corresponding author), Kaohsiung Med Univ, Dept Neurosurg, Coll Med, Fac Med, Kaohsiung, Taiwan.	actinpactinp@yahoo.com.tw; chihlung1@yahoo.com	MPRAH, ANDY/J-5558-2016; Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Chai, Chee-Yin/0000-0003-0486-9742; Su, Yu-feng/0000-0003-0355-3981				Autier P, 2000, OSTEOPOROSIS INT, V11, P373, DOI 10.1007/s001980070102; Aytac IA, 1999, BJU INT, V84, P50; Barassi A, 2014, J SEX MED, V11, P2792, DOI 10.1111/jsm.12661; Barron Anna M, 2012, Front Biosci (Elite Ed), V4, P976, DOI 10.2741/E434; Billups KL, 2008, INT J IMPOT RES, V20, P236, DOI 10.1038/sj.ijir.3901634; Blanker MH, 2001, J AM GERIATR SOC, V49, P436, DOI 10.1046/j.1532-5415.2001.49088.x; Chao CH, 2015, ANDROLOGY-US, V3, P666, DOI 10.1111/andr.12052; Chou PS, 2015, J SEX MED, V12, P804, DOI 10.1111/jsm.12792; Chun J, 2001, UROL CLIN N AM, V28, P249, DOI 10.1016/S0094-0143(05)70135-X; Chung SD, 2011, J SEX MED, V8, P240, DOI 10.1111/j.1743-6109.2010.01973.x; COOPER C, 1992, OSTEOPOROSIS INT, V2, P285, DOI 10.1007/BF01623184; Corsonello A, 2011, CURR OPIN PULM MED, V17, pS21, DOI 10.1097/01.mcp.0000410744.75216.d0; Diem SJ, 2013, OSTEOPOROSIS INT, V24, P111, DOI 10.1007/s00198-012-1975-0; Frost M, 2012, OSTEOPOROSIS INT, V23, P521, DOI 10.1007/s00198-011-1575-4; Gandaglia G, 2014, EUR UROL, V65, P968, DOI 10.1016/j.eururo.2013.08.023; Gao X, 2007, AM J EPIDEMIOL, V166, P1446, DOI 10.1093/aje/kwm246; Giuliano FA, 2004, UROLOGY, V64, P1196, DOI 10.1016/j.urology.2004.08.059; Huang CY, 2012, CEPHALALGIA, V32, P366, DOI 10.1177/0333102412439801; Jacka FN, 2005, MENOPAUSE, V12, P88, DOI 10.1097/00042192-200512010-00015; Keller JJ, 2012, J SEX MED, V9, P1745, DOI 10.1111/j.1743-6109.2012.02736.x; Keller JJ, 2012, ANN RHEUM DIS, V71, P1102, DOI 10.1136/annrheumdis-2011-200890; Koseoglu N, 2005, J UROLOGY, V174, P249, DOI 10.1097/01.ju.0000163259.33846.74; Kronzon I, 2006, CIRCULATION, V114, P63, DOI 10.1161/CIRCULATIONAHA.105.593418; Lai SW, 2013, J EPIDEMIOL, V23, P109, DOI 10.2188/jea.JE20120071; Martinez-Reig M, 2012, J AM MED DIR ASSOC, V13, P770, DOI 10.1016/j.jamda.2012.07.011; McFarlane Samy I, 2006, J Cardiometab Syndr, V1, P53, DOI 10.1111/j.0197-3118.2006.05457.x; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Michelson D, 1996, NEW ENGL J MED, V335, P1176, DOI 10.1056/NEJM199610173351602; Moore CS, 2014, PSYCHOL AGING, V29, P163, DOI 10.1037/a0035463; Mourikis I, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0074-y; Muneer A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g129; Nagai K, 2012, J AM GERIATR SOC, V60, P1188, DOI 10.1111/j.1532-5415.2012.03982.x; Nazir A, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2012.07.018; Nordstrom P, 2012, J BONE MINER RES, V27, P2291, DOI 10.1002/jbmr.1683; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Pastuszak Alexander W, 2014, Curr Sex Health Rep, V6, P164; Polonsky TS, 2009, ATHEROSCLEROSIS, V207, P440, DOI 10.1016/j.atherosclerosis.2009.05.005; Rhoden EL, 2002, INT J IMPOT RES, V14, P245, DOI 10.1038/sj.ijir.3900859; Rosen RC, 2001, UROL CLIN N AM, V28, P269, DOI 10.1016/S0094-0143(05)70137-3; SCHWEIGER U, 1994, AM J PSYCHIAT, V151, P1691; Seftel AD, 2004, J UROLOGY, V171, P2341, DOI 10.1097/01.ju.0000125198.32936.38; Sennerby U, 2007, OSTEOPOROSIS INT, V18, P1355, DOI 10.1007/s00198-007-0386-0; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Shabsigh R, 2008, INT J CLIN PRACT, V62, P791, DOI 10.1111/j.1742-1241.2008.01696.x; Shen TC, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000448; Solomon H, 2003, HEART, V89, P251, DOI 10.1136/heart.89.3.251; Tang ZY, 2014, BMC UROL, V14, DOI 10.1186/1471-2490-14-52; Vlachopoulos CV, 2013, CIRC-CARDIOVASC QUAL, V6, P99, DOI 10.1161/CIRCOUTCOMES.112.966903; Whitney J, 2012, J AM MED DIR ASSOC, V13, P535, DOI 10.1016/j.jamda.2012.03.009; Wittert G, 2014, ASIAN J ANDROL, V16, P262, DOI 10.4103/1008-682X.122586; Wong SYS, 2005, OSTEOPOROSIS INT, V16, P610, DOI 10.1007/s00198-004-1730-2; Yang CM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000990	52	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153467	10.1371/journal.pone.0153467	http://dx.doi.org/10.1371/journal.pone.0153467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078254	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700059
J	Armstrong, C; Samuel, J; Yarlett, A; Cooper, SM; Stembridge, M; Stohr, EJ				Armstrong, Craig; Samuel, Jake; Yarlett, Andrew; Cooper, Stephen-Mark; Stembridge, Mike; Stohr, Eric J.			The Effects of Exercise Intensity vs. Metabolic State on the Variability and Magnitude of Left Ventricular Twist Mechanics during Exercise	PLOS ONE			English	Article							HEART-FAILURE; TORSION; STRESS; HUMANS; PRELOAD; STRAIN; IMPACT; OUTPUT; REST	Increased left ventricular (LV) twist and untwisting rate (LV twist mechanics) are essential responses of the heart to exercise. However, previously a large variability in LV twist mechanics during exercise has been observed, which complicates the interpretation of results. This study aimed to determine some of the physiological sources of variability in LV twist mechanics during exercise. Sixteen healthy males (age: 22 +/- 4 years, (V) over dotO(2peak): 45.5 +/- 6.9 ml.kg(-1).min(-1), range of individual anaerobic threshold (IAT): 32-69% of (V) over dotO(2peak)) were assessed at rest and during exercise at: i) the same relative exercise intensity, 40%(peak), ii) at 2% above IAT, and, iii) at 40%(peak) with hypoxia (40%(peak)+HYP). LV volumes were not significantly different between exercise conditions (P > 0.05). However, the mean margin of error of LV twist was significantly lower (F-2,F-47 = 2.08, P < 0.05) during 40% peak compared with IAT (3.0 vs. 4.1 degrees). Despite the same workload and similar LV volumes, hypoxia increased LV twist and untwisting rate (P < 0.05), but the mean margin of error remained similar to that during 40% peak (3.2 degrees, P > 0.05). Overall, LV twist mechanics were linearly related to rate pressure product. During exercise, the intra-individual variability of LV twist mechanics is smaller at the same relative exercise intensity compared with IAT. However, the absolute magnitude (degrees) of LV twist mechanics appears to be associated with the prevailing rate pressure product. Exercise tests that evaluate LV twist mechanics should be standardised by relative exercise intensity and rate pressure product be taken into account when interpreting results.	[Armstrong, Craig; Samuel, Jake; Yarlett, Andrew; Cooper, Stephen-Mark; Stembridge, Mike; Stohr, Eric J.] Cardiff Metropolitan Univ, Discipline Physiol & Hlth, Cardiff, S Glam, Wales	Cardiff Metropolitan University	Stohr, EJ (corresponding author), Cardiff Metropolitan Univ, Discipline Physiol & Hlth, Cardiff, S Glam, Wales.	estohr@cardiffmet.ac.uk		Stembridge, Mike/0000-0003-0818-6420				American College., 2006, ACSMS GUID EX TEST P; ARTS T, 1984, CARDIOVASC RES, V18, P183, DOI 10.1093/cvr/18.3.183; ASTRAND PO, 1964, J APPL PHYSIOL, V19, P268, DOI 10.1152/jappl.1964.19.2.268; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BEYAR R, 1986, CIRC RES, V58, P664, DOI 10.1161/01.RES.58.5.664; Burns AT, 2010, ECHOCARDIOGR-J CARD, V27, P407, DOI 10.1111/j.1540-8175.2009.01037.x; Campagna JA, 2003, ANESTHESIOLOGY, V98, P1250; Donal E, 2012, EUR HEART J-CARD IMG, V13, P656, DOI 10.1093/ehjci/jes010; Dong SJ, 1999, AM J PHYSIOL-HEART C, V277, pH1053, DOI 10.1152/ajpheart.1999.277.3.H1053; Doucende G, 2010, CIRC-CARDIOVASC IMAG, V3, P586, DOI 10.1161/CIRCIMAGING.110.943522; Duncker DJ, 2015, PROG CARDIOVASC DIS, V57, P409, DOI 10.1016/j.pcad.2014.12.002; Duncker DJ, 1998, CIRC RES, V82, P1312, DOI 10.1161/01.RES.82.12.1312; Esch BT, 2009, J PHYSIOL-LONDON, V587, P2375, DOI 10.1113/jphysiol.2009.170100; Esch BT, 2009, J APPL PHYSIOL, V106, P362, DOI 10.1152/japplphysiol.00144.2008; Goebel B, 2013, INT J CARDIOVAS IMAG, V29, P561, DOI 10.1007/s10554-012-0117-2; Helle-Valle T, 2005, CIRCULATION, V112, P3149, DOI 10.1161/CIRCULATIONAHA.104.531558; HUCKABEE WE, 1961, AM J PHYSIOL, V200, P1169, DOI 10.1152/ajplegacy.1961.200.6.1169; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Notomi Y, 2005, J AM COLL CARDIOL, V45, P2034, DOI 10.1016/j.jacc.2005.02.082; Notomi Y, 2006, CIRCULATION, V113, P2524, DOI 10.1161/CIRCULATIONAHA.105.596502; Opdahl A, 2012, CIRCULATION, V126, P1441, DOI 10.1161/CIRCULATIONAHA.111.080861; Patterson SW, 1914, J PHYSIOL-LONDON, V48, P357; Rognmo O, 2012, CIRCULATION, V126, P1436, DOI 10.1161/CIRCULATIONAHA.112.123117; SAHN SA, 1977, J APPL PHYSIOL, V43, P1019, DOI 10.1152/jappl.1977.43.6.1019; Soullier C, 2012, CIRC-CARDIOVASC IMAG, V5, P324, DOI 10.1161/CIRCIMAGING.111.968859; Stembridge M, 2014, J APPL PHYSIOL, V117, P334, DOI 10.1152/japplphysiol.00233.2014; Stohr EJ, 2015, EXP PHYSIOL, V100, P507, DOI 10.1113/EP085081; Stohr EJ, 2014, AM J PHYSIOL-HEART C, V306, pH225, DOI 10.1152/ajpheart.00938.2012; Stohr EJ, 2012, J PHYSIOL-LONDON, V590, P2107, DOI 10.1113/jphysiol.2012.227850; Stohr EJ, 2011, J APPL PHYSIOL, V111, P891, DOI 10.1152/japplphysiol.00528.2011; Stohr EJ, 2011, AM J PHYSIOL-HEART C, V301, pH478, DOI 10.1152/ajpheart.00314.2011; Stohr EJ, 2011, EXP PHYSIOL, V96, P114, DOI 10.1113/expphysiol.2010.055137; Tan YT, 2009, J AM COLL CARDIOL, V54, P36, DOI 10.1016/j.jacc.2009.03.037; van Mil ACCM, 2016, EXP PHYSL IN PRESS; Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001; WAGNER PD, 1986, J APPL PHYSIOL, V61, P260, DOI 10.1152/jappl.1986.61.1.260; Wasserman K, 1990, CIRCULATION S2, V81, P1114; Weiner RB, 2012, J PHYSIOL-LONDON, V590, P5141, DOI 10.1113/jphysiol.2012.236166; Weiner RB, 2010, CIRC-CARDIOVASC IMAG, V3, P672, DOI 10.1161/CIRCIMAGING.109.932921	40	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154065	10.1371/journal.pone.0154065	http://dx.doi.org/10.1371/journal.pone.0154065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100099	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500134
J	Chakraborty, B; Bhakta, S; Sengupta, J				Chakraborty, Biprashekhar; Bhakta, Sayan; Sengupta, Jayati			Mechanistic Insight into the Reactivation of BCAII Enzyme from Denatured and Molten Globule States by Eukaryotic Ribosomes and Domain V rRNAs	PLOS ONE			English	Article							PROTEIN-FOLDING ACTIVITY; CARBONIC-ANHYDRASE-B; ESCHERICHIA-COLI; IN-VITRO; GUANIDINIUM CHLORIDE; 70S RIBOSOME; INTERMEDIATE; AGGREGATION; CHAPERONES; YEAST	In all life forms, decoding of messenger-RNA into polypeptide chain is accomplished by the ribosome. Several protein chaperones are known to bind at the exit of ribosomal tunnel to ensure proper folding of the nascent chain by inhibiting their premature folding in the densely crowded environment of the cell. However, accumulating evidence suggests that ribosome may play a chaperone role in protein folding events in vitro. Ribosome-mediated folding of denatured proteins by prokaryotic ribosomes has been studied extensively. The RNA-assisted chaperone activity of the prokaryotic ribosome has been attributed to the domain V, a span of 23S rRNA at the intersubunit side of the large subunit encompassing the Peptidyl Transferase Centre. Evidently, this functional property of ribosome is unrelated to the nascent chain protein folding at the exit of the ribosomal tunnel. Here, we seek to scrutinize whether this unique function is conserved in a primitive kinetoplastid group of eukaryotic species Leishmania donovani where the ribosome structure possesses distinct additional features and appears markedly different compared to other higher eukaryotic ribosomes. Bovine Carbonic Anhydrase II (BCAII) enzyme was considered as the model protein. Our results manifest that domain V of the large subunit rRNA of Leishmania ribosomes preserves chaperone activity suggesting that ribosome-mediated protein folding is, indeed, a conserved phenomenon. Further, we aimed to investigate the mechanism underpinning the ribosome-assisted protein reactivation process. Interestingly, the surface plasmon resonance binding analyses exhibit that rRNA guides productive folding by directly interacting with molten globule-like states of the protein. In contrast, native protein shows no notable affinity to the rRNA. Thus, our study not only confirms conserved, RNA-mediated chaperoning role of ribosome but also provides crucial insight into the mechanism of the process.	[Chakraborty, Biprashekhar; Bhakta, Sayan; Sengupta, Jayati] CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Sengupta, J (corresponding author), CSIR, Indian Inst Chem Biol, Struct Biol & Bioinformat Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	jayati@iicb.res.in			CSIR-Indian Institute of Chemical Biology, Kolkata, India; CSIR Network project 'UNSEEN'; DST (India) [GAP327]	CSIR-Indian Institute of Chemical Biology, Kolkata, India; CSIR Network project 'UNSEEN'; DST (India)(Department of Science & Technology (India))	This work was partially supported by CSIR-Indian Institute of Chemical Biology, Kolkata, India, and CSIR Network project 'UNSEEN' and DST (India) sponsored project GAP327. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Argent RH, 2000, J BIOL CHEM, V275, P9263, DOI 10.1074/jbc.275.13.9263; Barbezier N, 2011, EMBO MOL MED, V3, P35, DOI 10.1002/emmm.201000109; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bonander N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-10; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chattopadhyay S, 1996, P NATL ACAD SCI USA, V93, P8284, DOI 10.1073/pnas.93.16.8284; Chattopadhyay S, 1999, BBA-PROTEIN STRUCT M, V1429, P293, DOI 10.1016/S0167-4838(98)00179-4; CHATTOPADHYAY S, 1994, BIOCHEM J, V300, P717, DOI 10.1042/bj3000717; Choi SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002677; Choi SI, 2009, RNA BIOL, V6, P21, DOI 10.4161/rna.6.1.7441; CLELAND JL, 1990, BIOCHEMISTRY-US, V29, P11072, DOI 10.1021/bi00502a009; Creighton TE, 1997, TRENDS BIOCHEM SCI, V22, P6, DOI 10.1016/S0968-0004(96)20030-1; Das A, 2011, J BIOL CHEM, V286, P43771, DOI 10.1074/jbc.M111.263574; Das B, 1996, EUR J BIOCHEM, V235, P613, DOI 10.1111/j.1432-1033.1996.00613.x; Das D, 2012, J BIOL CHEM, V287, P37508, DOI 10.1074/jbc.M112.396127; Das Debasis, 2008, Biotechnology Journal, V3, P999, DOI 10.1002/biot.200800098; Dos Reis S, 2011, BIOCHIMIE, V93, P1047, DOI 10.1016/j.biochi.2011.03.002; GHOSH A, 1994, NUCLEIC ACIDS RES, V22, P1663, DOI 10.1093/nar/22.9.1663; Hammarstrom P, 1999, J BIOL CHEM, V274, P32897, DOI 10.1074/jbc.274.46.32897; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hashem Y, 2013, NATURE, V494, P385, DOI 10.1038/nature11872; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jha SK, 2014, P NATL ACAD SCI USA, V111, P4856, DOI 10.1073/pnas.1315453111; Jha SK, 2009, P NATL ACAD SCI USA, V106, P12289, DOI 10.1073/pnas.0905744106; Katranidis A, 2009, ANGEW CHEM INT EDIT, V48, P1758, DOI 10.1002/anie.200806070; Komar AA, 1997, J BIOL CHEM, V272, P10646; Kudlicki W, 1997, FOLD DES, V2, P101, DOI 10.1016/S1359-0278(97)00014-X; Malakar D, 2008, BBA-GEN SUBJECTS, V1780, P937, DOI 10.1016/j.bbagen.2008.03.014; Michaeli S, 2011, FUTURE MICROBIOL, V6, P459, DOI [10.2217/fmb.11.20, 10.2217/FMB.11.20]; Naeem A, 2011, CELL BIOCHEM BIOPHYS, V61, P237, DOI 10.1007/s12013-011-9200-x; Pal D, 1997, NUCLEIC ACIDS RES, V25, P5047, DOI 10.1093/nar/25.24.5047; Pang YH, 2013, J BIOL CHEM, V288, P19081, DOI 10.1074/jbc.M113.466748; Pathak BK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096425; Rajaraman K, 1996, J BIOL CHEM, V271, P27595, DOI 10.1074/jbc.271.44.27595; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Samanta D, 2008, J BACTERIOL, V190, P3344, DOI 10.1128/JB.01800-07; Samanta D, 2009, BIOCHEM BIOPH RES CO, V384, P137, DOI 10.1016/j.bbrc.2009.04.106; Santucci R, 2008, MINI-REV MED CHEM, V8, P57, DOI 10.2174/138955708783331522; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Sorensen HP, 2004, BIOCHEM BIOPH RES CO, V319, P715, DOI 10.1016/j.bbrc.2004.05.081; Svetlov MS, 2006, PROTEIN SCI, V15, P242, DOI 10.1110/ps.051752506; UVERSKY VN, 1992, FEBS LETT, V314, P89, DOI 10.1016/0014-5793(92)81468-2; Uversky VN, 1996, J MOL BIOL, V255, P215, DOI 10.1006/jmbi.1996.0018; Voisset C, 2011, BIOTECHNOL J, V6, P668, DOI 10.1002/biot.201100021; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Wong W, 2014, ELIFE, V3, DOI 10.7554/eLife.03080	51	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153928	10.1371/journal.pone.0153928	http://dx.doi.org/10.1371/journal.pone.0153928			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099964	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500097
J	Chen, J; Raju, GS; Jogunoori, W; Menon, V; Majumdar, A; Chen, JS; Gi, YJ; Jeong, YS; Phan, L; Belkin, M; Gu, SJ; Kundra, S; Mistry, NA; Zhang, JP; Su, XP; Li, SL; Lin, SH; Javle, M; McMurray, JS; Rahlfs, TF; Mishra, B; White, J; Rashid, A; Beauchemin, N; Weston, BR; Shafi, MA; Stroehlein, JR; Davila, M; Akbani, R; Weinstein, JN; Wu, XF; Mishra, L				Chen, Jian; Raju, Gottumukkala S.; Jogunoori, Wilma; Menon, Vipin; Majumdar, Avijit; Chen, Jiun-Sheng; Gi, Young Jin; Jeong, Yun Seong; Liem Phan; Belkin, Mitchell; Gu, Shoujun; Kundra, Suchin; Mistry, Nipun A.; Zhang, Jianping; Su, Xiaoping; Li, Shulin; Lin, Sue-Hwa; Javle, Milind; McMurray, John S.; Rahlfs, Thomas F.; Mishra, Bibhuti; White, Jon; Rashid, Asif; Beauchemin, Nicole; Weston, Brian R.; Shafi, Mehnaz A.; Stroehlein, John R.; Davila, Marta; Akbani, Rehan; Weinstein, John N.; Wu, Xifeng; Mishra, Lopa			Mutational Profiles Reveal an Aberrant TGF-beta-CEA Regulated Pathway in Colon Adenomas	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; COLORECTAL-CANCER; CARCINOEMBRYONIC ANTIGEN; MICROSATELLITE INSTABILITY; CELL-ADHESION; STEM-CELLS; TUMORIGENESIS; HOMEOSTASIS; PROGRESSION; MORTALITY	Mutational processes and signatures that drive early tumorigenesis are centrally important for early cancer prevention. Yet, to date, biomarkers and risk factors for polyps (adenomas) that inordinately and rapidly develop into colon cancer remain poorly defined. Here, we describe surprisingly high mutational profiles through whole-genome sequence (WGS) analysis in 2 of 4 pairs of benign colorectal adenoma tissue samples. Unsupervised hierarchical clustered transcriptomic analysis of a further 7 pairs of adenomas reveals distinct mutational signatures regardless of adenoma size. Transitional single nucleotide substitutions of C:G>T:A predominate in the adenoma mutational spectrum. Strikingly, we observe mutations in the TGF-beta pathway and CEA-associated genes in 4 out of 11 adenomas, overlapping with the Wnt pathway. Immunohistochemical labeling reveals a nearly 5-fold increase in CEA levels in 23% of adenoma samples with a concomitant loss of TGF-beta signaling. We also define a functional role by which the CEA B3 domain interacts with TGFBR1, potentially inactivating the tumor suppressor function of TGF-beta signaling. Our study uncovers diverse mutational processes underlying the transition from early adenoma to cancer. This has broad implications for biomarker-driven targeting of CEA/TGF-beta in high-risk adenomas and may lead to early detection of aggressive adenoma to CRC progression.	[Chen, Jian; Raju, Gottumukkala S.; Menon, Vipin; Majumdar, Avijit; Chen, Jiun-Sheng; Gi, Young Jin; Jeong, Yun Seong; Kundra, Suchin; Weston, Brian R.; Shafi, Mehnaz A.; Stroehlein, John R.; Davila, Marta; Mishra, Lopa] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA; [Jogunoori, Wilma; Belkin, Mitchell; Mishra, Bibhuti; White, Jon; Mishra, Lopa] Vet Affairs Med Ctr, Inst Clin Res, 50 Irving St NW, Washington, DC 20422 USA; [Liem Phan] Univ Texas MD Anderson Canc Ctr, Dept Mol Oncol, Houston, TX 77030 USA; [Liem Phan] Univ Texas MD Anderson Canc Ctr, Dept Cellular Oncol, Houston, TX 77030 USA; [Gu, Shoujun; Mishra, Lopa] George Washington Univ, Dept Surg, Ctr Translat Med, Washington, DC USA; [Gu, Shoujun; Mishra, Lopa] George Washington Univ, George Washington Canc Ctr, Washington, DC USA; [Mistry, Nipun A.; Zhang, Jianping; Su, Xiaoping; Akbani, Rehan; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat, Houston, TX 77030 USA; [Mistry, Nipun A.; Zhang, Jianping; Su, Xiaoping; Akbani, Rehan; Weinstein, John N.] Univ Texas MD Anderson Canc Ctr, Dept Computat Biol, Houston, TX 77030 USA; [Li, Shulin] Univ Texas MD Anderson Canc Ctr, Dept Pediat, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Javle, Milind] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [McMurray, John S.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Rahlfs, Thomas F.] Univ Texas MD Anderson Canc Ctr, Dept Anesthesiol & Perioperat Med, Houston, TX 77030 USA; [Rashid, Asif] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Beauchemin, Nicole] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Beauchemin, Nicole] McGill Univ, Dept Med, Montreal, PQ, Canada; [Beauchemin, Nicole] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; George Washington University; George Washington University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; McGill University; McGill University; McGill University; McGill University; University of Texas System; UTMD Anderson Cancer Center	Mishra, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Houston, TX 77030 USA.; Mishra, L (corresponding author), Vet Affairs Med Ctr, Inst Clin Res, 50 Irving St NW, Washington, DC 20422 USA.; Mishra, L (corresponding author), George Washington Univ, Dept Surg, Ctr Translat Med, Washington, DC USA.; Mishra, L (corresponding author), George Washington Univ, George Washington Canc Ctr, Washington, DC USA.	lmishra@GWU.edu	Akbani, Rehan/AAG-1490-2019; Menon, Vipin Kumar/J-7451-2019; Li, Shulin/D-6478-2011	Mishra, Lopa/0000-0002-6850-0808; Chen, Jiun-Sheng/0000-0002-0708-6498; Menon, Vipin/0000-0001-7404-678X; Weinstein, John/0000-0001-9401-6908; Phan, Liem/0000-0003-1194-216X	US National Institutes of Health NCI [RO1 CA106614, RO1 CA042857, PO1 CA130821, RC2 AA019392]; Multidisciplinary Research Program (MRP); Science & Technology Acquisition and Retention (STARs) [P30 CA016672, P30 DK56338]; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA130821, U24CA210949, R01CA106614, R01CA042857] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019392, R01AA023146] Funding Source: NIH RePORTER	US National Institutes of Health NCI; Multidisciplinary Research Program (MRP); Science & Technology Acquisition and Retention (STARs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This research was supported by US National Institutes of Health NCI, RO1 CA106614 (L.M.), RO1 CA042857 (L.M.), PO1 CA130821 (L.M.), RC2 AA019392 (L.M., H.T), Multidisciplinary Research Program (MRP) Proposal (L.M.), and Science & Technology Acquisition and Retention Funding (STARs) (L.M.), P30 CA016672 (L.M., R.D.,), and P30 DK56338 (L.M., M.E.).	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Barclay RL, 2006, NEW ENGL J MED, V355, P2533, DOI 10.1056/NEJMoa055498; BEAUCHEMIN N, 1987, MOL CELL BIOL, V7, P3221, DOI 10.1128/MCB.7.9.3221; Beauchemin N, 2013, CANC METASTASIS REV; Beauchemin N, 2013, CANCER METAST REV, V32, P643, DOI 10.1007/s10555-013-9444-6; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Chen LF, 2012, IMMUNITY, V37, P930, DOI 10.1016/j.immuni.2012.07.016; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Delker DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088367; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; International Agency of Research on Cancer, 2014, GLOBOCAN 2012 EST CA; Kreso A, 2014, NAT MED, V20, P29, DOI 10.1038/nm.3418; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; Li Y, 2010, CANCER RES, V70, P8159, DOI 10.1158/0008-5472.CAN-10-1073; Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756; Loberg M, 2014, NEW ENGL J MED, V371, P799, DOI 10.1056/NEJMoa1315870; Majumdar A, 2012, NAT REV GASTRO HEPAT, V9, P530, DOI 10.1038/nrgastro.2012.114; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mishra L, 2005, ONCOGENE, V24, P5775, DOI 10.1038/sj.onc.1208924; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muturi HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074654; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; OBRIEN MJ, 1990, GASTROENTEROLOGY, V98, P371, DOI 10.1016/0016-5085(90)90827-N; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Principe DR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt369; Roda G, 2014, MUCOSAL IMMUNOL, V7, P615, DOI 10.1038/mi.2013.80; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Samara RN, 2007, CANCER RES, V67, P4774, DOI 10.1158/0008-5472.CAN-06-4315; Shaukat A, 2013, NEW ENGL J MED, V369, P1106, DOI 10.1056/NEJMoa1300720; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tang Y, 2005, CANCER RES, V65, P4228, DOI 10.1158/0008-5472.CAN-04-4585; Tiernan JP, 2013, BRIT J CANCER, V108, P662, DOI 10.1038/bjc.2012.605; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yashiro M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-303; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370	39	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153933	10.1371/journal.pone.0153933	http://dx.doi.org/10.1371/journal.pone.0153933			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100181	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500099
J	Guan, HY; Xu, XB; He, CM; Liu, CX; Liu, Q; Dong, R; Liu, TS; Wang, LM				Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming			Fine Mapping and Candidate Gene Analysis of the Leaf-Color Gene ygl-1 in Maize	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; CHLOROPHYLL ANTENNA SIZE; B-DEFICIENT MUTANTS; CHLOROPLAST BIOGENESIS; ARABIDOPSIS-THALIANA; THYLAKOID MEMBRANES; FUNCTIONAL-ANALYSIS; PROTEIN-TRANSPORT; CPSRP PATHWAY; RICE	A novel yellow-green leaf mutant yellow-green leaf-1 (ygl-1) was isolated in self-pollinated progenies from the cross of maize inbred lines Ye478 and Yuanwu02. The mutant spontaneously showed yellow-green character throughout the lifespan. Meanwhile, the mutant reduced contents of chlorophyll and Car, arrested chloroplast development and lowered the capacity of photosynthesis compared with the wild-type Lx7226. Genetic analysis revealed that the mutant phenotype was controlled by a recessive nuclear gene. The ygl-1 locus was initially mapped to an interval of about 0.86 Mb in bin 1.01 on the short arm of chromosome 1 using 231 yellow-green leaf individuals of an F2 segregating population from ygl-1/Lx7226. Utilizing four new polymorphic SSR markers, the ygl-1 locus was narrowed down to a region of about 48 kb using 2930 and 2247 individuals of F2 and F3 mapping populations, respectively. Among the three predicted genes annotated within this 48 kb region, GRMZM2G007441, which was predicted to encode a cpSRP43 protein, had a 1-bp nucleotide deletion in the coding region of ygl-1 resulting in a frame shift mutation. Semi-quantitative RT-PCR analysis revealed that YGL-1 was constitutively expressed in all tested tissues and its expression level was not significantly affected in the ygl-1 mutant from early to mature stages, while light intensity regulated its expression both in the ygl-1 mutant and wild type seedlings. Furthermore, the mRNA levels of some genes involved in chloroplast development were affected in the six-week old ygl-1 plants. These findings suggested that YGL-1 plays an important role in chloroplast development of maize.	[Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Shandong Acad Agr Sci, Maize Res Inst, Jinan, Peoples R China; [Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Minist Agr, Key Lab Biol & Genet Improvement North Summer Mai, Jinan, Peoples R China; [Guan, Haiying; Xu, Xiangbo; He, Chunmei; Liu, Chunxiao; Liu, Qiang; Dong, Rui; Liu, Tieshan; Wang, Liming] Natl Maize Improvement Sub Ctr, Jinan, Peoples R China	Shandong Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Liu, TS; Wang, LM (corresponding author), Shandong Acad Agr Sci, Maize Res Inst, Jinan, Peoples R China.; Liu, TS; Wang, LM (corresponding author), Minist Agr, Key Lab Biol & Genet Improvement North Summer Mai, Jinan, Peoples R China.; Liu, TS; Wang, LM (corresponding author), Natl Maize Improvement Sub Ctr, Jinan, Peoples R China.	gongsi@188.com; lmwang@saas.ac.cn			Post-doctoral Innovative Projects of Shandong Province, China [201403017]	Post-doctoral Innovative Projects of Shandong Province, China	This work was supported by the Post-doctoral Innovative Projects of Shandong Province, China (201403017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge C, 2009, FEBS J, V276, P1177, DOI 10.1111/j.1742-4658.2009.06875.x; Amin P, 1999, PLANT PHYSIOL, V121, P61, DOI 10.1104/pp.121.1.61; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Beale SI, 2005, TRENDS PLANT SCI, V10, P309, DOI 10.1016/j.tplants.2005.05.005; BEDBROOK JR, 1978, P NATL ACAD SCI USA, V75, P3060, DOI 10.1073/pnas.75.7.3060; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chen G, 2005, PLANT J, V41, P364, DOI 10.1111/j.1365-313X.2004.02308.x; Chen H, 2013, PLANT CELL REP, V32, P1855, DOI 10.1007/s00299-013-1498-y; Cline K, 1996, ANNU REV CELL DEV BI, V12, P1, DOI 10.1146/annurev.cellbio.12.1.1; Comparot-Moss S, 2009, J EXP BOT, V60, P2481, DOI 10.1093/jxb/erp141; CRAIG E, 1990, ANTON LEEUW INT J G, V58, P137, DOI 10.1007/BF00548924; CROSSLAND LD, 1984, P NATL ACAD SCI-BIOL, V81, P4060, DOI 10.1073/pnas.81.13.4060; Deng XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099564; Falbel TG, 1996, PHYSIOL PLANTARUM, V97, P311, DOI 10.1034/j.1399-3054.1996.970214.x; Falbel TG, 1996, PLANT PHYSIOL, V112, P821, DOI 10.1104/pp.112.2.821; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; GHIRARDI ML, 1988, BIOCHIM BIOPHYS ACTA, V932, P130, DOI 10.1016/0005-2728(88)90147-8; GREENE BA, 1988, PLANT PHYSIOL, V87, P357, DOI 10.1104/pp.87.2.357; HU Z, 1981, Acta Genetica Sinica, V8, P256; Hutin C, 2002, PLANT J, V29, P531, DOI 10.1046/j.0960-7412.2001.01211.x; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kirst H, 2014, BIOTECHNOL ADV, V32, P66, DOI 10.1016/j.biotechadv.2013.08.018; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Klimyuk VI, 1995, MOL GEN GENET, V249, P357, DOI 10.1007/BF00287097; KROL M, 1995, PLANT PHYSIOL, V107, P873, DOI 10.1104/pp.107.3.873; Kumar AM, 2000, PLANT PHYSIOL, V122, P49, DOI 10.1104/pp.122.1.49; KYOZUKA J, 1993, PLANT PHYSIOL, V102, P991, DOI 10.1104/pp.102.3.991; Naested H, 2004, J CELL SCI, V117, P4807, DOI 10.1242/jcs.01360; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Nussaume L, 2008, NAT CHEM BIOL, V4, P529, DOI 10.1038/nchembio0908-529; Olinares PDB, 2011, BBA-BIOENERGETICS, V1807, P999, DOI 10.1016/j.bbabio.2010.12.003; Pilgrim ML, 1998, PLANT J, V13, P177, DOI 10.1046/j.1365-313X.1998.00021.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sawers RJH, 2006, PLANT MOL BIOL, V60, P95, DOI 10.1007/s11103-005-2880-0; Sawers RJH, 2004, PLANT PHYSIOL, V136, P2771, DOI 10.1104/pp.104.046417; Sawers RJH, 2002, PLANT PHYSIOL, V130, P155, DOI 10.1104/pp.006411; Schnell DJ, 1998, ANNU REV PLANT PHYS, V49, P97, DOI 10.1146/annurev.arplant.49.1.97; Schultes NP, 2000, PLANT J, V21, P317, DOI 10.1046/j.1365-313x.2000.00676.x; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Shi DY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080107; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Sun XiaoQiu, 2011, Acta Agronomica Sinica, V37, P991, DOI 10.3724/SP.J.1006.2011.00991; TERAO T, 1985, PLANT CELL PHYSIOL, V26, P1361; Tian XQ, 2013, GENES GENOM, V35, P87, DOI 10.1007/s13258-013-0069-5; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Voelker R, 1995, MOL GEN GENET, V249, P507, DOI 10.1007/BF00290576; Wu ZM, 2007, PLANT PHYSIOL, V145, P29, DOI 10.1104/pp.107.100321; Xing AQ, 2014, PLANT J, V79, P192, DOI 10.1111/tpj.12568; Xing C, 2008, BIOTECHNOLOGY B, V5, P10; Xu J, 2013, DNA RES, V20, P497, DOI 10.1093/dnares/dst026; Yoo SC, 2009, PLANT PHYSIOL, V150, P388, DOI 10.1104/pp.109.136648; Yu QB, 2009, PLANT J, V59, P1011, DOI 10.1111/j.1365-313X.2009.03930.x; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; Zhao Y, 2001, ACTA BOT SIN, V43, P877	59	16	19	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153962	10.1371/journal.pone.0153962	http://dx.doi.org/10.1371/journal.pone.0153962			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100184	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500111
J	Camerota, M; Bollen, KA				Camerota, Marie; Bollen, Kenneth A.			Birth Weight, Birth Length, and Gestational Age as Indicators of Favorable Fetal Growth Conditions in a US Sample	PLOS ONE			English	Article							ORIGINS; RISK	The "fetal origins" hypothesis suggests that fetal conditions not only affect birth characteristics such as birth weight and gestational age, but also have lifelong health implications. Despite widespread interest in this hypothesis, few methodological advances have been proposed to improve the measurement and modeling of fetal conditions. A Statistics in Medicine paper by Bollen, Noble, and Adair examined favorable fetal growth conditions (FFGC) as a latent variable. Their study of Filipino children from Cebu provided evidence consistent with treating FFGC as a latent variable that largely mediates the effects of mother's characteristics on birth weight, birth length, and gestational age. This innovative method may have widespread utility, but only if the model applies equally well across diverse settings. Our study assesses whether the FFGC model of Cebu replicates and generalizes to a very different population of children from North Carolina (N = 705) and Pennsylvania (N = 494). Using a series of structural equation models, we find that key features of the Cebu analysis replicate and generalize while we also highlight differences between these studies. Our results support treating fetal conditions as a latent variable when researchers test the fetal origins hypothesis. In addition to contributing to the substantive literature on measuring fetal conditions, we also discuss the meaning and challenges involved in replicating prior research.	[Camerota, Marie; Bollen, Kenneth A.] Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA; [Bollen, Kenneth A.] Univ N Carolina, Dept Sociol, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Camerota, M (corresponding author), Univ N Carolina, Dept Psychol & Neurosci, Chapel Hill, NC USA.	marie.camerota@unc.edu	Camerota, Marie/AAD-4789-2021	Camerota, Marie/0000-0001-8293-6467	National Institute of Child Health and Human Development [P01 HD39667]; National Institute on Drug Abuse; Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01 HD031921]; Carolina Population Center and its NIH/NICHD center [P2C HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921, P2CHD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD039667] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Carolina Population Center and its NIH/NICHD center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Support for the Family Life Project was provided by National Institute of Child Health and Human Development Grant P01 HD39667, with co-funding from the National Institute on Drug Abuse (https://www.nichd.nih.gov). Bollen acknowledges partial support from Grant P01 HD031921, "National Longitudinal Study of Adolescent to Adult Health: Wave V," from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and general support from the Carolina Population Center and its NIH/NICHD center grant (P2C HD050924). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171; Bollen K., 2015, SOCIAL BEHAV EC SCI, P1; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bollen KA, 2013, STAT MED, V32, P2950, DOI 10.1002/sim.5771; Brandt MJ, 2014, J EXP SOC PSYCHOL, V50, P217, DOI 10.1016/j.jesp.2013.10.005; Burchinal M, 2008, PARENT-SCI PRACT, V8, P41, DOI 10.1080/15295190701830672; Caughey AB, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.034; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Dill BT, 2001, BLACKWELL COMPANIONS, P197; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Huxley RR, 2000, J HYPERTENS, V18, P815, DOI 10.1097/00004872-200018070-00002; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Lederman S A, 1998, Matern Child Health J, V2, P123; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; Moonesinghe R, 2007, PLOS MED, V4, P218, DOI 10.1371/journal.pmed.0040028; Muthen L.K., 2020, MPLUS; Paternoster R, 1998, CRIMINOLOGY, V36, P859, DOI 10.1111/j.1745-9125.1998.tb01268.x; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Vernon-Feagans L, 2014, FAMILY LIFE PROJECT, DOI 10.3886/ICPSR34602.v1; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Zhang JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064542	24	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153800	10.1371/journal.pone.0153800	http://dx.doi.org/10.1371/journal.pone.0153800			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097023	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600059
J	Gilroy, KL; Terry, A; Naseer, A; de Ridder, J; Allahyar, A; Wang, WW; Carpenter, E; Mason, A; Wong, GKS; Cameron, ER; Kilbey, A; Neil, JC				Gilroy, Kathryn L.; Terry, Anne; Naseer, Asif; de Ridder, Jeroen; Allahyar, Amin; Wang, Weiwei; Carpenter, Eric; Mason, Andrew; Wong, Gane K-S; Cameron, Ewan R.; Kilbey, Anna; Neil, James C.			Gamma-Retrovirus Integration Marks Cell Type-Specific Cancer Genes: A Novel Profiling Tool in Cancer Genomics	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; INSERTIONAL MUTAGENESIS; REGULATORY ELEMENTS; SUPER-ENHANCERS; HIV-1 INTEGRASE; LEUKEMOGENESIS; IDENTIFICATION; DETERMINANTS; DISRUPTION; MUTATIONS	Retroviruses have been foundational in cancer research since early studies identified protooncogenes as targets for insertional mutagenesis. Integration of murine gamma-retroviruses into the host genome favours promoters and enhancers and entails interaction of viral integrase with host BET/bromodomain factors. We report that this integration pattern is conserved in feline leukaemia virus (FeLV), a gamma-retrovirus that infects many human cell types. Analysis of FeLV insertion sites in the MCF-7 mammary carcinoma cell line revealed strong bias towards active chromatin marks with no evidence of significant post-integration growth selection. The most prominent FeLV integration targets had little overlap with the most abundantly expressed transcripts, but were strongly enriched for annotated cancer genes. A meta-analysis based on several gamma-retrovirus integration profiling (GRIP) studies in human cells (CD34+, K562, HepG2) revealed a similar cancer gene bias but also remarkable cell-type specificity, with prominent exceptions including a universal integration hotspot at the long non-coding RNA MALAT1. Comparison of GRIP targets with databases of super-enhancers from the same cell lines showed that these have only limited overlap and that GRIP provides unique insights into the upstream drivers of cell growth. These observations elucidate the oncogenic potency of the gamma-retroviruses and support the wider application of GRIP to identify the genes and growth regulatory circuits that drive distinct cancer types.	[Gilroy, Kathryn L.; Terry, Anne; Naseer, Asif; Cameron, Ewan R.; Kilbey, Anna; Neil, James C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland; [de Ridder, Jeroen; Allahyar, Amin] Delft Univ Technol, Delft Bioinformat Lab, Fac EEMCS, Delft, Netherlands; [Wang, Weiwei; Carpenter, Eric; Wong, Gane K-S] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Mason, Andrew] Univ Alberta, Ctr Excellence Gastrointestinal Inflammat & Immun, Edmonton, AB, Canada; [Naseer, Asif] Khyber Med Univ, Phase 5, Peshawar, Kyber Pakhtunkh, Pakistan	University of Glasgow; Delft University of Technology; University of Alberta; University of Alberta; Khyber Medical University	Gilroy, KL; Neil, JC (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland.	Kathryn.Gilroy@glasgow.ac.uk; James.Neil@glasgow.ac.uk	WONG, Gane Ka-Shu/G-5784-2013	WONG, Gane Ka-Shu/0000-0001-6108-5560; Gilroy, Kathryn/0000-0003-4607-194X; Allahyar, Amin/0000-0003-2567-0273	Cancer Research UK [A11951]; Bloodwise [13046]; VENI from NWO (Netherlands Organisation for Scientific Research) [639.021.233]; Canadian Institutes for Health Research [MOP 97798]; Alberta Innovates Technology Futures (AITF); Innovates Centre of Research Excellence (iCORE); Cancer Research UK [11951] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Bloodwise; VENI from NWO (Netherlands Organisation for Scientific Research); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Futures (AITF); Innovates Centre of Research Excellence (iCORE); Cancer Research UK(Cancer Research UK)	KLG, AT, AN, AK, ERC and JCN were supported by a joint programme from Cancer Research UK and Bloodwise (grant numbers A11951 (CRUK) and 13046 (Bloodwise); URLs are http://www.cancerresearchuk.org/ and https://bloodwise.org.uk/). JdR was funded by a VENI grant (639.021.233) from NWO (Netherlands Organisation for Scientific Research, http://www.nwo.nl/). AM was funded by Canadian Institutes for Health Research (MOP 97798, http://www.cihr-irsc.gc.ca/). GK-SW was funded by Alberta Innovates Technology Futures (AITF, http://www.albertatechfutures.ca/) and Innovates Centre of Research Excellence (iCORE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiyer S, 2014, NUCLEIC ACIDS RES, V42, P5917, DOI 10.1093/nar/gku175; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Cattoglio C, 2010, BLOOD, V116, P5507, DOI 10.1182/blood-2010-05-283523; Chapuy B, 2013, CANCER CELL, V24, P777, DOI 10.1016/j.ccr.2013.11.003; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Davie K, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004994; De Rijck J, 2013, CELL REP, V5, P886, DOI 10.1016/j.celrep.2013.09.040; Fan H, 1997, TRENDS MICROBIOL, V5, P74, DOI 10.1016/S0966-842X(96)10076-7; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gupta SS, 2013, J VIROL, V87, P12721, DOI 10.1128/JVI.01942-13; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hanlon L, 2003, J VIROL, V77, P1059, DOI 10.1128/JVI.77.2.1059-1068.2003; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; Huser CA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004167; Hwang HC, 2002, P NATL ACAD SCI USA, V99, P11293, DOI 10.1073/pnas.162356099; JARRETT O, 1969, NATURE, V224, P1208, DOI 10.1038/2241208a0; Khan A, 2016, NUCLEIC ACIDS RES, V44, pD164, DOI 10.1093/nar/gkv1002; Kool J, 2010, CANCER RES, V70, P520, DOI 10.1158/0008-5472.CAN-09-2736; LaFave MC, 2014, NUCLEIC ACIDS RES, V42, P4257, DOI 10.1093/nar/gkt1399; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mattison J, 2010, CANCER RES, V70, P883, DOI 10.1158/0008-5472.CAN-09-1737; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Naseer A, 2015, VIRUSES-BASEL, V7, P2014, DOI 10.3390/v7042014; Pott S, 2015, NAT GENET, V47, P8, DOI 10.1038/ng.3167; Sharma A, 2013, P NATL ACAD SCI USA, V110, P12036, DOI 10.1073/pnas.1307157110; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sorensen KD, 2007, VIROLOGY, V362, P179, DOI 10.1016/j.virol.2006.12.016; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sugai J, 2001, J VIROL, V75, P6841, DOI 10.1128/JVI.75.15.6841-6849.2001; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; TSATSANIS C, 1994, J VIROL, V68, P8296, DOI 10.1128/JVI.68.12.8296-8303.1994; Uren AG, 2005, ONCOGENE, V24, P7656, DOI 10.1038/sj.onc.1209043; Wang W, 2015, ALIMENT PHARM THER, V41, P393, DOI 10.1111/apt.13054; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yoshimoto R, 2016, BBA-GENE REGUL MECH, V1859, P192, DOI 10.1016/j.bbagrm.2015.09.012; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao YJ, 2013, J MED CHEM, V56, P7498, DOI 10.1021/jm4014407; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	42	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154070	10.1371/journal.pone.0154070	http://dx.doi.org/10.1371/journal.pone.0154070			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097319	gold, Green Accepted, Green Published			2022-12-27	WOS:000374543600085
J	Yuan, SM; Nie, WC; He, F; Jia, ZW; Gao, XD				Yuan, Si-Min; Nie, Wen-Chao; He, Fei; Jia, Zhi-Wen; Gao, Xiang-Dong			Kin2, the Budding Yeast Ortholog of Animal MARK/PAR-1 Kinases, Localizes to the Sites of Polarized Growth and May Regulate Septin Organization and the Cell Wall	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; FISSION YEAST; CYCLE; EXOCYTOSIS; GTPASE; FAMILY	MARK/PAR-1 protein kinases play important roles in cell polarization in animals. Kin1 and Kin2 are a pair of MARK/PAR-1 orthologs in the budding yeast Saccharomyces cerevisiae. They participate in the regulation of secretion and ER stress response. However, neither the subcellular localization of these two kinases nor whether they may have other cellular functions is clear. Here, we show that Kin2 localizes to the sites of polarized growth in addition to localization on the plasma membrane. The localization to polarity sites is mediated by two targeting domains-TD1 and TD2. TD1 locates in the N-terminal region that spans the protein kinase domain whereas TD2 locates in the C-terminal end that covers the KA1 domain. We also show that an excess of Kin2 activity impaired growth, septin organization, and chitin deposition in the cell wall. Both TD1 and TD2 contribute to this function. Moreover, we find that the C-terminal region of Kin2 interacts with Cdc11, a septin subunit, and Pea2, a component of the polarisome that is known to play a role in septin organization. These findings suggest that Kin2 may play a role in the regulation of the septin cytoskeleton and the cell wall. Finally, we show that the C-terminal region of Kin2 interacts with Rho3, a Rho GTPase, whereas the N-terminal region of Kin2 interacts with Bmh1, a 14-3-3 protein. We speculate that Kin2 may be regulated by Bmh1, Rho3, or Pea2 in vivo. Our study provides new insight in the localization, function, and regulation of Kin2.	[Yuan, Si-Min; Nie, Wen-Chao; He, Fei; Jia, Zhi-Wen; Gao, Xiang-Dong] Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China; [Gao, Xiang-Dong] Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China	Wuhan University	Gao, XD (corresponding author), Wuhan Univ, Coll Life Sci, Dept Microbiol, Wuhan 430072, Peoples R China.; Gao, XD (corresponding author), Hubei Prov Cooperat Innovat Ctr Ind Fermentat, Wuhan, Peoples R China.	xdgao@whu.edu.cn		Gao, Xiang-Dong/0000-0002-1008-2324	National Natural Science Foundation of China [31370124, 31570076]; National Infrastructure of Natural Resources for Science and Technology Program of China [NIMR-2014-8]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Infrastructure of Natural Resources for Science and Technology Program of China	This work was supported by the National Natural Science Foundation of China (grant no. 31370124 and 31570076) to XDG and by National Infrastructure of Natural Resources for Science and Technology Program of China (no. NIMR-2014-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo JE, 2001, J CELL BIOL, V155, P581, DOI 10.1083/jcb.200106065; Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Anshu A, 2015, MOL CELL BIOL, V35, P199, DOI 10.1128/MCB.00981-14; Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bi EF, 1996, MOL CELL BIOL, V16, P5264; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Bouquin N, 2000, J CELL SCI, V113, P1435; Cadou A, 2010, MOL MICROBIOL, V77, P1186, DOI 10.1111/j.1365-2958.2010.07281.x; Donavan M, 1994, YEAST, V10, P113; Drewes G, 2003, FEBS LETT, V554, P45, DOI 10.1016/S0014-5793(03)01080-9; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Elbert M, 2005, MOL BIOL CELL, V16, P532, DOI 10.1091/mbc.E04-07-0549; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079; Gao XD, 2003, J CELL BIOL, V162, P635, DOI 10.1083/jcb.200302038; Gao XD, 2007, MOL BIOL CELL, V18, P2542, DOI 10.1091/mbc.e06-09-0822; Gasser B, 2007, APPL ENVIRON MICROB, V73, P6499, DOI 10.1128/AEM.01196-07; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gong T, 2013, EUKARYOT CELL, V12, P368, DOI 10.1128/EC.00277-12; Guo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016744; Guo S, 1996, NATURE, V382, P455, DOI 10.1038/382455a0; He F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123326; James P, 1996, GENETICS, V144, P1425; Katoda J, 2004, MOL BIOL CELL, V15, P5329; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; LAMB A, 1991, YEAST, V7, P219, DOI 10.1002/yea.320070304; LEVIN DE, 1990, P NATL ACAD SCI USA, V87, P8272, DOI 10.1073/pnas.87.21.8272; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luo JY, 2004, J CELL BIOL, V165, P843, DOI 10.1083/jcb.200401040; Luo YP, 2014, NEW PHYTOL, V204, P943, DOI 10.1111/nph.12953; MATSUI Y, 1992, MOL CELL BIOL, V12, P5690, DOI 10.1128/MCB.12.12.5690; Moravcevic K, 2010, CELL, V143, P966, DOI 10.1016/j.cell.2010.11.028; Mortensen EM, 2002, MOL BIOL CELL, V13, P2091, DOI 10.1091/mbc.01-10-0500; Morton DG, 2002, DEV BIOL, V241, P47, DOI 10.1006/dbio.2001.0489; Mylonakis E, 2004, MOL MICROBIOL, V54, P407, DOI 10.1111/j.1365-2958.2004.04310.x; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Pruyne D, 2000, J CELL SCI, V113, P571; Richman TJ, 2002, EUKARYOT CELL, V1, P458, DOI 10.1128/EC.1.3.458-468.2002; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053; Steczkiewicz K, 2010, CELL CYCLE, V9, P201, DOI 10.4161/cc.9.1.10510; Suzuki A, 2004, CURR BIOL, V14, P1425, DOI 10.1016/j.cub.2004.08.021; Tassan JP, 2004, BIOL CELL, V96, P193, DOI 10.1016/j.biolcel.2003.10.009; TIBBETTS M, 1994, EXP CELL RES, V213, P93, DOI 10.1006/excr.1994.1177; Tochio N, 2006, PROTEIN SCI, V15, P2534, DOI 10.1110/ps.062391106; Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725; van Heusden GPH, 2006, YEAST, V23, P159, DOI 10.1002/yea.1338; Wu H, 2010, MOL CELL BIOL, V30, P5207, DOI 10.1128/MCB.00366-10; Yin QY, 2005, J BIOL CHEM, V280, P20894, DOI 10.1074/jbc.M500334200	55	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153992	10.1371/journal.pone.0153992	http://dx.doi.org/10.1371/journal.pone.0153992			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096577	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600080
J	Dawson, SJ; Chivers, ML				Dawson, Samantha J.; Chivers, Meredith L.			Gender-Specificity of Initial and Controlled Visual Attention to Sexual Stimuli in Androphilic Women and Gynephilic Men	PLOS ONE			English	Article							GENERALIZED ANXIETY DISORDER; EYE-MOVEMENTS; INSTRUCTIONAL-CONTROL; HETEROSEXUAL WOMEN; PHALLOMETRIC TEST; VOLUNTARY CONTROL; AROUSAL; PATTERNS; INHIBITION; VALIDATION	Research across groups and methods consistently finds a gender difference in patterns of specificity of genital response; however, empirically supported mechanisms to explain this difference are lacking. The information-processing model of sexual arousal posits that automatic and controlled cognitive processes are requisite for the generation of sexual responses. Androphilic women's gender-nonspecific response patterns may be the result of sexually-relevant cues that are common to both preferred and nonpreferred genders capturing attention and initiating an automatic sexual response, whereas men's attentional system may be biased towards the detection and response to sexually-preferred cues only. In the present study, we used eye tracking to assess visual attention to sexually-preferred and nonpreferred cues in a sample of androphilic women and gynephilic men. Results support predictions from the information-processing model regarding gendered processing of sexual stimuli in men and women. Men's initial attention patterns were gender-specific, whereas women's were nonspecific. In contrast, both men and women exhibited gender-specific patterns of controlled attention, although this effect was stronger among men. Finally, measures of attention and self-reported attraction were positively related in both men and women. These findings are discussed in the context of the information-processing model and evolutionary mechanisms that may have evolved to promote gendered attentional systems.	[Dawson, Samantha J.; Chivers, Meredith L.] Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Chivers, ML (corresponding author), Queens Univ, Dept Psychol, Kingston, ON K7L 3N6, Canada.	Meredith.Chivers@queensu.ca			Natural Sciences and Engineering Research Council of Canada Discover Grant; Canada Foundation for Innovation Infrastructure Operating Fund; Ontario Trillium Scholarship	Natural Sciences and Engineering Research Council of Canada Discover Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation Infrastructure Operating Fund; Ontario Trillium Scholarship	This work was supported by the Natural Sciences and Engineering Research Council of Canada Discover Grant (MLC), Canada Foundation for Innovation Infrastructure Operating Fund (MLC), and Ontario Trillium Scholarship (SJD). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CAUSES RAPE UNDERSTA; [Anonymous], 2007, PSYCHOPHYSIOLOGY SEX; Bancroft J, 2003, ENCY COGNITIVE SCI; BECK JG, 1994, ARCH SEX BEHAV, V23, P665, DOI 10.1007/BF01541818; Bjorklund DF, 1996, PSYCHOL BULL, V120, P163, DOI 10.1037/0033-2909.120.2.163; Blanchard R, 2001, PSYCHOL ASSESSMENT, V13, P118, DOI 10.1037/1040-3590.13.1.118; Bradley BP, 2000, COGNITION EMOTION, V14, P789, DOI 10.1080/02699930050156636; Bradley MM, 2015, INT J PSYCHOPHYSIOL, V98, P54, DOI 10.1016/j.ijpsycho.2015.06.008; Buodo G, 2002, MOTIV EMOTION, V26, P123, DOI 10.1023/A:1019886501965; Calvo MG, 2004, MOTIV EMOTION, V28, P221, DOI 10.1023/B:MOEM.0000040153.26156.ed; CASH TF, 1995, J PERS ASSESS, V64, P466, DOI 10.1207/s15327752jpa6403_6; CERNY JA, 1978, BEHAV THER, V9, P847, DOI 10.1016/S0005-7894(78)80016-1; Chivers ML, 2007, J PERS SOC PSYCHOL, V93, P1108, DOI 10.1037/0022-3514.93.6.1108; Chivers ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142575; Chivers ML, 2012, ARCH SEX BEHAV, V41, P185, DOI 10.1007/s10508-012-9937-3; Chivers ML, 2004, PSYCHOL SCI, V15, P736, DOI 10.1111/j.0956-7976.2004.00750.x; Chivers ML, 2005, BIOL PSYCHOL, V70, P115, DOI 10.1016/j.biopsycho.2004.12.002; de Jong DC, 2009, J SEX RES, V46, P237, DOI 10.1080/00224490902747230; DEKKER J, 1985, BEHAV RES THER, V23, P139, DOI 10.1016/0005-7967(85)90022-1; FISHER WA, 1988, J SEX RES, V25, P123, DOI 10.1080/00224498809551448; Forsythe A, 2008, BEHAV RES METHODS, V40, P116, DOI 10.3758/BRM.40.1.116; FREUND K, 1989, J CONSULT CLIN PSYCH, V57, P100, DOI 10.1037/0022-006X.57.1.100; Freund K, 1991, PSYCHOL ASSESSMENT J, V3, P254, DOI DOI 10.1037/1040-3590.3.2.254; Fromberger P, 2013, J ABNORM PSYCHOL, V122, P587, DOI 10.1037/a0030659; Fromberger P, 2012, J SEX MED, V9, P1868, DOI 10.1111/j.1743-6109.2012.02754.x; Fromberger P, 2012, ARCH SEX BEHAV, V41, P919, DOI 10.1007/s10508-011-9816-3; Gerdes ABM, 2009, J NEURAL TRANSM, V116, P725, DOI 10.1007/s00702-008-0167-8; Graham CA, 2006, ARCH SEX BEHAV, V35, P397, DOI 10.1007/s10508-006-9041-7; HEIMAN JR, 1983, J PSYCHOSOM RES, V27, P105, DOI 10.1016/0022-3999(83)90086-7; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM., 1992, EYE MOVEMENTS VISUAL, P260, DOI [DOI 10.1007/978-1-4612-2852-3_15, 10.1007/978-1-4612-2852-3_15]; Herbenick D, 2013, J SEX MED, V10, P1516, DOI 10.1111/jsm.12124; Herbenick D, 2010, J SEX MED, V7, P1822, DOI 10.1111/j.1743-6109.2010.01728.x; Hermans D, 1999, COGNITION EMOTION, V13, P419, DOI 10.1080/026999399379249; Hoffman JE, 1998, ATTENTION, P119; Huberman JS, 2015, PSYCHOPHYSIOLOGY, V52, P1382, DOI 10.1111/psyp.12466; Huberman JS, J SEX RES IN PRESS, P1; Janssen E, 2002, J SEX RES, V39, P114, DOI 10.1080/00224490209552130; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kinsey Alfred, 1953, SEXUAL BEHAV HUMAN F; LAAN E, 1993, BEHAV RES THER, V31, P25, DOI 10.1016/0005-7967(93)90039-W; Laan E., 1994, THESIS U AMSTERDAM A; LALUMIERE ML, 1992, BEHAV ASSESS, V14, P121; LAWS DR, 1969, J APPL BEHAV ANAL, V2, P93, DOI 10.1901/jaba.1969.2-93; Lykins AD, 2008, ARCH SEX BEHAV, V37, P219, DOI 10.1007/s10508-007-9208-x; Lykins AD, 2006, ARCH SEX BEHAV, V35, P569, DOI 10.1007/s10508-006-9065-z; Mogg K, 2000, J ABNORM PSYCHOL, V109, P695, DOI 10.1037/0021-843X.109.4.695; Mogg K, 2007, BIOL PSYCHOL, V76, P163, DOI 10.1016/j.biopsycho.2007.07.005; Morrison MA, 2002, J HOMOSEXUAL, V43, P15, DOI 10.1300/J082v43n02_02; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Nummenmaa L, 2012, ARCH SEX BEHAV, V41, P1439, DOI 10.1007/s10508-012-9911-0; Ohman A, 2005, PSYCHONEUROENDOCRINO, V30, P953, DOI 10.1016/j.psyneuen.2005.03.019; Olatunji BO, 2007, J ANXIETY DISORD, V21, P918, DOI 10.1016/j.janxdis.2006.12.005; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Peterson ZD, 2010, ARCH SEX BEHAV, V39, P880, DOI 10.1007/s10508-009-9546-y; Ponseti J, 2010, ARCH SEX BEHAV, V39, P1073, DOI 10.1007/s10508-009-9587-2; Renfro KJ, 2015, HORM BEHAV, V75, P33, DOI 10.1016/j.yhbeh.2015.07.013; Rieger G, 2005, PSYCHOL SCI, V16, P579, DOI 10.1111/j.1467-9280.2005.01578.x; Rieger G, 2015, BIOL PSYCHOL, V104, P56, DOI 10.1016/j.biopsycho.2014.11.009; Rieger G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040256; Rinck M, 2006, J ABNORM PSYCHOL, V115, P231, DOI 10.1037/0021-843X.115.2.231; Rohner JC, 2002, COGNITION EMOTION, V16, P837, DOI 10.1080/02699930143000572; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Rupp HA, 2007, HORM BEHAV, V51, P524, DOI 10.1016/j.yhbeh.2007.01.008; Seto MC, 2000, PSYCHOL ASSESSMENT, V12, P319, DOI 10.1037/1040-3590.12.3.319; Sheen J, 2009, J SEX RES, V46, P358, DOI 10.1080/00224490902775843; Snowden RJ, 2013, ARCH SEX BEHAV, V42, P475, DOI 10.1007/s10508-012-9920-z; Spape J, 2014, BIOL PSYCHOL, V102, P1, DOI 10.1016/j.biopsycho.2014.07.008; Spector IP, 1996, J SEX MARITAL THER, V22, P175; Spiering M, 2003, J SEX RES, V40, P134, DOI 10.1080/00224490309552175; Spiering M, 2006, J SEX RES, V43, P268, DOI 10.1080/00224490609552325; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEIGER JH, 1980, PSYCHOL BULL, V87, P245, DOI 10.1037/0033-2909.87.2.245; STEINMAN DL, 1981, ARCH SEX BEHAV, V10, P529, DOI 10.1007/BF01541588; Suschinsky KD, 2011, PSYCHOL SCI, V22, P159, DOI 10.1177/0956797610394660; Suschinsky KD, 2009, ARCH SEX BEHAV, V38, P559, DOI 10.1007/s10508-008-9339-8; Tollison CD., 1979, J BEHAV ASSESS, V1, P305, DOI [10.1007/BF01321372, DOI 10.1007/BF01321372]; Toothaker LE, 1991, MULTIPLE COMP RES; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Tsujimura A, 2009, J SEX MED, V6, P1011, DOI 10.1111/j.1743-6109.2008.01031.x; van Lunsen RHW, 2004, MENOPAUSE, V11, P741, DOI 10.1097/01.GME.0000143704.48324.46; Wallen K, 2010, HORM BEHAV, V57, P263, DOI 10.1016/j.yhbeh.2009.12.005; WINCZE JP, 1984, ARCH SEX BEHAV, V13, P361, DOI 10.1007/BF01541908; Yarbus A.L., 1965, ROLE EYE MOVEMENTS V	87	36	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152785	10.1371/journal.pone.0152785	http://dx.doi.org/10.1371/journal.pone.0152785			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088358	gold, Green Published, Green Submitted			2022-12-27	WOS:000374527000009
J	Liu, J; Hao, ZY; Ma, LL; Ji, YR; Bartlam, M; Wang, YY				Liu, Jie; Hao, Zhenyu; Ma, Lili; Ji, Yurui; Bartlam, Mark; Wang, Yingying			Spatio-Temporal Variations of High and Low Nucleic Acid Content Bacteria in an Exorheic River	PLOS ONE			English	Article							SEASONAL DYNAMICS; COASTAL WATERS; CYTOMETRIC CHARACTERISTICS; PICOPLANKTON COMMUNITY; CELLS; HNA; POPULATIONS; DIVERSITY; GROWTH; BLOOM	Bacteria with high nucleic acid (HNA) and low nucleic acid (LNA) content are commonly observed in aquatic environments. To date, limited knowledge is available on their temporal and spatial variations in freshwater environments. Here an investigation of HNA and LNA bacterial abundance and their flow cytometric characteristics was conducted in an exorheic river (Haihe River, Northern China) over a one year period covering September (autumn) 2011, December (winter) 2011, April (spring) 2012, and July (summer) 2012. The results showed that LNA and HNA bacteria contributed similarly to the total bacterial abundance on both the spatial and temporal scale. The variability of HNA on abundance, fluorescence intensity (FL1) and side scatter (SSC) were more sensitive to environmental factors than that of LNA bacteria. Meanwhile, the relative distance of SSC between HNA and LNA was more variable than that of FL1. Multivariate analysis further demonstrated that the influence of geographical distance (reflected by the salinity gradient along river to ocean) and temporal changes (as temperature variation due to seasonal succession) on the patterns of LNA and HNA were stronger than the effects of nutrient conditions. Furthermore, the results demonstrated that the distribution of LNA and HNA bacteria, including the abundance, FL1 and SSC, was controlled by different variables. The results suggested that LNA and HNA bacteria might play different ecological roles in the exorheic river.	[Liu, Jie; Hao, Zhenyu; Ma, Lili; Ji, Yurui; Wang, Yingying] Nankai Univ, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Wang, Yingying] Nankai Univ, Coll Environm Sci & Engn, Tianjin Key Lab Environm Remediat & Pollut Contro, Tianjin 300071, Peoples R China; [Bartlam, Mark] Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300071, Peoples R China; [Bartlam, Mark] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Liu, Jie] Tsinghua Univ, Grad Sch Shenzhen, State Environm Protect Key Lab Microorganism Appl, Shenzhen 518057, Guangdong, Peoples R China; [Ma, Lili] Southwest Petr Univ, Coll Chem & Chem Engn, Chengdu, Sichuan, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Southwest Petroleum University	Wang, YY (corresponding author), Nankai Univ, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.; Wang, YY (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Tianjin Key Lab Environm Remediat & Pollut Contro, Tianjin 300071, Peoples R China.	wangyy@nankai.edu.cn	wang, yan/GSE-6489-2022; HAO, ZHENYU/AAF-3810-2019; wang, yingying/GRS-3058-2022; Liu, Jie/GRN-8750-2022	Bartlam, Mark/0000-0001-5173-5080; Liu, Jie/0000-0002-3849-6414	National Key Basic Research Program of China [2015CB459000]; National Natural Science Foundation, China [31322012]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation, China(National Natural Science Foundation of China (NSFC))	The authors are grateful to the financial support from National Key Basic Research Program of China (2015CB459000) and National Natural Science Foundation, China (31322012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade L, 2007, BRAZ J MICROBIOL, V38, P330, DOI 10.1590/S1517-83822007000200028; Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x; Bouvier T, 2011, MICROB ECOL, V62, P669, DOI 10.1007/s00248-011-9862-3; Calvo-Diaz A, 2006, AQUAT MICROB ECOL, V42, P159, DOI 10.3354/ame042159; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Gilbert JA, 2012, ISME J, V6, P298, DOI 10.1038/ismej.2011.107; Gomes A, 2015, DEEP-SEA RES PT I, V96, P59, DOI 10.1016/j.dsr.2014.11.007; Gozdereliler E, 2013, APPL ENVIRON MICROB, V79, P367, DOI 10.1128/AEM.02536-12; Huete-Stauffer TM, 2012, AQUAT MICROB ECOL, V67, P211, DOI 10.3354/ame01590; Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7; Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001; Lebaron P, 2002, AQUAT MICROB ECOL, V28, P131, DOI 10.3354/ame028131; Liu J, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.7015.00329, 10.3389/fmicb.2015.00329]; Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005; Ma Lili, 2016, Front Microbiol, V7, P250, DOI 10.3389/fmicb.2016.00250; Ma LL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/526362; Nishimura Y, 2005, APPL ENVIRON MICROB, V71, P5828, DOI 10.1128/AEM.71.10.5828-5836.2005; Palesse S, 2014, MICROB ECOL, V68, P740, DOI 10.1007/s00248-014-0441-2; Ramette A, 2007, FEMS MICROBIOL ECOL, V62, P142, DOI 10.1111/j.1574-6941.2007.00375.x; Ramseier MK, 2011, WATER RES, V45, P1490, DOI 10.1016/j.watres.2010.11.016; Read DS, 2015, ISME J, V9, P516, DOI 10.1038/ismej.2014.166; Rosel S, 2012, AQUAT MICROB ECOL, V66, P169, DOI 10.3354/ame01568; Salcher MM, 2011, ISME J, V5, P1242, DOI 10.1038/ismej.2011.8; Salter I, 2015, ISME J, V9, P347, DOI 10.1038/ismej.2014.129; Santic D, 2014, MEDITERR MAR SCI, V15, P179; Santic D, 2013, HELGOLAND MAR RES, V67, P471, DOI 10.1007/s10152-012-0336-x; Santic D, 2012, ACTA ADRIAT, V53, P25; Schattenhofer M, 2011, SYST APPL MICROBIOL, V34, P470, DOI 10.1016/j.syapm.2011.01.008; Solic M, 2009, AQUAT MICROB ECOL, V58, P15, DOI 10.3354/ame01342; Van Wambeke F, 2011, BIOGEOSCIENCES, V8, P1853, DOI 10.5194/bg-8-1853-2011; Vila-Costa M, 2012, ENVIRON MICROBIOL, V14, P1390, DOI 10.1111/j.1462-2920.2012.02720.x; Wang YY, 2009, ISME J, V3, P889, DOI 10.1038/ismej.2009.46; Williams TJ, 2009, ISME J, V3, P1036, DOI 10.1038/ismej.2009.52; Worden AZ, 2004, LIMNOL OCEANOGR, V49, P168, DOI 10.4319/lo.2004.49.1.0168	35	13	16	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153678	10.1371/journal.pone.0153678	http://dx.doi.org/10.1371/journal.pone.0153678			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082986	gold, Green Submitted, Green Published			2022-12-27	WOS:000374291800044
J	Yuen, CM; Kammerer, JS; Marks, K; Navin, TR; France, AM				Yuen, Courtney M.; Kammerer, J. Steve; Marks, Kala; Navin, Thomas R.; France, Anne Marie			Recent Transmission of Tuberculosis - United States, 2011-2014	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; OUTBREAK; HOMELESS; COUNTY; GENOTYPE	Tuberculosis is an infectious disease that may result from recent transmission or from an infection acquired many years in the past; there is no diagnostic test to distinguish the two causes. Cases resulting from recent transmission are particularly concerning from a public health standpoint. To describe recent tuberculosis transmission in the United States, we used a field-validated plausible source-case method to estimate cases likely resulting from recent transmission during January 2011-September 2014. We classified cases as resulting from either limited or extensive recent transmission based on transmission cluster size. We used logistic regression to analyze patient characteristics associated with recent transmission. Of 26,586 genotyped cases, 14% were attributable to recent transmission, 39% of which were attributable to extensive recent transmission. The burden of cases attributed to recent transmission was geographically heterogeneous and poorly predicted by tuberculosis incidence. Extensive recent transmission was positively associated with American Indian/Alaska Native (adjusted prevalence ratio [aPR] = 3.6 (95% confidence interval [CI] 2.9-4.4), Native Hawaiian/Pacific Islander (aPR = 3.2, 95% CI 2.3-4.5), and black (aPR = 3.0, 95% CI 2.6-3.5) race, and homelessness (aPR = 2.3, 95% CI 2.0-2.5). Extensive recent transmission was negatively associated with foreign birth (aPR = 0.2, 95% CI 0.2-0.2). Tuberculosis control efforts should prioritize reducing transmission among higher-risk populations.	[Yuen, Courtney M.; Kammerer, J. Steve; Marks, Kala; Navin, Thomas R.; France, Anne Marie] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Yuen, Courtney M.] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA; [France, Anne Marie] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Harvard University; Brigham & Women's Hospital; Centers for Disease Control & Prevention - USA	France, AM (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA.	hgj6@cdc.gov		Yuen, Courtney/0000-0002-5219-2599				Althomsons SP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048754; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Bloss E, 2011, PUBLIC HEALTH REP, V126, P677, DOI 10.1177/003335491112600510; Bruchfeld J, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017871; *CDCP, 2002, MMWR-MORBID MORTAL W, V51, P232; Centers for Disease Control and Prevention, 2015, REP TUB US 2014; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P539; Dobbins Claire, 2012, Morbidity and Mortality Weekly Report, V61, P186; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; France AM, 2015, AM J EPIDEMIOL, V182, P799, DOI 10.1093/aje/kwv121; Funk EA, 2003, INT J TUBERC LUNG D, V7, pS349; Kaushik KS, 2011, J MED MICROBIOL, V60, P408, DOI 10.1099/jmm.0.027540-0; Knorr J, 2013, MMWR-MORBID MORTAL W, V62, P904; Lofy KH, 2006, INT J TUBERC LUNG D, V10, P683; McMillen CW, 2008, B HIST MED, V82, P608, DOI 10.1353/bhm.0.0094; Mitruka K, 2011, EMERG INFECT DIS, V17, P425, DOI 10.3201/eid1703.101550; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Nava-Aguilera E, 2009, INT J TUBERC LUNG D, V13, P17; Nguyen LN, 2004, RESPIROLOGY, V9, P313, DOI 10.1111/j.1440-1843.2004.00603.x; Oeltmann JE, 2006, EMERG INFECT DIS, V12, P1156, DOI 10.3201/eid1207.051436; Pevzner ES, 2010, AM J PUBLIC HEALTH, V100, P2481, DOI 10.2105/AJPH.2009.162388; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Rodwell TC, 2012, INFECT GENET EVOL, V12, P1917, DOI 10.1016/j.meegid.2012.08.022; Schneider E, 2005, CLIN CHEST MED, V26, P183, DOI 10.1016/j.ccm.2005.02.007; Simet SM, 2015, ALCOHOL RES-CURR REV, V37, P199	25	88	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153728	10.1371/journal.pone.0153728	http://dx.doi.org/10.1371/journal.pone.0153728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082644	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800049
J	Chen, CH				Chen, Chia-Hsiang			Development of a Melting Curve-Based Allele-Specific PCR of Apolipoprotein E (APOE) Genotyping Method for Genomic DNA, Guthrie Blood Spot, and Whole Blood	PLOS ONE			English	Article							E GENE POLYMORPHISM; ALZHEIMERS-DISEASE; EPSILON-4 ALLELE; ASSOCIATION; SCHIZOPHRENIA; METAANALYSIS; DEPRESSION; DISORDERS; AUTISM; PTSD	Genetic polymorphisms of apolipoprotein E (APOE) are associated with various health conditions and diseases, such as Alzheimer's disease, cardiovascular diseases, type 2 diabetes, etc. Hence, genotyping of APOE has broad applications in biomedical research and clinical settings, particularly in the era of precision medicine. The study aimed to develop a convenient and accurate method with flexible throughput to genotype the APOE polymorphisms. A melting curve-based allele-specific PCR method was developed to genotype two single nucleotide polymorphisms (SNPs) of APOE, i.e. rs429358 at codon 112 and rs7412 at codon 158. These two SNPs determine the genotype of APOE2, E3, and E4. PCR-based Sanger sequencing was used as the reference method for APOE genotyping. A 100% concordance rate was obtained in 300 subjects between the melting curve-based allele-specific PCR method and the Sanger sequencing method. This method was applied to a genetic association analysis of APOE and schizophrenia consisting of 711 patients with schizophrenia and 665 control subjects from Taiwan. However, no significant differences in the allele and genotype frequencies were detected between these two groups. Further experiments showed that DNA dissolved from blood collected on Guthrie filter paper and total blood cell lysate without DNA extraction can be used in the melting curve-based allele-specific PCR method. Thus, we suggest that this is a fast, accurate and robust APOE genotyping method with a flexible throughput and suitable for DNA template from different preparations. This convenient method shall meet the different needs of various research and clinical laboratories.	[Chen, Chia-Hsiang] Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan; [Chen, Chia-Hsiang] Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Chen, CH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Psychiat, Taoyuan, Taiwan.; Chen, CH (corresponding author), Chang Gung Univ, Dept & Grad Inst Biomed Sci, Taoyuan, Taiwan.	cchen3801@gmail.com		Chen, Chia-Hsiang/0000-0002-8232-2403	Chang Gung Memorial Hospital-Linkou, Taiwan [CMRPG3C1771, CMRPG3C1772]	Chang Gung Memorial Hospital-Linkou, Taiwan(Chang Gung Memorial Hospital)	The study was supported by grants CMRPG3C1771 and CMRPG3C1772 from Chang Gung Memorial Hospital-Linkou, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Ashley-Koch AE, 2007, PSYCHIAT GENET, V17, P221, DOI 10.1097/YPG.0b013e32809c2f75; Gonzalez-Castro TB, 2015, SCHIZOPHR RES, V169, P355, DOI 10.1016/j.schres.2015.08.031; Bellivier F, 1997, NEUROSCI LETT, V233, P45, DOI 10.1016/S0304-3940(97)00624-1; Calero O, 2009, J NEUROSCI METH, V183, P238, DOI 10.1016/j.jneumeth.2009.06.033; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Feng F, 2015, J CLIN NEUROSCI, V22, P1232, DOI 10.1016/j.jocn.2015.02.012; Gatt JM, 2015, J PSYCHIATR RES, V60, P1, DOI 10.1016/j.jpsychires.2014.09.014; Gibbons AS, 2011, FRONT BIOSCI-LANDMRK, V16, P962, DOI 10.2741/3729; Giunco CT, 2009, PSYCHIAT GENET, V19, P338, DOI 10.1097/YPG.0b013e3283328e41; Johnson LA, 2015, NEUROPSYCHOPHARMACOL, V40, P2443, DOI 10.1038/npp.2015.95; Kassam I, 2016, J NEUROL NEUROSUR PS, V87, P433, DOI 10.1136/jnnp-2015-310500; Kessing LV, 1999, BIOL PSYCHIAT, V45, P430, DOI 10.1016/S0006-3223(98)00038-9; Liu WQ, 2003, SCHIZOPHR RES, V62, P225, DOI 10.1016/S0920-9964(02)00384-5; Liu Y, 2015, J NEUROL NEUROSUR PS, V86, P127, DOI 10.1136/jnnp-2014-307719; Lopez MF, 2014, EXPERT REV PROTEOMIC, V11, P371, DOI 10.1586/14789450.2014.901892; Lyons MJ, 2013, AM J MED GENET B, V162, P762, DOI 10.1002/ajmg.b.32154; Martinez-Barrondo S, 2006, EUR PSYCHIAT, V21, P59, DOI 10.1016/j.eurpsy.2005.04.012; Martorelli L, 2001, MOL PSYCHIATR, V6, P307, DOI 10.1038/sj.mp.4000855; Ozder A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-183; Persico AM, 2004, PSYCHIAT GENET, V14, P73, DOI 10.1097/01.ypg.0000128768.37838.17; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Rihn BH, 2009, CLIN EXP MED, V9, P61, DOI 10.1007/s10238-008-0012-2; Skoog I, 2015, BIOL PSYCHIAT, V78, P730, DOI 10.1016/j.biopsych.2015.01.006; de Souza MGS, 2010, CNS NEUROSCI THER, V16, P316, DOI 10.1111/j.1755-5949.2010.00153.x; Thomas EA, 2002, MOL NEUROBIOL, V26, P369, DOI 10.1385/MN:26:2-3:369; Villeneuve S, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00154; Wang J, 2005, BIOTECHNIQUES, V39, P885, DOI 10.2144/000112028; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Xu MQ, 2006, SCHIZOPHR RES, V84, P228, DOI 10.1016/j.schres.2006.02.015; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Zhan XH, 2015, EXP THER MED, V9, P469, DOI 10.3892/etm.2014.2097	32	3	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153593	10.1371/journal.pone.0153593	http://dx.doi.org/10.1371/journal.pone.0153593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078154	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700088
J	Voronin, D; Bachu, S; Shlossman, M; Unnasch, TR; Ghedin, E; Lustigman, S				Voronin, Denis; Bachu, Saheed; Shlossman, Michael; Unnasch, Thomas R.; Ghedin, Elodie; Lustigman, Sara			Glucose and Glycogen Metabolism in Brugia malayi Is Associated with Wolbachia Symbiont Fitness	PLOS ONE			English	Article							FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; ONCHOCERCA-VOLVULUS; FILARIAL; ENDOBACTERIA; ENDOSYMBIONT; DOXYCYCLINE; DEPLETION; GENOME; INHIBITION; EFFICACY	Wolbachia are endosymbiotic bacteria found in the majority of arthropods and filarial nematodes of medical and veterinary importance. They have evolved a wide range of symbiotic associations. In filarial nematodes that cause human lymphatic filariasis (Wuchereria bancrofti, Brugia malayi) or onchocerciasis (Onchocerca volvulus), Wolbachia are important for parasite development, reproduction and survival. The symbiotic bacteria rely in part on nutrients and energy sources provided by the host. Genomic analyses suggest that the strain of Wolbachia found in B. malayi (wBm) lacks the genes for two glycolytic enzymes-6-phosphofructokinase and pyruvate kinase-and is thus potentially unable to convert glucose into pyruvate, an important substrate for energy generation. The Wolbachia surface protein, wBm00432, is complexed to six B. malayi glycolytic enzymes, including aldolase. In this study we characterized two B. malayi aldolase isozymes and found that their expression is dependent on Wolbachia fitness and number. We confirmed by immuno-transmission electron microscopy that aldolase is associated with the Wolbachia surface. RNAi experiments suggested that aldolase-2 plays a significant role in both Wolbachia survival and embryogenesis in B. malayi. Treatment with doxycycline reduced Wolbachia fitness and increased the amount of both glucose and glycogen detected in the filarial parasite, indicating that glucose metabolism and glycogen storage in B. malayi are associated with Wolbachia fitness. This metabolic co-dependency between Wolbachia and its filarial nematode indicates that glycolysis could be a shared metabolic pathway between the bacteria and B. malayi, and thus a potential new target for anti-filarial therapy.	[Voronin, Denis; Bachu, Saheed; Shlossman, Michael; Lustigman, Sara] New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol, New York, NY 10065 USA; [Unnasch, Thomas R.] Univ S Florida, Coll Publ Hlth, Dept Global Hlth, Global Hlth Infect Dis Res Program, Tampa, FL 33612 USA; [Ghedin, Elodie] NYU, Ctr Genom & Syst Biol, Dept Biol, New York, NY 10003 USA; [Ghedin, Elodie] NYU, Coll Global Publ Hlth, New York, NY 10003 USA	New York Blood Center; State University System of Florida; University of South Florida; New York University; New York University	Voronin, D (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, Mol Parasitol, New York, NY 10065 USA.	DVoronin@NYBloodCenter.org	Ghedin, Elodie/Y-5654-2019	Ghedin, Elodie/0000-0002-1515-725X; Voronin, Denis/0000-0003-2652-0787	National Institutes of Health [AI072465, R56AI101372]; New York Blood Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI101372, R01AI072465] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Blood Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health grant number AI072465 and R56AI101372 to TRU, EG and SL, and in part also by New York Blood Center intramural funding to SL.; We thank the National Institute of Allergy and Infectious Diseases (NIAID, USA)/National Institutes of Health (NIH, USA) Filariasis Research Reagent Repository Center (FR3) for supplying B. malayi adult female worms and microfilariae, and for also supplying the A. viteae adult female worms. This study was supported by National Institutes of Health grant number AI072465 and R56AI101372 to TRU, EG and SL, and in part also by New York Blood Center intramural funding to SL.	Bandi C, 1999, INT J PARASITOL, V29, P357, DOI 10.1016/S0020-7519(98)00200-8; Bandi C, 2001, VET PARASITOL, V98, P215, DOI 10.1016/S0304-4017(01)00432-0; Bulman CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003534; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Dudkina N.V., 2004, Tsitologiya, V46, P208; El Ridi RAF, 2013, J ADV RES, V4, P467, DOI 10.1016/j.jare.2012.05.002; Fischer K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086383; Ford L, 2005, J BIOL CHEM, V280, P40845, DOI 10.1074/jbc.M504434200; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Foster JM, 2009, PARASITOL RES, V104, P1047, DOI 10.1007/s00436-008-1287-7; Fraga A, 2013, PLOS ONE, P8; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Ganapathy-Kanniappan S, 2013, ANTICANCER RES, V33, P13; Ghedin E, 2008, SYMBIOSIS, V46, P77; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Gill AC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003224; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoerauf A, 2003, MICROBES INFECT, V5, P261, DOI 10.1016/S1286-4579(03)00026-1; Hoerauf A, 2001, LANCET, V357, P1415, DOI 10.1016/S0140-6736(00)04581-5; Hoerauf A, 2008, MED MICROBIOL IMMUN, V197, P295, DOI 10.1007/s00430-007-0062-1; Inoue T, 1997, ARCH BIOCHEM BIOPHYS, V339, P226, DOI 10.1006/abbi.1996.9813; Isayev O, 2014, ONCOTARGET, V5, P5177, DOI 10.18632/oncotarget.2120; JOHNSON LN, 1992, FASEB J, V6, P2274, DOI 10.1096/fasebj.6.6.1544539; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; Kremer N, 2009, PLOS PATHOG, P5; Landmann F, 2011, PLOS PATHOG, P7; Landmann F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-16; Li BW, 2004, MOL BIOCHEM PARASIT, V137, P329, DOI 10.1016/j.molbiopara.2004.07.002; Lustigman S, 2014, INT J PARASITOL-DRUG, V4, P267, DOI 10.1016/j.ijpddr.2014.08.001; McGarry HF, 2004, MOL BIOCHEM PARASIT, V135, P57, DOI 10.1016/j.molbiopara.2004.01.006; Melnikow E, 2013, PLOS NEGLECT TROP D, P7; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Nguyen BD, 2012, P NATL ACAD SCI USA, V109, P1263, DOI 10.1073/pnas.1117884109; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Palm DC, 2013, FEBS J, V280, P2, DOI 10.1111/febs.12059; Raverdy S, 2008, MOL BIOCHEM PARASIT, V160, P163, DOI 10.1016/j.molbiopara.2008.04.014; Say RF, 2010, NATURE, V464, P1077, DOI 10.1038/nature08884; Scatena R, 2008, EXPERT OPIN INV DRUG, V17, P1533, DOI 10.1517/13543784.17.10.1533 ; Slatko BE, 2014, MOL BIOCH PARASITOLO; Specht S, 2008, PARASITOL RES, V103, P1303, DOI 10.1007/s00436-008-1133-y; Strubing U, 2010, INT J PARASITOL, V40, P1193, DOI 10.1016/j.ijpara.2010.03.004; Taylor MJ, 2013, CELL MICROBIOL, V15, P520, DOI 10.1111/cmi.12084; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Wu B., 2009, P 1 ACM INT WORKSH C, P3, DOI DOI 10.1145/1651274.1651277	47	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153812	10.1371/journal.pone.0153812	http://dx.doi.org/10.1371/journal.pone.0153812			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078260	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700109
J	Pisani, P; Caporuscio, F; Carlino, L; Rastelli, G				Pisani, Pasquale; Caporuscio, Fabiana; Carlino, Luca; Rastelli, Giulio			Molecular Dynamics Simulations and Classical Multidimensional Scaling Unveil New Metastable States in the Conformational Landscape of CDK2	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; PROTEIN-KINASE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION LOOP; SRC KINASE; INHIBITORS; PHOSPHORYLATION; MECHANISM; TRANSITIONS	Protein kinases are key regulatory nodes in cellular networks and their function has been shown to be intimately coupled with their structural flexibility. However, understanding the key structural mechanisms of large conformational transitions remains a difficult task. CDK2 is a crucial regulator of cell cycle. Its activity is finely tuned by Cyclin E/A and the catalytic segment phosphorylation, whereas its deregulation occurs in many types of cancer. ATP competitive inhibitors have failed to be approved for clinical use due to toxicity issues raised by a lack of selectivity. However, in the last few years type III allosteric inhibitors have emerged as an alternative strategy to selectively modulate CDK2 activity. In this study we have investigated the conformational variability of CDK2. A low dimensional conformational landscape of CDK2 was modeled using classical multidimensional scaling on a set of 255 crystal structures. Microsecond-scale plain and accelerated MD simulations were used to populate this landscape by using an out-of-sample extension of multidimensional scaling. CDK2 was simulated in the apo-form and in complex with the allosteric inhibitor 8-anilino-1-napthalenesulfonic acid (ANS). The apo-CDK2 landscape analysis showed a conformational equilibrium between an Src-like inactive conformation and an active-like form. These two states are separated by different metastable states that share hybrid structural features with both forms of the kinase. In contrast, the CDK2/ANS complex landscape is compatible with a conformational selection picture where the binding of ANS in proximity of the alpha C helix causes a population shift toward the inactive conformation. Interestingly, the new metastable states could enlarge the pool of candidate structures for the development of selective allosteric CDK2 inhibitors. The method here presented should not be limited to the CDK2 case but could be used to systematically unmask similar mechanisms throughout the human kinome.	[Pisani, Pasquale; Caporuscio, Fabiana; Carlino, Luca; Rastelli, Giulio] Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy	Universita di Modena e Reggio Emilia	Rastelli, G (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Via Campi 103, I-41125 Modena, Italy.	giulio.rastelli@unimore.it	Rastelli, Giulio/D-2224-2015	Rastelli, Giulio/0000-0002-2474-0607	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 15993]; Nando Peretti Foundation [2013-25]	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Nando Peretti Foundation	This work was supported by a grant from the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 15993) and The Nando Peretti Foundation, Award number 2013-25.	Alexander LT, 2015, ACS CHEM BIOL, V10, P2116, DOI 10.1021/acschembio.5b00398; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Betzi S, 2011, ACS CHEM BIOL, V6, P492, DOI 10.1021/cb100410m; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; D'Abramo M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00128; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vivo M, 2011, FUTURE MED CHEM, V3, P1551, DOI [10.4155/FMC.11.113, 10.4155/fmc.11.113]; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Eckart C, 1936, PSYCHOMETRIKA, V1, P211, DOI 10.1007/BF02288367; Endicott JA, 2013, BIOCHEM SOC T, V41, P1008, DOI 10.1042/BST20130097; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Esposito L, 2013, CURR PHARM DESIGN, V19, P5327, DOI 10.2174/13816128113199990377; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones E., SCIPY OPEN SOURCE SC; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Lawrie AM, 1997, NAT STRUCT BIOL, V4, P796, DOI 10.1038/nsb1097-796; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Levy Y, 2001, J CHEM PHYS, V114, P993, DOI 10.1063/1.1329646; Li Y, 2015, INT J MOL SCI, V16, P9314, DOI 10.3390/ijms16059314; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MARDIA KV, 1978, COMMUN STAT A-THEOR, V7, P1233, DOI 10.1080/03610927808827707; Meng YL, 2015, J PHYS CHEM B, V119, P1443, DOI 10.1021/jp511792a; Meng YL, 2014, J MOL BIOL, V426, P423, DOI 10.1016/j.jmb.2013.10.001; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Palmieri L, 2013, DRUG DISCOV TODAY, V18, P407, DOI 10.1016/j.drudis.2012.11.009; Python Software Foundation, 2013, PYTH LANG REF VERS 2; Rabiller M, 2010, ARCH PHARM, V343, P193, DOI 10.1002/ardp.201000028; Rizzolio F, 2010, CURR DRUG TARGETS, V11, P279, DOI 10.2174/138945010790711978; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shukla D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4397; Steichen JM, 2010, J BIOL CHEM, V285, P3825, DOI 10.1074/jbc.M109.061820; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; TORGERSON WS, 1952, PSYCHOMETRIKA, V17, P401; Trosset MW, 2008, COMPUT STAT DATA AN, V52, P4635, DOI 10.1016/j.csda.2008.02.031; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zuccotto F, 2010, J MED CHEM, V53, P2681, DOI 10.1021/jm901443h	51	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154066	10.1371/journal.pone.0154066	http://dx.doi.org/10.1371/journal.pone.0154066			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100206	Green Published, gold			2022-12-27	WOS:000374898500135
J	Alemzadeh, H; Raman, J; Leveson, N; Kalbarczyk, Z; Iyer, RK				Alemzadeh, Homa; Raman, Jaishankar; Leveson, Nancy; Kalbarczyk, Zbigniew; Iyer, Ravishankar K.			Adverse Events in Robotic Surgery: A Retrospective Study of 14 Years of FDA Data	PLOS ONE			English	Article							LAPAROSCOPIC PROSTATECTOMY; SURGICAL SYSTEM; MALFUNCTION; FAILURE	Background Use of robotic systems for minimally invasive surgery has rapidly increased during the last decade. Understanding the causes of adverse events and their impact on patients in robot-assisted surgery will help improve systems and operational practices to avoid incidents in the future. Methods By developing an automated natural language processing tool, we performed a comprehensive analysis of the adverse events reported to the publicly available MAUDE database (maintained by the U.S. Food and Drug Administration) from 2000 to 2013. We determined the number of events reported per procedure and per surgical specialty, the most common types of device malfunctions and their impact on patients, and the potential causes for catastrophic events such as patient injuries and deaths. Results During the study period, 144 deaths (1.4% of the 10,624 reports), 1,391 patient injuries (13.1%), and 8,061 device malfunctions (75.9%) were reported. The numbers of injury and death events per procedure have stayed relatively constant (mean = 83.4, 95% confidence interval (CI), 74.2-92.7 per 100,000 procedures) over the years. Surgical specialties for which robots are extensively used, such as gynecology and urology, had lower numbers of injuries, deaths, and conversions per procedure than more complex surgeries, such as cardiothoracic and head and neck (106.3 vs. 232.9 per 100,000 procedures, Risk Ratio = 2.2, 95% CI, 1.9-2.6). Device and instrument malfunctions, such as falling of burnt/broken pieces of instruments into the patient (14.7%), electrical arcing of instruments (10.5%), unintended operation of instruments (8.6%), system errors (5%), and video/imaging problems (2.6%), constituted a major part of the reports. Device malfunctions impacted patients in terms of injuries or procedure interruptions. In 1,104 (10.4%) of all the events, the procedure was interrupted to restart the system (3.1%), to convert the procedure to non-robotic techniques (7.3%), or to reschedule it (2.5%). Conclusions Despite widespread adoption of robotic systems for minimally invasive surgery in the U.S., a non-negligible number of technical difficulties and complications are still being experienced during procedures. Adoption of advanced techniques in design and operation of robotic surgical systems and enhanced mechanisms for adverse event reporting may reduce these preventable incidents in the future.	[Alemzadeh, Homa; Kalbarczyk, Zbigniew; Iyer, Ravishankar K.] Univ Illinois, Coordinated Sci Lab, Urbana, IL USA; [Raman, Jaishankar] Rush Univ, Med Ctr, Dept Surg, Chicago, IL 60612 USA; [Leveson, Nancy] MIT, Dept Aeronaut & Astronaut, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; Rush University; Massachusetts Institute of Technology (MIT)	Alemzadeh, H (corresponding author), Univ Illinois, Coordinated Sci Lab, Urbana, IL USA.	alemzad1@illinois.edu	Raman, Jaishankar/K-1219-2019	Alemzadeh, Homa/0000-0001-5279-842X	National Science Foundation [NSF CNS 15-45069, NSF CNS 13-14891]; OSF Foundation (Peoria, IL); Infosys; IBM	National Science Foundation(National Science Foundation (NSF)); OSF Foundation (Peoria, IL); Infosys; IBM(International Business Machines (IBM))	This research was supported, in part, by grants no. NSF CNS 15-45069 and NSF CNS 13-14891 from the National Science Foundation, Jump ARCHES Endowment for Engineering and Health Care Innovation from the OSF Foundation (Peoria, IL), an unrestricted grant from Infosys, and a faculty award from IBM (HA, ZK, and RKI received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agcaoglu O, 2012, SURG ENDOSC, V26, P3580, DOI 10.1007/s00464-012-2370-9; Andonian S, 2008, CAN J UROL, V15, P3912; [Anonymous], 2013, INT SURG COMM MED DE; Barbash GI, 2010, NEW ENGL J MED, V363, P701, DOI 10.1056/NEJMp1006602; Borden Lester S Jr, 2007, Can J Urol, V14, P3499; Breitenstein S, 2008, ANN SURG, V247, P987, DOI 10.1097/SLA.0b013e318172501f; Buchs NC, 2014, AM J SURG, V207, P84, DOI 10.1016/j.amjsurg.2013.06.007; Chen CC, 2012, INT J UROL, V19, P736, DOI 10.1111/j.1442-2042.2012.03010.x; Citron Research, 2013, INT SURG ANG BROK WI; Citron Research, 2012, HAS HAL BEEN BROK IN; Cooper Michol A, 2013, J HEALTHCARE QUALITY; Damiano RJ, 2007, J THORAC CARDIOV SUR, V134, P559, DOI 10.1016/j.jtcvs.2006.08.026; Dhawan R, 2012, J THORAC CARDIOV SUR, V143, P1056, DOI 10.1016/j.jtcvs.2011.06.023; Eichel L., 2005, AUA UPDATE SERIES, V24, P106; Finan MA, 2010, SURG ENDOSC, V24, P1256, DOI 10.1007/s00464-009-0756-0; Fischer B, 2008, WORLD J UROL, V26, P595, DOI 10.1007/s00345-008-0287-7; Friedman DCW, 2013, SURG ENDOSC, V27, P1503, DOI 10.1007/s00464-012-2659-8; Fuller A, 2012, PROC SPIE, V8207, DOI 10.1117/12.909456; Gonzalez R, 2006, DIS COLON RECTUM, V49, P197, DOI 10.1007/s10350-005-0258-7; Gupta P, 2013, J UROLOGY, V189, pE351, DOI 10.1016/j.juro.2013.02.423; Hannaford B, 2013, IEEE T BIO-MED ENG, V60, P954, DOI 10.1109/TBME.2012.2228858; Hauser RG, 2010, EUROPACE, V12, P395, DOI 10.1093/europace/eup375; Holzhey DM, 2013, CIRCULATION, V128, P483, DOI 10.1161/CIRCULATIONAHA.112.001402; Homa Alemzadeh, 2015, AM COLL SURG 8 ANN M; Homa Alemzadeh, 2015, SIGBED REV, V12; Kaushik D, 2010, J ENDOUROL, V24, P571, DOI 10.1089/end.2009.0489; Kazanzidesf Peter, 2014, ROB AUT ICRA 2014 IE; Kim WT, 2009, UROLOGY, V74, P1234, DOI 10.1016/j.urology.2009.05.071; Kozlowski PM, 2006, J UROLOGY, V175, P372, DOI 10.1016/S0022-5347(18)33384-6; Lavery HJ, 2008, J ENDOUROL, V22, P2165, DOI 10.1089/end.2007.0407; Lee J, 2011, ANN SURG ONCOL, V18, P226, DOI 10.1245/s10434-010-1220-z; Lin Henry C, 2006, Comput Aided Surg, V11, P220, DOI 10.1080/10929080600989189; Lucas SM, 2012, BJU INT, V109, P1222, DOI 10.1111/j.1464-410X.2011.10692.x; Lum MJH, 2009, INT J ROBOT RES, V28, P1183, DOI 10.1177/0278364909101795; Manning Christopher, 1999, FDN STAT NATURAL LAN; Manoucheri E, 2014, J MINIM INVAS GYN, V21, P592, DOI 10.1016/j.jmig.2013.12.122; Marusch F, 2001, DIS COLON RECTUM, V44, P207, DOI 10.1007/BF02234294; Modi P, 2008, EUR J CARDIO-THORAC, V34, P943, DOI 10.1016/j.ejcts.2008.07.057; Mues AC, 2011, UROLOGY, V77, P104, DOI 10.1016/j.urology.2010.01.093; Murphy D, 2007, Minerva Urol Nefrol, V59, P191; Robertson C, 2013, BJU INT, V112, P798, DOI 10.1111/bju.12247; Robicsek F, 2008, J THORAC CARDIOV SUR, V135, P243, DOI 10.1016/j.jtcvs.2007.05.072; Seco M, 2013, ANN CARDIOTHORAC SUR, V2, P704, DOI 10.3978/j.issn.2225-319X.2013.10.18; Sik Ham Won, 2009, UROLOGY, V73, P209; Simorov A, 2012, SURG ENDOSC, V26, P2117, DOI 10.1007/s00464-012-2182-y; Taylor R. H., 2008, SPRINGER HDB ROBOTIC, P1199, DOI DOI 10.1007/978-3-540-30301-5_53; U.S. Department of Health and Human Services Office of Inspector General, 2009, ADV EV REP MED DEV; U.S. Food and Drug Administration, 2013, COMP ASS ROB SURG SY; Zorn KC, 2007, J ENDOUROL, V21, P1341, DOI 10.1089/end.2006.0455	49	143	148	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151470	10.1371/journal.pone.0151470	http://dx.doi.org/10.1371/journal.pone.0151470			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097160	gold, Green Published			2022-12-27	WOS:000374543600004
J	Emmerling, F; Schuhmann, T; Lobbestael, J; Arntz, A; Brugman, S; Sack, AT				Emmerling, Franziska; Schuhmann, Teresa; Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne; Sack, Alexander Thomas			The Role of the Insular Cortex in Retaliation	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; PROACTIVE AGGRESSION; ANTERIOR INSULA; NEURAL BASIS; BRAIN; FMRI; VALIDITY; VALENCE	The insular cortex has consistently been associated with various aspects of emotion regulation and social interaction, including anger processing and overt aggression. Aggression research distinguishes proactive or instrumental aggression from retaliation, i. e. aggression in response to provocation. Here, we investigated the specific role of the insular cortex during retaliation, employing a controlled behavioral aggression paradigm implementing different levels of provocation. Fifteen healthy male volunteers underwent whole brain functional magnetic resonance imaging (fMRI) to identify brain regions involved in interaction with either a provoking or a non-provoking opponent. FMRI group analyses were complemented by examining the parametric modulations of brain activity related to the individual level of displayed aggression. These analyses identified a hemispheric lateralization as well as an anatomical segregation of insular cortex with specifically the left posterior part being involved in retaliation. The left-lateralization of insular activity during retaliation is in accordance with evidence from electro-physiological studies, suggesting left-lateralized frontocortical dominance during anger processing and aggressive acts. The posterior localization of insular activity, on the other hand, suggests a spatial segregation within insular cortex with particularly the posterior part being involved in the processing of emotions that trigger intense bodily sensations and immediate action tendencies.	[Emmerling, Franziska; Schuhmann, Teresa; Sack, Alexander Thomas] Maastricht Univ, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands; [Emmerling, Franziska; Schuhmann, Teresa; Sack, Alexander Thomas] Maastricht Brain Imaging Ctr, Maastricht, Netherlands; [Lobbestael, Jill; Arntz, Arnoud; Brugman, Suzanne] Maastricht Univ, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Netherlands; [Arntz, Arnoud] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University; University of Amsterdam	Emmerling, F (corresponding author), Maastricht Univ, Dept Cognit Neurosci, NL-6200 MD Maastricht, Netherlands.; Emmerling, F (corresponding author), Maastricht Brain Imaging Ctr, Maastricht, Netherlands.	franziska.emmerling@maastrichtuniversity.nl	Arntz, Arnoud/M-3011-2013	Arntz, Arnoud/0000-0002-7992-2272; Sack, Alexander/0000-0002-1471-0885; Lobbestael, Jill/0000-0001-9205-3115	Netherlands Organization for Scientific Research (NWO) [HCMI 10-19]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a grant from the Netherlands Organization for Scientific Research (NWO; HCMI 10-19); http://www.nwo.nl/en/research-and-results/programmes/nihc/hcmi/index.html.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Anderson CA, 1999, CURR DIR PSYCHOL SCI, V8, P3, DOI 10.1111/1467-8721.00002; BERNSTEIN S, 1987, AGGRESSIVE BEHAV, V13, P15, DOI 10.1002/1098-2337(1987)13:1<15::AID-AB2480130104>3.0.CO;2-K; Beyer F, 2015, CEREB CORTEX, V25, P3057, DOI 10.1093/cercor/bhu101; Beyer F, 2014, SOC COGN AFFECT NEUR, V9, P1552, DOI 10.1093/scan/nst146; Brunnlieb C, 2013, SOC NEUROSCI-UK, V8, P148, DOI 10.1080/17470919.2013.763654; Cacioppo S, 2013, CURRENT TRENDS NEURO, V7, P1; Cacioppo S, 2012, J SEX MED, V9, P1048, DOI 10.1111/j.1743-6109.2012.02651.x; Chester DS, 2016, SOCIAL COGNITIVE AFF; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dambacher F, 2015, SOC COGN AFFECT NEUR, V10, P508, DOI 10.1093/scan/nsu077; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GIANCOLA PR, 1995, AGGRESSIVE BEHAV, V21, P199, DOI 10.1002/1098-2337(1995)21:3<199::AID-AB2480210303>3.0.CO;2-Q; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Kramer UM, 2007, NEUROIMAGE, V38, P203, DOI 10.1016/j.neuroimage.2007.07.029; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lotze M, 2007, NEUROIMAGE, V34, P470, DOI 10.1016/j.neuroimage.2006.09.028; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Pelphrey KA, 2004, J COGNITIVE NEUROSCI, V16, P1706, DOI 10.1162/0898929042947900; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; Poulin F, 2000, PSYCHOL ASSESSMENT, V12, P115, DOI 10.1037/1040-3590.12.2.115; Raine A, 2006, AGGRESSIVE BEHAV, V32, P159, DOI 10.1002/ab.20115; Rankin KP, 2009, NEUROIMAGE, V47, P2005, DOI 10.1016/j.neuroimage.2009.05.077; Reynolds SM, 2008, NAT NEUROSCI, V11, P423, DOI 10.1038/nn2061; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Sterzer P, 2010, BRAIN STRUCT FUNCT, V214, P611, DOI 10.1007/s00429-010-0252-2; Talairach J., 1988, COPLANAR STEREOTAXIC; TAYLOR SP, 1967, J PERS, V35, P297, DOI 10.1111/j.1467-6494.1967.tb01430.x; van Honk J, 2006, PSYCHOL SCI, V17, P963, DOI 10.1111/j.1467-9280.2006.01813.x; Zilbovicius M, 2006, TRENDS NEUROSCI, V29, P359, DOI 10.1016/j.tins.2006.06.004	34	20	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152000	10.1371/journal.pone.0152000	http://dx.doi.org/10.1371/journal.pone.0152000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096431	Green Published, gold			2022-12-27	WOS:000374543600007
J	Moly, PK; Cooley, JR; Zeltzer, SL; Yatskievych, TA; Antin, PB				Moly, Pricila K.; Cooley, James R.; Zeltzer, Sebastian L.; Yatskievych, Tatiana A.; Antin, Parker B.			Gastrulation EMT Is Independent of P-Cadherin Downregulation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SNAIL; EPITHELIAL-MESENCHYMAL TRANSITIONS; EXPRESSION; GENE; SLUG	Epithelial-mesenchymal transition (EMT) is an evolutionarily conserved process during which cells lose epithelial characteristics and gain a migratory phenotype. Although downregulation of epithelial cadherins by Snail and other transcriptional repressors is generally considered a prerequisite for EMT, recent studies have challenged this view. Here we investigate the relationship between E-cadherin and P-cadherin expression and localization, Snail function and EMT during gastrulation in chicken embryos. Expression analyses show that while E-cadherin transcripts are detected in the epiblast but not in the primitive streak or mesoderm, P-cadherin mRNA and protein are present in the epiblast, primitive and mesoderm. Antibodies that specifically recognize E-cadherin are not presently available. During EMT, P-cadherin relocalizes from the lateral surfaces of epithelial epiblast cells to a circumferential distribution in emerging mesodermal cells. Cells electroporated with an E-cadherin expression construct undergo EMT and migrate into the mesoderm. An examination of Snail function showed that reduction of Slug (SNAI2) protein levels using a morpholino fails to inhibit EMT, and expression of human or chicken Snail in epiblast cells fails to induce EMT. In contrast, cells expressing the Rho inhibitor peptide C3 rapidly exit the epiblast without activating Slug or the mesoderm marker N-cadherin. Together, these experiments show that epiblast cells undergo EMT while retaining P-cadherin, and raise questions about the mechanisms of EMT regulation during avian gastrulation.	[Moly, Pricila K.; Cooley, James R.; Zeltzer, Sebastian L.; Yatskievych, Tatiana A.; Antin, Parker B.] Univ Arizona, Dept Cellular & Mol Med, 1656 E Mabel St,POB 245217, Tucson, AZ 85724 USA	University of Arizona	Antin, PB (corresponding author), Univ Arizona, Dept Cellular & Mol Med, 1656 E Mabel St,POB 245217, Tucson, AZ 85724 USA.	pba@email.arizona.edu		Antin, Parker/0000-0001-9066-7412	NIH [P41 HD064559]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P41HD064559, P41HD088362] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH grant P41 HD064559 to PBA.	Acloque H, 2011, DEV CELL, V21, P546, DOI 10.1016/j.devcel.2011.07.005; AKTORIES K, 1989, TRENDS PHARMACOL SCI, V10, P415, DOI 10.1016/0165-6147(89)90191-0; Alves CC, 2007, J PATHOL, V211, P507, DOI 10.1002/path.2138; Nieto MA, 2012, SEMIN CANCER BIOL, V22, P361, DOI 10.1016/j.semcancer.2012.05.003; Nieto MA, 2011, ANNU REV CELL DEV BI, V27, P347, DOI 10.1146/annurev-cellbio-092910-154036; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Conacci-Sorrell M, 2003, J CELL BIOL, V163, P847, DOI 10.1083/jcb.200308162; GRAU Y, 1984, GENETICS, V108, P347; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Hardy KM, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-20; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Lim J, 2012, DEVELOPMENT, V139, P3471, DOI 10.1242/dev.071209; Liu JP, 1998, DEVELOPMENT, V125, P5055; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; NIETO MA, 1994, SCIENCE, V264, P835, DOI 10.1126/science.7513443; Ohkubo T, 2004, J CELL SCI, V117, P1675, DOI 10.1242/jcs.01004; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Schafer G, 2014, J CELL SCI, V127, P1511, DOI 10.1242/jcs.139485; Shamir ER, 2014, J CELL BIOL, V204, P839, DOI 10.1083/jcb.201306088; Straub BK, 2011, J CELL BIOL, V195, P873, DOI 10.1083/jcb.201106023; Takeichi M, 2011, DEV CELL, V21, P24, DOI 10.1016/j.devcel.2011.06.002; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Williams M, 2014, DEV CELL, V29, P34, DOI 10.1016/j.devcel.2014.02.007; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153591	10.1371/journal.pone.0153591	http://dx.doi.org/10.1371/journal.pone.0153591			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097030	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000374543600044
J	Tien, SM; Hsu, CY; Chen, BS				Tien, Shin-Ming; Hsu, Chih-Yuan; Chen, Bor-Sen			Engineering Bacteria to Search for Specific Concentrations of Molecules by a Systematic Synthetic Biology Design Method	PLOS ONE			English	Article							CHEMOTAXIS; MODEL; POPULATIONS; COLI; CELL	Bacteria navigate environments full of various chemicals to seek favorable places for survival by controlling the flagella's rotation using a complicated signal transduction pathway. By influencing the pathway, bacteria can be engineered to search for specific molecules, which has great potential for application to biomedicine and bioremediation. In this study, genetic circuits were constructed to make bacteria search for a specific molecule at particular concentrations in their environment through a synthetic biology method. In addition, by replacing the "brake component" in the synthetic circuit with some specific sensitivities, the bacteria can be engineered to locate areas containing specific concentrations of the molecule. Measured by the swarm assay qualitatively and microfluidic techniques quantitatively, the characteristics of each "brake component" were identified and represented by a mathematical model. Furthermore, we established another mathematical model to anticipate the characteristics of the "brake component". Based on this model, an abundant component library can be established to provide adequate component selection for different searching conditions without identifying all components individually. Finally, a systematic design procedure was proposed. Following this systematic procedure, one can design a genetic circuit for bacteria to rapidly search for and locate different concentrations of particular molecules by selecting the most adequate "brake component" in the library. Moreover, following simple procedures, one can also establish an exclusive component library suitable for other cultivated environments, promoter systems, or bacterial strains.	[Tien, Shin-Ming; Hsu, Chih-Yuan; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan	National Tsing Hua University	Chen, BS (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017		Ministry of Science and Technology, Taiwan [MOST 103-2745-E-007-001-ASP]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors are grateful for the support provided by the Ministry of Science and Technology, Taiwan, through grant no. MOST 103-2745-E-007-001-ASP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2008, BIOPHYS J, V95, P4481, DOI 10.1529/biophysj.108.134510; Ahmed T, 2010, INTEGR BIOL-UK, V2, P604, DOI 10.1039/c0ib00049c; Anderson JC, 2006, J MOL BIOL, V355, P619, DOI 10.1016/j.jmb.2005.10.076; Chen BS, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-136; Derr P, 2006, J MOL BIOL, V355, P923, DOI 10.1016/j.jmb.2005.11.025; Dyer CM, 2004, J MOL BIOL, V342, P1325, DOI 10.1016/j.jmb.2004.07.084; Goldberg SD, MOL SYSTEMS BIOL, V5; Hazelbauer GL, 2007, TRENDS BIOCH SCI, V33; Hsu CY, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S5-S7; Hsu CY, IEEE ACM T IN PRESS; Hwang IY, 2014, ACS SYNTH BIOL, V3, P228, DOI 10.1021/sb400077j; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Lee YY, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-109; Levin-Karp A, 2013, ACS SYNTH BIOL, V2, P327, DOI 10.1021/sb400002n; Lin B, 2012, CURR OPIN CHEM BIOL, V16, P307, DOI 10.1016/j.cbpa.2012.04.012; LOVELY PS, 1975, J THEOR BIOL, V50, P477, DOI 10.1016/0022-5193(75)90094-6; Mishler DM, 2010, CURR OPIN BIOTECH, V21, P653, DOI 10.1016/j.copbio.2010.05.007; RIVERO MA, 1989, CHEM ENG SCI, V44, P2881, DOI 10.1016/0009-2509(89)85098-5; Scharf BE, 1998, J BACTERIOL, V180, P5123, DOI 10.1128/JB.180.19.5123-5128.1998; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Schuster M, 1998, MOL MICROBIOL, V27, P1065, DOI 10.1046/j.1365-2958.1998.00756.x; Sinha J, 2010, NAT CHEM BIOL, V6, P464, DOI 10.1038/nchembio.369; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; Taghavi S, 1997, RES MICROBIOL, V148, P536, DOI 10.1016/S0923-2508(97)88361-1; Tindall MJ, 2008, B MATH BIOL, V70, P1570, DOI 10.1007/s11538-008-9322-5; Tindall MJ, 2008, B MATH BIOL, V70, P1525, DOI 10.1007/s11538-008-9321-6; Topp S, 2007, J AM CHEM SOC, V129, P6807, DOI 10.1021/ja0692480; Weiss LE, 2008, BIOTECHNOLOGY BIOENG, V100; WOLFE AJ, 1989, P NATL ACAD SCI USA, V86, P6973, DOI 10.1073/pnas.86.18.6973; Zhu XY, 1996, J BACTERIOL, V178, P4208, DOI 10.1128/jb.178.14.4208-4215.1996	30	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152146	10.1371/journal.pone.0152146	http://dx.doi.org/10.1371/journal.pone.0152146			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096615	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600008
J	Biering-Sorensen, T; Mogelvang, R; de Knegt, MC; Olsen, FJ; Galatius, S; Jensen, JS				Biering-Sorensen, Tor; Mogelvang, Rasmus; de Knegt, Martina Chantal; Olsen, Flemming Javier; Galatius, Soren; Jensen, Jan Skov			Cardiac Time Intervals by Tissue Doppler Imaging M-Mode: Normal Values and Association with Established Echocardiographic and Invasive Measures of Systolic and Diastolic Function	PLOS ONE			English	Article							MYOCARDIAL PERFORMANCE INDEX; LEFT-VENTRICULAR FUNCTION; HEART-FAILURE; GENERAL-POPULATION; PROGNOSTIC VALUE; SURFACE-AREA; STRAIN-RATE; INFARCTION; RECOMMENDATIONS; MEN	Purpose To define normal values of the cardiac time intervals obtained by tissue Doppler imaging (TDI) M-mode through the mitral valve (MV). Furthermore, to evaluate the association of the myocardial performance index (MPI) obtained by TDI M-mode (MPITD1) and the conventional method of obtaining MPI (MPIconv), with established echocardiographic and invasive measures of systolic and diastolic function. Methods In a large community based population study (n = 974), where all are free of any cardiovascular disease and cardiovascular risk factors, cardiac time intervals, including isovolumic relaxation time (IVRT), isovolumic contraction time (IVCT), and ejection time (ET) were obtained by TDI M-mode through the MV. IVCT/ET, IVRT/ET and the MPI ((IVRT+IVCT)/ET) were calculated. We also included a validation population (n = 44) of patients who underwent left heart catheterization and had the MPH! and MPIconv measured. Results IVRT, IVRT/ET and MPI all increased significantly with increasing age in both genders (p<0.001 for all). IVCT, ET, IVRT/ET, and MPI differed significantly between males and females, displaying that women, in general exhibit better cardiac function. MPITDI was significantly associated with invasive (dP/dt max) and echocardiographic measures of systolic (LVEF, global longitudinal strain and global strainrate s) and diastolic function (e', global strainrate e)(p<0.05 for all), whereas MPIconv was significantly associated with LVEF, e' and global strainrate e (p<0.05 for all). Conclusion Normal values of cardiac time intervals differed between genders and deteriorated with increasing age. The MPH! (but not MPIconv) is associated with most invasive and established echocardiographic measures of systolic and diastolic function.	[Biering-Sorensen, Tor; Mogelvang, Rasmus; de Knegt, Martina Chantal; Olsen, Flemming Javier; Galatius, Soren; Jensen, Jan Skov] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark; [Biering-Sorensen, Tor; Mogelvang, Rasmus; Jensen, Jan Skov] Univ Copenhagen, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Biering-Sorensen, Tor; Jensen, Jan Skov] Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Biering-Sorensen, T (corresponding author), Univ Copenhagen, Herlev & Gentofte Hosp, Dept Cardiol, Copenhagen, Denmark.; Biering-Sorensen, T (corresponding author), Univ Copenhagen, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark.; Biering-Sorensen, T (corresponding author), Univ Copenhagen, Inst Clin Med, Fac Hlth Sci, Copenhagen, Denmark.	tor.biering@gmail.com	Olsen, Flemming/AAS-8127-2021	Olsen, Flemming Javier/0000-0001-9511-8375; Biering-Sorensen, Tor/0000-0003-4209-2778; de Knegt, Martina/0000-0001-7668-0338	Faculty of Health Sciences, University of Copenhagen, Denmark	Faculty of Health Sciences, University of Copenhagen, Denmark	This study was financially supported by the Faculty of Health Sciences, University of Copenhagen, Denmark. The sponsor had no role in the study design, data collection, data analysis, data interpretation, or writing of the manuscript.	Arnlov J, 2004, EUR HEART J, V25, P2220, DOI 10.1016/j.ehj.2004.10.021; Biering-Sorensen T, 2016, INT J CARDIOVAS IMAG, V32, P789, DOI 10.1007/s10554-016-0839-7; Biering-Sorensen T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002687; Biering-Sorensen T, 2015, HEART, V101, P954, DOI 10.1136/heartjnl-2014-307137; Biering-Sorensen T, 2013, CIRC-CARDIOVASC IMAG, V6, P457, DOI 10.1161/CIRCIMAGING.112.000230; Biering-Sorensen T, 2011, AM J CARDIOL, V107, P478, DOI 10.1016/j.amjcard.2010.09.044; Chung AK, 2006, CIRCULATION, V113, P1597, DOI 10.1161/CIRCULATIONAHA.105.574400; Cui W, 2008, J AM SOC ECHOCARDIOG, V21, P361, DOI 10.1016/j.echo.2007.05.034; Dalen H, 2010, EUR J ECHOCARDIOGR, V11, P176, DOI 10.1093/ejechocard/jep194; DUBOIS D, 1989, NUTRITION, V5, P303; Duzenli MA, 2009, HEART VESSELS, V24, P8, DOI 10.1007/s00380-008-1069-2; Harada K, 2001, AM J CARDIOL, V88, P927, DOI 10.1016/S0002-9149(01)01912-9; Kaya MG, 2014, J THORAC DIS, V6, P429, DOI 10.3978/j.issn.2072-1439.2014.03.19; Kjaergaard J, 2005, J AM SOC ECHOCARDIOG, V18, P1058, DOI 10.1016/j.echo.2005.03.043; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Meric M, 2014, INT J CARDIOVAS IMAG, V30, P1057, DOI 10.1007/s10554-014-0449-1; Mogelvang R, 2015, EUR HEART J-CARD IMG, V16, P1331, DOI 10.1093/ehjci/jev180; Mogelvang R, 2009, EUR HEART J, V30, P731, DOI 10.1093/eurheartj/ehn596; Moller JE, 2003, AM HEART J, V145, P147, DOI 10.1067/mhj.2003.46; Nagueh SF, 2009, EUR J ECHOCARDIOGR, V10, P165, DOI 10.1093/ejechocard/jep007; Ruggiero A, 2013, INT J CLIN ONCOL, V18, P927, DOI 10.1007/s10147-012-0458-9; Su HM, 2007, ECHOCARDIOGR-J CARD, V24, P252, DOI 10.1111/j.1540-8175.2007.00382.x; Tei C, 1995, J Cardiol, V26, P135; Tei C, 1995, J Cardiol, V26, P357; Tei C, 1997, J AM SOC ECHOCARDIOG, V10, P169, DOI 10.1016/S0894-7317(97)70090-7; Tekten T, 2003, ECHOCARDIOGR-J CARD, V20, P503, DOI 10.1046/j.1540-8175.2003.03086.x; Tekten T, 2003, JPN HEART J, V44, P403, DOI 10.1536/jhj.44.403; Varol E, 2010, HEART VESSELS, V25, P400, DOI 10.1007/s00380-009-1225-3; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002; WEISSLER AM, 1968, CIRCULATION, V37, P149, DOI 10.1161/01.CIR.37.2.149	31	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153636	10.1371/journal.pone.0153636	http://dx.doi.org/10.1371/journal.pone.0153636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093636	Green Published, gold			2022-12-27	WOS:000374541200035
J	Hampel, M; Jakobi, M; Schmitz, L; Meyer, U; Finkernagel, F; Doehlemann, G; Heimel, K				Hampel, Martin; Jakobi, Mareike; Schmitz, Lara; Meyer, Ute; Finkernagel, Florian; Doehlemann, Gunther; Heimel, Kai			Unfolded Protein Response (UPR) Regulator Cib1 Controls Expression of Genes Encoding Secreted Virulence Factors in Ustilago maydis	PLOS ONE			English	Article							PATHOGENIC DEVELOPMENT; TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; REPLACEMENT MUTANTS; FUNGAL EFFECTOR; MESSENGER-RNA; CLP1 PROTEIN; ER-STRESS; IRE1; GENOME	The unfolded protein response (UPR), a conserved eukaryotic signaling pathway to ensure protein homeostasis in the endoplasmic reticulum (ER), coordinates biotrophic development in the corn smut fungus Ustilago maydis. Exact timing of UPR activation is required for virulence and presumably connected to the elevated expression of secreted effector proteins during infection of the host plant Zea mays. In the baker's yeast Saccharomyces cerevisiae, expression of UPR target genes is induced upon binding of the central regulator Hac1 to unfolded protein response elements (UPREs) in their promoters. While a role of the UPR in effector secretion has been described previously, we investigated a potential UPR-dependent regulation of genes encoding secreted effector proteins. In silico prediction of UPREs in promoter regions identified the previously characterized effector genes pit2 and tin1-1, as bona fide UPR target genes. Furthermore, direct binding of the Hac1-homolog Cib1 to the UPRE containing promoter fragments of both genes was confirmed by quantitative chromatin immunoprecipitation (qChIP) analysis. Targeted deletion of the UPRE abolished Cib1-dependent expression of pit2 and significantly affected virulence. Furthermore, ER stress strongly increased Pit2 expression and secretion. This study expands the role of the UPR as a signal hub in fungal virulence and illustrates, how biotrophic fungi can coordinate cellular physiology, development and regulation of secreted virulence factors.	[Hampel, Martin; Jakobi, Mareike; Schmitz, Lara; Heimel, Kai] Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany; [Hampel, Martin; Heimel, Kai] Univ Gottingen, Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany; [Meyer, Ute; Doehlemann, Gunther] Univ Cologne, Inst Bot, Gyrhofstr 15, Cologne, Germany; [Meyer, Ute; Doehlemann, Gunther] Univ Cologne, Cluster Excellence Plant Sci, D-50931 Cologne, Germany; [Finkernagel, Florian] Univ Marburg, Inst Mol Biol & Tumor Res IMT, Marburg, Germany	University of Gottingen; University of Cologne; University of Cologne; Philipps University Marburg	Heimel, K (corresponding author), Inst Microbiol & Genet, Dept Mol Microbiol & Genet, Gottingen, Germany.; Heimel, K (corresponding author), Univ Gottingen, Ctr Mol Biosci GZMB, D-37073 Gottingen, Germany.	kheimel@gwdg.de	Doehlemann, Gunther/C-1777-2008	Heimel, Kai/0000-0002-1396-8622; Doehlemann, Gunther/0000-0002-7353-8456	Deutsche Forschungsgemeinschaft [HE6977/2-1]; German Research Foundation; Gottingen University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Research Foundation(German Research Foundation (DFG)); Gottingen University	This work was supported by Deutsche Forschungsgemeinschaft grant (HE6977/2-1), www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank members of the Heimel lab for constructive comments on the manuscript, Anika Klewing for support during the initial screening procedure, J. Kamper and J. Ulrich for expert advice on ChIP analysis and G. Braus for generous support. We thank Daniela Assmann for excellent technical support. We acknowledge support by the German Research Foundation and the Open Access Publication Funds of the Gottingen University.	Basse CW, 2002, MOL MICROBIOL, V43, P75, DOI 10.1046/j.1365-2958.2002.02742.x; Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Baumann S, 2012, J CELL SCI, V125, P2740, DOI 10.1242/jcs.101212; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brefort T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003866; Cheon SA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002177; Chujo T, 2014, MOL MICROBIOL, V92, P413, DOI 10.1111/mmi.12567; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; de Jonge R, 2011, CURR OPIN PLANT BIOL, V14, P400, DOI 10.1016/j.pbi.2011.03.005; Djamei A, 2011, NATURE, V478, P395, DOI 10.1038/nature10454; Doehlemann G, 2011, MOL MICROBIOL, V81, P751, DOI 10.1111/j.1365-2958.2011.07728.x; Doehlemann G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000290; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Flor-Parra I, 2006, PLANT CELL, V18, P2369, DOI 10.1105/tpc.106.042754; Fordyce PM, 2012, P NATL ACAD SCI USA, V109, pE3084, DOI 10.1073/pnas.1212457109; Freitag J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002044; Heimel K, 2013, PLANT CELL, V25, P4262, DOI 10.1105/tpc.113.115899; Heimel K, 2010, PLANT CELL, V22, P2908, DOI 10.1105/tpc.110.076265; Heimel K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001035; Hemetsberger C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002684; Holliday R., 1974, HDB GENETICS, P575, DOI 10.1007/978-1-4899-1710-2_31; Joubert A, 2011, MOL MICROBIOL, V79, P1305, DOI 10.1111/j.1365-2958.2010.07522.x; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kamper J, 2004, MOL GENET GENOMICS, V271, P103, DOI 10.1007/s00438-003-0962-8; Khrunyk Y, 2010, NEW PHYTOL, V187, P957, DOI 10.1111/j.1469-8137.2010.03413.x; Kimata Y, 2007, J CELL BIOL, V179, P75, DOI 10.1083/jcb.200704166; Kleemann J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002643; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lanver D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004272; Lanver D, 2010, PLANT CELL, V22, P2085, DOI 10.1105/tpc.109.073734; Laurie JD, 2012, PLANT CELL, V24, P1733, DOI 10.1105/tpc.112.097261; Lo Presti L, 2015, NEW PHYTOL; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Mahlert M, 2006, MOL MICROBIOL, V59, P567, DOI 10.1111/j.1365-2958.2005.04952.x; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; MORI K, 1992, EMBO J, V11, P2583, DOI 10.1002/j.1460-2075.1992.tb05323.x; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Mueller AN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003177; Mueller O, 2008, FUNGAL GENET BIOL, V45, pS63, DOI 10.1016/j.fgb.2008.03.012; Mulder HJ, 2004, MOL GENET GENOMICS, V271, P130, DOI 10.1007/s00438-003-0965-5; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Ogawa N, 2004, GENES CELLS, V9, P95, DOI 10.1111/j.1365-2443.2004.00704.x; Redkar A, 2015, PLANT CELL, V27, P1332, DOI 10.1105/tpc.114.131086; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scherer M, 2006, PLANT CELL, V18, P2388, DOI 10.1105/tpc.106.043521; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Skibbe DS, 2010, SCIENCE, V328, P89, DOI 10.1126/science.1185775; Soyer JL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004227; Stergiopoulos I, 2009, ANNU REV PHYTOPATHOL, V47, P233, DOI 10.1146/annurev.phyto.112408.132637; Tanaka S, 2014, ELIFE, V3, DOI 10.7554/eLife.01355; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TSUKUDA T, 1988, MOL CELL BIOL, V8, P3703, DOI 10.1128/MCB.8.9.3703; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	58	12	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153861	10.1371/journal.pone.0153861	http://dx.doi.org/10.1371/journal.pone.0153861			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093436	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200052
J	Widmer, RJ; Allison, TG; Keane, B; Dallas, A; Bailey, KR; Lerman, LO; Lerman, A				Widmer, R. Jay; Allison, Thomas G.; Keane, Brendie; Dallas, Anthony; Bailey, Kent R.; Lerman, Lilach O.; Lerman, Amir			Workplace Digital Health Is Associated with Improved Cardiovascular Risk Factors in a Frequency-Dependent Fashion: A Large Prospective Observational Cohort Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; OVERWEIGHT; INTERVENTIONS; PROGRAM; DISEASE; POPULATION; PREVENTION; EMPLOYEES; BEHAVIOR	Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the US. Emerging employer-sponsored work health programs (WHP) and Digital Health Intervention (DHI) provide monitoring and guidance based on participants' health risk assessments, but with uncertain success. DHI-mobile technology including online and smartphone interventions-has previously been found to be beneficial in reducing CVD outcomes and risk factors, however its use and efficacy in a large, multisite, primary prevention cohort has not been described to date. We analyzed usage of DHI and change in intermediate markers of CVD over the course of one year in 30,974 participants of a WHP across 81 organizations in 42 states between 2011 and 2014, stratified by participation log-ins categorized as no (n = 14,173), very low (<12/yr, n = 12,260), monthly (n = 3,360), weekly (n = 651), or semiweekly (at least twice per week). We assessed changes in weight, waist circumference, body mass index (BMI), blood pressure, lipids, and glucose at one year, as a function of participation level. We utilized a Poisson regression model to analyze variables associated with increased participation. Those with the highest level of participation were slightly, but significantly (p<0.0001), older (48.3 +/- 11.2 yrs) than non-participants (47.7 +/- 12.2 yr) and more likely to be females (63.7% vs 37.3% p<0.0001). Significant improvements in weight loss were demonstrated with every increasing level of DHI usage with the largest being in the semi-weekly group (-3.39 +/- 1.06 lbs; p = 0.0013 for difference from weekly). Regression analyses demonstrated that greater participation in the DHI (measured by log-ins) was significantly associated with older age (p<0.001), female sex (p<0.001), and Hispanic ethnicity (p<0.001). The current study demonstrates the success of DHI in a large, community cohort to modestly reduce CVD risk factors in individuals with high participation rate. Furthermore, participants previously underrepresented in WHPs (females and Hispanics) and those with an increased number of CVD risk factors including age and elevated BMI show increased adherence to DHI, supporting the use of this low-cost intervention to improve CVD health.	[Widmer, R. Jay; Allison, Thomas G.; Bailey, Kent R.; Lerman, Amir] Mayo Clin & Coll Med, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; [Keane, Brendie; Dallas, Anthony] CareHere Inc, Nashville, TN USA; [Lerman, Lilach O.] Mayo Clin & Coll Med, Dept Internal Med, Div Nephrol & Hypertens, Rochester, MN 55905 USA; [Bailey, Kent R.] Mayo Clin & Coll Med, Div Biomed Stat & Informat, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Lerman, A (corresponding author), Mayo Clin & Coll Med, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA.	lerman.amir@mayo.edu	Fazli, Ghazal/AAE-8320-2022; Lerman, Lilach/M-4962-2017		Binational Industrial Research and Development (BIRD) Foundation [1303]; CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH) [UL1 TR000135]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000135] Funding Source: NIH RePORTER	Binational Industrial Research and Development (BIRD) Foundation; CTSA from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by Binational Industrial Research and Development (BIRD) Foundation #1303. This publication was also made possible by CTSA Grant Number UL1 TR000135 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH. The funder provided support in the form of salaries for authors Allison, Lennon, and Lerman, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Furthermore, authors Keane and Dallas, despite employment with CareHere at the time of authorship, had no financial relationship to the study and CareHere had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen LL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2340; Anderson LM, 2009, AM J PREV MED, V37, P340, DOI 10.1016/j.amepre.2009.07.003; Colkesen EB, 2011, J OCCUP MED TOXICOL,, V6, DOI 10.1186/1745-6673-6-5; Cooper AF, 2002, CLIN REHABIL, V16, P541, DOI 10.1191/0269215502cr524oa; Dekkers JC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-49; Foley L, 2014, PROVIDING BILLING ME; Groeneveld IF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-836; Gussenhoven AHM, 2013, WORK, V46, P337, DOI 10.3233/WOR-121555; HHS UD, 2015, GUID IND FO IN PRESS; Jacobs N, 2011, PATIENT EDUC COUNS, V85, P122, DOI 10.1016/j.pec.2010.08.024; Lerner D, 2013, J OCCUP ENVIRON MED, V55, P209, DOI 10.1097/JOM.0b013e3182728d3c; Lopez M. H., 2013, CLOSING DIGITAL DIVI; Mozaffarian D., 2014, CIRCULATION; Roger VL, 2012, CIRCULATION, V125, P188, DOI 10.1161/CIR.0b013e3182456d46; Widmer RJ, 2015, J CARDIOVASC TRANSL, V8, P283, DOI 10.1007/s12265-015-9629-1; Widmer RJ, 2015, MAYO CLIN PROC, V90, P469, DOI 10.1016/j.mayocp.2014.12.026; Widmer RJ, 2014, AM HEART J, V167, P93, DOI 10.1016/j.ahj.2013.09.019; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	19	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152657	10.1371/journal.pone.0152657	http://dx.doi.org/10.1371/journal.pone.0152657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092940	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200008
J	Woods, RT; Orrell, M; Bruce, E; Edwards, RT; Hoare, Z; Hounsome, B; Keady, J; Moniz-Cook, E; Orgeta, V; Rees, J; Russell, I				Woods, Robert T.; Orrell, Martin; Bruce, Errollyn; Edwards, Rhiannon T.; Hoare, Zoe; Hounsome, Barry; Keady, John; Moniz-Cook, Esme; Orgeta, Vasiliki; Rees, Janice; Russell, Ian			REMCARE: Pragmatic Multi-Centre Randomised Trial of Reminiscence Groups for People with Dementia and their Family Carers: Effectiveness and Economic Analysis	PLOS ONE			English	Article							QUALITY-OF-LIFE; ALZHEIMERS-DISEASE; OLDER ADULTS; SCALE; INTERVENTION; MAINTENANCE; DEPRESSION; CAREGIVERS; THERAPY; ANXIETY	Background Joint reminiscence groups, involving people with dementia and family carers together, are popular, but the evidence-base is limited. This study aimed to assess the effectiveness and cost-effectiveness of joint reminiscence groups as compared to usual care. Methods This multi-centre, pragmatic randomised controlled trial had two parallel arms: intervention group and usual-care control group. A restricted dynamic method of randomisation was used, with an overall allocation ratio of 1: 1, restricted to ensure viable sized intervention groups. Assessments, blind to treatment allocation, were carried out at baseline, three months and ten months (primary end-point), usually in the person's home. Participants were recruited in eight centres, mainly through NHS Memory Clinics and NHS community mental health teams. Included participants were community resident people with mild to moderate dementia (DSM-IV), who had a relative or other care-giver in regular contact, to act as informant and willing and able to participate in intervention. 71% carers were spouses. 488 people with dementia (mean age 77.5) were randomised: 268 intervention, 220 control; 350 dyads completed the study (206 intervention, 144 control). The intervention evaluated was joint reminiscence groups (with up to 12 dyads) weekly for twelve weeks; monthly maintenance sessions for further seven months. Sessions followed a published treatment manual and were held in a variety of community settings. Two trained facilitators in each centre were supported by volunteers. Primary outcome measures were self-reported quality of life for the person with dementia (QoL-AD), psychological distress for the carer (General Health Questionnaire, GHQ-28). Secondary outcome measures included: autobiographical memory and activities of daily living for the person with dementia; carer stress for the carer; mood, relationship quality and service use and costs for both. Results The intention to treat analysis (ANCOVA) identified no differences in outcome between the intervention and control conditions on primary or secondary outcomes (self-reported QoL-AD mean difference 0.07 (-1.21 to 1.35), F = 0.48, p = 0.53). Carers of people with dementia allocated to the reminiscence intervention reported a significant increase in anxiety on a General Health Questionnaire-28 sub-scale at the ten month end-point (mean difference 1.25 (0.25 to 2.26), F = 8.28, p = 0.04). Compliance analyses suggested improved autobiographical memory, quality of life and relationship quality for people with dementia attending more reminiscence sessions, however carers attending more groups showed increased care-giving stress. Economic analyses from a public sector perspective indicated that joint reminiscence groups are unlikely to be cost-effective. There were no significant adverse effects attributed to the intervention. Potential limitations of the study include less than optimal attendance at the group sessions-only 57% of participants attended at least half of the intervention sessions over the 10 month period, and a higher rate of study withdrawal in the control group. Conclusions This trial does not support the clinical effectiveness or cost-effectiveness of joint reminiscence groups. Possible beneficial effects for people with dementia who attend sessions as planned are offset by raised anxiety and stress in their carers. The reasons for these discrepant outcomes need to be explored further, and may necessitate reappraisal of the movement towards joint interventions.	[Woods, Robert T.] Bangor Univ, Dementia Serv Dev Ctr Wales, Bangor, Gwynedd, Wales; [Orrell, Martin] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2RD, England; [Bruce, Errollyn] Univ Bradford, Bradford Dementia Grp, Bradford BD7 1DP, W Yorkshire, England; [Edwards, Rhiannon T.] Bangor Univ, Ctr Econ & Policy Hlth, Bangor, Gwynedd, Wales; [Hoare, Zoe] Bangor Univ, North Wales Org Randomised Trials Hlth & Social C, Bangor, Gwynedd, Wales; [Hounsome, Barry] Bangor Univ, Ctr Econ & Policy Hlth, Bangor, Gwynedd, Wales; [Keady, John] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Moniz-Cook, Esme] Univ Hull, Fac Hlth & Social Care, Dementia Care Res, Kingston Upon Hull HU6 7RX, N Humberside, England; [Orgeta, Vasiliki] Univ London, Div Psychiat, London, England; [Rees, Janice] Ystrad Mynach Hosp, Aneurin Bevan Hlth Board, Ystrad Mynach, Caerphilly, Wales; [Russell, Ian] Swansea Univ, West Wales Org Rigorous Trials Hlth, Ctr Hlth Informat Res & Evaluat, Swansea, W Glam, Wales	Bangor University; University of Nottingham; University of Bradford; Bangor University; Bangor University; Bangor University; University of Manchester; University of Hull; University of London; Swansea University	Woods, RT (corresponding author), Bangor Univ, Dementia Serv Dev Ctr Wales, Bangor, Gwynedd, Wales.	b.woods@bangor.ac.uk	Woods, Bob/E-7140-2011; Keady, John/P-4992-2014	Woods, Bob/0000-0002-6781-651X; Orrell, Martin/0000-0002-1169-3530; Orgeta, Vasiliki/0000-0001-8643-5061; Keady, John/0000-0001-8243-6913; Moniz-Cook, Esme/0000-0002-7232-4632; Hoare, Zoe/0000-0003-1803-5482	National Institute of Health Research Health Technology Assessment Programme [06/304/229]; Medical Research Council [G0300932]; National Institute for Health Research [06/304/229] Funding Source: researchfish; MRC [G0300932] Funding Source: UKRI	National Institute of Health Research Health Technology Assessment Programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Institute of Health Research Health Technology Assessment Programme Ref: 06/304/229, http://www.nets.nihr.ac.uk/programmes/hta and Medical Research Council Ref: G0300932, http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agar S, 1997, AGING MENT HEALTH, V1, P166, DOI 10.1080/13607869757263; ALEXOPOULOS GS, 1988, BIOL PSYCHIAT, V23, P271, DOI 10.1016/0006-3223(88)90038-8; Beecham J, 1992, MEASURING MENTAL HLT, P163; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Bucks RS, 1996, AGE AGEING, V25, P113, DOI 10.1093/ageing/25.2.113; Curtis L., 2010, UNIT COSTS HLTH SOCI; Department of Health, 2010, NHS REF COSTS 2009 1; Donaldson C, 1998, INT J GERIATR PSYCH, V13, P248; EuroQol, EQ 5D; Flint AJ, 1996, INT J GERIATR PSYCH, V11, P991, DOI 10.1002/(SICI)1099-1166(199611)11:11<991::AID-GPS423>3.0.CO;2-8; Fossey J, 2006, BMJ-BRIT MED J, V332, P756, DOI 10.1136/bmj.38782.575868.7C; Gibson F., 2004, PRESENT USING REMINI; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Gudex C, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-33; Keady J, 2013, OXFORD TXB OLD AGE P, P213; Kopelman MD, 1990, AUTOBIOGRAPHICAL MEM; Kurz A, 2012, ALZ DIS ASSOC DIS, V26, P246, DOI 10.1097/WAD.0b013e318231e46e; Logsdon RG, 2002, PSYCHOSOM MED, V64, P510, DOI 10.1097/00006842-200205000-00016; MacPherson S, 2009, AGING MENT HEALTH, V13, P744, DOI 10.1080/13607860902918207; Marriott A, 2000, BRIT J PSYCHIAT, V176, P557, DOI 10.1192/bjp.176.6.557; Melunsky N, 2015, DEMENTIA-LONDON, V14, P842, DOI 10.1177/1471301213516332; NICE-SCIE, 2006, DEM SUPP PEOPL DEM T, V42; Olazaran J, 2010, DEMENT GERIATR COGN, V30, P161, DOI 10.1159/000316119; Orrell M, 2014, BRIT J PSYCHIAT, V204, P454, DOI 10.1192/bjp.bp.113.137414; Pattie AH, 1979, MANUAL FOR THE CLIFT; Richards K, 2003, AGING MENT HEALTH, V7, P7, DOI 10.1080/1360786021000058157; Russell D, 2011, STAT MED, V30, P922, DOI 10.1002/sim.4175; Schweitzer P, 2008, REMEMBERING YESTERDA; Shankar KK, 1999, AGING MENT HEALTH, V3, P39, DOI 10.1080/13607869956424; Spruytte N, 2002, PSYCHOL PSYCHOTHER-T, V75, P295, DOI 10.1348/147608302320365208; Subramaniam Ponnusamy, 2010, International Journal of Computers in Healthcare, V1, P106, DOI 10.1504/IJCIH.2010.037457; Thorgrimsen L, 2003, ALZ DIS ASSOC DIS, V17, P201, DOI 10.1097/00002093-200310000-00002; Wang JJ, 2007, INT J GERIATR PSYCH, V22, P1235, DOI 10.1002/gps.1821; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Woods B, 2005, REMINISCENCE THERAPY; Woods RT, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16480; Woods RT, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-64; ZARIT SH, 1982, GERONTOLOGIST, V22, P373, DOI 10.1093/geront/22.4.373	38	53	53	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152843	10.1371/journal.pone.0152843	http://dx.doi.org/10.1371/journal.pone.0152843			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9NW	27093052	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200009
J	Cui, TX; Wang, YJ; Sun, R; Qiao, C; Fan, WJ; Jiang, GQ; Hao, LY; Zhang, L				Cui, Tianxiang; Wang, Yujie; Sun, Rui; Qiao, Chen; Fan, Wenjie; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei			Estimating Vegetation Primary Production in the Heihe River Basin of China with Multi-Source and Multi-Scale Data	PLOS ONE			English	Article							NET PRIMARY PRODUCTIVITY; GROSS PRIMARY PRODUCTION; PRIMARY PRODUCTION GPP; LEAF-AREA INDEX; EDDY-COVARIANCE; ECOSYSTEM MODEL; USE EFFICIENCY; CLIMATE-CHANGE; SURFACE; FOREST	Estimating gross primary production (GPP) and net primary production (NPP) are significant important in studying carbon cycles. Using models driven by multi-source and multi-scale data is a promising approach to estimate GPP and NPP at regional and global scales. With a focus on data that are openly accessible, this paper presents a GPP and NPP model driven by remotely sensed data and meteorological data with spatial resolutions varying from 30 m to 0.25 degree and temporal resolutions ranging from 3 hours to 1 month, by integrating remote sensing techniques and eco-physiological process theories. Our model is also designed as part of the Multi-source data Synergized Quantitative (MuSyQ) Remote Sensing Production System. In the presented MuSyQ-NPP algorithm, daily GPP for a 10-day period was calculated as a product of incident photosynthetically active radiation (PAR) and its fraction absorbed by vegetation (FPAR) using a light use efficiency (LUE) model. The autotrophic respiration (Ra) was determined using eco-physiological process theories and the daily NPP was obtained as the balance between GPP and Ra. To test its feasibility at regional scales, our model was performed in an arid and semi-arid region of Heihe River Basin, China to generate daily GPP and NPP during the growing season of 2012. The results indicated that both GPP and NPP exhibit clear spatial and temporal patterns in their distribution over Heihe River Basin during the growing season due to the temperature, water and solar influx conditions. After validated against ground-based measurements, MODIS GPP product (MOD17A2H) and results reported in recent literature, we found the MuSyQ-NPP algorithm could yield an RMSE of 2.973 gC m(-2) d(-1) and an R of 0.842 when compared with ground-based GPP while an RMSE of 8.010 gC m(-2) d(-1) and an R of 0.682 can be achieved for MODIS GPP, the estimated NPP values were also well within the range of previous literature, which proved the reliability of our modelling results. This research suggested that the utilization of multi-source data with various scales would help to the establishment of an appropriate model for calculating GPP and NPP at regional scales with relatively high spatial and temporal resolution.	[Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Normal Univ, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China; [Cui, Tianxiang; Sun, Rui; Qiao, Chen; Jiang, Guoqing; Hao, Lvyuan; Zhang, Lei] Beijing Key Lab Remote Sensing Environm & Digital, Beijing, Peoples R China; [Wang, Yujie] Northwest Reg Climate Ctr, Lanzhou, Peoples R China; [Wang, Yujie] Nanjing Univ, Sch Atmospher Sci, Nanjing 210008, Jiangsu, Peoples R China; [Fan, Wenjie] Peking Univ, Inst Remote Sensing & Geog Informat Syst, Beijing 100871, Peoples R China	Beijing Normal University; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS; Beijing Normal University; Nanjing University; Peking University	Sun, R (corresponding author), Beijing Normal Univ, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Sun, R (corresponding author), Chinese Acad Sci, State Key Lab Remote Sensing Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China.; Sun, R (corresponding author), Beijing Normal Univ, Sch Geog & Remote Sensing Sci, Beijing 100875, Peoples R China.; Sun, R (corresponding author), Beijing Key Lab Remote Sensing Environm & Digital, Beijing, Peoples R China.	sunrui@bnu.edu.cn	Cui, Tianxiang/ABA-4631-2020	Cui, Tianxiang/0000-0001-7546-1408	National Natural Science Foundation of China [41471349]; National Key Project of Scientific and Technical Supporting Programs - Ministry of Science AMP; Technology of China [2013BAC03B02]; National High Technology Research and Development Program of China (863 Program) [2012AA12A304]; Fundamental Research Funds for the Central Universities [2014kJJCA02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project of Scientific and Technical Supporting Programs - Ministry of Science AMP; Technology of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was funded by the National Natural Science Foundation of China (41471349), the National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (2013BAC03B02), the National High Technology Research and Development Program of China (863 Program, 2012AA12A304), and the Fundamental Research Funds for the Central Universities (2014kJJCA02).	Chen JM, 1999, ECOL MODEL, V124, P99, DOI 10.1016/S0304-3800(99)00156-8; [陈正华 CHEN Zhenghua], 2008, [自然资源学报, Journal of Natural Resources], V23, P263; Coops NC, 2007, REMOTE SENS ENVIRON, V107, P385, DOI 10.1016/j.rse.2006.09.010; Falge E, 2002, AGR FOREST METEOROL, V113, P53, DOI 10.1016/S0168-1923(02)00102-8; Fan L, 2015, REMOTE SENS-BASEL, V7, P3114, DOI 10.3390/rs70303114; Fan WJ, 2014, IEEE J-STARS, V7, P3945, DOI 10.1109/JSTARS.2014.2325673; Feng X, 2007, J ENVIRON MANAGE, V85, P563, DOI 10.1016/j.jenvman.2006.09.021; FIELD CB, 1995, REMOTE SENS ENVIRON, V51, P74, DOI 10.1016/0034-4257(94)00066-V; [卢玲 LU Ling], 2005, [中国沙漠, Journal of Desert Research], V25, P823; FROUIN R, 1995, REMOTE SENS ENVIRON, V51, P98, DOI 10.1016/0034-4257(94)00068-X; Leith H., 1975, PRIMARY PRODUCTIVITY, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Leuning R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006562; Li X, 2001, J ARID ENVIRON, V48, P521, DOI 10.1006/jare.2000.0715; Li X. B., 2013, THESIS; Li XQ, 2013, APPL GEOCHEM, V35, P99, DOI 10.1016/j.apgeochem.2013.04.001; Li X, 2013, B AM METEOROL SOC, V94, P1145, DOI 10.1175/BAMS-D-12-00154.1; Liao YR, 2013, INT GEOSCI REMOTE SE, P169, DOI 10.1109/IGARSS.2013.6721118; Liu B, 2010, ENVIRON EARTH SCI, V59, P1235, DOI 10.1007/s12665-009-0112-7; Liu J, 1997, REMOTE SENS ENVIRON, V62, P158, DOI 10.1016/S0034-4257(97)00089-8; Liu J, 1999, J GEOPHYS RES-ATMOS, V104, P27735, DOI 10.1029/1999JD900768; Liu SM, 2011, HYDROL EARTH SYST SC, V15, P1291, DOI 10.5194/hess-15-1291-2011; Los SO, 2000, J HYDROMETEOROL, V1, P183, DOI 10.1175/1525-7541(2000)001<0183:AGYBLS>2.0.CO;2; Lu DS, 2006, INT J REMOTE SENS, V27, P1297, DOI 10.1080/01431160500486732; Ma MG, 2006, INT J REMOTE SENS, V27, P3473, DOI 10.1080/01431160600593031; Matsushita B, 2004, ECOL MODEL, V178, P371, DOI 10.1016/j.ecolmodel.2004.03.012; Matsushita B, 2002, REMOTE SENS ENVIRON, V81, P58, DOI 10.1016/S0034-4257(01)00331-5; McGuire AD, 1995, J BIOGEOGR, V22, P785, DOI 10.2307/2845980; MELILLO JM, 1993, NATURE, V363, P234, DOI 10.1038/363234a0; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Pachavo G, 2014, INT J APPL EARTH OBS, V30, P217, DOI 10.1016/j.jag.2014.02.007; Pan XD, 2014, J HYDROMETEOROL, V15, P1560, DOI 10.1175/JHM-D-13-0202.1; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Piao S.L., 2001, CHIN J PLANT ECOL, V25, P603, DOI DOI 10.3321/J.ISSN:1005-264X.2001.05.015; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Prieto-Blanco A, 2009, REMOTE SENS ENVIRON, V113, P137, DOI 10.1016/j.rse.2008.09.002; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Propastin P, 2009, REMOTE SENS-BASEL, V1, P159, DOI 10.3390/rs1030159; Qiao C, 2015, IEEE GEOSCI REMOTE S, V12, P369, DOI 10.1109/LGRS.2014.2342219; Rodell M, 2004, B AM METEOROL SOC, V85, P381, DOI 10.1175/BAMS-85-3-381; Ruimy A, 1994, J GEOPHYS RES-ATMOS, V99, P5263, DOI 10.1029/93JD03221; Running S. W., 2015, USERS GUIDE DAILY GP; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; SINCLAIR TR, 1989, CROP SCI, V29, P90, DOI 10.2135/cropsci1989.0011183X002900010023x; Sun R., 1999, CHINESE J APPL ECOLO, V10, P757; Turner DP, 2003, REMOTE SENS ENVIRON, V88, P256, DOI 10.1016/j.rse.2003.06.005; Turner DP, 2003, GLOBAL CHANGE BIOL, V9, P383, DOI 10.1046/j.1365-2486.2003.00573.x; Uchijima Z., 1985, J AGROMETEOROL, V40, P343, DOI DOI 10.2480/AGRMET.40.343; Wang HM, 2004, ATMOS ENVIRON, V38, P7021, DOI 10.1016/j.atmosenv.2004.02.071; Wang P, 2007, J ENVIRON MANAGE, V85, P607, DOI 10.1016/j.jenvman.2006.08.017; Wang XF, 2012, INT J APPL EARTH OBS, V17, P94, DOI 10.1016/j.jag.2011.09.009; Wen J, 2012, HIWATER VISIBLE NEAR; Weng DM, 1984, GEOPHYS RES, V3, P24; WOFSY SC, 1993, SCIENCE, V260, P1314, DOI 10.1126/science.260.5112.1314; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xu ZW, 2013, J GEOPHYS RES-ATMOS, V118, P13140, DOI 10.1002/2013JD020260; Zhang Hongyi, 2006, THESIS; ZHANG K, 2006, WATER RESOUR RES, V46; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120660; Zhang Yushun, 2014, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V34, P2085, DOI 10.7606/j.issn.1000-4025.2014.10.2085; Zhong B, 2014, SCI CHINA EARTH SCI, V57, P1790, DOI 10.1007/s11430-014-4877-5; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115; Zhou Y, 2007, J ENVIRON MANAGE, V85, P574, DOI 10.1016/j.jenvman.2006.04.024; Zhu HZ, 2006, THESIS; Zhu Wen-Quan, 2007, Zhiwu Shengtai Xuebao, V31, P413	70	26	31	7	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153971	10.1371/journal.pone.0153971	http://dx.doi.org/10.1371/journal.pone.0153971			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088356	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000059
J	Liang, H; Zhang, Q; Lu, JJ; Yang, GL; Tian, N; Wang, XJ; Tan, Y; Tan, DM				Liang, Hao; Zhang, Qian; Lu, Junjie; Yang, Genling; Tian, Na; Wang, Xiaojie; Tan, Yi; Tan, Dongmei			MSX2 Induces Trophoblast Invasion in Human Placenta	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GENE-EXPRESSION; DIFFERENTIATION; PREECLAMPSIA; IMPLANTATION; PREGNANCY; CELLS; ADENOCARCINOMA; 1ST-TRIMESTER; METHYLATION	Normal implantation depends on appropriate trophoblast growth and invasion. Inadequate trophoblast invasion results in pregnancy-related disorders, such as early miscarriage and pre-eclampsia, which are dangerous to both the mother and fetus. Msh Homeobox 2 (MSX2), a member of the MSX family of homeobox proteins, plays a significant role in the proliferation and differentiation of various cells and tissues, including ectodermal organs, teeth, and chondrocytes. Recently, MSX2 was found to play important roles in the invasion of cancer cells into adjacent tissues via the epithelial-mesenchymal transition (EMT). However, the role of MSX2 in trophoblastic invasion during placental development has yet to be explored. In the present study, we detected MSX2 expression in cytotrophoblast, syncytiotrophoblast, and extravillous cytotrophoblast cells of first or third trimester human placentas via immunohistochemistry analysis. Furthermore, we found that the in vitro invasive ability of HTR8/SVneo cells was enhanced by exogenous overexpression of MSX2, and that this effect was accompanied by increased protein expression of matrix metalloproteinase-2 (MMP-2), vimentin, and beta-catenin. Conversely, treatment of HTR8/SVneo cells with MSX2-specific siRNAs resulted in decreased protein expression of MMP-2, vimentin, and beta-catenin, and reduced invasion levels in a Matrigel invasion test. Notably, however, treatment with the MSX2 overexpression plasmid and the MSX2 siRNAs had no effect on the mRNA expression levels of beta-catenin. Meanwhile, overexpression of MSX2 and treatment with the MSX2-specific siRNA resulted in decreased and increased E-cadherin expression, respectively, in JEG-3 cells. Lastly, the protein expression levels of MSX2 were significantly lower in human pre-eclamptic placental villi than in the matched control placentas. Collectively, our results suggest that MSX2 may induce human trophoblast cell invasion, and dysregulation of MSX2 expression may be associated with pre-eclampsia.	[Liang, Hao; Zhang, Qian; Lu, Junjie; Yang, Genling; Tian, Na; Wang, Xiaojie; Tan, Yi; Tan, Dongmei] Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China	Chongqing Medical University	Tan, DM (corresponding author), Chongqing Med Univ, Lab Anim Ctr, Chongqing, Peoples R China.	dongmei_tan@yeah.net	tian, na/GVR-9226-2022		National Natural Science Foundation of China [31171436, 81501259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (31171436 to Y.T, 81501259 to Q.Z) (http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelova M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002959; Bai Q, 2012, STEM CELL REV REP, V8, P150, DOI 10.1007/s12015-011-9301-3; Carson DD, 2002, MOL HUM REPROD, V8, P871, DOI 10.1093/molehr/8.9.871; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Di Bari MG, 2009, J CELL PHYSIOL, V219, P659, DOI 10.1002/jcp.21712; Fisher SJ, 2015, AM J OBSTET GYNECOL, V213, pS115, DOI 10.1016/j.ajog.2015.08.042; Fritz R, 2014, INT J DEV BIOL, V58, P261, DOI 10.1387/ijdb.140011da; Fu JJ, 2010, J BIOL CHEM, V285, P10870, DOI 10.1074/jbc.M109.004200; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Hamada S, 2007, J CELL PHYSIOL, V213, P768, DOI 10.1002/jcp.21148; James JL, 2005, REPRODUCTION, V130, P95, DOI 10.1530/rep.1.00723; Jay PY, 2005, J CARDIOVASC ELECTR, V16, P82, DOI 10.1046/j.1540-8167.2005.04365.x; JOWETT AK, 1993, DEVELOPMENT, V117, P461; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Lanigan F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2621; Lyall F, 2006, AUST NZ J OBSTET GYN, V46, P266, DOI 10.1111/j.1479-828X.2006.00589.x; Mohamed OA, 2005, P NATL ACAD SCI USA, V102, P8579, DOI 10.1073/pnas.0500612102; Nallasamy S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002500; Nissi R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-2; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Phippard DJ, 1996, DEVELOPMENT, V122, P2729; Pollheimer J, 2006, AM J PATHOL, V168, P1134, DOI 10.2353/ajpath.2006.050686; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Renfree MB, 2014, INT J DEV BIOL, V58, P175, DOI 10.1387/ijdb.140059mr; Richter A, 2014, STEM CELLS, V32, P636, DOI 10.1002/stem.1592; Sagomonyants K, 2014, CONNECT TISSUE RES, V55, P53, DOI 10.3109/03008207.2014.923867; Satoh K, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00430; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Sonderegger S, 2010, PLACENTA, V31, P839, DOI 10.1016/j.placenta.2010.07.011; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Van der Auwera I, 2008, BRIT J CANCER, V99, P1735, DOI 10.1038/sj.bjc.6604705; van Dijk Marie, 2014, Front Genet, V5, P38, DOI 10.3389/fgene.2014.00038; Vicovac L, 1996, ACTA ANAT, V156, P202; Yeh J, 2009, WOUND REPAIR REGEN, V17, P639, DOI 10.1111/j.1524-475X.2009.00535.x; Zhai Y, 2011, ONCOGENE, V30, P4152, DOI 10.1038/onc.2011.123; Zhang HL, 1997, MOL CELL BIOL, V17, P2920, DOI 10.1128/MCB.17.5.2920; Zhang Z, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-17; Zhou Z, 2009, PLACENTA, V30, P929, DOI 10.1016/j.placenta.2009.09.003	41	15	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153656	10.1371/journal.pone.0153656	http://dx.doi.org/10.1371/journal.pone.0153656			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088357	gold, Green Published, Green Submitted			2022-12-27	WOS:000374527000039
J	Ayad, S; Babazade, R; Elsharkawy, H; Nadar, V; Lokhande, C; Makarova, N; Khanna, R; Sessler, DI; Turan, A				Ayad, Sabry; Babazade, Rovnat; Elsharkawy, Hesham; Nadar, Vinayak; Lokhande, Chetan; Makarova, Natalya; Khanna, Rashi; Sessler, Daniel I.; Turan, Alparslan			Comparison of Transversus Abdominis Plane Infiltration with Liposomal Bupivacaine versus Continuous Epidural Analgesia versus Intravenous Opioid Analgesia	PLOS ONE			English	Article							COLORECTAL SURGERY; OPEN-LABEL; TAP BLOCK; EFFICACY; MOTOR; PAIN	Epidural analgesia is considered the standard of care but cannot be provided to all patients Liposomal bupivacaine has been approved for field blocks such as transversus abdominis plane (TAP) blocks but has not been clinically compared against other modalities. In this retrospective propensity matched cohort study we thus tested the primary hypothesis that TAP infiltration are noninferior (not worse) to continuous epidural analgesia and superior (better) to intravenous opioid analgesia in patients recovering from major lower abdominal surgery. 318 patients were propensity matched on 18 potential factors among three groups (106 per group): 1) TAP infiltration with bupivacaine liposome; 2) continuous Epidural analgesia with plain bupivacaine; and; 3) intravenous patient-controlled analgesia (IV PCA). We claimed TAP noninferior (not worse) over Epidural if TAP was noninferior (not worse) on total morphine-equivalent opioid and time-weighted average pain score (10-point scale) within first 72 hours after surgery with noninferiority deltas of 1 (10-point scale) for pain and an increase less of 20% in the mean morphine equivalent opioid consumption. We claimed TAP or Epidural groups superior (better) over IV PCA if TAP or Epidural was superior on opioid consumption and at least noninferior on pain outcome. Multivariable linear regressions within the propensity-matched cohorts were used to model total morphine-equivalent opioid dose and time-weighted average pain score within first 72 hours after surgery; joint hypothesis framework was used for formal testing. TAP infiltration were noninferior to Epidural on both primary outcomes (p<0.001). TAP infiltration were noninferior to IV PCA on pain scores (p = 0.001) but we did not find superiority on opioid consumption (p = 0.37). We did not find noninferiority of Epidural over IV PCA on pain scores (P = 0.13) and nor did we find superiority on opioid consumption (P = 0.98). TAP infiltration with liposomal bupivacaine and continuous epidural analgesia were similar in terms of pain and opioid consumption, and not worse in pain compared with IV PCA. TAP infiltrations might be a reasonable alternative to epidural analgesia in abdominal surgical patients. A large randomized trial comparing these techniques is justified.	[Ayad, Sabry] Fairview Hosp, Dept Anesthesiol & Pain Management, Cleveland, OH USA; [Ayad, Sabry] Cleveland Clin, Dept Outcomes Res, Anesthesiol Inst Cleveland, Cleveland, OH 44106 USA; [Babazade, Rovnat] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Babazade, Rovnat] Cleveland Clin, Dept Outcomes Res, Cleveland, OH 44106 USA; [Elsharkawy, Hesham] Cleveland Clin, Dept Gen Anesthesiol, Inst Anesthesiol, Cleveland, OH 44106 USA; [Elsharkawy, Hesham; Nadar, Vinayak; Lokhande, Chetan; Makarova, Natalya; Khanna, Rashi; Sessler, Daniel I.; Turan, Alparslan] Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, Cleveland, OH 44106 USA; [Makarova, Natalya] Cleveland Clin, Dept Qualitat Hlth Sci, Inst Anesthesiol, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; University of Texas System; University of Texas Medical Branch Galveston; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Turan, A (corresponding author), Cleveland Clin, Dept Outcomes Res, Inst Anesthesiol, Cleveland, OH 44106 USA.	turana@ccf.org	Sessler, Daniel/D-3504-2011; ayad, sabry/ABA-8262-2020	Sessler, Daniel/0000-0001-9932-3077; AYAD, SABRY/0000-0002-6728-9297	Pacira Pharmaceuticals, Inc.	Pacira Pharmaceuticals, Inc.	The study was supported by Pacira Pharmaceuticals, Inc. The sponsor was not involved in data acquisition, analysis, nor interpretation of the results. This manuscript was written by the investigators. None of the authors has a personal financial interest in this research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAJ SURG PROC WER DE; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; CEDERHOLM I, 1994, REGION ANESTH, V19, P18; Chahar Praveen, 2012, J Pain Res, V5, P257, DOI 10.2147/JPR.S27894; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Findlay JM, 2012, SURG-J R COLL SURG E, V10, P361, DOI 10.1016/j.surge.2012.07.005; Finnerty O, 2013, MINERVA ANESTESIOL, V79, P1415; Finnerty O, 2012, CURR OPIN ANESTHESIO, V25, P610, DOI 10.1097/ACO.0b013e328357b165; Ganapathy S, 2015, EUR J ANAESTH, V32, P797, DOI 10.1097/EJA.0000000000000345; Horlocker TT, 2003, REGION ANESTH PAIN M, V28, P172, DOI 10.1053/rapm.2003.50046; Kadam VR, 2013, ANAESTH INTENS CARE, V41, P476, DOI 10.1177/0310057X1304100407; Kadam VR, 2011, J ANESTH, V25, P786, DOI 10.1007/s00540-011-1201-9; Konigsrainer I, 2009, ANAESTHESIA, V64, P27, DOI 10.1111/j.1365-2044.2008.05655.x; Marret E, 2007, BRIT J SURG, V94, P665, DOI 10.1002/bjs.5825; Mascha EJ, 2012, ANESTH ANALG, V114, P1304, DOI 10.1213/ANE.0b013e3182504435; Niraj G, 2014, ANAESTHESIA, V69, P348, DOI 10.1111/anae.12546; Niraj G, 2011, ANAESTHESIA, V66, P465, DOI 10.1111/j.1365-2044.2011.06700.x; Rosenbaum PR, 1983, CENTRAL ROLE PROPENS, DOI [10.1093/biomet/70.1.41, DOI 10.1093/BIOMET/70.1.41]; Spanjersberg WR, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007635.pub2; Turan A, 2013, CLIN J PAIN, V29, P1050, DOI 10.1097/AJP.0b013e318287a258; Vissers KCP, 2010, PAIN PRACT, V10, P85, DOI 10.1111/j.1533-2500.2009.00335.x; Wu YQ, 2013, ANESTH ANALG, V117, P507, DOI 10.1213/ANE.0b013e318297fcee	22	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153675	10.1371/journal.pone.0153675	http://dx.doi.org/10.1371/journal.pone.0153675			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082959	Green Published, gold			2022-12-27	WOS:000374291800043
J	Chen, ZM; Wang, HY; Liu, XW; Liu, YZ; Gao, SS; Zhou, JM				Chen, Zhaoming; Wang, Huoyan; Liu, Xiaowei; Liu, Yongzhe; Gao, Shuaishuai; Zhou, Jianmin			The Effect of N Fertilizer Placement on the Fate of Urea-N-15 and Yield of Winter Wheat in Southeast China	PLOS ONE			English	Article							NITROGEN USE EFFICIENCY; SUMMER MAIZE ROTATION; CROPPING SYSTEM; N-15-LABELED FERTILIZER; MICROBIAL COMMUNITY; SOIL PROPERTIES; SPRING WHEAT; BREAD WHEAT; ROOT-ZONE; RECOVERY	A field micro-plot experiment using nitrogen isotope (N-15) labeling was conducted to determine the effects of placement methods (broadcast and band) and N rates (60, 150 and 240 kg ha(-1)) on the fate of urea(-15)N in the wheat-soil system in Guangde County of Anhui Province, China. N fertilizer applied in bands increased grain yield by 15% compared with broadcast application. The N fertilizer application rate had a significant effect on grain yield, straw yield and aboveground biomass, as well as on N uptake and N concentration of wheat. The recovery of urea-N-15 was a little higher for broadcast (34.0-39.0%) than for band treatment (31.2-38.2%). Most of the soil residual N was retained in the 0-20 cm soil layer. At the N rates of 60 and 240 kg ha(-1), the residual N-15 was higher for band (34.4 and 108.7 kg ha(-1), respectively) than for broadcast application (29.6 and 88.4 kg ha(-1), respectively). Compared with broadcast treatment, banded placement of N fertilizer decreased the N loss in the wheat-soil system. Band application one time is an alternative N management practice for winter wheat in this region.	[Chen, Zhaoming; Wang, Huoyan; Liu, Xiaowei; Liu, Yongzhe; Gao, Shuaishuai; Zhou, Jianmin] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210018, Jiangsu, Peoples R China; [Chen, Zhaoming; Liu, Xiaowei; Gao, Shuaishuai] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, HY (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing 210018, Jiangsu, Peoples R China.	hywang@issas.ac.cn			National Basic Research Program of China [2013CB127401]; National Department Public Benefit Research Foundation of China [201203013]; National Natural Science Foundation of China [41271309]; Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences [ISSASIP1649]	National Basic Research Program of China(National Basic Research Program of China); National Department Public Benefit Research Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences	This work was supported by the National Basic Research Program of China (2013CB127401), the National Department Public Benefit Research Foundation of China (201203013), the National Natural Science Foundation of China (41271309), and the Program of the 13th Five-Year Plan in the Institute of Soil Science, Chinese Academy of Sciences (ISSASIP1649).	Angus JF, 2014, CROP PASTURE SCI, V65, P337, DOI 10.1071/CP13337; Blankenau K, 2000, J PLANT NUTR SOIL SC, V163, P475, DOI 10.1002/1522-2624(200010)163:5<475::AID-JPLN475>3.0.CO;2-W; Cui ZL, 2011, SOIL SCI SOC AM J, V75, P976, DOI 10.2136/sssaj2010.0117; Dai XL, 2014, PLANT SOIL, V384, P141, DOI 10.1007/s11104-014-2190-x; Duan W, 2015, INT J PLANT PROD, V9, P237; Engel R, 2010, J ENVIRON QUAL, V39, P115, DOI 10.2134/jeq2009.0130; Fan MS, 2007, NUTR CYCL AGROECOSYS, V79, P255, DOI 10.1007/s10705-007-9112-8; Fuertes-Mendizabal T, 2010, EUR J AGRON, V33, P52, DOI 10.1016/j.eja.2010.03.001; Grant CA, 2001, CAN J PLANT SCI, V81, P17, DOI 10.4141/P00-091; Guo RY, 2008, PLANT SOIL, V313, P55, DOI 10.1007/s11104-008-9679-0; Haile D, 2012, J SOIL SCI PLANT NUT, V12, P389, DOI 10.4067/S0718-95162012005000002; HAMID A, 1995, BIOL FERT SOILS, V20, P185, DOI 10.1007/BF00336556; Hartmann TE, 2015, FIELD CROP RES, V174, P30, DOI 10.1016/j.fcr.2015.01.006; Ichir LL, 2003, NUTR CYCL AGROECOSYS, V66, P201, DOI 10.1023/A:1023976600760; Jayasundara S, 2007, NUTR CYCL AGROECOSYS, V79, P141, DOI 10.1007/s10705-007-9103-9; Jayasundara S, 2010, CAN J SOIL SCI, V90, P55, DOI 10.4141/CJSS08085; Jia SL, 2011, NUTR CYCL AGROECOSYS, V90, P331, DOI 10.1007/s10705-011-9433-5; Ju XT, 2007, PEDOSPHERE, V17, P52, DOI 10.1016/S1002-0160(07)60007-1; Lam SK, 2012, NUTR CYCL AGROECOSYS, V92, P133, DOI 10.1007/s10705-011-9477-6; Liang B, 2013, BIOL FERT SOILS, V49, P977, DOI 10.1007/s00374-013-0789-3; Lopez-Bellido L, 2005, FIELD CROP RES, V94, P86, DOI 10.1016/j.fcr.2004.11.004; Ma BL, 2006, J PLANT NUTR, V29, P469, DOI 10.1080/01904160500525065; MAHLER RL, 1994, AGRON J, V86, P637, DOI 10.2134/agronj1994.00021962008600040010x; Malhi SS, 1996, CAN J SOIL SCI, V76, P93, DOI 10.4141/cjss96-013; Mooleki SP, 2010, CAN J PLANT SCI, V90, P319, DOI 10.4141/CJPS09075; Ottman MJ, 2000, SOIL SCI SOC AM J, V64, P1883, DOI 10.2136/sssaj2000.6451883x; Peng YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037726; Petersen J, 2002, COMMUN SOIL SCI PLAN, V33, P163, DOI 10.1081/CSS-120002385; Petersen J, 2001, NUTR CYCL AGROECOSYS, V61, P215, DOI 10.1023/A:1013756715438; Rees RM, 1997, NUTR CYCL AGROECOSYS, V47, P81; Shen JB, 2013, J EXP BOT, V64, P1181, DOI 10.1093/jxb/ers342; Shi ZL, 2012, EUR J AGRON, V40, P86, DOI 10.1016/j.eja.2012.01.006; Shi ZL, 2012, FIELD CROP RES, V127, P241, DOI 10.1016/j.fcr.2011.11.025; Tran TS, 2000, CAN J SOIL SCI, V80, P533, DOI 10.4141/S99-098; Wang D, 2011, ACTA AGR SCAND B-S P, V61, P681, DOI 10.1080/09064710.2010.534108; [王火焰 Wang Huoyan], 2013, [土壤, Soils], V45, P785; Wang Q, 2010, PLANT SOIL, V337, P325, DOI 10.1007/s11104-010-0530-z; Xue LH, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/115010; Yang JB, 2013, BIOL FERT SOILS, V49, P23, DOI 10.1007/s00374-012-0692-3; Yevdokimov I, 2008, BIOL FERT SOILS, V44, P1103, DOI 10.1007/s00374-008-0315-1; Zhao SC, 2014, AGR ECOSYST ENVIRON, V194, P29, DOI 10.1016/j.agee.2014.05.006; Zhao X, 2009, PLANT SOIL, V319, P225, DOI 10.1007/s11104-008-9865-0; Zhou SL, 2008, ENVIRON POLLUT, V152, P723, DOI 10.1016/j.envpol.2007.06.047; Zhu ZL, 2002, NUTR CYCL AGROECOSYS, V63, P117, DOI 10.1023/A:1021107026067	44	25	27	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153701	10.1371/journal.pone.0153701	http://dx.doi.org/10.1371/journal.pone.0153701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082246	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800047
J	Huleihel, M; Shufan, E; Zeiri, L; Salman, A				Huleihel, Mahmoud; Shufan, Elad; Zeiri, Leila; Salman, Ahmad			Detection of Vero Cells Infected with Herpes Simplex Types 1 and 2 and Varicella Zoster Viruses Using Raman Spectroscopy and Advanced Statistical Methods	PLOS ONE			English	Article							COLORECTAL-CANCER RELAPSE; INFRARED-SPECTROSCOPY; IN-VIVO; BREAST-CANCER; BIOCHEMICAL DIFFERENCES; EPITHELIAL CANCERS; FTIR SPECTROSCOPY; OPTICAL DIAGNOSIS; TISSUE; MICROSPECTROSCOPY	Of the eight members of the herpes family of viruses, HSV1, HSV2, and varicella zoster are the most common and are mainly involved in cutaneous disorders. These viruses usually are not life-threatening, but in some cases they might cause serious infections to the eyes and the brain that can lead to blindness and possibly death. An effective drug (acyclovir and its derivatives) is available against these viruses. Therefore, early detection and identification of these viral infections is highly important for an effective treatment. Raman spectroscopy, which has been widely used in the past years in medicine and biology, was used as a powerful spectroscopic tool for the detection and identification of these viral infections in cell culture, due to its sensitivity, rapidity and reliability. Our results showed that it was possible to differentiate, with a 97% identification success rate, the uninfected Vero cells that served as a control, from the Vero cells that were infected with HSV-1, HSV-2, and VZV. For that, linear discriminant analysis (LDA) was performed on the Raman spectra after principal component analysis (PCA) with a leave one out (LOO) approach. Raman spectroscopy in tandem with PCA and LDA enable to differentiate among the different herpes viral infections of Vero cells in time span of few minutes with high accuracy rate. Understanding cell molecular changes due to herpes viral infections using Raman spectroscopy may help in early detection and effective treatment.	[Huleihel, Mahmoud] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel; [Shufan, Elad; Salman, Ahmad] SCE, Dept Phys, Beer Sheva, Israel; [Zeiri, Leila] Ben Gurion Univ Negev, Dept Chem, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Salman, A (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, Beer Sheva, Israel.	mahmoudh@bgu.ac.il; ahmad@sce.ac.il		Salman, Ahmad/0000-0003-4953-8648				Agarwal R, 2006, J ORGANOMET CHEM, V691, P2902, DOI 10.1016/j.jorganchem.2006.02.032; Argov S, 2002, J BIOMED OPT, V7, P248, DOI 10.1117/1.1463051; Bergholt MS, 2011, INT J CANCER, V128, P2673, DOI 10.1002/ijc.25618; Bergholt MS, 2010, ANALYST, V135, P3162, DOI 10.1039/c0an00336k; Bishop CM, 2006, PATTERN RECOGN, Vxx; Bodanese B, 2010, PHOTOMED LASER SURG, V28, pS119, DOI 10.1089/pho.2009.2565; Carter EA, 2001, PRACT SPECTROSC SERI, V24, P421; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chayavichitsilp P, 2009, PEDIATR REV, V30, P119, DOI 10.1542/pir.30-4-119; Cheng WT, 2005, MICROSC RES TECHNIQ, V68, P75, DOI 10.1002/jemt.20229; Diem M, 2000, BIOPOLYMERS, V57, P282, DOI 10.1002/1097-0282(2000)57:5<282::AID-BIP50>3.0.CO;2-R; Dovbeshko GI, 2002, BIOPOLYMERS, V67, P470, DOI 10.1002/bip.10165; Draux F, 2009, ANALYST, V134, P542, DOI 10.1039/b812610k; Duda R.O., 2006, PATTERN CLASSIFICATI; Dukor RK, 2006, HANDBOOK OF VIBRATIO; EBERLE R, 1989, J MED VIROL, V27, P309, DOI 10.1002/jmv.1890270410; Eckel R, 2001, VIB SPECTROSC, V27, P165, DOI 10.1016/S0924-2031(01)00134-5; Elisseeff A, 2002, LEARNING THEORY AND; Ellis DI, 2006, ANALYST, V131, P875, DOI 10.1039/b602376m; Erukhimovitch V, 2011, ANALYST, V136, P2818, DOI 10.1039/c1an15319f; Erukhimovitch V, 2002, PHOTOCHEM PHOTOBIOL, V76, P446, DOI 10.1562/0031-8655(2002)076<0446:SCOHAM>2.0.CO;2; Evgeniou T, 2004, MACH LEARN, V55, P71, DOI 10.1023/B:MACH.0000019805.88351.60; Faolain EO, 2005, J HISTOCHEM CYTOCHEM, V53, P121, DOI 10.1177/002215540505300114; Farquharson S, 2005, J RAMAN SPECTROSC, V36, P208, DOI 10.1002/jrs.1277; Feofanov AV, 2000, BIOPHYS J, V78, P499, DOI 10.1016/S0006-3495(00)76612-4; Fujioka N, 2004, CANCER DETECT PREV, V28, P32, DOI 10.1016/j.cdp.2003.11.004; Georgakoudi I, 2002, CANCER RES, V62, P682; Gniadecka M, 2004, J INVEST DERMATOL, V122, P443, DOI 10.1046/j.0022-202X.2004.22208.x; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Hawi SR, 1997, J LIPID RES, V38, P1591; Huang Y, 2009, NANO LETT, V9, P2914, DOI 10.1021/nl901234x; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; Huleihel M, 2001, J APPL PHYCOL, V13, P127, DOI 10.1023/A:1011178225912; Kamemoto LE, 2010, APPL SPECTROSC, V64, P255, DOI 10.1366/000370210790918364; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Keller MD, 2008, DIS MARKERS, V25, P323, DOI 10.1155/2008/230307; Kos G, 2003, ANAL CHEM, V75, P1211, DOI 10.1021/ac0260903; Krafft C, 2004, ANAL BIOANAL CHEM, V378, P60, DOI 10.1007/s00216-003-2266-6; Krishna CM, 2004, APPL SPECTROSC, V58, P1128, DOI 10.1366/0003702041959460; Lau DP, 2003, LASER SURG MED, V32, P210, DOI 10.1002/lsm.10084; Lieber CA, 2008, LASER SURG MED, V40, P461, DOI 10.1002/lsm.20653; Mariani MM, 2010, ANAL CHEM, V82, P4259, DOI 10.1021/ac1006987; Markoulatos P, 1997, J CLIN LAB ANAL, V11, P146, DOI 10.1002/(SICI)1098-2825(1997)11:3&lt;146::AID-JCLA5&gt;3.0.CO;2-8; Matthaus C, 2006, APPL SPECTROSC, V60, P1, DOI 10.1366/000370206775382758; Meqdam MM, 2001, MICROBIOS, V105, P111; Min YK, 2005, J RAMAN SPECTROSC, V36, P73, DOI 10.1002/jrs.1280; Moor K, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.6.067003; Mourant JR, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1928050; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Naumann A, 2009, ANALYST, V134, P1215, DOI 10.1039/b821286d; Naumann D, 1998, P SPIE; Notingher I, 2002, MATER CHARACT, V49, P255, DOI 10.1016/S1044-5803(03)00029-9; O Faolain E, 2005, VIB SPECTROSC, V38, P121, DOI 10.1016/j.vibspec.2005.02.013; Pomerantz A, 2014, J PHOTOCH PHOTOBIO B, V141, P308, DOI 10.1016/j.jphotobiol.2014.10.005; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Ruiz-Chica AJ, 2004, J RAMAN SPECTROSC, V35, P93, DOI 10.1002/jrs.1107; Salman A, 2016, VIB SPECTROSC, V83, P17, DOI 10.1016/j.vibspec.2016.01.002; Salman A, 2015, ANALYST, V140, P3098, DOI [10.1039/c5an00213c, 10.1039/C5AN00213C]; Salman A, 2014, METHODS, V68, P325, DOI 10.1016/j.ymeth.2014.02.021; Salman A, 2014, METHODS, V68, P364, DOI 10.1016/j.ymeth.2014.02.022; Salman A, 2013, BBA-GEN SUBJECTS, V1830, P2720, DOI 10.1016/j.bbagen.2012.11.023; Salman A, 2003, J BIOCHEM BIOPH METH, V55, P141, DOI 10.1016/S0165-022X(02)00182-3; Salman A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.7.075007; Salman A, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.017002; Salman Ahmad, 2001, Cellular and Molecular Biology Online Papers, V47, pOL159; Schulz H, 2007, VIB SPECTROSC, V43, P13, DOI 10.1016/j.vibspec.2006.06.001; Shafer-Peltier KE, 2002, J RAMAN SPECTROSC, V33, P552, DOI 10.1002/jrs.877; Shaw RA, 1999, J MOL STRUCT, V481, P1, DOI 10.1016/S0022-2860(98)00648-6; SHI YF, 1993, J IMMUNOL METHODS, V164, P149, DOI 10.1016/0022-1759(93)90307-S; Silveira L, 2003, J CLIN LASER MED SUR, V21, P203, DOI 10.1089/104454703768247774; Smith E, 2005, MODERN RAMAN SPECTROSCOPY: A PRACTICAL APPROACH, P1; Stone N, 2004, FARADAY DISCUSS, V126, P141, DOI 10.1039/b304992b; Stone N, 2002, J RAMAN SPECTROSC, V33, P564, DOI 10.1002/jrs.882; van Manen HJ, 2008, ANAL CHEM, V80, P9576, DOI 10.1021/ac801841y; VERMA SP, 1977, CANCER RES, V37, P3490; Vogel R, 2012, J VIROL, V86, P143, DOI 10.1128/JVI.05694-11; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108; Yoshida S, 1997, BIOSPECTROSCOPY, V3, P281, DOI 10.1002/(SICI)1520-6343(1997)3:4<281::AID-BSPY3>3.0.CO;2-7; Zonios GI, 1996, IEEE T BIO-MED ENG, V43, P113, DOI 10.1109/10.481980	80	5	5	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153599	10.1371/journal.pone.0153599	http://dx.doi.org/10.1371/journal.pone.0153599			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078266	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700089
J	Navarro-Retamal, C; Gaete-Eastman, C; Herrera, R; Caballero, J; Alzate-Morales, JH				Navarro-Retamal, Carlos; Gaete-Eastman, Carlos; Herrera, Raul; Caballero, Julio; Alzate-Morales, Jans H.			Structural and Affinity Determinants in the Interaction between Alcohol Acyltransferase from F. x ananassa and Several Alcohol Substrates: A Computational Study	PLOS ONE			English	Article							PROTEIN STRUCTURES; STRUCTURE PREDICTION; PROPOSED MECHANISM; MOLECULAR-DYNAMICS; VINORINE SYNTHASE; STRAWBERRY; AROMA; BAHD; ACETYLTRANSFERASE; SIMULATION	Aroma and flavor are important factors of fruit quality and consumer preference. The specific pattern of aroma is generated during ripening by the accumulation of volatiles compounds, which are mainly esters. Alcohol acyltransferase (AAT) (EC 2.3.1.84) catalyzes the esterification reaction of aliphatic and aromatic alcohols and acyl-CoA into esters in fruits and flowers. In Fragaria x ananassa, there are different volatiles compounds that are obtained from different alcohol precursors, where octanol and hexanol are the most abundant during fruit ripening. At present, there is not structural evidence about the mechanism used by the AAT to synthesize esters. Experimental data attribute the kinetic role of this enzyme to 2 amino acidic residues in a highly conserved motif (HXXXD) that is located in the middle of the protein. With the aim to understand the molecular and energetic aspects of volatiles compound production from F. x ananassa, we first studied the binding modes of a series of alcohols, and also different acyl-CoA substrates, in a molecular model of alcohol acyltransferase from Fragaria x ananassa (SAAT) using molecular docking. Afterwards, the dynamical behavior of both substrates, docked within the SAAT binding site, was studied using routine molecular dynamics (MD) simulations. In addition, in order to correlate the experimental and theoretical data obtained in our laboratories, binding free energy calculations were performed; which previous results suggested that octanol, followed by hexanol, presented the best affinity for SAAT. Finally, and concerning the SAAT molecular reaction mechanism, it is suggested from molecular dynamics simulations that the reaction mechanism may proceed through the formation of a ternary complex, in where the Histidine residue at the HXXXD motif deprotonates the alcohol substrates. Then, a nucleophilic attack occurs from alcohol charged oxygen atom to the carbon atom at carbonyl group of the acyl CoA. This mechanism is in agreement with previous results, obtained in our group, in alcohol acyltransferase from Vasconcellea pubescens (VpAAT1).	[Navarro-Retamal, Carlos; Caballero, Julio; Alzate-Morales, Jans H.] Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile; [Gaete-Eastman, Carlos; Herrera, Raul] Univ Talca, Inst Ciencias Biol, Lab Fisiol Vegetal & Genet Mol, Casilla 747, Talca, Chile	Universidad de Talca; Universidad de Talca	Alzate-Morales, JH (corresponding author), Univ Talca, Fac Ingn, Ctr Bioinformat & Simulac Mol, 2 Norte 685,Casilla 721, Talca, Chile.; Herrera, R (corresponding author), Univ Talca, Inst Ciencias Biol, Lab Fisiol Vegetal & Genet Mol, Casilla 747, Talca, Chile.	raherrera@utalca.cl; jalzate@utalca.cl	Caballero, Julio/G-3654-2014; Herrera, Raul/T-6935-2017; Jans, Alzate-Morales/A-5407-2008	Caballero, Julio/0000-0003-0182-1444; Herrera, Raul/0000-0002-3369-0939; Jans, Alzate-Morales/0000-0001-9624-7849	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); Anillos Cientificos de Ciencia y Tecnologia [ACT-1110]; Proyecto Bicentenario de Ciencia y Tecnologia (PBCT) [PSD-17]; Government of Chile through CONICYT;  [Anillo ACT-1110]	Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Anillos Cientificos de Ciencia y Tecnologia; Proyecto Bicentenario de Ciencia y Tecnologia (PBCT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/PBCT); Government of Chile through CONICYT; 	CNR thanks Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT) for a doctoral fellowship. RH thanks Anillos Cientificos de Ciencia y Tecnologia, ACT-1110, for financial support. CGE thanks Proyecto Bicentenario de Ciencia y Tecnologia (PBCT), PSD-17, for a postdoctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. l; The authors thank to "Centro de Bioinformatica y Simulacion Molecular" at Universidad de Talca for providing the computational time and resources to successfully accomplish all computational simulations reported in this work. Carlos Navarro-Retamal thanks Government of Chile for a doctoral fellowship awarded through CONICYT. R.H. thanks to Anillo ACT-1110 for financial support and C. Gaete-Eastman acknowledges the PBCT PSD-17 Postdoctoral program. The authors thank Dr. Luis Morales-Quintana for useful discussions and technical assistance.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Aharoni A, 2000, PLANT CELL, V12, P647, DOI 10.1105/tpc.12.5.647; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2009, DESM MOL DYN SYST VE; [Anonymous], 2012, PRIM VERS 3 1; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balbontin C, 2007, POSTHARVEST BIOL TEC, V43, P67, DOI 10.1016/j.postharvbio.2006.08.005; Bayer A, 2004, BIOORGAN MED CHEM, V12, P2787, DOI 10.1016/j.bmc.2004.02.029; Beekwilder J, 2004, PLANT PHYSIOL, V135, P1865, DOI 10.1104/pp.104.042580; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; D'Auria JC, 2006, CURR OPIN PLANT BIOL, V9, P331, DOI 10.1016/j.pbi.2006.03.016; Galaz S, 2013, FEBS J, V280, P1344, DOI 10.1111/febs.12127; Gonzalez M, 2009, J AGR FOOD CHEM, V57, P9123, DOI 10.1021/jf901693j; Hancock JF, 1999, HORTSCIENCE, V34, P814, DOI 10.21273/HORTSCI.34.5.814; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen WL, 1998, J COMPUT CHEM, V19, P1179, DOI 10.1002/(SICI)1096-987X(19980730)19:10<1179::AID-JCC6>3.0.CO;2-J; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewinsohn E, 2001, PLANT PHYSIOL, V127, P1256, DOI 10.1104/pp.127.3.1256; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morales-Quintana L, 2013, J CHEM INF MODEL, V53, P2689, DOI 10.1021/ci400409s; Morales-Quintana L, 2012, MOL SIMULAT, V38, P912, DOI 10.1080/08927022.2012.672738; Morales-Quintana L, 2011, J MOL GRAPH MODEL, V29, P635, DOI 10.1016/j.jmgm.2010.11.011; Moya-Leon MA, 2004, POSTHARVEST BIOL TEC, V34, P211, DOI 10.1016/j.postharvbio.2004.05.005; NEMETHY G, 1983, J PHYS CHEM-US, V87, P1883, DOI 10.1021/j100234a011; Olias R, 2002, J AGR FOOD CHEM, V50, P4031, DOI 10.1021/jf011460u; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shalit M, 2001, J AGR FOOD CHEM, V49, P794, DOI 10.1021/jf001075p; SHAW WV, 1991, ANNU REV BIOPHYS BIO, V20, P363, DOI 10.1146/annurev.biophys.20.1.363; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Suzuki H, 2003, BIOCHEMISTRY-US, V42, P1764, DOI 10.1021/bi020618g; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulrich D, 2007, GENET RESOUR CROP EV, V54, P1185, DOI 10.1007/s10722-006-9009-4; Unno H, 2007, J BIOL CHEM, V282, P15812, DOI 10.1074/jbc.M700638200; Xiang ZX, 2006, CURR PROTEIN PEPT SC, V7, P217, DOI 10.2174/138920306777452312	41	12	12	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153057	10.1371/journal.pone.0153057	http://dx.doi.org/10.1371/journal.pone.0153057			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078149	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700018
J	dos Santos, JPR; Vasconcellos, RCD; Pires, LPM; Balestre, M; Von Pinho, RG				Rigal dos Santos, Jhonathan Pedroso; de Castro Vasconcellos, Renato Coelho; Miranda Pires, Luiz Paulo; Balestre, Marcio; Von Pinho, Renzo Garcia			Inclusion of Dominance Effects in the Multivariate GBLUP Model	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; LINEAR UNBIASED PREDICTION; GENOMIC SELECTION; PLANT; REGRESSION; EPISTASIS; PROSPECTS; MAIZE	New proposals for models and applications of prediction processes with data on molecular markers may help reduce the financial costs of and identify superior genotypes in maize breeding programs. Studies evaluating Genomic Best Linear Unbiased Prediction (GBLUP) models including dominance effects have not been performed in the univariate and multivariate context in the data analysis of this crop. A single cross hybrid construction procedure was performed in this study using phenotypic data and actual molecular markers of 4,091 maize lines from the public database Panzea. A total of 400 simple hybrids resulting from this process were analyzed using the univariate and multivariate GBLUP model considering only additive effects additive plus dominance effects. Historic heritability scenarios of five traits and other genetic architecture settings were used to compare models, evaluating the predictive ability and estimation of variance components. Marginal differences were detected between the multivariate and univariate models. The main explanation for the small discrepancy between models is the low-to moderate-magnitude correlations between the traits studied and moderate heritabilities. These conditions do not favor the advantages of multivariate analysis. The inclusion of dominance effects in the models was an efficient strategy to improve the predictive ability and estimation quality of variance components.	[Rigal dos Santos, Jhonathan Pedroso; de Castro Vasconcellos, Renato Coelho] Univ Fed Lavras, Dept Biol DBI, Lavras, MG, Brazil; [Balestre, Marcio] Univ Fed Lavras, Dept Exact Sci DEX, Lavras, MG, Brazil; [Miranda Pires, Luiz Paulo; Von Pinho, Renzo Garcia] Univ Fed Lavras, Dept Agr DAG, Lavras, MG, Brazil	Universidade Federal de Lavras; Universidade Federal de Lavras; Universidade Federal de Lavras	Balestre, M (corresponding author), Univ Fed Lavras, Dept Exact Sci DEX, Lavras, MG, Brazil.	marciobalestre@dex.ufla.br	Santos, Jhonathan Pedroso Rigal dos/AAF-7570-2019	Santos, Jhonathan Pedroso Rigal dos/0000-0001-9030-702X; Coelho de Castro Vasconcellos, Renato/0000-0002-2610-601X	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-01745-13]	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	We acknowledge the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais for supporting this research, Grant # APQ-01745-13. We also acknowledge the two anonymous reviewers for their constructive comments, which helped us to improve the manuscript.	Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Balestre M, 2013, EUPHYTICA, V189, P225, DOI 10.1007/s10681-012-0790-1; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Calinski T, 2005, BIOMETRICS, V61, P448, DOI 10.1111/j.1541-0420.2005.00334.x; Calus MPL, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-26; CALVIN JA, 1991, ANN STAT, V19, P850, DOI 10.1214/aos/1176348124; COCKERHAM CC, 1954, GENETICS, V39, P859; Da Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087666; de los Campos G, 2014, GENETICS, P1; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de Oliveira EJ, 2012, EUPHYTICA, V187, P263, DOI 10.1007/s10681-012-0722-0; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Falconer D. S., 1996, INTRO QUANTITATIVE G; Gianola D., 2014, P 10 WORLD C GEN APP, P6; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Guo G, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-30; Hallauer AR, 2010, HANDB PLANT BREED, V6, P1, DOI 10.1007/978-1-4419-0766-0; Henderson C. R, 1984, APPL LINEAR MODELS A; HENDERSON CR, 1976, J ANIM SCI, V43, P1188, DOI 10.2527/jas1976.4361188x; HENDERSON CR, 1985, J ANIM SCI, V60, P111, DOI 10.2527/jas1985.601111x; Heslot N, 2014, CROP SCI IN PRESS; Heslot N, 2012, CROP SCI, V52, P146, DOI 10.2135/cropsci2011.06.0297; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jia Y, 2012, GENETICS, V192, P1513, DOI 10.1534/genetics.112.144246; Kao CH, 2002, GENETICS, V160, P1243; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Malosetti M, 2008, EUPHYTICA, V161, P241, DOI 10.1007/s10681-007-9594-0; Massman JM, 2013, THEOR APPL GENET, V126, P13, DOI 10.1007/s00122-012-1955-y; Meuwissen THE, 2001, GENETICS, V157, P1819; Morota G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00363; Munoz PR, 2014, GENETICS, V198, P1759, DOI 10.1534/genetics.114.171322; Nishio M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085792; Ober U, 2011, GENETICS, V188, P695, DOI 10.1534/genetics.111.128694; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Romay MC, GENOME BIOL, V14, P1; Stranger BE, 2011, GENETICS, V187, P367, DOI 10.1534/genetics.110.120907; Team R Core, R LANG ENV STAT COMP; Technow F, 2014, GENETICS, V197, P1343, DOI 10.1534/genetics.114.165860; Vitezica ZG, 2013, GENETICS, V195, P1223, DOI 10.1534/genetics.113.155176; Yang RC, 2004, GENETICS, V167, P1493, DOI 10.1534/genetics.103.020016; Zeng ZB, 2005, GENETICS, V169, P1711, DOI 10.1534/genetics.104.035857	43	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152045	10.1371/journal.pone.0152045	http://dx.doi.org/10.1371/journal.pone.0152045			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074056	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200014
J	Heuer, A; Schubo, A				Heuer, Anna; Schuboe, Anna			The Focus of Attention in Visual Working Memory: Protection of Focused Representations and Its Individual Variation	PLOS ONE			English	Article							SHORT-TERM-MEMORY; ORIENTING ATTENTION; NEURAL MEASURES; SPATIAL ATTENTION; INFORMATION; MAINTENANCE; MODULATION; CAPACITY; LOCATIONS; STORAGE	Visual working memory can be modulated according to changes in the cued task relevance of maintained items. Here, we investigated the mechanisms underlying this modulation. In particular, we studied the consequences of attentional selection for selected and unselected items, and the role of individual differences in the efficiency with which attention is deployed. To this end, performance in a visual working memory task as well as the CDA/SPCN and the N2pc, ERP components associated with visual working memory and attentional processes, were analysed. Selection during the maintenance stage was manipulated by means of two successively presented retrocues providing spatial information as to which items were most likely to be tested. Results show that attentional selection serves to robustly protect relevant representations in the focus of attention while unselected representations which may become relevant again still remain available. Individuals with larger retrocueing benefits showed higher efficiency of attentional selection, as indicated by the N2pc, and showed stronger maintenance-associated activity (CDA/SPCN). The findings add to converging evidence that focused representations are protected, and highlight the flexibility of visual working memory, in which information can be weighted according its relevance.	[Heuer, Anna; Schuboe, Anna] Univ Marburg, Expt & Biol Psychol, Marburg, Germany	Philipps University Marburg	Heuer, A (corresponding author), Univ Marburg, Expt & Biol Psychol, Marburg, Germany.	anna.heuer@uni-marburg.de		Heuer, Anna/0000-0002-3088-1609	Deutsche Forschungsgemeinschaft (DFG) [60402257]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; IRTG 1901 "The Brain In Action", grant number 60402257) to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astle D. E., 2009, FRONT HUM NEUROSCI, V3, P1, DOI [DOI 10.3389/NEURO.09.006.2009, 10.3389/neuro.09.006.2009]; Astle DE, 2012, ATTEN PERCEPT PSYCHO, V74, P146, DOI 10.3758/s13414-011-0218-3; Awh E, 2001, TRENDS COGN SCI, V5, P119, DOI 10.1016/S1364-6613(00)01593-X; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Chun MM, 2011, NEUROPSYCHOLOGIA, V49, P1407, DOI 10.1016/j.neuropsychologia.2011.01.029; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; COWAN N, 1993, MEM COGNITION, V21, P162, DOI 10.3758/BF03202728; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Culham JC, 2001, NEURON, V32, P737, DOI 10.1016/S0896-6273(01)00499-8; Dell'Acqua R, 2010, NEUROPSYCHOLOGIA, V48, P419, DOI 10.1016/j.neuropsychologia.2009.09.033; Drew T, 2008, J NEUROSCI, V28, P4183, DOI 10.1523/JNEUROSCI.0556-08.2008; Drew T, 2012, J COGNITIVE NEUROSCI, V24, P440, DOI 10.1162/jocn_a_00107; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Fukuda K, 2011, PSYCHOL SCI, V22, P361, DOI 10.1177/0956797611398493; Fukuda K, 2009, J NEUROSCI, V29, P8726, DOI 10.1523/JNEUROSCI.2145-09.2009; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Griffin IC, 2003, J COGNITIVE NEUROSCI, V15, P1176, DOI 10.1162/089892903322598139; Gunseli E, 2015, PSYCHON B REV, V22, P1334, DOI 10.3758/s13423-014-0796-x; Ikkai A, 2010, J NEUROPHYSIOL, V103, P1963, DOI 10.1152/jn.00978.2009; Ishihara S, 2010, ISHIHARAS TESTS FOR; Janczyk M, 2008, MEMORY, V16, P374, DOI 10.1080/09658210801941742; Jolicoeur P, 2006, PSYCHOL RES-PSYCH FO, V70, P414, DOI 10.1007/s00426-005-0008-4; Jovicich J, 2001, J COGNITIVE NEUROSCI, V13, P1048, DOI 10.1162/089892901753294347; Kiyonaga A, 2013, PSYCHON B REV, V20, P228, DOI 10.3758/s13423-012-0359-y; Klaver P, 1999, NEUROREPORT, V10, P2001, DOI 10.1097/00001756-199907130-00002; Kuo BC, 2012, J COGNITIVE NEUROSCI, V24, P51, DOI 10.1162/jocn_a_00087; Kuo BC, 2009, J NEUROSCI, V29, P8032, DOI 10.1523/JNEUROSCI.0952-09.2009; Landman R, 2003, VISION RES, V43, P149, DOI 10.1016/S0042-6989(02)00402-9; LaRocque JJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00005; LaRocque JJ, 2013, J COGNITIVE NEUROSCI, V25, P127, DOI 10.1162/jocn_a_00305; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Lepsien J, 2007, CEREB CORTEX, V17, P2072, DOI 10.1093/cercor/bhl116; Lepsien J, 2011, NEUROPSYCHOLOGIA, V49, P1569, DOI 10.1016/j.neuropsychologia.2011.03.011; Lewis-Peacock JA, 2012, J COGNITIVE NEUROSCI, V24, P61, DOI 10.1162/jocn_a_00140; Luck S.J., 2005, INTRO EVENT RELATED; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Machizawa MG, 2012, PSYCHOL SCI, V23, P554, DOI 10.1177/0956797611431988; Makovski T, 2007, PSYCHON B REV, V14, P1072, DOI 10.3758/BF03193093; Matsukura M, 2007, PERCEPT PSYCHOPHYS, V69, P1422, DOI 10.3758/BF03192957; Mayer JS, 2007, NEUROIMAGE, V36, P441, DOI 10.1016/j.neuroimage.2007.03.007; Mazza V, 2013, J COGNITIVE NEUROSCI, V25, P697, DOI 10.1162/jocn_a_00349; Mazza V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017453; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; McCollough AW, 2007, CORTEX, V43, P77, DOI 10.1016/S0010-9452(08)70447-7; Murray AM, 2013, PSYCHOL SCI, V24, P550, DOI 10.1177/0956797612457782; Nee DE, 2013, NEUROIMAGE, V74, P1, DOI 10.1016/j.neuroimage.2013.02.019; Nee DE, 2009, NEUROIMAGE, V45, P963, DOI 10.1016/j.neuroimage.2009.01.005; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Oberauer K, 2002, J EXP PSYCHOL LEARN, V28, P411, DOI 10.1037//0278-7393.28.3.411; Oberauer K, 2012, CURR DIR PSYCHOL SCI, V21, P164, DOI 10.1177/0963721412444727; Olivers CNL, 2011, TRENDS COGN SCI, V15, P327, DOI 10.1016/j.tics.2011.05.004; Olivers CNL, 2011, NEUROPSYCHOLOGIA, V49, P1553, DOI 10.1016/j.neuropsychologia.2010.11.033; Pagano S, 2014, BRAIN RES, V1543, P244, DOI 10.1016/j.brainres.2013.11.025; Pagano S, 2012, NEUROPSYCHOLOGIA, V50, P754, DOI 10.1016/j.neuropsychologia.2012.01.009; Pertzov Y, 2013, J EXP PSYCHOL HUMAN, V39, P1224, DOI 10.1037/a0030947; Poch C, 2014, EUR J NEUROSCI, V40, P2399, DOI 10.1111/ejn.12589; Rerko L, 2013, J EXP PSYCHOL LEARN, V39, P1075, DOI 10.1037/a0031172; Robitaille N, 2010, NEUROIMAGE, V53, P1334, DOI 10.1016/j.neuroimage.2010.07.027; Sligte IG, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00175; Sligte IG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001699; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Tamber-Rosenau BJ, 2011, J COGNITIVE NEUROSCI, V23, P2905, DOI 10.1162/jocn.2011.21608; Todd JJ, 2005, COGN AFFECT BEHAV NE, V5, P144, DOI 10.3758/CABN.5.2.144; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; van Moorselaar D, 2015, J EXP PSYCHOL LEARN, V41, P1755, DOI 10.1037/xlm0000124; Van Velzen J, 2003, PSYCHOPHYSIOLOGY, V40, P827, DOI 10.1111/1469-8986.00083; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Williams M, 2013, PSYCHON B REV, V20, P348, DOI 10.3758/s13423-012-0354-3; Woodman GF, 2008, PSYCHON B REV, V15, P223, DOI 10.3758/PBR.15.1.223; Xu YD, 2006, NATURE, V440, P91, DOI 10.1038/nature04262; Zokaei N, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00853	73	20	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154228	10.1371/journal.pone.0154228	http://dx.doi.org/10.1371/journal.pone.0154228			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27099938	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500169
J	Imhoff, S; da Silva, AP; Ghiberto, PJ; Tormena, CA; Pilatti, MA; Libardi, PL				Imhoff, Silvia; da Silva, Alvaro Pires; Ghiberto, Pablo J.; Tormena, Cassio A.; Pilatti, Miguel A.; Libardi, Paulo L.			Physical Quality Indicators and Mechanical Behavior of Agricultural Soils of Argentina	PLOS ONE			English	Article							LIMITING WATER RANGE; ORGANIC-MATTER; BULK-DENSITY; COMPRESSION; COMPACTION; CORN; MOLLISOLS; CAPACITY; TEXTURE; STRESS	Mollisols of Santa Fe have different tilth and load support capacity. Despite the importance of these attributes to achieve a sustainable crop production, few information is available. The objectives of this study are i) to assess soil physical indicators related to plant growth and to soil mechanical behavior; and ii) to establish relationships to estimate the impact of soil loading on the soil quality to plant growth. The study was carried out on Argiudolls and Hapludolls of Santa Fe. Soil samples were collected to determine texture, organic matter content, bulk density, water retention curve, soil resistance to penetration, least limiting water range, critical bulk density for plant growth, compression index, pre-consolidation pressure and soil compressibility. Water retention curve and soil resistance to penetration were linearly and significantly related to clay and organic matter (R-2 = 0.91 and R-2 = 0.84). The pedotransfer functions of water retention curve and soil resistance to penetration allowed the estimation of the least limiting water range and critical bulk density for plant growth. A significant nonlinear relationship was found between critical bulk density for plant growth and clay content (R-2 = 0.98). Compression index was significantly related to bulk density, water content, organic matter and clay plus silt content (R-2 = 0.77). Pre-consolidation pressure was significantly related to organic matter, clay and water content (R-2 = 0.77). Soil compressibility was significantly related to initial soil bulk density, clay and water content. A nonlinear and significantly pedotransfer function (R-2 = 0.88) was developed to predict the maximum acceptable pressure to be applied during tillage operations by introducing critical bulk density for plant growth in the compression model. The developed pedotransfer function provides a useful tool to link the mechanical behavior and tilth of the soils studied.	[Imhoff, Silvia] Consejo Nacl Invest Cient & Tecn, Esperanza, Santa Fe, Argentina; [Imhoff, Silvia; Ghiberto, Pablo J.; Pilatti, Miguel A.] Univ Nacl Litoral, Fac Ciencias Agr, Dept Ciencias Ambiente, Esperanza, Santa Fe, Argentina; [da Silva, Alvaro Pires; Libardi, Paulo L.] Univ Sao Paulo, Dept Ciencia Solo, Escola Super Agr Luiz de Queiroz, Sao Paulo, Brazil; [Tormena, Cassio A.] Univ Estadual Maringa, Dept Agron, Maringa, Parana, Brazil	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of the Littoral; Universidade de Sao Paulo; Universidade Estadual de Maringa	Imhoff, S (corresponding author), Consejo Nacl Invest Cient & Tecn, Esperanza, Santa Fe, Argentina.; Imhoff, S (corresponding author), Univ Nacl Litoral, Fac Ciencias Agr, Dept Ciencias Ambiente, Esperanza, Santa Fe, Argentina.	simhoff@fca.unl.edu.ar	da Silva, Alvaro Pires/C-5973-2012; Tormena, Cassio/X-3091-2018	da Silva, Alvaro Pires/0000-0002-1544-7310; Tormena, Cassio/0000-0003-2351-9289; Imhoff, Silvia/0000-0001-7330-9728	CONICET (National Council of Scientific and Technical Research), Argentina; CNPq (National Council for Scientific and Technological Development), Brazil	CONICET (National Council of Scientific and Technical Research), Argentina; CNPq (National Council for Scientific and Technological Development), Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by CONICET (National Council of Scientific and Technical Research), Argentina (to SI), www.conicet.gov.ar; and CNPq (National Council for Scientific and Technological Development), Brazil (to APS), www.cnpq.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrou A, 1998, J AGR ENG RES, V71, P75, DOI 10.1006/jaer.1998.0300; An J, 2015, SOIL TILL RES, V145, P216, DOI 10.1016/j.still.2014.09.002; Aragon A, 2000, SOIL TILL RES, V56, P197, DOI 10.1016/S0167-1987(00)00144-6; Arthur E, 2013, GEODERMA, V193, P236, DOI 10.1016/j.geoderma.2012.09.001; Arvidsson J, 1998, SOIL TILL RES, V49, P159, DOI 10.1016/S0167-1987(98)00164-0; Benjamin JG, 2014, BIOENERG RES, V7, P468, DOI 10.1007/s12155-013-9400-x; Benjamin JG, 2013, AGRON J, V105, P713, DOI 10.2134/agronj2012.0104; BLAKE G. R., 1986, METHODS SOIL ANAL PH, P363, DOI DOI 10.2136/SSSAB00KSER5.1.2ED.C13; Botta GF, 2006, SOIL TILL RES, V86, P9, DOI 10.1016/j.still.2005.01.014; Bouma J., 1989, Advances in Soil Science, V9, P177; Busscher W. J., 1990, Transactions of the ASAE, V33, P519, DOI 10.13031/2013.31360; Miretti MC, 2010, SCI AGR, V67, P604, DOI 10.1590/S0103-90162010000500015; Chen GH, 2014, SOIL TILL RES, V136, P61, DOI 10.1016/j.still.2013.09.004; Cosentino D.J., 2002, CIENC SUELO, V20, P9; Daddow R.L., 1983, WSDGTN00005 USDA FOR; daSilva AP, 1997, SOIL SCI SOC AM J, V61, P877, DOI 10.2136/sssaj1997.03615995006100030023x; DASILVA AP, 1994, SOIL SCI SOC AM J, V58, P1775, DOI 10.2136/sssaj1994.03615995005800060028x; daSilva AP, 1996, PLANT SOIL, V184, P323, DOI 10.1007/BF00010461; Defossez P, 2002, SOIL TILL RES, V67, P41, DOI 10.1016/S0167-1987(02)00030-2; Diaz-Zorita M, 2000, SOIL TILL RES, V54, P121, DOI 10.1016/S0167-1987(00)00089-1; Fling A.L., 2002, METHODS SOIL ANAL 4, P229, DOI [10.2136/sssabookser5.4.c10, DOI 10.2136/SSSABOOKSER5.4.C10]; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Wilson MG, 2013, GEODERMA, V192, P354, DOI 10.1016/j.geoderma.2012.05.021; Horn R., 1994, Soil compaction in crop production., P45; Imhoff S, 2004, SOIL SCI SOC AM J, V68, P17, DOI 10.2136/sssaj2004.0017; Imhoff S, 2010, GEODERMA, V158, P268, DOI 10.1016/j.geoderma.2010.05.005; JACKSON M.L., 1982, ANALISIS QUIMICO SUE; Ghiberto PJ, 2015, SCI AGR, V72, P167, DOI 10.1590/0103-9016-2013-0414; Kaufmann M, 2010, J PLANT NUTR SOIL SC, V173, P573, DOI 10.1002/jpln.200900129; Keller T, 2007, EUR J SOIL SCI, V58, P1373, DOI 10.1111/j.1365-2389.2007.00944.x; Keller T, 2015, SOIL USE MANAGE, V31, P321, DOI 10.1111/sum.12175; Keller T, 2007, SOIL TILL RES, V92, P45, DOI 10.1016/j.still.2006.01.001; Keller T, 2011, GEODERMA, V163, P13, DOI 10.1016/j.geoderma.2011.02.006; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Lapen DR, 2004, SOIL TILL RES, V78, P151, DOI 10.1016/j.still.2004.02.004; LARSON WE, 1980, SOIL SCI SOC AM J, V44, P450, DOI 10.2136/sssaj1980.03615995004400030002x; Lipiec J, 2003, GEODERMA, V116, P107, DOI 10.1016/S0016-7061(03)00097-1; MCBRIDE RA, 1989, SOIL SCI SOC AM J, V53, P178, DOI 10.2136/sssaj1989.03615995005300010033x; McNabb DH, 1996, SOIL SCI SOC AM J, V60, P333, DOI 10.2136/sssaj1996.03615995006000020003x; MORRAS HJM, 1995, GEODERMA, V64, P281, DOI 10.1016/0016-7061(94)00024-5; Mosconi F, 1981, MAPA SUELOS PROVINCI; Mosteller F., 1977, DATA ANAL REGRESSION; Neter J, 1985, APPL LINEAR REGRESSI; OSULLIVAN MF, 1992, SOIL TILL RES, V24, P257, DOI 10.1016/0167-1987(92)90091-O; Pilatti MA, 2000, J SUSTAIN AGR, V17, P89, DOI 10.1300/J064v17n01_08; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; ROSS PJ, 1991, SOIL SCI SOC AM J, V55, P923, DOI 10.2136/sssaj1991.03615995005500040004x; Safadoust A, 2014, AGR WATER MANAGE, V136, P34, DOI 10.1016/j.agwat.2014.01.007; Saffih-Hdadi K, 2009, SOIL TILL RES, V105, P96, DOI 10.1016/j.still.2009.05.012; SAS Institute Inc, 1991, SAS STAT US GUID VER; Soane B. D., 1994, Soil compaction in crop production., P1; SOANE BD, 1990, SOIL TILL RES, V16, P179, DOI 10.1016/0167-1987(90)90029-D; Soriano A., 1991, ECOSYSTEMS WORLD A, P367; Tang AM, 2009, GEODERMA, V148, P282, DOI 10.1016/j.geoderma.2008.10.012; Thornthwaite CW, 1948, GEOGR REV, V38, P55, DOI 10.2307/210739; To J, 2005, GEODERMA, V126, P261, DOI 10.1016/j.geoderma.2004.08.006; VEPRASKAS MJ, 1984, SOIL SCI SOC AM J, V48, P1220, DOI 10.2136/sssaj1984.03615995004800060003x; Wosten JHM, 2001, J HYDROL, V251, P123, DOI 10.1016/S0022-1694(01)00464-4; Zhang B, 2005, SOIL SCI SOC AM J, V69, P864, DOI 10.2136/sssaj2003.0256; Zhang HQ, 1997, SOIL SCI SOC AM J, V61, P239, DOI 10.2136/sssaj1997.03615995006100010033x	60	29	32	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153827	10.1371/journal.pone.0153827	http://dx.doi.org/10.1371/journal.pone.0153827			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099925	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500073
J	Inagaki, Y; Fujioka, M; Kanzaki, S; Watanabe, K; Oishi, N; Itakura, G; Yasuda, A; Shibata, S; Nakamura, M; Okano, HJ; Okano, H; Ogawa, K				Inagaki, Yozo; Fujioka, Masato; Kanzaki, Sho; Watanabe, Kotaro; Oishi, Naoki; Itakura, Go; Yasuda, Akimasa; Shibata, Shinsuke; Nakamura, Masaya; Okano, Hirotaka James; Okano, Hideyuki; Ogawa, Kaoru			Sustained Effect of Hyaluronic Acid in Subcutaneous Administration to the Cochlear Spiral Ganglion	PLOS ONE			English	Article							SENSORINEURAL HEARING-LOSS; SPINAL-CORD-INJURY; INNER EAR BARRIER; STEM-CELLS; GENE; EXPRESSION; INJECTION; HANDICAP; DELIVERY; MICE	The spatiotemporal distribution of drugs in the inner ear cannot be precisely evaluated because of its small area and complex structure. In the present study, we used hyaluronic acid (HA)-dispersed luciferin to image transgenic mice and to determine the effect of HA on controlled drug delivery to the cochlea. GFAP-luc mice, which express luciferase in cochlear spiral ganglion cells, were subcutaneously administered HA-luciferin (HA-sc) or luciferin dissolved in saline (NS-sc) or intraperitoneally administered luciferin dissolved in saline (NS-ip). The bioluminescence of luciferin was monitored in vivo in real time. The peak time and half-life of fluorescence emission were significantly increased in HA-sctreated mice compared with those in NS-sc- and NS-ip-treated mice; however, significant differences were not observed in peak photon counts. We detected differences in the pharmacokinetics of luciferin in the inner ear, including its sustained release, in the presence of HA. The results indicate the clinical potential of using HA for controlled drug delivery to the cochlea.	[Inagaki, Yozo; Fujioka, Masato; Kanzaki, Sho; Watanabe, Kotaro; Oishi, Naoki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan; [Itakura, Go; Yasuda, Akimasa; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped, Shinjuku Ku, Tokyo, Japan; [Shibata, Shinsuke; Okano, Hirotaka James; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 160, Japan	Keio University; Keio University; Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo, Japan.	skan@a7.keio.jp	Okano, Hideyuki/I-7584-2019; Okano, Hideyuki/X-9131-2019; Shibata, Shinsuke/AAM-6620-2020; Oishi, Naoki/ABG-7065-2020; Nakamura, Masaya/K-4111-2013	Okano, Hideyuki/0000-0001-7482-5935; Oishi, Naoki/0000-0001-8204-9518; Okano, Hirotaka James/0000-0003-4611-7098; Fujioka, Masato/0000-0002-5317-0885; Shibata, Shinsuke/0000-0002-1185-9043	MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI [25861590, 24592560, 15H04991]; MHLW (Comprehensive Research on Disability Health and Welfare); Takeda Science Foundation; MEXT KAKENHI [25861590, 24592560, 15H04991]	MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI; MHLW (Comprehensive Research on Disability Health and Welfare); Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant-in-Aid for Young Scientists (B) (25861590) to Y.I., a MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI Grant-in-Aid for Scientific Research (C) (24592560) and (B) (15H04991), grants from the MHLW (Comprehensive Research on Disability Health and Welfare) and the Takeda Science Foundation to M.F., and a grant from MEXT (Ministry of Education, Culture, Sports, Science and Technology) KAKENHI to S.K.; We are grateful to Ayano Mitsui for technical assistance and Makoto Hosoya for helpful comments and discussions. This work was supported by a MEXT KAKENHI Grant-in-Aid for Young Scientists (B) (25861590) to Y.I, a MEXT KAKENHI Grant-in-Aid for Scientific Research (C) (24592560) and (B) (15H04991), grants from the MHLW (Comprehensive Research on Disability Health and Welfare) and the Takeda Science Foundation to M.F, and a grant from MEXT KAKENHI to S.K.	Balazs EA, 2008, CURR PHARM BIOTECHNO, V9, P236, DOI 10.2174/138920108785161596; Bear Zachary W, 2014, Mo Med, V111, P352; Borden RC, 2011, AUDIOL NEURO-OTOL, V16, P1, DOI 10.1159/000313506; Crane RA, 2015, LARYNGOSCOPE, V125, P209, DOI 10.1002/lary.24834; Dallan I, 2014, J LARYNGOL OTOL, V128, P669, DOI 10.1017/S0022215114001595; Gibbs P, 2011, CANCER CHEMOTH PHARM, V67, P153, DOI 10.1007/s00280-010-1303-3; Goldman SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018269; Goto M, 2001, CLIN EXP RHEUMATOL, V19, P377; Gouveris H, 2011, OTOL NEUROTOL, V32, P756, DOI 10.1097/MAO.0b013e31821a3fc3; Iwasaki S, 2013, OTOL NEUROTOL, V34, P644, DOI 10.1097/MAO.0b013e318287f1fe; Kanzaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048480; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Ogawa K, 2002, OTOL NEUROTOL, V23, P665, DOI 10.1097/00129492-200209000-00011; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Saito T, 2001, BRAIN RES, V895, P253, DOI 10.1016/S0006-8993(01)02020-0; Shibata SB, 2012, HUM GENE THER, V23, P302, DOI 10.1089/hum.2011.086; Tomioka K, 2013, QUAL LIFE RES, V22, P1151, DOI 10.1007/s11136-012-0235-2; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Yamazaki M, 2012, NEURORADIOLOGY, V54, P1161, DOI 10.1007/s00234-012-1078-9; Zhang WS, 2003, DRUG METAB DISPOS, V31, P1054, DOI 10.1124/dmd.31.8.1054; Zhang ZJ, 2000, BRAIN RES, V852, P116, DOI 10.1016/S0006-8993(99)02223-4; Zhu LY, 2004, NEUROSCI LETT, V367, P210, DOI 10.1016/j.neulet.2004.06.020	22	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153957	10.1371/journal.pone.0153957	http://dx.doi.org/10.1371/journal.pone.0153957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099926	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500109
J	Linzmeier, BJ; Kozdon, R; Peters, SE; Valley, JW				Linzmeier, Benjamin J.; Kozdon, Reinhard; Peters, Shanan E.; Valley, John W.			Oxygen Isotope Variability within Nautilus Shell Growth Bands	PLOS ONE			English	Article							EARLY-LIFE-HISTORY; WESTERN INTERIOR SEAWAY; CHAMBERED CEPHALOPODS; ARCTICA-ISLANDICA; HABITAT; POMPILIUS; CARBON; FRACTIONATION; MACROMPHALUS; TEMPERATURE	Nautilus is often used as an analogue for the ecology and behavior of extinct externally shelled cephalopods. Nautilus shell grows quickly, has internal growth banding, and is widely believed to precipitate aragonite in oxygen isotope equilibrium with seawater. Pieces of shell from a wild-caught Nautilus macromphalus from New Caledonia and from a Nautilus belauensis reared in an aquarium were cast in epoxy, polished, and then imaged. Growth bands were visible in the outer prismatic layer of both shells. The thicknesses of the bands are consistent with previously reported daily growth rates measured in aquarium reared individuals. In situ analysis of oxygen isotope ratios using secondary ion mass spectrometry (SIMS) with 10 mu m beam-spot size reveals inter-and intra-band delta O-18 variation. In the wild-caught sample, a traverse crosscutting 45 growth bands yielded delta O-18 values ranging 2.5 parts per thousand, from +0.9 to -1.6 parts per thousand (VPDB), a range that is larger than that observed in many serial sampling of entire shells by conventional methods. The maximum range within a single band (similar to 32 mu m) was 1.5 parts per thousand, and 27 out of 41 bands had a range larger than instrumental precision (+/- 2 SD = 0.6 parts per thousand). The results from the wild individual suggest depth migration is recorded by the shell, but are not consistent with a simple sinusoidal, diurnal depth change pattern. To create the observed range of delta O-18, however, this Nautilus must have traversed a temperature gradient of at least similar to 12 degrees C, corresponding to approximately 400 m depth change. Isotopic variation was also measured in the aquarium-reared sample, but the pattern within and between bands likely reflects evaporative enrichment arising from a weekly cycle of refill and replacement of the aquarium water. Overall, this work suggests that depth migration behavior in ancient nektonic mollusks could be elucidated by SIMS analysis across individual growth bands.	[Linzmeier, Benjamin J.; Peters, Shanan E.; Valley, John W.] Univ Wisconsin, Dept Geosci, Madison, WI USA; [Kozdon, Reinhard] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Kozdon, Reinhard; Valley, John W.] Univ Wisconsin, Dept Geosci, WiscSIMS, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Linzmeier, BJ (corresponding author), Univ Wisconsin, Dept Geosci, Madison, WI USA.	blinzmeier@wisc.edu	Valley, John W./B-3466-2011; Linzmeier, Benjamin J./AAD-5397-2020; Peters, Shanan E/A-5620-2013	Valley, John W./0000-0003-3530-2722; Linzmeier, Benjamin J./0000-0002-3148-4971; Peters, Shanan E/0000-0002-3346-4317	Geoscience Department at UW-Madison; Sigma Xi; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences [DE-FG02-93ER14389]; National Science Foundation [EAR-1053466, EAR-1355590]; Directorate For Geosciences [1355590] Funding Source: National Science Foundation	Geoscience Department at UW-Madison; Sigma Xi; U.S. Department of Energy Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for this study came from the Geoscience Department at UW-Madison, Sigma Xi, and the U.S. Department of Energy Office of Science, Office of Basic Energy Sciences under Award Number DE-FG02-93ER14389. WiscSIMS is partially supported by the National Science Foundation (EAR-1053466 and -1355590). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Auclair AC, 2004, CHEM GEOL, V207, P91, DOI 10.1016/j.chemgeo.2004.02.006; BARBIN V, 1992, LETHAIA, V25, P391, DOI 10.1111/j.1502-3931.1992.tb01642.x; Basil JA, 2000, J EXP BIOL, V203, P1409; BERRY WILLIAM B. N., 1968, NATURE [LONDON], V217, P938, DOI 10.1038/217938b0; Cappa CD, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003597; Carlson B, 1992, HAWAII SHELL NEWS, pXL; Carlson B, 1991, CHAMBERED NAUT NEWSL; CARLSON BA, 1984, PAC SCI, V38, P183; Cavosie AJ, 2005, EARTH PLANET SC LETT, V235, P663, DOI 10.1016/j.epsl.2005.04.028; Clark GR, 1999, PALAEOGEOGR PALAEOCL, V149, P305, DOI 10.1016/S0031-0182(98)00208-9; CLARK GR, 1974, ANNU REV EARTH PL SC, V2, P77, DOI 10.1146/annurev.ea.02.050174.000453; Cochran JK, 2003, PALAEOGEOGR PALAEOCL, V191, P45, DOI 10.1016/S0031-0182(02)00642-9; COCHRAN JK, 1984, NATURE, V308, P725, DOI 10.1038/308725a0; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; COPLEN TB, 1988, CHEM GEOL, V72, P293, DOI 10.1016/0168-9622(88)90042-5; CRICK RE, 1985, J MAR BIOL ASSOC UK, V65, P415, DOI 10.1017/S0025315400050517; CROCKER KC, 1985, GEOCHIM COSMOCHIM AC, V49, P2527, DOI 10.1016/0016-7037(85)90120-6; de Aguiar DC, 2012, BIOIKOS, P26; Dennis KJ, 2013, EARTH PLANET SC LETT, V362, P51, DOI 10.1016/j.epsl.2012.11.036; DOGUZHAEVA L, 1982, LETHAIA, V15, P385, DOI 10.1111/j.1502-3931.1982.tb01703.x; Dunstan AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016311; EICHLER R, 1966, SCIENCE, V153, P734, DOI 10.1126/science.153.3737.734; Fatherree JW, 1998, PALAIOS, V13, P376, DOI 10.2307/3515325; Friedmann I, 1977, DATA GEOCHEMISTRY; Goodwin DH, 2001, PALAIOS, V16, P387, DOI 10.2307/3515578; Gregoire C, 1987, ULTRASTRUCTURE NAUTI, P463; GROSSMAN EL, 1986, CHEM GEOL, V59, P59, DOI 10.1016/0168-9622(86)90057-6; Guiguer KRRA, 2003, RAPID COMMUN MASS SP, V17, P463, DOI 10.1002/rcm.935; Guzman N, 2007, MICROSC MICROANAL, V13, P397, DOI 10.1017/S1431927607070705; Hamada T., 1987, Topics in Geobiology, P579; House M.R., 1987, Topics in Geobiology, P53; Jackson GD, 2001, MAR BIOL, V138, P819, DOI 10.1007/s002270000496; JONES DS, 1983, AM SCI, V71, P384; JONES DS, 1989, MAR BIOL, V102, P225, DOI 10.1007/BF00428284; JONES DS, 1980, PALEOBIOLOGY, V6, P331, DOI 10.1017/S0094837300006837; KAHN PGK, 1978, NATURE, V275, P606, DOI 10.1038/275606a0; Kampstra P., 2014, PACKAGE BEANPLOT; Kim ST, 2007, CHEM GEOL, V246, P135, DOI 10.1016/j.chemgeo.2007.08.005; Kim ST, 2007, GEOCHIM COSMOCHIM AC, V71, P4704, DOI 10.1016/j.gca.2007.04.019; Kita NT, 2015, J ANAL ATOM SPECTROM, V30, P1207, DOI 10.1039/c4ja00349g; Kita NT, 2009, CHEM GEOL, V264, P43, DOI 10.1016/j.chemgeo.2009.02.012; Kozdon R, 2009, CHEM GEOL, V258, P327, DOI 10.1016/j.chemgeo.2008.10.032; Kozdon R, 2013, PALEOCEANOGRAPHY, V28, P517, DOI 10.1002/palo.20048; Kozdon R, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002056; Kruta I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087479; LANDMAN NH, 1988, EARTH PLANET SC LETT, V89, P28, DOI 10.1016/0012-821X(88)90030-1; LANDMAN NH, 1983, PALEOBIOLOGY, V9, P269, DOI 10.1017/S0094837300007685; LANDMAN NH, 1983, LETHAIA, V16, P248, DOI 10.1111/j.1502-3931.1983.tb01150.x; LANDMAN NH, 1994, PALEOBIOLOGY, V20, P40, DOI 10.1017/S009483730001112X; Lecuyer C., 2006, eEarth, V1, P1; Linzmeier BJ., 2012, THESIS U WISCONSIN M; Locarnini R. A., 2013, WORLD OCEAN ATLAS 20, V1; Loudon ASI, 2012, CURR BIOL, V22, pR570, DOI 10.1016/j.cub.2012.06.023; Lukeneder A, 2015, TOP GEOBIOL, V43, P689, DOI 10.1007/978-94-017-9630-9_18; Lukeneder A, 2010, EARTH PLANET SC LETT, V296, P103, DOI 10.1016/j.epsl.2010.04.053; Martin A.W., 1978, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V156, P207; Matta ME, 2013, RAPID COMMUN MASS SP, V27, P691, DOI 10.1002/rcm.6502; MCCONNAUGHEY T, 1989, GEOCHIM COSMOCHIM AC, V53, P151, DOI 10.1016/0016-7037(89)90282-2; Meisel DV, 2006, J COMP PSYCHOL, V120, P191, DOI 10.1037/0735-7036.120.3.191; Meyers S., 2014, ASTROCHRON R PACKAGE; Miyaji T, 2010, PALAEOGEOGR PALAEOCL, V286, P107, DOI 10.1016/j.palaeo.2009.11.032; Moriya K, 2003, GEOLOGY, V31, P167, DOI 10.1130/0091-7613(2003)031<0167:DHOLCA>2.0.CO;2; Moriya K, 2015, TOP GEOBIOL, V43, P793, DOI 10.1007/978-94-017-9630-9_19; Mutvei H., 1964, Arkiv for Zoologi, V16, P221; OBA T, 1992, MAR BIOL, V113, P211; Ohno A, 2015, LETHAIA, V48, P332, DOI 10.1111/let.12109; Okamoto Takashi, 1996, Topics in Geobiology, V13, P225; Orland IJ, 2009, QUATERNARY RES, V71, P27, DOI 10.1016/j.yqres.2008.08.005; Orland IJ, 2012, THESIS U WISCONSIN M; Rasband W., 2006, IMAGEJ; Ritterbush KA, 2012, PALEOBIOLOGY, V38, P424, DOI 10.1666/10027.1; Rollion-Bard C, 2003, CORAL REEFS, V22, P405, DOI 10.1007/s00338-003-0347-9; SAUNDERS WB, 1983, PALEOBIOLOGY, V9, P280, DOI 10.1017/S0094837300007697; SAUNDERS WB, 1984, PALEOBIOLOGY, V10, P469, DOI 10.1017/S0094837300008472; Schlogl J, 2011, PALAEOGEOGR PALAEOCL, V308, P330, DOI 10.1016/j.palaeo.2011.05.037; Schone BR, 2005, PALAIOS, V20, P78, DOI 10.2110/palo.2003.p03-101; Stevens K, 2015, PALAEOGEOGR PALAEOCL, V417, P164, DOI 10.1016/j.palaeo.2014.10.031; TAYLOR BE, 1983, PALAEOGEOGR PALAEOCL, V41, P1, DOI 10.1016/0031-0182(83)90072-X; THOMPSON I, 1980, MAR BIOL, V57, P25, DOI 10.1007/BF00420964; TOURTELOT HA, 1969, GEOL SOC AM BULL, V80, P1903, DOI 10.1130/0016-7606(1969)80[1903:DOOACI]2.0.CO;2; Valley J.W., 2009, SECONDARY ION MASS S, V41, P19; WARD P, 1984, NATURE, V309, P248, DOI 10.1038/309248a0; WARD P, 1978, J EXP ZOOL, V205, P5, DOI 10.1002/jez.1402050103; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1985, PALEOBIOLOGY, V11, P438, DOI 10.1017/S0094837300011726; Watanabe T, 2003, GEOCHIM COSMOCHIM AC, V67, P1349, DOI 10.1016/S0016-7037(02)01221-8; Westermann B, 2004, J EXP ZOOL PART A, V301A, P930, DOI 10.1002/jez.a.116; Westermann Gerd E.G., 1996, Topics in Geobiology, V13, P607; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Wilkinson BH, 2002, PALAEOGEOGR PALAEOCL, V185, P95, DOI 10.1016/S0031-0182(02)00279-1; Willey A, 1902, CONTRIBUTION NATURAL; Zakharov YD, 2006, GEOSCI J, V10, P331, DOI 10.1007/BF02910374	93	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153890	10.1371/journal.pone.0153890	http://dx.doi.org/10.1371/journal.pone.0153890			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100183	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500087
J	Magalhaes, T; Robles, R; Felder, DL; Mantelatto, FL				Magalhaes, Tatiana; Robles, Rafael; Felder, Darryl L.; Mantelatto, Fernando L.			Integrative Taxonomic Study of the Purse Crab Genus Persephona Leach, 1817 (Brachyura: Leucosiidae): Combining Morphology and Molecular Data	PLOS ONE			English	Article							SAO-PAULO STATE; BENTHIC INVERTEBRATES; PHYLOGENETIC ANALYSIS; MEDITERRANEA HERBST; DECAPOD CRUSTACEANS; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL 16S; SEXUAL-MATURITY; NORTHERN COAST; UBATUBA BAY	Marine crabs of the genus Persephona Leach, 1817 are restricted to American waters of the western Atlantic and eastern Pacific Oceans. Subfamilial assignment of this taxon has varied between authors and its species composition remain in question. We conducted a comparative study based on morphology and molecular phylogenetics for all ten recognized species of Persephona, along with Iliacantha hancocki. We tested whether Persephona finneganae, P. lichtensteinii, and P. crinita represent a single species as suggested by some authors; whether specimens identified as P. punctata, P. mediterranea, and P. aquilonaris warrant treatment as separate species; and whether I. hancocki should be regarded as a junior synonym of P. subovata. Diagnostic morphological characters (of the carapace, chelipeds, and third maxillipeds) were used along with gonopod (male first pleopod 1) features and live coloration. The 16S rRNA and the Cytochrome Oxidase I (COI) (DNA barcoding) mitochondrial genes were used as molecular markers. Both morphological and molecular analyses revealed that putative specimens of P. crinita from Brazil and those assigned to P. finneganae were no different from specimens presently assignable to P. lichtensteinii. P. finneganae is regarded as a junior synonym of P. lichtensteinii, and we apply P. crinita only to specimens we examined from the Gulf of Mexico. Specimens from Brazil previously reported as P. crinita are herewith concluded to represent P. lichtensteinii. Additionally, P. townsendi is a junior synonym of P. orbicularis, Iliacantha hancocki is concluded to be a junior synonym of P. subovata, while P. aquilonaris and P. mediterranea are found to represent separate species. On the basis of our revisions, eight species of Persephona are considered valid, and the reported distribution for P. crinita is restricted.	[Magalhaes, Tatiana; Robles, Rafael; Mantelatto, Fernando L.] Univ Sao Paulo, LBSC, Dept Biol, FFCLRP, Sao Paulo, Brazil; [Felder, Darryl L.] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA	Universidade de Sao Paulo; University of Louisiana Lafayette	Mantelatto, FL (corresponding author), Univ Sao Paulo, LBSC, Dept Biol, FFCLRP, Sao Paulo, Brazil.	flmantel@usp.br	Robles, Rafael/F-1967-2010; Magalhães, Tatiana/U-5666-2018; Mantelatto, Fernando/N-9536-2019; Mantelatto, Fernando/GQI-1333-2022; robles, rafael/Y-4087-2019	Robles, Rafael/0000-0003-0531-5557; Magalhães, Tatiana/0000-0003-1573-3533; Mantelatto, Fernando/0000-0002-8497-187X; Mantelatto, Fernando/0000-0002-8497-187X; robles, rafael/0000-0003-0531-5557	CAPES; CNPq [301359/2007-5, 473050/2007-2, 302748/2010-5, 304968/2014-5, 157489/2010-8, 500460/2010-8]; CAPES (Ciencias do Mar II) [2005/2014 - 23038.004308/201414]; Postgraduate Program in Comparative Biology of the FFCLRP/USP via PROAP/CAPES; Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo [2011.1.2642.59.2]; U.S. NSF/AToL [EF-0531603]; U.S. NSF/RAPID [DEB 1045690]; GoMRI [GRI-112-8]; FAPESP [2013/05663-8];  [FAPESP Tematico Biota 2010/50188-8];  [Colecoes Cientificas 2009/54931-0]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Ciencias do Mar II)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program in Comparative Biology of the FFCLRP/USP via PROAP/CAPES; Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo; U.S. NSF/AToL; U.S. NSF/RAPID; GoMRI; FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); ; 	The present study was part of a master's thesis by TM supported by scientific fellowships from CAPES. Financial support was provided by research grants (FAPESP Tematico Biota 2010/50188-8; Colecoes Cientificas 2009/54931-0), CNPq (Proc. 301359/2007-5; 473050/2007-2; 302748/2010-5; 304968/2014-5), and CAPES (Ciencias do Mar II Proc. 2005/2014 - 23038.004308/201414) to FLM. TM and RR were under continued support by a PhD fellowship from CAPES and post-doctoral fellowships from CNPQ (Proc. 157489/2010-8; 500460/2010-8) and FAPESP (Proc. 2013/05663-8), respectively. We are grateful to the Postgraduate Program in Comparative Biology of the FFCLRP/USP for partial financial support via PROAP/CAPES. Additional funding for work by TM at UL-Lafayette period was provided by grants from Pro-Reitoria de Pos-Graduacao da Universidade de Sao Paulo (Proc. 2011.1.2642.59.2) to FLM/TM and U.S. NSF/AToL EF-0531603, U.S. NSF/RAPID DEB 1045690, and GoMRI grant GRI-112-8 to DLF.	Abele L, 1970, THESIS FLORIDA STATE; ABELE L G, 1971, Crustaceana (Leiden), V21, P218, DOI 10.1163/156854071X00427; Abele L.G., 1986, TECHNICAL SERIES, V8, P1; Almeida Alexandre O., 2008, Nauplius, V16, P23; Almeida AC, 2013, J MAR BIOL ASSOC UK, V93, P1581, DOI 10.1017/S002531541200197X; Almeida EAB, 2008, APIDOLOGIE, V39, P75, DOI 10.1051/apido:2007063; Alvarez Fernando, 1999, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V70, P1; Anker A, 2011, ZOOTAXA, P63; Ariza Paola, 2008, Bol. Invest. Mar. Cost., V37, P155; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barros MP, 2001, B MUSEU PARAENSE E Z, V17, P15; Behre E. H., 1950, Occasional Papers of the Marine Laboratory Baton Rouge, VNo. 6, P1; BELL T., 1855, T LINNEAN SOC LOND 4, V21, P277, DOI DOI 10.1111/J.1096-3642.1852.TB00464.X; Bertini G, 2004, BIODIVERS CONSERV, V13, P2185, DOI 10.1023/B:BIOC.0000047900.96123.34; Bertini G, 2010, INVERTEBR REPROD DEV, V54, P7, DOI 10.1080/07924259.2010.9652311; Boone L., 1930, Bulletin of the Vanderbilt Marine Museum, V2, P1; Bordin G, 1987, SERIE ZOOLOGIA, V66, P3; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; Bracken-Grissom HD, 2014, SYST BIOL, V63, P457, DOI 10.1093/sysbio/syu008; Braga Adriane A., 2005, Biota Neotropica, V5, P1; Branco Joaquim Olinto, 2004, Rev. Bras. Zool., V21, P91, DOI 10.1590/S0101-81752004000100016; Brandis D, 1999, J MORPHOL, V239, P157, DOI 10.1002/(SICI)1097-4687(199902)239:2<157::AID-JMOR4>3.0.CO;2-E; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Browne P, 1956, CIVIL NATURAL HIST J; Buhay JE, 2008, J CRUSTACEAN BIOL, V28, P57, DOI 10.1651/07-2827R.1; Buitendijk A. M., 1950, Zoologische Mededeelingen Leiden, V30, P269; BULL JJ, 1993, SYST BIOL, V42, P384, DOI 10.2307/2992473; Camp DK, 1998, CHECKLISTS SELECTED; Carvalho F.L., 2010, NAUPLIUS, V18, P109; CERAMEVIVAS MJ, 1966, ECOLOGY, V47, P260, DOI 10.2307/1933773; Coelho P.A., 1981, Revista Nordestina de Biologia, V3, P67; COELHO P. A., 1983, ANAIS SOC NORDESTINA, V1, P133; Coelho P.A., 1972, TRABALHOS INSTITUTO, V13, P133, DOI 10.5914/tropocean.v13i1.2555; COELHO PA, 1986, CADERNOS OMEGA U FED, V2, P79; Coelho PA, 2008, ZOOTAXA, P1; Collins J.S.H., 2009, Scripta Geologica (Leiden), V138, P23; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Compton H, 1962, SURVEY COMMERCIAL SH, V20; Correa-Sandoval F, 1991, CATALOGO BIBLIOGRAFI; Costa FO, CANADIAN J FISHERIES, V64, P272; Crane J, 1937, SCI CONTRIBUTIONS NE, V22, P97; de Abreu J., 1980, Boletim do Instituto Oceanografico, V29, P1; de CASTRO ALCEU LEMOS, 1962, ARQ MUS NAC [RIO DE JANEIRO], V52, P37; del Solar EM, 1970, CATALOGO CRUSTACEOS; Desbonne I, 1867, CRUSTADES GUADELOUPE; DiMauro Jr AA, 1982, REDISCOVERY T BELLS, V76, P155; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fabricius JC., 1798, ENTOMOLOGIAE SYSTE S; Fausto-Filho J, 1968, B SOC CEARENSE AGRON, V9, P462; Fausto-Filho J., 1966, ARQUIVOS ESTACAO BIO, V6, P31; Felder D. L., 2009, GULF MEXICO ORIGIN W, V1, P1, DOI DOI 10.1086/659907; Felder DL., 1973, ANNOTATED KEY CRABS; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng YW, 2011, MOL BIOL REP, V38, P291, DOI 10.1007/s11033-010-0107-1; Finnegan S., 1931, J LINNEAN SOC LONDON, V37, P607, DOI [DOI 10.1111/J.1096-3642.1931.TB02367.X, 10.1111/j.1096-3642.1931.tb02367.x]; Furlan M, 2013, AN ACAD BRAS CIENC, V85, P1345, DOI 10.1590/0001-3765201394812; Garth J. S., 1946, Allan Hancock Pacific Expedition, V5, P341; GARTH JOHN S., 1948, BULL AMER MUS NAT HIST, V92, P1; GARTH JS, 1960, SYST ZOOL, V9, P105, DOI 10.2307/2411960; GARTH JS, 1966, ZOOLOGICA-N Y, V51, P1; Garth JS, 1991, GALAPAGOS MARINE INV; Garth SJ, 1957, LUNDS U ARSSKRIFT, V7, P1; Gibbes L.R, 1850, P AM ASS ADV SCI, V3, P165; Gomes Correa M.M., 1980, Atas da Sociedade de Biologia do Rio de Janeiro, V21, P59; GUINOT-DUMORTIER D., 1959, BULL MUS NATL HIST NAT [PARIS], V31, P423; Hall T, 2005, BIOL SEQUENCE ALIGNM; Harrison JS, 2004, MOL PHYLOGENET EVOL, V30, P743, DOI 10.1016/S1055-7903(03)00250-1; Hay W. P., 1918, Bulletin US Bureau Fisheries, V35; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hendrickx M. E., 1997, CANGREJOS BRAQUIUROS; Hendrickx ME, 1996, REV BIOL TROP, V44, P945; Hendrickx Michel E., 1993, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V64, P1; Hendrickx Michel E., 1995, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V65, P125; Herbst JFW, 1782, BERLIN STRALSUND, V3, P1; Hildebrand HH, 1954, PUBL I MAR SCI U TEX, V3, P229; Hirose GL, 2012, ZOOTAXA, P17, DOI 10.11646/zootaxa.3167.1.2; Holthuis L. B., 1959, ZOOLOGISCHE VERHANDE, V44, P1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kingsley JS, 1878, P ACAD NAT SCI PHILA, V30, P316; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Leach WE, 1817, ZOOLOGICAL MISCELLAN, V3; Lefebure T, 2006, MOL PHYLOGENET EVOL, V40, P435, DOI 10.1016/j.ympev.2006.03.014; Lemaitre R, 1991, B INVEST MAR COST, V21, P33; Lichtenstein KH, 1815, MAGAZIN GESELLSCHAFF, V7, P135; Linnaeus C, 1767, SYSTEMA NATURAE REGN, VI, DOI 10.5962/bhl.title.542; Luederwaldt H., 1919, Revista do Museu Paulista, V11; Magalhaes C, 2010, ZOOTAXA, P52; Mantelatto FLM, 2006, ZOOSYSTEMA, V28, P495; Mantelatto FL, 2003, COMP PARASITOL, V70, P211, DOI 10.1654/4066; Mantelatto FLM, 2000, J SHELLFISH RES, V19, P701; Martin JW, 2009, DECAPOD CRUSTACEAN P; Martinez Gaston, 2009, Pan-American Journal of Aquatic Sciences, V4, P279; Martinez-Iglesias JC, 1986, POEYANA, V332, P5; MAURER D, 1984, J NAT HIST, V18, P47, DOI 10.1080/00222938400770071; Melo GAS, 2006, MAN ID BRACH CAR SIR; Miers EJ., 1886, REPORT SCI RESULTS V; Milne Edwards H., 1837, HIST NATURELLE CRUST, V2; Moreira C., 1901, ARCHIVOMUSEU NACL, V11, P1; Moreira C, 1903, ARCH MUSEU NACL RIO, V12, P119; Moscoso V., 2012, B I MAR PER, V27, P8; Munasinghe DHN, 2003, J CRUSTACEAN BIOL, V23, P402, DOI 10.1651/0278-0372(2003)023[0402:UOMDSF]2.0.CO;2; NEGREIROSFRANSOZO ML, 1989, CRUSTACEANA, V57, P177, DOI 10.1163/156854089X00509; Nei M., 2000, MOL EVOLUTION PHYLOG; Neigel JE, 2009, GULF MEXICO ORIGIN W, V1; Ng Peter K.L., 2008, Raffles Bulletin of Zoology Supplement, V17, P1; Ocampo EH, 2013, ZOOL J LINN SOC-LOND, V169, P27, DOI 10.1111/zoj.12045; Ortiz M, 2011, RESTAURACION ACTUALI, V4, P45; OVERSTREET RM, 1978, GULF RES REP, V6, P145; Palumbi Stephen R., 1991, Molecular Marine Biology and Biotechnology, V1, P27; Parra A, 1787, DESCRIPCION DIFERENT; PAUL R K G, 1980, Bulletin Southern California Academy of Sciences, V79, P109; Pileggi LG, 2014, ZOOKEYS, P109, DOI 10.3897/zookeys.457.6818; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powers L.W., 1977, CONTRIBUTIONS MARINE, V20, P1; Rambaut A., 2007, TRACER V1 4 MCMC TRA; Vieira RRR, 2010, BIOTA NEOTROP, V10, P431, DOI 10.1590/S1676-06032010000300036; Rathbun M. J., 1937, Bulletin United States National Museum, Vno. 166, P1; Rathbun M. J., 1898, P US NATL MUS, V21, P567, DOI [10.5479/si.00963801.21-1162.567, DOI 10.5479/SI.00963801.21-1162.567]; RATHBUN MARY J., 1933, PROC BIOL SOC WASHINGTON, V46, P183; RATHBUN MARY J., 1931, JOUR WASHINGTON ACAD SCI, V21, P125; RATHBUN MARY J., 1935, PROC BIOL SOC WASHINGTON, V48, P1; RATHBUN MARY J., 1935, PROC BIOL SOC WASHINGTON, V48, P49; Rathbun MJ, 1893, P US NATIONAL MUSEUM, V16, P223, DOI DOI 10.5479/SI.00963801.933.223; Rathbun MJ., 1901, B US FISH COMM, V20, P1; Raz-Guzman Andrea, 1992, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V63, P29; Rieger PJ, 1999, NAUPLIUS, V7, P193; Robles R, 2007, MAR BIOL, V150, P1265, DOI 10.1007/s00227-006-0437-7; Rodrigues da Costa H, 1968, RECUEIL TRAVAUX STAT, V43, P333; Rodriguez de la Cruz MC, 1987, CRUSTACEOS DECAPODOS; Rodriguez G, 1980, CRUSTACEOS DECAPODOS; Rouse WL, 1970, Q J FLA ACAD SCI, V32, P127; Ruiz T, 2013, REV MEX BIODIVERS, V84, P280, DOI 10.7550/rmb.27685; Schubart CD, 2006, B FR PECHE PISCIC, P1019, DOI 10.1051/kmae:2006008; Schubart CD, 2000, CRUSTACEAN ISS, V12, P817; Schubart CD, 2000, MAR BIOL, V137, P11, DOI 10.1007/s002270000325; Severino-Rodrigues Evandro, 2002, Boletim do Instituto de Pesca (Sao Paulo), V28, P33; Silva JM, 2012, MARINE ECOLOGY, V34, P157; Sosa-Hernandez P, 1980, ESTUDIO PROSPECTIVE; Souza JAF, 1997, NAUPLIUS, V5, P33; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVCIC Z, 1973, SYST ZOOL, V22, P625, DOI 10.2307/2412966; STIMPSON W., 1859, ANN LYCEUM NATURAL H, V7, P49, DOI DOI 10.1111/J.1749-6632.1862.TB00142.X; Stimpson W., 1871, B MUS COMP ZOOL HARV, V2, P109; Tabb D. C., 1961, Bulletin of Marine Science of the Gulf and Caribbean, V11, P552; Taissoun NE, 1986, B CENTRO INVESTIGACI, V17, P121; Takeda M, 1983, CRUSTACEANS MOLLUSKS, P19; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAVARES MS, 1993, CRUSTACEAN ISS, V8, P7; TAYLOR AC, 1984, J MAR BIOL ASSOC UK, V64, P7, DOI 10.1017/S0025315400059609; Terossi M, 2012, CRUSTACEANA, V85, P685, DOI 10.1163/156854012X643762; Thoma B. P., 2013, ZOOLOGICAL J LINNEAN, V170, P86, DOI DOI 10.1111/Z0J12093; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torres MFA, 1998, THESIS I OCEANOGRAFI; Vargas-Castillo R, 2008, REV BIOL TROP, V56, P105; Vargas-Zamora JA, 2012, REV BIOL TROP, V60, P1763; Vazquez-Bader AR, 1994, PUBLICACIONES ESPECI, V12; von Martens E, 1872, ARCH NATURGESCH, V38, P77; WASS MARVIN L., 1955, QUART JOUR FLORIDA ACAD SCI, V18, P129; Weber LI, 2000, HYDROBIOLOGIA, V420, P211, DOI 10.1023/A:1003905115208; Wehrtmann IS, 2007, REV BIOL TROP, V55, P121; Werding B, 1989, SENCKENBERG BIOL, V70, P405; Williams A.B., 1984, pi; Williams AB, 1965, FISHERY B, V65, P1	164	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152627	10.1371/journal.pone.0152627	http://dx.doi.org/10.1371/journal.pone.0152627			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099956	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500013
J	Cardinaels, EPM; Altintas, S; Versteylen, MO; Joosen, IA; Jellema, LJC; Wildberger, JE; Das, M; Crijns, HJ; Bekers, O; van Dieijen-Visser, MP; Kietselaer, BL; Mingels, AMA				Cardinaels, Eline P. M.; Altintas, Sibel; Versteylen, Mathijs O.; Joosen, Ivo A.; Jellema, Laurens-Jan C.; Wildberger, Joachim E.; Das, Marco; Crijns, Harry J.; Bekers, Otto; van Dieijen-Visser, Marja P.; Kietselaer, Bastiaan L.; Mingels, Alma M. A.			High-Sensitivity Cardiac Troponin Concentrations in Patients with Chest Discomfort: Is It the Heart or the Kidneys As Well?	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ACUTE MYOCARDIAL-INFARCTION; GLOMERULAR-FILTRATION-RATE; RENAL-INSUFFICIENCY; NATRIURETIC PEPTIDE; COMPUTED-TOMOGRAPHY; AORTIC-STENOSIS; EARLY-DIAGNOSIS; CYSTATIN C; T ASSAY	Background High-sensitivity cardiac troponins (hs-cTn) are the preferred biomarkers to detect myocardial injury, making them promising risk-stratifying tools for patients with symptoms of chest pain. However, circulating hs-cTn are also elevated in other conditions like renal dysfunction, complicating appropriate interpretation of low-level hs-cTn concentrations. Methods A cross-sectional analysis was performed in 1864 patients with symptoms of chest discomfort from the cardiology outpatient department who underwent cardiac computed tomographic angiography (CCTA). Serum samples were analyzed using hs-cTnT and hs-cTnI assays. Renal function was measured by the estimated glomerular filtration rate (eGFR), established from serum creatinine and cystatin C. On follow-up, the incidence of adverse events was assessed. Results Median hs-cTnT and hs-cTnI concentrations were 7.2(5.8-9.2) ng/L and 2.6(1.8-4.1) ng/L, respectively. Multivariable regression analysis revealed that both assay results were more strongly associated with eGFR (hs-cTnT: st beta:-0.290; hs-cTnI: st beta:-0.222) than with cardiac imaging parameters, such as coronary calcium score, CCTA plaque severity score and left ventricular mass (all p< 0.01). Furthermore, survival analysis indicated lower relative risks in patients with normal compared to reduced renal function for hs-cTnT [HR(95% CI), 1.02 (1.00-1.03) compared to 1.07(1.05-1.09)] and hs-cTnI [1.01(1.00-1.01) compared to 1.02 (1.01-1.02)] (all p< 0.001). Conclusion In patients with chest discomfort, we identified an independent influence of renal function on hs-cTn concentrations besides CAD, that affected the association of hs-cTn concentrations with adverse events. Estimating renal function is therefore warranted when interpreting baseline hs-cTn concentrations.	[Cardinaels, Eline P. M.; Bekers, Otto; van Dieijen-Visser, Marja P.; Mingels, Alma M. A.] Maastricht Univ, Cent Diagnost Lab, Dept Clin Chem, Cardiovasc Res Inst Maastricht CARIM,Med Ctr, NL-6200 MD Maastricht, Netherlands; [Altintas, Sibel; Versteylen, Mathijs O.; Joosen, Ivo A.; Crijns, Harry J.; Kietselaer, Bastiaan L.] Maastricht Univ, CARIM, Dept Cardiol, Med Ctr, NL-6200 MD Maastricht, Netherlands; [Jellema, Laurens-Jan C.] Gelre Hosp, Dept Clin Chem & Hematol, Apeldoorn, Netherlands; [Wildberger, Joachim E.; Das, Marco; Kietselaer, Bastiaan L.] Maastricht Univ, Dept Radiol, CARIM, Med Ctr, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Gelre Hospitals; Maastricht University; Maastricht University Medical Centre (MUMC)	Mingels, AMA (corresponding author), Maastricht Univ, Cent Diagnost Lab, Dept Clin Chem, Cardiovasc Res Inst Maastricht CARIM,Med Ctr, NL-6200 MD Maastricht, Netherlands.	alma.mingels@mumc.nl		Wildberger, Joachim/0000-0002-4810-6854	Stichting De Weijerhorst	Stichting De Weijerhorst	This work was supported by a research grant from Stichting De Weijerhorst (http://www.deweijerhorst.nl/weijerhorst/home) to M.Pv.D-V. The hs-cTnI kits were kindly provided by Abbott Diagnostics. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Alcalai R, 2007, ARCH INTERN MED, V167, P276, DOI 10.1001/archinte.167.3.276; Anavekar NS, 2004, KIDNEY INT S; Bansal N, 2015, J AM SOC NEPHROL, V26, P946, DOI 10.1681/ASN.2014010108; Beatty AL, 2013, JAMA INTERN MED, V173, P763, DOI 10.1001/jamainternmed.2013.116; Bonaca M, 2010, J AM COLL CARDIOL, V55, P2118, DOI 10.1016/j.jacc.2010.01.044; Cardinaels EP, 2015, J AM MED DIR ASS; Chenevier-Gobeaux C, 2013, AM J CARDIOL, V111, P1701, DOI 10.1016/j.amjcard.2013.02.024; Chin CWL, 2014, EUR HEART J, V35, P2312, DOI 10.1093/eurheartj/ehu189; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi C, 2003, JAMA-J AM MED ASSOC, V290, P353, DOI 10.1001/jama.290.3.353; deFilippi C, 2012, CLIN CHEM, V58, P1342, DOI 10.1373/clinchem.2012.185322; Dubin RF, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-229; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Galiuto L, 2011, THE EAE TEXTBOOK OF; Giannitsis E, 2013, NAT REV CARDIOL, V10, P623, DOI 10.1038/nrcardio.2013.129; Giannitsis E, 2010, CLIN CHEM, V56, P254, DOI 10.1373/clinchem.2009.132654; Hassan HC, 2014, CLIN CHEM, V60, P389, DOI 10.1373/clinchem.2013.207142; Hermann LK, 2010, AM J CARDIOL, V105, P1561, DOI 10.1016/j.amjcard.2010.01.014; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Irfan A, 2012, AM J MED, V125, P491, DOI 10.1016/j.amjmed.2011.10.031; Januzzi JL, 2010, CIRCULATION, V121, P1227, DOI 10.1161/CIRCULATIONAHA.109.893826; Joosen IA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047267; Korosoglou G, 2011, HEART, V97, P823, DOI 10.1136/hrt.2010.193201; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laufer EM, 2010, ARTERIOSCL THROM VAS, V30, P1269, DOI 10.1161/ATVBAHA.109.200394; Mingels AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035059; Mishra RK, 2013, AM J KIDNEY DIS, V61, P701, DOI 10.1053/j.ajkd.2012.11.034; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Omland T, 2013, J AM COLL CARDIOL, V61, P1240, DOI 10.1016/j.jacc.2012.12.026; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Reichlin T, 2011, CIRCULATION, V124, P136, DOI 10.1161/CIRCULATIONAHA.111.023937; Reichlin T, 2009, NEW ENGL J MED, V361, P858, DOI 10.1056/NEJMoa0900428; Rosjo H, 2011, AM J CARDIOL, V108, P88, DOI 10.1016/j.amjcard.2011.02.346; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Scheven L, 2012, EUR HEART J, V33, P2272, DOI 10.1093/eurheartj/ehs163; Thygesen K, 2012, CIRCULATION, V126, P2020, DOI 10.1161/CIR.0b013e31826e1058; Tsutamoto T, 2009, EUR J HEART FAIL, V11, P653, DOI 10.1093/eurjhf/hfp072; Voskoboev NV, 2011, CLIN CHEM, V57, P1209, DOI 10.1373/clinchem.2011.164798; Wildi K, 2015, CIRCULATION, V131, P2032, DOI 10.1161/CIRCULATIONAHA.114.014129; Ziebig R, 2003, CLIN CHEM, V49, P1191, DOI 10.1373/49.7.1191	41	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153300	10.1371/journal.pone.0153300	http://dx.doi.org/10.1371/journal.pone.0153300			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096420	Green Published, gold			2022-12-27	WOS:000374543600031
J	Hurtt, GC; Thomas, RQ; Fisk, JP; Dubayah, RO; Sheldon, SL				Hurtt, G. C.; Thomas, R. Q.; Fisk, J. P.; Dubayah, R. O.; Sheldon, S. L.			The Impact of Fine-Scale Disturbances on the Predictability of Vegetation Dynamics and Carbon Flux	PLOS ONE			English	Article							LARGE-FOOTPRINT LIDAR; TROPICAL RAIN-FOREST; BIOMASS; MODEL; TOPOGRAPHY; LANDSCAPE	Predictions from forest ecosystem models are limited in part by large uncertainties in the current state of the land surface, as previous disturbances have important and lasting influences on ecosystem structure and fluxes that can be difficult to detect. Likewise, future disturbances also present a challenge to prediction as their dynamics are episodic and complex and occur across a range of spatial and temporal scales. While large extreme events such as tropical cyclones, fires, or pest outbreaks can produce dramatic consequences, small fine-scale disturbance events are typically much more common and may be as or even more important. This study focuses on the impacts of these smaller disturbance events on the predictability of vegetation dynamics and carbon flux. Using data on vegetation structure collected for the same domain at two different times, i.e. "repeat lidar data", we test high-resolution model predictions of vegetation dynamics and carbon flux across a range of spatial scales at an important tropical forest site at La Selva Biological Station, Costa Rica. We found that predicted height change from a height-structured ecosystem model compared well to lidar measured height change at the domain scale (similar to 150 ha), but that the model-data mismatch increased exponentially as the spatial scale of evaluation decreased below 20 ha. We demonstrate that such scale-dependent errors can be attributed to errors predicting the pattern of fine-scale forest disturbances. The results of this study illustrate the strong impact fine-scale forest disturbances have on forest dynamics, ultimately limiting the spatial resolution of accurate model predictions.	[Hurtt, G. C.; Fisk, J. P.; Dubayah, R. O.; Sheldon, S. L.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA; [Thomas, R. Q.] Virginia Tech, Dept Forest Resources & Environm Conservat, Blacksburg, VA USA; [Fisk, J. P.] Appl Geosolut, Durham, NH USA	University System of Maryland; University of Maryland College Park; Virginia Polytechnic Institute & State University	Hurtt, GC (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	gchurtt@umd.edu	Hurtt, George/A-8450-2012; Thomas, R Quinn/B-1611-2013	Hurtt, George/0000-0001-7278-202X; Thomas, R Quinn/0000-0003-1282-7825; Fisk, Justin/0000-0002-7232-3832	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was supported by research grants from the NASA Terrestrial Ecology and Interdisciplinary Science Research Programs.	Antokarakis AS, 2011, ECOLOGICAL APPL, V21; Antonarakis AS, 2014, GEOPHYS RES LETT, V41, P2535, DOI 10.1002/2013GL058373; Blair JB, 1999, ISPRS J PHOTOGRAMM, V54, P115, DOI 10.1016/S0924-2716(99)00002-7; BOTKIN DB, 1972, J ECOL, V60, P849, DOI 10.2307/2258570; Chambers JQ, 2007, SCIENCE, V318, P1107, DOI 10.1126/science.1148913; Chambers JQ, 2013, P NATL ACAD SCI USA, V110, P3949, DOI 10.1073/pnas.1202894110; Chambers JQ, 2009, ECOL LETT, V12, pE22, DOI 10.1111/j.1461-0248.2009.01398.x; Clark DB, 2000, FOREST ECOL MANAG, V137, P185, DOI 10.1016/S0378-1127(99)00327-8; Drake JB, 2003, GLOBAL ECOL BIOGEOGR, V12, P147, DOI 10.1046/j.1466-822X.2003.00010.x; Drake JB, 2002, REMOTE SENS ENVIRON, V79, P305, DOI 10.1016/S0034-4257(01)00281-4; Drake JB, 2002, REMOTE SENS ENVIRON, V81, P378, DOI 10.1016/S0034-4257(02)00013-5; Dubayah RO, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000933; Dwyer E, 2000, INT J REMOTE SENSING, V21; Fisher JI, 2008, ECOL LETT, V11, P554, DOI 10.1111/j.1461-0248.2008.01169.x; Fisk JP, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/4/045017; Frolking S, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000911; Hofton MA, 2002, J GEODYN, V34, P491, DOI 10.1016/S0264-3707(02)00046-7; Hurtt GC, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2009JG000937; Hurtt GC, 1998, GLOBAL CHANGE BIOL, V4, P581, DOI 10.1046/j.1365-2486.1998.t01-1-00203.x; Hurtt GC, 2004, ECOL APPL, V14, P873, DOI 10.1890/02-5317; Kellner JR, 2009, ECOL LETT, V12, P887, DOI 10.1111/j.1461-0248.2009.01345.x; Kellner JR, 2009, ECOL LETT, V12, P155, DOI 10.1111/j.1461-0248.2008.01274.x; MCDADE L. A., 1994, SELVA ECOLOGY NATURA; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Sellers PJ, 1995, OVERVIEW ISLSCP I GL, V1-5; Shugart H.H., 1984, THEORY FOREST DYNAMI; Thomas RQ, 2008, CAN J REMOTE SENS, V34, pS351, DOI 10.5589/m08-036	28	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152883	10.1371/journal.pone.0152883	http://dx.doi.org/10.1371/journal.pone.0152883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093157	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200010
J	Klein, SR; Jiang, H; Hossain, MB; Fan, XJ; Gumin, J; Dong, A; Alonso, MM; Gomez-Manzano, C; Fueyo, J				Klein, Sarah R.; Jiang, Hong; Hossain, Mohammad B.; Fan, Xuejun; Gumin, Joy; Dong, Andrew; Alonso, Marta M.; Gomez-Manzano, Candelaria; Fueyo, Juan			Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens	PLOS ONE			English	Article							MHC CLASS-II; NUCLEAR ANTIGEN; PHOSPHORYLATION; COMBINATION; EXPRESSION; MATURATION; PROTEIN; FUSION; VECTOR; GROWTH	Adenoviruses are highly immunogenic and are being examined as potential vectors for immunotherapy. Infection by oncolytic adenovirus is followed by massive autophagy in cancer cells. Here, we hypothesize that autophagy regulates the processing of adenoviral proteins for antigen presentation. To test this hypothesis, we first examined the presentation of viral antigens by infected cells using an antibody cocktail of viral capsid proteins. We found that viral antigens were processed by JNK-mediated autophagy, and that autophagy was required for their presentation. Consistent with these results, splenocytes isolated from virus-immunized mice were activated by infected cells in an MHC II-dependent manner. We then hypothesize that this mechanism can be utilized to generate an efficient cancer vaccine. To this end, we constructed an oncolytic virus encompassing an EGFRvIII cancer-specific epitope in the adenoviral fiber. Infection of cancer cells with this fiber-modified adenovirus resulted in recognition of infected cancer cells by a specific anti-EGFRvIII antibody. However, inhibition of autophagy drastically decreased the capability of the specific antibody to detect the cancer-related epitope in infected cells. Our data suggest that combination of adenoviruses with autophagy inducers may enhance the processing and presentation of cancer-specific antigens incorporated into capsid proteins.	[Klein, Sarah R.; Jiang, Hong; Hossain, Mohammad B.; Fan, Xuejun; Dong, Andrew; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Klein, Sarah R.; Gomez-Manzano, Candelaria; Fueyo, Juan] Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Gumin, Joy; Fueyo, Juan] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Brain Tumor Ctr, Houston, TX 77030 USA; [Alonso, Marta M.] Univ Navarra, Univ Navarra Clin, Dept Med Oncol, E-31080 Pamplona, Spain; [Gomez-Manzano, Candelaria] Univ Texas MD Anderson Canc Ctr, Dept Genet, Brain Tumor Ctr, Houston, TX 77030 USA; [Klein, Sarah R.] Dana Farber Canc Inst, Dept Neurooncol, Boston, MA USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Navarra; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Dana-Farber Cancer Institute	Fueyo, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Brain Tumor Ctr, Dept Neurooncol, Houston, TX 77030 USA.; Fueyo, J (corresponding author), Univ Texas Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA.; Fueyo, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Brain Tumor Ctr, Houston, TX 77030 USA.	jfueyo@mdanderson.org	Alonso, Marta M/AAI-9457-2020	Alonso, Marta M/0000-0002-7520-7351; Fueyo, Juan/0000-0001-6941-2335; Gomez-Manzano, Candelaria/0000-0002-1259-2133	NIH (Cancer Center Support Grant-Sequencing and Microarray Facility and Research Animal Support Facilities) [P30CA016672, P50CA127001, R01NS069964]; Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA127001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069964] Funding Source: NIH RePORTER	NIH (Cancer Center Support Grant-Sequencing and Microarray Facility and Research Animal Support Facilities)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marnie Rose Foundation; Will Power Foundation; Schissler Foundation; American Legion Auxiliary; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the NIH (P50CA127001; R01NS069964; Cancer Center Support Grant P30CA016672-Sequencing and Microarray Facility and Research Animal Support Facilities), the Marnie Rose Foundation, the Will Power Foundation, the Schissler Foundation, and the American Legion Auxiliary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2007, CANCER GENE THER, V14, P756, DOI 10.1038/sj.cgt.7701067; Alonso MM, 2008, MOL THER, V16, P487, DOI 10.1038/sj.mt.6300400; ANDERSSON M, 1985, CELL, V43, P215, DOI 10.1016/0092-8674(85)90026-1; Basner-Tschakarjan E, 2006, J GENE MED, V8, P1300, DOI 10.1002/jgm.964; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bessis N, 2004, GENE THER, V11, pS10, DOI 10.1038/sj.gt.3302364; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Birmingham CL, 2008, NATURE, V451, P350, DOI 10.1038/nature06479; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; HECHT TT, 1983, J IMMUNOL, V131, P1049; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097407; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Klein SR, 2015, ONCOGENE, V34, P5295, DOI 10.1038/onc.2014.452; Krause A, 2006, J VIROL, V80, P5523, DOI 10.1128/JVI.02667-05; Mahasreshti PJ, 2006, GYNECOL ONCOL, V100, P521, DOI 10.1016/j.ygyno.2005.08.042; Martins I, 2007, EUR J IMMUNOL, V37, P788, DOI 10.1002/eji.200636620; Matthews QL, 2011, MOL PHARMACEUT, V8, P3, DOI 10.1021/mp100214b; Minamitani T, 2011, J VIROL, V85, P4035, DOI 10.1128/JVI.02160-10; Munz C, 2000, J EXP MED, V191, P1649, DOI 10.1084/jem.191.10.1649; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Piao Y, 2009, CANCER GENE THER, V16, P256, DOI 10.1038/cgt.2008.75; Piya S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029467; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Sumpter R, 2011, AUTOPHAGY, V7, P260, DOI 10.4161/auto.7.3.14281; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Worgall S, 2004, J VIROL, V78, P2572, DOI 10.1128/JVI.78.5.2572-2580.2004; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	40	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153814	10.1371/journal.pone.0153814	http://dx.doi.org/10.1371/journal.pone.0153814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093696	Green Submitted, gold, Green Published			2022-12-27	WOS:000374541200045
J	Reyes, E; Thrasher, P; Bonsall, MB; Klug, H				Reyes, Elijah; Thrasher, Patsy; Bonsall, Michael B.; Klug, Hope			Population-Level Density Dependence Influences the Origin and Maintenance of Parental Care	PLOS ONE			English	Article							LIFE-HISTORY; EVOLUTIONARY TRANSITIONS; SURVIVAL; MORTALITY; BENEFITS; COSTS; SIZE	Parental care is a defining feature of animal breeding systems. We now know that both basic life-history characteristics and ecological factors influence the evolution of care. However, relatively little is known about how these factors interact to influence the origin and maintenance of care. Here, we expand upon previous work and explore the relationship between basic life-history characteristics (stage-specific rates of mortality and maturation) and the fitness benefits associated with the origin and the maintenance of parental care for two broad ecological scenarios: the scenario in which egg survival is density dependent and the case in which adult survival is density dependent. Our findings suggest that high off-spring need is likely critical in driving the origin, but not the maintenance, of parental care regardless of whether density dependence acts on egg or adult survival. In general, parental care is more likely to result in greater fitness benefits when baseline adult mortality is low if 1) egg survival is density dependent or 2) adult mortality is density dependent and mutant density is relatively high. When density dependence acts on egg mortality, low rates of egg maturation and high egg densities are less likely to lead to strong fitness benefits of care. However, when density dependence acts on adult mortality, high levels of egg maturation and increasing adult densities are less likely to maintain care. Juvenile survival has relatively little, if any, effect on the origin and maintenance of egg-only care. More generally, our results suggest that the evolution of parental care will be influenced by an organism's entire life history characteristics, the stage at which density dependence acts, and whether care is originating or being maintained.	[Reyes, Elijah; Thrasher, Patsy; Klug, Hope] Univ Tennessee, Dept Biol Geol & Environm Sci, Chattanooga, TN USA; [Bonsall, Michael B.] Univ Oxford, Dept Zool, Math Ecol Res Grp, S Parks Rd, Oxford, England; [Bonsall, Michael B.] Univ Oxford, St Peters Coll, Oxford, England	University of Tennessee System; University of Tennessee at Chattanooga; University of Oxford; University of Oxford	Klug, H (corresponding author), Univ Tennessee, Dept Biol Geol & Environm Sci, Chattanooga, TN USA.	hope-klug@utc.edu		Reyes, Elijah/0000-0002-1081-0061				Alonso-Alvarez C, 2012, EVOLUTION OF PARENTAL CARE, P40; Alonzo SH, 2010, TRENDS ECOL EVOL, V25, P99, DOI 10.1016/j.tree.2009.07.012; Beck CW, 1998, ANIM BEHAV, V55, P439, DOI 10.1006/anbe.1997.0619; BELLOWS TS, 1981, J ANIM ECOL, V50, P139, DOI 10.2307/4037; Bonsall MB, 2011, J EVOLUTION BIOL, V24, P1335, DOI 10.1111/j.1420-9101.2011.02269.x; Bonsall MB, 2011, J EVOLUTION BIOL, V24, P645, DOI 10.1111/j.1420-9101.2010.02203.x; Brown JL, 2010, AM NAT, V175, P436, DOI 10.1086/650727; CARLISLE TR, 1982, ANIM BEHAV, V30, P824, DOI 10.1016/S0003-3472(82)80156-5; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Einum S, 2005, OECOLOGIA, V143, P203, DOI 10.1007/s00442-004-1793-y; FORRESTER GE, 1995, OECOLOGIA, V103, P275, DOI 10.1007/BF00328615; Gilbert JDJ, 2015, EVOLUTION, V69, P1255, DOI 10.1111/evo.12656; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Huang WS, 2013, J ANIM ECOL, V82, P429, DOI 10.1111/1365-2656.12015; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Klug H, 2007, AM NAT, V170, P886, DOI 10.1086/522936; Klug H, 2006, EVOLUTION, V60, P2087, DOI 10.1111/j.0014-3820.2006.tb01846.x; Klug H, 2014, ECOL EVOL, V4, P2330, DOI 10.1002/ece3.1083; Klug H, 2013, ECOL EVOL, V3, P779, DOI 10.1002/ece3.493; Klug H, 2013, ECOL EVOL, V3, P792, DOI 10.1002/ece3.494; Klug H, 2010, EVOLUTION, V64, P823, DOI 10.1111/j.1558-5646.2009.00854.x; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; Kokko H, 2012, EVOLUTION OF PARENTAL CARE, P101; Kolliker M, 2007, BEHAV ECOL SOCIOBIOL, V61, P1489, DOI 10.1007/s00265-007-0381-7; Lack D., 1954, P343; Mank JE, 2005, EVOLUTION, V59, P1570; McNamara JM, 2000, J THEOR BIOL, V205, P605, DOI 10.1006/jtbi.2000.2093; Ohman MD, 2001, NATURE, V412, P638, DOI 10.1038/35088068; Otto SP, 2007, BIOL GUIDE MATH MODE; Payne AG, 2002, P ROY SOC B-BIOL SCI, V269, P2095, DOI 10.1098/rspb.2002.2144; Requena GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046701; Reynolds JD, 2002, PHILOS T R SOC B, V357, P269, DOI 10.1098/rstb.2001.0930; Royle NJ, 2012, EVOLUTION OF PARENTAL CARE, P1; Sargent R.C., 1986, P275; SARGENT RC, 1987, AM NAT, V129, P32, DOI 10.1086/284621; SHINE R, 1989, AM NAT, V134, P311, DOI 10.1086/284982; SHINE R, 1978, J THEOR BIOL, V75, P417, DOI 10.1016/0022-5193(78)90353-3; SIEMENS DH, 1992, ENVIRON ENTOMOL, V21, P610, DOI 10.1093/ee/21.3.610; SINCLAIR ARE, 1985, OECOLOGIA, V65, P266, DOI 10.1007/BF00379227; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Summers K, 1999, HERPETOLOGICA, V55, P254; Thiel M, 1999, J CRUSTACEAN BIOL, V19, P60, DOI 10.2307/1549547; TRIVERS RL, 1974, AM ZOOL, V14, P249; Webb JN, 2002, PHILOS T R SOC B, V357, P331, DOI 10.1098/rstb.2001.0934; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson E.O., 1975, P1; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; WINKLER DW, 1987, AM NAT, V130, P526, DOI 10.1086/284729	51	2	2	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153839	10.1371/journal.pone.0153839	http://dx.doi.org/10.1371/journal.pone.0153839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093056	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200049
J	Tian, N; Guo, QY; Zhou, Q; Cao, PY; Hong, LY; Chen, MH; Yang, X; Yu, XQ				Tian, Na; Guo, Qunying; Zhou, Qian; Cao, Peiyi; Hong, Lingyao; Chen, Menghua; Yang, Xiao; Yu, Xueqing			The Impact of Fluid Overload and Variation on Residual Renal Function in Peritoneal Dialysis Patient	PLOS ONE			English	Article							EXTRACELLULAR VOLUME EXPANSION; BIOELECTRICAL-IMPEDANCE ANALYSIS; LEFT-VENTRICULAR HYPERTROPHY; BODY-COMPOSITION; PREDICTORS; ADEQUACY; DECLINE; BIOIMPEDANCE; REMOVAL; SODIUM	Background The effect of fluid overload and variation on residual renal function (RRF) in peritoneal dialysis (PD) patients is controversial. Methods Retrospective cohort study was designed. One-hundred and ninety PD patients with measured glomerular filtration rate (mGFR). >= 3ml/min/1.73m(2) were recruit. Fluid status of every participant was assessed by bioelectrical impedance analysis (BIA) every 3 months for 1 year. The cohort was divided into three hydration groups, namely persistent overhydration (PO) group, intermittent overhydration (IO) group and normal hydration (NH) group. Additionally, participants were also divided into high or low fluid variation groups. The decline rate of RRF and the event of anuria were followed up for 1 year. The association of fluid overload with RRF loss was evaluated by Cox proportional hazard models adjusted for confounders. Results Thirty-six (18.9%) patients developed anuria. The decline rate of mGFR in both PO and IO groups were significantly faster than that of NH group (PO vs NH: -0.2 vs -0.1 ml/min/1.73m(2)/month, p < 0.01; IO vs NH: -0.2 vs -0.1 ml/min/1.73m(2)/month, p < 0.01). Kaplan-Meier analysis showed poorer RRF outcome in both PO and IO groups compared with that of NH group (PO vs NH: p < 0.001; IO vs NH: p = 0.006). Patients with high fluid variation had worse RRF survival than those with low fluid variation (p = 0.04). Adjusted Cox regression models indicated the hazard ratio of RRF loss in PO group was 8.90-folds higher (95% confidence interval 3.07-31.89) than that in NH group. Conclusions These findings suggested fluid overload was independently associated with the decline of RRF in PD patients.	[Tian, Na; Guo, Qunying; Zhou, Qian; Cao, Peiyi; Hong, Lingyao; Yang, Xiao; Yu, Xueqing] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth & Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Menghua] Ningxia Med Univ, Gen Hosp, Dept Nephrol, Ningxia, Peoples R China	Sun Yat Sen University; Ningxia Medical University	Yu, XQ (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Key Lab Nephrol,Minist Hlth & Guangdong Prov, Guangzhou 510275, Guangdong, Peoples R China.	yuxq@mail.sysu.edu.cn	tian, na/GVR-9226-2022	Qian, Zhou/0000-0003-3954-5449; Yang, Xiao/0000-0003-0437-2015				Avila-Diaz M, 2006, PERITON DIALYSIS INT, V26, P574; Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158, DOI 10.1681/ASN.V12102158; Burke SW, 2000, ADV RENAL REPLACE TH, V7, P210, DOI 10.1053/jarr.2000.8120; Cheng LT, 2006, NEPHRON CLIN PRACT, V104, pC47, DOI 10.1159/000093670; Cooper BA, 2000, KIDNEY INT, V58, P408, DOI 10.1046/j.1523-1755.2000.00180.x; Davenport A, 2011, BLOOD PURIFICAT, V32, P226, DOI 10.1159/000329732; Davenport A, 2010, NEPHRON CLIN PRACT, V114, pC60, DOI 10.1159/000245070; Dell'Aqulla R, 2008, NEFROLOGIA, V28, P67; Fan S, 2012, INT J ARTIF ORGANS, V35, P338, DOI 10.5301/ijao.5000080; Foley RN, 1998, J AM SOC NEPHROL, V9, P267; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Gunal AI, 2004, RENAL FAILURE, V26, P405, DOI 10.1081/JDI-120039825; Guo QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053294; Haapio M, 2012, CONTRIB NEPHROL, V178, P238, DOI 10.1159/000337885; Herget-Rosenthal S, 2012, KIDNEY BLOOD PRESS R, V35, P233, DOI 10.1159/000332887; Ignace S, 2009, NEPHROL DIAL TRANSPL, V24, P1685, DOI 10.1093/ndt/gfp077; Jansen MAM, 2002, KIDNEY INT, V62, P1046, DOI 10.1046/j.1523-1755.2002.00505.x; Johnson DW, 2003, PERITON DIALYSIS INT, V23, P276; Jones CH, 1998, NEPHROL DIAL TRANSPL, V13, P393, DOI 10.1093/oxfordjournals.ndt.a027836; Lameire N, 1997, PERITON DIALYSIS INT, V17, pS102; Liao CT, 2008, PERITON DIALYSIS INT, V28, pS191; Lopez-Menchero R, 1999, NEPHRON, V83, P219, DOI 10.1159/000045514; McCafferty K, 2014, KIDNEY INT, V85, P151, DOI 10.1038/ki.2013.273; Moissl UM, 2006, PHYSIOL MEAS, V27, P921, DOI 10.1088/0967-3334/27/9/012; Morinaga H, 2012, PERITON DIALYSIS INT, V32, P453, DOI 10.3747/pdi.2011.00032; Piraino B, 2005, PERITON DIALYSIS INT, V25, P107; RALLISON LR, 1993, J AM COLL NUTR, V12, P66; Rodriguez-Carmona A, 2004, AM J KIDNEY DIS, V44, P132, DOI 10.1053/j.ajkd.2004.03.035; Van Biesen W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017148; Van Biesen W, 2008, J NEPHROL, V21, P299; Van den Ham ECH, 1999, J AM SOC NEPHROL, V10, P1067; vanOlden RW, 1996, J AM SOC NEPHROL, V7, P745; Wang AYM, 2002, KIDNEY INT, V62, P639, DOI 10.1046/j.1523-1755.2002.00471.x; Wang AYM, 2005, AM J KIDNEY DIS, V45, P715, DOI 10.1053/j.ajkd.2004.12.012; Wang AYM, 2001, J AM SOC NEPHROL, V12, P2450, DOI 10.1681/ASN.V12112450; Weiner DE, 2014, AM J KIDNEY DIS, V64, P685, DOI 10.1053/j.ajkd.2014.07.003	36	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153115	10.1371/journal.pone.0153115	http://dx.doi.org/10.1371/journal.pone.0153115			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093429	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200012
J	Alqahtani, MF; Smith, CM; Weiss, SL; Dawson, S; Ranaivo, HR; Wainwright, MS				Alqahtani, Mashael F.; Smith, Craig M.; Weiss, Scott L.; Dawson, Susan; Ranaivo, Hantamalala Ralay; Wainwright, Mark S.			Evaluation of New Diagnostic Biomarkers in Pediatric Sepsis: Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-1, Mid-Regional Pro-Atrial Natriuretic Peptide, and Adipocyte Fatty-Acid Binding Protein	PLOS ONE			English	Article							CRITICALLY-ILL CHILDREN; NEURON-SPECIFIC ENOLASE; C-REACTIVE PROTEIN; MATRIX-METALLOPROTEINASES; PROGNOSTIC VALUE; ISCHEMIC-STROKE; BACTERIAL-INFECTION; PROCALCITONIN; MARKERS; EPIDEMIOLOGY	Elevated plasma concentrations of matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1), mid-regional pro-atrial natriuretic peptide (mrProANP), and adipocyte fatty-acid-binding proteins (A-FaBPs) have been investigated as biomarkers for sepsis or detection of acute neurological injuries in adults, but not children. We carried out a single-center, prospective observational study to determine if these measures could serve as biomarkers to identify children with sepsis. A secondary aim was to determine if these biomarkers could identify children with neurologic complications of sepsis. A total of 90 patients <= 18 years-old were included in this study. 30 with severe sepsis or septic shock were compared to 30 age-matched febrile and 30 age-matched healthy controls. Serial measurements of each biomarker were obtained, beginning on day 1 of ICU admission. In septic patients, MMP9-/TIMP-1 ratios (Median, IQR, n) were reduced on day 1 (0.024, 0.004-0.174, 13), day 2 (0.020, 0.002-0.109, 10), and day 3 (0.018, 0.003-0.058, 23) compared with febrile (0.705, 0.187-1.778, 22) and healthy (0.7, 0.4-1.2, 29) (p< 0.05) controls. A-FaBP and mrProANP (Median, IQR ng/mL, n) were elevated in septic patients compared to control groups on first 2 days after admission to the PICU (p < 0.05). The area under the curve (AUC) for MMP-9/TIMP-1 ratio, mrProANP, and A-FaBP to distinguish septic patients from healthy controls were 0.96, 0.99, and 0.76, respectively. MMP-9/TIMP-1 ratio was inversely and mrProANP was directly related to PIM-2, PELOD, and ICU and hospital LOS (p < 0.05). A-FaBP level was associated with PELOD, hospital and ICU length of stay (p < 0.05). MMP-9/TIMP-1 ratio associated with poor Glasgow Outcome Score (p < 0.05). A-FaBP levels in septic patients with neurological dysfunction (29.3, 17.2-54.6, 7) were significantly increased compared to septic patients without neurological dysfunction (14.6, 13.32-0.6, 11). MMP-9/TIMP-1 ratios were significantly lower, while A-FaBP and mrProANP were higher in septic patients compared to the control groups. Each biomarker was associated with hospital morbidity and length of stay. These results suggest that these biomarkers merit further prospective study for the early identification of children with sepsis.	[Alqahtani, Mashael F.; Smith, Craig M.; Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA; [Smith, Craig M.; Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Neurol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA; [Smith, Craig M.; Ranaivo, Hantamalala Ralay; Wainwright, Mark S.] Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA; [Weiss, Scott L.] Univ Penn, Childrens Hosp Philadelphia, Dept Anesthesiol & Crit Care Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Dawson, Susan] Swedish Covenant Hosp, Dept Pathol & Lab Med, Chicago, IL USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Wainwright, MS (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Crit Care, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.; Wainwright, MS (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Dept Pediat, Div Neurol, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.; Wainwright, MS (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Ruth D & Ken M Davee Pediat Neurocrit Care Progra, Northwestern Feinberg Sch Med, Chicago, IL 60611 USA.	m-wainwright@northwestern.edu		Weiss, Scott/0000-0002-7040-3281	Medical Research Junior Board Foundation of Ann & Robert H. Lurie Children's Hospital of Chicago	Medical Research Junior Board Foundation of Ann & Robert H. Lurie Children's Hospital of Chicago	This study was supported by a grant from the Medical Research Junior Board Foundation of Ann & Robert H. Lurie Children's Hospital of Chicago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Als LC, 2013, CRIT CARE MED, V41, P1094, DOI 10.1097/CCM.0b013e318275d032; Arkader R, 2006, ARCH DIS CHILD, V91, P117, DOI 10.1136/adc.2005.077446; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bronner MB, 2009, PEDIATR CRIT CARE ME, V10, P636, DOI 10.1097/PCC.0b013e3181ae5c1a; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Dal-Pizzol F, 2013, MOL NEUROBIOL, V48, P62, DOI 10.1007/s12035-013-8433-7; Degos V, 2013, ANESTHESIOLOGY, V118, P1123, DOI 10.1097/ALN.0b013e318286cf36; Fischer M, 2014, CEREBROVASC DIS, V37, P128, DOI 10.1159/000357215; Goldstein Brahm, 2005, Pediatr Crit Care Med, V6, P2; Hartman ME, 2013, PEDIATR CRIT CARE ME, V14, P686, DOI 10.1097/PCC.0b013e3182917fad; Hoffmann U, 2006, SCAND J INFECT DIS, V38, P867, DOI 10.1080/00365540600702058; Hsu AA, 2008, PEDIATR CRIT CARE ME, V9, P245, DOI 10.1097/PCC.0b013e3181727b22; Huang CL, 2013, CRIT CARE, V17, DOI 10.1186/cc12498; Katan M, 2010, J AM COLL CARDIOL, V56, P1045, DOI 10.1016/j.jacc.2010.02.071; Kiemer AK, 2000, J IMMUNOL, V165, P175, DOI 10.4049/jimmunol.165.1.175; Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922; Lipinska-Gediga M, 2012, INFECTION, V40, P303, DOI 10.1007/s15010-011-0235-0; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094318; Lorente L, 2009, CRIT CARE, V13, DOI 10.1186/cc8115; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Muhl D, 2011, J CRIT CARE, V26, P550, DOI 10.1016/j.jcrc.2011.02.011; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nguyen DN, 2006, CRIT CARE MED, V34, P1967, DOI 10.1097/01.CCM.0000217218.51381.49; Opdenakker G, 2001, TRENDS IMMUNOL, V22, P571, DOI 10.1016/S1471-4906(01)02023-3; Ramos-Fernandez M, 2011, J STROKE CEREBROVASC, V20, P47, DOI 10.1016/j.jstrokecerebrovasdis.2009.10.008; Rosenberg GA, 1998, STROKE, V29, P2189, DOI 10.1161/01.STR.29.10.2189; Ruth A, 2014, PEDIATR CRIT CARE ME, V15, P828, DOI 10.1097/PCC.0000000000000254; Schlapbach LJ, 2015, LANCET INFECT DIS, V15, P46, DOI 10.1016/S1473-3099(14)71003-5; Seligman R, 2008, INTENS CARE MED, V34, P2084, DOI 10.1007/s00134-008-1173-x; Simon L, 2004, CLIN INFECT DIS, V39, P206, DOI 10.1086/421997; Simon L, 2008, PEDIATR CRIT CARE ME, V9, P407, DOI 10.1097/PCC.0b013e31817285a6; Skilton MR, 2011, NEUROLOGY, V76, P1954, DOI 10.1212/WNL.0b013e31821e55d2; Tso AWK, 2011, NEUROLOGY, V76, P1968, DOI 10.1212/WNL.0b013e31821e54b3; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vollmar AM, 1996, ENDOCRINOLOGY, V137, P1706, DOI 10.1210/en.137.5.1706; Weiss SL, 2015, AM J RESP CRIT CARE, V191, P1147, DOI 10.1164/rccm.201412-2323OC; Weiss SL, 2012, PEDIATR CRIT CARE ME, V13, pE210, DOI 10.1097/PCC.0b013e318238b5cd; Yao B, 2014, NEUROCHEM RES, V39, P1263, DOI 10.1007/s11064-014-1308-0; Yazdan-Ashoori P, 2011, J CRIT CARE, V26, P556, DOI 10.1016/j.jcrc.2011.01.008	39	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153645	10.1371/journal.pone.0153645	http://dx.doi.org/10.1371/journal.pone.0153645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089280	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000036
J	Dreger, S; Krille, L; Maier, W; Pokora, R; Blettner, M; Zeeb, H				Dreger, Steffen; Krille, Lucian; Maier, Werner; Pokora, Roman; Blettner, Maria; Zeeb, Hajo			Regional Deprivation and Non-Cancer Related Computed Tomography Use in Pediatric Patients in Germany: Cross-Sectional Analysis of Cohort Data	PLOS ONE			English	Article							RADIATION-EXPOSURE; CT SCANS; SUBSEQUENT RISK; BRAIN-TUMORS; LEUKEMIA; CHILDREN; TRAUMA	Background Conflicting findings were observed in recent studies assessing the association between patients' area-level socio-economic status and the received number of computed tomography (CT) examinations in children. The aim was to investigate the association between area-level socio-economic status and variation in CT examination practice for pediatric patients in Germany. Methods Data from Radiology Information Systems for children aged 0 to <15 years without cancer who had at least one CT examination between 2001 and 2010 were extracted in 20 hospitals across Germany. The small-area German Index of Multiple Deprivation (GIMD) was used to assess regional deprivation. The GIMD scores were classified into least, medium and most deprived areas and linked with the patient's last known postal code. A multinomial logistic regression model was used to assess the association between patients' CT numbers and regional deprivation adjusting for age, sex, and location of residence (urban/rural). Results A total of 37,810 pediatric patients received 59,571 CT scans during the study period. 27,287 (72%) children received only one CT, while n = 885 (2.3%) received six or more. Increasing numbers of CT examinations in non-cancer patients were significantly associated with higher regional deprivation, which increased, although CI overlap, for higher CT categories: '2-3 CT' odds ratio (OR) = 1.45, 95% CI: 1.40-1.50; '4-5 CT' OR = 1.48, 95% CI: 1.38-1.59; '6+CT' OR = 1.54, 95% CI: 1.41-1.69. In addition, male sex, higher age categories, and specific body regions were positively associated with increased numbers of CT examinations. Conclusion We observed a positive association between regional deprivation and CT numbers in non-cancer pediatric patients. Limitations of the ecological approach and the lack of differentiation of CT details have to be acknowledged. More information on CT indications is necessary for a full assessment of this finding. In addition, further work on ways to assess socioeconomic status more accurately may be required.	[Dreger, Steffen; Zeeb, Hajo] Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany; [Krille, Lucian; Pokora, Roman; Blettner, Maria] Univ Med Ctr Mainz, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Krille, Lucian] Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France; [Maier, Werner] German Res Ctr Environm Hlth GmbH, Inst Hlth Econ & Hlth Care Management, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Zeeb, Hajo] Univ Bremen, Hlth Sci Bremen, D-28359 Bremen, Germany	Leibniz Institute for Prevention Research & Epidemiology (BIPS); Johannes Gutenberg University of Mainz; World Health Organization; International Agency for Research on Cancer (IARC); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Bremen	Dreger, S (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Bremen, Germany.	dreger@bips.uni-bremen.de	Zeeb, Hajo/I-2701-2019; Pokora, Roman/AAG-4753-2022; Pokora, Roman/AFK-6503-2022	Zeeb, Hajo/0000-0001-7509-242X; Maier, Werner/0000-0003-4356-7296	German Federal Ministry of Education and Research [02NUK016A, 02NUK016CX]; French Embassy	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); French Embassy	This work was supported by the German Federal Ministry of Education and Research (http://www.bmbf.de/en/), grant numbers 02NUK016A and 02NUK016CX. LK received a research-stipend from the French Embassy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brix G, 2005, RADIOLOGE, V45, P340, DOI 10.1007/s00117-005-1184-3; Bundesamt fuer Strahlenschutz, 2013, ENV RAD RAD EXP 2011; Edwards P, 2008, ARCH DIS CHILD, V93, P485, DOI 10.1136/adc.2007.116541; Ellsaesser G, 2014, ACCIDENTS VIOLENCE S; Galanski M, 2006, RESULTS NATION WIDE; Huang WY, 2014, BRIT J CANCER, V110, P2354, DOI 10.1038/bjc.2014.103; Janssens L, 2014, INJURY, V45, P1190, DOI 10.1016/j.injury.2014.04.027; Journy N, 2015, BRIT J CANCER, V112, P185, DOI 10.1038/bjc.2014.526; Krille L, 2015, RADIAT ENVIRON BIOPH, V54, P1, DOI 10.1007/s00411-014-0580-3; Krille L, 2011, EUR J EPIDEMIOL, V26, P249, DOI 10.1007/s10654-011-9549-6; Kuznetsov L, 2012, INT J PUBLIC HEALTH, V57, P827, DOI 10.1007/s00038-012-0342-4; Licaj I, 2011, J SAFETY RES, V42, P171, DOI 10.1016/j.jsr.2011.05.004; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Maier W, 2012, GESUNDHEITSWESEN, V74, P416, DOI 10.1055/s-0031-1280846; Maier W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089661; Malik K., 2013, HUMAN DEV REPORT 201; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; Mettler F. A., 2008, HEALTH PHYS, V95, P502, DOI DOI 10.1097/01.HP; Mettler FA, 2008, RADIOLOGY, V248, P254, DOI 10.1148/radiol.2481071451; Meulepas JM, 2014, EUR J EPIDEMIOL, V29, P293, DOI 10.1007/s10654-014-9900-9; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-24; Rattay P, 2013, BUNDESGESUNDHEITSBLA, V56, P832, DOI 10.1007/s00103-013-1665-x; United Nations Scientific Committee on Atomic Radiation (UNSCEAR), 2013, UNSCEAR 20202021 REP, V2	25	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153644	10.1371/journal.pone.0153644	http://dx.doi.org/10.1371/journal.pone.0153644			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089125	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000035
J	Grandclerc, S; De Labrouhe, D; Spodenkiewicz, M; Lachal, J; Moro, MR				Grandclerc, Salome; De Labrouhe, Diane; Spodenkiewicz, Michel; Lachal, Jonathan; Moro, Marie-Rose			Relations between Nonsuicidal Self-Injury and Suicidal Behavior in Adolescence: A Systematic Review	PLOS ONE			English	Review							HARM; PREDICTORS; MUTILATION; SYMPTOMS; PATHWAYS; IDEATION; SAMPLE; NSSI	Nonsuicidal self-injury (NSSI) and suicidal behaviors, both important issues in adolescent health care, are frequently associated and possibly clinically related. Our objective was to explore the views of relations between nonsuicidal self-injury and suicidal behaviors during adolescence and young adulthood (11-25 years) expressed in the scientific (medical and psychological) literature. We adopted a textual approach to the process of synthesis to tell the story of the findings from the included studies. Our narrative systematic review of 64 articles found that they share the same risk factors. Integrated models envision nonsuicidal self-injury as a gateway enabling teens to acquire the capability for suicide. Because suicidal behavior short-circuits thought, it is difficult to conceive an intention to die during adolescents' acts of self-injury. Intention is constructed by the narrative of the act, influenced by numerous elements from the psychopathologic, cultural, religious, and philosophic context. Techniques of mentalizing-based treatments and work on the meaning that adolescents attribute to their behaviors might improve care.	[Grandclerc, Salome; De Labrouhe, Diane; Lachal, Jonathan; Moro, Marie-Rose] Hop Cochin, AP HP, Maison Solenn, 27 Rue Faubourg St Jacques, F-75674 Paris, France; [Grandclerc, Salome; De Labrouhe, Diane; Lachal, Jonathan; Moro, Marie-Rose] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Grandclerc, Salome; De Labrouhe, Diane; Spodenkiewicz, Michel; Lachal, Jonathan; Moro, Marie-Rose] Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Villejuif, France; [Spodenkiewicz, Michel] Grp Hosp Pitie Salpetriere, APHP, Serv Psychiat Enfant & Adolescent, F-75634 Paris, France; [Spodenkiewicz, Michel] Univ Paris 06, Paris, France; [Spodenkiewicz, Michel] Inst Syst Intelligents & Robot, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Grandclerc, S (corresponding author), Hop Cochin, AP HP, Maison Solenn, 27 Rue Faubourg St Jacques, F-75674 Paris, France.; Grandclerc, S (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Grandclerc, S (corresponding author), Univ Paris Sud, Univ Paris Saclay, UVSQ, CESP,INSERM, Villejuif, France.	salomegrandclerc1987@gmail.com	; LACHAL, Jonathan/G-9444-2014	Spodenkiewicz, Michel/0000-0002-6332-602X; LACHAL, Jonathan/0000-0002-6282-7359				Allen JG, 2003, B MENNINGER CLIN, V67, P1; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, P1629; Andover M.S., 2012, CHILD ADOL PSYCH MEN, V6, P1, DOI [10.1186/1753-2000-6-11, DOI 10.1186/1753-2000-6-11]; Andover MS, 2010, PSYCHIAT RES, V178, P101, DOI 10.1016/j.psychres.2010.03.019; Andover MS, 2010, ARCH SUICIDE RES, V14, P79, DOI 10.1080/13811110903479086; Anestis MD, 2011, J PSYCHIATR RES, V45, P603, DOI 10.1016/j.jpsychires.2010.10.013; Asarnow JR, 2011, J AM ACAD CHILD PSY, V50, P772, DOI 10.1016/j.jaac.2011.04.003; Aseltine RH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-161; Baetens I, 2011, ARCH SUICIDE RES, V15, P56, DOI 10.1080/13811118.2011.540467; Bateman AW, 2016, INTEGRATED TREATMENT, P148; Brausch AM, 2010, J YOUTH ADOLESCENCE, V39, P233, DOI 10.1007/s10964-009-9482-0; Bureau JF, 2010, J YOUTH ADOLESCENCE, V39, P484, DOI 10.1007/s10964-009-9470-4; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Chavagnat J-J, 2005, PREVENTION SUICIDE; Choi-Kain LW, 2008, AM J PSYCHIAT, V165, P1127, DOI 10.1176/appi.ajp.2008.07081360; Claes L, 2010, PERS INDIV DIFFER, V48, P83, DOI 10.1016/j.paid.2009.09.001; COID J, 1983, LANCET, V2, P545; Connor JJ, 2006, J FAM PSYCHOL, V20, P143, DOI 10.1037/0893-3200.20.1.143; Cooper J, 2005, AM J PSYCHIAT, V162, P297, DOI 10.1176/appi.ajp.162.2.297; Darche MA., 1990, PSYCHIATRIC HOSPITAL, V21, P31; Darke S, 2010, SUICIDE LIFE-THREAT, V40, P587, DOI 10.1521/suli.2010.40.6.587; Dougherty DM, 2009, PSYCHIAT RES, V169, P22, DOI 10.1016/j.psychres.2008.06.011; Favaro A, 2008, J AFFECT DISORDERS, V105, P285, DOI 10.1016/j.jad.2007.05.010; Favazza AR, 1998, J NERV MENT DIS, V186, P259, DOI 10.1097/00005053-199805000-00001; FAVAZZA AR, 1989, HOSP COMMUNITY PSYCH, V40, P137; Firestone R W, 1990, J Am Coll Health, V38, P207; Fonagy P, 2015, PERSONAL DISORD, V6, P380, DOI 10.1037/per0000113; Fox C, 2004, DELIBERATE SELF HARM; Franklin JC, 2011, PSYCHIAT RES, V189, P362, DOI 10.1016/j.psychres.2011.08.001; Gicquel Ludovic, 2011, AUTOMUTILATIONS ADOL; Glenn CR, 2009, PERS INDIV DIFFER, V46, P25, DOI 10.1016/j.paid.2008.08.020; Glenn JJ, 2014, PSYCHIAT RES, V220, P921, DOI 10.1016/j.psychres.2014.08.016; Guertin T, 2001, J AM ACAD CHILD PSY, V40, P1062, DOI 10.1097/00004583-200109000-00015; Haim A, 1970, SUICIDES ADOLESCENTS; Hamza CA, 2012, CLIN PSYCHOL REV, V32, P482, DOI 10.1016/j.cpr.2012.05.003; Hargus E, 2009, SUICIDE LIFE-THREAT, V39, P518, DOI 10.1521/suli.2009.39.5.518; HAWTON K, 1982, BRIT J PSYCHIAT, V141, P286, DOI 10.1192/bjp.141.3.286; Hawton K, 2012, LANCET, V379, P2373, DOI 10.1016/S0140-6736(12)60322-5; Heath N, 2007, CAN AC CHILD AD PSYC; Herrera A, 2006, SOC SCI MED, V62, P805, DOI 10.1016/j.socscimed.2005.06.055; Hilt LM, 2008, J EARLY ADOLESCENCE, V28, P455, DOI 10.1177/0272431608316604; Hjelmeland H, 2010, SUICIDE LIFE-THREAT, V40, P74, DOI 10.1521/suli.2010.40.1.74; Hohmann AG, 2005, NATURE, V435, P1108, DOI 10.1038/nature03658; Hooley JM, 2010, PERSONAL DISORD, V1, P170, DOI 10.1037/a0020106; Hukkanen R, 2003, NORD J PSYCHIAT, V57, P131, DOI 10.1080/08039480310000969; International Society for the Study of Self-injury, 2007, DEF ISS SURR OUR UND; Jacobson CM, 2008, J CLIN CHILD ADOLESC, V37, P363, DOI 10.1080/15374410801955771; Joiner T. E., 2005, WHY PEOPLE DIE SUICI; Klonsky ED, 2009, J PSYCHOPATHOL BEHAV, V31, P215, DOI 10.1007/s10862-008-9107-z; Lachal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127359; Leibenluft E., 1987, J PERS DISORD, V1, P317, DOI [10.1521/pedi.1987.1.4.317, DOI 10.1521/PEDI.1987.1.4.317]; Linehan M M, 1986, Ann N Y Acad Sci, V487, P16; Lonetto R, 1988, DIS CEST QUOI QUAND; Menninger K. A, 1938, MAN HIMSELF; Muehlenkamp Jennifer J, 2007, Arch Suicide Res, V11, P69, DOI 10.1080/13811110600992902; Muehlenkamp Jennifer J, 2012, Child Adolesc Psychiatry Ment Health, V6, P10, DOI 10.1186/1753-2000-6-10; Muehlenkamp JJ, 2011, J CHILD PSYCHOL PSYC, V52, P148, DOI 10.1111/j.1469-7610.2010.02305.x; Muehlenkamp JJ, 2010, J YOUTH ADOLESCENCE, V39, P306, DOI 10.1007/s10964-009-9450-8; Muehlenkamp JJ, 2004, SUICIDE LIFE-THREAT, V34, P12, DOI 10.1521/suli.34.1.12.27769; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nock MK, 2006, PSYCHIAT RES, V144, P65, DOI 10.1016/j.psychres.2006.05.010; Nock MK, 2009, J ABNORM PSYCHOL, V118, P816, DOI 10.1037/a0016948; Nock MK, 2005, J ABNORM PSYCHOL, V114, P140, DOI 10.1037/0021-843X.114.1.140; Nock MK, 2004, J CONSULT CLIN PSYCH, V72, P885, DOI 10.1037/0022-006X.72.5.885; Medina CMO, 2011, SUICIDOL ONLINE-SOL, V2, P17; Orri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096716; Osafo J, 2011, TRANSCULT PSYCHIATRY, V48, P643, DOI 10.1177/1363461511417319; Papadatos C, 1991, CHILDREN DEATH DEATH; PATTISON EM, 1983, AM J PSYCHIAT, V140, P867; Piaget J., 1929, REPRESENTATION MONDE; Plener PL, 2009, PSYCHOL MED, V39, P1549, DOI 10.1017/S0033291708005114; Popay J., 2006, GUIDANCE CONDUCT NAR; Prinstein MJ, 2008, J CONSULT CLIN PSYCH, V76, P92, DOI 10.1037/0022-006X.76.1.92; Ross RR, 1979, SELF MUTILATION; Ross S, 2002, J YOUTH ADOLESCENCE, V31, P67, DOI 10.1023/A:1014089117419; Rouchon J- F, 2015, VULNERABILITE PSYCHI, P71; Scoliers G, 2009, SOC PSYCH PSYCH EPID, V44, P601, DOI 10.1007/s00127-008-0469-z; Shilubane HN, 2012, J YOUTH STUD, V15, P177, DOI 10.1080/13676261.2011.634400; Simpson M. A., 1980, MANY FACES SUICIDE I, P257; Sinclair J, 2005, BRIT MED J, V330, P1112, DOI 10.1136/bmj.38441.503333.8F; Skegg K, 2005, LANCET, V366, P1471, DOI 10.1016/S0140-6736(05)67600-3; Stanley B, 2001, AM J PSYCHIAT, V158, P427, DOI 10.1176/appi.ajp.158.3.427; Suyemoto KL, 1998, CLIN PSYCHOL REV, V18, P531, DOI 10.1016/S0272-7358(97)00105-0; Tang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017977; Timson D, 2012, J ADOLESCENCE, V35, P1307, DOI 10.1016/j.adolescence.2012.05.001; Tuisku V, 2014, J AFFECT DISORDERS, V152, P313, DOI 10.1016/j.jad.2013.09.031; Tulloch AL, 1997, J ADOLESCENT HEALTH, V21, P267, DOI 10.1016/S1054-139X(97)00118-3; Turner BJ, 2013, ARCH SUICIDE RES, V17, P397, DOI 10.1080/13811118.2013.802660; Van Orden KA, 2008, J CONSULT CLIN PSYCH, V76, P72, DOI 10.1037/0022-006X.76.1.72; Van Orden KA, 2010, PSYCHOL REV, V117, P575, DOI 10.1037/a0018697; Victor SE, 2014, CLIN PSYCHOL REV, V34, P282, DOI 10.1016/j.cpr.2014.03.005; Walsh B, 2006, TREATING SELF INJURY, P46; Walsh BW, 1988, SELF MUTILATION THEO, Vxiii; Whitlock J, 2007, ARCH PEDIAT ADOL MED, V161, P634, DOI 10.1001/archpedi.161.7.634; Whitlock J, 2013, J ADOLESCENT HEALTH, V52, P486, DOI 10.1016/j.jadohealth.2012.09.010; Whitlock J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000240; Wilkinson P, 2013, EUR CHILD ADOLES PSY, V22, pS75, DOI 10.1007/s00787-012-0365-7; Wilkinson P, 2011, AM J PSYCHIAT, V168, P495, DOI 10.1176/appi.ajp.2010.10050718; World Health Organization, 2002, WORLD REPORT VIOLENC; World Health Organization, 2014, PREV SUIC PREV SUIC; Ystgaard M, 2009, J ADOLESCENCE, V32, P875, DOI 10.1016/j.adolescence.2008.10.010	101	124	125	5	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153760	10.1371/journal.pone.0153760	http://dx.doi.org/10.1371/journal.pone.0153760			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089157	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000045
J	Grecka, E; Statkiewicz, M; Gorska, A; Biernacka, M; Grygorowicz, MA; Masnyk, M; Chmielewski, M; Gawarecka, K; Chojnacki, T; Swiezewska, E; Malecki, M				Grecka, Emilia; Statkiewicz, Malgorzata; Gorska, Agnieszka; Biernacka, Marzena; Grygorowicz, Monika Anna; Masnyk, Marek; Chmielewski, Marek; Gawarecka, Katarzyna; Chojnacki, Tadeusz; Swiezewska, Ewa; Malecki, Maciej			Prenyl Ammonium Salts - New Carriers for Gene Delivery: A B16-F10 Mouse Melanoma Model	PLOS ONE			English	Article							LINKED CATIONIC LIPIDS; IN-VITRO; TISSUE INHIBITOR; DRUG CARRIERS; TRANSFECTION; COMPLEXES; LIPOPLEX; THERAPY; VECTORS; DOTAP	Purpose Prenyl ammonium iodides (Amino-Prenols, APs), semi-synthetic polyprenol derivatives were studied as prospective novel gene transfer agents. Methods AP-7, -8, -11 and -15 (aminoprenols composed of 7, 8, 11 or 15 isoprene units, respectively) were examined for their capacity to form complexes with pDNA, for cytotoxicity and ability to transfect genes to cells. Results All the carriers were able to complex DNA. The highest, comparable to commercial reagents, transfection efficiency was observed for AP-15. Simultaneously, AP-15 exhibited the lowest negative impact on cell viability and proliferation-considerably lower than that of commercial agents. AP-15/DOPE complexes were also efficient to introduce pDNA to cells, without much effect on cell viability. Transfection with AP-15/DOPE complexes influenced the expression of a very few among 44 tested genes involved in cellular lipid metabolism. Furthermore, complexes containing AP-15 and therapeutic plasmid, encoding the TIMP metallopeptidase inhibitor 2 (TIMP2), introduced the TIMP2 gene with high efficiency to B16-F10 melanoma cells but not to B16-F10 melanoma tumors in C57BL/6 mice, as confirmed by TIMP2 protein level determination. Conclusion Obtained results indicate that APs have a potential as non-viral vectors for cell transfection.	[Grecka, Emilia] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland; [Grecka, Emilia] Natl Res Inst Mother & Child, Dept Pharmacol, Warsaw, Poland; [Statkiewicz, Malgorzata] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Genet, Warsaw, Poland; [Gorska, Agnieszka; Malecki, Maciej] Med Univ Warsaw, Dept Appl Pharm & Bioengn, Warsaw, Poland; [Biernacka, Marzena; Grygorowicz, Monika Anna] Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Immunol, Warsaw, Poland; [Masnyk, Marek; Chmielewski, Marek] Inst Organ Chem PAS, Warsaw, Poland; [Gawarecka, Katarzyna; Chojnacki, Tadeusz; Swiezewska, Ewa] Inst Biochem & Biophys PAS, Warsaw, Poland	Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Polish Academy of Sciences; Institute of Organic Chemistry of the Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Grecka, E (corresponding author), Maria Sklodowska Curie Mem Canc Ctr & Inst Oncol, Dept Mol & Translat Oncol, Warsaw, Poland.	emilia.grecka@outlook.com	Gawarecka, Katarzyna/N-6184-2014; Górska, Agnieszka/N-9664-2018	Górska, Agnieszka/0000-0002-5562-6903; Statkiewicz, Malgorzata/0000-0003-2170-1909; Swiezewska, Ewa/0000-0002-3439-8948	Polish National Cohesion Strategy Innovative Economy Grant [UDA-POIG 01.03.01-14-036/09]	Polish National Cohesion Strategy Innovative Economy Grant	This work was supported by Polish National Cohesion Strategy Innovative Economy Grant UDA-POIG 01.03.01-14-036/09 (ES, MC, M. Malecki). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari SS, 2015, HEAT SHOCK PROTEINS, V9, P219, DOI 10.1007/978-3-319-17211-8_12; Al-Dosari MS, 2009, AAPS J, V11, P671, DOI 10.1208/s12248-009-9143-y; BARTHEL F, 1993, DNA CELL BIOL, V12, P553, DOI 10.1089/dna.1993.12.553; Bentinger M, 2008, J BIOL CHEM, V283, P14645, DOI 10.1074/jbc.M710202200; Bourboulia D, 2011, AM J PATHOL, V179, P2589, DOI 10.1016/j.ajpath.2011.07.035; Bouxsein NF, 2007, BIOCHEMISTRY-US, V46, P4785, DOI 10.1021/bi062138l; Brand K, 2000, CANCER RES, V60, P5723; Brandwijk RJMGE, 2007, TRENDS MOL MED, V13, P200, DOI 10.1016/j.molmed.2007.03.001; Bryant LM, 2013, HUM GENE THER CL DEV, V24, P55, DOI 10.1089/humc.2013.087; Butler GS, 1999, J BIOL CHEM, V274, P20391, DOI 10.1074/jbc.274.29.20391; Giron-Gonzalez MD, 2016, BIOCONJUGATE CHEM, V27, P549, DOI 10.1021/acs.bioconjchem.5b00576; Eastman SJ, 1997, BBA-BIOMEMBRANES, V1325, P41, DOI 10.1016/S0005-2736(96)00242-8; FARHOOD H, 1995, BBA-BIOMEMBRANES, V1235, P289, DOI 10.1016/0005-2736(95)80016-9; FELGNER JH, 1994, J BIOL CHEM, V269, P2550; Furuhata M, 2008, J NANOSCI NANOTECHNO, V8, P2308, DOI 10.1166/jnn.2008.170; Gashti AB, 2012, J PHARM RES, V5, P4361; Gawrys O, 2014, PHARMACOL REP, V66, P273, DOI 10.1016/j.pharep.2013.09.009; Gawrys O, 2014, EUR J LIPID SCI TECH, V116, P659, DOI 10.1002/ejlt.201300489; Goyal R, 2012, NANOMED-NANOTECHNOL, V8, P167, DOI 10.1016/j.nano.2011.06.001; Haq M, 2000, CANCER RES, V60, P3207; Hartley MD, 2012, ARCH BIOCHEM BIOPHYS, V517, P83, DOI 10.1016/j.abb.2011.10.018; Jacobsen LB, 2009, BIOTECHNIQUES, V47, P617, DOI 10.2144/000113132; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kawakami S, 2004, INT J PHARMACEUT, V278, P255, DOI 10.1016/j.ijpharm.2004.03.013; Kearns MD, 2010, CHEM PHYS LIPIDS, V163, P755, DOI 10.1016/j.chemphyslip.2010.08.001; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Liu D, GENE THER MOL BIOL, P59; Lonez C, 2012, ADV DRUG DELIVER REV, V64, P1749, DOI 10.1016/j.addr.2012.05.009; Louis MH, 2006, CANCER GENE THER, V13, P367, DOI 10.1038/sj.cgt.7700893; Madeja Z, 2007, ACTA BIOCHIM POL, V54, P873, DOI 10.18388/abp.2007_3191; Massing U, 2000, CHEM PHYS LIPIDS, V105, P189, DOI 10.1016/S0009-3084(00)00121-3; Miloszewska J, 2010, CELL PROLIFERAT, V43, P229, DOI 10.1111/j.1365-2184.2010.00671.x; Misra SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068305; Mochizuki S, 2013, BBA-BIOMEMBRANES, V1828, P412, DOI 10.1016/j.bbamem.2012.10.017; Nguyen HK, 2000, GENE THER, V7, P126, DOI 10.1038/sj.gt.3301052; Nguyen LT, 2007, BIOL PHARM BULL, V30, P751, DOI 10.1248/bpb.30.751; Obata Y, 2010, NANOMED-NANOTECHNOL, V6, P70, DOI 10.1016/j.nano.2009.04.005; Paecharoenchai O, 2012, AAPS PHARMSCITECH, V13, P1302, DOI 10.1208/s12249-012-9857-5; Palizban AA, 2007, J DRUG TARGET, V15, P351, DOI 10.1080/10611860701349364; Parvizi P, 2014, INT J PHARMACEUT, V461, P145, DOI 10.1016/j.ijpharm.2013.11.045; Podgornik R, 2004, GENE THERAPY THERAPE, P301; Qiao WH, 2013, EUR J LIPID SCI TECH, V115, P483, DOI 10.1002/ejlt.201200265; Regelin AE, 2000, BBA-BIOMEMBRANES, V1464, P151, DOI 10.1016/S0005-2736(00)00126-7; Rosenzweig HS, 2001, BIOCONJUGATE CHEM, V12, P258, DOI 10.1021/bc000099z; Rubanyi Gabor M., 2001, Molecular Aspects of Medicine, V22, P113, DOI 10.1016/S0098-2997(01)00004-8; Saito Y, 2006, BIOL PHARM BULL, V29, P1986, DOI 10.1248/bpb.29.1986; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sato M, 1999, MOL CELL BIOL, V19, P471; Scarzello M, 2005, J AM CHEM SOC, V127, P10420, DOI 10.1021/ja0515147; Shi J, 2016, COLLOID SURFACE B, V141, P417, DOI 10.1016/j.colsurfb.2016.02.018; Sun S, 2013, NANOMED-NANOTECHNOL, V9, P849, DOI 10.1016/j.nano.2013.01.006; Templeton NS, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/173465; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; de Ilarduya CT, 2010, EUR J PHARM SCI, V40, P159, DOI 10.1016/j.ejps.2010.03.019; Valente P, 1998, INT J CANCER, V75, P246, DOI 10.1002/(SICI)1097-0215(19980119)75:2<246::AID-IJC13>3.0.CO;2-B; VALTERSSON C, 1985, J BIOL CHEM, V260, P2742; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Walker S, 1998, ADV DRUG DELIVER REV, V30, P61, DOI 10.1016/S0169-409X(97)00107-5; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Weinberg R. A., 2013, BIOL CANC; Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019; Zakharova LY, 2016, COLLOID SURFACE B, V140, P269, DOI 10.1016/j.colsurfb.2015.12.045; Zhi DF, 2012, BIOORG MED CHEM LETT, V22, P3837, DOI 10.1016/j.bmcl.2012.01.097	63	4	4	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153633	10.1371/journal.pone.0153633	http://dx.doi.org/10.1371/journal.pone.0153633			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088717	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000032
J	Perez, GIP; Gao, Z; Jourdain, R; Ramirez, J; Gany, F; Clavaud, C; Demaude, J; Breton, L; Blaser, MJ				Perez, Guillermo I. Perez; Gao, Zhan; Jourdain, Roland; Ramirez, Julia; Gany, Francesca; Clavaud, Cecile; Demaude, Julien; Breton, Lionel; Blaser, Martin J.			Body Site Is a More Determinant Factor than Human Population Diversity in the Healthy Skin Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; CUTANEOUS BACTERIAL; FUNGAL POPULATIONS; ABCC11 ALLELE; ODOR; QUANTITATION; GREENGENES; PSORIASIS; DISEASE; PROFILE	We studied skin microbiota present in three skin sites (forearm, axilla, scalp) in men from six ethnic groups living in New York City. Methods. Samples were obtained at baseline and after four days following use of neutral soap and stopping regular hygiene products, including shampoos and deodorants. DNA was extracted using the MoBio Power Lyzer kit and 16S rRNA gene sequences determined on the IIlumina MiSeq platform, using QIIME for analysis. Results. Our analysis confirmed skin swabbing as a useful method for sampling different areas of the skin because DNA concentrations and number of sequences obtained across subject libraries were similar. We confirmed that skin location was the main factor determining the composition of bacterial communities. Alpha diversity, expressed as number of species observed, was greater in arm than on scalp or axilla in all studied groups. We observed an unexpected increase in a-diversity on arm, with similar tendency on scalp, in the South Asian group after subjects stopped using their regular shampoos and deodorants. Significant differences at phylum and genus levels were observed between subjects of the different ethnic origins at all skin sites. Conclusions. We conclude that ethnicity and particular soap and shampoo practices are secondary factors compared to the ecological zone of the human body in determining cutaneous microbiota composition.	[Perez, Guillermo I. Perez; Gao, Zhan; Blaser, Martin J.] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Jourdain, Roland; Clavaud, Cecile; Demaude, Julien; Breton, Lionel] LOreal Res & Innovat, Aulnay Sous Bois, France; [Ramirez, Julia; Gany, Francesca] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Demaude, Julien] LOreal Res & Innovat, Clark, NJ USA; [Blaser, Martin J.] Vet Affairs Med Ctr, New York Harbor Dept, New York, NY USA	New York University; NYU Langone Medical Center; L'Oreal Group; Memorial Sloan Kettering Cancer Center; L'Oreal Group; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Perez, GIP (corresponding author), NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA.	perezg02@med.nyu.edu	Perez, Guillermo Perez/AAJ-3761-2020	Gao, Zhan/0000-0003-0976-8836; Perez Perez, Guillermo/0000-0002-0131-5798	Diane Belfer program in Human Microbial Ecology from the National Institutes of Health [UH2 AR057506-01S1]; L'Oreal Research and Innovation grant; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [UH2AR057506] Funding Source: NIH RePORTER	Diane Belfer program in Human Microbial Ecology from the National Institutes of Health; L'Oreal Research and Innovation grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by the Diane Belfer program in Human Microbial Ecology, UH2 AR057506-01S1 from the National Institutes of Health, and L'Oreal Research and Innovation grant. Cecile Clavaud, Roland Jourdain, Julien Demaude, and Lionel Breton are employees of L'Oreal Research & Innovation.	Aagaard K, 2013, FASEB J, V27, P1012, DOI 10.1096/fj.12-220806; Akaza N, 2015, J DERMATOL; Alekseyenko AV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-31; Alexeyev OA, 2013, EXP DERMATOL, V22, P443, DOI 10.1111/exd.12160; Alexis AE, 2012, J DRUGS DERMATOL, V11, pS30; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Blaser MJ, 2013, ISME J, V7, P85, DOI 10.1038/ismej.2012.81; Callewaert C, 2014, APPL ENVIRON MICROB, V80, P6611, DOI 10.1128/AEM.01422-14; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Clavaud C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058203; Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eilers KG, 2012, SOIL BIOL BIOCHEM, V50, P58, DOI 10.1016/j.soilbio.2012.03.011; EVANS CA, 1976, J CLIN MICROBIOL, V3, P576; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Findley K, 2013, NATURE, V498, P367, DOI 10.1038/nature12171; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gao Z, 2010, J CLIN MICROBIOL, V48, P3575, DOI 10.1128/JCM.00597-10; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2012, ANNU REV GENOM HUM G, V13, P151, DOI 10.1146/annurev-genom-090711-163814; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Harker M, 2014, J DERMATOL SCI, V73, P23, DOI 10.1016/j.jdermsci.2013.08.016; Hospodsky D, 2014, MICROBIOL-SGM, V160, P1144, DOI 10.1099/mic.0.075390-0; Kong HH, 2012, J INVEST DERMATOL, V132, P933, DOI 10.1038/jid.2011.417; Li W, 2014, MICROBIOL RES, V169, P686, DOI 10.1016/j.micres.2014.02.008; Marples M. J., 1965, ECOLOGY HUMAN SKIN; Martin A, 2010, J INVEST DERMATOL, V130, P529, DOI 10.1038/jid.2009.254; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Pappas A, 2013, DERM-ENDOCRINOL, V5, P319, DOI 10.4161/derm.25366; Picardo M, 2014, J CLIN GASTROENTEROL, V48, pS85, DOI 10.1097/MCG.0000000000000241; SanMiguel A, 2015, CELL MOL LIFE SCI, V72, P1499, DOI 10.1007/s00018-014-1812-z; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Stanford JA, 2013, SEMIN IMMUNOL, V25, P370, DOI [10.1016/j.smim.2013.09.005, DOI 10.1016/J.SMIM.2013.09.005]; Statnikov A, 2013, SCI REP-UK, V3, DOI 10.1038/srep02620; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; Wang LL, 2015, EXP DERMATOL, V24, P398, DOI 10.1111/exd.12684; Weyrich LS, 2015, AUSTRALAS J DERMATOL, V56, P268, DOI 10.1111/ajd.12253; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Yoshiura K, 2006, NAT GENET, V38, P324, DOI 10.1038/ng1733	46	85	85	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0151990	10.1371/journal.pone.0151990	http://dx.doi.org/10.1371/journal.pone.0151990			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088867	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000003
J	Bianchi, E; Boekelheide, K; Sigman, M; Lamb, DJ; Hall, SJ; Hwang, K				Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Lamb, Dolores J.; Hall, Susan J.; Hwang, Kathleen			Ghrelin Inhibits Post-Operative Adhesions via Blockage of the TGF-beta Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR; SMAD7 EXPRESSION; FIBROSIS; RECEPTOR; TGF-BETA-1; MICE; FIBROGENESIS; CELLS; MODEL	Post-operative adhesions are a critical problem in pelvic and abdominal surgery despite a multitude of studies dedicated to finding modalities to prevent their occurrence. Ghrelin administration promotes an anti-fibrotic response in a surgical mouse model of adhesion-induction, but the mechanisms mediating this effect have not been established. In the current study, the molecular mechanisms that underlie the anti-adhesion effect of ghrelin were investigated. Post-surgical adhesions were experimentally created in C57BL/6 wild-type mice via a combination of ischemic peritoneal buttons and cecal multiple abrasions. Ghrelin or saline intraperitoneal injections were given twice daily from two days before surgery to selected time points post-surgically to assess the phenotypic and molecular effects of treatment (1 day (n = 20), 4 days (n = 20) and 20 days (n = 40) after surgery). Endpoints included the scoring of adhesions and gene and protein expression analysis of pro-fibrogenic factors conducted on peritoneal ischemic tissue by quantitative PCR and Western blot. Ghrelin administration significantly reduced post-surgical adhesions and down-regulated pro-inflammatory gene and protein expression, including Tgfb3 and Tgfbr2. The up-regulation of inhibitory proteins Smad6 and Smad7 confirmed the ghrelin-induced blockage of TGF-beta signaling. Ghrelin is a candidate therapeutic drug for post-operative adhesion prevention, inhibiting inflammatory responses via blockage of the TGF-beta signaling pathway at the onset of surgery before the occurrence of the granulation-remodeling phase.	[Bianchi, Enrica; Sigman, Mark; Hwang, Kathleen] Brown Univ, Div Urol, Providence, RI 02912 USA; [Bianchi, Enrica; Boekelheide, Kim; Sigman, Mark; Hall, Susan J.; Hwang, Kathleen] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Lamb, Dolores J.] Baylor Coll Med, Dept Mol & Cellular Biol, Scott Dept Urol, Ctr Reprod Med, Houston, TX 77030 USA	Brown University; Brown University; Baylor College of Medicine	Hwang, K (corresponding author), Brown Univ, Div Urol, Providence, RI 02912 USA.; Hwang, K (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	Kathleen_Hwang@brown.edu	Sigman, Mark/P-3343-2019; Hwang, Kathleen/ABE-1339-2021	Bianchi, Enrica/0000-0002-8135-9730	American Society for Reproductive Medicine and Lifespan Hospital System Research Funds	American Society for Reproductive Medicine and Lifespan Hospital System Research Funds	This work was supported by a grant from The American Society for Reproductive Medicine and Lifespan Hospital System Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bianchi E, 2016, J SURG RES, V201, P226, DOI 10.1016/j.jss.2015.10.044; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Cieslik KA, 2011, AM J PATHOL, V179, P1792, DOI 10.1016/j.ajpath.2011.06.022; Delporte C, 2013, SCIENTIFICA, V2013, DOI 10.1155/2013/518909; Derynck R, 1997, BBA-REV CANCER, V1333, pF105, DOI 10.1016/S0304-419X(97)00017-6; Desbiens KM, 2003, BIOCHEM J, V372, P631, DOI 10.1042/BJ20021565; Di Filippo C, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/13901; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Fukui N, 2000, J ORTHOPAED RES, V18, P212, DOI 10.1002/jor.1100180208; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Gorvy DA, 2005, AM J PATHOL, V167, P1005, DOI 10.1016/S0002-9440(10)61190-X; Hellebrekers BWJ, 2011, BRIT J SURG, V98, P1503, DOI 10.1002/bjs.7657; Holmdahl L, 1997, EUR J SURG, V163, P24; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Homdahl L, 1999, EUR J SURG, V165, P1012; Imazu Y, 2011, EUR J PHARMACOL, V672, P153, DOI 10.1016/j.ejphar.2011.09.183; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Koca SS, 2014, CLIN EXP DERMATOL, V39, P176, DOI 10.1111/ced.12195; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Liu T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/276850; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Mao YQ, 2015, INT J MOL SCI, V16, P21911, DOI 10.3390/ijms160921911; MAZUJI MK, 1964, ARCH SURG-CHICAGO, V89, P1011; MENZIES D, 1991, SURG GYNECOL OBSTET, V172, P362; Meyer-ter-Vehn T, 2006, INVEST OPHTH VIS SCI, V47, P1500, DOI 10.1167/iovs.05-0361; MONTZ FJ, 1991, AM J OBSTET GYNECOL, V165, P1539; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Robertson D, 2010, J OBSTET GYNAECOL CA, V32, P598, DOI 10.1016/S1701-2163(16)34530-3; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Sun GX, 2015, J UROLOGY, V193, P2107, DOI 10.1016/j.juro.2014.11.098; Takeda R, 2006, J AM SOC NEPHROL, V17, P113, DOI 10.1681/ASN.2004080626; Taya Y, 1999, DEVELOPMENT, V126, P3869; Tesauro M, 2010, CURR DIABETES REV, V6, P228, DOI 10.2174/157339910791658871; Wang G, 2014, WOUND REPAIR REGEN, V22, P631, DOI 10.1111/wrr.12203; Wang J, 2013, INT J MOL SCI, V14, P10369, DOI 10.3390/ijms140510369; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366; Yue JB, 2000, METH MOL B, V142, P125; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	46	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153968	10.1371/journal.pone.0153968	http://dx.doi.org/10.1371/journal.pone.0153968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082244	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800065
J	Jiang, F; Zhou, XY; Huang, J				Jiang, Feng; Zhou, Xiangyu; Huang, Jing			Long Non-Coding RNA-ROR Mediates the Reprogramming in Cardiac Hypertrophy	PLOS ONE			English	Article							CARDIOMYOCYTE HYPERTROPHY; HEART-FAILURE; MICRORNAS; TRANSCRIPTION; ROLES; CELLS	Background Cardiac hypertrophy associated with various cardiovascular diseases results in heart failure and sudden death. A clear understanding of the mechanisms of hypertrophy will benefit the development of novel therapies. Long non-coding RNAs (lncRNAs) have been shown to play essential roles in many biological process, however, whether lncRNA-ROR plays functional roles in the reprogramming of cardiomyocyte remains unclear. Methodology/Principal Findings Here we show that lncRNA-ROR plays important roles in the pathogenesis of cardiac hypertrophy. In hypertrophic heart and cardiomyocytes, the expression of lncRNA-ROR is dramatically increased, downregulation of which attenuates the hypertrophic responses. Furthermore, the expression of lncRNA-ROR negatively correlates with miR-133, whose expression is increased when lncRNA-ROR is knocked down. In line with this, overexpression of miR-133 prevents the elevation of lncRNA-ROR and re-expression of ANP and BNP in cardiomyocytes subject to phenylephrine treatment. Conclusions/Significance Taken together, our study demonstrates that lncRNA-ROR promotes cardiac hypertrophy via interacting with miR-133, indicating that lncRNA-ROR could be targeted for developing novel antihypertrophic therapeutics.	[Jiang, Feng; Huang, Jing] Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China; [Zhou, Xiangyu] Southwest Med Univ, Affiliated Hosp, Dept Vasc & Thyroid Surg, Luzhou, Sichuan, Peoples R China	Chongqing Medical University; Southwest Medical University	Huang, J (corresponding author), Chongqing Med Univ, Affiliated Hosp 2, Dept Cardiol, Chongqing, Peoples R China.	huangjing_201511@163.com						Abdellatif M, 2010, CIRC RES, V106, P16, DOI 10.1161/CIRCRESAHA.109.212183; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; BISHOPRIC NH, 1991, P NATL ACAD SCI USA, V88, P2132, DOI 10.1073/pnas.88.6.2132; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Carreno JE, 2006, REV ESP CARDIOL, V59, P473, DOI 10.1016/S1885-5857(06)60796-2; Chen HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064757; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Gardner DG, 2003, TRENDS ENDOCRIN MET, V14, P411, DOI 10.1016/S1043-2760(03)00113-9; Hilfiker-Kleiner D, 2006, CARDIOVASC RES, V71, P108, DOI 10.1016/j.cardiores.2006.02.032; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Liu ZH, 2015, EURASIP J WIREL COMM, P1, DOI 10.1186/s13638-015-0367-5; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Martins PAD, 2012, CARDIOVASC RES, V93, P563, DOI 10.1093/cvr/cvs013; Matkovich SJ, 2014, P NATL ACAD SCI USA, V111, P12264, DOI 10.1073/pnas.1410622111; Qureshi IA, 2012, NAT REV NEUROSCI, V13, P528, DOI 10.1038/nrn3234; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2015, CIRC RES, V116, P751, DOI 10.1161/CIRCRESAHA.116.303549; Wang N, 2009, IUBMB LIFE, V61, P566, DOI 10.1002/iub.204; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164	23	89	94	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152767	10.1371/journal.pone.0152767	http://dx.doi.org/10.1371/journal.pone.0152767			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082978	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800008
J	Kihal-Talantikite, W; Vigneau, C; Deguen, S; Siebert, M; Couchoud, C; Bayat, S				Kihal-Talantikite, Wahida; Vigneau, Cecile; Deguen, Severine; Siebert, Muriel; Couchoud, Cecile; Bayat, Sahar			Influence of Socio-Economic Inequalities on Access to Renal Transplantation and Survival of Patients with End-Stage Renal Disease	PLOS ONE			English	Article							DONOR KIDNEY-TRANSPLANTATION; UNITED-STATES; WAITING-LIST; NEIGHBORHOOD POVERTY; SOCIAL INEQUALITIES; DIABETES-MELLITUS; DIALYSIS PATIENTS; DISPARITIES; RECIPIENTS; MORTALITY	Background Public and scientific concerns about the social gradient of end-stage renal disease and access to renal replacement therapies are increasing. This study investigated the influence of social inequalities on the (i) access to renal transplant waiting list, (ii) access to renal transplantation and (iii) patients' survival. Methods All incident adult patients with end-stage renal disease who lived in Bretagne, a French region, and started dialysis during the 2004-2009 period were geocoded in census-blocks. To each census-block was assigned a level of neighborhood deprivation and a degree of urbanization. Cox proportional hazards models were used to identify factors associated with each study outcome. Results Patients living in neighborhoods with low level of deprivation had more chance to be placed on the waiting list and less risk of death (HR = 1.40 95% CI: [1.1-1.7]; HR = 0.82 95% CI: [0.7-0.98]), but this association did not remain after adjustment for the patients' clinical features. The likelihood of receiving renal transplantation after being waitlisted was not associated with neighborhood deprivation in univariate and multivariate analyses. Conclusions In a mixed rural and urban French region, patients living in deprived or advantaged neighborhoods had the same chance to be placed on the waiting list and to undergo renal transplantation. They also showed the same mortality risk, when their clinical features were taken into account.	[Kihal-Talantikite, Wahida; Deguen, Severine] Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France; [Vigneau, Cecile; Siebert, Muriel] CHU Pontchaillou, Serv Nephrol, Rennes, France; [Vigneau, Cecile] Univ Rennes 1, UMR 6290, Equipe Kyca, Rennes, France; [Couchoud, Cecile] REIN Registry, Agence Biomed, La Plaine St Denis, France; [Bayat, Sahar] EA MOS, Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France	CHU Rennes; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes	Kihal-Talantikite, W (corresponding author), Sorbonne Paris Cite, EHESP Sch Publ Hlth, Rennes, France.	Wahida.kihal@ehesp.fr	vigneau, cecile/I-3178-2015		French Biomedicine Agency	French Biomedicine Agency	This study was supported by grants from French Biomedicine Agency.	Alexander GC, 1998, JAMA-J AM MED ASSOC, V280, P1148, DOI 10.1001/jama.280.13.1148; Axelrod DA, 2010, CLIN J AM SOC NEPHRO, V5, P2276, DOI 10.2215/CJN.04940610; Bayat S, 2015, AM J TRANSPLANT, V15, P1050, DOI 10.1111/ajt.13095; Couchoud C, 2006, NEPHROL DIAL TRANSPL, V21, P411, DOI 10.1093/ndt/gfi198; Couchoud C, 2012, TRANSPLANTATION, V94, P513, DOI 10.1097/TP.0b013e31825d156a; Dudley CRK, 2009, TRANSPLANTATION, V88, P96, DOI 10.1097/TP.0b013e3181aa901a; Evans JMM, 2000, DIABETIC MED, V17, P478, DOI 10.1046/j.1464-5491.2000.00309.x; Garg J, 2012, NEPHROL DIAL TRANSPL, V27, P1239, DOI 10.1093/ndt/gfr445; Garg PP, 2000, J AM SOC NEPHROL, V11, P958, DOI 10.1681/ASN.V115958; Garg PP, 1999, NEW ENGL J MED, V341, P1653, DOI 10.1056/NEJM199911253412205; Goldfarb-Rumyantzev AS, 2011, CLIN TRANSPLANT, V25, P834, DOI 10.1111/j.1399-0012.2010.01391.x; Halla YN, 2008, AM J TRANSPLANT, V8, P2402, DOI 10.1111/j.1600-6143.2008.02413.x; Hommel K, 2010, NEPHROL DIAL TRANSPL, V25, P2624, DOI 10.1093/ndt/gfq110; Joshi S, 2012, CLIN TRANSPLANT, V26, pE337, DOI 10.1111/j.1399-0012.2012.01679.x; Keith D, 2008, CLIN J AM SOC NEPHRO, V3, P463, DOI 10.2215/CJN.02220507; Kihal-Talantikite W, 2015, CLIN KIDNEY J, V8, P7, DOI 10.1093/ckj/sfu131; Kihal-Talantikite W, 2013, ENVIRON HEALTH-GLOB, V12, DOI 10.1186/1476-069X-12-109; Kihal-Talantikite W, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-191; Lalloue B, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-21; Laupacis A, 1996, KIDNEY INT, V50, P235, DOI 10.1038/ki.1996.307; Mathur AK, 2010, AM J TRANSPLANT, V10, P1069, DOI 10.1111/j.1600-6143.2010.03043.x; Meier-Kriesche HU, 2004, AM J TRANSPLANT, V4, P1662, DOI 10.1111/j.1600-6143.2004.00573.x; Miskulin DC, 2003, AM J KIDNEY DIS, V41, P149, DOI 10.1053/ajkd.2003.50034; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; O'Hare AM, 2006, KIDNEY INT, V69, P343, DOI 10.1038/sj.ki.5000044; Oniscu GC, 2003, BRIT MED J, V327, P1261, DOI 10.1136/bmj.327.7426.1261; Organisation for Economic Co-operation and Development, 1994, CREAT RUR IND SHAP T; Patzer RE, 2009, J AM SOC NEPHROL, V20, P1333, DOI 10.1681/ASN.2008030335; PERNEGER TV, 1994, ANN INTERN MED, V121, P912, DOI 10.7326/0003-4819-121-12-199412150-00002; PORT FK, 1993, JAMA-J AM MED ASSOC, V270, P1339, DOI 10.1001/jama.270.11.1339; Roodnat JI, 2012, TRANSPLANTATION, V93, P518, DOI 10.1097/TP.0b013e318243030f; Sandhu GS, 2013, CLIN TRANSPLANT, V27, P598, DOI 10.1111/ctr.12177; Satayathum S, 2005, KIDNEY INT, V68, P330, DOI 10.1111/j.1523-1755.2005.00412.x; Saunders MR, 2010, AM J TRANSPLANT, V10, P1912, DOI 10.1111/j.1600-6143.2010.03206.x; Schaeffner ES, 2008, AM J KIDNEY DIS, V51, P811, DOI 10.1053/j.ajkd.2008.01.019; Schold JD, 2011, CLIN J AM SOC NEPHRO, V6, P1760, DOI 10.2215/CJN.08620910; Sequist TD, 2004, AM J KIDNEY DIS, V44, P344, DOI 10.1053/j.ajkd.2004.04.039; Strang WN, 2005, ST HEAL T, V116, P77; Tonelli M, 2009, JAMA-J AM MED ASSOC, V301, P1681, DOI 10.1001/jama.2009.545; van Eupen M, 2012, LAND USE POLICY, V29, P473, DOI 10.1016/j.landusepol.2011.07.007; Vard T, 2005, 21669 EUR; Wolfe RA, 2000, AM J KIDNEY DIS, V36, P1025, DOI 10.1053/ajkd.2000.19106; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; YOUNG EW, 1994, KIDNEY INT, V45, P907, DOI 10.1038/ki.1994.120	44	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153431	10.1371/journal.pone.0153431	http://dx.doi.org/10.1371/journal.pone.0153431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082113	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800019
J	Smith, JN; Emlen, DJ; Pearson, DE				Smith, Jennifer N.; Emlen, Douglas J.; Pearson, Dean E.			Linking Native and Invader Traits Explains Native Spider Population Responses to Plant Invasion	PLOS ONE			English	Article							IMPACTS; DIVERSITY; ABUNDANCE; RESOURCE; COMMUNITIES; COMPETITION; LIMITATION; PATTERNS; BEHAVIOR	Theoretically, the functional traits of native species should determine how natives respond to invader-driven changes. To explore this idea, we simulated a large-scale plant invasion using dead spotted knapweed (Centaurea stoebe) stems to determine if native spiders' web-building behaviors could explain differences in spider population responses to structural changes arising from C. stoebe invasion. After two years, irregular web-spiders were >30 times more abundant and orb weavers were >23 times more abundant on simulated invasion plots compared to controls. Additionally, irregular web-spiders on simulated invasion plots built webs that were 4.4 times larger and 5.0 times more likely to capture prey, leading to >2-fold increases in recruitment. Orb-weavers showed no differences in web size or prey captures between treatments. Web-spider responses to simulated invasion mimicked patterns following natural invasions, confirming that C. stoebe's architecture is likely the primary attribute driving native spider responses to these invasions. Differences in spider responses were attributable to differences in web construction behaviors relative to historic web substrate constraints. Orb-weavers in this system constructed webs between multiple plants, so they were limited by the overall quantity of native substrates but not by the architecture of individual native plant species. Irregular web-spiders built their webs within individual plants and were greatly constrained by the diminutive architecture of native plant substrates, so they were limited both by quantity and quality of native substrates. Evaluating native species traits in the context of invader-driven change can explain invasion outcomes and help to identify factors limiting native populations.	[Smith, Jennifer N.; Emlen, Douglas J.; Pearson, Dean E.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Pearson, Dean E.] US Forest Serv, Rocky Mt Res Stn, USDA, Missoula, MT USA; [Smith, Jennifer N.] Natl Ecol Observ Network NEON Inc, Prairie Peninsula Domain, Field Operat, Manhattan, KS USA	University of Montana System; University of Montana; United States Department of Agriculture (USDA); United States Forest Service	Smith, JN (corresponding author), Univ Montana, Div Biol Sci, Missoula, MT 59812 USA.; Smith, JN (corresponding author), Natl Ecol Observ Network NEON Inc, Prairie Peninsula Domain, Field Operat, Manhattan, KS USA.	jsmith@neoninc.org		Smith, Jennifer/0000-0001-8671-6103	Rocky Mountain Research Station; University of Montana; Sigma Xi; Mazamas Graduate Student Research Grant; USDA Forest Service	Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); University of Montana; Sigma Xi; Mazamas Graduate Student Research Grant; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	This work was funded by the Rocky Mountain Research Station, USDA Forest Service (DEP); The University of Montana (JNS, DJE); Sigma Xi Grants-in-Aid of Research, https://www.sigmaxi.org/programs/grants-in-aid (JNS); and the Mazamas Graduate Student Research Grant, http://mazamas.org/resources/research-grants/ (JNS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bially A, 2000, FRESHWATER BIOL, V43, P85, DOI 10.1046/j.1365-2427.2000.00526.x; Bruggisser OT, 2012, BASIC APPL ECOL, V13, P706, DOI 10.1016/j.baae.2012.10.001; Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1; Callaway RM, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P1; Cardoso P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021710; CHAMBERLIN RALPH V., 1958, BULL AMER MUS NAT HIST, V116, P1; Cunha ER, 2012, WETLANDS, V32, P369, DOI 10.1007/s13157-012-0272-1; DONDALE CD, 2003, ORB WEAVING SPIDERS; Hesselberg T, 2015, CURR ZOOL, V61, P313, DOI 10.1093/czoolo/61.2.313; Hesselberg T, 2010, ETHOLOGY, V116, P535, DOI 10.1111/j.1439-0310.2010.01760.x; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Jackson R.A., 1978, Revue Arachnologique, V1, P133; Jensen GL, 2005, SPIDER IDENTIFICATIO; Kreiter NA, 2001, OECOLOGIA, V127, P417, DOI 10.1007/s004420000607; Krink T, 1998, P ROY SOC B-BIOL SCI, V265, P2051, DOI 10.1098/rspb.1998.0539; Lau JA, 2013, OIKOS, V122, P474, DOI 10.1111/j.1600-0706.2012.20774.x; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; LEVI H W, 1981, Bulletin of the Museum of Comparative Zoology, V149, P271; LEVI H W, 1977, Bulletin of the Museum of Comparative Zoology, V148, P185; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; Maron JL, 2008, AM NAT, V172, pS18, DOI 10.1086/588303; McNett BJ, 2000, ECOL ENTOMOL, V25, P423, DOI 10.1046/j.1365-2311.2000.00279.x; Mitchell CE, 2003, NATURE, V421, P625, DOI 10.1038/nature01317; MIYASHITA T, 1991, Acta Arachnologica, V40, P17, DOI 10.2476/asjaa.40.17; Moya-Larano J, 2003, OIKOS, V101, P539, DOI 10.1034/j.1600-0706.2003.12316.x; Nentwig W., 1987, P249; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Ortega YK, 2005, ECOL APPL, V15, P651, DOI 10.1890/04-0119; Ortega YK, 2014, BIOL INVASIONS, V16, P1757, DOI 10.1007/s10530-013-0625-6; Ortega YK, 2006, OECOLOGIA, V149, P340, DOI 10.1007/s00442-006-0438-8; Parker JD, 2006, SCIENCE, V311, P1459, DOI 10.1126/science.1121407; Pearson DE, 2008, ECOL APPL, V18, P321, DOI 10.1890/07-0766.1; Pearson DE, 2012, BIOL INVASIONS, V14, P901, DOI 10.1007/s10530-011-0126-4; Pearson DE, 2010, AM NAT, V176, P394, DOI 10.1086/656274; Pearson DE, 2009, OECOLOGIA, V159, P549, DOI 10.1007/s00442-008-1241-5; Petillon J, 2010, BIOL INVASIONS, V12, P3219, DOI 10.1007/s10530-010-9714-y; Petillon J, 2010, ANN ZOOL FENN, V47, P79, DOI 10.5735/086.047.0201; Pinheiro J., 2011, NLME LINEAR NONLINEA; Poulsen JR, 2007, AM NAT, V170, P167, DOI 10.1086/518945; Pysek Petr, 2007, V193, P97; R Core Team, 2021, R LANGUAGE ENV STAT; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Rodriguez LF, 2006, BIOL INVASIONS, V8, P927, DOI 10.1007/s10530-005-5103-3; SAS, 2009, SAS STAT US GUID VER; Schirmel J, 2013, BIOL INVASIONS, V15, P1089, DOI 10.1007/s10530-012-0352-4; Tingle CCD, 2002, ECOLOGICAL MONITORIN, P159; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VOLLRATH F, 1992, ADV STUD BEHAV, V21, P147, DOI 10.1016/S0065-3454(08)60144-8; Weiher E, 1999, OIKOS, V87, P355, DOI 10.2307/3546751; WHEELER GS, 1990, AM MIDL NAT, V123, P124, DOI 10.2307/2425765; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; Wise DH, 2006, ANNU REV ENTOMOL, V51, P441, DOI 10.1146/annurev.ento.51.110104.150947; Wise DH, 1993, SPIDERS ECOLOGICAL W	54	6	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153661	10.1371/journal.pone.0153661	http://dx.doi.org/10.1371/journal.pone.0153661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082240	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800038
J	Wallace, J; Hu, R; Mosbruger, TL; Dahlem, TJ; Stephens, WZ; Rao, DS; Round, JL; O'Connell, RM				Wallace, Jared; Hu, Ruozhen; Mosbruger, Timothy L.; Dahlem, Timothy J.; Stephens, W. Zac; Rao, Dinesh S.; Round, June L.; O'Connell, Ryan M.			Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell Growth	PLOS ONE			English	Article							DOWN-REGULATION; FLT3 MUTATIONS; EXPRESSION; MIR-150; SIGNATURES; NETWORK; CANCER; LINES; P53	Mammalian microRNA expression is dysregulated in human cancer. However, the functional relevance of many microRNAs in the context of tumor biology remains unclear. Using CRISPR-Cas9 technology, we performed a global loss-of-function screen to simultaneously test the functions of individual microRNAs and protein-coding genes during the growth of a myeloid leukemia cell line. This approach identified evolutionarily conserved human microRNAs that suppress or promote cell growth, revealing that microRNAs are extensively integrated into the molecular networks that control tumor cell physiology. miR-155 was identified as a top microRNA candidate promoting cellular fitness, which we confirmed with two distinct miR-155-targeting CRISPR-Cas9 lentiviral constructs. Further, we performed anti-correlation functional profiling to predict relevant microRNA-tumor suppressor gene or microRNA-oncogene interactions in these cells. This analysis identified miR-150 targeting of p53, a connection that was experimentally validated. Taken together, our study describes a powerful genetic approach by which the function of individual microRNAs can be assessed on a global level, and its use will rapidly advance our understanding of how microRNAs contribute to human disease.	[Wallace, Jared; Hu, Ruozhen; Stephens, W. Zac; Round, June L.; O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Dahlem, Timothy J.] Univ Utah, Mutat Generat & Detect Core, HSC Core Res Facil, Salt Lake City, UT USA; [Mosbruger, Timothy L.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Rao, Dinesh S.] Univ Calif Los Angeles, Dept Pathol, Los Angeles, CA 90024 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; University of California System; University of California Los Angeles	O'Connell, RM (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT USA.	ryan.oconnell@path.utah.edu	Rao, Dinesh/AAE-9625-2019; Rao, Dinesh/ABG-1257-2021	Rao, Dinesh/0000-0002-0794-9337	University of Utah [5P30CA042014-24]; NIH [DP2GM111099-01]; Gabrielle Angel's Foundation Award; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM111099] Funding Source: NIH RePORTER	University of Utah; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gabrielle Angel's Foundation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the University of Utah Flow Cytometry Facility in addition to the National Cancer Institute through Award Number 5P30CA042014-24. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. This work was also supported by the NIH New Innovator Award DP2GM111099-01 (R.M.O.) and the Gabrielle Angel's Foundation Award http://www.gabriellesangels.org (R.M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, LEUKEMIA, V19, P1042, DOI 10.1038/sj.leu.2403749; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen Y, 2013, J CLIN INVEST, V123, P2395, DOI 10.1172/JCI66553; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Garzon R, 2008, P NATL ACAD SCI USA, V105, P3945, DOI 10.1073/pnas.0800135105; Gerloff D, 2015, LEUKEMIA, V29, P535, DOI 10.1038/leu.2014.231; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Han YC, 2010, J EXP MED, V207, P475, DOI 10.1084/jem.20090831; He Y, 2014, ONCOGENE, V33, P3887, DOI 10.1038/onc.2013.346; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcucci G, 2011, BLOOD, V117, P1121, DOI 10.1182/blood-2010-09-191312; Mizuki M, 2000, BLOOD, V96, P3907, DOI 10.1182/blood.V96.12.3907; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; O'Connell RM, 2010, P NATL ACAD SCI USA, V107, P14235, DOI 10.1073/pnas.1009798107; Pedranzini L, 2010, LEUKEMIA RES, V34, P1287, DOI 10.1016/j.leukres.2010.02.012; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Wang DT, 2013, ONCOL REP, V30, P492, DOI 10.3892/or.2013.2453; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Zhang N, 2013, FEBS LETT, V587, P2346, DOI 10.1016/j.febslet.2013.05.059	23	37	39	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153689	10.1371/journal.pone.0153689	http://dx.doi.org/10.1371/journal.pone.0153689			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081855	Green Published, gold			2022-12-27	WOS:000374291800045
J	Hall, JA; MacLeay, J; Yerramilli, M; Obare, E; Yerramilli, M; Schiefelbein, H; Paetau-Robinson, I; Jewell, DE				Hall, Jean A.; MacLeay, Jennifer; Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.			Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Cats	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; L-CARNITINE SUPPLEMENTATION; OXIDATIVE STRESS; RENAL-INSUFFICIENCY; FUNCTION BIOMARKERS; DOGS; SURVIVAL; SDMA	A prospective study was conducted in client-owned geriatric cats to evaluate the short- term effects of a test food on serum symmetric dimethylarginine (SDMA) and creatinine (Cr) concentrations. Test food contained functional lipids (fish oil), antioxidants (vitamins C and E), L-carnitine, botanicals (vegetables), highly bioavailable protein, and amino acid supplements. Cats (n = 80) were fed either test food or owner's-choice foods (non-nutritionally controlled cohort). Cats were included based on age (>= 9 years), indoor only, neutered, and free of chronic disease. At baseline, all cats had serum Cr concentrations within the reference interval. Renal function biomarkers and urinalysis results at baseline and after consuming test food or owner's-choice foods for 3 and 6 months were evaluated. Cats consuming test food showed significant decreases in serum Cr and BUN concentrations across time. Overall, cats consuming owner's-choice foods showed significant increases in serum SDMA concentrations at 3 and 6 months compared with baseline (P <= 0.05), whereas in cats consuming test food serum SDMA concentrations did not change. At baseline or during the 6-month feeding trial, 23 (28.8%) cats had increased serum SDMA, but normal serum Cr consistent with IRIS Stage 1 chronic kidney disease. This included 6 cats fed test food and 17 cats fed owner's-choice foods. In the 6 cats fed test food, serum SDMA decreased in 3 cats and remained stable in 1 cat, whereas in the 17 cats fed owner's-choice foods, serum SDMA increased in 13 cats and decreased or remained stable in 4 cats. The increase in serum SDMA concentration was significant (P = 0.02) only for cats fed owner's-choice foods. These results suggest that nonazotemic cats with elevated serum SDMA (early renal insufficiency) when fed a food designed to promote healthy aging are more likely to demonstrate stable renal function compared with cats fed owner's-choice foods. Cats fed owner's-choice foods were more likely to demonstrate progressive renal insufficiency.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [MacLeay, Jennifer; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA; [Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). The funding decision makers had no role in study design, data collection and analysis, or preparation of the manuscript.	Allen T., 2010, SMALL ANIMAL CLIN NU, P765; Bartges JW, 2012, VET CLIN N AM-SMALL, V42, P669, DOI 10.1016/j.cvsm.2012.04.008; Boudouris G, 2013, INT UROL NEPHROL, V45, P1137, DOI 10.1007/s11255-012-0334-6; Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9; Brown SA, 2000, J LAB CLIN MED, V135, P275, DOI 10.1067/mlc.2000.105178; Brown SA, 2008, VET CLIN N AM-SMALL, V38, P157, DOI 10.1016/j.cvsm.2007.11.001; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Elliott J, 2000, J SMALL ANIM PRACT, V41, P235, DOI 10.1111/j.1748-5827.2000.tb03932.x; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2016, J VET INTERN MED; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; International Renal Interest Society, IRIS 2009 STAG CKD; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P891, DOI 10.1093/ndt/gfs038; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Moffitt TA, 2013, J NEPHROL, V26, P403, DOI 10.5301/jn.5000135; Plantinga EA, 2005, VET REC, V157, P185, DOI 10.1136/vr.157.7.185; Polzin DJ, 2013, J VET EMERG CRIT CAR, V23, P205, DOI 10.1111/vec.12034; Ringseis R, 2013, EUR J NUTR, V52, P1421, DOI 10.1007/s00394-013-0511-0; Ross SJ, 2006, JAVMA-J AM VET MED A, V229, P949, DOI 10.2460/javma.229.6.949; Sahebkar A, 2015, J MED BIOCHEM, V34, P151, DOI 10.2478/jomb-2014-0030; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Veldink H, 2013, NEPHROL DIAL TRANSPL, V28, P1434, DOI 10.1093/ndt/gfs554; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Xu H, 2015, J NUTR, V145, P729, DOI 10.3945/jn.114.205187	30	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153654	10.1371/journal.pone.0153654	http://dx.doi.org/10.1371/journal.pone.0153654			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078852	gold, Green Published			2022-12-27	WOS:000374131700101
J	Kwon, SG; Hwang, JH; Park, DH; Kim, TW; Kang, DG; Kang, KH; Kim, IS; Park, HC; Na, CS; Ha, J; Kim, CW				Kwon, Seul Gi; Hwang, Jung Hye; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Kang, Kyung Hee; Kim, Il-Suk; Park, Hwa Chun; Na, Chong-Sam; Ha, Jeongim; Kim, Chul Wook			Identification of Differentially Expressed Genes Associated with Litter Size in Berkshire Pig Placenta	PLOS ONE			English	Article							ENDOTHELIAL LIPASE; ENDOMETRIUM; MEISHAN; LIPOPROTEIN; GESTATION; PREGNANCY; TRANSPORT; OVULATION; BINDING; TRAITS	Improvement in litter size has become of great interest in the pig industry because fecundity is directly related to sow reproductive life. Improved reproduction has thus been achieved by elucidating the molecular functions of genes associated with fecundity. In the present study, we identified differentially expressed genes (DEGs) via transcriptomic analysis using RNA-sequencing (RNA-Seq) in Berkshire pig placentas from larger (LLG, mean litter size >12) and smaller (SLG, mean litter size < 6.5) litter size groups. In total 588 DEGs were identified (p < 0.05, > 1.5-fold change), of which 98 were upregulated, while 490 were downregulated in the LLG compared with the SLG. Gene Ontology (GO) enrichment was also performed. We concluded that 129 of the 588 DEGs were closely related to litter size according to reproduction related genes selected based on previous reports, as 110 genes were downregulated and 19 upregulated in the LLG compared with the SLG. RT-qPCR utilizing specific primers targeting the early growth response 2 (EGR2), pheromaxein c subunit (PHEROC) and endothelial lipase (LIPG) genes showed high accordance with RNA-Seq results. Furthermore, we investigated the upstream regulators of these three genes in the placenta. We found that WNT9B, a Wnt signaling pathway molecule, and IL-6, known inducers of EGR2 and LIPG, respectively, were significantly increased in LLG compared with SLG. We believe that the induction of IL-6 and LIPG may play an important role in increasing nutrition supply through the placenta from the sow to the piglet during gestation. These results provide novel molecular insights into pig reproduction.	[Kwon, Seul Gi; Hwang, Jung Hye; Park, Da Hye; Kim, Tae Wan; Kang, Deok Gyeong; Kang, Kyung Hee; Ha, Jeongim; Kim, Chul Wook] Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea; [Kim, Il-Suk] Gyeongnam Natl Univ Sci & Technol, Dept Anim Resource Technol, Jinju, South Korea; [Park, Hwa Chun] Dasan Pig Breeding Co, Namwon, South Korea; [Na, Chong-Sam] Chonbuk Natl Univ, Dept Anim Biotechnol, Jeonju 561756, South Korea	Gyeongnam National University of Science and Technology; Gyeongnam National University of Science and Technology; Jeonbuk National University	Ha, J; Kim, CW (corresponding author), Gyeongnam Natl Univ Sci & Technol, Swine Sci & Technol Ctr, Jinju, South Korea.	jiha@gntech.ac.kr; cwkim@gntech.ac.kr			Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2011-0022965]; Export Promotion Technology Development Program of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea [313012-05]; Dasan Pig Breeding Co.	Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Export Promotion Technology Development Program of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea; Dasan Pig Breeding Co.	This work was supported by grants from the Priority Research Centers Program (no.2011-0022965) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology, from the Export Promotion Technology Development Program (no. 313012-05) of Ministry of Food, Agriculture, Forestry and Fisheries, Republic of Korea. The Dasan Pig Breeding Co. provided support in the form of a salary for author HCP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Anders S, 2014, BIOINFORMATICS; Badellino KO, 2008, CIRCULATION, V117, P678, DOI 10.1161/CIRCULATIONAHA.107.707349; Chen X, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.123075; CHRISTENSON RK, 1993, J ANIM SCI, V71, P3060, DOI 10.2527/1993.71113060x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fernandez-Rodriguez A, 2011, BIOL REPROD, V84, P299, DOI 10.1095/biolreprod.110.085589; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Franczak A, 2013, REPROD BIOL, V13, P229, DOI 10.1016/j.repbio.2013.07.001; Fu Yanfeng, 2014, Yichuan, V36, P1243, DOI 10.3724/SP.J.1005.2014.1243; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; HALEY CS, 1993, J REPROD FERTIL, P247; Hernandez SC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.104679; Hsieh M, 2007, MOL CELL BIOL, V27, P1914, DOI 10.1128/MCB.01919-06; Humaidan P, 2011, FERTIL STERIL, V95, P2034, DOI 10.1016/j.fertnstert.2011.02.013; Knoefler Martin, 2013, Frontiers in Genetics, V4, P190, DOI 10.3389/fgene.2013.00190; Lager S, 2011, PLACENTA, V32, P121, DOI 10.1016/j.placenta.2010.10.012; Leclerc N, 2008, J CELL BIOCHEM, V103, P1938, DOI 10.1002/jcb.21587; Lee JH, 2015, ASIAN AUSTRAL J ANIM, V28, P1388, DOI 10.5713/ajas.15.0097; Noguera JL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-636; Park SJ, 2015, GENE, V558, P152, DOI 10.1016/j.gene.2014.12.052; Quesnel H, 2008, ANIMAL, V2, P1842, DOI 10.1017/S175173110800308X; Robert J, 2013, ARTERIOSCL THROM VAS, V33, P2699, DOI 10.1161/ATVBAHA.113.301363; ROBERTSON AF, 1976, SOUTHERN MED J, V69, P1358, DOI 10.1097/00007611-197610000-00031; Rothschild M, 1996, P NATL ACAD SCI USA, V93, P201, DOI 10.1073/pnas.93.1.201; Rozen S, 2000, Methods Mol Biol, V132, P365; SaintJeannet JP, 1997, P NATL ACAD SCI USA, V94, P13713, DOI 10.1073/pnas.94.25.13713; Sonderegger S, 2007, PLACENTA, V28, pS97, DOI 10.1016/j.placenta.2006.11.003; Spencer T E, 2004, J Anim Sci, V82 E-Suppl, pE4; Spotter A, 2006, VET J, V172, P234, DOI 10.1016/j.tvjl.2005.11.013; Spotter A, 2002, ANIM GENET, V33, P166, DOI 10.1046/j.1365-2052.2002.0831i.x; Su LJ, 2010, REPROD FERT DEVELOP, V22, P1175, DOI 10.1071/RD10046; Sun JQ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-219; Vallet JL, 2007, J ANIM SCI, V85, P3267, DOI 10.2527/jas.2007-0368; Vallet JL, 2005, ANIM GENET, V36, P97, DOI 10.1111/j.1365-2052.2005.01233.x; Vonnahme KA, 2002, J ANIM SCI, V80, P1311; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Zaman G, 2012, J BIOL CHEM, V287, P3946, DOI 10.1074/jbc.M111.252742	37	37	37	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153311	10.1371/journal.pone.0153311	http://dx.doi.org/10.1371/journal.pone.0153311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078025	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700037
J	Unterseher, M; Siddique, A; Brachmann, A; Persoh, D				Unterseher, Martin; Siddique, Abu Bakar; Brachmann, Andreas; Persoh, Derek			Diversity and Composition of the Leaf Mycobiome of Beech (Fagus sylvatica) Are Affected by Local Habitat Conditions and Leaf Biochemistry	PLOS ONE			English	Article							PHYLLOSPHERE FUNGAL ASSEMBLAGES; INHABITING ENDOPHYTIC FUNGI; SPECIES RICHNESS; COMMUNITY; ELEVATION; LITTER; COLONIZATION; BIODIVERSITY; MICROBIOME; GRADIENT	Comparative investigations of plant-associated fungal communities (mycobiomes) in distinct habitats and under distinct climate regimes have been rarely conducted in the past. Nowadays, high-throughput sequencing allows routine examination of mycobiome responses to environmental changes and results at an unprecedented level of detail. In the present study, we analysed Illumina-generated fungal ITS1 sequences from European beech (Fagus sylvatica) originating from natural habitats at two different altitudes in the German Alps and from a managed tree nursery in northern Germany. In general, leaf-inhabiting mycobiome diversity and composition correlated significantly with the origin of the trees. Under natural condition the mycobiome was more diverse at lower than at higher elevation, whereas fungal diversity was lowest in the artificial habitat of the tree nursery. We further identified significant correlation of leaf chlorophylls and flavonoids with both habitat parameters and mycobiome biodiversity. The present results clearly point towards a pronounced importance of local stand conditions for the structure of beech leaf mycobiomes and for a close interrelation of phyllosphere fungi and leaf physiology.	[Unterseher, Martin; Siddique, Abu Bakar] Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landschaftsokol, Greifswald, Germany; [Brachmann, Andreas] LMU Munchen, Biozentrum, Bereich Genet, Martinsried, Germany; [Persoh, Derek] Ruhr Univ Bochum, AG Geobot, Univ Str 150, Bochum, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Munich; Ruhr University Bochum	Unterseher, M (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Bot & Landschaftsokol, Greifswald, Germany.	martin.unterseher@uni-greifswald.de	Brachmann, Andreas/I-2241-2013; , Abu Bakar Siddique/R-1776-2018; Persoh, Derek/G-4527-2010	Brachmann, Andreas/0000-0001-7980-8173; , Abu Bakar Siddique/0000-0002-3178-523X; Persoh, Derek/0000-0001-5561-0189	Deutsche Forschungsgemeinschaft (DFG) [UN262/9-1, PE1673/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG) as part of the full research project grant "Patterns and processes in endophyte ecology - studies in optimal and extreme habitats of European Beech to reveal the underlying principles" to MU (UN262/9-1) and DP (PE1673/4-1). Project description is available at http://gepris.dfg.de/gepris/projekt/245215303?language=en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Bahnweg G, 2005, PLANT BIOLOGY, V7, P659, DOI 10.1055/s-2005-872943; Balint M, 2015, MOL ECOL, V24, P235, DOI 10.1111/mec.13018; Balint M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053987; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Bengtsson-Palme J, 2013, METHODS ECOL EVOL, V4, P914, DOI 10.1111/2041-210X.12073; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Blaalid R, 2014, MOL ECOL, V23, P649, DOI 10.1111/mec.12622; Bresson CC, 2011, TREE PHYSIOL, V31, P1164, DOI 10.1093/treephys/tpr084; Brown SP, 2015, FUNGAL ECOL, V13, P221, DOI 10.1016/j.funeco.2014.08.006; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collado J, 2007, FEMS MICROBIOL ECOL, V60, P521, DOI 10.1111/j.1574-6941.2007.00294.x; Cordier T, 2012, NEW PHYTOL, V196, P510, DOI 10.1111/j.1469-8137.2012.04284.x; Cordier T, 2012, FUNGAL ECOL, V5, P509, DOI 10.1016/j.funeco.2011.12.004; de Hoog GS, 1998, MYCOSES, V41, P183, DOI 10.1111/j.1439-0507.1998.tb00321.x; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hartig S.M., 2013, CURR PROTOC MOL BIOL, DOI [10.1002/0471142727.mb1415-102, DOI 10.1002/0471142727.MB1415S102, DOI 10.1002/0471142727.MB1415-102]; Hashizume Y, 2008, FOREST PATHOL, V38, P218, DOI 10.1111/j.1439-0329.2008.00547.x; Helander M, 2007, NEW PHYTOL, V175, P547, DOI 10.1111/j.1469-8137.2007.02110.x; Higginbotham SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073192; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Horn K, 2013, AM J BOT, V100, P2158, DOI 10.3732/ajb.1300011; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Kemler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081718; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Korner C, 2005, SCIENCE, V309, P1360, DOI 10.1126/science.1113977; Korner C, 1998, OECOLOGIA, V115, P445, DOI 10.1007/s004420050540; Koskimaki JJ, 2009, EUROPEAN J PLANT PAT; Matulich KL, 2015, ISME J, V9, P2477, DOI 10.1038/ismej.2015.58; Meyer S, 2006, PLANT CELL ENVIRON, V29, P1338, DOI 10.1111/j.1365-3040.2006.01514.x; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Nilsson RH, 2015, MICROBES ENVIRON, V30, P145, DOI 10.1264/jsme2.ME14121; Olbrich M, 2010, ENVIRON POLLUT, V158, P1043, DOI 10.1016/j.envpol.2009.09.020; Osono T, 2011, FUNGAL ECOL, V4, P375, DOI 10.1016/j.funeco.2011.02.004; Persoh D, 2015, FUNGAL DIVERS, V75, P1, DOI 10.1007/s13225-015-0334-9; Persoh D, 2013, FUNGAL DIVERS, V60, P55, DOI 10.1007/s13225-013-0225-x; Persoh D, 2013, PLANT SOIL, V362, P175, DOI 10.1007/s11104-012-1271-y; Petrini O., 1991, MICROBIOLOGY PHYLLOS, P175; Porras-Alfaro A, 2011, ANNU REV PHYTOPATHOL, V49, P291, DOI 10.1146/annurev-phyto-080508-081831; Reissinger A, 2001, MYCOL RES, V105, P563, DOI 10.1017/S0953756201003823; Richardson AD, 2004, PLANT SOIL, V260, P291, DOI 10.1023/B:PLSO.0000030179.02819.85; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Saikkonen K, 2013, J CHEM ECOL, V39, P962, DOI 10.1007/s10886-013-0310-3; Scholtysik A, 2013, MYCOL PROG, V12, P291, DOI 10.1007/s11557-012-0835-9; SCHULZ B, 1993, MYCOL RES, V97, P1447, DOI 10.1016/S0953-7562(09)80215-3; Siddique AB, 2016, FUNGAL ECOL, V20, P175, DOI 10.1016/j.funeco.2015.12.009; SIMBERLOFF DS, 1969, ECOLOGY, V50, P278, DOI 10.2307/1934856; Solis MJL, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-014-1019-6; Tedersoo L, 2014, SCIENCE, V346, P1078, DOI 10.1126/science.1256688; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Unterseher M, 2007, MYCOL PROG, V6, P201, DOI 10.1007/s11557-007-0541-1; Unterseher M, 2008, FEMS MICROBIOL LETT, V282, P205, DOI 10.1111/j.1574-6968.2008.01128.x; Unterseher M, 2013, FUNGAL DIVERS, V60, P43, DOI 10.1007/s13225-013-0222-0; Unterseher M, 2012, FUNGAL DIVERS, V54, P133, DOI 10.1007/s13225-012-0167-8; Unterseher M, 2011, FOR SCI, V80, P31, DOI 10.1007/978-94-007-1599-8_2; Unterseher M, 2009, MYCOL RES, V113, P645, DOI 10.1016/j.mycres.2009.02.002; Vohnik M, 2013, FUNGAL ECOL, V6, P281, DOI 10.1016/j.funeco.2013.03.006; Wang Y, 2012, METHODS ECOL EVOL, V3, P471, DOI 10.1111/j.2041-210X.2012.00190.x; Warton DI, 2012, METHODS ECOL EVOL, V3, P89, DOI 10.1111/j.2041-210X.2011.00127.x; Weig AR, 2013, MYCOL PROG, V12, P719, DOI 10.1007/s11557-012-0883-1; Weiss M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016793; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	65	30	34	0	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152878	10.1371/journal.pone.0152878	http://dx.doi.org/10.1371/journal.pone.0152878			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078859	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700011
J	Goh, CJ; Choi, D; Park, DB; Kim, H; Hahn, Y				Goh, Chul Jun; Choi, Dongjin; Park, Dong-Bin; Kim, Hyein; Hahn, Yoonsoo			MOXD2, a Gene Possibly Associated with Olfaction, Is Frequently Inactivated in Birds	PLOS ONE			English	Article							EVOLUTION; INSIGHTS; TRANSDUCTION; COMPONENT; PRIMATES; ECOLOGY; MAMMALS; MOUSE; TREE	Vertebrate MOXD2 encodes a monooxygenase DBH-like 2 protein that could be involved in neurotransmitter metabolism, potentially during olfactory transduction. Loss of MOXD2 in apes and whales has been proposed to be associated with evolution of olfaction in these clades. We analyzed 57 bird genomes to identify MOXD2 sequences and found frequent loss of MOXD2 in 38 birds. Among the 57 birds, 19 species appeared to have an intact MOXD2 that encoded a full-length protein; 32 birds had a gene with open reading frame-disrupting point mutations and/or exon deletions; and the remaining 6 species did not show any MOXD2 sequence, suggesting a whole-gene deletion. Notably, among 10 passerine birds examined, 9 species shared a common genomic deletion that spanned several exons, implying the gene loss occurred in a common ancestor of these birds. However, 2 closely related penguin species, each of which had an inactive MOXD2, did not share any mutation, suggesting an independent loss after their divergence. Distribution of the 38 birds without an intact MOXD2 in the bird phylogenetic tree clearly indicates that MOXD2 loss is widespread and independent in bird lineages. We propose that widespread MOXD2 loss in some bird lineages may be implicated in the evolution of olfactory perception in these birds.	[Goh, Chul Jun; Choi, Dongjin; Park, Dong-Bin; Kim, Hyein; Hahn, Yoonsoo] Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea	Chung Ang University	Hahn, Y (corresponding author), Chung Ang Univ, Res Ctr Biomol & Biosyst, Dept Life Sci, Seoul 156756, South Korea.	hahny@cau.ac.kr		HAHN, YOONSOO/0000-0003-4273-9842	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea [2012R1A1B3001513]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology, Republic of Korea	This study was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1B3001513), Republic of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton RA, 2006, AM J PRIMATOL, V68, P545, DOI 10.1002/ajp.20251; Combarros O, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-162; Corfield JR, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00102; Cubells JF, 2011, HUM GENET, V130, P635, DOI 10.1007/s00439-011-0989-6; Dong D, 2009, GENOME BIOL EVOL, V1, P258, DOI 10.1093/gbe/evp026; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Hahn Y, 2006, HUM GENET, V119, P169, DOI 10.1007/s00439-005-0125-6; Hahn Y, 2005, BIOINFORMATICS, V21, pI186, DOI 10.1093/bioinformatics/bti1000; Hahn Y, 2007, MOL BIOL EVOL, V24, P2203, DOI 10.1093/molbev/msm146; Hayden S, 2010, GENOME RES, V20, P1, DOI 10.1101/gr.099416.109; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jiang PH, 2012, P NATL ACAD SCI USA, V109, P4956, DOI 10.1073/pnas.1118360109; Khan I, 2015, MOL BIOL EVOL, V32, P2832, DOI 10.1093/molbev/msv155; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104085; Kiselyov K, 2010, VITAM HORM, V83, P197, DOI 10.1016/S0083-6729(10)83008-0; Kishida T, 2007, BIOLOGY LETT, V3, P428, DOI 10.1098/rsbl.2007.0191; Li C, 2014, GIGASCIENCE, V3, DOI 10.1186/2047-217X-3-27; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Timmers HJLM, 2004, ANN NY ACAD SCI, V1018, P520, DOI 10.1196/annals.1296.064; Yim HS, 2014, NAT GENET, V46, P88, DOI 10.1038/ng.2835; Yu L, 2010, MOL BIOL EVOL, V27, P1467, DOI 10.1093/molbev/msq027; Zhang GJ, 2014, SCIENCE, V346, P1311, DOI 10.1126/science.1251385; Zhao HB, 2015, CURR BIOL, V25, pR141, DOI 10.1016/j.cub.2015.01.026; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207	31	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152431	10.1371/journal.pone.0152431	http://dx.doi.org/10.1371/journal.pone.0152431			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074048	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131200024
J	Xu, WG; Shen, H; Qi, XF; Wang, ZY; Wang, YF; Hu, QG; Han, W				Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei			Prognostic Factors of Primary Intraosseous Squamous Cell Carcinoma (PIOSCC): A Retrospective Review	PLOS ONE			English	Review							NECK-CANCER; ODONTOGENIC CYST; PHASE-II; HEAD; CHEMOTHERAPY; CISPLATIN; TRIAL; FLUOROURACIL; DOCETAXEL	Objectives To delineate clinical and pathological features and determine the prognostic factors of primary intraosseous squamous cell carcinoma (PIOSCC). Materials and methods Patients diagnosed with PIOSCC, attending the department of oral and maxillofacial surgery, Nanjing stomatological hospital between 2005 and 2015, were identified and retrospectively reviewed for clinical and pathological characteristics. Therapeutic modalities were measured and related follow-up data recorded, in order to determine prognostic factors of PIOSSC. Results A total of 77 patients with PIOSCC were included in the study. Mean age at diagnosis was 58.8 years, (range, 37 - 81 years). Of the 77 patients, there were 58 men and 19 women. The most common location of disease was the mandible (71.42%), particularly the posterior mandible. The common presenting symptoms included jaw swelling (79.2%) and ulceration (42.65%). The estimated 2-year and 5-year overall survival were 68.9% and 38.8%, respectively. Univariate analysis identified the following as negative prognostic factors: histological grade, N classification, nodal status and treatment modalities. However, multivariate analysis determined positive nodal status, high histological grade and advanced N classification as the independent significant prognostic factors. Conclusion Our results demonstrate several clinical and pathological features of PIOSCC and identify important prognostic factors associated with overall survival in PIOSCC. These prognostic factors include nodal status, histological grade, N classification, and treatment modalities, all of which are important for patient counseling and may be useful for the development of new treatment approaches.	[Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China; [Xu Wenguang; Shen Hao; Qi Xiaofeng; Wang Zhiyong; Wang Yufeng; Hu Qingang; Han Wei] Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Cent Lab Stomatol, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Han, W (corresponding author), Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Dept Oral & Maxillofacial Surg, Nanjing 210008, Jiangsu, Peoples R China.; Han, W (corresponding author), Nanjing Univ, Sch Med, Nanjing Stomatol Hosp, Cent Lab Stomatol, Nanjing 210008, Jiangsu, Peoples R China.	doctorhanwei@hotmail.com	Xu, Wenguang/GSD-4983-2022		National Natural Science Foundation of China [81302351]; Jiangsu provincial natural science foundation [BK2012075, BK 20131080]; Distinguished young investigator project of Nanjing [JQX14010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu provincial natural science foundation(Natural Science Foundation of Jiangsu Province); Distinguished young investigator project of Nanjing	This work was supported by the National Natural Science Foundation of China (81302351, HW) (http://www.nsfc.gov.cn/); Jiangsu provincial natural science foundation (Grant No BK2012075, BK 20131080, HW) (http://www.jstd.gov.cn/); and Distinguished young investigator project of Nanjing (JQX14010, HW) (http://www.jstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes L., 2005, PATHOLOGY GENETICS H, V9; Bodner L, 2011, J ORAL PATHOL MED, V40, P733, DOI 10.1111/j.1600-0714.2011.01058.x; Boni P, 2016, J ORAL MAXIL SURG, V74, P541, DOI 10.1016/j.joms.2015.09.009; Chaisuparat R, 2006, ORAL SURG ORAL MED O, V101, P196, DOI 10.1016/j.tripleo.2005.03.037; Dimitrakopoulos I, 2005, J ORAL MAXIL SURG, V63, P1227, DOI 10.1016/j.joms.2005.04.009; Domenge C, 2000, BRIT J CANCER, V83, P1594, DOI 10.1054/bjoc.2000.1512; Edge SB, 2010, AJCC CANC STAGING MA; Eversole LR, 2005, WHO CLASSIFICATION T, P290; Garden AS, 2004, J CLIN ONCOL, V22, P2856, DOI 10.1200/JCO.2004.12.012; Geetha P, 2015, J CANCER RES THER, V11, DOI 10.4103/0973-1482.140814; Gibson MK, 2005, J CLIN ONCOL, V23, P3562, DOI 10.1200/JCO.2005.01.057; Huang JW, 2009, ARCH PATHOL LAB MED, V133, P1834, DOI 10.1043/1543-2165-133.11.1834; PACCAGNELLA A, 1994, J NATL CANCER I, V86, P265, DOI 10.1093/jnci/86.4.265; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Pindborg JJ, 1972, HISTOLOGIC TYPING OD, P35; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Rapidis AD, 2006, ORAL ONCOL, V42, P675, DOI 10.1016/j.oraloncology.2005.12.006; SHEAR M, 1969, J PATHOL, V97, P645, DOI 10.1002/path.1710970409; SUEI Y, 1994, J ORAL MAXIL SURG, V52, P580, DOI 10.1016/0278-2391(94)90094-9; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; WALDRON CA, 1989, ORAL SURG ORAL MED O, V67, P716, DOI 10.1016/0030-4220(89)90014-5; Woolgar JA, 2013, HEAD NECK-J SCI SPEC, V35, P906, DOI 10.1002/hed.22922; Yamada T, 2009, J CRANIO MAXILL SURG, V37, P448, DOI 10.1016/j.jcms.2009.05.006	23	12	14	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153646	10.1371/journal.pone.0153646	http://dx.doi.org/10.1371/journal.pone.0153646			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074366	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200114
J	Sadredini, M; Danielsen, TK; Aronsen, JM; Manotheepan, R; Hougen, K; Sjaastad, I; Stokke, MK				Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg			Beta-Adrenoceptor Stimulation Reveals Ca2+ Waves and Sarcoplasmic Reticulum Ca2+ Depletion in Left Ventricular Cardiomyocytes from Post-Infarction Rats with and without Heart Failure	PLOS ONE			English	Article							RYANODINE RECEPTOR FUNCTION; SUDDEN CARDIAC DEATH; CALCIUM-RELEASE; DILATED CARDIOMYOPATHY; MYOCARDIAL-INFARCTION; PHOSPHORYLATION; MYOCYTES; CONTRACTILITY; SENSITIVITY; ARRHYTHMOGENESIS	Abnormal cellular Ca2+ handling contributes to both contractile dysfunction and arrhythmias in heart failure. Reduced Ca2+ transient amplitude due to decreased sarcoplasmic reticulum Ca2+ content is a common finding in heart failure models. However, heart failure models also show increased propensity for diastolic Ca2+ release events which occur when sarcoplasmic reticulum Ca2+ content exceeds a certain threshold level. Such Ca2+ release events can initiate arrhythmias. In this study we aimed to investigate if both of these aspects of altered Ca2+ homeostasis could be found in left ventricular cardiomyocytes from rats with different states of cardiac function six weeks after myocardial infarction when compared to sham-operated controls. Video edge-detection, whole-cell Ca2+ imaging and confocal linescan imaging were used to investigate cardiomyocyte contractile properties, Ca2+ transients and Ca2+ waves. In baseline conditions, i. e. without beta-adrenoceptor stimulation, cardiomyocytes from rats with large myocardial infarction, but without heart failure, did not differ from sham-operated animals in any of these aspects of cellular function. However, when exposed to beta-adrenoceptor stimulation, cardiomyocytes from both non-failing and failing rat hearts showed decreased sarcoplasmic reticulum Ca2+ content, decreased Ca2+ transient amplitude, and increased frequency of Ca2+ waves. These results are in line with a decreased threshold for diastolic Ca2+ release established by other studies. In the present study, factors that might contribute to a lower threshold for diastolic Ca2+ release were increased THR286 phosphorylation of Ca2+/calmodulin-dependent protein kinase II and increased protein phosphatase 1 abundance. In conclusion, this study demonstrates both decreased sarcoplasmic reticulum Ca2+ content and increased propensity for diastolic Ca2+ release events in ventricular cardiomyocytes from rats with heart failure after myocardial infarction, and that these phenomena are also found in rats with large myocardial infarctions without heart failure development. Importantly, beta-adrenoceptor stimulation is necessary to reveal these perturbations in Ca2+ handling after a myocardial infarction.	[Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Aronsen, Jan Magnus; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway; [Sadredini, Mani; Danielsen, Tore Kristian; Manotheepan, Ravinea; Hougen, Karina; Sjaastad, Ivar; Stokke, Mathis Korseberg] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Stokke, Mathis Korseberg] Lovisenberg Diakonale Hosp, Clin Internal Med, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Sadredini, M (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway.; Sadredini, M (corresponding author), Univ Oslo, Ctr Heart Failure Res, Oslo, Norway.	mani.sadredini@medisin.uio.no	Stokke, Mathis/AAJ-9111-2020	Stokke, Mathis/0000-0002-8869-8153; Sadredini, Mani/0000-0001-6015-7411				Ahmmed GU, 2000, CIRC RES, V86, P558, DOI 10.1161/01.RES.86.5.558; Alter P, 2012, INT J CARDIOL, V157, P233, DOI 10.1016/j.ijcard.2011.07.092; Anand IS, 1997, CIRCULATION, V96, P3974, DOI 10.1161/01.cir.96.11.3974; Belevych AE, 2012, CIRC RES, V110, P569, DOI 10.1161/CIRCRESAHA.111.260455; Belevych AE, 2011, CARDIOVASC RES, V90, P493, DOI 10.1093/cvr/cvr025; Bers DM, 2003, CIRC RES, V93, P487, DOI 10.1161/01.RES.0000091871.54907.6B; Bers DM., 2006, ALTERED CARDIAC MYOC, P380; BEUCKELMANN DJ, 1992, CIRCULATION, V85, P1046, DOI 10.1161/01.CIR.85.3.1046; Bokenes J, 2008, BASIC RES CARDIOL, V103, P328, DOI 10.1007/s00395-008-0719-y; Chandrashekhar Y, 1999, J AM COLL CARDIOL, V34, P594, DOI 10.1016/S0735-1097(99)00222-3; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Chu GX, 2002, CARDIOVASC RES, V54, P105, DOI 10.1016/S0008-6363(02)00230-4; Diaz ME, 2005, CELL CALCIUM, V38, P391, DOI 10.1016/j.ceca.2005.06.017; Eisner DA, 2009, J MOL CELL CARDIOL, V46, P474, DOI 10.1016/j.yjmcc.2008.12.005; Fischer TH, 2014, EUR J HEART FAIL, V16, P1292, DOI 10.1002/ejhf.163; Fujisawa H, 2001, J BIOCHEM-TOKYO, V129, P193, DOI 10.1093/oxfordjournals.jbchem.a002843; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gupta RC, 2003, CARDIAC SR COUPLED P, pH2373; Hobai IA, 2001, CIRCULATION, V103, P1577; Huke S, 2007, J MOL CELL CARDIOL, V42, P590, DOI 10.1016/j.yjmcc.2006.12.007; Ishitani T, 2001, J PHARMACOL EXP THER, V298, P613; Kilic A, 2006, J THORAC CARDIOV SUR, V132, P900, DOI 10.1016/j.jtcvs.2006.07.016; Kubalova Z, 2005, P NATL ACAD SCI USA, V102, P14104, DOI 10.1073/pnas.0504298102; Lehnart SE, 2006, P NATL ACAD SCI USA, V103, P7906, DOI 10.1073/pnas.0602133103; Li M, 2004, CIRCULATION, V109, P120, DOI 10.1161/01.CIR.0000105721.71640.DA; Liu B, 2014, J PHYSIOL-LONDON, V592, P1957, DOI 10.1113/jphysiol.2013.264689; Louch WE, 2013, J MOL CELL CARDIOL, V58, P41, DOI 10.1016/j.yjmcc.2013.01.014; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lunde IG, 2012, CARDIAC O GLCNAC SIG, P162; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Marston SB, 2008, J MOL CELL CARDIOL, V45, P603, DOI 10.1016/j.yjmcc.2008.07.004; MUKHARJI J, 1984, AM J CARDIOL, V54, P31, DOI 10.1016/0002-9149(84)90299-6; MUSCH TI, 1986, CIRCULATION, V74, P431, DOI 10.1161/01.CIR.74.2.431; Myles RC, 2015, J PHYSIOL-LONDON, V593, P1479, DOI 10.1113/jphysiol.2014.279638; Neumann J, 1997, J MOL CELL CARDIOL, V29, P265, DOI 10.1006/jmcc.1996.0271; Oda T, 2015, J MOL CELL CARDIOL, V85, P240, DOI 10.1016/j.yjmcc.2015.06.009; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Ribeiro AJS, 2014, ACS APPL MATER INTER, V6, P15516, DOI 10.1021/am5042324; Sanders P, 2004, CIRCULATION, V110, P897, DOI 10.1161/01.CIR.0000139336.69955.AB; SELYE H., 1960, ANGIOLOGY, V11, P398, DOI 10.1177/000331976001100505; Sjaastad I, 2000, J APPL PHYSIOL, V89, P1445, DOI 10.1152/jappl.2000.89.4.1445; Terentyev D, 2003, J PHYSIOL-LONDON, V552, P109, DOI 10.1113/jphysiol.2003.046367; Venetucci LA, 2008, CARDIOVASC RES, V77, P285, DOI 10.1093/cvr/cvm009; Wang QL, 2015, J MOL CELL CARDIOL, V89, P177, DOI 10.1016/j.yjmcc.2015.11.009; Wasserstrom JA, 2000, AM J PHYSIOL-HEART C, V279, pH798, DOI 10.1152/ajpheart.2000.279.2.H798; Wehrens XHT, 2006, P NATL ACAD SCI USA, V103, P511, DOI 10.1073/pnas.0510113103; Wehrens XHT, 2003, CELL, V113, P829, DOI 10.1016/S0092-8674(03)00434-3; Wisloff U, 2001, CARDIOVASC RES, V50, P495, DOI 10.1016/S0008-6363(01)00210-3; Young AA, 2001, CARDIOVASC RES, V49, P308, DOI 10.1016/S0008-6363(00)00248-0; Zhao ZZ, 2012, AM J PHYSIOL-HEART C, V302, pH1636, DOI 10.1152/ajpheart.00742.2011	50	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153887	10.1371/journal.pone.0153887	http://dx.doi.org/10.1371/journal.pone.0153887			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096943	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600066
J	Schmidt-Richberg, A; Ledig, C; Guerrero, R; Molina-Abril, H; Frangi, A; Rueckert, D				Schmidt-Richberg, Alexander; Ledig, Christian; Guerrero, Ricardo; Molina-Abril, Helena; Frangi, Alejandro; Rueckert, Daniel		Alzheimer's Dis Neuroimaging	Learning Biomarker Models for Progression Estimation of Alzheimer's Disease	PLOS ONE			English	Article							TRANSITION-PROBABILITIES; QUANTILE REGRESSION; TIME; ATLAS; CLASSIFICATION; CONSTRUCTION; ATROPHY; POINT; RATES	Being able to estimate a patient's progress in the course of Alzheimer's disease and predicting future progression based on a number of observed biomarker values is of great interest for patients, clinicians and researchers alike. In this work, an approach for disease progress estimation is presented. Based on a set of subjects that convert to a more severe disease stage during the study, models that describe typical trajectories of biomarker values in the course of disease are learned using quantile regression. A novel probabilistic method is then derived to estimate the current disease progress as well as the rate of progression of an individual by fitting acquired biomarkers to the models. A particular strength of the method is its ability to naturally handle missing data. This means, it is applicable even if individual biomarker measurements are missing for a subject without requiring a retraining of the model. The functionality of the presented method is demonstrated using synthetic and -employing cognitive scores and image-based biomarkers-real data from the ADNI study. Further, three possible applications for progress estimation are demonstrated to underline the versatility of the approach: classification, construction of a spatio-temporal disease progression atlas and prediction of future disease progression.	[Schmidt-Richberg, Alexander; Ledig, Christian; Guerrero, Ricardo; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Biomed Image Anal Grp, London, England; [Molina-Abril, Helena; Frangi, Alejandro] Univ Sheffield, Ctr Computat Imaging & Simulat Technol Biomed CIS, Sheffield, S Yorkshire, England	Imperial College London; University of Sheffield	Schmidt-Richberg, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Biomed Image Anal Grp, London, England.	alexander.schmidt-richberg@philips.com	Frangi, Alejandro F/C-6500-2008	Frangi, Alejandro F/0000-0002-2675-528X; Molina-Abril, Helena/0000-0001-5595-132X; Ledig, Christian/0000-0003-4862-3138	VPH-DARE@IT [FP7-ICT-2011-9-601055]	VPH-DARE@IT	This work was supported by VPH-DARE@IT, project identifier: FP7-ICT-2011-9-601055 (funding of ASR).	Bron E, 2015, NEUROIMAGE UNPUB; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Caro JJ, 2001, NEUROLOGY, V57, P964, DOI 10.1212/WNL.57.6.964; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Coley N, 2011, ALZHEIMERS DEMENT, V7, P602, DOI 10.1016/j.jalz.2011.01.005; Cuingnet R, 2011, NEUROIMAGE, V56, P766, DOI 10.1016/j.neuroimage.2010.06.013; Davis BC, 2010, INT J COMPUT VISION, V90, P255, DOI 10.1007/s11263-010-0367-1; Delor I, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.54; Donohue MC, 2014, ALZHEIMERS DEMENT, V10, pS400, DOI 10.1016/j.jalz.2013.10.003; Doody RS, 2010, ALZHEIMERS RES THER, V2, DOI [10.1186/alzrt25, 10.1186/alzrt38]; Doody RS, 2001, ARCH NEUROL-CHICAGO, V58, P449, DOI 10.1001/archneur.58.3.449; Durrleman S, 2013, INT J COMPUT VISION, V103, P22, DOI 10.1007/s11263-012-0592-x; Fonteijn HM, 2012, NEUROIMAGE, V60, P1880, DOI 10.1016/j.neuroimage.2012.01.062; Gaser C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067346; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Green C, 2011, VALUE HEALTH, V14, P621, DOI 10.1016/j.jval.2010.12.008; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; Guerrero R, 2014, NEUROIMAGE, V94, P275, DOI 10.1016/j.neuroimage.2014.03.036; Guerrero R, 2014, LECT NOTES COMPUT SC, V8679, P77, DOI 10.1007/978-3-319-10581-9_10; Hastie T., 1986, STAT SCI, V1, P297; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Hua X, 2010, NEUROIMAGE, V51, P63, DOI 10.1016/j.neuroimage.2010.01.104; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; Jack CR, 2012, ARCH NEUROL-CHICAGO, V69, P856, DOI 10.1001/archneurol.2011.3405; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2004, NEUROLOGY, V62, P591, DOI 10.1212/01.WNL.0000110315.26026.EF; Joshi S, 2004, NEUROIMAGE, V23, pS151, DOI 10.1016/j.neuroimage.2004.07.068; Kazemi K, 2007, NEUROIMAGE, V37, P463, DOI 10.1016/j.neuroimage.2007.05.004; Koenker R., 2010, ECONOMETRIC SOC MONO, V2005, P295; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Li CX, 2015, BIOMETRICS, V71, P625, DOI 10.1111/biom.12313; Lorenzi M, 2015, NEUROIMAGE, V115, P224, DOI 10.1016/j.neuroimage.2015.04.051; Lorenzi M, 2015, NEUROBIOL AGING, V36, pS42, DOI 10.1016/j.neurobiolaging.2014.07.046; Moradi E, 2014, NEUROIMAGE IN PRESS; Neumann PJ, 2001, NEUROLOGY, V57, P957, DOI 10.1212/WNL.57.6.957; Razlighi QR, 2014, J ALZHEIMERS DIS, V38, P661, DOI 10.3233/JAD-131142; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabuncu MR, 2014, NEUROIMAGE, V97, P9, DOI 10.1016/j.neuroimage.2014.04.015; Schmidt-Richberg Alexander, 2015, Inf Process Med Imaging, V24, P387, DOI 10.1007/978-3-319-19992-4_30; Schuh A, 2014, SPATIO TEMP IN PRESS; Serag A, 2012, NEUROIMAGE, V59, P2255, DOI 10.1016/j.neuroimage.2011.09.062; Sherwood B, 2015, ALZHEIMERS DEMENTIA; Singh N, 2014, MED IMAGE ANAL, V18, P616, DOI 10.1016/j.media.2014.01.001; Spackman DE, 2012, CURR ALZHEIMER RES, V9, P1050; Stallard E, 2010, MED DECIS MAKING, V30, P625, DOI 10.1177/0272989X10363479; Wolz R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025446; Yang E, 2011, J ALZHEIMERS DIS, V26, P745, DOI 10.3233/JAD-2011-110551; Yee TW, 2004, STAT MED, V23, P2295, DOI 10.1002/sim.1822; Yeo IK, 2000, BIOMETRIKA, V87, P954, DOI 10.1093/biomet/87.4.954; Young AL, 2014, BRAIN, V137, P2564, DOI 10.1093/brain/awu176	50	15	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153040	10.1371/journal.pone.0153040	http://dx.doi.org/10.1371/journal.pone.0153040			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096739	Green Published, Green Accepted, gold			2022-12-27	WOS:000374543600025
J	Sun, DL; Lee, TMC; Wang, ZX; Chan, CCH				Sun, Delin; Lee, Tatia M. C.; Wang, Zhaoxin; Chan, Chetwyn C. H.			Unfolding the Spatial and Temporal Neural Processing of Making Dishonest Choices	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; SOCIAL DECISION-MAKING; RISK-TAKING; SOURCE RECONSTRUCTION; DECEPTIVE RESPONSES; EXECUTIVE PROCESSES; PREFRONTAL CORTEX; HUMAN AWARENESS; INSULA; GAME	To understand the neural processing that underpins dishonest behavior in an economic exchange game task, this study employed both functional magnetic resonance imaging (fMRI) and event-related potential (ERP) methodologies to examine the neural conditions of 25 participants while they were making either dishonest or honest choices. It was discovered that dishonest choices, contrary to honest choices, elicited stronger fMRI activations in bilateral striatum and anterior insula. It also induced fluctuations in ERP amplitudes within two time windows, which are 270-30 milliseconds before and 110-290 milliseconds after the response, respectively. Importantly, when making either dishonest or honest choices, human and computer counterparts were associated with distinct fMRI activations in the left insula and different ERP amplitudes at medial and right central sites from 80 milliseconds before to 250 milliseconds after the response. These results support the hypothesis that there would be distinct neural processing during making dishonest decisions, especially when the subject considers the interests of the counterpart. Furthermore, the fMRI and ERP findings, together with ERP source reconstruction, clearly delineate the temporal sequence of the neural processes of a dishonest decision: the striatum is activated before response, then the left insula is involved around the time of response, and finally the thalamus is activated after response.	[Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China; [Sun, Delin; Lee, Tatia M. C.] Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China; [Lee, Tatia M. C.] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, Zhaoxin] E China Normal Univ, Sch Psychol & Cognit Sci, Inst Cognit Neurosci, Key Lab Brain Funct Genom MOE & STCSM, Shanghai 200062, Peoples R China; [Chan, Chetwyn C. H.] Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; East China Normal University; Hong Kong Polytechnic University	Lee, TMC (corresponding author), Univ Hong Kong, Neuropsychol Lab, Hong Kong, Hong Kong, Peoples R China.; Lee, TMC (corresponding author), Univ Hong Kong, Lab Cognit Affect Neurosci, Hong Kong, Hong Kong, Peoples R China.; Lee, TMC (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China.; Chan, CCH (corresponding author), Hong Kong Polytech Univ, Dept Rehabil Sci, Appl Cognit Neurosci Lab, Hong Kong, Hong Kong, Peoples R China.	tmclee@hku.hk; chetwyn.chan@polyu.edu.hk	Sun, Delin/H-8070-2019	Sun, Delin/0000-0003-3283-423X; Chan, Chetwyn C. H./0000-0003-0307-6337	University of Hong Kong; National Natural Science Fund of China [31070986]; KKHo International Charitable Foundation	University of Hong Kong(University of Hong Kong); National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); KKHo International Charitable Foundation	This work was supported by The University of Hong Kong May Endowed Professorship in Neuropsychology and the National Natural Science Fund of China (Ref: 31070986). The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding to pay the Open Access publication charges for this article was provided by the the KKHo International Charitable Foundation.	Abe N, 2014, BRAIN COGNITION, V90, P41, DOI 10.1016/j.bandc.2014.06.005; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Craig AD, 2011, ANN NY ACAD SCI, V1225, P72, DOI 10.1111/j.1749-6632.2011.05990.x; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Vignemont F, 2006, TRENDS COGN SCI, V10, P435, DOI 10.1016/j.tics.2006.08.008; Duerden EG, 2013, NEUROIMAGE, V78, P159, DOI 10.1016/j.neuroimage.2013.04.014; Fehr E, 2007, TRENDS COGN SCI, V11, P419, DOI 10.1016/j.tics.2007.09.002; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Greene JD, 2009, P NATL ACAD SCI USA, V106, P12506, DOI 10.1073/pnas.0900152106; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Henson RN, 2010, HUM BRAIN MAPP, V31, P1512, DOI 10.1002/hbm.20956; Hilbig BE, 2009, J RES PERS, V43, P516, DOI 10.1016/j.jrp.2009.01.003; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Johnson R, 2005, COGNITIVE BRAIN RES, V24, P386, DOI 10.1016/j.cogbrainres.2005.02.011; Johnson R, 2008, NEUROIMAGE, V39, P469, DOI 10.1016/j.neuroimage.2007.08.032; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2007, J NEUROSCI, V27, P8174, DOI 10.1523/JNEUROSCI.1564-07.2007; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Krajbich I, 2009, J NEUROSCI, V29, P2188, DOI 10.1523/JNEUROSCI.5086-08.2009; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Lee TMC, 2009, CEREB CORTEX, V19, P1303, DOI 10.1093/cercor/bhn172; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; Montague PR, 2007, NEURON, V56, P14, DOI 10.1016/j.neuron.2007.09.020; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Rilling JK, 2008, NEUROPSYCHOLOGIA, V46, P1256, DOI 10.1016/j.neuropsychologia.2007.11.033; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; ROGERS CR, 1964, J ABNORM SOC PSYCH, V68, P160, DOI 10.1037/h0046419; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SAXE L, 1991, AM PSYCHOL, V46, P409, DOI 10.1037/0003-066X.46.4.409; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sip KE, 2010, NEUROPSYCHOLOGIA, V48, P3619, DOI 10.1016/j.neuropsychologia.2010.08.013; Sun DL, 2015, CEREB CORTEX, V25, P927, DOI 10.1093/cercor/bht284; Sun DL, 2015, NEUROPSYCHOLOGIA, V68, P148, DOI 10.1016/j.neuropsychologia.2015.01.013; van den Bos W, 2009, SOC COGN AFFECT NEUR, V4, P294, DOI 10.1093/scan/nsp009; Vrij A., 2004, DETECTION DECEPTION; Wager TD, 2005, NEUROIMAGE, V26, P99, DOI 10.1016/j.neuroimage.2005.01.011; Wu DC, 2011, BRAIN RES, V1389, P115, DOI 10.1016/j.brainres.2011.02.084; Yu RJ, 2009, J COGNITIVE NEUROSCI, V21, P684, DOI 10.1162/jocn.2009.21034; Zhang HJ, 2012, BRAIN BEHAV, V2, P415, DOI 10.1002/brb3.62	48	10	11	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153660	10.1371/journal.pone.0153660	http://dx.doi.org/10.1371/journal.pone.0153660			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096474	gold, Green Published			2022-12-27	WOS:000374543600048
J	Verstraelen, H; Vervaet, C; Remon, JP				Verstraelen, Hans; Vervaet, Chris; Remon, Jean-Paul			Rationale and Safety Assessment of a Novel Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release, Intended for Long-Term Protection of the Vaginal Microbiome	PLOS ONE			English	Article							MUCOSAL IRRITATION TEST; BACTERIAL-VAGINOSIS; ORAL METRONIDAZOLE; LOCAL TOLERANCE; HEALTH; MECHANISMS; GLYCOGEN; FLUID; FORMULATIONS; NONOXYNOL-9	Bacterial vaginosis is a prevalent state of dysbiosis of the vaginal microbiota with wide-ranging impact on human reproductive health. Based on recent insights in community ecology of the vaginal microbiome, we hypothesize that sustained vaginal DL-lactic acid enrichment will enhance the recruitment of lactobacilli, while counteracting bacterial vaginosis-associated bacteria. We therefore aimed to develop an intravaginal device that would be easy to insert and remove, while providing sustained DL-lactic acid release into the vaginal lumen. The final prototype selected is a vaginal ring matrix system consisting of a mixture of ethylene vinyl acetate and methacrylic acid -methyl methacrylate copolymer loaded with 150 mg DL -lactic acid with an UD-lactic acid ratio of 1:1. Preclinical safety assessment was performed by use of the Slug Mucosal Irritation test, a non-vertebrate assay to evaluate vaginal mucosal irritation, which revealed no irritation. Clinical safety was evaluated in a phase I trial with six healthy nulliparous premenopausal volunteering women, with the investigational drug left in place for 7 days. Colposcopic monitoring according to the WHO/CONRAD guidelines for the evaluation of vaginal products, revealed no visible cervicovaginal mucosal changes. No adverse events related to the investigational product occurred. Total release from the intravaginal ring over 7 days was estimated through high performance liquid chromatography at 37.1 (standard deviation 0.9) mg DL -lactic acid. Semisolid lactic acid formulations have been studied to a limited extent in the past and typically consist of a large volume of excipients and very high doses of lactic acid, which is of major concern to mucosal safety. We have documented the feasability of enriching the vaginal environment with pure DL -lactic acid with a prototype intravaginal ring. Though the efficacy of this platform remains to be established possibly requiring further development, this approach may offer a novel avenue to modulate and protect the vaginal microbiota.	[Verstraelen, Hans] Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Vervaet, Chris; Remon, Jean-Paul] Univ Ghent, Dept Pharmaceut, Lab Pharmaceut Technol, Fac Pharmaceut Sci, B-9000 Ghent, Belgium	Ghent University; Ghent University	Verstraelen, H (corresponding author), Univ Ghent, Dept Obstet & Gynaecol, Fac Med & Hlth Sci, B-9000 Ghent, Belgium.	hans.verstraelen@ugent.be	Verstraelen, Hans/A-5602-2008; Verstraelen, Hans/AAA-8694-2019	Verstraelen, Hans/0000-0002-4070-1587	Ghent University Industrial Research Fund (IOF) [F2011/IOF-Advanced/131]	Ghent University Industrial Research Fund (IOF)	The study was funded by the Ghent University Industrial Research Fund (IOF) under grant number F2011/IOF-Advanced/131, http://www.techtransfer.ugent.be/en/support-for-academics/industrial-research-fund. HV, CV, and JPR obtained funding through this grant for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens E, 2002, TOXICOL APPL PHARM, V182, P169, DOI 10.1006/taap.2002.9444; Adriaens E, 2008, SEX TRANSM DIS, V35, P512, DOI 10.1097/OLQ.0b013e3181644669; Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Aldunate M, 2013, J ANTIMICROB CHEMOTH, V68, P2015, DOI 10.1093/jac/dkt156; ANDERSCH B, 1990, GYNECOL OBSTET INVES, V30, P114, DOI 10.1159/000293230; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; BOEKE AJP, 1993, GENITOURIN MED, V69, P388; Brache V, 2010, CONTRACEPTION, V82, P418, DOI 10.1016/j.contraception.2010.04.012; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Decena DCD, 2006, J OBSTET GYNAECOL RE, V32, P243, DOI 10.1111/j.1447-0756.2006.00383.x; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; Dhondt MMM, 2005, EUR J PHARM BIOPHARM, V60, P419, DOI 10.1016/j.ejpb.2005.01.012; Dhondt MMM, 2004, SEX TRANSM DIS, V31, P229, DOI 10.1097/01.OLQ.0000118422.62336.FA; Fichorova RN, 2015, TOXICOL APPL PHARM, V285, P198, DOI 10.1016/j.taap.2015.02.017; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Gong Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107758; GREAVES WL, 1988, OBSTET GYNECOL, V72, P799; Hay P, 2009, CURR OPIN INFECT DIS, V22, P82, DOI 10.1097/QCO.0b013e32832180c6; Hladik F, 2015, ELIFE, V4, DOI 10.7554/eLife.04525; HOLST E, 1990, SCAND J INFECT DIS, V22, P625, DOI 10.3109/00365549009027109; Homayouni A, 2014, J LOW GENIT TRACT DI, V18, P79, DOI 10.1097/LGT.0b013e31829156ec; Huang HH, 2014, ARCH GYNECOL OBSTET, V289, P1225, DOI 10.1007/s00404-013-3117-0; Hussain A, 2005, J CONTROL RELEASE, V103, P301, DOI 10.1016/j.jconrel.2004.11.034; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Karlyshev AV, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01221-13; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Linhares I. M., 2011, AM J OBSTET GYNECOL, V120, P1, DOI [10.1016/j.ajog.2010.07.010, DOI 10.1016/J.AJOG.2010.07.010, DOI 10.1016/J.AJ0G.2010.07.010]; Lopes dos Santos Santiago G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045281; Macklaim JM, 2011, P NATL ACAD SCI USA, V108, P4688, DOI 10.1073/pnas.1000086107; Martin DH, 2012, AM J MED SCI, V343, P2, DOI 10.1097/MAJ.0b013e31823ea228; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; Mastromarino P, 2013, NEW MICROBIOL, V36, P229; Mendes-Soares H, 2014, J BACTERIOL, V196, P1458, DOI 10.1128/JB.01439-13; Mirmonsef P, 2015, MENOPAUSE, V22, P702, DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2012, AIDS RES HUM RETROV, V28, P76, DOI [10.1089/AID.2011.0071, 10.1089/aid.2011.0071]; Nasioudis D, 2015, REPROD SCI, V22, P1393, DOI 10.1177/1933719115581000; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Ojala T, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1070; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; PHEIFER TA, 1978, NEW ENGL J MED, V298, P1429, DOI 10.1056/NEJM197806292982601; Power SE, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.01070-13; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Reid G, 2015, AM J REPROD IMMUNOL, V73, P1, DOI 10.1111/aji.12319; Senok AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006289.pub2; Sirota I, 2014, SEMIN REPROD MED, V32, P35, DOI 10.1055/s-0033-1361821; Smith-McCune K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129769; Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041; Spear GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132646; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Srinivasan S, 2015, MBIO, V6, DOI 10.1128/mBio.00204-15; Stumpf RM, 2013, AM J PHYS ANTHROPOL, V152, P119, DOI 10.1002/ajpa.22395; Van Damme L, 2002, LANCET, V360, P971, DOI 10.1016/S0140-6736(02)11079-8; van de Wijgert JHHM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105998; van Oostrum N, 2013, HUM REPROD, V28, P1809, DOI 10.1093/humrep/det096; Verstraelen H, 2013, CURR OPIN INFECT DIS, V26, P86, DOI 10.1097/QCO.0b013e32835c20cd; Verstraelen H, 2009, EXPERT REV ANTI-INFE, V7, P1109, DOI [10.1586/eri.09.87, 10.1586/ERI.09.87]; Verstraelen H, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-116; WHO/CONRAD, 2004, MAN STAND COLP EV VA; Witkin SS, 2015, BJOG-INT J OBSTET GY, V122, P213, DOI 10.1111/1471-0528.13115; Witkin SS, 2013, MBIO, V4, DOI 10.1128/mBio.00460-13; Yeoman CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056111; Yildirim S, 2014, ISME J, V8, P2431, DOI 10.1038/ismej.2014.90	69	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153441	10.1371/journal.pone.0153441	http://dx.doi.org/10.1371/journal.pone.0153441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093291	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200021
J	Corkrey, R; McMeekin, TA; Bowman, JP; Ratkowsky, DA; Olley, J; Ross, T				Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom			The Biokinetic Spectrum for Temperature	PLOS ONE			English	Article							PROTEIN-FOLDING THERMODYNAMICS; SACCHAROMYCES-CEREVISIAE; QUANTILE REGRESSION; METABOLIC THEORY; SYSTEMS BIOLOGY; GROWTH-RATE; LIFE; THERMOSTABILITY; ADAPTATION; HYPOTHESIS	We identify and describe the distribution of temperature-dependent specific growth rates for life on Earth, which we term the biokinetic spectrum for temperature. The spectrum has the potential to provide for more robust modeling in thermal ecology since any conclusions derived from it will be based on observed data rather than using theoretical assumptions. It may also provide constraints for systems biology model predictions and provide insights in physiology. The spectrum has Delta-shape with a sharp peak at around 42 degrees C. At higher temperatures up to 60 degrees C there was a gap of attenuated growth rates. We found another peak at 67 degrees C and a steady decline in maximum rates thereafter. By using Bayesian quantile regression to summarise and explore the data we were able to conclude that the gap represented an actual biological transition between mesophiles and thermophiles that we term the Mesophile-Thermophile Gap ( MTG). We have not identified any organism that grows above the maximum rate of the spectrum. We used a thermodynamic model to recover the Delta-shape, suggesting that the growth rate limits arise from a trade-off between activity and stability of proteins. The spectrum provides underpinning principles that will find utility in models concerned with the thermal responses of biological processes.	[Corkrey, Ross; McMeekin, Tom A.; Bowman, John P.; Ratkowsky, David A.; Olley, June; Ross, Tom] Univ Tasmania, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tas, Australia	University of Tasmania	Corkrey, R (corresponding author), Univ Tasmania, Sch Land & Food, Tasmanian Inst Agr, Hobart, Tas, Australia.	scorkrey@utas.edu.au	Bowman, John P/C-2414-2014; Bowman, John P./ABF-5108-2020; Corkrey, Stephen/C-2424-2014	Bowman, John P/0000-0002-4528-9333; Bowman, John P./0000-0002-4528-9333; Corkrey, Stephen/0000-0002-2242-2891; Ross, Tom/0000-0001-9916-7772				BALDWIN RL, 1986, P NATL ACAD SCI USA, V83, P8069, DOI 10.1073/pnas.83.21.8069; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Brocchieri L, 2005, NUCLEIC ACIDS RES, V33, P3390, DOI 10.1093/nar/gki615; Brooks SP, 1998, J ROY STAT SOC D-STA, V47, P69, DOI 10.1111/1467-9884.00117; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Clarke A, 2006, FUNCT ECOL, V20, P405, DOI 10.1111/j.1365-2435.2006.01109.x; Clarke A, 2014, INT J ASTROBIOL, V13, P141, DOI 10.1017/S1473550413000438; Corkrey R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096100; Corkrey R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032003; Cruz ALB, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-151; Das Rajdeep, 2000, Functional and Integrative Genomics, V1, P76, DOI 10.1007/s101420050009; Davies PCW, 2005, ASTROBIOLOGY, V5, P154, DOI 10.1089/ast.2005.5.154; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Gilks W.R., 1996, MARKOV CHAIN MONTE C, P89; GILKS WR, 1994, STATISTICIAN, V43, P179, DOI 10.2307/2348942; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hulbert AJ, 2014, SYSTEMS, V2, P186, DOI 10.3390/systems2020186; Iyer-Biswas S, 2014, P NATL ACAD SCI USA, V111, P15912, DOI 10.1073/pnas.1403232111; Kirk PDW, 2015, SCIENCE, V350, P386, DOI 10.1126/science.aac9505; Kitano H, 2002, NATURE, V420, P206, DOI 10.1038/nature01254; KOCH AL, 1988, CAN J MICROBIOL, V34, P421, DOI 10.1139/m88-074; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; LIESACK W, 1992, BIODIVERS CONSERV, V1, P250, DOI 10.1007/BF00693763; MAKHATADZE GI, 1993, J MOL BIOL, V232, P639, DOI 10.1006/jmbi.1993.1416; MURPHY KP, 1990, SCIENCE, V247, P559, DOI 10.1126/science.2300815; PIRT SJ, 1982, ARCH MICROBIOL, V133, P300, DOI 10.1007/BF00521294; Postmus J, 2008, J BIOL CHEM, V283, P23524, DOI 10.1074/jbc.M802908200; Postmus J, 2011, MICROBIOL-SGM, V157, P3500, DOI 10.1099/mic.0.050039-0; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1993, J MOL BIOL, V232, P660, DOI 10.1006/jmbi.1993.1417; Ratkowsky DA, 2005, J THEOR BIOL, V233, P351, DOI 10.1016/j.jtbi.2004.10.016; RATKOWSKY DA, 1983, J BACTERIOL, V154, P1222, DOI 10.1128/JB.154.3.1222-1226.1983; Ross T, 1993, THESIS U TASMANIA HO; Ross T., 1997, INT INST REFRIG, P64; Sabath N, 2013, GENOME BIOL EVOL, V5, P966, DOI 10.1093/gbe/evt050; Thompson MJ, 1999, J MOL BIOL, V290, P595, DOI 10.1006/jmbi.1999.2889; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WIEGEL J, 1990, FEMS MICROBIOL LETT, V75, P155, DOI 10.1016/0378-1097(90)90529-Y; Yu KM, 2001, STAT PROBABIL LETT, V54, P437, DOI 10.1016/S0167-7152(01)00124-9; Zhang JZ, 2000, TRENDS GENET, V16, P107, DOI 10.1016/S0168-9525(99)01922-8	43	19	19	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153343	10.1371/journal.pone.0153343	http://dx.doi.org/10.1371/journal.pone.0153343			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088362	gold, Green Published, Green Submitted			2022-12-27	WOS:000374527000019
J	Huang, KH; Mychack, A; Tchorzewski, L; Janakiraman, A				Huang, Kuo-Hsiang; Mychack, Aaron; Tchorzewski, Lukasz; Janakiraman, Anuradha			Characterization of the FtsZ C-Terminal Variable (CTV) Region in Z-Ring Assembly and Interaction with the Z-Ring Stabilizer ZapD in E. coli Cytokinesis	PLOS ONE			English	Article							CELL-DIVISION PROTEIN; CRYSTAL-STRUCTURE; FUNCTIONAL ANALYSES; IN-VITRO; ZIPA; PROMOTES; BINDING; TAIL; SUPERRESOLUTION; LOCALIZATION	Polymerization of a ring-like cytoskeletal structure, the Z-ring, at midcell is a highly conserved feature in virtually all bacteria. The Z-ring is composed of short protofilaments of the tubulin homolog FtsZ, randomly arranged and held together through lateral interactions. In vitro, lateral associations between FtsZ protofilaments are stabilized by crowding agents, high concentrations of divalent cations, or in some cases, low pH. In vivo, the last 4-10 amino acid residues at the C-terminus of FtsZ (the C-terminal variable region, CTV) have been implicated in mediating lateral associations between FtsZ protofilaments through charge shielding. Multiple Z-ring associated proteins (Zaps), also promote lateral interactions between FtsZ protofilaments to stabilize the FtsZ ring in vivo. Here we characterize the complementary role/s of the CTV of E. coli FtsZ and the FtsZ-ring stabilizing protein ZapD, in FtsZ assembly. We show that the net charge of the FtsZ CTV not only affects FtsZ protofilament bundling, confirming earlier observations, but likely also the length of the FtsZ protofilaments in vitro. The CTV residues also have important consequences for Z-ring assembly and interaction with ZapD in the cell. ZapD requires the FtsZ CTV region for interaction with FtsZ in vitro and for localization to midcell in vivo. Our data suggest a mechanism in which the CTV residues, particularly K380, facilitate a conformation for the conserved carboxy-terminal residues in FtsZ, that lie immediately N-terminal to the CTV, to enable optimal contact with ZapD. Further, phylogenetic analyses suggest a correlation between the nature of FtsZ CTV residues and the presence of ZapD in the beta-gamma-proteobacterial species.	[Huang, Kuo-Hsiang; Mychack, Aaron; Tchorzewski, Lukasz; Janakiraman, Anuradha] CUNY City Coll, Dept Biol, 160 Convent Ave,MR 526, New York, NY USA; [Huang, Kuo-Hsiang; Mychack, Aaron; Janakiraman, Anuradha] CUNY, Grad Ctr, 365 Fifth Ave, New York, NY USA; [Tchorzewski, Lukasz] Alpha Labs LLC, 14-26 28th Ave, Long Isl City, NY USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System	Janakiraman, A (corresponding author), CUNY City Coll, Dept Biol, 160 Convent Ave,MR 526, New York, NY USA.	anuj@ccny.cuny.edu			National Science Foundation [MCB 1158059]; National Institute on Minority Health and Health Disparities award [8G12MD007603-29]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute on Minority Health and Health Disparities award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was funded by a National Science Foundation grant (MCB 1158059) to AJ. A National Institute on Minority Health and Health Disparities award (8G12MD007603-29) provides core facility support to the City College of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Bhattacharya A, 2015, INT J BIOL MACROMOL, V81, P435, DOI 10.1016/j.ijbiomac.2015.08.030; Buske PJ, 2013, MOL MICROBIOL, V89, P249, DOI 10.1111/mmi.12272; Buske PJ, 2012, J BIOL CHEM, V287, P10945, DOI 10.1074/jbc.M111.330324; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Buss J, 2013, MOL MICROBIOL, V89, P1099, DOI 10.1111/mmi.12331; Camberg JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094964; Dajkovic A, 2010, MOL MICROBIOL, V78, P651, DOI 10.1111/j.1365-2958.2010.07352.x; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; DEBOER P, 1992, NATURE, V359, P254, DOI 10.1038/359254a0; Du SS, 2015, MOL MICROBIOL, V95, P173, DOI 10.1111/mmi.12854; Du SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004460; Durand-Heredia J, 2012, J BACTERIOL, V194, P3189, DOI 10.1128/JB.00176-12; Durand-Heredia JM, 2011, J BACTERIOL, V193, P1405, DOI 10.1128/JB.01258-10; Ebersbach G, 2008, MOL MICROBIOL, V68, P720, DOI 10.1111/j.1365-2958.2008.06190.x; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Galli E, 2012, J BACTERIOL, V194, P292, DOI 10.1128/JB.05821-11; Galli E, 2010, MOL MICROBIOL, V76, P1514, DOI 10.1111/j.1365-2958.2010.07183.x; Gardner KAJA, 2013, MOL MICROBIOL, V89, P264, DOI 10.1111/mmi.12279; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Gueiros FJ, 2002, GENE DEV, V16, P2544, DOI 10.1101/gad.1014102; Guo F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012680; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Haney SA, 2001, J BIOL CHEM, V276, P11980, DOI 10.1074/jbc.M009810200; Huang KH, 2013, J BACTERIOL, V195, P1859, DOI 10.1128/JB.02157-12; Rico AI, 2010, MOL MICROBIOL, V76, P760, DOI 10.1111/j.1365-2958.2010.07134.x; Janakiraman A, 2004, P NATL ACAD SCI USA, V101, P835, DOI 10.1073/pnas.0305747101; Krol E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043293; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Lutkenhaus J, 2012, CYTOSKELETON, V69, P778, DOI 10.1002/cm.21054; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Mohammadi T, 2009, BIOCHEMISTRY-US, V48, P11056, DOI 10.1021/bi901461p; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; MUKHERJEE A, 1993, P NATL ACAD SCI USA, V90, P1053, DOI 10.1073/pnas.90.3.1053; Oliva MA, 2004, NAT STRUCT MOL BIOL, V11, P1243, DOI 10.1038/nsmb855; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Ortiz C, 2015, FEBS LETT, V589, P3822, DOI 10.1016/j.febslet.2015.11.030; Osawa M, 2008, SCIENCE, V320, P792, DOI 10.1126/science.1154520; Osawa M, 2009, EMBO J, V28, P3476, DOI 10.1038/emboj.2009.277; Pacheco-Gomez R, 2013, BIOCHEM J, V449, P795, DOI 10.1042/BJ20120140; Pazos M, 2013, J BIOL CHEM, V288, P3219, DOI 10.1074/jbc.M112.434944; PHOENIX P, 1988, J BACTERIOL, V170, P4338, DOI 10.1128/jb.170.9.4338-4342.1988; Pichoff S, 2002, EMBO J, V21, P685, DOI 10.1093/emboj/21.4.685; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Powell BS, 1998, J BACTERIOL, V180, P1053, DOI 10.1128/JB.180.5.1053-1062.1998; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; RAYCHAUDHURI D, 1994, J BIOL CHEM, V269, P22941; RAYCHAUDHURI D, 1992, NATURE, V359, P251, DOI 10.1038/359251a0; Roach EJ, 2014, J BIOL CHEM, V289, P23276, DOI 10.1074/jbc.M114.561928; Romberg L, 2001, J BIOL CHEM, V276, P11743, DOI 10.1074/jbc.M009033200; Rowlett VW, 2014, BIOPHYS J, V107, pL17, DOI 10.1016/j.bpj.2014.08.024; Schmitz AM, 2009, NAT METHODS, V6, P500, DOI 10.1038/nmeth.1337; Schumacher MA, 2016, J BIOL CHEM, V291, P2485, DOI 10.1074/jbc.M115.697037; Shen B, 2009, MOL MICROBIOL, V72, P410, DOI 10.1111/j.1365-2958.2009.06651.x; Si FW, 2013, BIOPHYS J, V105, P1976, DOI 10.1016/j.bpj.2013.09.030; Szwedziak P, 2014, ELIFE, V3, DOI 10.7554/eLife.04601; Szwedziak P, 2012, EMBO J, V31, P2249, DOI 10.1038/emboj.2012.76; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weiss DS, 1999, J BACTERIOL, V181, P508, DOI 10.1128/JB.181.2.508-520.1999; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Yu XC, 2000, J BACTERIOL, V182, P6203, DOI 10.1128/JB.182.21.6203-6213.2000	64	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153337	10.1371/journal.pone.0153337	http://dx.doi.org/10.1371/journal.pone.0153337			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088231	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000018
J	Firouzabadi, N; Ghazanfari, N; Shoushtari, AA; Erfani, N; Fathi, F; Bazrafkan, M; Bahramali, E				Firouzabadi, Negar; Ghazanfari, Nima; Shoushtari, Ali Alavi; Erfani, Nasrallah; Fathi, Farshid; Bazrafkan, Mozhdeh; Bahramali, Ehsan			Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; SERUM ACE ACTIVITY; ALZHEIMERS-DISEASE; SPECTRUM DISORDER; INSERTION/DELETION POLYMORPHISM; IRANIAN POPULATION; MAJOR DEPRESSION; OXIDATIVE STRESS; BLOOD-PRESSURE; BRAIN	Background Autism is a disease of complex nature with a significant genetic component. The importance of renin-angiotensin system (RAS) elements in cognition and behavior besides the interaction of angiotensin II (Ang II), the main product of angiotensin-converting enzyme (ACE), with neurotransmitters in CNS, especially dopamine, proposes the involvement of RAS in autism. Since the genetic architecture of autism has remained elusive, here we postulated that genetic variations in RAS are associated with autism. Methods Considering the relation between the three polymorphisms of ACE (I/D, rs4343 and rs4291) with the level of ACE activity, we have investigated this association with autism, in a case-control study. Genotype and allele frequencies of polymorphisms were determined in DNAs extracted from venous blood of 120 autistic patients and their age and sex-matched healthy controls, using polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism (PCR-RFLP) methods. Results There were strong associations between both DD genotype of ACE I/D and the D allele, with autism (P = 0.006, OR = 2.9, 95% CI = 1.64-5.13 and P = 0.006, OR = 2.18, 95% CI = 1.37-3.48 respectively). Furthermore, a significant association between the G allele of rs4343 and autism was observed (P = 0.006, OR = 1.84, 95% CI = 1.26-2.67). Moreover, haplotype analysis revealed an association between DTG haplotype and autism (P = 0.008). Conclusion Our data suggests the involvement of RAS genetic diversity in increasing the risk of autism.	[Firouzabadi, Negar] Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran; [Ghazanfari, Nima] Shiraz Univ Med Sci, Int Branch, Sch Pharm, Dept Pharmacol, Shiraz, Iran; [Shoushtari, Ali Alavi] Shiraz Univ Med Sci, Hafez Hosp, Sch Med, Dept Psychiat, Shiraz, Iran; [Erfani, Nasrallah; Fathi, Farshid] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Canc Immunol Grp, Shiraz, Iran; [Bazrafkan, Mozhdeh] Shiraz Univ Med Sci, Sch Rehabil, Dept Speech Therapy, Shiraz, Iran; [Firouzabadi, Negar; Bahramali, Ehsan] Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran	Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science; Shiraz University of Medical Science	Firouzabadi, N (corresponding author), Shiraz Univ Med Sci, Sch Pharm, Dept Pharmacol & Toxicol, Shiraz, Iran.; Firouzabadi, N (corresponding author), Fasa Univ Med Sci, Noncommunicable Dis Res Ctr, Fasa, Iran.	Firouzabadi@sums.ac.ir	bahramali, ehsan/M-2673-2017; Erfani, Nasrollah/C-9376-2011; Firouzabadi, Negar/M-3046-2016; Firouzabadi, Negar/GLU-7552-2022	Erfani, Nasrollah/0000-0002-4158-9128; Firouzabadi, Negar/0000-0002-9293-9845; Fathi, Farshid/0000-0002-0280-7612				American Psychiatric Association, 2000, DIAGNOSTIC STAT MANU; Amouyel P, 2000, ANN NY ACAD SCI, V903, P437, DOI 10.1111/j.1749-6632.2000.tb06395.x; Baghai TC, 2004, NEUROSCI LETT, V363, P38, DOI 10.1016/j.neulet.2004.03.052; Baghai TC, 2002, NEUROSCI LETT, V328, P299, DOI 10.1016/S0304-3940(02)00527-X; Bahramali E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010282; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Bohus B, 1998, PROG BRAIN RES, V119, P555; Boucher J, 2012, PSYCHOL BULL, V138, P458, DOI 10.1037/a0026869; Curin JM, 2003, J AUTISM DEV DISORD, V33, P443, DOI 10.1023/A:1025019030121; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Firouzabadi N, 2012, PSYCHIAT RES, V200, P336, DOI 10.1016/j.psychres.2012.05.002; Firouzabadi N, 2011, EUR J PHARMACOL, V668, P241, DOI 10.1016/j.ejphar.2011.07.023; Fombonne E, 2009, PEDIATR RES, V65, P591, DOI 10.1203/PDR.0b013e31819e7203; Gadow KD, 2008, J CHILD PSYCHOL PSYC, V49, P1331, DOI 10.1111/j.1469-7610.2008.01952.x; Gard PR, 2004, EXPERT OPIN THER TAR, V8, P7, DOI 10.1517/eott.8.1.7.26409; Gard PR, 2002, EUR J PHARMACOL, V438, P1, DOI 10.1016/S0014-2999(02)01283-9; Ghanizadeh A, 2012, CURR MED CHEM, V19, P4000, DOI 10.2174/092986712802002572; GILLBERG C, 1987, BRIT J PSYCHIAT, V151, P89, DOI 10.1192/bjp.151.1.89; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Hamilton PJ, 2013, MOL PSYCHIATR, V18, P1315, DOI 10.1038/mp.2013.102; Henley SJ, 2014, MMWR-MORBID MORTAL W, V63, P1; Hidding E, 2016, CLIN GENETICS; Hou DR, 2008, CHINESE MED J-PEKING, V121, P2320, DOI 10.1097/00029330-200811020-00019; JASPARD E, 1993, J BIOL CHEM, V268, P9496; Jesner O. S., 2007, COCHRANE DATABASE SY, V1; Katzung BG, 2004, BASIC CLIN PHARM; Kehoe PG, 2003, J RENIN-ANGIO-ALDO S, V4, P80, DOI 10.3317/jraas.2003.017; Krug DA, 1978, ABC AUTISM BEHAV CHE; Luna B, 2002, NEUROLOGY, V59, P834, DOI 10.1212/WNL.59.6.834; Makkonen I, 2008, DEV MED CHILD NEUROL, V50, P593, DOI 10.1111/j.1469-8749.2008.03027.x; Mandell DS, 2008, PEDIATRICS, V121, pE441, DOI 10.1542/peds.2007-0984; Mateos L, 2011, UPREGULATION BRAIN R; McDougle CJ, 1998, ARCH GEN PSYCHIAT, V55, P633, DOI 10.1001/archpsyc.55.7.633; McKinley MJ, 2003, INT J BIOCHEM CELL B, V35, P901, DOI 10.1016/S1357-2725(02)00306-0; MEDELSOHN FA, 1993, BRAIN RES, V613, P221, DOI DOI 10.1016/0006-8993(93)90902-Y; Mertens B, 2009, J RENIN ANGIOTENSIN; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Nakamura K, 2010, ARCH GEN PSYCHIAT, V67, P59, DOI 10.1001/archgenpsychiatry.2009.137; Nakanishi M, 2007, EUR J NEUROSCI, V25, P649, DOI 10.1111/j.1460-9568.2007.05309.x; Nakasato A, 2008, BRAIN RES, V1193, P128, DOI 10.1016/j.brainres.2007.11.043; Nietzel MT, 1996, CONTEMP PSYCHOL, V41, P642; Pastores S M, 1996, New Horiz, V4, P252; POUSSET F, 1994, BIOMED PHARMACOTHER, V48, P425, DOI 10.1016/0753-3322(94)90003-5; Reiersen Angela M, 2008, Expert Rev Neurother, V8, P657, DOI 10.1586/14737175.8.4.657; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; Rodriguez-Pallares J, 2008, NEUROBIOL DIS, V31, P58, DOI 10.1016/j.nbd.2008.03.003; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P19, DOI 10.1111/1469-7610.00423; Saavedra JM, 2006, NEUROPSYCHOPHARMACOL, V31, P1123, DOI 10.1038/sj.npp.1300921; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Salmon B, 1999, AM J MED GENET, V88, P551, DOI 10.1002/(SICI)1096-8628(19991015)88:5<551::AID-AJMG21>3.3.CO;2-R; Samadi SA, 2012, AUTISM, V16, P5, DOI 10.1177/1362361311407091; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; SHANMUGAM V, 1993, PCR METH APPL, V3, P120; Struthers AD, 2004, CARDIOVASC RES, V61, P663, DOI 10.1016/j.cardiores.2003.11.037; Theoharides TC, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-168; Toma C, 2013, WORLD J BIOL PSYCHIA, V14, P516, DOI 10.3109/15622975.2011.602719; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Wright JW, 2008, PROG NEUROBIOL, V84, P157, DOI 10.1016/j.pneurobio.2007.10.009; Wright JW, 2011, PROG NEUROBIOL, V95, P49, DOI 10.1016/j.pneurobio.2011.07.001; Wright JW, 2004, PROG NEUROBIOL, V72, P263, DOI 10.1016/j.pneurobio.2004.03.003; Wu J, 2012, MOL NEUROBIOL, V45, P605, DOI 10.1007/s12035-012-8278-5; YOKOSAWA H, 1983, BIOCHEM BIOPH RES CO, V116, P735, DOI 10.1016/0006-291X(83)90586-7; Zhu XF, 2001, AM J HUM GENET, V68, P1139, DOI 10.1086/320104	67	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153667	10.1371/journal.pone.0153667	http://dx.doi.org/10.1371/journal.pone.0153667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082637	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800040
J	Ahn, H; Lee, K; Kim, JM; Kwon, SH; Lee, SH; Lee, SY; Jeong, D				Ahn, Heejin; Lee, Kyunghee; Kim, Jin Man; Kwon, So Hyun; Lee, Seoung Hoon; Lee, Soo Young; Jeong, Daewon			Accelerated Lactate Dehydrogenase Activity Potentiates Osteoclastogenesis via NFATc1 Signaling	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; BONE-RESORPTION; DIFFERENTIATION; FUSION; IDENTIFICATION; ACTIVATION; PRECURSORS; ACIDOSIS; ATPASE; CELLS	Osteoclasts seem to be metabolic active during their differentiation and bone-resorptive activation. However, the functional role of lactate dehydrogenase (LDH), a tetrameric enzyme consisting of an A and/or B subunit that catalyzes interconversion of pyruvate to lactate, in RANKL-induced osteoclast differentiation is not known. In this study, RANKL treatment induced gradual gene expression and activation of the LDH A(2)B(2) isotype during osteoclast differentiation as well as the LDH A(1)B(3) and B-4 isotypes during osteoclast maturation after pre-osteoclast formation. Glucose consumption and lactate production in growth media were accelerated during osteoclast differentiation, together with enhanced expression of H+-lactate co-transporter and increased extracellular acidification, demonstrating that glycolytic metabolism was stimulated during differentiation. Further, oxygen consumption via mitochondria was stimulated during osteoclast differentiation. On the contrary, depletion of LDH-A or LDH-B subunit suppressed both glycolytic and mitochondrial metabolism, resulting in reduced mature osteoclast formation via decreased osteoclast precursor fusion and down-regulation of the osteoclastogenic critical transcription factor NFATc1 and its target genes. Collectively, our findings suggest that RANKL-induced LDH activation stimulates glycolytic and mitochondrial respiratory metabolism, facilitating mature osteoclast formation via osteoclast precursor fusion and NFATc1 signaling.	[Ahn, Heejin; Lee, Kyunghee; Kim, Jin Man; Kwon, So Hyun; Jeong, Daewon] Yeungnam Univ, Dept Microbiol, Coll Med, Lab Bone Metab & Control, Daegu, South Korea; [Lee, Seoung Hoon] Wonkwang Univ, Dept Oral Microbiol & Immunol, Coll Dent, Iksan, South Korea; [Lee, Soo Young] Ewha Womans Univ, Dept Life Sci, Seoul, South Korea; [Lee, Soo Young] Ewha Womans Univ, Res Ctr Cellular Homeostasis, Seoul, South Korea	Yeungnam University; Wonkwang University; Ewha Womans University; Ewha Womans University	Jeong, D (corresponding author), Yeungnam Univ, Dept Microbiol, Coll Med, Lab Bone Metab & Control, Daegu, South Korea.	dwjeong@ynu.ac.kr			Yeungnam University Research Grant	Yeungnam University Research Grant	This study was supported by the 2014 Yeungnam University Research Grant.	Ahmed N, 1997, BIOCHEM J, V327, P369, DOI 10.1042/bj3270369; Ahn H, 2012, BIOCHEM BIOPH RES CO, V418, P144, DOI 10.1016/j.bbrc.2011.12.149; Arnett TR, 2010, ARCH BIOCHEM BIOPHYS, V503, P103, DOI 10.1016/j.abb.2010.07.021; BARON R, 1986, AM J PATHOL, V122, P363; Baumgart E, 1996, J BIOL CHEM, V271, P3846; Bottero V, 2006, CELL DEATH DIFFER, V13, P785, DOI 10.1038/sj.cdd.4401888; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown D, 1996, J EXP BIOL, V199, P2345; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; Francis MJO, 2002, INT J BIOCHEM CELL B, V34, P459, DOI 10.1016/S1357-2725(01)00142-X; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Ha BG, 2008, PROTEOMICS, V8, P2625, DOI 10.1002/pmic.200701192; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Huh YJ, 2006, CELL DEATH DIFFER, V13, P1138, DOI 10.1038/sj.cdd.4401793; Indo Y, 2013, J BONE MINER RES, V28, P2392, DOI 10.1002/jbmr.1976; Jang M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.85; Jeong DW, 2001, BIOCHEM BIOPH RES CO, V289, P1141, DOI 10.1006/bbrc.2001.6091; Kim JM, 2007, CELL PHYSIOL BIOCHEM, V20, P935, DOI 10.1159/000110454; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kwak HB, 2010, BONE, V46, P724, DOI 10.1016/j.bone.2009.10.042; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyazaki T, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.385369; Morrison MS, 1998, J PHYSIOL-LONDON, V511, P495, DOI 10.1111/j.1469-7793.1998.495bh.x; Oursler MJ, 2010, J CELL BIOCHEM, V110, P1058, DOI 10.1002/jcb.22640; Palokangas H, 1997, J CELL SCI, V110, P1767; Rodan GA, 2000, SCIENCE, V289, P1508, DOI 10.1126/science.289.5484.1508; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Vignery A, 2000, INT J EXP PATHOL, V81, P291, DOI 10.1046/j.1365-2613.2000.00164.x; Wilson SR, 2009, J BIOL CHEM, V284, P2584, DOI 10.1074/jbc.M805280200	33	23	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153886	10.1371/journal.pone.0153886	http://dx.doi.org/10.1371/journal.pone.0153886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077737	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700115
J	Berlin, C; Juni, P; Endrich, O; Zwahlen, M				Berlin, Claudia; Juni, Peter; Endrich, Olga; Zwahlen, Marcel			Revascularization Treatment of Emergency Patients with Acute ST-Segment Elevation Myocardial Infarction in Switzerland: Results from a Nationwide, Cross-Sectional Study in Switzerland for 2010-2011	PLOS ONE			English	Article							MANAGEMENT; MORTALITY; HOSPITALS; PHYSICIAN; OUTCOMES; GENDER; ACCESS; IMPACT; CARE	Background Cardiovascular diseases are the leading cause of death worldwide and in Switzerland. When applied, treatment guidelines for patients with acute ST-segment elevation myocardial infarction (STEMI) improve the clinical outcome and should eliminate treatment differences by sex and age for patients whose clinical situations are identical. In Switzerland, the rate at which STEMI patients receive revascularization may vary by patient and hospital characteristics. Aims To examine all hospitalizations in Switzerland from 2010-2011 to determine if patient or hospital characteristics affected the rate of revascularization (receiving either a percutaneous coronary intervention or a coronary artery bypass grafting) in acute STEMI patients. Data and Methods We used national data sets on hospital stays, and on hospital infrastructure and operating characteristics, for the years 2010 and 2011, to identify all emergency patients admitted with the main diagnosis of acute STEMI. We then calculated the proportion of patients who were treated with revascularization. We used multivariable multilevel Poisson regression to determine if receipt of revascularization varied by patient and hospital characteristics. Results Of the 9,696 cases we identified, 71.6% received revascularization. Patients were less likely to receive revascularization if they were female, and 80 years or older. In the multivariable multilevel Poisson regression analysis, there was a trend for small-volume hospitals performing fewer revascularizations but this was not statistically significant while being female (Relative Proportion = 0.91, 95% CI: 0.86 to 0.97) and being older than 80 years was still associated with less frequent revascularization. Conclusion Female and older patients were less likely to receive revascularization. Further research needs to clarify whether this reflects differential application of treatment guidelines or limitations in this kind of routine data.	[Berlin, Claudia; Zwahlen, Marcel] Univ Bern, ISPM, Bern, Switzerland; [Juni, Peter] Univ Toronto, AHRC, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Juni, Peter] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Endrich, Olga] Univ Hosp Bern, Inselspital, CH-3010 Bern, Switzerland	University of Bern; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Bern; University of Bern; University Hospital of Bern	Zwahlen, M (corresponding author), Univ Bern, ISPM, Bern, Switzerland.	marcel.zwahlen@ispm.unibe.ch	Zwahlen, Marcel/AFF-8559-2022; Juni, Peter/Q-8700-2016	Zwahlen, Marcel/0000-0002-6772-6346; Juni, Peter/0000-0002-5985-0670; Berlin, Claudia/0000-0003-3505-348X; Endrich, Olga/0000-0003-0839-9821	Swiss National Science Foundation (SNSF) [32473B_138056]; SFSO [11362]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); SFSO	This study was funded by the Swiss National Science Foundation (SNSF), grant number 32473B_138056 (www.snf.ch). Grant holder was MZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Special thanks goes to Prof. Andre Busato who developed the original design of the study and was responsible for data and funding acquisition. Unfortunately, he died November 2013. We thank the SFSO for their persistent support in conducting the study (contract number: 11362). We also thank Kali Tal for her editorial assistance. The comments of the reviewers had a great influence in improving our analysis. We really appreciated their help. Thank you.	Alexandrescu Roxana, 2012, Acute Card Care, V14, P5, DOI 10.3109/17482941.2012.655291; Alter DA, 2001, JAMA-J AM MED ASSOC, V285, P2101, DOI 10.1001/jama.285.16.2101; Birkhead J, 2006, BMJ-BRIT MED J, V332, P1306, DOI 10.1136/bmj.38849.440914.AE; Blais C, 2012, CAN J CARDIOL, V28, P169, DOI 10.1016/j.cjca.2011.10.009; Claassen M, 2012, WORLD J CARDIOL, V4, P36, DOI 10.4330/wjc.v4.i2.36; Gnavi R, 2014, INT J CARDIOL, V176, P724, DOI 10.1016/j.ijcard.2014.07.107; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Insam C, 2014, EUR J PREV CARDIOL, V21, P541, DOI 10.1177/2047487312469122; Insam C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-270; Leurent G, 2014, ARCH CARDIOVASC DIS, V107, P291, DOI 10.1016/j.acvd.2014.04.005; O'Flaherty M, 2013, HEART, V99, P159, DOI 10.1136/heartjnl-2012-302300; Pilgrim T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137047; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Radovanovic D, 2014, HEART, V100, P288, DOI 10.1136/heartjnl-2013-304588; Radovanovic D, 2012, EUR HEART J-ACUTE CA, V1, P183, DOI 10.1177/2048872612454021; Radovanovic D, 2010, SWISS MED WKLY, V140, P314, DOI smw-12986; SFSO, 2006, KRANK; SFSO, 2014, TOD STERBL DER HAUPT; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tung YC, 2014, MED CARE, V52, P519, DOI 10.1097/MLR.0000000000000132; Weiss J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106845; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	23	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153326	10.1371/journal.pone.0153326	http://dx.doi.org/10.1371/journal.pone.0153326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078262	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700039
J	Freitas, HR; Ferraz, G; Ferreira, GC; Ribeiro-Resende, VT; Chiarini, LB; do Nascimento, JLM; Oliveira, KRHM; Pereira, TD; Ferreira, LGB; Kubrusly, RC; Faria, RX; Herculano, AM; Reis, RAD				Freitas, Hercules R.; Ferraz, Gabriel; Ferreira, Gustavo C.; Ribeiro-Resende, Victor T.; Chiarini, Luciana B.; do Nascimento, Jose Luiz M.; Matos Oliveira, Karen Renata H.; Pereira, Tiago de Lima; Ferreira, Leonardo G. B.; Kubrusly, Regina C.; Faria, Robson X.; Herculano, Anderson Manoel; de Melo Reis, Ricardo A.			Glutathione-Induced Calcium Shifts in Chick Retinal Glial Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; MULLER GLIA; RELEASE; NEURONS; GLUTAMATE; GLIOTRANSMISSION; IDENTIFICATION; DYSREGULATION; HOMEOSTASIS; RECEPTORS	Neuroglia interactions are essential for the nervous system and in the retina Muller cells interact with most of the neurons in a symbiotic manner. Glutathione (GSH) is a low-molecular weight compound that undertakes major antioxidant roles in neurons and glia, however, whether this compound could act as a signaling molecule in neurons and/or glia is currently unknown. Here we used embryonic avian retina to obtain mixed retinal cells or purified Muller glia cells in culture to evaluate calcium shifts induced by GSH. A dose response curve (0.1-10mM) showed that 5-10mM GSH, induced calcium shifts exclusively in glial cells (later labeled and identified as 2M6 positive cells), while neurons responded to 50mM KCl (labeled as beta(III) tubulin positive cells). BBG 100nM, a P2X7 blocker, inhibited the effects of GSH on Muller glia. However, addition of DNQX 70 mu M and MK-801 20 mu M, non-NMDA and NMDA blockers, had no effect on GSH calcium induced shift. Oxidized glutathione (GSSG) at 5mM failed to induce calcium mobilization in glia cells, indicating that the antioxidant and/or structural features of GSH are essential to promote elevations in cytoplasmic calcium levels. Indeed, a short GSH pulse (60s) protects Muller glia from oxidative damage after 30 min of incubation with 0.1% H2O2. Finally, GSH induced GABA release from chick embryonic retina, mixed neuron-glia or from Muller cell cultures, which were inhibited by BBG or in the absence of sodium. GSH also induced propidium iodide uptake in Muller cells in culture in a P2X7 receptor dependent manner. Our data suggest that GSH, in addition to antioxidant effects, could act signaling calcium shifts at the millimolar range particularly in Muller glia, and could regulate the release of GABA, with additional protective effects on retinal neuron-glial circuit.	[Freitas, Hercules R.; Ferreira, Gustavo C.; Ribeiro-Resende, Victor T.; de Melo Reis, Ricardo A.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, RJ, Brazil; [Ferraz, Gabriel] Univ Fed Rio de Janeiro, Ctr Hlth Sci, Inst Biol Sci, Rio De Janeiro, RJ, Brazil; [Ferreira, Gustavo C.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, Rio De Janeiro, RJ, Brazil; [Chiarini, Luciana B.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Lab Neurogenesis, Rio De Janeiro, RJ, Brazil; [do Nascimento, Jose Luiz M.; Matos Oliveira, Karen Renata H.; Pereira, Tiago de Lima; Herculano, Anderson Manoel] Fed Univ Para, Inst Biol, BR-66059 Belem, Para, Brazil; [Kubrusly, Regina C.] Univ Fed Fluminense, Dept Physiol & Pharmacol, Neuropharmacol Lab, Niteroi, RJ, Brazil; [Ferreira, Leonardo G. B.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Lab Inflammat, Rio De Janeiro, Brazil; [Faria, Robson X.] Oswaldo Cruz Fdn FIOCRUZ, Inst Oswaldo Cruz, Lab Toxoplasmosis, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Para; Universidade Federal Fluminense; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Reis, RAD (corresponding author), Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Neurochem Lab, Rio De Janeiro, RJ, Brazil.	ramreis@biof.ufrj.br	Herculano, Anderson M/M-9016-2017; de Melo Reis, Ricardo A/E-9962-2011; Kubrusly, Regina C C/E-2626-2018; Chiarini, Luciana B/J-3644-2015; Freitas, Hércules Rezende/M-7198-2015	de Melo Reis, Ricardo A/0000-0001-9689-4085; Kubrusly, Regina C C/0000-0002-6016-2197; Freitas, Hércules Rezende/0000-0003-1584-9157; do Nascimento, jose/0000-0003-3647-9124	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES [PRO-AMAZONIA - 3288/2013]; CNPq; Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES [PRO-AMAZONIA - 3288/2013]	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (Instituto Nacional de Ciencia e Tecnologia de Neurociencia Translacional INCT-INNT), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) to RAMR, VTRR, GCF and CAPES (PRO-AMAZONIA - 3288/2013) to AMH. HRF is recipient of a CAPES M.Sc. fellowship; RAMR, AMH, JLMN and GCF have a research fellowship (CNPq).; Grants from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), (Instituto Nacional de Ciencia e Tecnologia de Neurocienca Translacional INCT-INNT), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior CAPES (PRO-AMAZONIA - 3288/2013) and CAPES supported this work. Hercules R. Freitas is recipient of a CAPES M.Sc. fellowship; RAMR, AMH, JLMN and GCF have a research fellowship (CNPq). We are indebted to the technical support of Luciano C. Ferreira.	Agulhon C, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00139; Anccasi RM, 2013, PURINERG SIGNAL, V9, P15, DOI 10.1007/s11302-012-9324-5; Aoyama K, 2015, MOLECULES, V20, P8742, DOI 10.3390/molecules20058742; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Browne R W, 1998, Methods Mol Biol, V108, P347; Chin TY, 2006, ACTA PHARMACOL SIN, V27, P853, DOI 10.1111/j.1745-7254.2006.00379.x; Reis RAD, 2011, CELL MOL NEUROBIOL, V31, P835, DOI 10.1007/s10571-011-9673-6; Reis RAD, 2008, NEUROCHEM RES, V33, P1466, DOI 10.1007/s11064-008-9604-1; Schitine CS, 2007, NEUROTOX RES, V12, P145, DOI 10.1007/BF03033923; Dickinson DA, 2002, BIOCHEM PHARMACOL, V64, P1019, DOI 10.1016/S0006-2952(02)01172-3; DONASCIMENTO JLM, 1985, J NEUROCHEM, V45, P1820; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Dringen R, 2003, BIOL CHEM, V384, P505, DOI 10.1515/BC.2003.059; DUARTE CB, 1992, BRAIN RES, V591, P27, DOI 10.1016/0006-8993(92)90974-E; Faria RX, 2016, J BIOENERG BIOMEMBR, V48, P309, DOI 10.1007/s10863-016-9649-9; Garcia TB, 2011, NEUROCHEM RES, V36, P412, DOI 10.1007/s11064-010-0356-3; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Guimaraes-Souza EM, 2011, NEUROSCIENCE, V179, P23, DOI 10.1016/j.neuroscience.2011.01.035; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; HOFMANN HD, 1991, J NEUROCHEM, V56, P923, DOI 10.1111/j.1471-4159.1991.tb02010.x; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Janaky R, 2000, NEUROSCIENCE, V95, P617; Janaky R, 2007, NEUROCHEM RES, V32, P1357, DOI 10.1007/s11064-007-9315-z; Johnson WM, 2012, NUTRIENTS, V4, P1399, DOI 10.3390/nu4101399; Keelan J, 2001, J NEUROSCI RES, V66, P873, DOI 10.1002/jnr.10085; LOPEZCOLOME AM, 1993, GLIA, V9, P127, DOI 10.1002/glia.440090206; Maggesissi RS, 2009, VISION RES, V49, P2494, DOI 10.1016/j.visres.2009.08.004; Molz S, 2015, PURINERG SIGNAL, V11, P117, DOI 10.1007/s11302-014-9438-z; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; PETIT JM, 1993, BIOL CELL, V78, P1, DOI 10.1016/0248-4900(93)90109-R; Portugal CC, 2009, J NEUROCHEM, V108, P507, DOI 10.1111/j.1471-4159.2008.05786.x; Reis RAM, 2002, J NEUROBIOL, V50, P13, DOI 10.1002/neu.10008; Rice ME, 2000, TRENDS NEUROSCI, V23, P209, DOI 10.1016/S0166-2236(99)01543-X; Rice ME, 1998, NEUROSCIENCE, V82, P1213; Sarthy V., 2001, PERSP VIS R; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schitine CS, 2015, NEUROCHEM INT, V82, P42, DOI 10.1016/j.neuint.2015.02.004; SCHLOSSHAUER B, 1991, DEVELOPMENT, V111, P789; Schuck PF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126606; Ventura Ana Lucia Marques, 2013, Methods Mol Biol, V964, P25, DOI 10.1007/978-1-62703-251-3_3	43	28	28	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153677	10.1371/journal.pone.0153677	http://dx.doi.org/10.1371/journal.pone.0153677			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078878	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700102
J	Salvoza, NC; Klinzing, DC; Gopez-Cervantes, J; Baclig, MO				Salvoza, Noel C.; Klinzing, David C.; Gopez-Cervantes, Juliet; Baclig, Michael O.			Association of Circulating Serum miR-34a and miR-122 with Dyslipidemia among Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; AMERICAN ASSOCIATION; HEPATIC STEATOSIS; MICRORNAS; STEATOHEPATITIS; EXPRESSION; DIAGNOSIS; MARKERS; PCR; RECOMMENDATIONS	Non-alcoholic fatty liver disease (NAFLD) covers a spectrum of diseases from simple steatosis to non-alcoholic steatohepatitis, with approximately 20% risk of progressing to fibrosis and cirrhosis. The aim of this study was to compare the relative expression levels of circulating miR-21, miR-34a, miR-122, miR-125b and miR-375 between healthy controls and NAFLD patients, and to assess the feasibility of microRNAs as potential biomarkers for NAFLD. A cross-sectional study was conducted to evaluate circulating serum miRNAs as potential diagnostic markers for NAFLD. Twenty-eight clinically diagnosed and histologically-confirmed NAFLD patients, as well as 36 healthy controls were enrolled in this study. The relative expression of serum microRNAs were calculated using the comparative cycle threshold with spiked-in C. elegans miR-39 as exogenous internal control. Serum levels of miR-34a and miR-122 were significantly higher in NAFLD patients than in healthy controls (P = <0.0001). Positive correlations were observed between serum miR-34a with very low density lipoprotein cholesterol (VLDL-C) and triglyceride levels. However, the expression levels of miR-34a and miR-122 did not correlate with the histological features of NAFLD. Interestingly, receiver operating characteristic (ROC) curve analysis revealed that miR-34a and miR-122 are potential markers for discriminating NAFLD patients from healthy controls with an area under the curve (AUC) values of 0.781 and 0.858, respectively. Serum levels of miR-34a and miR-122 were found to be significantly higher among NAFLD patients, and were positively correlated with VLDL-C and triglyceride levels. Thus, circulating miR-34a and miR-122 can be used as potential biomarkers for discriminating NAFLD patients from healthy controls. Larger cohorts are required to validate the utility of miR-34a and miR-122 in monitoring liver injury.	[Salvoza, Noel C.; Klinzing, David C.; Baclig, Michael O.] St Lukes Med Ctr, Res & Biotechnol, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines; [Gopez-Cervantes, Juliet] St Lukes Med Ctr, Liver Dis & Transplant Ctr, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines; [Salvoza, Noel C.] West Visayas State Univ, Coll Med, Iloilo 5000, Philippines; [Klinzing, David C.] AIT Biotech Pte Ltd, Sci Pk 1, Singapore 118261, Singapore	Saint Lukes Medical Center - Philippines; Saint Lukes Medical Center - Philippines	Baclig, MO (corresponding author), St Lukes Med Ctr, Res & Biotechnol, 279 E Rodriguez Sr Blvd, Quezon City 1112, Philippines.	mobaclig@stluke.com.ph	Baclig, Michael O./AAS-3749-2020; Baclig, Michael/G-5458-2014	Baclig, Michael O./0000-0001-6733-3916; Baclig, Michael/0000-0001-6733-3916; Salvoza, Noel/0000-0002-6394-2383	Research and Biotechnology, St. Luke's Medical Center-Quezon City [12-002a]	Research and Biotechnology, St. Luke's Medical Center-Quezon City	This work was supported by a research grant to the St. Luke's Liver Diseases Study Group (Project no. 12-002a) through the Research and Biotechnology, St. Luke's Medical Center-Quezon City. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a research grant to the St. Luke's Liver Diseases Study Group (Project no. 12-002a) through the Research and Biotechnology, St. Luke's Medical Center-Quezon City. The authors thank Cynthia A. Mapua and Dr. Jun Reandelar for their help in the statistical analysis.	Agrawal S, 2012, J CLIN EXP HEPATOL, V2, P122, DOI 10.1016/S0973-6883(12)60101-7; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P645, DOI 10.1038/nrgastro.2013.182; Blachier M, 2013, J HEPATOL, V58, P593, DOI 10.1016/j.jhep.2012.12.005; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Farina NH, 2014, J CELL BIOCHEM, V115, P805, DOI 10.1002/jcb.24745; Ferreira DMS, 2014, FEBS J, V281, P2503, DOI 10.1111/febs.12806; Hyysalo J, 2014, J HEPATOL, V60, P839, DOI 10.1016/j.jhep.2013.12.009; Koberle V, 2013, EUR J CANCER, V49, P3442, DOI 10.1016/j.ejca.2013.06.002; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Leti F, 2015, TRANSL RES, V166, P304, DOI 10.1016/j.trsl.2015.04.014; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Meyer SU, 2010, BIOTECHNOL LETT, V32, P1777, DOI 10.1007/s10529-010-0380-z; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Miyaaki H, 2014, LIVER INT, V34, pE302, DOI 10.1111/liv.12429; Myers RP, 2012, LIVER INT, V32, P902, DOI 10.1111/j.1478-3231.2012.02781.x; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V37, P1202, DOI 10.1053/jhep.2003.50193; Petta S, 2011, ALIMENT PHARM THER, V33, P1350, DOI 10.1111/j.1365-2036.2011.04668.x; Piscaglia F, 2014, EUR J RADIOL, V83, P450, DOI 10.1016/j.ejrad.2013.06.009; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Roderburg C, 2014, J HEPATOL, V61, P1434, DOI 10.1016/j.jhep.2014.07.017; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Sanyal AJ, 2015, HEPATOLOGY, V61, P1392, DOI 10.1002/hep.27678; Sasso M, 2010, ULTRASOUND MED BIOL, V36, P1825, DOI 10.1016/j.ultrasmedbio.2010.07.005; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen F, 2014, WORLD J GASTROENTERO, V20, P4702, DOI 10.3748/wjg.v20.i16.4702; Spengler EK, 2015, MAYO CLIN PROC, V90, P1233, DOI 10.1016/j.mayocp.2015.06.013; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tannapfel A, 2011, VIRCHOWS ARCH, V458, P511, DOI 10.1007/s00428-011-1066-1; WHO, A HLTH LIF; Yamada H, 2015, CLIN CHIM ACTA, V446, P267, DOI 10.1016/j.cca.2015.05.002; Yamada H, 2013, CLIN CHIM ACTA, V424, P99, DOI 10.1016/j.cca.2013.05.021; Zelber-Sagi S, 2014, LIVER INT, V34, pE128, DOI 10.1111/liv.12318	38	91	97	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153497	10.1371/journal.pone.0153497	http://dx.doi.org/10.1371/journal.pone.0153497			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077736	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700065
J	Lian, M; Madden, PA; Lynskey, MT; Colditz, GA; Lessov-Schlaggar, CN; Schootman, M; Heath, AC				Lian, Min; Madden, Pamela A.; Lynskey, Michael T.; Colditz, Graham A.; Lessov-Schlaggar, Christina N.; Schootman, Mario; Heath, Andrew C.			Geographic Variation in Maternal Smoking during Pregnancy in the Missouri Adolescent Female Twin Study (MOAFTS)	PLOS ONE			English	Article							MULTILEVEL ANALYSIS; CIGARETTE-SMOKING; PARENTAL SMOKING; SOCIOECONOMIC DEPRIVATION; FINANCIAL INCENTIVES; UNITED-STATES; BIRTH COHORT; RISK-FACTORS; NEIGHBORHOOD; ASSOCIATIONS	Objective Despite well-known adverse health effects of maternal smoking during pregnancy (MSP), it is still unclear if MSP varies geographically and if neighborhood socioeconomic deprivation (SED) plays an important role in MSP. This study aims to investigate small-area geographic variation in MSP and examine the association of SED with MSP. Methods The Missouri Adolescent Female Twin Study (MOAFTS) is a cohort study of female like-sex twins born in Missouri to Missouri-resident parents during 1975-1985. Biological mothers completed a baseline interview in 1995-1998 and reported MSP with the twins. Residential address of the mother at birth was geocoded. We developed a census tract-level SED index using a common factor approach based on 21 area-level socioeconomic variables from the 1980 Census data. Multilevel logistic regressions estimated geographic heterogeneity (random effect) in MSP and the odds ratios (ORs, fixed effects) of neighborhood SED associated with MSP. Results Of 1658 MOAFTS mothers, 35.2% reported any MSP and 21.9% reported MSP beyond the first trimester. Neighborhood SED was associated with any MSP (the highest vs. the lowest quartile: OR = 1.90, 95% confidence interval [CI] = 1.40-2.57, P-trend<0.001) and MSP beyond the first trimester (OR = 1.98, 95% CI = 1.38-2.85, P-trend = 0.002) in unadjusted analyses. After adjusting for individual covariates (demographics, socioeconomic conditions, alcohol use, and parents' cohabitation), neighborhood SED was not associated with MSP, but geographic variation still persisted in MSP (variance = 0.41, P = 0.003) and in MSP beyond the first trimester (variance = 0.82, P<0.001). Conclusions Neighborhood SED was associated with MSP in unadjusted analyses but this association could be explained by individual socioeconomic conditions. Nonetheless, significant geographic variation in MSP persisted and was not accounted for by differences in neighborhood SED. To develop effective interventions to reduce MSP, further studies are necessary to explore underlying reasons for its geographic variation.	[Lian, Min] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Lian, Min; Madden, Pamela A.; Colditz, Graham A.; Lessov-Schlaggar, Christina N.; Schootman, Mario; Heath, Andrew C.] Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, Canc Prevent & Control Program, St Louis, MO 63110 USA; [Lian, Min; Madden, Pamela A.; Colditz, Graham A.; Lessov-Schlaggar, Christina N.; Schootman, Mario; Heath, Andrew C.] Washington Univ, Sch Med, St Louis, MO USA; [Madden, Pamela A.; Lessov-Schlaggar, Christina N.; Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Lynskey, Michael T.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Addict Dept, London WC2R 2LS, England; [Colditz, Graham A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Schootman, Mario] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA; [Heath, Andrew C.] Washington Univ, Sch Med, Midwest Alcoholism Res Ctr, St Louis, MO USA	Washington University (WUSTL); Barnes-Jewish Hospital; Siteman Cancer Center; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of London; King's College London; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL)	Lian, M (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Lian, M (corresponding author), Barnes Jewish Hosp, Alvin J Siteman Canc Ctr, Canc Prevent & Control Program, St Louis, MO 63110 USA.; Lian, M (corresponding author), Washington Univ, Sch Med, St Louis, MO USA.	mlian@wustl.edu	Lynskey, michael T/B-9179-2016; Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291; Lynskey, Michael/0000-0001-9989-737X	National Cancer Institute at the National Institutes of Health [K07 CA178331]; National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health [R01 AA021492]; NCI Cancer Center Support grant [P30 CA091842]; NATIONAL CANCER INSTITUTE [K07CA178331, P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021492, K05AA017688] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Alcohol Abuse and Alcoholism at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported in part by a Career Development Award from the National Cancer Institute (K07 CA178331), and a research award from the National Institute on Alcohol Abuse and Alcoholism (R01 AA021492), both at the National Institutes of Health. We also thank the Health Behavior, Communication and Outreach Core for provided services, supported in part by a NCI Cancer Center Support grant (P30 CA091842) awarded to the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, Missouri. No conflicts of interest were declared. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Mamun A, 2006, TOB CONTROL, V15, P452, DOI 10.1136/tc.2006.016790; Al-Sahab B, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-24; Bailey BA, 2015, HEALTH EDUC BEHAV, V42, P824, DOI 10.1177/1090198115590780; Baron R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074197; Bell JF, 2007, J URBAN HEALTH, V84, P372, DOI 10.1007/s11524-006-9152-4; Boyd KA, 2016, ADDICTION, V111, P360, DOI 10.1111/add.13160; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Centers for Disease Control and Prevention, INF HLTH CAR PROV PU; Chaix B, 2005, AM J EPIDEMIOL, V162, P171, DOI 10.1093/aje/kwi175; Chuang YC, 2005, J EPIDEMIOL COMMUN H, V59, P568, DOI 10.1136/jech.2004.029041; Colditz GA, 2015, NEW ENGL J MED, V372, P665, DOI 10.1056/NEJMe1414318; Coleman T, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010078.pub2; Cui Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084640; Dior UP, 2014, ATHEROSCLEROSIS, V235, P430, DOI 10.1016/j.atherosclerosis.2014.05.937; Durmus B, 2011, AM J CLIN NUTR, V94, P164, DOI 10.3945/ajcn.110.009225; Eiden RD, 2011, J STUD ALCOHOL DRUGS, V72, P926, DOI 10.15288/jsad.2011.72.926; Gillum RF, 2008, SOUTH MED J, V101, P686, DOI 10.1097/SMJ.0b013e31817a76cc; Gilman SE, 2008, AM J PUBLIC HEALTH, V98, P448, DOI 10.2105/AJPH.2006.102772; Hawkins SS, 2014, AM J PUBLIC HEALTH, V104, P1464, DOI 10.2105/AJPH.2014.301955; Heath A C, 1999, Twin Res, V2, P145, DOI 10.1375/136905299320566013; Heath AC, 2003, TWIN RES, V6, P297, DOI 10.1375/136905203322296656; Higgins ST, 2009, DRUG ALCOHOL DEPEN, V104, pS100, DOI 10.1016/j.drugalcdep.2009.03.013; Howe LD, 2012, INT J EPIDEMIOL, V41, P722, DOI 10.1093/ije/dys025; Ino T, 2012, INT J OBESITY, V36, P554, DOI 10.1038/ijo.2011.255; Jamal A, 2014, MMWR-MORBID MORTAL W, V63, P1108; Kiernan K, 2006, SOC SCI MED, V63, P335, DOI 10.1016/j.socscimed.2006.01.006; Ko TJ, 2014, PEDIATR NEONATOL, V55, P20, DOI 10.1016/j.pedneo.2013.05.005; Kratz LM, 2012, SUBST USE MISUSE, V47, P718, DOI 10.3109/10826084.2012.664238; Langley K, 2012, AM J EPIDEMIOL, V176, P261, DOI 10.1093/aje/kwr510; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; Lee LJ, 2013, PEDIATR CARDIOL, V34, P398, DOI 10.1007/s00246-012-0470-x; Lian M, 2014, BREAST CANCER RES TR, V147, P661, DOI 10.1007/s10549-014-3135-z; Lian M, 2011, AM J EPIDEMIOL, V174, P828, DOI 10.1093/aje/kwr162; Masho SW., 2014, J WOMENS HLTH CARE, V3, P1000179, DOI [10.4172/2167-0420.1000179, DOI 10.4172/2167-0420.1000179]; Mathews T. J., 2004, Morbidity and Mortality Weekly Report, V53, P911; Mattsson K, 2015, EUR J EPIDEMIOL, V30, P231, DOI 10.1007/s10654-014-9985-1; McCullagh P, 1989, GEN LINEAR MODELS; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Naughton F, 2008, ADDICTION, V103, P566, DOI 10.1111/j.1360-0443.2008.02140.x; Nguyen KH, 2013, TOB CONTROL, V22, P184, DOI 10.1136/tobaccocontrol-2011-050157; Obel C, 2011, INT J EPIDEMIOL, V40, P338, DOI 10.1093/ije/dyq185; Ondersma SJ, 2012, NICOTINE TOB RES, V14, P351, DOI 10.1093/ntr/ntr221; Pearce J, 2009, J EPIDEMIOL COMMUN H, V63, P69, DOI 10.1136/jech.2007.070656; Raisanen S, 2014, PREV MED, V67, P6, DOI 10.1016/j.ypmed.2014.06.026; Ringel JS, 2001, AM J PUBLIC HEALTH, V91, P1851, DOI 10.2105/AJPH.91.11.1851; Rydell M, 2014, AM J EPIDEMIOL, V179, P1409, DOI 10.1093/aje/kwu074; Secker-Walker RH, 1998, PREV MED, V27, P422, DOI 10.1006/pmed.1998.0287; Shenassa ED, 2015, EPIDEMIOLOGY, V26, P441, DOI 10.1097/EDE.0000000000000270; Shoff C, 2013, SOC SCI MED, V78, P50, DOI 10.1016/j.socscimed.2012.11.027; Talati A, 2013, AM J PSYCHIAT, V170, P1178, DOI 10.1176/appi.ajp.2013.12121500; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Taylor AE, 2014, ADDICTION, V109, P1013, DOI 10.1111/add.12514; Ussher M, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2145; Wakschlag LS, 2002, AM J PUBLIC HEALTH, V92, P966, DOI 10.2105/AJPH.92.6.966; Yang TC, 2014, SOC SCI MED, V107, P26, DOI 10.1016/j.socscimed.2014.01.030; Zhu SH, 2002, ADDICT BEHAV, V27, P649, DOI 10.1016/S0306-4603(01)00199-X	57	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153930	10.1371/journal.pone.0153930	http://dx.doi.org/10.1371/journal.pone.0153930			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100091	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500098
J	Cooney, L; Hawcutt, D; Sinha, I				Cooney, Lewis; Hawcutt, Daniel; Sinha, Ian			The Evidence for Intravenous Theophylline Levels between 10-20mg/L in Children Suffering an Acute Exacerbation of Asthma: A Systematic Review	PLOS ONE			English	Review							CONTROLLED-TRIAL; CLINICAL-TRIALS; DOUBLE-BLIND; AMINOPHYLLINE; EFFICACY; THERAPY; STAY	Background Intravenous theophyllines are a second line treatment for children suffering an acute exacerbation of asthma. Various guidelines and formularies recommend aiming for serum theophylline levels between 10-20mg/l. This review aims to assess the evidence underpinning this recommendation. Methods A systematic review comparing outcomes of children who achieved serum theophylline concentrations between 10-20mg/l with those who did not. Primary outcomes were time until resolution of symptoms, mortality and need for mechanical ventilation. Secondary outcomes were date until discharge criteria are met, actual discharge, adverse effects and FEV1. Data sources MEDLINE, CINAHL, CENTRAL and Web of Science. Search performed in October 2015. Eligibility criteria Interventional or observational studies utilizing intravenous theophyllines for an acute exacerbation of asthma in children where serum theophylline levels and clinical outcomes were measured. Findings 10 RCTs and 2 observational studies were included. Children with serum levels between 10-20mg/l did not have a reduction in duration of symptoms, length of hospital stay or need for mechanical ventilation or better spirometric results compared with levels <10mg/l. Levels above 20mg/l are not associated with higher rates of adverse effects. This study is limited due to heterogeneity in the way theophylline levels were reported and poor surveillance of adverse effects across studies. Conclusion Dosing strategies aiming for levels between 10-20mg/l are not associated with better outcomes. Clinicians should rely on clinical outcomes and not serum levels when using intravenous theophyllines in children suffering an acute exacerbation of asthma.	[Cooney, Lewis; Hawcutt, Daniel] Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Hawcutt, Daniel; Sinha, Ian] Alder Hey Childrens Hosp, Alder Hey Clin Res Facil, Natl Inst Hlth Res, Liverpool L12 2AP, Merseyside, England	University of Liverpool; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Liverpool	Hawcutt, D (corresponding author), Univ Liverpool, Inst Translat Med, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.; Hawcutt, D (corresponding author), Alder Hey Childrens Hosp, Alder Hey Clin Res Facil, Natl Inst Hlth Res, Liverpool L12 2AP, Merseyside, England.	dhawcutt@liverpool.ac.uk		Hawcutt, Dan/0000-0002-8120-6507	NIHR alder hey clinical research facility	NIHR alder hey clinical research facility	DH is part funded by the NIHR alder hey clinical research facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2013, AM J RESP CRIT CARE, V188, P901, DOI 10.1164/rccm.201302-0388PP; BIEN JP, 1995, CLIN PEDIATR, V34, P475, DOI 10.1177/000992289503400905; British Thoracic Society, 2014, SIGN 141 BRIT GUID M; CARTER E, 1993, J PEDIATR-US, V122, P470, DOI 10.1016/S0022-3476(05)83443-2; D'Avila RS, 2008, RESP MED, V102, P156, DOI 10.1016/j.rmed.2007.07.030; Dalabih AR, 2014, PULM PHARMACOL THER, V27, P57, DOI 10.1016/j.pupt.2013.03.001; DIGIULIO GA, 1993, J PEDIATR-US, V122, P464, DOI 10.1016/S0022-3476(05)83442-0; FOX J, 1982, AM J DIS CHILD, V136, P928, DOI 10.1001/archpedi.1982.03970460058012; GLEESON JGA, 1989, EUR J PEDIATR, V148, P577, DOI 10.1007/BF00441563; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; JACKSON RH, 1964, DIS CHEST, V45, P75, DOI 10.1378/chest.45.1.75; Kenyon N, 2015, CLIN REV ALLERG IMMU, V48, P1, DOI 10.1007/s12016-013-8395-6; Loke YK, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-32; MITENKO PA, 1973, NEW ENGL J MED, V289, P600, DOI 10.1056/NEJM197309202891202; NEEDLEMAN JP, 1995, ARCH PEDIAT ADOL MED, V149, P206, DOI 10.1001/archpedi.1995.02170140088016; Nuhoglu Y, 1998, ANN ALLERG ASTHMA IM, V80, P395, DOI 10.1016/S1081-1206(10)62990-0; Paediatric Formulary Committee, 2014, BRIT NAT FORM CHILDR; PIERSON W, 1971, PEDIATRICS, V48, P642; Ream RS, 2001, CHEST, V119, P1480, DOI 10.1378/chest.119.5.1480; RESAR RK, 1979, CHEST, V76, P11, DOI 10.1378/chest.76.1.11; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Sinha IP, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-103; Soldin OP, 2002, THER DRUG MONIT, V24, P1, DOI 10.1097/00007691-200202000-00001; STRAUSS RE, 1994, PEDIATRICS, V93, P205; TURNERWARWICK M, 1957, BRIT MED J, V2, P67, DOI 10.1136/bmj.2.5036.67; World Health Organisation, 2013, ASTHM FACTSH; Yung M, 1998, ARCH DIS CHILD, V79, P405, DOI 10.1136/adc.79.5.405	28	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153877	10.1371/journal.pone.0153877	http://dx.doi.org/10.1371/journal.pone.0153877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096742	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600065
J	Mosbacher, JB; Michelsen, A; Stelvig, M; Hendrichsen, DK; Schmidt, NM				Mosbacher, Jesper Bruun; Michelsen, Anders; Stelvig, Mikkel; Hendrichsen, Ditte Katrine; Schmidt, Niels Martin			Show Me Your Rump Hair and I Will Tell You What You Ate - The Dietary History of Muskoxen (Ovibos moschatus) Revealed by Sequential Stable Isotope Analysis of Guard Hairs	PLOS ONE			English	Article							NITROGEN ISOTOPES; MAMMALIAN HERBIVORES; CARBON ISOTOPES; BODY CONDITION; PROTEIN STATUS; PEARY CARIBOU; BANKS ISLAND; DYNAMICS; DELTA-N-15; NUTRITION	The nutritional state of animals is tightly linked to the ambient environment, and for northern ungulates the state strongly influences vital population demographics, such as pregnancy rates. Continuously growing tissues, such as hair, can be viewed as dietary records of animals over longer temporal scales. Using sequential data on nitrogen stable isotopes (delta N-15) in muskox guard hairs from ten individuals in high arctic Northeast Greenland, we were able to reconstruct the dietary history of muskoxen over approximately 2.5 years with a high temporal resolution of app. 9 days. The dietary chronology included almost three full summer and winter periods. The diet showed strong intra-and inter-annual seasonality, and was significantly linked to changes in local environmental conditions (temperature and snow depth). The summer diets were highly similar across years, reflecting a graminoid-dominated diet. In contrast, winter diets were markedly different between years, a pattern apparently linked to snow conditions. Snow-rich winters had markedly higher delta N-15 values than snow-poor winters, indicating that muskoxen had limited access to forage, and relied more heavily on their body stores. Due to the close link between body stores and calf production in northern ungulates, the dietary winter signals could eventually serve as an indicator of calf production the following spring. Our study opens the field for further studies and longer chronologies to test such links. The method of sequential stable isotope analysis of guard hairs thus constitutes a promising candidate for population-level monitoring of animals in remote, arctic areas.	[Mosbacher, Jesper Bruun; Schmidt, Niels Martin] Aarhus Univ, Dept Biosci, Arctic Res Ctr, Frederiksborgvej 399, DK-4000 Roskilde, Denmark; [Michelsen, Anders] Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen O, Denmark; [Michelsen, Anders] Univ Copenhagen, Ctr Permafrost, Oster Voldgade 10, DK-1350 Copenhagen K, Denmark; [Stelvig, Mikkel] Copenhagen Zoo, Roskildevej 38, DK-2000 Frederiksberg, Denmark; [Hendrichsen, Ditte Katrine] Norwegian Inst Nat Res, Hogskoleringen 9, NO-7034 Trondheim, Norway	Aarhus University; University of Copenhagen; University of Copenhagen; Norwegian Institute Nature Research	Mosbacher, JB (corresponding author), Aarhus Univ, Dept Biosci, Arctic Res Ctr, Frederiksborgvej 399, DK-4000 Roskilde, Denmark.	jemo@bios.au.dk	Stelvig, Mikkel/ABB-3399-2020; Michelsen, Anders/L-5279-2014; Schmidt, Niels Martin/G-3843-2011	Michelsen, Anders/0000-0002-9541-8658; Schmidt, Niels Martin/0000-0002-4166-6218; Stelvig, Mikkel/0000-0002-2272-7492	15. Juni Fonden [2011-A-74]; Danish Environmental Protection Agency; Danish National Research Foundation [DNRF100]	15. Juni Fonden; Danish Environmental Protection Agency; Danish National Research Foundation(Danmarks Grundforskningsfond)	This work was supported by 15. Juni Fonden, 2011-A-74, http://www.15junifonden.dk/, NMS, JBM; Danish Environmental Protection Agency, http://mst.dk/, NMS; The Danish National Research Foundation, DNRF100, http://dg.dk/, AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; Adamczewski JZ, 1998, THERIOGENOLOGY, V50, P605, DOI 10.1016/S0093-691X(98)00165-4; Barboza PS, 2004, INT CONGR SER, V1275, P327, DOI 10.1016/j.ics.2004.09.040; Ben-David M, 1998, ECOLOGY, V79, P2567, DOI 10.2307/176846; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Boertmann D, 1990, RANGIFER, V12, P5; Callaghan TV, 2011, AMBIO, V40, P17, DOI 10.1007/s13280-011-0212-y; Cerling TE, 2009, P NATL ACAD SCI USA, V106, P8093, DOI 10.1073/pnas.0902192106; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Ehrich D, 2015, ECOSYSTEMS, V18, P404, DOI 10.1007/s10021-014-9834-9; Elberling B, 2008, ADV ECOL RES, V40, P223, DOI 10.1016/S0065-2504(07)00010-4; Falk JM, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/4/045001; FLOOD PF, 1989, CAN J ZOOL, V67, P1143, DOI 10.1139/z89-164; Gaye-Siessegger J, 2004, NATURWISSENSCHAFTEN, V91, P90, DOI 10.1007/s00114-003-0496-2; Gilg O, 2012, ANN NY ACAD SCI, V1249, P166, DOI 10.1111/j.1749-6632.2011.06412.x; Gray DR, 1987, MUSKOXEN POLAR BEAR; Gunn A., 1982, P1021; Gustine DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103471; Gustine DD, 2012, J MAMMAL, V93, P778, DOI 10.1644/11-MAMM-A-164.1; Gustine DD, 2011, OIKOS, V120, P1546, DOI 10.1111/j.1600-0706.2011.19215.x; Gustine DD, 2011, J WILDLIFE MANAGE, V75, P178, DOI 10.1002/jwmg.11; Gustine DD, 2010, PHYSIOL BIOCHEM ZOOL, V83, P687, DOI 10.1086/652729; Hansen BU, 2008, ADV ECOL RES, V40, P111, DOI 10.1016/S0065-2504(07)00006-2; Hilderbrand GV, 1999, CAN J ZOOL, V77, P1623, DOI 10.1139/cjz-77-10-1623; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; HOBSON KA, 1993, CONDOR, V95, P388, DOI 10.2307/1369361; Ims RA, 2013, CONSERVATION ARCTIC; Jingfors K, 1982, J WILDLIFE MANGAEMEN, V64, P450; Kazmin VD, 2009, ZOOL ZH, V88, P990; KLEIN DR, 1991, HOLARCTIC ECOL, V14, P152; KLEIN DR, 1990, HOLARCTIC ECOL, V13, P269; KLEIN DR, 1994, OECOLOGIA, V97, P439, DOI 10.1007/BF00325880; Kristensen DK, 2011, CAN J ZOOL, V89, P892, DOI [10.1139/Z11-073, 10.1139/z11-073]; Larter NC, 2004, POLAR RES-SWEDEN, V23, P131, DOI 10.1111/j.1751-8369.2004.tb00003.x; Larter NC, 2001, APPL VEG SCI, V4, P115, DOI 10.1111/j.1654-109X.2001.tb00242.x; Larter NC, 2001, ARCT ANTARCT ALP RES, V33, P123, DOI 10.2307/1552212; Mannel TT, 2007, GLOBAL ECOL BIOGEOGR, V16, P583, DOI 10.1111/j.1466-8238.2007.00322.x; Mekota AM, 2009, RECHTSMEDIZIN, V19, P431, DOI 10.1007/s00194-009-0630-3; Mekota AM, 2006, RAPID COMMUN MASS SP, V20, P1604, DOI 10.1002/rcm.2477; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Mizukami RN, 2005, URSUS, V16, P93, DOI 10.2192/1537-6176(2005)016[0093:EOFHBM]2.0.CO;2; Mosbacher JB, 2016, ARCT ANTARCT ALP RES; Murray JL, 1991, BIOMASS DISTRIBUTION; Oelbermann K, 2002, OECOLOGIA, V130, P337, DOI 10.1007/s004420100813; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Reynolds PE, 1998, J WILDLIFE MANAGE, V62, P734, DOI 10.2307/3802350; Rowell JE, 2001, J ANIM SCI, V79, P1670; Schmidt NM, 2015, POLAR BIOL, V38, P1667, DOI 10.1007/s00300-015-1733-9; Schmidt NM, 2014, ZACKENBERG ECOLOGICA; Schwertl M, 2003, RAPID COMMUN MASS SP, V17, P1312, DOI 10.1002/rcm.1042; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sponheimer M, 2003, INT J OSTEOARCHAEOL, V13, P80, DOI 10.1002/oa.655; Stocker T. F., 2013, CLIMATE CHANGE 2013; Szpak P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053763; Tener JS., 1965, MUSKOXEN CANADA BIOL; THING H, 1987, HOLARCTIC ECOL, V10, P95; von Holstein ICC, 2014, RAPID COMMUN MASS SP, V28, P2121, DOI 10.1002/rcm.6999; West AG, 2004, FUNCT ECOL, V18, P616, DOI 10.1111/j.0269-8463.2004.00862.x; West JB, 2006, TRENDS ECOL EVOL, V21, P408, DOI 10.1016/j.tree.2006.04.002; White RG, 1997, J ZOOL, V243, P13, DOI 10.1111/j.1469-7998.1997.tb05752.x; WHITE RG, 1989, CAN J ZOOL, V67, P1125, DOI 10.1139/z89-162; WILKINSON PF, 1975, J ZOOL, V177, P363, DOI 10.1111/j.1469-7998.1975.tb02239.x; Wittemyer G, 2009, CHEM GEOL, V267, P3, DOI 10.1016/j.chemgeo.2008.08.010; Zazzo A, 2015, RAPID COMMUN MASS SP, V29, P1357, DOI 10.1002/rcm.7228	66	25	25	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152874	10.1371/journal.pone.0152874	http://dx.doi.org/10.1371/journal.pone.0152874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097032	Green Published, gold			2022-12-27	WOS:000374543600019
J	Rubab, K; Mustafa, M				Rubab, Khansa; Mustafa, M.			Cattaneo-Christov Heat Flux Model for MHD Three-Dimensional Flow of Maxwell Fluid over a Stretching Sheet	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; MIXED CONVECTION; MAGNETIC-FIELD; NANOFLUID; CHANNEL; SLIP	This letter investigates the MHD three-dimensional flow of upper -convected Maxwell (UCM) fluid over a bi-directional stretching surface by considering the Cattaneo-Christov heat flux model. This model has tendency to capture the characteristics of thermal relaxation time. The governing partial differential equations even after employing the boundary layer approximations are non linear. Accurate analytic solutions for velocity and temperature distributions are computed through well-known homotopy analysis method (HAM). It is noticed that velocity decreases and temperature rises when stronger magnetic field strength is accounted. Penetration depth of temperature is a decreasing function of thermal relaxation time. The analysis for classical Fourier heat conduction law can be obtained as a special case of the present work. To our knowledge, the Cattaneo-Christov heat flux model law for three-dimensional viscoelastic flow problem is just introduced here.	[Rubab, Khansa; Mustafa, M.] NUST, SNS, Islamabad 44000, Pakistan	National University of Sciences & Technology - Pakistan	Mustafa, M (corresponding author), NUST, SNS, Islamabad 44000, Pakistan.	meraj_mm@hotmail.com	Mustafa Hashmi, Meraj/P-1769-2014					Cattaneo C., 1948, ATTI SEMIN MAT FIS, V3, P83, DOI DOI 10.1007/978-3-642-11051-1_5; Christov CI, 2009, MECH RES COMMUN, V36, P481, DOI 10.1016/j.mechrescom.2008.11.003; Ciarletta M, 2010, MECH RES COMMUN, V37, P445, DOI 10.1016/j.mechrescom.2010.06.002; Dhanai R, 2016, POWDER TECHNOL, V288, P140, DOI 10.1016/j.powtec.2015.11.004; Fetecau C, 2009, INT J NONLIN MECH, V44, P1085, DOI 10.1016/j.ijnonlinmec.2009.08.003; Fourier J.-B.J., 1822, THEORIE ANAL CHALEUR; Gul T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126698; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103843; Gul T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097552; Hakeem AKA, 2015, J MAGN MAGN MATER, V381, P243, DOI 10.1016/j.jmmm.2014.12.010; Han SH, 2014, APPL MATH LETT, V38, P87, DOI 10.1016/j.aml.2014.07.013; Hayat T, 2016, J MAGN MAGN MATER, V401, P733, DOI 10.1016/j.jmmm.2015.10.107; Hayat T, 2015, J MAGN MAGN MATER, V395, P48, DOI 10.1016/j.jmmm.2015.07.027; Hayat T, 2012, INT J NUMER METH FL, V68, P233, DOI 10.1002/fld.2503; Hayat T, 2016, J MAGN MAGN MATER, V401, P296, DOI 10.1016/j.jmmm.2015.10.039; Hayat T, 2010, Z NATURFORSCH A, V65, P401, DOI 10.1515/zna-2010-0505; Hsiao KL, 2014, ARAB J SCI ENG, V39, P4325, DOI 10.1007/s13369-014-1065-z; Hsiao KL, 2011, INT J NONLIN MECH, V46, P1, DOI 10.1016/j.ijnonlinmec.2010.06.005; Karra S, 2011, INT J NONLIN MECH, V46, P819, DOI 10.1016/j.ijnonlinmec.2011.02.013; Khan JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137363; Kumari M, 2009, INT J NONLIN MECH, V44, P1048, DOI 10.1016/j.ijnonlinmec.2009.08.002; Liao S, 2004, APPL MATH COMPUT, V147, P499, DOI [10.1016/S0096-3003(02)00790-7, 10.1016/50096-3003(02)00790-7]; Liao S., 2012, HOMOTOPY ANAL METHOD; Mabood F, 2015, J MAGN MAGN MATER, V374, P569, DOI 10.1016/j.jmmm.2014.09.013; Mushtaq A, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000361; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4907927; Mustafa M, 2015, AIP ADV, V5, DOI 10.1063/1.4917306; Rashidi MM, 2016, J MAGN MAGN MATER, V401, P159, DOI 10.1016/j.jmmm.2015.10.034; Shateyi S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-196; Straughan B, 2010, INT J HEAT MASS TRAN, V53, P95, DOI 10.1016/j.ijheatmasstransfer.2009.10.001; Tibullo V, 2011, MECH RES COMMUN, V38, P77, DOI 10.1016/j.mechrescom.2010.10.008; Zheng LC, 2012, MATH COMPUT MODEL, V56, P133, DOI 10.1016/j.mcm.2011.11.080	32	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153481	10.1371/journal.pone.0153481	http://dx.doi.org/10.1371/journal.pone.0153481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093542	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200023
J	Seraphin, MN; Lauzardo, M; Doggett, RT; Zabala, J; Morris, JG; Blackburn, JK				Seraphin, Marie Nancy; Lauzardo, Michael; Doggett, Richard T.; Zabala, Jose; Morris, J. Glenn, Jr.; Blackburn, Jason K.			Spatiotemporal Clustering of Mycobacterium tuberculosis Complex Genotypes in Florida: Genetic Diversity Segregated by Country of Birth	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; POPULATION-GENETICS; UNITED-STATES; TRANSMISSION; IMMIGRATION; OUTBREAK; STRAINS; DATABASE; LINEAGE; REGION	Background Tuberculosis (TB) is caused by members of the Mycobacterium tuberculosis complex (MTBC). Although the MTBC is highly clonal, between -strain genetic diversity has been observed. In low TB incidence settings, immigration may facilitate the importation of MTBC strains with a potential to complicate TB control efforts. Methods We investigated the genetic diversity and spatiotemporal clustering of 2,510 MTBC strains isolated in Florida, United States, between 2009 and 2013 and genotyped using spoligotyping and 24 -locus MIRU-VNTR. We mapped the genetic diversity to the centroid of patient residential zip codes using a geographic information system (GIS). We assessed transmission dynamics and the influence of immigration on genotype clustering using space-time permutation models adjusted for foreign-born population density and county-level HIV risk and multinomial models stratified by country of birth and timing of immigration in SaTScan. Principal Findings Among the 2,510 strains, 1,245 were reported among foreign-born persons; including 408 recent immigrants (<5 years). Strain allelic diversity (h) ranged from low to medium in most locations and was most diverse in urban centers where foreign -born population density was also high. Overall, 21.5% of cases among U.S.-born persons and 4.6% among foreign-born persons clustered genotypically and spatiotemporally and involved strains of the Haarlem family. One Haarlem space-time cluster identified in the mostly rural northern region of Florida included US/Canada-born individuals incarcerated at the time of diagnosis; two clusters in the mostly urban southern region of Florida were composed predominantly of foreign born persons. Both groups had HIV prevalence above twenty percent. Conclusions/Significance Almost five percent of TB cases reported in Florida during 2009-2013 were potentially due to recent transmission. Improvements to TB screening practices among the prison population and recent immigrants are likely to impact TB control. Due to the monomorphic nature of available markers, whole genome sequencing is needed to conclusively delineate recent transmission events between U.S. and foreign-born persons.	[Seraphin, Marie Nancy; Lauzardo, Michael; Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA; [Seraphin, Marie Nancy; Lauzardo, Michael; Morris, J. Glenn, Jr.; Blackburn, Jason K.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Seraphin, Marie Nancy] Univ Florida, Coll Med, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [Doggett, Richard T.; Zabala, Jose] Florida Dept Hlth, TB Control Sect, Bur Communicable Dis, Tallahassee, FL USA; [Blackburn, Jason K.] Univ Florida, Dept Geog, Spatial Epidemiol & Ecol Res Lab, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Florida Department of Health; State University System of Florida; University of Florida	Seraphin, MN (corresponding author), Univ Florida, Coll Med, Dept Med, Div Infect Dis & Global Med, Gainesville, FL USA.; Seraphin, MN (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.; Seraphin, MN (corresponding author), Univ Florida, Coll Med, Dept Epidemiol, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.	nseraphin@ufl.edu	Seraphin, Marie/AAQ-4366-2020; Blackburn, Jason/AAV-9445-2020	Seraphin, Marie/0000-0002-2120-6011; Blackburn, Jason/0000-0003-0928-4831	College of Medicine, University of Florida [00107788]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427, KL2TR001429] Funding Source: NIH RePORTER	College of Medicine, University of Florida; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	MNS is supported by a grant from the College of Medicine, University of Florida (grant number 00107788), to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, MMWR Recomm Rep, V48, P1; [Anonymous], 2010, PLOS MED, V7, DOI [10.1371/journal.pmed.1000383, DOI 10.1371/JOURNAL.PMED.1000383]; Asghar RJ, 2009, J URBAN HEALTH, V86, P776, DOI 10.1007/s11524-009-9378-z; Bamrah S, 2013, INT J TUBERC LUNG D, V17, P1414, DOI 10.5588/ijtld.13.0270; Barro AS, 2015, APPL GEOGR, V60, P29, DOI 10.1016/j.apgeog.2015.02.014; Braden CR, 1997, J INFECT DIS, V175, P1446, DOI 10.1086/516478; Brites D, 2012, INFECT GENET EVOL, V12, P678, DOI 10.1016/j.meegid.2011.08.010; Brudey K, 2006, J CLIN MICROBIOL, V44, P183, DOI 10.1128/JCM.44.1.183-191.2006; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cain KP, 2008, JAMA-J AM MED ASSOC, V300, P405, DOI 10.1001/jama.300.4.405; Cavanaugh JS, 2012, AM J PSYCHIAT, V169, P569, DOI 10.1176/appi.ajp.2011.11081311; Centers for Disease Control and Prevention (CDC), 2012, MMWR Morb Mortal Wkly Rep, V61, P539; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P101; Centers for Disease Control and Prevention (CDC), 2016, REP TUB US; Chaoui I, 2014, INFECT GENET EVOL, V21, P463, DOI 10.1016/j.meegid.2013.05.023; Click ES, 2012, CLIN INFECT DIS, V54, P211, DOI 10.1093/cid/cir788; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Farnia P, 2006, J INFECTION, V53, P331, DOI 10.1016/j.jinf.2005.12.020; Fenner L, 2012, J CLIN MICROBIOL, V50, P388, DOI 10.1128/JCM.05392-11; Ferdinand S, 2003, J CLIN MICROBIOL, V41, P694, DOI 10.1128/JCM.41.2.694-702.2003; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2012, PHILOS T R SOC B, V367, P850, DOI 10.1098/rstb.2011.0316; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Garzelli C, 2010, CLIN MICROBIOL INFEC, V16, P1691, DOI [10.1111/j.1469-0691.2009.03149.x, 10.1111/j.1469-0691.2010.03149.x]; Ghosh S, 2012, INFECT GENET EVOL, V12, P782, DOI 10.1016/j.meegid.2011.10.013; Haase I, 2007, INT J TUBERC LUNG D, V11, P632; Hawthorne B., 2009, GEOSPATIAL MODELLING; Hightower J, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0453-2; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Keshavjee S, 2012, NEW ENGL J MED, V367, P931, DOI 10.1056/NEJMra1205429; Kulaga S, 2004, AM J EPIDEMIOL, V159, P507, DOI 10.1093/aje/kwh065; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M., 2014, SATSCAN US GUID VERS; Lillebaek T, 2001, J CLIN MICROBIOL, V39, P855, DOI 10.1128/JCM.39.3.855-861.2001; Malakmadze N, 2005, CLIN INFECT DIS, V40, P366, DOI 10.1086/427112; Marais BJ, 2006, J CLIN MICROBIOL, V44, P3539, DOI 10.1128/JCM.01291-06; Mardassi H, 2005, EMERG INFECT DIS, V11, P957; Martins MC, 2013, INFECT GENET EVOL, V14, P39, DOI 10.1016/j.meegid.2012.10.015; Mazars E, 2001, P NATL ACAD SCI USA, V98, P1901, DOI 10.1073/pnas.98.4.1901; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Oren E, 2011, AM J PUBLIC HEALTH, V101, P1256, DOI 10.2105/AJPH.2010.300030; Ricks PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027405; Rodwell TC, 2012, INFECT GENET EVOL, V12, P1917, DOI 10.1016/j.meegid.2012.08.022; Root ED, 2009, SOC SCI MED, V68, P1361, DOI 10.1016/j.socscimed.2009.01.034; SELANDER RK, 1986, APPL ENVIRON MICROB, V51, P873, DOI 10.1128/AEM.51.5.873-884.1986; Sterling TR, 2006, CLIN INFECT DIS, V42, P1711, DOI 10.1086/504332; Svensson K, 2009, EMERG INFECT DIS, V15, P1937, DOI 10.3201/eid1512.090487; Teeter LD, 2013, TUBERCULOSIS, V93, pS38, DOI 10.1016/S1472-9792(13)70009-X; Tuite AR, 2013, INT J TUBERC LUNG D, V17, P1322, DOI 10.5588/ijtld.13.0145; United States Census Bureau, 2015, POP EST JUL 1 2014 V; University of Florida, ZIP COD AR 5 DIG FLO; Vanhomwegen J, 2011, J CLIN MICROBIOL, V49, P834, DOI 10.1128/JCM.01952-10; Walker TM, 2014, LANCET RESP MED, V2, P285, DOI 10.1016/S2213-2600(14)70027-X; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, GLOB TUB REP 2015; World Health Organization, 2014, GLOB TUB CONTR 2014; Yimer SA, 2015, J CLIN MICROBIOL, V53, P1301, DOI 10.1128/JCM.03566-14	60	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153575	10.1371/journal.pone.0153575	http://dx.doi.org/10.1371/journal.pone.0153575			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9NW	27093156	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200030
J	Zuberi, M; Khan, I; Mir, R; Gandhi, G; Ray, PC; Saxena, A				Zuberi, Mariyam; Khan, Imran; Mir, Rashid; Gandhi, Gauri; Ray, Prakash Chandra; Saxena, Alpana			Utility of Serum miR-125b as a Diagnostic and Prognostic Indicator and Its Alliance with a Panel of Tumor Suppressor Genes in Epithelial Ovarian Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION; LUNG-CANCER; UP-REGULATION; CELLS; PROLIFERATION; RESISTANCE; HYPERMETHYLATION; METHYLATION; BIOMARKERS; CARCINOMA	MicroRNAs (miRNAs) have been found to be dysregulated in epithelial ovarian cancer (EOC) and may function as either tumor suppressor genes (TSGs) or as oncogenes. Hypermethylation of miRNA silences the tumour suppressive function of a miRNA or hypermethylation of a TSG regulating that miRNA (or vice versa) leads to its loss of function. The present study aims to evaluate the impact of aberrant microRNA-125b (miR-125b) expression on various clinicopathological features in epithelial ovarian cancer and its association with anomalous methylation of several TSGs. We enrolled 70 newly diagnosed cases of epithelial ovarian cancer, recorded their clinical history and 70 healthy female volunteers. Serum miR-125b levels were determined by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and the methylation status of various TSGs was investigated by methylation specific PCR. ROC curves were constructed to estimate the diagnostic and prognostic usefulness of miR-125b. The Kaplan-Meier method was applied to compare survival curves. Expression of miR-125b was found to be significantly upregulated (p<0.0001) in comparison with healthy controls. The expression level of miR-125b was found to be significantly associated with FIGO stage, lymph node and distant metastasis. ROC curve for diagnostic potential yielded significant AUC with an equitable sensitivity and specificity. ROC curves for prognosis yielded significant AUCs for histological grade, distal metastasis, lymph node status and survival. The expression of miR-125b also correlated significantly with the hypermethylation of TSGs. Our results indicate that DNA hypermethylation may be involved in the inactivation of miR-125b and miR-125b may function as a potential independent biomarker for clinical outcome in EOC.	[Zuberi, Mariyam; Ray, Prakash Chandra; Saxena, Alpana] Maulana Azad Med Coll & Associated Hosp, Dept Biochem, New Delhi, India; [Khan, Imran] Univ Illinois, Dept Surg, Chicago, IL 60680 USA; [Mir, Rashid] Univ Tabuk, Fac Appl Med Sci, Tabuk 71491, Saudi Arabia; [Gandhi, Gauri] Lok Nayak Hosp, Dept Obstet & Gynaecol, New Delhi, India	Maulana Azad Medical College; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Tabuk	Saxena, A (corresponding author), Maulana Azad Med Coll & Associated Hosp, Dept Biochem, New Delhi, India.	alpanasaxena@hotmail.com	Mir, Rashid/AAH-1895-2019; Mir, Rashid/GOV-3522-2022; Zuberi, Mariyam/Q-6524-2019	Zuberi, Mariyam/0000-0001-6104-1365				Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Banno K, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/738274; Banzhaf-Strathmann J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-30; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Budd WT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142373; Catto JWF, 2011, EUR UROL, V59, P671, DOI 10.1016/j.eururo.2011.01.044; Chen H, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/345080; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Gadducci A, 2014, GYNECOL ENDOCRINOL, V30, P266, DOI 10.3109/09513590.2013.871525; Giray BG, 2014, MOL BIOL REP, V41, P4513, DOI 10.1007/s11033-014-3322-3; Guan Y, 2011, INT J CANCER, V128, P2274, DOI 10.1002/ijc.25575; He J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056647; Heinzelmann J, 2014, ANN SURG ONCOL, V21, P1046, DOI 10.1245/s10434-013-3361-3; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Jiang FZ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-425; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kinose Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249393; Kong FF, 2011, J HUAZHONG U SCI-MED, V31, P543, DOI 10.1007/s11596-011-0487-z; Lee M, 2015, ONCOTARGET; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lujambio A, 2007, CELL CYCLE, V6, P1455; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Luo S, 2015, BIOCHEM BIOPH RES CO, V462, P85, DOI 10.1016/j.bbrc.2015.04.023; Ma YX, 2012, J CANCER RES CLIN, V138, P2045, DOI 10.1007/s00432-012-1285-0; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nishida N, 2011, INT J ONCOL, V38, P1437, DOI 10.3892/ijo.2011.969; Nishida N, 2011, CLIN CANCER RES, V17, P2725, DOI 10.1158/1078-0432.CCR-10-2132; Pallares J, 2008, MODERN PATHOL, V21, P691, DOI 10.1038/modpathol.2008.38; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prueitt RL, 2008, PROSTATE, V68, P1152, DOI 10.1002/pros.20786; Ribeiro J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/304584; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Romero PV, 2015, LEUKEMIA, V29, P2442, DOI 10.1038/leu.2015.117; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Suzuki H, 2012, MOL ONCOL, V6, P567, DOI 10.1016/j.molonc.2012.07.007; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; Vilquin P, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0515-1; Wan Y, 2014, NEUROREPORT, V25, P289, DOI 10.1097/WNR.0000000000000085; Wang F., 2016, TECHNOL CANC RES TRE; Wang H, 2012, PLOS ONE, V7, P34210, DOI DOI 10.1371/J0URNAL.P0NE.0034210; Wang M, 2015, BRIT J CANCER, V112, P874, DOI 10.1038/bjc.2015.3; Wang XK, 2015, MOL MED REP, V11, P3880, DOI 10.3892/mmr.2014.3142; Wu N, 2013, BRIT J CANCER, V109, P2853, DOI 10.1038/bjc.2013.672; WU SH, 2015, BIOMED RES INT; Xie XH, 2015, TUMOR BIOL, V36, P7185, DOI 10.1007/s13277-015-3438-7; Yamada A, 2015, CLIN CANCER RES, V21, P4234, DOI 10.1158/1078-0432.CCR-14-2793; Yang QL, 2015, ONCOTARGET, V6, P3268, DOI 10.18632/oncotarget.3065; Zang B, 2015, INT J CLIN EXP PATHO, V8, P13687; Zhao X, 2015, AM J TRANSL RES, V7, P2346; Zhou JN, 2015, HEPATOLOGY, V62, P801, DOI 10.1002/hep.27887	56	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153902	10.1371/journal.pone.0153902	http://dx.doi.org/10.1371/journal.pone.0153902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092777	gold, Green Published			2022-12-27	WOS:000374541200057
J	Noor, Z; Burgess, SL; Watanabe, K; Petri, WA				Noor, Zannatun; Burgess, Stacey L.; Watanabe, Koji; Petri, William A., Jr.			Interleukin-25 Mediated Induction of Angiogenin-4 Is Interleukin-13 Dependent	PLOS ONE			English	Article							INNATE IMMUNITY; EXPRESSION; INFECTION	The intestinal surface is directly exposed to both commensal microorganisms as well as pathogens with a single layer of epithelium separating luminal microorganisms from internal tissues. Antimicrobial peptides play a crucial role in allowing epithelial cells to contain in the lumen beneficial and pathogenic microorganisms. The commensal dependent, epithelial produced, Th2 cytokine IL-25 can induce IL-13 and potentially the antimicrobial peptide angiogenin- 4. Here we show that IL-13 downstream of IL-25 is required to induce angiogenin-4. IL25 mediated induction of angiogenin-4 is furthermore not dependent on IL-22 or IL-17.	[Noor, Zannatun; Burgess, Stacey L.; Watanabe, Koji; Petri, William A., Jr.] Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA USA; [Watanabe, Koji] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan	University of Virginia; National Center for Global Health & Medicine - Japan	Petri, WA (corresponding author), Univ Virginia Hlth Syst, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA USA.	wap3g@virginia.edu	Burgess, Stacey L./ABC-5292-2021; Petri, William A./D-3639-2019; Petri, William/AAL-3642-2020	Petri, William/0000-0002-7268-1218; Noor, Zannatun/0000-0002-9431-358X	NIH [5R01 AI026649]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026649, R01AI043596] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant 5R01 AI026649. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angkasekwinai P, 2013, INFECT IMMUN, V81, P3731, DOI 10.1128/IAI.00646-13; Angkasekwinai P, 2010, NAT IMMUNOL, V11, P250, DOI 10.1038/ni.1846; Datta R, 2005, INFECT IMMUN, V73, P4025, DOI 10.1128/IAI.73.7.4025-4033.2005; Forman RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042248; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Steenwinckel V, 2009, J IMMUNOL, V182, P4737, DOI 10.4049/jimmunol.0801941; Stockinger S, 2014, J INNATE IMMUN, V6, P530, DOI 10.1159/000357644; Walker CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084553; Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	12	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153572	10.1371/journal.pone.0153572	http://dx.doi.org/10.1371/journal.pone.0153572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089535	gold, Green Submitted, Green Published			2022-12-27	WOS:000374527000027
J	Araujo, OC; Rosa, AS; Fernandes, A; Niel, C; Villela-Nogueira, CA; Pannain, V; Araujo, NM				Araujo, Oscar C.; Rosa, Agatha S.; Fernandes, Arlete; Niel, Christian; Villela-Nogueira, Cristiane A.; Pannain, Vera; Araujo, Natalia M.			RASSF1A and DOK1 Promoter Methylation Levels in Hepatocellular Carcinoma, Cirrhotic and Non-Cirrhotic Liver, and Correlation with Liver Cancer in Brazilian Patients	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; DNA METHYLATION; TUMOR-SUPPRESSOR; HYPERMETHYLATION; ASSOCIATION; BLOOD	Hepatocellular carcinoma (HCC) is the second most common cause of cancer mortality worldwide. Most cases of HCC are associated with cirrhosis related to chronic hepatitis B virus or hepatitis C virus infections. Hypermethylation of promoter regions is the main epigenetic mechanism of gene silencing and has been involved in HCC development. The aim of this study was to determine whether aberrant methylation of RASSF1A and DOK1 gene promoters is associated with the progression of liver disease in Brazilian patients. Methylation levels were measured by pyrosequencing in 41 (20 HCC, 9 cirrhotic, and 12 non-cirrhotic) liver tissue samples. Mean rates of methylation in RASSF1A and DOK1 were 16.2% and 12.0% in non-cirrhotic, 26.1% and 19.6% in cirrhotic, and 59.1% and 56.0% in HCC tissues, respectively, showing a gradual increase according to the progression of the disease, with significantly higher levels in tumor tissues. In addition, hypermethylation of RASSF1A and DOK1 was found in the vast majority (88%) of the HCC cases. Interestingly, DOK1 methylation levels in HCC samples were significantly higher in the group of younger (<40 years) patients, and higher in moderately differentiated than in poorly differentiated tumors (p < 0.05). Our results reinforce the hypothesis that hypermethylation of RASSF1A and DOK1 contributes to hepatocarcinogenesis and is associated to clinicopathological characteristics. RASSF1A and DOK1 promoter hypermethylation may be a valuable biomarker for early diagnosis of HCC and a potential molecular target for epigenetic-based therapy.	[Araujo, Oscar C.; Rosa, Agatha S.; Niel, Christian; Araujo, Natalia M.] Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil; [Fernandes, Arlete; Pannain, Vera] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Dept Pathol, Rio De Janeiro, Brazil; [Villela-Nogueira, Cristiane A.] Univ Fed Rio de Janeiro, Clementino Fraga Filho Univ Hosp, Hepatol Div, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Araujo, NM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Mol Virol Lab, BR-21045900 Rio De Janeiro, Brazil.	nmaraujo@ioc.fiocruz.br	nogueira, cristiane villela/G-7002-2012; Araujo, Natalia M/B-6596-2013; Araujo, Oscar/N-3146-2013	nogueira, cristiane villela/0000-0003-1355-2368; Araujo, Oscar/0000-0002-9681-2980	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [444071/2014-8]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/111.528/2013]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/), grant number 444071/2014-8, to NMA, and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/), grant number E-26/111.528/2013, to NMA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527; Carrilho FJ, 2010, CLINICS, V65, P1285, DOI 10.1590/S1807-59322010001200010; Colombo M, 2015, LIVER INT, V35, P129, DOI 10.1111/liv.12713; de Vogel S, 2009, CANCER EPIDEM BIOMAR, V18, P3086, DOI 10.1158/1055-9965.EPI-09-0289; Di Gioia S, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-89; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Gao W, 2008, CARCINOGENESIS, V29, P1901, DOI 10.1093/carcin/bgn170; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; Hernandez-Vargas H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009749; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; INCA, 2015, CANC DE FIG; Issa JP, 1999, CRIT REV ONCOL HEMAT, V32, P31, DOI 10.1016/S1040-8428(99)00019-0; Lambert MP, 2011, J HEPATOL, V54, P705, DOI 10.1016/j.jhep.2010.07.027; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Park IY, 2007, GASTROENTEROLOGY, V132, P1476, DOI 10.1053/j.gastro.2007.01.034; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Saulnier A, 2012, INT J CANCER, V130, P2484, DOI 10.1002/ijc.26299; Tischoff I, 2008, WORLD J GASTROENTERO, V14, P1741, DOI 10.3748/wjg.14.1741; Um TH, 2011, J HEPATOL, V54, P939, DOI 10.1016/j.jhep.2010.08.021; Waki T, 2003, ONCOGENE, V22, P4128, DOI 10.1038/sj.onc.1206651; WHO/IARC, 2015, GLOBOCAN 2012 EST CA; Zhang FF, 2011, EPIGENETICS-US, V6, P623, DOI 10.4161/epi.6.5.15335; Zhang XY, 2013, J GASTROENTEROL, V48, P132, DOI 10.1007/s00535-012-0621-0; Zhang YJ, 2002, MOL CARCINOGEN, V35, P85, DOI 10.1002/mc.10076; Zhao ZH, 2013, WORLD J GASTROENTERO, V19, P7189, DOI 10.3748/wjg.v19.i41.7189	28	17	21	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153796	10.1371/journal.pone.0153796	http://dx.doi.org/10.1371/journal.pone.0153796			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078152	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700108
J	Sun, XP; Wang, Z; Guo, XX; Li, HY; Gu, ZL				Sun, Xuepeng; Wang, Zhe; Guo, Xiaoxian; Li, Hongye; Gu, Zhenglong			Coordinated Evolution of Transcriptional and Post-Transcriptional Regulation for Mitochondrial Functions in Yeast Strains	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE STRAINS; QUANTITATIVE TRAIT LOCUS; GENE-EXPRESSION; BUDDING YEAST; ADAPTIVE EVOLUTION; PROTEIN EXPRESSION; CELL-CYCLE; NUCLEAR; TRANSLATION; GENOMES	Evolution of gene regulation has been proposed to play an important role in environmental adaptation. Exploring mechanisms underlying coordinated evolutionary changes at various levels of gene regulation could shed new light on how organism adapt in nature. In this study, we focused on regulatory differences between a laboratory Saccharomyces cerevisiae strain BY4742 and a pathogenic S. cerevisiae strain, YJM789. The two strains diverge in many features, including growth rate, morphology, high temperature tolerance, and pathogenicity. Our RNA-Seq and ribosomal footprint profiling data showed that gene expression differences are pervasive, and genes functioning in mitochondria are mostly divergent between the two strains at both transcriptional and translational levels. Combining functional genomics data from other yeast strains, we further demonstrated that significant divergence of expression for genes functioning in the electron transport chain (ETC) was likely caused by differential expression of a transcriptional factor, HAP4, and that post-transcriptional regulation mediated by an RNA-binding protein, PUF3, likely led to expression divergence for genes involved in mitochondrial translation. We also explored mitonuclear interactions via mitochondrial DNA replacement between strains. Although the two mitochondrial genomes harbor substantial sequence divergence, neither growth nor gene expression were affected by mitochondrial DNA replacement in both fermentative and respiratory growth media, indicating compatible mitochondrial and nuclear genomes between these two strains in the tested conditions. Collectively, we used mitochondrial functions as an example to demonstrate for the first time that evolution at both transcriptional and post-transcriptional levels could lead to coordinated regulatory changes underlying strain specific functional variations.	[Sun, Xuepeng; Wang, Zhe; Guo, Xiaoxian; Gu, Zhenglong] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Sun, Xuepeng; Li, Hongye] Zhejiang Univ, Coll Agr & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	Cornell University; Zhejiang University	Gu, ZL (corresponding author), Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA.	zg27@cornell.edu	Wang, Zhe/H-9269-2019; Li, Hong-Ye/AAX-2736-2020	Li, Hong-Ye/0000-0001-7427-0706	Cornell University; NSF [MCB-1243588]; NIH [1R01AI085286]; China Scholarship Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085286] Funding Source: NIH RePORTER	Cornell University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by startup funds from Cornell University, NSF MCB-1243588 and NIH 1R01AI085286 awarded to ZG. XS is supported by a visiting student fellowship from China Scholarship Council.	Artieri CG, 2014, GENOME RES, V24, P2011, DOI 10.1101/gr.175893.114; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Brion C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-681; Bullard JH, 2010, P NATL ACAD SCI USA, V107, P5058, DOI 10.1073/pnas.0912959107; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Field Y, 2009, NAT GENET, V41, P438, DOI 10.1038/ng.324; Fraser HB, 2010, P NATL ACAD SCI USA, V107, P2977, DOI 10.1073/pnas.0912245107; Freel KC, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov023; Gaisne M, 1999, CURR GENET, V36, P195, DOI 10.1007/s002940050490; Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054; Gardin J, 2014, ELIFE, V3, DOI 10.7554/eLife.03735; Gerashchenko MV, 2012, P NATL ACAD SCI USA, V109, P17394, DOI 10.1073/pnas.1120799109; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Hansen KD, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq224; Hickman MJ, 2007, MOL CELL BIOL, V27, P7414, DOI 10.1128/MCB.00887-07; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ingolia NT, 2014, NAT REV GENET, V15, P205, DOI 10.1038/nrg3645; Ingolia NT, 2010, METHOD ENZYMOL, V470, P119, DOI 10.1016/S0076-6879(10)70006-9; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jiang HF, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001030; Kemmeren P, 2014, CELL, V157, P740, DOI 10.1016/j.cell.2014.02.054; Khan Z, 2013, SCIENCE, V342, P1100, DOI 10.1126/science.1242379; Khan Z, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.34; Kurtzman CP, 2006, TOP CURR GENET, V15, P29, DOI 10.1007/b106654; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; LANCASHIRE WE, 1979, MOL GEN GENET, V170, P333, DOI 10.1007/BF00267067; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Levin L, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00448; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Luo DP, 2013, NAT GENET, V45, P573, DOI 10.1038/ng.2570; MCCUSKER JH, 1994, GENETICS, V136, P1261; McManus CJ, 2014, GENOME RES, V24, P422, DOI 10.1101/gr.164996.113; Meiklejohn CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003238; Moqtaderi Z, 2013, P NATL ACAD SCI USA, V110, P11073, DOI 10.1073/pnas.1309384110; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Oleksiak MF, 2002, NAT GENET, V32, P261, DOI 10.1038/ng983; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Paliwal S, 2014, GENETICS, V198, P1251, DOI 10.1534/genetics.114.168575; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Quenault T, 2011, TRENDS CELL BIOL, V21, P104, DOI 10.1016/j.tcb.2010.09.013; Raghevendran V, 2006, J BIOL CHEM, V281, P12308, DOI 10.1074/jbc.M512972200; Saveanu C, 2001, J BIOL CHEM, V276, P15861, DOI 10.1074/jbc.M010864200; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Skelly DA, 2013, GENOME RES, V23, P1496, DOI 10.1101/gr.155762.113; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; TAWFIK OW, 1989, J CLIN MICROBIOL, V27, P1689, DOI 10.1128/JCM.27.7.1689-1691.1989; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treu L, 2014, ENVIRON MICROBIOL, V16, P1378, DOI 10.1111/1462-2920.12327; TRUMBLY RJ, 1983, J BACTERIOL, V156, P36, DOI 10.1128/JB.156.1.36-48.1983; Tsankov AM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000414; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wang Z, 2015, GENOME BIOL EVOL, V7, P1155, DOI 10.1093/gbe/evv059; Wei W, 2007, P NATL ACAD SCI USA, V104, P12825, DOI 10.1073/pnas.0701291104; Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652	70	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153523	10.1371/journal.pone.0153523	http://dx.doi.org/10.1371/journal.pone.0153523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077367	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131700073
J	Yu, FQ; Zhang, XG; Huang, Z; Chu, MG; Song, T; Falk, KC; Deora, A; Chen, QL; Zhang, Y; McGregor, L; Gossen, BD; McDonald, MR; Peng, G				Yu, Fengqun; Zhang, Xingguo; Huang, Zhen; Chu, Mingguang; Song, Tao; Falk, Kevin C.; Deora, Abhinandan; Chen, Qilin; Zhang, Yan; McGregor, Linda; Gossen, Bruce D.; McDonald, Mary Ruth; Peng, Gary			Identification of Genome-Wide Variants and Discovery of Variants Associated with Brassica rapa Clubroot Resistance Gene Rcr1 through Bulked Segregant RNA Sequencing	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; PLASMODIOPHORA-BRASSICAE; CHINESE-CABBAGE; RFLP MARKERS; CONFERRING RESISTANCE; ARABIDOPSIS-THALIANA; DISEASE-RESISTANCE; CAMPESTRIS L; NAPUS	Clubroot, caused by Plasmodiophora brassicae, is an important disease on Brassica species worldwide. A clubroot resistance gene, Rcr1, with efficacy against pathotype 3 of P. brassicae, was previously mapped to chromosome A03 of B. rapa in pak choy cultivar "Flower Nabana". In the current study, resistance to pathotypes 2, 5 and 6 was shown to be associated with Rcr1 region on chromosome A03. Bulked segregant RNA sequencing was performed and short read sequences were assembled into 10 chromosomes of the B. rapa reference genome v1.5. For the resistant (R) bulks, a total of 351.8 million (M) sequences, 30,836.5 million bases (Mb) in length, produced 120-fold coverage of the reference genome. For the susceptible (S) bulks, 322.9 M sequences, 28,216.6 Mb in length, produced 109-fold coverage. In total, 776.2 K single nucleotide polymorphisms (SNPs) and 122.2 K insertion / deletion (InDels) in R bulks and 762.8 K SNPs and 118.7 K InDels in S bulks were identified; each chromosome had about 87% SNPs and 13% InDels, with 78% monomorphic and 22% polymorphic variants between the R and S bulks. Polymorphic variants on each chromosome were usually below 23%, but made up 34% of the variants on chromosome A03. There were 35 genes annotated in the Rcr1 target region and variants were identified in 21 genes. The numbers of poly variants differed significantly among the genes. Four out of them encode Toll-Interleukin-1 receptor / nucleotide-binding site / leucine- rich-repeat proteins; Bra019409 and Bra019410 harbored the higher numbers of polymorphic variants, which indicates that they are more likely candidates of Rcr1. Fourteen SNP markers in the target region were genotyped using the Kompetitive Allele Specific PCR method and were confirmed to associate with Rcr1. Selected SNP markers were analyzed with 26 recombinants obtained from a segregating population consisting of 1587 plants, indicating that they were completely linked to Rcr1. Nine SNP markers were used for marker-assisted introgression of Rcr1 into B. napus canola from B. rapa, with 100% accuracy in this study.	[Yu, Fengqun; Zhang, Xingguo; Huang, Zhen; Chu, Mingguang; Song, Tao; Falk, Kevin C.; Chen, Qilin; Zhang, Yan; McGregor, Linda; Gossen, Bruce D.; Peng, Gary] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada; [Deora, Abhinandan; McDonald, Mary Ruth] Univ Guelph, Dept Plant Agr, Guelph, ON N1G 2W1, Canada; [Zhang, Xingguo] Henan Agr Univ, Zhengzhou, Peoples R China; [Huang, Zhen] Northwest A&F Univ, Yangling, Shaanxi, Peoples R China; [Deora, Abhinandan] Syngenta Canada Inc, Plattsville, ON, Canada	Agriculture & Agri Food Canada; University of Guelph; Henan Agricultural University; Northwest A&F University - China; Syngenta	Yu, FQ (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	fengqun.yu@agr.gc.ca	McDonald, Mary Ruth/R-8809-2019; Gossen, Bruce/W-3414-2019	McDonald, Mary Ruth/0000-0002-2881-815X; Gossen, Bruce/0000-0001-5869-930X				Bancroft I, 2011, NAT BIOTECHNOL, V29, P762, DOI 10.1038/nbt.1926; Beissinger TM, 2013, GENETICS, V193, P1073, DOI 10.1534/genetics.112.147710; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Chen JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085307; Cho KH, 2012, J HORTIC SCI BIOTECH, V87, P325, DOI 10.1080/14620316.2012.11512872; Chu MG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1166; CRETE R., 1963, CANADIAN JOUR PLANT SCI, V43, P349; Diederichsen E, 2006, ACTA HORTIC, P307, DOI 10.17660/ActaHortic.2006.706.35; Diederichsen E, 2009, J PLANT GROWTH REGUL, V28, P265, DOI 10.1007/s00344-009-9100-0; Dixon GR, 2009, J PLANT GROWTH REGUL, V28, P194, DOI 10.1007/s00344-009-9090-y; FIGDORE SS, 1993, EUPHYTICA, V69, P33, DOI 10.1007/BF00021723; Fuchs H, 1996, MOL PLANT MICROBE IN, V9, P91, DOI 10.1094/MPMI-9-0091; Gao F, 2014, J AM SOC HORTIC SCI, V139, P247, DOI 10.21273/JASHS.139.3.247; Gautam M, 2013, ALIEN GENE TRANSFER, V2, P207; GOWERS S, 1982, EUPHYTICA, V31, P971, DOI 10.1007/BF00039237; Grandclement C, 1996, THEOR APPL GENET, V93, P86, DOI 10.1007/BF00225731; Harper AL, 2012, NAT BIOTECHNOL, V30, P798, DOI 10.1038/nbt.2302; Hasan MJ, 2012, CAN J PLANT SCI, V92, P501, DOI [10.4141/CJPS2010-006, 10.4141/cjps2010-006]; Hatakeyama K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054745; Hayashida N, 2008, J JPN SOC HORTIC SCI, V77, P150, DOI 10.2503/jjshs1.77.150; Hirai M, 2004, THEOR APPL GENET, V108, P639, DOI 10.1007/s00122-003-1475-x; Howard RJ, 2010, CAN J PLANT PATHOL, V32, P43, DOI 10.1080/07060661003621761; Hu ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034253; Iversen GR, 1997, SPRINGER UNDERGRADUA; JOHNSTON TD, 1974, EUPHYTICA, V23, P681, DOI 10.1007/BF00022490; Kageyama K, 2009, J PLANT GROWTH REGUL, V28, P203, DOI 10.1007/s00344-009-9101-z; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Kato T, 2013, BREEDING SCI, V63, P116, DOI 10.1270/jsbbs.63.116; Kuginuki Y, 1997, EUPHYTICA, V98, P149, DOI 10.1023/A:1003147815692; LANDRY BS, 1992, GENOME, V35, P409, DOI 10.1139/g92-061; Li QF, 2013, THEOR APPL GENET, V126, P2073, DOI 10.1007/s00122-013-2119-4; Liu SY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036406, 10.1371/journal.pone.0030349]; Mammadov Jafar, 2012, Int J Plant Genomics, V2012, P728398, DOI 10.1155/2012/728398; Manzanares-Dauleux MJ, 2000, THEOR APPL GENET, V101, P885, DOI 10.1007/s001220051557; Marian AJ, 2010, CURR OPIN CARDIOL, V25, P182, DOI 10.1097/HCO.0b013e3283389683; Matsumoto E, 1998, EUPHYTICA, V104, P79, DOI 10.1023/A:1018370418201; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Moriguchi K, 1999, BREEDING SCI, V49, P257, DOI 10.1270/jsbbs.49.257; Nagaoka T, 2010, THEOR APPL GENET, V120, P1335, DOI 10.1007/s00122-010-1259-z; Nikolaev SI, 2004, P NATL ACAD SCI USA, V101, P8066, DOI 10.1073/pnas.0308602101; Nomura K, 2005, PLANT BREEDING, V124, P371, DOI 10.1111/j.1439-0523.2005.01105.x; Pang WX, 2014, HORTIC ENVIRON BIOTE, V55, P540, DOI 10.1007/s13580-014-0079-5; Paritosh K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-463; Peng G, 2014, CAN J PLANT PATHOL, V36, P99, DOI 10.1080/07060661.2013.860398; Pfender WF, 2011, THEOR APPL GENET, V122, P1467, DOI 10.1007/s00122-011-1546-3; Piao ZY, 2004, THEOR APPL GENET, V108, P1458, DOI 10.1007/s00122-003-1577-5; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rahman H, 2011, CAN J PLANT SCI, V91, P447, DOI [10.4141/CJPS10073, 10.4141/cjps10073]; Riahi L, 2013, GENET RESOUR CROP EV, V60, P1139, DOI 10.1007/s10722-012-9910-y; Rocherieux J, 2004, THEOR APPL GENET, V108, P1555, DOI 10.1007/s00122-003-1580-x; Saito M, 2006, THEOR APPL GENET, V114, P81, DOI 10.1007/s00122-006-0412-1; Sakamoto K, 2008, THEOR APPL GENET, V117, P759, DOI 10.1007/s00122-008-0817-0; Sathya B, 2015, APPL TRANSL GENOM, V4, P4, DOI 10.1016/j.atg.2014.12.003; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Strelkov SE, 2007, J PHYTOPATHOL, V155, P706, DOI 10.1111/j.1439-0434.2007.01303.x; Strelkov SE, 2006, CAN J PLANT PATHOL, V28, P467, DOI 10.1080/07060660609507321; Strelkov SE, 2014, CAN J PLANT PATHOL, V36, P27, DOI 10.1080/07060661.2013.863807; Suwabe K, 2003, THEOR APPL GENET, V107, P997, DOI 10.1007/s00122-003-1309-x; Suwabe K, 2006, GENETICS, V173, P309, DOI 10.1534/genetics.104.038968; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Takano S, 2014, MOL BREEDING, V34, P1007, DOI 10.1007/s11032-014-0093-4; Tomita H, 2013, MOL BREEDING, V32, P889, DOI 10.1007/s11032-013-9918-9; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Ueno H, 2012, PLANT MOL BIOL, V80, P621, DOI 10.1007/s11103-012-9971-5; Voorrips RE, 1997, THEOR APPL GENET, V94, P75, DOI 10.1007/s001220050384; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Werner S, 2008, THEOR APPL GENET, V116, P363, DOI 10.1007/s00122-007-0674-2; WILLIAMS PH, 1966, PHYTOPATHOLOGY, V56, P624; Xue S, 2008, PLANT DIS, V92, P456, DOI 10.1094/PDIS-92-3-0456; Yang HA, 2013, THEOR APPL GENET, V126, P511, DOI 10.1007/s00122-012-1997-1; Yang HA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-318; Yu F, 2012, MOL BREEDING, V30, P1495, DOI 10.1007/s11032-012-9735-6; Zhang H, 2015, PLANT PATHOL; Zhang T, 2014, MOL BREEDING, V34, P1173, DOI 10.1007/s11032-014-0108-1	76	41	46	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153218	10.1371/journal.pone.0153218	http://dx.doi.org/10.1371/journal.pone.0153218			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078023	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700027
J	Maxwell, DJ; Partridge, JC; Roberts, NW; Boonham, N; Foster, GD				Maxwell, Daniel J.; Partridge, Julian C.; Roberts, Nicholas W.; Boonham, Neil; Foster, Gary D.			The Effects of Plant Virus Infection on Polarization Reflection from Leaves	PLOS ONE			English	Article							MYZUS-PERSICAE SULZ; CUTICULAR WAX; PAPILIO BUTTERFLIES; VECTOR INTERACTIONS; FEEDING-BEHAVIOR; EPICUTICULAR WAX; POTATO PLANTS; ARABIDOPSIS; APHID; TRANSMISSION	Alteration of leaf surface phenotypes due to virus infection has the potential to affect the likelihood of colonisation by insect vectors, or to affect their feeding activities. The aim of this study was to investigate whether viruses that rely on insects for their transmission, and which can be sensitive to the polarization of light, affect the percentage polarization of light reflected from leaves. We also set out to discover whether a correlation exists between the expression of ECERIFERUM (CER) genes involved in cuticular wax synthesis and the polarization of the light reflected from the leaf surfaces. It was found that the aphid-vectored viruses Potato virus Y and Cucumber mosaic virus (CMV) caused significant reductions in the percentage polarization of light reflected from the abaxial surfaces of leaves of Nicotiana tabacum, whereas the non-insect-vectored viruses Tobacco mosaic virus and Pepino mosaic virus did not induce this effect. In Arabidopsis thaliana, there was little difference in the impacts of CMV and the non-insect-vectored Turnip vein clearing virus on polarization reflection, with both viruses increasing the percentage polarization of light reflected from the abaxial surfaces of leaves. There was a trend towards increased accumulation of CER6 transcripts in N. tabacum and A. thaliana when infected with aphid-vectored viruses. No significant effect of infection on trichome densities was found in A. thaliana, suggesting that alterations to the formation of cuticular waxes may be the more likely phenotypic change on the leaf surface contributing to the changes in polarization reflection. The possible impacts and adaptive significance of these effects with regard to viral transmission by insects are discussed.	[Maxwell, Daniel J.; Partridge, Julian C.; Roberts, Nicholas W.; Foster, Gary D.] Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Partridge, Julian C.] Univ Western Australia, Sch Anim Biol, Perth, WA 6009, Australia; [Partridge, Julian C.] Univ Western Australia, Oceans Inst, Perth, WA 6009, Australia; [Boonham, Neil] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England	University of Bristol; University of Western Australia; University of Western Australia; Food & Environment Research Agency	Foster, GD (corresponding author), Univ Bristol, Sch Biol Sci, 24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	gary.foster@bristol.ac.uk	Partridge, Julian C/F-2097-2014; Foster, Gary D/A-7985-2011	Partridge, Julian C/0000-0003-3788-2900; Foster, Gary D/0000-0002-1979-1397; Roberts, Nicholas/0000-0002-4540-6683; Boonham, Neil/0000-0002-8886-5708	Natural Environment Research Council; Central Science Laboratories	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Central Science Laboratories	This work was supported by the Natural Environment Research Council and Central Science Laboratories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez AE, 2007, ENTOMOL EXP APPL, V125, P135, DOI 10.1111/j.1570-7458.2007.00607.x; Bernard A, 2012, PLANT CELL, V24, P3106, DOI 10.1105/tpc.112.099796; BODNARYK RP, 1992, CAN J PLANT SCI, V72, P1295, DOI 10.4141/cjps92-163; Boquel S, 2011, EUR J PLANT PATHOL, V129, P507, DOI 10.1007/s10658-010-9732-8; Carmo-Sousa M, 2014, VIRUS RES, V186, P38, DOI 10.1016/j.virusres.2013.12.012; CASTLE SJ, 1993, ENTOMOL EXP APPL, V69, P51, DOI 10.1007/BF02380673; Dacke M, 2003, NATURE, V424, P33, DOI 10.1038/424033a; Donaldson JR, 2007, ENVIRON ENTOMOL, V36, P918, DOI 10.1603/0046-225X(2007)36[918:AEOSVO]2.0.CO;2; DUELLI P, 1975, J COMP PHYSIOL, V102, P43, DOI 10.1007/BF00657484; DUELLI P, 1973, J COMP PHYSIOL, V86, P37, DOI 10.1007/BF00694476; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Fereres A, 2009, VIRUS RES, V141, P158, DOI 10.1016/j.virusres.2008.10.020; FERRAR P, 1969, B ENTOMOL RES, V58, P653, DOI 10.1017/S0007485300057370; Foster JJ, 2014, CURR BIOL, V24, P1415, DOI 10.1016/j.cub.2014.05.007; GRANT L, 1987, REMOTE SENS ENVIRON, V22, P309, DOI 10.1016/0034-4257(87)90064-2; GRANT L, 1987, ENVIRON EXP BOT, V27, P139, DOI 10.1016/0098-8472(87)90064-5; GRANT L, 1993, PHYSIOL PLANTARUM, V88, P1, DOI 10.1111/j.1399-3054.1993.tb01753.x; HE XD, 1991, ACM SIGGRAPH COMPUTE, V25, P175, DOI DOI 10.1145/127719; Hooker TS, 2007, PLANT CELL, V19, P904, DOI 10.1105/tpc.106.049304; Hooker TS, 2002, PLANT PHYSIOL, V129, P1568, DOI 10.1104/pp.003707; Horvath G, 2002, J EXP BIOL, V205, P3281; Horvath G., 2004, POLARIZED LIGHT ANIM; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Irwin ME, 2007, APHIDS AS CROP PESTS, P153, DOI 10.1079/9780851998190.0153; Kelber A, 2001, J EXP BIOL, V204, P2469; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kinoshita M, 2011, PHILOS T R SOC B, V366, P688, DOI 10.1098/rstb.2010.0200; Koch K, 2008, MICRON, V39, P759, DOI 10.1016/j.micron.2007.11.010; KRING JB, 1977, ANN ENTOMOL SOC AM, V70, P855, DOI 10.1093/aesa/70.6.855; Kunst L, 2003, PROG LIPID RES, V42, P51, DOI 10.1016/S0163-7827(02)00045-0; Lightle D, 2014, ENTOMOL EXP APPL; LIN JT, 1993, J INSECT PHYSIOL, V39, P555, DOI 10.1016/0022-1910(93)90037-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu SY, 2012, PLANT PHYSIOL, V159, P930, DOI 10.1104/pp.112.198697; Lu SY, 2009, PLANT J, V59, P553, DOI 10.1111/j.1365-313X.2009.03892.x; Martiniere A, 2013, ELIFE, V2, DOI 10.7554/eLife.00183; Mauck KE, 2014, INTEGR COMP BIOL, V54, P193, DOI 10.1093/icb/icu012; Mauck K, 2012, FUNCT ECOL, V26, P1162, DOI 10.1111/j.1365-2435.2012.02026.x; Mauck KE, 2014, PLANT CELL ENVIRON, V37, P1427, DOI 10.1111/pce.12249; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; Moury B, 2007, P NATL ACAD SCI USA, V104, P17891, DOI 10.1073/pnas.0702739104; Ng JCK, 2006, ANNU REV PHYTOPATHOL, V44, P183, DOI 10.1146/annurev.phyto.44.070505.143325; Nishino K, 2011, OPT EXPRESS, V19, P6020, DOI 10.1364/OE.19.006020; Pighin JA, 2004, SCIENCE, V306, P702, DOI 10.1126/science.1102331; Powell G, 1999, ENTOMOL EXP APPL, V91, P115, DOI 10.1023/A:1003639225674; Power AG, 1996, ECOLOGY, V77, P1004, DOI 10.2307/2265571; Radcliffe EB, 2002, AM J POTATO RES, V79, P353, DOI 10.1007/BF02870173; Roberts NW, 2011, PHILOS T R SOC B, V366, P627, DOI 10.1098/rstb.2010.0206; ROSSEL S, 1984, J COMP PHYSIOL, V154, P607, DOI 10.1007/BF01350213; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Stafford CA, 2011, P NATL ACAD SCI USA, V108, P9350, DOI 10.1073/pnas.1100773108; VANDERBILT VC, 1985, IEEE T GEOSCI REMOTE, V23, P722, DOI 10.1109/TGRS.1985.289390; VANDERBILT VC, 1985, P IEEE, V73, P1012, DOI 10.1109/PROC.1985.13232; Watson MA, 1939, PROC R SOC SER B-BIO, V127, P543, DOI 10.1098/rspb.1939.0039; Whitney HM, 2012, PLOS ONE, V7, P66, DOI 10.1371/journal.pone.0029476; Wildermuth H, 1998, NATURWISSENSCHAFTEN, V85, P297, DOI 10.1007/s001140050504	57	10	11	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152836	10.1371/journal.pone.0152836	http://dx.doi.org/10.1371/journal.pone.0152836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100188	Green Published, gold			2022-12-27	WOS:000374898500015
J	Plass-Johnson, JG; Taylor, MH; Husain, AAA; Teichberg, MC; Ferse, SCA				Plass-Johnson, Jeremiah G.; Taylor, Marc H.; Husain, Aidah A. A.; Teichberg, Mirta C.; Ferse, Sebastian C. A.			Non-Random Variability in Functional Composition of Coral Reef Fish Communities along an Environmental Gradient	PLOS ONE			English	Article							SPECIES COOCCURRENCE; DIVERSITY INDEXES; STABLE STATES; REDUNDANCY; VULNERABILITY; DEGRADATION; ASSEMBLAGES; COMPLEXITY; FRAMEWORK; ABUNDANCE	Changes in the coral reef complex can affect predator-prey relationships, resource availability and niche utilisation in the associated fish community, which may be reflected in decreased stability of the functional traits present in a community. This is because particular traits may be favoured by a changing environment, or by habitat degradation. Furthermore, other traits can be selected against because degradation can relax the association between fishes and benthic habitat. We characterised six important ecological traits for fish species occurring at seven sites across a disturbed coral reef archipelago in Indonesia, where reefs have been exposed to eutrophication and destructive fishing practices for decades. Functional diversity was assessed using two complementary indices (FRic and RaoQ) and correlated to important environmental factors (live coral cover and rugosity, representing local reef health, and distance from shore, representing a cross-shelf environmental gradient). Indices were examined for both a change in their mean, as well as temporal (short-term; hours) and spatial (cross-shelf) variability, to assess whether fish-habitat association became relaxed along with habitat degradation. Furthermore, variability in individual traits was examined to identify the traits that are most affected by habitat change. Increases in the general reef health indicators, live coral cover and rugosity (correlated with distance from the mainland), were associated with decreases in the variability of functional diversity and with community-level changes in the abundance of several traits (notably home range size, maximum length, microalgae, detritus and small invertebrate feeding and reproductive turnover). A decrease in coral cover increased variability of RaoQ while rugosity and distance both inversely affected variability of FRic; however, averages for these indices did not reveal patterns associated with the environment. These results suggest that increased degradation of coral reefs is associated with increased variability in fish community functional composition resulting from selective impacts on specific traits, thereby affecting the functional response of these communities to increasing perturbations.	[Plass-Johnson, Jeremiah G.; Teichberg, Mirta C.; Ferse, Sebastian C. A.] Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany; [Plass-Johnson, Jeremiah G.] Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany; [Plass-Johnson, Jeremiah G.] Univ Nice Sophia Antipolis, Fac Sci, ECOMERS, F-06189 Nice, France; [Taylor, Marc H.] Leibniz Ctr Trop Marine Ecol ZMT, Dept Theoret Ecol & Modelling, Bremen, Germany; [Taylor, Marc H.] Thunen Inst Sea Fisheries, Hamburg, Germany; [Husain, Aidah A. A.] Hasanuddin Univ, Ctr Marine Coastal & Small Isl Res, Makassar, Indonesia; [Ferse, Sebastian C. A.] Univ Hawaii Manoa, Dept Geog, Honolulu, HI 96822 USA	Leibniz Zentrum fur Marine Tropenforschung (ZMT); University of Bremen; UDICE-French Research Universities; Universite Cote d'Azur; Leibniz Zentrum fur Marine Tropenforschung (ZMT); Johann Heinrich von Thunen Institute; Universitas Hasanuddin; University of Hawaii System; University of Hawaii Manoa	Plass-Johnson, JG (corresponding author), Leibniz Ctr Trop Marine Ecol ZMT, Dept Ecol, Bremen, Germany.; Plass-Johnson, JG (corresponding author), Univ Bremen, Fac Biol & Chem FB2, D-28359 Bremen, Germany.; Plass-Johnson, JG (corresponding author), Univ Nice Sophia Antipolis, Fac Sci, ECOMERS, F-06189 Nice, France.	jplass@uni-bremen.de	Ferse, Sebastian/AAH-8048-2021; Plass-Johnson, Jeremiah G./H-7215-2019; Taylor, Marc/AAI-6598-2021	Ferse, Sebastian/0000-0003-0930-5356; Plass-Johnson, Jeremiah G./0000-0001-6131-4714; Taylor, Marc/0000-0001-9730-6994	Bundesministerium fur Bildung und Forschung [03F0643A, 01LN1303A]; Open Access Fund of the Leibniz Association	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Open Access Fund of the Leibniz Association	This work was supported by Grant number: 03F0643A Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/en/), recieved by MT; 01LN1303A Bundesministerium fur Bildung und Forschung (http://www.bmbf.de/en/), received by SCAF. The publication of this article was funded by the Open Access Fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez LJ, 2011, ECOSPHERE, V2, DOI [10.1890/ES11-00104.1, 10.1890/ES11-00185.1]; Ault TR, 1998, ECOL MONOGR, V68, P25, DOI 10.1890/0012-9615(1998)068[0025:SATPFO]2.0.CO;2; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Bellwood DR, 2006, P ROY SOC B-BIOL SCI, V273, P101, DOI 10.1098/rspb.2005.3276; Botta-Dukat Z, 2005, J VEG SCI, V16, P533, DOI 10.1111/j.1654-1103.2005.tb02393.x; Brandl SJ, 2013, CORAL REEFS, V32, P835, DOI 10.1007/s00338-013-1042-0; Burke L., 2011, REEFS RISK REVISITED; Bythell JC, 2000, MAR ECOL PROG SER, V204, P93, DOI 10.3354/meps204093; CHAPMAN MG, 1995, J EXP MAR BIOL ECOL, V189, P103, DOI 10.1016/0022-0981(95)00017-L; Cleary DFR, 2005, ESTUAR COAST SHELF S, V65, P557, DOI 10.1016/j.ecss.2005.06.025; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; D'agata S, 2014, CURR BIOL, V24, P555, DOI 10.1016/j.cub.2014.01.049; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Dudgeon SR, 2010, MAR ECOL PROG SER, V413, P201, DOI 10.3354/meps08751; Edinger EN, 1998, MAR POLLUT BULL, V36, P617, DOI 10.1016/S0025-326X(98)00047-2; Eggers SL, 2014, GLOBAL CHANGE BIOL, V20, P713, DOI 10.1111/gcb.12421; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Ferse SCA, 2008, P 11 INT COR REEF S, P1225; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Gotelli NJ, 2000, ECOLOGY, V81, P2606, DOI 10.1890/0012-9658(2000)081[2606:NMAOSC]2.0.CO;2; Gotelli NJ, 2002, ECOLOGY, V83, P2091, DOI 10.2307/3072040; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; HATCHER BG, 1984, CORAL REEFS, V3, P199, DOI 10.1007/BF00288255; Holmlund CM, 1999, ECOL ECON, V29, P253, DOI 10.1016/S0921-8009(99)00015-4; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; KNOWLTON N, 1992, AM ZOOL, V32, P674; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Kulbicki M, 2005, CYBIUM, V29, P235; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; Lindahl U, 2001, MAR POLLUT BULL, V42, P127, DOI 10.1016/S0025-326X(00)00167-3; Lindfield SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092628; Mason NWH, 2008, J ANIM ECOL, V77, P661, DOI 10.1111/j.1365-2656.2008.01379.x; Mason NWH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075219; Mason NWH, 2013, J VEG SCI, V24, P794, DOI 10.1111/jvs.12013; McClanahan TR, 2007, MAR ECOL PROG SER, V340, P221, DOI 10.3354/meps340221; Micheli F, 2014, BIOL CONSERV, V171, P186, DOI 10.1016/j.biocon.2013.12.029; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Mouillot D, 2007, ESTUAR COAST SHELF S, V71, P443, DOI 10.1016/j.ecss.2006.08.022; Mouillot D, 2014, P NATL ACAD SCI USA, V111, P13757, DOI 10.1073/pnas.1317625111; Mouillot D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001569; Mouillot D, 2013, TRENDS ECOL EVOL, V28, P167, DOI 10.1016/j.tree.2012.10.004; Nystrom M, 2006, AMBIO, V35, P30, DOI 10.1639/0044-7447(2006)035[0030:RARDOF]2.0.CO;2; O'Gorman EJ, 2011, P ROY SOC B-BIOL SCI, V278, P1886, DOI 10.1098/rspb.2010.2036; Ohman MC, 1997, ENVIRON BIOL FISH, V49, P45, DOI 10.1023/A:1007309230416; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Plass-Johnson JG, 2015, LIMNOL OCEANOGR, V60, P1382, DOI 10.1002/lno.10105; Plass-Johnson JP, CORAL REEFS, DOI 10.007/s00338-015-1369-9; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Renema W, 2001, PALAEOGEOGR PALAEOCL, V175, P125, DOI 10.1016/S0031-0182(01)00389-3; Risk M.J., 1972, Atoll Res Bull, VNo. 153, P1; Roberts CM, 1999, TRENDS ECOL EVOL, V14, P241, DOI 10.1016/S0169-5347(98)01584-5; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Sale P. F., 2002, CORAL REEF FISHES DY; Sale PF., 1997, AM SCI, V111, P337; Sawall Y, 2011, CORAL REEFS, V30, P841, DOI 10.1007/s00338-011-0764-0; SHEPHERD ARD, 1992, ENVIRON BIOL FISH, V33, P367, DOI 10.1007/BF00010949; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Villeger S, 2008, ECOLOGY, V89, P2290, DOI 10.1890/07-1206.1; Villeger S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040679; Villeger S, 2010, ECOL APPL, V20, P1512, DOI 10.1890/09-1310.1; Violle C, 2007, OIKOS, V116, P882, DOI 10.1111/j.2007.0030-1299.15559.x; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wood S., 2012, PACKAGE MGCV R PACKA; Zobel M, 1997, TRENDS ECOL EVOL, V12, P266, DOI 10.1016/S0169-5347(97)01096-3	74	28	29	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154014	10.1371/journal.pone.0154014	http://dx.doi.org/10.1371/journal.pone.0154014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100189	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500123
J	Gebremariam, G; Asmamaw, G; Hussen, M; Hailemariam, MZ; Asegu, D; Astatkie, A; Amsalu, AG				Gebremariam, Gebreslassie; Asmamaw, Getachew; Hussen, Muktar; Hailemariam, Mengistu Z.; Asegu, Demissie; Astatkie, Ayalew; Amsalu, Anteneh G.			Impact of HIV Status on Treatment Outcome of Tuberculosis Patients Registered at Arsi Negele Health Center, Southern Ethiopia: A Six Year Retrospective Study	PLOS ONE			English	Article							TB PATIENTS; COHORT; NONADHERENCE	Background Despite implementation of different strategies, the burden and mortality of human immunodeficiency virus (HIV)-associated tuberculosis (TB) remains a challenge in Ethiopia. The aim of this study was to assess the impact of HIV status on treatment outcome of tuberculosis patients registered at Arsi Negele Health Center, Southern Ethiopia. Methods A six-year retrospective data (from September 2008 to August 2014) of tuberculosis patients (n = 1649) registered at the directly observed therapy short-course (DOTS) clinic of Arsi Negele Health Center was reviewed. Treatment outcome and tuberculosis type were categorized according to the national tuberculosis control program guideline. Data were entered and analyzed using SPSS version 20. Multinomial logistic regression analysis was used to examine the effect of HIV status separately on default/failure and death in relation to those who were successfully treated. Odds ratios with 95% confidence intervals were used to check the presence and strength of association between TB treatment outcome and HIV status and other independent variables. Results Out of the 1649 TB patients, 94.7% (1562) have been tested for HIV of whom 156(10%) were HIV co-infected. The mean (standard deviation) age of the patients was 28.5(15.5) years. The majority were new TB cases (96.7%), male (53.7%), urban (54.7%), and had smear negative pulmonary TB (44.1%). Overall, the treatment success rate of TB patients with or without HIV was 87.3%. Using cure/completion as reference, patients without known HIV status had significantly higher odds of default /failure [aOR, 4.26; 95% CI, 1.684-10.775] and transfer-out [aOR, 2.92; 95% CI, 1.545-5.521] whereas those who tested positive for HIV had a significantly higher odds of death [aOR, 6.72; 95% CI, 3.704-12.202] and transferout [aOR, 2.02; 95% CI, 1.111-3.680]. Conclusion Overall, treatment outcome and HIV testing coverage for TB patients is promising to reach the WHO target in the study area. However, default/failure among patients without known HIV status, and higher rate of mortality among HIV positive TB patients and transfer-out cases deserves concern. Therefore further prospective studies on quality of services, socioeconomics and psychology of this group should be conducted.	[Gebremariam, Gebreslassie; Asmamaw, Getachew; Hussen, Muktar; Hailemariam, Mengistu Z.; Asegu, Demissie] Hawassa Univ, Dept Med Lab Sci, Hawassa, Ethiopia; [Astatkie, Ayalew] Hawassa Univ, Sch Publ & Environm Hlth, Hawassa, Ethiopia; [Amsalu, Anteneh G.] Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia	Hawassa University; Hawassa University; University of Gondar	Amsalu, AG (corresponding author), Univ Gondar, Dept Med Microbiol, Gondar, Ethiopia.	ant.amsalu@gmail.com	HAILEMARIAM, MENGISTU/AAL-4397-2021; Astatkie, Ayalew/I-1167-2019; zenebe, MENGISTU Hailemariam/GSE-3937-2022	Astatkie, Ayalew/0000-0002-4840-9601; Assegu, Demissie/0000-0003-3914-838X; Amsalu, Anteneh/0000-0001-7919-4546				Addis Z, 2013, IJBAR; Ambadekar NN, 2015, PUBLIC HEALTH, V129, P783, DOI 10.1016/j.puhe.2015.03.006; Biadglegne F, 2013, INT J BIOL MED RES, V4, P2942; Cheru F, 2013, J PHARM BIOMED SCI, V34, P1606; ENDRIS M, 2014, TUBERC RES TREAT, V2014, DOI DOI 10.1155/2014/726193; Falvo JV, 2011, AM J RESP CELL MOL, V45, P1116, DOI 10.1165/rcmb.2011-0186TR; Federal Democratic Republic of Ethiopia Ministry of Health/Ethiopian Public Health Institute, 2014, IMPLEMENTATION GUIDE; Federal Ministry of Health of Ethiopia, 2008, MAN TUB LEPR TB HIV; Federal Ministry of Health of Ethiopia, 2013, NAT TB HIV SENT SURV; Federal Ministry of Health of Ethiopia, 2010, FED MIN HLTH ETH TUB; Fiseha T, 2015, J BIOENG BIOMED SCI, V2015, P1, DOI DOI 10.4172/2155-9538.1000139; Garrido MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039134; Gebremariam MK, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-651; Getahun B, 2013, BRAZ J INFECT DIS, V17, P521, DOI 10.1016/j.bjid.2012.12.010; Hamusse SD, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25382; Harries AD, 2009, SAFRJ EPID INFECT, V24; Ifebunandu NA, 2012, TROP DOCT, V42, P74, DOI 10.1258/td.2011.110421; Kittikraisak W, 2009, T ROY SOC TROP MED H, V103, P59, DOI 10.1016/j.trstmh.2008.09.003; Maruza M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-351; Mayer KH, 2010, CLIN INFECT DIS, V50, pS67, DOI 10.1086/651475; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Nahid P, 2007, AM J RESP CRIT CARE, V175, P1199, DOI 10.1164/rccm.200509-1529OC; Naidoo P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-396; Ngamvithayapong J, 2000, AIDS, V14, P1413, DOI 10.1097/00002030-200007070-00015; Ofoegbu OS, 2015, S AFR FAM PRACT, V57, P50, DOI 10.1080/20786190.2014.995913; Oshi Daniel Chukwunweolu, 2014, Tuberc Res Treat, V2014, P202983, DOI 10.1155/2014/202983; Ruiz-Navarro MD, 2005, ARCH BRONCONEUMOL, V41, P363; Sanchez M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033129; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Stop TB partnership, 2010, GLOB PLAN STOP TB 20; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; Tola HH, 2015, IRAN J PUBLIC HEALTH, V44, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2014, GLOB TUB REP 2014; World health organization, 2015, UPD SHEET EP HIV AID; Yone EWP, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-190	37	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153239	10.1371/journal.pone.0153239	http://dx.doi.org/10.1371/journal.pone.0153239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096159	Green Submitted, gold, Green Published			2022-12-27	WOS:000374543600030
J	Moriyama, M; Hosokawa, T; Tanahashi, M; Nikoh, N; Fukatsu, T				Moriyama, Minoru; Hosokawa, Takahiro; Tanahashi, Masahiko; Nikoh, Naruo; Fukatsu, Takema			Suppression of Bedbug's Reproduction by RNA Interference of Vitellogenin	PLOS ONE			English	Article							BED-BUG; TRAUMATIC INSEMINATION; MOLECULAR CHARACTERIZATION; HEMIPTERA; GENES; RESISTANCE; COCKROACH; RECEPTOR; PROTEIN; FUTURE	Recent resurgence of the bedbug Cimex lectularius is a global problem on the public health. On account of the worldwide rise of insecticide-resistant bedbug populations, exploration of new approaches to the bedbug control and management is anticipated. In this context, gene silencing by RNA interference (RNAi) has been considered for its potential application to pest control and management, because RNAi enables specific suppression of target genes and thus flexible selection of target traits to be disrupted. In this study, in an attempt to develop a control strategy targeting reproduction of the bedbug, we investigated RNAi-mediated gene silencing of vitellogenin (Vg), a major yolk protein precursor essential for oogenesis. From the bedbug transcriptomes, we identified a typical Vg gene and a trun-cated Vg gene, which were designated as ClVg and ClVg-like, respectively. ClVg gene was highly expressed mainly in the fat body of adult females, which was more than 100 times higher than the expression level of ClVg-like gene, indicating that ClVg gene is the primary functional Vg gene in the bedbug. RNAi-mediated suppression of ClVg gene expression in adult females resulted in drastically reduced egg production, atrophied ovaries, and inflated abdomen due to hypertrophied fat bodies. These phenotypic consequences are expected not only to suppress the bedbug reproduction directly but also to deteriorate its feeding and survival indirectly via behavioral modifications. These results suggest the potential of ClVg gene as a promising target for RNAi-based population management of the bedbug.	[Moriyama, Minoru; Hosokawa, Takahiro; Tanahashi, Masahiko; Fukatsu, Takema] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Hosokawa, Takahiro] Kyushu Univ, Fac Sci, Fukuoka 812, Japan; [Nikoh, Naruo] Open Univ Japan, Dept Liberal Arts, Chiba, Japan; [Fukatsu, Takema] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Fukatsu, Takema] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Kyushu University; University of Tokyo; University of Tsukuba	Moriyama, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.	m-moriyama@aist.go.jp		Hosokawa, Takahiro/0000-0001-7618-1774	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science KAKENHI [25221107]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [14J09621] Funding Source: KAKEN	Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was financially supported by the Program for Promotion of Basic and Applied Research for Innovations in Bio-oriented Industry (BRAIN) to TF and NN, and by the Japan Society for the Promotion of Science KAKENHI grant no. 25221107 to TF and NN. MM and MT were supported by the Japan Society for the Promotion of Science Fellowship for Young Scientists.	Araujo RN, 2006, INSECT BIOCHEM MOLEC, V36, P683, DOI 10.1016/j.ibmb.2006.05.012; Avarre JC, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-3; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Boldbaatar D, 2010, J INSECT PHYSIOL, V56, P1587, DOI 10.1016/j.jinsphys.2010.05.019; Burand JP, 2013, J INVERTEBR PATHOL, V112, pS68, DOI 10.1016/j.jip.2012.07.012; Christiaens O, 2014, CURR OPIN INSECT SCI, V6, P15, DOI 10.1016/j.cois.2014.09.012; Ciudad L, 2006, FEBS J, V273, P325, DOI 10.1111/j.1742-4658.2005.05066.x; Crawley MJ, 2005, STAT INTRO USING R; Davies TGE, 2012, MED VET ENTOMOL, V26, P241, DOI 10.1111/j.1365-2915.2011.01006.x; DAVIS NT, 1964, J INSECT PHYSIOL, V10, P947, DOI 10.1016/0022-1910(64)90083-6; Delaunay P, 2011, CLIN INFECT DIS, V52, P200, DOI 10.1093/cid/ciq102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gade G, 2003, PEST MANAG SCI, V59, P1063, DOI 10.1002/ps.755; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gu JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021329; Gu LQ, 2013, CROP PROT, V45, P36, DOI 10.1016/j.cropro.2012.10.004; Guidugli KR, 2005, FEBS LETT, V579, P4961, DOI 10.1016/j.febslet.2005.07.085; HAGEDORN HH, 1979, ANNU REV ENTOMOL, V24, P475, DOI 10.1146/annurev.en.24.010179.002355; Hall M, 1999, P NATL ACAD SCI USA, V96, P1965, DOI 10.1073/pnas.96.5.1965; Harlan Harold J., 2006, American Entomologist, V52, P99; Hirai M, 1998, INSECT BIOCHEM MOLEC, V28, P537, DOI 10.1016/S0965-1748(98)00052-6; Hoffmann KH, 1998, PHYTOPARASITICA, V26, P323, DOI 10.1007/BF02981447; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Johnson CG, 1941, J HYG-CAMBRIDGE, V41, P345, DOI 10.1017/S0022172400012560; Kim YH, 2015, PESTIC BIOCHEM PHYS, V120, P109, DOI 10.1016/j.pestbp.2015.01.002; Lee JM, 2000, INSECT BIOCHEM MOLEC, V30, P189, DOI 10.1016/S0965-1748(99)00127-7; Li J, 2013, INSECT SCI, V20, P31, DOI [10.1111/j.1744-7917.2012.01558.x, 10.1111/j.1744-7917.2012.01550.x]; Lu HL, 2009, FEBS J, V276, P3110, DOI 10.1111/j.1742-4658.2009.07029.x; Mamidala P, 2013, COMP BIOCHEM PHYS B, V164, P275, DOI 10.1016/j.cbpb.2013.02.002; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Martin D, 2006, J INSECT PHYSIOL, V52, P410, DOI 10.1016/j.jinsphys.2005.12.002; Melo ACA, 2000, INSECT BIOCHEM MOLEC, V30, P549, DOI 10.1016/S0965-1748(00)00023-0; Mitchell RD, 2007, INSECT BIOCHEM MOLEC, V37, P375, DOI 10.1016/j.ibmb.2007.01.005; Moriyama M, 2012, APPL ENTOMOL ZOOL, V47, P233, DOI 10.1007/s13355-012-0112-z; Morrow EH, 2003, P ROY SOC B-BIOL SCI, V270, P2377, DOI 10.1098/rspb.2003.2514; Provost-Javier KN, 2010, INSECT MOL BIOL, V19, P423, DOI 10.1111/j.1365-2583.2010.00999.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reinhardt K, 2005, ECOL ENTOMOL, V30, P607, DOI 10.1111/j.0307-6946.2005.00730.x; Reinhardt K, 2003, P ROY SOC B-BIOL SCI, V270, P2371, DOI 10.1098/rspb.2003.2515; Reinhardt K, 2007, ANNU REV ENTOMOL, V52, P351, DOI 10.1146/annurev.ento.52.040306.133913; Robinson-Rechavi M, 2000, BIOINFORMATICS, V16, P296, DOI 10.1093/bioinformatics/16.3.296; Santos D, 2014, CURR OPIN INSECT SCI, V6, P9, DOI 10.1016/j.cois.2014.09.013; Sappington TW, 1998, INSECT BIOCHEM MOLEC, V28, P277, DOI 10.1016/S0965-1748(97)00110-0; Siva-Jothy MT, 2006, PHILOS T ROY SOC B, V361, P269, DOI 10.1098/rstb.2005.1789; Smagghe G, 2014, CURR OPIN INSECT SCI, V6, pIV, DOI 10.1016/j.cois.2014.11.001; Stutt AD, 2001, P NATL ACAD SCI USA, V98, P5683, DOI 10.1073/pnas.101440698; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tufail M, 2001, ARCH INSECT BIOCHEM, V48, P72, DOI 10.1002/arch.1059; Tufail M, 2008, J INSECT PHYSIOL, V54, P1447, DOI 10.1016/j.jinsphys.2008.08.007; Tufail M, 2007, ARCH INSECT BIOCHEM, V66, P190, DOI 10.1002/arch.20212; Tufail M, 2014, ENTOMOL SCI, V17, P269, DOI 10.1111/ens.12086; Usinger R. L., 1966, MONOGRAPH CIMICIDAE; Weeks ENI, 2011, PEST MANAG SCI, V67, P10, DOI 10.1002/ps.2024; Yu N, 2013, INSECT SCI, V20, P4, DOI 10.1111/j.1744-7917.2012.01534.x; Zhang H, 2013, INSECT SCI, V20, P15, DOI 10.1111/j.1744-7917.2012.01513.x; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zhu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031037	59	38	40	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153984	10.1371/journal.pone.0153984	http://dx.doi.org/10.1371/journal.pone.0153984			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096422	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600079
J	Schulten, HJ; Hussein, D; Al-Adwani, F; Karim, S; Al-Maghrabi, J; Al-Sharif, M; Jamal, A; Al-Ghamdi, F; Baeesa, SS; Bangash, M; Chaudhary, A; Al-Qahtani, M				Schulten, Hans-Juergen; Hussein, Deema; Al-Adwani, Fatima; Karim, Sajjad; Al-Maghrabi, Jaudah; Al-Sharif, Mona; Jamal, Awatif; Al-Ghamdi, Fahad; Baeesa, Saleh S.; Bangash, Mohammed; Chaudhary, Adeel; Al-Qahtani, Mohammed			Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression	PLOS ONE			English	Article							THERAPEUTIC TARGET; NETRIN-1; GLIOBLASTOMA; REVEALS; METHYLATION; MIGRATION; PROFILES; PROTEINS; NETWORK; COMPLEX	Meningiomas are the most common primary brain tumors bearing in a minority of cases an aggressive phenotype. Although meningiomas are stratified according to their histology and clinical behavior, the underlying molecular genetics predicting aggressiveness are not thoroughly understood. We performed whole transcript expression profiling in 10 grade I and four grade II meningiomas, three of which invaded the brain. Microarray expression analysis identified deleted in colorectal cancer (DCC) as a differentially expressed gene (DEG) enabling us to cluster meningiomas into DCC low expression (3 grade I and 3 grade II tumors), DCC medium expression (2 grade I and 1 grade II tumors), and DCC high expression (5 grade I tumors) groups. Comparison between the DCC low expression and DCC high expression groups resulted in 416 DEGs (p-value < 0.05; fold change > 2). The most significantly downregulated genes in the DCC low expression group comprised DCC, phosphodiesterase 1C (PDE1C), calmodulin-dependent 70kDa olfactomedin 2 (OLFM2), glutathione S-transferase mu 5 (GSTM5), phosphotyrosine interaction domain containing 1 (PID1), sema domain, transmembrane domain (TM) and cytoplasmic domain, (semaphorin) 6D (SEMA6D), and indolethylamine N-methyltransferase (INMT). The most significantly upregulated genes comprised chromosome 5 open reading frame 63 (C5orf63), homeodomain interacting protein kinase 2 (HIPK2), and basic helix-loop-helix family, member e40 (BHLHE40). Biofunctional analysis identified as predicted top upstream regulators beta-estradiol, TGFB1, Tgf beta complex, LY294002, and dexamethasone and as predicted top regulator effectors NFkB, PIK3R1, and CREBBP. The microarray expression data served also for a comparison between meningiomas from female and male patients and for a comparison between brain invasive and non-invasive meningiomas resulting in a number of significant DEGs and related biofunctions. In conclusion, based on its expression levels, DCC may constitute a valid biomarker to identify those benign meningiomas at risk for progression.	[Schulten, Hans-Juergen; Al-Adwani, Fatima; Karim, Sajjad; Chaudhary, Adeel; Al-Qahtani, Mohammed] King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia; [Schulten, Hans-Juergen; Karim, Sajjad; Chaudhary, Adeel; Al-Qahtani, Mohammed] King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia; [Hussein, Deema] King Abdulaziz Univ, King Fahad Med Res Ctr, Jeddah 21413, Saudi Arabia; [Al-Adwani, Fatima; Al-Sharif, Mona] King Abdulaziz Univ, Dept Biol, Jeddah 21413, Saudi Arabia; [Al-Maghrabi, Jaudah; Jamal, Awatif; Al-Ghamdi, Fahad] King Abdulaziz Univ Hosp, Fac Med, Dept Pathol, Jeddah, Saudi Arabia; [Al-Maghrabi, Jaudah] King Faisal Specialist Hosp & Res Ctr, Dept Pathol, Jeddah, Saudi Arabia; [Baeesa, Saleh S.; Bangash, Mohammed] King Abdulaziz Univ Hosp, Dept Surg, Div Neurosurg, Jeddah, Saudi Arabia	King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh; King Faisal Specialist Hospital & Research Center; King Abdulaziz University; King Abdulaziz University Hospital - Jeddah; King Saud University; King Abdulaziz University Hospital - Riyadh	Schulten, HJ (corresponding author), King Abdulaziz Univ, Ctr Excellence Genom Med Res, Jeddah 21413, Saudi Arabia.; Schulten, HJ (corresponding author), King Abdulaziz Univ, KACST Technol Innovat Ctr Personalized Med, Jeddah 21413, Saudi Arabia.	hschulten@kau.edu.sa	Baeesa, Saleh S/G-5519-2011; Schulten, Hans-Juergen/AAP-4754-2021; Al-Maghrabi, Jaudah/L-4367-2013; Schulten, Hans-Juergen/H-9854-2012; Al-Qahtani, Mohammed Hussain/AAZ-1729-2020; Karim, Sajjad/H-9897-2012; Hussein, Deema/AAW-1297-2020	Baeesa, Saleh S/0000-0002-3053-7912; Schulten, Hans-Juergen/0000-0002-4907-3222; Al-Maghrabi, Jaudah/0000-0002-0812-9592; Karim, Sajjad/0000-0003-0907-2097; Hussein, Deema/0000-0002-8316-489X; AL-Sharif, Mona/0000-0002-7138-4203	King Abdulaziz City for Science and Technology (KACST) [AT-32-98]; KACST Technology Innovation Center in Personalized Medicine [13-CIPM-07]	King Abdulaziz City for Science and Technology (KACST); KACST Technology Innovation Center in Personalized Medicine	HJS (PI), and DH, SK, JM, AJ, SSB, MB (Co-Is) were supported by King Abdulaziz City for Science and Technology (KACST) grant AT-32-98, and DH (PI) and MB (Co-I) by KACST Technology Innovation Center in Personalized Medicine grant 13-CIPM-07.	Aarhus M, 2011, ACTA NEUROCHIR, V153, P447, DOI 10.1007/s00701-010-0906-0; Berezovsky AD, 2014, NEOPLASIA, V16, DOI 10.1016/j.neo.2014.03.006; Carvalho LH, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-64; Castets M, 2012, NATURE, V482, P534, DOI 10.1038/nature10708; Celis-Aguilar E, 2012, GENET RES INT, V2012, DOI 10.1155/2012/856157; Chen DQ, 2015, INT J BREAST CANCER, V2015, DOI 10.1155/2015/539721; Chu UB, 2014, BIOCHEMISTRY-US, V53, P2956, DOI 10.1021/bi500175p; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; Collier Fiona M, 2009, J Cell Death, V2, P9; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; D'Orazi G, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-63; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Deshmukh H, 2008, ONCOGENE, V27, P4745, DOI 10.1038/onc.2008.110; Ekstrand BC, 1995, ONCOGENE, V11, P2393; Engstrom PG, 2012, GENOME MED, V4, DOI 10.1186/gm377; Erdreich-Epstein A, 2014, NEURO-ONCOLOGY, V16, DOI 10.1093/neuonc/nou208.11; Etcheverry A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-701; Finci LI, 2014, NEURON, V83, P839, DOI 10.1016/j.neuron.2014.07.010; Haddick PCG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084823; Hara A, 2001, J CLIN PATHOL, V54, P860, DOI 10.1136/jcp.54.11.860; Domingues PH, 2014, NEURO-ONCOLOGY, V16, P735, DOI 10.1093/neuonc/not325; Domingues PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074798; Hibi K, 2009, WORLD J SURG, V33, P1053, DOI 10.1007/s00268-008-9909-x; Jarjour AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025408; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kim KK, 2014, NAT STRUCT MOL BIOL, V21, P901, DOI 10.1038/nsmb.2892; Kim KK, 2013, J CELL BIOL, V200, P443, DOI 10.1083/jcb.201206146; Krimpenfort P, 2012, NATURE, V482, P538, DOI 10.1038/nature10790; Latini FRM, 2008, ENDOCR-RELAT CANCER, V15, P787, DOI 10.1677/ERC-08-0079; Lee HS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084201; Lee ICJ, 2014, J BIOL CHEM, V289, P26989, DOI 10.1074/jbc.M114.588079; Lee Y, 2010, BRAIN PATHOL, V20, P751, DOI 10.1111/j.1750-3639.2009.00356.x; Liu Y, 2013, INT J MOL MED, V31, P855, DOI 10.3892/ijmm.2013.1279; Luo Y, 2015, ONCOTARGET, V6, P22564, DOI 10.18632/oncotarget.4197; Lusis EA, 2005, CANCER RES, V65, P7121, DOI 10.1158/0008-5472.CAN-05-0043; Mehlen P, 1998, NATURE, V395, P801, DOI 10.1038/27441; Mille F, 2009, CELL DEATH DIFFER, V16, P1344, DOI 10.1038/cdd.2009.75; Nakaya N, 2012, J BIOL CHEM, V287, P37171, DOI 10.1074/jbc.M112.389916; Ozmadenci D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8398; Pechenino AS, 2009, NEUROBIOL LEARN MEM, V91, P313, DOI 10.1016/j.nlm.2008.09.017; Perez-Magan E, 2012, J NEUROPATH EXP NEUR, V71, P882, DOI 10.1097/NEN.0b013e31826bf704; Perez-Magan E, 2010, NEURO-ONCOLOGY, V12, P1278, DOI 10.1093/neuonc/noq081; Pujol-Gimenez J, 2015, J CANCER, V6, P139, DOI 10.7150/jca.10429; Qu XH, 2002, J BIOL CHEM, V277, P35574, DOI 10.1074/jbc.M206451200; Reyes-Mugica M, 1998, LAB INVEST, V78, P669; ReyesMugica M, 1997, CANCER RES, V57, P382; Roforth MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095987; Rowther FB, 2016, MOL CARCINOGEN, V55, P268, DOI 10.1002/mc.22276; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulten HJ, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S1-S6; Senchenko VN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015612; Shibuya M, 2015, NEUROL MED-CHIR, V55, P14, DOI 10.2176/nmc.ra.2014-0233; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sidoryk M, 2004, NEUROREPORT, V15, P575, DOI 10.1097/00001756-200403220-00001; Tamada Y, 2011, IEEE ACM T COMPUT BI, V8, P683, DOI 10.1109/TCBB.2010.68; Torres-Martin M, 2014, ONCOL REP, V32, P2327, DOI 10.3892/or.2014.3526; Torres-Martin M, 2013, INT J ONCOL, V42, P848, DOI 10.3892/ijo.2013.1798; Trabzuni D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3771; van den Boom J, 2003, AM J PATHOL, V163, P1033, DOI 10.1016/S0002-9440(10)63463-3; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Yan W, 2014, DIGEST DIS SCI, V59, P1213, DOI 10.1007/s10620-013-3016-z; Yang J, 2015, ONCOTARGET, V6, P11125, DOI 10.18632/oncotarget.3575; Zhang CM, 2009, ACTA PHARMACOL SIN, V30, P120, DOI 10.1038/aps.2008.9; Zhang L, 2011, MED ONCOL, V28, P907, DOI 10.1007/s12032-010-9537-9	65	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153681	10.1371/journal.pone.0153681	http://dx.doi.org/10.1371/journal.pone.0153681			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096627	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600049
J	Yue, JQ; Mao, XH; Xu, K; Lu, LS; Liu, SJ; Chen, F; Wang, JM				Yue, Jiqiang; Mao, Xuhua; Xu, Kun; Lu, Lingshuang; Liu, Sijun; Chen, Feng; Wang, Jianming			Prevalence, Awareness, Treatment and Control of Diabetes Mellitus in a Chinese Population	PLOS ONE			English	Article							GLUCOSE CONTROL; RISK-FACTORS; ADULTS; COMPLICATIONS; HYPERTENSION; INTERASIA; CHILDREN; EXERCISE; WEIGHT; BURDEN	Objective The purpose of this study is to evaluate the prevalence, awareness, treatment and glycemic control of diabetes mellitus (DM) in a Chinese population. The findings from this study are expected to offer scientific evidence to better prevent and control the growing number of reported and untreated cases. Methods A cross-sectional survey was conducted in Jiangsu, China. We recruited permanent residents over 18 years of age from eight towns in Jintan (JT) and six towns in Yangzhong (YZ) using a three-stage stratified cluster sampling method. The rates of DM prevalence, awareness, treatment and control as well as their related factors were analyzed. Results A total number of 15404 people were entered into the analysis. The DM prevalence, awareness, treatment and control rates were 7.31%, 58.35%, 51.87% and 14.12%, respectively. Multivariable logistic regression analysis showed that being female was positively related to prevalence (OR = 1.21, 95% CI: 1.07-1.37), awareness (OR = 1.52, 95% CI: 1.19-1.93), treatment (OR = 1.48, 95% CI: 1.17-1.88) and control (OR = 1.87, 95% CI: 1.30-2.67) of DM. Having a family history of diabetes was significantly correlated with DM risk (OR = 1.86, 95% CI: 1.37-2.54) and increased awareness (OR = 3.12, 95% CI: 2.19-4.47), treatment (OR = 3.47, 95% CI: 2.45-4.90) and control (OR = 1.81, 95% CI: 1.22-2.68) of DM. Former smoking status (OR = 1.82, 95% CI: 1.23-2.71), overweight (OR = 2.11, 95% CI: 1.72-2.60) and obesity (OR = 3.46, 95% CI: 2.67-4.50) were related to the risk of DM. Additionally, we found current drinking status to be positively correlated with DM risk (OR = 1.30, 95% CI: 1.01-1.66) and negatively correlated with DM awareness (OR = 0.41, 95% CI: 0.29-0.59) and treatment (OR = 0.41, 95% CI: 0.29-0.59). Our study highlights the high prevalence and inadequate awareness, treatment and control of DM in the Chinese population. Conclusions Management and prevention of DM-related complications should be considered an essential strategy by governments and society. This study assessed the reasons why DM has been increasing and established the first step in determining where to start regarding preventative methods.	[Yue, Jiqiang; Xu, Kun; Liu, Sijun; Chen, Feng; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing 211166, Jiangsu, Peoples R China; [Mao, Xuhua] Yixing Peoples Hosp, Dept Clin Lab, Wuxi 214200, Peoples R China; [Lu, Lingshuang; Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China; [Wang, Jianming] Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Social Med & Hlth Educ, Nanjing 211166, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol, Nanjing 211166, Jiangsu, Peoples R China.; Wang, JM (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Innovat Ctr Social Risk Governance Hlth, Nanjing 211166, Jiangsu, Peoples R China.	jmwang@njmu.edu.cn	lu, lu/HII-7530-2022	Wang, Jianming/0000-0002-9151-284X	Qing Lan Project; Philosophy and Social Science Research Fund of Jiangsu College [2014SJB164]; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A067]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Qing Lan Project(Jiangsu Polytech Institute); Philosophy and Social Science Research Fund of Jiangsu College; Top-notch Academic Programs Project of Jiangsu Higher Education Institutions; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	The Qing Lan Project (2014), Philosophy and Social Science Research Fund of Jiangsu College (2014SJB164), Top-notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A067) and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) supported this study. The funders had no role in the study design, data collection and analysis, decision to publish, or in the preparation of the manuscript.	Ades PA, 2015, PREV MED, V80, P50, DOI 10.1016/j.ypmed.2015.03.014; Aljoudi AS, 2009, ANN SAUDI MED, V29, P15, DOI 10.4103/0256-4947.51813; Arakawa S, 2015, DIABETOL INT, V6, P19, DOI 10.1007/s13340-014-0166-y; Chan JCN, 2001, DIABETES RES CLIN PR, V54, pS19; Chen HM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-69; Collison KS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-234; Dajani R, 2012, J DIABETES COMPLICAT, V26, P175, DOI 10.1016/j.jdiacomp.2012.03.009; Danne T, 2005, DIABETES CARE, V28, P2100, DOI 10.2337/diacare.28.9.2100; Rodrigues AMD, 2016, JAMA PEDIATR, V170, P487, DOI 10.1001/jamapediatrics.2015.4365; Faeh D, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-163; Gupta A, 2014, BMJ OPEN DIAB RES CA, V2, DOI 10.1136/bmjdrc-2014-000048; Hu DS, 2008, DIABETES RES CLIN PR, V81, P250, DOI 10.1016/j.diabres.2008.04.008; Hu DS, 2009, DIABETES RES CLIN PR, V84, P288, DOI 10.1016/j.diabres.2009.02.021; Hu HM, 2015, DIABETES THER, V6, P7, DOI 10.1007/s13300-015-0096-0; Ji LN, 2015, J DIABETES, V7, P166, DOI 10.1111/1753-0407.12165; Ji LN, 2012, DIABETES RES CLIN PR, V98, P173, DOI 10.1016/j.diabres.2012.10.002; Kemp TM, 2005, DIABETES CARE, V28, P1490, DOI 10.2337/diacare.28.6.1490; Kim CR, 2016, KOREAN J FAM MED, V37, P51, DOI 10.4082/kjfm.2016.37.1.51; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Li H, 2012, DIABETES RES CLIN PR, V98, P226, DOI 10.1016/j.diabres.2012.05.010; Li MZ, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/753150; McDonald M, 2009, J GERONTOL A-BIOL, V64, P256, DOI 10.1093/gerona/gln016; Porapakkham Y, 2008, SINGAP MED J, V49, P868; Rahman MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118365; Rampal S, 2010, ASIA-PAC J PUBLIC HE, V22, P194, DOI 10.1177/1010539509334816; Sims M, 2011, ANN EPIDEMIOL, V21, P892, DOI 10.1016/j.annepidem.2011.05.006; Singh Arvind Kumar, 2012, Indian J Community Med, V37, P236, DOI 10.4103/0970-0218.103472; SONGER TJ, 1992, DIABETES METAB REV, V8, P389, DOI 10.1002/dmr.5610080406; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vijan S, 1997, J GEN INTERN MED, V12, P567, DOI 10.1046/j.1525-1497.1997.07111.x; Wang C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103594; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yang YN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035270; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	34	34	37	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153791	10.1371/journal.pone.0153791	http://dx.doi.org/10.1371/journal.pone.0153791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096738	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600057
J	Sabler, IM; Berkovitch, M; Sandbank, J; Kozer, E; Dagan, Z; Goldman, M; Bahat, H; Stav, K; Zisman, A; Klin, B; Abu-Kishk, I				Sabler, Itay M.; Berkovitch, Matitiahu; Sandbank, Judith; Kozer, Eran; Dagan, Zahi; Goldman, Michael; Bahat, Hilla; Stav, Kobi; Zisman, Amnon; Klin, Baruch; Abu-Kishk, Ibrahim			Exposure to Hyperbaric Oxygen Intensified Vancomycin-Induced Nephrotoxicity in Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; SUPEROXIDE-DISMUTASE; CEREBRAL-ISCHEMIA; RENAL-FUNCTION; HIGH-PRESSURE; CELLS; DYSFUNCTION; MECHANISMS; EXPRESSION; PROTECTION	It has been suggested that oxidative stress is a potential mechanism for vancomycin-induced nephrotoxicity and hyperbaric oxygen therapy (HBO) has been shown to be effective in treating renal toxicity that has been pharmacologically induced in animal models. The aim of this study was to investigate the effect of HBO therapy on vancomycin-induced nephrotoxicity in rats. The study group comprised 36 Sprague Dawley male rats. We treated 30 with 500 mg/kg of intraperitoneal vancomycin once a day for 7 days. Half of these rats received a daily 1-hour treatment with HBO at 2 Atmospheres (ATM) on the same 7 days and formed the HBO+ group. The other 15 subjects received no HBO treatment (HBO-group). The remaining six rats served as the control group, three received HBO treatments alone and no treatment was administered to the other three rats. Laboratory results were obtained on day 8 and the intervention and control groups were compared. Rats in the HBO + group gained less weight than the HBO-group (11.6 grams vs 22.6 grams; P = 0,008) and had significantly higher serum blood urea nitrogen (99.6 vs 52.6 mg/dL; P< 0.001), serum creatinine (0.42 vs 0.16 mg/dL; P = 0.001) and magnesium (3.6 vs 3.1mg/dL; P = 0.014). The vancomycin blood levels were also higher in the HBO+ group (27.8 vs 6.7 mu g/mL; P = 0.078). There were no pathological kidney changes in the control group. All the kidneys from the treated groups (vancomycin + HBO and vancomycin HBO-) showed moderate to severe histopathological changes with no statistical significance between them. This study demonstrated that exposure to hyperbaric oxygen intensified vancomycin-induced nephrotoxicity in rats.	[Sabler, Itay M.; Stav, Kobi; Zisman, Amnon] Tel Aviv Univ, Sackler Sch Med, Dept Urol, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Berkovitch, Matitiahu; Dagan, Zahi] Tel Aviv Univ, Sackler Sch Med, Clin Pharmacol Unit, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Sandbank, Judith] Tel Aviv Univ, Sackler Sch Med, Dept Pathol, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Kozer, Eran; Klin, Baruch; Abu-Kishk, Ibrahim] Tel Aviv Univ, Sackler Sch Med, Div Pediat, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel; [Goldman, Michael; Bahat, Hilla] Tel Aviv Univ, Sackler Sch Med, Pediat Nephrol Serv, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel	Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine; Shamir Medical Center (Assaf Harofeh); Tel Aviv University; Sackler Faculty of Medicine	Abu-Kishk, I (corresponding author), Tel Aviv Univ, Sackler Sch Med, Div Pediat, Assaf Harofeh Med Ctr, IL-69978 Tel Aviv, Israel.	abukishki@gmail.com	Stav, Kobi/AAH-1523-2019					APPEL GB, 1986, AM J KIDNEY DIS, V8, P75, DOI 10.1016/S0272-6386(86)80116-0; ARONOFF GR, 1981, ANTIMICROB AGENTS CH, V19, P306, DOI 10.1128/AAC.19.2.306; Aydinoz S, 2007, RENAL FAILURE, V29, P257, DOI 10.1080/08860220601166487; Berkovitch M, 2014, SCI WORLD J, DOI 10.1155/2014/105069; Chen LF, 2014, J FORMOS MED ASSOC, V113, P620, DOI 10.1016/j.jfma.2014.03.012; Cisek LJ, 1998, J ENDOUROL, V12, P95, DOI 10.1089/end.1998.12.95; Dieterich C, 2009, TOXICOL SCI, V107, P258, DOI 10.1093/toxsci/kfn203; Djurhuus R, 1999, UNDERSEA HYPERBAR M, V26, P75; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gregorevic P, 2001, EUR J APPL PHYSIOL, V86, P24, DOI 10.1007/s004210100503; Hong S, 2007, AM J MED SCI, V334, P296, DOI 10.1097/MAJ.0b013e3180a6ec1e; Huang SHS, 2011, TRANSL RES, V157, P357, DOI 10.1016/j.trsl.2011.01.002; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kellum John A, 2002, Curr Opin Crit Care, V8, P509, DOI 10.1097/00075198-200212000-00005; KIM YS, 1991, J NEUROSCI RES, V29, P100, DOI 10.1002/jnr.490290111; King DW, 2004, TOXICOL IN VITRO, V18, P797, DOI 10.1016/j.tiv.2004.03.013; Levine DP, 2006, CLIN INFECT DIS, V42, pS5, DOI 10.1086/491709; Lin H, 2012, J TRAUMA ACUTE CARE, V72, P1220, DOI 10.1097/TA.0b013e318246ee70; MARRE R, 1984, J ANTIMICROB CHEMOTH, V14, P253, DOI 10.1093/jac/14.3.253; Mrsic-Pelcic J, 2004, NEUROCHEM INT, V44, P585, DOI 10.1016/j.neuint.2003.10.004; Nakamura T, 1996, J PHARM PHARMACOL, V48, P1197, DOI 10.1111/j.2042-7158.1996.tb03920.x; Nishino Y, 2003, FREE RADICAL RES, V37, P373, DOI 10.1080/1071576031000061002; Oktem F, 2005, TOXICOLOGY, V215, P227, DOI 10.1016/j.tox.2005.07.009; Piantadosi CA, 2008, FREE RADICAL BIO MED, V45, P562, DOI 10.1016/j.freeradbiomed.2008.05.013; Rachmilewitz D, 1998, GUT, V43, P512, DOI 10.1136/gut.43.4.512; SOKOL PP, 1991, J PHARMACOL EXP THER, V259, P1283; THOM SR, 1987, UNDERSEA BIOMED RES, V14, P485; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Wada K, 2000, ACT NEUR S, V76, P285; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022	30	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152554	10.1371/journal.pone.0152554	http://dx.doi.org/10.1371/journal.pone.0152554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092557	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200006
J	Vernerova, L; Spoutil, F; Vlcek, M; Krskova, K; Penesova, A; Meskova, M; Marko, A; Raslova, K; Vohnout, B; Rovensky, J; Killinger, Z; Jochmanova, I; Lazurova, I; Steiner, G; Smolen, J; Imrich, R				Vernerova, Lucia; Spoutil, Frantisek; Vlcek, Miroslav; Krskova, Katarina; Penesova, Adela; Meskova, Milada; Marko, Andrea; Raslova, Katarina; Vohnout, Branislav; Rovensky, Jozef; Killinger, Zdenko; Jochmanova, Ivana; Lazurova, Ivica; Steiner, Guenter; Smolen, Josef; Imrich, Richard			A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study	PLOS ONE			English	Article							GENE-ENVIRONMENT INTERACTIONS; GENOME-WIDE ASSOCIATION; HLA-DRB1 SHARED EPITOPE; SUSCEPTIBILITY LOCI; RISK; ANTIBODIES; COHORT; PROGRESSION; VARIANTS; PREDICTION	Introduction The aim of the study was to analyse genetic architecture of RA by utilizing multiparametric statistical methods such as linear discriminant analysis (LDA) and redundancy analysis (RDA). Methods A total of 1393 volunteers, 499 patients with RA and 894 healthy controls were included in the study. The presence of shared epitope (SE) in HLA-DRB1 and 11 SNPs (PTPN22 C/T (rs2476601), STAT4 G/T (rs7574865), CTLA4 A/G (rs3087243), TRAF1/C5 A/G (rs3761847), IRF5 T/C (rs10488631), TNFAIP3 C/T (rs5029937), AFF3 A/T (rs11676922), PADI4 C/T (rs2240340), CD28 T/C (rs1980422), CSK G/A (rs34933034) and FCGR3A A/C (rs396991), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and clinical status was analysed using the LDA and RDA. Results HLA-DRB1, PTPN22, STAT4, IRF5 and PADI4 significantly discriminated between RA patients and healthy controls in LDA. The correlation between RA diagnosis and the explanatory variables in the model was 0.328 (Trace = 0.107; F = 13.715; P = 0.0002). The risk variants of IRF5 and CD28 genes were found to be common determinants for seropositivity in RDA, while positivity of RF alone was associated with the CTLA4 risk variant in heterozygous form. The correlation between serologic status and genetic determinants on the 1st ordinal axis was 0.468, and 0.145 on the 2nd one (Trace = 0.179; F = 6.135; P = 0.001). The risk alleles in AFF3 gene together with the presence of ACPA were associated with higher clinical severity of RA. Conclusions The association among multiple risk variants related to T cell receptor signalling with seropositivity may play an important role in distinct clinical phenotypes of RA. Our study demonstrates that multiparametric analyses represent a powerful tool for investigation of mutual relationships of potential risk factors in complex diseases such as RA.	[Vernerova, Lucia; Vlcek, Miroslav; Krskova, Katarina; Penesova, Adela; Meskova, Milada; Marko, Andrea; Imrich, Richard] Slovak Acad Sci, Inst Clin & Translat Res, Biomed Ctr, Bratislava, Slovakia; [Spoutil, Frantisek] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic; [Spoutil, Frantisek] Acad Sci Czech Republ, Inst Expt Med, Prague, Czech Republic; [Krskova, Katarina; Raslova, Katarina; Vohnout, Branislav] Slovak Med Univ, Bratislava, Slovakia; [Rovensky, Jozef] Natl Inst Rheumat Dis, Piestany, Slovakia; [Killinger, Zdenko] Comenius Univ, Fac Med, Dept Internal Med 5, Bratislava, Slovakia; [Jochmanova, Ivana; Lazurova, Ivica] Safarik Univ, Fac Med, Dept Internal Med 1, Kosice, Slovakia; [Steiner, Guenter; Smolen, Josef] Med Univ Vienna, Div Rheumatol, Dept Internal Med 3, Vienna, Austria; [Vernerova, Lucia] Inst Rheumatol, Prague, Czech Republic	Slovak Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Slovak Medical University Bratislava; Comenius University Bratislava; University of Pavol Jozef Safarik Kosice; Medical University of Vienna; Institute of Rheumatology	Vernerova, L (corresponding author), Slovak Acad Sci, Inst Clin & Translat Res, Biomed Ctr, Bratislava, Slovakia.; Vernerova, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.	vernerova@revma.cz	Jochmanova, Ivana/I-9011-2016; Imrich, Richard/ABC-7247-2021; Jochmanova, Ivana/AAG-1856-2020; Vernerova, Lucia/N-9976-2019; Vernerova, Lucia/G-4735-2015; Vlček, Miroslav/H-5833-2018; Spoutil, Frantisek/I-6725-2019; Penesova, Adela/ABH-4065-2020	Jochmanova, Ivana/0000-0003-2346-461X; Imrich, Richard/0000-0002-1747-7150; Vernerova, Lucia/0000-0001-6087-2175; Vernerova, Lucia/0000-0001-6087-2175; Vlček, Miroslav/0000-0002-6845-3167; Spoutil, Frantisek/0000-0002-7310-3487; Lazurova, Ivica/0000-0002-3163-1097; Steiner, Guenter/0000-0002-5089-7405	Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 2/0084/12, VEGA 2/0018/12]; grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS by Austria-Slovakia Cross-border Cooperation Operational Programme [ATMOS N00024];  [N00024 RASGENAS]	Ministry of Education, Science, Research and Sport of the Slovak Republic; grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS by Austria-Slovakia Cross-border Cooperation Operational Programme; 	This work was supported by the grants VEGA 2/0084/12 and VEGA 2/0018/12 awarded by The Ministry of Education, Science, Research and Sport of the Slovak Republic to RI and MV. Further it was supported by the grant Genetics and Mechanisms of Rheumatoid Arthritis RASGENAS (ATMOS N00024) awarded to RI by Austria-Slovakia Cross-border Cooperation Operational Programme 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank particularly all the study participants and collaborating rheumatologists from outpatient clinics. This work was supported by the grants VEGA 2/0084/12, VEGA 2/0018/12 and N00024 RASGENAS.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Barton A, 2009, HUM MOL GENET, V18, P2518, DOI 10.1093/hmg/ddp177; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Chibnik LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024380; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; Dieguez-Gonzalez R, 2008, ARTHRITIS RHEUM-US, V58, P1264, DOI 10.1002/art.23426; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Foreman HCC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033098; Fransen J, 2005, CLIN EXP RHEUMATOL, V23, pS93; FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137, DOI 10.1002/art.1780230202; Gough SCL, 2005, IMMUNOL REV, V204, P102, DOI 10.1111/j.0105-2896.2005.00249.x; Han TU, 2009, ARTHRITIS RHEUM-US, V60, P2577, DOI 10.1002/art.24759; Holoshitz J, 2010, CURR OPIN RHEUMATOL, V22, P293, DOI 10.1097/BOR.0b013e328336ba63; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Janssens ACJW, 2004, AM J HUM GENET, V74, P585, DOI 10.1086/382052; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Karlson EW, 2013, ARTHRIT CARE RES, V65, P1147, DOI 10.1002/acr.22005; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Kerekes G, 2014, NAT REV RHEUMATOL, V10, P691, DOI 10.1038/nrrheum.2014.121; Knevel R, 2013, ARTHRITIS RHEUM-US, V65, P1684, DOI 10.1002/art.37938; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Li CW, 2015, J GENET GENOMICS, V42, P107, DOI 10.1016/j.jgg.2015.02.003; Liu CY, 2011, HUM GENET, V129, P473, DOI 10.1007/s00439-010-0943-z; Lu Qing, 2009, BMC Proc, V3 Suppl 7, pS49; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; McClure A, 2009, RHEUMATOLOGY, V48, P1369, DOI 10.1093/rheumatology/kep272; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Meyer O, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1896; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Plenge RM, 2005, AM J HUM GENET, P77; Plenge RM, 2009, CURR OPIN RHEUMATOL, V21, P262, DOI 10.1097/BOR.0b013e32832a2e2d; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Romo-Tena J, 2013, AUTOIMMUN REV, V12, P1171, DOI 10.1016/j.autrev.2013.07.002; Sandholm N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002921; Scott IC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003808; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stark K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2699; STASTNY P, 1976, J CLIN INVEST, V57, P1148, DOI 10.1172/JCI108382; Steiner G, 2009, SEMIN ARTHRITIS RHEU, V38, P372, DOI 10.1016/j.semarthrit.2008.01.015; Ursini F, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002552; van der Helm-van Mil AHM, 2005, ARTHRITIS RES THER, V7, pR949, DOI 10.1186/ar1767; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; van der Helm-van Mil AHM, 2010, ANN RHEUM DIS, V69, P1694, DOI 10.1136/ard.2009.123828; Viatte S, 2016, ARTHRITIS RHEUMATOLO; Viatte S, 2012, ANN RHEUM DIS, V71, P1984, DOI 10.1136/annrheumdis-2011-201225; Wang C, 2011, J RHEUMATOL, V38, P2130, DOI 10.3899/jrheum.110322; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405	55	16	17	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153316	10.1371/journal.pone.0153316	http://dx.doi.org/10.1371/journal.pone.0153316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092776	gold, Green Submitted, Green Published			2022-12-27	WOS:000374541200017
J	Bispo, PD; dos Santos, JR; Valeriano, MD; Graca, PMLD; Balzter, H; Franca, H; Bispo, PD				Bispo, Polyanna da Conceicao; dos Santos, Joao Roberto; Valeriano, Marcio de Morisson; Lima de Alencastro Graca, Paulo Mauricio; Balzter, Heiko; Franca, Helena; Bispo, Pitagoras da Conceicao			Predictive Models of Primary Tropical Forest Structure from Geomorphometric Variables Based on SRTM in the Tapajos Region, Brazilian Amazon	PLOS ONE			English	Article							RAIN-FOREST; SOIL PROPERTIES; VEGETATION COVER; CLIMATE-CHANGE; TOPOGRAPHY; BIODIVERSITY; DIVERSITY; NITROGEN; BIOMASS; HETEROGENEITY	Surveying primary tropical forest over large regions is challenging. Indirect methods of relating terrain information or other external spatial datasets to forest biophysical parameters can provide forest structural maps at large scales but the inherent uncertainties need to be evaluated fully. The goal of the present study was to evaluate relief characteristics, measured through geomorphometric variables, as predictors of forest structural characteristics such as average tree basal area (BA) and height (H) and average percentage canopy openness (CO). Our hypothesis is that geomorphometric variables are good predictors of the structure of primary tropical forest, even in areas, with low altitude variation. The study was performed at the Tapajos National Forest, located in the Western State of Para, Brazil. Forty-three plots were sampled. Predictive models for BA, H and CO were parameterized based on geomorphometric variables using multiple linear regression. Validation of the models with nine independent sample plots revealed a Root Mean Square Error (RMSE) of 3.73 m(2)/ha (20%) for BA, 1.70 m (12%) for H, and 1.78% (21%) for CO. The coefficient of determination between observed and predicted values were r(2) = 0.32 for CO, r(2) = 0.26 for H and r(2) = 0.52 for BA. The models obtained were able to adequately estimate BA and CO. In summary, it can be concluded that relief variables are good predictors of vegetation structure and enable the creation of forest structure maps in primary tropical rainforest with an acceptable uncertainty.	[Bispo, Polyanna da Conceicao; Franca, Helena] UFABC, Ciencia & Tecnol Ambiental, Sao Paulo, Brazil; [Bispo, Polyanna da Conceicao; Balzter, Heiko] Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England; [dos Santos, Joao Roberto; Valeriano, Marcio de Morisson] Inst Nacl Pesquisas Espaciais, Div Sensoriamento Remoto, Sao Paulo, Brazil; [Lima de Alencastro Graca, Paulo Mauricio] INPA, Coordenacao Dinam Ambiental, Manaus, Amazonas, Brazil; [Balzter, Heiko] Univ Leicester, Natl Ctr Earth Observat, Leicester, Leics, England; [Bispo, Pitagoras da Conceicao] Univ Estadual Paulista UNESP, Dept Ciencias Biol, Fac Ciencias & Letras Assis, Sao Paulo, Brazil	Universidade Federal do ABC (UFABC); University of Leicester; Instituto Nacional de Pesquisas Espaciais (INPE); Institute Nacional de Pesquisas da Amazonia; University of Leicester; Universidade Estadual Paulista	Bispo, PD (corresponding author), UFABC, Ciencia & Tecnol Ambiental, Sao Paulo, Brazil.; Bispo, PD (corresponding author), Univ Leicester, Dept Geog, Ctr Landscape & Climate Res, Leicester LE1 7RH, Leics, England.	polybispo@gmail.com	de Alencastro Graça, Paulo Maurício L/B-3375-2013; França, Helena/K-2344-2016; Balzter, Heiko/B-5976-2008	Balzter, Heiko/0000-0002-9053-4684; Graca, Paulo/0000-0003-2173-1518; /0000-0002-7356-8882	Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training); European Union [660020]; CNPq (National Council for Scientific and Technological Development); Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB); Royal Society [2011/R3]; Natural Environment Research Council; Sao Paulo State University (UNESP, Brazil); Natural Environment Research Council [nceo020005] Funding Source: researchfish; NERC [nceo020005] Funding Source: UKRI	Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training); European Union(European Commission); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Sao Paulo State University (UNESP, Brazil); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	PolCB was supported by Universidade Federal do ABC (PNPD-CAPES, Council for Advanced Professional Training) in 2015 and currently is supported by European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 660020. JRS, MMV and PitCB were supported by CNPq (National Council for Scientific and Technological Development), PMLG was supported by Instituto Nacional de Ciencia e Tecnologia dos Servicos Ambientais da Amazonia (SERVAMB) and HB was supported by Royal Society Wolfs on Research Merit Award (2011/R3) and by Natural Environment Research Council, which support the National Centre for Earth Observation. The Sao Paulo State University (UNESP, Brazil) funded the publication fee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba SI, 2002, J TROP ECOL, V18, P215, DOI 10.1017/S0266467402002146; Anselin L., 1996, SPATIAL ANAL PERSPEC, P111, DOI [10.1201/9780203739051-8, DOI 10.1201/9780203739051-8]; Bispo PC, 2014, CAN J REMOTE SENS, V40, P26, DOI 10.1080/07038992.2014.913477; Bispo PD, 2012, AUSTRAL ECOL, V37, P491, DOI 10.1111/j.1442-9993.2011.02310.x; Bispo Polyanna da Conceição, 2009, Acta Amaz., V39, P81, DOI 10.1590/S0044-59672009000100008; Boncina A, 2000, GLOBAL ECOL BIOGEOGR, V9, P201, DOI 10.1046/j.1365-2699.2000.00155.x; Catterall CP, 2001, AUSTRAL ECOL, V26, P56, DOI 10.1111/j.1442-9993.2001.01074.pp.x; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Chen ZS, 1997, PLANT ECOL, V132, P229, DOI 10.1023/A:1009762704553; Cramer W, 2001, GLOBAL CHANGE BIOL, V7, P357, DOI 10.1046/j.1365-2486.2001.00383.x; Danson FM, 2007, IEEE GEOSCI REMOTE S, V4, P157, DOI 10.1109/LGRS.2006.887064; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; Diaz L, 2006, FOREST ECOL MANAG, V223, P54, DOI 10.1016/j.foreco.2005.10.061; Dikau R., 1989, 3 DIMENSIONAL APPL G, V1st, P51, DOI 10.1201/9781003069454-5; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fisk MC, 1998, ECOLOGY, V79, P2253, DOI 10.1890/0012-9658(1998)079[2253:TPOAAB]2.0.CO;2; Florinsky IV, 1996, CATENA, V27, P123, DOI 10.1016/0341-8162(96)00005-7; Franklin J, 1995, PROG PHYS GEOG, V19, P474, DOI 10.1177/030913339501900403; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Galvao LS, 2011, REMOTE SENS ENVIRON, V115, P2350, DOI 10.1016/j.rse.2011.04.035; Gao T, 2014, FOREST ECOL MANAG, V330, P82, DOI 10.1016/j.foreco.2014.07.007; Giller PS, 1984, COMMUNITY STRUCTURE; Gonçalves Fábio Guimarães, 2008, Acta Amaz., V38, P229, DOI 10.1590/S0044-59672008000200006; Griffiths RP, 2009, FOREST ECOL MANAG, V257, P1, DOI 10.1016/j.foreco.2008.08.010; Hunter MO, 2013, BIOGEOSCIENCES, V10, P8385, DOI 10.5194/bg-10-8385-2013; IBAMA (Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis), 2004, FLOR NAC TAP PLAN MA; Jarvis A, 2009, TERRAIN CONTROLS TRE; Kafkenscheid RLLJ, 2000, THESIS VRIJE U JAMAI; Lambin EF, 2003, ANNU REV ENV RESOUR, V28, P205, DOI 10.1146/annurev.energy.28.050302.105459; LAUENROTH WK, 1993, ECOL MODEL, V67, P49, DOI 10.1016/0304-3800(93)90099-E; Liu J, 2014, FOREST ECOL MANAG, V330, P75, DOI 10.1016/j.foreco.2014.06.045; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Neter J., 1996, APPL LINEAR STAT MOD; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Orians G, 2011, BIODIVERSITY ECOSYST; Pardini R, 2005, BIOL CONSERV, V124, P253, DOI 10.1016/j.biocon.2005.01.033; Pereira HM, 2013, SCIENCE, V339, P277, DOI 10.1126/science.1229931; Qi F, 2003, INT J GEOGR INF SCI, V17, P771, DOI 10.1080/13658810310001596049; RADAMBRASIL Departamento Nacional de Producao Mineral, 1976, FOLH AS 21 SANT GEOL, V10; RAGHUBANSHI AS, 1992, SOIL BIOL BIOCHEM, V24, P145, DOI 10.1016/0038-0717(92)90270-8; Rawi CSM, 2013, AQUAT ECOL, V47, P75, DOI 10.1007/s10452-012-9426-8; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; Schmidt J, 2003, INT J GEOGR INF SCI, V17, P797, DOI 10.1080/13658810310001596058; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Shary PA, 2013, RUSS J ECOL+, V44, P9, DOI 10.1134/S1067413613010116; Shary PA, 2002, GEODERMA, V107, P1, DOI 10.1016/S0016-7061(01)00136-7; Silver WL, 1999, BIOGEOCHEMISTRY, V44, P301, DOI 10.1007/BF00996995; Tateno R, 2003, ECOL RES, V18, P559, DOI 10.1046/j.1440-1703.2003.00578.x; Valeriano MD, 2012, APPL GEOGR, V32, P300, DOI 10.1016/j.apgeog.2011.05.004; Valeriano MM, 2008, INPE15318RPE818 COOR; Valeriano MM, 2010, INPE16702RPQ854 COOR; Valeriano MM., 2000, REV BRASILEIRA AGROM, V8, P255; Velaquez-Rosas N, 2002, BIOTROPICA, V34, P534, DOI 10.1646/0006-3606(2002)034[0534:EVOLTI]2.0.CO;2; Veloso R B, 1991, CLASSIFICACAO VEGETA; VITOUSEK PM, 1986, ANNU REV ECOL SYST, V17, P137, DOI 10.1146/annurev.es.17.110186.001033; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x; Williams M, 2002, ECOSYSTEMS, V5, P692, DOI 10.1007/s10021-002-0165-x; Wilson J.P., 2000, TERRAIN ANAL PRINCIP; Xin ZB, 2008, SCI CHINA SER D, V51, P67, DOI 10.1007/s11430-007-0137-2	59	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152009	10.1371/journal.pone.0152009	http://dx.doi.org/10.1371/journal.pone.0152009			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089013	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000004
J	Duan, XP; Zhang, ZD; Wang, J; Zuo, KJ				Duan, Xingpeng; Zhang, Zhidong; Wang, Jin; Zuo, Kaijing			Characterization of a Novel Cotton Subtilase Gene GbSBT1 in Response to Extracellular Stimulations and Its Role in Verticillium Resistance	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; PROTEASE INHIBITOR; SERINE-PROTEASE; TOMATO PLANTS; DAHLIAE; PATHOGENESIS; EXPRESSION; TARGETS; VE1; IDENTIFICATION	Verticillium wilt is a disastrous vascular disease in plants caused by Verticillium dahliae. Verticillium pathogens secrete various disease-causing effectors in cotton. This study identified a subtilase gene GbSBT1 from Gossypium babardense and investigated the roles against V. dahliae infection. GbSBT1 gene expression is responsive to V. dahliae defense signals, jasmonic acid, and ethylene treatments. Moreover, the GbSBT1 protein is mainly localized in the cell membrane and moves into the cytoplasm following jasmonic acid and ethylene treatments. Silencing GbSBT1 gene expression through virus-induced GbSBT1 gene silencing reduced the tolerance of Pima-90 (resistant genotype), but not facilitated the infection process of V. dahliae in Coker-312 (sensitive genotype). Moreover, the ectopically expressed GbSBT1 gene enhanced the resistance of Arabidopsis to Fusarium oxysporum and V. dahliae infection and activated the expression levels of defense-related genes. Furthermore, pull-down, yeast two-hybrid assay, and BiFC analysis revealed that GbSBT1 interacts with a prohibitin (PHB)-like protein expressed in V. dahliae pathogens during infection. In summary, GbSBT1 recognizes the effector PHB protein secreted from V. dahliae and is involved in Verticillium-induced resistance in cotton.	[Duan, Xingpeng; Zhang, Zhidong; Zuo, Kaijing] Shanghai Jiao Tong Univ, Sch Agr & Life Sci, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China; [Wang, Jin] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Zuo, KJ (corresponding author), Shanghai Jiao Tong Univ, Sch Agr & Life Sci, Plant Biotechnol Res Ctr, Shanghai 200030, Peoples R China.	kjzuo@sjtu.edu.cn			Basic Research Project of MOST in China (973 Project) [2013CB733903]; National High-Tech (863) Program of China [2012AA02A703]; Natural Science Foundation of China [31071458]; China Transgenic Program [2013AA08005-003]	Basic Research Project of MOST in China (973 Project); National High-Tech (863) Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Transgenic Program	This work was supported by the Basic Research Project of MOST in China (973 Project) (2013CB733903), the National High-Tech (863) Program of China (No. 2012AA02A703), the Natural Science Foundation of China (31071458) and China Transgenic Program (2013AA08005-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers GJM, 2009, PLANT CELL, V21, P944, DOI 10.1105/tpc.108.062158; Che P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001140; Christians MJ, 2007, J EXP BOT, V58, P2237, DOI 10.1093/jxb/erm086; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; El-Bebany AF, 2010, PROTEOMICS, V10, P289, DOI 10.1002/pmic.200900426; Figueiredo A, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00739; Fradin EF, 2011, PLANT PHYSIOL, V156, P2255, DOI 10.1104/pp.111.180067; Fradin EF, 2009, PLANT PHYSIOL, V150, P320, DOI 10.1104/pp.109.136762; Gao W, 2013, MOL CELL PROTEOMICS, V12, P3690, DOI 10.1074/mcp.M113.031013; Gao XQ, 2011, PLANT J, V66, P293, DOI 10.1111/j.1365-313X.2011.04491.x; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Jorda L, 1999, J BIOL CHEM, V274, P2360, DOI 10.1074/jbc.274.4.2360; Kim BA, 2016, J INFECT DIS, V213, P131, DOI 10.1093/infdis/jiv362; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Li C, 2014, PLANT PHYSIOL, V166, P2179, DOI 10.1104/pp.114.246694; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; SAUPE S, 1994, P NATL ACAD SCI USA, V91, P5927, DOI 10.1073/pnas.91.13.5927; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Sheen J., 2002, TRANSIENT EXPRESSION; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Tian MY, 2007, PLANT PHYSIOL, V143, P364, DOI 10.1104/pp.106.090050; Tian MY, 2004, J BIOL CHEM, V279, P26370, DOI 10.1074/jbc.M400941200; Tian MY, 2005, PLANT PHYSIOL, V138, P1785, DOI 10.1104/pp.105.061226; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Tornero P, 1996, PLANT J, V10, P315, DOI 10.1046/j.1365-313X.1996.10020315.x; van der Hoorn RAL, 2008, ANNU REV PLANT BIOL, V59, P191, DOI 10.1146/annurev.arplant.59.032607.092835; Wang Y, 2010, PLANT CELL, V22, P249, DOI 10.1105/tpc.109.072066; Xie CJ, 2013, J GEN PLANT PATHOL, V79, P335, DOI 10.1007/s10327-013-0467-1; Xu J, 2014, PLANT J, V77, P222, DOI 10.1111/tpj.12382; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zuo KJ, 2005, MOL BIOL+, V39, P191, DOI 10.1007/s11008-005-0028-6	38	32	38	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153988	10.1371/journal.pone.0153988	http://dx.doi.org/10.1371/journal.pone.0153988			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088499	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000060
J	Liu, Y; Bouhenni, RA; Dufresne, CP; Semba, RD; Edward, DP				Liu, Ying; Bouhenni, Rachida A.; Dufresne, Craig P.; Semba, Richard D.; Edward, Deepak P.			Differential Expression of Vitreous Proteins in Young and Mature New Zealand White Rabbits	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; DIABETIC-RETINOPATHY; CRYSTALLINS; HUMOR; IDENTIFICATION; LOCALIZATION; MODEL	Different anatomical regions have been defined in the vitreous humor including central vitreous, basal vitreous, vitreous cortex, vitreoretinal interface and zonule. In this study we sought to characterize changes in the proteome of vitreous humor (VH) related to compartments or age in New Zealand white rabbits (NZW). Vitreous humor was cryo-collected from young and mature New Zealand white rabbit eyes, and dissected into anterior and posterior compartments. All samples were divided into 4 groups: Young Anterior (YA), Young Posterior (YP), Mature Anterior (MA) and Mature Posterior (MP) vitreous. Tryptic digests of total proteins were analyzed by liquid chromatography followed by tandem mass spectrometry. Spectral count was used to determine the relative protein abundances and identify proteins with statistical differences between compartment and age groups. Western blotting was performed to validate some of the differentially expressed proteins. Our results showed that 231, 375, 273 and 353 proteins were identified in the YA, YP, MA and MP respectively. Fifteen proteins were significantly differentially expressed between YA and YP, and 11 between MA and MP. Carbonic anhydrase III, lambda crystallin, alpha crystallin A and B, beta crystallin B1 and B2 were more abundant in the anterior region, whereas vimentin was less abundant in the anterior region. For comparisons between age groups, 4 proteins were differentially expressed in both YA relative to MA and YP relative to MP. Western blotting confirmed the differential expression of carbonic anhydrase III, alpha crystallin B and beta crystallin B2. The protein profiles of the vitreous humor showed age-and compartmentrelated differences. This differential protein profile provides a baseline for understanding the vitreous compartmentalization in the rabbit and suggests that further studies profiling proteins in different compartments of the vitreous in other species may be warranted.	[Liu, Ying; Semba, Richard D.; Edward, Deepak P.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Bouhenni, Rachida A.] Summa Hlth Syst, Akron, OH USA; [Dufresne, Craig P.] Thermo Fisher Sci, W Palm Beach, FL USA; [Liu, Ying] Changsha Aier Eye Hosp, Changsha, Hunan, Peoples R China	Johns Hopkins University; Johns Hopkins Medicine; King Khaled Eye Specialist Hospital; Summa Health System; Thermo Fisher Scientific	Edward, DP (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.; Edward, DP (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	dedwar39@jhmi.edu			Air Force Medical Support Agency [FA8650-13-2-6370]; National Institutes of Health [R01 EY024596]; Thermo Fisher Scientific Company; NATIONAL EYE INSTITUTE [R01EY024596, P30EY001765] Funding Source: NIH RePORTER	Air Force Medical Support Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thermo Fisher Scientific Company; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study is sponsored by Air Force Medical Support Agency under agreement number FA8650-13-2-6370 and National Institutes of Health grant (R01 EY024596). The funders provided financial support in the form of salaries for authors [YL, RAB, RDS and DPE] as well as research materials, and Thermo Fisher Scientific Company provided support in the form of salaries for author [CPD], but they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Angi M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/148039; Aretz S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-22; Bahk SC, 2007, J PROTEOME RES, V6, P3891, DOI 10.1021/pr070133k; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bouhenni RA, 2011, EXP EYE RES, V92, P67, DOI 10.1016/j.exer.2010.11.004; del Amo EM, 2015, EXP EYE RES, V137, P111, DOI 10.1016/j.exer.2015.05.003; Dunmire JJ, 2011, MOL VIS, V17, P779; Fort PE, 2011, EXP EYE RES, V92, P98, DOI 10.1016/j.exer.2010.11.008; Gao BB, 2008, J PROTEOME RES, V7, P2516, DOI 10.1021/pr800112g; Grossniklaus HE, 2013, INVEST OPHTH VIS SCI, V54, DOI 10.1167/iovs.13-12711; HAGEMAN GS, 1991, P NATL ACAD SCI USA, V88, P2716, DOI 10.1073/pnas.88.7.2716; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Jester JV, 2008, SEMIN CELL DEV BIOL, V19, P82, DOI 10.1016/j.semcdb.2007.09.015; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Kim T, 2007, PROTEOMICS, V7, P4203, DOI 10.1002/pmic.200700745; Kodama M., 2013, J BIOMED SCI ENG, V6, P739; Le Goff MM, 2008, EYE, V22, P1214, DOI 10.1038/eye.2008.21; LOVICU FJ, 1995, INVEST OPHTH VIS SCI, V36, P1459; MACARI M, 1978, LAB ANIM, V12, P37, DOI 10.1258/002367778780953305; Meng E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107142; Murthy KR, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-29; Nakanishi T, 2002, J CHROMATOGR B, V776, P89, DOI 10.1016/S1570-0232(02)00078-8; Ouchi M, 2005, EXP EYE RES, V81, P176, DOI 10.1016/j.exer.2005.01.020; Rocha AS, 2014, ELECTROPHORESIS, V35, P2495, DOI 10.1002/elps.201400049; Semba RD, 2013, PROTEOMICS, V13, P2500, DOI 10.1002/pmic.201300075; Shitama T, 2008, PROTEOM CLIN APPL, V2, P1265, DOI 10.1002/prca.200800017; SJOSTRAND J, 1992, ACTA OPHTHALMOL, V70, P814; Skeie JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082140; Skeie JM, 2011, JOVE-J VIS EXP, DOI 10.3791/2455; Spencer WH, 1996, OPHTHALMIC PATHOLOGY, P334; Sreekumar PG, 2013, INVEST OPHTH VIS SCI, V54, P2787, DOI 10.1167/iovs.12-11571; WISTRAND PJ, 1986, INVEST OPHTH VIS SCI, V27, P419; Wu CW, 2004, AM J OPHTHALMOL, V137, P655, DOI 10.1016/j.ajo.2003.11.009; Yasukawa M, 2013, INT J BIOL SCI, V9, P382, DOI 10.7150/ijbs.5510; Yee KMP, 2015, INVEST OPHTH VIS SCI, V56, P7036, DOI 10.1167/iovs.15-16809; Yu J, 2008, PROTEOMICS, V8, P3667, DOI 10.1002/pmic.200700824; Zernii EY, 2015, CNS NEUROLOGICAL DIS	38	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153560	10.1371/journal.pone.0153560	http://dx.doi.org/10.1371/journal.pone.0153560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089221	gold, Green Published			2022-12-27	WOS:000374527000025
J	Nam, BH; Jung, M; Subramaniyam, S; Yoo, SI; Markkandan, K; Moon, JY; Kim, YO; Kim, DG; An, CM; Shin, Y; Jung, HJ; Park, JH				Nam, Bo-Hye; Jung, Myunghee; Subramaniyam, Sathiyamoorthy; Yoo, Seung-il; Markkandan, Kesavan; Moon, Ji-Young; Kim, Young-Ok; Kim, Dong-Gyun; An, Cheul Min; Shin, Younhee; Jung, Ho-jin; Park, Jun-hyung			Transcriptome Analysis Revealed Changes of Multiple Genes Involved in Haliotis discus hannai Innate Immunity during Vibrio parahemolyticus Infection	PLOS ONE			English	Article							RNA-SEQ DATA; DISK ABALONE; MOLECULAR CHARACTERIZATION; EXPRESSION ANALYSIS; CLONING; POLYMORPHISMS; FERRITIN; TOOL	Abalone (Haliotis discus hannai) is one of the most valuable marine aquatic species in Korea, Japan and China. Tremendous exposure to bacterial infection is common in aquaculture environment, especially by Vibrio sp. infections. It's therefore necessary and urgent to understand the mechanism of H. discus hannai host defense against Vibrio parahemolyticus infection. However studies on its immune system are hindered by the lack of genomic resources. In the present study, we sequenced the transcriptome of control and bacterial challenged H. discus hannai tissues. Totally, 138 MB of reference transcriptome were obtained from de novo assembly of 34 GB clean bases from ten different libraries and annotated with the biological terms (GO and KEGG). A total of 10,575 transcripts exhibiting the differentially expression at least one pair of comparison and the functional annotations highlight genes related to immune response, cell adhesion, immune regulators, redox molecules and mitochondrial coding genes. Mostly, these groups of genes were dominated in hemocytes compared to other tissues. This work is a prerequisite for the identification of those physiological traits controlling H. discus hannai ability to survive against Vibrio infection.	[Nam, Bo-Hye; Moon, Ji-Young; Kim, Young-Ok; Kim, Dong-Gyun; An, Cheul Min] Natl Fisheries Res & Dev Inst, Biotechnol Res Div, Aquaculture Ind Dept, Busan 619902, South Korea; [Jung, Myunghee; Subramaniyam, Sathiyamoorthy; Yoo, Seung-il; Markkandan, Kesavan; Shin, Younhee; Jung, Ho-jin; Park, Jun-hyung] Insilicogen Inc, Codes Div, Suwon 441813, Gyeonggi Do, South Korea		Park, JH (corresponding author), Insilicogen Inc, Codes Div, Suwon 441813, Gyeonggi Do, South Korea.	jhpark@insilicogen.com		Park, Junhyung/0000-0002-0805-6362	National Fisheries Research and Development Institute, Republic of Korea [RP-2015-BT-013]; Insilicogen Inc.	National Fisheries Research and Development Institute, Republic of Korea; Insilicogen Inc.	This study was funded by a grant from the National Fisheries Research and Development Institute (RP-2015-BT-013), Republic of Korea. Insilicogen Inc. provided support in the form of salaries for authors [MHJ, SS, SIY, KM, YHS, HJJ and JHP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bathige SDNK, 2014, FISH SHELLFISH IMMUN, V39, P263, DOI 10.1016/j.fsi.2014.05.012; Bester-Van der Merwe A, 2013, INT J MOL SCI, V14, P19341, DOI 10.3390/ijms140919341; Cardinaud M, 2014, APPL ENVIRON MICROB, V80, P6328, DOI 10.1128/AEM.01036-14; Cheng PZ, 2007, FISH SHELLFISH IMMUN, V22, P77, DOI 10.1016/j.fsi.2006.03.014; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cook PA., 2014, MOD EC, V5, P1181, DOI DOI 10.4236/ME.2014.513110; De Wit P, 2013, MOL ECOL, V22, P2884, DOI 10.1111/mec.12081; De Zoysa M, 2007, FISH SHELLFISH IMMUN, V23, P624, DOI 10.1016/j.fsi.2007.01.013; De Zoysa M, 2011, FISH SHELLFISH IMMUN, V31, P155, DOI 10.1016/j.fsi.2011.04.001; Ding JF, 2015, FISH SHELLFISH IMMUN, V42, P379, DOI 10.1016/j.fsi.2014.11.005; Ding JF, 2011, FISH SHELLFISH IMMUN, V30, P163, DOI 10.1016/j.fsi.2010.10.008; Ekanayake PM, 2008, FISH SHELLFISH IMMUN, V24, P267, DOI 10.1016/j.fsi.2007.11.007; Franchini Paolo, 2011, BMC Research Notes, V4, DOI 10.1186/1756-0500-4-59; Ghosh J, 2011, DEV COMP IMMUNOL, V35, P959, DOI 10.1016/j.dci.2010.12.009; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Huang ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051279; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Jackson DJ, 2010, MOL BIOL EVOL, V27, P591, DOI 10.1093/molbev/msp278; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jing X, 2011, FISH SHELLFISH IMMUN, V30, P851, DOI 10.1016/j.fsi.2011.01.007; Joung HJ, 2014, FISH SHELLFISH IMMUN, V38, P184, DOI 10.1016/j.fsi.2014.03.018; Kim Dong-Gyun, 2012, [Journal of Life Science, 생명과학회지], V22, P642, DOI 10.5352/JLS.2012.22.5.642; Kim KY, 2007, FISH SHELLFISH IMMUN, V23, P1043, DOI 10.1016/j.fsi.2007.04.010; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li HF, 2010, J INVERTEBR PATHOL, V103, P116, DOI 10.1016/j.jip.2009.11.009; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068233; Maynard BT, 2005, MAR BIOTECHNOL, V7, P645, DOI 10.1007/s10126-005-0013-z; Premachandra HKA, 2012, DEV COMP IMMUNOL, V38, P495, DOI 10.1016/j.dci.2012.06.010; Qiu R, 2013, FISH SHELLFISH IMMUN, V34, P1376, DOI 10.1016/j.fsi.2013.02.025; Ren HL, 2009, DEV COMP IMMUNOL, V33, P980, DOI 10.1016/j.dci.2009.04.003; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Robinson NA, 2014, MITOCHONDRIAL DNA; Salinas-Clarot K, 2011, FISH SHELLFISH IMMUN, V30, P430, DOI 10.1016/j.fsi.2010.09.009; Shiel BP, 2015, MAR BIOTECHNOL, V17, P23, DOI 10.1007/s10126-014-9591-y; Sokolova IM, 2009, ISJ-INVERT SURVIV J, V6, P49; Valenzuela-Munoz V, 2014, AQUAC RES, V45, P1026, DOI 10.1111/are.12044; Wan Q, 2008, COMP BIOCHEM PHYS B, V150, P187, DOI 10.1016/j.cbpb.2008.03.002; Wan Q, 2009, COMP BIOCHEM PHYS C, V150, P558, DOI 10.1016/j.cbpc.2009.08.003; Wang KJ, 2008, DEV COMP IMMUNOL, V32, P1326, DOI 10.1016/j.dci.2008.04.007; Wu CL, 2010, COMP BIOCHEM PHYS C, V152, P424, DOI 10.1016/j.cbpc.2010.07.002; Yang EC, 2014, MITOCHONDR DNA, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang J, 2014, FISH SHELLFISH IMMUN, V41, P466, DOI 10.1016/j.fsi.2014.09.032	44	24	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153474	10.1371/journal.pone.0153474	http://dx.doi.org/10.1371/journal.pone.0153474			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088873	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000023
J	Cacioppo, CN; Chandler, AE; Towne, MC; Beggs, AH; Holm, IA				Cacioppo, Cara N.; Chandler, Ariel E.; Towne, Meghan C.; Beggs, Alan H.; Holm, Ingrid A.			Expectation versus Reality: The Impact of Utility on Emotional Outcomes after Returning Individualized Genetic Research Results in Pediatric Rare Disease Research, a Qualitative Interview Study	PLOS ONE			English	Article							INFORMED-CONSENT; ETHICAL-ISSUES; CHILDREN; ATTITUDES; PERSPECTIVES; PARTICIPANTS; EXPERIENCES; BELIEFS; PARENTS; COHORT	Purpose Much information on parental perspectives on the return of individual research results (IRR) in pediatric genomic research is based on hypothetical rather than actual IRR. Our aim was to understand how the expected utility to parents who received IRR on their child from a genetic research study compared to the actual utility of the IRR received. Methods We conducted individual telephone interviews with parents who received IRR on their child through participation in the Manton Center for Orphan Disease Research Gene Discovery Core (GDC) at Boston Children's Hospital (BCH). Results Five themes emerged around the utility that parents expected and actually received from IRR: predictability, management, family planning, finding answers, and helping science and/or families. Parents expressing negative or mixed emotions after IRR return were those who did not receive the utility they expected from the IRR. Conversely, parents who expressed positive emotions were those who received as much or greater utility than expected. Conclusions Discrepancies between expected and actual utility of IRR affect the experiences of parents and families enrolled in genetic research studies. An informed consent process that fosters realistic expectations between researchers and participants may help to minimize any negative impact on parents and families.	[Cacioppo, Cara N.; Chandler, Ariel E.; Towne, Meghan C.; Beggs, Alan H.; Holm, Ingrid A.] Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Div Genet & Genom, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Holm, IA (corresponding author), Harvard Univ, Sch Med, Boston Childrens Hosp, Manton Ctr Orphan Dis Res,Div Genet & Genom, Boston, MA USA.	Ingrid.holm@childrens.harvard.edu		Holm, Ingrid/0000-0003-4712-8821; Beggs, Alan/0000-0001-8818-0568; Towne, Meghan/0000-0001-9460-2368	National Human Genome Research Institute (NHGRI) [R01HG006615, RCHG005491, U01HG006828]; National Institute of Child Health and Human Development (NICHD); NHGRI [U19HD077671]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U19HD077671] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006615, U01HG006828] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Human Genome Research Institute (NHGRI) grants R01HG006615, RCHG005491, and U01HG006828, and by the National Institute of Child Health and Human Development (NICHD) and NHGRI grant U19HD077671. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke W, 2014, AM J MED GENET C, V166, P105, DOI 10.1002/ajmg.c.31393; Dorval M, 2007, CANCER EPIDEM BIOMAR, V16, P157, DOI 10.1158/1055-9965.EPI-06-0340; Fernandez CV, 2009, J CLIN ONCOL, V27, P878, DOI 10.1200/JCO.2008.18.5223; Harris ED, 2012, GENET MED, V14, P330, DOI 10.1038/gim.2011.25; Heaney C, 2010, GENET TEST MOL BIOMA, V14, P821, DOI 10.1089/gtmb.2010.0066; Jenkins MM, 2008, AM J MED GENET C, V148C, P40, DOI 10.1002/ajmg.c.30157; Kaufman D, 2006, GENET MED, V14, P1170; Kleiderman E, 2014, J MED ETHICS, V40, P691, DOI 10.1136/medethics-2013-101648; Lakes KD, 2013, AM J MED GENET A, V161A, P38, DOI 10.1002/ajmg.a.35673; Meltzer LA, 2006, AM J BIOETHICS, V6, P28, DOI 10.1080/15265160600935811; Murphy J, 2008, AM J BIOETHICS, V8, P36, DOI 10.1080/15265160802513093; Ramoni RB, 2013, GENET MED, V15, P882, DOI 10.1038/gim.2013.58; Reilly PR, 1997, NAT GENET, V15, P16, DOI 10.1038/ng0197-16; Ries NM, 2010, BMC MED ETHICS, V11, DOI 10.1186/1472-6939-11-4; Rigter T, 2014, CLIN GENET, V85, P417, DOI 10.1111/cge.12299; Sapp JC, 2014, CLIN GENET, V85, P120, DOI 10.1111/cge.12254; Taylor HA, 2013, AM J BIOETHICS, V13, P61, DOI 10.1080/15265161.2013.828523; Wade CH, 2013, ANNU REV GENOM HUM G, V14, P535, DOI 10.1146/annurev-genom-091212-153425; Zawati MH, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-72	19	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153597	10.1371/journal.pone.0153597	http://dx.doi.org/10.1371/journal.pone.0153597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082877	Green Published, gold			2022-12-27	WOS:000374291800033
J	Cripps, G; Flynn, KJ; Lindeque, PK				Cripps, Gemma; Flynn, Kevin J.; Lindeque, Penelope K.			Ocean Acidification Affects the Phyto-Zoo Plankton Trophic Transfer Efficiency	PLOS ONE			English	Article							FOOD QUALITY; CO2 CONCENTRATIONS; HATCHING SUCCESS; EGG-PRODUCTION; ELEVATED CO2; PHYTOPLANKTON; TEMPERATURE; GROWTH; CARBON; SIZE	The critical role played by copepods in ocean ecology and biogeochemistry warrants an understanding of how these animals may respond to ocean acidification (OA). Whilst an appreciation of the potential direct effects of OA, due to elevated pCO(2), on copepods is improving, little is known about the indirect impacts acting via bottom-up (food quality) effects. We assessed, for the first time, the chronic effects of direct and/or indirect exposures to elevated pCO(2) on the behaviour, vital rates, chemical and biochemical stoichiometry of the calanoid copepod Acartia tonsa. Bottom-up effects of elevated pCO(2) caused species-specific biochemical changes to the phytoplanktonic feed, which adversely affected copepod population structure and decreased recruitment by 30%. The direct impact of elevated pCO(2) caused gender-specific respiratory responses in A. tonsa adults, stimulating an enhanced respiration rate in males (> 2-fold), and a suppressed respiratory response in females when coupled with indirect elevated pCO(2) exposures. Under the combined indirect +direct exposure, carbon trophic transfer efficiency from phytoplankton-to-zooplankton declined to < 50% of control populations, with a commensurate decrease in recruitment. For the first time an explicit role was demonstrated for biochemical stoichiometry in shaping copepod trophic dynamics. The altered biochemical composition of the CO2-exposed prey affected the biochemical stoichiometry of the copepods, which could have ramifications for production of higher tropic levels, notably fisheries. Our work indicates that the control of phytoplankton and the support of higher trophic levels involving copepods have clear potential to be adversely affected under future OA scenarios.	[Cripps, Gemma] Univ Southampton, Natl Oceanog Ctr, Ocean & Earth Sci, Southampton, Hants, England; [Flynn, Kevin J.] Swansea Univ, Biosci, Swansea, W Glam, Wales; [Lindeque, Penelope K.] Plymouth Marine Lab, Marine Ecol & Biodivers, Plymouth, Devon, England	NERC National Oceanography Centre; University of Southampton; Swansea University; Plymouth Marine Laboratory	Flynn, KJ (corresponding author), Swansea Univ, Biosci, Swansea, W Glam, Wales.	K.J.Flynn@swansea.ac.uk	Lindeque, Penelope/AAE-9193-2019; Flynn, Kevin/AAA-3253-2021	Flynn, Kevin/0000-0001-6913-5884; Lindeque, Penelope/0000-0003-1789-7515	Natural Environment Research Council (UK); Defra [NE/F003455/1, NE/H01750X/1]; Natural Environment Research Council PhD studentship; NERC [NE/F003455/1, NE/H01750X/1, pml010009] Funding Source: UKRI; Natural Environment Research Council [NE/F003455/1, pml010009, NE/H01750X/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded in part by Natural Environment Research Council (UK) and Defra grants NE/F003455/1 and NE/H01750X/1 to KJF, and by a Natural Environment Research Council PhD studentship to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Boersma M, 2008, INT REV HYDROBIOL, V93, P479, DOI 10.1002/iroh.200811066; Burkhardt S, 1999, LIMNOL OCEANOGR, V44, P683, DOI 10.4319/lo.1999.44.3.0683; Calosi P, 2013, PHIL T R SOC B, V368; CHESSON J, 1983, ECOLOGY, V64, P1297, DOI 10.2307/1937838; COWLES TJ, 1988, MAR BIOL, V100, P41, DOI 10.1007/BF00392953; Cripps G, 2014, GLOBAL CHANGE BIOL, V20, P3377, DOI 10.1111/gcb.12582; Cripps IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022736; Dodd LF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0333; EDERINGTON MC, 1995, LIMNOL OCEANOGR, V40, P860, DOI 10.4319/lo.1995.40.5.0860; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Fitzer SC, 2012, J EXP MAR BIOL ECOL, V418, P30, DOI 10.1016/j.jembe.2012.03.009; Flynn KJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2604; Flynn KJ, 1996, J EXP MAR BIOL ECOL, V196, P357, DOI 10.1016/0022-0981(95)00140-9; Frangoulis C, 2010, PROG OCEANOGR, V84, P43, DOI 10.1016/j.pocean.2009.09.005; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Fu FX, 2007, J PHYCOL, V43, P485, DOI 10.1111/j.1529-8817.2007.00355.x; HANSEN B, 1994, LIMNOL OCEANOGR, V39, P395, DOI 10.4319/lo.1994.39.2.0395; Henriksen CI, 2007, MAR ECOL PROG SER, V331, P119, DOI 10.3354/meps331119; Hildebrandt N, 2014, MAR POLLUT BULL, V80, P59, DOI 10.1016/j.marpolbul.2014.01.050; HOUDE SEL, 1987, MAR ECOL PROG SER, V40, P69, DOI 10.3354/meps040069; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Isari S, 2016, ICES J MAR SCI, V73, P650, DOI 10.1093/icesjms/fsv078; Isari S, 2015, J PLANKTON RES, V37, P912, DOI 10.1093/plankt/fbv057; Isari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084742; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Jones RH, 2002, MAR ECOL PROG SER, V235, P147, DOI 10.3354/meps235147; KLEPPEL GS, 1993, MAR ECOL PROG SER, V99, P183, DOI 10.3354/meps099183; LANDRY MR, 1988, B MAR SCI, V43, P509; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li W, 2012, MAR POLLUT B, V64, P1; Manriquez PH, 2014, MAR ECOL PROG SER, V502, P157, DOI 10.3354/meps10703; Mauchline J., 1998, ADV MARINE BIOL; Mayers JJ, 2013, BIORESOURCE TECHNOL, V148, P215, DOI 10.1016/j.biortech.2013.08.133; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Mitra A, 2005, J PLANKTON RES, V27, P393, DOI 10.1093/plankt/fbi022; Mitra A, 2006, BIOL LETTERS, V2, P194, DOI 10.1098/rsbl.2006.0447; Montechiaro F, 2010, J PLANT PHYSIOL, V167, P110, DOI 10.1016/j.jplph.2009.07.013; Pedersen SA, 2014, ENVIRON SCI TECHNOL, V48, P12275, DOI 10.1021/es501581j; Pedersen SA, 2014, J TOXICOL ENV HEAL A, V77, P535, DOI 10.1080/15287394.2014.887421; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner H-O, 2013, CLIMATE CHANGE 201 A; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rossoll D, 2013, MAR ECOL PROG SER, V486, P37, DOI 10.3354/meps10352; Rossoll D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034737; Schoo KL, 2013, MAR BIOL, V160, P2145, DOI 10.1007/s00227-012-2121-4; Schultz M, 2009, J PLANKTON RES, V31, P553, DOI 10.1093/plankt/fbp010; Stehfest K, 2005, PLANT PHYSIOL BIOCH, V43, P717, DOI 10.1016/j.plaphy.2005.07.001; Thor P, 2015, GLOBAL CHANGE BIOL, V21, P2261, DOI 10.1111/gcb.12815; Thor P, 2015, MAR BIOL, V162, P799, DOI 10.1007/s00227-015-2625-9; Thornton DCO, 2009, ECOL LETT; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P5, DOI [10.1007/s10584-011-0148-z, 10.1007/s10584-011-0157-y]; Verity PG, 1996, MAR ECOL PROG SER, V130, P277, DOI 10.3354/meps130277; Verschoor AM, 2013, FRESHWATER BIOL, V58, P597, DOI 10.1111/j.1365-2427.2012.02833.x; Verspagen JMH, 2014, ECOL LETT, V17, P951, DOI 10.1111/ele.12298; Wood HL, 2008, P ROY SOC LON B, V275, P1967; Wynn-Edwards C, 2014, WATER-SUI, V6, P1840, DOI 10.3390/w6061840; Zervoudaki S, 2014, MEDITERR MAR SCI, V15, P74, DOI 10.12681/mms.553; Zhang DJ, 2011, ACTA OCEANOL SIN, V30, P86, DOI 10.1007/s13131-011-0165-9	60	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151739	10.1371/journal.pone.0151739	http://dx.doi.org/10.1371/journal.pone.0151739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082737	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800005
J	Falcone, E; Grandoni, L; Garibaldi, F; Manni, I; Filligoi, G; Piaggio, G; Gurtner, A				Falcone, Emmanuela; Grandoni, Luca; Garibaldi, Francesca; Manni, Isabella; Filligoi, Giancarlo; Piaggio, Giulia; Gurtner, Aymone			Infinity: An In-Silico Tool for Genome-Wide Prediction of Specific DNA Matrices in miRNA Genomic Loci	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; COLORECTAL-CANCER; MUTANT P53; MICRORNAS; DATABASE; RNA; EXPRESSION; GENE; REPRESSION; PROMOTERS	Motivation miRNAs are potent regulators of gene expression and modulate multiple cellular processes in physiology and pathology. Deregulation of miRNAs expression has been found in various cancer types, thus, miRNAs may be potential targets for cancer therapy. However, the mechanisms through which miRNAs are regulated in cancer remain unclear. Therefore, the identification of transcriptional factor-miRNA crosstalk is one of the most update aspects of the study of miRNAs regulation. Results In the present study we describe the development of a fast and user-friendly software, named infinity, able to find the presence of DNA matrices, such as binding sequences for transcriptional factors, on similar to 65kb (kilobase) of 939 human miRNA genomic sequences, simultaneously. Of note, the power of this software has been validated in vivo by performing chromatin immunoprecipitation assays on a subset of new in silico identified target sequences (CCAAT) for the transcription factor NF-Y on colon cancer deregulated miRNA loci. Moreover, for the first time, we have demonstrated that NF-Y, through its CCAAT binding activity, regulates the expression of miRNA-181a, -181b, -21, -17, -130b, -301b in colon cancer cells. Conclusions The infinity software that we have developed is a powerful tool to underscore new TF/miRNA regulatory networks. Availability and Implementation Infinity was implemented in pure Java using Eclipse framework, and runs on Linux and MS Windows machine, with MySQL database. The software is freely available on the web at https://github.com/bio-devel/infinity. The website is implemented in JavaScript, PHP and HTML with all major browsers supported.	[Falcone, Emmanuela; Garibaldi, Francesca; Manni, Isabella; Piaggio, Giulia; Gurtner, Aymone] Regina Elena Inst Canc Res, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy; [Grandoni, Luca; Filligoi, Giancarlo] Univ Roma La Sapienza, Fac Informat Engn Stat & Informat, Dept Informat Engn Elect & Telecommun DIET, Piazzale Aldo Moro 5, I-00185 Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome	Piaggio, G; Gurtner, A (corresponding author), Regina Elena Inst Canc Res, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy.	piaggio@ifo.it; gurtner@ifo.it	Gurtner, Aymone/J-7217-2018; Manni, Isabella/ABH-6460-2020; Piaggio, Giulia/J-7214-2018; gurtner, aymone/AAB-8843-2020; Piaggio, Giulia/AAD-7336-2022	Gurtner, Aymone/0000-0002-7661-9059; Manni, Isabella/0000-0003-4823-0596; Piaggio, Giulia/0000-0003-2114-1892; gurtner, aymone/0000-0002-7661-9059; 	AIRC, Associazione Italiana per la Ricerca sul Cancro [MFAG11752, IG13234]; Fondazione Umberto Veronesi Fellowship	AIRC, Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi)	This work has been supported by grant from AIRC, Associazione Italiana per la Ricerca sul Cancro, to A.G. and G.P. (grant number MFAG11752, IG13234), www.AIRC.IT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr C. D'annunzio for critically reading the article, Maria Pia Gentileschi for technical advice, Daniela Bona for secretary assistance. Aymone Gurtner was supported by a Fondazione Umberto Veronesi Fellowship.	Arndt GM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-374; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bhattacharya A, 2003, CANCER RES, V63, P8167; Bhattacharyya Malay, 2012, Genomics Proteomics & Bioinformatics, V10, P310, DOI 10.1016/j.gpb.2012.08.005; BOYER RS, 1977, COMMUN ACM, V20, P762, DOI 10.1145/359842.359859; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chan P, 1999, JAVA CLASS LIB SUPPL, V2; Chien CH, 2011, NUCLEIC ACIDS RES, V39, P9345, DOI 10.1093/nar/gkr604; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Dolfini D, 2013, CELL DEATH DIFFER, V20, P676, DOI 10.1038/cdd.2013.13; Dolfini D, 2009, CELL CYCLE, V8, P4127, DOI 10.4161/cc.8.24.10240; Dong GZ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0057-x; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fleming JD, 2013, GENOME RES, V23, P1195, DOI 10.1101/gr.148080.112; Friard O, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-435; Garibaldi F, 2016, ONCOGENE, V35, P3760, DOI 10.1038/onc.2016.51; Georgakilas G, 2016, NUCLEIC ACIDS RES, V44, pD190, DOI 10.1093/nar/gkv1254; Gurtner A, 2003, MOL BIOL CELL, V14, P2706, DOI 10.1091/mbc.E02-09-0600; Gurtner A, 2010, CANCER RES, V70, P9711, DOI 10.1158/0008-5472.CAN-10-0721; Gurtner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002047; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hamed M, 2015, NUCLEIC ACIDS RES, V43, pW283, DOI 10.1093/nar/gkv418; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; Li XL, 2014, FEBS LETT, V588, P2610, DOI 10.1016/j.febslet.2014.03.054; Liao JM, 2014, J MOL CELL BIOL, V6, P206, DOI 10.1093/jmcb/mju018; Lin PL, 2014, CARCINOGENESIS, V35, P2175, DOI 10.1093/carcin/bgu110; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Mantovani R, 1998, NUCLEIC ACIDS RES, V26, P1135, DOI 10.1093/nar/26.5.1135; MANTOVANI R, 1994, J BIOL CHEM, V269, P20340; Monzo M, 2008, CELL RES, V18, P823, DOI 10.1038/cr.2008.81; Mosakhani N, 2012, GENE CHROMOSOME CANC, V51, P1, DOI 10.1002/gcc.20925; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Pichler M, 2014, J CLIN PATHOL, V67, DOI 10.1136/jclinpath-2013-201904; Psathas JN, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014175; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schetter AJ, 2011, SEMIN ONCOL, V38, P734, DOI 10.1053/j.seminoncol.2011.08.009; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Speir ML, 2016, NUCLEIC ACIDS RES, V44, pD717, DOI 10.1093/nar/gkv1275; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Vlachos IS, 2013, CLIN BIOCHEM, V46, P879, DOI 10.1016/j.clinbiochem.2013.03.006; Wang J, 2010, NUCLEIC ACIDS RES, V38, pD119, DOI 10.1093/nar/gkp803; Wang SP, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004665; Wang YX, 2010, J DIGEST DIS, V11, P50, DOI 10.1111/j.1751-2980.2009.00413.x; Woods K, 2007, J BIOL CHEM, V282, P2130, DOI 10.1074/jbc.C600252200; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yamanaka K, 2009, GENOMICS, V94, P219, DOI 10.1016/j.ygeno.2009.06.003; Yang JH, 2013, NUCLEIC ACIDS RES, V41, pD177, DOI 10.1093/nar/gks1060	54	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153658	10.1371/journal.pone.0153658	http://dx.doi.org/10.1371/journal.pone.0153658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082112	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800037
J	Helms, JA; Godfrey, A				Helms, Jackson A.; Godfrey, Aaron			Dispersal Polymorphisms in Invasive Fire Ants	PLOS ONE			English	Article							ALTERNATIVE REPRODUCTIVE TACTICS; SOLENOPSIS-INVICTA; GEMINATA HYMENOPTERA; SOCIAL PARASITISM; FLIGHT ENERGETICS; QUEEN DIMORPHISM; ATTA-TEXANA; ORCHID BEES; EVOLUTION; SIZE	In the Found or Fly (FoF) hypothesis ant queens experience reproduction-dispersal tradeoffs such that queens with heavier abdomens are better at founding colonies but are worse flyers. We tested predictions of FoF in two globally invasive fire ants, Solenopsis geminata (FABRICIUS, 1804) and S. invicta (BUREN, 1972). Colonies of these species may produce two different monogyne queen types-claustral queens with heavy abdomens that found colonies independently, and parasitic queens with small abdomens that enter conspecific nests. Claustral and parasitic queens were similarly sized, but the abdomens of claustral queens weighed twice as much as those of their parasitic counterparts. Their heavier abdomens adversely impacted morphological predictors of flight ability, resulting in 32-38% lower flight muscle ratios, 55-63% higher wing loading, and 32-33% higher abdomen drag. In lab experiments maximum flight durations in claustral S. invicta queens decreased by about 18 minutes for every milligram of abdomen mass. Combining our results into a simple fitness tradeoff model, we calculated that an average parasitic S. invicta queen could produce only 1/3 as many worker offspring as a claustral queen, but could fly 4 times as long and have a 17-to 36-fold larger potential colonization area. Investigations of dispersal polymorphisms and their associated tradeoffs promises to shed light on range expansions in invasive species, the evolution of alternative reproductive strategies, and the selective forces driving the recurrent evolution of parasitism in ants.	[Helms, Jackson A.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA; [Godfrey, Aaron] ZIN Technol Inc, Middleburg Hts, OH USA	University of Oklahoma System; University of Oklahoma - Norman	Helms, JA (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	jackson.a.helms-1@ou.edu	Helms, Jackson/J-5667-2019	Helms, Jackson/0000-0001-6709-6770	National Science Foundation Graduate Research Fellowship; University of Oklahoma Alumni Fellowship	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); University of Oklahoma Alumni Fellowship	This work was supported by the National Science Foundation Graduate Research Fellowship to JAH, and University of Oklahoma Alumni Fellowship to JAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS C T, 1976, Florida Entomologist, V59, P411, DOI 10.2307/3494191; ALEXANDER DE, 1990, BIOL BULL, V179, P186, DOI 10.2307/1541768; Bernasconi G, 1999, ANIM BEHAV, V57, P371, DOI 10.1006/anbe.1998.0955; BOURKE AFG, 1991, BIOL J LINN SOC, V43, P157, DOI 10.1111/j.1095-8312.1991.tb00591.x; Brown MJF, 2003, EVOL ECOL RES, V5, P305; Bruna EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022937; BUSCHINGER A, 1986, TRENDS ECOL EVOL, V1, P155, DOI 10.1016/0169-5347(86)90044-3; Buschinger A, 2009, MYRMECOL NEWS, V12, P219; Cade BS, 2003, FRONT ECOL ENVIRON, V1, P412, DOI 10.1890/1540-9295(2003)001[0412:AGITQR]2.0.CO;2; CHAI P, 1990, AM NAT, V135, P748, DOI 10.1086/285072; Darveau CA, 2005, J EXP BIOL, V208, P3581, DOI 10.1242/jeb.01776; DAVIDSON DW, 1982, BEHAV ECOL SOCIOBIOL, V10, P245, DOI 10.1007/BF00302813; DAVIS MA, 1984, ECOLOGY, V65, P230, DOI 10.2307/1939475; DeHeer CJ, 2002, ANIM BEHAV, V64, P655, DOI 10.1006/anbe.2002.3095; DeHeer CJ, 1998, BEHAV ECOL, V9, P130, DOI 10.1093/beheco/9.2.130; Dillon ME, 2004, J EXP BIOL, V207, P417, DOI 10.1242/jeb.00777; Duckworth RA, 2008, AM NAT, V172, pS4, DOI 10.1086/588289; Dudley R., 2000, BIOMECHANICS INSECT; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Fjerdingstad EJ, 2004, EVOLUTION, V58, P1056, DOI 10.1111/j.0014-3820.2004.tb00439.x; Fjerdingstad EJ, 1997, INSECT SOC, V44, P209, DOI 10.1007/s000400050042; Gotzek D, 2015, MOL ECOL, V24, P374, DOI 10.1111/mec.13040; GU H, 1995, ENTOMOL EXP APPL, V76, P25, DOI 10.1007/BF02382308; HARRISON RG, 1980, ANNU REV ECOL SYST, V11, P95, DOI 10.1146/annurev.es.11.110180.000523; HEDENSTROM A, 1992, J THEOR BIOL, V158, P535, DOI 10.1016/S0022-5193(05)80714-3; Heinze J, 1995, RES POPUL ECOL, V37, P135, DOI 10.1007/BF02515814; Heinze J, 2000, TRENDS ECOL EVOL, V15, P508, DOI 10.1016/S0169-5347(00)01995-9; Helms JA, 2015, INSECT SOC, V62, P171, DOI 10.1007/s00040-015-0391-9; Helms JA, 2014, MYRMECOL NEWS, V19, P85; Holldobler B., 1990, pi; HOLM S, 1979, SCAND J STAT, V6, P65; HUNG A C F, 1978, Southwestern Naturalist, V23, P205, DOI 10.2307/3669769; KELLER L, 1989, OECOLOGIA, V80, P236, DOI 10.1007/BF00380157; Keller RA, 2014, ELIFE, V3, DOI 10.7554/eLife.01539; King JR, 2009, BIOL INVASIONS, V11, P373, DOI 10.1007/s10530-008-9254-x; KOENKER R., 2013, QUANTREG QUANTILE RE; Lachaud JP, 1999, OECOLOGIA, V120, P515, DOI 10.1007/s004420050885; Marden JH, 2000, ANNU REV PHYSIOL, V62, P157, DOI 10.1146/annurev.physiol.62.1.157; MARDEN JH, 1987, J EXP BIOL, V130, P235; MARKIN G P, 1971, Journal of the Georgia Entomological Society, V6, P145; MARTINEZ T, 1994, J INSECT PHYSIOL, V40, P723, DOI 10.1016/0022-1910(94)90100-7; MCINNES DA, 1995, BEHAV ECOL SOCIOBIOL, V36, P367; Mezey JG, 2005, EVOLUTION, V59, P1027; MINTZER AC, 1987, INSECT SOC, V34, P108, DOI 10.1007/BF02223829; MORRILL WL, 1974, ENVIRON ENTOMOL, V3, P265, DOI 10.1093/ee/3.2.265; MOSER JC, 1967, INSECT SOC, V14, P295, DOI 10.1007/BF02252831; Norberg U, 2002, BIOL J LINN SOC, V77, P445, DOI 10.1046/j.1095-8312.2002.00115.x; NORBERG UM, 1987, PHILOS T R SOC B, V316, P337; PEAKIN G J, 1972, Ekologia polska, V20, P55; Peeters C, 2001, ANNU REV ENTOMOL, V46, P601, DOI 10.1146/annurev.ento.46.1.601; Peeters C, 2012, MYRMECOL NEWS, V16, P75; PORTER SD, 1986, ANN ENTOMOL SOC AM, V79, P723, DOI 10.1093/aesa/79.4.723; PORTER SD, 1985, BEHAV ECOL SOCIOBIOL, V16, P323, DOI 10.1007/BF00295545; R Core Team, 2012, R LANG ENV STAT COMP; Rayner J.M.V., 1988, Current Ornithology, V5, P1; ROSS KG, 1995, ANNU REV ECOL SYST, V26, P631, DOI 10.1146/annurev.es.26.110195.003215; Ross KG, 1997, HEREDITY, V78, P590; Ruppell O, 1998, INSECT SOC, V45, P67, DOI 10.1007/s000400050069; Ruppell O, 1999, INSECT SOC, V46, P6, DOI 10.1007/s000400050106; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shelton TG, 2006, J INSECT BEHAV, V19, P115, DOI 10.1007/s10905-005-9012-1; Shik JZ, 2013, ENTOMOL EXP APPL, V149, P99, DOI 10.1111/eea.12117; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; SUNDSTROM L, 1995, BEHAV ECOL, V6, P132, DOI 10.1093/beheco/6.2.132; TRAGER JC, 1991, J NEW YORK ENTOMOL S, V99, P141; Tschinkel W. R, 2013, FIRE ANTS; Tschinkel WR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079559; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; TSCHINKEL WR, 1988, ANN ENTOMOL SOC AM, V81, P76, DOI 10.1093/aesa/81.1.76; Tschinkel WR, 1996, INSECT SOC, V43, P267, DOI 10.1007/BF01242928; TSCHINKEL WR, 1988, PHYSIOL ENTOMOL, V13, P327, DOI 10.1111/j.1365-3032.1988.tb00484.x; TSCHINKEL WR, 1993, BEHAV ECOL SOCIOBIOL, V33, P209, DOI 10.1007/BF02027118; Vogel S., 1994, LIFE MOVING FLUIDS P; Vogt JT, 2000, J INSECT PHYSIOL, V46, P697, DOI 10.1016/S0022-1910(99)00158-4; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; WERNER PA, 1976, AM NAT, V110, P959, DOI 10.1086/283120; West-Eberhard MJ, 2005, P NATL ACAD SCI USA, V102, P6543, DOI 10.1073/pnas.0501844102; WESTEBERHARD MJ, 1986, P NATL ACAD SCI USA, V83, P1388, DOI 10.1073/pnas.83.5.1388; Wetterer JK, 2011, MYRMECOL NEWS, V14, P21; WHITCOMB W H, 1973, Environmental Entomology, V2, P1101, DOI 10.1093/ee/2.6.1101; WOJCIK DP, 1983, FLA ENTOMOL, V66, P101, DOI 10.2307/3494556; Zera AJ, 1997, ANNU REV ENTOMOL, V42, P207, DOI 10.1146/annurev.ento.42.1.207	82	9	9	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153955	10.1371/journal.pone.0153955	http://dx.doi.org/10.1371/journal.pone.0153955			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082115	gold, Green Published			2022-12-27	WOS:000374291800064
J	Sehgal, IS; Dhooria, S; Gupta, N; Bal, A; Ram, B; Aggarwal, AN; Behera, D; Agarwal, R				Sehgal, Inderpaul Singh; Dhooria, Sahajal; Gupta, Nalini; Bal, Amanjit; Ram, Babu; Aggarwal, Ashutosh Nath; Behera, Digambar; Agarwal, Ritesh			Impact of Endobronchial Ultrasound (EBUS) Training on the Diagnostic Yield of Conventional Transbronchial Needle Aspiration for Lymph Node Stations 4R and 7	PLOS ONE			English	Article							EXPERIENCE; BRONCHOSCOPY; SARCOIDOSIS	Background There is sparse literature on whether training in endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) improves the diagnostic yield of conventional TBNA (cTBNA). Objectives The aim of this study was to evaluate the diagnostic yield of cTBNA before and after the introduction of EBUS. Methods This was a retrospective analysis of patients who underwent cTBNA at our center. The study was divided into two periods, before and after the introduction of EBUS at our facility. The diagnostic yield of cTBNA was compared between the study periods. Rapid on-site cytological examination was not available. Results A total of 1,050 patients (61.6% men; mean age 45.6 years) underwent cTBNA during the study period (849 before EBUS; 201 after EBUS). Sarcoidosis (n = 527) followed by bronchogenic carcinoma (n = 222) formed the most common indications for performing cTBNA. There was a significant increase in both the success of obtaining a representative sample (from 71% to 85%), and the diagnostic yield (from 33% to 49.5%) of cTBNA, after the introduction of EBUS. The increase in the diagnostic yield of cTBNA after introduction of EBUS remained significant even after adjusting for years of performing cTBNA and the type of anesthesia (topical vs. sedation and topical) on a multivariate analysis. Conclusion The diagnostic yield of cTBNA at our facility increased after the introduction of EBUS-TBNA. However, given the retrospective nature of the study, prospective studies are required to confirm our findings.	[Sehgal, Inderpaul Singh; Dhooria, Sahajal; Ram, Babu; Aggarwal, Ashutosh Nath; Behera, Digambar; Agarwal, Ritesh] Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India; [Gupta, Nalini] Postgrad Inst Med Educ & Res, Dept Cytol & Gynecol Pathol, Chandigarh 160012, India; [Bal, Amanjit] Postgrad Inst Med Educ & Res, Dept Histopathol, Chandigarh 160012, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Agarwal, R (corresponding author), Postgrad Inst Med Educ & Res, Dept Pulm Med, Chandigarh 160012, India.	agarwal.ritesh@outlook.in	Sehgal, Inderpaul/AAA-8165-2021; Sehgal, Inderpaul/GYE-2441-2022; Agarwal, Ritesh/A-3063-2009	Sehgal, Inderpaul/0000-0002-6505-6019; Agarwal, Ritesh/0000-0003-2547-7668				Agarwal R, 2014, J BRONCHOL INTERN PU, V21, P284, DOI 10.1097/LBR.0000000000000096; Agarwal R, 2013, RESP CARE, V58, P683, DOI 10.4187/respcare.02101; Baldi M, 2015, CHEST, V147, pE113, DOI 10.1378/chest.14-2705; Bonifazi M, 2013, RESPIRATION, V86, P123, DOI 10.1159/000350466; Chokhani Ramesh, 2004, Nepal Med Coll J, V6, P24; Cordovilla R, 2014, J BRONCHOL INTERN PU, V21, P322, DOI 10.1097/LBR.0000000000000097; Dhooria S, 2015, ANN THORAC SURG, V99, P1894, DOI 10.1016/j.athoracsur.2015.02.055; Dhooria S, 2015, THORAX, V70, P587, DOI 10.1136/thoraxjnl-2015-206805; Dhooria S, 2014, J THORAC CARDIOV SUR, V148, P662, DOI 10.1016/j.jtcvs.2014.01.028; Feller-Kopman David J, 2013, Ann Am Thorac Soc, V10, P127, DOI 10.1513/AnnalsATS.201208-052OC; Goyal A, 2014, J BRONCHOL INTERN PU, V21, P220, DOI 10.1097/LBR.0000000000000081; Gupta D, 2014, CHEST, V146, P547, DOI 10.1378/chest.13-2339; Hermens FHW, 2008, RESPIRATION, V75, P189, DOI 10.1159/000112793; Herth FJF, 2006, THORAX, V61, P795, DOI 10.1136/thx.2005.047829; Kaur H, 2015, CHEST, V148, P739, DOI 10.1378/chest.15-0022; Khan A, 2011, NATL MED J INDIA, V24, P136; Krasnik M, 2003, THORAX, V58, P1083, DOI 10.1136/thorax.58.12.1083; Kupeli E, 2012, J BRONCHOL INTERN PU, V19, P115, DOI 10.1097/LBR.0b013e31824dd19a; Mehta Atul C, 2013, Ann Am Thorac Soc, V10, P685, DOI 10.1513/AnnalsATS.201308-272ED; Sehgal IS, 2016, J BRONCHOL INTERN PU, V23, pE1, DOI 10.1097/LBR.0000000000000242; Srinivasan A, 2013, INDIAN J MED RES, V137, P803	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153793	10.1371/journal.pone.0153793	http://dx.doi.org/10.1371/journal.pone.0153793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27083009	Green Published, gold			2022-12-27	WOS:000374291800053
J	Almeida, JL; Gil-Santana, L; Oliveira, CAM; Castro, S; Cafezeiro, AS; Daltro, C; Netto, EM; Kornfeld, H; Andrade, BB				Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Oliveira, Carolina A. M.; Castro, Simone; Cafezeiro, Aparecida S.; Daltro, Carla; Netto, Eduardo M.; Kornfeld, Hardy; Andrade, Bruno B.			Glucose Metabolism Disorder Is Associated with Pulmonary Tuberculosis in Individuals with Respiratory Symptoms from Brazil	PLOS ONE			English	Article							DIABETES-MELLITUS; DISEASE; TRENDS; RISK; TB	Background Diabetes mellitus (DM) has been associated with increased risk for pulmonary tuberculosis (PTB) in endemic settings but it is unknown whether PTB risk is also increased by pre-DM. Here, we prospectively examined the association between glucose metabolism disorder (GMD) and PTB in patients with respiratory symptoms at a tuberculosis primary care reference center in Brazil. Methods Oral glucose tolerance test was performed and levels of fasting plasma glucose and glycohemoglobin (HbA1c) were measured in a cohort of 892 individuals presenting with respiratory symptoms of more than two weeks duration. Patients were also tested for PTB with sputum cultures. Prevalence of pre-DM and DM (based on HbA1c) was estimated and tested for association with incident PTB. Other TB risk factors including smoking history were analyzed. Results The majority of the study population (63.1%) exhibited GMD based on HbA1c >= 5.7%. Patients with GMD had higher prevalence of PTB compared to normoglycemic patients. Individuals with DM exhibited increased frequency of TB-related symptoms and detection of acid-fast bacilli in sputum smears. Among patients with previous DM diagnosis, sustained hyperglycemia (HbA1c >= 7.0%) was associated with increased TB prevalence. Smoking history alone was not significantly associated with TB in our study population but the combination of smoking and HbA1c >= 7.0% was associated with 6 times higher odds for PTB. Conclusions Sustained hyperglycemia and pre-DM are independently associated with active PTB. This evidence raises the question whether improving glycemic control in diabetic TB patients would reduce the risk of TB transmission and simultaneously reduce the clinical burden of disease. A better understanding of mechanisms underlying these associations, especially those suggesting that pre-DM may be a factor driving susceptibility to TB is warranted.	[Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, LIMI, UMI, BR-40296710 Salvador, BA, Brazil; [Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] FTC, Curso Med, BR-41741590 Salvador, BA, Brazil; [Almeida-Junior, Jilson L.; Gil-Santana, Leonardo; Andrade, Bruno B.] Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, BR-40210320 Salvador, BA, Brazil; [Oliveira, Carolina A. M.; Castro, Simone; Cafezeiro, Aparecida S.; Netto, Eduardo M.; Andrade, Bruno B.] Fundacao Jose Silveira, IBIT, Ctr Pesquisa, BR-40210320 Salvador, BA, Brazil; [Daltro, Carla; Netto, Eduardo M.] Univ Fed Bahia, Hosp Univ Prof Edgard Santos, BR-40110060 Salvador, BA, Brazil; [Kornfeld, Hardy] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA	Fundacao Oswaldo Cruz; Universidade Federal da Bahia; University of Massachusetts System; University of Massachusetts Worcester	Andrade, BB (corresponding author), Fundacao Oswaldo Cruz FIOCRUZ, Ctr Pesquisas Goncalo Moniz CPqGM, LIMI, UMI, BR-40296710 Salvador, BA, Brazil.; Andrade, BB (corresponding author), FTC, Curso Med, BR-41741590 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, Multinatl Org Network Sponsoring Translat & Epide, BR-40210320 Salvador, BA, Brazil.; Andrade, BB (corresponding author), Fundacao Jose Silveira, IBIT, Ctr Pesquisa, BR-40210320 Salvador, BA, Brazil.	Bruno.andrade@bahia.fiocruz.br	Andrade, Bruno/AAI-2248-2020; Netto, Eduardo/D-1432-2013; Kornfeld, Hardy/AAS-2903-2021	Netto, Eduardo/0000-0003-1691-6761; 	Conselho Nacional de Pesquisa e Tecnologia - CNPq, Brazil [559276/2009-5]; Fundacao Jose Silveira (intramural program), Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia; Government of India's Department of Biotechnology; Indian Council of Medical Research; United States National Institutes of Health [USB1-31149-XX-13]	Conselho Nacional de Pesquisa e Tecnologia - CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Jose Silveira (intramural program), Brazil; Fundacao de Amparo a Pesquisa do Estado da Bahia; Government of India's Department of Biotechnology; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Conselho Nacional de Pesquisa e Tecnologia - CNPq (grant number: 559276/2009-5), Brazil and Fundacao Jose Silveira (intramural program), Brazil. The authors JLA-J and LG-S received research fellowships from Fundacao de Amparo a Pesquisa do Estado da Bahia. HK's participation was supported by the Government of India's Department of Biotechnology, the Indian Council of Medical Research, the United States National Institutes of Health distributed by CRDF Global through grant #USB1-31149-XX-13.	Alisjahbana B, 2007, CLIN INFECT DIS, V45, P428, DOI 10.1086/519841; American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Azzurri A, 2005, MICROBES INFECT, V7, P1, DOI 10.1016/j.micinf.2004.09.004; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Conde MB, 2009, J BRAS PNEUMOL, V35, P1018, DOI 10.1590/S1806-37132009001000011; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Gil-Santana L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146876; International Diabetes Federation, 2013, IDF DIAB ATLT; Jee SH, 2009, AM J EPIDEMIOL, V170, P1478, DOI 10.1093/aje/kwp308; Kumar NP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112108; Lonnroth K, 2014, LANCET DIABETES ENDO, V2, P730, DOI 10.1016/S2213-8587(14)70109-3; Lohmann EM, 2012, INT J TUBERC LUNG D, V16, P1477, DOI 10.5588/ijtld.12.0129; Mahishale Vinay, 2015, Chonnam Med J, V51, P86, DOI 10.4068/cmj.2015.51.2.86; Marais BJ, 2013, LANCET INFECT DIS, V13, P436, DOI 10.1016/S1473-3099(13)70015-X; Martinez N, 2014, EUR J IMMUNOL, V44, P617, DOI 10.1002/eji.201344301; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; Milman S, 2011, MED CLIN N AM, V95, P309, DOI 10.1016/j.mcna.2010.11.004; Odone A, 2014, LANCET DIABETES ENDO, V2, P754, DOI 10.1016/S2213-8587(14)70164-0; Oni T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0750-1; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Reis-Santos B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100082; Salvi SS, 2009, LANCET, V374, P733, DOI 10.1016/S0140-6736(09)61303-9; Sen Tiyas, 2009, J Assoc Physicians India, V57, P660; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Slatery E, 2014, NEGLECTED NONCOMPLIA; Sullivan T, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001269; Viswanathan AA, 2014, LUNG INDIA, V31, P244, DOI 10.4103/0970-2113.135764; Viswanathan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041367; Wang JY, 2015, CHEST, V147, P520, DOI 10.1378/chest.14-0918; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2015, 2015 GLOB TUB REP; Yip J, 1998, J CLIN ENDOCR METAB, V83, P2773, DOI 10.1210/jc.83.8.2773	33	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153590	10.1371/journal.pone.0153590	http://dx.doi.org/10.1371/journal.pone.0153590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078026	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700087
J	Guzy, G; Polczyk, R; Szpitalak, M; Vernon, H				Guzy, Grazyna; Polczyk, Romuald; Szpitalak, Malwina; Vernon, Howard			Age Moderates the Relationships between Family Functioning and Neck Pain/Disability	PLOS ONE			English	Article							SELF-RATED DISABILITY; CHRONIC PAIN; PSYCHOLOGICAL-FACTORS; GENERAL-POPULATION; COPING STYLES; FEAR; ACCEPTANCE; BELIEFS; IMPACT; MODEL	This cross-sectional clinical study was designed to explore the relationships between family functioning, coping styles, and neck pain and neck disability. It was hypothesized that better family functioning and more effective coping styles would be associated with less pain and pain-related disability. It also was hypothesized that these relationships would be stronger in older people because they have fewer resources, more limited coping styles, and may depend more on their family for support. In this study, 88 women with chronic non-traumatic neck pain completed the Family Assessment Measure (FAM), Coping Inventory for Stressful Situations (CISS), Neck Disability Index (NDI), and a Visual-Analogue Scale (VAS) measuring the subjective intensity of neck pain. Zero-order and partial correlations and hierarchical stepwise regression were performed. CISS was not correlated with the NDI orVAS. Good family functioning was correlated with lower NDI and VAS scores. Age was found to moderate the relationship between the FAM and both NDI and VAS. This relationship was significant and positive in older patients, but non-significant in younger patients. It was concluded that better family functioning is associated with lower neck disability and pain intensity, especially in the case of older women suffering from non-traumatic neck pain.	[Guzy, Grazyna] Univ Phys Educ, Dept Physiotherapy, Krakow, Poland; [Polczyk, Romuald; Szpitalak, Malwina] Jagiellonian Univ, Inst Psychol, Krakow, Poland; [Vernon, Howard] Canadian Mem Chiropract Coll, Toronto, ON, Canada	Jagiellonian University	Guzy, G (corresponding author), Univ Phys Educ, Dept Physiotherapy, Krakow, Poland.	grazyna.guzy@fizjoterapia.eu			University of Physical Education in Cracow, Poland [257/KF/2009]	University of Physical Education in Cracow, Poland	This work was supported by University of Physical Education in Cracow, Poland; 257/KF/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhtadze MA, 2012, J MANIP PHYSIOL THER, V35, P76, DOI 10.1016/j.jmpt.2011.12.006; Beauvale Andrzej, 2002, Psychiatr Pol, V36, P29; Berg CA, 2007, PSYCHOL BULL, V133, P920, DOI 10.1037/0033-2909.133.6.920; Buitenhuis J, 2008, SPINE, V33, P2427, DOI 10.1097/BRS.0b013e318183c6ca; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Cierpka M, 1994, DIE FAMILIENBOGEN; Connidis I, 1983, CANADIAN J AGING, V2, P91; Cote P, 2004, PAIN, V112, P267, DOI 10.1016/j.pain.2004.09.004; Cui JA, 2009, PSYCHIAT CLIN NEUROS, V63, P147, DOI 10.1111/j.1440-1819.2009.01934.x; den Hollander M, 2010, EXPERT REV NEUROTHER, V10, P1733, DOI [10.1586/ERN.10.115, 10.1586/ern.10.115]; Endler NS., 1999, COPING INVENTORY STR, V2; Esteve R, 2007, ANN BEHAV MED, V33, P179, DOI 10.1007/BF02879899; Guzy G, 2013, DISABIL REHABIL, V35, P2132, DOI 10.3109/09638288.2013.771706; Hart S, 2000, PSYCHOL HEALTH, V15, P869, DOI 10.1080/08870440008405588; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Higgins NC, 2015, J PSYCHOL, V149, P737, DOI 10.1080/00223980.2014.977759; Hogg-Johnson S, 2009, J MANIP PHYSIOL THER, V32, pS46, DOI 10.1016/j.jmpt.2008.11.010; Howell ER, 2012, J MUSCULOSKELET PAIN, V20, P18, DOI 10.3109/10582452.2011.635849; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Hurwitz EL, 2006, DISABIL REHABIL, V28, P1319, DOI 10.1080/09638280600641509; Jagger C, 2008, LANCET, V372, P2124, DOI 10.1016/S0140-6736(08)61594-9; Kemler MA, 2002, J PAIN SYMPTOM MANAG, V23, P433, DOI 10.1016/S0885-3924(02)00386-X; Kerns R. D., 2002, PSYCHOL APPROACHES P, P256; Kerns RD, 2003, SEMIN PAIN MED, V1, P79, DOI DOI 10.1016/S1537-5897(03)00007-7; Lewandowski Wendy, 2007, Issues Ment Health Nurs, V28, P1019, DOI 10.1080/01612840701522200; Luo XM, 2004, VALUE HEALTH, V7, P61, DOI 10.1111/j.1524-4733.2004.71264.x; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Mackenbach JP, 2013, LANCET, V381, P1125, DOI 10.1016/S0140-6736(12)62082-0; McCarthy MJH, 2007, EUR SPINE J, V16, P2111, DOI 10.1007/s00586-007-0503-y; McCracken LA, 2003, PAIN, V105, P197, DOI 10.1016/S0304-3959(03)00202-1; McCracken LM, 2014, PRIM HEALTH CARE RES, V15, P312, DOI 10.1017/S1463423613000273; Nieto R, 2008, SPINE, V33, pE630, DOI 10.1097/BRS.0b013e31817eb836; Nieto R, 2011, DISABIL REHABIL, V33, P389, DOI 10.3109/09638288.2010.491576; Nieto R, 2009, EUR J PAIN, V13, P518, DOI 10.1016/j.ejpain.2008.06.005; Nolte E, 2002, SOC SCI MED, V55, P1905, DOI 10.1016/S0277-9536(01)00320-3; Riddle DL, 1998, PHYS THER, V78, P951, DOI 10.1093/ptj/78.9.951; Romano JM, 2001, HDB PAIN ASSESSMENT, P346; Skinner H, 2000, J FAM THER, V22, P190, DOI 10.1111/1467-6427.00146; Skinner H.A., 1983, CANADIAN J COMMUNITY, V2, P91, DOI [10.7870/cjcmh-1983-0018, DOI 10.7870/CJCMH-1983-0018]; Strelau J, 2007, CISS KWESRIONARIUSZ; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Thomas MR, 1991, HEADACHE Q-CURR TREA, V2, P307; Turk DC, 2002, J CONSULT CLIN PSYCH, V70, P678, DOI 10.1037//0022-006X.70.3.678; VERNON H, 1991, J MANIP PHYSIOL THER, V14, P409; Vernon H, 2011, J MANIP PHYSIOL THER, V34, P506, DOI 10.1016/j.jmpt.2011.08.011; Vernon H, 2010, SPINE, V35, pE16, DOI 10.1097/BRS.0b013e3181b135aa; Vlaeyen JWS, 2012, PAIN, V153, P1144, DOI 10.1016/j.pain.2011.12.009; Voerman JS, 2015, EUR J PAIN, V19, P1544, DOI 10.1002/ejp.689; Vos CJ, 2008, BRIT J GEN PRACT, V58, P624, DOI 10.3399/bjgp08X330762; Williamson A, 2005, J CLIN NURS, V14, P798, DOI 10.1111/j.1365-2702.2005.01121.x; Young SB, 2009, PAIN MED, V10, P310, DOI 10.1111/j.1526-4637.2009.00571.x	51	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153606	10.1371/journal.pone.0153606	http://dx.doi.org/10.1371/journal.pone.0153606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078854	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700091
J	Chen, PT; Chen, CL; Lin, LTW; Lo, CH; Hu, CJ; Chen, RPY; Wang, SSS				Chen, Po-Ting; Chen, Chao-Long; Lin, Lilian Tsai-Wei; Lo, Chun-Hsien; Hu, Chaur-Jong; Chen, Rita P. -Y.; Wang, Steven S. -S.			Design of Peptide Substrate for Sensitively and Specifically Detecting Two A beta-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; BRAIN; METABOLISM; PATHOLOGY; TARGETS; CELLS	Upregulation of neprilysin (NEP) to reduce A beta accumulation in the brain is a promising strategy for the prevention of Alzheimer's disease (AD). This report describes the design and synthesis of a quenched fluorogenic peptide substrate qf-A beta(12-16) AAC (with the sequence VHHQKAAC), which has a fluorophore, Alexa-350, linked to the side-chain of its C-terminal cysteine and a quencher, Dabcyl, linked to its N-terminus. This peptide emitted strong fluorescence upon cleavage. Our results showed that qf-A beta(12-16) AAC is more sensitive to NEP than the previously reported peptide substrates, so that concentrations of NEP as low as 0.03 nM could be detected at peptide concentration of 2 mu M. Moreover, qfA beta(12-16) AAC had superior enzymatic specificity for both NEP and angiotensin-converting enzyme (ACE), but was inert with other A beta-degrading enzymes. This peptide, used in conjunction with a previously reported peptide substrate qf-A beta(1-7) C [which is sensitive to NEP and insulin-degrading enzyme (IDE)], could be used for high-throughput screening of compounds that only upregulate NEP. The experimental results of cell-based activity assays using both qf-A beta(1-7) C and qf-A beta(12-16) AAC as the substrates confirm that somatostatin treatment most likely upregulates IDE, but not NEP, in neuroblastoma cells.	[Chen, Po-Ting; Chen, Rita P. -Y.] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan; [Chen, Po-Ting; Chen, Rita P. -Y.] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; [Chen, Chao-Long; Lin, Lilian Tsai-Wei; Lo, Chun-Hsien; Wang, Steven S. -S.] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan; [Hu, Chaur-Jong] Taipei Med Univ, Dept Neurol, Shuang Ho Hosp, Taipei 110, Taiwan	National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; Taipei Medical University; Shuang Ho Hospital	Chen, RPY (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan.; Chen, RPY (corresponding author), Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan.; Wang, SSS (corresponding author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.	pyc@gate.sinica.edu.tw; sswang@ntu.edu.tw	Chen, Rita P/M-8397-2013	Chen, Rita P/0000-0003-3987-033X; Lin, Lilian/0000-0003-2769-8763	Academia Sinica; Ministry of Science and Technology, Taiwan [NSC 97-2113-M-001-014-MY2, 102-2113-M-001-013-MY3, MOST 104-2221-E-002-172]	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Academia Sinica and the Ministry of Science and Technology, Taiwan (project no. NSC 97-2113-M-001-014-MY2, 102-2113-M-001-013-MY3 and MOST 104-2221-E-002-172). The MALDI mass spectroscopy and the enzyme specificity and sensitivity assays were conducted in the Biophysics Instrumentation Laboratory of the Institute of Biological Chemistry, Academia Sinica.	Ayoub S, 2006, J PHARM PHARMACOL, V58, P495, DOI 10.1211/jpp.58.4.0009; Ayoub S, 2008, PHARM BIOL, V46, P425, DOI 10.1080/13880200802055891; Blurton-Jones M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt440; Caccamo A, 2005, NEUROBIOL AGING, V26, P645, DOI 10.1016/j.neurobiolaging.2004.06.013; Chen PT, 2010, J NEUROSCI METH, V190, P57, DOI 10.1016/j.jneumeth.2010.04.024; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Guan H, 2009, J NEUROSCI RES, V87, P1462, DOI 10.1002/jnr.21944; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hsu RL, 2009, J AGR FOOD CHEM, V57, P503, DOI 10.1021/jf803072r; Iwata N, 2005, PHARMACOL THERAPEUT, V108, P129, DOI 10.1016/j.pharmthera.2005.03.010; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jakob-Roetne R, 2009, ANGEW CHEM INT EDIT, V48, P3030, DOI 10.1002/anie.200802808; Liu YX, 2010, MOL CELL NEUROSCI, V45, P101, DOI 10.1016/j.mcn.2010.05.014; Mandavilli A, 2006, NAT MED, V12, P747, DOI 10.1038/nm0706-747; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Moreth J, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-18; Nalivaeva NN, 2012, J NEUROCHEM, V120, P167, DOI 10.1111/j.1471-4159.2011.07510.x; Park MH, 2013, BRAIN RES, V1529, P113, DOI 10.1016/j.brainres.2013.05.045; Rafii MS, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-7; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Tundo G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034376; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; Vardy ERLC, 2005, TRENDS MOL MED, V11, P464, DOI 10.1016/j.molmed.2005.08.004; Wang DS, 2003, BIOCHEM BIOPH RES CO, V310, P236, DOI 10.1016/j.bbrc.2003.09.003; Yasojima K, 2001, NEUROSCI LETT, V297, P97, DOI 10.1016/S0304-3940(00)01675-X	26	3	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153360	10.1371/journal.pone.0153360	http://dx.doi.org/10.1371/journal.pone.0153360			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096746	gold, Green Published			2022-12-27	WOS:000374543600033
J	Dhanda, SK; Vir, P; Singla, D; Gupta, S; Kumar, S; Raghava, GPS				Dhanda, Sandeep Kumar; Vir, Pooja; Singla, Deepak; Gupta, Sudheer; Kumar, Shailesh; Raghava, Gajendra P. S.			A Web-Based Platform for Designing Vaccines against Existing and Emerging Strains of Mycobacterium tuberculosis	PLOS ONE			English	Article							T-CELL EPITOPES; PROTECTIVE EFFICACY; SUBUNIT VACCINES; MULTIDRUG-RESISTANT; SECRETION SYSTEMS; VIRULENCE FACTORS; INTERFERON-GAMMA; IMMUNE-RESPONSE; BCG; PREDICTION	Development of an effective vaccine against drug-resistant Mycobacterium tuberculosis (Mtb) is crucial for saving millions of premature deaths every year due to tuberculosis. This paper describes a web portal developed for assisting researchers in designing vaccines against emerging Mtb strains using traditional and modern approaches. Firstly, we annotated 59 genomes of Mycobacterium species to understand similarity/dissimilarity between tuberculoid, non-tuberculoid and vaccine strains at genome level. Secondly, antigen-based vaccine candidates have been predicted in each Mtb strain. Thirdly, epitopes-based vaccine candidates were predicted/discovered in above antigen-based vaccine candidates that can stimulate all arms of immune system. Finally, a database of predicted vaccine candidates at epitopes as well at antigen level has been developed for above strains. In order to design vaccine against a newly sequenced genome of Mtb strain, server integrates three modules for identification of strain-, antigen-, epitope-specific vaccine candidates. We observed that 103522 unique peptides (9mers) had the potential to induce an antibody response and/or promiscuous binder to MHC alleles and/or have the capability to stimulate T lymphocytes. In summary, this web-portal will be useful for researchers working on designing vaccines against Mtb including drug-resistant strains. Availability: The database is available freely at http://crdd.osdd.net/raghava/mtbveb/.	[Dhanda, Sandeep Kumar; Vir, Pooja; Singla, Deepak; Gupta, Sudheer; Kumar, Shailesh; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Raghava, GPS (corresponding author), Inst Microbial Technol, Bioinformat Ctr, Chandigarh 160036, India.	raghava@imtech.res.in	Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009; Vir, Pooja/ABI-3569-2020; Dhanda, Sandeep Kumar/J-8471-2016; Singla, Deepak/C-9629-2015	Raghava, Gajendra P.S./0000-0002-8902-2876; Vir, Pooja/0000-0002-6816-5122; Dhanda, Sandeep Kumar/0000-0003-1381-7434; Singla, Deepak/0000-0003-0131-7950; Kumar, Shailesh/0000-0002-1872-9903; Gupta, Sudheer/0000-0002-6836-6696	Council of Scientific and Industrial Research through OSDD consortium; Council of Scientific and Industrial Research through GENESIS projects; Department of Biotechnology, Government of India through BTISNET; Indian Council of Medical Research	Council of Scientific and Industrial Research through OSDD consortium; Council of Scientific and Industrial Research through GENESIS projects; Department of Biotechnology, Government of India through BTISNET; Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	The authors acknowledge the Council of Scientific and Industrial Research funding through OSDD consortium and GENESIS projects. The authors are also thankful to Department of Biotechnology, Government of India for funding the project through BTISNET. SKD acknowledges the Indian Council of Medical Research for a fellowship.	Abebe F, 2009, CLIN EXP IMMUNOL, V157, P235, DOI 10.1111/j.1365-2249.2009.03967.x; Akhter Y, 2012, BIOCHIMIE, V94, P110, DOI 10.1016/j.biochi.2011.09.026; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Andersen P, 2005, MICROBES INFECT, V7, P911, DOI 10.1016/j.micinf.2005.03.013; Andersen P, 2007, NAT REV MICROBIOL, V5, P484, DOI 10.1038/nrmicro1703; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Behr MA, 2002, LANCET INFECT DIS, V2, P86, DOI 10.1016/S1473-3099(02)00182-2; Bentley SD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001552; Bertholet S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001094; Bhasin M, 2004, VACCINE, V22, P3195, DOI 10.1016/j.vaccine.2004.02.005; Bhasin M, 2007, J BIOSCIENCES, V32, P31, DOI 10.1007/s12038-007-0004-5; Bottai D, 2015, VACCINE, V33, P2710, DOI 10.1016/j.vaccine.2015.03.083; Caminero JA, 2010, LANCET INFECT DIS, V10, P621, DOI 10.1016/S1473-3099(10)70139-0; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chaudhuri Rupanjali, 2014, Syst Synth Biol, V8, P27, DOI 10.1007/s11693-014-9135-9; Collins DM, 2000, IMMUNOL CELL BIOL, V78, P342, DOI 10.1046/j.1440-1711.2000.00937.x; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Dhanda SK, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/263952; Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30; Doherty TM, 2007, EXPERT OPIN BIOL TH, V7, P1539, DOI 10.1517/14712598.7.10.1539; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Elhay MJ, 1997, IMMUNOL CELL BIOL, V75, P595, DOI 10.1038/icb.1997.94; Foged C, 2011, THER DELIV, V2, P1057, DOI 10.4155/TDE.11.68; Forrellad MA, 2013, VIRULENCE, V4, P3, DOI 10.4161/viru.22329; Galagan JE, 2014, NAT REV GENET, V15, P307, DOI 10.1038/nrg3664; Ganguly N, 2008, TUBERCULOSIS, V88, P510, DOI 10.1016/j.tube.2008.05.002; Gunawardena HP, 2013, J PROTEOME RES, V12, P5463, DOI 10.1021/pr400334k; He YQ, 2014, NUCLEIC ACIDS RES, V42, pD1124, DOI 10.1093/nar/gkt1133; Jalapathy KV, 2004, FEMS IMMUNOL MED MIC, V40, P139, DOI 10.1016/S0928-8244(03)00303-1; Kalra M, 2007, CLIN IMMUNOL, V125, P173, DOI 10.1016/j.clim.2007.07.007; Kaufmann SHE, 2012, TRENDS IMMUNOL, V33, P373, DOI 10.1016/j.it.2012.03.004; McShane H, 2011, NAT MED, V17, P1185, DOI 10.1038/nm.2503; Mukai T, 2009, J IMMUNOL, V183, P6561, DOI 10.4049/jimmunol.0803857; MURRAY HW, 1994, AM J MED, V97, P459, DOI 10.1016/0002-9343(94)90326-3; Okkels LM, 2003, INFECT IMMUN, V71, P6116, DOI 10.1128/IAI.71.11.6116-6123.2003; Olsen AW, 2004, INFECT IMMUN, V72, P6148, DOI 10.1128/IAI.72.10.6148-6150.2004; Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC; Romano M, 2008, VACCINE, V26, P6053, DOI 10.1016/j.vaccine.2008.09.025; Rook GAW, 2005, VACCINE, V23, P2115, DOI 10.1016/j.vaccine.2005.01.069; Rowland R, 2011, EXPERT REV VACCINES, V10, P645, DOI [10.1586/ERV.11.28, 10.1586/erv.11.28]; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Simeone R, 2015, TUBERCULOSIS, V95, pS150, DOI 10.1016/j.tube.2015.02.019; Singh H, 2003, BIOINFORMATICS, V19, P1009, DOI 10.1093/bioinformatics/btg108; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062216; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004; Wang JL, 2010, MOL BIOL REP, V37, P1793, DOI 10.1007/s11033-009-9613-4; WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992; Wong EB, 2013, TRENDS MICROBIOL, V21, P493, DOI 10.1016/j.tim.2013.05.002; Young DB, 2003, NAT MED, V9, P503, DOI 10.1038/nm868; Young SL, 2010, IMMUNOL CELL BIOL, V88, P651, DOI 10.1038/icb.2010.25; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	55	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153771	10.1371/journal.pone.0153771	http://dx.doi.org/10.1371/journal.pone.0153771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096425	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600055
J	Kubota, Y; Kawamura, H; Sakai, M; Tsumuraya, R; Tashiro, M; Yusa, K; Kubo, N; Sato, H; Kawahara, M; Katoh, H; Kanai, T; Ohno, T; Nakano, T				Kubota, Yoshiki; Kawamura, Hidemasa; Sakai, Makoto; Tsumuraya, Ryou; Tashiro, Mutsumi; Yusa, Ken; Kubo, Nobuteru; Sato, Hiro; Kawahara, Masahiro; Katoh, Hiroyuki; Kanai, Tatsuaki; Ohno, Tatsuya; Nakano, Takashi			Changes in Rectal Dose Due to Alterations in Beam Angles for Setup Uncertainty and Range Uncertainty in Carbon-Ion Radiotherapy for Prostate Cancer	PLOS ONE			English	Article							INTENSITY-MODULATED PROTON; RADIATION-THERAPY; ROBUST OPTIMIZATION; ALGORITHM; SPACER; MODEL	Background and Purpose Carbon-ion radiotherapy of prostate cancer is challenging in patients with metal implants in one or both hips. Problems can be circumvented by using fields at oblique angles. To evaluate the influence of setup and range uncertainties accompanying oblique field angles, we calculated rectal dose changes with oblique orthogonal field angles, using a device with fixed fields at 0 degrees and 90 degrees and a rotating patient couch. Material and Methods Dose distributions were calculated at the standard angles of 0 degrees and 90 degrees, and then at 30 degrees and 60 degrees. Setup uncertainty was simulated with changes from -2 mm to +2 mm for fields in the anterior-posterior, left-right, and cranial-caudal directions, and dose changes from range uncertainty were calculated with a 1 mm water-equivalent path length added to the target isocenter in each angle. The dose distributions regarding the passive irradiation method were calculated using the K2 dose algorithm. Results The rectal volumes with 0 degrees, 30 degrees, 60 degrees, and 90 degrees field angles at 95% of the prescription dose were 3.4 +/- 0.9 cm(3), 2.8 +/- 1.1 cm(3), 2.2 +/- 0.8 cm(3), and 3.8 +/- 1.1 cm(3), respectively. As compared with 90 degrees fields, 30 degrees and 60 degrees fields had significant advantages regarding setup uncertainty and significant disadvantages regarding range uncertainty, but were not significantly different from the 90 degrees field setup and range uncertainties. Conclusions The setup and range uncertainties calculated at 30 degrees and 60 degrees field angles were not associated with a significant change in rectal dose relative to those at 90 degrees.	[Kubota, Yoshiki; Kawamura, Hidemasa; Sakai, Makoto; Tsumuraya, Ryou; Tashiro, Mutsumi; Yusa, Ken; Kubo, Nobuteru; Sato, Hiro; Kawahara, Masahiro; Katoh, Hiroyuki; Kanai, Tatsuaki; Ohno, Tatsuya; Nakano, Takashi] Gunma Univ, Heavy Ion Med Ctr, Gunma, Japan	Gunma University	Kubota, Y (corresponding author), Gunma Univ, Heavy Ion Med Ctr, Gunma, Japan.	y_kubota@gunma-u.ac.jp	Sato, Hiro/GWU-7659-2022; Sakai, Makoto/AAW-1902-2020; Kubota, Yoshiki/ABI-7675-2020	Sakai, Makoto/0000-0001-9928-2375; Tashiro, Mutsumi/0000-0003-3253-0527	Grants-in-Aid for Scientific Research [26860396, 25670527, 25461905] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Bassler N, 2010, RADIOTHER ONCOL, V95, P87, DOI 10.1016/j.radonc.2010.02.026; Chan TCY, 2013, EUR J OPER RES, V231, P745, DOI 10.1016/j.ejor.2013.06.003; Christodouleas JP, 2013, MED DOSIM, V38, P315, DOI 10.1016/j.meddos.2013.03.002; Chu M, 2005, PHYS MED BIOL, V50, P5463, DOI 10.1088/0031-9155/50/23/003; Huang K, 2012, INT J RADIAT ONCOL, V84, P402, DOI 10.1016/j.ijrobp.2011.12.035; Inaniwa T, 2011, PHYS MED BIOL, V56, P4749, DOI 10.1088/0031-9155/56/15/008; Jakel O, 2007, PHYS MED BIOL, V52, P635, DOI 10.1088/0031-9155/52/3/007; Kanai T, 1999, INT J RADIAT ONCOL, V44, P201, DOI 10.1016/S0360-3016(98)00544-6; Kanematsu N, 2003, PHYS MED BIOL, V48, P1053, DOI 10.1088/0031-9155/48/8/307; Kanematsu N, 2008, MED PHYS, V35, P602, DOI 10.1118/1.2829878; Kanematsu N, 2007, MED PHYS, V34, P1907, DOI 10.1118/1.2733812; Kanematsu N, 2006, PHYS MED BIOL, V51, P4807, DOI 10.1088/0031-9155/51/19/006; Kanematsu N, 2011, PHYS MEDICA, V27, P97, DOI 10.1016/j.ejmp.2010.05.001; Kanematsu Nobuyuki, 2003, Igaku Butsuri, V23, P140; Kraft G, 2000, PROG PART NUCL PHYS, V45, pS473, DOI 10.1016/S0146-6410(00)00112-5; Kubota Y, 2015, J APPL CLIN MED PHYS, V16, P100, DOI 10.1120/jacmp.v16i4.5400; Kurosawa Yuji, 2012, Nihon Hoshasen Gijutsu Gakkai Zasshi, V68, P290; Liu W, 2012, MED PHYS, V39, P1079, DOI 10.1118/1.3679340; Mah D, 2002, INT J RADIAT ONCOL, V54, P568, DOI 10.1016/S0360-3016(02)03008-0; Ohno Tatsuya, 2011, Cancers (Basel), V3, P4046, DOI 10.3390/cancers3044046; RENNER TR, 1987, MED PHYS, V14, P825, DOI 10.1118/1.596009; Rucinski A, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0348-1; Tang SK, 2012, INT J RADIAT ONCOL, V83, P408, DOI 10.1016/j.ijrobp.2011.06.1974; Tashiro M, 2013, RADIOL PHYS TECHNOL, V6, P356, DOI 10.1007/s12194-013-0208-3; Weber DC, 2012, INT J RADIAT ONCOL, V84, pE311, DOI 10.1016/j.ijrobp.2012.03.028	25	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153894	10.1371/journal.pone.0153894	http://dx.doi.org/10.1371/journal.pone.0153894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097041	Green Published, gold			2022-12-27	WOS:000374543600067
J	van Lier, A; McDonald, SA; Bouwknegt, M; Kretzschmar, ME; Havelaar, AH; Mangen, MJJ; Wallinga, J; de Melker, HE				van Lier, Alies; McDonald, Scott A.; Bouwknegt, Martijn; Kretzschmar, Mirjam E.; Havelaar, Arie H.; Mangen, Marie-Josee J.; Wallinga, Jacco; de Melker, Hester E.		EPI Grp	Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011	PLOS ONE			English	Article							ADJUSTED LIFE YEARS; COMMUNITY-ACQUIRED PNEUMONIA; PUBLIC-HEALTH POLICY; LEGIONNAIRES-DISEASE; GLOBAL BURDEN; FUTURE BURDEN; HEPATITIS-B; EUROPE; PATHOGENS; PERTUSSIS	Background Infectious disease burden estimates provided by a composite health measure give a balanced view of the true impact of a disease on a population, allowing the relative impact of diseases that differ in severity and mortality to be monitored over time. This article presents the first national disease burden estimates for a comprehensive set of 32 infectious diseases in the Netherlands. Methods and Findings The average annual disease burden was computed for the period 2007-2011 for selected infectious diseases in the Netherlands using the disability-adjusted life years (DALY) measure. The pathogen-and incidence-based approach was adopted to quantify the burden due to both morbidity and premature mortality associated with all short and long-term consequences of infection. Natural history models, disease progression probabilities, disability weights, and other parameters were adapted from previous research. Annual incidence was obtained from statutory notification and other surveillance systems, which was corrected for under-ascertainment and under-reporting. The highest average annual disease burden was estimated for invasive pneumococcal disease (9444 DALYs/year; 95% uncertainty interval [UI]: 8911-9961) and influenza (8670 DALYs/year; 95% UI: 8468-8874), which represents 16% and 15% of the total burden of all 32 diseases, respectively. The remaining 30 diseases ranked by number of DALYs/year from high to low were: HIV infection, legionellosis, toxoplasmosis, chlamydia, campylobacteriosis, pertussis, tuberculosis, hepatitis C infection, Q fever, norovirus infection, salmonellosis, gonorrhoea, invasive meningococcal disease, hepatitis B infection, invasive Haemophilus influenzae infection, shigellosis, listeriosis, giardiasis, hepatitis A infection, infection with STEC O157, measles, cryptosporidiosis, syphilis, rabies, variant Creutzfeldt-Jakob disease, tetanus, mumps, rubella, diphtheria, and poliomyelitis. The very low burden for the latter five diseases can be attributed to the National Immunisation Programme. The average disease burden per individual varied from 0.2 (95% UI: 0.1-0.4) DALYs per 100 infections for giardiasis, to 5081 and 3581 (95% UI: 3540-3611) DALYs per 100 infections for rabies and variant Creutz-feldt-Jakob disease, respectively. Conclusions For guiding and supporting public health policy decisions regarding the prioritisation of interventions and preventive measures, estimates of disease burden and the comparison of burden between diseases can be informative. Although the collection of disease-specific parameters and estimation of incidence is a process subject to continuous improvement, the current study established a baseline for assessing the impact of future public health initiatives.	[van Lier, Alies; McDonald, Scott A.; Bouwknegt, Martijn; Kretzschmar, Mirjam E.; Mangen, Marie-Josee J.; Wallinga, Jacco; de Melker, Hester E.; EPI Grp] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands; [Kretzschmar, Mirjam E.; Mangen, Marie-Josee J.] UMCU, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Havelaar, Arie H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	Netherlands National Institute for Public Health & the Environment; Unilever; Utrecht University; Utrecht University Medical Center; State University System of Florida; University of Florida	McDonald, SA (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control, Bilthoven, Netherlands.	scott.mcdonald@rivm.nl	Wallinga, Jacco/C-4382-2018; Siebert, Uwe/M-5057-2019; Havelaar, Arie H./P-8495-2014; Cassini, Alessandro/A-5122-2019; Ricciardi, Walter/K-3342-2018	Wallinga, Jacco/0000-0003-1725-5627; Siebert, Uwe/0000-0001-6425-7671; Havelaar, Arie H./0000-0002-6456-5460; Cassini, Alessandro/0000-0002-7973-6445; Colzani, Edoardo/0000-0001-8105-5027; de Wit, G. Ardine/0000-0002-1375-7657; Mangen, Marie-Josee J./0000-0001-8914-2045; Ricciardi, Walter/0000-0002-5655-688X; Franco, Elisabetta/0000-0002-1179-4411; Friesema, Ingrid/0000-0001-9943-0518; Kretzschmar, Mirjam/0000-0002-4394-7697	National Institute for Public Health and the Environment (RIVM); Pfizer; National Institute for Public Health and the Environment (RIVM); Pfizer	National Institute for Public Health and the Environment (RIVM); Pfizer(Pfizer); National Institute for Public Health and the Environment (RIVM); Pfizer(Pfizer)	This study was supported by the National Institute for Public Health and the Environment (RIVM). No additional funding has been acquired. M-JM's research funding is partially supported by grants provided to UMCU by Pfizer. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink F, 2004, 210021001 RIVM; [Anonymous], EURO SURVEILL; Beaute J, 2013, EUROSURVEILLANCE, V18, P6; Beaute J, 2013, EUR RESPIR J, V42, P1454, DOI 10.1183/09031936.00089113; Beaute J, 2012, EMERG INFECT DIS, V18, P1811, DOI 10.3201/eid1811.120496; Begg S., 2007, BURDEN DIS INJURY AU; Bijkerk P, 2013, 150205001 RIVM; Bouwknegt M, 2013, INT J ENV RES PUB HE, V10, P2888, DOI 10.3390/ijerph10072888; Bradshaw D, 2003, SAMJ S AFR MED J, V93, P682; Brandsema PS, 2014, EPIDEMIOL INFECT, V142, P2360, DOI 10.1017/S0950268813003476; Braun J J, 2004, Ned Tijdschr Geneeskd, V148, P836; Bundhamcharoen K, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-53; Cassini A, 2013, LANCET S2, V381, pS27; Crowcroft NS, 2002, ARCH DIS CHILD, V86, P336, DOI 10.1136/adc.86.5.336; de Wit GA, 2015, SEX TRANSM INFECT; Devleesschauwer B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1196; Devleesschauwer B, 2014, INT J PUBLIC HEALTH, V59, P565, DOI 10.1007/s00038-014-0552-z; European Centre for Disease Prevention and Control, 2010, METH PROT EST BURD C; European Centre for Disease Prevention and Control (ECDC), 2011, CURR FUT BURD COMM D; European Centre for Disease Prevention and Control (ECDC)/WHO Regional Office for Europe, 2012, TUB SURV MON EUR 201; Evaluation team RIVM, 2010, 210261008 RIVM; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Gold MR, 2002, MED CARE, V40, P260, DOI 10.1097/00005650-200203000-00009; Gommer AM, 2010, VERLOREN LEVENSJAREN; Haagsma JA, 2009, 330331001 RIVM; Hahne S, 2005, EUROSURVEILLANCE, V10; Hahne S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067866; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Jankovic S, 2007, EUR J PUBLIC HEALTH, V17, P80, DOI 10.1093/eurpub/ckl072; Karagiannis I, 2009, EPIDEMIOL INFECT, V137, P181, DOI 10.1017/S095026880800099X; Knol MJ, 2013, EUROSURVEILLANCE, V18; Kramer MA, 2008, INFECTIEZIEKTENBULLE, V19, P161; Kretzschmar M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001205; Kwong JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044103; Lai T, 2009, EUR J PUBLIC HEALTH, V19, P541, DOI 10.1093/eurpub/ckp038; Lobue P, 2010, RESPIROLOGY, V15, P603, DOI 10.1111/j.1440-1843.2010.01751.x; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; Mangen MJJ, 2014, 210474001 RIVM; Mathers CD, 2001, B WORLD HEALTH ORGAN, V79, P1076; McDonald SA, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1046; McKenna MT, 2005, AM J PREV MED, V28, P415, DOI 10.1016/j.amepre.2005.02.009; Melse JM, 1998, 431501028 RIVM; Mokdad AH, 2014, LANCET, V383, P309, DOI 10.1016/S0140-6736(13)62189-3; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 1996, GLOBAL BURDEN DIS; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P495; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Naghavi M, 2003, POPUL HEALTH METR, V7, P9, DOI DOI 10.1186/1478-7954-7-9; Plass D, 2014, EPIDEMIOL INFECT, V142, P2024, DOI 10.1017/S0950268813003312; Plass D, 2014, DTSCH ARZTEBL INT, V111, P629, DOI 10.3238/arztebl.2014.0629; Public Health Group, 2005, VICT BURD DIS STUD M; Rahamat-Langendoen J, 2006, 210211003 RIVM; Schmid BV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058674; Schneeberger PM, 2004, SCAND J INFECT DIS, V36, P269, DOI 10.1080/00365540410020127; Slump E, 2012, TUBERCULOSE IN NEDER; Soetens LC, 2013, 150002003 RIVM; Statistics Netherlands (CBS), 2007, DEATHS MAIN PRIM CAU; Stout JE, 1997, NEW ENGL J MED, V337, P682, DOI 10.1056/NEJM199709043371006; van den Hof S, 2001, EMERG INFECT DIS, V7, P593; van den Hof S, 1998, 213676008 RIVM; van den Wijngaard CC, EUR J PUBLIC H UNPUB; van der Hoek W, 2012, EUROSURVEILLANCE, V17, P11; van der Maas NAT, 2013, VACCINE, V31, P4541, DOI 10.1016/j.vaccine.2013.07.060; van Deursen AMM, 2012, EMERG INFECT DIS, V18, P1729, DOI 10.3201/eid1811.120329; van Lier A, 2014, STATE INFECT DIS NET; van Lier E Alies, 2009, Ned Tijdschr Geneeskd, V153, P950; von Baum H, 2008, CLIN INFECT DIS, V46, P1356, DOI 10.1086/586741; Vose D., 2008, RISK ANAL QUANTITATI; Wiersinga WJ, 2011, DUTCH GUIDELINES ON; World Health Organization, 2008, GLOB BURD DIS 2004 U	71	52	53	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153106	10.1371/journal.pone.0153106	http://dx.doi.org/10.1371/journal.pone.0153106			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097024	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600027
J	Valdovinos-Flores, C; Gaspar-Ramirez, O; Heras-Ramirez, ME; Lara-Alvarez, C; Dorantes-Ugalde, JA; Saldana-Loza, LM				Valdovinos-Flores, Cesar; Gaspar-Ramirez, Octavio; Elena Heras-Ramirez, Maria; Lara-Alvarez, Carlos; Antonio Dorantes-Ugalde, Jose; Maria Saldana-Loza, Luz			Boron and Coumaphos Residues in Hive Materials Following Treatments for the Control of Aethina tumida Murray	PLOS ONE			English	Article							COLEOPTERA; BEETLE; FOODS	In the search of alternatives for controlling Aethina tumida Murray, we recently proposed the BAA trap which uses boric acid and an attractant which mimics the process of fermentation caused by Kodamaea ohmeri in the hive. This yeast is excreted in the feces of A. tumida causing the fermentation of pollen and honey of infested hives and releasing compounds that function as aggregation pheromones to A. tumida. Since the boron is the toxic element in boric acid, the aim of this article is to assess the amount of boron residues in honey and beeswax from hives treated with the BAA trap. For this aim, the amount of bioaccumulated boron in products of untreated hives was first determined and then compared with the amount of boron of products from hives treated with the BAA trap in two distinct climatic and soil conditions. The study was conducted in the cities of Padilla, Tamaulipas, and Valladolid, Yucatan (Mexico) from August 2014 to March 2015. The quantity of boron in honey was significantly less in Yucatan than in Tamaulipas; this agrees with the boron deficiency among Luvisol and Leptosol soils found in Yucatan compared to the Vertisol soil found in Tamaulipas. In fact, the honey from Yucatan has lower boron levels than those reported in the literature. The BAA treatment was applied for four months, results show that the BAA trap does not have any residual effect in either honey or wax; i.e., there is no significant difference in boron content before and after treatment. On the other hand, the organophosphate pesticide coumaphos was found in 100% of wax samples and in 64% of honey samples collected from Yucatan. The concentration of coumaphos in honey ranges from 0.005 to 0.040 mg/kg, which are below Maximum Residue Limit (MRL) allowed in the European Union (0.1 mg/kg) but 7.14% of samples exceeded the MRL allowed in Canada (0.02 mg/kg).	[Valdovinos-Flores, Cesar] Univ Nacl Autonoma Mexico, Dept Med Genom & Toxicol Ambiental, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Gaspar-Ramirez, Octavio; Elena Heras-Ramirez, Maria] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Noroeste Apodaca, Nuevo Leon, Mexico; [Lara-Alvarez, Carlos] Ctr Invest Matemat, Unidad Zacatecas, Zacatecas, Mexico; [Antonio Dorantes-Ugalde, Jose; Maria Saldana-Loza, Luz] Serv Apicolas Queretaro, Queretaro, Mexico	Universidad Nacional Autonoma de Mexico	Lara-Alvarez, C (corresponding author), Ctr Invest Matemat, Unidad Zacatecas, Zacatecas, Mexico.	carlos.lara@cimat.mx	Lara-Alvarez, Carlos A/I-2214-2017; Lara-Alvarez, Carlos/AAC-1374-2019	Lara-Alvarez, Carlos A/0000-0001-7856-7398; Lara-Alvarez, Carlos/0000-0001-7856-7398; Valdovinos-Flores, Cesar/0000-0002-8153-5394	Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA); Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT) [CATEDRAS-3163]	Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA); Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Funding was received from Secretaria de Agriculture, Ganaderia, Desarrollo Rural, Pesca y Alimentacion, Mexico (SAGARPA). The work was partially supported by grant CATEDRAS-3163 from Consejo Nacional de Ciencia y Tecnologia, Mexico (CONACYT), http://www.conacyt.mx (to CLA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency CPMR, 2009, EMRL200918 AG CPMR P; ALCANTARA EA, 2007, SOIL FERTILITY CALCA; Anderson David L., 1994, Journal of Food Composition and Analysis, V7, P59, DOI 10.1006/jfca.1994.1006; [Anonymous], 2014, NOM000SAGZOO2014; Berry JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076536; Buchholz S, 2008, J APICULT RES, V47, P202, DOI 10.1080/00218839.2008.11101460; CHENG C, 1993, DEV PLANT SOIL SCI, V45, P405; CICOPLAFEST, 2004, CAT OF PLAG; Eischen FA, 1999, AM BEE J US; EPA (Environmental Protection Agency), 2008, 815R08012 EPA; EPA (Environmental Protection Agency), 2007, COUM HUM HLTH RISK A; Gobierno del Estado de Tamaulipas, 2011, ATL RIEG MUN GUEM HI; Haarmann T, 2002, J ECON ENTOMOL, V95, P28, DOI 10.1603/0022-0493-95.1.28; Harari R, 2010, ENVIRON HEALTH PERSP, V118, P890, DOI 10.1289/ehp.0901582; Hood WMM, 2004, BEE WORLD, V85, P51, DOI 10.1080/0005772X.2004.11099624; HUNT CD, 1991, J AM DIET ASSOC, V91, P558; INEGI, 2009, PRONT INF GEOGR MUN; Kamel F, 2004, ENVIRON HEALTH PERSP, V112, P950, DOI 10.1289/ehp.7135; Karazafiris E, 2008, PEST MANAG SCI, V64, P165, DOI 10.1002/ps.1493; Lehotay SJ, 2007, J AOAC INT, V90, P485; Lloyd J. E., 2002, AM BEETLES VOLUME 2, P187; Mutinelli F, 2014, J APICULT RES, V53, P569, DOI 10.3896/IBRA.1.53.5.13; Nastassiades M, 2002, 18 ANN WAST TEST QUA, P231; Neumann P, 2004, APIDOLOGIE, V35, P229, DOI 10.1051/apido:2004010; Neumann P, 2008, J APICULT RES, V47, P181, DOI 10.1080/00218839.2008.11101453; Norma Oficial Mexicana, 1995, NOM117SSA11994; Reyes-Escobar O, 2015, J APICULT RES, V54, P226, DOI 10.1080/00218839.2015.1137704; Saldana L.M, 2014, MANUAL NUEVOS MANEJO; SERA, 2006, HUM HLTH EC RISK ASS; SIACON (Sistema de Informacin Agroalimentaria de Consulta), 2010, BAS DAT ACT AGR PEC; Siede R, 2013, J APPL ENTOMOL, V137, P661, DOI 10.1111/jen.12048; Spiewok S, 2006, J APICULT RES, V45, P47, DOI 10.1080/00218839.2006.11101313; Torto B, 2007, P NATL ACAD SCI USA, V104, P8374, DOI 10.1073/pnas.0702813104; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547	34	11	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153551	10.1371/journal.pone.0153551	http://dx.doi.org/10.1371/journal.pone.0153551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092938	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200028
J	Cavuoto, LA; Maikala, RV				Cavuoto, Lora A.; Maikala, Rammohan V.			Obesity and the Role of Short Duration Submaximal Work on Cardiovascular and Cerebral Hemodynamics	PLOS ONE			English	Article							HEART-RATE RECOVERY; BLOOD-FLOW; EXERCISE; HEALTHY; ASSOCIATION; RESPONSES; DISEASE; TIME; MEN; BMI	The objective of this study was to compare gas exchange, cardiac and cerebral hemodynamic responses between 10 non-obese and 10 obese men during submaximal work. With the increasing prevalence of obesity, there is a need to understand the impact of obesity on work-induced responses. Participants completed a step-wise incremental cycling until they reached 60% of their age-predicted maximum heart rate. Gas exchange, cardiac and prefrontal cortex hemodynamic responses were simultaneously measured during rest, work, and recovery. The non-obese group reached similar to 43% of their predicted maximal aerobic capacity as compared to similar to 34% in the obese group, with the non-obese working at a relatively higher workload and for more duration than the obese. The obese had elevated baseline heart rate and reduced whole-body oxygen uptake per body weight at baseline and task termination. Other cardiac and cerebral responses, although increased from baseline, were similar between groups during submaximal effort. In the obese, during recovery oxygen uptake and heart-rate recovery were slowest; cardiac output and rate pressure product were greatest, and left ventricle ejection time was shortest. However, both groups exhibited similar cerebral hemodynamics during recovery. These finding imply that, irrespective of their low aerobic fitness, obesity does not impair myocardial performance and cerebrovascular function during graded submaximal work, however, recovery from a short duration of work was influenced by their fitness level. Since a majority of activities of daily living are performed at individual's submaximal level, understanding influence of obesity on submaximal work is critical.	[Cavuoto, Lora A.] Univ Buffalo, Ind & Syst Engn, Buffalo, NY 14260 USA; [Maikala, Rammohan V.] Providence Reg Med Ctr, Providence Strateg & Management Serv, Everett, WA 98201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Cavuoto, LA (corresponding author), Univ Buffalo, Ind & Syst Engn, Buffalo, NY 14260 USA.	loracavu@buffalo.edu	Cavuoto, Lora/F-4295-2016	Cavuoto, Lora/0000-0003-4717-8378	American Society of Safety Engineers (ASSE) Foundation-Liberty Mutual Safety Research Fellowship	American Society of Safety Engineers (ASSE) Foundation-Liberty Mutual Safety Research Fellowship	This work was supported by the American Society of Safety Engineers (ASSE) Foundation-Liberty Mutual Safety Research Fellowship awarded to the first author. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2008, PHYSIOL REV, V88, P389, DOI 10.1152/physrev.00017.2007; ALEXANDE.JK, 1972, CIRCULATION, V45, P310, DOI 10.1161/01.CIR.45.2.310; ALPERT MA, 1989, AM J CARDIOL, V63, P1478, DOI 10.1016/0002-9149(89)90012-X; Arena R, 2014, PROG CARDIOVASC DIS, V56, P457, DOI 10.1016/j.pcad.2013.08.001; Lins TCB, 2015, REV PORT CARDIOL, V34, P27, DOI 10.1016/j.repc.2014.07.006; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; BOUDOULAS H, 1990, EUR HEART J, V11, P93, DOI 10.1093/eurheartj/11.suppl_I.93; Cavuoto LA, 2015, EUR J APPL PHYSIOL, V115, P1905, DOI 10.1007/s00421-015-3171-3; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; DEDIVITIIS O, 1981, CIRCULATION, V64, P477, DOI 10.1161/01.CIR.64.3.477; Dimkpa U, 2010, EUR J APPL PHYSIOL, V108, P695, DOI 10.1007/s00421-009-1276-2; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franco RL, 2013, EUR J APPL PHYSIOL, V113, P2015, DOI 10.1007/s00421-013-2626-7; GOBEL FL, 1978, CIRCULATION, V57, P549, DOI 10.1161/01.CIR.57.3.549; Gondoni LA, 2009, NUTR METAB CARDIOVAS, V19, P170, DOI 10.1016/j.numecd.2008.07.001; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Goran M, 2000, INT J OBESITY, V24, P841, DOI 10.1038/sj.ijo.0801241; Hansen D, 2014, OBES REV, V15, P894, DOI 10.1111/obr.12202; Ide K, 1999, J APPL PHYSIOL, V87, P1604, DOI 10.1152/jappl.1999.87.5.1604; IMAI K, 1994, J AM COLL CARDIOL, V24, P1529, DOI 10.1016/0735-1097(94)90150-3; JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152; Karabulut M, 2017, CLIN PHYSIOL FUNCT I, V37, P1, DOI 10.1111/cpf.12258; Karason K, 1998, OBES RES, V6, P422, DOI 10.1002/j.1550-8528.1998.tb00374.x; Lafortuna CL, 2008, EUR J APPL PHYSIOL, V103, P707, DOI 10.1007/s00421-008-0758-y; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Levinger I, 2009, J STRENGTH COND RES, V23, P1548, DOI 10.1519/JSC.0b013e3181a026e5; LICATA G, 1991, INT J OBESITY, V15, P295; Mathew B, 2008, J AM BOARD FAM MED, V21, P562, DOI 10.3122/jabfm.2008.06.080080; MERTENS H M, 1981, Clinical Cardiology, V4, P22; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nobrega ACL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/478965; PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; Rooks CR, 2010, PROG NEUROBIOL, V92, P134, DOI 10.1016/j.pneurobio.2010.06.002; Salvadori A, 1999, RESPIRATION, V66, P25, DOI 10.1159/000029333; SAVIN WM, 1982, J APPL PHYSIOL, V53, P1572, DOI 10.1152/jappl.1982.53.6.1572; Secher NH, 2008, J APPL PHYSIOL, V104, P306, DOI 10.1152/japplphysiol.00853.2007; Wang GJ, 2008, OBESITY, V16, pS88, DOI 10.1038/oby.2008.469; Wasserman K., 2012, PRINCIPLES EXERCISE, V1, P8; White WB, 1999, AM J HYPERTENS, V12, p50S, DOI 10.1016/S0895-7061(98)00280-5; WILLEMS JL, 1970, CIRCULATION, V42, P37, DOI 10.1161/01.CIR.42.1.37; Willeumier KC, 2011, OBESITY, V19, P1095, DOI 10.1038/oby.2011.16	43	3	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153826	10.1371/journal.pone.0153826	http://dx.doi.org/10.1371/journal.pone.0153826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088872	Green Published, gold			2022-12-27	WOS:000374527000053
J	Hames, SC; Ardigo, M; Soyer, HP; Bradley, AP; Prow, TW				Hames, Samuel C.; Ardigo, Marco; Soyer, H. Peter; Bradley, Andrew P.; Prow, Tarl W.			Automated Segmentation of Skin Strata in Reflectance Confocal Microscopy Depth Stacks	PLOS ONE			English	Article								Reflectance confocal microscopy (RCM) is a powerful tool for in-vivo examination of a variety of skin diseases. However, current use of RCM depends on qualitative examination by a human expert to look for specific features in the different strata of the skin. Developing approaches to quantify features in RCM imagery requires an automated understanding of what anatomical strata is present in a given en-face section. This work presents an automated approach using a bag of features approach to represent en-face sections and a logistic regression classifier to classify sections into one of four classes (stratum corneum, viable epidermis, dermal-epidermal junction and papillary dermis). This approach was developed and tested using a dataset of 308 depth stacks from 54 volunteers in two age groups (2030 and 50-70 years of age). The classification accuracy on the test set was 85.6%. The mean absolute error in determining the interface depth for each of the stratum corneum/viable epidermis, viable epidermis/dermal-epidermal junction and dermal-epidermal junction/papillary dermis interfaces were 3.1 mu m, 6.0 mu m and 5.5 mu m respectively. The probabilities predicted by the classifier in the test set showed that the classifier learned an effective model of the anatomy of human skin.	[Hames, Samuel C.; Soyer, H. Peter; Prow, Tarl W.] Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia; [Ardigo, Marco] San Gallicano Dermatol Inst IRCCS, Rome, Italy; [Bradley, Andrew P.] Univ Queensland, Sch Informat Technol & Elect Engn, Brisbane, Qld, Australia	University of Queensland; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); University of Queensland	Prow, TW (corresponding author), Univ Queensland, Sch Med, Dermatol Res Ctr, Translat Res Inst, Brisbane, Qld, Australia.	t.prow@uq.edu.au	Bradley, Andrew P./C-5685-2009; Ardigo, Marco/E-5741-2018; Bradley, Andrew P./O-8516-2019; Soyer, H. Peter/W-3791-2017; Soyer, H. Peter/E-6000-2010; Prow, Tarl/AAB-8359-2019; Prow, Tarl W/A-4764-2010	Bradley, Andrew P./0000-0003-0109-6844; Ardigo, Marco/0000-0002-5772-4937; Bradley, Andrew P./0000-0003-0109-6844; Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; Prow, Tarl/0000-0003-2892-6238; Prow, Tarl W/0000-0003-2892-6238	Cancer Council Queensland [APP1058641]	Cancer Council Queensland(Cancer Council Queensland)	This work was supported by Cancer Council Queensland (www.cancerqld.org.au) through grant APP1058641. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avni U, 2011, IEEE T MED IMAGING, V30, P733, DOI 10.1109/TMI.2010.2095026; Caicedo JC, 2009, LECT NOTES ARTIF INT, V5651, P126, DOI 10.1007/978-3-642-02976-9_17; Coates Adam, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P561, DOI 10.1007/978-3-642-35289-8_30; Dhillon IS, 2001, MACH LEARN, V42, P143, DOI 10.1023/A:1007612920971; Fulkerson B, 2008, LECT NOTES COMPUT SC, V5302, P179, DOI 10.1007/978-3-540-88682-2_15; Gareau D, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3552639; Gareau D, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3524301; Gerger A, 2005, J INVEST DERMATOL, V124, P493, DOI 10.1111/j.0022-202X.2004.23569.x; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Hames S, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.rg58m, DOI 10.5061/DRYAD.RG58M]; Hames S, 2015, DIG IM COMP IN PRESS; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Koller S, 2011, J EUR ACAD DERMATOL, V25, P554, DOI 10.1111/j.1468-3083.2010.03834.x; Koller S, 2009, EXP DERMATOL, V18, P536, DOI 10.1111/j.1600-0625.2008.00822.x; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kurugol S, 2015, J INVEST DERMATOL, V135, P710, DOI 10.1038/jid.2014.379; Nguyen MH, 2009, IEEE I CONF COMP VIS, P1925, DOI 10.1109/ICCV.2009.5459426; Ng A. Y., 2004, P 21 INT C MACH LEAR, DOI [10.1145/1015330.1015435, DOI 10.1145/1015330.1015435]; Nister D., 2006, IEEE COMP SOC C COMP, P2161, DOI DOI 10.1109/CVPR.2006.264; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Puig S, 2012, REFLECTANCE CONFOCAL, P23; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Raphael AP, 2013, EXP DERMATOL, V22, P458, DOI 10.1111/exd.12176; Somoza E, 2014, LECT NOTES COMPUT SC, V8815, P141, DOI 10.1007/978-3-319-11755-3_16; Tamaki T, 2013, MED IMAGE ANAL, V17, P78, DOI 10.1016/j.media.2012.08.003; Wurm EMT, 2012, BRIT J DERMATOL, V167, P270, DOI 10.1111/j.1365-2133.2012.10943.x	26	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153208	10.1371/journal.pone.0153208	http://dx.doi.org/10.1371/journal.pone.0153208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088865	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000013
J	Krishna, KH; Vadlamudi, Y; Kumar, MS				Krishna, K. Hari; Vadlamudi, Yallamandayya; Kumar, Muthuvel Suresh			Viral Evolved Inhibition Mechanism of the RNA Dependent Protein Kinase PKR's Kinase Domain, a Structural Perspective	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; HUMAN-IMMUNODEFICIENCY-VIRUS; MOLECULAR-DYNAMICS; ENERGY LANDSCAPES; ANTIRETROVIRAL THERAPY; SUBSTRATE RECOGNITION; HIGH-THROUGHPUT; WEB SERVER; ACTIVATION; EIF2-ALPHA	The protein kinase PKR activated by viral dsRNA, phosphorylates the eIF2 alpha, which inhibit the mechanism of translation initiation. Viral evolved proteins mimicking the eIF2 alpha block its phosphorylation and help in the viral replication. To decipher the molecular basis for the PKR's substrate and inhibitor interaction mechanisms, we carried the molecular dynamics studies on the catalytic domain of PKR in complex with substrate eIF2 alpha a, and inhibitors TAT and K3L. The studies conducted show the altered domain movements of N lobe, which confers open and close state to the substrate-binding cavity. In addition, PKR exhibits variations in the secondary structural transition of the activation loop residues, and inter molecular contacts with the substrate and the inhibitors. Phosphorylation of the P+1 loop at the Thr-451 increases the affinity of the binding proteins exhibiting its role in the phosphorylation events. The implications of structural mechanisms uncovered will help to understand the basis of the evolution of the host-viral and the viral replication mechanisms.	[Krishna, K. Hari; Vadlamudi, Yallamandayya; Kumar, Muthuvel Suresh] Pondicherry Univ, Ctr Bioinformat, Pondicherry, India	Pondicherry University	Kumar, MS (corresponding author), Pondicherry Univ, Ctr Bioinformat, Pondicherry, India.	suresh.bic@pondiuni.edu.in		Hari Krishna, K/0000-0001-7037-7485; Hari Krishna, K/0000-0001-8676-2046				Alakent B, 2004, J CHEM PHYS, V121, P4759, DOI 10.1063/1.1778377; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; Boehm M, 1998, SOLUTION ST IN PRESS; Brand SR, 1997, J BIOL CHEM, V272, P8388, DOI 10.1074/jbc.272.13.8388; Cai RR, 2000, ARCH BIOCHEM BIOPHYS, V373, P361, DOI 10.1006/abbi.1999.1583; Cheshire JL, 1999, J BIOL CHEM, V274, P4801, DOI 10.1074/jbc.274.8.4801; Clemens MJ, 2004, ONCOGENE, V23, P3180, DOI 10.1038/sj.onc.1207544; Cole JL, 2007, TRENDS BIOCHEM SCI, V32, P57, DOI 10.1016/j.tibs.2006.12.003; COX S, 1994, CURR OPIN STRUC BIOL, V4, P893, DOI 10.1016/0959-440X(94)90272-0; Dar AC, 2005, CELL, V122, P887, DOI 10.1016/j.cell.2005.06.044; Dar AC, 2002, MOL CELL, V10, P295, DOI 10.1016/S1097-2765(02)00590-7; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Esterhuyse T, 1993, Nurs RSA, V8, P14; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Greub G, 2000, LANCET, V356, P1800, DOI 10.1016/S0140-6736(00)03232-3; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2000, PHYS REV E, V62, P8438, DOI 10.1103/PhysRevE.62.8438; Hinnebusch AG, 2005, NAT STRUCT MOL BIOL, V12, P835, DOI 10.1038/nsmb1005-835; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; ICHIYE T, 1991, PROTEINS, V11, P205, DOI 10.1002/prot.340110305; Ito T, 2004, STRUCTURE, V12, P1693, DOI 10.1016/j.str.2004.07.010; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KawagishiKobayashi M, 1997, MOL CELL BIOL, V17, P4146, DOI 10.1128/MCB.17.7.4146; Kumari R, 2014, J CHEM INF MODEL, V54, P1951, DOI 10.1021/ci500020m; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Loo YM, 2007, CURR TOP MICROBIOL, V316, P295; Margreitter C, 2013, NUCLEIC ACIDS RES, V41, pW422, DOI 10.1093/nar/gkt416; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCMILLAN NAJ, 1995, VIROLOGY, V213, P413, DOI 10.1006/viro.1995.0014; MEURS E, 1990, CELL, V62, P379, DOI 10.1016/0092-8674(90)90374-N; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petrov D, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003154; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Romano PR, 1998, MOL CELL BIOL, V18, P2282, DOI 10.1128/MCB.18.4.2282; Sharp TV, 1997, EUR J BIOCHEM, V250, P85, DOI 10.1111/j.1432-1033.1997.00085.x; Tavernelli I, 2003, BIOPHYS J, V85, P2641, DOI 10.1016/S0006-3495(03)74687-6; Taylor SS, 2005, CELL, V122, P823, DOI 10.1016/j.cell.2005.09.007; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Wales DJ, 2005, PHYS BIOL, V2, pS86, DOI 10.1088/1478-3975/2/4/S02; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wriggers W, 1997, PROTEINS, V29, P1; Zhang F, 2001, J BIOL CHEM, V276, P24946, DOI 10.1074/jbc.M102108200	59	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153680	10.1371/journal.pone.0153680	http://dx.doi.org/10.1371/journal.pone.0153680			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088597	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000041
J	Yan, B; Yang, LM; Hao, LP; Yang, C; Quan, L; Wang, LH; Wu, Z; Li, XP; Gao, YT; Sun, Q; Yuan, JM				Yan, Bei; Yang, Li-Ming; Hao, Li-Peng; Yang, Chen; Quan, Lei; Wang, Li-Hong; Wu, Zheng; Li, Xiao-Pan; Gao, Yu-Tang; Sun, Qiao; Yuan, Jian-Min			Determinants of Quality of Life for Breast Cancer Patients in Shanghai, China	PLOS ONE			English	Article							LONG-TERM; SOCIAL SUPPORT; FUNCTIONAL ASSESSMENT; SURVIVORS; THERAPY; WOMEN; CHEMOTHERAPY; MEDICINE; POPULATION; DIAGNOSIS	Purpose To evaluate the association of social support status, health insurance and clinical factors with the quality of life of Chinese women with breast cancer. Methods Information on demographics, clinical characteristics, and social support status was collected from 1,160 women with newly diagnosed breast cancer in Shanghai, China. The Perceived Social Support Scale was used to assess different sources of social support for breast cancer patients. The quality of life was evaluated using the Functional Assessment of Cancer Therapy-Breast Cancer that consisted of five domains: breast cancer-specific, emotional, functional, physical, and social & family well-being. Multivariate linear regression models were used to evaluate the associations of demographic variables, clinical characteristics, and social support status with the quality of life measures. Results Adequate social support from family members, friends and neighbors, and higher scores of Perceived Social Support Scale were associated with significantly improved quality of life of breast cancer patients. Higher household income, medical insurance plans with low copayment, and treatment with traditional Chinese medicine for breast cancer all were associated with higher (better) scores of quality of life measures whereas patients receiving chemotherapy had significantly lower scores of quality of life. Conclusion Social support and financial aids may significantly improve the quality of life of breast cancer survivors.	[Yan, Bei; Yang, Li-Ming; Hao, Li-Peng; Yang, Chen; Wang, Li-Hong; Wu, Zheng; Li, Xiao-Pan; Sun, Qiao] Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China; [Yan, Bei; Quan, Lei; Yuan, Jian-Min] Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA; [Quan, Lei] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510641, Guangdong, Peoples R China; [Gao, Yu-Tang] Shanghai Jiao Tong Univ, Dept Epidemiol, Shanghai Canc Inst, Renji Hosp, Shanghai 200030, Peoples R China; [Yuan, Jian-Min] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA	Shanghai Center for Disease Control & Prevention; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; South China University of Technology; Shanghai Jiao Tong University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sun, Q (corresponding author), Shanghai Pudong New Area Ctr Dis Control & Preven, Shanghai, Peoples R China.; Yuan, JM (corresponding author), Univ Pittsburgh, Inst Canc, Div Canc Control & Populat Sci, Pittsburgh, PA USA.; Yuan, JM (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA.	qsun@pdcdc.sh.cn; yuanj@upmc.edu	Quan, Lei/GXN-1280-2022; Gao, Y./GWZ-3665-2022; Gao, Yu/HGE-1937-2022; Li, xiaopan/X-5965-2019; gao, yi/HCI-8298-2022	Li, xiaopan/0000-0002-9625-478X; 	Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai [PWRq2012-24]; National Cancer Institute of the National Institutes of Health [R01CA144034, UM1CA182876]; Pudong Health and Family Planning Commission of Shanghai Funding;  [PWZz2013-15]; NATIONAL CANCER INSTITUTE [UM1CA182876, R01CA144034] Funding Source: NIH RePORTER	Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Pudong Health and Family Planning Commission of Shanghai Funding; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by award number PWRq2012-24 of the Young Medical Talents Training Program of the Pudong Health Bureau of Shanghai (BY). Research reported in this publication was also partially supported by the National Cancer Institute of the National Institutes of Health under award numbers R01CA144034 and UM1CA182876 (J-MY). Grant number: PWZz2013-15. Funding agency: Pudong Health and Family Planning Commission of Shanghai Funding to QS.	Ahles TA, 2005, J CLIN ONCOL, V23, P4399, DOI 10.1200/JCO.2005.03.343; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P2335; Allemani C, 2014, LANCET, DOI S0140-6736(14)62038-9; [Anonymous], 1996, J CLIN ONCOL, V14, P671; Ashing-Giwa K, 1999, CANCER, V85, P418, DOI 10.1002/(SICI)1097-0142(19990115)85:2<418::AID-CNCR20>3.0.CO;2-9; Baker F, 2005, CANCER, V104, P2565, DOI 10.1002/cncr.21488; Bloom JR, 2007, PSYCHO-ONCOLOGY, V16, P691, DOI 10.1002/pon.1208; Bloom JR, 2004, PSYCHO-ONCOL, V13, P147, DOI 10.1002/pon.794; Brady MJ, 1997, J CLIN ONCOL, V15, P974, DOI 10.1200/JCO.1997.15.3.974; Broeckel JA, 2000, BREAST CANCER RES TR, V62, P141, DOI 10.1023/A:1006401914682; Cancer IAFRO, 2012, GLOBOCAN 2012 EST CA; Carlsson M, 1996, QUAL LIFE RES, V5, P265, DOI 10.1007/BF00434748; Casso D, 2004, HEALTH QUAL LIFE OUT, V2, P1; CELLA DF, 1994, J PAIN SYMPTOM MANAG, V9, P186, DOI 10.1016/0885-3924(94)90129-5; Cella DF, 1993, J CLIN ONCOL, V11, P5709; Costanzo ES, 2007, BRIT J CANCER, V97, P1625, DOI 10.1038/sj.bjc.6604091; Ediebah DE, 2014, BRIT J CANCER, V110, P2427, DOI 10.1038/bjc.2014.208; Fang QY, 2012, CHIN J SOCIAL MED, V295, P333; Ferrell BR, 1997, CANCER NURS, V20, P398, DOI 10.1097/00002820-199712000-00003; Ferrell BR, 1998, CANCER NURS, V21, P1, DOI 10.1097/00002820-199802000-00001; Ganz PA, 2002, JNCI-J NATL CANCER I, V94, P39; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Kroenke CH, 2013, BREAST CANCER RES TR, V139, P515, DOI 10.1007/s10549-013-2477-2; Kwan ML, 2010, BREAST CANCER RES TR, V123, P507, DOI 10.1007/s10549-010-0764-8; Lee H L, 2001, J Nurs Res, V9, P57; Lee YW, 2014, CANCER-AM CANCER SOC, V120, P1338, DOI 10.1002/cncr.28579; Liang WJ, 2011, CHIN MATERNAL CHILD, V26, P1472; Lo LC, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-232; Lu W, 2009, BREAST CANCER RES TR, V114, P357, DOI 10.1007/s10549-008-0008-3; Manning-Walsh J, 2005, JOGNN-J OBST GYN NEO, V34, P482, DOI 10.1177/0884217505278310; Movsas B, 2003, SEMIN RADIAT ONCOL, V13, P235, DOI 10.1016/S1053-4296(03)00029-8; Parkin DM, 2005, CANC INCIDENCE 5 CON, VI-VIII; Peuckmann V, 2007, BREAST CANCER RES TR, V104, P39, DOI 10.1007/s10549-006-9386-6; [裘佳佳 QIU Jia-jia], 2010, [中华护理杂志, Chinese Journal of Nursing], V45, P47; Quinten C, 2014, CANCER-AM CANCER SOC, V120, P302, DOI 10.1002/cncr.28382; Ng R, 2012, BREAST CANCER RES TR, V131, P619, DOI 10.1007/s10549-011-1764-z; Schou I, 2005, QUAL LIFE RES, V14, P1813, DOI 10.1007/s11136-005-4344-z; Sharma A, 2013, INT J SURG ONCOL, V2013, DOI 10.1155/2013/269510; Shimozuma Kojiro, 2002, Breast Cancer, V9, P100, DOI 10.1007/BF02967573; Trejo-Ochoa Jose Luis, 2013, Ginecol Obstet Mex, V81, P510; Xiao CH, 2005, NANFANG J NURS, V12, P80, DOI DOI 10.3969/J.ISSN.1008-9969.2005.05.038; Xu L, 2007, INTEGR CANCER THER, V6, P208, DOI 10.1177/1534735407305705; Yan YL, 2012, CHIN HLTH EC, V31, P30; You J, 2014, SUPPORT CARE CANCER, V22, P697, DOI 10.1007/s00520-013-2024-z; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17	45	50	53	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153714	10.1371/journal.pone.0153714	http://dx.doi.org/10.1371/journal.pone.0153714			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082440	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000374291800048
J	Reis, JGC; Reis, CSM; da Costa, DCS; Lucena, MM; Schubach, AD; Oliveira, RDC; Rolla, VC; Conceicao-Silva, F; Valete-Rosalino, CM				Correa Reis, Joao Gustavo; Mota Reis, Clarissa Souza; Silva da Costa, Daniel Cesar; Lucena, Marcia Mendonca; Schubach, Armando de Oliveira; Carvalhaes Oliveira, Raquel de Vasconcellos; Rolla, Valeria Cavalcanti; Conceicao-Silva, Fatima; Valete-Rosalino, Claudia Maria			Factors Associated with Clinical and Topographical Features of Laryngeal Tuberculosis	PLOS ONE			English	Article							LARYNGITIS	Introduction Laryngeal tuberculosis (LTB) is the most frequent granulomatous disease of the larynx and represents less than 2% of extrapulmonary TB cases. There are no pathognomonic clinical and endoscopic features of this disease and studies on LTB that can assist in its diagnostic characterization are lacking. Objective To identify factors associated with clinical and topographical features of LTB. Method a retrospective cross-sectional study was conducted from the medical records of 36 patients with confirmed LTB diagnosis. Results Dysphonia and cough were the main symptoms presented by patients and the true vocal folds the most frequently affected site. The average of the duration of the disease evolution was significantly higher in patients with dysphonia than in patients without this symptom. We observed association between dysphonia and true vocal fold lesions and between odynophagia and lesions in the epiglottis, arytenoids and aryepiglottic folds. Odynophagia was more frequent in individuals with lesions in four or more laryngeal sites. Weight loss equal or above 10% of the body weight was more frequent in patients with odynophagia as first symptom and in patients with ulcerated lesion. Dyspnea on exertion was more frequent in individuals with more extensive laryngeal lesions. The percentage of smokers with lesions in four or more laryngeal sites was greater than that found in non-smokers. Laryngeal tissue fragment bacilloscopy and culture examinations were less positive than sputum ones. Conclusions Smoking appears to be associated with the development of more extensive LTB lesions, and LTB with dyspnea on exertion and odynophagia with consequent impairment of nutritional status. We emphasize the need for histopathologic confirmation, once positive sputum bacteriological examinations seem not to necessarily reflect laryngeal involvement.	[Correa Reis, Joao Gustavo; Mota Reis, Clarissa Souza; Silva da Costa, Daniel Cesar; Lucena, Marcia Mendonca; Schubach, Armando de Oliveira; Carvalhaes Oliveira, Raquel de Vasconcellos; Rolla, Valeria Cavalcanti; Valete-Rosalino, Claudia Maria] Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Rio De Janeiro, RJ, Brazil; [Correa Reis, Joao Gustavo; Silva da Costa, Daniel Cesar; Conceicao-Silva, Fatima] Oswaldo Cruz Fdn FIOCRUZ, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil; [Correa Reis, Joao Gustavo] Bonsucesso Fed Hosp, Dept Bronchoesophagolaryngol & Head & Neck Surg, Rio De Janeiro, RJ, Brazil; [Lucena, Marcia Mendonca; Valete-Rosalino, Claudia Maria] Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Valete-Rosalino, CM (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Evandro Chagas Natl Inst Infect Dis INI, Rio De Janeiro, RJ, Brazil.; Conceicao-Silva, F (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Lab Immunoparasitol, Rio De Janeiro, RJ, Brazil.; Valete-Rosalino, CM (corresponding author), Univ Fed Rio de Janeiro, Fac Med, Dept Otorhinolaryngol & Ophthalmol, Rio De Janeiro, Brazil.	fconcei@ioc.fiocruz.br; claudia.valete@ini.fiocruz.br	Valete-Rosalino, Cláudia Maria/AAR-4293-2021; Rolla, Valeria Cavalcanti/AAI-6078-2021; Oliveira, Raquel de V C de/S-7443-2016	Rolla, Valeria Cavalcanti/0000-0002-0841-1408; Oliveira, Raquel de V C de/0000-0001-9387-8645	National Scientific and Technological Development Board -CNPq-Proep-IOC [402557/2011-5]; Research Support Foundation of the State of Rio de Janeiro-FAPERJ [E26/111.230/2014]; Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil [PAEF/IOC- Codigo IOC-008-FIO-15-47, E-26/102.183/2013, E-26/111.717/2012]; CNPq, Brazil; FAPERJ, Brazil; FAPERJ	National Scientific and Technological Development Board -CNPq-Proep-IOC; Research Support Foundation of the State of Rio de Janeiro-FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ), Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ, Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by the National Scientific and Technological Development Board -CNPq-Proep-IOC (402557/2011-5); Research Support Foundation of the State of Rio de Janeiro-FAPERJ (E26/111.230/2014); Projeto PAEF/IOC- Codigo IOC-008-FIO-15-47: Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E-26/111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.; National Scientific and Technological Development Board -CNPq-Proep-IOC (402557/2011-5); Research Support Foundation of the State of Rio de Janeiro-FAPERJ (E26/111.230/2014); Projeto PAEF/IOC- Codigo IOC-008-FIO-15-47. Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State (FAPERJ) (E-26/102.183/2013; E-26/111.717/2012), Brazil. AOS is the recipient of fellowships from CNPq and FAPERJ, Brazil. CMVR is the recipient of fellowships from FAPERJ. The funders had no role in study design data collection and analysis, decision to publish, or preparing the manuscript.	Agarwal P, 1998, J LARYNGOL OTOL, V112, P45, DOI 10.1017/S0022215100139878; BAILEY CM, 1981, LARYNGOSCOPE, V91, P93; Barbosa de S A Leonardo Conrado, 2007, Braz J Otorhinolaryngol, V73, P862, DOI 10.1016/S1808-8694(15)31188-5; Bhat VK, 2009, AM J OTOLARYNG, V30, P327, DOI 10.1016/j.amjoto.2008.07.005; Brasil, 2014, B EP CONTR TUB BRAS; COULDERY AD, 1990, J LARYNGOL OTOL, V104, P255, DOI 10.1017/S0022215100112423; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; GALIETTI F, 1989, EUR RESPIR J, V2, P731; Gandhi S, 2012, INDIAN J OTOLARYNGOL, V64, P244, DOI 10.1007/s12070-011-0333-4; Garcia Roberta I. D., 2004, Rev. Bras. Otorrinolaringol., V70, P255, DOI 10.1590/S0034-72992004000200017; Hasibi Mehrdad, 2013, Acta Med Iran, V51, P638; Kandiloros DC, 1997, J LARYNGOL OTOL, V111, P619, DOI 10.1017/S0022215100138137; LEVENSON MJ, 1984, LARYNGOSCOPE, V94, P1094; Lim JY, 2006, EUR ARCH OTO-RHINO-L, V263, P838, DOI 10.1007/s00405-006-0063-5; Ling L, 2010, INT J INFECT DIS, V14, pE230, DOI 10.1016/j.ijid.2009.05.002; Loehrl TA, 2001, AM J MED, V111, P113, DOI 10.1016/S0002-9343(01)00856-7; Lucena MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126876; Ministerio da Saude (BR), 2008, MAN NAC VIG LAB TUB; Ministerio da Saude Secretaria de Vigilancia^ em Saude Programa Nacional de Controle da Tuberculose, 2013, MAN REC TUB, P288; Morales Puebla J M, 2006, An Otorrinolaringol Ibero Am, V33, P591; Nalini B, 2006, AM J OTOLARYNG, V27, P39, DOI 10.1016/j.amjoto.2005.07.005; Nishiike S, 2002, ANN OTO RHINOL LARYN, V111, P916, DOI 10.1177/000348940211101010; Oliveira AGL, 2013, ACTA TROP, V128, P36, DOI 10.1016/j.actatropica.2013.06.005; Porras Alonso E, 2002, Rev Laryngol Otol Rhinol (Bord), V123, P47; Prasad KC, 2007, J LARYNGOL OTOL, V121, P979, DOI 10.1017/S0022215107006913; RAMADAN HH, 1993, J OTOLARYNGOL, V22, P39; Ricciardiello F, 2006, Acta Otorhinolaryngol Ital, V26, P38; Rizzo Paolo Boscolo, 2003, International Journal of Infectious Diseases, V7, P129, DOI 10.1016/S1201-9712(03)90008-7; Sataloff RT, 2007, OTOLARYNG CLIN N AM, V40, P909, DOI 10.1016/j.otc.2007.05.002; Shin JE, 2000, LARYNGOSCOPE, V110, P1950, DOI 10.1097/00005537-200011000-00034; da Costa DCS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109790; Silva L, 2008, EUR ARCH OTO-RHINO-L, V265, P675, DOI 10.1007/s00405-007-0533-4; SODA A, 1989, LARYNGOSCOPE, V99, P1147; Topak M, 2008, EUR ARCH OTO-RHINO-L, V265, P327, DOI 10.1007/s00405-007-0459-x; Wang CC, 2007, OTOLARYNG HEAD NECK, V137, P582, DOI 10.1016/j.otohns.2007.04.002; WHO, 2013, QUEST ANSW 2013 REV; WHO, 2015, TUBERCULOSIS; World Health Organization, 2007, UN MON TB TOB CONTR	38	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153450	10.1371/journal.pone.0153450	http://dx.doi.org/10.1371/journal.pone.0153450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077734	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700055
J	Groschel, M; Gotze, R; Muller, S; Ernst, A; Basta, D				Groeschel, Moritz; Goetze, Romy; Mueller, Susanne; Ernst, Arne; Basta, Dietmar			Central Nervous Activity upon Systemic Salicylate Application in Animals with Kanamycin-Induced Hearing Loss - A Manganese-Enhanced MRI (MEMRI) Study	PLOS ONE			English	Article							RAT INFERIOR COLLICULUS; GUINEA-PIG COCHLEA; PRIMARY AUDITORY-CORTEX; OUTER HAIR-CELLS; NOISE-INDUCED HYPERACTIVITY; ANTI-INFLAMMATORY DRUGS; RESONANCE-IMAGING MEMRI; NEURAL ACTIVITY; INDUCED TINNITUS; BEHAVIORAL PARADIGM	This study investigated the effect of systemic salicylate on central auditory and non-auditory structures in mice. Since cochlear hair cells are known to be one major target of salicylate, cochlear effects were reduced by using kanamycin to remove or impair hair cells. Neuronal brain activity was measured using the non-invasive manganese-enhanced magnetic resonance imaging technique. For all brain structures investigated, calcium-related neuronal activity was increased following systemic application of a sodium salicylate solution: probably due to neuronal hyperactivity. In addition, it was shown that the central effect of salicylate was not limited to the auditory system. A general alteration of calcium-related activity was indicated by an increase in manganese accumulation in the preoptic area of the anterior hypothalamus, as well as in the amygdala. The present data suggest that salicylate-induced activity changes in the auditory system differ from those shown in studies of noise trauma. Since salicylate action is reversible, central pharmacological effects of salicylate compared to those of (permanent) noise-induced hearing impairment and tinnitus might induce different pathophysiologies. These should therefore, be treated as different causes with the same symptoms.	[Groeschel, Moritz; Goetze, Romy; Ernst, Arne; Basta, Dietmar] Charite, Unfallkrankenhaus Berlin, Dept Otolaryngol, Berlin, Germany; [Mueller, Susanne] Charite, Neurosci Res Ctr NWFZ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Basta, D (corresponding author), Charite, Unfallkrankenhaus Berlin, Dept Otolaryngol, Berlin, Germany.	dietmar.basta@rz.hu-berlin.de		Mueller, Susanne/0000-0002-5053-2211				BANNWARTH B, 1989, BIOMED PHARMACOTHER, V43, P121, DOI 10.1016/0753-3322(89)90140-6; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Basta D, 2008, HEARING RES, V240, P42, DOI 10.1016/j.heares.2008.02.005; Bauer CA, 1999, OTOLARYNG HEAD NECK, V121, P457, DOI 10.1016/S0194-5998(99)70237-8; Bauer CA, 2000, HEARING RES, V147, P175, DOI 10.1016/S0378-5955(00)00130-1; BOETTCHER FA, 1991, AM J OTOLARYNG, V12, P33, DOI 10.1016/0196-0709(91)90071-M; Brennan JF, 1996, DEV PSYCHOBIOL, V29, P69, DOI 10.1002/(SICI)1098-2302(199601)29:1<69::AID-DEV4>3.3.CO;2-R; Brozoski TJ, 2007, HEARING RES, V228, P168, DOI 10.1016/j.heares.2007.02.003; Caperton KK, 2011, OTOL NEUROTOL, V32, P301, DOI 10.1097/MAO.0b013e3182009d46; Cazals Y, 1998, J NEUROPHYSIOL, V80, P2113, DOI 10.1152/jn.1998.80.4.2113; Chen GD, 2003, HEARING RES, V177, P81, DOI 10.1016/S0378-5955(02)00802-X; CHEN GD, 1995, HEARING RES, V82, P158, DOI 10.1016/0378-5955(94)00174-O; Chen GD, 2013, HEARING RES, V295, P100, DOI 10.1016/j.heares.2012.11.016; Chen GY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108659; Chen YC, 2015, ELIFE, V4, DOI 10.7554/eLife.06576; CORY D A, 1987, Magnetic Resonance Imaging, V5, P65, DOI 10.1016/0730-725X(87)90485-1; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; DIDIER A, 1993, HEARING RES, V69, P199, DOI 10.1016/0378-5955(93)90108-D; DRAPEAU P, 1984, J PHYSIOL-LONDON, V348, P493, DOI 10.1113/jphysiol.1984.sp015121; Eddy L B, 1975, Biomed Sci Instrum, V11, P51; Eggermont JJ, 1998, HEARING RES, V117, P149, DOI 10.1016/S0378-5955(98)00008-2; Evans E F, 1982, Br J Audiol, V16, P101, DOI 10.3109/03005368209081454; Evans E F, 1981, Ciba Found Symp, V85, P108; GRAHAM JDP, 1948, Q J MED, V17, P153; Groschel M, 2011, NEUROIMAGE, V57, P190, DOI 10.1016/j.neuroimage.2011.04.022; Guitton MJ, 2003, J NEUROSCI, V23, P3944; HALLA JT, 1991, ANN RHEUM DIS, V50, P682, DOI 10.1136/ard.50.10.682; HALLA JT, 1988, ANN RHEUM DIS, V47, P134, DOI 10.1136/ard.47.2.134; Holt AG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014260; Hu SS, 2015, EUROPEAN ARCH OTORHI; JAGER BV, 1946, AM J MED SCI, V211, P273, DOI 10.1097/00000441-194603000-00004; Jansen TTG, 2013, OTOL NEUROTOL, V34, P1496, DOI 10.1097/MAO.0b013e318291c610; JASTREBOFF PJ, 1986, ARCH OTOLARYNGOL, V112, P1050; JASTREBOFF PJ, 1988, BEHAV NEUROSCI, V102, P811, DOI 10.1037/0735-7044.102.6.811; JASTREBOFF PJ, 1986, J ACOUST SOC AM, V80, P1384, DOI 10.1121/1.394391; Jin Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126956; Jin YM, 2006, HEARING RES, V216, P168, DOI 10.1016/j.heares.2006.02.002; Jung DJ, 2014, NEUROIMAGE, V100, P642, DOI 10.1016/j.neuroimage.2014.06.055; Kakehata S, 1996, J NEUROSCI, V16, P4881; Kaltenbach JA, 2000, HEARING RES, V147, P282, DOI 10.1016/S0378-5955(00)00138-6; KANG YS, 1984, INVEST RADIOL, V19, P399, DOI 10.1097/00004424-198409000-00012; Kenmochi M, 1997, HEARING RES, V113, P110, DOI 10.1016/S0378-5955(97)00137-8; Kimitsuki T, 2011, NEUROSCI LETT, V504, P28, DOI 10.1016/j.neulet.2011.08.050; Kimitsuki T, 2009, AURIS NASUS LARYNX, V36, P152, DOI 10.1016/j.anl.2008.05.005; KITA H, 1981, BRAIN RES, V205, P111, DOI 10.1016/0006-8993(81)90723-X; Lee JH, 2005, MAGN RESON MED, V53, P640, DOI 10.1002/mrm.20368; Liberman M C, 1978, Acta Otolaryngol Suppl, V358, P1; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Lin YJ, 1997, MAGN RESON MED, V38, P378, DOI 10.1002/mrm.1910380305; Liu YX, 2007, NEUROPHARMACOLOGY, V53, P870, DOI 10.1016/j.neuropharm.2007.08.015; Liu YX, 2005, HEARING RES, V205, P271, DOI 10.1016/j.heares.2005.03.028; Liu YX, 2004, NEUROSCI LETT, V369, P115, DOI 10.1016/j.neulet.2004.07.037; Liu YX, 2004, HEARING RES, V193, P68, DOI 10.1016/j.heares.2004.03.006; Lobarinas E, 2006, ACTA OTO-LARYNGOL, V126, P13, DOI 10.1080/03655230600895408; Lobarinas E, 2004, HEARING RES, V190, P109, DOI 10.1016/S0378-5955(04)00019-X; Lu J, 2011, NEUROSCIENCE, V189, P187, DOI 10.1016/j.neuroscience.2011.04.073; Lue AJC, 1999, HEARING RES, V135, P163, DOI 10.1016/S0378-5955(99)00102-1; Ma WLD, 2006, HEARING RES, V212, P9, DOI 10.1016/j.heares.2005.10.003; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Manabe Y, 1997, HEARING RES, V103, P192, DOI 10.1016/S0378-5955(96)00181-5; Manzoor NF, 2013, HEARING RES, V295, P114, DOI 10.1016/j.heares.2012.04.003; MCCAIN HW, 1987, CAN J PHYSIOL PHARM, V65, P558, DOI 10.1139/y87-094; MCFADDEN D, 1984, AM J OTOLARYNG, V5, P235, DOI 10.1016/S0196-0709(84)80033-2; MONGAN E, 1973, JAMA-J AM MED ASSOC, V226, P142, DOI 10.1001/jama.226.2.142; Mulders WHAM, 2009, NEUROSCIENCE, V164, P733, DOI 10.1016/j.neuroscience.2009.08.036; Muller M, 2003, HEARING RES, V183, P37, DOI 10.1016/S0378-5955(03)00217-X; Muly SM, 2004, J NEUROSCI RES, V75, P585, DOI 10.1002/jnr.20011; MYERS EN, 1965, NEW ENGL J MED, V273, P587, DOI 10.1056/NEJM196509092731104; NARITA K, 1990, BRAIN RES, V510, P289, DOI 10.1016/0006-8993(90)91379-U; Norena AJ, 2010, NEUROSCIENCE, V166, P1194, DOI 10.1016/j.neuroscience.2009.12.063; Ochi K, 1997, HEARING RES, V105, P105, DOI 10.1016/S0378-5955(96)00201-8; Patel CR, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00235; Paxinos G., 2001, MOUSE BRAIN STEREOTA; REED JR, 1975, CLIN TOXICOL, V8, P623, DOI 10.3109/15563657508990087; Ruttiger L, 2003, HEARING RES, V180, P39, DOI 10.1016/S0378-5955(03)00075-3; Salvi RJ, 2000, HEARING RES, V147, P261, DOI 10.1016/S0378-5955(00)00136-2; SATINOFF E, 1972, SCIENCE, V176, P532, DOI 10.1126/science.176.4034.532; Seki S, 2003, HEARING RES, V180, P28, DOI 10.1016/S0378-5955(03)00074-1; SHEHATA WE, 1991, ACTA OTO-LARYNGOL, V111, P707, DOI 10.3109/00016489109138403; Silva AC, 2004, NMR BIOMED, V17, P532, DOI 10.1002/nbm.945; Stolzberg D, 2011, NEUROSCIENCE, V180, P157, DOI 10.1016/j.neuroscience.2011.02.005; Stolzberg D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00028; Sun W, 2009, NEUROSCIENCE, V159, P325, DOI 10.1016/j.neuroscience.2008.12.024; Takeda A, 2003, BRAIN RES REV, V41, P79, DOI 10.1016/S0165-0173(02)00234-5; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; TUNSTALL MJ, 1995, J PHYSIOL-LONDON, V485, P739, DOI 10.1113/jphysiol.1995.sp020765; Wallhausser-Franke E, 2003, EXP BRAIN RES, V153, P649, DOI 10.1007/s00221-003-1614-2; Wang HT, 2008, HEARING RES, V236, P42, DOI 10.1016/j.heares.2007.11.015; Wu JL, 2003, HEARING RES, V176, P80, DOI 10.1016/S0378-5955(02)00747-5; Yang G, 2007, HEARING RES, V226, P244, DOI 10.1016/j.heares.2006.06.013; Yu X, 2005, NAT NEUROSCI, V8, P961, DOI 10.1038/nn1477; Zacharek MA, 2002, HEARING RES, V172, P137, DOI 10.1016/S0378-5955(02)00575-0; Zhang FY, 2014, CELL PHYSIOL BIOCHEM, V34, P753, DOI 10.1159/000363040; Zheng YW, 2006, BRAIN RES, V1123, P201, DOI 10.1016/j.brainres.2006.09.045	94	5	5	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153386	10.1371/journal.pone.0153386	http://dx.doi.org/10.1371/journal.pone.0153386			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078034	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700047
J	Hao, WR; Friedman, A				Hao, Wenrui; Friedman, Avner			Serum uPAR as Biomarker in Breast Cancer Recurrence: A Mathematical Model	PLOS ONE			English	Article							UROKINASE-PLASMINOGEN-ACTIVATOR; TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; CARCINOMA IN-SITU; TISSUE FACTOR; FACTOR EXPRESSION; INHIBITOR; RECEPTOR; CELLS; FIBROBLASTS	There are currently over 2.5 million breast cancer survivors in the United States and, according to the American Cancer Society, 10 to 20 percent of these women will develop recurrent breast cancer. Early detection of recurrence can avoid unnecessary radical treatment. However, self-examination or mammography screening may not discover a recurring cancer if the number of surviving cancer cells is small, while biopsy is too invasive and cannot be frequently repeated. It is therefore important to identify non-invasive biomarkers that can detect early recurrence. The present paper develops a mathematical model of cancer recurrence. The model, based on a system of partial differential equations, focuses on tissue biomarkers that include the plasminogen system. Among them, only uPAR is known to have significant correlation to its concentration in serum and could therefore be a good candidate for serum biomarker. The model includes uPAR and other associated cytokines and cells. It is assumed that the residual cancer cells that survived primary cancer therapy are concentrated in the same location within a region with a very small diameter. Model simulations establish a quantitative relation between the diameter of the growing cancer and the total uPAR mass in the cancer. This relation is used to identify uPAR as a potential serum biomarker for breast cancer recurrence.	[Hao, Wenrui; Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hao, WR (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.	hao.50@mbi.osu.edu		HAO, WENRUI/0000-0002-6925-7424	Mathematical Biosciences Institute; National Science Foundation [DMS 0931642]	Mathematical Biosciences Institute; National Science Foundation(National Science Foundation (NSF))	The authors have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642.; The authors have been supported by the Mathematical Biosciences Institute and the National Science Foundation under Grant DMS 0931642. The authors thank J.F. Rabajante for this many comments that helped improve the presentation of the paper.	Acker T, 2001, MECH DEVELOP, V108, P45, DOI 10.1016/S0925-4773(01)00471-3; Benz CC, 2008, CRIT REV ONCOL HEMAT, V66, P65, DOI 10.1016/j.critrevonc.2007.09.001; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; BLASI F, 1987, J CELL BIOL, V104, P801, DOI 10.1083/jcb.104.4.801; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Ceruti P, 2013, EXP HEMATOL ONCOL, V2, DOI 10.1186/2162-3619-2-12; Chen D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107511; Chen D, 2012, B MATH BIOL, V74, P2752, DOI 10.1007/s11538-012-9776-3; Chorostowska-Wynimko J, 2003, MOL CANCER THER, V2, P19; Chung LP, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3676; COLLEN D, 1979, BLOOD, V53, P313; Connolly BM, 2010, BLOOD, V116, P1593, DOI 10.1182/blood-2010-03-276642; Curino A, 2002, ONCOGENE, V21, P8830, DOI 10.1038/sj.onc.1205951; Degnim AC, 2014, BREAST CANCER RES TR, V144, P539, DOI 10.1007/s10549-014-2896-8; Delozier T, 2000, ANN ONCOL, V11, P515, DOI 10.1023/A:1008321415065; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; Dublin E, 2000, AM J PATHOL, V157, P1219, DOI 10.1016/S0002-9440(10)64637-8; Duffy MJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0428-4; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; ESTREICHER A, 1990, J CELL BIOL, V111, P783, DOI 10.1083/jcb.111.2.783; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Foundation BCR, 2016, BREAST CANC STAT RES; Foundation USBCR, 2016, US BREAST CANC STAT; Freedman GM, 2000, ONCOLOGY-NY, V14, P1561; Fujimoto H, 2009, INT J CANCER, V125, P1276, DOI 10.1002/ijc.24378; Gandhari M, 2006, INT J ONCOL, V28, P1463; Guney N, 2006, MED ONCOL, V23, P335, DOI 10.1385/MO:23:3:335; Hao WR, 2014, P NATL ACAD SCI USA, V111, P14193, DOI 10.1073/pnas.1413970111; Hao WR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090497; Harbeck N, 1999, BRIT J CANCER, V80, P419, DOI 10.1038/sj.bjc.6690373; Harbeck N, 2008, BREAST CARE, V3, P11, DOI 10.1159/000151734; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Hildenbrand R, 1999, J LEUKOCYTE BIOL, V66, P40, DOI 10.1002/jlb.66.1.40; Hildenbrand R, 2008, HISTOL HISTOPATHOL, V23, P227, DOI 10.14670/HH-23.227; Hildenbrand R, 2009, HISTOL HISTOPATHOL, V24, P869, DOI 10.14670/HH-24.869; HOFLAND LJ, 1995, INT J CANCER, V60, P93, DOI 10.1002/ijc.2910600114; Hu Q, 2013, ONCOGENE, V32, P3933, DOI 10.1038/onc.2012.414; Illemann M, 2014, CANCER MED-US, V3, P855, DOI 10.1002/cam4.242; Jesneck JL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-164; Kantelhardt EJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-140; Kariko K, 1999, GENE THER, V6, P1092, DOI 10.1038/sj.gt.3300930; Kim Y, 2010, J MATH BIOL, V61, P401, DOI 10.1007/s00285-009-0307-2; Kwaan Hau C., 2009, V148, P43, DOI 10.1007/978-0-387-79962-9_4; Kwon Gui Young, 2005, Cancer Res Treat, V37, P103, DOI 10.4143/crt.2005.37.2.103; LeBeau AM, 2013, CANCER RES, V73, P2070, DOI 10.1158/0008-5472.CAN-12-3526; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Li WY, 2003, WOUND REPAIR REGEN, V11, P239, DOI 10.1046/j.1524-475X.2003.11402.x; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110126; Lijnen HR, 2000, BIOCHEMISTRY-US, V39, P479, DOI 10.1021/bi992014r; LINDHOUT T, 1992, BLOOD, V79, P2909; Louzoun Y, 2014, J THEOR BIOL, V351, P74, DOI 10.1016/j.jtbi.2014.02.028; Lwaleed BA, 2000, SAUDI MED J, V21, P722; Mallmann MR, 2012, PLOS ONE, V7; Mantovani A, 2006, CANCER METAST REV, V25, P315, DOI 10.1007/s10555-006-9001-7; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Mego M, 2015, BREAST J, V21, P155, DOI 10.1111/tbj.12388; Memarzedeh S, 2002, P NATL ACAD SCI USA, V99, P10647, DOI 10.1073/pnas.152127499; Mirabelli P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/685641; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nielsen BS, 2001, LAB INVEST, V81, P1485, DOI 10.1038/labinvest.3780363; Olson MW, 1997, J BIOL CHEM, V272, P29975, DOI 10.1074/jbc.272.47.29975; PABORSKY LR, 1989, BIOCHEMISTRY-US, V28, P8072, DOI 10.1021/bi00446a016; Pultz BD, 2014, J CANCER, V5, P559, DOI 10.7150/jca.8925; Quillin ML, 2000, ACTA CRYSTALLOGR D, V56, P791, DOI 10.1107/S090744490000679X; Rha SY, 2000, CANCER LETT, V150, P137, DOI 10.1016/S0304-3835(99)00376-6; Romero L, 2004, AM J SURG, V188, P371, DOI 10.1016/j.amjsurg.2004.06.034; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Rubinstein WS, 2002, ONCOLOGY-NY, V16, P1082; Ruf W, 2010, THROMB RES, V125, pS36, DOI 10.1016/S0049-3848(10)70010-4; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Samoszuk M, 2005, BREAST CANCER RES, V7, pR274, DOI 10.1186/bcr995; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Shui YB, 2003, INVEST OPHTH VIS SCI, V44, P3911, DOI 10.1167/iovs.02-1226; Sieuwerts AM, 1998, INT J CANCER, V76, P829, DOI 10.1002/(SICI)1097-0215(19980610)76:6<829::AID-IJC11>3.0.CO;2-Y; Soon PSH, 2013, ENDOCR-RELAT CANCER, V20, P1, DOI 10.1530/ERC-12-0227; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Strojan P, 1998, EUR J CANCER, V34, P1193, DOI 10.1016/S0959-8049(98)00029-X; Szomolay B, 2012, J THEOR BIOL, V303, P141, DOI 10.1016/j.jtbi.2012.03.024; Thielemann A, 2013, WSPOLCZESNA ONKOL, V17, P440, DOI 10.5114/wo.2013.38567; Ueno T, 2000, BRIT J CANCER, V83, P164; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530	81	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153508	10.1371/journal.pone.0153508	http://dx.doi.org/10.1371/journal.pone.0153508			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078836	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700071
J	Kim, JY; Yang, S; Lee, JI; Chang, MJ				Kim, Je-Yon; Yang, Seungwon; Lee, Jangik I.; Chang, Min Jung			Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							DIPEPTIDYL PEPTIDASE-4 INHIBITOR; GLUCAGON-LIKE PEPTIDE-1; IMPROVES GLYCEMIC CONTROL; ADD-ON THERAPY; PLACEBO-CONTROLLED TRIAL; DRUG-NAIVE PATIENTS; DOUBLE-BLIND; JAPANESE PATIENTS; COMBINATION THERAPY; GLUCOSE CONTROL	Background To assess the cardiovascular (CV) risk associated with the use of incretin-based therapy in adult patients with type 2 diabetes mellitus (T2DM) primary prevention group with low CV risks. Methods The clinical studies on incretin-based therapy published in medical journals until August 2014 were comprehensively searched using MEDLINE, EMBASE and CENTRAL with no language restriction. The studies were systemically reviewed and evaluated for CV risks using a meta-analysis approach and where they meet the following criteria: clinical trial, incidence of predefined CV disease, T2DM with no comorbidities, age > 18 years old, duration of at least 12 weeks, incretin-based therapy compared with other antihyperglycaemic agents or placebo. Statistical analyses were performed using a Mantel-Haenszel (M-H) test. The odds ratios (OR) and their 95% confidence interval (CI) were estimated and displayed for comparison. Results A total of 75 studies comprising 45,648 patients with T2DM were selected. The pooled estimate demonstrated no significance in decreased CV risk with incretin-based therapy versus control (M-H OR, 0.90; 95% CI, 0.81-1.00). Conclusions This meta-analysis suggests that incretin-based therapy show no significant protective effect on CV events in T2DM primary prevention group with low CV risks. Prospective randomized controlled trials are required to confirm the results of this analysis.	[Kim, Je-Yon; Chang, Min Jung] Yonsei Univ, Dept Pharmaceut Med & Regulatory Sci, Coll Med, Inchon, South Korea; [Kim, Je-Yon; Chang, Min Jung] Yonsei Univ, Dept Pharmaceut Med & Regulatory Sci, Coll Pharm, Inchon, South Korea; [Yang, Seungwon; Chang, Min Jung] Yonsei Univ, Dept Pharm, Coll Pharm, Inchon, South Korea; [Yang, Seungwon; Chang, Min Jung] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea; [Lee, Jangik I.] Seoul Natl Univ, Coll Pharm, Seoul, South Korea; [Lee, Jangik I.] Seoul Natl Univ, Pharmaceut Sci Res Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University; Seoul National University (SNU); Seoul National University (SNU)	Chang, MJ (corresponding author), Yonsei Univ, Dept Pharmaceut Med & Regulatory Sci, Coll Med, Inchon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Dept Pharmaceut Med & Regulatory Sci, Coll Pharm, Inchon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Dept Pharm, Coll Pharm, Inchon, South Korea.; Chang, MJ (corresponding author), Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea.	mjchang@yonsei.ac.kr			Global Center of Excellence in Clinical Trials, Yonsei University Health System - Ministry of Health & Welfare, Republic of Korea [HI14C1234]	Global Center of Excellence in Clinical Trials, Yonsei University Health System - Ministry of Health & Welfare, Republic of Korea	This study was supported by Global Center of Excellence in Clinical Trials (HI14C1234), Yonsei University Health System funded by Ministry of Health & Welfare, Republic of Korea.; Authors would like to thank Mr. Byunghak Jin, Mr. Jaeyul Yoo for their contributions to this research. This study was supported by Global Center of Excellence in Clinical Trials (HI14C1234), Yonsei University Health System funded by Ministry of Health & Welfare, Republic of Korea.	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; [Anonymous], 2008, GUIDANCE IND DIABETE; [Anonymous], 2011, ASSESSING RISK BIAS; Aschner P, 2010, DIABETES OBES METAB, V12, P252, DOI 10.1111/j.1463-1326.2009.01187.x; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Barnett AH, 2012, CURR MED RES OPIN, V28, P513, DOI 10.1185/03007995.2012.665046; Bergenstal R, 2009, CURRENT MED RES OPIN, V25, P65; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Blonde L, 2009, DIABETES OBES METAB, V11, P978, DOI 10.1111/j.1463-1326.2009.01080.x; Bolli G, 2009, DIABETES OBES METAB, V11, P589, DOI 10.1111/j.1463-1326.2008.01023.x; Bosi E, 2009, DIABETES OBES METAB, V11, P506, DOI 10.1111/j.1463-1326.2009.01040.x; Bosi E, 2007, DIABETES CARE, V30, P890, DOI 10.2337/dc06-1732; Chacra AR, 2011, DIABETES VASC DIS RE, V8, P150, DOI 10.1177/1479164111404574; Courreges JP, 2008, DIABETIC MED, V25, P1129, DOI 10.1111/j.1464-5491.2008.02484.x; Del Prato S, 2011, EXPERT OPIN PHARMACO, V12, P2759, DOI 10.1517/14656566.2011.613825; Del PS, 2011, DIABETES OBESITY MET, V13, P258; Dobs AS, 2013, J DIABETES, V5, P68, DOI 10.1111/j.1753-0407.2012.00223.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eurich DT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2267; Filozof C, 2010, DIABETIC MED, V27, P318, DOI 10.1111/j.1464-5491.2010.02938.x; Fonseca V, 2012, DIABETES OBES METAB, V14, P365, DOI 10.1111/j.1463-1326.2011.01553.x; Fonseca V, 2013, J DIABETES COMPLICAT, V27, P177, DOI 10.1016/j.jdiacomp.2012.09.007; Fonseca VA, 2012, DIABETES CARE, V35, P1225, DOI 10.2337/dc11-1935; Forst T, 2010, DIABETIC MED, V27, P1409, DOI 10.1111/j.1464-5491.2010.03131.x; Gallwitz B, 2012, LANCET, V380, P475, DOI 10.1016/S0140-6736(12)60691-6; Gallwitz B, 2012, LANCET, V379, P2270, DOI 10.1016/S0140-6736(12)60479-6; Garber A, 2011, DIABETES OBES METAB, V13, P348, DOI 10.1111/j.1463-1326.2010.01356.x; Garber AJ, 2008, DIABETES OBES METAB, V10, P1047, DOI 10.1111/j.1463-1326.2008.00859.x; Garber AJ, 2007, DIABETES OBES METAB, V9, P166, DOI 10.1111/j.1463-1326.2006.00684.x; Goke B, 2013, INT J CLIN PRACT, V67, P307, DOI 10.1111/ijcp.12119; Goldstein DE, 2004, DIABETES CARE, V27, P1761, DOI 10.2337/diacare.27.7.1761; Goodman M, 2009, HORM METAB RES, V41, P368, DOI 10.1055/s-0028-1104604; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Grunberger G, 2012, DIABETIC MED, V29, P1260, DOI 10.1111/j.1464-5491.2012.03745.x; Gu K, 1998, DIABETES CARE, V21, P1138, DOI 10.2337/diacare.21.7.1138; Haak T, 2012, DIABETES OBES METAB, V14, P565, DOI 10.1111/j.1463-1326.2012.01590.x; Henry RR, 2011, DIABETES OBES METAB, V13, P850, DOI 10.1111/j.1463-1326.2011.01417.x; Hiatt WR, 2013, NEW ENGL J MED, V369, P1285, DOI 10.1056/NEJMp1309610; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hollander PL, 2011, DIABETES VASC DIS RE, V8, P125, DOI 10.1177/1479164111404575; Inagaki N, 2014, LANCET DIABETES ENDO, V2, P125, DOI 10.1016/S2213-8587(13)70149-9; Inagaki N, 2012, CLIN THER, V34, P1892, DOI 10.1016/j.clinthera.2012.07.007; Iwamoto Y, 2010, ENDOCR J, V57, P383, DOI 10.1507/endocrj.K09E-272; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI DOI 10.1001/JAMA.2013.284427; Kaku K, 2011, DIABETES OBES METAB, V13, P1028, DOI 10.1111/j.1463-1326.2011.01460.x; Kaku K, 2011, J DIABETES INVEST, V2, P441, DOI 10.1111/j.2040-1124.2011.00128.x; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Marso SP, 2011, DIABETES VASC DIS RE, V8, P237, DOI 10.1177/1479164111408937; Matthews DR, 2010, DIABETES OBES METAB, V12, P780, DOI 10.1111/j.1463-1326.2010.01233.x; Matyjaszek-Matuszek B, 2013, ENDOKRYNOL POL, V64, P375, DOI 10.5603/EP.2013.0021; Meigs JB, 2003, ACTA DIABETOL, V40, pS358, DOI 10.1007/s00592-003-0120-0; Mohan V, 2009, DIABETES RES CLIN PR, V83, P106, DOI 10.1016/j.diabres.2008.10.009; Monami M, 2014, NUTR METAB CARDIOVAS, V24, P689, DOI 10.1016/j.numecd.2014.01.017; Monami M, 2013, DIABETES OBES METAB, V15, P112, DOI 10.1111/dom.12000; Moses RG, 2014, DIABETES OBES METAB, V16, P443, DOI 10.1111/dom.12234; Nauck M, 2013, DIABETES OBES METAB, V15, P204, DOI 10.1111/dom.12012; Nauck MA, 2007, DIABETES OBES METAB, V9, P194, DOI 10.1111/j.1463-1326.2006.00704.x; Nauck MA, 2009, INT J CLIN PRACT, V63, P46, DOI 10.1111/j.1742-1241.2008.01933.x; Nonaka K, 2008, DIABETES RES CLIN PR, V79, P291, DOI 10.1016/j.diabres.2007.08.021; Olansky L, 2011, DIABETES OBES METAB, V13, P841, DOI 10.1111/j.1463-1326.2011.01416.x; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perez-Monteverde A, 2011, INT J CLIN PRACT, V65, P930, DOI 10.1111/j.1742-1241.2011.02749.x; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Pfutzner A, 2011, DIABETES OBES METAB, V13, P567, DOI 10.1111/j.1463-1326.2011.01385.x; Philis-Tsimikas A, 2013, DIABETES OBES METAB, V15, P760, DOI 10.1111/dom.12115; Pinget M, 2013, DIABETES OBES METAB, V15, P1000, DOI 10.1111/dom.12121; Pratley RE, 2006, HORM METAB RES, V38, P423, DOI 10.1055/s-2006-944546; Pratley RE, 2013, DIABETES OBES METAB, V15, P234, DOI 10.1111/dom.12009; Pratley RE, 2009, DIABETES OBES METAB, V11, P167, DOI 10.1111/j.1463-1326.2008.01016.x; Pratley RE, 2009, CURR MED RES OPIN, V25, P2361, DOI 10.1185/03007990903156111; Ratner R, 2010, DIABETIC MED, V27, P556, DOI 10.1111/j.1464-5491.2010.02990.x; Raz I, 2008, CURR MED RES OPIN, V24, P537, DOI [10.1185/030079908X260925, 10.1185/030079908X260925 ]; Reasner C, 2011, DIABETES OBES METAB, V13, P644, DOI 10.1111/j.1463-1326.2011.01390.x; Riddle MC, 2013, DIABETES CARE, V36, P2489, DOI 10.2337/dc12-2454; Rosenstock J, 2009, DIABETES OBES METAB, V11, P1145, DOI 10.1111/j.1463-1326.2009.01124.x; Rosenstock J, 2009, DIABETES OBES METAB, V11, P571, DOI 10.1111/j.1463-1326.2008.01021.x; Rosenstock J, 2006, CLIN THER, V28, P1556, DOI 10.1016/j.clinthera.2006.10.007; Rosenstock J, 2014, J DIABETES COMPLICAT, V28, P386, DOI 10.1016/j.jdiacomp.2014.01.012; Ross SA, 2012, CURR MED RES OPIN, V28, P1465, DOI 10.1185/03007995.2012.714360; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Scheen AJ, 2013, NAT REV CARDIOL, V10, P73, DOI 10.1038/nrcardio.2012.183; Scherbaum WA, 2008, DIABETES OBES METAB, V10, P1114, DOI 10.1111/j.1463-1326.2008.00875.x; Schernthaner G, 2013, DIABETES CARE, V36, P2508, DOI 10.2337/dc12-2491; Schweizer A, 2010, DIABETES OBES METAB, V12, P485, DOI 10.1111/j.1463-1326.2010.01215.x; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seino Y, 2012, DIABETES OBES METAB, V14, P927, DOI 10.1111/j.1463-1326.2012.01620.x; Seino Y, 2014, CURR MED RES OPIN, V30, P1095, DOI 10.1185/03007995.2014.896327; Seino Y, 2012, J DIABETES INVEST, V3, P517, DOI 10.1111/j.2040-1124.2012.00226.x; Sterne JAC, 2000, J CLIN EPIDEMIOL, V53, P1119, DOI 10.1016/S0895-4356(00)00242-0; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Strain WD, 2013, LANCET, V382, P409, DOI 10.1016/S0140-6736(13)60995-2; Tajima N, 2013, J DIABETES INVEST, V4, P595, DOI 10.1111/jdi.12116; Tajima N, 2011, DIABETOL INT, V2, P32, DOI 10.1007/s13340-011-0022-2; Taskinen MR, 2011, DIABETES OBES METAB, V13, P65, DOI 10.1111/j.1463-1326.2010.01326.x; Terra SG, 2011, EXP CLIN ENDOCR DIAB, V119, P401, DOI 10.1055/s-0031-1273737; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vilsboll T, 2010, DIABETES OBES METAB, V12, P167, DOI 10.1111/j.1463-1326.2009.01173.x; White JL, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-17; White WB, 2013, DIABETES OBES METAB, V15, P668, DOI 10.1111/dom.12093; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; White WB, 2011, AM HEART J, V162, P620, DOI 10.1016/j.ahj.2011.08.004; Williams-Herman D, 2009, CURR MED RES OPIN, V25, P569, DOI 10.1185/03007990802705679 ; Wysham C, 2014, DIABETES CARE, V37, P2159, DOI [10.2337/dc13-2760, 10.2337/dc15-er07b]; Yang WY, 2011, DIABETES RES CLIN PR, V94, P217, DOI 10.1016/j.diabres.2011.07.035	106	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153502	10.1371/journal.pone.0153502	http://dx.doi.org/10.1371/journal.pone.0153502			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078018	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700067
J	LeBlanc, S; Tobalske, B; Quinton, M; Springthorpe, D; Szkotnicki, B; Wuerbel, H; Harlander-Matauschek, A				LeBlanc, Stephanie; Tobalske, Bret; Quinton, Margaret; Springthorpe, Dwight; Szkotnicki, Bill; Wuerbel, Hanno; Harlander-Matauschek, Alexandra			Physical Health Problems and Environmental Challenges Influence Balancing Behaviour in Laying Hens	PLOS ONE			English	Article							KEEL BONE DEFORMITIES; OLDER-PEOPLE; RISK-FACTORS; POSTURAL STABILITY; HORIZONTAL PERCHES; HOUSING SYSTEMS; VISUAL CONTROL; SPINAL-CORD; BIRDS; LOCOMOTION	With rising public concern for animal welfare, many major food chains and restaurants are changing their policies, strictly buying their eggs from non-cage producers. However, with the additional space in these cage-free systems to perform natural behaviours and movements comes the risk of injury. We evaluated the ability to maintain balance in adult laying hens with health problems (footpad dermatitis, keel damage, poor wing feather cover; n = 15) using a series of environmental challenges and compared such abilities with those of healthy birds (n = 5). Environmental challenges consisted of visual and spatial constraints, created using a head mask, perch obstacles, and static and swaying perch states. We hypothesized that perch movement, environmental challenges, and diminished physical health would negatively impact perching performance demonstrated as balance (as measured by time spent on perch and by number of falls of the perch) and would require more exaggerated correctional movements. We measured perching stability whereby each bird underwent eight 30-second trials on a static and swaying perch: with and without disrupted vision (head mask), with and without space limitations (obstacles) and combinations thereof. Video recordings (600 Hz) and a three-axis accelerometer/gyroscope (100 Hz) were used to measure the number of jumps/falls, latencies to leave the perch, as well as magnitude and direction of both linear and rotational balance-correcting movements. Laying hens with and without physical health problems, in both challenged and unchallenged environments, managed to perch and remain off the ground. We attribute this capacity to our training of the birds. Environmental challenges and physical state had an effect on the use of accelerations and rotations to stabilize themselves on a perch. Birds with physical health problems performed a higher frequency of rotational corrections to keep the body centered over the perch, whereas, for both health categories, environmental challenges required more intense and variable movement corrections. Collectively, these results provide novel empirical support for the effectiveness of training, and highlight that overcrowding, visual constraints, and poor physical health all reduce perching performance.	[LeBlanc, Stephanie; Quinton, Margaret; Szkotnicki, Bill; Harlander-Matauschek, Alexandra] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Tobalske, Bret] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Springthorpe, Dwight] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Wuerbel, Hanno] Univ Bern, VPH Inst, Div Anim Welf, Bern, Switzerland	University of Guelph; University of Montana System; University of Montana; University of California System; University of California Berkeley; University of Bern	Harlander-Matauschek, A (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	aharland@uoguelph.ca	Wuerbel, Hanno/D-6281-2012	Wuerbel, Hanno/0000-0002-2934-3010	Swiss Federal Food Safety and Veterinary Office [2.13.09]; AgrilInnovation Program under the Growing Forward 2 Policy [CPC2-3.2.2]	Swiss Federal Food Safety and Veterinary Office; AgrilInnovation Program under the Growing Forward 2 Policy	This work was supported by Grant number 2.13.09 Swiss Federal Food Safety and Veterinary Office http://www.blv.admin.ch/?lang=en to AH and CPC2-3.2.2 AgrilInnovation Program under the Growing Forward 2 Policy, http://www.agr.gc.ca/eng/about-us/key-departmental-initiatives/growing-forward-2/?id=1294780620963 to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M., 2012, PATHOLOGIC BASIS VET, P89; Alerstam T, 1993, BIRD MIGRATION, P69; Birn-Jeffery AV, 2014, J EXP BIOL, V217, P3786, DOI 10.1242/jeb.102640; Borghuis J, 2008, SPORTS MED, V38, P893, DOI 10.2165/00007256-200838110-00002; Brauer SG, 2001, J GERONTOL A-BIOL, V56, pM489, DOI 10.1093/gerona/56.8.M489; BUTLER PJ, 1991, J EXP BIOL, V160, P233; Carrano MT, 1999, J MORPHOL, V240, P237, DOI 10.1002/(SICI)1097-4687(199906)240:3<237::AID-JMOR3>3.3.CO;2-E; CARSTENS P., 1936, Arch. Geflugelk., V10, P97; Carter SE, 1997, AGE AGEING, V26, P195, DOI 10.1093/ageing/26.3.195; Clark WD, 2008, POULTRY SCI, V87, P1964, DOI 10.3382/ps.2008-00115; DAANJE A, 1950, BEHAVIOUR, V3, P48, DOI 10.1163/156853951X00214; Daley MA, 2011, PHILOS T R SOC B, V366, P1580, DOI 10.1098/rstb.2010.0338; Davis H, 2004, BIPEDS ASCENDING AVI; Day BL, 2005, CURR BIOL, V15, pR583, DOI 10.1016/j.cub.2005.07.053; Dial KP, 2011, P ROY SOC B-BIOL SCI, V278, P1610, DOI 10.1098/rspb.2010.1984; Dial TR, 2012, J EXP BIOL, V215, P3693, DOI 10.1242/jeb.062018; Fleming RH, 2006, BRIT POULTRY SCI, V47, P742, DOI 10.1080/00071660601077949; Fleming RH, 2004, BRIT POULTRY SCI, V45, P320, DOI 10.1080/00071660410001730815; Galton PM, 2012, J EXP ZOOL PART A, V317A, P205, DOI 10.1002/jez.1714; GIBSON JJ, 1958, BRIT J PSYCHOL, V49, P182, DOI 10.1111/j.2044-8295.1958.tb00656.x; GIESBRECHT FG, 1985, BIOMETRICS, V41, P477, DOI 10.2307/2530872; Greenewalt C.H., 1962, SMITHSON MISC COLLNS, V144, P1, DOI DOI 10.1007/S00360-016-1016-Y; Grossi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088458; Habig C, 2013, BRIT POULTRY SCI, V54, P413, DOI 10.1080/00071668.2013.792405; Harlander-Matauschek A, 2009, ANIM BEHAV, V78, P485, DOI 10.1016/j.anbehav.2009.05.020; HASAN SS, 1990, J BIOMECH, V23, P783, DOI 10.1016/0021-9290(90)90025-X; Heers AM, 2011, J EXP BIOL, V214, P717, DOI 10.1242/jeb.051177; HODOS W, 1990, VISION RES, V30, P653, DOI 10.1016/0042-6989(90)90091-X; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; Kappeli S, 2011, BRIT POULTRY SCI, V52, P531, DOI 10.1080/00071668.2011.615059; Kambic RE, 2014, J EXP BIOL, V217, P2770, DOI 10.1242/jeb.101428; LEE DN, 1980, PHILOS T R SOC B, V290, P169, DOI 10.1098/rstb.1980.0089; LEE DN, 1977, SCAND J PSYCHOL, V18, P224, DOI 10.1111/j.1467-9450.1977.tb00281.x; Lord SR, 2006, AGE AGEING, V35, P55, DOI 10.1093/ageing/afl088; Martin GR, 2009, J VISION, V9, DOI 10.1167/9.11.14; Mathie MJ, 2004, PHYSIOL MEAS, V25, pR1, DOI 10.1088/0967-3334/25/2/R01; Mayagoitia RE, 2002, J BIOMECH, V35, P537, DOI 10.1016/S0021-9290(01)00231-7; Moe-Nilssen R, 2002, GAIT POSTURE, V16, P60, DOI 10.1016/S0966-6362(01)00200-4; Moinard C, 2004, BRIT POULTRY SCI, V45, P578, DOI 10.1080/00071660400006321; Morrison A, 2013, CLINICOECONOMIC OUTC, V5, P9, DOI 10.2147/CEOR.S38721; Muir GD, 2000, BRAIN RES BULL, V53, P719, DOI 10.1016/S0361-9230(00)00404-4; Muller W, 1998, J EXP BIOL, V201, P2591; Nasr MAF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042420; Necker R, 1999, EUR J MORPHOL, V37, P211, DOI 10.1076/ejom.37.2.211.4758; Necker R, 2000, J COMP PHYSIOL A, V186, P409, DOI 10.1007/s003590050440; Necker R, 2006, J COMP PHYSIOL A, V192, P439, DOI 10.1007/s00359-006-0105-x; Necker Reinhold, 2000, P57, DOI 10.1016/B978-012747605-6/50005-5; Park JW, 2014, J PHYS THER SCI, V26, P381, DOI 10.1589/jpts.26.381; Patel M, 2014, NEUROSCI LETT, V579, P97, DOI 10.1016/j.neulet.2014.07.010; Perrin PP, 1997, GERONTOLOGY, V43, P223; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pradels A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065510; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Provini P, 2014, J EXP BIOL, V217, P2659, DOI 10.1242/jeb.104588; Provini P, 2012, J EXP BIOL, V215, P4115, DOI 10.1242/jeb.074484; QUINN TH, 1990, ZOOMORPHOLOGY, V109, P281, DOI 10.1007/BF00312195; Redfern MS, 2001, J ANXIETY DISORD, V15, P81, DOI 10.1016/S0887-6185(00)00043-8; Ritchie B.W., 1997, AVIAN MED PRINCIPLES; Rodenburg TB, 2008, ANIM WELFARE, V17, P363; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Sandilands V, 2009, BRIT POULTRY SCI, V50, P395, DOI 10.1080/00071660903110844; SAVORY CJ, 1995, WORLD POULTRY SCI J, V51, P215, DOI 10.1079/WPS19950016; Scott GB, 1997, BRIT POULTRY SCI, V38, P48, DOI 10.1080/00071669708417939; Sturnieks DL, 2008, NEUROPHYSIOL CLIN, V38, P467, DOI 10.1016/j.neucli.2008.09.001; SULLIVAN G. E., 1962, AUSTRALIAN JOUR ZOOL, V10, P458, DOI 10.1071/ZO9620458; Szulc P, 2005, J BONE MINER RES, V20, P721, DOI 10.1359/JBMR.041230; Taylor PE, 2003, APPL ANIM BEHAV SCI, V83, P99, DOI 10.1016/S0168-1591(03)00127-8; Tobalske BW, 2008, J EXP BIOL, V211, P170, DOI 10.1242/jeb.007476; Uhlenberg, 2002, ENCY AGING; Wang G, 1998, BRIT POULTRY SCI, V39, P191, DOI 10.1080/00071669889114; Wang Z, 2004, CAN J ANIM SCI, V84, P1, DOI 10.4141/A03-123; Wearing SC, 2006, OBES REV, V7, P13, DOI 10.1111/j.1467-789X.2006.00215.x; Wilkins LJ, 2011, VET REC, V169, P414, DOI 10.1136/vr.d4831; Wilkins LJ, 2004, VET REC, V155, P547, DOI 10.1136/vr.155.18.547	76	21	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153477	10.1371/journal.pone.0153477	http://dx.doi.org/10.1371/journal.pone.0153477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078835	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700061
J	Zhang, QL; Cox, M; Liang, ZK; Brinkmann, F; Cardenas, PA; Duff, R; Bhavsar, P; Cookson, W; Moffatt, M; Chung, KF				Zhang, Qingling; Cox, Michael; Liang, Zhike; Brinkmann, Folke; Cardenas, Paul A.; Duff, Rachael; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan			Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes	PLOS ONE			English	Article							RELATIVE CORTICOSTEROID INSENSITIVITY; CHILDHOOD ASTHMA; INDUCED SPUTUM; INFLAMMATION; CELLS; HYPERRESPONSIVENESS; INFECTIONS; DIVERSITY; BACTERIA; COUNTS	Background The lower airways harbor a community of bacterial species which is altered in asthma. Objectives We examined whether the lower airway microbiota were related to measures of asthma severity. Methods We prospectively recruited 26 severe asthma, 18 non-severe asthma and 12 healthy subjects. DNA was extracted from induced sputum and PCR amplification of the V3-V5 region of bacterial 16S rRNA gene was performed. Results We obtained 138,218 high quality sequences which were rarefied at 133 sequences/sample. Twenty OTUs had sequences >= 1% of total. There were marked differences in the distribution of Phyla between groups (P = 2.8x10(-118)). Bacteroidetes and Fusobacteria were reduced in non-severe and severe asthmatic groups. Proteobacteria were more common in non-severe asthmatics compared to controls (OR = 2.26; 95% CI = 1.94-2.64) and Firmicutes were increased in severe asthmatics compared to controls (OR = 2.15; 95% CI = 1.89-2.45). Streptococcal OTUs amongst the Firmicutes were associated with recent onset asthma, rhinosinusitis and sputum eosinophilia. Conclusions Sputum microbiota in severe asthma differs from healthy controls and non-severe asthmatics, and is characterized by the presence of Streptococcus spp with eosinophilia. Whether these organisms are causative for the pathophysiology of asthma remains to be determined.	[Zhang, Qingling; Cox, Michael; Liang, Zhike; Brinkmann, Folke; Cardenas, Paul A.; Duff, Rachael; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England; [Zhang, Qingling; Liang, Zhike; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Royal Brompton & Harefield NHS Trust, Resp Biomed Res Unit, London, England; [Zhang, Qingling; Liang, Zhike; Bhavsar, Pankaj; Cookson, William; Moffatt, Miriam; Chung, Kian Fan] Imperial Coll London, London, England; [Zhang, Qingling; Liang, Zhike; Chung, Kian Fan] Guangzhou Med Univ, Affiliated Hosp 1, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Imperial College London; Royal Brompton & Harefield NHS Foundation Trust; Royal Brompton Hospital; Imperial College London; Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Cookson, William/HHC-1790-2022; Brinkmann, Folke/GQA-9081-2022	Chung, Kian Fan/0000-0001-7101-1426; Brinkmann, Folke/0000-0002-4307-4232; Cardenas, Paul/0000-0001-9626-4489; Cox, Michael/0000-0002-4002-1506	NIHR Respiratory Biomedical Research Unit; Asmarley Trust; Centre for Respiratory Infection Basic Science Fellowship; Guangzhou Respiratory Institute; Royal Brompton & Harefield NHS Trust; Imperial College London, UK; Medical Research Council [G1000758] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10016, NF-SI-0512-10126, NF-SI-0509-10080] Funding Source: researchfish; Asthma UK [MRC-AsthmaUKCentre, MRC-Asthma UK Centre] Funding Source: researchfish	NIHR Respiratory Biomedical Research Unit; Asmarley Trust; Centre for Respiratory Infection Basic Science Fellowship; Guangzhou Respiratory Institute; Royal Brompton & Harefield NHS Trust; Imperial College London, UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK	This work was supported by the NIHR Respiratory Biomedical Research Unit, Royal Brompton & Harefield NHS Trust and Imperial College London, UK, and by the Asmarley Trust. WC and MF are Senior Investigators of the Wellcome Trust. KFC is an NIHR Senior Investigator. MC was supported by the Centre for Respiratory Infection Basic Science Fellowship. QZ and ZL were supported by the Guangzhou Respiratory Institute, and KFC is a Visiting Professor of the Guangzhou Respiratory Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, Am J Respir Crit Care Med, V162, P2341; Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardenas PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046803; CAZZOLA M, 1991, CLIN THER, V13, P157; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Chung KF, 2014, DRUGS, V74, P719, DOI 10.1007/s40265-014-0213-9; Chung KF, 2013, LANCET RESP MED, V1, P639, DOI 10.1016/S2213-2600(13)70128-0; Chung KF, 2014, EUR RESPIR J, V43, P343, DOI 10.1183/09031936.00202013; Deykin A, 2005, J ALLERGY CLIN IMMUN, V115, P720, DOI 10.1016/j.jaci.2004.12.1129; Donnelly D, 2007, THORAX, V62, P80, DOI 10.1136/thx.2006.058933; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105; Goleva E, 2013, AM J RESP CRIT CARE, V188, P1193, DOI 10.1164/rccm.201304-0775OC; Green BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100645; Hew M, 2006, AM J RESP CRIT CARE, V174, P134, DOI 10.1164/rccm.200512-1930OC; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2015, J ALLERGY CLIN IMMUN; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Huang YJ, 2013, AM J RESP CRIT CARE, V187, P1382, DOI 10.1164/rccm.201303-0488WS; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Jatakanon A, 1998, AM J RESP CRIT CARE, V157, pA875; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; Kraft M, 2000, CLIN CHEST MED, V21, P301, DOI 10.1016/S0272-5231(05)70268-9; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Marri PR, 2013, J ALLERGY CLIN IMMUN, V131, P346, DOI 10.1016/j.jaci.2012.11.013; McKinley L, 2008, J IMMUNOL, V181, P4089, DOI 10.4049/jimmunol.181.6.4089; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Morris A, 2013, AM J RESP CRIT CARE, V187, P1067, DOI 10.1164/rccm.201210-1913OC; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Peters MC, 2014, J ALLERGY CLIN IMMUN, V133, P388, DOI 10.1016/j.jaci.2013.07.036; PIN I, 1992, THORAX, V47, P25, DOI 10.1136/thx.47.1.25; Pragman AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047305; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Ramesh R, 2014, J EXP MED, V211, P89, DOI 10.1084/jem.20130301; Robinson DS, 2003, EUR RESPIR J, V22, P478, DOI 10.1183/09031936.03.00017003; Schwerk N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027913; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; Wood LG, 2010, FREE RADICAL RES, V44, P146, DOI 10.3109/10715760903362576; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Xu X, 2014, ENV MICROBIOLOGY; Yadav V, 2013, INT J PHARMACEUT, V457, P268, DOI 10.1016/j.ijpharm.2013.09.007; Zhang QL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-35	50	113	115	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152724	10.1371/journal.pone.0152724	http://dx.doi.org/10.1371/journal.pone.0152724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078029	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700007
J	da Silva, AFA; Machado, FB; Pavarino, EC; Biselli-Perico, JM; Zampieri, BL; Francisco, RD; Rodrigues, PTM; Machado, DT; Santos-Reboucas, CB; Fernandes, MG; Lopes, SMCD; Rios, AFL; Medina-Acosta, E				Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Pavarino, Erika Cristina; Biselli-Perico, Joice Matos; Zampieri, Bruna Lancia; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Santos-Reboucas, Cintia Barros; Fernandes, Maria Gomes; Chuva de Sousa Lopes, Susana Marina; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique			Trisomy 21 Alters DNA Methylation in Parent-of-Origin-Dependent and -Independent Manners	PLOS ONE			English	Article							MATERNAL UNIPARENTAL DISOMY; DOWN-SYNDROME; GENE-EXPRESSION; HUMAN GENOME; PATERNAL AGE; TRANSCRIPTION FACTORS; IMPRINTED GENES; SEQUENCING DATA; STEM-CELLS; CHROMOSOME-21	The supernumerary chromosome 21 in Down syndrome differentially affects the methylation statuses at CpG dinucleotide sites and creates genome-wide transcriptional dysregulation of parental alleles, ultimately causing diverse pathologies. At present, it is unknown whether those effects are dependent or independent of the parental origin of the nondis-joined chromosome 21. Linkage analysis is a standard method for the determination of the parental origin of this aneuploidy, although it is inadequate in cases with deficiency of samples from the progenitors. Here, we assessed the reliability of the epigenetic 5(m)CpG imprints resulting in the maternally (oocyte)-derived allele methylation at a differentially methylated region (DMR) of the candidate imprinted WRB gene for asserting the parental origin of chromosome 21. We developed a methylation-sensitive restriction enzyme-specific PCR assay, based on the WRB DMR, across single nucleotide polymorphisms (SNPs) to examine the methylation statuses in the parental alleles. In genomic DNA from blood cells of either disomic or trisomic subjects, the maternal alleles were consistently methylated, while the paternal alleles were unmethylated. However, the supernumerary chromosome 21 did alter the methylation patterns at the RUNX1 (chromosome 21) and TMEM131 (chromosome 2) CpG sites in a parent-of-origin-independent manner. To evaluate the 5(m)CpG imprints, we conducted a computational comparative epigenomic analysis of transcriptome RNA sequencing (RNA-Seq) and histone modification expression patterns. We found allele fractions consistent with the transcriptional biallelic expression of WRB and ten neighboring genes, despite the similarities in the confluence of both a 17-histone modification activation backbone module and a 5-histone modification repressive module between the WRB DMR and the DMRs of six imprinted genes. We concluded that the maternally inherited 5(m)CpG imprints at the WRB DMR are uncoupled from the parental allele expression of WRB and ten neighboring genes in several tissues and that trisomy 21 alters DNA methylation in parent-of-origin-dependent and -independent manners.	[Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Lopes Rios, Alvaro Fabricio; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil; [Alves da Silva, Antonio Francisco; Machado, Filipe Brum; Francisco Junior, Ronaldo da Silva; Mozer Rodrigues, Pedro Thyago; Machado, Douglas Terra; Medina-Acosta, Enrique] Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil; [Alves da Silva, Antonio Francisco; Medina-Acosta, Enrique] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil; [Machado, Filipe Brum] Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil; [Pavarino, Erika Cristina; Biselli-Perico, Joice Matos; Zampieri, Bruna Lancia] Fac Med Sao Jose Rio Preto, Sao Paulo, Brazil; [Santos-Reboucas, Cintia Barros] Univ Estado Rio de Janeiro, Dept Genet, BR-20550011 Rio De Janeiro, Brazil; [Fernandes, Maria Gomes; Chuva de Sousa Lopes, Susana Marina] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Universidade do Estado do Rio de Janeiro; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Biotechnol Lab, Rio De Janeiro, Brazil.; da Silva, AFA; Machado, FB; Medina-Acosta, E (corresponding author), Hosp Escola Alvaro Alvim, Mol Identificat & Diagnost Unit, Rio De Janeiro, Brazil.; da Silva, AFA; Medina-Acosta, E (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Grad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.; Machado, FB (corresponding author), Univ Estadual Norte Fluminense, Ctr Biosci & Biotechnol, Postgrad Program Biosci & Biotechnol, Rio De Janeiro, Brazil.	filipebma@yahoo.com.br; anttonio.allves@gmail.com; quique@uenf.br	Zampieri, Bruna/F-7120-2012; Zampieri, Bruna/GOV-3140-2022; Biselli, Joice/AAZ-6259-2021; Medina-Acosta, E./AAN-9724-2021; Junior, Ronaldo S F/I-4073-2014; Santos-Rebouças, Cíntia Barros/C-2230-2018; Pavarino, Érika C/L-5899-2016; Biselli, Joice Matos/B-6913-2014; Rios, Álvaro Fabrício Lopes/AGN-5862-2022; Medina-Acosta, Enrique/G-3041-2010	Zampieri, Bruna/0000-0003-0091-1894; Zampieri, Bruna/0000-0003-0091-1894; Medina-Acosta, E./0000-0002-2529-0548; Junior, Ronaldo S F/0000-0001-7419-3907; Santos-Rebouças, Cíntia Barros/0000-0003-4729-2373; Pavarino, Érika C/0000-0003-0959-0695; Medina-Acosta, Enrique/0000-0002-2529-0548; Matos Biselli, Joice/0000-0001-5105-9537; Terra Machado, Douglas/0000-0002-6580-7628	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [E-26/110.775/2011, E-26/111.715/2012, E26/010.001036/2015]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [301034/2012-5]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Universidade Estadual do Norte Fluminense	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Universidade Estadual do Norte Fluminense	Research supported by grants #E-26/110.775/2011 and #E-26/111.715/2012 and #E26/010.001036/2015 to EM-A from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (http://www.faperj.br/) and #301034/2012-5 to EM-A from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (http://cnpq.br/). AFAS receive a graduate fellowship from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico. FBM received a postgraduate fellowship form the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior. RSFJ received an undergraduate fellowship from Universidade Estadual do Norte Fluminense (http://www.uenf.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONARAKIS SE, 1991, NEW ENGL J MED, V324, P872, DOI 10.1056/NEJM199103283241302; Bacalini MG, 2015, AGING-US, V7, P82; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baran Y, 2015, GENOME RES, V25, P927, DOI 10.1101/gr.192278.115; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; BLOUIN JL, 1993, AM J HUM GENET, V53, P1074; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; Court F, 2014, GENOME RES, V24, P554, DOI 10.1101/gr.164913.113; Court F, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-5; CREAUGOLDBERG N, 1987, HUM GENET, V76, P396, DOI 10.1007/BF00272452; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; De Souza E, 2010, ARCH DIS CHILD, V95, P893, DOI 10.1136/adc.2009.176438; Deelen P, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0152-4; Docherty LE, 2014, J MED GENET, V51, P229, DOI 10.1136/jmedgenet-2013-102116; ERICKSON JD, 1981, J MED GENET, V18, P22, DOI 10.1136/jmg.18.1.22; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; GAULDEN ME, 1992, MUTAT RES, V296, P69, DOI 10.1016/0165-1110(92)90033-6; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; HATCH M, 1990, HUM GENET, V85, P355; HENDERSON DJ, 1994, HUM MOL GENET, V3, P1373, DOI 10.1093/hmg/3.8.1373; Heyn H, 2012, P NATL ACAD SCI USA, V109, P10522, DOI 10.1073/pnas.1120658109; Hodges E, 2011, MOL CELL, V44, P17, DOI 10.1016/j.molcel.2011.08.026; Joergensen MW, 2013, PRENATAL DIAG, V33, P1131, DOI 10.1002/pd.4206; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jones MJ, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-58; Kazaura MR, 2002, PAEDIATR PERINAT EP, V16, P314, DOI 10.1046/j.1365-3016.2002.00446.x; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkel K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001212; Krueger F, 2012, NAT METHODS, V9, P145, DOI [10.1038/NMETH.1828, 10.1038/nmeth.1828]; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Letourneau A, 2014, NATURE, V508, P345, DOI 10.1038/nature13200; Li YR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000533; Liehr T., 2014, UNIPARENTAL DISOMY U; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Machado FB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103714; Mansuet-Lupo A, 2009, FORENSIC SCI INT-GEN, V3, P141, DOI 10.1016/j.fsigen.2008.09.010; Rodriguez JM, 2013, NUCLEIC ACIDS RES, V41, pD110, DOI 10.1093/nar/gks1058; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Meguro M, 2001, NAT GENET, V28, P19, DOI 10.1038/ng0501-19; Muranjan M, 2010, INDIAN PEDIATR, V47, P429, DOI 10.1007/s13312-010-0078-2; Okae H, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004868; Oliver TR, 2009, AM J MED GENET A, V149A, P1685, DOI 10.1002/ajmg.a.32942; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Proudhon C, 2010, BRIEF FUNCT GENOMICS, V9, P374, DOI 10.1093/bfgp/elq020; RACHMILEWITZ J, 1992, FEBS LETT, V309, P25, DOI 10.1016/0014-5793(92)80731-U; Raney BJ, 2014, BIOINFORMATICS, V30, P1003, DOI 10.1093/bioinformatics/btt637; ROBINSON WP, 1994, AM J HUM GENET, V54, P290; Rogan PK, 1999, AM J MED GENET, V83, P69, DOI 10.1002/(SICI)1096-8628(19990305)83:1<69::AID-AJMG14>3.0.CO;2-Q; Sambrook J., 2001, MOL CLONING LAB MANU; Sebastian A, 2014, BIOINFORMATICS, V30, P258, DOI 10.1093/bioinformatics/btt663; Slabicki M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000408; Smith RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-571; Song Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081148; Steyaert S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku847; Stoll C., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P265; SUTHERLAND E, 1992, J MOL BIOL, V225, P327, DOI 10.1016/0022-2836(92)90925-A; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Venkatraman A, 2013, NATURE, V500, P345, DOI 10.1038/nature12303; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wang X, 2014, HEREDITY, V113, P156, DOI 10.1038/hdy.2014.18; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Whitaker JW, 2015, NAT METHODS, V12, P265, DOI [10.1038/NMETH.3065, 10.1038/nmeth.3065]; Wood DLA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126911; Xie W, 2013, CELL, V153, P1134, DOI 10.1016/j.cell.2013.04.022; Zeng J, 2012, AM J HUM GENET, V91, P455, DOI 10.1016/j.ajhg.2012.07.024; Zigman WB, 2013, DEV DISABIL RES REV, V18, P51, DOI 10.1002/ddrr.1128; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	75	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154108	10.1371/journal.pone.0154108	http://dx.doi.org/10.1371/journal.pone.0154108			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100087	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500146
J	Bosch-Belmar, M; M'Rabet, C; Dhaouadi, R; Chalghaf, M; Yahia, MND; Fuentes, V; Piraino, S; Yahia, OKD				Bosch-Belmar, Mar; M'Rabet, Charaf; Dhaouadi, Raouf; Chalghaf, Mohamed; Yahia, Mohamed Nejib Daly; Fuentes, Veronica; Piraino, Stefano; Yahia, Ons Kefi-Daly			Jellyfish Stings Trigger Gill Disorders and Increased Mortality in Farmed Sparus aurata (Linnaeus, 1758) in the Mediterranean Sea	PLOS ONE			English	Article							PELAGIA-NOCTILUCA CNIDARIA; TENACIBACULUM-MARITIMUM; PERIPHYLLA-PERIPHYLLA; FISH; DISEASE; EPITHELIOCYSTIS; TEMPERATURE; INFECTION; SCYPHOZOA; BEHAVIOR	Jellyfish are of particular concern for marine finfish aquaculture. In recent years repeated mass mortality episodes of farmed fish were caused by blooms of gelatinous cnidarian stingers, as a consequence of a wide range of hemolytic, cytotoxic, and neurotoxic properties of associated cnidocytes venoms. The mauve stinger jellyfish Pelagia noctiluca (Scyphozoa) has been identified as direct causative agent for several documented fish mortality events both in Northern Europe and the Mediterranean Sea aquaculture farms. We investigated the effects of P. noctiluca envenomations on the gilthead sea bream Sparus aurata by in vivo laboratory assays. Fish were incubated for 8 hours with jellyfish at 3 different densities in 300 l experimental tanks. Gill disorders were assessed by histological analyses and histopathological scoring of samples collected at time intervals from 3 hours to 4 weeks after initial exposure. Fish gills showed different extent and severity of gill lesions according to jellyfish density and incubation time, and long after the removal of jellyfish from tanks. Jellyfish envenomation elicits local and systemic inflammation reactions, histopathology and gill cell toxicity, with severe impacts on fish health. Altogether, these results shows P. noctiluca swarms may represent a high risk for Mediterranean finfish aquaculture farms, generating significant gill damage after only a few hours of contact with farmed S. aurata. Due to the growth of the aquaculture sector and the increased frequency of jellyfish blooms in the coastal waters, negative interactions between stinging jellyfish and farmed fish are likely to increase with the potential for significant economic losses.	[Bosch-Belmar, Mar; Piraino, Stefano] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, Lecce, Italy; [M'Rabet, Charaf; Yahia, Ons Kefi-Daly] Natl Agron Inst Tunis, Res Grp Oceanog & Plankton, Tunis, Tunisia; [Dhaouadi, Raouf] Ecole Natl Med Vet, Sidi Thabet Ariana, Tunisia; [Chalghaf, Mohamed] Inst Super Peche & Aquaculture Bizerte, Bizerte, Tunisia; [Yahia, Mohamed Nejib Daly] Fac Sci Bizerte, Jarzouna, Tunisia; [Fuentes, Veronica] CSIC, ICM, Barcelona, Spain; [Bosch-Belmar, Mar; Piraino, Stefano] Consorzio Nazl Interuniv Sci Mare, CONISMA, Rome, Italy	University of Salento; Universite de Carthage; Universite de la Manouba; Universite de Carthage; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); CoNISMa	Bosch-Belmar, M; Piraino, S (corresponding author), Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali, Lecce, Italy.; Bosch-Belmar, M; Piraino, S (corresponding author), Consorzio Nazl Interuniv Sci Mare, CONISMA, Rome, Italy.	mar.b.belmar@gmail.com; stefano.piraino@unisalento.it	Piraino, Stefano/J-5234-2012	Piraino, Stefano/0000-0002-8752-9390; Kefi Daly Yahia, Ons/0000-0001-9532-8989; Bosch Belmar, Maria del Mar/0000-0002-1712-5745; Mohamed Nejib, DALY YAHIA/0000-0002-1049-2171	EU [I-A/1.3/098, 266445]; CERES project (Climate Change and European Aquatic Resources) [678193]	EU(European Commission); CERES project (Climate Change and European Aquatic Resources)	The present work was developed within the framework of the EU-funded projects MED-JELLYRISK, (www.jellyrisk.eu) (ENPI CBCMED programme, grant no. I-A/1.3/098), and VECTORS, (http://www.marine-vectors.eu) (Vectors of Change in Oceans and Seas Marine Life, Impact on Economic Sectors, grant no. 266445). Moreover, CERES project, (http://ceresproject.eu) (Climate Change and European Aquatic Resources, grant no. 678193) belonging to European Union's Horizon 2020 research and innovation programme has also partially supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATES R M L, 1988, Zoologische Mededelingen (Leiden), V62, P29; Avendano-Herrera R, 2006, DIS AQUAT ORGAN, V71, P255, DOI 10.3354/dao071255; AXIAK V, 1984, UNEP WORKSH JELL BLO, P121; Baxter E.J., 2011, 13 C NAC AC BARC; Baxter EJ, 2011, AQUACULT ENV INTERAC, V1, P245, DOI 10.3354/aei00024; Baxter EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018529; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Bruno DW, 1985, B EUR ASS FISH PATHO, V5, P1984; Byrne M, 2013, INTEGR COMP BIOL, V53, P582, DOI 10.1093/icb/ict049; Canepa Antonio, 2014, P237; Carlson C, 2010, P REL MAINT S; CIESM, 2001, CIESM WORKSHOP SERIE, V14, P112; Colloca F, 2015, SPARUS AURATA; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; D'Ambra I, 2015, MAR BIOL, V162, P247, DOI 10.1007/s00227-014-2569-5; Delannoy CMJ, 2011, AQUACULTURE, V311, P255, DOI 10.1016/j.aquaculture.2010.11.033; Doyle TK, 2008, J PLANKTON RES, V30, P963, DOI 10.1093/plankt/fbn052; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ 2; Ferguson HW, 2010, J VET DIAGN INVEST, V22, P376, DOI 10.1177/104063871002200305; Ferraris M, 2012, J PLANKTON RES, V34, P874, DOI 10.1093/plankt/fbs049; FIS, 2014, JELL KILLS 1000S SAL; Fossa J., 2003, FISK HAVET, V2, P99; FRANQUEVILLE C, 1971, Tethys, V3, P11; He W, 2015, COMP BIOCHEM PHYS A, V187, P232, DOI 10.1016/j.cbpa.2014.05.004; Helmholz H, 2010, HYDROBIOLOGIA, V645, P223, DOI 10.1007/s10750-010-0216-9; HOFFMAN GL, 1969, ANTON VAN LEE J M S, V35, P146, DOI 10.1007/BF02219125; Ingerslev HC, 2010, FISH SHELLFISH IMMUN, V29, P440, DOI 10.1016/j.fsi.2010.05.002; MALEJ A, 1989, J EXP MAR BIOL ECOL, V126, P259, DOI 10.1016/0022-0981(89)90191-3; March MI, 2015, J MATERN-FETAL NEO M, V28, P1285, DOI 10.3109/14767058.2014.951624; dos Santos DCM, 2012, EXP TOXICOL PATHOL, V64, P861, DOI 10.1016/j.etp.2011.03.007; Milisenda G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094600; Mitchell S. O., 2013, Veterinary Record Case Reports, V1, pe100045, DOI 10.1136/vetreccr.100045rep; Mitchell SO, 2011, J FISH DIS, V34, P411, DOI 10.1111/j.1365-2761.2011.01251.x; Mitchell SO, 2012, AQUACULT INT, V20, P813, DOI 10.1007/s10499-012-9504-x; Nowak BF, 2006, J FISH DIS, V29, P573, DOI 10.1111/j.1365-2761.2006.00747.x; Park IS, 2011, LAB ANIMAL, V40, P45, DOI 10.1038/laban0211-45; Powell MD, 2005, DIS AQUAT ORGAN, V63, P169, DOI 10.3354/dao063169; Purcell JE, 2013, WOODHEAD PUBL FOOD S, P404, DOI 10.1533/9780857097460.2.404; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Rodger HD, 2011, REV FISH BIOL FISHER, V21, P423, DOI 10.1007/s11160-010-9182-6; Rosa S, 2013, J MARINE SYST, V111, P97, DOI 10.1016/j.jmarsys.2012.10.001; Ruane N. M., 2012, FISH VET J, V13, P17; Seaton D.D., 1989, Aquaculture Information Series, P1; Sornes TA, 2007, J PLANKTON RES, V29, P157, DOI 10.1093/plankt/fbm003; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Youngbluth MJ, 2001, HYDROBIOLOGIA, V451, P321, DOI 10.1023/A:1011874828960; ZAVODNIK D, 1987, MAR BIOL, V94, P265, DOI 10.1007/BF00392939	48	23	23	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154239	10.1371/journal.pone.0154239	http://dx.doi.org/10.1371/journal.pone.0154239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100175	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500171
J	Loturco, I; Pereira, LA; Kobal, R; Maldonado, T; Piazzi, AF; Bottino, A; Kitamura, K; Abad, CCC; de Arruda, M; Nakamura, FY				Loturco, Irineu; Pereira, Lucas Adriano; Kobal, Ronaldo; Maldonado, Thiago; Piazzi, Alessandro Fromer; Bottino, Altamiro; Kitamura, Katia; Cal Abad, Cesar Cavinato; de Arruda, Miguel; Nakamura, Fabio Yuzo			Improving Sprint Performance in Soccer: Effectiveness of Jump Squat and Olympic Push Press Exercises	PLOS ONE			English	Article							VERTICAL JUMP; POWER; STRENGTH; ACCELERATION; FORCE; SPEED; HIP; AGILITY; PLAYERS; IMPULSE	Training at the optimum power load (OPL) is an effective way to improve neuromuscular abilities of highly trained athletes. The purpose of this study was to test the effects of training using the jump squat (JS) or Olympic push-press (OPP) exercises at the OPL during a short-term preseason on speed-power related abilities in high-level under-20 soccer players. The players were divided into two training groups: JS group (JSG) and OPP group (OPPG). Both groups undertook 12 power-oriented sessions, using solely JS or OPP exercises. Pre-and post-6 weeks of training, athletes performed squat jump (SJ), countermovement jump (CMJ), sprinting speed (5, 10, 20 and 30 m), change of direction (COD) and speed tests. To calculate the transfer effect coefficient (TEC) between JS and MPP OPP and the speed in 5, 10, 20, and 30 m, the ratio between the result gain (effect size [ES]) in the untrained exercise and result gain in the trained exercise was calculated. Magnitude based inference and ES were used to test the meaningful effects. The TEC between JS and VEL 5, 10, 20, and 30 m ranged from 0.77 to 1.29, while the only TEC which could be calculated between OPP and VEL 5 was rather low (0.2). In addition, the training effects of JS on jumping and speed related abilities were superior (ES ranging from small to large) to those caused by OPP (trivial ES). To conclude, the JS exercise is superior to the OPP for improving speed-power abilities in elite young soccer players.	[Loturco, Irineu; Pereira, Lucas Adriano; Kobal, Ronaldo; Kitamura, Katia; Cal Abad, Cesar Cavinato; Nakamura, Fabio Yuzo] NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil; [Maldonado, Thiago; Piazzi, Alessandro Fromer; Bottino, Altamiro] Palmeiras Sport Soc, Sao Paulo, SP, Brazil; [de Arruda, Miguel] Univ Estadual Campinas, Campinas, SP, Brazil; [Nakamura, Fabio Yuzo] Univ Estadual Londrina, Londrina, PR, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Londrina	Loturco, I (corresponding author), NAR Nucleus High Performance Sport, Sao Paulo, SP, Brazil.	irineu.loturco@terra.com.br	Pereira, Lucas/S-3110-2019; Loturco, Irineu/AAH-4916-2019; Nakamura, Fábio Yuzo/AAC-3069-2020; PEREIRA, LUCAS/HHZ-5877-2022; Kobal, Ronaldo/AAU-8415-2021	Pereira, Lucas/0000-0003-1079-2446; Loturco, Irineu/0000-0003-1309-2568; Nakamura, Fábio Yuzo/0000-0002-5336-3652; Kobal, Ronaldo/0000-0003-0243-2133				Adams K., 1992, J STRENGTH COND RES, V6, P36, DOI DOI 10.1519/00124278-199202000-00006; Barnes C, 2014, INT J SPORTS MED, V35, P1095, DOI 10.1055/s-0034-1375695; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Beardsley C, 2014, STRENGTH COND J, V36, P49, DOI 10.1519/SSC.0000000000000047; Bloomquist K, 2013, EUR J APPL PHYSIOL, V113, P2133, DOI 10.1007/s00421-013-2642-7; Bobbert MF, 1996, MED SCI SPORT EXER, V28, P1402, DOI 10.1097/00005768-199611000-00009; Chiu LZF, 2006, J STRENGTH COND RES, V20, P555; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Delecluse C, 1997, SPORTS MED, V24, P147, DOI 10.2165/00007256-199724030-00001; Engebretsen AH, 2010, AM J SPORT MED, V38, P1147, DOI 10.1177/0363546509358381; Faude O, 2013, J SPORT SCI, V31, P1460, DOI 10.1080/02640414.2013.796065; Garnacho-Castano MV, 2015, J SPORT SCI MED, V14, P128; Harrison CB, 2015, INT J SPORTS MED, V36, P929, DOI 10.1055/s-0034-1396825; Hewit JK, 2012, INT J SPORTS SCI COA, V7, P493, DOI 10.1260/1747-9541.7.3.493; Hill-Haas SV, 2009, INT J SPORTS MED, V30, P636, DOI 10.1055/s-0029-1220730; Holmberg PM, 2013, STRENGTH COND J, V35, P79, DOI 10.1519/SSC.0b013e3182889f47; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunter JP, 2005, J APPL BIOMECH, V21, P31, DOI 10.1123/jab.21.1.31; Impellizzeri FM, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038497; Katis A, 2009, J SPORT SCI MED, V8, P374; Kilgallon M, 2010, STRENGTH COND J, V32, P26, DOI 10.1519/SSC.0b013e3181e92d37; Lake JP, 2014, J STRENGTH COND RES, V28, P2552, DOI 10.1519/JSC.0000000000000438; Lees A, 2004, J STRENGTH COND RES, V18, P787, DOI 10.1519/00124278-200411000-00018; Little T, 2005, J STRENGTH COND RES, V19, P76; Loturco I, 2015, J STRENGTH IN PRESS; Loturco I, 2015, INT J SPORT IN PRESS; Loturco I, 2016, J STRENGTH COND RES, V30, P109, DOI 10.1519/JSC.0000000000001075; Loturco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140102; Loturco I, 2015, J STRENGTH COND RES, V29, P1966, DOI 10.1519/JSC.0000000000000849; Loturco I, 2015, J SPORT SCI, V33, P1283, DOI 10.1080/02640414.2015.1022574; Loturco I, 2015, J STRENGTH COND RES, V29, P758, DOI 10.1519/JSC.0000000000000660; Loturco I, 2014, J STRENGTH COND RES, V28, P1826, DOI 10.1519/JSC.0000000000000329; Loturco I, 2013, J SPORT SCI MED, V12, P109; Moss BM, 1997, EUR J APPL PHYSIOL, V75, P193, DOI 10.1007/s004210050147; Noon MR, 2015, J SPORTS SCI, V18, P1; Ohton DD, 1988, STRENGTH COND J, V10, P4; Plisk SS, 2003, STRENGTH COND J, V25, P19, DOI 10.1519/1533-4295(2003)025<0019:PS>2.0.CO;2; Rampinini E, 2007, J SPORT SCI, V25, P659, DOI 10.1080/02640410600811858; Requena B, 2011, J STRENGTH COND RES, V25, P2193, DOI 10.1519/JSC.0b013e3181e86132; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Schache AG, 2011, MED SCI SPORT EXER, V43, P1260, DOI 10.1249/MSS.0b013e3182084929; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Sleivert G, 2004, EUR J APPL PHYSIOL, V91, P46, DOI 10.1007/s00421-003-0941-0; Stone MH, 2003, J STRENGTH COND RES, V17, P140; Tsiokanos A, 2002, ISOKINET EXERC SCI, V10, P107, DOI 10.3233/IES-2002-0092; Waller M, 2013, STRENGTH COND J, V35, P82, DOI 10.1519/SSC.0b013e318276c36e; Wilson JM, 2008, J STRENGTH COND RES, V22, P1705, DOI 10.1519/JSC.0b013e31817ae4a7; Yamauchi J, 2007, J STRENGTH COND RES, V21, P703, DOI 10.1519/00124278-200708000-00009; Zatsiorsky V., 2006, SCI PRACTICE STRENGT, V2nd ed.	50	40	40	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153958	10.1371/journal.pone.0153958	http://dx.doi.org/10.1371/journal.pone.0153958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100085	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500110
J	Pulla, S; Riotte, J; Suresh, HS; Dattaraja, HS; Sukumar, R				Pulla, Sandeep; Riotte, Jean; Suresh, H. S.; Dattaraja, H. S.; Sukumar, Raman			Controls of Soil Spatial Variability in a Dry Tropical Forest	PLOS ONE			English	Article							DECIDUOUS FOREST; WEATHERING FLUXES; SOUTH-INDIA; MULE HOLE; NITROGEN-FIXATION; N-MINERALIZATION; CHEMICAL FLUXES; WESTERN-GHATS; NUTRIENTS; EROSION	We examined the roles of lithology, topography, vegetation and fire in generating local-scale (< 1 km(2)) soil spatial variability in a seasonally dry tropical forest (SDTF) in southern India. For this, we mapped soil (available nutrients, Al, total C, pH, moisture and texture in the top 10cm), rock outcrops, topography, all native woody plants >= 1 cm diameter at breast height (DBH), and spatial variation in fire frequency (times burnt during the 17 years preceding soil sampling) in a permanent 50-ha plot. Unlike classic catenas, lower elevation soils had lesser moisture, plant-available Ca, Cu, Mn, Mg, Zn, B, clay and total C. The distribution of plant-available Ca, Cu, Mn and Mg appeared to largely be determined by the whole-rock chemical composition differences between amphibolites and hornblende-biotite gneisses. Amphibolites were associated with summit positions, while gneisses dominated lower elevations, an observation that concurs with other studies in the region which suggest that hillslope-scale topography has been shaped by differential weathering of lithologies. Neither NO3--N nor NH4+-N was explained by the basal area of trees belonging to Fabaceae, a family associated with N-fixing species, and no long-term effects of fire on soil parameters were detected. Local-scale lithological variation is an important first-order control over soil variability at the hillslope scale in this SDTF, by both direct influence on nutrient stocks and indirect influence via control of local relief.	[Pulla, Sandeep; Suresh, H. S.; Dattaraja, H. S.; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Riotte, Jean] Indian Inst Sci, Indofrench Cell Water Sci, Bangalore 560012, Karnataka, India; [Riotte, Jean] Univ Toulouse 3, CNRS, IRD, Geosci Environm Toulouse, F-31400 Toulouse, France	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sukumar, R (corresponding author), Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India.	rsuku@ces.iisc.ernet.in	Raman, Sukumar/C-9809-2013; Riotte, Jean/K-7185-2017; Pulla, Sandeep/AAV-5488-2021; IFCWS, LMI/C-5187-2013	Riotte, Jean/0000-0002-5563-1913; Pulla, Sandeep/0000-0002-2959-8929; 	Ministry of Environment and Forests, Government of India, India; Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA; Department of Science and Technology, Ministry of Science and Technology, Government of India, India; Institut National des Sciences de l'Univers (INSU-CNRS); Institut de Recherche pour le Developpement, France	Ministry of Environment and Forests, Government of India, India; Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA; Department of Science and Technology, Ministry of Science and Technology, Government of India, India; Institut National des Sciences de l'Univers (INSU-CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut de Recherche pour le Developpement, France	This work was supported by 1) Ministry of Environment and Forests, Government of India, India (http://www.moef.nic.in) (grant recipient: RS); 2) Centre for Tropical Forest Science, Smithsonian Tropical Research Institute, USA (http://www.forestgeo.si.edu); 3) Department of Science and Technology, Ministry of Science and Technology, Government of India, India (http://dst.gov.in) (grant recipient: RS); and 4) Institut National des Sciences de l'Univers (INSU-CNRS) (http://www.insu.cnrs.fr) & Institut de Recherche pour le Developpement (http://www.ird.fr), France (grant recipient: JR).	Baldeck CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI [10.1098/rspb.2012.2532, 10.1098/rspb.2013.0548]; Barbiero L, 2010, GEODERMA, V156, P173, DOI 10.1016/j.geoderma.2010.02.014; Barbiero L, 2007, CATENA, V70, P313, DOI 10.1016/j.catena.2006.10.013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bern CR, 2005, ECOLOGY, V86, P626, DOI 10.1890/03-0766; Beven K.J., 1979, HYDROL SCI B, V24, P43, DOI [10.1080/02626667909491834, DOI 10.1080/02626667909491834]; Binkley D., 1995, Special Publication - Agronomy Society of New Zealand, P1; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Braun JJ, 2012, GEOCHIM COSMOCHIM AC, V99, P243, DOI 10.1016/j.gca.2012.09.024; Braun JJ, 2009, GEOCHIM COSMOCHIM AC, V73, P935, DOI 10.1016/j.gca.2008.11.013; Callaham MA, 2008, RESTOR ECOL, V16, P604, DOI 10.1111/j.1526-100X.2008.00490.x; Campo J, 1998, OECOLOGIA, V115, P167, DOI 10.1007/s004420050504; Campo J., 2001, Agrociencia, V35, P245; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Chardon D, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005299; Clark DB, 1998, J ECOL, V86, P101, DOI 10.1046/j.1365-2745.1998.00238.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cotler H, 2006, CATENA, V65, P107, DOI 10.1016/j.catena.2005.11.004; DeBano LF, 2000, J HYDROL, V231, P195, DOI 10.1016/S0022-1694(00)00194-3; Dockersmith IC, 1999, PLANT SOIL, V209, P137, DOI 10.1023/A:1004503023973; DRECHSEL P, 1991, PLANT SOIL, V131, P29, DOI 10.1007/BF00010417; DRURY SA, 1980, TECTONOPHYSICS, V65, pT1, DOI 10.1016/0040-1951(80)90073-6; Durand N, 2007, QUATERN INT, V162, P35, DOI 10.1016/j.quaint.2006.10.026; DUTILLEUL P, 1993, BIOMETRICS, V49, P305, DOI 10.2307/2532625; Ettema CH, 2002, TRENDS ECOL EVOL, V17, P177, DOI 10.1016/S0169-5347(02)02496-5; Fine PVA, 2005, EVOLUTION, V59, P1464; Fortin M., 2000, B ECOL SOC AM, V81, P201, DOI DOI 10.2307/20168439; Fu P. M., 1999, P 19 ANN ESRI US C, V1, P31; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; GARCIAOLIVA F, 1995, GEODERMA, V68, P135, DOI 10.1016/0016-7061(95)00030-R; George M, 1988, FOREST SOIL VEGETATI; Gessler PE, 2000, SOIL SCI SOC AM J, V64, P2046, DOI 10.2136/sssaj2000.6462046x; Giardina CP, 2000, SOIL SCI SOC AM J, V64, P399, DOI 10.2136/sssaj2000.641399x; Grogan James, 2006, Acta Amaz., V36, P483, DOI 10.1590/S0044-59672006000400009; Gunnell Y, 1998, BASIN RES, V10, P281, DOI 10.1046/j.1365-2117.1998.00072.x; Gunnell Y, 1997, CATENA, V29, P239, DOI 10.1016/S0341-8162(96)00070-7; Gunnell Y, 2014, WOR GEOMORPHOL LANDS, P195, DOI 10.1007/978-94-017-8029-2_20; Hirobe M, 2003, PLANT SOIL, V249, P309, DOI 10.1023/A:1022804326662; Holloway JM, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2002GB001862; Jenny H., 1941, FACTORS SOIL FORMATI, DOI 10.1097/00010694-194111000-00009; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Khomo L, 2011, CATENA, V87, P119, DOI 10.1016/j.catena.2011.05.017; Kodandapani N, 2008, FOREST ECOL MANAG, V256, P607, DOI 10.1016/j.foreco.2008.05.006; KUMAR BM, 1992, FOREST ECOL MANAG, V50, P181, DOI 10.1016/0378-1127(92)90335-7; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; LECHOWICZ MJ, 1991, J ECOL, V79, P687, DOI 10.2307/2260661; Maher K, 2011, EARTH PLANET SC LETT, V312, P48, DOI 10.1016/j.epsl.2011.09.040; Montano NM, 2013, REV BIOL TROP, V61, P439; Marechal JC, 2009, J HYDROL, V364, P272, DOI 10.1016/j.jhydrol.2008.11.006; McShea W, 2011, ECOLOGY CONSERVATION, P59; Mehta P, 2014, THESIS JAWAHARLAL NE; Meissner B, 2002, PRECAMBRIAN RES, V114, P149, DOI 10.1016/S0301-9268(01)00222-4; Mengel K, 1982, Principles of plant nutrition.; Mondal N, 2014, CURR SCI INDIA, V107, P1590; MOONEY HA, 1995, SEASONALLY DRY TROPI, P1, DOI DOI 10.1017/CBO9780511753398.001; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; MURPHY PG, 1986, ANNU REV ECOL SYST, V17, P67, DOI 10.1146/annurev.es.17.110186.000435; Paoli GD, 2006, J ECOL, V94, P157, DOI 10.1111/j.1365-2745.2005.01077.x; Phillips JD, 2005, GEODERMA, V124, P73, DOI 10.1016/j.geoderma.2004.04.004; Porder S, 2006, ECOLOGY, V87, P594, DOI 10.1890/05-0394; Porder S, 2009, ECOLOGY, V90, P623, DOI 10.1890/07-1739.1; R Core Team, 2021, R LANGUAGE ENV STAT; RAGHUBANSHI AS, 1992, SOIL BIOL BIOCHEM, V24, P145, DOI 10.1016/0038-0717(92)90270-8; Riotte J, 2014, PROCED EARTH PLAN SC, V10, P34, DOI 10.1016/j.proeps.2014.08.007; Riotte J, 2014, GEOCHIM COSMOCHIM AC, V145, P116, DOI 10.1016/j.gca.2014.09.015; Rodriguez A, 2009, GEODERMA, V151, P303, DOI 10.1016/j.geoderma.2009.04.019; ROY S, 1994, J ECOL, V82, P503, DOI 10.2307/2261259; ROY S, 1995, SOIL BIOL BIOCHEM, V27, P33, DOI 10.1016/0038-0717(94)00138-Q; Roy S, 1996, Oecologia Montana, V5, P21; Ruiz L, 2010, J HYDROL, V380, P460, DOI 10.1016/j.jhydrol.2009.11.020; Samuel VO, 2014, PRECAMBRIAN RES, V245, P146, DOI 10.1016/j.precamres.2014.02.002; Schaetzl RJ, 2005, SOILS: GENESIS AND GEOMORPHOLOGY, P1, DOI 10.1017/CBO9780511815560; Schaetzl R.J., 2013, TREATISE GEOMORPHOLO, P145, DOI [10.1016/B978-0-12-374739-6.00074-9, DOI 10.1016/B978-0-12-374739-6.00074-9]; SCHWERTMANN U, 1991, PLANT SOIL, V130, P1, DOI 10.1007/BF00011851; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; Sharma A, 2000, CHEM GEOL, V166, P203, DOI 10.1016/S0009-2541(99)00222-3; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Singh Jay Shankar, 2007, Tropical Ecology, V48, P27; SINGH JS, 1989, NATURE, V338, P499, DOI 10.1038/338499a0; SOLTIS DE, 1995, P NATL ACAD SCI USA, V92, P2647, DOI 10.1073/pnas.92.7.2647; Srikantappa C, 1988, MEMOIR GEOL SOC INDI, V11, P117; Sukumar R., 2005, P510, DOI 10.1017/CBO9780511541971.022; SUKUMAR R, 1992, CURR SCI INDIA, V62, P608; Toledo M, 2012, J ECOL, V100, P253, DOI 10.1111/j.1365-2745.2011.01890.x; Townsend AR, 2007, ECOLOGY, V88, P107, DOI 10.1890/0012-9658(2007)88[107:COFNRI]2.0.CO;2; Violette A, 2010, GEOCHIM COSMOCHIM AC, V74, P7059, DOI 10.1016/j.gca.2010.09.006; Violette A, 2010, CHEM GEOL, V277, P42, DOI 10.1016/j.chemgeo.2010.07.009; Vitousek P, 2003, ECOSYSTEMS, V6, P762, DOI 10.1007/s10021-003-0199-8; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601	91	12	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153212	10.1371/journal.pone.0153212	http://dx.doi.org/10.1371/journal.pone.0153212			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100088	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000374898500026
J	Regan, S; Meigs, JB; Grinspoon, SK; Triant, VA				Regan, Susan; Meigs, James B.; Grinspoon, Steven K.; Triant, Virginia A.			Determinants of Smoking and Quitting in HIV-Infected Individuals	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; MYOCARDIAL-INFARCTION RATES; RISK-FACTORS; ANTIRETROVIRAL THERAPY; CIGARETTE-SMOKING; MENTAL-ILLNESS; TOBACCO USE; IMMUNODEFICIENCY; CESSATION; POPULATION	Background Cigarette smoking is widespread among HIV-infected patients, who confront increased risk of smoking-related co-morbidities. The effects of HIV infection and HIV-related variables on smoking and smoking cessation are incompletely understood. We investigated the correlates of smoking and quitting in an HIV-infected cohort using a validated natural language processor to determine smoking status. Method We developed and validated an algorithm using natural language processing (NLP) to ascertain smoking status from electronic health record data. The algorithm was applied to records for a cohort of 3487 HIV-infected from a large health care system in Boston, USA, and 9446 uninfected control patients matched 3: 1 on age, gender, race and clinical encounters. NLP was used to identify and classify smoking-related portions of free-text notes. These classifications were combined into patient-year smoking status and used to classify patients as ever versus never smokers and current smokers versus non-smokers. Generalized linear models were used to assess associations of HIV with 3 outcomes, ever smoking, current smoking, and current smoking in analyses limited to ever smokers (persistent smoking), while adjusting for demographics, cardiovascular risk factors, and psychiatric illness. Analyses were repeated within the HIV cohort, with the addition of CD4 cell count and HIV viral load to assess associations of these HIV-related factors with the smoking outcomes. Results Using the natural language processing algorithm to assign annual smoking status yielded sensitivity of 92.4, specificity of 86.2, and AUC of 0.89 (95% confidence interval [CI] 0.88-0.91). Ever and current smoking were more common in HIV-infected patients than controls (54% vs. 44% and 42% vs. 30%, respectively, both P< 0.001). In multivariate models HIV was independently associated with ever smoking (adjusted rate ratio [ARR] 1.18, 95% CI 1.13-1.24, P < 0.001), current smoking (ARR 1.33, 95% CI 1.25-1.40, P< 0.001), and persistent smoking (ARR 1.11, 95% CI 1.07-1.15, P< 0.001). Within the HIV cohort, having a detectable HIV RNA was significantly associated with all three smoking outcomes. Conclusions HIV was independently associated with both smoking and not quitting smoking, using a novel algorithm to ascertain smoking status from electronic health record data and accounting for multiple confounding clinical factors. Further research is needed to identify HIV-related barriers to smoking cessation and develop aggressive interventions specific to HIV-infected patients.	[Regan, Susan; Meigs, James B.; Triant, Virginia A.] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA; [Regan, Susan; Meigs, James B.; Grinspoon, Steven K.; Triant, Virginia A.] Harvard Univ, Sch Med, Boston, MA USA; [Grinspoon, Steven K.] Massachusetts Gen Hosp, Program Nutr Metab, Boston, MA 02114 USA; [Triant, Virginia A.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Regan, S (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.; Regan, S (corresponding author), Harvard Univ, Sch Med, Boston, MA USA.	sregan@partners.org	Meigs, James/P-3927-2019	Meigs, James/0000-0002-2439-2657	American Heart Association [10CRP2790003]; National Institutes of Health [K24 DK080140, K24 DK064545, K01 AI073109]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL125029, R21HL122138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI073109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK080140, K24DK064545] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by American Heart Association 10CRP2790003 (VAT) and National Institutes of Health K24 DK080140 (JBM), K24 DK064545 (SKG), and K01 AI073109 (VAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard A, 2007, AIDS PATIENT CARE ST, V21, P458, DOI 10.1089/apc.2006.0142; Burkhalter JE, 2005, NICOTINE TOB RES, V7, P511, DOI 10.1080/14622200500186064; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1227; Clark C, 2008, J AM MED INFORM ASSN, V15, P36, DOI 10.1197/jamia.M2442; Clifford GM, 2012, BRIT J CANCER, V106, P447, DOI 10.1038/bjc.2011.558; Currier JS, 2003, JAIDS-J ACQ IMM DEF, V33, P506, DOI 10.1097/00126334-200308010-00012; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Duval X, 2008, ANTIVIR THER, V13, P389; Elzi L, 2006, ANTIVIR THER, V11, P787; Fiore MC, 2008, TREATING TOBACCO USE; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Friis-Moller N, 2003, AIDS, V17, P1179, DOI 10.1097/00002030-200305230-00010; Gritz ER, 2004, NICOTINE TOB RES, V6, P71, DOI 10.1080/14622200310001656885; Grover KW, 2012, ADDICT BEHAV, V37, P682, DOI 10.1016/j.addbeh.2012.01.014; Hazlehurst B, 2005, AM J PREV MED, V29, P434, DOI 10.1016/j.amepre.2005.08.007; Heinze DT, 2008, J AM MED INFORM ASSN, V15, P40, DOI 10.1197/jamia.M2438; Helleberg M, 2013, CLIN INFECT DIS, V56, P727, DOI 10.1093/cid/cis933; Huber M, 2012, HIV MED, V13, P387, DOI 10.1111/j.1468-1293.2011.00984.x; Klein D, 2002, J ACQ IMMUN DEF SYND, V30, P471, DOI 10.1097/00126334-200208150-00002; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Lasser K, 2000, JAMA-J AM MED ASSOC, V284, P2606, DOI 10.1001/jama.284.20.2606; Lifson AR, 2010, AM J PUBLIC HEALTH, V100, P1896, DOI 10.2105/AJPH.2009.188664; Mamary EM, 2002, AIDS PATIENT CARE ST, V16, P39, DOI 10.1089/108729102753429389; McGinnis KA, 2011, NICOTINE TOB RES, V13, P1233, DOI 10.1093/ntr/ntr206; Mdodo R, 2015, ANN INTERN MED, V162, P335, DOI 10.7326/M14-0954; Petoumenos K, 2011, HIV MED, V12, P412, DOI 10.1111/j.1468-1293.2010.00901.x; Prochaska JJ, 2011, NEW ENGL J MED, V365, P196, DOI 10.1056/NEJMp1105248; Saves M, 2003, CLIN INFECT DIS, V37, P292, DOI 10.1086/375844; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Silverberg MJ, 2014, JAIDS-J ACQ IMM DEF, V65, P160, DOI 10.1097/QAI.0000000000000009; Tipping B, 2007, J NEUROL NEUROSUR PS, V78, P1320, DOI 10.1136/jnnp.2007.116103; Triant VA, 2012, CLIN INFECT DIS, V54, P408, DOI 10.1093/cid/cir829; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Triant VA, 2012, J INFECT DIS, V205, pS355, DOI 10.1093/infdis/jis195; Triant VA, 2010, JAIDS-J ACQ IMM DEF, V55, P615, DOI 10.1097/QAI.0b013e3181f4b752; Vidrine DJ, 2012, NICOTINE TOB RES, V14, P106, DOI 10.1093/ntr/ntr121; Vidrine DJ, 2006, AIDS, V20, P253, DOI 10.1097/01.aids.0000198094.23691.58; Vittecoq D, 2003, AIDS, V17, pS70, DOI 10.1097/00002030-200304001-00010; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Zeng Qing T, 2006, BMC Med Inform Decis Mak, V6, P30, DOI 10.1186/1472-6947-6-30; Ziedonis D, 2008, NICOTINE TOB RES, V10, P1691, DOI 10.1080/14622200802443569	41	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153103	10.1371/journal.pone.0153103	http://dx.doi.org/10.1371/journal.pone.0153103			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27099932	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500025
J	Wang, B; Zhang, YH; Hao, BZ; Xu, XX; Zhao, ZG; Wang, ZM; Xue, QW				Wang, Bin; Zhang, Yinghua; Hao, Baozhen; Xu, Xuexin; Zhao, Zhigan; Wang, Zhimin; Xue, Qingwu			Grain Yield and Water Use Efficiency in Extremely-Late Sown Winter Wheat Cultivars under Two Irrigation Regimes in the North China Plain	PLOS ONE			English	Article							NITROGEN DYNAMICS; LEAF SENESCENCE; GROWTH; DATE	Wheat production is threatened by water shortages and groundwater over-draft in the North China Plain (NCP). In recent years, winter wheat has been increasingly sown extremely late in early to mid-November after harvesting cotton or pepper. To improve water use efficiency (WUE) and guide the extremely late sowing practices, a 3-year field experiment was conducted under two irrigation regimes (W1, one-irrigation, 75 mm at jointing; W2, two-irrigation, 75 mm at jointing and 75 mm at anthesis) in 3 cultivars differing in spike size (HS4399, small spike; JM22, medium spike; WM8, large spike). Wheat was sown in early to mid-November at a high seeding rate of 800-850 seeds m(-2). Average yields of 7.42 t ha(-1) and WUE of 1.84 kg m(-3) were achieved with an average seasonal evapotranspiration (ET) of 404 mm. Compared with W2, wheat under W1 did not have yield penalty in 2 of 3 years, and had 7.9% lower seasonal ET and 7.5% higher WUE. The higher WUE and stable yield under W1 was associated with higher 1000-grain weight (TGW) and harvest index (HI). Among the 3 cultivars, JM22 had 5.9%-8.9% higher yield and 4.2%-9.3% higher WUE than WM8 and HS4399. The higher yield in JM22 was attributed mainly to higher HI and TGW due to increased post-anthesis biomass and deeper seasonal soil water extraction. In conclusion, one-irrigation with a medium-sized spike cultivar JM22 could be a useful strategy to maintain yield and high WUE in extremely late-sown winter wheat at a high seeding rate in the NCP.	[Wang, Bin; Zhang, Yinghua; Xu, Xuexin; Zhao, Zhigan; Wang, Zhimin] China Agr Univ, Coll Agron, Beijing 100193, Peoples R China; [Wang, Bin; Xue, Qingwu] Texas A&M AgriLife Res & Extens Ctr Amarillo, Amarillo, TX 79106 USA; [Hao, Baozhen] Xinxiang Univ, Sch Sci & Technol, Xinxiang 453003, Henan, Peoples R China	China Agricultural University; Xinxiang University	Wang, ZM (corresponding author), China Agr Univ, Coll Agron, Beijing 100193, Peoples R China.; Xue, QW (corresponding author), Texas A&M AgriLife Res & Extens Ctr Amarillo, Amarillo, TX 79106 USA.	zhimin206@263.net; qxue@ag.tamu.edu	Zhao, Zhigan/E-8963-2015; Zhang, Yinghua/HGE-7633-2022; Xue, Qingwu/AAE-2431-2020	Zhao, Zhigan/0000-0003-1533-7215; Zhang, Yinghua/0000-0002-1356-6084; Xue, Qingwu/0000-0002-6470-3245	National Basic Research Program of China (973 Program) [2012CB955904]; Special Fund for Agro-scientific Research in the Public Interest in China [201303133]; Earmarked Fund for Modern Agro-Industry Technology Research System [CARS-3]; National Natural Science Foundation of China [31401297]; China Scholarship Council; Science and Technology Innovation Program of Food Crop High Yield and Efficiency	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest in China; Earmarked Fund for Modern Agro-Industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); Science and Technology Innovation Program of Food Crop High Yield and Efficiency	This study was supported by the National Basic Research Program of China (973 Program, 2012CB955904), the Special Fund for Agro-scientific Research in the Public Interest in China (201303133), the Earmarked Fund for Modern Agro-Industry Technology Research System (CARS-3), the National Natural Science Foundation of China (31401297), the China Scholarship Council and the Science and Technology Innovation Program of Food Crop High Yield and Efficiency.	[Anonymous], CHINA STAT YB; Araki H, 2012, FIELD CROP RES, V137, P27, DOI 10.1016/j.fcr.2012.09.006; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; Cui ZL, 2011, SOIL SCI SOC AM J, V75, P976, DOI 10.2136/sssaj2010.0117; Du TS, 2014, FOOD ENERGY SECUR, V3, P7, DOI 10.1002/fes3.40; Ercoli L, 2008, EUR J AGRON, V28, P138, DOI 10.1016/j.eja.2007.06.002; Fang Y, 2010, EUR J AGRON, V33, P257, DOI 10.1016/j.eja.2010.07.001; Feng B, 2014, J AGRON CROP SCI, V200, P143, DOI 10.1111/jac.12045; HAUN JR, 1973, AGRON J, V65, P116, DOI 10.2134/agronj1973.00021962006500010035x; Hossain MA, 2011, FIELD CROP RES, V123, P100, DOI 10.1016/j.fcr.2011.05.005; Hu YK, 2010, J HYDROL, V393, P219, DOI 10.1016/j.jhydrol.2010.08.017; Jiang D, 2008, PLANT SOIL, V304, P301, DOI 10.1007/s11104-008-9556-x; KIRBY EJM, 1988, FIELD CROP RES, V18, P127, DOI 10.1016/0378-4290(88)90004-4; Li HM, 2005, AGR WATER MANAGE, V76, P8, DOI 10.1016/j.agwat.2005.01.006; Li QQ, 2010, AGR WATER MANAGE, V97, P1676, DOI 10.1016/j.agwat.2010.05.025; Lu DJ, 2015, FIELD CROP RES, V171, P157, DOI 10.1016/j.fcr.2014.10.012; Ma SC, 2008, FIELD CROP RES, V105, P56, DOI 10.1016/j.fcr.2007.07.005; Meng QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068783; Nleya T, 2014, AGRON J, V106, P915, DOI 10.2134/agronj13.0417; Qiu GY, 2008, AGR FOREST METEOROL, V148, P1848, DOI 10.1016/j.agrformet.2008.06.010; Reynolds M, 2009, J EXP BOT, V60, P1899, DOI 10.1093/jxb/erp016; SAS Institute Inc, 2009, SAS STAT 92 US GUID, Vsecond; Sokoto M. B., 2013, American Journal of Plant Sciences, V4, P122; Subedi KD, 1998, FIELD CROP RES, V55, P141, DOI 10.1016/S0378-4290(97)00073-7; Sun HY, 2007, IND CROP PROD, V25, P239, DOI 10.1016/j.indcrop.2006.12.003; Sun HY, 2015, EUR J AGRON, V70, P48, DOI 10.1016/j.eja.2015.07.001; Tapley M, 2013, AGRON J, V105, P509, DOI 10.2134/agronj2012.0379; Wang D, 2013, FIELD CROP RES, V151, P35, DOI 10.1016/j.fcr.2013.07.009; Wang WX, 2014, BEIJING AGR, V6, P58; White RG, 2010, PLANT CELL ENVIRON, V33, P133, DOI 10.1111/j.1365-3040.2009.02059.x; Xue Q, 2014, CROP SCI, V54, P34, DOI 10.2135/cropsci2013.02.0108; Xue QW, 2006, J PLANT PHYSIOL, V163, P154, DOI 10.1016/j.jplph.2005.04.026; Yang JC, 2004, PLANTA, V220, P331, DOI 10.1007/s00425-004-1338-y; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; [张胜全 ZHANG Sheng-Quan], 2009, [生态学报, Acta Ecologica Sinica], V29, P2035; Zhang XY, 2015, AGR WATER MANAGE, V153, P32, DOI 10.1016/j.agwat.2015.02.001; Zhang XY, 2010, AGR WATER MANAGE, V97, P1117, DOI 10.1016/j.agwat.2009.06.003; Zhang XY, 2004, HYDROL PROCESS, V18, P2275, DOI 10.1002/hyp.5533; Zhang YP, 2011, FIELD CROP RES, V123, P187, DOI 10.1016/j.fcr.2011.04.014; Zhong YQW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098850	40	31	40	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153695	10.1371/journal.pone.0153695	http://dx.doi.org/10.1371/journal.pone.0153695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100187	Green Published, gold			2022-12-27	WOS:000374898500051
J	Ferdous, Z; Qureshi, MA; Jayaprakash, P; Parekh, K; John, A; Oz, M; Raza, H; Dobrzynski, H; Adrian, TE; Howarth, FC				Ferdous, Zannatul; Qureshi, Muhammad Anwar; Jayaprakash, Petrilla; Parekh, Khatija; John, Annie; Oz, Murat; Raza, Haider; Dobrzynski, Halina; Adrian, Thomas Edward; Howarth, Frank Christopher			Different Profile of mRNA Expression in Sinoatrial Node from Streptozotocin-Induced Diabetic Rat	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; RECEPTOR POTENTIAL CHANNELS; VENTRICULAR MYOCYTES; GENE-EXPRESSION; HEART-FAILURE; INTRACELLULAR CALCIUM; CONDUCTING SYSTEM; BEATING RATE; CA2+; CONTRACTION	Background Experiments in isolated perfused heart have shown that heart rate is lower and sinoatrial node (SAN) action potential duration is longer in streptozotocin (STZ)-induced diabetic rat compared to controls. In sino-atrial preparations the pacemaker cycle length and sino-atrial conduction time are prolonged in STZ heart. To further clarify the molecular basis of electrical disturbances in the diabetic heart the profile of mRNA encoding a wide variety of proteins associated with the generation and transmission of electrical activity has been evaluated in the SAN of STZ-induced diabetic rat heart. Methodology/Principal Findings Heart rate was measured in isolated perfused heart with an extracellular suction electrode. Expression of mRNA encoding a variety of intercellular proteins, intracellular Ca2+-transport and regulatory proteins, cell membrane transport proteins and calcium, sodium and potassium channel proteins were measured in SAN and right atrial (RA) biopsies using real-time reverse transcription polymerase chain reaction techniques. Heart rate was lower in STZ (203 +/- 7 bpm) compared to control (239 +/- 11 bpm) rat. Among many differences in the profile of mRNA there are some worthy of particular emphasis. Expression of genes encoding some proteins were significantly downregulated in STZ-SAN: calcium channel, Cacng4 (7-fold); potassium channel, Kcnd2 whilst genes encoding some other proteins were significantly upregulated in STZ-SAN: gap junction, Gjc1; cell membrane transport, Slc8a1, Trpc1, Trpc6 (4-fold); intracellular Ca2+-transport, Ryr3; calcium channel Cacna1g, Cacna1h, Cacnb3; potassium channels, Kcnj5, Kcnk3 and natriuretic peptides, Nppa (5-fold) and Nppb (7-fold). Conclusions/Significance Collectively, this study has demonstrated differences in the profile of mRNA encoding a variety of proteins that are associated with the generation, conduction and regulation of electrical signals in the SAN of STZ-induced diabetic rat heart. Data from this study will provide a basis for a substantial range of future studies to investigate whether these changes in mRNA translate into changes in electrophysiological function.	[Ferdous, Zannatul; Qureshi, Muhammad Anwar; Jayaprakash, Petrilla; Parekh, Khatija; Adrian, Thomas Edward; Howarth, Frank Christopher] UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates; [John, Annie; Raza, Haider] UAE Univ, Coll Med & Hlth Sci, Dept Biochem, Al Ain, U Arab Emirates; [Oz, Murat] UAE Univ, Coll Med & Hlth Sci, Dept Pharmacol, Al Ain, U Arab Emirates; [Dobrzynski, Halina] Univ Manchester, Inst Cardiovasc Sci, Manchester, Lancs, England	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University; University of Manchester	Howarth, FC (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates.	chris.howarth@uaeu.ac.ae	Ferdous, Zannatul/GZA-6825-2022	Ferdous, Zannatul/0000-0002-6007-2183; Adrian, Thomas/0000-0002-5051-1111; Jayaprakash, Petrilla/0000-0001-5433-6587; Dobrzynski, Halina/0000-0003-4754-5975; Raza, Haider/0000-0001-9680-5388	UAE University; LABCO, a partner of SIGMA-ALDRICH	UAE University; LABCO, a partner of SIGMA-ALDRICH	This work was supported by UAE University and LABCO, a partner of SIGMA-ALDRICH. UAE University provided a grant to support this research project. LABCO did not provide any funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes TA, 2008, AM J CARDIOL, V101, P634, DOI 10.1016/j.amjcard.2007.10.025; Azer J, 2012, J MOL CELL CARDIOL, V53, P715, DOI 10.1016/j.yjmcc.2012.08.020; Benvenuti LA, 1997, ACTA HISTOCHEM, V99, P187, DOI 10.1016/S0065-1281(97)80041-4; Bon RS, 2013, BRIT J PHARMACOL, V170, P459, DOI 10.1111/bph.12274; Burgess DL, 1999, GENOME RES, V9, P1204, DOI 10.1101/gr.9.12.1204; Colecraft HM, 2002, J PHYSIOL-LONDON, V541, P435, DOI 10.1113/jphysiol.2002.018515; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; Duffy HS, 2006, ADV CARDIOL, V42, P1, DOI 10.1159/000092550; Gaber EM, 2014, EXP PHYSIOL, V99, P881, DOI 10.1113/expphysiol.2013.077594; Guinamard R, 2007, BBA-MOL BASIS DIS, V1772, P885, DOI 10.1016/j.bbadis.2007.02.007; Harper MT, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003701; Howarth FC, 2007, MOL CELL BIOCHEM, V305, P145, DOI 10.1007/s11010-007-9537-z; Howarth FC, 2007, MOL CELL BIOCHEM, V300, P39, DOI 10.1007/s11010-006-9366-5; Howarth FC, 2006, MOL CELL BIOCHEM, V289, P21, DOI 10.1007/s11010-006-9143-5; Howarth FC, 2012, MOL CELL BIOCHEM, V361, P267, DOI 10.1007/s11010-011-1112-y; Howarth FC, 2009, MOL CELL BIOCHEM, V328, P57, DOI 10.1007/s11010-009-0074-9; Howarth FC, 2005, EXP PHYSIOL, V90, P827, DOI 10.1113/expphysiol.2005.031252; Howarth FC, 2005, PEPTIDES, V26, P691, DOI 10.1016/j.peptides.2004.12.003; Howarth FC, 2009, J MED SCI, V2, P108; Howarth FC, 2008, EXP PHYSIOL, V93, P362, DOI 10.1113/expphysiol.2007.040055; Howarth FC, 2006, ANN NY ACAD SCI, V1084, P155, DOI 10.1196/annals.1372.007; Jansen JA, 2010, J MOL CELL CARDIOL, V48, P76, DOI 10.1016/j.yjmcc.2009.08.018; Jones SA, 2004, J PHYSIOL-LONDON, V560, P429, DOI 10.1113/jphysiol.2004.072108; Laing SP, 2003, DIABETOLOGIA, V46, P760, DOI 10.1007/s00125-003-1116-6; Li JN, 2012, J APPL MATH, DOI 10.1155/2012/809243; Maltsev VA, 2004, BIOPHYS J, V86, P2596, DOI 10.1016/S0006-3495(04)74314-3; Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49; McGrath MF, 2005, TRENDS ENDOCRIN MET, V16, P469, DOI 10.1016/j.tem.2005.10.007; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; Movahed MR, 2007, DIABETES OBES METAB, V9, P276, DOI 10.1111/j.1463-1326.2006.00609.x; Nishida M, 2008, N-S ARCH PHARMACOL, V378, P395, DOI 10.1007/s00210-008-0321-8; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; Nishida M, 2010, YAKUGAKU ZASSHI, V130, P295, DOI 10.1248/yakushi.130.295; Perrin MJ, 2012, HEART RHYTHM, V9, P610, DOI 10.1016/j.hrthm.2011.11.019; Piccini JP, 2004, AM J MED, V116, P64, DOI 10.1016/j.amjmed.2003.10.021; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Raza H, 2015, CELL PHYSIOL BIOCHEM, V35, P1241, DOI 10.1159/000373947; Rowell J, 2010, J CARDIOVASC TRANSL, V3, P516, DOI 10.1007/s12265-010-9208-4; Salem KA, 2013, MOL CELL BIOCHEM, V380, P83, DOI 10.1007/s11010-013-1662-2; Salem KA, 2012, EXP PHYSIOL, V97, P1281, DOI 10.1113/expphysiol.2012.066639; SKEPPER JN, 1989, HISTOCHEM J, V21, P72, DOI 10.1007/BF01005982; Springer J, 2012, J MOL CELL CARDIOL, V52, P1122, DOI 10.1016/j.yjmcc.2012.01.018; Sun YH, 2010, BIOCHEM BIOPH RES CO, V394, P955, DOI 10.1016/j.bbrc.2010.03.096; Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9; Vespasiani G, 1996, COMPUT METH PROG BIO, V51, P211, DOI 10.1016/S0169-2607(96)01774-9; Vindis C, 2010, BIOCHEM BIOPH RES CO, V391, P979, DOI 10.1016/j.bbrc.2009.12.001; Vinogradova TM, 2010, CIRC RES, V107, P767, DOI 10.1161/CIRCRESAHA.110.220517; Volpe M, 2014, EUR HEART J, V35, P419, DOI 10.1093/eurheartj/eht466; Ward ML, 2008, PROG BIOPHYS MOL BIO, V97, P232, DOI 10.1016/j.pbiomolbio.2008.02.009; Watanabe H, 2009, CIRC J, V73, P419, DOI 10.1253/circj.CJ-08-1153; Watanabe M, 2012, AM J PHYSIOL-HEART C, V303, pH86, DOI 10.1152/ajpheart.00010.2012; Yamamoto M, 2006, CARDIOVASC RES, V72, P271, DOI 10.1016/j.cardiores.2006.07.026; Yang L, 2011, FASEB J, V25, P928, DOI 10.1096/fj.10-172353; Yanni J, 2010, J MOL CELL CARDIOL, V48, P653, DOI 10.1016/j.yjmcc.2009.08.023; Yanni J, 2011, CIRC-HEART FAIL, V4, P496, DOI 10.1161/CIRCHEARTFAILURE.110.957647; Yuill KH, 2010, EXP PHYSIOL, V95, P508, DOI 10.1113/expphysiol.2009.050286	56	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153934	10.1371/journal.pone.0153934	http://dx.doi.org/10.1371/journal.pone.0153934			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096430	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600071
J	Lin, HR; Wu, YH; Yen, WC; Yang, CM; Chiu, DTY				Lin, Hsin-Ru; Wu, Yi-Hsuan; Yen, Wei-Chen; Yang, Chuen-Mao; Chiu, Daniel Tsun-Yee			Diminished COX-2/PGE(2)-Mediated Antiviral Response Due to Impaired NOX/MAPK Signaling in G6PD-Knockdown Lung Epithelial Cells	PLOS ONE			English	Article							NF-KAPPA-B; FAMILY NADPH OXIDASES; INDUCED CYCLOOXYGENASE-2 EXPRESSION; ACTIVATED PROTEIN-KINASES; INNATE IMMUNE-RESPONSE; SMOOTH-MUSCLE-CELLS; NOX FAMILY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; HOST-DEFENSE; COX-2 EXPRESSION	Glucose-6-phosphate dehydrogenase (G6PD) provides the reducing agent NADPH to meet the cellular needs for reductive biosynthesis and the maintenance of redox homeostasis. G6PD-deficient cells experience a high level of oxidative stress and an increased susceptibility to viral infections. Cyclooxygenase-2 (COX-2) is a key mediator in the regulation of viral replication and inflammatory response. In the current study, the role of G6PD on the inflammatory response was determined in both scramble control and G6PD-knockdown (G6PD-kd) A549 cells upon tumor necrosis factor-alpha (TNF-alpha) stimulation. A decreased expression pattern of induced COX-2 and reduced production of downstream PGE2 occurred upon TNF-alpha stimulation in G6PD-kd A549 cells compared with scramble control A549 cells. TNF-alpha-induced antiviral activity revealed that decreased COX-2 expression enhanced the susceptibility to coronavirus 229E infection in G6PD-kd A549 cells and was a result of the decreased phosphorylation levels of MAPK (p38 and ERK1/2) and NF-kappa B. The impaired inflammatory response in G6PD-kd A549 cells was found to be mediated through NADPH oxidase (NOX) signaling as elucidated by cell pretreatment with a NOX2-siRNA or NOX inhibitor, diphenyleneiodonium chloride (DPI). In addition, NOX activity with TNF-alpha treatment in G6PD-kd A549 cells was not up-regulated and was coupled with a decrease in NOX subunit expression at the transcriptional level, implying that TNF-alpha-mediated NOX signaling requires the participation of G6PD. Together, these data suggest that G6PD deficiency affects the cellular inflammatory response and the decreased TNF-alpha-mediated antiviral response in G6PD-kd A549 cells is a result of dysregulated NOX/MAPK/NF-kappa B/COX-2 signaling.	[Lin, Hsin-Ru] Chang Gung Univ, Mol Med Res Ctr, Taoyuan, Taiwan; [Wu, Yi-Hsuan; Chiu, Daniel Tsun-Yee] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Yen, Wei-Chen] Chang Gung Univ, Grad Inst Biomed Sci, Coll Med, Taoyuan, Taiwan; [Yang, Chuen-Mao; Chiu, Daniel Tsun-Yee] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Yang, Chuen-Mao] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan; [Chiu, Daniel Tsun-Yee] Chang Gung Mem Hosp, Dept Pediat Hematol, Linkou, Taiwan	Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Chiu, DTY (corresponding author), Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan.; Yang, CM; Chiu, DTY (corresponding author), Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan.; Yang, CM (corresponding author), Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Taoyuan, Taiwan.; Chiu, DTY (corresponding author), Chang Gung Mem Hosp, Dept Pediat Hematol, Linkou, Taiwan.	chuenmao@mail.cgu.edu.tw; dtychiu@mail.cgu.edu.tw		Yang, Chuen-Mao/0000-0002-3208-5438	Chang Gung University; Chang Gung Memorial Hospital [BMRP098, CMRPD1C0772, CMRPD1C0773, CMRPD3D0161, CMRPD3D0162, CMRPD1B0332, CMRPD1C0562, CMRPD1B0383, CMRPD1C0103]; Ministry of Science and Technology [MOST103-2320-B-182-026-MY2, MOST103-2321-B-182-006, MOST101-2320-B-182-039-MY3]; Ministry of Education of Taiwan [EMRPD1E1651]	Chang Gung University; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Education of Taiwan(Ministry of Education, Taiwan)	The work was supported by grants from Chang Gung University and Chang Gung Memorial Hospital (BMRP098, CMRPD1C0772, CMRPD1C0773, CMRPD3D0161 and CMRPD3D0162 to DTYC, CMRPD1B0332 to Healthy Aging Research Center, CMRPD1C0562, CMRPD1B0383 and CMRPD1C0103 to CMY), the Ministry of Science and Technology (MOST103-2320-B-182-026-MY2 to DTYC, MOST103-2321-B-182-006 and MOST101-2320-B-182-039-MY3 to CMY) and the Ministry of Education of Taiwan (EMRPD1E1651 to Chang Gung University). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2013, J CLIN DIAGN RES, V7, P3012, DOI 10.7860/JCDR/2013/6159.3892; Azevedo EP, 2015, J BIOL CHEM, V290, P22174, DOI 10.1074/jbc.M115.640094; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brasier AR, 2014, ADV EXP MED BIOL, V795, P233, DOI 10.1007/978-1-4614-8603-9_15; Carette C, 2011, DIABETES METAB, V37, P79, DOI 10.1016/j.diabet.2010.09.004; Chen CC, 2001, MOL PHARMACOL, V59, P493, DOI 10.1124/mol.59.3.493; Coulombe F, 2014, IMMUNITY, V40, P554, DOI 10.1016/j.immuni.2014.02.013; Davis BK, 2014, INFLAMM BOWEL DIS, V20, P2412, DOI 10.1097/MIB.0000000000000151; Del Corno M, 2014, J VIROL, V88, P11045, DOI 10.1128/JVI.00307-14; Fang JL, 2012, J VIROL, V86, P1010, DOI 10.1128/JVI.06169-11; Fink K, 2013, CELL RES, V23, P673, DOI 10.1038/cr.2013.47; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Grandvaux N, 2007, BIOCHIMIE, V89, P1113, DOI 10.1016/j.biochi.2007.04.008; Grandvaux N, 2015, CLIN SCI, V128, P337, DOI 10.1042/CS20140321; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Ham M, 2013, MOL CELL BIOL, V33, P2425, DOI 10.1128/MCB.01260-12; Hecker PA, 2013, AM J PHYSIOL-HEART C, V304, pH491, DOI 10.1152/ajpheart.00721.2012; Heymann Anthony D, 2012, Diabetes Care, V35, pe58, DOI 10.2337/dc11-2527; Ho HY, 2014, FREE RADICAL RES, V48, P1028, DOI 10.3109/10715762.2014.913788; Ho HY, 2007, REDOX REP, V12, P109, DOI 10.1179/135100007X200209; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Jiang F, 2011, PHARMACOL REV, V63, P218, DOI 10.1124/pr.110.002980; Kim HJ, 2013, AM J RESP CELL MOL, V49, P855, DOI 10.1165/rcmb.2013-0003OC; Lee IT, 2013, J NUTR BIOCHEM, V24, P124, DOI 10.1016/j.jnutbio.2012.03.009; Leto TL, 2006, ANTIOXID REDOX SIGN, V8, P1549, DOI 10.1089/ars.2006.8.1549; Leto TL, 2009, ANTIOXID REDOX SIGN, V11, P2607, DOI [10.1089/ars.2009.2637, 10.1089/ARS.2009.2637]; Liang Y, 2004, CELL MOL IMMUNOL, V1, P343; Lin CC, 2004, CELL SIGNAL, V16, P597, DOI 10.1016/j.cellsig.2003.10.002; Lin CJ, 2010, FREE RADICAL BIO MED, V49, P361, DOI 10.1016/j.freeradbiomed.2010.04.019; Lin CK, 2015, BRIT J PHARMACOL, V172, P4481, DOI 10.1111/bph.13233; Lin HR, 2013, J PROTEOME RES, V12, P3434, DOI 10.1021/pr4002959; Liu L, 2012, J BIOL CHEM, V287, P11899, DOI 10.1074/jbc.M111.308064; Matsui R, 2005, CIRCULATION, V112, P257, DOI 10.1161/CIRCULATIONAHA.104.499095; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Mukhopadhyay S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-125; Ou Jun-Bin, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P751; Rossen JWA, 2004, J VIROL, V78, P9721, DOI 10.1128/JVI.78.18.9721-9730.2004; Sajjan US, 2013, CURR OPIN PULM MED, V19, P125, DOI 10.1097/MCP.0b013e32835cef10; Segal BH, 2012, FREE RADICAL BIO MED, V53, P72, DOI 10.1016/j.freeradbiomed.2012.04.022; Son Yong, 2011, J Signal Transduct, V2011, P792639, DOI 10.1155/2011/792639; Soucy-Faulkner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000930; Spencer NY, 2011, J BIOL CHEM, V286, P8977, DOI 10.1074/jbc.M110.193821; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; van Zwieten R, 2014, FREE RADICAL BIO MED, V67, P377, DOI 10.1016/j.freeradbiomed.2013.11.022; Vareille M, 2011, CLIN MICROBIOL REV, V24, P210, DOI 10.1128/CMR.00014-10; Wan GH, 2002, ENDOCRINE, V19, P191, DOI 10.1385/ENDO:19:2:191; Wu YH, 2008, J INFECT DIS, V197, P812, DOI 10.1086/528377; Wu YH, 2015, VIRUSES-BASEL, V7, P6689, DOI 10.3390/v7122966; Yang CM, 2009, AM J PHYSIOL-LUNG C, V297, pL892, DOI 10.1152/ajplung.00151.2009; Yang HC, 2011, MICROBES INFECT, V13, P109, DOI 10.1016/j.micinf.2010.10.008; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049128; Zhou YQ, 2015, VIRUSES-BASEL, V7, P3116, DOI 10.3390/v7062762	56	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153462	10.1371/journal.pone.0153462	http://dx.doi.org/10.1371/journal.pone.0153462			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097228	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600036
J	Tang, L; Li, XT; Wang, BJ; Luo, GX; Gu, LY; Chen, LY; Liu, K; Gao, Y; Zhang, X				Tang, Lu; Li, Xintao; Wang, Baojun; Luo, Guoxiong; Gu, Liangyou; Chen, Luyao; Liu, Kan; Gao, Yu; Zhang, Xu			Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							RENAL-CELL CARCINOMA; PRETREATMENT NEUTROPHIL; PSA RESPONSE; SURVIVAL; PREDICTOR; INFLAMMATION; PROGRESSION; VALIDATION; MARKER; CRP	Objective and Background Increasing evidence suggests that inflammation plays an essential role in cancer development and progression. The inflammation marker neutrophil-lymphocyte ratio (NLR) is correlated with prognosis across a wide variety of tumor types, but its prognostic value in prostate cancer (PCa) remains controversial. In the present meta-analysis, the prognostic value of NLR in PCa patients is investigated. Methods We performed a meta-analysis to determine the predictive value of NLR for overall survival (OS), recurrence-free survival (RFS), and clinical features in patients with PCa. We systematically searched PubMed, ISI Web of Science, and Embase for relevant studies published up to October 2015. Results A total of 9418 patients from 18 studies were included in the meta-analysis. Elevated pretreatment NLR predicted poor OS (HR 1.628, 95% CI 1.410-1.879) and RFS (HR 1.357, 95% CI 1.126-1.636) in all patients with PCa. However, NLR was insignificantly associated with OS in the subgroup of patients with localized PCa (HR 1.439, 95% CI 0.753-2.75). Increased NLR was also significantly correlated with lymph node involvement (OR 1.616, 95% CI 1.167-2.239) but not with pathological stage (OR 0.827, 95% CI 0.637-1.074) or Gleason score (OR 0.761, 95% CI 0.555-1.044). Conclusions The present meta-analysis indicated that NLR could predict the prognosis for patients with locally advanced or castration-resistant PCa. Patients with higher NLR are more likely to have poorer prognosis than those with lower NLR.	[Tang, Lu; Li, Xintao; Wang, Baojun; Luo, Guoxiong; Gu, Liangyou; Chen, Luyao; Liu, Kan; Gao, Yu; Zhang, Xu] Chinese PLA Med Acad, Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital	Zhang, X (corresponding author), Chinese PLA Med Acad, Chinese Peoples Liberat Army Gen Hosp, Dept Urol, State Key Lab Kidney Dis, Beijing 100853, Peoples R China.	xzhang@tjh.tjmu.edu.cn			National Natural Science Foundation of China [81100561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors received funding from the National Natural Science Foundation of China (No.81100561).	Alkhouri N, 2012, LIVER INT, V32, P297, DOI 10.1111/j.1478-3231.2011.02639.x; Bahig H, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1599-9; Balta S, 2013, CLIN APPL THROMB-HEM, V19, P579, DOI 10.1177/1076029612475023; CALMAN KC, 1975, GUT, V16, P490, DOI 10.1136/gut.16.6.490; Chen Hengqi, 2014, Zhonghua Zhong Liu Za Zhi, V36, P294; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Martino M, 2013, BJU INT, V111, pE348, DOI 10.1111/bju.12067; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Esper Dema Halasa, 2005, Nutr Clin Pract, V20, P369, DOI 10.1177/0115426505020004369; Gokce MI, 2015, CUAJ-CAN UROL ASSOC, V9, pE761, DOI 10.5489/cuaj.3091; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karaman M, 2013, CLIN EXP HYPERTENS, V35, P516, DOI 10.3109/10641963.2012.758734; Kawahara T, 2015, ONCOTARGET, V6, P32169, DOI 10.18632/oncotarget.5081; Leibowitz-Amit R, 2014, ANN ONCOL, V25, P657, DOI 10.1093/annonc/mdt581; Li MX, 2014, INT J CANCER, V134, P2403, DOI 10.1002/ijc.28536; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; Luo Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001670; Mano Y, 2013, ANN SURG, V258, P301, DOI 10.1097/SLA.0b013e318297ad6b; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Minardi D, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1036-1; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Nuhn P, 2014, BJU INT, V114, pE11, DOI 10.1111/bju.12531; Pinato DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083279; Schmidt H, 2005, BRIT J CANCER, V93, P273, DOI 10.1038/sj.bjc.6602702; Sonpavde G, 2014, CLIN GENITOURIN CANC, V12, P317, DOI 10.1016/j.clgc.2014.03.005; Steffens S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-399; Stotz M, 2013, BRIT J CANCER, V109, P416, DOI 10.1038/bjc.2013.332; Sumbul AT, 2014, INT UROL NEPHROL, V46, P1531, DOI 10.1007/s11255-014-0664-7; Tanik S, 2014, ASIAN PAC J CANCER P, V15, P6375, DOI 10.7314/APJCP.2014.15.15.6375; Templeton AJ, 2014, CANCER-AM CANCER SOC, V120, P3346, DOI 10.1002/cncr.28890; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Teramukai S, 2009, EUR J CANCER, V45, P1950, DOI 10.1016/j.ejca.2009.01.023; Wells G., 2014, NEWCASTLE OTTAWA SCA; Xue TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096072; Yodying H, 2015, ANN SURG ONCOLOGY; Zhang GM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001473; Zhao QT, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S90875	43	54	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153981	10.1371/journal.pone.0153981	http://dx.doi.org/10.1371/journal.pone.0153981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096158	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600078
J	Ruggajo, P; Svarstad, E; Leh, S; Marti, HP; Reisaether, AV; Vikse, BE				Ruggajo, Paschal; Svarstad, Einar; Leh, Sabine; Marti, Hans-Peter; Reisaether, Anna Varberg; Vikse, Bjorn Egil			Low Birth Weight and Risk of Progression to End Stage Renal Disease in IgA Nephropathy-A Retrospective Registry-Based Cohort Study	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; GLOMERULAR-FILTRATION-RATE; YOUNG-ADULT AGE; BLOOD-PRESSURE; GESTATIONAL-AGE; PROGNOSTIC FACTORS; SALT SENSITIVITY; CLINICAL-COURSE; KIDNEY-DISEASE; IMMUNE-SYSTEM	Background Low Birth Weight (LBW) is a surrogate for fetal undernutrition and is associated with impaired nephron development in utero. In this study, we investigate whether having been born LBW and/or small for gestational age (SGA) predict progression to ESRD in IgA nephropathy (IgAN) patients. Study Design Retrospective registry-based cohort study. Settings & Participants The Medical Birth Registry has recorded all births since 1967 and the Norwegian Renal Registry has recorded all patients with ESRD since 1980. Based on data from the Norwegian Kidney Biopsy Registry we included all patients diagnosed with IgAN in Norway from 1988-2013. These registries were linked and we analysed risk of progression to ESRD associated with LBW(defined as birth weight less than the 10th percentile) and/or SGA (defined as birth weight less than the 10th percentile for gestational week) by Cox regression statistics. Results We included 471 patients, of whom 74 developed ESRD. As compared to patients without LBW, patients with LBW had a hazard ratio (HR) of 2.0 (95% confidence interval 1.1-3.7) for the total cohort, 2.2 (1.1-4.4) for males and 1.3 (0.30-5.8) for females. Corresponding HRs for SGA were 2.2 (1.1-4.2), 2.7 (1.4-5.5) and 0.8 (0.10-5.9). Further analyses showed that as compared to patients with neither LBW nor SGA, patients with either SGA or LBW did not have significantly increased risks (HRs of 1.3/1.4) but patients who were both LBW and SGA had an increased risk (HR 3.2 (1.5-6.8). Limitation Mean duration of follow-up only 10 years and maximum age only 46 years. Conclusion Among IgAN patients, LBW and/or SGA was associated with increased risk for progression to ESRD, the association was stronger in males.	[Ruggajo, Paschal] MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania; [Ruggajo, Paschal; Svarstad, Einar; Leh, Sabine; Marti, Hans-Peter; Vikse, Bjorn Egil] Univ Bergen, Dept Clin Med, Bergen, Norway; [Svarstad, Einar; Marti, Hans-Peter] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Reisaether, Anna Varberg] Norwegian Inst Publ Hlth, Med Birth Registry Norway, Bergen, Norway; [Reisaether, Anna Varberg] Oslo Univ Hosp, Dept Transplantat Med, Rikshosp, N-0450 Oslo, Norway; [Vikse, Bjorn Egil] Haugesund Hosp, Dept Med, Haugesund, Norway	Muhimbili University of Health & Allied Sciences; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Norwegian Institute of Public Health (NIPH); University of Oslo; National Hospital Norway	Ruggajo, P (corresponding author), MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania.; Ruggajo, P (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	prugajo@yahoo.com	Leh, Sabine/E-6053-2011; Ruggajo, Paschal/R-2018-2019	Leh, Sabine/0000-0002-0764-2941; 				ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Bacchetta J, 2009, KIDNEY INT, V76, P445, DOI 10.1038/ki.2009.201; Barbour SJ, 2012, AM J KIDNEY DIS, V59, P865, DOI 10.1053/j.ajkd.2012.02.326; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bellinger DL, 2008, J IMMUNOTOXICOL, V5, P419, DOI 10.1080/15476910802483415; Bjorksten B, 2009, CURR OPIN ALLERGY CL, V9, P185, DOI 10.1097/ACI.0b013e32832abfc2; Botha JH, 1998, EUR J CLIN PHARMACOL, V53, P337, DOI 10.1007/s002280050389; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Canetta PA, 2014, CLIN J AM SOC NEPHRO, V9, P617, DOI 10.2215/CJN.07260713; Chacko B, 2005, NEPHROLOGY, V10, P496, DOI 10.1111/j.1440-1797.2005.00445.x; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Curhan GC, 1996, CIRCULATION, V94, P3246, DOI 10.1161/01.CIR.94.12.3246; Dahlstrom BL, 2006, ACTA OBSTET GYN SCAN, V85, P916, DOI 10.1080/00016340500442449; DAMICO G, 1987, Q J MED, V64, P709; DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004; DAMICO G, 1992, AM J KIDNEY DIS, V20, P315, DOI 10.1016/S0272-6386(12)70293-7; de Boer MP, 2008, HYPERTENSION, V51, P928, DOI 10.1161/HYPERTENSIONAHA.107.101881; Fan ZJ, 2006, PUBLIC HEALTH REP, V121, P239, DOI 10.1177/003335490612100304; Ferguson LR, 2010, MUTAT RES-FUND MOL M, V690, P3, DOI 10.1016/j.mrfmmm.2010.03.007; Floege J, 2000, J AM SOC NEPHROL, V11, P2395, DOI 10.1681/ASN.V11122395; Glinianaia SV, 2000, ACTA OBSTET GYN SCAN, V79, P450, DOI 10.1034/j.1600-0412.2000.079006450.x; Goto M, 2009, NEPHROL DIAL TRANSPL, V24, P3068, DOI 10.1093/ndt/gfp273; Hallan S, 2008, AM J KIDNEY DIS, V51, P10, DOI 10.1053/j.ajkd.2007.09.013; HANNEDOUCHE T, 1993, CLIN NEPHROL, V39, P312; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; HOOD SA, 1981, CLIN NEPHROL, V16, P55; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hoy WE, 2012, KIDNEY INT, V82, P1321, DOI 10.1038/ki.2012.307; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; Hughson M, 2003, KIDNEY INT, V63, P2113, DOI 10.1046/j.1523-1755.2003.00018.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Ji H, 2007, GENDER MED, V4, P56, DOI 10.1016/S1550-8579(07)80009-X; Keijzer-Veen MG, 2007, AM J KIDNEY DIS, V50, P542, DOI 10.1053/j.ajkd.2007.06.015; Keijzer-Veen MG, 2005, J AM SOC NEPHROL, V16, P2762, DOI 10.1681/ASN.2004090783; KITAJIMA T, 1983, JPN J MED, V22, P219; Knoop T, 2015, AM J NEPHROL, V41, P210, DOI 10.1159/000381403; Knoop T, 2013, AM J KIDNEY DIS, V62, P883, DOI 10.1053/j.ajkd.2013.04.019; Komatsu H, 2015, CLIN EXP NEPHROL, P1; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Lackland D T, 2001, J Clin Hypertens (Greenwich), V3, P29, DOI 10.1111/j.1524-6175.2001.00828.x; Lee H, 2013, AM J NEPHROL, V37, P74, DOI 10.1159/000345960; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; LEVY M, 1988, AM J KIDNEY DIS, V12, P340, DOI 10.1016/S0272-6386(88)80021-0; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Luyckx VA, 2015, NAT REV NEPHROL, V11, P135, DOI 10.1038/nrneph.2014.251; Luyckx VA, 2013, LANCET, V382, P273, DOI 10.1016/S0140-6736(13)60311-6; Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; MERLETBENICHOU C, 1994, PEDIATR NEPHROL, V8, P175, DOI 10.1007/BF00865473; Mu M, 2012, ARCH CARDIOVASC DIS, V105, P99, DOI 10.1016/j.acvd.2011.10.006; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Rodriguez MM, 2004, PEDIATR DEVEL PATHOL, V7, P17, DOI 10.1007/s10024-003-3029-2; Ruggajo P, 2015, AM J KIDNEY DIS; Schmidt IM, 2005, KIDNEY INT, V68, P731, DOI 10.1111/j.1523-1755.2005.00451.x; Schreuder MF, 2009, CLIN J AM SOC NEPHRO, V4, P1774, DOI 10.2215/CJN.02230409; SILBIGER SR, 1995, AM J KIDNEY DIS, V25, P515, DOI 10.1016/0272-6386(95)90119-1; Simonetti GD, 2008, HYPERTENSION, V52, P625, DOI 10.1161/HYPERTENSIONAHA.108.114983; Skjaerven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x; Treluyer JM, 2002, ANTIMICROB AGENTS CH, V46, P1381, DOI 10.1128/AAC.46.5.1381-1387.2002; Tsuboi N, 2010, CLIN J AM SOC NEPHRO, V5, P39, DOI 10.2215/CJN.04680709; VANDERPEET J, 1977, CLIN NEPHROL, V8, P335; Vikse BE, 2002, NEPHROL DIAL TRANSPL, V17, P1603, DOI 10.1093/ndt/17.9.1603; Vikse BE, 2010, NEPHROL DIAL TRANSPL; Vikse BE, 2008, J AM SOC NEPHROL, V19, P151, DOI 10.1681/ASN.2007020252; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yiu V, 1999, AM J KIDNEY DIS, V33, P253, DOI 10.1016/S0272-6386(99)70297-0; Zidar N, 1998, NEPHRON, V79, P28, DOI 10.1159/000044987; Zidar N, 1998, KIDNEY INT, V54, P1320, DOI 10.1046/j.1523-1755.1998.00121.x	72	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153819	10.1371/journal.pone.0153819	http://dx.doi.org/10.1371/journal.pone.0153819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092556	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000374541200046
J	Zhang, M; Hutter, G; Kahn, SA; Azad, TD; Gholamin, S; Xu, CY; Liu, J; Achrol, AS; Richard, C; Sommerkamp, P; Schoen, MK; McCracken, MN; Majeti, R; Weissman, I; Mitra, SS; Cheshier, SH				Zhang, Michael; Hutter, Gregor; Kahn, Suzana A.; Azad, Tej D.; Gholamin, Sharareh; Xu, Chelsea Y.; Liu, Jie; Achrol, Achal S.; Richard, Chase; Sommerkamp, Pia; Schoen, Matthew Kenneth; McCracken, Melissa N.; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.			Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; REGULATORY PROTEIN-ALPHA; HEMATOPOIETIC STEM-CELLS; SIRP-ALPHA; APOPTOTIC CELLS; CANCER-CELLS; GM-CSF; CD47; SURVIVAL; PROGRESSION	Tumor-associated macrophages (TAMs) represent an important cellular subset within the glioblastoma (WHO grade IV) microenvironment and are a potential therapeutic target. TAMs display a continuum of different polarization states between antitumorigenic M1 and protumorigenic M2 phenotypes, with a lower M1/M2 ratio correlating with worse prognosis. Here, we investigated the effect of macrophage polarization on anti-CD47 antibody-mediated phagocytosis of human glioblastoma cells in vitro, as well as the effect of anti-CD47 on the distribution of M1 versus M2 macrophages within human glioblastoma cells grown in mouse xenografts. Bone marrow -derived mouse macrophages and peripheral blood derived human macrophages were polarized in vitro toward M1 or M2 phenotypes and verified by flow cytometry. Primary human glioblastoma cell lines were offered as targets to mouse and human M1 or M2 polarized macrophages in vitro. The addition of an anti-CD47 monoclonal antibody led to enhanced tumor -cell phagocytosis by mouse and human M1 and M2 macrophages. In both cases, the anti-CD47-induced phagocytosis by M1 was more prominent than that for M2. Dissected tumors from human glioblastoma xenografted within NOD.Cg-Prkdcscid 112rgtmlwil ISzJ mice and treated with anti-CD47 showed a significant increase of M1 macrophages within the tumor. These data show that anti-CD47 treatment leads to enhanced tumor cell phagocytosis by both M1 and M2 macrophage subtypes with a higher phagocytosis rate by M1 macrophages. Furthermore, these data demonstrate that anti-CD47 treatment alone can shift the phenotype of macrophages toward the M1 subtype in vivo.	[Zhang, Michael; Hutter, Gregor; Kahn, Suzana A.; Azad, Tej D.; Gholamin, Sharareh; Xu, Chelsea Y.; Achrol, Achal S.; Richard, Chase; Sommerkamp, Pia; Schoen, Matthew Kenneth; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Div Pediat Neurosurg, Dept Neurosurg, Lucile Packard Childrens Hosp,Sch Med, Stanford, CA 94305 USA; [Hutter, Gregor; Kahn, Suzana A.; Gholamin, Sharareh; Liu, Jie; Sommerkamp, Pia; McCracken, Melissa N.; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Hutter, Gregor; Kahn, Suzana A.; Gholamin, Sharareh; Sommerkamp, Pia; Majeti, Ravi; Weissman, Irving; Mitra, Siddhartha S.; Cheshier, Samuel H.] Stanford Univ, Ludwig Ctr Canc Stem Cell Res & Med Stanford, Sch Med, Stanford, CA 94305 USA	Lucile Packard Children's Hospital (LPCH); Stanford University; Stanford University; Stanford University	Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Div Pediat Neurosurg, Dept Neurosurg, Lucile Packard Childrens Hosp,Sch Med, Stanford, CA 94305 USA.; Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.; Mitra, SS; Cheshier, SH (corresponding author), Stanford Univ, Ludwig Ctr Canc Stem Cell Res & Med Stanford, Sch Med, Stanford, CA 94305 USA.	ssmitra@stanford.edu; cheshier@stanford.edu	Hutter, Gregor/A-1254-2011; Hutter, Gregor/Q-6698-2019	Hutter, Gregor/0000-0002-7570-3902; Hutter, Gregor/0000-0002-7570-3902; Gholamin, Sharareh/0000-0001-7425-6074; Sommerkamp, Pia/0000-0002-1148-2493; Xu, Chelsea/0000-0001-5153-4625; Majeti, Ravindra/0000-0002-5814-0984; Azad, Tej/0000-0001-7823-4294; Zhang, Michael/0000-0002-7067-0689	Lucile Packard Foundation for Children's Health; Stanford NIH-NCATS-CTSA [UL1 TR001085]; Child Health Research Institute of Stanford University; Seibel Scholar's Fellowship; Siebel Stem Cell Institute; University of California; Berkeley-Stanford Consortium; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford; American Brain Tumor Association; Neurosurgery Research Foundation; Stanford Medical Scholars Research Program; St. Baldrick's Foundation; Swiss National Science Foundation [P-155336]; Novartis Foundation for medical-biological research; NATIONAL CANCER INSTITUTE [T32CA009151] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Stanford NIH-NCATS-CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Child Health Research Institute of Stanford University; Seibel Scholar's Fellowship; Siebel Stem Cell Institute; University of California(University of California System); Berkeley-Stanford Consortium; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford; American Brain Tumor Association; Neurosurgery Research Foundation; Stanford Medical Scholars Research Program; St. Baldrick's Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for medical-biological research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was funded by the Lucile Packard Foundation for Children's Health, Stanford NIH-NCATS-CTSA UL1 TR001085 and Child Health Research Institute of Stanford University (http://chri.stanford.edu/) to SHC; Seibel Scholar's Fellowship, The Siebel Stem Cell Institute, A University of California, Berkeley-Stanford Consortium to SSM; Ludwig Center for Cancer Stem Cell Research and Medicine at Stanford (http://med.stanford.edu/ludwigcenter.html) to SSM, SHC; American Brain Tumor Association (http://www.abta.org/) to MZ; Neurosurgery Research Foundation (http://www.nref.org/) to MZ; Stanford Medical Scholars Research Program (http://med.stanford.edu/medscholars.html) to MZ; St. Baldrick's Foundation (http://www.stbaldricks.org/ to SHC; Price Charities to SSM, SHC; Swiss National Science Foundation Grant P-155336 (www.snf.ch) to GH; and Novartis Foundation for medical-biological research (www.stiftungmedbiol.novartis.com) to GH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenghat FJ, 2012, J CELL SCI, V125, P5535, DOI 10.1242/jcs.111260; Alifieris C, 2015, PHARMACOL THERAPEUT, V152, P63, DOI 10.1016/j.pharmthera.2015.05.005; Badie B, 2000, NEUROSURGERY, V46, P957, DOI 10.1097/00006123-200004000-00035; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; Boukhari A, 2015, ANTICANCER RES, V35, P149; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; Burger P, 2012, BLOOD, V119, P5512, DOI 10.1182/blood-2011-10-386805; da Fonseca ACC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/264124; Casulo C, 2013, LEUKEMIA RES, V37, P1178, DOI 10.1016/j.leukres.2013.03.021; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Chao MP, 2012, NAT REV CANCER, V12, P58, DOI 10.1038/nrc3171; Chao MP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001375; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Ding P, 2014, CELL BIOCHEM BIOPHYS, V70, P1625, DOI 10.1007/s12013-014-0105-3; dos Santos MA, 2015, J NEURO-ONCOL, V123, P307, DOI 10.1007/s11060-015-1802-5; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Engstrom A, 2014, INT J ONCOL, V44, P385, DOI 10.3892/ijo.2013.2203; Feng MY, 2015, P NATL ACAD SCI USA, V112, P2145, DOI 10.1073/pnas.1424907112; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Ghassabeh GH, 2006, BLOOD, V108, P575, DOI 10.1182/blood-2005-04-1485; Goerdt S, 1999, PATHOBIOLOGY, V67, P222, DOI 10.1159/000028096; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Iizuka A, 2014, IMMUNOL LETT, V159, P15, DOI 10.1016/j.imlet.2014.02.004; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kim MJ, 2008, TUMOR BIOL, V29, P28, DOI 10.1159/000132568; Kioi M, 2010, J CLIN INVEST, V120, P694, DOI 10.1172/JCI40283; Kushchayev SV, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2012.11.059; Lee JH, 2013, CANCER RES, V73, P3604, DOI 10.1158/0008-5472.CAN-12-4563; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Liu J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137345; Ma JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-112; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Moestrup SK, 2004, ANN MED, V36, P347, DOI 10.1080/07853890410033171; Morganti JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093650; Nuvolone M, 2013, J EXP MED, V210, P2539, DOI 10.1084/jem.20131274; Pan YF, 2013, HEPATOLOGY, V58, P680, DOI 10.1002/hep.26391; Parney IF, 2006, J NEURO-ONCOL, V78, P71, DOI 10.1007/s11060-005-9058-0; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Pyonteck SM, 2013, NAT MED, V19, P1264, DOI 10.1038/nm.3337; Sarkar S, 2014, NAT NEUROSCI, V17, P46, DOI 10.1038/nn.3597; Sayegh ET, 2014, J NEURO-ONCOL, V119, P531, DOI 10.1007/s11060-014-1502-6; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Soto-Pantoja DR, 2012, P NATL ACAD SCI USA, V109, pE2842, DOI 10.1073/pnas.1205441109; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang FQ, 2013, J CLIN PATHOL, V66, P1058, DOI 10.1136/jclinpath-2012-201286; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wong ASL, 2014, J IMMUNOL, V193, P4833, DOI 10.4049/jimmunol.1401984; Zen K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3436; Zhang MY, 2014, J OVARIAN RES, V7, DOI 10.1186/1757-2215-7-19; Zhao XW, 2012, P NATL ACAD SCI USA, V109, pE2843, DOI 10.1073/pnas.1209265109; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	59	151	159	5	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153550	10.1371/journal.pone.0153550	http://dx.doi.org/10.1371/journal.pone.0153550			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092773	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200027
J	Rosca, L; Duguleana, M				Rosca, Lucian; Duguleana, Mihai			An Online Observer for Minimization of Pulsating Torque in SMPM Motors	PLOS ONE			English	Article							LITHIUM-ION BATTERY; COGGING TORQUE; RIPPLE REDUCTION; IDENTIFICATION; DESIGN; DRIVES	A persistent problem of surface mounted permanent magnet (SMPM) motors is the non-uniformity of the developed torque. Either the motor design or the motor control needs to be improved in order to minimize the periodic disturbances. This paper proposes a new control technique for reducing periodic disturbances in permanent magnet (PM) electro-mechanical actuators, by advancing a new observer/estimator paradigm. A recursive estimation algorithm is implemented for online control. The compensating signal is identified and added as feedback to the control signal of the servo motor. Compensation is evaluated for different values of the input signal, to show robustness of the proposed method.	[Rosca, Lucian] Univ Lucian Blaga Sibiu, Fac Engn, Sibiu, Romania; [Duguleana, Mihai] Univ Transilvania Brasov, Dept Prod Design & Robot, Brasov, Romania	Lucian Blaga University of Sibiu; Transylvania University of Brasov	Duguleana, M (corresponding author), Univ Transilvania Brasov, Dept Prod Design & Robot, Brasov, Romania.	mihai.duguleana@unitbv.ro	Duguleana, Mihai/AAA-5482-2019	Duguleana, Mihai/0000-0002-7009-356X	Ministry of Labor, Family and Social Protection, Romania [POSDRU/159/1.5/S/137070]; European Social Fund	Ministry of Labor, Family and Social Protection, Romania; European Social Fund(European Social Fund (ESF))	The work performed by MD was supported by the strategic grant POSDRU/159/1.5/S/137070 (2014) of the Ministry of Labor, Family and Social Protection, Romania (http://www.mmuncii.ro/j33/index.php/en/), co-financed by the European Social Fund (http://ec.europa.eu/esf/home.jsp) - Investing in People, within the Sectoral Operational Programme Human Resources Development 2007-2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreescu GD, 2008, IEEE T ENERGY CONVER, V23, P393, DOI 10.1109/TEC.2007.914386; Ashabani M, 2011, IEEE T MAGN, V47, P795, DOI 10.1109/TMAG.2010.2104327; Berendsen C. S., 1993, IEEE Transactions on Power Electronics, V8, P231, DOI 10.1109/63.223976; Bianchi N, 2000, IND APPL C 2000 2000, V1; Branan C, 2002, RULES THUMB CHEM ENG; Butterworth S., 1930, EXP WIRELESS WIRELES, V7, P536; Chapman S. J., 2007, MATLAB PROGRAMMING E; Cros J, 1993, POW EL APPL 1993 5 E; Eom JB, 2001, J MAGN MAGN MATER, V226, P1229, DOI 10.1016/S0304-8853(01)00053-1; Fang JC, 2012, IEEE T POWER ELECTR, V27, P4630, DOI 10.1109/TPEL.2011.2176143; Gieras J. F., 2009, PERMANENT MAGNET MOT, V3rd; Hanselman DC, 1997, ELECT POWER APPL IEE, V144; Hasanien HM, 2010, ENERG CONVERS MANAGE, V51, P98, DOI 10.1016/j.enconman.2009.08.027; HOANG LH, 1986, IEEE T IND APPL, V22, P748, DOI 10.1109/TIA.1986.4504787; Holtz J, 1996, IEEE T IND ELECTRON, V43, P309, DOI 10.1109/41.491355; Hu XS, 2011, J CENT SOUTH UNIV T, V18, P1525, DOI 10.1007/s11771-011-0869-1; Hu XS, 2013, SIMUL MODEL PRACT TH, V34, P1, DOI 10.1016/j.simpat.2013.01.001; Isermann R., 2005, MECHATRONIC SYSTEMS; Islam MR, 2009, THESIS U AKRON; Jahns TM, 1996, IEEE T IND ELECTRON, V43, P321, DOI 10.1109/41.491356; Kim TS, 2001, IND EL SOC 2001 IECO, V2; Lateb R, 2006, IEEE T MAGN, V42, P442, DOI 10.1109/TMAG.2005.862756; Levi E, 2008, IEEE T IND ELECTRON, V55, P1893, DOI 10.1109/TIE.2008.918488; Ljung L., 1998, SYSTEM IDENTIFICATIO; Lu HF, 2008, IEEE T POWER ELECTR, V23, P950, DOI 10.1109/TPEL.2007.915667; Martins CA, 2002, IEEE T POWER ELECTR, V17, P286, DOI 10.1109/63.988948; MATSUI N, 1993, IEEE T IND APPL, V29, P187, DOI 10.1109/28.195906; Matsui N., 1993, MOT CONTR P 1993 AS; MURAI Y, 1989, IEEE T IND APPL, V25, P441, DOI 10.1109/28.31214; PILLAY P, 1989, IEEE T IND APPL, V25, P274, DOI 10.1109/28.25542; Pope J. E., 1996, RULES THUMB MECH ENG; Rakib I, 2009, IND APPL IEEE T, V45.1, P152; Renato C, 1989, INT APPL SOC ANN M 1; Ruderman M, 2008, P 17 WORLD C IFAC; Seguritan A., 2002, P 15 IFAC WORLD C AU, P6; Sun FC, 2011, ENERGY, V36, P3531, DOI 10.1016/j.energy.2011.03.059; Talaba D, 2012, ROBOT CIM-INT MANUF, V28, P637, DOI 10.1016/j.rcim.2012.03.005; Vivier S, 2006, INT C EL MACH ICEM; Weeks M, 2010, DIGITAL SIGNAL PROCE; Yang Y, 2005, EL MACH SYST 2005 IC, V1; Yang Y, 2007, IND EL APPL 2007 ICI; Yang YB, 2006, IEEE T MAGN, V42, P1135, DOI 10.1109/TMAG.2006.871452; Zhang JZ, 2008, ENERG CONVERS MANAGE, V49, P2100, DOI 10.1016/j.enconman.2008.02.017; Zhang L, 2014, ENERGIES, V7, P3204, DOI 10.3390/en7053204; Zhu ZQ, 2000, IEEE T ENERGY CONVER, V15, P407, DOI 10.1109/60.900501	46	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153255	10.1371/journal.pone.0153255	http://dx.doi.org/10.1371/journal.pone.0153255			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089182	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000015
J	Wang, Y; Zekveld, AA; Naylor, G; Ohlenforst, B; Jansma, EP; Lorens, A; Lunner, T; Kramer, SE				Wang, Yang; Zekveld, Adriana A.; Naylor, Graham; Ohlenforst, Barbara; Jansma, Elise P.; Lorens, Artur; Lunner, Thomas; Kramer, Sophia E.			Parasympathetic Nervous System Dysfunction, as Identified by Pupil Light Reflex, and Its Possible Connection to Hearing Impairment	PLOS ONE			English	Article							NEURAL FUNCTION-TESTS; AUTONOMIC DYSFUNCTION; RATE-VARIABILITY; PUPILLOMETRIC EVALUATION; RHEUMATOID-ARTHRITIS; DYNAMIC PUPILLOMETRY; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; AGE; RESPONSES	Context Although the pupil light reflex has been widely used as a clinical diagnostic tool for autonomic nervous system dysfunction, there is no systematic review available to summarize the evidence that the pupil light reflex is a sensitive method to detect parasympathetic dysfunction. Meanwhile, the relationship between parasympathetic functioning and hearing impairment is relatively unknown. Objectives To 1) review the evidence for the pupil light reflex being a sensitive method to evaluate parasympathetic dysfunction, 2) review the evidence relating hearing impairment and parasympathetic activity and 3) seek evidence of possible connections between hearing impairment and the pupil light reflex. Methods Literature searches were performed in five electronic databases. All selected articles were categorized into three sections: pupil light reflex and parasympathetic dysfunction, hearing impairment and parasympathetic activity, pupil light reflex and hearing impairment. Results Thirty-eight articles were included in this review. Among them, 36 articles addressed the pupil light reflex and parasympathetic dysfunction. We summarized the information in these data according to different types of parasympathetic-related diseases. Most of the studies showed a difference on at least one pupil light reflex parameter between patients and healthy controls. Two articles discussed the relationship between hearing impairment and parasympathetic activity. Both studies reported a reduced parasympathetic activity in the hearing impaired groups. The searches identified no results for pupil light reflex and hearing impairment. Discussion and Conclusions As the first systematic review of the evidence, our findings suggest that the pupil light reflex is a sensitive tool to assess the presence of parasympathetic dysfunction. Maximum constriction velocity and relative constriction amplitude appear to be the most sensitive parameters. There are only two studies investigating the relationship between parasympathetic activity and hearing impairment, hence further research is needed. The pupil light reflex could be a candidate measurement tool to achieve this goal.	[Wang, Yang; Zekveld, Adriana A.; Ohlenforst, Barbara; Kramer, Sophia E.] Vrije Univ Amsterdam Med Ctr, Sect Ear & Hearing, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands; [Wang, Yang; Zekveld, Adriana A.; Ohlenforst, Barbara; Kramer, Sophia E.] Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Wang, Yang; Ohlenforst, Barbara; Lunner, Thomas] Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark; [Zekveld, Adriana A.] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Linkoping Univ, Linnaeus Ctr HEAD, Swedish Inst Disabil Res, Linkoping, Sweden; [Zekveld, Adriana A.; Lunner, Thomas] Univ Orebro, Linnaeus Ctr HEAD, Swedish Inst Disabil Res, Linkoping, Sweden; [Naylor, Graham] MRC CSO Inst Hearing Res, Scottish Sect, Glasgow, Lanark, Scotland; [Jansma, Elise P.] Vrije Univ Amsterdam, Med Lib, Amsterdam, Netherlands; [Lorens, Artur] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Lunner, Thomas] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oticon; Linkoping University; Linkoping University; Orebro University; Vrije Universiteit Amsterdam; Institute of Physiology & Hearing Pathology; Linkoping University	Wang, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, Sect Ear & Hearing, Dept Otolaryngol Head & Neck Surg, Amsterdam, Netherlands.; Wang, Y (corresponding author), Vrije Univ Amsterdam Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands.; Wang, Y (corresponding author), Oticon AS, Eriksholm Res Ctr, Snekkersten, Denmark.	y.wang@vumc.nl	Lorens, Artur/AAO-7553-2020; Naylor, Graham/S-2902-2018; Jansma, Elise P/E-8358-2016; Jansma, Elise/AAG-7983-2020; Naylor, Graham/AAN-7408-2021	Naylor, Graham/0000-0003-1544-1944; Jansma, Elise P/0000-0002-1516-2171; Naylor, Graham/0000-0003-1544-1944; Kramer, Sophia E./0000-0002-0451-8179; Zekveld, Adriana/0000-0003-1320-6908	LISTEN [607373]; Chief Scientist Office [IHR] Funding Source: researchfish	LISTEN; Chief Scientist Office	Support was provided by LISTEN 607373 under FP7-PEOPLE [http://cordis.europa.eu/project/rcn/109214_en.html]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlan AM, 2014, AUTONOMIC FUNCTION R; Bar KJ, 2008, CLIN NEUROPHYSIOL, V119, P2209, DOI 10.1016/j.clinph.2008.06.012; Bainbridge KE, 2008, ANN INTERN MED, V149, P1, DOI 10.7326/0003-4819-149-1-200807010-00231; BAKES A, 1990, BRIT J CLIN PHARMACO, V30, P377, DOI 10.1111/j.1365-2125.1990.tb03787.x; BARBUR JL, 1992, OPHTHAL PHYSL OPT, V12, P137, DOI 10.1111/j.1475-1313.1992.tb00276.x; Barendregt PJ, 1996, ANN RHEUM DIS, V55, P612, DOI 10.1136/ard.55.9.612; Baum P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054546; Bergamin O, 1998, GRAEF ARCH CLIN EXP, V236, P567, DOI 10.1007/s004170050122; Bergamin O, 2003, INVEST OPHTH VIS SCI, V44, P1546, DOI 10.1167/iovs.02-0468; Bitsios P, 1996, AGE AGEING, V25, P432, DOI 10.1093/ageing/25.6.432; Bitsios P, 1996, J PSYCHOPHARMACOL, V10, P279, DOI 10.1177/026988119601000404; Bittner DM, 2014, J ALZHEIMERS DIS, V42, P1469, DOI 10.3233/JAD-140969; Bittner DM, 2014, J ALZHEIMERS DIS; Bremner F, 2006, J NEUROL NEUROSUR PS, V77, P1163, DOI 10.1136/jnnp.2006.092833; Bremner FD, 2012, INVEST OPHTH VIS SCI, V53, P7343, DOI 10.1167/iovs.12-10881; Bumke O., 1911, PHYSL PATHOLOGIE IRI; Calabresi P, 2006, LANCET NEUROL, V5, P974, DOI 10.1016/S1474-4422(06)70600-7; Davis BC, 2013, PHYSIOL MEAS, V34, P873, DOI 10.1088/0967-3334/34/8/873; DEVOS A, 1989, DIABETES RES CLIN EX, V10, P191; DRUMMOND PD, 1988, BRAIN, V111, P1199, DOI 10.1093/brain/111.5.1199; Dutsch M, 2004, J NEUROL SCI, V222, P75, DOI 10.1016/j.jns.2004.04.008; Dutsch M, 2002, J NEUROL SCI, V195, P77, DOI 10.1016/S0022-510X(01)00686-4; Fan XF, 2011, IEEE T BIO-MED ENG, V58, P36, DOI 10.1109/TBME.2010.2080678; Fan XF, 2009, AUTON NEUROSCI-BASIC, V147, P9, DOI 10.1016/j.autneu.2008.12.010; Fan XF, 2009, INVEST OPHTH VIS SCI, V50, P1137, DOI 10.1167/iovs.08-2329; Feinberg Richard, 1965, LATENCY PUPILLARY RE; FERNANDEZ C, 1960, Laryngoscope, V70, P363; Ferrari GL, 2010, BIOMED ENG ONLINE, V9, DOI 10.1186/1475-925X-9-26; Flachenecker P, 2001, MULT SCLER, V7, P327, DOI 10.1177/135245850100700509; Fotiou DF, 2009, INT J PSYCHOPHYSIOL, V73, P143, DOI 10.1016/j.ijpsycho.2009.01.011; Fotiou F, 2000, INT J PSYCHOPHYSIOL, V37, P111, DOI 10.1016/S0167-8760(00)00099-4; Giza E, 2011, INT J NEUROSCI, V121, P37, DOI 10.3109/00207454.2010.526730; HAKEREM G, 1964, ANN NY ACAD SCI, V105, P820, DOI 10.1111/j.1749-6632.1964.tb42965.x; Harle DE, 2005, OPHTHAL PHYSL OPT, V25, P240, DOI 10.1111/j.1475-1313.2005.00291.x; Hasson D, 2009, INT J PSYCHOPHYSIOL, V74, P93, DOI 10.1016/j.ijpsycho.2009.07.009; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Horner KC, 2003, NEUROSCI BIOBEHAV R, V27, P437, DOI 10.1016/S0149-7634(03)00071-X; Hotta H, 2010, GERIATR GERONTOL INT, V10, pS127, DOI 10.1111/j.1447-0594.2010.00592.x; INOUE H, 1988, ACTA OTO-LARYNGOL, V105, P582, DOI 10.3109/00016488809119524; Kaltsatou A, 2011, EUR J APPL PHYSIOL, V111, P2079, DOI 10.1007/s00421-011-1836-0; Kang P, 2012, CLIN AUTON RES, V22, P161, DOI 10.1007/s10286-012-0158-6; Keivanidou A, 2010, CARDIOL J, V17, P65; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Kramer SE, 1997, AUDIOLOGY, V36, P155; Kramer SE, 2013, LANG COGNITIVE PROC, V28, P426, DOI 10.1080/01690965.2011.642267; Kramer SE, 2006, INT J AUDIOL, V45, P503, DOI 10.1080/14992020600754583; KURODA N, 1989, DIABETES RES CLIN PR, V6, P89, DOI 10.1016/0168-8227(89)90111-3; LANTING P, 1988, J NEUROL, V235, P245, DOI 10.1007/BF00314357; LEDEN I, 1983, SCAND J RHEUMATOL, V12, P166, DOI 10.3109/03009748309102905; Lensch E, 2011, AUTOIMMUN DIS, V2011, DOI 10.4061/2011/803841; Levy D M, 1992, Clin Auton Res, V2, P335, DOI 10.1007/BF01824304; Liberati A, 2009, BMJ, V339, pb2700, DOI DOI 10.1136/BMJ.B2700; Loewenfeld I. E., 1999, PUPIL ANATOMY PHYSL; LOWENSTEIN O, 1956, ARCH OPHTHALMOL-CHIC, V55, P565, DOI 10.1001/archopht.1956.00930030569015; LOWENSTEIN O, 1964, AM J OPHTHALMOL, V57, P569, DOI 10.1016/0002-9394(64)92504-8; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; Micieli G, 1995, FUNCT NEUROL, V10, P273; Micieli G, 1991, Clin Auton Res, V1, P55, DOI 10.1007/BF01826058; Micieli G, 1989, Funct Neurol, V4, P105; Morte A, 2005, NEUROPSYCHOBIOLOGY, V52, P169, DOI 10.1159/000088859; Muppidi S, 2013, CLIN AUTON RES, V23, P297, DOI 10.1007/s10286-013-0209-7; Mylius V, 2003, CLIN AUTON RES, V13, P16, DOI 10.1007/s10286-003-0065-y; Nachtegaal J, 2009, EAR HEARING, V30, P302, DOI 10.1097/AUD.0b013e31819c6e01; Nanas S, 2006, INT J CARDIOL, V110, P393, DOI 10.1016/j.ijcard.2005.10.032; Ofte HK, 2014, REDUCED CRANIAL PARA; Parikh SM, 2002, J NEUROL SCI, V200, P1, DOI 10.1016/S0022-510X(02)00126-0; PERRY F, 1989, PAIN, V39, P77, DOI 10.1016/0304-3959(89)90177-2; PFEIFER MA, 1985, DIABETES CARE, V8, P576, DOI 10.2337/diacare.8.6.576; PFEIFER MA, 1982, DIABETES CARE, V5, P518, DOI 10.2337/diacare.5.5.518; PIHA SJ, 1994, INT J OBESITY, V18, P547; Pozzessere G, 1996, AGING-CLIN EXP RES, V8, P55, DOI 10.1007/BF03340116; Pozzessere G, 1997, CLIN AUTON RES, V7, P315, DOI 10.1007/BF02267724; Pronk M, 2011, INT J AUDIOL, V50, P594, DOI 10.3109/14992027.2011.582165; Purves D., 2004, NEUROSCIENCE, VThird; Ramaekers D, 1998, EUR HEART J, V19, P1334, DOI 10.1053/euhj.1998.1084; Robertson D, 2004, PRIMER AUTONOMIC NER; Ross M.D., 1981, NEURONAL MECH HEARIN, P31, DOI [10.1007/978-1-4684-3908-3_3, DOI 10.1007/978-1-4684-3908-3_3]; ROSSI M, 1989, CLIN SCI, V76, P567, DOI 10.1042/cs0760567; RUBIN LS, 1980, INT J NEUROSCI, V11, P301, DOI 10.3109/00207458009147594; Saraswathi P V, 2013, Indian J Physiol Pharmacol, V57, P23; Seaward BL, 2006, MANAGING STRESS PRIN; Shechter A, 2002, NEUROLOGY, V58, P422, DOI 10.1212/WNL.58.3.422; Staal MA, 2004, STRESS COGNITION HUM; Steinhauer S. R., 1993, PSYCHOL MED, V5, P687; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Steinhauer SR, 2000, INT J PSYCHOPHYSIOL, V39, P21, DOI 10.1016/S0167-8760(00)00119-7; Stratton JR, 2003, J AM COLL CARDIOL, V41, P2077, DOI 10.1016/S0735-1097(03)00418-2; Strawbridge WJ, 2000, GERONTOLOGIST, V40, P320, DOI 10.1093/geront/40.3.320; Tales A, 2001, AGING CLIN EXP RES, V13, P473; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; THOMSEN LL, 1995, CLIN AUTON RES, V5, P243, DOI 10.1007/BF01818887; UHLMANN RF, 1989, JAMA-J AM MED ASSOC, V261, P1916, DOI 10.1001/jama.261.13.1916; USUI S, 1995, ANN BIOMED ENG, V23, P375, DOI 10.1007/BF02584438; Vinik AI, 2003, DIABETES CARE, V26, P1553, DOI 10.2337/diacare.26.5.1553; Westphal, 1907, DTSCH MED WOCHENS, P1080; Yamada M, 1999, Auris Nasus Larynx, V26, P419, DOI 10.1016/S0385-8146(99)00021-8; Yamaji K., 2000, Systems and Computers in Japan, V31, P22, DOI 10.1002/(SICI)1520-684X(200004)31:4<22::AID-SCJ3>3.0.CO;2-W; Yarnitsky D, 2003, HEADACHE, V43, P704, DOI 10.1046/j.1526-4610.2003.03127.x; Yuan D, 2014, NEUROLOGY, V82; ZAHORSKAMARKIEWICZ B, 1993, INT J OBESITY, V17, P21; Zangemeister WH, 2009, NEUROL INT, V1, P65, DOI 10.4081/ni.2009.e19; Zekveld AA, 2011, EAR HEARING, V32, P498, DOI 10.1097/AUD.0b013e31820512bb; Zekveld AA, 2010, EAR HEARING, V31, P480, DOI 10.1097/AUD.0b013e3181d4f251	103	46	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153566	10.1371/journal.pone.0153566	http://dx.doi.org/10.1371/journal.pone.0153566			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089436	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000026
J	Ji, WB; Arnst, C; Tipton, AR; Bekier, ME; Taylor, WR; Yen, TJ; Liu, ST				Ji, Wenbin; Arnst, Christopher; Tipton, Aaron R.; Bekier, Michael E., II; Taylor, William R.; Yen, Tim J.; Liu, Song-Tao			OTSSP167 Abrogates Mitotic Checkpoint through Inhibiting Multiple Mitotic Kinases	PLOS ONE			English	Article							LEUCINE-ZIPPER KINASE; CLOSED MAD2 C-MAD2; AURORA-B; STEM-CELL; CHROMOSOMAL INSTABILITY; MICROTUBULE ATTACHMENT; THR-3 PHOSPHORYLATION; TARGETING CANCER; GENE-EXPRESSION; PROTEIN-KINASE	OTSSP167 was recently characterized as a potent inhibitor for maternal embryonic leucine zipper kinase (MELK) and is currently tested in Phase I clinical trials for solid tumors that have not responded to other treatment. Here we report that OTSSP167 abrogates the mitotic checkpoint at concentrations used to inhibit MELK. The abrogation is not recapitulated by RNAi mediated silencing of MELK in cells. Although OTSSP167 indeed inhibits MELK, it exhibits off-target activity against Aurora B kinase in vitro and in cells. Furthermore, OTSSP167 inhibits BUB1 and Haspin kinases, reducing phosphorylation at histones H2A(T120) and H3(T3) and causing mislocalization of Aurora B and associated chromosomal passenger complex from the centromere/kinetochore. The results suggest that OTSSP167 may have additional mechanisms of action for cancer cell killing and caution the use of OTSSP167 as a MELK specific kinase inhibitor in biochemical and cellular assays.	[Ji, Wenbin; Arnst, Christopher; Tipton, Aaron R.; Bekier, Michael E., II; Taylor, William R.; Liu, Song-Tao] Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA; [Yen, Tim J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Tipton, Aaron R.] Oklahoma Med Res Fdn, Cell Cycle & Canc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Bekier, Michael E., II] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University System of Ohio; University of Toledo; Fox Chase Cancer Center; Oklahoma Medical Research Foundation; University of Michigan System; University of Michigan	Liu, ST (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	sliu@utnet.utoledo.edu	Liu, Song-Tao/Y-4732-2019	Liu, Song-Tao/0000-0002-9623-8579	National Institutes of Health [CA06927, CA182651, CA16970, R15 GM084410, R15 GM100440, R01CA169500]; DoD [OC100172]; Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE [P30CA006927, R01CA169500, R21CA182651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100440, R15GM084410] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD(United States Department of Defense); Commonwealth of Pennsylvania; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Core Grants CA06927, CA182651, and CA16970 to TJY, R15 GM084410 and R15 GM100440 to WRT, and R01CA169500 to STL. TJY was also supported by DoD OC100172, an Appropriation from the Commonwealth of Pennsylvania, and generous gifts from Mrs. C Greenberg and the Bucks County Board of Associates. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badouel C, 2006, CELL CYCLE, V5, P883, DOI 10.4161/cc.5.8.2683; Badouel C, 2010, EXP CELL RES, V316, P2166, DOI 10.1016/j.yexcr.2010.04.019; Barford D, 2011, PHILOS T R SOC B, V366, P3605, DOI 10.1098/rstb.2011.0069; Beke L, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150194; Bekier ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7775; Blot J, 2002, DEV BIOL, V241, P327, DOI 10.1006/dbio.2001.0525; Canevari G, 2013, BIOCHEMISTRY-US, V52, P6380, DOI 10.1021/bi4005864; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chartrain I, 2006, BIOL CELL, V98, P253, DOI 10.1042/BC20050041; Chartrain I, 2007, CELL BIOL INT, V31, P196, DOI 10.1016/j.cellbi.2006.10.005; Chung S, 2013, CELL CYCLE, V12, P1655, DOI 10.4161/cc.24988; Chung SY, 2012, ONCOTARGET, V3, P1629; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Davezac N, 2002, ONCOGENE, V21, P7630, DOI 10.1038/sj.onc.1205870; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Du T, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-100; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Ganguly R, 2014, MOL CANCER THER, V13, P1393, DOI 10.1158/1535-7163.MCT-13-0764; Gil M, 1997, GENE, V195, P295, DOI 10.1016/S0378-1119(97)00181-9; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Gross S, 2015, J CLIN INVEST, V125, P1780, DOI 10.1172/JCI76094; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Heyer BS, 1997, MOL REPROD DEV, V47, P148, DOI 10.1002/(SICI)1098-2795(199706)47:2&lt;148::AID-MRD4&gt;3.0.CO;2-M; Jia LY, 2013, TRENDS BIOCHEM SCI, V38, P302, DOI 10.1016/j.tibs.2013.03.004; Jiang PF, 2013, INT J MOL SCI, V14, P21551, DOI 10.3390/ijms141121551; Joshi K, 2013, STEM CELLS, V31, P1051, DOI 10.1002/stem.1358; Kappadakunnel M, 2010, J NEURO-ONCOL, V96, P359, DOI 10.1007/s11060-009-9983-4; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kuner R, 2013, J MOL MED, V91, P237, DOI 10.1007/s00109-012-0949-1; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Le Page Y, 2011, J CELL SCI, V124, P958, DOI 10.1242/jcs.069567; Liu H, 2013, CURR BIOL, V23, P1927, DOI 10.1016/j.cub.2013.07.078; Mahasenan KV, 2012, J CHEM INF MODEL, V52, P1345, DOI 10.1021/ci300040c; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nakano I, 2009, METHODS MOL BIOL, V568, P37, DOI 10.1007/978-1-59745-280-9_4; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Takeuchi K, 2011, BIOL PHARM BULL, V34, P1774, DOI 10.1248/bpb.34.1774; Tassan Jean-Pierre, 2011, Commun Integr Biol, V4, P483, DOI 10.4161/cib.4.4.15669; Tipton AR, 2013, J BIOL CHEM, V288, P35149, DOI 10.1074/jbc.M113.522375; Tipton AR, 2012, BMC CELL BIOL, V13, DOI 10.1186/1471-2121-13-15; Tipton AR, 2011, CELL CYCLE, V10, P3740, DOI 10.4161/cc.10.21.17919; Tipton AR, 2011, J BIOL CHEM, V286, P21173, DOI 10.1074/jbc.M111.238543; TIWARI RK, 1987, EMBO J, V6, P3373, DOI 10.1002/j.1460-2075.1987.tb02659.x; Vagnarelli P, 2004, CHROMOSOMA, V113, P211, DOI 10.1007/s00412-004-0307-3; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang JH, 2015, MOL CELL, V58, P708, DOI 10.1016/j.molcel.2015.05.001; Wang KX, 2014, J BIOL CHEM, V289, P23928, DOI 10.1074/jbc.M114.585315; Wang YB, 2014, ELIFE, V3, DOI 10.7554/eLife.01763; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Westhorpe FG, 2011, J CELL SCI, V124, P3905, DOI 10.1242/jcs.093286; Yamagishi Y, 2012, NAT CELL BIOL, V14, P746, DOI 10.1038/ncb2515; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	67	33	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153518	10.1371/journal.pone.0153518	http://dx.doi.org/10.1371/journal.pone.0153518			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082996	Green Submitted, gold, Green Published			2022-12-27	WOS:000374291800026
J	Admoni-Elisha, L; Nakdimon, I; Shteinfer, A; Prezma, T; Arif, T; Arbel, N; Melkov, A; Zelichov, O; Levi, I; Shoshan-Barmatz, V				Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Zelichov, Ori; Levi, Itai; Shoshan-Barmatz, Varda			Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment	PLOS ONE			English	Article							ANION CHANNEL VDAC; APOPTOTIC CELL-DEATH; IN-VIVO; CASPASE ACTIVATION; CYTOCHROME-C; CATHEPSIN-S; B-CELLS; EXPRESSION; CANCER; BCL-2	In many cancers, cells undergo re-programming of metabolism, cell survival and anti-apoptotic defense strategies, with the proteins mediating this reprogramming representing potential biomarkers. Here, we searched for novel biomarker proteins in chronic lymphocytic leukemia (CLL) that can impact diagnosis, treatment and prognosis by comparing the protein expression profiles of peripheral blood mononuclear cells from CLL patients and healthy donors using specific antibodies, mass spectrometry and binary logistic regression analyses and other bioinformatics tools. Mass spectrometry (LC-HR-MS/MS) analysis identified 1,360 proteins whose expression levels were modified in CLL-derived lymphocytes. Some of these proteins were previously connected to different cancer types, including CLL, while four other highly expressed proteins were not previously reported to be associated with cancer, and here, for the first time, DDX46 and AK3 are linked to CLL. Down-regulation expression of two of these proteins resulted in cell growth inhibition. High DDX46 expression levels were associated with shorter survival of CLL patients and thus can serve as a prognosis marker. The proteins with modified expression include proteins involved in RNA splicing and translation and particularly mitochondrial proteins involved in apoptosis and metabolism. Thus, we focused on several metabolism-and apoptosis-modulating proteins, particularly on the voltage-dependent anion channel 1 (VDAC1), regulating both metabolism and apoptosis. Expression levels of Bcl-2, VDAC1, MAVS, AIF and SMAC/Diablo were markedly increased in CLL-derived lymphocytes. VDAC1 levels were highly correlated with the amount of CLL-cancerous CD19+/CD5+ cells and with the levels of all other apoptosis-modulating proteins tested. Binary logistic regression analysis demonstrated the ability to predict probability of disease with over 90% accuracy. Finally, based on the changes in the levels of several proteins in CLL patients, as revealed from LC-HR-MS/MS, we could distinguish between patients in a stable disease state and those who would be later transferred to anti-cancer treatments. The over-expressed proteins can thus serve as potential biomarkers for early diagnosis, prognosis, new targets for CLL therapy, and treatment guidance of CLL, forming the basis for personalized therapy.	[Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Admoni-Elisha, Lee; Nakdimon, Itay; Shteinfer, Anna; Prezma, Tal; Arif, Tasleem; Arbel, Nir; Melkov, Anna; Shoshan-Barmatz, Varda] Ben Gurion Univ Negev, Natl Inst Biotechnol, IL-84105 Beer Sheva, Israel; [Zelichov, Ori; Levi, Itai] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Dept Hematol, IL-84105 Beer Sheva, Israel; [Zelichov, Ori; Levi, Itai] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University	Shoshan-Barmatz, V (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	vardasb@bgu.ac.il	Arif, Tasleem/AAA-2741-2020	Arif, Tasleem/0000-0001-9881-0076	Leukemia & Lymphoma Society, LLS TRP Grant [6336-11]; Leukemia & Lymphoma Society	Leukemia & Lymphoma Society, LLS TRP Grant; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society)	This work was supported by a grant from the Leukemia & Lymphoma Society, LLS TRP Grant #6336-11.; This research was supported by a grant from the Leukemia & Lymphoma Society.	Abu-Hamad S, 2008, J BIOL CHEM, V283, P13482, DOI 10.1074/jbc.M708216200; Abu-Hamad S, 2009, J CELL SCI, V122, P1906, DOI 10.1242/jcs.040188; Agrawal SG, 2008, BLOOD, V111, P2790, DOI 10.1182/blood-2007-10-110460; Arbel N, 2012, J BIOL CHEM, V287, P23152, DOI 10.1074/jbc.M112.345918; Arbel N, 2010, J BIOL CHEM, V285, P6053, DOI 10.1074/jbc.M109.082990; Arellano-Llamas A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-256; Arif T, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.9; Arzoine L, 2009, J BIOL CHEM, V284, P3946, DOI 10.1074/jbc.M803614200; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465; Baig RM, 2013, DIS MARKERS, V34, P71, DOI [10.3233/DMA-120952, 10.1155/2013/795410]; Bao Shi-Ting, 2006, Hepatobiliary Pancreat Dis Int, V5, P580; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Bleeker FE, 2009, HUM MUTAT, V30, P7, DOI 10.1002/humu.20937; Brahimi-Horn MC, 2012, CANCER RES, V72, P2140, DOI 10.1158/0008-5472.CAN-11-3940; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Butrym A, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0560-5; Campbell AM, 2008, J BIOENERG BIOMEMBR, V40, P193, DOI 10.1007/s10863-008-9138-x; Catalina-Rodriguez O, 2012, ONCOTARGET, V3, P1220; Chang PY, 2014, J CELL PHYSIOL, V229, P309, DOI 10.1002/jcp.24448; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Cowling VH, 2014, ONCOGENE, V33, P3519, DOI 10.1038/onc.2013.338; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Di Pietro SM, 2006, MOL BIOL CELL, V17, P4027, DOI 10.1091/mbc.E06-05-0379; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dupont WD, 2010, CANCER, V116, P8, DOI 10.1002/cncr.24702; Dutta B, 2014, MOL CELL PROTEOMICS, V13, P3236, DOI 10.1074/mcp.M114.038232; Feng G, 2014, LEUKEMIA LYMPHOMA, V55, P2699, DOI 10.3109/10428194.2014.891026; Flannery T, 2003, AM J PATHOL, V163, P175, DOI 10.1016/S0002-9440(10)63641-3; Frezza C, 2009, SEMIN CANCER BIOL, V19, P4, DOI 10.1016/j.semcancer.2008.11.008; Gormley JA, 2011, BRIT J CANCER, V105, P1487, DOI 10.1038/bjc.2011.408; Gottardi D, 1996, BRIT J HAEMATOL, V94, P612, DOI 10.1046/j.1365-2141.1996.d01-1856.x; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Guan K, 2013, MOL CELL BIOL, V33, P3137, DOI 10.1128/MCB.00030-13; Guryca V, 2012, PROTEOMICS, V12, P1207, DOI 10.1002/pmic.201100430; Ha SA, 2008, INT J CANCER, V122, P501, DOI 10.1002/ijc.23146; HANADA M, 1993, BLOOD, V82, P1820; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangen E, 2010, TRENDS BIOCHEM SCI, V35, P278, DOI 10.1016/j.tibs.2009.12.008; Hirabayashi R, 2013, STEM CELLS DEV, V22, P2532, DOI 10.1089/scd.2012.0623; Hoog JO, 2001, J BIOMED SCI, V8, P71, DOI 10.1159/000054015; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang HY, 2013, J BIOL CHEM, V288, P19870, DOI 10.1074/jbc.M112.448290; Hudler P, 2014, SCI WORLD J, DOI 10.1155/2014/260348; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; Kaemmerer D, 2014, CLIN EXP METASTAS, V31, P817, DOI 10.1007/s10585-014-9672-3; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Kempkensteffen C, 2008, J CANCER RES CLIN, V134, P543, DOI 10.1007/s00432-007-0317-7; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Kitada S, 2004, JNCI-J NATL CANCER I, V96, P642, DOI 10.1093/jnci/djh153; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Lee CEH, 2007, LEUKEMIA RES, V31, P1247, DOI 10.1016/j.leukres.2006.10.013; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Lemasters JJ, 2006, BBA-MOL BASIS DIS, V1762, P181, DOI 10.1016/j.bbadis.2005.10.006; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Lokamani I, 2014, PATHOL ONCOL RES, V20, P119, DOI 10.1007/s12253-013-9670-9; Ma MPC, 2012, J CELL SCI, V125, P4372, DOI 10.1242/jcs.105981; McKenney AS, 2013, J CLIN INVEST, V123, P3672, DOI 10.1172/JCI67266; Meldrum Cliff, 2011, Clin Biochem Rev, V32, P177; Miretti S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001828; Noma T, 2001, BIOCHEM J, V358, P225, DOI 10.1042/0264-6021:3580225; Oktem G, 2014, ONCOL REP, V32, P641, DOI 10.3892/or.2014.3252; Parker WB, 2011, CANCER GENE THER, V18, P390, DOI 10.1038/cgt.2011.4; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pepper C, 1997, BRIT J CANCER, V76, P935, DOI 10.1038/bjc.1997.487; Perez-Andres M, 2010, CYTOM PART B-CLIN CY, V78B, pS47, DOI 10.1002/cyto.b.20547; Placzek WJ, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.18; Prezma T, 2013, CELL DEATH IN PRESS; Rajkumar T, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-80; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Rossi D, 2012, EXPERT REV HEMATOL, V5, P593, DOI [10.1586/EHM.12.58, 10.1586/ehm.12.58]; Schimmer Aaron D, 2003, Curr Treat Options Oncol, V4, P211, DOI 10.1007/s11864-003-0022-y; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sevrioukova IF, 2011, ANTIOXID REDOX SIGN, V14, P2545, DOI 10.1089/ars.2010.3445; Shibata T, 2007, DIAGN MOL PATHOL, V16, P1, DOI 10.1097/01.pdm.0000213471.92925.51; Shinohara Y, 2000, EUR J BIOCHEM, V267, P6067, DOI 10.1046/j.1432-1327.2000.01687.x; Shoshan-Barmatz V, 2012, CURR MED CHEM, V19, P714, DOI 10.2174/092986712798992110; Shoshan-Barmatz V., 2014, BIOCH BIOPHYS ACTA; Shoshan-Barmatz V, 2010, BBA-BIOENERGETICS, V1797, P1281, DOI 10.1016/j.bbabio.2010.03.003; Shoshan-Barmatz V, 2010, MOL ASPECTS MED, V31, P227, DOI 10.1016/j.mam.2010.03.002; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Spender LC, 2009, CELL DEATH DIFFER, V16, P593, DOI 10.1038/cdd.2008.183; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Starczynski J, 2005, J CLIN ONCOL, V23, P1514, DOI 10.1200/JCO.2005.02.192; Tainsky MA, 2009, BBA-REV CANCER, V1796, P176, DOI 10.1016/j.bbcan.2009.04.004; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tritschler I, 2009, INT J CANCER, V125, P530, DOI 10.1002/ijc.24443; Ueda K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018567; Viatour P, 2003, LEUKEMIA, V17, P1349, DOI 10.1038/sj.leu.2402982; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Wade R, 2011, HAEMATOL-HEMATOL J, V96, P1496, DOI 10.3324/haematol.2011.043471; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050; Zaid H, 2005, CELL DEATH DIFFER, V12, P751, DOI 10.1038/sj.cdd.4401599; Zha S, 2005, PROSTATE, V63, P316, DOI 10.1002/pros.20177	104	11	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0148500	10.1371/journal.pone.0148500	http://dx.doi.org/10.1371/journal.pone.0148500			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078856	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700001
J	Alcaide, ML; Strbo, N; Romero, L; Jones, DL; Rodriguez, VJ; Arheart, K; Martinez, O; Bolivar, H; Podack, ER; Fischl, MA				Alcaide, Maria L.; Strbo, Natasa; Romero, Laura; Jones, Deborah L.; Rodriguez, Violeta J.; Arheart, Kristopher; Martinez, Octavio; Bolivar, Hector; Podack, Eckhard R.; Fischl, Margaret A.			Bacterial Vaginosis Is Associated with Loss of Gamma Delta T Cells in the Female Reproductive Tract in Women in the Miami Women Interagency HIV Study (WIHS): A Cross Sectional Study	PLOS ONE			English	Article							HIGH-RISK; INTRAVAGINAL PRACTICES; VAGINAL INFECTIONS; UNINFECTED WOMEN; CYTOKINE LEVELS; AFRICAN WOMEN; MUCOSAL; VIRUS; TRANSMISSION; ACQUISITION	Bacterial vaginosis (BV) is the most common female reproductive tract infection and is associated with an increased risk of acquiring and transmitting HIV by a mechanism that is not well understood. Gamma delta (GD) T cells are essential components of the adaptive and innate immune system, are present in the female reproductive tract, and play an important role in epithelial barrier protection. GD1 cells predominate in the mucosal tissue and are important in maintaining mucosal integrity. GD2 cells predominate in peripheral blood and play a role in humoral immunity and in the immune response to pathogens. HIV infection is associated with changes in GD T cells frequencies in the periphery and in the female reproductive tract. The objective of this study is to evaluate if changes in vaginal flora occurring with BV are associated with changes in endocervical GD T cell responses, which could account for increased susceptibility to HIV. Seventeen HIV-infected (HIV+) and 17 HIV-uninfected (HIV-) pre-menopausal women underwent collection of vaginal swabs and endocervical cytobrushes. Vaginal flora was assessed using the Nugent score. GD T cells were assessed in cytobrush samples by flow cytometry. Median Nugent score was 5.0 and 41% of women had abnormal vaginal flora. In HIV uninfected women there was a negative correlation between Nugent score and cervical GD1 T cells (b for interaction = -0.176, p<0.01); cervical GD1 T cells were higher in women with normal vaginal flora than in those with abnormal flora (45.00% vs 9.95%, p = 0.005); and cervical GD2 T cells were higher in women with abnormal flora than in those with normal flora (1.70% vs 0.35%, p = 0.023). GD T cells in the genital tract are protective (GD1) and are targets for HIV entry (GD2). The decrease in cervical GD1 and increase in GD2 T cells among women with abnormal vaginal flora predisposes women with BV to HIV acquisition. We propose to use GD T cell as markers of female genital tract vulnerability to HIV.	[Alcaide, Maria L.; Bolivar, Hector; Fischl, Margaret A.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Strbo, Natasa; Romero, Laura; Podack, Eckhard R.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Jones, Deborah L.; Rodriguez, Violeta J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Arheart, Kristopher] Univ Miami, Miller Sch Med, Dept Epidemiol & Publ Hlth, Miami, FL 33136 USA; [Martinez, Octavio] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami	Alcaide, ML (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA.	malcaide@med.miami.edu	Rodriguez, Violeta J/I-6290-2019	Rodriguez, Violeta J/0000-0001-8543-2061; , Octavio/0000-0002-0254-6854; Alcaide, Maria/0000-0003-4648-0145	National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine [P30AI073961]; Miami Women's Interagency HIV Infection Study (WIHS) [U01 AI103397]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23HD074489]; University of Miami National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities [UL1TR000460, 1KL2TR000461]; National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); National Cancer Institute (NCI); National Institute on Drug Abuse (NIDA); National Institute on Mental Health (NIMH); National Institute of Dental and Craniofacial Research (NIDCR); National Institute on Alcohol Abuse and Alcoholism (NIAAA); National Institute on Deafness and other Communication Disorders (NIDCD); NIH Office of Research on Women's Health; UCSF CTSA [UL1-TR000004]; Atlanta CTSA [UL1-TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD074489, U01HD032632] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000004, UL1TR000460, KL2TR000461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI103390, U01AI103397, P30AI073961, U01AI103408, U01AI103401, U01AI031834, U01AI034994, U01AI035004, U01AI034989, U01AI034993, U01AI042590] Funding Source: NIH RePORTER	National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine; Miami Women's Interagency HIV Infection Study (WIHS); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); University of Miami National Center for Advancing Translational Sciences; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute on Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Deafness and other Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Office of Research on Women's Health (ORWH)); UCSF CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Atlanta CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Institutes of Health though: the Miami Center for AIDS Research (CFAR) at the University of Miami Miller School of Medicine [P30AI073961], Miami Women's Interagency HIV Infection Study (WIHS) [U01 AI103397], the Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23HD074489], University of Miami National Center for Advancing Translational Sciences and the National Institute on Minority Health and Health Disparities [UL1TR000460 and 1KL2TR000461]. The WIHS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Cancer Institute (NCI), the National Institute on Drug Abuse (NIDA), and the National Institute on Mental Health (NIMH). Targeted supplemental funding for specific projects is also provided by the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Deafness and other Communication Disorders (NIDCD), and the NIH Office of Research on Women's Health. WIHS data collection is also supported by UL1-TR000004 (UCSF CTSA) and UL1-TR000454 (Atlanta CTSA). Data in this manuscript were collected by the Women's Interagency HIV Study (WIHS). The contents of this publication are solely the responsibility of the authors and do not represent the official views of the National Institutes of Health (NIH). WIHS (Principal Investigators): UAB-MS WIHS (Michael Saag, Mirjam-Colette Kempf, and Deborah Konkle-Parker), U01-AI-103401; Atlanta WIHS (Ighovwerha Ofotokun and Gina Wingood), U01-AI-103408; Bronx WIHS (Kathryn Anastos), U01-AI-035004; Brooklyn WIHS (Howard Minkoff and Deborah Gustafson), U01-AI-031834; Chicago WIHS (Mardge Cohen and Audrey French), U01-AI-034993; Metropolitan Washington WIHS (Mary Young), U01-AI-034994; Miami WIHS (Margaret Fischl and Lisa Metsch), U01-AI-103397; UNC WIHS (Adaora Adimora), U01-AI-103390; Connie Wofsy Women's HIV Study, Northern California (Ruth Greenblatt, Bradley Aouizerat, and Phyllis Tien), U01-AI-034989; WIHS Data Management and Analysis Center (Stephen Gange and Elizabeth Golub), U01-AI-042590; Southern California WIHS (Alexandra Levine and Marek Nowicki), U01-HD-032632 (WIHS I - WIHS IV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; AUTRAN B, 1989, CLIN EXP IMMUNOL, V75, P206; Bloom BS, 1996, NEW ENGL J MED, V334, P1338; Brotman RM, 2008, AM J EPIDEMIOL, V168, P188, DOI 10.1093/aje/kwn103; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Cohen CR, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001251; Eade CR, 2015, PROTEIN PEPTIDE LETT, V22, P672, DOI 10.2174/0929866522666150309155735; Farquhar C, 2010, AIDS, V24, P153, DOI 10.1097/QAD.0b013e32832326d8; Fethers KA, 2008, CLIN INFECT DIS, V47, P1426, DOI 10.1086/592974; Ghosh M, 2014, AM J REPROD IMMUNOL, V71, P575, DOI 10.1111/aji.12250; Greenblatt RM, 1999, SEX TRANSM DIS, V26, P143, DOI 10.1097/00007435-199903000-00004; Hayday A, 2003, NAT REV IMMUNOL, V3, P233, DOI 10.1038/nri1030; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; Hedges SR, 2006, J INFECT DIS, V193, P556, DOI 10.1086/499824; Hilber AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009119; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Holmes KK, 2008, SEXUALLY TRANSMITTED, V4th; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P184, DOI 10.1097/OLQ.0b013e3181c04865; Koumans EH, 2007, SEX TRANSM DIS, V34, P864, DOI 10.1097/OLQ.0b013e318074e565; Kyongo JK, 2015, CLIN VACCINE IMMUNOL, V22, P526, DOI 10.1128/CVI.00762-14; Laxmi U, 2012, J MATERN-FETAL NEO M, V25, P64, DOI 10.3109/14767058.2011.565390; Low N, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000416; Mares D, 2008, J REPROD IMMUNOL, V77, P91, DOI 10.1016/j.jri.2007.04.004; McClelland RS, 2006, AIDS, V20, P269, DOI 10.1097/01.aids.0000196165.48518.7b; Mincheva-Nilsson L, 2000, INT IMMUNOL, V12, P585, DOI 10.1093/intimm/12.5.585; Mincheva-Nilsson Lucia, 2003, Reprod Biol Endocrinol, V1, P120, DOI 10.1186/1477-7827-1-120; Mirmonsef P, 2012, CURR HIV RES, V10, P202, DOI 10.2174/157016212800618165; Mitchell CM, 2008, AIDS RES HUM RETROV, V24, P667, DOI [10.1089/aid.2007.0268, 10.1089/aid.2008.0268]; Mukura LR, 2012, AIDS RES HUM RETROV, V28, P1533, DOI [10.1089/aid.2011.0394, 10.1089/AID.2011.0394]; Muzny CA, 2014, SEX TRANSM DIS, V41, P58, DOI 10.1097/OLQ.0000000000000057; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Nakasone C, 2007, MICROBES INFECT, V9, P251, DOI 10.1016/j.micinf.2006.11.015; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Pauza CD, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00687; Poles MA, 2003, J VIROL, V77, P10456, DOI 10.1128/JVI.77.19.10456-10467.2003; Saba E, 2010, MUCOSAL IMMUNOL, V3, P280, DOI 10.1038/mi.2010.2; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Strbo N, 2016, AM J REPROD IMMUNOL, V75, P134, DOI 10.1111/aji.12458; Thurman AR, 2015, AIDS RES HUM RETROV, V31, P1139, DOI 10.1089/aid.2015.0006; Watts DH, 2006, JAIDS-J ACQ IMM DEF, V43, P161, DOI 10.1097/01.qai.0000242448.90026.13; Zariffard MR, 2005, J INFECT DIS, V191, P1913, DOI 10.1086/429922	42	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153045	10.1371/journal.pone.0153045	http://dx.doi.org/10.1371/journal.pone.0153045			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078021	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700017
J	Guo, YM; Zhou, HJ; Qin, LY; Pang, ZZ; Qin, T; Ren, HY; Pan, Z; Zhou, JK				Guo, Yumei; Zhou, Haijian; Qin, Liyun; Pang, Zhizhao; Qin, Tian; Ren, Hongyu; Pan, Zhuo; Zhou, Jikun			Frequency, Antimicrobial Resistance and Genetic Diversity of Klebsiella pneumoniae in Food Samples	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; MEDIATED QUINOLONE RESISTANCE; EXTENDED-SPECTRUM; FLUOROQUINOLONE RESISTANCE; MOLECULAR CHARACTERIZATION; CARBAPENEM RESISTANCE; ESCHERICHIA-COLI; CHICKEN MEAT; PREVALENCE; GYRA	This study aimed to assess the frequency of Klebsiella pneumoniae in food samples and to detect antibiotic resistance phenotypes, antimicrobial resistance genes and the molecular subtypes of the recovered isolates. A total of 998 food samples were collected, and 99 (9.9%) K. pneumoniae strains were isolated; the frequencies were 8.2% (4/49) in fresh raw seafood, 13.8% (26/188) in fresh raw chicken, 11.4% (34/297) in frozen raw food and 7.5% (35/464) in cooked food samples. Antimicrobial resistance was observed against 16 antimicrobials. The highest resistance rate was observed for ampicillin (92.3%), followed by tetracycline (31.3%), trimethoprim-sulfamethoxazole (18.2%), and chloramphenicol (10.1%). Two K. pneumoniae strains were identified as extended-spectrum beta-lactamase (ESBL)-one strain had three beta-lactamases genes (bla(SHV), bla(CTX-M-1), and bla(CTX-M-10)) and one had only the bla(SHV) gene. Nineteen multidrug-resistant (MDR) strains were detected; the percentage of MDR strains in fresh raw chicken samples was significantly higher than in other sample types (P<0.05). Six of the 18 trimethoprim-sulfamethoxazole-resistant strains carried the folate pathway inhibitor gene (dhfr). Four isolates were screened by PCR for quinolone resistance genes; aac(6')-Ib-cr, qnrB, qnrA and qnrS were detected. In addition, gyrA gene mutations such as T247A (Ser83Ile), C248T (Ser83Phe), and A260C (Asp87Ala) and a parC C240T (Ser80Ile) mutation were identified. Five isolates were screened for aminoglycosides resistance genes; aacA4, aacC2, and aadA1 were detected. Pulsed-field gel electrophoresis-based subtyping identified 91 different patterns. Our results indicate that food, especially fresh raw chicken, is a reservoir of antimicrobial-resistant K. pneumoniae, and the potential health risks posed by such strains should not be underestimated. Our results demonstrated high prevalence, antibiotic resistance rate and genetic diversity of K. pneumoniae in food in China. Improved control and prevention strategies are urgently needed.	[Guo, Yumei; Qin, Liyun; Pang, Zhizhao; Pan, Zhuo; Zhou, Jikun] Shijiazhuang Ctr Dis Control & Prevent, Shijiazhuang, Peoples R China; [Zhou, Haijian; Qin, Tian; Ren, Hongyu] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China; [Zhou, Haijian; Qin, Tian] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Zhou, JK (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	zhouhaijian@icdc.cn; zhoujikun@vip.inhe.net			National Health and Family Planning Commission of the People's Republic of China [2012ZX10004215, 2008ZX10004-008]	National Health and Family Planning Commission of the People's Republic of China	This work was supported by 2012ZX10004215, 2008ZX10004-008 from National Health and Family Planning Commission of the People's Republic of China (http://www.nhfpc.gov.cn/). HZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aathithan S, 2010, INT J ANTIMICROB AG, V36, P239, DOI 10.1016/j.ijantimicag.2010.04.010; An SC, 2012, FEMS MICROBIOL LETT, V332, P137, DOI 10.1111/j.1574-6968.2012.02586.x; Anderl JN, 2000, ANTIMICROB AGENTS CH, V44, P1818, DOI 10.1128/AAC.44.7.1818-1824.2000; BISSONNETTE L, 1992, J BACTERIOL, V174, P1248, DOI 10.1128/jb.174.4.1248-1257.1992; Calbo E, 2011, CLIN INFECT DIS, V52, P743, DOI 10.1093/cid/ciq238; Campos CB, 2014, INT J MED MICROBIOL, V304, P678, DOI 10.1016/j.ijmm.2014.04.012; Casella T, 2015, INT J FOOD MICROBIOL, V197, P88, DOI 10.1016/j.ijfoodmicro.2014.12.001; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Chen FJ, 2003, MICROB DRUG RESIST, V9, P265, DOI 10.1089/107662903322286472; Chon JW, 2015, FOODBORNE PATHOG DIS, V12, P190, DOI 10.1089/fpd.2014.1847; Clinical and Laboratory Standards Institute (CLSI), 2014, M100S242014 CLSI; Coudron PE, 2003, J CLIN MICROBIOL, V41, P772, DOI 10.1128/JCM.41.2.772-777.2003; Deguchi T, 1997, ANTIMICROB AGENTS CH, V41, P699, DOI 10.1128/AAC.41.3.699; Dhillon RHP, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/625170; Diancourt L, 2005, J CLIN MICROBIOL, V43, P4178, DOI 10.1128/JCM.43.8.4178-4182.2005; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Espedido BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059920; Gao Wei, 2009, Zhongguo Kangshengsu Zazhi, V34, P48; Han H, 2013, INT J ENV RES PUB HE, V10, P2720, DOI 10.3390/ijerph10072720; Hernandez-Alles S, 1999, ANTIMICROB AGENTS CH, V43, P937, DOI 10.1128/AAC.43.4.937; Hopkins KL, 2005, INT J ANTIMICROB AG, V25, P358, DOI 10.1016/j.ijantimicag.2005.02.006; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Kawakami S, 2000, Kansenshogaku Zasshi, V74, P24; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Krishnarnurthy V, 2013, J CLIN DIAGN RES, V7, P1975, DOI 10.7860/JCDR/2013/6544.3376; Kuchenmulller T, 2013, REV SCI TECH OIE, V32, P459; Leavitt A, 2010, J ANTIMICROB CHEMOTH, V65, P243, DOI 10.1093/jac/dkp417; Li B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042280; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Marchaim D, 2008, ANTIMICROB AGENTS CH, V52, P1413, DOI 10.1128/AAC.01103-07; McLinden T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-509; Meier S, 2011, INFECTION, V39, P333, DOI 10.1007/s15010-011-0132-6; Messai Y, 2008, PATHOL BIOL, V56, P319, DOI 10.1016/j.patbio.2008.05.008; Nawaz M, 2012, INT J FOOD MICROBIOL, V155, P179, DOI 10.1016/j.ijfoodmicro.2012.02.002; Oliver A, 2001, ANTIMICROB AGENTS CH, V45, P616, DOI 10.1128/AAC.45.2.616-620.2001; Park CH, 2006, ANTIMICROB AGENTS CH, V50, P3953, DOI 10.1128/AAC.00915-06; Perez-Perez FJ, 2002, J CLIN MICROBIOL, V40, P2153, DOI 10.1128/JCM.40.6.2153-2162.2002; Pfeifer Y, 2010, INT J MED MICROBIOL, V300, P371, DOI 10.1016/j.ijmm.2010.04.005; Falomir MP, 2013, FOODBORNE PATHOG DIS, V10, P1002, DOI 10.1089/fpd.2013.1552; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2005, ANTIMICROB AGENTS CH, V49, P3001, DOI 10.1128/AAC.49.7.3001-3003.2005; Schlesinger J, 2005, ANTIMICROB AGENTS CH, V49, P1150, DOI 10.1128/AAC.49.3.1150-1156.2005; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; Tumbarello M, 2007, ANTIMICROB AGENTS CH, V51, P1987, DOI 10.1128/AAC.01509-06; Turner MS, 2009, J ANTIMICROB CHEMOTH, V64, P960, DOI 10.1093/jac/dkp338; Velhner M, 2014, ZOONOSES PUBLIC HLTH, V61, P364, DOI 10.1111/zph.12081; Weigel LM, 1998, ANTIMICROB AGENTS CH, V42, P2661, DOI 10.1128/AAC.42.10.2661; Woodford N, 2010, J CLIN MICROBIOL, V48, P2999, DOI 10.1128/JCM.00341-10; Wu H, 2012, GENET MOL RES, V11, P3357, DOI 10.4238/2012.September.24.1; Wu HY, 2015, FOODBORNE PATHOG DIS, V12, P228, DOI 10.1089/fpd.2014.1859; Yang JY, 2011, MICROB DRUG RESIST, V17, P363, DOI 10.1089/mdr.2011.0034; Younes A, 2011, J ANTIMICROB CHEMOTH, V66, P313, DOI 10.1093/jac/dkq453; [张永标 Zhang Yongbiao], 2004, [中华微生物学和免疫学杂志, Chinese Journal of Microbiology and Immunology], V24, P577; Zimhony O, 2006, ANTIMICROB AGENTS CH, V50, P3179, DOI 10.1128/AAC.00218-06	57	37	42	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153561	10.1371/journal.pone.0153561	http://dx.doi.org/10.1371/journal.pone.0153561			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078494	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700079
J	Kasi, P; Wright, J; Khamis, H; Birznieks, I; van Schaik, A				Kasi, Patrick; Wright, James; Khamis, Heba; Birznieks, Ingvars; van Schaik, Andre			The Bayesian Decoding of Force Stimuli from Slowly Adapting Type I Fibers in Humans	PLOS ONE			English	Article							HUMAN TACTILE AFFERENTS; TIME-RESCALING THEOREM; GLABROUS SKIN AREA; HUMAN HAND; STATISTICAL-MODELS; NEURAL SPIKING; PRECISION GRIP; POPULATION; RESPONSES; SIGNALS	It is well known that signals encoded by mechanoreceptors facilitate precise object manipulation in humans. It is therefore of interest to study signals encoded by the mechanoreceptors because this will contribute further towards the understanding of fundamental sensory mechanisms that are responsible for coordinating force components during object manipulation. From a practical point of view, this may suggest strategies for designing sensory-controlled biomedical devices and robotic manipulators. We use a two-stage nonlinear decoding paradigm to reconstruct the force stimulus given signals from slowly adapting type one (SA-I) tactile afferents. First, we describe a nonhomogeneous Poisson encoding model which is a function of the force stimulus and the force's rate of change. In the decoding phase, we use a recursive nonlinear Bayesian filter to reconstruct the force profile, given the SA-I spike patterns and parameters described by the encoding model. Under the current encoding model, the mode ratio of force to its derivative is: 1.26 to 1.02. This indicates that the force derivative contributes significantly to the rate of change to the SA-I afferent spike modulation. Furthermore, using recursive Bayesian decoding algorithms is advantageous because it can incorporate past and current information in order to make predictions-consistent with neural systems-with little computational resources. This makes it suitable for interfacing with prostheses.	[Kasi, Patrick; Wright, James; Birznieks, Ingvars; van Schaik, Andre] Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia; [Khamis, Heba] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Birznieks, Ingvars] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Birznieks, Ingvars] Neurosci Res Australia, Sydney, NSW, Australia	Western Sydney University; University of New South Wales Sydney; University of New South Wales Sydney; Neuroscience Research Australia	Kasi, P (corresponding author), Univ Western Sydney, MARCS Inst Brain Behav & Dev, Sydney, NSW, Australia.	p.kasi@ywesternsydney.edu.au	Birznieks, Ingvars/D-4181-2012; B, Ingvars/Q-8634-2019	Birznieks, Ingvars/0000-0003-4916-1254; B, Ingvars/0000-0003-4916-1254; van Schaik, Andre/0000-0001-6140-017X	Western Sydney University and Australian	Western Sydney University and Australian	This work was supported by Western Sydney University and Australian (PhD Scholarship to Patrick Kasi), http://www.westernsydney.edu.au/marcs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aimonetti JM, 2007, J PHYSIOL-LONDON, V580, P649, DOI 10.1113/jphysiol.2006.123075; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Barbieri R, 2004, NEURAL COMPUT, V16, P277, DOI 10.1162/089976604322742038; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Birznieks I, 2010, J PHYSIOL-LONDON, V588, P1057, DOI 10.1113/jphysiol.2009.185314; BOLANOWSKI SJ, 1988, J ACOUST SOC AM, V84, P1680, DOI 10.1121/1.397184; Brisben AJ, 1999, J NEUROPHYSIOL, V81, P1548, DOI 10.1152/jn.1999.81.4.1548; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Brown EN, 1998, J NEUROSCI, V18, P7411; Cajigas I, 2012, J NEUROSCI METH, V211, P245, DOI 10.1016/j.jneumeth.2012.08.009; Chen Z, 2013, COMPUT INTEL NEUROSC, V2013, DOI 10.1155/2013/251905; Dandekar K, 2003, J BIOMECH ENG-T ASME, V125, P682, DOI 10.1115/1.1613673; Eden UT, 2008, INT CONF ACOUST SPEE, P5201, DOI 10.1109/ICASSP.2008.4518831; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Georgopoulos AP, 1999, J COMPUT NEUROSCI, V6, P279, DOI 10.1023/A:1008810007672; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; Haslinger R, 2010, NEURAL COMPUT, V22, P2477, DOI 10.1162/NECO_a_00015; Jenmalm P, 2003, EUR J NEUROSCI, V18, P164, DOI 10.1046/j.1460-9568.2003.02721.x; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; JOHANSSON RS, 1987, EXP BRAIN RES, V66, P141; JOHANSSON RS, 1984, EXP BRAIN RES, V56, P550; JOHANSSON RS, 1978, J PHYSIOL-LONDON, V281, P101, DOI 10.1113/jphysiol.1978.sp012411; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; Kasi PK, 2009, I IEEE EMBS C NEUR E, P10, DOI 10.1109/NER.2009.5109222; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kass RE, 2014, ANALYSIS OF NEURAL D; Khamis H, 2015, J NEUROPHYSIOL, V114, P474, DOI 10.1152/jn.00040.2015; Kim SS, 2010, J NEUROPHYSIOL, V104, P1484, DOI 10.1152/jn.00187.2010; Kim SS, 2009, IEEE T BIOMED CIRC S, V3, P398, DOI 10.1109/TBCAS.2009.2032396; KNIBESTOL M, 1975, J PHYSIOL-LONDON, V245, P63, DOI 10.1113/jphysiol.1975.sp010835; Koyama S, 2010, ANN I STAT MATH, V62, P37, DOI 10.1007/s10463-009-0249-x; LOEWENSTEIN WR, 1966, J PHYSIOL-LONDON, V182, P346, DOI 10.1113/jphysiol.1966.sp007827; LOFVENBERG J, 1984, BRAIN RES, V301, P65, DOI 10.1016/0006-8993(84)90403-7; Macefield V.G., 2008, ENCY NEUROSCIENCE, P914; Macefield VG, 1996, EXP BRAIN RES, V108, P172; McGill KC, 2005, J NEUROSCI METH, V149, P121, DOI 10.1016/j.jneumeth.2005.05.015; McGill KC, 2002, IEEE T BIO-MED ENG, V49, P640, DOI 10.1109/TBME.2002.1010847; Mendel J.M., 1995, LESSONS ESTIMATION T; Meng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085269; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; OGATA Y, 1988, J AM STAT ASSOC, V83, P9, DOI 10.1080/01621459.1988.10478560; Pawitan Y, 2001, ALL LIKELIHOOD STAT; PHILLIPS JR, 1981, J NEUROPHYSIOL, V46, P1204, DOI 10.1152/jn.1981.46.6.1204; Rieke F., 1997, SPIKES EXPLORING NEU; RUIZ S, 1995, J NEUROPHYSIOL, V73, P525, DOI 10.1152/jn.1995.73.2.525; Saal HP, 2014, TRENDS NEUROSCI, V37, P689, DOI 10.1016/j.tins.2014.08.012; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Scott SH, 2001, NATURE, V413, P161, DOI 10.1038/35093102; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; Srinivasan L, 2007, J NEUROPHYSIOL, V98, P2456, DOI 10.1152/jn.01118.2006; Sripati AP, 2006, J NEUROPHYSIOL, V95, P3852, DOI 10.1152/jn.01240.2005; Stanley GB, 1999, J NEUROSCI, V19, P8036, DOI 10.1523/jneurosci.19-18-08036.1999; Truccolo W, 2005, J NEUROPHYSIOL, V93, P1074, DOI 10.1152/jn.00697.2004; VALLBO AB, 1968, EXP NEUROL, V21, P270, DOI 10.1016/0014-4886(68)90041-1; Vallbo AB, 2004, J APPL PHYSIOL, V96, P1262, DOI 10.1152/japplphysiol.00470.2003; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Zhang Y, 2012, IEEE ENG MED BIO, P2740, DOI 10.1109/EMBC.2012.6346531	62	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153366	10.1371/journal.pone.0153366	http://dx.doi.org/10.1371/journal.pone.0153366			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077750	Green Published, gold			2022-12-27	WOS:000374131700045
J	Rustad, PI; Sailer, M; Cumming, KT; Jeppesen, PB; Kolnes, KJ; Sollie, O; Franch, J; Ivy, JL; Daniel, H; Jensen, J				Rustad, Per I.; Sailer, Manuela; Cumming, Kristoffer T.; Jeppesen, Per B.; Kolnes, Kristoffer J.; Sollie, Ove; Franch, Jesper; Ivy, John L.; Daniel, Hannelore; Jensen, Jorgen			Intake of Protein Plus Carbohydrate during the First Two Hours after Exhaustive Cycling Improves Performance the following Day	PLOS ONE			English	Article							MUSCLE GLYCOGEN UTILIZATION; WELL-TRAINED MEN; ENDURANCE EXERCISE; PROLONGED EXERCISE; NITROGEN-BALANCE; DIETARY-PROTEIN; AMINO-ACID; RECOVERY; HUMANS; METABOLISM	Intake of protein immediately after exercise stimulates protein synthesis but improved recovery of performance is not consistently observed. The primary aim of the present study was to compare performance 18 h after exhaustive cycling in a randomized diet-controlled study (175 kJ.kg(-1) during 18 h) when subjects were supplemented with protein plus carbohydrate or carbohydrate only in a 2-h window starting immediately after exhaustive cycling. The second aim was to investigate the effect of no nutrition during the first 2 h and low total energy intake (113 kJ.kg(-1) during 18 h) on performance when protein intake was similar. Eight endurance-trained subjects cycled at 237 +/- 6 Watt (similar to 72% VO2max) until exhaustion (TTE) on three occasions, and supplemented with 1.2 g carbohydrate.kg(-1).h(-1) (CHO), 0.8 g carbohydrate + 0.4 g protein.kg(-1).h(-1) (CHO+PRO) or placebo without energy (PLA). Intake of CHO+PROT increased plasma glucose, insulin, and branch chained amino acids, whereas CHO only increased glucose and insulin. Eighteen hours later, subjects performed another TTE at 237 +/- 6 Watt. TTE was increased after intake of CHO+PROT compared to CHO (63.5 +/- 4.4 vs 49.8 +/- 5.4 min; p<0.05). PLA reduced TTE to 42.8 +/- 5.1 min (p<0.05 vs CHO). Nitrogen balance was positive in CHO+PROT, and negative in CHO and PLA. In conclusion, performance was higher 18 h after exhaustive cycling with intake of CHO+PROT compared to an isocaloric amount of carbohydrate during the first 2 h post exercise. Intake of a similar amount of protein but less carbohydrate during the 18 h recovery period reduced performance.	[Rustad, Per I.; Cumming, Kristoffer T.; Kolnes, Kristoffer J.; Sollie, Ove; Jensen, Jorgen] Norwegian Sch Sport Sci, Dept Phys Performance, POB 4014 Ulleval Stad, N-0806 Oslo, Norway; [Sailer, Manuela; Daniel, Hannelore] Tech Univ Munich, ZIEL Inst Food & Hlth, D-80290 Munich, Germany; [Jeppesen, Per B.] Aarhus Univ, Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Franch, Jesper] Aalborg Univ, Dept Hlth Sci & Technol, Aalborg, Denmark; [Ivy, John L.] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Exercise Physiol & Metab Lab, Austin, TX 78712 USA; [Jensen, Jorgen] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark	Norwegian School of Sport Sciences; Technical University of Munich; Aarhus University; Aalborg University; University of Texas System; University of Texas Austin; University of Copenhagen	Jensen, J (corresponding author), Norwegian Sch Sport Sci, Dept Phys Performance, POB 4014 Ulleval Stad, N-0806 Oslo, Norway.; Jensen, J (corresponding author), Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark.	jorgen.jensen@nih.no		Kolnes, Kristoffer Jensen/0000-0001-8824-5173; Franch, Jesper/0000-0002-8668-2385	Norwegian School of Sport Sciences	Norwegian School of Sport Sciences	The study was funded by Norwegian School of Sport Sciences.	Berardi JM, 2006, MED SCI SPORT EXER, V38, P1106, DOI 10.1249/01.mss.0000222826.49358.f3; Berardi JM, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-24; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Betts JA, 2005, INT J SPORT NUTR EXE, V15, P590, DOI 10.1123/ijsnem.15.6.590; Betts JA, 2010, SPORTS MED, V40, P941, DOI 10.2165/11536900-000000000-00000; Blomstrand E, 1999, J PHYSIOL-LONDON, V514, P293, DOI 10.1111/j.1469-7793.1999.293af.x; Blomstrand E, 2001, AM J PHYSIOL-ENDOC M, V281, pE365, DOI 10.1152/ajpendo.2001.281.2.E365; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Borsheim E, 2004, J APPL PHYSIOL, V96, P674, DOI 10.1152/japplphysiol.00333.2003; Brosnan JT, 2006, J NUTR, V136, p207S, DOI 10.1093/jn/136.1.207S; COSTILL DL, 1981, AM J CLIN NUTR, V34, P1831, DOI 10.1093/ajcn/34.9.1831; COSTILL DL, 1971, J APPL PHYSIOL, V31, P834, DOI 10.1152/jappl.1971.31.6.834; COYLE EF, 1986, J APPL PHYSIOL, V61, P165, DOI 10.1152/jappl.1986.61.1.165; Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb; Ferguson-Stegall L, 2011, J STRENGTH COND RES, V25, P1210, DOI 10.1519/JSC.0b013e318212db21; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; GALBO H, 1977, J APPL PHYSIOL, V42, P525, DOI 10.1152/jappl.1977.42.4.525; GALBO H, 1979, ACTA PHYSIOL SCAND, V107, P19, DOI 10.1111/j.1748-1716.1979.tb06438.x; Goedecke JH, 2000, AM J PHYSIOL-ENDOC M, V279, pE1325, DOI 10.1152/ajpendo.2000.279.6.E1325; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Howarth KR, 2010, J APPL PHYSIOL, V109, P431, DOI 10.1152/japplphysiol.00108.2009; Howarth KR, 2009, J APPL PHYSIOL, V106, P1394, DOI 10.1152/japplphysiol.90333.2008; Ivy JL, 2002, J APPL PHYSIOL, V93, P1337, DOI 10.1152/japplphysiol.00394.2002; LEMON PWR, 1980, J APPL PHYSIOL, V48, P624, DOI 10.1152/jappl.1980.48.4.624; Levenhagen DK, 2002, MED SCI SPORT EXER, V34, P828, DOI 10.1097/00005768-200205000-00016; Levenhagen DK, 2001, AM J PHYSIOL-ENDOC M, V280, pE982, DOI 10.1152/ajpendo.2001.280.6.E982; Maughan RJ, 2013, ENCY SPORTS MED IOC, P113, DOI [DOI 10.1002/, DOI 10.1002/9781118692318.CH8]; Millard-Stafford M, 2005, INT J SPORT NUTR EXE, V15, P610, DOI 10.1123/ijsnem.15.6.610; Moore DR, 2014, APPL PHYSIOL NUTR ME, P1; Morifuji M, 2010, AMINO ACIDS, V38, P1109, DOI 10.1007/s00726-009-0321-0; Nelson AR, 2012, MED SCI SPORT EXER, V44, P57, DOI 10.1249/MSS.0b013e3182290371; Osterberg KL, 2008, J SPORT SCI, V26, P227, DOI 10.1080/02640410701459730; Otocka-Kmiecik A., 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/230271; Perronet F, 1991, CAN J SPORT SCI, V16, P23; PHILLIPS SM, 1993, J APPL PHYSIOL, V75, P2134, DOI 10.1152/jappl.1993.75.5.2134; RITCHIE SE, 1991, INT J SPORTS MED, V12, P27, DOI 10.1055/s-2007-1024650; Romano-Ely BC, 2006, MED SCI SPORT EXER, V38, P1608, DOI 10.1249/01.mss.0000229458.11452.e9; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Rowlands DS, 2008, APPL PHYSIOL NUTR ME, V33, P39, DOI 10.1139/H07-136; Rowlands DS, 2007, INT J SPORT NUTR EXE, V17, P521, DOI 10.1123/ijsnem.17.6.521; Rowlands DS, 2011, PHYSIOL GENOMICS, V43, P1004, DOI 10.1152/physiolgenomics.00073.2011; Sailer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063950; Saunders MJ, 2004, MED SCI SPORT EXER, V36, P1233, DOI 10.1249/01.MSS.0000132377.66177.9F; She PX, 2010, J APPL PHYSIOL, V108, P941, DOI 10.1152/japplphysiol.01248.2009; Souza TP, 2014, BIOL SPORT, V31, P271, DOI 10.5604/20831862.1120934; TARNOPOLSKY MA, 1988, J APPL PHYSIOL, V64, P187, DOI 10.1152/jappl.1988.64.1.187; Thomson JS, 2011, APPL PHYSIOL NUTR ME, V36, P242, DOI [10.1139/h10-104, 10.1139/H10-104]; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Williams MB, 2003, J STRENGTH COND RES, V17, P12, DOI 10.1519/1533-4287(2003)017<0012:EORBOG>2.0.CO;2; WOLFE RR, 1982, J APPL PHYSIOL, V52, P458, DOI 10.1152/jappl.1982.52.2.458; ZAWADZKI KM, 1992, J APPL PHYSIOL, V72, P1854, DOI 10.1152/jappl.1992.72.5.1854	52	23	26	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153229	10.1371/journal.pone.0153229	http://dx.doi.org/10.1371/journal.pone.0153229			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078151	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700028
J	Schar, RT; Fiechter, M; Z'Graggen, WJ; Soll, N; Krejci, V; Wiest, R; Raabe, A; Beck, J				Schaer, Ralph T.; Fiechter, Michael; Z'Graggen, Werner J.; Soell, Nicole; Krejci, Vladimir; Wiest, Roland; Raabe, Andreas; Beck, Juergen			No Routine Postoperative Head CT following Elective Craniotomy - A Paradigm Shift?	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; EXTUBATION; HEMATOMA; SCANS; CARE	Introduction Patient management following elective cranial surgery often includes routine postoperative computed tomography (CT). We analyzed whether a regime of early extubation and close neurological monitoring without routine CT is safe, and compared the rate of postoperative emergency neurosurgical intervention with published data. Methods Four hundred ninety-two patients were prospectively analyzed; 360 had supra-and 132 had infratentorial lesions. Extubation within one hour after skin closure was aimed for in all cases. CT was performed within 48 hours only in cases of unexpected neurological findings. Results Four-hundred sixty-nine of the 492 patients (95.3%) were extubated within one hour, 20 (4.1%) within 3 hours, and three (0.6%) within 3 to 10 hours. Emergency CT within 48 hours was performed for 43/492 (8.7%) cases. Rate of recraniotomy within 48 hours for patients with postoperative hemorrhage was 0.8% (n = 4), and 0.8% (n = 4) required placement of an external ventricular drain (EVD). Of 469 patients extubated within one hour, 3 required recraniotomy and 2 required EVD placements. Of 23 patients with delayed extubation, 1 recraniotomy and 2 EVDs were required. Failure to extubate within one hour was associated with a significantly higher risk of surgical intervention within 48 hours (rate 13.0%, p = 0.004, odds ratio 13.9, 95% confidence interval [3.11-62.37]). Discussion Early extubation combined with close neurological monitoring is safe and omits the need for routine postoperative CT. Patients not extubated within one hour do need early CT, since they had a significantly increased risk of requiring emergency neurosurgical intervention.	[Schaer, Ralph T.; Fiechter, Michael; Z'Graggen, Werner J.; Soell, Nicole; Raabe, Andreas; Beck, Juergen] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Krejci, Vladimir] Univ Bern, Inselspital, Univ Hosp Bern, Dept Anesthesiol, CH-3010 Bern, Switzerland; [Z'Graggen, Werner J.] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurol, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Bern, Inselspital, Univ Hosp Bern, Dept Neuroradiol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Beck, J (corresponding author), Univ Bern, Inselspital, Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	juergen.beck@insel.ch	Schär, Ralph T./P-3895-2019; Schär, Ralph/C-5289-2017	Schär, Ralph T./0000-0001-8998-9668; Schär, Ralph/0000-0001-8998-9668; Z'Graggen, Werner/0000-0002-5684-4419; Beck, Jurgen/0000-0002-7687-6098				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Anandalwar SP, 2016, J NEUROSURG, V125, P667, DOI 10.3171/2015.9.JNS151379; Bruder N, 1999, ANESTH ANALG, V89, P674, DOI 10.1097/00000539-199909000-00027; Bruder Nicolas J, 2002, Curr Opin Anaesthesiol, V15, P477, DOI 10.1097/00001503-200210000-00001; Cata JP, 2011, J NEUROSURG ANESTH, V23, P25, DOI 10.1097/ANA.0b013e3181eee548; Citerio G, 2012, EUR J ANAESTH, V29, P371, DOI 10.1097/EJA.0b013e32835422db; Fontes RBV, 2014, J NEUROSURG, V121, P307, DOI 10.3171/2014.4.JNS132429; Garrett MC, 2013, NEUROSURGERY, V73, P209, DOI 10.1227/01.neu.0000430328.25516.dd; Jiang ZY, 2013, OTOLARYNG HEAD NECK, V149, P786, DOI 10.1177/0194599813502311; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Khaldi A, 2010, J NEUROSURG, V113, P1021, DOI 10.3171/2009.11.JNS081048; Kondziolka D, 2010, J NEUROSURG, V113, P1019, DOI 10.3171/2009.10.JNS091531; Lassen B, 2011, NEUROSURGERY, V68, P1259, DOI 10.1227/NEU.0b013e31820c0441; LIN JP, 1977, NEURORADIOLOGY, V12, P185, DOI 10.1007/BF00332366; Magni G, 2005, J NEUROSURG ANESTH, V17, P134, DOI 10.1097/01.ana.0000167447.33969.16; Magni G, 2007, J NEUROSURG ANESTH, V19, P229, DOI 10.1097/ANA.0b013e31806e5f5a; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; PALMER JD, 1994, NEUROSURGERY, V35, P1061, DOI 10.1227/00006123-199412000-00007; Rhondali O, 2011, J NEUROSURG ANESTH, V23, P118, DOI 10.1097/ANA.0b013e318206d5f8; Schucht P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079846; Seifman MA, 2011, NEUROSURG REV, V34, P393, DOI 10.1007/s10143-010-0304-3; TAYLOR WAS, 1995, J NEUROSURG, V82, P48, DOI 10.3171/jns.1995.82.1.0048; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	24	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153499	10.1371/journal.pone.0153499	http://dx.doi.org/10.1371/journal.pone.0153499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077906	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700066
J	Yabu, JM; Siebert, JC; Maecker, HT				Yabu, Julie M.; Siebert, Janet C.; Maecker, Holden T.			Immune Profiles to Predict Response to Desensitization Therapy in Highly HLA-Sensitized Kidney Transplant Candidates	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RENAL-TRANSPLANTATION; RECIPIENTS; TOLERANCE; SIGNATURE; RITUXIMAB; HUMANS	Background Kidney transplantation is the most effective treatment for end-stage kidney disease. Sensitization, the formation of human leukocyte antigen (HLA) antibodies, remains a major barrier to successful kidney transplantation. Despite the implementation of desensitization strategies, many candidates fail to respond. Current progress is hindered by the lack of biomarkers to predict response and to guide therapy. Our objective was to determine whether differences in immune and gene profiles may help identify which candidates will respond to desensitization therapy. Methods and Findings Single-cell mass cytometry by time-of-flight (CyTOF) phenotyping, gene arrays, and phosphoepitope flow cytometry were performed in a study of 20 highly sensitized kidney transplant candidates undergoing desensitization therapy. Responders to desensitization therapy were defined as 5% or greater decrease in cumulative calculated panel reactive antibody (cPRA) levels, and non-responders had 0% decrease in cPRA. Using a decision tree analysis, we found that a combination of transitional B cell and regulatory T cell (Treg) frequencies at baseline before initiation of desensitization therapy could distinguish responders from non-responders. Using a support vector machine (SVM) and longitudinal data, TRAF3IP3 transcripts and HLA-DR-CD38+CD4+T cells could also distinguish responders from non-responders. Combining all assays in a multivariate analysis and elastic net regression model with 72 analytes, we identified seven that were highly interrelated and eleven that predicted response to desensitization therapy. Conclusions Measuring baseline and longitudinal immune and gene profiles could provide a useful strategy to distinguish responders from non-responders to desensitization therapy. This study presents the integration of novel translational studies including CyTOF immunophenotyping in a multivariate analysis model that has potential applications to predict response to desensitization, select candidates, and personalize medicine to ultimately improve overall outcomes in highly sensitized kidney transplant candidates.	[Yabu, Julie M.] Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA; [Siebert, Janet C.] CytoAnalytics, Denver, CO USA; [Maecker, Holden T.] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Palo Alto, CA 94304 USA	Stanford University; Stanford University	Yabu, JM (corresponding author), Stanford Univ, Sch Med, Dept Med, Palo Alto, CA 94304 USA.	jyabu@cal.berkeley.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K23AI104401]; Institute for Immunity, Transplantation and Infection (ITI) Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104401] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute for Immunity, Transplantation and Infection (ITI) Seed Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number K23AI104401 (JMY) and the Institute for Immunity, Transplantation and Infection (ITI) Seed Grant (JMY) supported research reported in this publication. JCS (CytoAnalytics) performed data analysis as work-for-hire, which was paid for via a gift from the Moore Foundation. The funders provided support in the form of salaries for authors (JMY and JCS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles are articulated in the author contributions' section.	Borrego F, 2006, IMMUNOL RES, V35, P263, DOI 10.1385/IR:35:3:263; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hadad U, 2014, IMMUNOL RES, V58, P259, DOI 10.1007/s12026-014-8493-4; Leibler C, 2014, AM J TRANSPLANT, V14, P1173, DOI 10.1111/ajt.12721; Leipold MD, 2015, METHODS MOL BIOL, V1343, P81, DOI 10.1007/978-1-4939-2963-4_7; Lemy A, 2010, NEPHROL DIAL TRANSPL, V25, P3480, DOI 10.1093/ndt/gfq502; Mallone R, 2011, CLIN EXP IMMUNOL, V163, P33, DOI 10.1111/j.1365-2249.2010.04272.x; Newell KA, 2015, AM J TRANSPLANT, V15, P2908, DOI 10.1111/ajt.13480; Newell KA, 2010, J CLIN INVEST, V120, P1836, DOI 10.1172/JCI39933; Peng S, 2015, CLIN EXP IMMUNOL, V182, P57, DOI 10.1111/cei.12658; Pinheiro JC, 2009, MIXED EFFECTS MODELS; Resch T, 2015, TRANSPLANTATION, V99, P1335, DOI 10.1097/TP.0000000000000757; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sagoo P, 2010, J CLIN INVEST, V120, P1848, DOI 10.1172/JCI39922; Sidner Richard A, 2004, Hum Antibodies, V13, P55; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stegall MD, 2009, AM J TRANSPLANT, V9, P998, DOI 10.1111/j.1600-6143.2009.02612.x; TOYODA M, 1994, J CLIN IMMUNOL, V14, P178, DOI 10.1007/BF01533367; Vieira CA, 2004, TRANSPLANTATION, V77, P542, DOI 10.1097/01.TP.0000112934.12622.2B; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Witten IH, 2011, MOR KAUF D, P1; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Woodle ES, 2015, AM J TRANSPLANT, V15, P101, DOI 10.1111/ajt.13050; Zou Q, 2015, J EXP MED, V212, P1323, DOI 10.1084/jem.20150110	25	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153355	10.1371/journal.pone.0153355	http://dx.doi.org/10.1371/journal.pone.0153355			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078882	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700042
J	Rautiola, J; Lampinen, A; Mirtti, T; Ristimaki, A; Joensuu, H; Bono, P; Saharinen, P				Rautiola, Juhana; Lampinen, Anita; Mirtti, Tuomas; Ristimaki, Ari; Joensuu, Heikki; Bono, Petri; Saharinen, Pipsa			Association of Angiopoietin-2 and Ki-67 Expression with Vascular Density and Sunitinib Response in Metastatic Renal Cell Carcinoma	PLOS ONE			English	Article							MICROVESSEL DENSITY; TARGETED THERAPY; LUNG METASTASIS; TUMOR-THERAPY; ANGIOGENESIS; CANCER; VEGF; INHIBITORS; BIOMARKERS; GROWTH	The Angiopoietin-2 (Ang2, Angpt2) growth factor is a context-dependent antagonist/agonist ligand of the endothelial Tie2 receptor tyrosine kinase and known to promote tumour angiogenesis and metastasis. Angiopoietin antagonists have been tested in clinical cancer trials in combination with VEGF-based anti-angiogenic therapy, including sunitinib, which is widely used as a first-line therapy for metastatic renal cell carcinoma (mRCC). However, little is known about Ang2 protein expression in human tumours and the correlation of tumour Ang2 expression with tumour vascularization, tumour cell proliferation and response to anti-angiogenic therapies. Here, we evaluated, using immunohistochemistry, the expression of Ang2, CD31 and the cell proliferation marker Ki-67 in the primary kidney cancer from 136 mRCC patients, who received first-line sunitinib after nephrectomy. Ang2 protein expression was restrained to RCC tumour vessels, and correlated with tumour vascularization and response to sunitinib. High pre-therapeutic Ang2 expression, and more strongly, combined high expression of both Ang2 and CD31, were associated with a high clinical benefit rate (CBR). Low cancer Ki-67 expression, but not Ang2 or CD31 expression, was associated with favourable progression-free (PFS) and overall survival (OS) as compared to patients with high Ki-67 expression (PFS 6.5 vs. 10.6 months, P = 0.009; OS, 15.7 vs. 28.5 months, P = 0.015). In summary, in this study to investigate endothelial Ang2 in mRCC patients treated with first-line sunitinib, high cancer Ang2 expression was associated with the CBR, but not PFS or OS, whereas low Ki-67 expression was significantly associated with long PFS and OS.	[Rautiola, Juhana; Joensuu, Heikki; Bono, Petri] Helsinki Univ Hosp, Ctr Comprehens Canc, POB 180, Helsinki 00029, Finland; [Rautiola, Juhana; Joensuu, Heikki; Bono, Petri] Univ Helsinki, FIN-00014 Helsinki, Finland; [Lampinen, Anita; Saharinen, Pipsa] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Lampinen, Anita; Saharinen, Pipsa] Univ Helsinki, Dept Virol, Haartman Inst, Biomedicum Helsinki, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Saharinen, Pipsa] Biomedicum Helsinki, Wihuri Res Inst, Haartmaninkatu 8, FI-00290 Helsinki, Finland; [Mirtti, Tuomas] Univ Helsinki, Inst Mol Med Finland, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Univ Helsinki, Res Programs Unit, Pathol, POB 400, FI-00029 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Univ Helsinki, HUSLAB, POB 400, FI-00029 Helsinki, Finland; [Mirtti, Tuomas; Ristimaki, Ari] Helsinki Univ Hosp, POB 400, FI-00029 Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Wihuri Research Institute; University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Saharinen, P (corresponding author), Univ Helsinki, Res Programs Unit, Translat Canc Biol, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland.; Saharinen, P (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Biomedicum Helsinki, Haartmaninkatu 8,POB 63, FI-00014 Helsinki, Finland.; Saharinen, P (corresponding author), Biomedicum Helsinki, Wihuri Res Inst, Haartmaninkatu 8, FI-00290 Helsinki, Finland.	Pipsa.Saharinen@Helsinki.fi	Saharinen, Pipsa I/C-9601-2016	Saharinen, Pipsa I/0000-0003-2652-0584; Joensuu, Heikki/0000-0003-0281-2507; Mirtti, Tuomas/0000-0003-0455-9891	Cancer Foundation [271845]; Academy of Finland Centre of Excellence Program	Cancer Foundation; Academy of Finland Centre of Excellence Program(Academy of Finland)	Funded by https://www.cancersociety.fi/grants/cancer-foundation-grants/; Cancer Foundation (PS) and 271845; https://www.aka.fi; Academy of Finland Centre of Excellence Program 2014-2019 (to PS, HJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins MB, 2015, J CLIN ONCOL; Busch J, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-295; Cheng SH, 2014, INT J CLIN EXP PATHO, V7, P5855; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Conroy AL, 2012, CRIT CARE MED, V40, P952, DOI 10.1097/CCM.0b013e3182373157; Coppin C, 2011, BJU INT, V108, P1556, DOI 10.1111/j.1464-410X.2011.10629.x; Currie MJ, 2002, J PATHOL, V198, P502, DOI 10.1002/path.1228; Daly C, 2013, CANCER RES, V73, P108, DOI 10.1158/0008-5472.CAN-12-2064; del Puerto-Nevado L, 2014, BRIT J CANCER, V110, P2700, DOI 10.1038/bjc.2014.225; Demasi APD, 2012, HEAD NECK PATHOL, V6, P10, DOI 10.1007/s12105-011-0302-y; Dornbusch J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076386; Dudderidge TJ, 2005, CLIN CANCER RES, V11, P2510, DOI 10.1158/1078-0432.CCR-04-1776; Eklund L, 2013, EXP CELL RES, V319, P1271, DOI 10.1016/j.yexcr.2013.03.011; Escudier B, 2014, ANN ONCOL, V25, P49, DOI 10.1093/annonc/mdu259; Fagiani E, 2013, CANCER LETT, V328, P18, DOI 10.1016/j.canlet.2012.08.018; Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685; Gayed BA, 2014, BJU INT, V113, P668, DOI 10.1111/bju.12263; Gerald D, 2013, CANCER RES, V73, P1649, DOI 10.1158/0008-5472.CAN-12-4697; Gerlinger M, 2014, NAT GENET, V46, P225, DOI 10.1038/ng.2891; Goede V, 2010, BRIT J CANCER, V103, P1407, DOI 10.1038/sj.bjc.6605925; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Joo HJ, 2004, BJU INT, V93, P291, DOI 10.1111/j.1464-410X.2004.04604.x; Keskin D, 2015, CELL REP, V10, P1066, DOI 10.1016/j.celrep.2015.01.035; Kienast Y, 2013, CLIN CANCER RES, V19, P6730, DOI 10.1158/1078-0432.CCR-13-0081; Kumpers P, 2009, CRIT CARE, V13, DOI 10.1186/cc7866; Li CY, 2013, EUR J DRUG METAB PH, V2013, pII, DOI DOI 10.1371/J0URNAL.P0NE.0075388; Mazzieri R, 2011, CANCER CELL, V19, P512, DOI 10.1016/j.ccr.2011.02.005; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Milam KE, 2015, TISSUE BARRIERS, V3, DOI DOI 10.4161/21688362.2014.957508; Monk BJ, 2014, LANCET ONCOL; Motzer RJ, 2014, CANCER CHEMOTH PHARM, V74, P739, DOI 10.1007/s00280-014-2539-0; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Nakayama T, 2004, HISTOPATHOLOGY, V44, P232, DOI 10.1111/j.0309-0167.2004.01817.x; Ngo TC, 2014, UROL ONCOL-SEMIN ORI, V32, P243, DOI 10.1016/j.urolonc.2013.07.011; Parikh SM, 2006, PLOS MED, V3, P356, DOI 10.1371/journal.pmed.0030046; Porta C, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-105; Powles T, 2011, BRIT J CANCER, V104, P741, DOI 10.1038/sj.bjc.6606061; Ravaud A, 2013, ANN ONCOL, V24, P2935, DOI 10.1093/annonc/mdt288; Rigamonti N, 2014, CELL REP, V8, P696, DOI 10.1016/j.celrep.2014.06.059; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Sennino B, 2012, NAT REV CANCER, V12, P699, DOI 10.1038/nrc3366; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Sharpe K, 2013, CLIN CANCER RES, V19, P6924, DOI 10.1158/1078-0432.CCR-13-1631; Sounni NE, 2014, CELL METAB, V20, P280, DOI 10.1016/j.cmet.2014.05.022; Srivastava K, 2014, CANCER CELL, V26, P880, DOI 10.1016/j.ccell.2014.11.005; Tollefson MK, 2007, CANCER, V110, P783, DOI 10.1002/cncr.22840; Virman J, 2015, ANTICANCER RES, V35, P921; Wang XE, 2014, TRANSL ONCOL, V7, P188, DOI 10.1016/j.tranon.2014.02.003; Yao X, 2007, CLIN CANCER RES, V13, P161, DOI 10.1158/1078-0432.CCR-06-0774	53	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153745	10.1371/journal.pone.0153745	http://dx.doi.org/10.1371/journal.pone.0153745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100185	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500063
J	Dowdy, NJ; Conner, WE				Dowdy, Nicolas J.; Conner, William E.			Acoustic Aposematism and Evasive Action in Select Chemically Defended Arctiine (Lepidoptera: Erebidae) Species: Nonchalant or Not?	PLOS ONE			English	Article							BIG BROWN BATS; CYCNIA-TENERA; MOTH SOUNDS; BEHAVIOR; DISCRIMINATION; SEQUESTRATION; CLICKS	Tiger moths (Erebidae: Arctiinae) have experienced intense selective pressure from echolocating, insectivorous bats for over 65 million years. One outcome has been the evolution of acoustic signals that advertise the presence of toxins sequestered from the moths' larval host plants, i. e. acoustic aposematism. Little is known about the effectiveness of tiger moth anti-bat sounds in their natural environments. We used multiple infrared cameras to reconstruct bat-moth interactions in three-dimensional (3-D) space to examine how functional sound-producing organs called tymbals affect predation of two chemically defended tiger moth species: Pygarctia roseicapitis (Arctiini) and Cisthene martini (Lithosiini). P. roseicapitis and C. martini with intact tymbals were 1.8 and 1.6 times less likely to be captured by bats relative to those rendered silent. 3-D flight path and acoustic analyses indicated that bats actively avoided capturing sound-producing moths. Clicking behavior differed between the two tiger moth species, with P. roseicapitis responding in an earlier phase of bat attack. Evasive flight behavior in response to bat attacks was markedly different between the two tiger moth species. P. roseicapitis frequently paired evasive dives with aposematic sound production. C. martini were considerably more nonchalant and employed evasion in fewer interactions. Our results show that acoustic aposematism is effective at deterring bat predation in a natural context and that this strategy is likely to be the ancestral function of tymbal organs within the Arctiinae.	[Dowdy, Nicolas J.; Conner, William E.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA	Wake Forest University	Dowdy, NJ (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	njdowdy@gmail.com	Dowdy, Nicolas/AAT-1537-2021	Dowdy, Nicolas/0000-0002-5453-2569	National Science Foundation [IOS 0951160]	National Science Foundation(National Science Foundation (NSF))	This material is based upon work supported by the National Science Foundation [IOS 0951160 to WEC]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHARYA L, 1992, CAN J ZOOL, V70, P1292, DOI 10.1139/z92-180; Barber JR, 2006, J EXP BIOL, V209, P2637, DOI 10.1242/jeb.02295; Barber JR, 2007, P NATL ACAD SCI USA, V104, P9331, DOI 10.1073/pnas.0703627104; Barber JR, 2009, J EXP BIOL, V212, P2141, DOI 10.1242/jeb.029991; Bernays EA, 2004, J INSECT BEHAV, V17, P41, DOI 10.1023/B:JOIR.0000025131.16275.0f; BLEST AD, 1963, PROC R SOC SER B-BIO, V158, P196, DOI 10.1098/rspb.1963.0042; COHEN JA, 1983, J CHEM ECOL, V9, P521, DOI 10.1007/BF00990224; Conner WE, 2012, ANNU REV ENTOMOL, V57, P21, DOI 10.1146/annurev-ento-121510-133537; Corcoran AJ, 2012, J EXP BIOL, V215, P4278, DOI 10.1242/jeb.076943; Corcoran AJ, 2011, J EXP BIOL, V214, P2416, DOI 10.1242/jeb.054783; Corcoran AJ, 2010, CURR ZOOL, V56, P358, DOI 10.1093/czoolo/56.3.358; Dawson JW, 2004, J COMP PHYSIOL A, V190, P69, DOI 10.1007/s00359-003-0474-3; Dunning D. C., 1968, Zeitschrift fuer Tierpsychologie, V25, P129; DUNNING DC, 1965, SCIENCE, V147, P173, DOI 10.1126/science.147.3654.173; DUNNING DC, 1995, BIOTROPICA, V27, P227, DOI 10.2307/2388998; DUNNING DC, 1992, CAN J ZOOL, V70, P2218, DOI 10.1139/z92-298; FULLARD JH, 1984, J COMP PHYSIOL, V154, P249, DOI 10.1007/BF00604990; FULLARD JH, 1977, CAN J ZOOL, V55, P1213, DOI 10.1139/z77-160; Gamberale-Stille G, 2004, P ROY SOC B-BIOL SCI, V271, P2621, DOI 10.1098/rspb.2004.2893; Gastwirth JL, LAWSTAT R PACKAGE BI; Ghose K, 2009, J EXP BIOL, V212, P693, DOI 10.1242/jeb.019380; Hesbacher S, 1995, J CHEM ECOL, V21, P2079, DOI 10.1007/BF02033864; Hristov N, 2005, CHEMOECOLOGY, V15, P105, DOI 10.1007/s00049-005-0301-0; Hristov NI, 2005, NATURWISSENSCHAFTEN, V92, P164, DOI 10.1007/s00114-005-0611-7; KNOWLTON CARROL B., 1967, TRANS AMER ENTOMOL SOC, V93, P41; Masters WM, 1996, J COMP PHYSIOL A, V179, P703, DOI 10.1007/BF00216134; MILLER LA, 1991, J COMP PHYSIOL A, V168, P571, DOI 10.1007/BF00215079; R Core Team, R LANG ENV STAT COMP; Ratcliffe JM, 2005, J EXP BIOL, V208, P4689, DOI 10.1242/jeb.01927; ROEDER K. D., 1962, ANIMAL BEHAVIOUR, V10, P300, DOI 10.1016/0003-3472(62)90053-2; Scott CH, 2014, SYST ENTOMOL, V39, P286, DOI 10.1111/syen.12047; Svoboda T, 2005, PRESENCE-VIRTUAL AUG, V14, P407, DOI 10.1162/105474605774785325; Tougaard J., 2004, ECHOLOCATION BATS DO, P365; Triblehorn JD, 2008, J EXP BIOL, V211, P555, DOI 10.1242/jeb.005736; Yack JE, 2008, SENSES COMPREHENSIVE, V3, P35, DOI DOI 10.1016/B978-012370880-9.00003-7; Zaspel JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101975	36	19	19	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152981	10.1371/journal.pone.0152981	http://dx.doi.org/10.1371/journal.pone.0152981			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096408	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600023
J	Hayat, T; Jabeen, S; Shafiq, A; Alsaedi, A				Hayat, T.; Jabeen, Sumaira; Shafiq, Anum; Alsaedi, A.			Radiative Squeezing Flow of Second Grade Fluid with Convective Boundary Conditions	PLOS ONE			English	Article							HEAT-TRANSFER; THERMAL-RADIATION; NANOFLUID FLOW; AXISYMMETRICAL FLOW; STAGNATION POINT; SURFACE; SIMULATION; ANNULUS	Influence of magnetohydrodynamic (MHD) flow between two parallel disks is considered. Heat transfer analysis is disclosed due to thermal radiation and convective boundary condition. Appropriate transformations are invoked to obtain the ordinary differential system. This system is solved using homotopic approach. Convergence of the obtained solution is discussed. Variations of embedded parameters into the governing problems are graphically discussed. Skin friction coefficient and Nusselt number are numerically computed and analyzed. It is noticed that temperature profile is increasing function of radiation parameter.	[Hayat, T.; Jabeen, Sumaira; Shafiq, Anum] Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan; [Hayat, T.; Alsaedi, A.] King Abdulaziz Univ, Nonlinear Anal & Appl Math NAAM Res Grp, Dept Math, Fac Sci, Jeddah 21589, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Shafiq, A (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad 44000, Pakistan.	anumshafiq@ymail.com	Hayat, Tasawar/Y-2524-2019; Shafiq, Anum/F-9967-2018; Alsaedi, Ahmed/A-2094-2013	Shafiq, Anum/0000-0001-7186-7216; Alsaedi, Ahmed/0000-0003-3452-8922				Bachok N, 2013, J FRANKLIN I, V350, P2736, DOI 10.1016/j.jfranklin.2013.07.002; Bhattacharyya, 2013, J THERMODYN, V2013; Bhattacharyya K, 2012, INT J HEAT MASS TRAN, V55, P2945, DOI 10.1016/j.ijheatmasstransfer.2012.01.051; Domairry G, 2009, MATH PROBL ENG, V2009, DOI 10.1155/2009/603916; Farooq U, 2014, APPL MATH COMPUT, V242, P528, DOI 10.1016/j.amc.2014.05.126; Ganji DD, 2014, FRONT MECH ENG-PRC, V9, P270, DOI 10.1007/s11465-014-0303-0; Hashmi MM, 2012, NONLINEAR ANAL-MODEL, V17, P418, DOI 10.15388/NA.17.4.14048; Hayat T, 2015, ALEX ENG J, V54, P205, DOI 10.1016/j.aej.2015.03.013; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4928321; Hayat T, 2014, J AEROSPACE ENG, V27, DOI 10.1061/(ASCE)AS.1943-5525.0000360; Hayat T, 2013, J MECH, V29, P403, DOI 10.1017/jmech.2013.6; Hayat T, 2013, EUR PHYS J PLUS, V128, DOI 10.1140/epjp/i2013-13085-1; Hayat T, 2012, INT J NUMER METH FL, V69, P399, DOI 10.1002/fld.2565; Hayat T., 2013, WALAILAK J SCI TECH, V10, P29; Hayat T., 2013, J EGYPTIAN MATH SOC, V21, P379, DOI [10.1016/j.joems.2013.02.009, DOI 10.1016/J.JOEMS.2013.02.009]; Hayat T, 2015, Z NATURFORSCH A, V70, P333, DOI 10.1515/zna-2014-0280; Hayat T, 2015, AIP ADV, V5, DOI 10.1063/1.4927209; Kandelousi MS, 2014, PHYS LETT A, V378, P3331, DOI 10.1016/j.physleta.2014.09.046; Liao S., 2012, HOMOTOPY ANAL METHOD; Lin YH, 2015, POWDER TECHNOL, V274, P324, DOI 10.1016/j.powtec.2015.01.039; Mahmood M, 2007, HEAT MASS TRANSFER, V44, P165, DOI 10.1007/s00231-006-0218-3; Mirzaee F, 2015, J TAIBAH UNIV SCI, V9, P104, DOI 10.1016/j.jtusci.2014.06.006; Noeiaghdam S., 2015, AIN SHAMS E IN PRESS; Pal D, 2013, COMPUT MATH APPL, V66, P1161, DOI 10.1016/j.camwa.2013.07.010; Qayyum A, 2012, CHINESE PHYS LETT, V29, DOI 10.1088/0256-307X/29/3/034701; Rashidi MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109404; Rashidi MM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/923487; Shafiq A, 2013, BRAZ J CHEM ENG, V30, P599, DOI 10.1590/S0104-66322013000300017; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V294, P299, DOI 10.1016/j.cma.2015.06.010; Sheikholeslami M, 2015, INT J HEAT MASS TRAN, V89, P799, DOI 10.1016/j.ijheatmasstransfer.2015.05.110; Sheikholeslami M, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15115-4; Sheikholeslami M, 2016, INT J HEAT MASS TRAN, V92, P339, DOI 10.1016/j.ijheatmasstransfer.2015.08.066; Sheikholeslami M, 2015, J TAIWAN INST CHEM E, V56, P6, DOI 10.1016/j.jtice.2015.03.035; Sheikholeslami M, 2015, IEEE T NANOTECHNOL, V14, P561, DOI 10.1109/TNANO.2015.2416318; Sheikholeslami M, 2015, COMPUT METHOD APPL M, V283, P651, DOI 10.1016/j.cma.2014.09.038; Sheikholeslami M, 2015, J MAGN MAGN MATER, V374, P36, DOI 10.1016/j.jmmm.2014.08.021; Sheikholeslami M, 2015, PHYSICA A, V417, P273, DOI 10.1016/j.physa.2014.09.053; Sheikholeslami M, 2014, ENERGY, V75, P400, DOI 10.1016/j.energy.2014.07.089; Stefan M.J., 1874, MATH NATURWISSENCHAF, V69, P713; Sui JZ, 2015, INT J HEAT MASS TRAN, V85, P1023, DOI 10.1016/j.ijheatmasstransfer.2015.02.014	40	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152555	10.1371/journal.pone.0152555	http://dx.doi.org/10.1371/journal.pone.0152555			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096616	gold, Green Submitted, Green Published			2022-12-27	WOS:000374543600016
J	Ikdahl, E; Rollefstad, S; Hisdal, J; Olsen, IC; Pedersen, TR; Kvien, TK; Semb, AG				Ikdahl, Eirik; Rollefstad, Silvia; Hisdal, Jonny; Olsen, Inge C.; Pedersen, Terje R.; Kvien, Tore K.; Semb, Anne Grete			Sustained Improvement of Arterial Stiffness and Blood Pressure after Long-Term Rosuvastatin Treatment in Patients with Inflammatory Joint Diseases: Results from the RORA-AS Study	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; AUGMENTATION INDEX; HYPERTENSION; ATORVASTATIN; METAANALYSIS; STATINS	Objective Patients with inflammatory joint diseases (IJD) have a high prevalence of hypertension and increased arterial stiffness. The aim of the present study was to evaluate the effect of longterm rosuvastatin treatment on arterial stiffness, measured by augmentation index (Alx) and aortic pulse wave velocity (aPWV), and blood pressure (BP) in IJD patients with established atherosclerosis. Methods Eighty-nine statin naive IJD patients with carotid atherosclerotic plaque(s) (rheumatoid arthritis n = 55, ankylosing spondylitis n = 23, psoriatic arthritis n = 11) received rosuvastatin for 18 months to achieve low-density lipoprotein cholesterol goal <1.8 mmol/L. Change in Alx (AA1x), aPWV (AaPWV), systolic BP (AsBP) and diastolic BP (AdBP) from baseline to study end was assessed by paired samples t -tests. Linear regression was applied to evaluate associations between cardiovascular disease (CVD) risk factors, rheumatic disease specific variables and medication, and,6,Alx, AaPWV, AsBP and AdBP. Results Alx, aPWV, sBP and dBP were significantly reduced from baseline to study end. The mean (95`)/X1) changes were:,Delta AIx: -0.34 (-0.03, -0.65)% (p = 0.03), Delta PWV: -1.69 (-0.21, -3.17) m/s2 (p = 0.03), AsBP: -5.27 (-1.61, -8.93)mmHg (p = 0.004) and Delta dBP -2.93 (-0.86, -5.00) mmHg (p = 0.01). In linear regression models, AaPWV was significantly correlated with AsBP and AdBP (for all: p<0.001). Conclusions There is an unmet need of studies evaluating CVD prevention in IJD patients. We have shown for the first time that long-term intensive lipid lowering with rosuvastatin improved arterial stiffness and induced a clinically significant BP reduction in patients with IJD. These improvements were linearly correlated and may represent novel insight into the pleiotropic effects by statins.	[Ikdahl, Eirik; Rollefstad, Silvia; Semb, Anne Grete] Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma Clin, Oslo, Norway; [Hisdal, Jonny] Oslo Univ Hosp Aker, Sect Vasc Invest, Oslo, Norway; [Olsen, Inge C.; Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Pedersen, Terje R.] Oslo Univ Hosp, Ctr Prevent Med, Oslo, Norway; [Pedersen, Terje R.] Univ Oslo, Fac Med, Oslo, Norway	Diakonhjemmet Hospital; University of Oslo; Diakonhjemmet Hospital; University of Oslo; University of Oslo	Ikdahl, E (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Prevent Cardiorheuma Clin, Oslo, Norway.	eirik.ikdahl@medisin.uio.no	Hisdal, Jonny/B-4112-2014; emery, paul/B-3560-2013; Olsen, Inge Christoffer/R-9128-2019	Olsen, Inge Christoffer/0000-0001-6889-5873	South-Eastern Norway Regional Health Authority [2013064, 2013010]	South-Eastern Norway Regional Health Authority	AGS and SR received grants from The South-Eastern Norway Regional Health Authority to conduct the RORA-AS study (http://www.helse-sorost.no/omoss_/english_/), Grant numbers: 2013064 and 2013010. The study medication (rosuvastatin) in the RORA-AS study was provided by AstraZeneca (http//www.astrazeneca,com/). AstraZeneca had no further involvement in the study concerning data collection, analyses, interpretation or publication.	AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445; Angel K, 2011, FUND CLIN PHARMACOL, V25, P511, DOI 10.1111/j.1472-8206.2010.00872.x; Bodnar N, 2011, J RHEUMATOL, V38, P723, DOI 10.3899/jrheum.100668; Borghi C, 2004, AM HEART J, V148, P285, DOI 10.1016/j.ahj.2004.02.003; Boutouyrie P, 2011, DRUGS, V71, P1689, DOI 10.2165/11593790-000000000-00000; Bramwell JC, 1922, LANCET, V1, P891; Briasoulis A, 2013, J CLIN HYPERTENS, V15, P310, DOI 10.1111/jch.12081; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Costa L, 2012, CLIN RHEUMATOL, V31, P711, DOI 10.1007/s10067-011-1892-1; Cypiene A, 2010, MED LITH, V46, P522, DOI 10.3390/medicina46080075; Ferrier KE, 2002, J AM COLL CARDIOL, V39, P1020, DOI 10.1016/S0735-1097(02)01717-5; Gonzalez A, 2008, ANN RHEUM DIS, V67, P64, DOI 10.1136/ard.2006.059980; Han CL, 2006, J RHEUMATOL, V33, P2167; Hollan I, 2013, AUTOIMMUN REV, V12, P1004, DOI 10.1016/j.autrev.2013.03.013; Hongo M, 2008, CIRC J, V72, P722, DOI 10.1253/circj.72.722; Kelly RP, 2001, HYPERTENSION, V37, P1429, DOI 10.1161/01.HYP.37.6.1429; Maki-Petaja KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McCarey DW, 2004, LANCET, V363, P2015, DOI 10.1016/S0140-6736(04)16449-0; MERILLON JP, 1983, EUR HEART J, V4, P13, DOI 10.1093/eurheartj/4.suppl_G.13; Mitchell GF, 2014, HYPERTENSION, V64, P210, DOI 10.1161/HYPERTENSIONAHA.114.03449; Nichols WW, 2005, AM J HYPERTENS, V18, p3S, DOI 10.1016/j.amjhyper.2004.10.009; Panoulas VF, 2008, RHEUMATOLOGY, V47, P1286, DOI 10.1093/rheumatology/ken159; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Payne RA, 2010, HYPERTENSION, V55, P9, DOI 10.1161/HYPERTENSIONAHA.107.090464; Provan SA, 2011, ANN RHEUM DIS, V70, P812, DOI 10.1136/ard.2010.141523; Rollefstad S, 2015, ARTHRITIS RHEUMATOL, V67, P1718, DOI 10.1002/art.39114; Rollefstad S, 2013, ANN RHEUM DIS, V72, P1968, DOI 10.1136/annrheumdis-2012-202789; Roman MJ, 2006, J AM SOC ECHOCARDIOG, V19, P943, DOI 10.1016/j.echo.2006.04.020; Roman MJ, 2006, ANN INTERN MED, V144, P249, DOI 10.7326/0003-4819-144-4-200602210-00006; Shige H, 2001, ATHEROSCLEROSIS, V155, P245, DOI 10.1016/S0021-9150(00)00558-X; Stoner L, 2014, J ATHEROSCLER THROMB, V21, P11; Strazzullo P, 2007, HYPERTENSION, V49, P792, DOI 10.1161/01.HYP.0000259737.43916.42; Ubels FL, 2001, ATHEROSCLEROSIS, V154, P155, DOI 10.1016/S0021-9150(00)00450-0; Van Doornum S, 2004, ANN RHEUM DIS, V63, P1571, DOI 10.1136/ard.2003.018333; Weber T, 2004, CIRCULATION, V109, P184, DOI 10.1161/01.CIR.0000105767.94169.E3	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153440	10.1371/journal.pone.0153440	http://dx.doi.org/10.1371/journal.pone.0153440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093159	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200020
J	Ullah, R; Shah, MA; Tufail, S; Ismat, F; Imran, M; Iqbal, M; Mirza, O; Rhaman, M				Ullah, Raheem; Shah, Majid Ali; Tufail, Soban; Ismat, Fouzia; Imran, Muhammad; Iqbal, Mazhar; Mirza, Osman; Rhaman, Moazur			Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production	PLOS ONE			English	Article							ETCH VIRUS PROTEASE; AFFINITY PURIFICATION; EXPRESSION; STABILITY; CLONING	Proteases are widely used to remove affinity and solubility tags from recombinant proteins to avoid potential interference of these tags with the structure and function of the fusion partner. In recent years, great interest has been seen in use of the human rhinovirus 3C protease owing to its stringent sequence specificity and enhanced activity. Like other proteases, activity of the human rhinovirus 3C protease can be affected in part by the buffer components and additives that are generally employed for purification and stabilization of proteins, hence, necessitate their removal by tedious and time-consuming procedures before proteolysis can occur. To address this issue, we examined the effect of elution buffers used for common affinity based purifications, salt ions, stability/solubility and reducing agents, and detergents on the activity of the human rhinovirus 3C protease using three different fusion proteins at 4 degrees C, a temperature of choice for purification of many proteins. The results show that the human rhinovirus 3C protease performs better at 4 degrees C than the frequently used tobacco etch virus protease and its activity was insensitive to most of the experimental conditions tested. Though number of fusion proteins tested is limited, we expect that these finding will facilitate the use of the human rhinovirus 3C protease in recombinant protein production for pharmaceutical and biotechnological applications.	[Ullah, Raheem; Shah, Majid Ali; Tufail, Soban; Ismat, Fouzia; Imran, Muhammad; Iqbal, Mazhar; Rhaman, Moazur] NIBGE, Hlth Biotechnol Div, Drug Discovery & Struct Biol Grp, Faisalabad, Pakistan; [Ullah, Raheem; Shah, Majid Ali; Iqbal, Mazhar; Rhaman, Moazur] Pakistan Inst Engn & Appl Sci, PO Nilore, Islamabad, Pakistan; [Mirza, Osman] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Copenhagen, Denmark; [Imran, Muhammad] Forman Christian Coll, Lahore, Pakistan	Pakistan Institute of Engineering & Applied Science; Pakistan Institute of Engineering & Applied Science; University of Copenhagen	Rhaman, M (corresponding author), NIBGE, Hlth Biotechnol Div, Drug Discovery & Struct Biol Grp, Faisalabad, Pakistan.; Rhaman, M (corresponding author), Pakistan Inst Engn & Appl Sci, PO Nilore, Islamabad, Pakistan.	moazur.rahman@fulbrightmail.org	Iqbal, Mazhar/C-5536-2019; Rahman, Moazur/C-5515-2019	Iqbal, Mazhar/0000-0002-8675-1125; Rahman, Moazur/0000-0003-2892-1250; Mirza, Osman Asghar/0000-0001-9435-0690	International Centre for Genetic Engineering and Biotechnology, Italy [CRP/PAK10-01]; Higher Education Commission of Pakistan	International Centre for Genetic Engineering and Biotechnology, Italy; Higher Education Commission of Pakistan(Higher Education Commission of Pakistan)	We thank Samar Hasnain, University of Liverpool, UK for provision of TEV protease construct and Andreas Engel, Case Western Reserve University, USA for HRV 3C construct. We thank Gerard Huysmans for critical comments and for improving the manuscript. This work was supported by the International Centre for Genetic Engineering and Biotechnology, Italy [ grant No. CRP/PAK10-01; ( awarded to M. Rahman)] and PhD studentships by Higher Education Commission of Pakistan ( awarded to Raheem Ullah and Majid Ali Shah).	Block H, 2009, METHOD ENZYMOL, V463, P439, DOI 10.1016/S0076-6879(09)63027-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; Iram N, 2014, APPL MICROBIOL BIOT, V98, P1691, DOI 10.1007/s00253-013-5043-2; Leibly DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052482; Leong LEC, 1999, MOL BIOTECHNOL, V12, P269, DOI 10.1385/MB:12:3:269; Lundback AK, 2008, ANAL BIOCHEM, V382, P69, DOI 10.1016/j.ab.2008.07.018; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mohanty AK, 2003, PROTEIN EXPRES PURIF, V27, P109, DOI 10.1016/S1046-5928(02)00589-2; RIGGS P, 2001, CURR PROTOC MOL BIOL, P16; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Ruckenstein E, 2006, ADV COLLOID INTERFAC, V123, P97, DOI 10.1016/j.cis.2006.05.018; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Shah MS, 2016, BIOLOGICALS, V44, P19, DOI 10.1016/j.biologicals.2015.10.002; Simons P C, 1981, Methods Enzymol, V77, P235; Smyth DR, 2003, PROTEIN SCI, V12, P1313, DOI 10.1110/ps.0243403; Sun CS, 2012, PROTEIN EXPRES PURIF, V82, P226, DOI 10.1016/j.pep.2012.01.005; Vergis JM, 2011, PROTEIN EXPRES PURIF, V78, P139, DOI 10.1016/j.pep.2011.04.011; WALKER PA, 1994, BIO-TECHNOL, V12, P601, DOI 10.1038/nbt0694-601; Wang QM, 2001, VIROLOGY, V280, P80, DOI 10.1006/viro.2000.0760; Waugh DS, 2011, PROTEIN EXPRES PURIF, V80, P283, DOI 10.1016/j.pep.2011.08.005; Young CL, 2012, BIOTECHNOL J, V7, P620, DOI 10.1002/biot.201100155	24	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153436	10.1371/journal.pone.0153436	http://dx.doi.org/10.1371/journal.pone.0153436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093053	gold, Green Submitted, Green Published			2022-12-27	WOS:000374541200019
J	Wilkinson, JM; Ladinig, A; Bao, H; Kommadath, A; Stothard, P; Lunney, JK; Harding, JCS; Plastow, GS				Wilkinson, Jamie M.; Ladinig, Andrea; Bao, Hua; Kommadath, Arun; Stothard, Paul; Lunney, Joan K.; Harding, John C. S.; Plastow, Graham S.			Differences in Whole Blood Gene Expression Associated with Infection Time-Course and Extent of Fetal Mortality in a Reproductive Model of Type 2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Infection	PLOS ONE			English	Article							IMMUNE-RESPONSES; PREGNANT GILTS; VIRAL LOAD; RNA-SEQ; ACTIVATION; PLATELETS; PIGS; APOPTOSIS; PROTEINS; IDENTIFICATION	Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infection of pregnant females causes fetal death and increased piglet mortality, but there is substantial variation in the extent of reproductive pathology between individual dams. This study used RNA sequencing to characterize the whole blood transcriptional response to type 2 PRRSV in pregnant gilts during the first week of infection (at 0, 2, and 6 days post-inoculation), and attempted to identify gene expression signatures associated with a low or high level of fetal mortality rates (LFM and HFM; n = 8/group) at necropsy, 21 days post-inoculation. The initial response to infection measured at 2 days post -inoculation saw an upregulation of genes involved in innate immunity, such as interferon-stimulated antiviral genes and inflammatory markers, and apoptosis. A concomitant decrease in expression of protein synthesis and T lymphocyte markers was observed. By day 6 the pattern had reversed, with a drop in innate immune signaling and an increase in the expression of genes involved in cell division and T cell signaling. Differentially expressed genes (DEGs) associated with extremes of litter mortality rate were identified at all three time -points. Among the 15 DEGs upregulated in LFM gilts on all three days were several genes involved in platelet function, including integrins ITGA2B and ITGB3, and the chemokine PF4 (CXCL4). LFM gilts exhibited a higher baseline expression of interferon-stimulated and pro -inflammatory genes prior to infection, and of T cell markers two days post-infection, indicative of a more rapid progression of the immune response to PRRSV. This study has increased our knowledge of the early response to PRRSV in the blood of pregnant gilts, and could ultimately lead to the development of a biomarker panel that can be used to predict PRRSV-associated reproductive pathology.	[Wilkinson, Jamie M.; Bao, Hua; Kommadath, Arun; Stothard, Paul; Plastow, Graham S.] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Ladinig, Andrea; Harding, John C. S.] Univ Saskatchewan, Western Coll Vet Med, Dept Large Anim Clin Sci, Saskatoon, SK S7N 0W0, Canada; [Lunney, Joan K.] ARS, Anim Parasit Dis Lab, Beltsville Agr Res Ctr, USDA, Beltsville, MD USA; [Ladinig, Andrea] Univ Vet Med, Dept Farm Anim & Vet Publ Hlth, Univ Clin Swine, Vienna, Austria	University of Alberta; University of Saskatchewan; United States Department of Agriculture (USDA); University of Veterinary Medicine Vienna	Wilkinson, JM (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	jamie.wilkinson@ualberta.ca	Kommadath, Arun/I-4644-2019	Kommadath, Arun/0000-0003-3587-6670; Plastow, Graham/0000-0002-3774-3110; Ladinig, Andrea/0000-0001-5037-7269	Genome Canada; Genome Prairie; Alberta Livestock and Meat Agency; Alberta Innovates - Bio Solutions	Genome Canada(Genome Canada); Genome Prairie; Alberta Livestock and Meat Agency; Alberta Innovates - Bio Solutions	This work was funded by grants from Genome Canada (genomecanada.ca) and Genome Prairie (genomeprairie.ca) to support the following project: "Application of Genomics to Improve Swine Health and Welfare". Administrative support was provided by Genome Alberta (genomealberta.ca). HB and PS are grateful for financial support from the Alberta Livestock and Meat Agency (alma.alberta.ca) and Alberta Innovates - Bio Solutions (bio.albertainnovates.ca), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albina E, 1998, VET IMMUNOL IMMUNOP, V61, P49, DOI 10.1016/S0165-2427(97)00134-7; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arceo Maria E., 2013, Frontiers in Genetics, V3, P321, DOI 10.3389/fgene.2012.00321; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; CALVETE JJ, 1994, THROMB HAEMOSTASIS, V72, P1; Cao J, 2013, VET MICROBIOL, V164, P261, DOI 10.1016/j.vetmic.2013.03.001; Choi I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-954; Davenport EE, 2015, J MOL MED, V93, P105, DOI 10.1007/s00109-014-1212-8; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; Elzey BD, 2003, IMMUNITY, V19, P9, DOI 10.1016/S1074-7613(03)00177-8; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; FREEMAN GJ, 1992, J IMMUNOL, V149, P3795; Genini S, 2008, J GEN VIROL, V89, P2550, DOI 10.1099/vir.0.2008/003244-0; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Gomez-Laguna J, 2013, TRANSBOUND EMERG DIS, V60, P273, DOI 10.1111/j.1865-1682.2012.01338.x; Gomez-Laguna J, 2009, VIRAL IMMUNOL, V22, P261, DOI 10.1089/vim.2009.0003; Hu J, 2014, TRANSBOUND EMERG DIS, V61, P109, DOI 10.1111/tbed.12016; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Karniychuk UU, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-95; Karniychuk UU, 2011, MICROB PATHOGENESIS, V51, P194, DOI 10.1016/j.micpath.2011.04.001; Kommadath A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-452; Kunishima S, 2014, EUR J HAEMATOL, V92, P276, DOI 10.1111/ejh.12252; Labarque G, 2003, VET RES, V34, P249, DOI 10.1051/vetres:2003001; Ladinig A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0251-7; Ladinig A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0113-8; Ladinig A, 2014, VET RES, V45, DOI 10.1186/s13567-014-0128-1; Ladinig A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096104; Lewis CRG, 2009, J ANIM SCI, V87, P876, DOI 10.2527/jas.2008-0892; Li YM, 2014, VIRUS RES, V189, P29, DOI 10.1016/j.virusres.2014.04.011; McMorran BJ, 2012, SCIENCE, V338, P1348, DOI 10.1126/science.1228892; McMorran BJ, 2009, SCIENCE, V323, P797, DOI 10.1126/science.1166296; Miller LC, 2010, ADV VIROL, V2010, DOI 10.1155/2010/864181; Miller LC, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-208; Nascimento EJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007892; RILEY FL, 1977, TEX REP BIOL MED, V35, P239; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Gomez IM, 2014, VET MICROBIOL, V172, P186, DOI 10.1016/j.vetmic.2014.05.025; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; SAMUEL CE, 1991, VIROLOGY, V183, P1, DOI 10.1016/0042-6822(91)90112-O; Sener A, 2012, FOLIA BIOL-PRAGUE, V58, P193; Serao NVL, 2014, J ANIM SCI, V92, P2905, DOI 10.2527/jas.2014-7821; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STENBERG PE, 1984, J CELL BIOL, V98, P748, DOI 10.1083/jcb.98.2.748; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang G, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-2; Wang R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/315470; WARGNIER A, 1995, P NATL ACAD SCI USA, V92, P6930, DOI 10.1073/pnas.92.15.6930; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Xiao SQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011377; Yamaji S, 2002, BIOCHEM BIOPH RES CO, V297, P1324, DOI 10.1016/S0006-291X(02)02381-1; Yoshinaga SK, 1999, NATURE, V402, P827, DOI 10.1038/45582; Youssefian T, 2002, BLOOD, V99, P4021, DOI 10.1182/blood-2001-12-0191	58	10	10	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153615	10.1371/journal.pone.0153615	http://dx.doi.org/10.1371/journal.pone.0153615			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093427	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200032
J	Jasial, S; Hu, Y; Bajorath, J				Jasial, Swarit; Hu, Ye; Bajorath, Juergen			Determining the Degree of Promiscuity of Extensively Assayed Compounds	PLOS ONE			English	Article							DRUG DISCOVERY; POLYPHARMACOLOGY; DATABASE; PUBCHEM	In the context of polypharmacology, an emerging concept in drug discovery, promiscuity is rationalized as the ability of compounds to specifically interact with multiple targets. Promiscuity of drugs and bioactive compounds has thus far been analyzed computationally on the basis of activity annotations, without taking assay frequencies or inactivity records into account. Most recent estimates have indicated that bioactive compounds interact on average with only one to two targets, whereas drugs interact with six or more. In this study, we have further extended promiscuity analysis by identifying the most extensively assayed public domain compounds and systematically determining their promiscuity. These compounds were tested in hundreds of assays against hundreds of targets. In our analysis, assay promiscuity was distinguished from target promiscuity and separately analyzed for primary and confirmatory assays. Differences between the degree of assay and target promiscuity were surprisingly small and average and median degrees of target promiscuity of 2.6 to 3.4 and 2.0 were determined, respectively. Thus, target promiscuity remained at a low level even for most extensively tested active compounds. These findings provide further evidence that bioactive compounds are less promiscuous than drugs and have implications for pharmaceutical research. In addition to a possible explanation that drugs are more extensively tested for additional targets, the results would also support a "promiscuity enrichment model" according to which promiscuous compounds might be preferentially selected for therapeutic efficacy during clinical evaluation to ultimately become drugs.	[Jasial, Swarit; Hu, Ye; Bajorath, Juergen] Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Bonn, Germany	University of Bonn	Bajorath, J (corresponding author), Univ Bonn, Dept Life Sci Informat, B IT, LIMES Program Unit Chem Biol & Med Chem, Bonn, Germany.	bajorath@bit.uni-bonn.de		Jasial, Swarit/0000-0003-1415-8151				Baell J, 2014, NATURE, V513, P481, DOI 10.1038/513481a; Baell JB, 2015, ACS MED CHEM LETT, V6, P229, DOI 10.1021/acsmedchemlett.5b00032; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Bajorath J, 2014, DRUG DISCOV TODAY, V19, P357, DOI 10.1016/j.drudis.2014.02.004; Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031; Boran ADW, 2010, CURR OPIN DRUG DISC, V13, P297; Canny SA, 2012, BIOINFORMATICS, V28, P140, DOI 10.1093/bioinformatics/btr622; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Hu Ye, 2013, F1000Res, V2, P144, DOI 10.12688/f1000research.2-144.v1; Hu Ye, 2015, F1000Res, V4, P118, DOI 10.12688/f1000research.6473.1; Hu Ye, 2014, F1000Res, V3, P218, DOI 10.12688/f1000research.5250.1; Hu Y, 2013, DRUG DISCOV TODAY, V18, P644, DOI 10.1016/j.drudis.2013.03.002; Hu Y, 2013, AAPS J, V15, P808, DOI 10.1208/s12248-013-9488-0; Jacoby E, 2006, MOL BIOSYST, V2, P218, DOI 10.1039/b603004c; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Jasial S, 2016, ZENODO, DOI [10.5281/zenodo.44593, DOI 10.5281/ZENODO.44593]; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068; Lu JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040262; Lusher SJ, 2014, DRUG DISCOV TODAY, V19, P859, DOI 10.1016/j.drudis.2013.12.004; Mestres J, 2008, NAT BIOTECHNOL, V26, P983, DOI 10.1038/nbt0908-983; Paolini GV, 2006, NAT BIOTECHNOL, V24, P805, DOI 10.1038/nbt1228; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Wassermann AM, 2015, NAT CHEM BIOL, V11, P958, DOI 10.1038/nchembio.1936	25	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153873	10.1371/journal.pone.0153873	http://dx.doi.org/10.1371/journal.pone.0153873			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082988	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800062
J	Abuli, A; Castells, A; Bujanda, L; Lozano, JJ; Bessa, X; Hernandez, C; Alvarez-Urturi, C; Pellise, M; Esteban-Jurado, C; Hijona, E; Buron, A; Macia, F; Grau, J; Guayta, R; Castellvi-Bel, S; Andreu, M				Abuli, Anna; Castells, Antoni; Bujanda, Luis; Jose Lozano, Juan; Bessa, Xavier; Hernandez, Cristina; Alvarez-Urturi, Cristina; Pellise, Maria; Esteban-Jurado, Clara; Hijona, Elizabeth; Buron, Andrea; Macia, Francesc; Grau, Jaume; Guayta, Rafael; Castellvi-Bel, Sergi; Andreu, Montserrat		PROCOLON Res Grp	Genetic Variants Associated with Colorectal Adenoma Susceptibility	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; AMERICAN-CANCER-SOCIETY; TASK-FORCE; RISK; LOCI; METAANALYSIS; POPULATION; POLYPS; SURVEILLANCE; POLYPECTOMY	Background Common low-penetrance genetic variants have been consistently associated with colorectal cancer risk. Aim To determine if these genetic variants are associated also with adenoma susceptibility and may improve selection of patients with increased risk for advanced adenomas and/or multiplicity (>= 3 adenomas). Methods We selected 1,326 patients with increased risk for advanced adenomas and/or multiplicity and 1,252 controls with normal colonoscopy from population-based colorectal cancer screening programs. We conducted a case-control association study analyzing 30 colorectal cancer susceptibility variants in order to investigate the contribution of these variants to the development of subsequent advanced neoplasia and/or multiplicity. Results We found that 14 of the analyzed genetic variants showed a statistically significant association with advanced adenomas and/or multiplicity: the probability of developing these lesions increased with the number of risk alleles reaching a 2.3-fold risk increment in individuals with >= 17 risk alleles. Conclusions Nearly half of the genetic variants associated with colorectal cancer risk are also related to advanced adenoma and/or multiplicity predisposition. Assessing the number of risk alleles in individuals within colorectal cancer screening programs may help to identify better a subgroup with increased risk for advanced neoplasia and/or multiplicity in the general population.	[Abuli, Anna; Bessa, Xavier; Alvarez-Urturi, Cristina; Andreu, Montserrat] Pompeu Fabra Univ, Hosp Mar, Dept Gastroenterol, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain; [Castells, Antoni; Pellise, Maria; Esteban-Jurado, Clara; Castellvi-Bel, Sergi] Univ Barcelona, Dept Gastroenterol, Hosp Clin, CIBERehd,IDIBAPS, Villarroel 170, E-08036 Barcelona, Catalonia, Spain; [Bujanda, Luis; Hijona, Elizabeth] Univ Pais Vasco UPV EHU, Dept Gastroenterol, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Donostia,Inst Biodonostia, Doctor Begiristain Kalea, Donostia Gipuzkoa 20014, Spain; [Jose Lozano, Juan] CIBERehd, Plataforma Bioinformat, Villarroel 170, Barcelona 08036, Catalonia, Spain; [Hernandez, Cristina; Buron, Andrea; Macia, Francesc] Hosp Mar, Dept Epidemiol & Evaluat, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain; [Grau, Jaume] Hosp Clin Barcelona, Unitat Avaluacio Suport & Prevent, Rosello 138, E-08036 Barcelona, Catalonia, Spain; [Guayta, Rafael] Consell Collegis Farmaceut Catalunya, Planning & Res Unit, Barcelona 08009, Catalonia, Spain	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; University of Barcelona; Hospital Clinic de Barcelona	Andreu, M (corresponding author), Pompeu Fabra Univ, Hosp Mar, Dept Gastroenterol, IMIM Hosp Mar Med Res Inst, Passeig Maritim 25-29, Barcelona 08003, Catalonia, Spain.	mandreu@parcdesalutmar.cat	Moreira, Leticia/AAN-9863-2021; Castells, Antoni/ABC-1002-2021; Bujanda, Luis/AAB-2485-2021; Grau, Jaume/K-9869-2019; Serrano, Merce Comas/O-3825-2014; Buron, Andrea/E-5705-2016; Castells, Xavier/S-7798-2016; Pellise, Maria/ABC-3246-2021; Grau, Jaume/E-3570-2019; Macià, Francesc/N-2776-2017	Moreira, Leticia/0000-0002-4518-8591; Castells, Antoni/0000-0001-8431-2033; Bujanda, Luis/0000-0002-4353-9968; Serrano, Merce Comas/0000-0003-1926-2740; Buron, Andrea/0000-0003-3590-1303; Castells, Xavier/0000-0002-2528-0382; Grau, Jaume/0000-0002-6811-2215; Macià, Francesc/0000-0002-6090-5894; Lozano, Juan Jose/0000-0001-7613-3908; Esteban, Clara/0000-0002-4403-8073; Lopez-Ceron, Maria/0000-0002-7968-9204; Castellvi-Bel, Sergi/0000-0003-1217-5097; Bessa Caserras, Xavier/0000-0003-4680-1228; Balaguer, Francesc/0000-0002-0206-0539; Pellise, Maria/0000-0001-9739-4998; Seoane Urgorri, Agustin/0000-0001-8023-4445; Rodriguez de Miguel, Cristina/0000-0002-5576-0854	Instituto de Salud Carlos III-FEDER [RD09/0076/00036]; Pla Director d'Oncologia de Catalunya (XBTC); Fondo de Investigacion Sanitaria/FEDER [PI10/00918, PI11/00219, PI14/00173, PI14/00441]; Ministerio de Economia y Competitividad [SAF2010-19273]; Asociacion Espanola contra el Cancer (Fundacion Cientifica) [GCB13131592CAST]; COST Action [BM1206]; Fondo de Investigacion Sanitaria [CP 03-0070]; Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya) [2014SGR255, 2014SGR135]; Instituto de Salud Carlos III	Instituto de Salud Carlos III-FEDER(Instituto de Salud Carlos IIIEuropean Commission); Pla Director d'Oncologia de Catalunya (XBTC); Fondo de Investigacion Sanitaria/FEDER(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Economia y Competitividad(Spanish Government); Asociacion Espanola contra el Cancer (Fundacion Cientifica); COST Action(European Cooperation in Science and Technology (COST)); Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya)(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by grants from: Instituto de Salud Carlos III-FEDER (RD09/0076/00036), the Xarxa de Bancs de tumors sponsored by Pla Director d'Oncologia de Catalunya (XBTC), Fondo de Investigacion Sanitaria/FEDER (PI10/00918, PI11/00219, PI14/00173, PI14/00441), Ministerio de Economia y Competitividad (SAF2010-19273), Asociacion Espanola contra el Cancer (Fundacion Cientifica GCB13131592CAST), and COST Action BM1206 (SCB). SCB is supported by a contract from the Fondo de Investigacion Sanitaria (CP 03-0070) and Agencia de Gestio d'Ajuts Universitaris i de Recerca (Generalitat de Catalunya, 2014SGR255, 2014SGR135). CIBERehd is funded by the Instituto de Salud Carlos III.	Abuli A, 2010, GASTROENTEROLOGY, V139, P788, DOI 10.1053/j.gastro.2010.05.072; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt SI, 2008, HUM MOL GENET, V17, P2665, DOI 10.1093/hmg/ddn166; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Burnett-Hartman AN, 2014, AM J EPIDEMIOL, V180, P223, DOI 10.1093/aje/kwu114; Carvajal-Carmona LG, 2013, GASTROENTEROLOGY, V144, P53, DOI 10.1053/j.gastro.2012.09.016; Cheng THT, 2015, EUR J HUM GENET, V23, P260, DOI 10.1038/ejhg.2014.74; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fernandez-Rozadilla C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-55; Fletcher O, 2010, NAT REV CANCER, V10, P353, DOI 10.1038/nrc2840; Guittet L, 2007, GUT, V56, P210, DOI 10.1136/gut.2006.101428; HARDCASTLE JD, 1989, LANCET, V1, P1160; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jia WH, 2013, NAT GENET, V45, P191, DOI 10.1038/ng.2505; Jones AM, 2012, GUT, V61, P248, DOI 10.1136/gut.2011.239772; Kinnersley B, 2012, BRIT J CANCER, V107, P1001, DOI 10.1038/bjc.2012.329; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Neugut A I, 1997, Gastrointest Endosc Clin N Am, V7, P387; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Rossum LG, 2008, GASTROENTEROLOGY, V135, P82, DOI 10.1053/j.gastro.2008.03.040; Whitlock EP, 2008, ANN INTERN MED, V149, P638, DOI 10.7326/0003-4819-149-9-200811040-00245; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Winawer SJ, 2006, GASTROENTEROLOGY, V130, P1872, DOI 10.1053/j.gastro.2006.03.012; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhang B, 2012, CARCINOGENESIS, V33, P2417, DOI 10.1093/carcin/bgs308	38	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153084	10.1371/journal.pone.0153084	http://dx.doi.org/10.1371/journal.pone.0153084			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078840	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700021
J	Alagna, F; Cirilli, M; Galla, G; Carbone, F; Daddiego, L; Facella, P; Lopez, L; Colao, C; Mariotti, R; Cultrera, N; Rossi, M; Barcaccia, G; Baldoni, L; Muleo, R; Perrotta, G				Alagna, Fiammetta; Cirilli, Marco; Galla, Giulio; Carbone, Fabrizio; Daddiego, Loretta; Facella, Paolo; Lopez, Loredana; Colao, Chiara; Mariotti, Roberto; Cultrera, Nicol; Rossi, Martina; Barcaccia, Gianni; Baldoni, Luciana; Muleo, Rosario; Perrotta, Gaetano			Transcript Analysis and Regulative Events during Flower Development in Olive (Olea europaea L.)	PLOS ONE			English	Article							MADS-BOX GENES; CYTOPLASMIC MALE-STERILITY; POLLEN-PISTIL INTERACTIONS; SPERMIDINE SYNTHASE GENES; SELF-INCOMPATIBLE POLLEN; PROGRAMMED-CELL-DEATH; POLYAMINE METABOLISM; RECEPTOR KINASE; INFLORESCENCE DEVELOPMENT; EXPRESSION ANALYSIS	The identification and characterization of transcripts involved in flower organ development, plant reproduction and metabolism represent key steps in plant phenotypic and physiological pathways, and may generate high-quality transcript variants useful for the development of functional markers. This study was aimed at obtaining an extensive characterization of the olive flower transcripts, by providing sound information on the candidate MADS-box genes related to the ABC model of flower development and on the putative genetic and molecular determinants of ovary abortion and pollen-pistil interaction. The overall sequence data, obtained by pyrosequencing of four cDNA libraries from flowers at different developmental stages of three olive varieties with distinct reproductive features (Leccino, Frantoio and Dolce Agogia), included approximately 465,000 ESTs, which gave rise to more than 14,600 contigs and approximately 92,000 singletons. As many as 56,700 unigenes were successfully annotated and provided gene ontology insights into the structural organization and putative molecular function of sequenced transcripts and deduced proteins in the context of their corresponding biological processes. Differentially expressed genes with potential regulatory roles in biosynthetic pathways and metabolic networks during flower development were identified. The gene expression studies allowed us to select the candidate genes that play well-known molecular functions in a number of biosynthetic pathways and specific biological processes that affect olive reproduction. A sound understanding of gene functions and regulatory networks that characterize the olive flower is provided.	[Alagna, Fiammetta; Mariotti, Roberto; Cultrera, Nicol; Rossi, Martina; Baldoni, Luciana] CNR, Inst Biosci & Bioresources, Perugia, Italy; [Cirilli, Marco; Colao, Chiara; Muleo, Rosario] Univ Tuscia, Lab Mol Ecophysiol & Biotechnol Woody Plants, Dept Agr & Forestry Sci, Viterbo, Italy; [Galla, Giulio; Barcaccia, Gianni] Univ Padua, DAFNAE, Lab Plant Genet & Genom, Legnaro, PD, Italy; [Carbone, Fabrizio; Daddiego, Loretta; Facella, Paolo; Lopez, Loredana; Perrotta, Gaetano] Italian Natl Agcy New Technol Energy & Sustainabl, TRISAIA Res Ctr, Rotondella, MT, Italy; [Alagna, Fiammetta] Council Agr Res & Econ, Res Unit Table Grapes & Wine Growing Mediterranea, Bari, Italy; [Cirilli, Marco] Univ Milan, Dept Agr & Environm Sci, Milan, Italy; [Carbone, Fabrizio] Council Agr Res & Econ, Olive Growing & Olive Prod Ind Res Ctr, Arcavacata Di Rende, CS, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioscienze e Biorisorse (IBBR-CNR); Tuscia University; University of Padua; Italian National Agency New Technical Energy & Sustainable Economics Development; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); University of Milan; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Muleo, R (corresponding author), CNR, Inst Biosci & Bioresources, Perugia, Italy.	luciana.baldoni@ibbr.cnr.it; muleo@unitus.it	Galla, Giulio/GPK-8561-2022; Facella, Paolo/HHC-1895-2022; Carbone, Fabrizio/O-2443-2017; Cultrera, Nicolò G/P-7376-2018; Muleo, Rosario/AAI-7439-2020; Baldoni, Luciana/A-4411-2016; Alagna, Fiammetta/AAF-3169-2020; Carbone, Fabrizio/AAE-1065-2019; mariotti, roberto/AAG-7294-2021	Facella, Paolo/0000-0001-9076-3754; Carbone, Fabrizio/0000-0002-0393-7099; Cultrera, Nicolò G/0000-0003-1361-7539; Baldoni, Luciana/0000-0002-3221-333X; Carbone, Fabrizio/0000-0002-0393-7099; mariotti, roberto/0000-0002-9111-5123; Alagna, Fiammetta/0000-0003-1878-2023; BALDONI, LUCIANA/0000-0002-6636-0055; Perrotta, Gaetano/0000-0003-2037-1063; BARCACCIA, GIANNI/0000-0001-7478-5048; Galla, Giulio/0000-0002-4573-0897	"OLEA - Genomics and Breeding of Olive" Project - Italian Ministero delle politiche agricole alimentari e forestali [D.M. 27011/7643/10]; "Dondazione Anna Maria Catalano - ONLUS", Italy	"OLEA - Genomics and Breeding of Olive" Project - Italian Ministero delle politiche agricole alimentari e forestali; "Dondazione Anna Maria Catalano - ONLUS", Italy	This research was financed by the "OLEA - Genomics and Breeding of Olive" Project, funded by the Italian Ministero delle politiche agricole alimentari e forestali, D.M. 27011/7643/10. The grant from "Dondazione Anna Maria Catalano - ONLUS", Italy, also provided partial financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2007, P NATL ACAD SCI USA, V104, P6484, DOI 10.1073/pnas.0610717104; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Albert NW, 2014, PLANT CELL, V26, P962, DOI 10.1105/tpc.113.122069; ARIBAUD M, 1994, PHYTOCHEMISTRY, V37, P927, DOI 10.1016/S0031-9422(00)89506-0; Barcaccia G, 1012, ACTA HORTIC, V967, P43; Ben Sadok I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062831; Besnard G, 2000, THEOR APPL GENET, V100, P1018, DOI 10.1007/s001220051383; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bosch M, 2005, PLANT PHYSIOL, V138, P1334, DOI 10.1104/pp.105.059865; Bouranis DL, 1999, J PLANT NUTR, V22, P245, DOI 10.1080/01904169909365623; Breton CM, 2012, CR BIOL, V335, P563, DOI 10.1016/j.crvi.2012.07.006; Breton CM, 2014, TREE GENET GENOMES, V10, P1055, DOI 10.1007/s11295-014-0742-0; Carmona R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00625; Cavallotti A, 2003, PLANT SCI, V164, P241, DOI 10.1016/S0168-9452(02)00406-5; Chae K, 2009, PLANT CELL, V21, P3902, DOI 10.1105/tpc.109.070854; Chalivendra SC, 2013, J EXP BOT, V64, P265, DOI 10.1093/jxb/ers324; Chapman LA, 2010, J EXP BOT, V61, P1987, DOI 10.1093/jxb/erq021; Chia T, 2004, PLANT J, V37, P853, DOI 10.1111/j.1365-313X.2003.02012.x; Clement C, 1996, AM J BOT, V83, P459, DOI 10.2307/2446215; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Collani S, 2012, ACTA HORTIC, V967, P133, DOI 10.17660/ActaHortic.2012.967.15; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cuevas J, 2004, ANN BOT-LONDON, V93, P547, DOI 10.1093/aob/mch079; D'Aoust MA, 1999, PLANT CELL, V11, P2407, DOI 10.1105/tpc.11.12.2407; Danilevskaya ON, 2008, PLANT PHYSIOL, V147, P2054, DOI 10.1104/pp.107.115261; de Groot P, 2004, PLANT MOL BIOL, V55, P715, DOI 10.1007/s11103-004-1964-6; de la Rosa R, 2003, THEOR APPL GENET, V106, P1273, DOI 10.1007/s00122-002-1189-5; Diaz A, 2006, J AM SOC HORTIC SCI, V131, P250, DOI 10.21273/JASHS.131.2.250; Diaz-Riquelme J, 2009, PLANT PHYSIOL, V149, P354, DOI 10.1104/pp.108.131052; Doidy J, 2012, TRENDS PLANT SCI, V17, P413, DOI 10.1016/j.tplants.2012.03.009; Draie R, 2011, MOL PLANT PATHOL, V12, P638, DOI 10.1111/J.1364-3703.2010.00702.X; Gonzalez ME, 2011, PLANT PHYSIOL, V156, P2266, DOI 10.1104/pp.110.171413; EVANS PT, 1989, ANNU REV PLANT PHYS, V40, P235, DOI 10.1146/annurev.pp.40.060189.001315; Fernandez-Escobar R, 2008, ENVIRON EXP BOT, V64, P113, DOI 10.1016/j.envexpbot.2008.04.007; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Gao X. Q., 2010, FRONT BIOL, V5, P156, DOI [10.1007/s11515-010-0024-7, DOI 10.1007/S11515-010-0024-7]; GERATS AGM, 1988, PLANT PHYSIOL, V86, P390, DOI 10.1104/pp.86.2.390; Gil-Amado JA, 2012, PLANT CELL PHYSIOL, V54, P244, DOI DOI 10.1093/pcp/pcs179; Gil-Amado JA, 2012, PLANTA, V235, P1221, DOI 10.1007/s00425-011-1570-1; Gomez-Jimenez MC, 2010, PLANTA, V232, P629, DOI 10.1007/s00425-010-1198-6; Guo DP, 2003, PLANT GROWTH REGUL, V41, P33, DOI 10.1023/A:1027328416042; Hadfield KA, 1998, PLANT PHYSIOL, V117, P337, DOI 10.1104/pp.117.2.337; Heyer AG, 2004, PLANT J, V39, P161, DOI 10.1111/j.1365-313X.2004.02124.x; Higashiyama T, 2010, PLANT CELL PHYSIOL, V51, P177, DOI 10.1093/pcp/pcq008; Huang CK, 2004, J PLANT PHYSIOL, V161, P709, DOI 10.1078/0176-1617-01256; Huang JC, 2011, PLANT CELL PHYSIOL, V52, P1546, DOI 10.1093/pcp/pcr095; Imai A, 2004, PLANT PHYSIOL, V135, P1565, DOI 10.1104/pp.104.041699; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; Iwano M, 2012, CURR OPIN PLANT BIOL, V15, P78, DOI 10.1016/j.pbi.2011.09.003; Kakita M, 2007, PLANT CELL, V19, P3961, DOI 10.1105/tpc.106.049999; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; Kim J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9r87; Koonjul PK, 2005, J EXP BOT, V56, P179, DOI 10.1093/jxb/eri018; Kumar A, 2010, J EXP BOT, V61, P2001, DOI 10.1093/jxb/erq065; Lavee S, 1999, SCI HORTIC-AMSTERDAM, V82, P181, DOI 10.1016/S0304-4238(99)00057-6; Lebon G, 2008, J EXP BOT, V59, P2565, DOI 10.1093/jxb/ern135; Li ZN, 2012, J PLANT RES, V125, P381, DOI 10.1007/s10265-011-0456-4; Lombardo N., 2006, Advances in Horticultural Science, V20, P247; Losada JM, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-1; Lu Y, 2004, PLANTA, V218, P466, DOI 10.1007/s00425-003-1127-z; Madey E, 2002, PLANTA, V214, P625, DOI 10.1007/s004250100649; Mahajan M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028315; Marin-Rodriguez MC, 2002, J EXP BOT, V53, P2115, DOI 10.1093/jxb/erf089; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mollet JC, 2000, PLANT CELL, V12, P1737, DOI 10.1105/tpc.12.9.1737; Mookerjee S, 2005, THEOR APPL GENET, V111, P1174, DOI 10.1007/s00122-005-0049-5; Munoz-Merida A, 2013, DNA RES, V20, P93, DOI 10.1093/dnares/dss036; Murase K, 2004, SCIENCE, V303, P1516, DOI 10.1126/science.1093586; Naghiloo S, 2013, AM J BOT, V100, P647, DOI 10.3732/ajb.1200171; Nakamura Y, 2009, PLANT PHYSIOL BIOCH, V47, P535, DOI 10.1016/j.plaphy.2008.12.018; Nakatsuka A, 2008, SCI HORTIC-AMSTERDAM, V118, P314, DOI 10.1016/j.scienta.2008.06.016; Nandy S, 2013, CELL DEV BIOL, V2, P117; Oliver SN, 2005, PLANT CELL ENVIRON, V28, P1534, DOI 10.1111/j.1365-3040.2005.01390.x; Ozgenturk NO, 2010, COMP FUNCT GENOM, DOI 10.1155/2010/757512; Park SY, 2000, PLANT CELL, V12, P151, DOI 10.1105/tpc.12.1.151; Piotrowski M, 2003, J BIOL CHEM, V278, P1708, DOI 10.1074/jbc.M205699200; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; RASTOGI R, 1990, PLANT PHYSIOL, V93, P439, DOI 10.1104/pp.93.2.439; Reale L, 2006, SEX PLANT REPROD, V19, P151, DOI 10.1007/s00497-006-0032-6; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Reinhold H, 2011, PLANT CELL, V23, P1391, DOI 10.1105/tpc.110.081950; Ren G, 2007, PLANT SCI, V173, P621, DOI 10.1016/j.plantsci.2007.08.012; Rodrigo J, 2000, PHYSIOL PLANTARUM, V108, P35, DOI 10.1034/j.1399-3054.2000.108001035.x; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Rosati A, 2011, SCI HORTIC-AMSTERDAM, V127, P515, DOI 10.1016/j.scienta.2010.12.002; Samuel MA, 2009, PLANT CELL, V21, P2655, DOI 10.1105/tpc.109.069740; Saumitou-Laprade P, 2010, SCIENCE, V327, P1648, DOI 10.1126/science.1186687; Serrano I, 2008, SEX PLANT REPROD, V21, P99, DOI 10.1007/s00497-008-0075-y; Serrano I, 2012, J EXP BOT, V63, P1479, DOI 10.1093/jxb/err392; Serrano I, 2010, PLANT CELL REP, V29, P561, DOI [10.1007/s00299-010-0845-5, 10.1007/s00299-010-0858-0]; Sgromo C, 2010, PLANT BIOSYST, V144, P733, DOI 10.1080/11263501003764343; Shan HY, 2009, MOL BIOL EVOL, V26, P2229, DOI 10.1093/molbev/msp129; Shi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047810; Sinha R, 2013, PLANT MOL BIOL, V82, P169, DOI 10.1007/s11103-013-0051-2; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Suarez C, 2013, PLANTA, V237, P305, DOI 10.1007/s00425-012-1774-z; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang WH, 2002, PLANT CELL, V14, P2277, DOI 10.1105/tpc.003103; Tani E, 2009, PLANT PHYSIOL BIOCH, V47, P690, DOI 10.1016/j.plaphy.2009.03.013; Turktas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059876; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887; Valdivia ER, 2009, SEX PLANT REPROD, V22, P141, DOI 10.1007/s00497-009-0099-y; van der Linden CG, 2002, J EXP BOT, V53, P1025, DOI 10.1093/jexbot/53.371.1025; Wan LL, 2011, PLANTA, V233, P309, DOI 10.1007/s00425-010-1301-z; Wang K, 2015, CARBOHYD POLYM, V127, P264, DOI 10.1016/j.carbpol.2015.03.081; Wang Y, 2013, PLANT CELL, V25, P1383, DOI 10.1105/tpc.112.108993; Wu SB, 2002, J HORTIC SCI BIOTECH, V77, P665, DOI 10.1080/14620316.2002.11511554; Wu YJ, 2001, PLANT PHYSIOL, V126, P222, DOI 10.1104/pp.126.1.222; Yang S, 2008, ANN BOT-LONDON, V102, P483, DOI 10.1093/aob/mcn116; Yanik H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-10; Yeats TH, 2008, PROTEIN SCI, V17, P191, DOI 10.1110/ps.073300108; Zafra A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-36; Zanor MI, 2009, PLANT PHYSIOL, V150, P1204, DOI 10.1104/pp.109.136598; Zhang D, 2008, PLANT PHYSIOL, V148, P1368, DOI 10.1104/pp.108.124420; Zhang JS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-314; Zhao DQ, 2012, MOL BIOL REP, V39, P11263, DOI 10.1007/s11033-012-2036-7; Zienkiewicz K, 2010, J EXP BOT, V61, P1537, DOI 10.1093/jxb/erq022	119	31	31	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152943	10.1371/journal.pone.0152943	http://dx.doi.org/10.1371/journal.pone.0152943			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077738	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700015
J	Correa, MA; Okamoto, CK; Goncalves-de-Andrade, RM; van den Berg, CW; Tambourgi, DV				Correa, Mara A.; Okamoto, Cinthya K.; Goncalves-de-Andrade, Rute M.; van den Berg, Carmen W.; Tambourgi, Denise V.			Sphingomyelinase D from Loxosceles laeta Venom Induces the Expression of MMP7 in Human Keratinocytes: Contribution to Dermonecrosis	PLOS ONE			English	Article							ACUTE LUNG INJURY; MATRIX METALLOPROTEINASES; CATALYTIC MECHANISM; MOLECULAR-CLONING; SPIDER VENOM; MATRILYSIN; TETRACYCLINES; PROTEOGLYCAN; DEGRADATION; GELATINASES	Envenomation by Loxosceles spider is characterized by the development of dermonecrosis. In previous studies, we have demonstrated that increased expression/secretion of matrix metalloproteinases 2 and 9, induced by Loxosceles intermedia venom Class 2 SMases D (the main toxin in the spider venom), contribute to the development of cutaneous loxoscelism. In the present study we show that the more potent venom containing the Class 1 SMase D from Loxosceles laeta, in addition to increasing the expression/secretion of MMP2 and MMP9, also stimulates the expression of MMP7 (Matrilysin-1), which was associated with keratinocyte cell death. Tetracycline, a matrix metalloproteinase inhibitor, prevented cell death and reduced MMPs expression. Considering that L. laeta venom is more potent at inducing dermonecrosis than L. intermedia venom, our results suggest that MMP7 may play an important role in the severity of dermonecrosis induced by L. laeta spider venom SMase D. In addition, the inhibition of MMPs by e.g. tetracyclines may be considered for the treatment of the cutaneous loxoscelism.	[Correa, Mara A.; Okamoto, Cinthya K.; Goncalves-de-Andrade, Rute M.; Tambourgi, Denise V.] Butantan Inst, Immunochem Lab, Sao Paulo, Brazil; [van den Berg, Carmen W.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	Instituto Butantan; Cardiff University	Tambourgi, DV (corresponding author), Butantan Inst, Immunochem Lab, Sao Paulo, Brazil.	denise.tambourgi@butantan.gov.br	Tambourgi, Denise/H-7114-2016; Instituto Butantan, Center of Toxins Immune Response and Cell Signaling CeTICS/J-5731-2015	Tambourgi, Denise/0000-0003-1896-9074; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP); CeTICS Program FAPESP [2013/07467-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CeTICS Program FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by funds from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, Brazil (FAPESP), CeTICS Program FAPESP (2013/07467-1) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS JA, 1958, AM J TROP MED HYG, V7, P165, DOI 10.4269/ajtmh.1958.7.165; BUCHERL W, 1969, AM ZOOL, V9, P157; Burke B, 2004, IMMUNOBIOLOGY, V209, P51, DOI 10.1016/j.imbio.2004.04.005; de Oliveira KC, 2005, TOXICON, V45, P421, DOI 10.1016/j.toxicon.2004.08.022; Ferrara GID, 2009, TOXICON, V53, P743, DOI 10.1016/j.toxicon.2009.02.013; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; FORRESTER LJ, 1978, ARCH BIOCHEM BIOPHYS, V187, P355, DOI 10.1016/0003-9861(78)90046-2; FUTRELL JM, 1992, AM J MED SCI, V304, P261, DOI 10.1097/00000441-199210000-00008; Golub L M, 1998, Adv Dent Res, V12, P12; GOLUB LM, 1991, CRIT REV ORAL BIOL M, V2, P297, DOI 10.1177/10454411910020030201; Golub LM, 2011, PHARMACOL RES, V63, P99, DOI 10.1016/j.phrs.2010.10.003; Halpert I, 1996, P NATL ACAD SCI USA, V93, P9748, DOI 10.1073/pnas.93.18.9748; Hanemaaijer R, 1998, Adv Dent Res, V12, P114; Hartmann-Petersen S, 2009, BRIT J DERMATOL, V160, P1251, DOI 10.1111/j.1365-2133.2009.09031.x; Ii M, 2006, EXP BIOL MED, V231, P20; Jarvinen TM, 2007, BRIT J DERMATOL, V157, P970, DOI 10.1111/j.1365-2133.2007.08166.x; Kang C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057658; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; KURPIEWSKI G, 1981, BIOCHIM BIOPHYS ACTA, V678, P467, DOI 10.1016/0304-4165(81)90128-8; Li QL, 2002, CELL, V111, P635, DOI 10.1016/S0092-8674(02)01079-6; Mitsui H, 2014, J INVEST DERMATOL, V134, P1418, DOI 10.1038/jid.2013.494; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Murakami MT, 2006, BIOCHEM BIOPH RES CO, V342, P323, DOI 10.1016/j.bbrc.2006.01.123; Murakami MT, 2005, J BIOL CHEM, V280, P13658, DOI 10.1074/jbc.M412437200; MURPHY G, 1991, BIOCHEM J, V277, P277, DOI 10.1042/bj2770277; Nieman GF, 2001, CURR MED CHEM, V8, P317, DOI 10.2174/0929867013373570; Paixao-Cavalcante D, 2007, J INVEST DERMATOL, V127, P1410, DOI 10.1038/sj.jid.5700688; Paixao-Cavalcante D, 2006, J INVEST DERMATOL, V126, P61, DOI 10.1038/sj.jid.5700049; Pedrosa MD, 2002, BIOCHEM BIOPH RES CO, V298, P638, DOI 10.1016/S0006-291X(02)02521-4; Pedroso A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0561-4; Rivera IG, 2015, TOXINS, V7, P1457, DOI 10.3390/toxins7051457; Shapiro SD, 2003, NATURE, V421, P223, DOI 10.1038/421223a; SIRES UI, 1993, J BIOL CHEM, V268, P2069; Skiba B, 2005, PHOTODERMATOL PHOTO, V21, P173, DOI 10.1111/j.1600-0781.2005.00162.x; SMITH CW, 1970, LAB INVEST, V22, P90; Tambourgi DV, 2010, TOXICON, V56, P1113, DOI 10.1016/j.toxicon.2010.01.021; Tambourgi DV, 1998, BIOCHEM BIOPH RES CO, V251, P366, DOI 10.1006/bbrc.1998.9474; Tambourgi DV, 2005, J INVEST DERMATOL, V124, P725, DOI 10.1111/j.0022-202X.2005.23654.x; Tambourgi DV, 2004, MOL IMMUNOL, V41, P831, DOI 10.1016/j.molimm.2004.03.027; Vaalamo M, 1996, BRIT J DERMATOL, V135, P52; van Meeteren LA, 2004, J BIOL CHEM, V279, P10833, DOI 10.1074/jbc.C300563200; WASSERMAN GS, 1984, J TOXICOL-CLIN TOXIC, V21, P451, DOI 10.3109/15563658308990434; Wilson CL, 1996, INT J BIOCHEM CELL B, V28, P123, DOI 10.1016/1357-2725(95)00121-2	43	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153090	10.1371/journal.pone.0153090	http://dx.doi.org/10.1371/journal.pone.0153090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078876	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000374131700022
J	Goldstein, JD; Burlion, A; Zaragoza, B; Sendeyo, K; Polansky, JK; Huehn, J; Piaggio, E; Salomon, BL; Marodon, G				Goldstein, Jeremie D.; Burlion, Aude; Zaragoza, Bruno; Sendeyo, Kelhia; Polansky, Julia K.; Huehn, Jochen; Piaggio, Eliane; Salomon, Benoit L.; Marodon, Gilles			Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FOXP3; GENE-EXPRESSION; IN-VIVO; LYMPHOPROLIFERATIVE DISORDER; CIS-ELEMENT; TREG; INTERLEUKIN-2; SCURFY; LOCUS; MOUSE	The IL-2/JAK3/STAT-5 signaling pathway is involved on the initiation and maintenance of the transcription factor Foxp3 in regulatory T cells (Treg) and has been associated with demethylation of the intronic Conserved Non Coding Sequence-2 (CNS2). However, the role of the JAK/STAT pathway in controlling Foxp3 in the short term has been poorly investigated. Using two different JAK/STAT pharmacological inhibitors, we observed a detectable loss of Foxp3 after 10 min. of treatment that affected 70% of the cells after one hour. Using cycloheximide, a general inhibitor of mRNA translation, we determined that Foxp3, but not CD25, has a high turnover in IL-2 stimulated Treg. This reduction was correlated with a rapid reduction of Foxp3 mRNA. This loss of Foxp3 was associated with a loss in STAT-5 binding to the CNS2, which however remains demethylated. Consequently, Foxp3 expression returns to normal level upon restoration of basal JAK/STAT signaling in vivo. Reduced expression of several genes defining Treg identity was also observed upon treatment. Thus, our results demonstrate that Foxp3 has a rapid turn over in Treg partly controlled at the transcriptional level by the JAK/STAT pathway.	[Goldstein, Jeremie D.; Burlion, Aude; Zaragoza, Bruno; Sendeyo, Kelhia; Salomon, Benoit L.; Marodon, Gilles] Univ Paris 06, Sorbonne Univ, UMR S CR7, CIMI,INSERM,U1135,CNRS,ERL 8255, Paris, France; [Polansky, Julia K.; Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, Braunschweig, Germany; [Piaggio, Eliane] Inst Curie, INSERM, U932, Paris, France; [Goldstein, Jeremie D.] Inst Biomed, Bellinzona, Switzerland; [Polansky, Julia K.] German Rheumatism Res Ctr, Expt Rheumatol, Charitepl 1, Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Helmholtz Association; Helmholtz-Center for Infection Research; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Marodon, G (corresponding author), Univ Paris 06, Sorbonne Univ, UMR S CR7, CIMI,INSERM,U1135,CNRS,ERL 8255, Paris, France.	gilles.marodon@upmc.fr	marodon, gilles/E-7202-2017; Polansky-Biskup, Julia K./J-5937-2017; Salomon, Benoit L/M-2421-2017; Piaggio, Eliane/E-5260-2016; Salomon, Benoit/AAP-5209-2021	marodon, gilles/0000-0003-4889-6785; Polansky-Biskup, Julia K./0000-0003-4727-2540; Salomon, Benoit L/0000-0001-9673-5578; Piaggio, Eliane/0000-0002-2455-8442; Salomon, Benoit/0000-0001-9673-5578	ANR (Agence Nationale de la Recherche); AFM (Association Francaise contre les Myopathies); ANRS (Agence Nationale pour la Recherche contre le SIDA); German Research Foundation [CRC738, CRC854]	ANR (Agence Nationale de la Recherche)(French National Research Agency (ANR)); AFM (Association Francaise contre les Myopathies)(Association Francaise contre les Myopathies); ANRS (Agence Nationale pour la Recherche contre le SIDA); German Research Foundation(German Research Foundation (DFG))	This study was funded by grants from the ANR (Agence Nationale de la Recherche), the AFM (Association Francaise contre les Myopathies) and the ANRS (Agence Nationale pour la Recherche contre le SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors wish to thank Dr Sylvie Gregoire, Mr Claude Baillou and Mr Bruno Gouritin (UMR 7211, CIMI) for cell sorting, Beatrice Levacher (INSERM U959) for quantitative qPCR, Dr Nicolas Cagnard (INSERM U580 and Bioinformatics Platform, Faculty of Medicine Paris Descartes, Paris) for transcriptome analysis, Dr Thierry Rose (Pasteur Institute) for sharing reagents, Dr Antonio Bandeira (Institut Pasteur) for the Scurfy samples, and Dr Nicolas Petit, Dr Audrey Baeyens, Dr Gaelle Martin, Dr Yenkel Grinberg-Bleyer for their help in various aspects of the work. DNA methylation experiments were developed and performed by Udo Baron and Sven Olek at Epiontis GmbH. This study was funded by grants from the ANR (Agence Nationale de la Recherche to BLS and GM), the AFM (Association Francaise contre les Myopathies to GM), the ANRS (Agence Nationale pour la Recherche contre le SIDA to GM) and by the German Research Foundation (CRC738 and CRC854 to JH).	Bailey-Bucktrout SL, 2013, IMMUNITY, V39, P949, DOI 10.1016/j.immuni.2013.10.016; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Bending D, 2014, J IMMUNOL, V193, P2699, DOI 10.4049/jimmunol.1400599; Brown GR, 2000, BIOORG MED CHEM LETT, V10, P575, DOI 10.1016/S0960-894X(00)00051-2; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chen Q, 2011, J IMMUNOL, V186, P6329, DOI 10.4049/jimmunol.1100061; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; D'Cruz LM, 2005, NAT IMMUNOL, V6, P1152, DOI 10.1038/ni1264; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Duarte JH, 2009, EUR J IMMUNOL, V39, P948, DOI 10.1002/eji.200839196; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Goldstein JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019038; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lee SM, 2008, BLOOD, V111, P3599, DOI 10.1182/blood-2007-09-115014; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Luo XR, 2008, J IMMUNOL, V180, P2757, DOI 10.4049/jimmunol.180.5.2757; Mouly E, 2010, J EXP MED, V207, P2113, DOI 10.1084/jem.20092153; Murawski MR, 2006, ANN NY ACAD SCI, V1079, P198, DOI 10.1196/annals.1375.031; Ochs HD, 2001, NAT GENET, V27, P20, DOI DOI 10.1038/83713; Ogawa C, 2014, J IMMUNOL, V192, P475, DOI 10.4049/jimmunol.1301892; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Passerini L, 2008, INT IMMUNOL, V20, P421, DOI 10.1093/intimm/dxn002; Pesu M, 2008, NATURE, V455, P246, DOI 10.1038/nature07210; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Soper DM, 2007, EUR J IMMUNOL, V37, P1817, DOI 10.1002/eji.200737101; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Tang Q, 2008, IMMUNITY, V28, P687, DOI 10.1016/j.immuni.2008.03.016; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Wang Y, 2008, J IMMUNOL, V180, P1565, DOI 10.4049/jimmunol.180.3.1565; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	46	24	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153682	10.1371/journal.pone.0153682	http://dx.doi.org/10.1371/journal.pone.0153682			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077371	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700103
J	Korlimarla, A; Prabhu, JS; Remacle, J; Rajarajan, S; Raja, U; Anupama, CE; Srinath, BS; Manjunath, S; Gopinath, KS; Correa, M; Prasad, MSN; Sridhar, TS				Korlimarla, Aruna; Prabhu, Jyothi S.; Remacle, Jose; Rajarajan, Savitha; Raja, Uma; Anupama, C. E.; Srinath, B. S.; Manjunath, Suraj; Gopinath, K. S.; Correa, Marjorrie; Prasad, M. S. N.; Sridhar, T. S.			Identification of BRCA1 Deficiency Using Multi-Analyte Estimation of BRCA1 and Its Repressors in FFPE Tumor Samples from Patients with Triple Negative Breast Cancer	PLOS ONE			English	Article							OVARIAN-CANCER; MUTATION STATUS; PHENOTYPE; EXPRESSION; BRCANESS; PROTEIN; ID4; CHEMOTHERAPY; FEATURES; CELLS	Purpose Apart from germ-line BRCA1-mutated breast cancers, a significant proportion of women with sporadic triple negative breast cancer (TNBC) sub-type are known to harbour varying levels of BRCA1-dysfuction. There is currently no established diagnostic method to identify these patients. Methods The analysis was performed on 183 primary breast cancer tumor specimens from our longitudinal case-series archived as formalin-fixed-paraffin-embedded (FFPE) blocks comprising 71 TNBCs and 112 Hormone receptor positive HER2 negative (HR+HER2-) tumors. Transcript levels of BRCA1 and two of its repressors ID4 and microRNA182 were determined by TaqMan quantitative PCR. BRCA1 protein was detected immunohistochemically with the MS110 antibody. Results The representation of BRCA1 and its repressor ID4 as a ratio led to improved separation of TNBCs from HR(+)HER2-compared to either measure by itself. We then dichotomised the continuous distribution of each of the three measurements (Protein, MIRNA and transcript: repressor ratio) into categories of deficient (0) and adequate (1). A composite BRCA1 Deficiency Score (BDS) was computed by the addition of the score for all three measures. Samples deficient on 2 or more measures were deemed to be BRCA1 deficient; and 40% of all TNBCs met this criterion. Conclusion We propose here a simple multi-level assay of BRCA1 deficiency using the BRCA1:ID4 ratio as a critical parameter that can be performed on FFPE samples in clinical laboratories by the estimation of only 3 bio-markers. The ease of testing will hopefully encourage adoption and clinical validation.	[Korlimarla, Aruna; Prabhu, Jyothi S.; Remacle, Jose; Rajarajan, Savitha; Raja, Uma; Anupama, C. E.; Sridhar, T. S.] St Johns Res Inst, Div Mol Med, Bangalore, Karnataka, India; [Srinath, B. S.; Prasad, M. S. N.] Sri Shankara Canc Hosp & Res Ctr, Bangalore, Karnataka, India; [Manjunath, Suraj] St Johns Med Coll & Hosp, Dept Surg Oncol, Bangalore, Karnataka, India; [Gopinath, K. S.] Rangadore Mem Hosp, Bangalore, Karnataka, India; [Correa, Marjorrie] St Johns Med Coll & Hosp, Dept Pathol, Bangalore, Karnataka, India	St. John's National Academy of Health Sciences; St. John's Research Institute; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; St. John's Medical College	Korlimarla, A (corresponding author), St Johns Res Inst, Div Mol Med, Bangalore, Karnataka, India.	aruna@sjri.res.in	Prabhu, Jyothi/AAW-6361-2020	Prabhu, Jyothi/0000-0002-2269-3704; Manjunath, Suraj/0000-0002-4760-7366	Nadathur Estates Pvt Ltd, Bangalore, India; Bagaria Education Trust, Bangalore, India	Nadathur Estates Pvt Ltd, Bangalore, India; Bagaria Education Trust, Bangalore, India	The authors gratefully acknowledge Nadathur Estates Pvt Ltd, Bangalore, India for their generous funding which enabled this reasearch. The patient follow-up was supported by The Bagaria Education Trust, Bangalore, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinyemiju T, 2015, BREAST CANCER RES TR, V153, P211, DOI 10.1007/s10549-015-3528-7; Beger C, 2001, P NATL ACAD SCI USA, V98, P130, DOI 10.1073/pnas.98.1.130; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cheang MCU, 2008, CLIN CANCER RES, V14, P1368, DOI 10.1158/1078-0432.CCR-07-1658; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Gapstur SM, 1996, CANCER, V77, P1465, DOI 10.1002/(SICI)1097-0142(19960415)77:8<1465::AID-CNCR7>3.0.CO;2-B; Gazinska P, 2013, MODERN PATHOL, V26, P955, DOI 10.1038/modpathol.2012.244; Huo DZ, 2009, J CLIN ONCOL, V27, P4515, DOI 10.1200/JCO.2008.19.6873; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Konstantinopoulos PA, 2010, J CLIN ONCOL, V28, P3555, DOI 10.1200/JCO.2009.27.5719; Korlimarla A, 2014, J MOL DIAGN, V16, P253, DOI 10.1016/j.jmoldx.2013.11.003; Li S, 1998, J BIOL CHEM, V273, P6183, DOI 10.1074/jbc.273.11.6183; Lips EH, 2013, BRIT J CANCER, V108, P2172, DOI 10.1038/bjc.2013.144; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Milner R, 2013, VIRCHOWS ARCH, V462, P269, DOI 10.1007/s00428-012-1368-y; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Prabhu JS, 2014, J CANCER, V5, P156, DOI 10.7150/jca.7668; Prat A, 2014, BREAST CANCER RES TR, V147, P185, DOI 10.1007/s10549-014-3056-x; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2008, HUM PATHOL, V39, P857, DOI 10.1016/j.humpath.2007.10.011; Sikov WM, 2015, J CLIN ONCOL, V33, P13, DOI 10.1200/JCO.2014.57.0572; Spurdle AB, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0474-y; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2007, ONCOGENE, V26, P2126, DOI 10.1038/sj.onc.1210014; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Vollebergh MA, 2011, ANN ONCOL, V22, P1561, DOI 10.1093/annonc/mdq624; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wen YH, 2012, BREAST CANCER RES TR, V135, P93, DOI 10.1007/s10549-012-2070-0	29	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153113	10.1371/journal.pone.0153113	http://dx.doi.org/10.1371/journal.pone.0153113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077368	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700023
J	Lai, MJ; Chang, KC; Huang, SW; Luo, CH; Chiou, PY; Wu, CC; Lin, NT				Lai, Meng-Jiun; Chang, Kai-Chih; Huang, Shiuan-Wen; Luo, Cheng-Hung; Chiou, Pei-Yu; Wu, Chao-Chuan; Lin, Nien-Tsung			The Tail Associated Protein of Acinetobacter baumannii Phage phi AB6 Is the Host Specificity Determinant Possessing Exopolysaccharide Depolymerase Activity	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; RECEPTOR SPECIFICITY; GENOMIC ANALYSIS; BINDING; IDENTIFICATION; SITE; CELL; ADSORPTION; PATHOGEN; TP901-1	Acinetobacter baumannii is a non-fermenting, gram-negative bacterium. In recent years, the frequency of A. baumannii infections has continued to increase, and multidrug-resistant strains are emerging in hospitalized patients. Therefore, as therapeutic options become limited, the potential of phages as natural antimicrobial agents to control infections is worth reconsidering. In our previous study, we isolated ten virulent double-stranded DNA A. baumannii phages, phi AB1-9 and phi AB11, and found that each has a narrow host range. Many reports indicate that receptor-binding protein of phage mediates host recognition; however, understanding of the specific interactions between A. baumannii and phages remains very limited. In this study, host determinants of A. baumannii phages were investigated. Sequence comparison of phi AB6 and phi AB1 revealed high degrees of conservation among their genes except the tail fiber protein (ORF41 in phi AB1 and ORF40 in phi AB6). Furthermore, we found that ORF40(phi AB6) has polysaccharide depolymerase activity capable of hydrolyzing the A. baumannii exopolysaccharide and is a component of the phage tail apparatus determining host specificity. Thus, the lytic phages and their associated depolymerase not only have potential as alternative therapeutic agents for treating A. baumannii infections but also provide useful and highly specific tools for studying host strain exopolysaccharides and producing glycoconjugate vaccines.	[Lai, Meng-Jiun; Chang, Kai-Chih] Tzu Chi Univ, Dept Lab Med & Biotechnol, Hualien, Taiwan; [Huang, Shiuan-Wen; Lin, Nien-Tsung] Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien, Taiwan; [Luo, Cheng-Hung; Chiou, Pei-Yu; Lin, Nien-Tsung] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wu, Chao-Chuan] Buddhist Tzu Chi Gen Hosp, Dept Surg, Taipei, Taiwan	Tzu Chi University; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital	Lin, NT (corresponding author), Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien, Taiwan.; Lin, NT (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	ntlin@mail.tcu.edu.tw			Buddhist Tzu Chi General Hospital [TCSP98-03-01]; Tzu Chi University [TCIRP98003-02]	Buddhist Tzu Chi General Hospital; Tzu Chi University	This work was supported by grants TCSP98-03-01 from Buddhist Tzu Chi General Hospital and TCIRP98003-02 from Tzu Chi University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres D, 2010, BIOCHEM SOC T, V38, P1386, DOI 10.1042/BST0381386; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Chang KC, 2011, GENOMICS, V97, P249, DOI 10.1016/j.ygeno.2011.01.002; Chatterjee S, 2012, VIRUSES-BASEL, V4, P3162, DOI 10.3390/v4113162; Duplessis M, 2001, MOL MICROBIOL, V41, P325, DOI 10.1046/j.1365-2958.2001.02521.x; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5818, DOI 10.1128/AEM.70.10.5818-5824.2004; Glonti T, 2010, J APPL MICROBIOL, V108, P695, DOI 10.1111/j.1365-2672.2009.04469.x; HELLER KJ, 1984, VIROLOGY, V139, P11, DOI 10.1016/0042-6822(84)90325-8; Jakobsson E, 2007, BIOCHEM J, V405, P465, DOI 10.1042/BJ20070177; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Le S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068562; Lin NT, 2010, RES MICROBIOL, V161, P308, DOI 10.1016/j.resmic.2010.03.007; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Mahichi F, 2009, FEMS MICROBIOL LETT, V295, P211, DOI 10.1111/j.1574-6968.2009.01588.x; Montefour K, 2008, CRIT CARE NURSE, V28, P15; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Rakhuba DV, 2010, POL J MICROBIOL, V59, P145, DOI 10.33073/pjm-2010-023; RIEDE I, 1985, EMBO J, V4, P2343, DOI 10.1002/j.1460-2075.1985.tb03936.x; Schwarzer D, 2012, J VIROL, V86, P10384, DOI 10.1128/JVI.00801-12; Smith NL, 2005, P NATL ACAD SCI USA, V102, P17652, DOI 10.1073/pnas.0504782102; Spinelli S, 2006, J BIOL CHEM, V281, P14256, DOI 10.1074/jbc.M600666200; Veesler D, 2012, P NATL ACAD SCI USA, V109, P8954, DOI 10.1073/pnas.1200966109; Verma V, 2009, CURR MICROBIOL, V59, P274, DOI 10.1007/s00284-009-9430-y; Wang J, 2000, J BACTERIOL, V182, P508, DOI 10.1128/JB.182.2.508-512.2000; Yan JL, 2014, BIODRUGS, V28, P265, DOI 10.1007/s40259-013-0081-y; Zivanovic Y, 2014, J VIROL, V88, P1162, DOI 10.1128/JVI.02262-13	28	39	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153361	10.1371/journal.pone.0153361	http://dx.doi.org/10.1371/journal.pone.0153361			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077375	gold, Green Submitted, Green Published			2022-12-27	WOS:000374131700043
J	Qi, Q; Yeung, TPC; Lee, TY; Bauman, G; Crukley, C; Morrison, L; Hoffman, L; Yartsev, S				Qi, Qi; Yeung, Timothy Pok Chi; Lee, Ting-Yim; Bauman, Glenn; Crukley, Cathie; Morrison, Laura; Hoffman, Lisa; Yartsev, Slav			Evaluation of CT Perfusion Biomarkers of Tumor Hypoxia	PLOS ONE			English	Article							MELANOMA XENOGRAFTS; GLIOMAS; CANCER; EXPRESSION	Background Tumor hypoxia is associated with treatment resistance to cancer therapies. Hypoxia can be investigated by immunohistopathologic methods but such procedure is invasive. A non-invasive method to interrogate tumor hypoxia is an attractive option as such method can provide information before, during, and after treatment for personalized therapies. Our study evaluated the correlations between computed tomography (CT) perfusion parameters and immunohistopathologic measurement of tumor hypoxia. Methods Wistar rats, 18 controls and 19 treated with stereotactic radiosurgery (SRS), implanted with the C6 glioma tumor were imaged using CT perfusion on average every five days to monitor tumor growth. A final CT perfusion scan and the brain were obtained on average 14 days (8-22 days) after tumor implantation. Tumor hypoxia was detected immunohistopathologically with pimonidazole. The tumor, necrotic, and pimonidazole-positive areas on histology samples were measured. Percent necrotic area and percent hypoxic areas were calculated. Tumor volume (TV), blood flow (BF), blood volume (BV), and permeability-surface area product (PS) were obtained from the CT perfusion studies. Correlations between CT perfusion parameters and histological parameters were assessed by Spearman's rho correlation. A Bonferroni-corrected P value < 0.05 was considered significant. Results BF and BV showed significant correlations with percent hypoxic area rho = -0.88, P < 0.001 and rho = -0.81, P < 0.001, respectively, for control animals and rho = -0.7, P < 0.001 and rho = -0.6, P = 0.003, respectively, for all animals, while TV and BV were correlated (rho = -0.64, P = 0.01 and rho = -0.43, P = 0.043, respectively) with percent necrotic area. PS was not correlated with either percent necrotic or percent hypoxic areas. Conclusions Percent hypoxic area provided significant correlations with BF and BV, suggesting that CT perfusion parameters are potential non-invasive imaging biomarkers of tumor hypoxia.	[Qi, Qi; Yeung, Timothy Pok Chi; Lee, Ting-Yim; Bauman, Glenn; Hoffman, Lisa; Yartsev, Slav] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Yeung, Timothy Pok Chi; Lee, Ting-Yim; Crukley, Cathie] Univ Western Ontario, Robarts Res Inst, London, ON, Canada; [Lee, Ting-Yim; Morrison, Laura; Hoffman, Lisa] Lawson Hlth Res Inst, Lawson Imaging, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim; Bauman, Glenn; Yartsev, Slav] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Bauman, Glenn; Yartsev, Slav] London Reg Canc Program, London, ON, Canada; [Hoffman, Lisa] Univ Western Ontario, Dept Anat & Cell Biol, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Yartsev, S (corresponding author), Univ Western Ontario, Dept Med Biophys, London, ON, Canada.; Yartsev, S (corresponding author), Univ Western Ontario, Dept Oncol, London, ON, Canada.; Yartsev, S (corresponding author), London Reg Canc Program, London, ON, Canada.	slav.yartsev@lhsc.on.ca	Hoffman, Lisa/B-5324-2015; Bauman, Glenn S/D-5986-2011; Yartsev, Slav/AAN-6279-2021; Lee, Ting-Yim/M-1721-2013	Bauman, Glenn/0000-0002-5279-7360				Atkinson AJ, 2001, CLIN PHARMACOL THER, V69, P89, DOI 10.1067/mcp.2000.113989; Boucher Y, 1997, BRIT J CANCER, V75, P829, DOI 10.1038/bjc.1997.148; Du LY, 2007, PHYS MED BIOL, V52, P7087, DOI 10.1088/0031-9155/52/23/021; Egeland TAM, 2006, MAGN RESON MED, V55, P874, DOI 10.1002/mrm.20852; Gulliksrud K, 2010, RADIOTHER ONCOL, V97, P233, DOI 10.1016/j.radonc.2010.09.005; Halle C, 2012, CANCER RES, V72, P5285, DOI 10.1158/0008-5472.CAN-12-1085; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jankovic B, 2006, CYTOM PART B-CLIN CY, V70B, P45, DOI 10.1002/cyto.b.20086; Kondziolka D, 1996, J NEUROSURG, V84, P1033, DOI 10.3171/jns.1996.84.6.1033; Lehtio K, 2004, INT J RADIAT ONCOL, V59, P971, DOI 10.1016/j.ijrobp.2003.12.014; O'Connor JPB, 2016, CANCER RES, V76, P787, DOI 10.1158/0008-5472.CAN-15-2062; Overgaard J, 2011, RADIOTHER ONCOL, V100, P22, DOI 10.1016/j.radonc.2011.03.004; Ragnum HB, 2015, BRIT J CANCER, V112, P382, DOI 10.1038/bjc.2014.604; Rosenberger Christian, 2009, V466, P161, DOI 10.1007/978-1-59745-352-3_12; Schuuring J, 2005, INT J RADIAT ONCOL, V61, P529, DOI 10.1016/j.ijrobp.2004.09.063; Sun XL, 2011, MOL IMAGING BIOL, V13, P399, DOI 10.1007/s11307-010-0420-z; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Yeung TPC, 2015, EUR J RADIOL, V84, P2386, DOI 10.1016/j.ejrad.2015.02.012; Yeung TPC, 2015, J NEURO-ONCOL, V123, P93, DOI 10.1007/s11060-015-1766-5; Yeung TPC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109781	22	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153569	10.1371/journal.pone.0153569	http://dx.doi.org/10.1371/journal.pone.0153569			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078858	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700081
J	Rosato, R; Testa, S; Bertolotto, A; Confalonieri, P; Patti, F; Lugaresi, A; Grasso, MG; Toscano, A; Giordano, A; Solari, A				Rosato, Rosalba; Testa, Silvia; Bertolotto, Antonio; Confalonieri, Paolo; Patti, Francesco; Lugaresi, Alessandra; Grasso, Maria Grazia; Toscano, Anna; Giordano, Andrea; Solari, Alessandra			Development of a Short Version of MSQOL-54 Using Factor Analysis and Item Response Theory	PLOS ONE			English	Article							QUALITY-OF-LIFE; CROSS-CULTURAL ADAPTATION; REPORTED OUTCOME MEASURES; MULTIPLE-SCLEROSIS; QUESTIONNAIRE MSQOL-54; RASCH ANALYSIS; VALIDATION; GUIDELINES; CRITERIA; IMPACT	Background The Multiple Sclerosis Quality of Life-54 (MSQOL-54, 52 items grouped in 12 subscales plus two single items) is the most used MS specific health related quality of life inventory. Objective To develop a shortened version of the MSQOL-54. Methods MSQOL-54 dimensionality and metric properties were investigated by confirmatory factor analysis (CFA) and Rasch modelling (Partial Credit Model, PCM) on MSQOL-54s completed by 473 MS patients. Their mean age was 41 years, 65% were women, and median Expanded Disability Status Scale (EDSS) score was 2.0 (range 0-9.5). Differential item functioning (DIF) was evaluated for gender, age and EDSS. Dimensionality of the resulting short version was assessed by exploratory factor analysis (EFA) and CFA. Cognitive debriefing of the short instrument (vs. the original) was then performed on 12 MS patients. Results CFA of MSQOL-54 subscales showed that the data fitted the overall model well. Two subscales (Role Limitations-Physical, Role Limitations-Emotional) did not fit the PCM, and were removed; two other subscales (Health Perceptions, Social Function) did not fit the model, but were retained as single items. Sexual Satisfaction (single-item subscale) was also removed. The resulting MSQOL-29 consisted of 25 items grouped in 7 subscales, plus 4 single items. PCM fit statistics were within the acceptability range for all MSQOL-29 items except one which had significant DIF by age. EFA and CFA indicated adequate fit to the original two-factor (Physical and Mental Health Composites) hypothesis. Cognitive debriefing confirmed that MSQOL-29 was acceptable and had lost no key items. Conclusions The proposed MSQOL-29 is 50% shorter than MSQOL-54, yet preserves key quality of life dimensions. Prospective validation on a large, independent MS patient sample is ongoing.	[Rosato, Rosalba; Testa, Silvia; Toscano, Anna] Univ Turin, Dept Psychol, Turin, Italy; [Bertolotto, Antonio] Univ Hosp San Luigi Gonzaga, Clin Neurobiol Unit, Reg Referral Multiple Sclerosis Ctr CReSM, Orbassano, Italy; [Confalonieri, Paolo] Fdn IRCCS Neurol Inst C Besta, Unit Neuroimmunol, Milan, Italy; [Patti, Francesco] Univ Hosp Policlin Vittorio Emanuele, MS Ctr, Neurol Clin, Catania, Italy; [Lugaresi, Alessandra] G dAnnunzio Univ Chieti Pescara, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Grasso, Maria Grazia] IRCCS S Lucia Fdn, Multiple Sclerosis Unit, Rome, Italy; [Giordano, Andrea; Solari, Alessandra] Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy	University of Turin; Azienda Ospedaliero-Universitaria San Luigi Gonzaga; Azienda Ospedaliera Universitaria Policlinico Vittorio Emanuele Presidio Ferraotto; University of Catania; G d'Annunzio University of Chieti-Pescara; IRCCS Santa Lucia	Solari, A (corresponding author), Fdn IRCCS Neurol Inst C Besta, Unit Neuroepidemiol, Milan, Italy.	solari@istituto-besta.it	Solari, Alessandra/AAO-1741-2021; Bertolotto, Antonio/K-8346-2015; Testa, Silvia/AAH-2129-2021; Confalonieri, Paolo/AAS-8513-2021; Lugaresi, Alessandra/C-7743-2012; Giordano, Andrea/AAN-3738-2021	Solari, Alessandra/0000-0001-9930-7579; Bertolotto, Antonio/0000-0002-7052-1907; Testa, Silvia/0000-0002-8732-4790; Confalonieri, Paolo/0000-0001-8030-5725; Lugaresi, Alessandra/0000-0003-2902-5589; Giordano, Andrea/0000-0003-4466-9788; patti, francesco/0000-0002-6923-0846; ROSATO, Rosalba/0000-0002-4921-374X	Fondazione Italiana Sclerosi Multipla (FISM) [2013/R/20]	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM))	This study was supported by the Fondazione Italiana Sclerosi Multipla (FISM, www.aism.it, grant No. 2013/R/20 to RR). The funding sources had no role in study design, data collection, data analysis, data interpretation, or report writing.	Acquadro Catherine, 2003, Health Qual Life Outcomes, V1, P70, DOI 10.1186/1477-7525-1-70; Ashley L, 2014, J PSYCHOSOM RES, V77, P322, DOI 10.1016/j.jpsychores.2014.07.007; Bollen KA, 1989, STRUCTURAL EQUATIONS; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Coons SJ, 2009, VALUE HEALTH, V12, P419, DOI 10.1111/j.1524-4733.2008.00470.x; Coste J, 1997, J CLIN EPIDEMIOL, V50, P247, DOI 10.1016/S0895-4356(96)00363-0; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Denzin N., 2000, HDB QUALITATIVE RES; Duncan PW, 2003, ARCH PHYS MED REHAB, V84, P950, DOI 10.1016/S0003-9993(03)00035-2; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Fuvesi J, 2008, MULT SCLER J, V14, P391, DOI 10.1177/1352458507082724; Giordano A, 2009, J NEUROL NEUROSUR PS, V80, P1023, DOI 10.1136/jnnp.2008.171181; Goetz C, 2013, J CLIN EPIDEMIOL, V66, P710, DOI 10.1016/j.jclinepi.2012.12.015; Greenhalgh J, 2005, SOC SCI MED, V60, P833, DOI 10.1016/j.socscimed.2004.06.022; Hamel JF, 2015, STAT METHODS MED RES; Hays R. D., 1990, PSYCHOL ASSESSMENT J, V2, P22, DOI DOI 10.1037/1040-3590.2.1.22; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Idiman E, 2006, J NEUROL SCI, V240, P77, DOI 10.1016/j.jns.2005.09.009; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Hayas CL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-29; Linacre JM, USERS GUIDE WINSTEPS; Lundstrom M, 2009, J CATARACT REFR SURG, V35, P504, DOI 10.1016/j.jcrs.2008.11.038; Massacesi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113371; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Mitchell AJ, 2005, LANCET NEUROL, V4, P556, DOI 10.1016/S1474-4422(05)70166-6; Moore F, 2015, CAN J NEUROL SCI, V42, P55, DOI 10.1017/cjn.2014.128; Pekmezovic T, 2007, QUAL LIFE RES, V16, P1383, DOI 10.1007/s11136-007-9234-0; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; POTENZA MT, 1995, APPL PSYCH MEAS, V19, P23, DOI 10.1177/014662169501900104; Rasch G., 1960, PROBABILISTIC MODELS; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Smith AB, 2006, PSYCHO-ONCOLOGY, V15, P817, DOI 10.1002/pon.1015; Smith AB, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-33; Solari A, 2004, J NEUROL SCI, V222, P99, DOI 10.1016/j.jns.2004.04.027; Solari A, 1999, J NEUROL NEUROSUR PS, V67, P158, DOI 10.1136/jnnp.67.2.158; Solari Alessandra, 2005, Health Qual Life Outcomes, V3, P16, DOI 10.1186/1477-7525-3-16; Taft C, 2004, QUAL LIFE RES, V13, P251, DOI 10.1023/B:QURE.0000015290.76254.a5; Taoussi KE, 2012, REV NEUROL-FRANCE, V168, P444, DOI 10.1016/j.neurol.2011.10.011; VICKREY BG, 1995, QUAL LIFE RES, V4, P187, DOI 10.1007/BF02260859; Vickrey BG, 1997, J CLIN EPIDEMIOL, V50, P557, DOI 10.1016/S0895-4356(97)00001-2; Ware J.E., 2000, SF 36 HLTH SURVEY MA; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Wyrwich KW, 1999, J CLIN EPIDEMIOL, V52, P861, DOI 10.1016/S0895-4356(99)00071-2; Yamamoto Toshiyuki, 2004, Rinsho Shinkeigaku, V44, P417	46	21	21	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153466	10.1371/journal.pone.0153466	http://dx.doi.org/10.1371/journal.pone.0153466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078146	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700058
J	Yang, Z; Qdaisat, A; Hu, ZH; Wagar, EA; Reyes-Gibby, C; Meng, QH; Yeung, SCJ				Yang, Zhi; Qdaisat, Aiham; Hu, Zhihuang; Wagar, Elizabeth A.; Reyes-Gibby, Cielito; Meng, Qing H.; Yeung, Sai-Ching J.			Cardiac Troponin Is a Predictor of Septic Shock Mortality in Cancer Patients in an Emergency Department: A Retrospective Cohort Study	PLOS ONE			English	Article							SURVIVING SEPSIS CAMPAIGN; CHRONIC HEALTH EVALUATION; ORGAN DYSFUNCTION; PROGNOSTIC VALUE; ACUTE PHYSIOLOGY; SEVERITY SCORE; PROCALCITONIN; ELEVATION; MEDS; INSULT/INFECTION	Background Septic shock may be associated with myocardial damage; however, the prognostic value of cardiac enzymes in cancer patients with septic shock is unknown. In this study, we evaluated the prognostic significance of cardiac enzymes in combination with established prognostic factors in predicting the 7-day mortality rate of patients with septic shock, and we constructed a new scoring system, Septic Oncologic Patients in Emergency Department (SOPED), which includes cardiac enzymes, to predict 7-day mortality rates. Methods and Findings We performed a retrospective cohort study of 375 adult cancer patients with septic shock who visited the emergency department of a comprehensive cancer center between 01/01/2004 and 12/31/2013. The 7-day and 28-day mortality rates were 19.7% and 37.6%, respectively. The creatine kinase myocardial band fraction and troponin-I were significantly higher in patients who died in <= 7 days and <= 28 days than in those who did not. In Cox regression models, troponin-I >0.05 ng/mL plus Predisposition, Infection, Response, and Organ Failure (PIRO2011) or Mortality in Emergency Department Sepsis (MEDS) score was a significant predictor of survival for <= 7 days. With our new SOPED scoring system, the receiver operating characteristic area under the curve was 0.836, higher than those for PIRO2011 and MEDS. Conclusions Troponin-I >0.05 ng/mL was an important predictor of short-term mortality (<= 7 days). The SOPED scoring system, which incorporated troponin-I, was more prognostically accurate than were other scores for 7-day mortality. Large multicenter studies are needed to verify our results and prospectively validate the prognostic performance of the SOPED score.	[Yang, Zhi; Qdaisat, Aiham; Hu, Zhihuang; Reyes-Gibby, Cielito; Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Yang, Zhi] Guangzhou Med Univ, Guangzhou Peoples Hosp 1, Dept Intens Care, 1 Panfu Rd, Guangzhou, Guangdong, Peoples R China; [Hu, Zhihuang] Sun Yat Sen Univ, Dept Med Oncol, Ctr Canc, 651 Dongfeng East Rd,West F16, Guangzhou 510060, Guangdong, Peoples R China; [Wagar, Elizabeth A.; Meng, Qing H.] Univ Texas MD Anderson Canc Ctr, Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Yeung, Sai-Ching J.] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Guangzhou Medical University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Emergency Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Meng, QH (corresponding author), Univ Texas MD Anderson Canc Ctr, Lab Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Yeung, SCJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, 1515 Holcombe Blvd, Houston, TX 77030 USA.	qhmeng@mdanderson.org; syeung@mdanderson.org	Yeung, Sai-Ching/AAP-8079-2020; Meng, Q./GSI-6185-2022; Yeung, Sai-Ching/AAI-6178-2021; Qdaisat, Aiham/AAF-8763-2021; Qdaisat, Aiham/AHE-6024-2022	Yeung, Sai-Ching/0000-0001-5170-0822; Qdaisat, Aiham/0000-0003-0063-8461	Guangzhou First People's Hospital, Guangzhou Medical University; China Scholarship Council	Guangzhou First People's Hospital, Guangzhou Medical University; China Scholarship Council(China Scholarship Council)	Dr. Z Yang is supported by Guangzhou First People's Hospital, Guangzhou Medical University. Dr. ZH Hu is supported by China Scholarship Council.; Dr. Z. Yang is supported by Guangzhou First People's Hospital, Guangzhou Medical University. Dr. Z.H. Hu is supported by the China Scholarship Council. We thank Ms. Jeanie F. Woodruff and Ms. Ann M. Sutton of The University of Texas MD Anderson Cancer Center for editorial assistance.	[Anonymous], 2008, J CRIT CARE, DOI DOI 10.1016/j.jcrc.2007.08.003; Bessiere F, 2013, INTENS CARE MED, V39, P1181, DOI 10.1007/s00134-013-2902-3; Bion J, 2008, INTENS CARE MED, V34, P1163, DOI 10.1007/s00134-008-1090-z; Cardoso T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070806; Carpenter CR, 2009, J EMERG MED, V37, P319, DOI 10.1016/j.jemermed.2009.03.016; Chen YX, 2014, AM J EMERG MED, V32, P982, DOI 10.1016/j.ajem.2014.05.025; Cildir E, 2013, INTERN EMERG MED, V8, P255, DOI 10.1007/s11739-012-0890-x; Crowe Colleen A, 2010, J Emerg Trauma Shock, V3, P342, DOI 10.4103/0974-2700.70761; de Kruif MD, 2010, CRIT CARE MED, V38, P457, DOI 10.1097/CCM.0b013e3181b9ec33; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Favory R, 2006, CRIT CARE, V10, DOI 10.1186/cc4991; Furian T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.017; Geier F, 2013, WIEN KLIN WOCHENSCHR, V125, P508, DOI 10.1007/s00508-013-0407-2; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; John J, 2010, J CRIT CARE, V25, P270, DOI 10.1016/j.jcrc.2009.12.001; Jones AE, 2008, AM J EMERG MED, V26, P689, DOI 10.1016/j.ajem.2008.01.009; Jones AE, 2014, ANN EMERG MED, V63, P35, DOI 10.1016/j.annemergmed.2013.08.004; KNAUS WA, 1981, CRIT CARE MED, V9, P591, DOI 10.1097/00003246-198108000-00008; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kuo SH, 2013, AM J EMERG MED, V31, P916, DOI 10.1016/j.ajem.2013.02.045; Landesberg G, 2014, CRIT CARE MED, V42, P790, DOI 10.1097/CCM.0000000000000107; Lee CC, 2008, SHOCK, V29, P322, DOI 10.1097/SHK.0b013e31815077ca; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; Marshall JC, 2003, CRIT CARE MED, V31, P1560, DOI 10.1097/01.CCM.0000065186.67848.3A; Mehta NJ, 2004, INT J CARDIOL, V95, P13, DOI 10.1016/j.ijcard.2003.02.005; Nguyen HB, 2012, J CRIT CARE, V27, P362, DOI 10.1016/j.jcrc.2011.08.013; Osborn TM, 2014, CRIT CARE MED, V42, P1969, DOI 10.1097/CCM.0000000000000416; Povoa P, 2011, CRIT CARE, V15, DOI 10.1186/cc10242; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Scott EC, 2008, ANAESTH INTENS CARE, V36, P51, DOI 10.1177/0310057X0803600109; Shapiro NI, 2003, CRIT CARE MED, V31, P670, DOI 10.1097/01.CCM.0000054867.01688.D1; Sheyin O, 2014, HEART LUNG, V44, P75, DOI 10.1016/j.hrtlng.2014.10.002; ter Avest E, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-9; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang F, 2012, CRIT CARE, V16, DOI 10.1186/cc11331; Zhao YZ, 2013, AM J EMERG MED, V31, P1086, DOI 10.1016/j.ajem.2013.04.008; [No title captured]; [No title captured]	39	3	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153492	10.1371/journal.pone.0153492	http://dx.doi.org/10.1371/journal.pone.0153492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077648	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700064
J	Brubacher, JR; Chan, H; Erdelyi, S; Schuurman, N; Amram, O				Brubacher, Jeffrey R.; Chan, Herbert; Erdelyi, Shannon; Schuurman, Nadine; Amram, Ofer			The Association between Regional Environmental Factors and Road Trauma Rates: A Geospatial Analysis of 10 Years of Road Traffic Crashes in British Columbia, Canada	PLOS ONE			English	Article							POPULATION-BASED ANALYSIS; MOTOR-VEHICLE ACCIDENTS; TERM-FOLLOW-UP; INJURY SEVERITY; ALCOHOL; DRIVERS; STATES; DEPRIVATION; INVOLVEMENT; DETERRENCE	Background British Columbia, Canada is a geographically large jurisdiction with varied environmental and socio-cultural contexts. This cross-sectional study examined variation in motor vehicle crash rates across 100 police patrols to investigate the association of crashes with key explanatory factors. Methods Eleven crash outcomes (total crashes, injury crashes, fatal crashes, speed related fatal crashes, total fatalities, single-vehicle night-time crashes, rear-end collisions, and collisions involving heavy vehicles, pedestrians, cyclists, or motorcyclists) were identified from police collision reports and insurance claims and mapped to police patrols. Six potential explanatory factors (intensity of traffic law enforcement, speed limits, climate, remoteness, socioeconomic factors, and alcohol consumption) were also mapped to police patrols. We then studied the association between crashes and explanatory factors using negative binomial models with crash count per patrol as the response variable and explanatory factors as covariates. Results Between 2003 and 2012 there were 1,434,239 insurance claim collisions, 386,326 police reported crashes, and 3,404 fatal crashes. Across police patrols, there was marked variation in per capita crash rate and in potential explanatory factors. Several factors were associated with crash rates. Percent roads with speed limits <= 60 km/hr was positively associated with total crashes, injury crashes, rear end collisions, and collisions involving pedestrians, cyclists, and heavy vehicles; and negatively associated with single vehicle night-time crashes, fatal crashes, fatal speeding crashes, and total fatalities. Higher winter temperature was associated with lower rates of overall collisions, single vehicle night-time collisions, collisions involving heavy vehicles, and total fatalities. Lower socio-economic status was associated with higher rates of injury collisions, pedestrian collisions, fatal speeding collisions, and fatal collisions. Regions with dedicated traffic officers had fewer fatal crashes and fewer fatal speed related crashes but more rear end crashes and more crashes involving cyclists or pedestrians. The number of traffic citations per 1000 drivers was positively associated with total crashes, fatal crashes, total fatalities, fatal speeding crashes, injury crashes, single vehicle night-time crashes, and heavy vehicle crashes. Possible explanations for these associations are discussed. Conclusions There is wide variation in per capita rates of motor vehicle crashes across BC police patrols. Some variation is explained by factors such as climate, road type, remoteness, socioeconomic variables, and enforcement intensity. The ability of explanatory factors to predict crash rates would be improved if considered with local traffic volume by all travel modes.	[Brubacher, Jeffrey R.; Chan, Herbert; Erdelyi, Shannon] Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Schuurman, Nadine; Amram, Ofer] Simon Fraser Univ, Dept Geog, Burnaby, BC V5A 1S6, Canada	University of British Columbia; Simon Fraser University	Brubacher, JR (corresponding author), Univ British Columbia, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada.	Jbrubacher@shaw.ca		Brubacher, Jeffrey/0000-0002-4866-4231; amram, ofer/0000-0002-8835-3104	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (JRB) - (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CAN MOT VEH TRAFF CO; [Anonymous], 2006, CAN MOT VEH TRAFF CO; [Anonymous], 2009, INT ROAD TRAFFIC ACC; Baeseman Zachary J, 2009, WMJ, V108, P359; Bell N, 2012, CAN J PUBLIC HEALTH, V103, pS28, DOI 10.1007/BF03403826; Borgialli DA, 2000, ACAD EMERG MED, V7, P7, DOI 10.1111/j.1553-2712.2000.tb01882.x; Boufous S, 2008, J SAFETY RES, V39, P65, DOI 10.1016/j.jsr.2007.10.010; Cameron MP, 2012, AUST NZ J PUBL HEAL, V36, P537, DOI 10.1111/j.1753-6405.2012.00935.x; Canadian Council of Motor Transport Administrators, 2013, CAN MOT VEH TRAFF CO; Desapriya E, 2011, INJURY PREV, V17, P4, DOI 10.1136/ip.2010.026914; Dukic T, 2013, TRAFFIC INJ PREV, V14, P469, DOI 10.1080/15389588.2012.731546; Esposito T J, 1995, Prehosp Disaster Med, V10, P161; Fleury D, 2010, ACCIDENT ANAL PREV, V42, P1653, DOI 10.1016/j.aap.2010.04.004; FRIDSTROM L, 1995, ACCIDENT ANAL PREV, V27, P1; Gomez D, 2010, J TRAUMA, V69, P633, DOI 10.1097/TA.0b013e3181b8ef81; Gonzalez RP, 2007, J TRAUMA, V63, P1360, DOI 10.1097/TA.0b013e31815b83b3; Green J, 2011, ACCIDENT ANAL PREV, V43, P714, DOI 10.1016/j.aap.2010.10.016; Gruenewald PJ, 2010, J STUD ALCOHOL DRUGS, V71, P237, DOI 10.15288/jsad.2010.71.237; Hameed SM, 2010, J TRAUMA, V69, P1350, DOI 10.1097/TA.0b013e3181e751f7; Hewson P, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-15; Hyde LK, 2005, ANN EMERG MED, V45, P147, DOI 10.1016/j.annemergmed.2004.10.007; ICBC, 2007, TRAFF COLL STAT POL; Jones AW, 2009, FORENSIC SCI INT, V186, P56, DOI 10.1016/j.forsciint.2009.01.014; Mashta O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4397; Meliker JR, 2004, ACCIDENT ANAL PREV, V36, P1129, DOI 10.1016/j.aap.2004.06.002; Morland J, 2011, ACCIDENT ANAL PREV, V43, P1920, DOI 10.1016/j.aap.2011.05.002; Muelleman RL, 2007, J TRAUMA, V62, P221, DOI 10.1097/01.ta.0000231696.65548.06; Noland RB, 2004, ACCIDENT ANAL PREV, V36, P973, DOI 10.1016/j.aap.2003.11.001; Ponicki W. R., 2013, ACCIDENT ANAL PREV, V55, P135, DOI DOI 10.1016/J.AAP.2013.03.001; Road Safety and Motor Vehicle Regulation Directorate, 2011, RES TRANSP CAN RUR U; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Shepherd JP, 2001, LANCET, V358, P1717, DOI 10.1016/S0140-6736(01)06716-2; Simons R, 2010, J TRAUMA, V69, P11, DOI 10.1097/TA.0b013e3181e17b39; Tang TQ, 2011, PHYS LETT A, V375, P3845, DOI 10.1016/j.physleta.2011.08.006; Tay R, 2009, ACCIDENT ANAL PREV, V41, P663, DOI 10.1016/j.aap.2009.03.006; Theall KP, 2009, ALCOHOL ALCOHOLISM, V44, P491, DOI 10.1093/alcalc/agp042; Toomey TL, 2012, J STUD ALCOHOL DRUGS, V73, P21, DOI 10.15288/jsad.2012.73.21; Traynor TL, 2009, J SAFETY RES, V40, P421, DOI 10.1016/j.jsr.2009.10.003; Traynor TL, 2009, TRAFFIC INJ PREV, V10, P368, DOI 10.1080/15389580902995174; Treno AJ, 2007, ACCIDENT ANAL PREV, V39, P894, DOI 10.1016/j.aap.2006.12.011; Voas RB, 2008, TRAFFIC INJ PREV, V9, P22, DOI 10.1080/15389580701682114; Wagenaar AC, 2007, J SAFETY RES, V38, P493, DOI 10.1016/j.jsr.2007.06.001; Wagenaar AC, 2007, ACCIDENT ANAL PREV, V39, P982, DOI 10.1016/j.aap.2007.01.003; Wagenaar AC, 2007, ALCOHOL CLIN EXP RES, V31, P1399, DOI 10.1111/j.1530-0277.2007.00441.x; Wegman F, 2012, INT TRANSPORT FORUM; World Health Organization, 2009, GLOB STAT REP ROAD S	46	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153742	10.1371/journal.pone.0153742	http://dx.doi.org/10.1371/journal.pone.0153742			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27099930	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500061
J	Chang, ZH; Liu, Y; Dong, H; Teng, K; Han, LB; Zhang, XZ				Chang, Zhihui; Liu, Yang; Dong, Hui; Teng, Ke; Han, Liebao; Zhang, Xunzhong			Effects of Cytokinin and Nitrogen on Drought Tolerance of Creeping Bentgrass	PLOS ONE			English	Article							CELL-MEMBRANE STABILITY; TALL FESCUE CULTIVARS; HEAT-STRESS; ANTIOXIDANT ENZYMES; KENTUCKY BLUEGRASS; HORMONE METABOLISM; LIPID-PEROXIDATION; OXIDATIVE DAMAGE; GENE-EXPRESSION; ABSCISIC-ACID	Cytokinin (CK) is a vital plant hormone that controls many aspects of growth and development in plants. Nitrogen (N) is the indispensable macronutrient needed in plants and also one of the most important limiting factors for plant growth. This study was designed to investigate the simultaneous effects of CK and N on the visual turf quality and antioxidant metabolism of drought-stressed creeping bentgrass (Agrostis stolonifera L.). 'PennA-4' creeping bentgrass treated with trans-zeatin riboside at three rates of CK concentrations of 0, 10 and 100 mu M (designated by CK0, 10, and 100) and two nitrogen rates with 2.5 and 7.5 kg N.ha(-1) every 15 days (designated by low and high N) in a complete factorial arrangement was grown under two soil moisture regimes: well-watered and drought stress. Exogenous CK improved turf quality and delayed leaf wilting under drought stress, especially under high N. The grasses treated with CK10 and CK100 had lower O-2(-) production and H2O2 concentration than those without CK treatment. The CK100 treatment enhanced the activities of superoxide dismutase (SOD), ascorbate peroxidase (APX), catalase (CAT), and guaiacol peroxidase (POD) by 25%, 22%, 17% and 24%, respectively, relative to CK0. Moreover, the activity changes of the antioxidant enzyme isoforms were more significant under high N condition relative to low N condition. Our results demonstrated the beneficial impacts of CK and N on physiological reactions, especially antioxidant metabolism, and foliar application of CK at 10 or 100 muM plus 7.5 kg ha(-1) N biweekly may improve drought stress resistance of creeping bentgrass.	[Chang, Zhihui; Liu, Yang; Dong, Hui; Teng, Ke; Han, Liebao] Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China; [Zhang, Xunzhong] Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA	Beijing Forestry University; Virginia Polytechnic Institute & State University	Chang, ZH (corresponding author), Beijing Forestry Univ, Coll Forestry, Beijing 100083, Peoples R China.; Zhang, XZ (corresponding author), Virginia Polytech Inst & State Univ, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.	changzh@bjfu.edu.cn; xuzhang@vt.edu		Teng, Ke/0000-0002-4123-7843	Beijing Higher Education Young Elite Teacher Project [YETP0742]	Beijing Higher Education Young Elite Teacher Project	This study was supported by Beijing Higher Education Young Elite Teacher Project (YETP0742).	Ahmad R, 2014, J PLANT NUTR, V37, P942, DOI 10.1080/01904167.2013.868480; Akram M, 2014, COMMUN SOIL SCI PLAN, V45, P1336, DOI 10.1080/00103624.2013.875199; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; BEAUCHAMP CO, 1973, BIOCHIM BIOPHYS ACTA, V317, P50, DOI 10.1016/0005-2795(73)90198-0; Bergmeyer H.U., 1974, METHODS ENZYMATIC AN, P735; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; Boschma SP, 2015, GRASS FORAGE SCI, V70, P381, DOI 10.1111/gfs.12130; Chai Q, 2010, J AM SOC HORTIC SCI, V135, P125, DOI 10.21273/JASHS.135.2.125; Chance B., 1955, ASSAY CATALASES PERO; Chanda SV, 2003, J PLANT BIOL, V46, P41, DOI 10.1007/BF03030300; Clarke SF, 2002, PHYSIOL PLANTARUM, V114, P157, DOI 10.1034/j.1399-3054.2002.1140201.x; DaCosta M, 2007, J AM SOC HORTIC SCI, V132, P60, DOI 10.21273/JASHS.132.1.60; Dat JF, 1998, PLANT PHYSIOL, V116, P1351, DOI 10.1104/pp.116.4.1351; FIELDING JL, 1978, J EXP BOT, V29, P969, DOI 10.1093/jxb/29.4.969; Fu JM, 2003, J PLANT NUTR, V26, P81, DOI 10.1081/PLN-120016498; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; GIDROL X, 1994, EUR J BIOCHEM, V224, P21, DOI 10.1111/j.1432-1033.1994.tb19990.x; Havlova M, 2008, PLANT CELL ENVIRON, V31, P341, DOI 10.1111/j.1365-3040.2007.01766.x; He Xue-li, 2009, Yingyong Shengtai Xuebao, V20, P2118; He YL, 2010, J AM SOC HORTIC SCI, V135, P116, DOI 10.21273/JASHS.135.2.116; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hu LX, 2012, J PLANT PHYSIOL, V169, P146, DOI 10.1016/j.jplph.2011.08.020; Huang BR, 1999, HORTSCIENCE, V34, P897, DOI 10.21273/HORTSCI.34.5.897; Huang JJ, 2011, J PLANT PHYSIOL, V168, P768, DOI 10.1016/j.jplph.2010.10.010; Jiang MY, 2002, J EXP BOT, V53, P2401, DOI 10.1093/jxb/erf090; Jiang YW, 2000, CROP SCI, V40, P1358, DOI 10.2135/cropsci2000.4051358x; Jiang YW, 2001, CROP SCI, V41, P436, DOI 10.2135/cropsci2001.412436x; KOCHHAR S, 1979, AM J ENOL VITICULT, V30, P275; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu XH, 2002, CROP SCI, V42, P457, DOI 10.2135/cropsci2002.0457; Liu XH, 2002, CROP SCI, V42, P466, DOI 10.2135/cropsci2002.0466; Lopez-Huertas E, 1999, BIOCHEM J, V337, P531, DOI 10.1042/0264-6021:3370531; Man D, 2011, HORTSCIENCE, V46, P1027, DOI 10.21273/HORTSCI.46.7.1027; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; Pan Y, 2006, PLANT GROWTH REGUL, V49, P157, DOI 10.1007/s10725-006-9101-y; PREMACHANDRA GS, 1990, J AGR SCI-CAMBRIDGE, V115, P63, DOI 10.1017/S0021859600073925; Senthil-Kumar M, 2007, J PLANT PHYSIOL, V164, P111, DOI 10.1016/j.jplph.2006.09.009; Shigeoka S, 2002, J EXP BOT, V53, P1305, DOI 10.1093/jexbot/53.372.1305; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; SKOGQVIST I, 1974, PHYSIOL PLANTARUM, V32, P166, DOI 10.1111/j.1399-3054.1974.tb03746.x; Song XG, 2006, FUNCT PLANT BIOL, V33, P573, DOI 10.1071/FP05232; Srivalli B, 2003, PHYSIOL PLANTARUM, V119, P503, DOI 10.1046/j.1399-3054.2003.00125.x; Wang D, 2008, J INTEGR PLANT BIOL, V50, P1416, DOI 10.1111/j.1744-7909.2008.00748.x; Wang KH, 2007, CROP SCI, V47, P232, DOI 10.2135/cropsci2006.07.0498; Wang KH, 2012, J PLANT PHYSIOL, V169, P492, DOI 10.1016/j.jplph.2011.12.007; Wang KH, 2011, CROP SCI, V51, P2145, DOI 10.2135/cropsci2011.01.0024; WOODBURY W, 1971, ANAL BIOCHEM, V44, P301, DOI 10.1016/0003-2697(71)90375-7; Wu FZ, 2008, ENVIRON EXP BOT, V63, P248, DOI 10.1016/j.envexpbot.2007.11.002; Wu XX, 2015, ENVIRON EXP BOT, V116, P1, DOI 10.1016/j.envexpbot.2015.03.004; Xu LX, 2011, J AM SOC HORTIC SCI, V136, P247, DOI 10.21273/JASHS.136.4.247; Xu S, 2006, ENVIRON EXP BOT, V56, P274, DOI 10.1016/j.envexpbot.2005.03.002; Zavaleta-Mancera HA, 2007, J PLANT PHYSIOL, V164, P1572, DOI 10.1016/j.jplph.2007.02.003; Zhang XZ, 2008, CROP SCI, V48, P364, DOI 10.2135/cropsci2007.05.0262; Zhang XZ, 2009, CROP SCI, V49, P1893, DOI 10.2135/cropsci2008.09.0521; Zhu Y, 2014, CROP J, V2, P223, DOI 10.1016/j.cj.2014.04.005	59	56	62	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154005	10.1371/journal.pone.0154005	http://dx.doi.org/10.1371/journal.pone.0154005			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099963	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500121
J	Hiremath, J; Kang, KI; Xia, M; Elaish, M; Binjawadagi, B; Ouyang, K; Dhakal, S; Arcos, J; Torrelles, JB; Jiang, X; Lee, CW; Renukaradhya, GJ				Hiremath, Jagadish; Kang, Kyung-il; Xia, Ming; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Arcos, Jesus; Torrelles, Jordi B.; Jiang, X.; Lee, Chang Won; Renukaradhya, Gourapura J.			Entrapment of H1N1 Influenza Virus Derived Conserved Peptides in PLGA Nanoparticles Enhances T Cell Response and Vaccine Efficacy in Pigs	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; CROSS-PROTECTIVE IMMUNITY; SWINE INFLUENZA; CYTOTOXIC-T; MYCOBACTERIUM-VACCAE; PSEUDORABIES VIRUS; ANTIGEN; MUCOSAL; EXPRESSION; DELIVERY	Pigs are believed to be one of the important sources of emerging human and swine influenza viruses (SwIV). Influenza virus conserved peptides have the potential to elicit cross- protective immune response, but without the help of potent adjuvant and delivery system they are poorly immunogenic. Biodegradable polylactic-co-glycolic acid (PLGA) nanoparticle (PLGA-NP) based vaccine delivery system enhances cross-presentation of antigens by the professional antigen presenting cells. In this study, Norovirus P particle containing SwIV M2e (extracellular domain of the matrix protein 2) chimera and highly conserved two each of H1N1 peptides of pandemic 2009 and classical human influenza viruses were entrapped in PLGA-NPs. Influenza antibody-free pigs were vaccinated with PLGA-NPs peptides cocktail vaccine twice with or without an adjuvant, Mycobacterium vaccae whole cell lysate, intranasally as mist. Vaccinated pigs were challenged with a virulent heterologous zoonotic SwIV H1N1, and one week later euthanized and the lung samples were analyzed for the specific immune response and viral load. Clinically, pigs vaccinated with PLGA-NP peptides vaccine had no fever and flu symptoms, and the replicating challenged SwIV was undetectable in the bronchoalveolar lavage fluid. Immunologically, PLGA-NP peptides vaccination (without adjuvant) significantly increased the frequency of antigen-specific IFN. secreting CD4 and CD8 T cells response in the lung lymphocytes, despite not boosting the antibody response both at pre-and post-challenge. In summary, our data indicated that nanoparticlemediated delivery of conserved H1N1 influenza peptides induced the virus specific T cell response in the lungs and reduced the challenged heterologous virus load in the airways of pigs.	[Hiremath, Jagadish; Kang, Kyung-il; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Lee, Chang Won; Renukaradhya, Gourapura J.] Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, 1680 Madison Ave, Wooster, OH 44691 USA; [Hiremath, Jagadish; Kang, Kyung-il; Elaish, Mohamed; Binjawadagi, Basavaraj; Ouyang, Kang; Dhakal, Santosh; Lee, Chang Won; Renukaradhya, Gourapura J.] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Arcos, Jesus; Torrelles, Jordi B.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Xia, Ming; Jiang, X.] Univ Cincinnati, Coll Med, Div Infect Dis, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lee, CW; Renukaradhya, GJ (corresponding author), Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, 1680 Madison Ave, Wooster, OH 44691 USA.; Lee, CW; Renukaradhya, GJ (corresponding author), Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA.	lee.2854@osu.edu; gourapura.1@osu.edu	Elaish, Mohamed/AAT-4642-2020; Xia, Ming/AAY-7154-2021; Dhakal, Santosh/J-2906-2019	Dhakal, Santosh/0000-0002-4494-8608; Elaish, Mohamed/0000-0003-3628-5856	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2013-67015-20476]; Indian Council for Agricultural Research, India	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Indian Council for Agricultural Research, India	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-20476 from the USDA National Institute of Food and Agriculture. The first author of this paper was supported by International Fellowship (2010-11), by Indian Council for Agricultural Research, India.	AGUADO MT, 1992, IMMUNOBIOLOGY, V184, P113, DOI 10.1016/S0171-2985(11)80470-5; Bacon A, 2000, INFECT IMMUN, V68, P5764, DOI 10.1128/IAI.68.10.5764-5770.2000; Bertram U, 2010, DRUG DEV IND PHARM, V36, P581, DOI 10.3109/03639040903382673; Binjawadagi B, 2014, INT J NANOMED, V9, P1519, DOI 10.2147/IJN.S59924; Binjawadagi B, 2014, INT J NANOMED, V9, P679, DOI 10.2147/IJN.S56127; Blank F, 2013, AM J RESP CELL MOL, V49, P67, DOI 10.1165/rcmb.2012-0387OC; Chen Qi, 2012, Anim Health Res Rev, V13, P181, DOI 10.1017/S1466252312000175; Daum LT, 2002, EMERG INFECT DIS, V8, P408, DOI 10.3201/eid0804.010311; De Bruin TGM, 2000, VIRAL IMMUNOL, V13, P511; Denyer MS, 2006, VET IMMUNOL IMMUNOP, V110, P279, DOI 10.1016/j.vetimm.2005.10.005; Dwivedi V, 2013, VET MICROBIOL, V166, P47, DOI 10.1016/j.vetmic.2013.04.029; Dwivedi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051794; Dwivedi V, 2011, VACCINE, V29, P4058, DOI 10.1016/j.vaccine.2011.03.006; Guo YJ, 2004, VACCINE, V22, P3841, DOI 10.1016/j.vaccine.2004.07.012; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Heinen PP, 2002, J GEN VIROL, V83, P1851, DOI 10.1099/0022-1317-83-8-1851; Heit A, 2007, EUR J IMMUNOL, V37, P2063, DOI 10.1002/eji.200737169; Hernandez-Pando R, 2008, CLIN VACCINE IMMUNOL, V15, P1730, DOI 10.1128/CVI.00286-08; Ho CS, 2009, TISSUE ANTIGENS, V73, P307, DOI 10.1111/j.1399-0039.2009.01213.x; Hossain MJ, 2010, J CLIN MICROBIOL, V48, P2515, DOI 10.1128/JCM.02286-09; Ito F, 2008, COLLOID SURFACE B, V61, P25, DOI 10.1016/j.colsurfb.2007.06.029; Jung K, 2007, J VIROL, V81, P13681, DOI 10.1128/JVI.01702-07; Khatri M, 2010, J VIROL, V84, P11210, DOI 10.1128/JVI.01211-10; Kim B, 2002, J CONTROL RELEASE, V85, P191, DOI 10.1016/S0168-3659(02)00280-8; KIMMAN TG, 1995, IMMUNOLOGY, V86, P372; LEDERER E, 1975, MOL CELL BIOCHEM, V7, P87, DOI 10.1007/BF01792076; Lee CW, 2004, J VIROL METHODS, V119, P151, DOI 10.1016/j.jviromet.2004.03.014; Lu JM, 2009, EXPERT REV MOL DIAGN, V9, P325, DOI 10.1586/ERM.09.15; MNneil SE, 2005, J LEUKOCYTE BIOL, V78, P585, DOI 10.1189/jlb.0205074; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Panyam J, 2003, ADV DRUG DELIVER REV, V55, P329, DOI 10.1016/S0169-409X(02)00228-4; Purcell AW, 2007, NAT REV DRUG DISCOV, V6, P404, DOI 10.1038/nrd2224; Rajapaksa TE, 2010, J BIOL CHEM, V285, P23739, DOI 10.1074/jbc.M110.126359; Silva MSE, 2012, AVIAN DIS, V56, P601, DOI 10.1637/10087-022312-ResNote.1; Saalmuller A, 2002, VET IMMUNOL IMMUNOP, V87, P137, DOI 10.1016/S0165-2427(02)00045-4; Saini V, 2011, INT J PHARMACEUT, V408, P50, DOI 10.1016/j.ijpharm.2011.01.045; Schliehe C, 2011, J IMMUNOL, V187, P2112, DOI 10.4049/jimmunol.1002084; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Skinner MA, 2001, IMMUNOLOGY, V102, P225, DOI 10.1046/j.1365-2567.2001.01174.x; Talker SC, 2013, DEV COMP IMMUNOL, V40, P51, DOI 10.1016/j.dci.2013.01.003; Thomas C, 2011, MOL PHARMACEUT, V8, P405, DOI 10.1021/mp100255c; Vergara-Alert J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040524; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Woodrow KA, 2012, ANNU REV BIOMED ENG, V14, P17, DOI 10.1146/annurev-bioeng-071811-150054; Xia M, 2011, VACCINE, V29, P7670, DOI 10.1016/j.vaccine.2011.07.139; Yassine HM, 2009, VET MICROBIOL, V139, P132, DOI 10.1016/j.vetmic.2009.04.028; Yoshida M, 2006, J BIOMED MATER RES A, V79A, P393, DOI 10.1002/jbm.a.30798; Zhang LH, 2007, INT IMMUNOPHARMACOL, V7, P1732, DOI 10.1016/j.intimp.2007.09.012; Zhang NZ, 2011, J VIROL, V85, P11709, DOI 10.1128/JVI.05040-11; Zuckermann FA, 1996, IMMUNOLOGY, V87, P500, DOI 10.1046/j.1365-2567.1996.494570.x	50	53	56	0	159	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151922	10.1371/journal.pone.0151922	http://dx.doi.org/10.1371/journal.pone.0151922			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093541	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200003
J	Khungwanmaythawee, K; Sornjai, W; Paemanee, A; Jaratsittisin, J; Fucharoen, S; Svasti, S; Lithanatudom, P; Roytrakul, S; Smith, DR				Khungwanmaythawee, Kornpat; Sornjai, Wannapa; Paemanee, Atchara; Jaratsittisin, Janejira; Fucharoen, Suthat; Svasti, Saovaros; Lithanatudom, Pathrapol; Roytrakul, Sittiruk; Smith, Duncan R.			Mitochondrial Changes in beta degrees-Thalassemia/Hb E Disease	PLOS ONE			English	Article							MOLECULAR-BIOLOGY; ERYTHROPOIESIS; APOPTOSIS; AUTOPHAGY; MASS	The compound beta degrees-thalassemia/Hb E hemoglobinopathy is characterized by an unusually large range of presentation from essentially asymptomatic to a severe transfusion dependent state. While a number of factors are known that moderate presentation, these factors do not account for the full spectrum of presentation. Mitochondria are subcellular organelles that are pivotal in a number of cellular processes including oxidative phosphorylation and apoptosis. A mitochondrial protein enriched proteome was determined and validated from erythroblasts from normal controls and beta degrees-thalassemia/Hb E patients of different severities. Mitochondria were evaluated through the use of mitotracker staining, analysis of relative mitochondrial genome number and evaluation of mitochondrial gene expression in addition to assay of overall cellular redox status through the use of alamarBlue assays. Fifty differentially regulated mitochondrial proteins were identified. Mitotracker staining revealed significant differences in staining between normal control erythroblasts and those from beta degrees-thalassemia/Hb E patients. Differences in relative mitochondria number and gene expression were seen primarily in day 10 cells. Significant differences were seen in redox status as evaluated by alamarBlue staining in newly isolated CD34+ cells. Mitochondria mediate oxidative phosphorylation and apoptosis, both of which are known to be dysregulated in differentiating erythrocytes from V-thalassemia/Hb E patients. The evidence presented here suggest that there are inherent differences in these cells as early as the erythroid progenitor cell stage, and that maximum deficit is seen coincident with high levels of globin gene expression.	[Khungwanmaythawee, Kornpat; Sornjai, Wannapa; Paemanee, Atchara; Jaratsittisin, Janejira; Fucharoen, Suthat; Svasti, Saovaros; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya 73170, Nakorn Pathom, Thailand; [Paemanee, Atchara; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand; [Lithanatudom, Pathrapol] Chiang Mai Univ, Fac Sci, Dept Biol, 239 Huay Kaew Rd, Chiang Mai 50202, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chiang Mai University	Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamontol Sai 4, Salaya 73170, Nakorn Pathom, Thailand.	duncan.smi@mahidol.ac.th	Svasti, Saovaros/AAH-6111-2020; LITHANATUDOM, PATHRAPOL/AAQ-1131-2021; Smith, Duncan R/C-6891-2011	Smith, Duncan R/0000-0002-6592-9852; Paemanee, Atchara/0000-0001-9206-3153; Jaratsittisin, Janejira/0000-0002-0651-5377; Roytrakul, Sittiruk/0000-0003-3696-8390	Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund [BRG5780004, IRG5780009]; Thai Royal Golden Jubilee Research Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	Research Chair Grant from the National Science and Technology Development Agency; Thailand Research Fund(Thailand Research Fund (TRF)); Thai Royal Golden Jubilee Research Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	This work was supported by a Research Chair Grant from the National Science and Technology Development Agency and by the Thailand Research Fund ( BRG5780004 and IRG5780009). W. S. is supported by a Thai Royal Golden Jubilee Research Scholarship, J. J. is supported by a Thailand Graduate Institute of Science and Technology (TGIST) M. Sc. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0438; Agnello M, 2008, CYTOTECHNOLOGY, V56, P145, DOI 10.1007/s10616-008-9143-2; Chaisiripoomkere Watana, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P786; Cotter D, 2004, NUCLEIC ACIDS RES, V32, pD463, DOI 10.1093/nar/gkh048; Czarnecka AM, 2006, CANCER BIOL THER, V5, P714, DOI 10.4161/cbt.5.7.2975; Dong HJ, 2013, ELECTROPHORESIS, V34, P1957, DOI 10.1002/elps.201200557; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Fucharoen S, 1997, HEMOGLOBIN, V21, P299, DOI 10.3109/03630269709000664; Gobeill J, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat041; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Kholmukhamedov A, 2013, SHOCK, V39, P543, DOI 10.1097/SHK.0b013e318292300d; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Lithanatudom P, 2011, ANN HEMATOL, V90, P747, DOI 10.1007/s00277-010-1152-5; Mathias LA, 2000, EXP HEMATOL, V28, P1343, DOI 10.1016/S0301-472X(00)00555-5; Meisinger C, 2008, CELL, V134, P22, DOI 10.1016/j.cell.2008.06.043; Mortensen M, 2010, CELL CYCLE, V9, P1901, DOI 10.4161/cc.9.10.11603; NATHAN DG, 1966, AM J MED, V41, P815, DOI 10.1016/0002-9343(66)90039-8; Ney PA, 2011, CURR OPIN HEMATOL, V18, P152, DOI 10.1097/MOH.0b013e328345213e; Peng YT, 2015, APOPTOSIS, V20, P1135, DOI 10.1007/s10495-015-1143-z; Rampersad SN, 2012, SENSORS-BASEL, V12, P12347, DOI 10.3390/s120912347; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Wang JF, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104882, 10.1371/journal.pone.0094096]; Wannatung T, 2009, BRIT J HAEMATOL, V146, P557, DOI 10.1111/j.1365-2141.2009.07794.x; Weatherall DJ, 1998, BAILLIERE CLIN HAEM, V11, P127, DOI 10.1016/S0950-3536(98)80072-3; Wikan N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-96	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153831	10.1371/journal.pone.0153831	http://dx.doi.org/10.1371/journal.pone.0153831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092778	Green Published, gold			2022-12-27	WOS:000374541200047
J	Zhu, WY; Zhou, KY; Zha, Y; Chen, DD; He, JY; Ma, HJ; Liu, XG; Le, HB; Zhang, YK				Zhu, WangYu; Zhou, KaiYu; Zha, Yao; Chen, DongDong; He, JianYing; Ma, HaiJie; Liu, XiaoGuang; Le, HanBo; Zhang, YongKui			Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							NONINVASIVE BIOMARKERS; CIRCULATING MICRORNAS; PLASMA MICRORNAS; EXPRESSION; QUANTIFICATION; IDENTIFICATION; PROGNOSIS; MARKERS; FAMILY; BLOOD	Blood-circulating miRNAs could be useful as a biomarker to detect lung cancer early. We investigated the serum levels of four different miRNAs in patients with non-small cell lung cancer (NSCLC) and assessed their diagnostic value for NSCLC. Serum samples from 112 NSCLC patients and 104 controls (20 current smokers without lung cancer, 23 pneumonia patients, 21 gastric cancer patients, and 40 healthy controls) were subjected to Taqman probe-based quantitative reverse transcription-polymerase chain reaction (RT-PCR). The data showed that the serum levels of miR-182, miR-183, and miR-210 were significantly upregulated and that the miR-126 level was significantly downregulated in NSCLC patients, compared with the healthy controls. Further receiver operating characteristic (ROC) curve analysis revealed that the serum miR-182, miR-183, miR-210, or miR-126 level could serve as a diagnostic biomarker for NSCLC early detection, with a high sensitivity and specificity. The combination of these four miRNAs with carcinoembryonic antigen (CEA) further increased the diagnostic value, with an area under the curve (AUC) of 0.965 (sensitivity, 81.3%; specificity, 100.0%; and accuracy, 90.8%) using logistic regression model analysis. In addition, the relative levels of serum miR-182, miR-183, miR-210, and miR-126 could distinguish NSCLC or early-stage NSCLC from current tobacco smokers without lung cancer and pneumonia or gastric cancer patients with a high sensitivity and specificity. Data from the current study validated that the four serum miRNAs could serve as a tumor biomarker for NSCLC early diagnosis.	[Zhu, WangYu; Zhou, KaiYu; Zha, Yao; Chen, DongDong; He, JianYing; Ma, HaiJie; Liu, XiaoGuang] Wenzhou Med Univ, Lab Cytobiol & Mol Biol, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China; [Le, HanBo; Zhang, YongKui] Wenzhou Med Univ, Dept Cardiothorac Surg, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China; [Zhu, WangYu; Liu, XiaoGuang; Le, HanBo; Zhang, YongKui] Wenzhou Med Univ, Lung Canc Res Ctr, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Le, HB; Zhang, YK (corresponding author), Wenzhou Med Univ, Dept Cardiothorac Surg, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China.; Le, HB; Zhang, YK (corresponding author), Wenzhou Med Univ, Lung Canc Res Ctr, Zhoushan Hosp, Zhoushan 316021, Zhejiang, Peoples R China.	zslehanbo@163.com; zyk801801@126.com			Science and Technology Bureau of Zhoushan [2011C12039, 2011C12040]; Medical Bureau of Zhejiang Province [2015ZDA032, 2016143029]; Health Ministry-Medical Bureau of Zhejiang province [WKJ2014-2-021]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	Science and Technology Bureau of Zhoushan; Medical Bureau of Zhejiang Province; Health Ministry-Medical Bureau of Zhejiang province; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents	This research was supported in part by grants from the Science and Technology Bureau of Zhoushan (# 2011C12039, # 2011C12040) to YKZ and WYZ, the Medical Bureau of Zhejiang Province (# 2015ZDA032, # 2016143029) to HBL and WYZ, the Health Ministry-Medical Bureau of Zhejiang province (# WKJ2014-2-021) to YKZ, and the Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents to XGL. These funding agencies did not have any roles in the study design, data collection, data analysis, decision to publish, or preparation of the manuscript.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Aberle DR, 2013, NEW ENGL J MED, V369, P920, DOI 10.1056/NEJMoa1208962; Ajani JA, 2013, J NATL COMPR CANC NE, V11, P531, DOI 10.6004/jnccn.2013.0070; Asamura Hisao, 2008, J Thorac Oncol, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Balgkouranidou I, 2014, BRIT J CANCER, V110, P2054, DOI 10.1038/bjc.2014.104; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chen L, 2015, TUMOR BIOL, V36, P7439, DOI 10.1007/s13277-015-3430-2; Chen X, 2012, INT J CANCER, V130, P1620, DOI 10.1002/ijc.26177; Sebastien S, 2014, CLIN CANCER RES, V20, P4613, DOI 10.1158/1078-0432.CCR-13-3063; Crawford M, 2008, BIOCHEM BIOPH RES CO, V373, P607, DOI 10.1016/j.bbrc.2008.06.090; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Donnem T, 2011, CANCER-AM CANCER SOC, V117, P3193, DOI 10.1002/cncr.25907; Eilertsen M, 2014, LUNG CANCER, V83, P272, DOI 10.1016/j.lungcan.2013.11.005; Ettinger DS, 2014, J NATL COMPR CANC NE, V12, P1738, DOI 10.6004/jnccn.2014.0176; Fedorko M, 2015, INT J MOL SCI, V16, P23382, DOI 10.3390/ijms161023382; Han HS, 2013, INT J CANCER, V133, P645, DOI 10.1002/ijc.28054; Heegaard NHH, 2012, INT J CANCER, V130, P1378, DOI 10.1002/ijc.26153; Hu J, 2014, INT J CANCER, V135, P1187, DOI 10.1002/ijc.28757; Huang X, 2010, TRENDS MOL MED, V16, P230, DOI 10.1016/j.molmed.2010.03.004; Jusufovic E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045577; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Le HB, 2012, MED ONCOL, V29, P3190, DOI 10.1007/s12032-012-0303-z; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Li Q, 2015, BIOMED REP, V3, P792, DOI 10.3892/br.2015.524; Lin QF, 2012, J CANCER RES CLIN, V138, P85, DOI 10.1007/s00432-011-1068-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markou A, 2013, LUNG CANCER, V81, P388, DOI 10.1016/j.lungcan.2013.05.007; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Roa WH, 2012, CLIN INVEST MED, V35, pE271, DOI 10.25011/cim.v35i5.18700; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shen J, 2011, LAB INVEST, V91, P579, DOI 10.1038/labinvest.2010.194; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Tang DF, 2013, EUR J CANCER PREV, V22, P540, DOI 10.1097/CEJ.0b013e32835f3be9; Tang Xiaoqiong, 2015, Med Sci Monit, V21, P3427; Tomasetti M, 2012, CLIN BIOCHEM, V45, P575, DOI 10.1016/j.clinbiochem.2012.02.009; Wang P, 2015, CLIN LUNG CANCER, V16, P313, DOI 10.1016/j.cllc.2014.12.006; Wang PY, 2013, ONCOL LETT, V6, P1681, DOI 10.3892/ol.2013.1593; Wang Y, 2015, NEOPLASMA, V62, P798, DOI 10.4149/neo_2015_096; Weeraratne SD, 2012, ACTA NEUROPATHOL, V123, P539, DOI 10.1007/s00401-012-0969-5; Yang YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135168; Zhang CX, 2015, INT J CLIN EXP PATHO, V8, P655; Zhang QH, 2013, GENE, V527, P26, DOI 10.1016/j.gene.2013.06.006; Zheng DL, 2011, INT J CLIN EXP PATHO, V4, P575; Zheng G WH, 2013, PLOS ONE, V8; Zhu WY, 2014, CANCER INVEST, V32, P394, DOI 10.3109/07357907.2014.922569; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087780; Zhu WY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-393	47	92	94	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153046	10.1371/journal.pone.0153046	http://dx.doi.org/10.1371/journal.pone.0153046			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093275	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200011
J	Nakano, T; Kamei, R; Fujimura, T; Takaoka, Y; Hori, A; Lai, CY; Chiang, KC; Shimada, Y; Ohmori, N; Goto, T; Ono, K; Chen, CL; Goto, S; Kawamoto, S				Nakano, Toshiaki; Kamei, Rikiya; Fujimura, Takashi; Takaoka, Yuki; Hori, Ayane; Lai, Chia-Yun; Chiang, Kuei-Chen; Shimada, Yayoi; Ohmori, Naoya; Goto, Takeshi; Ono, Kazuhisa; Chen, Chao-Long; Goto, Shigeru; Kawamoto, Seiji			Impact of Histone H1 on the Progression of Allergic Rhinitis and Its Suppression by Neutralizing Antibody in Mice	PLOS ONE			English	Article							GROUP BOX-1 PROTEIN; CELLS; HMGB1; AUTOANTIBODIES; INHIBITION; EXPRESSION; REJECTION; ALLOGRAFT; THERAPY; VACCINE	Nuclear antigens are known to trigger off innate and adaptive immune responses. Recent studies have found that the complex of nucleic acids and core histones that are derived from damaged cells may regulate allergic responses. However, no fundamental study has been performed concerning the role of linker histone H1 in mast cell-mediated type I hyperreactivity. In this study, we explored the impact of histone H1 on mast cell-mediated allergic responses both in vitro and in vivo. In the course of a bona-fide experimental allergen sensitization model upon co-injection with alum adjuvant, ovalbumin (OVA), but not PBS, induced elevated levels of circulating histone H1. Intranasal challenge with histone H1 to OVA/alum-(but not PBS/alum)-sensitized mice induced significantly severer symptoms of allergic rhinitis than those in mice sensitized and challenged with OVA. A monoclonal antibody against histone H1 not only suppressed mast cell degranulation, but also ameliorated OVA-induced nasal hyperreactivity and IgE-mediated passive cutaneous anaphylaxis. Our present data suggest that nuclear histone H1 represents an alarmin-like endogenous mediator acting on mast cells, and that its blockage has a therapeutic potential for mast cellmediated type I hyperreactivity.	[Nakano, Toshiaki] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan; [Nakano, Toshiaki; Takaoka, Yuki; Lai, Chia-Yun; Chen, Chao-Long; Goto, Shigeru] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Liver Transplantat Ctr, Kaohsiung, Taiwan; [Nakano, Toshiaki; Takaoka, Yuki; Lai, Chia-Yun; Chen, Chao-Long; Goto, Shigeru] Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Div Transplant Immunol, Kaohsiung, Taiwan; [Kamei, Rikiya; Fujimura, Takashi; Hori, Ayane; Ono, Kazuhisa; Kawamoto, Seiji] Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan; [Takaoka, Yuki] Hiroshima Univ, Ctr Gene Sci, Higashihiroshima 724, Japan; [Chiang, Kuei-Chen; Shimada, Yayoi; Ohmori, Naoya; Goto, Takeshi] Josai Int Univ, Kazusa Inst Drug Discovery, Kisarazu, Japan; [Ohmori, Naoya; Goto, Takeshi; Goto, Shigeru] Josai Int Univ, Fac Nursing, Dept Nursing, Basic Med Sci Nursing, Togane, Japan; [Ono, Kazuhisa] Hiroshima Inst Technol, Dept Food Sci & Biotechnol, Fac Life Sci, Hiroshima, Japan; [Goto, Shigeru] Fukuoka Inst Occupat Hlth, Fukuoka, Japan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Hiroshima University; Hiroshima University; Hiroshima Institute of Technology	Nakano, T (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Kaohsiung, Taiwan.; Nakano, T (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Liver Transplantat Ctr, Kaohsiung, Taiwan.; Nakano, T (corresponding author), Kaohsiung Chang Gung Mem Hosp, Inst Translat Res Biomed, Div Transplant Immunol, Kaohsiung, Taiwan.; Kawamoto, S (corresponding author), Hiroshima Univ, Dept Mol Biotechnol, Grad Sch Adv Sci Matter, Higashihiroshima 724, Japan.	toshi.nakano@msa.hinet.net; skawa@hiroshima-u.ac.jp	Kawamoto, Seiji/F-3423-2015; Goto, Takeshi/GZL-7972-2022; Fujimura, Takashi/V-5310-2017	Kawamoto, Seiji/0000-0002-2056-4802; Fujimura, Takashi/0000-0001-7442-5974; Nakano, Toshiaki/0000-0003-3701-3449	Ministry of Science and Technology [NSC101-2320-B-182-037-MY3, MOST104-2320-B-182-030]; Chang Gung Memorial Hospital [CMRPD8C0561, CMRPD8D1381]; Japan Society for the Promotion of Science [G2404]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Ministry of Science and Technology (NSC101-2320-B-182-037-MY3 and MOST104-2320-B-182-030 to T.N.), Chang Gung Memorial Hospital (CMRPD8C0561 and CMRPD8D1381 to T.N.), and Japan Society for the Promotion of Science (Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation: G2404 to S.K. and K.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LC, 2007, J ALLERGY CLIN IMMUN, V120, P462, DOI 10.1016/j.jaci.2007.04.019; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Bellussi LM, 2013, J BIOL REG HOMEOS AG, V27, P791; Chiang KC, 2009, J IMMUNOL, V182, P4282, DOI 10.4049/jimmunol.0800641; Gong QA, 2010, J MOL MED, V88, P1289, DOI 10.1007/s00109-010-0681-7; Guibas GV, 2014, EXP TOXICOL PATHOL, V66, P469, DOI 10.1016/j.etp.2014.09.001; Hatada T, 2005, THROMB HAEMOSTASIS, V94, P975, DOI 10.1160/TH05-05-0316; Hong SM, 2013, AM J RHINOL ALLERGY, V27, P278, DOI 10.2500/ajra.2013.27.3909; Hsu LW, 2008, CLIN EXP IMMUNOL, V152, P576, DOI 10.1111/j.1365-2249.2008.03652.x; Hsu LW, 2012, J CELL PHYSIOL, V227, P3417, DOI 10.1002/jcp.24042; Hsu LW, 2005, MOL IMMUNOL, V42, P1155, DOI 10.1016/j.molimm.2004.11.010; Imanishi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4566; Kusano T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/491649; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Mishra B, 2010, J NEUROSCI, V30, P12400, DOI 10.1523/JNEUROSCI.6407-09.2010; Miyahara S, 2005, J ALLERGY CLIN IMMUN, V116, P1020, DOI 10.1016/j.jaci.2005.08.020; Monticelli LA, 2012, CURR OPIN IMMUNOL, V24, P284, DOI 10.1016/j.coi.2012.03.012; Nakano T, 2006, TRANSPLANT P, V38, P3605, DOI 10.1016/j.transproceed.2006.10.076; Nakano T, 2005, TRANSPL P, V37, P80, DOI 10.1016/j.transproceed.2004.12.290; Nakano T, 2004, TRANSPLANTATION, V77, P1595, DOI 10.1097/01.tp.0000123079.10650.71; Nakano T, 2008, TRANSPL IMMUNOL, V19, P87, DOI 10.1016/j.trim.2008.04.001; Nakano T, 2007, TRANSPL IMMUNOL, V17, P147, DOI 10.1016/j.trim.2007.01.003; Nakano T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/413928; Nakano T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/267156; Nakano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037202; Nakano T, 2010, IMMUNOLOGY, V129, P547, DOI 10.1111/j.1365-2567.2009.03149.x; Okuma Y, 2012, ANN NEUROL, V72, P373, DOI 10.1002/ana.23602; Onishi N, 2007, BIOSCI BIOTECH BIOCH, V71, P2551, DOI 10.1271/bbb.70378; Pawankar R, 2005, CHEM IMMUNOL ALLERGY, V87, P111, DOI 10.1159/000087639; Salpietro C, 2013, INT ARCH ALLERGY IMM, V161, P116, DOI 10.1159/000345246; Shang GH, 2009, RESP MED, V103, P1949, DOI 10.1016/j.rmed.2009.05.019; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Wang HC, 2009, SHOCK, V32, P348, DOI 10.1097/SHK.0b013e3181a551bd; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Zhang K, 2004, J ALLERGY CLIN IMMUN, V114, P321, DOI 10.1016/j.jaci.2004.03.058; Zou H, 2014, AM J TRANSPLANT, V14, P1765, DOI 10.1111/ajt.12781	40	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153630	10.1371/journal.pone.0153630	http://dx.doi.org/10.1371/journal.pone.0153630			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088594	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000031
J	Bettinazzi, S; Plazzi, F; Passamonti, M				Bettinazzi, Stefano; Plazzi, Federico; Passamonti, Marco			The Complete Female- and Male-Transmitted Mitochondrial Genome of Meretrix lamarckii	PLOS ONE			English	Article							DOUBLY UNIPARENTAL INHERITANCE; WATER MUSSELS BIVALVIA; TRANSFER-RNA GENES; OXIDASE-II GENE; TRANSMEMBRANE TOPOLOGY; DNA TRANSMISSION; ROLE-REVERSALS; CONTROL REGION; TRNASCAN-SE; BLUE MUSSEL	Bivalve mitochondrial genomes show many uncommon features, like additional genes, high rates of gene rearrangement, high A-T content. Moreover, Doubly Uniparental Inheritance (DUI) is a distinctive inheritance mechanism allowing some bivalves to maintain and transmit two separate sex-linked mitochondrial genomes. Many bivalve mitochondrial features, such as gene extensions or additional ORFs, have been proposed to be related to DUI but, up to now, this topic is far from being understood. Several species are known to show this unusual organelle inheritance but, being widespread only among Unionidae and Mytilidae, DUI distribution is unclear. We sequenced and characterized the complete female- (F) and male-transmitted (M) mitochondrial genomes of Meretrix lamarckii, which, in fact, is the second species of the family Veneridae where DUI has been demonstrated so far. The two mitochondrial genomes are comparable in length and show roughly the same gene content and order, except for three additional tRNAs found in the M one. The two sex-linked genomes show an average nucleotide divergence of 16%. A 100-aminoacid insertion in M. lamarckii M-cox2 gene was found; moreover, additional ORFs have been found in both F and M Long Unassigned Regions of M. lamarckii. Even if no direct involvement in DUI process has been demonstrated so far, the finding of cox2 insertions and supernumerary ORFs in M. lamarckii both strengthens this hypothesis and widens the taxonomical distribution of such unusual features. Finally, the analysis of inter-sex genetic variability shows that DUI species form two separate clusters, namely Unionidae and Mytilidae+Veneridae; this dichotomy is probably due to different DUI regimes acting on separate taxa.	[Bettinazzi, Stefano; Plazzi, Federico; Passamonti, Marco] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Bologna, Italy	University of Bologna	Plazzi, F (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Bologna, Italy.	federico.plazzi@unibo.it		Plazzi, Federico/0000-0001-5920-7557; Bettinazzi, Stefano/0000-0002-1129-0678				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arunkumar KP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000110; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Boyle EE, 2013, MAR BIOL, V160, P413, DOI 10.1007/s00227-012-2099-y; Breton S, 2007, TRENDS GENET, V23, P465, DOI 10.1016/j.tig.2007.05.011; Breton S, 2011, MOL BIOL EVOL, V28, P1645, DOI 10.1093/molbev/msq345; Breton S, 2010, MAR GENOM, V3, P11, DOI 10.1016/j.margen.2010.01.001; Breton S, 2009, GENETICS, V183, P1575, DOI 10.1534/genetics.109.110700; Cao LQ, 2004, GENETICS, V167, P835, DOI 10.1534/genetics.103.026187; Chakrabarti R, 2007, FEBS LETT, V581, P5213, DOI 10.1016/j.febslet.2007.10.006; Chapman EG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-165; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Curole JP, 2002, MOL BIOL EVOL, V19, P1323, DOI 10.1093/oxfordjournals.molbev.a004193; Curole JP, 2005, J MOL EVOL, V61, P381, DOI 10.1007/s00239-004-0192-7; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Degletagne C, 2016, MOL BIOL EVOL, V33, P375, DOI 10.1093/molbev/msv224; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diz AP, 2013, MOL CELL PROTEOMICS, V12, P3068, DOI 10.1074/mcp.M113.031401; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; Doucet-Beaupre H, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-50; Dreyer Hermann, 2006, Front Zool, V3, P13, DOI 10.1186/1742-9994-3-13; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faith JJ, 2003, GENETICS, V165, P735; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Fischer D, 1999, BIOINFORMATICS, V15, P759, DOI 10.1093/bioinformatics/15.9.759; Fonseca MM, 2008, MOL BIOL EVOL, V25, P805, DOI 10.1093/molbev/msn050; Fonseca MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106654; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; GAREY JR, 1989, J MOL EVOL, V28, P374, DOI 10.1007/BF02603072; Ghiselli F, 2013, GENOME BIOL EVOL, V5, P1535, DOI 10.1093/gbe/evt112; Ghiselli F, 2012, MOL BIOL EVOL, V29, P771, DOI 10.1093/molbev/msr248; Ghiselli F, 2011, MOL BIOL EVOL, V28, P949, DOI 10.1093/molbev/msq271; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Guerra D, 2014, GENE, V536, P316, DOI 10.1016/j.gene.2013.12.005; Hanada T, 2001, GENES CELLS, V6, P1019, DOI 10.1046/j.1365-2443.2001.00491.x; Hoeh WR, 2002, EVOLUTION, V56, P2252; Hoeh WR, 1997, MOL BIOL EVOL, V14, P959, DOI 10.1093/oxfordjournals.molbev.a025839; HOFFMANN RJ, 1992, GENETICS, V131, P397; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; JIN L, 1990, MOL BIOL EVOL, V7, P82; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kappner I, 2006, MOL PHYLOGENET EVOL, V40, P317, DOI 10.1016/j.ympev.2006.02.006; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kimura M., 1983, NEUTRAL THEORY MOL E, DOI [10.1017/CBO9780511623486, DOI 10.1017/CBO9780511623486]; Kosiol C, 2005, MOL BIOL EVOL, V22, P193, DOI 10.1093/molbev/msi005; Kyriakou E, 2014, GENE, V546, P448, DOI 10.1016/j.gene.2014.06.031; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LIS JT, 1975, NUCLEIC ACIDS RES, V2, P383, DOI 10.1093/nar/2.3.383; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Milani L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137468; Milani L, 2014, CURR GENET, V60, P163, DOI 10.1007/s00294-014-0420-7; Milani L, 2014, GENOME BIOL EVOL, V6, P391, DOI 10.1093/gbe/evu021; Milani L, 2013, J EXP ZOOL PART B, V320, P442, DOI 10.1002/jez.b.22520; Milani L, 2012, J EXP ZOOL PART B, V318B, P182, DOI 10.1002/jez.b.22004; Milbury CA, 2005, MAR BIOTECHNOL, V7, P697, DOI 10.1007/s10126-005-0004-0; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Passamonti M, 2001, CURR GENET, V39, P117, DOI 10.1007/s002940100188; Passamonti M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-442; Passamonti M, 2009, DNA CELL BIOL, V28, P79, DOI 10.1089/dna.2008.0807; Plazzi F, 2015, J ZOOL SYST EVOL RES, V53, P205, DOI 10.1111/jzs.12097; Plazzi F, 2015, J ZOOL SYST EVOL RES, V53, P87, DOI 10.1111/jzs.12078; Plazzi F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-409; Plazzi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027147; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Qi Z., 2004, SEASHELLS CHINA, P306; Quesada H, 1999, MOL BIOL EVOL, V16, P655, DOI 10.1093/oxfordjournals.molbev.a026148; R Core Team, 2021, R LANGUAGE ENV STAT; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodakis GC, 2007, J MOL EVOL, V65, P124, DOI 10.1007/s00239-005-0298-6; Rozen S, 2000, Methods Mol Biol, V132, P365; Saccone C, 2002, GENE, V286, P3, DOI 10.1016/S0378-1119(01)00807-1; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; Saunier A, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0259-z; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Seligmann H, 2006, J THEOR BIOL, V241, P321, DOI 10.1016/j.jtbi.2005.11.035; SKIBINSKI DOF, 1994, NATURE, V368, P817, DOI 10.1038/368817b0; SKIBINSKI DOF, 1994, GENETICS, V138, P801; Smietanka B, 2010, J MOL EVOL, V71, P385, DOI 10.1007/s00239-010-9393-4; Smith SA, 2008, BIOINFORMATICS, V24, P715, DOI 10.1093/bioinformatics/btm619; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun SE, 2015, GENE, V557, P61, DOI 10.1016/j.gene.2014.12.011; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusov T, ORF FINDER; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Theologidis I, 2008, EVOLUTION, V62, P959, DOI 10.1111/j.1558-5646.2008.00329.x; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wang HX, 2011, MAR GENOM, V4, P263, DOI 10.1016/j.margen.2011.06.006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu KF, 2011, MOL BIOL REP, V38, P3067, DOI 10.1007/s11033-010-9974-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zhuang Q., 2001, FAUNA SINICA PHYLLUM, P229; ZOUROS E, 1994, P NATL ACAD SCI USA, V91, P7463, DOI 10.1073/pnas.91.16.7463; ZOUROS E, 1994, NATURE, V368, P818, DOI 10.1038/368818a0; Zouros E, 2013, EVOL BIOL, V40, P1, DOI 10.1007/s11692-012-9195-2; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	111	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153631	10.1371/journal.pone.0153631	http://dx.doi.org/10.1371/journal.pone.0153631			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27083010	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800035
J	Smit, J; Thomsen, RW; Schonheyder, HC; Nielsen, H; Froslev, T; Sogaard, M				Smit, Jesper; Thomsen, Reimar Wernich; Schonheyder, Henrik Carl; Nielsen, Henrik; Froslev, Trine; Sogaard, Mette			Outcome of Community-Acquired Staphylococcus aureus Bacteraemia in Patients with Diabetes: A Historical Population-Based Cohort Study	PLOS ONE			English	Article							MORTALITY; COMORBIDITY; PREVALENCE; PREDICTORS; MANAGEMENT; RISK	Background Patients with diabetes (DM) experience increased risk of Staphylococcus aureus bacteraemia (SAB), but the prognostic impact of diabetes in patients with SAB remain unclear. Therefore, we investigated 30-day all-cause mortality in patients with and without DM. Methods Population-based medical databases were used to conduct a cohort study of all adult patients with community-acquired SAB in Northern Denmark, 2000-2011. Using Cox proportional hazards regression, we computed hazard ratios as estimates of 30-day mortality rate ratios (MRRs) among patients with and without DM. We further investigated whether the prognostic impact of DM differed among patients with and without recent preadmission healthcare contacts (within 30 days of the current hospitalization) and by age, sex, marital status, level of comorbidity, and DM-related characteristics (e.g., duration of DM and presence of DM complications). Results Among 2638 SAB patients, 713 (27.0%) had DM. Thirty-day cumulative mortality was 25.8% in patients with DM and 24.3% in patients without DM, for an adjusted MRR (aMRR) of 1.01 (95% confidence interval (CI), 0.84-1.20). In analyses with and without recent healthcare contacts, the corresponding aMRRs were 0.84 (95% CI, 0.62-1.14) and 1.13 (95% CI, 0.91-1.41), respectively. Compared to patients without DM, the aMRR was 0.94 (95% CI, 0.74-1.20) for male patients with DM and 1.13 (95% CI, 0.87-1.47) for female patients with DM. The prognostic influence of DM on mortality did not differ notably with age, level of comorbidity, or characteristics of patients with DM. Conclusion Patients with DM and community-acquired SAB did not experience higher 30-day mortality than patients without DM.	[Smit, Jesper; Schonheyder, Henrik Carl] Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark; [Smit, Jesper; Nielsen, Henrik] Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark; [Smit, Jesper; Thomsen, Reimar Wernich; Froslev, Trine; Sogaard, Mette] Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark; [Schonheyder, Henrik Carl; Nielsen, Henrik] Aalborg Univ, Dept Clin Med, Aalborg, Denmark	Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University	Smit, J (corresponding author), Aalborg Univ Hosp, Dept Clin Microbiol, Aalborg, Denmark.; Smit, J (corresponding author), Aalborg Univ Hosp, Dept Infect Dis, Aalborg, Denmark.; Smit, J (corresponding author), Aalborg Univ Hosp, Dept Clin Epidemiol, Aalborg, Denmark.	jesm@rn.dk		Thomsen, Reimar/0000-0001-9135-3474; Sogaard, Mette/0000-0002-2830-4968	Heinrich Kopp Foundation; Hertha Christensen Foundation; North Denmark Health Sciences Research Foundation; Danish Agency for Science [09-067009, 09-075724]; Danish Health and Medicines Authority; Danish Diabetes Association	Heinrich Kopp Foundation; Hertha Christensen Foundation; North Denmark Health Sciences Research Foundation; Danish Agency for Science; Danish Health and Medicines Authority; Danish Diabetes Association	This study was supported by research grants from The Heinrich Kopp, Hertha Christensen, and North Denmark Health Sciences Research Foundations. The Department of Clinical Epidemiology is a member of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2), supported by the Danish Agency for Science (grant nos. 09-067009 and 09-075724). DD2 is also supported by the Danish Health and Medicines Authority, the Danish Diabetes Association, and an unrestricted donation from Novo Nordisk A/S. Partners in the DD2 project are listed on the project website at www.DD2.nu. The sponsors did not have a role in any phase of the study conduct.	CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Grann Anne Fia, 2011, Clin Epidemiol, V3, P133, DOI 10.2147/CLEP.S17901; Hill PC, 2001, INTERN MED J, V31, P97, DOI 10.1111/j.1444-0903.2001.00029.x; Kaasch AJ, 2014, J INFECTION, V68, P242, DOI 10.1016/j.jinf.2013.10.015; Kaech C, 2006, CLIN MICROBIOL INFEC, V12, P345, DOI 10.1111/j.1469-0691.2005.01359.x; Kanafani ZA, 2009, EUR J CLIN MICROBIOL, V28, P1477, DOI 10.1007/s10096-009-0808-3; Kern WV, 2010, CURR OPIN INFECT DIS, V23, P346, DOI 10.1097/QCO.0b013e32833bcc8a; Koch K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070082; Laupland KB, 2003, J INFECT DIS, V187, P1452, DOI 10.1086/374621; LEIBOVICI L, 1991, DIABETES CARE, V14, P89, DOI 10.2337/diacare.14.2.89; Lenz R, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-85; Lesens O, 2003, INFECT CONT HOSP EP, V24, P890, DOI 10.1086/502156; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lopez-Cortes LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082958; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Mejer N, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-260; Mylotte JM, 2000, CLIN INFECT DIS, V31, P1170, DOI 10.1086/317421; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shorr AF, 2006, CRIT CARE MED, V34, P2588, DOI 10.1097/01.CCM.0000239121.09533.09; Smit J, 2016, INFECT CONT HOSP EP, V37, P208, DOI 10.1017/ice.2015.259; Sogaard M, 2011, EPIDEMIOL INFECT, V139, P772, DOI 10.1017/S095026881000169X; Thomsen RW, 2004, DIABETES CARE, V27, P70, DOI 10.2337/diacare.27.1.70; Thomsen RW, 2012, OPEN INFECT DIS J S1, V6, P27, DOI DOI 10.2174/1874279301206010027; Thwaites GE, 2011, LANCET INFECT DIS, V11, P208, DOI 10.1016/S1473-3099(10)70285-1; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Valles J, 2008, J INFECTION, V56, P27, DOI 10.1016/j.jinf.2007.10.001; van Hal SJ, 2012, CLIN MICROBIOL REV, V25, P362, DOI 10.1128/CMR.05022-11; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wiese L, 2013, J INFECTION, V67, P199, DOI 10.1016/j.jinf.2013.04.018	33	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153766	10.1371/journal.pone.0153766	http://dx.doi.org/10.1371/journal.pone.0153766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082873	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800051
J	Theriault, G; Michael, P; Nkongolo, K				Theriault, Gabriel; Michael, Paul; Nkongolo, Kabwe			Comprehensive Transcriptome Analysis of Response to Nickel Stress in White Birch (Betula papyrifera)	PLOS ONE			English	Article							METAL; POPULATIONS; GLUTATHIONE; TOLERANCE; REGION; ENZYME; MECHANISMS; TOXICITY; CADMIUM; SUDBURY	White birch (Betula papyrifera) is a dominant tree species of the Boreal Forest. Recent studies have shown that it is fairly resistant to heavy metal contamination, specifically to nickel. Knowledge of regulation of genes associated with metal resistance in higher plants is very sketchy. Availability and annotation of the dwarf birch (B. nana) enables the use of high throughout sequencing approaches to understanding responses to environmental challenges in other Betula species such as B. papyrifera. The main objectives of this study are to 1) develop and characterize the B. papyrifera transcriptome, 2) assess gene expression dynamics of B. papyrifera in response to nickel stress, and 3) describe gene function based on ontology. Nickel resistant and susceptible genotypes were selected and used for transcriptome analysis. A total of 208,058 trinity genes were identified and were assembled to 275,545 total trinity transcripts. The transcripts were mapped to protein sequences and based on best match; we annotated the B. papyrifera genes and assigned gene ontology. In total, 215,700 transcripts were annotated and were compared to the published B. nana genome. Overall, a genomic match for 61% transcripts with the reference genome was found. Expression profiles were generated and 62,587 genes were found to be significantly differentially expressed among the nickel resistant, susceptible, and untreated libraries. The main nickel resistance mechanism in B. papyrifera is a downregulation of genes associated with translation (in ribosome), binding, and transporter activities. Five candidate genes associated to nickel resistance were identified. They include Glutathione S-transferase, thioredoxin family protein, putative transmembrane protein and two Nramp transporters. These genes could be useful for genetic engineering of birch trees.	[Theriault, Gabriel; Michael, Paul; Nkongolo, Kabwe] Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada; [Nkongolo, Kabwe] Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada	Laurentian University; Laurentian University	Nkongolo, K (corresponding author), Laurentian Univ, Biomol Sci Program, Sudbury, ON P3E 2C6, Canada.; Nkongolo, K (corresponding author), Laurentian Univ, Dept Biol, Sudbury, ON P3E 2C6, Canada.	knkongolo@laurentian.ca			Natural Sciences and Engineering Council of Canada (NSERC)	Natural Sciences and Engineering Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Natural Sciences and Engineering Council of Canada (NSERC).	AMIRO BD, 1981, CAN J BOT, V59, P1623, DOI 10.1139/b81-221; Barghini E, 2015, GENOM DATA, V3, P143, DOI 10.1016/j.gdata.2015.01.004; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Dixon David P, 2010, Arabidopsis Book, V8, pe0131, DOI 10.1199/tab.0131; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; FREEDMAN B, 1980, CAN J BOT, V58, P2123, DOI 10.1139/b80-245; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Gajewska E, 2008, PLANT GROWTH REGUL, V54, P179, DOI 10.1007/s10725-007-9240-9; Gajewska E, 2007, BIOMETALS, V20, P27, DOI 10.1007/s10534-006-9011-5; Halimaa P, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00213; Hossain MA, 2012, J BOT; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Iannelli MA, 2002, PLANT PHYSIOL BIOCH, V40, P977, DOI 10.1016/S0981-9428(02)01455-9; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; Kalubi KN, 2015, ECOTOXICOLOGY, V24, P636, DOI 10.1007/s10646-014-1411-7; Kirkey FM, 2012, ENVIRON POLLUT, V164, P53, DOI 10.1016/j.envpol.2012.01.012; Kramer U, 2007, FEBS LETT, V581, P2263, DOI 10.1016/j.febslet.2007.04.010; Lemaire S, 1999, PLANT PHYSIOL, V120, P773, DOI 10.1104/pp.120.3.773; Mehes-Smith M, 2015, WATER AIR SOIL POLL, V226, DOI 10.1007/s11270-015-2382-x; Merlot S, 2014, J EXP BOT, V65, P1551, DOI 10.1093/jxb/eru025; Mizuno T, 2005, PLANT PHYSIOL BIOCH, V43, P793, DOI 10.1016/j.plaphy.2005.07.006; Molas J., 2001, Plant nutrition: food security and sustainability of agro-ecosystems through basic and applied research. Fourteenth International Plant Nutrition Colloquium, Hannover, Germany, P464; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; PANDOLFINI T, 1992, PLANT CELL ENVIRON, V15, P719, DOI 10.1111/j.1365-3040.1992.tb01014.x; PERALA DA, 1990, FOREST ECOL MANAG, V32, P1, DOI 10.1016/0378-1127(90)90104-J; Schickler H, 1999, PHYSIOL PLANTARUM, V105, P39, DOI 10.1034/j.1399-3054.1999.105107.x; Seregin IV, 2006, RUSS J PLANT PHYSL+, V53, P257, DOI 10.1134/S1021443706020178; Sevilla F, 2015, J EXP BOT; Skorzynska-Polit E, 2003, BIOL PLANTARUM, V47, P71, DOI 10.1023/A:1027332915500; Theriault G, 2015, P SUDB MIN ENV INT C; Theriault G, 2014, ECOL EVOL, V4, P3435, DOI 10.1002/ece3.1195; VANASSCHE F, 1990, PLANT CELL ENVIRON, V13, P195, DOI 10.1111/j.1365-3040.1990.tb01304.x; Wang N, 2013, MOL ECOL, V22, P3098, DOI 10.1111/mec.12131; Wei W, 2009, MOL BIOTECHNOL, V41, P15, DOI 10.1007/s12033-008-9088-x; Williams LE, 2000, BBA-BIOMEMBRANES, V1465, P104, DOI 10.1016/S0005-2736(00)00133-4; Winterhalder Keith, 1996, Environmental Reviews, V4, P185, DOI 10.1139/a96-011; Yan R, 2008, PLANT SOIL ENVIRON, V54, P294, DOI 10.17221/423-PSE	38	16	16	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153762	10.1371/journal.pone.0153762	http://dx.doi.org/10.1371/journal.pone.0153762			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082755	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800050
J	Felker, A; Nieuwenhuize, S; Dolbois, A; Blazkova, K; Hess, C; Low, LWL; Burger, S; Samson, N; Carney, TJ; Bartunek, P; Nevado, C; Mosimann, C				Felker, Anastasia; Nieuwenhuize, Susan; Dolbois, Aymeric; Blazkova, Kristyna; Hess, Christopher; Low, Larry W. L.; Burger, Sibylle; Samson, Natasha; Carney, Tom J.; Bartunek, Petr; Nevado, Cristina; Mosimann, Christian			In Vivo Performance and Properties of Tamoxifen Metabolites for CreERT2 Control	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; BREAST-CANCER-CELLS; ZEBRAFISH; ISOMERS; HYDROXYTAMOXIFEN; ANTIESTROGEN	Mutant Estrogen Receptor (ERT2) ligand-binding domain fusions with Cre recombinase are a key tool for spatio-temporally controlled genetic recombination with the Cre/lox system. CreERT2 is efficiently activated in a concentration-dependent manner by the Tamoxifen metabolite trans-4-OH-Tamoxifen (trans-4-OHT). Reproducible and efficient Cre/lox experimentation is hindered by the gradual loss of CreERT2 induction potency upon prolonged storage of dissolved trans-4-OHT, which potentially results from gradual trans-to-cis isomerization or degradation. Here, we combined zebrafish CreERT2 recombination experiments and cell culture assays to document the gradual activity loss of trans-4-OHT and describe the alternative Tamoxifen metabolite Endoxifen as more stable alternative compound. Endoxifen retains potent activation upon prolonged storage (3 months), yet consistently induces half the ERT2 domain fusion activity compared to fresh trans-4-OHT. Using H-1-NMR analysis, we reveal that trans-4-OHT isomerization is undetectable upon prolonged storage in either DMSO or Ethanol, ruling out isomer transformation as cause for the gradual loss of trans-4-OHT activity. We further establish that both trans-4-OHT and Endoxifen are insensitive to light exposure under regular laboratory handling conditions. We attribute the gradual loss of trans-4-OHT potency to precipitation over time, and show that heating of aged trans-4-OHT aliquots reinstates their CreERT2 induction potential. Our data establish Endoxifen as potent and reproducible complementary compound to 4-OHT to control ERT2 domain fusion proteins in vivo, and provide a framework for efficient chemically controlled recombination experiments.	[Felker, Anastasia; Nieuwenhuize, Susan; Hess, Christopher; Burger, Sibylle; Samson, Natasha; Mosimann, Christian] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Dolbois, Aymeric; Nevado, Cristina] Univ Zurich, Dept Chem, Zurich, Switzerland; [Blazkova, Kristyna; Bartunek, Petr] ASCR, Inst Mol Genet, CZ OPENSCREEN, Vvi, Prague, Czech Republic; [Low, Larry W. L.; Carney, Tom J.] ASTAR, Inst Mol & Cell Biol IMCB, Biopolis Dr, Singapore, Singapore; [Carney, Tom J.] Nanyang Technol Univ, Lee Kong Chian Sch Med, 50 Nanyang Ave, Singapore 639798, Singapore	University of Zurich; University of Zurich; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mosimann, C (corresponding author), Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland.	christian.mosimann@imls.uzh.ch	Nevado, Cristina/AAV-5962-2020; Blažková, Kristýna/S-4587-2017; Carney, Tom J/H-4389-2011; Bartunek, Petr/J-3897-2014	Blažková, Kristýna/0000-0002-7146-5177; Carney, Tom J/0000-0003-2371-1924; Bartunek, Petr/0000-0002-6202-7650; Mosimann, Christian/0000-0002-0749-2576	Canton of Zurich; Swiss National Science Foundation; Marie Curie CIG; Ministry of Education, Youth and Sports of the Czech Republic [LO1220]; Swiss National Science Foundation [00020_157083]	Canton of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie CIG; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work is supported by the Canton of Zurich, a Swiss National Science Foundation Professorship and Marie Curie CIG to C. M.; Ministry of Education, Youth and Sports of the Czech Republic (LO1220) to P. B.; and Swiss National Science Foundation grant 00020_157083 to A. D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess A, 2010, P NATL ACAD SCI USA, V107, P12564, DOI 10.1073/pnas.0914191107; Dickschen K, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-285; Fauq AH, 2010, BIOORG MED CHEM LETT, V20, P3036, DOI 10.1016/j.bmcl.2010.03.117; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Felker A, 2016, METHOD CELL BIOL, V135, P219, DOI 10.1016/bs.mcb.2016.01.009; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; Hans S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004640; Helland T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122339; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; KATZENELLENBOGEN BS, 1984, CANCER RES, V44, P112; Lawrence C, 2011, METHOD CELL BIOL, V104, P431, DOI 10.1016/B978-0-12-374814-0.00023-9; Lim YC, 2005, CANCER CHEMOTH PHARM, V55, P471, DOI 10.1007/s00280-004-0926-7; MacGregor JI, 1998, PHARMACOL REV, V50, P151; Manns J. E., 1993, Analytical Proceedings, V30, P161; Mosimann C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9146; Mosimann C, 2011, METHOD CELL BIOL, V104, P175, DOI 10.1016/B978-0-12-374814-0.00010-0; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; ROBERTSON DW, 1982, J ORG CHEM, V47, P2387, DOI 10.1021/jo00133a030; ROBERTSON DW, 1982, J STEROID BIOCHEM, V16, P1, DOI 10.1016/0022-4731(82)90137-6; Sinha DK, 2010, CHEMBIOCHEM, V11, P653, DOI 10.1002/cbic.201000008; WAKELING AE, 1991, CANCER RES, V51, P3867; Yu DD, 2003, J ORG CHEM, V68, P9489, DOI 10.1021/jo035164n	23	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152989	10.1371/journal.pone.0152989	http://dx.doi.org/10.1371/journal.pone.0152989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077909	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000374131700016
J	Heinecke, S				Heinecke, Steffi			The Gradual Transformation of the Polish Public Science System	PLOS ONE			English	Article							INCREASING RETURNS; PATH DEPENDENCE	This paper investigates institutional change in the Polish public science system (PPSS) in the past twenty years. Employing macro-statistical data, the paper argues that this change process has unfolded stepwise and relatively late despite major political and economic transformations in post-socialist Poland. Using a historical-institutionalist perspective, the paper focuses on processes of institutional change, including layering, displacement, and dismantling. One major finding is that the speed and depth of the gradual transformation differs considerably between the three research performing sectors of the Polish public science system. As the Polish Academy of Sciences was reproduced institutionally, the former governmental units for applied R&D were partly dismantled and displaced by private sector R&D units. In contrast, the Higher Education sector underwent a strong expansion and, thus, layering of new research activities and fields. Since policy shifts within the PPSS occurred relatively late, the more than two decades following the collapse of communism are of special interest to scholars of incremental, yet cumulative, institutional change.	[Heinecke, Steffi] Univ Wuppertal, Inst Sociol, Sch Human & Social Sci, Wuppertal, Germany	University of Wuppertal	Heinecke, S (corresponding author), Univ Wuppertal, Inst Sociol, Sch Human & Social Sci, Wuppertal, Germany.	sheinecke@uni-wuppertal.de			DAAD (Deutscher Akademischer Austauschdienst)	DAAD (Deutscher Akademischer Austauschdienst)(Deutscher Akademischer Austausch Dienst (DAAD))	The author (SH) received an individual research fellowship from the DAAD (Deutscher Akademischer Austauschdienst) in October 2012 until March 2013. During this period the statistical data presented in the paper was retrieved from the Central Statistical Office of Poland in Warsaw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdamski S, 1993, TRANSFORMATION NATL; [Anonymous], 2005, CONTINUITY EXPLORATI; [Anonymous], 2010, USTAWA DNIA 30 KWIEN; ARTHUR WB, 1989, ECON J, V99, P116, DOI 10.2307/2234208; Beek van U., 1995, TRANSFORMATION MITTE, P256; Beyer J, 2001, E EUR POLIT SOC, V15, P356, DOI 10.1177/0888325401015002007; BUNCE V, 1995, SLAVIC REV, V54, P111, DOI 10.2307/2501122; COLLIER RUTH BERINS, 1991, SHAPING POLITICAL AR, P27; Crawford B., 1997, LIBERALIZATION LENIN, P1; Crouch Colin., 2005, STREECK THELEN 2005A, P83; DAVID PA, 1985, AM ECON REV, V75, P332; Elster Jon, 1999, I DESIGN; Glowny Urzad Statystyczny, 2013, ROCZN STAT RZECZ POL, P420; Hall PA, 1996, POLIT STUD-LONDON, V44, P936, DOI 10.1111/j.1467-9248.1996.tb00343.x; Hallonsten O, 2013, SCI PUBL POLICY, V40, P591, DOI 10.1093/scipol/sct009; Hausner J., 1995, STRATEGIC CHOICE PAT; Heinze T, 2013, WISSENSCHAFT ALS BER, P74; JABLECKA J, 1995, SOC STUD SCI, V25, P727, DOI 10.1177/030631295025004007; Jablecka J, 2009, SCI PUBL POLICY, V36, P697, DOI 10.3152/030234209X475263; KARL TL, 1991, INT SOC SCI J, V43, P269; Kleiber M, 2003, FORUM AKAD, P11; Kolarska-Bobinska L., 2014, COMMUNICATION; Kozak M, 2015, SCIENTOMETRICS, V102, P1101, DOI 10.1007/s11192-014-1439-8; Kr?cken Georg., 2012, I ERNEUERUNGSFAHIGKE, P15, DOI [10.1007/978-3-531-94274-2_2, DOI 10.1007/978-3-531-94274-2_2]; Kwiek M., 2012, NATL HIGHER ED REFOR; Kwiek M, 2014, EUROPEAN J HIGHER ED, V4, P266; Kwiek M, 2012, SCI PUBL POLICY, V39, P641, DOI 10.1093/scipol/scs042; Lipowski A., 1991, BALCEROWICZ PROGRAMM, P39; Mahoney J, 2000, THEOR SOC, V29, P507, DOI 10.1023/A:1007113830879; Mayntz R, 1995, TRANSFORMATION MITTE; Meske M, 2004, SYSTEM TRANSFORMATIO; Meske W, 1998, TRANSFORMING SCI TEC; Narodowe Centrum Nauki, 2013, ANN REP 2012; OECD, 2014, MAIN SCI TECHN IND, V1; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; Sandstrom Ulf, 2014, CONTEXT COUNTS PATHW, P523; Saxonberg S., 2014, GENDERING FAMILY POL; Schimank U, 1995, TRANSFORMATION MITTE, P15; Schneider C, 1998, NATO ASI S 4 SCI TEC, V23, P222; Stark D., 1995, STRATEGIC CHOICE PAT, V70; Sztompka P., 2014, NAUKA, P7; Talaga A., 2012, POLSKA AKAD NIEPRZYD; Thelen K, 1999, ANNU REV POLIT SCI, V2, P369, DOI 10.1146/annurev.polisci.2.1.369; Thelen K., 2003, COMP HIST ANAL SOCIA, P208, DOI DOI 10.1017/CBO9780511803963.007; Tusk D., 2014, COMMUNICATION   0411; Whitley R, 2003, RES POLICY, V32, P1015, DOI 10.1016/S0048-7333(02)00112-9	46	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153260	10.1371/journal.pone.0153260	http://dx.doi.org/10.1371/journal.pone.0153260			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27077386	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700033
J	Rai, H; Sinha, N; Kumar, S; Sharma, AK; Agrawal, S				Rai, Himanshu; Sinha, Nakul; Kumar, Sudeep; Sharma, Ajay Kumar; Agrawal, Suraksha			Interleukin-1 Gene Cluster Polymorphisms and Their Association with Coronary Artery Disease: Separate Evidences from the Largest Case-Control Study amongst North Indians and an Updated Meta-Analysis	PLOS ONE			English	Article							RECEPTOR ANTAGONIST GENE; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; RISK; CELLS; IL-1; ATHEROSCLEROSIS; INVOLVEMENT; MECHANISMS; INHIBITOR	Several researchers have reported significant association of numerous single nucleotide polymorphisms (SNPs) residing in the interleukin-1 (IL-1) gene cluster with coronary artery disease (CAD). However, their association status amongst North Indian ancestry (NIA) have never been systematically assessed. Despite a published meta-analysis on this subject, their association status worldwide as well as amongst different major ancestral subgroups still remains unclear. We therefore decided to prospectively test the association of 11 IL-1 gene cluster SNPs with CAD, vide a case-control study amongst a cohort of NIA and attempted to validate our results with the help of an updated meta-analysis of all relevant published association studies. Included studies were segregated into ancestral subgroups and association statuses for each subgroup were determined. A total of 323 cases and 400 healthy, age and sex matched controls belonging to NIA were prospectively enrolled and subsequently genotyped for 11 selected IL-1 gene cluster SNPs. Although results for none of the evaluated IL-1 gene cluster SNPs reached the adjusted level of significance (p<0.0045), clear trends of association were seen for IL1B -511 C>T and IL1RN 86bp VNTR in several of the constructed genetic models (p range = 0.01-0.044 and 0.005-0.034 respectively). The presence of >1, 'T' (minor) allele of IL1B -511 C>T in a genotype seemed to provide protection against CAD (OR = 0.62, p = 0.044), while the presence of >1, 'C' (major) allele seemed to increase the risk of CAD (OR = 1.36, p = 0.041). The minor allele (allele 2) of IL1RN 86bp VNTR and its homozygous genotype (2/2 genotype) also seemed to carry an increased risk for CAD (OR = 1.62, p = 0.005 and OR = 2.25, p = 0.031 respectively). On the other hand, several haplotype combinations constructed out of IL1B and IL1RN gene variants clearly showed statistically significant associations with CAD (p<0.0045). Our meta-analysis was conducted for 8 previously assessed IL-1 SNPs. We included 53 different studies which involved a total sample of 26,210 (13,982 cases and 12,228 controls). Our pooled results concurred with the findings of our case-control study and was not able to deduce any statistically significant associations for any of the 8 studied SNPs (p>0.05). Subgroup analysis, however, yielded interesting results, where significant differences in association statuses were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C for select ancestral subgroups. The hints of associations deduced for subjects belonging to NIA in our case-control study for both IL1B -511 C>T and IL1RN 86bp VNTR were duly validated vide significant p values seen for NIA in all three genetic models (OR range = 0.62-0.76, p range = 0.01-0.04 and OR range = 1.51-2.25, p range = 0.004-0.04 respectively). On the other hand, Mixed Ancestry (MA) subgroup carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polymorphisms seemed to enjoy significant protection against CAD. A few other ancestral subgroups also demonstrated significant associations for a few of the studied SNPs vide one of the three genetic models. Clinical interpretation of derived results is however recommended.	[Rai, Himanshu; Sinha, Nakul; Kumar, Sudeep] Sanjay Gandhi Post Grad Inst Med Sci, Dept Cardiol, Lucknow, Uttar Pradesh, India; [Sharma, Ajay Kumar] Univ Lucknow, Dept Zool, Lucknow 226007, Uttar Pradesh, India; [Agrawal, Suraksha] Sanjay Gandhi Post Grad Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India; [Sinha, Nakul] Sahara India Med Inst, Dept Cardiol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Lucknow University; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Rai, H (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Cardiol, Lucknow, Uttar Pradesh, India.; Agrawal, S (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci, Dept Med Genet, Lucknow, Uttar Pradesh, India.	himanshurai1981@gmail.com; sur_ksha_agrawal@yahoo.co.in	Sharma, Ajay Kumar/HHC-1334-2022; Rai, Himanshu/GRX-9608-2022; Rai, Himanshu/N-7726-2016	Rai, Himanshu/0000-0003-3917-1934; Rai, Himanshu/0000-0003-3917-1934				Arman A, 2008, ARQ BRAS CARDIOL, V91, P268; Banerjee I, 2009, J THROMB THROMBOLYS, V27, P88, DOI 10.1007/s11239-007-0184-8; Bashour Lina, 2013, ISRN Dent, V2013, P195678, DOI 10.1155/2013/195678; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BOCHNER BS, 1991, J EXP MED, V173, P1553, DOI 10.1084/jem.173.6.1553; Cantagrel A, 1999, ARTHRITIS RHEUM, V42, P1093, DOI 10.1002/1529-0131(199906)42:6<1093::AID-ANR5>3.0.CO;2-P; Coker A, 2011, INT J IMMUNOGENET, V38, P201, DOI 10.1111/j.1744-313X.2010.00988.x; COZZOLINO F, 1990, P NATL ACAD SCI USA, V87, P6487, DOI 10.1073/pnas.87.17.6487; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DIGIOVINE FS, 1990, IMMUNOL TODAY, V11, P13; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Francis SE, 1999, CIRCULATION, V99, P861, DOI 10.1161/01.CIR.99.7.861; Geismar K, 2008, J PERIODONTOL, V79, P2322, DOI [10.1902/jop.2008.070454, 10.1902/jop.2008.070454 ]; Gong MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121147; Goracy J, 2011, ARCH MED RES, V42, P426, DOI 10.1016/j.arcmed.2011.08.002; GRAMSE M, 1986, BIOCHEM BIOPH RES CO, V139, P720, DOI 10.1016/S0006-291X(86)80050-X; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iacoviello L, 2005, ARTERIOSCL THROM VAS, V25, P222, DOI 10.1161/01.ATV.0000150039.60906.02; Iacoviello L, 2000, CIRCULATION, V101, pE193; Kariz S, 2007, COLLEGIUM ANTROPOL, V31, P503; Latkovskis G, 2004, EUR J IMMUNOGENET, V31, P207, DOI 10.1111/j.1365-2370.2004.00476.x; LIBBY P, 1988, J CLIN INVEST, V81, P487, DOI 10.1172/JCI113346; Licastro F, 2004, MECH AGEING DEV, V125, P575, DOI 10.1016/j.mad.2004.06.008; MANTEL N, 1959, J NATL CANCER I, V22, P719; Fragoso JM, 2010, IMMUNOL LETT, V133, P106, DOI 10.1016/j.imlet.2010.08.003; Momiyama Y, 2001, J AM COLL CARDIOL, V38, P712, DOI 10.1016/S0735-1097(01)01438-3; Napoleone E, 1997, BLOOD, V89, P541, DOI 10.1182/blood.V89.2.541; Offner FA, 1996, AM J PATHOL, V148, P1679; Ownby RL, 2006, ARCH GEN PSYCHIAT, V63, P530, DOI 10.1001/archpsyc.63.5.530; Panic N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083138; Ray KK, 2002, CLIN SCI, V103, P303, DOI 10.1042/cs1030303; Rios DLS, 2010, CYTOKINE, V50, P292, DOI 10.1016/j.cyto.2010.02.012; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Rywik TM, 2011, KARDIOL POL, V69, P881; Santtila S, 1998, SCAND J IMMUNOL, V47, P195; SCHWAGER I, 1994, BLOOD, V83, P152, DOI 10.1182/blood.V83.1.152.bloodjournal831152; Sinha Nakul, 2012, Indian Heart J, V64, P229, DOI 10.1016/S0019-4832(12)60078-9; Soylu O, 2008, EUR CYTOKINE NETW, V19, P42, DOI 10.1684/ecn.2008.0119; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stein JM, 2009, J PERIODONTOL, V80, P1095, DOI 10.1902/jop.2009.080639; STEINKASSERER A, 1992, GENOMICS, V13, P654, DOI 10.1016/0888-7543(92)90137-H; Timms AE, 2004, AM J HUM GENET, V75, P587, DOI 10.1086/424695; van Minkelen R, 2009, ATHEROSCLEROSIS, V203, P201, DOI 10.1016/j.atherosclerosis.2008.06.029; Vohnout B, 2003, HAEMATOLOGICA, V88, P54; Volzke H, 2004, CLIN SCI, V106, P35; Zee RYL, 2008, ATHEROSCLEROSIS, V201, P124, DOI 10.1016/j.atherosclerosis.2008.01.004; Zee RYL, 2001, THROMB HAEMOSTASIS, V86, P1141; Zhou L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045641	51	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153480	10.1371/journal.pone.0153480	http://dx.doi.org/10.1371/journal.pone.0153480			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078871	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700062
J	Chen, YG; Zhang, BW; Kording, KP				Chen, Youguo; Zhang, Bangwu; Kording, Konrad Paul			Speed Constancy or Only Slowness: What Drives the Kappa Effect	PLOS ONE			English	Article							TEMPORAL PERCEPTION; SPATIAL JUDGMENTS; MOTION PERCEPTION; CUTANEOUS RABBIT; BAYESIAN MODEL; WEBERS LAW; TIME; MOVEMENT; SPACE; ILLUSIONS	In the Kappa effect, two visual stimuli are given, and their spatial distance affects their perceived temporal interval. The classical model assumes constant speed while a competing Bayesian model assumes a slow speed prior. The two models are based on different assumptions about the statistical structure of the environment. Here we introduce a new visual experiment to distinguish between these models. When fit to the data, both the two models replicated human response, but the slowness model makes better behavioral predictions than the speed constancy model, and the estimated constant speed is close to the absolute threshold of speed. Our findings suggest that the Kappa effect appears to be due to slow speeds, and also modulated by spatial variance.	[Chen, Youguo; Zhang, Bangwu] Southwest Univ, Fac Psychol, Ctr Studies Psychol & Social Dev, Minist Educ,Key Lab Cognit & Personal, Chongqing, Peoples R China; [Kording, Konrad Paul] Northwestern Univ, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Southwest University - China; Northwestern University; Shirley Ryan AbilityLab	Chen, YG (corresponding author), Southwest Univ, Fac Psychol, Ctr Studies Psychol & Social Dev, Minist Educ,Key Lab Cognit & Personal, Chongqing, Peoples R China.	ygchen246@gmail.com	Kording, Konrad/A-1233-2007	Kording, Konrad/0000-0001-8408-4499	China Scholarship Council [201308500059]; National Natural Science Foundation of China [31200855, 31300845]; National Institutes of Health [1R01NS063399]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063399] Funding Source: NIH RePORTER	China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the China Scholarship Council (http://www.csc.edu.cn/): 201308500059 (YGC); National Natural Science Foundation of China (http://www.nsfc.gov.cn/): 31200855 (YGC) and 31300845 (YGC); and the National Institutes of Health (http://www.nih.gov/): 1R01NS063399 (KPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D, 2004, MODEL SELECTION MULT, V2nd; ANDERSON NH, 1974, HDB PERCEPTION, V2; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brannon EM, 2008, J COGNITIVE NEUROSCI, V20, P193, DOI 10.1162/jocn.2008.20016; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; COHEN J, 1953, NATURE, V172, P901, DOI 10.1038/172901a0; Cohen J, 1955, ACTA PSYCHOL, V11, P360; COLLYER CE, 1977, PERCEPT PSYCHOPHYS, V21, P357, DOI 10.3758/BF03199487; Duncan RO, 2003, NEURON, V38, P659, DOI 10.1016/S0896-6273(03)00265-4; Freeman TCA, 2010, CURR BIOL, V20, P757, DOI 10.1016/j.cub.2010.02.059; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Goldreich D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000333; Goldreich D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00221; Guilford J.P., 1954, J EDUC PSYCHOL, V2nd ed.; Hellstrom A, 2003, PERCEPT PSYCHOPHYS, V65, P1161, DOI 10.3758/BF03194842; Henry MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070646; Henry MJ, 2009, J EXP PSYCHOL HUMAN, V35, P551, DOI 10.1037/0096-1523.35.2.551; HUANG YL, 1982, PERCEPT PSYCHOPHYS, V32, P7, DOI 10.3758/BF03204862; Hurlimann F, 2002, VISION RES, V42, P2253, DOI 10.1016/S0042-6989(02)00119-0; Jazayeri M, 2010, NAT NEUROSCI, V13, P1020, DOI 10.1038/nn.2590; Jogan M, 2015, J NEUROSCI, V35, P9381, DOI 10.1523/JNEUROSCI.4801-14.2015; JONES B, 1982, PSYCHOL BULL, V91, P128, DOI 10.1037/0033-2909.91.1.128; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Masuda T, 2011, VISION RES, V51, P1728, DOI 10.1016/j.visres.2011.05.016; Miyazaki M, 2005, J NEUROPHYSIOL, V94, P395, DOI 10.1152/jn.01168.2004; Poppel E, 1997, TRENDS COGN SCI, V1, P56, DOI 10.1016/S1364-6613(97)01008-5; PRICEWILLIAMS DR, 1954, NATURE, V173, P363, DOI 10.1038/173363a0; Series P, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00668; Shi ZH, 2013, TRENDS COGN SCI, V17, P556, DOI 10.1016/j.tics.2013.09.009; Snowden RJ, 2006, PERCEPTION, V35, P9, DOI 10.1068/p5399; Stocker AA, 2006, NAT NEUROSCI, V9, P578, DOI 10.1038/nn1669; Szelag E, 2002, ACTA PSYCHOL, V110, P1, DOI 10.1016/S0001-6918(01)00067-1; Ulbrich P, 2007, ACTA PSYCHOL, V125, P51, DOI 10.1016/j.actpsy.2006.06.004; Vierordt K., 1868, ZEITSINN NACH VERSUC; Vintch B, 2014, J NEUROSCI, V34, P2592, DOI 10.1523/JNEUROSCI.2809-13.2014; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858; Welchman AE, 2008, P NATL ACAD SCI USA, V105, P12087, DOI 10.1073/pnas.0804378105; Yang J, 2012, J NEUROSCI, V32, P17632, DOI 10.1523/JNEUROSCI.1163-12.2012; Zhang RY, 2013, J NEUROSCI, V33, P4415, DOI 10.1523/JNEUROSCI.4744-12.2013	43	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154013	10.1371/journal.pone.0154013	http://dx.doi.org/10.1371/journal.pone.0154013			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100097	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500122
J	Le, HTMD; Angotzi, AR; Ebbesson, LOE; Karlsen, O; Ronnestad, I				Le, Hoang T. M. D.; Angotzi, Anna Rita; Ebbesson, Lars O. E.; Karlsen, Orjan; Ronnestad, Ivar			The Ontogeny and Brain Distribution Dynamics of the Appetite Regulators NPY, CART and pOX in Larval Atlantic Cod (Gadus morhua L.)	PLOS ONE			English	Article							NEUROPEPTIDE-Y NPY; HALIBUT HIPPOGLOSSUS-HIPPOGLOSSUS; MELANIN-CONCENTRATING HORMONE; MESSENGER-RNA EXPRESSION; ORANGE-SPOTTED GROUPER; SALMON SALMO-SALAR; TRANSCRIPT CART; MOLECULAR-CLONING; FEEDING-BEHAVIOR; FOOD-INTAKE	Similar to many marine teleost species, Atlantic cod undergo remarkable physiological changes during the early life stages with concurrent and profound changes in feeding biology and ecology. In contrast to the digestive system, very little is known about the ontogeny and the localization of the centers that control appetite and feed ingestion in the developing brain of fish. We examined the expression patterns of three appetite regulating factors (orexigenic: neuropeptide Y, NPY; prepro-orexin, pOX and anorexigenic: cocaine-and amphetamine-regulated transcript, CART) in discrete brain regions of developing Atlantic cod using chromogenic and double fluorescent in situ hybridization. Differential temporal and spatial expression patterns for each appetite regulator were found from first feeding (4 days post hatch; dph) to juvenile stage (76 dph). Neurons expressing NPY mRNA were detected in the telencephalon (highest expression), diencephalon, and optic tectum from 4 dph onward. CART mRNA expression had a wider distribution along the anterior-posterior brain axis, including both telencephalon and diencephalon from 4 dph. From 46 dph, CART transcripts were also detected in the olfactory bulb, region of the nucleus of medial longitudinal fascicle, optic tectum and midbrain tegmentum. At 4 and 20 dph, pOX mRNA expression was exclusively found in the preoptic region, but extended to the hypothalamus at 46 and 76 dph. Co-expression of both CART and pOX genes were also observed in several hypothalamic neurons throughout larval development. Our results show that both orexigenic and anorexigenic factors are present in the telencephalon, diencephalon and mesencephalon in cod larvae. The telencephalon mostly contains key factors of hunger control (NPY), while the diencephalon, and particularly the hypothalamus may have a more complex role in modulating the multifunctional control of appetite in this species. As the larvae develop, the overall progression in temporal and spatial complexity of NPY, CART and pOX mRNAs expression might be correlated to the maturation of appetite control regulation. These observations suggest that teleost larvae continue to develop the regulatory networks underlying appetite control after onset of exogenous feeding.	[Le, Hoang T. M. D.; Angotzi, Anna Rita; Ronnestad, Ivar] Univ Bergen, Dept Biol, Bergen, Norway; [Ebbesson, Lars O. E.] Uni Res AS, Uni Res Environm, Bergen, Norway; [Karlsen, Orjan] Inst Marine Res, Storebo, Norway; [Le, Hoang T. M. D.] Nha Trang Univ, Inst Aquaculture, Nha Trang, Khanh Hoa, Vietnam	University of Bergen; University of Bergen; Institute of Marine Research - Norway; Nha Trang University	Ronnestad, I (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	ivar.ronnestad@uib.no	Karlsen, Ørjan/K-6137-2012; Rønnestad, Ivar/A-1774-2013	Karlsen, Ørjan/0000-0001-5801-4200; Rønnestad, Ivar/0000-0001-8789-0197; Ebbesson, Lars Olof Ebbe/0000-0002-5965-1284; Angotzi, Anna Rita/0000-0002-3824-2350	Research Council of Norway [199482]; NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund)	Research Council of Norway(Research Council of Norway); NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund)	The study was part of a project on Atlantic cod development (CODE) funded by the Research Council of Norway (www.forskningsradet.no/en/) with project number: 199482. HTMDL was supported by NORAD Quota Scheme Scholarship (Norwegian State Educational Loan Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiya N, 2007, NEUROSCI LETT, V427, P16, DOI 10.1016/j.neulet.2007.07.043; Auditore PJ, 1994, NAFO SCI COUNCIL STU, P7; Barreiro-Iglesias A, 2010, NEUROSCIENCE, V167, P396, DOI 10.1016/j.neuroscience.2010.02.030; Bruin JC, 1980, COMP NEUROLOGY TELEN, P175; Buckley C, 2010, PEPTIDES, V31, P1737, DOI 10.1016/j.peptides.2010.05.017; Castro A, 1999, J COMP NEUROL, V414, P13, DOI 10.1002/(SICI)1096-9861(19991108)414:1<13::AID-CNE2>3.0.CO;2-R; Cerda-Reverter JM, 2000, J CHEM NEUROANAT, V19, P197, DOI 10.1016/S0891-0618(00)00063-6; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Chen R, 2005, COMP BIOCHEM PHYS B, V142, P79, DOI 10.1016/j.cbpc.2005.06.003; Chiba A, 1996, NEUROSCI LETT, V213, P49, DOI 10.1016/0304-3940(96)12828-7; CHIBA A, 1994, ARCH HISTOL CYTOL, V57, P77, DOI 10.1679/aohc.57.77; Dietrich MO, 2009, EUR J NEUROSCI, V30, P1688, DOI 10.1111/j.1460-9568.2009.06963.x; FAO, 2004, CULT AQ SPEC INF PRO; Faraco JH, 2006, J BIOL CHEM, V281, P29753, DOI 10.1074/jbc.M605811200; FERNALD RD, 1985, J COMP NEUROL, V238, P202, DOI 10.1002/cne.902380207; Gomes AS, 2015, COMP BIOCHEM PHYS A, V183, P116, DOI 10.1016/j.cbpa.2015.01.009; Gomes AS, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-11; Huesa G, 2005, J COMP NEUROL, V488, P476, DOI 10.1002/cne.20610; Huffman LS, 2012, J CHEM NEUROANAT, V44, P86, DOI 10.1016/j.jchemneu.2012.05.002; Hunter RG, 2004, TRENDS ENDOCRIN MET, V15, P454, DOI 10.1016/j.tem.2004.09.010; Johansen SD, 2009, NEW BIOTECHNOL, V25, P263, DOI 10.1016/j.nbt.2009.03.014; KAH O, 1989, FISH PHYSIOL BIOCHEM, V7, P69, DOI 10.1007/BF00004691; Kamisaka Y, 2011, MAR BIOL, V158, P233, DOI 10.1007/s00227-010-1554-x; Karlsen O, 2015, PEERJ, V3, DOI 10.7717/peerj.902; Kaslin J, 2004, J NEUROSCI, V24, P2678, DOI 10.1523/JNEUROSCI.4908-03.2004; Kehoe AS, 2007, COMP BIOCHEM PHYS A, V146, P451, DOI 10.1016/j.cbpa.2006.12.026; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kortner TM, 2011, COMP BIOCHEM PHYS A, V160, P190, DOI 10.1016/j.cbpa.2011.05.033; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kvale A, 2007, AQUACULTURE, V264, P457, DOI 10.1016/j.aquaculture.2006.12.024; KYLE AL, 1987, ANN NY ACAD SCI, V519, P97; Lin XW, 2000, COMP BIOCHEM PHYS A, V126, P415, DOI 10.1016/S1095-6433(00)00230-0; MacDonald E, 2009, HORM BEHAV, V56, P58, DOI 10.1016/j.yhbeh.2009.03.002; MacDonald E, 2009, GEN COMP ENDOCR, V161, P252, DOI 10.1016/j.ygcen.2009.01.021; MacDonald EE, 2010, GEN COMP ENDOCR, V169, P192, DOI 10.1016/j.ygcen.2010.09.014; Mathieu M, 2002, DEV BRAIN RES, V139, P255, DOI 10.1016/S0165-3806(02)00577-1; Meek J., 1998, P759; Mueller T., 2005, ATLAS EARLY ZEBRAFIS; Mukherjee A, 2012, J COMP NEUROL, V520, P770, DOI 10.1002/cne.22779; OIESTAD V, 1985, T AM FISH SOC, V114, P590, DOI 10.1577/1548-8659(1985)114&lt;590:MPOACJ&gt;2.0.CO;2; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; Sirkin DIP, 2013, TISSUE CELL, V45, P452, DOI 10.1016/j.tice.2013.09.001; PETER RE, 1979, FISH PHYSIOL, V8, P121; Ping HC, 2013, J ANIM PHYSL ANIM NU; Pirone A, 2008, ANAT HISTOL EMBRYOL, V37, P231, DOI 10.1111/j.1439-0264.2007.00836.x; PONTET A, 1989, CELL TISSUE RES, V255, P529; Ronnestad I., 2013, INT AQUAFEED MAG MAY, P3; Ronnestad I, 2013, REV AQUACULT, V5, pS59, DOI 10.1111/raq.12010; ROOS J, 1988, J COMP NEUROL, V270, P121, DOI 10.1002/cne.902700110; Sakurai T, 2002, SLEEP MED, V3, pS3, DOI 10.1016/S1389-9457(02)00156-9; Sandbakken M, 2012, J COMP NEUROL, V520, P3727, DOI 10.1002/cne.23125; SCHWASSM.HO, 1965, J COMP NEUROL, V124, P113, DOI 10.1002/cne.901240109; Silverstein JT, 1998, GEN COMP ENDOCR, V110, P157, DOI 10.1006/gcen.1998.7058; Singru PS, 2007, J COMP NEUROL, V502, P215, DOI 10.1002/cne.21295; Subhedar N, 1996, CELL TISSUE RES, V283, P313, DOI 10.1007/s004410050541; Traverso JM, 2003, ANAT HISTOL EMBRYOL, V32, P29, DOI 10.1046/j.1439-0264.2003.00434.x; VALLARINO M, 1988, BRAIN RES, V448, P67, DOI 10.1016/0006-8993(88)91102-X; VALLARINO M, 1995, J COMP NEUROL, V356, P537, DOI 10.1002/cne.903560405; Vallarino M, 1998, NEUROSCI LETT, V254, P5, DOI 10.1016/S0304-3940(98)00607-7; VECINO E, 1994, NEUROREPORT, V6, P127, DOI 10.1097/00001756-199412300-00033; VECINO E, 1990, J COMP NEUROL, V299, P229, DOI 10.1002/cne.902990207; Volkoff H, 2006, COMP BIOCHEM PHYS A, V144, P325, DOI 10.1016/j.cbpa.2005.10.026; Volkoff H, 2001, ENDOCRINOLOGY, V142, P5076, DOI 10.1210/en.142.12.5076; Volkoff H, 2005, GEN COMP ENDOCR, V142, P3, DOI 10.1016/j.ygcen.2004.11.001; Williams G, 2001, PHYSIOL BEHAV, V74, P683, DOI 10.1016/S0031-9384(01)00612-6; Williams KW, 2011, NAT NEUROSCI, V14, P277, DOI 10.1038/nn0311-277; Xu MY, 2007, MOL CELL ENDOCRINOL, V271, P28, DOI 10.1016/j.mce.2007.03.003; Yan AF, 2011, PEPTIDES, V32, P1363, DOI 10.1016/j.peptides.2011.05.004	69	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153743	10.1371/journal.pone.0153743	http://dx.doi.org/10.1371/journal.pone.0153743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100086	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000374898500062
J	Leecaster, M; Toth, DJA; Pettey, WBP; Rainey, JJ; Gao, HJ; Uzicanin, A; Samore, M				Leecaster, Molly; Toth, Damon J. A.; Pettey, Warren B. P.; Rainey, Jeanette J.; Gao, Hongjiang; Uzicanin, Amra; Samore, Matthew			Estimates of Social Contact in a Middle School Based on Self-Report and Wireless Sensor Data	PLOS ONE			English	Article							INFECTIOUS-DISEASE; MIXING PATTERNS; SPREAD; TRANSMISSION; INFLUENZA; NETWORKS; MODELS; CHALLENGES	Estimates of contact among children, used for infectious disease transmission models and understanding social patterns, historically rely on self-report logs. Recently, wireless sensor technology has enabled objective measurement of proximal contact and comparison of data from the two methods. These are mostly small-scale studies, and knowledge gaps remain in understanding contact and mixing patterns and also in the advantages and disadvantages of data collection methods. We collected contact data from a middle school, with 7th and 8th grades, for one day using self-report contact logs and wireless sensors. The data were linked for students with unique initials, gender, and grade within the school. This paper presents the results of a comparison of two approaches to characterize school contact networks, wireless proximity sensors and self-report logs. Accounting for incomplete capture and lack of participation, we estimate that "sensor-detectable", proximal contacts longer than 20 seconds during lunch and class-time occurred at 2 fold higher frequency than "self-reportable" talk/touch contacts. Overall, 55% of estimated talk-touch contacts were also sensor-detectable whereas only 15% of estimated sensor-detectable contacts were also talk-touch. Contacts detected by sensors and also in self-report logs had longer mean duration than contacts detected only by sensors (6.3 vs 2.4 minutes). During both lunch and class-time, sensor-detectable contacts demonstrated substantially less gender and grade assortativity than talk-touch contacts. Hallway contacts, which were ascertainable only by proximity sensors, were characterized by extremely high degree and short duration. We conclude that the use of wireless sensors and self-report logs provide complementary insight on in-school mixing patterns and contact frequency.	[Leecaster, Molly; Toth, Damon J. A.; Pettey, Warren B. P.; Samore, Matthew] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Leecaster, Molly; Toth, Damon J. A.; Pettey, Warren B. P.; Samore, Matthew] Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Toth, Damon J. A.] Univ Utah, Dept Math, Salt Lake City, UT 84112 USA; [Rainey, Jeanette J.; Gao, Hongjiang; Uzicanin, Amra] Ctr Dis Control & Prevent, Dept Global Migrat & Quarantine, Atlanta, GA USA; [Samore, Matthew] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Centers for Disease Control & Prevention - USA; Utah System of Higher Education; University of Utah	Leecaster, M (corresponding author), Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA.; Leecaster, M (corresponding author), Vet Affairs Salt Lake City Hlth Care Syst, Salt Lake City, UT USA.	molly.leecaster@hsc.utah.edu		Pettey, Warren/0000-0002-4436-3319	Centers for Disease Control and Prevention [1U01CK000177-01]	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by Centers for Disease Control and Prevention cooperative agreement 1U01CK000177-01 to MS and ML. The authors, JR, HG, and AU, from the funding organization participated in study design and preparation of the manuscript. The findings and conclusions in this study are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Barclay VC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087042; Beutels P, 2006, EPIDEMIOL INFECT, V134, P1158, DOI 10.1017/S0950268806006418; Bischoff WE, 2013, J INFECT DIS, V207, P1037, DOI 10.1093/infdis/jis773; Cauchemez S, 2011, P NATL ACAD SCI USA, P2; Centers for Disease Control and Prevention, 2010, MORBIDITY MORTALITY; Centers for Disease Control and Prevention, 2009, PINK BOOK EP PREV VA, V11, P135; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Christakis NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012948; Conlan AJK, 2011, P ROY SOC B-BIOL SCI, V278, P1467, DOI 10.1098/rspb.2010.1807; Eames K, 2015, EPIDEMICS-NETH, V10, P72, DOI 10.1016/j.epidem.2014.08.006; Eames K T D, 2010, Health Technol Assess, V14, P267, DOI 10.3310/hta14340-04; Eames KTD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002425; Forys A, 2013, 1 INT WORKSH SENS BI, P1; Fournet J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107878; Gesteland Per H, 2007, AMIA Annu Symp Proc, P274; Glass LM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-61; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Jackson M, 2011, DIFFUSION AND CONTAG, DOI 10.2139/ssrn.1950476; Kazandjieva ML J., 2010, P ACM WORKSH HOT TOP; Knoke D., 2008, SOCIAL NETWORK ANAL; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Lucet JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037893; Mastrandrea R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136497; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Min KT, 2014, 2014 IEEE 39TH CONFERENCE ON LOCAL COMPUTER NETWORKS WORKSHOPS (LCN WORKSHOPS), P557, DOI 10.1109/LCNW.2014.6927703; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Pellis L, 2015, EPIDEMICS-NETH, V10, P58, DOI 10.1016/j.epidem.2014.07.003; Potter GE, 2012, ANN APPL STAT, V6, P1, DOI 10.1214/11-AOAS505; Read JM, 2012, EPIDEMIOL INFECT, V140, P2117, DOI 10.1017/S0950268812000842; Read JM, 2008, J R SOC INTERFACE, V5, P1001, DOI 10.1098/rsif.2008.0013; Salathe M, 2010, P NATL ACAD SCI; Salathe M, 2010, P NATL ACAD SCI USA, V107, P22020, DOI 10.1073/pnas.1009094108; Smieszek T, 2012, EPIDEMIOL INFECT, V140, P744, DOI 10.1017/S0950268811001130; Smieszek T, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-136; Stehle J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023176; Toth DJA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0279; Wallinga J, 2006, AM J EPIDEMIOL, V164, P936, DOI 10.1093/aje/kwj317; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013	41	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153690	10.1371/journal.pone.0153690	http://dx.doi.org/10.1371/journal.pone.0153690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100090	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500050
J	Stewart, MKG; Plante, I; Penuela, S; Laird, DW				Stewart, Michael K. G.; Plante, Isabelle; Penuela, Silvia; Laird, Dale W.			Loss of Panx1 Impairs Mammary Gland Development at Lactation: Implications for Breast Tumorigenesis	PLOS ONE			English	Article							APOPTOTIC EPITHELIAL-CELLS; PANNEXIN 1; CHANNELS; RELEASE; FAMILY; ATP; DIFFERENTIATION; PROLIFERATION; CONNEXINS; EXPRESSION	Pannexin1 (Panx1) subunits oligomerize to form large-pore channels between the intracellular and extracellular milieu that have been shown to regulate proliferation, differentiation and cell death mechanisms. These key cellular responses are ultimately necessary for normal tissue development and function but the role of Panx1 in development, differentiation and function in many tissues remains unexplored, including that of the breast. Panx1 was identified to be expressed in the mammary gland through western blot and immunofluorescent analysis and is dynamically upregulated during pregnancy and lactation. In order to evaluate the role of Panx1 in the context of mammary gland development and function, Panx1(-/-) mice were evaluated in comparison to wild-type mice in the mammary glands of virgin, lactating and involuting mice. Our results revealed that Panx1 ablation did not affect virgin or involuting mammary glands following histological and whole mount analysis. Panx1 was necessary for timely alveolar development during early lactation based on a decreased number of alveolar lumen following histological analysis and reduced proliferation following Ki67 immunofluorescent labelling. Importantly, the loss of Panx1 in lactating mammary glands did not overtly affect epithelial or secretory differentiation of the mammary gland suggesting that Panx1 is not critical in normal mammary gland function. In addition, PANX1 mRNA expression was correlated with negative clinical outcomes in patients with breast cancer using in silico arrays. Together, our results suggest that Panx1 is necessary for timely alveolar development following the transition from pregnancy to lactation, which may have implications extending to patients with breast cancer.	[Stewart, Michael K. G.; Laird, Dale W.] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 5C1, Canada; [Plante, Isabelle] Univ Quebec, Inst Armand Frappier, Ctr INRS, 531 Blvd Prairies, Laval, PQ H7V 1B7, Canada; [Penuela, Silvia; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St, London, ON N6A 5C1, Canada	Western University (University of Western Ontario); University of Quebec; Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St, London, ON N6A 5C1, Canada.; Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, 1151 Richmond St, London, ON N6A 5C1, Canada.	dale.laird@schulich.uwo.ca	Penuela, Silvia/A-6961-2010; Plante, Isabelle/AAK-5997-2021; Laird, Dale W/AAL-2407-2020	Penuela, Silvia/0000-0003-4829-5517; Plante, Isabelle/0000-0003-2080-6450; Laird, Dale W/0000-0002-4568-3285	Canadian Breast Cancer Foundation; Ontario Graduate Scholarship; Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR)	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Breast Cancer Foundation (to D. W. L.), and by the Ontario Graduate Scholarship, Pamela Greenaway-Kohlmeier Translational Breast Cancer Research Unit and the Canadian Institutes of Health Research (CIHR) Strategic Training Program in Cancer Research and Technology Transfer (to M. K. G. S.).	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Blaug S, 2003, AM J PHYSIOL-CELL PH, V284, pC897, DOI 10.1152/ajpcell.00238.2002; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bry C, 2004, DEV BIOL, V267, P418, DOI 10.1016/j.ydbio.2003.11.022; Celetti SJ, 2010, J CELL SCI, V123, P1363, DOI 10.1242/jcs.056093; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Cowan KN, 2012, CELL COMMUN ADHES, V19, P45, DOI 10.3109/15419061.2012.712575; ENOMOTO K, 1994, PFLUG ARCH EUR J PHY, V427, P533, DOI 10.1007/BF00374271; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Forster C, 2002, P NATL ACAD SCI USA, V99, P15578, DOI 10.1073/pnas.192561299; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Howlin J, 2006, J MAMMARY GLAND BIOL, V11, P283, DOI 10.1007/s10911-006-9024-2; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Langlois S, 2014, J BIOL CHEM, V289, P30717, DOI 10.1074/jbc.M114.572131; Lee WJ, 2006, BBA-REV CANCER, V1765, P235, DOI 10.1016/j.bbcan.2005.12.001; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li S, 2011, GEN COMP ENDOCR, V174, P202, DOI 10.1016/j.ygcen.2011.08.019; Liong S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122633; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Macias H, 2012, WIRES DEV BIOL, V1, P533, DOI 10.1002/wdev.35; McLachlan E, 2007, J MEMBRANE BIOL, V218, P107, DOI 10.1007/s00232-007-9052-x; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2014, J INVEST DERMATOL, V134, P2026, DOI 10.1038/jid.2014.86; Penuela S, 2013, BBA-BIOMEMBRANES, V1828, P15, DOI 10.1016/j.bbamem.2012.01.017; Penuela S, 2012, J BIOL CHEM, V287, P29184, DOI 10.1074/jbc.M112.377176; Plante I, 2008, DEV BIOL, V318, P312, DOI 10.1016/j.ydbio.2008.03.033; Plante Isabelle, 2011, J Vis Exp, DOI 10.3791/2828; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qu Y, 2011, J IMMUNOL, V186, P6553, DOI 10.4049/jimmunol.1100478; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Sosinsky GE, 2011, CHANNELS, V5, P193, DOI 10.4161/chan.5.3.15765; Stewart MKG, 2015, REPRODUCTION, V149, pR279, DOI 10.1530/REP-14-0661; Stewart MKG, 2013, BIOCHEM J, V449, P401, DOI 10.1042/BJ20121070; Teleki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112541; Tong D, 2007, J CELL SCI, V120, P4016, DOI 10.1242/jcs.011775; TRAURIG HH, 1967, ANAT REC, V159, P239, DOI 10.1002/ar.1091590213; Vogt A, 2005, MOL BRAIN RES, V141, P113, DOI 10.1016/j.molbrainres.2005.08.002; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Wicki-Stordeur LE, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-11; ZWIERZCHOWSKI L, 1984, DIFFERENTIATION, V28, P179, DOI 10.1111/j.1432-0436.1984.tb00281.x	58	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154162	10.1371/journal.pone.0154162	http://dx.doi.org/10.1371/journal.pone.0154162			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099931	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000374898500157
J	Chen, YW; Wang, HC; Gao, LH; Liu, C; Jiang, YX; Qu, H; Li, CY; Jiang, JH				Chen, Ya-Wen; Wang, Hai-Cheng; Gao, Long-Hua; Liu, Chang; Jiang, Yu-Xi; Qu, Hong; Li, Cui-Ying; Jiang, Jiu-Hui			Osteoclastogenesis in Local Alveolar Bone in Early Decortication-Facilitated Orthodontic Tooth Movement	PLOS ONE			English	Article							ACCELERATED OSTEOGENIC ORTHODONTICS; TRANSCRIPTION FACTOR; DIFFERENTIATION; EXPRESSION; REPAIR; CELLS; JDP2	Objective In the current study, we aimed to investigate the effects of alveolar decortication on local bone remodeling, and to explore the possible mechanism by which decortication facilitates tooth movement. Materials and Methods Forty rabbits were included in the experiment. The left mandible was subjected to decortication-facilitated orthodontics, and the right mandible underwent traditional orthodontics as a control. The animals were sacrificed on the days 1, 3, 5, 7 and 14, after undergoing orthodontic procedures. Tooth movement was measured by Micro-CT, and the local periodontal tissues were investigated using H&E, Masson's trichrome and tartrate-resistant acid phosphatase (TRAP) staining. The mRNA levels of genes related to bone remodeling in the alveolar bone were analyzed using real-time PCR. Result On days 3, 5, 7 and 14, tooth movement was statistically accelerated by decortication (P < 0.05) and was accompanied by increased hyperemia. Despite the lack of new bone formation in both groups, more osteoclasts were noted in the decorticated group, with two peak counts (P < 0.05). The first peak count was consistent with the maximum values of ctsk and TRAP expression, and the second peak counts accompanied the maximum nfatc1 and jdp2 expression. The increased fra2 expression and the ratio of rankl/ opg also accompanied the second peak counts. Conclusions Following alveolar decortication, osteoclastogenesis was initially induced to a greater degree than the new bone formation which was thought to have caused a regional acceleratory phenomenon (RAP). The amount of steoclastogenesis in the decorticated alveolar bone was found to have two peaks, perhaps due to attenuated local resistance. The first peak count in osteoclasts may have been due to previously existing osteoclast precursors, whereas the second may represent the differentiation of peripheral blood mononuclear cells which came from circulation as the result of hyperemia.	[Chen, Ya-Wen; Jiang, Jiu-Hui] Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China; [Chen, Ya-Wen] First Hosp Jiaxing, Dept Stomatol, 1882 Zhonghuan South Rd, Jiaxing 314001, Peoples R China; [Wang, Hai-Cheng] Tongji Univ, Sch & Hosp Stomatol, Dept Pathol, Shanghai Engn Res Ctr Tooth Restorat & Regenerat, Shanghai 200072, Peoples R China; [Gao, Long-Hua; Qu, Hong] Dalian Med Univ, Dept Orthodont, Coll Stomatol, 9 Lushun South Rd West, Dalian 116044, Peoples R China; [Liu, Chang] Shandong Univ, Sch Stomatol, Dept Orthodont, 44 Wenhua West Rd, Jinan 250012, Peoples R China; [Jiang, Yu-Xi] Binzhou Med Univ, Dept Stomatol, 346 Guanhai Rd, Yantai 264003, Peoples R China; [Li, Cui-Ying] Peking Univ, Sch & Hosp Stomatol, Cent Lab, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China	Peking University; Tongji University; Dalian Medical University; Shandong University; Binzhou Medical University; Peking University	Jiang, JH (corresponding author), Peking Univ, Sch & Hosp Stomatol, Dept Orthodont, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China.; Qu, H (corresponding author), Dalian Med Univ, Dept Orthodont, Coll Stomatol, 9 Lushun South Rd West, Dalian 116044, Peoples R China.; Li, CY (corresponding author), Peking Univ, Sch & Hosp Stomatol, Cent Lab, 22 South Zhongguancun Ave, Beijing 100081, Peoples R China.	hongqu22@hotmail.com; licuiying_67@163.com; drjiangw@163.com		Jiang, Yu-Xi/0000-0001-8261-2905	National Natural Science Foundation of China [81171006, 81571002]; Beijing Natural Science Foundation [7162203]; Beijing Science and Technology Committee [Z121107001012024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Science and Technology Committee	The authors appreciated the help from the Center lab of the Peking University, School of Stomatology. This study was supported by the National Natural Science Foundation of China (No. 81171006, 81571002) and Beijing Natural Science Foundation (No. 7162203) and also by the Beijing Science and Technology Committee. (No. Z121107001012024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abtahi M, 2014, J CLIN PEDIATR DENT, V38, P285, DOI 10.17796/jcpd.38.3.n04h7105121663t6; Amit Goyal, 2012, J Clin Exp Dent, V4, pe292, DOI 10.4317/jced.50822; Baloul SS, 2011, AM J ORTHOD DENTOFAC, V139, pS83, DOI 10.1016/j.ajodo.2010.09.026; Belibasakis GN, 2012, J CLIN PERIODONTOL, V39, P239, DOI 10.1111/j.1600-051X.2011.01810.x; Faienza MF, 2014, INT J MED SCI, V11, P356, DOI 10.7150/ijms.7793; Helali AM, 2013, CURR DRUG TARGETS, V14, P1591, DOI 10.2174/13894501113149990202; HERMANSON PC, 1972, ANGLE ORTHOD, V42, P107; Jin L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096519; Kawaida R, 2003, J EXP MED, V197, P1029, DOI 10.1084/jem.20021321; Kogawa M, 2013, J STEROID BIOCHEM, V136, P59, DOI 10.1016/j.jsbmb.2012.09.008; Lee W, 2008, J DENT RES, V87, P861, DOI 10.1177/154405910808700904; Liem AML, 2015, BRIT J ORAL MAX SURG, V53, P491, DOI 10.1016/j.bjoms.2015.03.009; Maruyama K, 2012, IMMUNITY, V37, P1024, DOI 10.1016/j.immuni.2012.08.022; Ming LG, 2013, ENDOCRINOLOGY, V154, P1202, DOI 10.1210/en.2012-2086; Mostafa YA, 2009, AM J ORTHOD DENTOFAC, V136, P570, DOI 10.1016/j.ajodo.2007.10.052; Mouline CC, 2010, EUR CELLS MATER, V20, P379; Murphy KG, 2009, J ORAL MAXIL SURG, V67, P2160, DOI 10.1016/j.joms.2009.04.124; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; Owen Helen C, 2015, Intensive Care Med Exp, V3, P52, DOI 10.1186/s40635-015-0052-3; Park JW, 2013, J BIOMED MATER RES A, V101, P298, DOI 10.1002/jbm.a.34433; Puvaneswary S, 2013, INT J MED SCI, V10, P1608, DOI 10.7150/ijms.6496; Reifenrath J, 2014, J BIOMED MATER RES A, V102, P2884, DOI 10.1002/jbm.a.34920; Roberts-Harry D, 2004, BRIT DENT J, V196, P391, DOI 10.1038/sj.bdj.4811129; Schilling T, 1998, CALCIFIED TISSUE INT, V63, P160, DOI 10.1007/s002239900508; Sebaoun JD, 2008, J PERIODONTOL, V79, P1679, DOI [10.1902/jop.2008.080024, 10.1902/jop.2008.080024 ]; Teng GYY, 2014, J ORAL MAXIL SURG, V72, P19, DOI 10.1016/j.joms.2013.09.012; Wang HC, 2015, ORAL DIS, V21, P170, DOI 10.1111/odi.12231; Wang HC, 2013, ORAL DIS, V19, P162, DOI 10.1111/j.1601-0825.2012.01966.x; Wang L, 2009, AM J ORTHOD DENTOFAC, V136, DOI 10.1016/j.ajodo.2009.05.015; Wang ZL, 2015, MOL MED REP, V12, P3345, DOI 10.3892/mmr.2015.3795; Wattanaroonwong N, 2011, ARCH ORAL BIOL, V56, P212, DOI 10.1016/j.archoralbio.2010.10.004; Wilcko MT, 2009, J ORAL MAXIL SURG, V67, P2149, DOI 10.1016/j.joms.2009.04.095; Wilcko WM, 2001, INT J PERIODONT REST, V21, P9; Yamauchi K, 2015, CLIN IMPLANT DENT R, V17, pE376, DOI 10.1111/cid.12250; Yao C, 2014, J BIOL CHEM, V289, P6775, DOI 10.1074/jbc.M113.499210	35	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153937	10.1371/journal.pone.0153937	http://dx.doi.org/10.1371/journal.pone.0153937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096621	gold, Green Published			2022-12-27	WOS:000374543600072
J	Lou, YJ; Pan, YW; Gao, CY; Jiang, M; Lu, XG; Xu, YJ				Lou, Yanjing; Pan, Yanwen; Gao, Chuanyu; Jiang, Ming; Lu, Xianguo; Xu, Y. Jun			Response of Plant Height, Species Richness and Aboveground Biomass to Flooding Gradient along Vegetation Zones in Floodplain Wetlands, Northeast China	PLOS ONE			English	Article							SANJIANG PLAIN; FUNCTIONAL TRAITS; FEN VEGETATION; WATER DEPTH; ZONATION; GROWTH; PATTERNS; TEMPERATURE; COMPETITION; ECOSYSTEMS	Flooding regime changes resulting from natural and human activity have been projected to affect wetland plant community structures and functions. It is therefore important to conduct investigations across a range of flooding gradients to assess the impact of flooding depth on wetland vegetation. We conducted this study to identify the pattern of plant height, species richness and aboveground biomass variation along the flooding gradient in floodplain wetlands located in Northeast China. We found that the response of dominant species height to the flooding gradient depends on specific species, i.e., a quadratic response for Carex lasiocarpa, a negative correlation for Calamagrostis angustifolia, and no response for Carex appendiculata. Species richness showed an intermediate effect along the vegetation zone from marsh to wet meadow while aboveground biomass increased. When the communities were analysed separately, only the water table depth had significant impact on species richness for two Carex communities and no variable for C. angustifolia community, while height of dominant species influenced aboveground biomass. When the three abovementioned communities were grouped together, variations in species richness were mainly determined by community type, water table depth and community mean height, while variations in aboveground biomass were driven by community type and the height of dominant species. These findings indicate that if habitat drying of these herbaceous wetlands in this region continues, then two Carex marshes would be replaced gradually by C. angustifolia wet meadow in the near future. This will lead to a reduction in biodiversity and an increase in productivity and carbon budget. Meanwhile, functional traits must be considered, and should be a focus of attention in future studies on the species diversity and ecosystem function in this region.	[Lou, Yanjing; Pan, Yanwen; Gao, Chuanyu; Jiang, Ming; Lu, Xianguo] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China; [Xu, Y. Jun] Louisiana State Univ, Ctr Agr, Sch Renewable Nat Resources, Baton Rouge, LA 70803 USA	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Louisiana State University System; Louisiana State University	Lou, YJ (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Changchun, Peoples R China.	louyj@iga.ac.cn	Xu, Y. Jun/A-7681-2014; Gao, Chuanyu/O-3946-2019	Xu, Y. Jun/0000-0003-3646-626X; Gao, Chuanyu/0000-0003-2792-5022; lu, xian guo/0000-0001-7638-2787	National Natural Science Foundation of China [41371107]; National Basic Research Program of China [2012CB956103]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (no. 41371107) and the National Basic Research Program of China (no. 2012CB956103). The corresponding author, YJL, received the above-mentioned fundings. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; Bhattacharjee J, 2009, WETLANDS, V29, P690, DOI 10.1672/06-176.1; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; Chytry M, 2003, FOLIA GEOBOT, V38, P429, DOI 10.1007/BF02803250; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Cui BS, 2010, PLANT ECOL, V209, P279, DOI 10.1007/s11258-010-9723-z; Dwire KA, 2004, OECOLOGIA, V139, P309, DOI 10.1007/s00442-004-1498-2; Dwire KA, 2006, WETLANDS, V26, P131, DOI 10.1672/0277-5212(2006)26[131:PSDIRT]2.0.CO;2; Fu PY., 1995, CLAVIS PLANTATRUM CH; Garnier E, 2012, AGRON SUSTAIN DEV, V32, P365, DOI 10.1007/s13593-011-0036-y; Garssen AG, 2015, GLOBAL CHANGE BIOL, V21, P2881, DOI 10.1111/gcb.12921; GAUDET CL, 1988, NATURE, V334, P242, DOI 10.1038/334242a0; GLASER PH, 1990, J ECOL, V78, P1021, DOI 10.2307/2260950; Gosselink J.G., 2000, WETLANDS; Grace JB, 2001, OIKOS, V92, P193, DOI 10.1034/j.1600-0706.2001.920201.x; GRIME JP, 1973, NATURE, V242, P344, DOI 10.1038/242344a0; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Kotowski W, 2001, PLANT ECOL, V155, P147, DOI 10.1023/A:1013214716842; Lenssen J, 1999, OIKOS, V86, P523, DOI 10.2307/3546656; Lenssen JPM, 2005, J ECOL, V93, P138, DOI 10.1111/j.1365-2745.2004.00957.x; Li F, 2011, AQUAT ECOL, V45, P89, DOI 10.1007/s10452-010-9334-8; Lou YJ, 2015, J VEG SCI, V26, P643, DOI 10.1111/jvs.12270; Lou YJ, 2013, NORD J BOT, V31, P748, DOI 10.1111/j.1756-1051.2013.01721.x; Luo WB, 2008, WETLANDS, V28, P866, DOI 10.1672/07-225.1; Luo WB, 2009, HYDROBIOLOGIA, V624, P151, DOI 10.1007/s10750-008-9689-1; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Mittelbach GG, 2001, ECOLOGY, V82, P2381, DOI 10.1890/0012-9658(2001)082[2381:WITORB]2.0.CO;2; MOORE DRJ, 1989, VEGETATIO, V79, P99; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Seabloom EW, 1998, PLANT ECOL, V138, P203, DOI 10.1023/A:1009711919757; Shaver GR, 1998, ECOL MONOGR, V68, P75, DOI 10.1890/0012-9615(1998)068[0075:BACFIW]2.0.CO;2; Shi FX, 2015, ECOL ENG, V81, P158, DOI 10.1016/j.ecoleng.2015.04.054; SHIPLEY B, 1991, ECOLOGY, V72, P1658, DOI 10.2307/1940965; SHIPLEY B, 1991, CAN J BOT, V69, P1420, DOI 10.1139/b91-184; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Timmermann A, 2015, J APPL ECOL, V52, P21, DOI 10.1111/1365-2664.12374; van Eck WHJM, 2004, OIKOS, V107, P393, DOI 10.1111/j.0030-1299.2004.13083.x; Venn SE, 2011, PLANT ECOL, V212, P1491, DOI 10.1007/s11258-011-9923-1; Venterink HO, 2001, J ECOL, V89, P1033, DOI 10.1111/j.1365-2745.2001.00616.x; VERMEER JG, 1987, ACTA OECOL-OEC PLANT, V8, P321; Violle C, 2011, OIKOS, V120, P389, DOI 10.1111/j.1600-0706.2010.18525.x; Wang ZM, 2006, ENVIRON MONIT ASSESS, V112, P69, DOI 10.1007/s10661-006-0312-5; Wassen MJ, 2003, PLANT ECOL, V165, P27, DOI 10.1023/A:1021493327180; Weltzin JF, 2000, ECOLOGY, V81, P3464, DOI 10.1890/0012-9658(2000)081[3464:ROBAFP]2.0.CO;2; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WHEELER BD, 1982, J ECOL, V70, P179, DOI 10.2307/2259872; WHEELER BD, 1991, J ECOL, V79, P285, DOI 10.2307/2260713; Whitbeck M, 2006, WETLANDS, V26, P278, DOI 10.1672/0277-5212(2006)26[278:EONMFE]2.0.CO;2; Wu GL, 2013, J HYDROL, V476, P120, DOI 10.1016/j.jhydrol.2012.10.031; Xie YH, 2008, AQUAT BOT, V89, P292, DOI 10.1016/j.aquabot.2008.03.003; Zhang XH, 2014, J FRESHWATER ECOL, V29, P117, DOI 10.1080/02705060.2013.825821	53	35	40	9	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153972	10.1371/journal.pone.0153972	http://dx.doi.org/10.1371/journal.pone.0153972			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097325	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600077
J	Piou, V; Tabart, J; Urrutia, V; Hemptinne, JL; Vetillard, A				Piou, Vincent; Tabart, Jeremy; Urrutia, Virginie; Hemptinne, Jean-Louis; Vetillard, Angelique			Impact of the Phoretic Phase on Reproduction and Damage Caused by Varroa destructor (Anderson and Trueman) to Its Host, the European Honey Bee (Apis mellifera L.)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; JACOBSONI OUD; BROOD CELLS; FINDING BEHAVIOR; PCR ANALYSIS; DRONE BROOD; MITE; PARASITE; WORKER; INFESTATION	Varroa destructor is a parasitic mite of the honeybee that causes thousands of colony losses worldwide. The parasite cycle is composed of a phoretic and a reproductive phase. During the former, mites stay on adult bees, mostly on nurses, to feed on hemolymph. During the latter, the parasites enter brood cells and reproduce. We investigated if the type of bees on which Varroa stays during the phoretic phase and if the duration of this stay influenced the reproductive success of the parasite and the damage caused to bees. For that purpose, we used an in vitro rearing method developed in our laboratory to assess egg laying rate and the presence and number of fully molted daughters. The expression level of two Varroa vitellogenin genes (VdVg1 and VdVg2), known to vary throughout reproduction, was also quantified. Results showed that the status of the bees or time spent during the phoretic phase impacts neither reproduction parameters nor the Varroa vitellogenin genes levels of expression. However, we correlated these parameters to the gene expression and demonstrated that daughters expressed the vitellogenin genes at lower levels than their mother. Regarding the damage to bees, the data indicated that a longer stay on adult bees during the phoretic phase resulted in more frequent physical deformity in newborn bees. We showed that those mites carry more viral loads of the Deformed Wing Virus and hence trigger more frequently overt infections. This study provides new perspectives towards a better understanding of the Varroa-honeybee interactions.	[Piou, Vincent; Tabart, Jeremy; Urrutia, Virginie; Vetillard, Angelique] Ctr Univ Jean Francois Champoll, Lab Venins & Act Biol, EA 4357, PRES Univ Toulouse, Albi, France; [Hemptinne, Jean-Louis] Univ Toulouse 3, Lab Evolut & Divers Biol, ENFA, CNRS,UMR5174, F-31062 Toulouse, France	Universite Federale Toulouse Midi-Pyrenees (ComUE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Ecole Nationale Formation Agronomique (ENSFEA)	Vetillard, A (corresponding author), Ctr Univ Jean Francois Champoll, Lab Venins & Act Biol, EA 4357, PRES Univ Toulouse, Albi, France.	angelique.vetillard@univ-jfc.fr			Region Midi-Pyrenees; CUFR JFC; Labex TULIP	Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); CUFR JFC; Labex TULIP	Financial support for this study was provided by Region Midi-Pyrenees and CUFR JFC. VP was supported by a grant from Region Midi-Pyrenees. JLH was supported by a grant from Labex TULIP. No additional external funding received for this study. The funders has no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adjlane N., 2014, Mellifera, V14, P3; Al-Ghzawi S., 1992, Apidologie, V23, P369; Anderson DL, 2000, EXP APPL ACAROL, V24, P165, DOI 10.1023/A:1006456720416; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; Beetsma J, 1999, APIDOLOGIE, V30, P125, DOI 10.1051/apido:19990204; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BOOT WJ, 1995, ENTOMOL EXP APPL, V75, P1, DOI 10.1007/BF02382773; Borst DW, 2000, INSECT BIOCHEM MOLEC, V30, P813, DOI 10.1016/S0965-1748(00)00053-9; Cabrera AR, 2013, INSECT MOL BIOL, V22, P505, DOI 10.1111/imb.12040; Cabrera AR, 2014, ARCH INSECT BIOCHEM, V85, P61, DOI 10.1002/arch.21143; Cabrera AR, 2009, J INSECT PHYSIOL, V55, P1079, DOI 10.1016/j.jinsphys.2009.08.007; Calderon RA, 2012, EXP APPL ACAROL, V56, P297, DOI 10.1007/s10493-012-9518-0; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Cordon ARC, 2013, INSECT MOL BIOL, V22, P88, DOI 10.1111/imb.12006; Dainat B, 2013, J INVERTEBR PATHOL, V112, P278, DOI 10.1016/j.jip.2012.12.009; de Guzman LI, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.5.14; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Del Piccolo F, 2010, PARASITOLOGY, V137, P967, DOI 10.1017/S0031182009991867; DERUIJTER A, 1987, APIDOLOGIE, V18, P321, DOI 10.1051/apido:19870403; Di Prisco G, 2011, VIRUSES-BASEL, V3, P2425, DOI 10.3390/v3122425; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; DONZE G, 1994, BEHAV ECOL SOCIOBIOL, V34, P305, DOI 10.1007/BF00197001; Donze G, 1996, ECOL ENTOMOL, V21, P17, DOI 10.1111/j.1365-2311.1996.tb00261.x; Francis RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057540; Frey E, 2013, J INVERTEBR PATHOL, V113, P56, DOI 10.1016/j.jip.2013.01.007; FUCHS S, 1989, APIDOLOGIE, V20, P257, DOI 10.1051/apido:19890308; FUCHS S, 1994, EXP APPL ACAROL, V18, P309, DOI 10.1007/BF00132320; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; IFANTIDIS MD, 1983, J APICULT RES, V22, P200, DOI 10.1080/00218839.1983.11100588; Khongphinitbunjong K, 2015, J INSECT PHYSIOL, V72, P28, DOI 10.1016/j.jinsphys.2014.11.005; Kirrane MJ, 2011, J ECON ENTOMOL, V104, P1146, DOI 10.1603/EC11035; Klowden MJ, 2013, PHYSIOLOGICAL SYSTEMS IN INSECTS, 3RD EDITION, P1; KUNKEL JG, 1976, J INSECT PHYSIOL, V22, P809, DOI 10.1016/0022-1910(76)90248-1; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Martin S, 1997, EXP APPL ACAROL, V21, P539, DOI 10.1023/A:1018492231639; Martin S, 1998, ECOL MODEL, V109, P267, DOI 10.1016/S0304-3800(98)00059-3; MARTIN SJ, 1995, EXP APPL ACAROL, V19, P199, DOI 10.1007/BF00130823; MAY RM, 1978, J ANIM ECOL, V47, P249, DOI 10.2307/3934; NAZZI F, 1994, APIDOLOGIE, V25, P579, DOI 10.1051/apido:19940608; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Nordstrom S, 2003, EXP APPL ACAROL, V29, P293, DOI 10.1023/A:1025853731214; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; PAIN JANINE, 1966, ANN ABEILLE [PARIS], V9, P71, DOI 10.1051/apido:19660106; Pernal SF, 2005, EXP APPL ACAROL, V37, P1, DOI 10.1007/s10493-005-1117-x; Roberts JMK, 2015, MOL ECOL, V24, P2379, DOI 10.1111/mec.13185; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230; Samsinak K., 1972, Vcelarstvi, V25, P268; SCHULZ AE, 1984, APIDOLOGIE, V15, P401, DOI 10.1051/apido:19840404; SEELEY TD, 1991, ETHOLOGY, V87, P284; Solignac M, 2005, P ROY SOC B-BIOL SCI, V272, P411, DOI 10.1098/rspb.2004.2853; STEINER J, 1995, EXP APPL ACAROL, V19, P411, DOI 10.1007/BF00145158; Sturmer M., 1994, Apidologie, V25, P453; Tabart J, 2013, EXP APPL ACAROL, V61, P107, DOI 10.1007/s10493-013-9675-9; Tentcheva D, 2006, APIDOLOGIE, V37, P41, DOI 10.1051/apido:2005057; van Dooremalen C, 2013, J INSECT PHYSIOL, V59, P487, DOI 10.1016/j.jinsphys.2013.02.006; van Esch J., 1988, P57; Vetillard A, 2014, Liquid-tight and gas-permeable membrane, method for the production thereof, and use of such a membrane for the in vitro breeding of arthropods, Patent No. [WO2014086922A1, 2014086922]; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	60	18	20	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153482	10.1371/journal.pone.0153482	http://dx.doi.org/10.1371/journal.pone.0153482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096154	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600038
J	Talhouk, A; Kommoss, S; Mackenzie, R; Cheung, M; Leung, S; Chiu, DS; Kalloger, SE; Huntsman, DG; Chen, S; Intermaggio, M; Gronwald, J; Chan, FC; Ramus, SJ; Steidl, C; Scott, DW; Anglesio, MS				Talhouk, Aline; Kommoss, Stefan; Mackenzie, Robertson; Cheung, Martin; Leung, Samuel; Chiu, Derek S.; Kalloger, Steve E.; Huntsman, David G.; Chen, Stephanie; Intermaggio, Maria; Gronwald, Jacek; Chan, Fong C.; Ramus, Susan J.; Steidl, Christian; Scott, David W.; Anglesio, Michael S.			Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction	PLOS ONE			English	Article							GENE-EXPRESSION; OVARIAN-CANCER; RNA; SUBTYPES; VALIDATION; SIGNATURE	A major weakness in many high-throughput genomic studies is the lack of consideration of a clinical environment where one patient at a time must be evaluated. We examined generalizable and platform-specific sources of variation from NanoString gene expression data on both ovarian cancer and Hodgkin lymphoma patients. A reference-based strategy, applicable to single-patient molecular testing is proposed for batch effect correction. The proposed protocol improved performance in an established Hodgkin lymphoma classifier, reducing batch-to-batch misclassification while retaining accuracy and precision. We suggest this strategy may facilitate development of NanoString and similar molecular assays by accelerating prospective validation and clinical uptake of relevant diagnostics.	[Talhouk, Aline; Mackenzie, Robertson; Kalloger, Steve E.; Huntsman, David G.; Anglesio, Michael S.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Kommoss, Stefan] Univ Hosp Tuebingen, Dept Womens Hlth, Tubingen, Germany; [Cheung, Martin] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Leung, Samuel; Huntsman, David G.] Univ British Columbia, Vancouver Gen Hosp, GPEC, Vancouver, BC V5Z 1M9, Canada; [Leung, Samuel; Huntsman, David G.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [Chiu, Derek S.] Univ British Columbia, Dept Stat, Vancouver, BC V6T 1W5, Canada; [Kalloger, Steve E.] Pancreas Ctr BC, Vancouver, BC, Canada; [Huntsman, David G.; Anglesio, Michael S.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Chen, Stephanie] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Intermaggio, Maria; Ramus, Susan J.] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia; [Gronwald, Jacek] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Chan, Fong C.; Steidl, Christian; Scott, David W.] British Columbia Canc Agcy, Canc Res Ctr, Ctr Lymphoid Canc, Vancouver, BC V5Z 4E6, Canada; [Ramus, Susan J.] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia	University of British Columbia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of Southern California; University of New South Wales Sydney; Pomeranian Medical University; British Columbia Cancer Agency; Garvan Institute of Medical Research; St Vincents Hospital Sydney	Anglesio, MS (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.; Anglesio, MS (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	manglesio@bccrc.ca	Huntsman, David/ABE-6082-2020; Ramus, Susan/AAG-8352-2019; Gronwald, Jacek/A-4576-2017	Ramus, Susan/0000-0003-0005-7798; Gronwald, Jacek/0000-0002-3643-2871	Canadian Institutes for Health Research; Carraresi Foundation OVCARE Research Grant - Carraresi Foundation; BC Cancer Foundation; VGH and UBC Hospitals Foundation; Eve Appeal (The Oak Foundation); UBC+VGH Hospitals Foundation; NATIONAL CANCER INSTITUTE [R01CA172404] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Carraresi Foundation OVCARE Research Grant - Carraresi Foundation; BC Cancer Foundation; VGH and UBC Hospitals Foundation; Eve Appeal (The Oak Foundation); UBC+VGH Hospitals Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded directly by the Canadian Institutes for Health Research (Proof of Principle 1 Grant, to DGH and MSA), and a Carraresi Foundation OVCARE Research Grant (to MSA), supported by the Carraresi Foundation, BC Cancer Foundation and the VGH and UBC Hospitals Foundation. The United Kingdom Ovarian Cancer Population Study (UKOPS; an OTTA member contributor) was funded by the Eve Appeal (The Oak Foundation), and supported by researchers at the National Institute for Health Research University College London Hospitals Biomedical Research Centre. The OVCARE gynecological tissue bank receives funding from the BC Cancer Foundation and the UBC+VGH Hospitals Foundation. Funding bodies had no role in the design of the study; the collection, analysis, or interpretation of the data; the writing of the manuscript; or the decision to submit the manuscript for publication.	Altman N, 2009, BATCH EFFECTS NOISE, V34; Anglesio MS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0072162, 10.1371/annotation/ffcaf179-872f-470b-8bb6-f06d8ba6d03a]; [Anonymous], 2013, NANO46 GENES METHODS; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Chen C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017238; Chen JJ, 2004, BIOINFORMATICS, V20, P1436, DOI 10.1093/bioinformatics/bth118; Deng MC, 2009, J HEART LUNG TRANSPL, V28, pS229, DOI 10.1016/j.healun.2008.11.477; Gagnon-Bartsch JA, 2012, BIOSTATISTICS, V13, P539, DOI 10.1093/biostatistics/kxr034; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Jens-Uwe B, 2009, EUR ONCOL, V6, P36; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kit P., 2013, PROSIGNA BREAST CANC, P1; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Lazar C., 2012, BRIEF BIOINFORM; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Lin L, 1998, PDA J PHARM SCI TECH, V52, P55; Lu QZ, 2009, ANAL CHEM, V81, P8715, DOI 10.1021/ac901991x; LUO J, 2010, PHARMACOGENOMI S OCT, pS48, DOI DOI 10.1038/TPJ.2010.57; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Micheel C., 2012, EVOLUTION TRANSLATIO; Nielsen T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-177; Northcott PA, 2012, ACTA NEUROPATHOL, V123, P615, DOI 10.1007/s00401-011-0899-7; Novoradovskaya N, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-20; Parker HS, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1766; Patil P, 2015, BIOINFORMATICS, P1; Prokopec SD, 2013, RNA, V19, P51, DOI 10.1261/rna.034710.112; Reis PP, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-46; Scott DW, 2013, J CLIN ONCOL, V31, P692, DOI 10.1200/JCO.2012.43.4589; Shi LM, 2010, NAT BIOTECHNOL, V28, P827, DOI 10.1038/nbt.1665; Shi LM, 2004, EXPERT REV MOL DIAGN, V4, P761, DOI 10.1586/14737159.4.6.761; Slodkowska EA, 2009, EXPERT REV MOL DIAGN, V9, P417, DOI 10.1586/ERM.09.32; Sung PL, 2014, GYNECOL ONCOL, V133, P147, DOI 10.1016/j.ygyno.2014.02.016; Technologies N, 2000, EXPR DAT AN GUID; TEMSAMANI J, 1995, NUCLEIC ACIDS RES, V23, P1841, DOI 10.1093/nar/23.11.1841; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vargas J, 2013, PLOS CURR, DOI 10.1371/currents.eogt.0f04f6081905998fa92b99593478aeab; Veldman-Jones MH, 2015, CANCER RES; Walker WL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-494	40	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153844	10.1371/journal.pone.0153844	http://dx.doi.org/10.1371/journal.pone.0153844			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096160	Green Published, gold			2022-12-27	WOS:000374543600062
J	Frommherz, L; Bub, A; Hummel, E; Rist, MJ; Roth, A; Watzl, B; Kulling, SE				Frommherz, Lara; Bub, Achim; Hummel, Eva; Rist, Manuela J.; Roth, Alexander; Watzl, Bernhard; Kulling, Sabine E.			Age-Related Changes of Plasma Bile Acid Concentrations in Healthy Adults-Results from the Cross-Sectional KarMeN Study	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; HUMAN COLONIC MICROBIOTA; GALLSTONE FORMATION; HUMAN-SERUM; CHOLESTEROL; METABOLISM; PROFILE; GENDER; 7-ALPHA-HYDROXY-4-CHOLESTEN-3-ONE; QUANTIFICATION	Bile acids (BA) play an important role in lipid metabolism. They facilitate intestinal lipid absorption, and BA synthesis is the main catabolic pathway for cholesterol. The objective of this study was to investigate associations of age, sex, diet (fat intake) and parameters of lipid metabolism (triglycerides, LDL, HDL, body fat content) with fasting plasma BA concentration of healthy individuals. Fasting plasma samples from a cross-sectional study were used to determine the concentrations of 14 BA using an LC-MS stable isotope dilution assay. Triglycerides, LDL and HDL were analyzed by standard clinical chemistry methods and body fat content was measured with a DXA instrument. The dietary fat intake of the 24 h period prior to the sampling was assessed on the basis of a 24 h recall. Subsequent statistical data processing was done by means of a median regression model. Results revealed large inter-individual variations. Overall, higher median plasma concentrations of BA were observed in men than in women. Quantile regression showed significant interactions of selected BA with age and sex, affecting primarily chenodeoxycholic acid and its conjugates. No associations were found for LDL and the amount of fat intake (based on the percentage of energy intake from dietary fat as well as total fat intake). Additional associations regarding body fat content, HDL and triglycerides were found for some secondary BA plasma concentrations. We conclude that age and sex are associated with the fasting plasma concentrations. Those associations are significant and need to be considered in studies investigating the role of BA in the human metabolism.	[Frommherz, Lara; Kulling, Sabine E.] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Karlsruhe, Germany; [Bub, Achim; Rist, Manuela J.; Roth, Alexander; Watzl, Bernhard] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Physiol & Biochem Nutr, Karlsruhe, Germany; [Hummel, Eva] Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Nutr Behav, Karlsruhe, Germany		Frommherz, L (corresponding author), Fed Res Inst Nutr & Food, Max Rubner Inst, Dept Safety & Qual Fruit & Vegetables, Karlsruhe, Germany.	lara.frommherz@mri.bund.de		Frommherz, Lara/0000-0001-6178-3430; Kulling, Sabine E./0000-0002-9956-2702	German Federal Ministry of Food and Agriculture (BMEL)	German Federal Ministry of Food and Agriculture (BMEL)	The work was supported by the German Federal Ministry of Food and Agriculture (BMEL). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGELIN B, 1982, J CLIN INVEST, V70, P724, DOI 10.1172/JCI110668; [Anonymous], 2001, GUIDANCE IND BIOANAL; BARBARA L, 1980, PEDIATR RES, V14, P1222, DOI 10.1203/00006450-198011000-00014; Bathena SPR, 2015, TOXICOL SCI, V143, P296, DOI 10.1093/toxsci/kfu227; Bathena SPR, 2013, J CHROMATOGR B, V942, P53, DOI 10.1016/j.jchromb.2013.10.019; Bertolotti M, 2007, EUR J CLIN INVEST, V37, P501, DOI 10.1111/j.1365-2362.2007.01808.x; BERTOLOTTI M, 1993, J LIPID RES, V34, P1001; Brufau G, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-73; Burkard I, 2005, J CHROMATOGR B, V826, P147, DOI 10.1016/j.jchromb.2005.08.016; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Cariou B, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-48; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Duane WC, 1999, J LIPID RES, V40, P1194; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Einarsson C, 2001, HEPATOLOGY, V33, P1189, DOI 10.1053/jhep.2001.23790; EINARSSON K, 1985, NEW ENGL J MED, V313, P277, DOI 10.1056/NEJM198508013130501; EVERSON GT, 1991, J CLIN INVEST, V87, P237, DOI 10.1172/JCI114977; Faulds MH, 2012, J ENDOCRINOL, V212, P3, DOI 10.1530/JOE-11-0044; Galman C, 2011, J INTERN MED, V270, P580, DOI 10.1111/j.1365-2796.2011.02466.x; Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gunness P, 2016, MOL NUTR FOOD RES, V60, P642, DOI 10.1002/mnfr.201500686; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; HOFMANN AF, 1982, GASTROENTEROLOGY, V83, P738; Hofmann AF, 2014, J LIPID RES, V55, P1553, DOI 10.1194/jlr.R049437; KAWASAKI H, 1986, TOHOKU J EXP MED, V150, P353, DOI 10.1620/tjem.150.353; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Koenker R., 2015, QUANTREG QUANTILE RE, V5, P19; KRAMER W, 1995, BBA-LIPID LIPID MET, V1257, P230, DOI 10.1016/0005-2760(95)00075-N; LIA A, 1995, AM J CLIN NUTR, V62, P1245, DOI 10.1093/ajcn/62.6.1245; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Matysik S, 2011, CHEM PHYS LIPIDS, V164, P525, DOI 10.1016/j.chemphyslip.2011.05.003; Max Rubner-Institut, 2014, BUND BLS VERS 3 02; Novacek G, 2006, WIEN MED WOCHENSCHR, V156, P527, DOI 10.1007/s10354-006-0346-x; R Core Team, 2018, R LANG ENV STAT COMP; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; RODA A, 1982, J LIPID RES, V23, P490; Russell DW, 2009, J LIPID RES, V50, pS120, DOI 10.1194/jlr.R800026-JLR200; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Scherer M, 2009, J CHROMATOGR B, V877, P3920, DOI 10.1016/j.jchromb.2009.09.038; Slimani N, 1999, COMPUT METH PROG BIO, V58, P251, DOI 10.1016/S0169-2607(98)00088-1; STARKEY BJ, 1982, CLIN CHIM ACTA, V119, P165, DOI 10.1016/0009-8981(82)90329-1; Steiner C, 2012, CLIN SCI, V122, P385, DOI 10.1042/CS20110482; Steiner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025006; Steiner C, 2010, J CHROMATOGR B, V878, P2870, DOI 10.1016/j.jchromb.2010.08.045; Trottier J, 2011, CLIN PHARMACOL THER, V90, P279, DOI 10.1038/clpt.2011.124; Uhler ML, 1998, J CLIN ENDOCR METAB, V83, P410, DOI 10.1210/jc.83.2.410; Vallim TQD, 2013, CELL METAB, V17, P657, DOI 10.1016/j.cmet.2013.03.013; Vincent RP, 2013, ANN CLIN BIOCHEM, V50, P360, DOI 10.1177/0004563212473450; Wang HH, 2009, BBA-MOL CELL BIOL L, V1791, P1037, DOI 10.1016/j.bbalip.2009.06.006; Wang S, 2006, ENDOCRINOLOGY, V147, P4025, DOI 10.1210/en.2005-1485; Xiang XQ, 2012, BASIC CLIN PHARMACOL, V110, P245, DOI 10.1111/j.1742-7843.2011.00792.x; Xie GX, 2015, J PROTEOME RES, V14, P850, DOI 10.1021/pr500920q	55	41	41	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153959	10.1371/journal.pone.0153959	http://dx.doi.org/10.1371/journal.pone.0153959			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092559	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200066
J	Gao, SW; Yang, YY; Wang, CF; Guo, JL; Zhou, DG; Wu, QB; Su, YC; Xu, LP; Que, YX				Gao, Shiwu; Yang, Yingying; Wang, Chunfeng; Guo, Jinlong; Zhou, Dinggang; Wu, Qibin; Su, Yachun; Xu, Liping; Que, Youxiong			Transgenic Sugarcane with a cry1Ac Gene Exhibited Better Phenotypic Traits and Enhanced Resistance against Sugarcane Borer	PLOS ONE			English	Article							REAL-TIME PCR; COPY NUMBER; FIELD PERFORMANCE; PLANTS; EXPRESSION; RICE; TRANSFORMATION; REGENERATION; BAR; SELECTION	We developed sugarcane plants with improved resistance to the sugarcane borer, Diatraea saccharalis (F). An expression vector pGcry1Ac0229, harboring the cry1Ac gene and the selectable marker gene, bar, was constructed. This construct was introduced into the sugarcane cultivar FN15 by particle bombardment. Transformed plantlets were identified after selection with Phosphinothricin (PPT) and Basta. Plantlets were then screened by PCR based on the presence of cry1Ac and 14 cry1Ac positive plantlets were identified. Real-time quantitative PCR (RT-qPCR) revealed that the copy number of cry1Ac gene in the transgenic lines varied from 1 to 148. ELISA analysis showed that Cry1Ac protein levels in 7 transgenic lines ranged from 0.85 mu g/FWg to 70.92 mu g/FWg in leaves and 0.04 mu g/FWg to 7.22 mu g/FWg in stems, and negatively correlated to the rate of insect damage that ranged from 36.67% to 13.33%, respectively. Agronomic traits of six transgenic sugarcane lines with medium copy numbers were similar to the non-transgenic parental line. However, phenotype was poor in lines with high or low copy numbers. Compared to the non-transgenic control plants, all transgenic lines with medium copy numbers had relatively equal or lower sucrose yield and significantly improved sugarcane borer resistance, which lowered susceptibility to damage by insects. This suggests that the transgenic sugarcane lines harboring medium copy numbers of the cry1Ac gene may have significantly higher resistance to sugarcane borer but the sugarcane yield in these lines is similar to the non-transgenic control thus making them superior to the control lines.	[Gao, Shiwu; Yang, Yingying; Wang, Chunfeng; Guo, Jinlong; Zhou, Dinggang; Wu, Qibin; Su, Yachun; Xu, Liping; Que, Youxiong] Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou 350002, Fujian, Peoples R China	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs	Xu, LP; Que, YX (corresponding author), Fujian Agr & Forestry Univ, Minist Agr, Key Lab Sugarcane Biol & Genet Breeding, Fuzhou 350002, Fujian, Peoples R China.	xlpmail@126.com; queyouxiong@126.com		Zhou, Dinggang/0000-0001-5665-9312; Que, Youxiong/0000-0003-1111-5834	National Nature Science Foundation of China [31271782]; earmarked fund for the Modern Agriculture Technology of China [CARS-20]; Scientific Research Fund of Fujian Provincial Education Department [JA12124]; Science and Technology Major Project of Fujian Province [2015NZ0002-2]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked fund for the Modern Agriculture Technology of China; Scientific Research Fund of Fujian Provincial Education Department; Science and Technology Major Project of Fujian Province	This work was supported by National Nature Science Foundation of China ( 31271782), the earmarked fund for the Modern Agriculture Technology of China (CARS-20) and Scientific Research Fund of Fujian Provincial Education Department (JA12124) and Science and Technology Major Project of Fujian Province (2015NZ0002-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arencibia A, 1997, MOL BREEDING, V3, P247, DOI 10.1023/A:1009616318854; Arvinth S, 2010, PLANT CELL REP, V29, P383, DOI 10.1007/s00299-010-0829-5; Chen H, 2005, THEOR APPL GENET, V111, P1330, DOI 10.1007/s00122-005-0062-8; D'Hont A, 2001, INTERNATIONAL SOCIETY OF SUGAR CANE TECHNOLOGISTS, VOL II, PROCEEDINGS, P556; De Bolle MFC, 2007, PLANT MOL BIOL, V63, P533, DOI 10.1007/s11103-006-9107-x; De Paepe A, 2009, PLANT J, V59, P517, DOI 10.1111/j.1365-313X.2009.03889.x; DELANNAY X, 1989, BIO-TECHNOL, V7, P1265; Dominguez A, 2000, PLANT CELL REP, V19, P427, DOI 10.1007/s002990050751; Falco MC, 2003, PLANT PHYSIOL BIOCH, V41, P761, DOI 10.1016/S0981-9428(03)00100-1; Fischer G, 2008, SUGARCANE ETHANOL: CONTRIBUTIONS TO CLIMATE CHANGE MITIGATION AND THE ENVIRONMENT, P29; FUJIMOTO H, 1993, BIO-TECHNOL, V11, P1151, DOI 10.1038/nbt1093-1151; GalloMeagher M, 1996, CROP SCI, V36, P1367, DOI 10.2135/cropsci1996.0011183X003600050047x; Gao SW, 2008, THESIS FUJIAN AGR FO; GORDONKAMM WJ, 1990, PLANT CELL, V2, P603, DOI 10.1105/tpc.2.7.603; Guo JL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/904769; Hansom S., 1999, Proceedings of the XXIII ISSCT Congress, New Delhi, India, 22-26 February, 1999. Volume 2, P278; Kalunke R. M., 2009, Sugar Tech, V11, P355, DOI 10.1007/s12355-009-0061-1; KNOWLES BH, 1986, J CELL SCI, V83, P89; KOZIEL MG, 1993, BIO-TECHNOL, V11, P194, DOI 10.1038/nbt0293-194; Li HF, 2010, J SHANXI AGR U, V30, P332; Luo SL, 2003, J HAINAN U NAT SCI, V21, P259; Manickavasagam M, 2004, PLANT CELL REP, V23, P134, DOI 10.1007/s00299-004-0794-y; Milligan SB, 2003, CROP SCI, V43, P1729, DOI 10.2135/cropsci2003.1729; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PERLAK FJ, 1993, PLANT MOL BIOL, V22, P313, DOI 10.1007/BF00014938; PERLAK FJ, 1990, BIO-TECHNOL, V8, P939, DOI 10.1038/nbt1090-939; Raza G, 2010, AFR J BIOTECHNOL, V9, P8739; Ricaud C., 1989, DIS SUGARCANE MAJOR; Setamou M, 2002, J ECON ENTOMOL, V95, P469, DOI 10.1603/0022-0493-95.2.469; Song P, 2002, PLANT CELL REP, V20, P948, DOI 10.1007/s00299-001-0432-x; Suo GL, 2006, PLANT CELL REP, V25, P689, DOI 10.1007/s00299-006-0133-6; THOMPSON CJ, 1987, EMBO J, V6, P2519, DOI 10.1002/j.1460-2075.1987.tb02538.x; Tomkins JP, 1999, THEOR APPL GENET, V99, P419, DOI 10.1007/s001220051252; VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Wei HR, 2003, J PLANT PHYSIOL, V160, P1241, DOI 10.1078/0176-1617-01086; Weng H, 2004, PLANT MOL BIOL REP, V22, P289, DOI 10.1007/BF02773139; Weng LX, 2011, TRANSGENIC RES, V20, P759, DOI 10.1007/s11248-010-9456-8; Weng LX, 2006, PEST MANAG SCI, V62, P178, DOI 10.1002/ps.1144; White WH, 2001, CROP SCI, V41, P1706, DOI 10.2135/cropsci2001.1706; Xue BT, 2014, INT J MOL SCI, V15, P8846, DOI 10.3390/ijms15058846; Yan Zhao, 2007, Journal of Genetics and Genomics, V34, P824, DOI 10.1016/S1673-8527(07)60093-9; Yang LT, 2005, PLANT CELL REP, V23, P759, DOI 10.1007/s00299-004-0881-0; Yang XiaoJie, 2011, Journal of Agricultural Biotechnology, V19, P221; Yang XiaoJie, 2010, Genomics and Applied Biology, V29, P125; Yi CX, 2008, ANAL BIOCHEM, V375, P150, DOI 10.1016/j.ab.2007.11.022; Zhangsun D, 2007, BIOLOGIA, V62, P386, DOI 10.2478/s11756-007-0096-2; Zhou DG, 2014, SCI REP-UK, V4, DOI 10.1038/srep04912	49	24	29	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153929	10.1371/journal.pone.0153929	http://dx.doi.org/10.1371/journal.pone.0153929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093437	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200062
J	Wang, ZF; Chen, YP; Xie, SY; Lv, HK				Wang, Zhifang; Chen, Yaping; Xie, Shuyun; Lv, Huakun			Changing Epidemiological Characteristics of Hepatitis A in Zhejiang Province, China: Increased Susceptibility in Adults	PLOS ONE			English	Article							VACCINATION; DISEASES; ERA	Background Hepatitis A is a common acute hepatitis caused by hepatitis A virus (HAV). Annually, it affects 1.4 million people worldwide. Between 1991 and 1994, HAV infections were highly endemic in Zhejiang Province (China), with 78,720 reported HAV infections per year. Hepatitis A vaccine came on the market in 1995 and was implemented for voluntary immunization. Since 2008, hepatitis A vaccine has been integrated into the national childhood routine immunization program. Objective To understand the current epidemiological profile of hepatitis A in Zhejiang Province since hepatitis A vaccine has been available for nearly two decades. Methods This study used the 2005-2014 National Notifiable Diseases Reporting System data to evaluate the incidence rate of notified hepatitis A cases in Zhejiang Province. Results The overall trend of incidence rate of notified hepatitis A cases significantly decreased from 2005 to 2014 (P<0.001). During the study period, the reported incidence rate in individuals aged <= 19 years declined to the historically lowest record in 2014. Compared with individuals aged <= 19 years, those aged >= 20 years showed the highest incidence rate (P<0.001). Majority of HAV infected cases were Laborers, accounting for approximately 70% of reported cases. Conclusions Childhood immunization strategy with hepatitis A vaccine seemed to be effective in decreasing notified hepatitis A incidence rate in individuals aged <= 19 years. Those aged >= 20 years were observed to be the most susceptible population. The vast majority of hepatitis A cases were notified among Laborers. Therefore, we strongly suggest that future preventive and control measures should focus more on adults, particularly Laborers, in addition to the current childhood hepatitis A vaccination programme.	[Wang, Zhifang; Chen, Yaping; Xie, Shuyun; Lv, Huakun] Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China; [Wang, Zhifang] Zhejiang Prov Ctr Dis Control & Prevent, Dept Environm & Occupat Hlth, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention; Zhejiang Provincial Center for Disease Control & Prevention	Lv, HK (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept Immunizat Programme, Hangzhou, Zhejiang, Peoples R China.	chinachichi@hotmail.com		Lv, Huakun/0000-0002-3420-6942	National Science Foundation for Young Scientists of China [31500751]	National Science Foundation for Young Scientists of China	This project was supported by the National Science Foundation for Young Scientists of China (grant no. 31500751, https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list). Z.W. received this funding.	Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Brown GR, 2002, SOUTH MED J, V95, P826, DOI 10.1097/00007611-200295080-00010; Bruni R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149642; Cao JY, 2009, HEPATOL INT, V3, P356, DOI 10.1007/s12072-008-9116-8; Center for Disease Control and Prevention, 2015, SURV VIR HEP US 2012; Centers for Disease Control and Prevention, 2015, EPIDEMIOLOGY PREVENT, V13th, P135; Centre for Health Protection Department of Health Hong Kong Special Administrative Region, 2006, SCI COMM ENT INF FOO; Chen H, 1991, Zhonghua Liu Xing Bing Xue Za Zhi, V12, P87; Cui FQ, 2009, J EPIDEMIOL, V19, P189, DOI 10.2188/jea.JE20080087; Dai Y, 2003, CHIN J DIS CONTROL P, V7, P63; Division of viral hepatitis Centre for Disease Prevention and Control, 2013, SURVEILLANCE OF VIRA; Dong PM, 2012, J ZHENGZHOU U MED SC, V47, P94; European Centre for Disease Prevention and Control, 2014, ANN EP REP 2014 FOOD; Franco E, 2012, WORLD J HEPATOL, V4, P68, DOI 10.4254/wjh.v4.i3.68; Gossner C. M., 2015, EURO SURVEILL, V20; Jacobsen KH, 2005, INT J EPIDEMIOL, V34, P600, DOI 10.1093/ije/dyi062; Kong ZF, 2009, DIS SURVEILLANCE, V24, P301; Kong ZF, 2008, SHANGHAI J PREVENTIV, V20, P325; Lam E, 2015, HUM VACC IMMUNOTHER, V11, P2627, DOI 10.1080/21645515.2015.1096457; Liu Y, 2011, S CHINA J PREV MED, V37, P39; Mantovani SAS, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1164-9; Mao JS, 1991, VIRAL HEPATITIS CHIN, P111; Naing N N, 2000, Malays J Med Sci, V7, P10; Omar B. A, 2001, AGE STANDARDIZATION; SUI HT, 2007, CHINESE J VACCINES I, V13, P466; Tavoschi L, 2015, EUROSURVEILLANCE, V20, P20, DOI 10.2807/1560-7917.ES2015.20.29.21193; Tsou TP, 2011, VACCINE, V29, P2956, DOI 10.1016/j.vaccine.2011.02.001; Wang X.J., 2004, DIS SURVEILLANCE, V19, P290; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Wick Jeannette Y, 2012, Consult Pharm, V27, P472, DOI 10.4140/TCP.n.2012.472; World Health Organization, 2015, HEP A; Xu SS, 2013, REV CONSTRUCTING URB; Xu ZY, 2008, J VIRAL HEPATITIS, V15, P33, DOI 10.1111/j.1365-2893.2008.01026.x; Yang H, 2009, OCCUP HLTH, V25, P953; Yao J, 2000, CHINA PLANNED IMMUNI, V6, P138; Zhang LJ, 2009, EPIDEMIOL INFECT, V137, P428, DOI 10.1017/S0950268808001337; Zhu CJ, 2014, ZHEJIANG PROVINCIAL; Zhuang FC, 2012, HEPAT MON, V12, P100, DOI 10.5812/hepatmon.838	38	12	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153804	10.1371/journal.pone.0153804	http://dx.doi.org/10.1371/journal.pone.0153804			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093614	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200044
J	Boca, SM; Nishida, M; Harris, M; Rao, S; Cheema, AK; Gill, K; Seol, H; Morgenroth, LP; Henricson, E; McDonald, C; Mah, JK; Clemens, PR; Hoffman, EP; Hathout, Y; Madhavan, S				Boca, Simina M.; Nishida, Maki; Harris, Michael; Rao, Shruti; Cheema, Amrita K.; Gill, Kirandeep; Seol, Haeri; Morgenroth, Lauren P.; Henricson, Erik; McDonald, Craig; Mah, Jean K.; Clemens, Paula R.; Hoffman, Eric P.; Hathout, Yetrib; Madhavan, Subha			Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study	PLOS ONE			English	Article							DISEASE PROGRESSION; PROTEOMICS	Serum metabolite profiling in Duchenne muscular dystrophy (DMD) may enable discovery of valuable molecular markers for disease progression and treatment response. Serum samples from 51 DMD patients from a natural history study and 22 age-matched healthy volunteers were profiled using liquid chromatography coupled to mass spectrometry (LC-MS) for discovery of novel circulating serum metabolites associated with DMD. Fourteen metabolites were found significantly altered (1% false discovery rate) in their levels between DMD patients and healthy controls while adjusting for age and study site and allowing for an interaction between disease status and age. Increased metabolites included arginine, creatine and unknown compounds at m/z of 357 and 312 while decreased metabolites included creatinine, androgen derivatives and other unknown yet to be identified compounds. Furthermore, the creatine to creatinine ratio is significantly associated with disease progression in DMD patients. This ratio sharply increased with age in DMD patients while it decreased with age in healthy controls. Overall, this study yielded promising metabolic signatures that could prove useful to monitor DMD disease progression and response to therapies in the future.	[Boca, Simina M.; Nishida, Maki; Harris, Michael; Rao, Shruti; Madhavan, Subha] Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA; [Boca, Simina M.; Cheema, Amrita K.; Gill, Kirandeep; Madhavan, Subha] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Boca, Simina M.] Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA; [Seol, Haeri; Morgenroth, Lauren P.; Hoffman, Eric P.; Hathout, Yetrib] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Seol, Haeri; Morgenroth, Lauren P.; Hoffman, Eric P.; Hathout, Yetrib] George Washington Univ, Washington, DC USA; [Henricson, Erik; McDonald, Craig] Univ Calif Davis, Sch Med, Dept Phys Med & Rehabil, Davis, CA 95616 USA; [Mah, Jean K.] Univ Calgary, Dept Pediat, Alberta Childrens Hosp, Calgary, AB T2N 1N4, Canada; [Clemens, Paula R.] Dept Veteran Affairs Med Ctr, Neurol Serv, Pittsburgh, PA USA; [Clemens, Paula R.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA	Georgetown University; Georgetown University; Georgetown University; Georgetown University; Children's National Health System; George Washington University; University of California System; University of California Davis; Alberta Childrens Hospital; University of Calgary; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Innovat Ctr Biomed Informat, Washington, DC 20007 USA.; Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA.; Boca, SM (corresponding author), Georgetown Univ, Med Ctr, Dept Biostat Bioinformat & Biomath, Washington, DC 20007 USA.	smb310@georgetown.edu	Boca, Simina/ABE-3747-2020	Boca, Simina/0000-0002-1400-3398; Rao, Shruti/0000-0002-7235-0777; McDonald, Craig/0000-0002-8779-3220; Cheema, Amrita/0000-0003-4877-7583; Harris, Michael/0000-0001-8789-0912; Hoffman, Eric/0000-0001-6470-5139	National Institutes of Health/National Cancer Institute [P30CA051008]; National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR062380, P50AR060836]; NIH/NCI [P30CA051008]; NIH/NIAMS [R01AR062380, P50AR060836]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062380, P50AR060836, R01AR061875] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The following grants contributed to the funding of this study: National Institutes of Health/National Cancer Institute grant P30CA051008 (for the Proteomics and Metabolomics shared resource), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=P30CA051008& National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant R01AR062380 (PI: CM, funded authors: SMB, HS, LPM, EH, CM, SM), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=R01AR062380& National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases grant P50AR060836 (PI: PRC, funded authors: PRC, EPH), https://taggs.hhs.gov/AwardDetail.cfm?s_Award_Num=P50AR060836&n_Prog_Office_Code=106.; We wish to acknowledge the advice provided by Difei Wang and Hilary Parker. The authors would also like to acknowledge the Proteomics and Metabolomics shared resource partially supported by NIH/NCI grant P30CA051008. This work was supported by the NIH/NIAMS grants R01AR062380 (PI: Craig McDonald) and partially by the P50AR060836 (PI: Paula Clemens). The authors take full responsibility for the contents of this manuscript, which do not represent the views of the Department of Veterans Affairs or the U.S. Government. The authors would like to thank the patients and families who have volunteered their time to take part in this project. We would also like to thank the dedicated CINRG researchers who continue to commit countless hours. The CINRG network sites that contributed to this project include: University of California, Davis-Ted Abresch, Michelle Cregan, Erica Goude, Merete Glick, Linda Johnson, Jay Han, Erik Henricson, Nanette Joyce; Holland Bloorview Kids Rehabilitation-Laila Eliasoph, Elizabeth Hosaki, Angela Gonzales, Vivienne Harris; Alberta Children's Hospital-Angela Chiu, Karla Sanchez, Natalia Rincon, Tiffany Haig; Queen Silvia Children's Hospital-Anne-Christine Alhander, Lisa Wahlgren, Anne-Berit Ekstrom, AnnaKarin Kroksmark, Ulrika Sterky; Children's National Medical Center-Marissa Birkmeier, Sarah Kaminski, Allyn Toles; Royal Children's Hospital-Kate Carroll, Katy DeValle, Rachel Kennedy, Andrew Kornberg, Dani Villano; Hadassah Hebrew University Hospital-Adina Bar Leve, Elana Wisband, Debbie Yaffe; Instituto de Neurosciencias Fundacion Favaloro-Luz Andreone, Jose Corderi, Lilia Mesa, Lorena Levi; Children's Hospital of Pittsburgh of UPMC and the University of Pittsburgh-Hoda Abdel-Hamid, Christopher Bise, Ann Craig, Casey Nguyen, Andrea Smith, Jason Weimer; Washington University, St. Louis-M. Al-Lozi, Julaine Florence, Betsy Malkus, Renee Renna, Jeanine Schierbacker, Catherine Seiner, Charlie Wulf; Children's Hospital of Virginia-Susan Blair, Barbara Grillo, Karen Jones, Eugenio Monasterio; University of Tennessee, Memphis-Meegan Barrett-Adair, Judy Clift, Cassandra Feliciano, Rachel Young; Children's Hospital of Westmead-Kristy Rose, Richard Webster, Stephanie Wicks; University of Alberta-Lucia Chen, Cameron Kennedy; The CINRG Coordinating Center- Adrienne Arrieta, Tanisha Brown-Caines, Avital Cnaan, Tina Duong, Fengming Hu, Lauren Morgenroth, Wenze Tang.	Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Ayoglu B, 2014, EMBO MOL MED, V6, P918, DOI 10.15252/emmm.201303724; Bello L, 2015, NEUROLOGY S, V84; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Cacchiarelli D, 2011, EMBO MOL MED, V3, P258, DOI 10.1002/emmm.201100133; DANIELI GA, 1977, HUM GENET, V35, P225, DOI 10.1007/BF00393974; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Griffin JL, 2009, GENOME MED, V1, DOI 10.1186/gm32; Guertin KA, 2014, AM J CLIN NUTR; Hathout Y, 2014, HUM MOL GENET; Hathout Y, 2015, P NATL ACAD SCI USA, V112, P7153, DOI 10.1073/pnas.1507719112; Henricson EK, 2013, MUSCLE NERVE, V48, P55, DOI 10.1002/mus.23808; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2013, DISCOV MED, V16, P233; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055; Kuhl C, 2012, ANAL CHEM, V84, P283, DOI 10.1021/ac202450g; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Mah JK, 2014, NEUROMUSCULAR DISORD, V24, P482, DOI 10.1016/j.nmd.2014.03.008; Martin FC, 2014, PROTEOM CLIN APPL, V8, P269, DOI 10.1002/prca.201300072; McAdam Laura C, 2012, Acta Myol, V31, P16; McDonald CM, 2013, MUSCLE NERVE, V48, P32, DOI 10.1002/mus.23807; MORRISON D, 1994, RESP MED, V88, P659, DOI 10.1016/S0954-6111(05)80062-9; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; OKINAKA S, 1961, ARCH NEUROL-CHICAGO, V4, P520, DOI 10.1001/archneur.1961.00450110050006; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; PLAUCHU H, 1981, J GENET HUM, V29, P59; Rouillon J, 2014, NEUROMUSCULAR DISORD, V24, P563, DOI 10.1016/j.nmd.2014.03.012; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wishart DS, 2012, NUCLEIC ACIDS RES; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263; Zhang H, 2015, DIS MARKERS	39	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153461	10.1371/journal.pone.0153461	http://dx.doi.org/10.1371/journal.pone.0153461			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082433	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000374291800021
J	Churbanov, AY; Karafet, TM; Morozov, IV; Mikhalskaia, VY; Zytsar, MV; Bondar, AA; Posukh, OL				Churbanov, Alexander Y.; Karafet, Tatiana M.; Morozov, Igor V.; Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Bondar, Alexander A.; Posukh, Olga L.			Whole Exome Sequencing Reveals Homozygous Mutations in RAI1, OTOF, and SLC26A4 Genes Associated with Nonsyndromic Hearing Loss in Altaian Families (South Siberia)	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; ENLARGED VESTIBULAR AQUEDUCT; ACID-INDUCED 1; RETINOIC ACID; 17P11.2 DELETIONS; PENDRED-SYNDROME; PDS MUTATIONS; MOUSE MODELS; INNER-EAR; PROTEIN	Hearing loss (HL) is one of the most common sensorineural disorders and several dozen genes contribute to its pathogenesis. Establishing a genetic diagnosis of HL is of great importance for clinical evaluation of deaf patients and for estimating recurrence risks for their families. Efforts to identify genes responsible for HL have been challenged by high genetic heterogeneity and different ethnic-specific prevalence of inherited deafness. Here we present the utility of whole exome sequencing (WES) for identifying candidate causal variants for previously unexplained nonsyndromic HL of seven patients from four unrelated Altaian families (the Altai Republic, South Siberia). The WES analysis revealed homozygous missense mutations in three genes associated with HL. Mutation c.2168A>G (SLC26A4) was found in one family, a novel mutation c.1111G>C (OTOF) was revealed in another family, and mutation c.5254G>A (RAI1) was found in two families. Sanger sequencing was applied for screening of identified variants in an ethnically diverse cohort of other patients with HL (n = 116) and in Altaian controls (n = 120). Identified variants were found only in patients of Altaian ethnicity (n = 93). Several lines of evidences support the association of homozygosity for discovered variants c.5254G>A (RAI1), c.1111C>G (OTOF), and c.2168A>G (SLC26A4) with HL in Altaian patients. Local prevalence of identified variants implies possible founder effect in significant number of HL cases in indigenous population of the Altai region. Notably, this is the first reported instance of patients with RAI1 missense mutation whose HL is not accompanied by specific traits typical for Smith-Magenis syndrome. Presumed association of RAI1 gene variant c.5254G>A with isolated HL needs to be proved by further experimental studies.	[Churbanov, Alexander Y.; Karafet, Tatiana M.] Univ Arizona, Arizona Res Labs, Div Biotechnol, Tucson, AZ USA; [Morozov, Igor V.; Bondar, Alexander A.] Russian Acad Sci, Siberian Branch, Inst Chem Biol & Fundamental Med, SB RAS Genom Core Facil, Novosibirsk, Russia; [Morozov, Igor V.; Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Posukh, Olga L.] Novosibirsk State Univ, Novosibirsk 630090, Russia; [Mikhalskaia, Valeriia Yu; Zytsar, Marina V.; Posukh, Olga L.] Russian Acad Sci, Siberian Branch, Fed Res Ctr Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk, Russia	University of Arizona; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS	Posukh, OL (corresponding author), Novosibirsk State Univ, Novosibirsk 630090, Russia.; Posukh, OL (corresponding author), Russian Acad Sci, Siberian Branch, Fed Res Ctr Inst Cytol & Genet, Lab Human Mol Genet, Novosibirsk, Russia.	posukh@bionet.nsc.ru	Morozov, Igor/AAH-5352-2021; Danilchenko, Valeriia/AAD-8799-2020; Posukh, Olga L/Q-6065-2016; Bondar, Alexander/AAA-7087-2020; Zytzar, Marina/AAG-1707-2021	Morozov, Igor/0000-0002-0307-4203; Danilchenko, Valeriia/0000-0001-5658-5974; Posukh, Olga L/0000-0003-1352-3591; Bondar, Alexander/0000-0001-9181-0487; 	Chinese Academy of Sciences Fellowship for Young International Scientists [2011Y1SA09]; NSFC [31150110466]; Siberian Branch of the Russian Academy of Sciences [0324-2015-0004, 0324-2015-0031]	Chinese Academy of Sciences Fellowship for Young International Scientists; NSFC(National Natural Science Foundation of China (NSFC)); Siberian Branch of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by grant #2011Y1SA09 from the Chinese Academy of Sciences Fellowship for Young International Scientists and NSFC grant #31150110466 (to AYC), by the State Project #0324-2015-0004, and by grant #0324-2015-0031 from the Siberian Branch of the Russian Academy of Sciences (to OLP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bi WM, 2007, HUM MOL GENET, V16, P1802, DOI 10.1093/hmg/ddm128; Bi W, 2006, AM J MED GENET A, V140A, P2454, DOI 10.1002/ajmg.a.31510; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bok J, 2011, P NATL ACAD SCI USA, V108, P161, DOI 10.1073/pnas.1010547108; Carmona-Mora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045155; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carmona-Mora P, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-63; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Di Cicco M, 2001, INT J PEDIATR OTORHI, V59, P147, DOI 10.1016/S0165-5876(01)00475-X; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Du W, 2013, INT J PEDIATR OTORHI, V77, P1670, DOI 10.1016/j.ijporl.2013.07.023; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Elsea SH, 2008, EUR J HUM GENET, V16, P412, DOI 10.1038/sj.ejhg.5202009; Elsea SH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001827; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Fragoso YD, 2015, BRAIN STRUCT FUNCT, V220, P1195, DOI 10.1007/s00429-014-0712-1; Frenz DA, 2010, AM J MED GENET A, V152A, P2947, DOI 10.1002/ajmg.a.33670; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Girirajan S, 2009, CLIN GENET, V75, P364, DOI 10.1111/j.1399-0004.2008.01135.x; Girirajan S, 2006, GENET MED, V8, P417, DOI 10.1097/01.gim.0000228215.32110.89; Girotto G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080323; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Hayes S, 2000, HUM MOL GENET, V9, P1753, DOI 10.1093/hmg/9.12.1753; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; Joober R, 1999, AM J MED GENET, V88, P694, DOI 10.1002/(SICI)1096-8628(19991215)88:6<694::AID-AJMG20>3.3.CO;2-9; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; Kim HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079063; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lacaria M, 2013, AM J MED GENET A, V161A, P1561, DOI 10.1002/ajmg.a.35941; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Mahdieh N, 2012, INT J PEDIATR OTORHI, V76, P1610, DOI 10.1016/j.ijporl.2012.07.030; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Pangrsic T, 2012, TRENDS NEUROSCI, V35, P671, DOI 10.1016/j.tins.2012.08.002; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Posukh O, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-12; Potapov L.P., 1969, ETHNICAL STRUCTURE O; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Raz Y, 1999, DEV BIOL, V213, P180, DOI 10.1006/dbio.1999.9364; Redin C, 2014, J MED GENET, V51, P724, DOI 10.1136/jmedgenet-2014-102554; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodriguez-Ballesteros M, 2008, HUM MUTAT, V29, P823, DOI 10.1002/humu.20708; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shearer AE, 2010, P NATL ACAD SCI USA, V107, P21104, DOI 10.1073/pnas.1012989107; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Smith R.J.H., 1993, GENEREVIEWS; Toulouse A, 2003, GENOMICS, V82, P162, DOI 10.1016/S0888-7543(03)00101-0; Truong HT, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-142; Tsukamoto K, 2003, EUR J HUM GENET, V11, P916, DOI 10.1038/sj.ejhg.5201073; Usami S, 1999, HUM GENET, V104, P188, DOI 10.1007/s004390050933; van der Zwaag B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005324; Vieira GH, 2012, EUR J HUM GENET, V20, P148, DOI 10.1038/ejhg.2011.167; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Wang DY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-79; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Williams SR, 2012, AM J HUM GENET, V90, P941, DOI 10.1016/j.ajhg.2012.04.013; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; YLIKOSKI J, 1994, J COMP NEUROL, V349, P596, DOI 10.1002/cne.903490407	63	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153841	10.1371/journal.pone.0153841	http://dx.doi.org/10.1371/journal.pone.0153841			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082237	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800056
J	Rume, FI; Affuso, A; Serrecchia, L; Rondinone, V; Manzulli, V; Campese, E; Di Taranto, P; Biswas, PK; Ahsan, CR; Yasmin, M; Fasanella, A; Hugh-Jones, M				Rume, Farzana Islam; Affuso, Alessia; Serrecchia, Luigina; Rondinone, Valeria; Manzulli, Viviana; Campese, Emanuele; Di Taranto, Pietro; Biswas, Paritosh Kumar; Ahsan, Chowdhury Rafiqul; Yasmin, Mahmuda; Fasanella, Antonio; Hugh-Jones, Martin			Genotype Analysis of Bacillus anthracis Strains Circulating in Bangladesh	PLOS ONE			English	Article							OUTBREAK	In Bangladesh, anthrax, caused by the bacterium Bacillus anthracis, is considered an endemic disease affecting ruminants with sporadic zoonotic occurrences in humans. Due to the lack of knowledge about risks from an incorrect removal of infected carcasses, the disease is not properly monitored, and because of the socio-economic conditions, the situation is under-reported and under-diagnosed. For sensitive species, anthrax represents a fatal outcome with sudden death and sometimes bleeding from natural orifices. The most common source of infection for ruminants is ingestion of spores during grazing in contaminated pastures or through grass and water contaminated with anthrax spores. Domestic cattle, sheep and goats can also become infected through contaminated bone meal (used as feed) originating from anthrax-infected carcasses. The present investigation was conducted to isolate B. anthracis organisms from 169 samples (73 soil, 1 tissue, 4 bone and 91 bone meal samples) collected from 12 different districts of Bangladesh. The sampling was carried out from 2012 to 2015. Twelve samples resulted positive for B. anthracis. Biomolecular analyses were conducted starting from the Canonical Single Nucleotide Polymorphism (CanSNP) to analyze the phylogenetic origin of strains. The analysis of genotype, obtained through the Multiple Locus Variable Number Tandem Repeat Analysis (MLVA) with the analysis of 15 Variable Number Tandem Repeats (VNTR), demonstrated four different genotypes: two of them were previously identified in the district of Sirajganj. The sub-genotyping, conducted with Single Nucleotide Repeats analysis, revealed the presence of eight subgenotypes. The data of the present study concluded that there was no observed correlation between imported cattle feed and anthrax occurrence in Bangladesh and that the remarkable genetic variations of B. anthracis were found in the soil of numerous outbreaks in this country.	[Affuso, Alessia; Serrecchia, Luigina; Rondinone, Valeria; Manzulli, Viviana; Campese, Emanuele; Di Taranto, Pietro; Fasanella, Antonio] Anthrax Reference Inst Italy, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy; [Rume, Farzana Islam; Ahsan, Chowdhury Rafiqul; Yasmin, Mahmuda] Univ Dhaka, Dept Microbiol, Dhaka 1000, Bangladesh; [Biswas, Paritosh Kumar] Chittagong Vet & Anim Sci Univ, Dept Microbiol & Vet Publ Hlth, Chittagong, Bangladesh; [Rume, Farzana Islam] Patuakhali Sci & Technol Univ, Dept Microbiol & Virol, Patuakhali, Bangladesh; [Hugh-Jones, Martin] Louisiana State Univ, Sch Coast & Environm, Baton Rouge, LA 70803 USA	IZS Puglia e Basilicata; University of Dhaka; Louisiana State University System; Louisiana State University	Affuso, A (corresponding author), Anthrax Reference Inst Italy, Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy.	alessia.affuso@gmail.com	Manzulli, Viviana/AAC-4932-2022	RONDINONE, VALERIA/0000-0001-7842-8697; Di Taranto, Pietro/0000-0002-0805-9360	Ministry of Health of Italy [IZSPB 06/13]; Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences	Ministry of Health of Italy(Ministry of Health, Italy); Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences	This study was funded by the Ministry of Health of Italy, Current Research 2013 "IZSPB 06/13" that supported the work of Istituto Zooprofilattico Sperimentale of Puglia and Basilicata. Work of FIR in Bangladesh was funded by the Bangladesh Academy of Sciences under BAS-USDA Program in Agricultural and Life Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed BN, 2010, BANG J MED MICROBIOL, V4, P46, DOI [10.3329/bjmm.v4i1.8470, DOI 10.3329/BJMM.V4I1.8470]; Ahsan MM, 2013, THAI J VET MED, V43, P449; Biswas PK, 2012, EPIDEMIOL INFECT, V140, P1888, DOI 10.1017/S0950268811002408; DAVIES DG, 1972, J HYG-CAMB, V70, P455, DOI 10.1017/S0022172400063038; DRAGON DC, 1995, CAN VET J, V36, P295; Fasanella A, 2013, EPIDEMIOL INFECT, V141, P1021, DOI 10.1017/S0950268812001227; Fasanella A, 2001, VACCINE, V19, P4214, DOI 10.1016/S0264-410X(01)00159-1; Fasanella A, 2013, VIRULENCE, V4, P659, DOI 10.4161/viru.26517; Fasanella A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-167; Fowler R. A., 2011, Journal of Bioterrorism and Biodefense, V2, P107; Hugh-Jones M, 2009, MOL ASPECTS MED, V30, P356, DOI 10.1016/j.mam.2009.08.003; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Jayedul Hassan, 2015, Journal of Advanced Veterinary and Animal Research, V2, P158; Keim P, 2000, J BACTERIOL, V182, P2928, DOI 10.1128/JB.182.10.2928-2936.2000; Kenefic LJ, 2008, LETT APPL MICROBIOL, V46, P600, DOI 10.1111/j.1472-765X.2008.02353.x; Mongoh MN, 2008, ZOONOSES PUBLIC HLTH, V55, P279, DOI 10.1111/j.1863-2378.2008.01135.x; Van Ert MN, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000461; WHO, 2008, ANTHRAX HUMANS ANIMA	18	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153548	10.1371/journal.pone.0153548	http://dx.doi.org/10.1371/journal.pone.0153548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082248	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800029
J	Gabbiadini, A; Riva, P; Andrighetto, L; Volpato, C; Bushman, BJ				Gabbiadini, Alessandro; Riva, Paolo; Andrighetto, Luca; Volpato, Chiara; Bushman, Brad J.			Acting like a Tough Guy: Violent-Sexist Video Games, Identification with Game Characters, Masculine Beliefs, & Empathy for Female Violence Victims	PLOS ONE			English	Article							SEXUAL-HARASSMENT; ROLE NORMS; AGGRESSION; MEDIA; SELF; PERCEPTIONS; WOMEN; MODEL	Empathy-putting oneself in another's shoes-has been described as the "social glue" that holds society together. This study investigates how exposure to sexist video games can decrease empathy for female violence victims. We hypothesized that playing violent-sexist video games would increase endorsement of masculine beliefs, especially among participants who highly identify with dominant and aggressive male game characters. We also hypothesized that the endorsement of masculine beliefs would reduce empathy toward female violence victims. Participants (N = 154) were randomly assigned to play a violent-sexist game, a violent-only game, or a non-violent game. After gameplay, measures of identification with the game character, traditional masculine beliefs, and empathy for female violence victims were assessed. We found that participants' gender and their identification with the violent male video game character moderated the effects of the exposure to sexist-violent video games on masculine beliefs. Our results supported the prediction that playing violent-sexist video games increases masculine beliefs, which occurred for male (but not female) participants who were highly identified with the game character. Masculine beliefs, in turn, negatively predicted empathic feelings for female violence victims. Overall, our study shows who is most affected by the exposure to sexist-violent video games, and why the effects occur. (200 words)	[Gabbiadini, Alessandro; Riva, Paolo; Volpato, Chiara] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Andrighetto, Luca] Univ Genoa, Dept Educ, Genoa, Italy; [Bushman, Brad J.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA; [Bushman, Brad J.] Vrije Univ Amsterdam, Amsterdam, Netherlands	University of Milano-Bicocca; University of Genoa; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam	Gabbiadini, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	ale.gabbiadini@gmail.com	Bushman, Brad/ABG-3412-2021; Gabbiadini, Alessandro/AAQ-4195-2021; Bushman, Brad/AAN-6427-2021; Riva, Paolo/D-8130-2011	Gabbiadini, Alessandro/0000-0002-7593-8007; Bushman, Brad/0000-0002-1266-5101; Riva, Paolo/0000-0002-9855-994X	MIUR, Ministry of Education, Universities and Research of Italy [20123X2PXT 003]; PRIN [20123X2PXT_003]	MIUR, Ministry of Education, Universities and Research of Italy(Ministry of Education, Universities and Research (MIUR)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This work is supported by PRIN (2012)-20123X2PXT 003 grant to the first and the third authors, provided by MIUR, Ministry of Education, Universities and Research of Italy.; The authors declare that they have no competing interests or any business relationships with the manufacturers of the video games and products cited in the text. This work is supported by PRIN (2012)-20123X2PXT_003 grant to the first and the third authors. We want to thank "G. Maironi da Ponte" high school institute, especially Prof. Mazzotti and Mr. Maffeis, for supporting us in the data collection process.	Anderson CA, 2010, PSYCHOL BULL, V136, P151, DOI 10.1037/a0018251; Bailenson JN, 2006, COMP SUPP COMP W SER, V34, P1; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Bushman BJ, 2011, SOC PSYCHOL PERS SCI, V2, P29, DOI 10.1177/1948550610379506; Bushman BJ, 2009, PSYCHOL SCI, V20, P273, DOI 10.1111/j.1467-9280.2009.02287.x; Carnagey NL, 2007, J EXP SOC PSYCHOL, V43, P489, DOI 10.1016/j.jesp.2006.05.003; Cohen Jonathan, 2001, MASS COMMUN SOC, V4, P245, DOI [10.4324/9781315164441-14, DOI 10.1207/S15327825MCS0403_01, 10.1207/S15327825MCS0403_01]; Connell R., 2013, GENDER POWER SOC PER; Dill KE, 2008, J EXP SOC PSYCHOL, V44, P1402, DOI 10.1016/j.jesp.2008.06.002; Dill KE, 2007, SEX ROLES, V57, P851, DOI 10.1007/s11199-007-9278-1; Dunn RA, 2012, COMPUT HUM BEHAV, V28, P97, DOI 10.1016/j.chb.2011.08.015; EISENBERG N, 1987, PSYCHOL BULL, V101, P91, DOI 10.1037/0033-2909.101.1.91; ESRB, 2014, MUCH YOU KNOW VID GA; Flood M, 2009, TRAUMA VIOLENCE ABUS, V10, P125, DOI 10.1177/1524838009334131; Fox J, 2015, PSYCHOL WOMEN QUART, V39, P349, DOI 10.1177/0361684314553578; Gabbiadini A, 2014, J MEDIA PSYCHOL-GER, V26, P141, DOI 10.1027/1864-1105/a000119; Gabbiadini A, 2014, SOC PSYCHOL PERS SCI, V5, P451, DOI 10.1177/1948550613509286; Galdi S, 2014, PSYCHOL WOMEN QUART, V38, P398, DOI 10.1177/0361684313515185; Goldstein NJ, 2007, J PERS SOC PSYCHOL, V92, P402, DOI 10.1037/0022-3514.92.3.402; Gotz M, 2005, LEA COMMUN SER, P1; Gray KL, 2012, NEW REV HYPERMEDIA M, V18, P261, DOI 10.1080/13614568.2012.746740; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hasan Y, 2013, J EXP SOC PSYCHOL, V49, P224, DOI 10.1016/j.jesp.2012.10.016; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hoffman ML., 2008, HDB EMOTIONS, P440; Jansz J, 2005, COMMUN THEOR, V15, P219, DOI 10.1111/j.1468-2885.2005.tb00334.x; Klimmt C, 2010, MEDIA PSYCHOL, V13, P323, DOI 10.1080/15213269.2010.524911; Konijn EA, 2007, DEV PSYCHOL, V43, P1038, DOI 10.1037/0012-1649.43.4.1038; Krahe B, 2010, J APPL DEV PSYCHOL, V31, P401, DOI 10.1016/j.appdev.2010.07.003; Levant R F, 1998, Cult Divers Ment Health, V4, P227, DOI 10.1037/1099-9809.4.3.227; Levant RF, 2010, PSYCHOL MEN MASCULIN, V11, P25, DOI 10.1037/a0017637; Lin JH, 2013, J COMMUN, V63, P682, DOI 10.1111/jcom.12044; Mahalik J.R., 2003, PSYCHOL MEN MASCULIN, V4, P3, DOI [10.1037/1524-9220.4.1.3, DOI 10.1037/1524-9220.4.1.3]; Murnen SK, 2002, SEX ROLES, V46, P359, DOI 10.1023/A:1020488928736; Peng W, 2008, CYBERPSYCHOL BEHAV, V11, P649, DOI 10.1089/cpb.2007.0229; Raney AA, 2004, COMMUN THEOR, V14, P348, DOI 10.1111/j.1468-2885.2004.tb00319.x; SANDAY PR, 1981, J SOC ISSUES, V37, P5, DOI 10.1111/j.1540-4560.1981.tb01068.x; Statista, 2015, DAIL TIM SPENT PLAYI; Van Looy J, 2012, MEDIA PSYCHOL, V15, P197, DOI 10.1080/15213269.2012.674917; Volpato C., 2013, LATERZA; Wells GL, 1999, PERS SOC PSYCHOL B, V25, P1115, DOI 10.1177/01461672992512005; Yang GS, 2014, AGGRESSIVE BEHAV, V40, P537, DOI 10.1002/ab.21551	44	48	49	9	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152121	10.1371/journal.pone.0152121	http://dx.doi.org/10.1371/journal.pone.0152121			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UC	27074057	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131200015
J	Mirizzi, G; Giannoni, A; Ripoli, A; Iudice, G; Bramanti, F; Emdin, M; Passino, C				Mirizzi, Gianluca; Giannoni, Alberto; Ripoli, Andrea; Iudice, Giovanni; Bramanti, Francesca; Emdin, Michele; Passino, Claudio			Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure	PLOS ONE			English	Article							INITIATE LIFESAVING TREATMENT; CHEYNE-STOKES RESPIRATION; CENTRAL SLEEP-APNEA; CAROTID-BODY; PERIPHERAL CHEMOSENSITIVITY; BAROREFLEX IMPAIRMENT; HOSPITALIZED-PATIENTS; ORGANIZED PROGRAM; RISK-FACTORS; EXERCISE	Background Peripheral and central chemoreflex sensitivity, assessed by the hypoxic or hypercapnic ventilatory response (HVR and HCVR, respectively), is enhanced in heart failure (HF) patients, is involved in the pathophysiology of the disease, and is under investigation as a potential therapeutic target. Chemoreflex sensitivity assessment is however demanding and, therefore, not easily applicable in the clinical setting. We aimed at evaluating whether common clinical variables, broadly obtained by routine clinical and instrumental evaluation, could predict increased HVR and HCVR. Methods and results 191 patients with systolic HF (left ventricular ejection fraction-LVEF-<50%) underwent chemoreflex assessment by rebreathing technique to assess HVR and HCVR. All patients underwent clinical and neurohormonal evaluation, comprising: echocardiogram, cardiopulmonary exercise test (CPET), daytime cardiorespiratory monitoring for breathing pattern evaluation. Regarding HVR, multivariate penalized logistic regression, Bayesian Model Averaging (BMA) logistic regression and random forest analysis identified, as predictors, the presence of periodic breathing and increased slope of the relation between ventilation and carbon dioxide production (VE/VCO2) during exercise. Again, the above-mentioned statistical tools identified as HCVR predictors plasma levels of N-terminal fragment of proBNP and VE/VCO2 slope. Conclusions In HF patients, the simple assessment of breathing pattern, alongside with ventilatory efficiency during exercise and natriuretic peptides levels identifies a subset of patients presenting with increased chemoreflex sensitivity to either hypoxia or hypercapnia.	[Mirizzi, Gianluca; Giannoni, Alberto; Ripoli, Andrea; Iudice, Giovanni; Bramanti, Francesca; Emdin, Michele; Passino, Claudio] Fdn Toscana G Monasterio, Dept Cardiol & Cardiovasc Med, Pisa, Italy; [Emdin, Michele; Passino, Claudio] Scuola Super Sant Anna, Pisa, Italy	Scuola Superiore Sant'Anna	Mirizzi, G (corresponding author), Fdn Toscana G Monasterio, Dept Cardiol & Cardiovasc Med, Pisa, Italy.	gianlucamiri@gmail.com	Giannoni, Alberto/K-3255-2016	Giannoni, Alberto/0000-0001-9314-2005; PASSINO, Claudio/0000-0002-0723-4753				Abraham WT, 2008, J AM COLL CARDIOL, V52, P347, DOI 10.1016/j.jacc.2008.04.028; Apostolo A, 2015, INT J CARDIOL, V189, P134, DOI 10.1016/j.ijcard.2015.03.422; Blain GM, 2010, J PHYSIOL-LONDON, V588, P2455, DOI 10.1113/jphysiol.2010.187211; Bradley TD, 2003, CIRCULATION, V107, P1822, DOI 10.1161/01.CIR.0000061758.05044.64; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chenuel BJ, 2006, J APPL PHYSIOL, V101, P76, DOI 10.1152/japplphysiol.01617.2005; Chua TP, 1996, J AM COLL CARDIOL, V27, P650, DOI 10.1016/0735-1097(95)00523-4; Del Rio R, 2013, J AM COLL CARDIOL, V62, P2422, DOI 10.1016/j.jacc.2013.07.079; Dempsey JA, 2012, ADV EXP MED BIOL, V758, P343, DOI 10.1007/978-94-007-4584-1_46; Despas F, 2012, J HYPERTENS, V30, P753, DOI 10.1097/HJH.0b013e328350136c; Ding YF, 2011, J PHYSIOL-LONDON, V589, P245, DOI 10.1113/jphysiol.2010.200584; Duffin J, 2011, RESP PHYSIOL NEUROBI, V177, P71, DOI 10.1016/j.resp.2011.04.009; Emdin M, 2004, CLIN CHEM LAB MED, V42, P627, DOI 10.1515/CCLM.2004.108; Flynn KE, 2009, JAMA-J AM MED ASSOC, V301, P1451, DOI 10.1001/jama.2009.457; Francis DP, 2000, CIRCULATION, V102, P2214; Gao L, 2007, J APPL PHYSIOL, V102, P37, DOI 10.1152/japplphysiol.00681.2006; Giannoni A, 2008, CLIN SCI, V114, P489, DOI 10.1042/CS20070292; Giannoni A, 2016, INT J CARDIOL, V202, P200, DOI 10.1016/j.ijcard.2015.09.007; Giannoni A, 2009, J AM COLL CARDIOL, V53, P1975, DOI 10.1016/j.jacc.2009.02.030; Javaheri S, 1999, NEW ENGL J MED, V341, P949, DOI 10.1056/NEJM199909233411304; Khoo MCK, 2000, RESP PHYSIOL, V122, P167, DOI 10.1016/S0034-5687(00)00157-2; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Li YL, 2006, CARDIOVASC RES, V71, P129, DOI 10.1016/j.cardiores.2006.03.017; Manisty CH, 2006, J PHYSIOL-LONDON, V577, P387, DOI 10.1113/jphysiol.2006.116764; Marcus NJ, 2014, J PHYSIOL-LONDON, V592, P391, DOI 10.1113/jphysiol.2013.266221; Moraes DJA, 2011, AM J PHYSIOL-REG I, V300, pR1476, DOI 10.1152/ajpregu.00825.2010; Nattie E, 2009, J APPL PHYSIOL, V106, P1464, DOI 10.1152/japplphysiol.00112.2008; Niewinski P, 2013, INT J CARDIOL, V168, P2506, DOI 10.1016/j.ijcard.2013.03.011; Niewinski P, 2013, J CARD FAIL, V19, P408, DOI 10.1016/j.cardfail.2013.03.013; O'Connor CM, 2008, AM HEART J, V156, P662, DOI 10.1016/j.ahj.2008.04.030; Paton JFR, 2013, HYPERTENSION, V61, P5, DOI 10.1161/HYPERTENSIONAHA.111.00064; Poletti R, 2009, INT J CARDIOL, V137, P47, DOI 10.1016/j.ijcard.2008.06.028; Ponikowski P, 1999, CIRCULATION, V100, P2418, DOI 10.1161/01.CIR.100.24.2418; Ponikowski P, 2001, CIRCULATION, V104, P544, DOI 10.1161/hc3101.093699; Ponikowski P, 1997, CIRCULATION, V96, P2586, DOI 10.1161/01.CIR.96.8.2586; Rocha I, 2003, EXP PHYSIOL, V88, P309, DOI 10.1113/eph8802476; Sin DD, 1999, AM J RESP CRIT CARE, V160, P1101, DOI 10.1164/ajrccm.160.4.9903020; Solin P, 2000, AM J RESP CRIT CARE, V162, P2194, DOI 10.1164/ajrccm.162.6.2002024; Wang DL, 2004, STAT MED, V23, P3451, DOI 10.1002/sim.1930; Wasserman K, 1997, CIRCULATION, V96, P2221, DOI 10.1161/01.cir.96.7.2221; Yamada K, 2004, AM HEART J, V148, P964, DOI 10.1016/j.ahj.2004.05.030; YAMASHIRO Y, 1993, SLEEP, V16, P513, DOI 10.1093/sleep/16.6.513	42	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153510	10.1371/journal.pone.0153510	http://dx.doi.org/10.1371/journal.pone.0153510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099934	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500037
J	Lin, CH; Hsieh, SC; Keng, LT; Lee, HS; Chang, HT; Liao, WY; Ho, CC; Yu, CJ				Lin, Chou-Han; Hsieh, Song-Chou; Keng, Li-Ta; Lee, Ho-Sheng; Chang, Hou-Tai; Liao, Wei-Yu; Ho, Chao-Chi; Yu, Chong-Jen			Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; CRITICALLY-ILL PATIENTS; BACTERIAL-INFECTION; SERUM PROCALCITONIN; DIAGNOSTIC-ACCURACY; STREM-1; MARKERS; SEPSIS; FLARES	Background Both procalcitonin (PCT) and soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) have been investigated separately as indicators of infection in patients with autoimmune diseases. Our study simultaneously evaluated both PCT and sTREM-1 along with C-reactive protein (CRP) in febrile patients with autoimmune diseases. Methods Fifty-nine patients were enrolled in the study. The patients were categorized into the infection group (n = 24) or the disease flare group (n = 35). sTREM-1, PCT and CRP concentrations at fever onset were compared between the two groups of patients. Results sTREM-1 and CRP did not differ between the two groups. PCT [median (range), ng/ml] was higher in the infection group than in the disease flare group [0.53 (0.02-12.85) vs. 0.12 (0.02-19.23), p = 0.001]. The area under the receiver-operating characteristic (ROC) for diagnosis of infection was 0.75 for PCT (p = 0.001), 0.63 for CRP (p = 0.09) and 0.52 for sTREM-1 (p = 0.79). Using 0.2 ng/ml as the cutoff value for PCT, sensitivity was 0.75 and specificity was 0.77. Negative predictive values for PCT were 92%, 87% and 82% for a prevalence of infection of 20%, 30%, and 40%, respectively. Neither immunosuppressants nor biomodulators affected the level of the three biomarkers. However, in patients treated with corticosteroids, the levels of sTREM-1 and CRP were significantly decreased compared with the untreated patients. Conclusions Setting PCT at a lower cutoff value could provide useful information on excluding infection in febrile patients with autoimmune diseases. The possible effect of corticosteroids on the level of sTREM-1 as an infection marker deserves further study.	[Lin, Chou-Han; Chang, Hou-Tai] Far Eastern Mem Hosp, Dept Internal Med, New Taipei, Taiwan; [Hsieh, Song-Chou; Liao, Wei-Yu; Ho, Chao-Chi; Yu, Chong-Jen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Keng, Li-Ta] Natl Taiwan Univ Hosp, Dept Internal Med, Hsin Chu Branch, Hsinchu, Taiwan; [Lee, Ho-Sheng] E Da Hosp, Dept Internal Med, Kaohsiung, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; E-Da Hospital	Ho, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	ccho1203@ntu.edu.tw	Liao, Wei-Yu/HGE-3881-2022; houtai, chang/AAB-1479-2019	Yu, Chong-Jen/0000-0001-5664-9392; HO, CHAO-CHI/0000-0002-8156-2413; LIAO, WEI-YU/0000-0001-6383-3470; LI-TA, KENG/0000-0003-2772-8037				Barati M, 2010, J CRIT CARE, V25, DOI 10.1016/j.jcrc.2009.10.004; Borchers AT, 2010, AUTOIMMUN REV, V9, pA277, DOI 10.1016/j.autrev.2009.12.008; Brunkhorst R, 2000, INTENS CARE MED, V26, pS199, DOI 10.1007/BF02900738; Buhaescu I, 2010, SEMIN ARTHRITIS RHEU, V40, P176, DOI 10.1016/j.semarthrit.2009.10.004; Collins CE, 2009, ANN RHEUM DIS, V68, P1768, DOI 10.1136/ard.2008.089557; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; de Kruif MD, 2008, INTENS CARE MED, V34, P518, DOI 10.1007/s00134-007-0955-x; Eberhard OK, 1997, ARTHRITIS RHEUM, V40, P1250, DOI 10.1002/1529-0131(199707)40:7<1250::AID-ART9>3.0.CO;2-A; Gibot S, 2004, NEW ENGL J MED, V350, P451, DOI 10.1056/NEJMoa031544; Gibot S, 2004, ANN INTERN MED, V141, P9, DOI 10.7326/0003-4819-141-1-200407060-00009; Hirayama K, 2011, NEPHROL DIAL TRANSPL, V26, P868, DOI 10.1093/ndt/gfq506; Joo K, 2011, J KOREAN MED SCI, V26, P1147, DOI 10.3346/jkms.2011.26.9.1147; Kim J, 2009, CLIN EXP RHEUMATOL, V27, P773; Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005; Latour-Perez J, 2010, CLIN BIOCHEM, V43, P720, DOI 10.1016/j.clinbiochem.2010.03.001; Limper M, 2010, J INFECTION, V60, P409, DOI 10.1016/j.jinf.2010.03.016; Lin CH, 2011, CRIT CARE MED, V39, P993, DOI 10.1097/CCM.0b013e31820a92dc; Mihailidou Ira, 2013, Front Public Health, V1, P50, DOI 10.3389/fpubh.2013.00050; Mok CC, 2011, ARTHRITIS RHEUM-US, V63, P1182, DOI 10.1002/art.30277; Molad Y, 2013, INFLAMMATION, V36, P1519, DOI 10.1007/s10753-013-9694-z; Moosig F, 1998, ARTHRITIS RHEUM, V41, P566, DOI 10.1002/1529-0131(199803)41:3<566::AID-ART30>3.0.CO;2-U; Muller B, 2002, J LEUKOCYTE BIOL, V72, P643; Peschken CA, 2012, ARTHRITIS RES THER, V14; Pihusch M, 2006, EUR J HAEMATOL, V76, P93, DOI 10.1111/j.0902-4441.2005.00568.x; Rinaldi S, 2006, CRIT CARE MED, V34, P2334, DOI 10.1097/01.CCM.0000233872.04706.BB; Schwenger V, 1998, INFECTION, V26, P274, DOI 10.1007/BF02962246; Sciascia S, 2012, AUTOIMMUN REV, V12, P157, DOI 10.1016/j.autrev.2012.03.009; Sciascia S, 2013, BEST PRACT RES CL RH, V27, P377, DOI 10.1016/j.berh.2013.07.002; Scire CA, 2006, CLIN EXP RHEUMATOL, V24, P123; Seam N, 2012, CRIT CARE MED, V40, P495, DOI 10.1097/CCM.0b013e318232da5e; Seror R, 2010, ANN RHEUM DIS, V69, P1103, DOI 10.1136/ard.2009.110619; Shi Y, 2013, INTENS CARE MED, V39, P2233, DOI 10.1007/s00134-013-3103-9; Sitter T, 2002, J NEPHROL, V15, P297; Stevens RJ, 2005, RHEUMATOLOGY, V44, P402, DOI 10.1093/rheumatology/keh509; Tamaki K, 2008, J RHEUMATOL, V35, P114; Valentini G, 2001, ANN RHEUM DIS, V60, P592, DOI 10.1136/ard.60.6.592; Wu JY, 2012, ARTHRITIS RHEUM-US, V64, P3034, DOI 10.1002/art.34512	37	5	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153938	10.1371/journal.pone.0153938	http://dx.doi.org/10.1371/journal.pone.0153938			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096761	gold, Green Published			2022-12-27	WOS:000374543600073
J	Lin, QQ; Li, Z; Wei, R; Lei, QF; Liu, YY; Cai, XD				Lin, Qianqian; Li, Zhong; Wei, Rui; Lei, Qingfeng; Liu, Yunyun; Cai, Xiaodong			Increased Risk of Post-Thrombolysis Intracranial Hemorrhage in Acute Ischemic Stroke Patients with Leukoaraiosis: A Meta-Analysis	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; SYMPTOMATIC INTRACEREBRAL HEMORRHAGE; BLOOD-BRAIN-BARRIER; WHITE-MATTER LESIONS; CEREBRAL MICROBLEEDS; ANTIPLATELET THERAPY; POOLED ANALYSIS; ASSOCIATION; AGE; RECURRENCE	Background Leukoaraiosis is common in patients with acute ischemic stroke. The results from many studies investigating the association between leukoaraiosis and intracranial hemorrhage after thrombolysis remain conflicting. Methods A meta-analysis was performed to compare the risk of post-thrombolytic intracranial hemorrhage in patients with and without leukoaraiosis. Relevant reports were identified by searching PubMed, EmBase, Cochrane Library, and ISI Web of Science through December 2015 using a combination of subjective and random terms. Eligible studies that were original articles with a clear definition of leukoaraiosis and intracranial hemorrhage were selected and analyzed. Funnel plots, Egger's test, and Begg's test were conducted to assess the publication bias. Sensitivity analysis was also performed to evaluate the influence of each individual study. Results Eleven trials that enrolled 6912 participants were included. There was a significantly increased risk for acute ischemic stroke patients with leukoaraiosis (odds ratio: 1.89, 95% confidence interval 1.51-2.37, P< 0.001). Low heterogeneity and less publication bias was detected among these studies. The results of both computed tomography and magnetic resonance imaging performed on the subgroups of leukoaraiosis were significant. Furthermore, an association between leukoaraiosis and symptomatic intracranial hemorrhage was also confirmed. The odds ratios remained stable with no obvious variations on the sensitivity analysis. The limitations consisted of types of including trials and not matching some baseline variables. Conclusions The results of this meta-analysis show that leukoaraiosis approximately doubles the incidence of intracranial hemorrhage after thrombolytic therapy. However, it does not critically affect decision making regarding thrombolysis for patients with acute ischemic stroke. Additional investigations are required.	[Lin, Qianqian; Li, Zhong; Wei, Rui; Lei, Qingfeng; Liu, Yunyun; Cai, Xiaodong] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Li, Z (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	lzhong@mail.sysu.edu.cn			Natural Science Foundation of Guangdong Province, China [2015A030313128, 2014A030307025]; Key Science and Technology Project of Guangzhou Tianhe District, China [201404KW028]; Science and Technology Project of Shenzhen City, China [JCYJ20150403151851068]	Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Key Science and Technology Project of Guangzhou Tianhe District, China; Science and Technology Project of Shenzhen City, China	Support was provided by the Natural Science Foundation of Guangdong Province, China (No: 2015A030313128) to ZL [http://www.gdstc.gov.cn/]; The Natural Science Foundation of Guangdong Province, China (No: 2014A030307025) to ZL [http://www.gdstc.gov.cn/]; The Key Science and Technology Project of Guangzhou Tianhe District, China (No: 201404KW028) to ZL [http://www.thst.gov.cn/]; The Science and Technology Project of Shenzhen City, China (No: JCYJ20150403151851068) to ZL [http://www.szsti.gov.cn/services/plan/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany M, 2006, RADIOLOGY, V238, P240, DOI 10.1148/radiol.2381040551; Alshekhlee A, 2010, STROKE, V41, P2259, DOI 10.1161/STROKEAHA.110.588632; Aries MJH, 2010, EUR J NEUROL, V17, P866, DOI 10.1111/j.1468-1331.2010.02963.x; AWAD IA, 1986, STROKE, V17, P1084, DOI 10.1161/01.STR.17.6.1084; Bejot Y, 2016, REV NEUROL-FRANCE, V172, P59, DOI 10.1016/j.neurol.2015.07.013; Bernbaum M, 2015, J CEREBR BLOOD F MET, V35, P1610, DOI 10.1038/jcbfm.2015.92; Bridges LR, 2014, J NEUROPATH EXP NEUR, V73, P1026, DOI 10.1097/NEN.0000000000000124; Charidimou A, 2015, NEUROLOGY, V85, P927, DOI 10.1212/WNL.0000000000001923; Choi JH, 2011, J KOREAN NEUROSURG S, V50, P75, DOI 10.3340/jkns.2011.50.2.75; Costello CA, 2012, J CLIN NEUROSCI, V19, P360, DOI 10.1016/j.jocn.2011.08.014; Curtze S, 2015, STROKE, V46, P1554, DOI 10.1161/STROKEAHA.115.008941; Demchuk AM, 2008, CEREBROVASC DIS, V26, P120, DOI 10.1159/000139658; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Fiehler J, 2007, STROKE, V38, P2738, DOI 10.1161/STROKEAHA.106.480848; Fiehler J, 2009, J NEUROIMAGING, V19, P311, DOI 10.1111/j.1552-6569.2008.00240.x; Gorner A, 2007, J NEUROL, V254, P284, DOI 10.1007/s00415-006-0311-z; Gorter JW, 1999, NEUROLOGY, V53, P1319, DOI 10.1212/WNL.53.6.1319; Gottesman RF, 2010, STROKE, V41, P3, DOI 10.1161/STROKEAHA.109.566992; HACHINSKI VC, 1987, ARCH NEUROL-CHICAGO, V44, P21, DOI 10.1001/archneur.1987.00520130013009; Hacke W, 2004, LANCET, V363, P768; Henninger N, 2012, CEREBROVASC DIS, V33, P525, DOI 10.1159/000337335; Jokinen H, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00455; Kapeller P, 2003, STROKE, V34, P441, DOI 10.1161/01.STR.0000049766.26453.E9; Kato H, 2002, STROKE, V33, P1536, DOI 10.1161/01.STR.0000018012.65108.86; Kumral E, 2015, J STROKE CEREBROVASC, V24, P573, DOI 10.1016/j.jstrokecerebrovasdis.2014.10.002; Lansberg MG, 2007, STROKE, V38, P2275, DOI 10.1161/STROKEAHA.106.480475; Lucatelli P, 2015, J NEURORADIOLOGY, DOI [10.1016/j.neufad.2015.11.003, DOI 10.1016/J.NEUFAD.2015.11.003]; McAlpine H, 2014, J STROKE CEREBROVASC, V23, P2431, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.012; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995, NEW ENGL J MED, V333, P1581, DOI [10.1056/NEJM199512143332401, DOI 10.1056/NEJM199512143332401]; Neumann-Haefelin T, 2006, STROKE, V37, P2463, DOI 10.1161/01.STR.0000239321.53203.ea; Ntaios G, 2015, NEUROLOGY, V84, P1213, DOI 10.1212/WNL.0000000000001402; Palumbo V, 2007, NEUROLOGY, V68, P1020, DOI 10.1212/01.wnl.0000257817.29883.48; Peng B, 2013, CHINESE MED J-PEKING, V126, P3403, DOI 10.3760/cma.j.issn.0366-6999.20131822; Pluta R, 2008, ACT NEUR S, V102, P353, DOI 10.1007/978-3-211-85578-2_67; Schulz UG, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000261; Smith EE, 2002, NEUROLOGY, V59, P193, DOI 10.1212/WNL.59.2.193; Strbian D, 2011, Neurology, V77, P341, DOI 10.1212/WNL.0b013e3182267b8c; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tamura Y, 2015, GERIATR GERONTOL INT, V15, P34, DOI 10.1111/ggi.12666; Tanne D, 2002, CIRCULATION, V105, P1679, DOI 10.1161/01.CIR.0000012747.53592.6A; Uyttenboogaart M, 2008, ARCH NEUROL-CHICAGO, V65, P607, DOI 10.1001/archneur.65.5.noc70077; VANSWIETEN JC, 1990, J NEUROL NEUROSUR PS, V53, P1080, DOI 10.1136/jnnp.53.12.1080; von Kummer R, 2002, STROKE, V33, P1446, DOI 10.1161/01.STR.0000016923.99605.75; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Wang DN, 2015, J STROKE CEREBROVASC, V24, P2728, DOI 10.1016/j.jstrokecerebrovasdis.2015.08.003; Wardlaw JM, 2015, LANCET NEUROL, V14, P485, DOI 10.1016/S1474-4422(15)00012-5; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; Whiteley WN, 2012, STROKE, V43, P2904, DOI 10.1161/STROKEAHA.112.665331; Willer L, 2015, J STROKE CEREBROVASC, V24, P1126, DOI 10.1016/j.jstrokecerebrovasdis.2014.12.018; Yadav BK, 2014, J STROKE CEREBROVASC, V23, P1199, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.017; Yadav BK, 2015, J STROKE CEREBROVASC, V24, P1662, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.038; Yaghi S, 2015, JAMA NEUROL, V72, P1451, DOI 10.1001/jamaneurol.2015.2371; Zheng TH, 2012, CHIN J CEREBROVASC D, V9; Zupan M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0416-z	56	18	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153486	10.1371/journal.pone.0153486	http://dx.doi.org/10.1371/journal.pone.0153486			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096292	gold, Green Submitted, Green Published			2022-12-27	WOS:000374543600039
J	Vallin, M; Polyzoi, M; Marrone, G; Rosales-Klintz, S; Wisell, KT; Lundborg, CS				Vallin, Martina; Polyzoi, Maria; Marrone, Gaetano; Rosales-Klintz, Senia; Wisell, Karin Tegmark; Lundborg, Cecilia Stalsby			Knowledge and Attitudes towards Antibiotic Use and Resistance - A Latent Class Analysis of a Swedish Population-Based Sample	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; PUBLIC KNOWLEDGE; BACTERIAL-RESISTANCE; EXPECTATIONS; BEHAVIOR; PARENTS	Background In 2006, a study investigating knowledge and attitudes regarding antibiotic use and resistance in Sweden, indicated high level of knowledge but also areas in need of improvement. Objective (i) To provide an update on the knowledge and attitudes to antibiotic use and resistance of the Swedish population, and (ii) to identify which groups within the population are in particular need of improved knowledge or attitudes. Methods A questionnaire was sent by post in 2013 to 2,500 randomly-selected individuals aged 1874, living in Sweden. Latent class analyses were conducted to group respondents based on their responses. The association between socio-demographic characteristics and the probability of belonging to each latent class was assessed. Results The response rate was 57%. Ninety-four per cent of the responders knew that bacteria could become resistant to antibiotics and the majority answered correctly to the questions regarding antibiotic resistance development. The respondents expressed confidence in doctors who decided not to prescribe antibiotics. Three latent classes related to 'knowledge regarding antibiotic use and resistance', two regarding 'attitudes towards antibiotic accessibility and infection prevention' and three regarding 'attitudes towards antibiotic use and effects' were revealed. Men, younger and more educated people were more knowledgeable but males had a less restrictive attitude. Respondents with high levels of knowledge on antibiotics were more likely to have appropriate restrictive attitudes to antibiotics. Conclusion Knowledge on antibiotic use and resistance is maintained high and has improved in Sweden compared to 2006. People with lower education and elderly are especially in need of improved knowledge about antibiotic use and resistance.	[Vallin, Martina; Polyzoi, Maria; Marrone, Gaetano; Rosales-Klintz, Senia; Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Tomtebodavagen 18A, Stockholm, Sweden; [Wisell, Karin Tegmark] Publ Hlth Agcy Sweden, Nobels Vag 18, Solna, Sweden	Karolinska Institutet; Public Health Agency of Sweden	Marrone, G (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Tomtebodavagen 18A, Stockholm, Sweden.	gaetano.marrone@ki.se		Stalsby Lundborg, Cecilia/0000-0001-6525-1861; Marrone, Gaetano/0000-0002-2991-1663; Rosales Klintz, Senia/0000-0002-2897-6123	Smittskyddsinstitutet	Smittskyddsinstitutet	The funding organization is Smittskyddsinstitutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre M, 2004, SCAND J INFECT DIS, V36, P192, DOI 10.1080/00365540410019372; Andre M, 2008, SCAND J INFECT DIS, V40, P648, DOI 10.1080/00365540801932439; Andre M, 2010, J ANTIMICROB CHEMOTH, V65, P1292, DOI 10.1093/jac/dkq104; [Anonymous], ALLT FLER SOKER INF; Ashworth M, 2016, BRIT J GEN PRACT, V66, pE40, DOI 10.3399/bjgp15X688105; Bell BG, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-13; Borg MA, 2012, J ANTIMICROB CHEMOTH, V67, P763, DOI 10.1093/jac/dkr541; Brookes-Howell L, 2012, J GEN INTERN MED, V27, P766, DOI 10.1007/s11606-011-1916-1; Cals JWL, 2007, BRIT J GEN PRACT, V57, P942, DOI 10.3399/096016407782605027; Cockburn J, 1997, BRIT MED J, V315, P520, DOI 10.1136/bmj.315.7107.520; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Deschepper R, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-123; Earnshaw S, 2009, EUROSURVEILLANCE, V14, P23; European Centre for Disease and Control, 2013, ANN EP REP REP 2011; Faber MS, 2010, EUROSURVEILLANCE, V15, P10; Hawkings NJ, 2007, J ANTIMICROB CHEMOTH, V59, P1155, DOI 10.1093/jac/dkm103; Kim SS, 2011, J KOREAN ACAD NURS, V41, P742, DOI 10.4040/jkan.2011.41.6.742; Lim Ka Keat, 2012, South Med Rev, V5, P26; Mangione-Smith R, 1999, PEDIATRICS, V103, P711, DOI 10.1542/peds.103.4.711; McNulty CAM, 2007, J ANTIMICROB CHEMOTH, V59, P727, DOI 10.1093/jac/dkl558; Mira JJ, 2014, PSYCHOL HEALTH MED, V19, P201, DOI 10.1080/13548506.2013.793370; Mitsi G, 2005, INT J ANTIMICROB AG, V25, P439, DOI 10.1016/j.ijantimicag.2005.02.009; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Oh AL, 2011, J INFECT DEV COUNTR, V5, P338; Public Health Agency of Sweden, SWED WORK CONT ANT R; Reboussin BA, 2008, J R STAT SOC A STAT, V171, P877, DOI 10.1111/j.1467-985X.2008.00544.x; Stivers T, 2003, J FAM PRACTICE, V52, P140; Stockholm County Drug Therapeutic Committee & Stockholm County Council, 2011, KLOKA LISTAN PAT ALL; The Swedish Institute for Communicable Disease Control, 2012, SWEDRES SVARM SWED A; TorranceRynard VL, 1997, STAT MED, V16, P2157, DOI 10.1002/(SICI)1097-0258(19971015)16:19<2157::AID-SIM653>3.0.CO;2-X; WHO, 2012, EVOLVING THREAT OF ANTIMICROBIAL RESISTANCE: OPTIONS FOR ACTION, P1; *WHO, 2005, PRIOR MED EUR WORLD; You JHS, 2008, INFECTION, V36, P153, DOI 10.1007/s15010-007-7214-5	33	65	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152160	10.1371/journal.pone.0152160	http://dx.doi.org/10.1371/journal.pone.0152160			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096751	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600009
J	Hempel, RJ; Bannantine, JP; Stabel, JR				Hempel, Randy J.; Bannantine, John P.; Stabel, Judith R.			Transcriptional Profiling of Ileocecal Valve of Holstein Dairy Cows Infected with Mycobacterium avium subsp Paratuberculosis	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; SSP PARATUBERCULOSIS; MACROPHAGE RESPONSE; IMMUNE-RESPONSES; RECEPTOR; TUBERCULOSIS; IMMUNOGLOBULIN; RECOGNITION	Johne's disease is a chronic infection of the small intestine caused by Mycobacterium avium subspecies paratuberculosis (MAP), an intracellular bacterium. The events of pathogen survival within the host cell(s), chronic inflammation and the progression from asymptomatic subclinical stage to an advanced clinical stage of infection, are poorly understood. This study examines gene expression in the ileocecal valve (ICV) of Holstein dairy cows at different stages of MAP infection. The ICV is known to be a primary site of MAP colonization and provides an ideal location to identify genes that are relevant to the progression of this disease. RNA was prepared from ICV tissues and RNA-Seq was used to compare gene transcription between clinical, subclinical, and uninfected control animals. Interpretation of the gene expression data was performed using pathway analysis and gene ontology categories containing multiple differentially expressed genes. Results demonstrated that many of the pathways that had strong differential gene expression between uninfected control and clinical cows were related to the immune system, such as the T-and B-cell receptor signaling, apoptosis, NOD-like receptor signaling, and leukocyte transendothelial migration pathways. In contrast, the comparison of gene transcription between control and subclinical cows identified pathways that were primarily involved in metabolism. The results from the comparison between clinical and subclinical animals indicate recruitment of neutrophils, up regulation of lysosomal peptidases, increase in immune cell transendothelial migration, and modifications of the extracelluar matrix. This study provides important insight into how cattle respond to a natural MAP infection at the gene transcription level within a key target tissue for infection.	[Hempel, Randy J.; Bannantine, John P.; Stabel, Judith R.] USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Stabel, JR (corresponding author), USDA ARS, Natl Anim Dis Ctr, POB 70, Ames, IA 50010 USA.	judy.stabel@ars.usda.gov		Bannantine, John/0000-0002-5692-7898				ALARCON B, 1991, EMBO J, V10, P903, DOI 10.1002/j.1460-2075.1991.tb08023.x; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bandaru A, 2014, EUR J IMMUNOL, V44, P2013, DOI 10.1002/eji.201343680; Bassey EOE, 1997, INFECT IMMUN, V65, P4869, DOI 10.1128/IAI.65.11.4869-4872.1997; Casey ME, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00023; Cho J, 2012, J DAIRY SCI, V95, P1855, DOI 10.3168/jds.2011-4787; COCITO C, 1994, CLIN MICROBIOL REV, V7, P328, DOI 10.1128/CMR.7.3.328-345.1994; Collins MT, 2003, ACTA VET SCAND, V44, P217; Coussens PM, 2002, INFECT IMMUN, V70, P5494, DOI 10.1128/IAI.70.10.5494-5502.2002; De Buck J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111872; Dudemaine PL, 2014, J DAIRY SCI, V97, P3382, DOI 10.3168/jds.2013-7059; Foy TM, 1996, ANNU REV IMMUNOL, V14, P591, DOI 10.1146/annurev.immunol.14.1.591; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gansert JL, 2003, J IMMUNOL, V170, P3154, DOI 10.4049/jimmunol.170.6.3154; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kabara E, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00215; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; Khalifeh MS, 2013, CLIN VACCINE IMMUNOL, V20, P1274, DOI 10.1128/CVI.00246-13; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koets A, 2002, INFECT IMMUN, V70, P3856, DOI 10.1128/IAI.70.7.3856-3864.2002; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuehnel MP, 2001, CELL MICROBIOL, V3, P551, DOI 10.1046/j.1462-5822.2001.00139.x; Kusner DJ, 1996, J EXP MED, V184, P585, DOI 10.1084/jem.184.2.585; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li FJ, 2014, CURR TOP MICROBIOL, V382, P29, DOI 10.1007/978-3-319-07911-0_2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma J, 2015, GENE THER, V22, P968, DOI 10.1038/gt.2015.73; MacHugh DE, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-25; Maattanen P, 2013, INFECT IMMUN, V81, P2861, DOI 10.1128/IAI.00339-13; Moreira LO, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00328; Nalpas NC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-230; Nalubamba K, 2008, MICROBES INFECT, V10, P598, DOI 10.1016/j.micinf.2008.02.005; Plain KM, 2011, INFECT IMMUN, V79, P3821, DOI 10.1128/IAI.05204-11; Pott J, 2009, CELL MICROBIOL, V11, P1802, DOI 10.1111/j.1462-5822.2009.01372.x; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Richardson ET, 2015, INFECT IMMUN, V83, P2242, DOI 10.1128/IAI.00135-15; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roderfeld M, 2012, MICROBES INFECT, V14, P545, DOI 10.1016/j.micinf.2012.01.004; Rue-Albrecht K, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00536; Sahoo M, 2011, THESCIENTIFICWORLDJO, V11, P2037, DOI 10.1100/2011/212680; SANCHEZ M, 1993, J EXP MED, V178, P1049, DOI 10.1084/jem.178.3.1049; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Seth M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005478; Siguroardottir OG, 2004, ADV DRUG DELIVER REV, V56, P819, DOI 10.1016/j.addr.2003.10.032; Smeed JA, 2010, VET IMMUNOL IMMUNOP, V135, P218, DOI 10.1016/j.vetimm.2009.11.015; Stabel JR, 2011, CLIN VACCINE IMMUNOL, V18, P1139, DOI 10.1128/CVI.00058-11; Stabel JR, 1998, J DAIRY SCI, V81, P283, DOI 10.3168/jds.S0022-0302(98)75577-8; Stabel JR, 2000, VET MICROBIOL, V77, P465, DOI 10.1016/S0378-1135(00)00331-X; Subharat S, 2012, VET IMMUNOL IMMUNOP, V149, P225, DOI 10.1016/j.vetimm.2012.07.005; Team RC, 2014, R LANG ENV STAT COMP; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102; Waters WR, 1999, INFECT IMMUN, V67, P1593; Xu ZW, 2010, CELL MOL IMMUNOL, V7, P11, DOI 10.1038/cmi.2009.108; Zhong L, 2009, VET IMMUNOL IMMUNOP, V131, P177, DOI 10.1016/j.vetimm.2009.04.007; ZURBRICK BG, 1988, INFECT IMMUN, V56, P1692, DOI 10.1128/IAI.56.7.1692-1697.1988	60	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153932	10.1371/journal.pone.0153932	http://dx.doi.org/10.1371/journal.pone.0153932			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093613	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200064
J	Sebald, J; Willi, M; Schoberleitner, I; Krogsdam, A; Orth-Holler, D; Trajanoski, Z; Lusser, A				Sebald, Johanna; Willi, Michaela; Schoberleitner, Ines; Krogsdam, Anne; Orth-Hoeller, Dorothea; Trajanoski, Zlatko; Lusser, Alexandra			Impact of the Chromatin Remodeling Factor CHD1 on Gut Microbiome Composition of Drosophila melanogaster	PLOS ONE			English	Article							LIFE-SPAN; IMMUNE HOMEOSTASIS; HOST GENOTYPE; BACTERIA; MODEL; DIVERSITY; DYSBIOSIS; SEQUENCE; INSIGHTS; DEFENSE	The composition of the intestinal microbiota of Drosophila has been studied in some detail in recent years. Environmental, developmental and host -specific genetic factors influence microbiome composition in the fly. Our previous work has indicated that intestinal bacterial load can be affected by chromatin-targeted regulatory mechanisms. Here we studied a potential role of the conserved chromatin assembly and remodeling factor CHD1 in the shaping of the gut microbiome in Drosophila melanogaster. Using high -throughput sequencing of 16S rRNA gene amplicons, we found that Chdl deletion mutant flies exhibit significantly reduced microbial diversity compared to rescued control strains. Specifically, although Acetobacteraceae dominated the microbiota of both Chdl wild -type and mutant guts, Chdl mutants were virtually monoassociated with this bacterial family, whereas in control flies other bacterial taxa constituted -20% of the microbiome. We further show age linked differences in microbial load and microbiota composition between Chdl mutant and control flies. Finally, diet supplementation experiments with Lactobacillus plantarum revealed that, in contrast to wild -type flies, Chdl mutant flies were unable to maintain higher L. plantarum titres over time. Collectively, these data provide evidence that loss of the chromatin remodeler CHD1 has a major impact on the gut microbiome of Drosophila melanogaster.	[Sebald, Johanna; Schoberleitner, Ines; Lusser, Alexandra] Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria; [Willi, Michaela; Krogsdam, Anne; Trajanoski, Zlatko] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Krogsdam, Anne] Med Univ Innsbruck, I Med GenomeSeq Core, Bioctr, A-6020 Innsbruck, Austria; [Orth-Hoeller, Dorothea] Med Univ Innsbruck, Div Hyg & Med Microbiol, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Lusser, A (corresponding author), Med Univ Innsbruck, Div Mol Biol, Bioctr, A-6020 Innsbruck, Austria.	alexandra.lusser@i-med.ac.at	Trajanoski, Zlatko/AAT-6703-2021; Krogsdam, Anne/AAM-7278-2020	Krogsdam, Anne/0000-0002-5478-0511; Schoberleitner, Ines/0000-0001-7988-722X; Willi, Michaela/0000-0002-2248-1998; Lusser, Alexandra/0000-0002-2226-9081; Orth-Holler, Dorothea/0000-0003-2904-5192	Austrian Science Fund (FWF); START [Y275-B12]; Austrian Academy of Sciences, DOC fellowship; Daniel Swarovski Fund [D-110410-022-011]; Austrian Science Fund (FWF) [Y 275] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); START(Austrian Science Fund (FWF)); Austrian Academy of Sciences, DOC fellowship; Daniel Swarovski Fund; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (FWF; https://www.fwf.ac.at); START Y275-B12 to AL. Austrian Academy of Sciences, DOC fellowship to JS; Daniel Swarovski Fund, D-110410-022-011 to JS.	Blum JE, 2013, MBIO, V4, DOI 10.1128/mBio.00860-13; Bonnay F, 2014, EMBO J, V33, P2349, DOI 10.15252/embj.201488456; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Brummel T, 2004, P NATL ACAD SCI USA, V101, P12974, DOI 10.1073/pnas.0405207101; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Charroux B, 2012, SEMIN IMMUNOL, V24, P17, DOI 10.1016/j.smim.2011.11.003; Clark RI, 2015, CELL REP, V12, P1656, DOI 10.1016/j.celrep.2015.08.004; Cleenwerck I, 2008, INT J SYST EVOL MICR, V58, P2180, DOI 10.1099/ijs.0.65778-0; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Corby-Harris V, 2007, APPL ENVIRON MICROB, V73, P3470, DOI 10.1128/AEM.02120-06; Cox CR, 2007, INFECT IMMUN, V75, P1565, DOI 10.1128/IAI.01496-06; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Erkosar B, 2014, FEBS LETT, V588, P4250, DOI 10.1016/j.febslet.2014.06.041; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Lee KA, 2014, DEV COMP IMMUNOL, V42, P102, DOI 10.1016/j.dci.2013.05.005; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Morettini S, 2011, NUCLEIC ACIDS RES, V39, P3103, DOI 10.1093/nar/gkq1298; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ren C, 2007, CELL METAB, V6, P144, DOI 10.1016/j.cmet.2007.06.006; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Sebald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043144; Sharon G, 2010, P NATL ACAD SCI USA, V107, P20051, DOI 10.1073/pnas.1009906107; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Storelli G, 2011, CELL METAB, V14, P403, DOI 10.1016/j.cmet.2011.07.012; Team RC, 2014, R LANG ENV STAT COMP; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Warnes M, 2014, PACKAGE GPLOTS; Wong ACN, 2013, ISME J, V7, P1922, DOI 10.1038/ismej.2013.86; Wong CNA, 2011, ENVIRON MICROBIOL, V13, P1889, DOI 10.1111/j.1462-2920.2011.02511.x	48	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153476	10.1371/journal.pone.0153476	http://dx.doi.org/10.1371/journal.pone.0153476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093431	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200022
J	Primativo, S; Spinelli, D; Zoccolotti, P; De Luca, M; Martelli, M				Primativo, Silvia; Spinelli, Donatella; Zoccolotti, Pierluigi; De Luca, Maria; Martelli, Marialuisa			Perceptual and Cognitive Factors Imposing "Speed Limits" on Reading Rate: A Study with the Rapid Serial Visual Presentation	PLOS ONE			English	Article							RESOURCE DEPLETION; ATTENTIONAL BLINK; WORD RECOGNITION; CONTEXT; SPAN; TIME; PSYCHOPHYSICS; INFORMATION; MECHANISMS; MOVEMENTS	Adults read at high speed, but estimates of their reading rate vary greatly, i.e., from 100 to 1500 words per minute (wpm). This discrepancy is likely due to different recording methods and to the different perceptual and cognitive processes involved in specific test conditions. The present study investigated the origins of these notable differences in RSVP reading rate (RR). In six experiments we investigated the role of many different perceptual and cognitive variables. The presence of a mask caused a steep decline in reading rate, with an estimated masking cost of about 200 wpm. When the decoding process was isolated, RR approached values of 1200 wpm. When the number of stimuli exceeded the short-term memory span, RR decreased to 800 wpm. The semantic context contributed to reading speed only by a factor of 1.4. Finally, eye movements imposed an upper limit on RR (around 300 wpm). Overall, data indicate a speed limit of 300 wpm, which corresponds to the time needed for eye movement execution, i.e., the most time consuming mechanism. Results reconcile differences in reading rates reported by different laboratories and thus provide suggestions for targeting different components of reading rate.	[Primativo, Silvia; Spinelli, Donatella; Zoccolotti, Pierluigi; De Luca, Maria; Martelli, Marialuisa] IRCCS Fdn Santa Lucia, Rome, Italy; [Primativo, Silvia; Zoccolotti, Pierluigi; Martelli, Marialuisa] Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy; [Primativo, Silvia] UCL, Dementia Res Ctr, UCL Inst Neurol, London, England; [Spinelli, Donatella] Univ Rome Foro Ital, Rome, Italy	IRCCS Santa Lucia; Sapienza University Rome; University of London; University College London; Foro Italico University of Rome	Primativo, S; Martelli, M (corresponding author), IRCCS Fdn Santa Lucia, Rome, Italy.; Primativo, S; Martelli, M (corresponding author), Univ Roma La Sapienza, Dipartimento Psicol, I-00185 Rome, Italy.; Primativo, S (corresponding author), UCL, Dementia Res Ctr, UCL Inst Neurol, London, England.	s.primativo@ucl.ac.uk; marialuisa.martelli@uniroma1.it	Zoccolotti, Pierluigi/H-4437-2019; De Luca, Maria/A-7169-2010; Martelli, Marialuisa/J-5757-2012	Zoccolotti, Pierluigi/0000-0002-6351-2455; De Luca, Maria/0000-0003-0084-3772; Martelli, Marialuisa/0000-0001-7806-9540; Primativo, Silvia/0000-0001-9632-850X	Department of Health; Sapienza University	Department of Health; Sapienza University	This work was supported by grants from the Department of Health and Sapienza University.	Ambinder MS, 2009, ATTEN PERCEPT PSYCHO, V71, P1495, DOI 10.3758/APP.71.7.1495; Ariga A, 2008, PSYCHOL RES-PSYCH FO, V72, P192, DOI 10.1007/s00426-006-0100-4; Baddeley A, 1986, DEVELOPMENT, V77, P1; BALOTA DA, 1985, COGNITIVE PSYCHOL, V17, P364, DOI 10.1016/0010-0285(85)90013-1; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Benedetto S, 2015, COMPUT HUM BEHAV, V45, P352, DOI 10.1016/j.chb.2014.12.043; Bonneh YS, 2007, VISION RES, V47, P1950, DOI 10.1016/j.visres.2007.02.015; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Buswell GT, 1921, J EDUC PSYCHOL, V12, P217, DOI 10.1037/h0070548; Carpenter P. A., 1983, EYE MOVEMENTS READIN, P275; Carver R. P., 1997, SCI STUD READ, V1, P3, DOI [10.1207/S1532799XSSR0101_2, DOI 10.1207/S1532799XSSR0101_2, DOI 10.1207/S1532799XSSR01012]; CARVER RP, 1982, READ RES QUART, V18, P56, DOI 10.2307/747538; CARVER RP, 1992, J READING, V36, P84; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 1998, VISION RES, V38, P2949, DOI 10.1016/S0042-6989(98)00072-8; Cohn HE, 2012, U.S. Patent Application, Patent No. [13/718,941, 13718941]; Colombo L, 2002, BRAIN LANG, V81, P398, DOI 10.1006/brln.2001.2533; Coltheart V, 2004, J EXP PSYCHOL LEARN, V30, P815, DOI 10.1037/0278-7393.30.4.815; Crutch SJ, 2011, NEUROCASE, V17, P160, DOI 10.1080/13554794.2010.504729; De Luca M, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00696; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; Dux PE, 2008, PSYCHON B REV, V15, P809, DOI 10.3758/PBR.15.4.809; Dux PE, 2006, NEURON, V52, P1109, DOI 10.1016/j.neuron.2006.11.009; Dux PE, 2009, PSYCHON B REV, V16, P219, DOI 10.3758/PBR.16.1.219; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; FELSTEN G, 1980, PSYCHOL BULL, V88, P329, DOI 10.1037/0033-2909.88.2.329; Fine EM, 1997, VISION RES, V37, P2639, DOI 10.1016/S0042-6989(97)00051-5; Fine EM, 1999, OPTOMETRY VISION SCI, V76, P764, DOI 10.1097/00006324-199911000-00025; Fine EM, 1996, OPTOMETRY VISION SCI, V73, P533, DOI 10.1097/00006324-199608000-00003; FORSTER KI, 1970, PERCEPT PSYCHOPHYS, V8, P215, DOI 10.3758/BF03210208; Freeman J, 2012, ATTEN PERCEPT PSYCHO, V74, P379, DOI 10.3758/s13414-011-0229-0; GILBERT LC, 1959, J EDUC PSYCHOL, V50, P8, DOI 10.1037/h0045592; GILBERT LC, 1959, J EDUC PSYCHOL, V50, P15, DOI 10.1037/h0040752; Gomez P, 2008, PSYCHOL REV, V115, P577, DOI 10.1037/a0012667; He YC, 2013, J VISION, V13, DOI 10.1167/13.7.14; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; Inhoff AW, 2011, J COGN PSYCHOL, V23, P543, DOI 10.1080/20445911.2011.546782; Kwon M, 2007, VISION RES, V47, P2889, DOI 10.1016/j.visres.2007.08.002; Kwon M, 2012, VISION RES, V62, P139, DOI 10.1016/j.visres.2012.03.025; Latham K, 1996, VISION RES, V36, P2665, DOI 10.1016/0042-6989(96)00022-3; Lee HW, 2010, J VISION, V10, DOI 10.1167/10.6.18; Legge GE, 2001, VISION RES, V41, P725, DOI 10.1016/S0042-6989(00)00295-9; Lev M, 2014, SCI REPORTS, V4; Martelli M, 2014, EXP BRAIN RES, V232, P237, DOI 10.1007/s00221-013-3735-6; McDowell ME, 2010, U.S. Patent Application, Patent No. [12/873,787, 12873787]; MORTON J, 1964, Q J EXP PSYCHOL, V16, P340, DOI 10.1080/17470216408416390; Neath I, 1996, MEMORY, V4, P225, DOI 10.1080/09658211.1996.9753032; Pelli DG, 2008, NAT NEUROSCI, V11, P1129, DOI 10.1038/nn.2187; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000680; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; Perea M, 2002, PERCEPT PSYCHOPHYS, V64, P785, DOI 10.3758/BF03194745; Perea M, 2012, Q J EXP PSYCHOL, V65, P911, DOI 10.1080/17470218.2011.636151; Perry C, 2010, COGNITIVE PSYCHOL, V61, P106, DOI 10.1016/j.cogpsych.2010.04.001; Polat U, 2006, VISION RES, V46, P953, DOI 10.1016/j.visres.2005.09.031; Polat U, 2005, VISION RES, V45, P1471, DOI 10.1016/j.visres.2004.12.014; Potter M.C., 1984, NEW METHODS READING, P91; POTTER MC, 1982, B PSYCHONOMIC SOC, V20, P134; RAYNER K, 1976, VISION RES, V16, P829, DOI 10.1016/0042-6989(76)90143-7; Rayner K, 2016, PSYCHOL SCI PUBL INT, V17, P4, DOI 10.1177/1529100615623267; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Rohenkohl G, 2011, J NEUROSCI, V31, P14076, DOI 10.1523/JNEUROSCI.3387-11.2011; RUBIN GS, 1992, VISION RES, V32, P895, DOI 10.1016/0042-6989(92)90032-E; Sass SM, 2006, OPTOMETRY VISION SCI, V83, P166, DOI 10.1097/01.opx.0000204752.43520.17; Schotter ER, 2014, PSYCHOL SCI; Song S, 2014, J VISION, V14, DOI 10.1167/14.5.3; Traficante D., 2004, GIORNALE ITALIANO PS, V31, P821; Traficante D., 2003, TRENDS LING STUD MON, V151, P45; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Whitney D, 2011, TRENDS COGN SCI, V15, P160, DOI 10.1016/j.tics.2011.02.005; Yager D, 1998, VISION RES, V38, P2527, DOI 10.1016/S0042-6989(98)00116-3; Yeshurun Y, 2015, J VISION, V15, DOI 10.1167/15.3.11; Yong KXX, 2015, NEUROLOGY, V85, P339, DOI 10.1212/WNL.0000000000001782; Yu DY, 2010, J VISION, V10, DOI 10.1167/10.2.21; Yu DY, 2007, J VISION, V7, DOI 10.1167/7.2.2; Zoccolotti P, 2013, CHILD NEUROPSYCHOL, V19, P639, DOI 10.1080/09297049.2012.718325	77	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153786	10.1371/journal.pone.0153786	http://dx.doi.org/10.1371/journal.pone.0153786			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088226	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000048
J	Schulze, J; Frank, K; Priess, JA; Meyer, MA				Schulze, Jule; Frank, Karin; Priess, Joerg A.; Meyer, Markus A.			Assessing Regional-Scale Impacts of Short Rotation Coppices on Ecosystem Services by Modeling Land-Use Decisions	PLOS ONE			English	Article							ENERGY CROPS; WOODY DEBRIS; BIOENERGY; FOREST; BIODIVERSITY; AGRICULTURE; TRADEOFFS; GLOBALIZATION; MISCANTHUS; PROTOCOL	Meeting the world's growing energy demand through bioenergy production involves extensive land-use change which could have severe environmental and social impacts. Second generation bioenergy feedstocks offer a possible solution to this problem. They have the potential to reduce land-use conflicts between food and bioenergy production as they can be grown on low quality land not suitable for food production. However, a comprehensive impact assessment that considers multiple ecosystem services (ESS) and biodiversity is needed to identify the environmentally best feedstock option, as trade-offs are inherent. In this study, we simulate the spatial distribution of short rotation coppices (SRCs) in the landscape of the Mulde watershed in Central Germany by modeling profit-maximizing farmers under different economic and policy-driven scenarios using a spatially explicit economic simulation model. This allows to derive general insights and a mechanistic understanding of regional-scale impacts on multiple ESS in the absence of large-scale implementation. The modeled distribution of SRCs, required to meet the regional demand of combined heat and power (CHP) plants for solid biomass, had little or no effect on the provided ESS. In the policy-driven scenario, placing SRCs on low or high quality soils to provide ecological focus areas, as required within the Common Agricultural Policy in the EU, had little effect on ESS. Only a substantial increase in the SRC production area, beyond the regional demand of CHP plants, had a relevant effect, namely a negative impact on food production as well as a positive impact on biodiversity and regulating ESS. Beneficial impacts occurred for single ESS. However, the number of sites with balanced ESS supply hardly increased due to larger shares of SRCs in the landscape. Regression analyses showed that the occurrence of sites with balanced ESS supply was more strongly driven by biophysical factors than by the SRC share in the landscape. This indicates that SRCs negligibly affect trade-offs between individual ESS. Coupling spatially explicit economic simulation models with environmental and ESS assessment models can contribute to a comprehensive impact assessment of bioenergy feedstocks that have not yet been planted.	[Schulze, Jule; Frank, Karin] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Schulze, Jule; Frank, Karin] Univ Osnabruck, Inst Environm Syst Res, Osnabruck, Germany; [Priess, Joerg A.; Meyer, Markus A.] UFZ Helmholtz Ctr Environm Res, Dept Computat Landscape Ecol, Leipzig, Germany; [Meyer, Markus A.] Univ Munich LMU, Dept Geog, Munich, Germany	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University Osnabruck; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Munich	Schulze, J (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany.; Schulze, J (corresponding author), Univ Osnabruck, Inst Environm Syst Res, Osnabruck, Germany.	jule.schulze@ufz.de	Priess, Joerg A./G-1697-2012; Meyer, Markus/AAV-5608-2020; Frank, Karin/D-6490-2015; Meyer, Markus/HIK-1821-2022; Meyer, Markus/AAY-9170-2020	Priess, Joerg A./0000-0002-0384-9240; Meyer, Markus/0000-0002-9463-1975; Frank, Karin/0000-0002-2769-0692; Meyer, Markus/0000-0003-4872-7164; 	Helmholtz Research Program "Terrestrial Environments"; European Union [282826]	Helmholtz Research Program "Terrestrial Environments"; European Union(European Commission)	This work was funded by the Helmholtz Research Program "Terrestrial Environments", http://www.helmholtz.de/en/research/earth_and_environment/terrestrial_environment/, and the European Union FP7 project SECTOR (Production of Solid Sustainable Energy Carriers by Means of Torrefaction), grant agreement number 282826, https://sector-project.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali W, 2009, THESIS DRESDEN U TEC; Alkemade R, 2009, ECOSYSTEMS, V12, P374, DOI 10.1007/s10021-009-9229-5; Altermann M, 1997, REGENERATION NACHHAL; Amer M, 2013, FUTURES, V46, P23, DOI 10.1016/j.futures.2012.10.003; Asbjornsen H, 2014, RENEW AGR FOOD SYST, V29, P101, DOI 10.1017/S1742170512000385; Aust C, 2014, GCB BIOENERGY, V6, P521, DOI 10.1111/gcbb.12083; Becker G., 2013, Schweizerische Zeitschrift fur Forstwesen, V164, P382, DOI 10.3188/szf.2013.0382; Berger T, 2001, AGR ECON-BLACKWELL, V25, P245, DOI 10.1111/j.1574-0862.2001.tb00205.x; Bischoff R, 2014, K FAKTOR MMK 100; BKG, 2014, DIG BAS LANDSCH BAS; Blumohr T, 2011, AGRARSTRUKTUREN DEUT; Board M, 2005, ECOSYSTEMS HUMAN WEL; Braunig A, 2013, DOKUMENTATION BERECH; Brown C, 2015, GCB BIOENERGY; Builtjes P, 2011, ABSCHLUSSBERICHT ZUM; Chum H, 2011, BIOENERGY; Das S, 2012, SPATIAL ANAL POTENTI; Djomo SN, 2015, RENEW SUST ENERG REV, V41, P845, DOI 10.1016/j.rser.2014.08.058; Drossart I, 2013, HOLZENERGIE BEDEUTUN; Edel M, 2012, INT J FOREST ENG, V23, P102; EEA, 2013, COR LAND COV 2006 RA; Eggleston H.S., 2006, GUIDELINES NATL GREE; Engelkamp P, 2007, EINFUHRUNG VOLKSWIRT; FAO Geonetwork, 2014, GLOB MAP MONTHL REF; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; FNR, 2013, BAS BIOEN DEUTSCHL; Fraver S, 2002, CAN J FOREST RES, V32, P2094, DOI 10.1139/X02-131; Furst C, 2013, J ENVIRON MANAGE, V127, pS96, DOI 10.1016/j.jenvman.2012.09.020; Glithero NJ, 2013, APPL ENERG, V107, P209, DOI 10.1016/j.apenergy.2013.02.032; Gollub G, 2005, ANWENDUNG AUSWERTUNG; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Hastings A, 2014, GCB BIOENERGY, V6, P108, DOI 10.1111/gcbb.12103; Hellmann F, 2011, BIOMASS BIOENERG, V35, P2411, DOI 10.1016/j.biombioe.2008.09.003; HOLLAND JH, 1992, DAEDALUS, V121, P17; Holland RA, 2015, RENEW SUST ENERG REV, V46, P30, DOI 10.1016/j.rser.2015.02.003; IEA, 2020, ENERGY TECHNOLOGY PE, DOI [10.1787/9789264109834-en, DOI 10.1787/9789264109834-EN]; Jackel G, 2012, AUFBEREITUNG GEMESSE; Kareiva P, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P1, DOI 10.1093/acprof:oso/9780199588992.001.0001; Kocoloski M, 2011, ENERG POLICY, V39, P47, DOI 10.1016/j.enpol.2010.09.003; Koellner T, 2013, INT J LIFE CYCLE ASS, V18, P1185, DOI 10.1007/s11367-013-0580-6; Kraxner F, 2013, BIOMASS BIOENERG, V57, P86, DOI 10.1016/j.biombioe.2013.02.003; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lawler JJ, 2014, P NATL ACAD SCI USA, V111, P7492, DOI 10.1073/pnas.1405557111; Le QB, 2012, ENVIRON MODELL SOFTW, V27-28, P83, DOI 10.1016/j.envsoft.2011.09.002; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; LfULG, 2011, POT NAT VEG PNV SACH; Lupp G, 2014, LAND USE POLICY, V36, P296, DOI 10.1016/j.landusepol.2013.08.012; MAKESCHIN F, 1994, BIOMASS BIOENERG, V6, P63, DOI 10.1016/0961-9534(94)90086-8; Mankiw NG, 2006, EC THOMSON LEARNING; Manning P, 2015, GCB BIOENERGY, V7, P570, DOI 10.1111/gcbb.12173; Matzenberger J, 2015, RENEW SUST ENERG REV, V43, P926, DOI 10.1016/j.rser.2014.10.106; Meehan TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080093; Meyer MA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034005; Meyer MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116336; Meyer MA, 2014, BIOMASS BIOENERG, V65, P151, DOI 10.1016/j.biombioe.2014.03.041; Meyfroidt P, 2013, CURR OPIN ENV SUST, V5, P438, DOI 10.1016/j.cosust.2013.04.003; Milner S, 2015, GCB BIOENERGY; Mouchet MA, 2014, GLOBAL ENVIRON CHANG, V28, P298, DOI 10.1016/j.gloenvcha.2014.07.012; Muller B, 2013, ENVIRON MODELL SOFTW, V48, P37, DOI 10.1016/j.envsoft.2013.06.003; Muller-Using S, 2009, EUR J FOREST RES, V128, P287, DOI 10.1007/s10342-009-0264-8; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Panagos P, 2006, EUROPEAN SOIL DATABA; Parker DC, 2008, GEOFORUM, V39, P789, DOI 10.1016/j.geoforum.2007.05.005; Pe'er G, 2014, SCIENCE, V344, P1090, DOI 10.1126/science.1253425; Polley H, 2012, BUNDESWALDINVENTUR G; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Priess J., 2016, POPULATION SCENARIOS; Priess JA, ENV MODELL IN PRESS; R Core Team, 2020, R LANG ENV STAT COMP; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Reckhow KH, 1980, MODELING PHOSPHOROUS; Renting H, 2009, J ENVIRON MANAGE, V90, pS112, DOI 10.1016/j.jenvman.2008.11.014; Rossberg D., 2007, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V59, P155; Rowe RL, 2011, BIOMASS BIOENERG, V35, P325, DOI 10.1016/j.biombioe.2010.08.046; Sachsen StaLa, 2007, KAMENZ STAT LANDESAM; Sage R, 2006, IBIS, V148, P184, DOI 10.1111/j.1474-919X.2006.00522.x; Sattler C, 2010, LAND USE POLICY, V27, P70, DOI 10.1016/j.landusepol.2008.02.002; Schmidt-Walter P, 2012, BIOENERG RES, V5, P546, DOI 10.1007/s12155-012-9237-8; Sherrington C, 2008, ENERG POLICY, V36, P2504, DOI 10.1016/j.enpol.2008.03.004; Skodawessely, 2010, BERATUNGSHANDBUCH KU; Strogies M, 2012, BERICHTERSTATTUNG UN; Tallis HT, 2013, INVEST 256 USERS GUI; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; TLS, 2007, ERNT BETR FELDFR GRU; Tolle MH, 2014, J GEOPHYS RES-ATMOS, V119, P2711, DOI 10.1002/2013JD020877; Valentine J, 2012, GCB BIOENERGY, V4, P1, DOI 10.1111/j.1757-1707.2011.01111.x; Vanloocke A, 2010, GCB BIOENERGY, V2, P180, DOI 10.1111/j.1757-1707.2010.01053.x; Weise H., 2014, THESIS U OSNABRUCK; Werling BP, 2014, P NATL ACAD SCI USA, V111, P1652, DOI 10.1073/pnas.1309492111; Wischmeier W. H., 1978, U. S. Department of Agriculture, Agriculture Handbook; Wochele S, 2014, CROP ALLOCATION MODE; Wochele-Marx S, 2015, CENTRAL GERMANY GIS; Wordehoff R., 2011, KOHLENSTOFFSTUDIE FO	95	18	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153862	10.1371/journal.pone.0153862	http://dx.doi.org/10.1371/journal.pone.0153862			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082742	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800059
J	Simons, CJP; Bartels-Velthuis, AA; Pijnenborg, GHM				Simons, Claudia J. P.; Bartels-Velthuis, Agna A.; Pijnenborg, Gerdina H. M.		GROUP Investigators	Cognitive Performance and Long-Term Social Functioning in Psychotic Disorder: A Three-Year Follow-Up Study	PLOS ONE			English	Article							RECENT-ONSET SCHIZOPHRENIA; NEGATIVE SYMPTOMS; 1ST-EPISODE SCHIZOPHRENIA; PREDICTIVE-VALUE; 1ST EPISODE; NEUROCOGNITION; DEFICITS; MEDIATION; MATRICS; SAMPLE	Objective Studies have linked cognitive functioning to everyday social functioning in psychotic disorders, but the nature of the relationships between cognition, social cognition, symptoms, and social functioning remains unestablished. Modelling the contributions of non-social and social cognitive ability in the prediction of social functioning may help in more clearly defining therapeutic targets to improve functioning. Method In a sample of 745 patients with a non-affective psychotic disorder, the associations between cognition and social cognition at baseline on the one hand, and self-reported social functioning three years later on the other, were analysed. First, case-control comparisons were conducted; associations were subsequently further explored in patients, investigating the potential mediating role of symptoms. Analyses were repeated in a subsample of 233 patients with recent-onset psychosis. Results Information processing speed and immediate verbal memory were stronger associated with social functioning in patients than in healthy controls. Most cognition variables significantly predicted social functioning at follow-up, whereas social cognition was not associated with social functioning. Symptoms were robustly associated with follow-up social functioning, with negative symptoms fully mediating most associations between cognition and follow-up social functioning. Illness duration did not moderate the strength of the association between cognitive functioning and follow-up social functioning. No associations were found between (social) cognition and follow-up social functioning in patients with recent-onset psychosis. Conclusions Although cognitive functioning is associated with later social functioning in psychotic disorder, its role in explaining social functioning outcome above negative symptoms appears only modest. In recent-onset psychosis, cognition may have a negligible role in predicting later social functioning. Moreover, social cognition tasks may not predict self-reported social functioning.	[Simons, Claudia J. P.] Inst Mental Hlth Care Eindhoven & De Kempen, GGzE, Eindhoven, Netherlands; [Simons, Claudia J. P.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Psychol,South Limburg Mental Hlth, Med Ctr,European Grad Sch Neurosci EURON, NL-6200 MD Maastricht, Netherlands; [Bartels-Velthuis, Agna A.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Groningen, Netherlands; [Pijnenborg, Gerdina H. M.] Univ Groningen, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Pijnenborg, Gerdina H. M.] GGZ Drenthe, Dept Psychot Disorders, Assen, Netherlands	Maastricht University; University of Groningen; University of Groningen	Simons, CJP (corresponding author), Inst Mental Hlth Care Eindhoven & De Kempen, GGzE, Eindhoven, Netherlands.	cjp.simons@ggze.nl			Geestkracht programme of the Dutch Health Research Council (ZON-MW) [10-000-1001]; Lundbeck; AstraZeneca; Eli Lilly; Janssen Cilag; Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre; GGZ Ingeest; Arkin; Dijk en Duin; GGZ Rivierduinen; Erasmus Medical Centre; GGZ Noord Holland Noord; Maastricht: Maastricht University Medical Centre; GGZ Eindhoven en De Kempen; GGZ Breburg; GGZ Oost-Brabant; Vincent van Gogh voor geestelijke gezondheidszorg; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGNet Warnsveld; Yulius Dordrecht; Parnassia psycho-medical centre The Hague; Utrecht: University Medical Centre Utrecht; Altrecht; GGZ Centraal; Riagg Amersfoort; Delta; European Community [HEALTH-F2-2009-241909]	Geestkracht programme of the Dutch Health Research Council (ZON-MW); Lundbeck(Lundbeck Corporation); AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Janssen Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre; GGZ Ingeest; Arkin; Dijk en Duin; GGZ Rivierduinen; Erasmus Medical Centre; GGZ Noord Holland Noord; Maastricht: Maastricht University Medical Centre; GGZ Eindhoven en De Kempen; GGZ Breburg; GGZ Oost-Brabant; Vincent van Gogh voor geestelijke gezondheidszorg; Mondriaan Zorggroep; Prins Clauscentrum Sittard; RIAGG Roermond; Universitair Centrum Sint-Jozef Kortenberg; CAPRI University of Antwerp; PC Ziekeren Sint-Truiden; PZ Sancta Maria Sint-Truiden; GGZ Overpelt; OPZ Rekem; Groningen: University Medical Center Groningen; Lentis; GGZ Friesland; GGZ Drenthe; Dimence; Mediant; GGNet Warnsveld; Yulius Dordrecht; Parnassia psycho-medical centre The Hague; Utrecht: University Medical Centre Utrecht; Altrecht; GGZ Centraal; Riagg Amersfoort; Delta; European Community(European Commission)	The infrastructure for the GROUP study is funded through the Geestkracht programme of the Dutch Health Research Council (ZON-MW, grant number 10-000-1001); matching funds from participating pharmaceutical companies (Lundbeck, AstraZeneca, Eli Lilly, Janssen Cilag); and participating universities and mental health care organizations (Amsterdam: Academic Psychiatric Centre of the Academic Medical Centre and the mental health institutions: GGZ Ingeest, Arkin, Dijk en Duin, GGZ Rivierduinen, Erasmus Medical Centre, GGZ Noord Holland Noord. Maastricht: Maastricht University Medical Centre and the mental health institutions: GGZ Eindhoven en De Kempen, GGZ Breburg, GGZ Oost-Brabant, Vincent van Gogh voor geestelijke gezondheidszorg, Mondriaan Zorggroep, Prins Clauscentrum Sittard, RIAGG Roermond, Universitair Centrum Sint-Jozef Kortenberg, CAPRI University of Antwerp, PC Ziekeren Sint-Truiden, PZ Sancta Maria Sint-Truiden, GGZ Overpelt, OPZ Rekem. Groningen: University Medical Center Groningen and the mental health institutions: Lentis, GGZ Friesland, GGZ Drenthe, Dimence, Mediant, GGNet Warnsveld, Yulius Dordrecht and Parnassia psycho-medical centre The Hague. Utrecht: University Medical Centre Utrecht and the mental health institutions Altrecht, GGZ Centraal, Riagg Amersfoort and Delta). The research leading to these results has received funding from the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).	Allott K, 2011, SCHIZOPHR RES, V125, P221, DOI 10.1016/j.schres.2010.11.001; ANDREASEN NC, 1992, ARCH GEN PSYCHIAT, V49, P615; Barder HE, 2013, SCHIZOPHR RES, V149, P63, DOI 10.1016/j.schres.2013.06.016; Bell M, 2009, SCHIZOPHRENIA BULL, V35, P738, DOI 10.1093/schbul/sbm169; BILDER RM, 1992, PSYCHOPHARMACOL BULL, V28, P353; BIRCHWOOD M, 1990, BRIT J PSYCHIAT, V157, P853, DOI 10.1192/bjp.157.6.853; Bowie CR, 2008, BIOL PSYCHIAT, V63, P505, DOI 10.1016/j.biopsych.2007.05.022; Brekke J, 2005, SCHIZOPHR RES, V80, P213, DOI 10.1016/j.schres.2005.07.008; Brekke JS, 2009, PSYCHOL MED, V39, P1637, DOI 10.1017/S003329170900539X; Couture SM, 2011, SCHIZOPHR RES, V125, P152, DOI 10.1016/j.schres.2010.09.020; Couture SM, 2006, SCHIZOPHR B, V32, P17; Dickerson F, 2011, J NERV MENT DIS, V199, P367, DOI 10.1097/NMD.0b013e31821cd0ff; Dickinson D, 2002, SCHIZOPHR RES, V56, P161, DOI 10.1016/S0920-9964(01)00229-8; Dickinson D, 2007, ARCH GEN PSYCHIAT, V64, P532, DOI 10.1001/archpsyc.64.5.532; Fervaha G, 2014, JAMA PSYCHIAT, V71, P1058, DOI 10.1001/jamapsychiatry.2014.1105; Fett AKJ, 2011, NEUROSCI BIOBEHAV R, V35, P573, DOI 10.1016/j.neubiorev.2010.07.001; Green MF, 2004, SCHIZOPHR RES, V72, P41, DOI 10.1016/j.schres.2004.09.009; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Green MF, 2008, SCHIZOPHRENIA BULL, V34, P1211, DOI 10.1093/schbul/sbm145; Heinrichs RW, 1998, NEUROPSYCHOLOGY, V12, P426, DOI 10.1037/0894-4105.12.3.426; Hoe M, 2012, PSYCHOL MED, V42, P2287, DOI 10.1017/S0033291712000578; Hoff AL, 2005, SCHIZOPHR RES, V78, P27, DOI 10.1016/j.schres.2005.05.010; Holthausen EAE, 2007, PSYCHIAT RES, V149, P71, DOI 10.1016/j.psychres.2005.07.037; Horan WP, 2012, SCHIZOPHRENIA BULL, V38, P865, DOI 10.1093/schbul/sbr001; Jabben N, 2008, SOC PSYCH PSYCH EPID, V43, P437, DOI 10.1007/s00127-008-0328-y; Janssens M, 2012, SCHIZOPHR RES, V142, P116, DOI 10.1016/j.schres.2012.10.003; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Korver N, 2012, INT J METH PSYCH RES, V21, P205, DOI 10.1002/mpr.1352; Lin CH, 2013, SCHIZOPHR RES, V146, P231, DOI 10.1016/j.schres.2013.02.009; McCleery A, 2014, SCHIZOPHR RES, V157, P33, DOI 10.1016/j.schres.2014.04.039; McGorry PD, 2007, AM J PSYCHIAT, V164, P859, DOI 10.1176/appi.ajp.164.6.859; Meijer J, 2012, ACTA PSYCHIAT SCAND, V125, P66, DOI 10.1111/j.1600-0447.2011.01777.x; Milev P, 2005, AM J PSYCHIAT, V162, P495, DOI 10.1176/appi.ajp.162.3.495; Nolan KA, 2004, AM J PSYCHIAT, V161, P359, DOI 10.1176/appi.ajp.161.2.359; Nuechterlein KH, 2011, SCHIZOPHRENIA BULL, V37, pS33, DOI 10.1093/schbul/sbr084; NUECHTERLEIN KH, 1984, SCHIZOPHRENIA BULL, V10, P160, DOI 10.1093/schbul/10.2.160; Pijnenborg GHM, 2009, J INT NEUROPSYCH SOC, V15, P239, DOI 10.1017/S1355617709090341; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Schmidt SJ, 2011, SCHIZOPHRENIA BULL, V37, pS41, DOI 10.1093/schbul/sbr079; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Siegel SJ, 2006, AM J PSYCHIAT, V163, P433, DOI 10.1176/appi.ajp.163.3.433; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; StataCorp, 2013, STATA STAT SOFTW REL; Stirling J, 2003, SCHIZOPHR RES, V65, P75, DOI 10.1016/S0920-9964(03)00014-8; Stouten LH, 2014, SCHIZOPHR RES, V158, P113, DOI 10.1016/j.schres.2014.06.023; Van der Elst W, 2005, J INT NEUROPSYCH SOC, V11, P290, DOI 10.1017/S1355617705050344; van't Wout M, 2004, SCHIZOPHR RES, V68, P271, DOI 10.1016/j.schres.2003.09.006; Ventura J, 2009, SCHIZOPHR RES, V113, P189, DOI 10.1016/j.schres.2009.03.035; Versmissen D, 2008, SCHIZOPHR RES, V99, P103, DOI 10.1016/j.schres.2007.09.024; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; WING JK, 1990, ARCH GEN PSYCHIAT, V47, P589	51	23	23	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151299	10.1371/journal.pone.0151299	http://dx.doi.org/10.1371/journal.pone.0151299			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082629	Green Published, gold			2022-12-27	WOS:000374291800004
J	Kollimada, SA; Kulkarni, AH; Ravan, A; Gundiah, N				Kollimada, Somanna A.; Kulkarni, Ankur H.; Ravan, Aniket; Gundiah, Namrata			Advancing Edge Speeds of Epithelial Monolayers Depend on Their Initial Confining Geometry	PLOS ONE			English	Article							COLLECTIVE CELL-MIGRATION; SIGNALING PATHWAYS; LEADER CELLS; ADHESION; GUIDANCE; FORCES; STIMULATION; ACTIVATION; MECHANICS; DYNAMICS	Collective cell migrations are essential in several physiological processes and are driven by both chemical and mechanical cues. The roles of substrate stiffness and confinement on collective migrations have been investigated in recent years, however few studies have addressed how geometric shapes influence collective cell migrations. Here, we address the hypothesis that the relative position of a cell within the confinement influences its motility. Monolayers of two types of epithelial cells-MCF7, a breast epithelial cancer cell line, and MDCK, a control epithelial cell line-were confined within circular, square, and cross-shaped stencils and their migration velocities were quantified upon release of the constraint using particle image velocimetry. The choice of stencil geometry allowed us to investigate individual cell motility within convex, straight and concave boundaries. Cells located in sharp, convex boundaries migrated at slower rates than those in concave or straight edges in both cell types. The overall cluster migration occurred in three phases: an initial linear increase with time, followed by a plateau region and a subsequent decrease in cluster speeds. An acto-myosin contractile ring, present in the MDCK but absent in MCF7 monolayer, was a prominent feature in the emergence of leader cells from the MDCK clusters which occurred every similar to 125 mu m from the vertex of the cross. Further, coordinated cell movements displayed vorticity patterns in MDCK which were absent in MCF7 clusters. We also used cytoskeletal inhibitors to show the importance of acto-myosin bounding cables in collective migrations through translation of local movements to create long range coordinated movements and the creation of leader cells within ensembles. To our knowledge, this is the first demonstration of how bounding shapes influence long-term migratory behaviours of epithelial cell monolayers. These results are important for tissue engineering and may also enhance our understanding of cell movements during developmental patterning and cancer metastasis.	[Kollimada, Somanna A.; Ravan, Aniket; Gundiah, Namrata] Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India; [Kulkarni, Ankur H.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore	Gundiah, N (corresponding author), Indian Inst Sci, Dept Mech Engn, Bangalore 560012, Karnataka, India.	namrata@mecheng.iisc.ernet.in		Kulkarni, Ankur/0000-0002-5207-3346	Department of Biotechnology, Government of India [DBT: BT/PR13926/MED/31/97/2010]; Department of Science and Technology, Government of India [DST: SR/S2/RJN-42/2009]; Department of Science and Technology	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Science and Technology(Department of Science & Technology (India))	This work was supported by the Department of Biotechnology, Government of India (DBT: BT/PR13926/MED/31/97/2010); and the Department of Science and Technology, Government of India (DST: SR/S2/RJN-42/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Dr TS Sridhar, St John's Research Institute for donation of MCF7 cells and Prof. S. Mayor, National Center for Biological Sciences (NCBS) for the MDCK cells used in this study. We are thankful to Prof Pramod Pullarkat, Raman Research Institute and Prof Sanjay Sane, NCBS for many helpful discussions. NG gratefully acknowledges the Department of Science and Technology for the Ramanujan fellowship and research grant and the Department of Biotechnology (Bioengineering and Biodesign) for program support.	Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bameta T, 2012, EPL-EUROPHYS LETT, V99, DOI 10.1209/0295-5075/99/18004; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Doxzen K, 2013, INTEGR BIOL-UK, V5, P1026, DOI 10.1039/c3ib40054a; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; GIERTHY JF, 1991, J CELL BIOCHEM, V45, P177, DOI 10.1002/jcb.240450209; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Jasaitis A, 2012, BIOPHYS J, V103, P175, DOI 10.1016/j.bpj.2012.06.009; Kabla AJ, 2012, J R SOC INTERFACE, V9, P3268, DOI 10.1098/rsif.2012.0448; Lecuit T, 2008, HFSP J, V2, P72, DOI 10.2976/1.2896332; Lee P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002007; Mark S, 2010, BIOPHYS J, V98, P361, DOI 10.1016/j.bpj.2009.10.022; Meghana C, 2011, P NATL ACAD SCI USA, V108, P9107, DOI 10.1073/pnas.1018652108; Mogilner A, 2009, CURR BIOL, V19, pR762, DOI 10.1016/j.cub.2009.06.053; Petitjean L, 2010, BIOPHYS J, V98, P1790, DOI 10.1016/j.bpj.2010.01.030; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Puliafito A, 2012, P NATL ACAD SCI USA, V109, P739, DOI 10.1073/pnas.1007809109; Rangamani P, 2011, BIOPHYS J, V100, P845, DOI 10.1016/j.bpj.2010.12.3732; Rausch S, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-32; Reffay M, 2014, NAT CELL BIOL, V16, P217, DOI 10.1038/ncb2917; Reffay M, 2011, BIOPHYS J, V100, P2566, DOI 10.1016/j.bpj.2011.04.047; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Sepulveda N, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002944; Serra-Picamal X, 2012, NAT PHYS, V8, P628, DOI [10.1038/NPHYS2355, 10.1038/nphys2355]; Tambe DT, 2011, NAT MATER, V10, P469, DOI [10.1038/NMAT3025, 10.1038/nmat3025]; Tarle V, 2015, INTEGR BIOL-UK, V7, P1218, DOI 10.1039/c5ib00092k; Thery M, 2006, CELL MOTIL CYTOSKEL, V63, P341, DOI 10.1002/cm.20126; Thompson D.W, 1917, GROWTH FORM; Trepat X, 2011, TRENDS CELL BIOL, V21, P638, DOI 10.1016/j.tcb.2011.06.006; Vedula SRK, 2012, P NATL ACAD SCI USA, V109, P12974, DOI 10.1073/pnas.1119313109; Wang XB, 2010, NAT CELL BIOL, V12, P591, DOI 10.1038/ncb2061; Yamaguchi N, 2015, SCI REP-UK, V5, DOI 10.1038/srep07656	34	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153471	10.1371/journal.pone.0153471	http://dx.doi.org/10.1371/journal.pone.0153471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078632	Green Published, Green Accepted, gold			2022-12-27	WOS:000374131700060
J	Lafranca, JA; van Bruggen, M; Kimenai, HJAN; Tran, TCK; Terkivatan, T; Betjes, MGH; IJzermans, JNM; Dor, FJMF				Lafranca, Jeffrey A.; van Bruggen, Mark; Kimenai, Hendrikus J. A. N.; Tran, Thi C. K.; Terkivatan, Turkan; Betjes, Michiel G. H.; IJzermans, Jan N. M.; Dor, Frank J. M. F.			Vascular Multiplicity Should Not Be a Contra-Indication for Live Kidney Donation and Transplantation	PLOS ONE			English	Article							LAPAROSCOPIC-DONOR-NEPHRECTOMY; SINGLE RENAL-ARTERIES; COMPLICATIONS; PROCUREMENT; EXPERIENCE; MANAGEMENT; RECIPIENTS; OUTCOMES; GRAFTS; IMPACT	Background Whether vascular multiplicity should be considered as contraindication and therefore 'extended donor criterion' is still under debate. Methods Data from all live kidney donors from 2006-2013 (n = 951) was retrospectively reviewed. Vascular anatomy as imaged by MRA, CTA or other modalities was compared with intraoperative findings. Furthermore, the influence of vascular multiplicity on outcome of donors and recipients was studied. Results In 237 out of 951 donors (25%), vascular multiplicity was present. CTA had the highest accuracy levels regarding vascular anatomy assessment. Regarding outcome of donors with vascular multiplicity, warm ischemia time (WIT) and skin-to-skin time were significantly longer if arterial multiplicity (AM) was present (5.1 vs. 4.0 mins and 202 vs. 178 mins). Skin-to-skin time was significantly longer, and complication rates were higher in donors with venous multiplicity (203 vs. 180 mins and 17.2% vs. 8.4%). Outcome of renal transplant recipients showed a significantly increased WIT (30 vs. 26.7 minutes), higher rate of DGF (13.9% vs. 6.9%) and lower rate of BPAR (6.9% vs. 13.9%) in patients receiving a kidney with AM compared to kidneys with singular anatomy. Conclusions We conclude that vascular multiplicity should not be a contra-indication, since it has little impact on clinical outcome in the donor as well as in renal transplant recipients.	[Lafranca, Jeffrey A.; van Bruggen, Mark; Kimenai, Hendrikus J. A. N.; Tran, Thi C. K.; Terkivatan, Turkan; IJzermans, Jan N. M.; Dor, Frank J. M. F.] Univ Med Ctr Rotterdam, Erasmus MC, Div HPB & Transplant Surg, Dept Surg, Rotterdam, Netherlands; [Betjes, Michiel G. H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Internal Med, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dor, FJMF (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Div HPB & Transplant Surg, Dept Surg, Rotterdam, Netherlands.	frank.dor@imperial.nhs.uk	van Eijck, casper/K-5983-2019	Betjes, Michiel/0000-0001-9435-6208; Lafranca, Jeffrey/0000-0002-2727-0524				Abbasi Eslamloo MA, 2011, EUR UROL SUPPL, V10, P608; Ahmadi AR, 2015, KIDNEY INT, V87, P31, DOI 10.1038/ki.2014.118; Andrews PA, 2012, TRANSPLANTATION, V93, P666, DOI 10.1097/TP.0b013e318247a7b7; Bessede T, 2012, TRANSPL INT, V25, P994, DOI 10.1111/j.1432-2277.2012.01533.x; Carter JT, 2005, AM J TRANSPLANT, V5, P1312, DOI 10.1111/j.1600-6143.2005.00859.x; Cooper M, 2013, CLIN TRANSPLANT; Del Pizzo JJ, 1999, J UROLOGY, V162, P31, DOI 10.1097/00005392-199907000-00008; Desai MR, 2007, UROLOGY, V69, P824, DOI 10.1016/j.urology.2007.01.026; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dutch Transplantation Foundation, 2013, YEAR REP 2013; Fettouh HA, 2008, J ENDOUROL, V22, P77, DOI 10.1089/end.2007.0115; Fuller TF, 2014, TRANSPLANTATION, V98, P1144, DOI 10.1097/TP.0000000000000324; Genc V, 2011, J KOREAN SURG SOC, V80, P272, DOI 10.4174/jkss.2011.80.4.272; Hsu THS, 2003, UROLOGY, V61, P323, DOI 10.1016/S0090-4295(02)02124-6; Hung CJ, 2012, TRANSPL P, V44, P36, DOI 10.1016/j.transproceed.2011.12.027; Husted TL, 2005, TRANSPL P, V37, P629, DOI 10.1016/j.transproceed.2004.12.128; Kadotani Y, 2005, SURG TODAY, V35, P459, DOI 10.1007/s00595-004-2967-2; Keller JE, 2009, SURG ENDOSC, V23, P2327, DOI 10.1007/s00464-009-0330-9; Kok NFM, 2008, TRANSPLANTATION, V85, P1760, DOI 10.1097/TP.0b013e318172802d; Nath J, 2015, TRANSPL P, V47, P373, DOI 10.1016/j.transproceed.2015.01.006; Omoto K, 2011, AM J TRANSPLANT, V11, P459; Paragi PR, 2011, WORLD J SURG, V35, P2159, DOI 10.1007/s00268-011-1168-6; Paramesh A, 2009, TRANSPLANTATION, V88, P1203, DOI 10.1097/TP.0b013e3181ba343a; ROZA AM, 1989, TRANSPLANTATION, V47, P397; Saidi R, 2009, ARCH SURG-CHICAGO, V144, P472, DOI 10.1001/archsurg.2009.49; Satyapal KS, 2001, SURG RADIOL ANAT, V23, P33, DOI 10.1007/s00276-001-0033-y; Tyson MD, 2011, UROLOGY, V77, P1116, DOI 10.1016/j.urology.2010.07.503; U.S. Renal Data System USRDS, 2013, ANN DAT REP ATL CHRO	28	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153460	10.1371/journal.pone.0153460	http://dx.doi.org/10.1371/journal.pone.0153460			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077904	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700056
J	Shusterman, A; Slusser, E; Halberda, J; Odic, D				Shusterman, Anna; Slusser, Emily; Halberda, Justin; Odic, Darko			Acquisition of the Cardinal Principle Coincides with Improvement in Approximate Number System Acuity in Preschoolers	PLOS ONE			English	Article							NUMERICAL EQUIVALENCE; DEVELOPMENTAL-CHANGE; INTUITIVE SENSE; REPRESENTATIONS; WORDS; DISCRIMINATION; KNOWLEDGE; COGNITION; INFANTS; ABILITY	Human mathematical abilities comprise both learned, symbolic representations of number and unlearned, non-symbolic evolutionarily primitive cognitive systems for representing quantities. However, the mechanisms by which our symbolic (verbal) number system becomes integrated with the non-symbolic (non-verbal) representations of approximate magnitude (supported by the Approximate Number System, or ANS) are not well understood. To explore this connection, forty-six children participated in a 6-month longitudinal study assessing verbal number knowledge and non-verbal numerical acuity. Cross-sectional analyses revealed a strong relationship between verbal number knowledge and ANS acuity. Longitudinal analyses suggested that increases in ANS acuity were most strongly related to the acquisition of the cardinal principle, but not to other milestones of verbal number acquisition. These findings suggest that experience with culture and language is intimately linked to changes in the properties of a core cognitive system.	[Shusterman, Anna] Wesleyan Univ, Dept Psychol, Middletown, CT USA; [Slusser, Emily] San Jose State Univ, Dept Child & Adolescent Dev, San Jose, CA 95192 USA; [Halberda, Justin] Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD USA; [Odic, Darko] Univ British Columbia, Dept Psychol, Vancouver, BC, Canada	Wesleyan University; California State University System; San Jose State University; Johns Hopkins University; University of British Columbia	Shusterman, A (corresponding author), Wesleyan Univ, Dept Psychol, Middletown, CT USA.	ashusterman@wesleyan.edu		Slusser, Emily/0000-0002-9422-8393; Odic, Darko/0000-0001-5783-2789; Halberda, Justin/0000-0002-5619-3249	National Science Foundation [DRL-0845966]; Division Of Research On Learning [1420196] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Research On Learning(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This work was supported by National Science Foundation DRL-0845966 to AS; www.nsf.gov. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari D, 2006, J COGNITIVE NEUROSCI, V18, P1820, DOI 10.1162/jocn.2006.18.11.1820; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Bonny JW, 2010, THESIS; Brannon EM, 2001, COGNITIVE PSYCHOL, V43, P53, DOI 10.1006/cogp.2001.0756; Carey S, 2009, THE ORIGIN OF CONCEP; Carey S, 2016, DO ANALOG NUMBER REP; Cheung P, 6 MONTH LON IN PRESS; Condry KF, 2008, J EXP PSYCHOL GEN, V137, P22, DOI 10.1037/0096-3445.137.1.22; Davidson K, 2012, COGNITION, V123, P162, DOI 10.1016/j.cognition.2011.12.013; Dehaene S., 2007, ATTENTION PERFORM, P527, DOI DOI 10.1093/ACPROF:OSO/9780199231447.003.0024; Dehaene S, 1997, THE NUMBER SENSE HOW; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; DeWind NK, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00068; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2008, COGNITION, V107, P1, DOI 10.1016/j.cognition.2007.07.006; Feigenson L, 2013, CHILD DEV PERSPECT, V7, P74, DOI 10.1111/cdep.12019; Flaherty M, 2011, COGNITION, V121, P427, DOI 10.1016/j.cognition.2011.07.007; Frank MC, 2008, COGNITION, V108, P819, DOI 10.1016/j.cognition.2008.04.007; Fuson KC, 1988, CHILDRENS COUNTING A; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Gelman R., 1978, THE CHILDS UNDERSTAN; Gilmore CK, 2010, COGNITION, V115, P394, DOI 10.1016/j.cognition.2010.02.002; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Gunderson EA, 2015, J EXP CHILD PSYCHOL, V130, P35, DOI 10.1016/j.jecp.2014.09.008; Gunderson EA, 2011, DEVELOPMENTAL SCI, V14, P1021, DOI 10.1111/j.1467-7687.2011.01050.x; Halberda J., 2012, P NATL ACAD SCI USA, V109; Halberda J., 2014, EVOLUTIONARY ORIGINS, P305, DOI DOI 10.1016/B978-0-12-420133-0.00012-0; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Halberda J, 2008, DEV PSYCHOL, V44, P1457, DOI 10.1037/a0012682; Huang YT, 2010, PSYCHOL SCI, V21, P600, DOI 10.1177/0956797610363552; Huntley-Fenner G, 2000, PSYCHOL SCI, V11, P147, DOI 10.1111/1467-9280.00230; Hyde DC, 2014, COGNITION, V131, P92, DOI 10.1016/j.cognition.2013.12.007; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; Le Corre M, 2007, COGNITION, V105, P395, DOI 10.1016/j.cognition.2006.10.005; Libertus ME, 2013, LEARN INDIVID DIFFER, V25, P126, DOI 10.1016/j.lindif.2013.02.001; Libertus ME, 2012, ACTA PSYCHOL, V141, P373, DOI 10.1016/j.actpsy.2012.09.009; Libertus ME, 2011, DEVELOPMENTAL SCI, V14, P1292, DOI 10.1111/j.1467-7687.2011.01080.x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Lyons IM, 2011, COGNITION, V121, P256, DOI 10.1016/j.cognition.2011.07.009; Mazzocco MMM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023749; Mix KS, 1999, J EXP CHILD PSYCHOL, V74, P309, DOI 10.1006/jecp.1999.2533; Mix KS, 1999, COGNITIVE DEV, V14, P269, DOI 10.1016/S0885-2014(99)00005-2; Mundy E, 2009, J EXP CHILD PSYCHOL, V103, P490, DOI 10.1016/j.jecp.2009.02.003; Mussolin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091839; Mussolin C, 2012, TRENDS NEUROSCI EDUC, V1, P21, DOI 10.1016/j.tine.2012.09.003; Negen J, 2015, BRIT J DEV PSYCHOL, V33, P92, DOI 10.1111/bjdp.12071; Negen J, 2012, CHILD DEV, V83, P2019, DOI 10.1111/j.1467-8624.2012.01815.x; Odic D, 2011, J VISION, V11, P985; Odic D, 2015, COGNITION, V138, P102, DOI 10.1016/j.cognition.2015.01.008; Odic D, 2013, DEV PSYCHOL, V49, P1103, DOI 10.1037/a0029472; Odic D, 2013, J EXP PSYCHOL LEARN, V39, P451, DOI 10.1037/a0028874; Park J, 2013, PSYCHOL SCI, V24, P2013, DOI 10.1177/0956797613482944; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2013, PSYCHOL SCI, V24, P1037, DOI 10.1177/0956797612464057; Piazza M, 2010, TRENDS COGN SCI, V14, P542, DOI 10.1016/j.tics.2010.09.008; Piazza M, 2010, COGNITION, V116, P33, DOI 10.1016/j.cognition.2010.03.012; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Rousselle L, 2008, DEV PSYCHOL, V44, P544, DOI 10.1037/0012-1649.44.2.544; Sarnecka BW, 2009, J EXP CHILD PSYCHOL, V103, P325, DOI 10.1016/j.jecp.2009.02.007; Sarnecka BW, 2015, THE OXFORD HANDBOOK, P291; Shusterman A, 2013, PROCEEDINGS OF THE 3, P8; Slusser EB, 2011, J EXP CHILD PSYCHOL, V110, P38, DOI 10.1016/j.jecp.2011.03.006; Starr A, 2013, P NATL ACAD SCI USA, V110, P18116, DOI 10.1073/pnas.1302751110; Sullivan J, 2014, CHILD DEV, V85, P1740, DOI 10.1111/cdev.12211; Sullivan J, 2013, Q J EXP PSYCHOL, V66, P389, DOI 10.1080/17470218.2012.715655; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; US Census Bureau, 2010, STATE AND COUNTRY QU; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; Wagner JB, 2011, COGNITION, V119, P10, DOI 10.1016/j.cognition.2010.11.014; Whalen J, 1999, PSYCHOL SCI, V10, P130, DOI 10.1111/1467-9280.00120; Wilson Anna J, 2006, Behav Brain Funct, V2, P20, DOI 10.1186/1744-9081-2-20; WYNN K, 1992, COGNITIVE PSYCHOL, V24, P220, DOI 10.1016/0010-0285(92)90008-P; WYNN K, 1990, COGNITION, V36, P155, DOI 10.1016/0010-0277(90)90003-3; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xu SZ, 2003, GENETICS, V163, P789	77	42	43	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153072	10.1371/journal.pone.0153072	http://dx.doi.org/10.1371/journal.pone.0153072			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078257	Green Published, gold			2022-12-27	WOS:000374131700019
J	Xie, N; Chen, LN; Wong, KM; Cui, YZ; Yang, HQ				Xie, Ning; Chen, Ling-Na; Wong, Khoon-Meng; Cui, Yong-Zhong; Yang, Han-Qi			Seed Set and Natural Regeneration of Dendrocalamus membranaceus Munro after Mass and Sporadic Flowering in Yunnan, China	PLOS ONE			English	Article							TEMPERATE FOREST; SOUTH-AMERICA; BAMBOO; PATAGONIA; GERMINATION; ARGENTINA; DEATH	The flowering periods of woody bamboos, seed set, natural regeneration and death after flowering have been rarely observed and evaluated in the field. Dendrocalamus membranaceus Munro, a tropical woody bamboo mainly distributed in the Yunnan, displayed both sporadic as well as gregarious (mass) flowering and fruited from 2006 to 2013 following severe droughts. The aim of this study is to examine potential differences in seed set and natural regeneration between the two flowering patterns in natural D. membranaceus forests. We investigated and analyzed seed set, seed germination, seedling growth and mortality in both mass and sporadic flowering populations. Observations were made over a period of three years to record changes in bamboo seedling density, height and culm diameter. We observed a low natural seed set ranging from 1.76% to 7.49%, and a relatively high seed germination rate in the nursery from 59.6% to 71.0% for both types of flowering populations. Seeds germinated in 5-7 days after sowing and the germination period lasted 10-15 days. Seed set and germination rates in mass-flowering populations were significantly higher than those of sporadically flowering stands. The seedlings within sporadically flowering populations died within two years. In comparison, seedling mortality in the mass flowering population increased over two periods of observation from 64.92% to 98.89%, yet there was good seedling establishment left over, which showed mean height and mean culm diameter increasing by 1053.25% and 410.71%, respectively, in the second year of observations, and 137.10%, and 217.48%, respectively, in the third year. There are significant differences in seed set, natural regeneration ability and sustainability of bamboo populations between the mass flowering and sporadically flowering populations of D. membranaceus. Sporadic flowering populations failed to produce effective regeneration, while mass flowering populations were able to regenerate successfully. This study provides useful insights for conservation and natural forest management of D. membranaceus. We consider the merits of introducing other genetic provenances towards long-term maintenance of the stand features at sporadically flowering sites; meanwhile, the most economic option for mass	[Xie, Ning; Chen, Ling-Na; Cui, Yong-Zhong; Yang, Han-Qi] Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Yunnan, Peoples R China; [Wong, Khoon-Meng] Singapore Bot Gardens, 1 Cluny Rd, Singapore 259569, Singapore	Chinese Academy of Forestry; Research Institute of Resources Insects, CAF	Yang, HQ (corresponding author), Chinese Acad Forestry, Res Inst Resources Insects, Kunming 650224, Yunnan, Peoples R China.	yanghanqikm@aliyun.com		Chen, LingNa/0000-0002-1051-0253	National Natural Science Foundation of China [31270662]; Department of Science and Technology of Yunnan Province [2014HB041, 2008OC001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Yunnan Province	This work was supported by National Natural Science Foundation of China (31270662), http://www.nsfc.gov.cn/; Department of Science and Technology of Yunnan Province (2014HB041, 2008OC001), http://www.ynstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2014, J FOREST RES-JPN, V19, P166, DOI 10.1007/s10310-013-0397-y; An MY, 2010, SHANDONG FORESTRY SC, V4, P111, DOI [10.3969/j.issn.1002-2724.2010.04.033, DOI 10.3969/J.ISSN.1002-2724.2010.04.033]; Austin AT, 2012, FUNCT ECOL, V26, P265, DOI 10.1111/j.1365-2435.2011.01910.x; Budke JC, 2010, FOREST ECOL MANAG, V260, P1345, DOI 10.1016/j.foreco.2010.07.028; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Demissew Sertse, 2011, Journal of Biodiversity and Environmental Sciences (JBES), V1, P16; Du Fan, 2000, Scientia Silvae Sinicae, V36, P57; Giordano CV, 2009, NEW PHYTOL, V181, P880, DOI 10.1111/j.1469-8137.2008.02708.x; Guerreiro C, 2014, J PLANT RES, V127, P307, DOI 10.1007/s10265-013-0593-z; Hui CM, 1989, J SW FORESTRY COLL, V9, P108; Hui CM, 1987, THESIS SW FORESTRY C; JANZEN DH, 1976, ANNU REV ECOL SYST, V7, P347, DOI 10.1146/annurev.es.07.110176.002023; Judziewicz EJ, 1999, AM BAMBOOS; Kitamura K, 2011, J PLANT RES, V124, P683, DOI 10.1007/s10265-010-0398-2; Koenig WD, 2003, TRENDS ECOL EVOL, V18, P157, DOI 10.1016/S0169-5347(03)00034-X; Li DZ, 2006, FLORA CHINA, V9, P1; MAKITA A, 1992, ECOL RES, V7, P245, DOI 10.1007/BF02347093; Marchesini VA, 2009, J VEG SCI, V20, P424, DOI 10.1111/j.1654-1103.2009.05768.x; Mizuki I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105051; Ramanayake SMSD, 1998, ANN BOT-LONDON, V82, P779, DOI 10.1006/anbo.1998.0754; Sun BX, 2003, FLORA OF YUNNAN, V9; Wong K. M., 1981, Malaysian Forester, V44, P453; Xue JR, 1995, BAMBOO RESOURCES DEV; Yang Han-qi, 2013, Forest Research, V26, P710; Yang HQ, 2012, INT J MOL SCI, V13, P4446, DOI 10.3390/ijms13044446; Yang YM, 2008, STUDY MASTER PLANNIN; ZHANG W, 1990, Forest Research, V3, P250; Zhu Hua, 2007, Acta Botanica Yunnanica, V29, P377	28	28	30	6	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153845	10.1371/journal.pone.0153845	http://dx.doi.org/10.1371/journal.pone.0153845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077651	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700114
J	Cigarroa, I; Lalanza, JF; Caimari, A; del Bas, JM; Capdevila, L; Arola, L; Escorihuela, RM				Cigarroa, Igor; Lalanza, Jaume F.; Caimari, Antoni; del Bas, Josep M.; Capdevila, Lluis; Arola, Lluis; Escorihuela, Rosa M.			Treadmill Intervention Attenuates the Cafeteria Diet-Induced Impairment of Stress-Coping Strategies in Young Adult Female Rats	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; NUCLEUS-ACCUMBENS SHELL; INDUCED OBESITY; PSYCHIATRIC-DISORDERS; INSULIN SENSITIVITY; PHYSICAL-EXERCISE; ANIMAL-MODELS; LIPID-CONTENT; LEPTIN; FOOD	The current prevalence of diet-induced overweight and obesity in adolescents and adults is continuously growing. Although the detrimental biochemical and metabolic consequences of obesity are widely studied, its impact on stress-coping behavior and its interaction with specific exercise doses (in terms of intensity, duration and frequency) need further investigation. To this aim, we fed adolescent rats either an obesogenic diet (cafeteria diet, CAF) or standard chow (ST). Each group was subdivided into four subgroups according to the type of treadmill intervention as follows: a sedentary group receiving no manipulation; a control group exposed to a stationary treadmill; a low-intensity treadmill group trained at 12 m/min; and a higher intensity treadmill group trained at 17 m/min. Both the diet and treadmill interventions started at weaning and lasted for 8 weeks. Subjects were tested for anxiety-like behavior in the open field test and for coping strategies in the two-way active avoidance paradigm at week 7 and were sacrificed at week 8 for biometric and metabolic characterization. CAF feeding increased the weight gain, relative retroperitoneal white adipose tissue (RWAT %), and plasma levels of glucose, insulin, triglycerides and leptin and decreased the insulin sensitivity. Treadmill intervention partially reversed the RWAT% and triglyceride alterations; at higher intensity, it decreased the leptin levels of CAF-fed animals. CAF feeding decreased the motor activity and impaired the performance in a two-way active avoidance assessment. Treadmill intervention reduced defecation in the shuttle box, suggesting diminished anxiety. CAF feeding combined with treadmill training at 17 m/min increased the time spent in the center of the open field and more importantly, partially reversed the two-way active avoidance deficit. In conclusion, this study demonstrates that at doses that decreased anxiety-like behavior, treadmill exercise partially improved the coping strategy in terms of active avoidance behavior in the CAF-fed animals. This effect was not observed at lower doses of treadmill training.	[Cigarroa, Igor; Lalanza, Jaume F.; Escorihuela, Rosa M.] Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain; [Cigarroa, Igor] Univ Santo Tomas, Fac Salud, Carrera Kinesiol, Los Angeles, Region Del Bio, Chile; [Caimari, Antoni; del Bas, Josep M.] CEICS, TECNIO, CTNS, GRNS, Reus, Spain; [Capdevila, Lluis] Univ Autonoma Barcelona, Dept Psicol Basica, Lab Psicol Esport, E-08193 Barcelona, Spain; [Arola, Lluis] Univ Rovira & Virgili, Dept Bioquim & Biotecnol, Nutrigen Res Grp, E-43007 Tarragona, Spain; [Arola, Lluis] CEICS, TECNIO, CTNS, Reus, Spain	Autonomous University of Barcelona; Universidad Santo Tomas; Autonomous University of Barcelona; Universitat Rovira i Virgili	Escorihuela, RM (corresponding author), Univ Autonoma Barcelona, Inst Neurociencies, Dept Psiquiatria & Med Legal, E-08193 Barcelona, Spain.	rosamaria.escorihuela@uab.cat	Arola, Lluís/C-6074-2011; F. Lalanza, Jaume/C-9186-2011; Capdevila, Lluis/I-2530-2015; cigarroa, igor/AAV-3527-2020; Escorihuela, Rosa M/L-4524-2014; del Bas, Josep Maria/K-9310-2019; del Bas, Josep M/K-2327-2014	Arola, Lluís/0000-0003-2767-1974; F. Lalanza, Jaume/0000-0003-2481-2188; Capdevila, Lluis/0000-0002-7319-4745; cigarroa, igor/0000-0003-0418-8787; Escorihuela, Rosa M/0000-0001-9368-5173; del Bas, Josep Maria/0000-0002-0700-2004; del Bas, Josep M/0000-0002-0700-2004; Caimari, Antoni/0000-0001-6144-0294	Spanish Ministry of Economy and Competitiveness [PSI 2011-29807-C02/PSIC]; ACCIO [TECRD11-1-0012, TECRD12-1-0005]; European Union [244995]; Generalitat de Catalunya [FI-DGR 2011]; Universidad Santo Tomas, Chile; CONYCYT/BECA CHILE/PAI [72150035]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ACCIO; European Union(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Universidad Santo Tomas, Chile; CONYCYT/BECA CHILE/PAI	The research leading to these results has received funding from the Spanish Ministry of Economy and Competitiveness (PSI 2011-29807-C02/PSIC), ACCIO (TECRD11-1-0012 and TECRD12-1-0005) and the European Union's Seventh Framework Programme FP7 2007-2013 under grant agreement no 244995 (BIOCLAIMS Project). JFL was supported by a pre-doctoral fellowship from the Generalitat de Catalunya (FI-DGR 2011). IC was supported by a pre-doctoral fellowship from Universidad Santo Tomas, Chile and a fellowship from CONYCYT/BECA CHILE/PAI 72150035. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alonso M, 2015, NUTR REV, V73, P296, DOI 10.1093/nutrit/nuv002; Alsio J, 2010, NEUROSCIENCE, V171, P779, DOI 10.1016/j.neuroscience.2010.09.046; Alsio J, 2009, GENES BRAIN BEHAV, V8, P193, DOI 10.1111/j.1601-183X.2008.00464.x; Asmundson GJG, 2013, DEPRESS ANXIETY, V30, P362, DOI 10.1002/da.22043; Baldo BA, 2005, BEHAV NEUROSCI, V119, P1195, DOI 10.1037/0735-7044.119.5.1195; Bayod S, 1985, J APPL PHYSIOL, V111, P1380, DOI DOI 10.1152/JAPPLPHYSI0L.00425.2011; Borai A, 2007, ANN CLIN BIOCHEM, V44, P324, DOI 10.1258/000456307780945778; Bourin M, 2015, DIALOGUES CLIN NEURO, V17, P295; Brandt N, 2010, AM J PHYSIOL-ENDOC M, V299, pE215, DOI 10.1152/ajpendo.00098.2010; Buchenauer T, 2009, PHYSIOL BEHAV, V98, P563, DOI 10.1016/j.physbeh.2009.09.003; Burghardt PR, 2004, BRAIN RES, V1019, P84, DOI 10.1016/j.brainres.2004.05.086; Dallman MF, 2010, TRENDS ENDOCRIN MET, V21, P159, DOI 10.1016/j.tem.2009.10.004; El Elj N, 2010, ANN ENDOCRINOL-PARIS, V71, P297, DOI 10.1016/j.ando.2010.02.002; Fernandez-Teruel A, 2002, GENOME RES, V12, P618, DOI [10.1101/gr.203402, 10.1101/gr.203402. Article published online before print in March ]; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Fulk LJ, 2004, INT J SPORTS MED, V25, P78; Garcia-Capdevila S, 2009, BEHAV BRAIN RES, V202, P162, DOI 10.1016/j.bbr.2009.03.020; Geiger BM, 2009, NEUROSCIENCE, V159, P1193, DOI 10.1016/j.neuroscience.2009.02.007; Goularte JF, 2012, BRIT J NUTR, V108, P1511, DOI 10.1017/S0007114511006933; Gray JA, 2000, NEUROPSYCHOLOGY ANXI; Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016; Heyne A, 2009, ADDICT BIOL, V14, P373, DOI 10.1111/j.1369-1600.2009.00175.x; Higa TS, 2014, LIFE SCI, V103, P41, DOI 10.1016/j.lfs.2014.02.039; Horio N, 2010, J PHARMACOL SCI, V112, P8, DOI 10.1254/jphs.09R07FM; Hung YH, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12232; Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Kennedy AJ, 2010, DIS MODEL MECH, V3, P156, DOI 10.1242/dmm.003467; Kenny PJ, 2011, NEURON, V69, P664, DOI 10.1016/j.neuron.2011.02.016; Lalanza JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep16166; Lalanza JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085049; Lalanza JF, 2012, PSYCHONEUROENDOCRINO, V37, P1745, DOI 10.1016/j.psyneuen.2012.03.008; Levin BE, 2004, AM J PHYSIOL-REG I, V286, pR771, DOI 10.1152/ajpregu.00650.2003; Low A, 2015, PSYCHOL SCI, V26, P1706, DOI 10.1177/0956797615597332; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Lutz Thomas A, 2012, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0561s58; Maniam J, 2010, PSYCHONEUROENDOCRINO, V35, P717, DOI 10.1016/j.psyneuen.2009.10.013; Martire SI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060407; Moscarello JM, 2013, J NEUROSCI, V33, P3815, DOI 10.1523/JNEUROSCI.2596-12.2013; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Narayanan NS, 2010, FRONT NEUROENDOCRIN, V31, P104, DOI 10.1016/j.yfrne.2009.10.004; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Patterson CM, 2009, AM J PHYSIOL-REG I, V296, pR537, DOI 10.1152/ajpregu.90859.2008; Perseghin G, 2001, J CLIN ENDOCR METAB, V86, P4776, DOI 10.1210/jc.86.10.4776; Pietilainen KH, 2008, OBESITY, V16, P409, DOI 10.1038/oby.2007.72; Pietrelli A, 2012, NEUROSCIENCE, V202, P252, DOI 10.1016/j.neuroscience.2011.11.054; Ramirez F, 2015, J NEUROSCI, V35, P3470, DOI 10.1523/JNEUROSCI.1331-14.2015; Reichelt AC, 2015, BRAIN BEHAV IMMUN, V43, P68, DOI 10.1016/j.bbi.2014.07.005; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Salim S, 2010, BEHAV BRAIN RES, V208, P545, DOI 10.1016/j.bbr.2009.12.039; Sampey BP, 2011, OBESITY, V19, P1109, DOI 10.1038/oby.2011.18; Scarpace PJ, 2009, AM J PHYSIOL-REG I, V296, pR493, DOI 10.1152/ajpregu.90669.2008; Scheggi S, 2013, NEUROSCIENCE, V236, P320, DOI 10.1016/j.neuroscience.2013.01.027; Schroeder M, 2010, HORM BEHAV, V57, P496, DOI 10.1016/j.yhbeh.2010.02.008; Shafat A, 2009, APPETITE, V52, P34, DOI 10.1016/j.appet.2008.07.004; Shigemura N, 2004, ENDOCRINOLOGY, V145, P839, DOI 10.1210/en.2003-0602; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Singh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00925; Souza CG, 2007, LIFE SCI, V81, P198, DOI 10.1016/j.lfs.2007.05.001; Steimer Thierry, 2011, Dialogues Clin Neurosci, V13, P495; Stice E, 2013, NEUROSCI BIOBEHAV R, V37, P2047, DOI 10.1016/j.neubiorev.2012.12.001; Vaisy M, 2010, INT J MOL MED, V25, P905, DOI 10.3892/ijmm_00000421; Valladolid-Acebes I, 2011, NEUROBIOL LEARN MEM, V95, P80, DOI 10.1016/j.nlm.2010.11.007; Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6; Wang J, 2008, ENDOCRINE, V33, P77, DOI 10.1007/s12020-008-9056-z; Warneke W, 2014, PHARMACOL BIOCHEM BE, V116, P45, DOI 10.1016/j.pbb.2013.11.016; Woo J, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-144; Wright T, 2011, PHYSIOL BEHAV, V103, P164, DOI 10.1016/j.physbeh.2011.01.008; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Zeeni N, 2013, STRESS, V16, P211, DOI 10.3109/10253890.2012.708952	74	14	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153687	10.1371/journal.pone.0153687	http://dx.doi.org/10.1371/journal.pone.0153687			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099927	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500049
J	Krzywinska, E; Cornillon, A; Allende-Vega, N; Vo, DN; Rene, C; Lu, ZY; Pasero, C; Olive, D; Fegueux, N; Ceballos, P; Hicheri, Y; Sobecki, M; Rossi, JF; Cartron, G; Villalba, M				Krzywinska, Ewelina; Cornillon, Amelie; Allende-Vega, Nerea; Vo, Dang-Nghiem; Rene, Celine; Lu, Zhao-Yang; Pasero, Christine; Olive, Daniel; Fegueux, Nathalie; Ceballos, Patrick; Hicheri, Yosr; Sobecki, Michal; Rossi, Jean-Francois; Cartron, Guillaume; Villalba, Martin			CD45 Isoform Profile Identifies Natural Killer (NK) Subsets with Differential Activity	PLOS ONE			English	Article							PROTEIN-TYROSINE-PHOSPHATASES; HEMATOLOGICAL CANCERS; CELL MATURATION; DEFICIENT MICE; ACTIVATION; METABOLISM; FAMILY; TRANSPLANTATION; CYTOTOXICITY; STIMULATION	The leucocyte-specific phosphatase CD45 is present in two main isoforms: the large CD45RA and the short CD45RO. We have recently shown that distinctive expression of these isoforms distinguishes natural killer (NK) populations. For example, co-expression of both isoforms identifies in vivo the anti tumor NK cells in hematological cancer patients. Here we show that low CD45 expression associates with less mature, CD56(bright), NK cells. Most NK cells in healthy human donors are CD45RA(+)CD45RO(-). The CD45RA(-)RO(+) phenotype, CD45RO cells, is extremely uncommon in B or NK cells, in contrast to T cells. However, healthy donors possess CD45RA(dim)RO(-) (CD45RAdim cells), which show immature markers and are largely expanded in hematopoietic stem cell transplant patients. Blood borne cancer patients also have more CD45RA(dim) cells that carry several features of immature NK cells. However, and in opposition to their association to NK cell progenitors, they do not proliferate and show low expression of the transferrin receptor protein 1/CD71, suggesting low metabolic activity. Moreover, CD45RA(dim) cells properly respond to in vitro encounter with target cells by degranulating or gaining CD69 expression. In summary, they are quiescent NK cells, with low metabolic status that can, however, respond after encounter with target cells.	[Krzywinska, Ewelina; Cornillon, Amelie; Allende-Vega, Nerea; Vo, Dang-Nghiem; Rene, Celine; Lu, Zhao-Yang; Villalba, Martin] Univ Montpellier I, INSERM, U1183, UFR Med, Montpellier, France; [Allende-Vega, Nerea; Villalba, Martin] CHU Montpellier, IRMB, F-34295 Montpellier, France; [Pasero, Christine; Olive, Daniel] Aix Marseille Univ, Ctr Cancerol Marseille, Plateforme Immunomonitoring Cancerol,CNRS, INSERM,U1068,Inst Paoli Calmettes,UM 105,UMR7258, Marseille, France; [Fegueux, Nathalie; Ceballos, Patrick; Hicheri, Yosr; Rossi, Jean-Francois; Cartron, Guillaume] Univ Montpellier I, CHU Montpellier, Dept Hematol Clin, 80 Ave Augustin Fliche, F-34295 Montpellier, France; [Sobecki, Michal] CNRS, UMR9198, Genome Biol Dept, I2BC, Gif Sur Yvette, France; [Cartron, Guillaume] Univ Montpellier, CNRS, UMR5235, F-34059 Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Universite de Montpellier; CHU de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Villalba, M (corresponding author), Univ Montpellier I, INSERM, U1183, UFR Med, Montpellier, France.; Villalba, M (corresponding author), CHU Montpellier, IRMB, F-34295 Montpellier, France.	martin.villalba@inserm.fr	Vo, Dang-Nghiem/AAE-8920-2021; villalba, martin/AAG-2604-2020; villalba, martin/N-7123-2017	villalba, martin/0000-0002-4385-4888; villalba, martin/0000-0002-4385-4888; Sobecki, Michal/0000-0002-8177-0327; Cartron, Guillaume/0000-0003-0659-9635; Allende-Vega, Nerea/0000-0001-5569-6461; Krzywinska, Ewelina/0000-0002-4311-2972	scientific program from the "Communaute de Travail des Pyrenees" [CTPP5/12]; charity CIEL; European Community Program SUDOE [CLiNK SOE2/P1/E341]; AOI from the CHU Montpellier [221826]; Fondation de France [0057921]; ARC [DOC20121206007]; La Ligue Contre le Cancer [TDKB13362]; Ministere de l'Enseignement Superieur et de la Recherche (MESR); Region Languedoc Roussillon [HEMODIAG_2020]; charity L'Un pour l'Autre; charity Ensangble	scientific program from the "Communaute de Travail des Pyrenees"; charity CIEL; European Community Program SUDOE; AOI from the CHU Montpellier; Fondation de France(Fondation de France); ARC(Australian Research Council); La Ligue Contre le Cancer(Ligue nationale contre le cancer); Ministere de l'Enseignement Superieur et de la Recherche (MESR)(Ministry of Research, France); Region Languedoc Roussillon(Region OccitanieRegion Ile-de-France); charity L'Un pour l'Autre; charity Ensangble	All of the authors' funders are public or charitable organizations. This work was supported by a scientific program from the "Communaute de Travail des Pyrenees" (CTPP5/12 to MV), the charities CIEL, L'Un pour l'Autre and Ensangble (09/2013) (MV), a grant from the European Community Program SUDOE (CLiNK SOE2/P1/E341 to MV and J-FR), an AOI from the CHU Montpellier (No221826) (GC and MV), a grant from Fondation de France (0057921) and fellowships from the ARC (DOC20121206007) and La Ligue Contre le Cancer (TDKB13362) to EK, and Ministere de l'Enseignement Superieur et de la Recherche (MESR) (DNV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; FACs analysis was performed at the platform Montpellier Rio Imaging (MRI). The collection of clinical data and samples (HEMODIAG_2020) at the CHRU Montpellier was supported by funding from Region Languedoc Roussillon.	Aguilo JI, 2009, J IMMUNOL, V182, P1972, DOI 10.4049/jimmunol.0801820; Allende-Vega N, 2015, ONCOTARGET, V6, P19228, DOI 10.18632/oncotarget.4653; Baier C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00459; Beziat V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011966; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Byth KF, 1996, J EXP MED, V183, P1707, DOI 10.1084/jem.183.4.1707; Catalan E, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.985924; Clausen J, 2003, IMMUNOBIOLOGY, V207, P85, DOI 10.1078/0171-2985-00219; Elpek KG, 2010, P NATL ACAD SCI USA, V107, P21647, DOI 10.1073/pnas.1012128107; Freud AG, 2014, SEMIN IMMUNOL, V26, P132, DOI 10.1016/j.smim.2014.02.008; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Grzywacz B, 2007, LEUKEMIA, V21, P356, DOI 10.1038/sj.leu.2404499; Hermiston ML, 2009, IMMUNOL REV, V228, P288, DOI 10.1111/j.1600-065X.2008.00752.x; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Hesslein DGT, 2006, P NATL ACAD SCI USA, V103, P7012, DOI 10.1073/pnas.0601851103; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Domaica CI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051677; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; KAPLAN R, 1990, P NATL ACAD SCI USA, V87, P7000, DOI 10.1073/pnas.87.18.7000; KISHIHARA K, 1993, CELL, V74, P143, DOI 10.1016/0092-8674(93)90302-7; Krzywinska E, 2015, EBIOMEDICINE, V2, P1364, DOI 10.1016/j.ebiom.2015.08.021; Kung C, 2000, NAT MED, V6, P343; Lajoie L, 2014, J IMMUNOL, V192, P741, DOI 10.4049/jimmunol.1301024; Lopez-Verges S, 2010, BLOOD, V116, P3865, DOI 10.1182/blood-2010-04-282301; Mason LH, 2006, J IMMUNOL, V176, P6615, DOI 10.4049/jimmunol.176.11.6615; McKenna DH, 2007, TRANSFUSION, V47, P520, DOI 10.1111/j.1537-2995.2006.01145.x; Mee PJ, 1999, EUR J IMMUNOL, V29, P2923, DOI 10.1002/(SICI)1521-4141(199909)29:09<2923::AID-IMMU2923>3.3.CO;2-P; Miller JS, 2005, BLOOD, V105, P3051, DOI 10.1182/blood-2004-07-2974; Moretta L, 2010, BLOOD, V116, P3689, DOI 10.1182/blood-2010-09-303057; Mustelin T, 2005, NAT REV IMMUNOL, V5, P43, DOI 10.1038/nri1530; Ramirez-Comet N, 2014, ONCOIMMUNOLOGY, V3, DOI [10.4161/21624011.2014.948705, DOI 10.4161/21624011.2014.948705]; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Rubnitz JE, 2010, J CLIN ONCOL, V28, P955, DOI 10.1200/JCO.2009.24.4590; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Sanchez-Martinez D, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.991613; Sanchez-Martinez D, 2014, INT J BIOCHEM CELL B, V49, P42, DOI 10.1016/j.biocel.2014.01.003; Tchilian EZ, 2001, J IMMUNOL, V166, P1308, DOI 10.4049/jimmunol.166.2.1308; Vey N, 2012, BLOOD, V120, P4317, DOI 10.1182/blood-2012-06-437558; Villalba M, 2014, ANTI-CANCER AGENT ME, V14, P223, DOI 10.2174/18715206113136660374; Villalba M, 2013, INT J BIOCHEM CELL B, V45, P106, DOI 10.1016/j.biocel.2012.04.024; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825	41	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150434	10.1371/journal.pone.0150434	http://dx.doi.org/10.1371/journal.pone.0150434			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100180	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500003
J	Chopra, A; Bond, MJ; Bleiler, M; Yeagley, M; Wright, D; Giardina, C				Chopra, Avijeet; Bond, Michael J.; Bleiler, Marina; Yeagley, Michelle; Wright, Dennis; Giardina, Charles			Efficient Activation of Apoptotic Signaling during Mitotic Arrest with AK301	PLOS ONE			English	Article							CELL-CYCLE CHECKPOINTS; POLYPOSIS-COLI PROTEIN; DOUBLE-STRAND BREAKS; CANCER-CELLS; COLORECTAL-CANCER; ADENOMATOUS POLYPOSIS; CHROMOSOME INSTABILITY; IONIZING-RADIATION; SPINDLE CHECKPOINT; KINASE INHIBITORS	Mitotic inhibitors are widely utilized chemotherapeutic agents that take advantage of mitotic defects in cancer cells. We have identified a novel class of piperazine-based mitotic inhibitors, of which AK301 is the most potent derivative identified to date (EC50 < 200 nM). Colon cancer cells arrested in mitosis with AK301 readily underwent a p53-dependent apoptosis following compound withdrawal and arrest release. This apoptotic response was significantly higher for AK301 than for other mitotic inhibitors tested (colchicine, vincristine, and BI 2536). AK301-treated cells exhibited a robust mitosis-associated DNA damage response, including ATM activation, gamma H2AX phosphorylation and p53 stabilization. The association between mitotic signaling and the DNA damage response was supported by the finding that Aurora B inhibition reduced the level of gamma H2AX staining. Confocal imaging of AK301-treated cells revealed multiple gamma-tubulin microtubule organizing centers attached to microtubules, but with limited centrosome migration, raising the possibility that aberrant microtubule pulling may underlie DNA breakage. AK301 selectively targeted APC-mutant colonocytes and promoted TNF-induced apoptosis in p53-mutant colon cancer cells. Our findings indicate that AK301 induces a mitotic arrest state with a highly active DNA damage response. Together with a reversible arrest state, AK301 is a potent promoter of a mitosis-to-apoptosis transition that can target cancer cells with mitotic defects.	[Chopra, Avijeet; Bond, Michael J.; Bleiler, Marina; Yeagley, Michelle; Giardina, Charles] Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT USA; [Wright, Dennis] Univ Connecticut, Sch Pharm, 69 N Eagleville Rd, Storrs, CT USA	University of Connecticut; University of Connecticut	Giardina, C (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, 91 N Eagleville Rd, Storrs, CT USA.	charles.giardina@uconn.edu	; Chopra, Avijeet/H-5611-2013	Bond, Michael/0000-0001-9552-4525; Chopra, Avijeet/0000-0001-6020-488X; Wright, Dennis/0000-0003-4634-3351; Bleiler, Marina/0000-0003-2256-589X	National Cancer Institute [R21CA158743]; NATIONAL CANCER INSTITUTE [R21CA158743] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant R21CA158743 from the National Cancer Institute to CG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by funding to R21CA158743 to CG.	Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Caldwell CM, 2009, ADV EXP MED BIOL, V656, P51, DOI 10.1007/978-1-4419-1145-2_5; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan KS, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.148; Chopra A, 2014, J BIOL CHEM, V289, P2978, DOI 10.1074/jbc.M113.499319; Chopra AS, 2013, CANCER BIOL THER, V14, P436, DOI 10.4161/cbt.23787; Chu MLH, 2008, J BIOL CHEM, V283, P21495, DOI 10.1074/jbc.M803026200; DAbaco GM, 1996, MOL CELL BIOL, V16, P884; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Flatt PM, 2000, DRUG METAB REV, V32, P283, DOI 10.1081/DMR-100102335; Forand A, 2004, BIOL REPROD, V71, P643, DOI 10.1095/biolreprod.104.027466; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Jover R, 2006, GUT, V55, P848, DOI 10.1136/gut.2005.073015; Kadauke S, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-6; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawakami H, 2015, J GASTROINTEST ONCOL, V6, P676, DOI 10.3978/j.issn.2078-6891.2015.065; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kim M, 2008, CANCER RES, V68, P3440, DOI 10.1158/0008-5472.CAN-08-0014; Klotz DM, 2012, J CELL SCI, V125, P887, DOI 10.1242/jcs.091843; Kuratnik A, 2012, BIOCHEM PHARMACOL, V83, P1217, DOI 10.1016/j.bcp.2012.01.024; Lampson MA, 2011, TRENDS CELL BIOL, V21, P133, DOI 10.1016/j.tcb.2010.10.007; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lesko AC, 2014, CURR DRUG TARGETS, V15, P90, DOI 10.2174/1389450114666131108155418; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li SW, 2012, INT J CANCER, V131, P1435, DOI 10.1002/ijc.27344; Liu LH, 2014, FEBS LETT, V588, P929, DOI 10.1016/j.febslet.2014.01.050; Mahmoud NN, 1997, CANCER RES, V57, P5045; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mogensen MM, 2002, J CELL BIOL, V157, P1041, DOI 10.1083/jcb.200203001; Phelps RA, 2009, CELL CYCLE, V8, P2549, DOI 10.4161/cc.8.16.9278; Rigatti MJ, 2012, MOL CARCINOGEN, V51, P363, DOI 10.1002/mc.20795; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Tao Y, 2008, ONCOGENE, V27, P3244, DOI 10.1038/sj.onc.1210990; Verma R, 2010, BIOCHEM PHARMACOL, V79, P565, DOI 10.1016/j.bcp.2009.09.020; Walsby E, 2008, HAEMATOLOGICA, V93, P662, DOI 10.3324/haematol.12148; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; WHITEHEAD RH, 1993, P NATL ACAD SCI USA, V90, P587, DOI 10.1073/pnas.90.2.587; Yamada HY, 2006, MOL CANCER THER, V5, P2963, DOI 10.1158/1535-7163.MCT-06-0319	47	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153818	10.1371/journal.pone.0153818	http://dx.doi.org/10.1371/journal.pone.0153818			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097159	Green Published, gold			2022-12-27	WOS:000374543600060
J	De Vleminck, A; Pardon, K; Beernaert, K; Houttekier, D; Vander Stichele, R; Deliens, L				De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Houttekier, Dirk; Vander Stichele, Robert; Deliens, Luc			How Do General Practitioners Conceptualise Advance Care Planning in Their Practice? A Qualitative Study	PLOS ONE			English	Article							OF-LIFE CARE; END; BARRIERS; COMMUNICATION; FACILITATORS; INTERVENTION; NETHERLANDS	Objectives To explore how GPs conceptualise advance care planning (ACP), based on their experiences with ACP in their practice. Methods Five focus groups were held with 36 GPs. Discussions were analysed using a constant comparative method. Results Four overarching themes in the conceptualisations of ACP were discerned: (1) the organisation of professional care required to meet patients' needs, (2) the process of preparing for death and discussing palliative care options, (3) the discussion of care goals and treatment decisions, (4) the completion of advance directives. Within these themes, ACP was both conceptualised in terms of content of ACP and/or in terms of tasks for the GP. A specific task that was mentioned throughout the discussion of the four different themes was (5) the task of actively initiating ACP by the GP versus passively waiting for patients' initiation. Conclusions This study illustrates that GPs have varying conceptualisations of ACP, of which some are more limited to specific aspects of ACP. A shared conceptualisation and agreement on the purpose and goals of ACP is needed to ensure successful implementation, as well as a systematic integration of ACP in routine practice that could lead to a better uptake of all the important elements of ACP.	[De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Houttekier, Dirk; Vander Stichele, Robert; Deliens, Luc] Univ Ghent, End Of Life Care Res Grp, Brussels, Belgium; [De Vleminck, Aline; Pardon, Koen; Beernaert, Kim; Houttekier, Dirk; Vander Stichele, Robert; Deliens, Luc] Vrije Univ Brussel, Brussels, Belgium; [Vander Stichele, Robert] Univ Ghent, Heymans Inst, B-9000 Ghent, Belgium; [Deliens, Luc] Ghent Univ Hosp, Dept Med Oncol, Ghent, Belgium	Ghent University; Vrije Universiteit Brussel; Ghent University; Ghent University; Ghent University Hospital	De Vleminck, A (corresponding author), Univ Ghent, End Of Life Care Res Grp, Brussels, Belgium.; De Vleminck, A (corresponding author), Vrije Univ Brussel, Brussels, Belgium.	adevlemi@vub.ac.be	Stichele, Robert Vander/K-7203-2015	Stichele, Robert Vander/0000-0001-9118-9651; Pardon, Koen/0000-0002-0571-709X; Beernaert, Kim/0000-0002-2520-3977	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT) [100036]	Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT)	This study is supported by a grant from the Flemish government agency for Innovation by Science and Technology (Agentschap voor Innovatie door Wetenschap en Technologie) (SBO IWT nr. 100036).	Abarshi E, 2011, J PALLIAT MED, V14, P323, DOI 10.1089/jpm.2010.0312; Ahluwalia SC, 2013, PATIENT EDUC COUNS, V91, P200, DOI 10.1016/j.pec.2012.12.016; [Anonymous], 2008, ADV DIR ADV CAR PLAN; Beernaert K, 2014, PALLIAT MED IN PRESS; Bernacki RE, 2014, JAMA INTERN MED 1020; Bischoff KE, 2013, J AM GERIATR SOC, V61, P209, DOI 10.1111/jgs.12105; Brinkman-Stoppelenburg A, 2014, PALLIAT MED; Curtis JR, 2000, ARCH INTERN MED, V160, P1690, DOI 10.1001/archinte.160.11.1690; de Casterle BD, 2012, INT J NURS STUD, V49, P360, DOI 10.1016/j.ijnurstu.2011.09.012; De Vleminck A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084905; De Vleminck A, 2013, SCAND J PRIM HEALTH, V31, P215, DOI 10.3109/02813432.2013.854590; Demarest S., 2012, ATTITUDES END OF LIF; Detering K, 2014, BMJ SUPPORT PALLIAT; Detering KM, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1345; Doe M, 2014, NATL WATER QUALITY S, P1; Evans N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057965; Gott M, 2009, PALLIATIVE MED, V23, P642, DOI 10.1177/0269216309106790; Hayhoe B, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588592; Hewitt-Taylor J, 2001, Nurs Stand, V15, P39; Houben CHM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004465; Keirse E, 2009, KCE REPORTS C, V115C; Kirchhoff KT, 2012, J AM GERIATR SOC, V60, P946, DOI 10.1111/j.1532-5415.2012.03917.x; KITZINGER J, 1994, SOCIOL HEALTH ILL, V16, P103, DOI 10.1111/1467-9566.ep11347023; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Knauft E, 2005, CHEST, V127, P2188, DOI 10.1378/chest.127.6.2188; Lovell A, 2014, PALLIAT MED; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Morrison RS, 2005, J AM GERIATR SOC, V53, P290, DOI 10.1111/j.1532-5415.2005.53116.x; Mullick A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6064; NHS End of Life Care Program, 2010, GOLD STAND FRAM; NHS End of Life Care Programme, 2008, ADV CAR PLANN GUID H; Pivodic L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084440; Prendergast TJ, 2001, CRIT CARE MED, V29, pN34, DOI 10.1097/00003246-200102001-00007; Raijmakers NJH, 2013, J PALLIAT MED, V16, P1055, DOI 10.1089/jpm.2012.0555; Reyniers T, 2014, ANN FAM MED, V12, P441, DOI 10.1370/afm.1666; Rhee JJ, 2011, AUST HEALTH REV, V35, P197, DOI 10.1071/AH10883; Rijksinstituut voor ziekte-en invaliditeitsverzekering (RIZIV), 2005, REG HUIS AANT PROF H; Royal College of Physicians, 2009, ADV CAR PLANN NAT GU, P1; Scott IA, 2013, MED J AUSTRALIA, V199, P662, DOI 10.5694/mja13.10158; Seymour Jane, 2010, BMC Palliat Care, V9, P4, DOI 10.1186/1472-684X-9-4; Slort W, 2011, PALLIATIVE MED, V25, P613, DOI 10.1177/0269216310395987; Snyder S, 2012, AM J HOSP PALLIAT CA; Sudore RL, 2010, ANN INTERN MED, V153, P256, DOI 10.7326/0003-4819-153-4-201008170-00008; van den Block L, 2015, EUR J PUBLIC HEALTH, V25, P569, DOI 10.1093/eurpub/ckv039; Van Mechelen W, 2014, ADV CARE PLANNING GU; van Wijmen MPS, 2010, BIOETHICS, V24, P118, DOI 10.1111/j.1467-8519.2009.01788.x; Walczak A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005745; Wilkinson AM., 2011, ADV CARE PLANNING EN	48	22	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153747	10.1371/journal.pone.0153747	http://dx.doi.org/10.1371/journal.pone.0153747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096846	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600050
J	Jonscher, KR; Alfonso-Garcia, A; Suhalim, JL; Orlicky, DJ; Potma, EO; Ferguson, VL; Bouxsein, ML; Bateman, TA; Stodieck, LS; Levi, M; Friedman, JE; Gridley, DS; Pecaut, MJ				Jonscher, Karen R.; Alfonso-Garcia, Alba; Suhalim, Jeffrey L.; Orlicky, David J.; Potma, Eric O.; Ferguson, Virginia L.; Bouxsein, Mary L.; Bateman, Ted A.; Stodieck, Louis S.; Levi, Moshe; Friedman, Jacob E.; Gridley, Daila S.; Pecaut, Michael J.			Spaceflight Activates Lipotoxic Pathways in Mouse Liver	PLOS ONE			English	Article							FARNESOID X RECEPTOR; ACYL-COA THIOESTERASES; HEPATIC STELLATE CELLS; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; LIPID-METABOLISM; FATTY-ACIDS; SPACE; EXPRESSION; ALPHA	Spaceflight affects numerous organ systems in the body, leading to metabolic dysfunction that may have long-term consequences. Microgravity-induced alterations in liver metabolism, particularly with respect to lipids, remain largely unexplored. Here we utilize a novel systems biology approach, combining metabolomics and transcriptomics with advanced Raman microscopy, to investigate altered hepatic lipid metabolism in mice following short duration spaceflight. Mice flown aboard Space Transportation System -135, the last Shuttle mission, lose weight but redistribute lipids, particularly to the liver. Intriguingly, spaceflight mice lose retinol from lipid droplets. Both mRNA and metabolite changes suggest the retinol loss is linked to activation of PPAR alpha-mediated pathways and potentially to hepatic stellate cell activation, both of which may be coincident with increased bile acids and early signs of liver injury. Although the 13-day flight duration is too short for frank fibrosis to develop, the retinol loss plus changes in markers of extracellular matrix remodeling raise the concern that longer duration exposure to the space environment may result in progressive liver damage, increasing the risk for nonalcoholic fatty liver disease.	[Jonscher, Karen R.] Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA; [Alfonso-Garcia, Alba; Suhalim, Jeffrey L.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [Suhalim, Jeffrey L.; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst & Med Clin, Irvine, CA 92715 USA; [Orlicky, David J.] Univ Colorado Anschutz Med Campus, Dept Pathol, Aurora, CO USA; [Ferguson, Virginia L.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Bouxsein, Mary L.] Harvard Univ, Sch Med, Dept Orthoped Surg, Boston, MA 02115 USA; [Bateman, Ted A.] Univ N Carolina, Dept Bioengn, Chapel Hill, NC USA; [Stodieck, Louis S.] Univ Colorado, BioServe Space Technol, Boulder, CO 80309 USA; [Levi, Moshe] Univ Colorado Anschutz Med Campus, Dept Med, Aurora, CO USA; [Friedman, Jacob E.] Univ Colorado Anschutz Med Campus, Dept Pediat, Aurora, CO USA; [Gridley, Daila S.; Pecaut, Michael J.] Loma Linda Univ, Sch Med, Dept Basic Sci, Div Radiat Res, Loma Linda, CA USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Loma Linda University	Jonscher, KR (corresponding author), Univ Colorado Anschutz Med Campus, Dept Anesthesiol, Aurora, CO USA.	karen.jonscher@ucdenver.edu	Gridley, Daila S/P-7711-2015; Ferguson, Virginia/K-6962-2012; Pecaut, Michael J/P-6481-2015	Ferguson, Virginia/0000-0002-8448-4406; Pecaut, Michael J/0000-0002-2915-9686; Alfonso-Garcia, Alba/0000-0002-6748-3751	National Aeronautics and Space Administration [NNX10AJ31G, NNX10AE39G]; Department of Anesthesiology at the University of Colorado Anschutz Medical Campus; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048520] Funding Source: NIH RePORTER	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Department of Anesthesiology at the University of Colorado Anschutz Medical Campus; LLUMC Department of Radiation Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially funded by the National Aeronautics and Space Administration grant NNX10AJ31G (D.S.G. and M.J.P.; www.nasa.gov) and NNX10AE39G (M.L.B.). Additional support was provided by Department of Anesthesiology at the University of Colorado Anschutz Medical Campus (K.R.J.) and the LLUMC Department of Radiation Medicine (D.S.G., M.J.P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; ATTILI AF, 1986, MED HYPOTHESES, V19, P57, DOI 10.1016/0306-9877(86)90137-4; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Baroni GS, 1998, HEPATOLOGY, V27, P720; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Carson FL, 1990, HISTOTECHNOLOGY SELF, Vx; Chen GX, 2015, CURR DRUG TARGETS, V16, P1281, DOI 10.2174/1389450116666150325231015; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS5; Cohen DE, 2013, ADIPOCYTE, V2, P3, DOI 10.4161/adip.21853; Cyphert HA, 2012, J BIOL CHEM, V287, P25123, DOI 10.1074/jbc.M112.375907; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9; Di Nunzio M, 2009, LIPIDS, V44, P1073, DOI 10.1007/s11745-009-3362-y; Dongol B, 2007, J LIPID RES, V48, P1781, DOI 10.1194/jlr.M700119-JLR200; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Evans CL, 2008, ANNU REV ANAL CHEM, V1, P883, DOI 10.1146/annurev.anchem.1.031207.112754; Failloux N, 2003, APPL SPECTROSC, V57, P1117, DOI 10.1366/00037020360695973; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2010, NAT REV GASTRO HEPAT, V7, P425, DOI 10.1038/nrgastro.2010.97; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Herrnberger L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115005; Hsu WH, 2013, J AGR FOOD CHEM, V61, P6873, DOI 10.1021/jf402082g; Hunt MC, 2014, BIOCHIMIE, V98, P45, DOI 10.1016/j.biochi.2013.12.018; Hunt MC, 2012, BBA-MOL BASIS DIS, V1822, P1397, DOI 10.1016/j.bbadis.2012.03.009; Hunt MC, 2002, PROG LIPID RES, V41, P99, DOI 10.1016/S0163-7827(01)00017-0; Ikejima K, 2002, GASTROENTEROLOGY, V122, P1399, DOI 10.1053/gast.2002.32995; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Jiao Y, 2015, ACTA PHARMACOL SIN, V36, P44, DOI 10.1038/aps.2014.116; Kane MA, 2012, BBA-MOL CELL BIOL L, V1821, P10, DOI 10.1016/j.bbalip.2011.09.012; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kulinski A, 2004, J BIOL CHEM, V279, P23916, DOI 10.1074/jbc.M312676200; KWAKYE JB, 1993, J LIPID RES, V34, P95; Lane HW, 1998, NUTR RES, V18, P1923, DOI 10.1016/S0271-5317(98)00162-6; Lengqvist J, 2004, MOL CELL PROTEOMICS, V3, P692, DOI 10.1074/mcp.M400003-MCP200; Liden M, 2006, J BIOL CHEM, V281, P13001, DOI 10.1074/jbc.R500027200; Lin J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3655353; Luis PBM, 2011, BIOCHEM PHARMACOL, V82, P1740, DOI 10.1016/j.bcp.2011.07.103; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Mazuy C, 2015, CELL MOL LIFE SCI, V72, P1631, DOI 10.1007/s00018-014-1805-y; Milliano MT, 2005, HEPATOL RES, V33, P225, DOI 10.1016/j.hepres.2005.08.007; Moise AR, 2009, MOL PHARMACOL, V76, P1228, DOI 10.1124/mol.109.060038; Narici MV, 2011, EUR J APPL PHYSIOL, V111, P403, DOI 10.1007/s00421-010-1556-x; Panchal SK, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/351982; Paquette J, 2010, BIOINFORMATICS, V26, P285, DOI 10.1093/bioinformatics/btp656; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Pollak NM, 2015, J BIOL CHEM, V290, P1295, DOI 10.1074/jbc.M114.604744; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Russell TD, 2008, J LIPID RES, V49, P206, DOI 10.1194/jlr.M700396-JLR200; Russell TD, 2007, J LIPID RES, V48, P1463, DOI 10.1194/jlr.M600474-JLR200; Senoo H, 2010, CELL BIOL INT, V34, P1247, DOI 10.1042/CBI20100321; Shaik FB, 2015, INFLAMM RES, V64, P9, DOI 10.1007/s00011-014-0780-y; Sharvit E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076541; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Sun GS, 2014, NUTRITION, V30, P125, DOI 10.1016/j.nut.2013.04.005; Sun GS, 2010, NUTRITION, V26, P1163, DOI 10.1016/j.nut.2009.09.018; Sung M, 2013, J MUSCULOSKEL NEURON, V13, P405; TAKASE S, 1992, LIFE SCI, V51, P1459, DOI 10.1016/0024-3205(92)90541-V; Tian J, 2010, J APPL PHYSIOL, V108, P162, DOI 10.1152/japplphysiol.00730.2009; Tobin BW, 2002, NUTRITION, V18, P842, DOI 10.1016/S0899-9007(02)00940-1; Topletz AR, 2015, MOL PHARMACOL, V87, P430, DOI 10.1124/mol.114.096784; Tou J, 2003, NUTRITION, V19, P947, DOI 10.1016/j.nut.2003.08.005; Trevino MB, 2015, DIABETES, V64, P1299, DOI 10.2337/db14-0559; Tsatsoulis A, 2013, METABOLISM, V62, P622, DOI 10.1016/j.metabol.2012.11.004; Wang Z, 2011, HEPATOL RES, V41, P475, DOI 10.1111/j.1872-034X.2011.00794.x; Weiner J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040221; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Wolins NE, 2006, FEBS LETT, V580, P5484, DOI 10.1016/j.febslet.2006.08.040; Wu WB, 2015, BIOCHIMIE, V115, P86, DOI 10.1016/j.biochi.2015.05.014; Yamamoto K, 1996, PHARMACOL RES, V33, P337, DOI 10.1006/phrs.1996.0046; Zhou D, 2006, LIPIDS, V41, P213, DOI 10.1007/s11745-006-5090-x	74	43	47	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152877	10.1371/journal.pone.0152877	http://dx.doi.org/10.1371/journal.pone.0152877			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097220	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600020
J	Li, Y; Cooper, SJB; Lancaster, ML; Packer, JG; Carthew, SM				Li, You; Cooper, Steven J. B.; Lancaster, Melanie L.; Packer, Jasmin G.; Carthew, Susan M.			Comparative Population Genetic Structure of the Endangered Southern Brown Bandicoot, Isoodon obesulus, in Fragmented Landscapes of Southern Australia	PLOS ONE			English	Article							FORESTRY PLANTATION ESTABLISHMENT; HABITAT FRAGMENTATION; MARSUPIAL CARNIVORE; GENOTYPING ERRORS; RECENT MIGRATION; COMMON FROG; CONNECTIVITY; DISPERSAL; DIFFERENTIATION; PROGRAM	Genetic connectivity is a key factor for maintaining the persistence of populations in fragmented landscapes. In highly modified landscapes such us peri-urban areas, organisms' dispersal among fragmented habitat patches can be reduced due to the surrounding matrix, leading to subsequent decreased gene flow and increased potential extinction risk in isolated sub-populations. However, few studies have compared within species how dispersal/gene flow varies between regions and among different forms of matrix that might be encountered. In the current study, we investigated gene flow and dispersal in an endangered marsupial, the southern brown bandicoot (Isoodon obesulus) in a heavily modified peri-urban landscape in South Australia, Australia. We used 14 microsatellite markers to genotype 254 individuals which were sampled from 15 sites. Analyses revealed significant genetic structure. Our analyses also indicated that dispersal was mostly limited to neighbouring sites. Comparisons of these results with analyses of a different population of the same species revealed that gene flow/dispersal was more limited in this peri-urban landscape than in a pine plantation landscape approximately 400 km to the south-east. These findings increase our understanding of how the nature of fragmentation can lead to profound differences in levels of genetic connectivity among populations of the same species.	[Li, You; Cooper, Steven J. B.; Lancaster, Melanie L.; Packer, Jasmin G.; Carthew, Susan M.] Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia; [Li, You; Cooper, Steven J. B.; Lancaster, Melanie L.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA 5005, Australia; [Li, You] Northwest Univ Nationalities, Lanzhou 730030, Gansu, Peoples R China; [Cooper, Steven J. B.] S Australian Museum, Evolutionary Biol Unit, N Terrace, Adelaide, SA 5000, Australia; [Carthew, Susan M.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia	University of Adelaide; University of Adelaide; Northwest Minzu University; Charles Darwin University	Li, Y (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA 5005, Australia.; Li, Y (corresponding author), Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Adelaide, SA 5005, Australia.; Li, Y (corresponding author), Northwest Univ Nationalities, Lanzhou 730030, Gansu, Peoples R China.	you.li@alumni.adelaide.edu.au	Packer, Jasmin G./ABD-2212-2020; Cooper, Steven JB/I-6291-2012	Packer, Jasmin G./0000-0002-6194-1299; 	Australian Research Council [LP0668987]; Native Vegetation Research Grants; Wildlife Conservation Fund Grants; Department of Environment, Water, and Natural Resources (DEWNR); Roy and Marjory Edwards Scholarship by Nature Foundation SA	Australian Research Council(Australian Research Council); Native Vegetation Research Grants; Wildlife Conservation Fund Grants; Department of Environment, Water, and Natural Resources (DEWNR); Roy and Marjory Edwards Scholarship by Nature Foundation SA	This work was financially supported by the Australian Research Council Linkage grant (LP0668987) (http://www.arc.gov.au/), Native Vegetation Research Grants, Wildlife Conservation Fund Grants, the Department of Environment, Water, and Natural Resources (DEWNR) (http://www.environment.sa.gov.au), and by the Roy and Marjory Edwards Scholarship provided by Nature Foundation SA (http://www.naturefoundation.org.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Arens P, 2007, LANDSCAPE ECOL, V22, P1489, DOI 10.1007/s10980-007-9132-4; Balkenhol N, 2009, MOL ECOL, V18, P4151, DOI 10.1111/j.1365-294X.2009.04322.x; Banks SC, 2005, MOL ECOL, V14, P1667, DOI 10.1111/j.1365-294X.2005.02525.x; Banks SC, 2005, BIOL CONSERV, V122, P581, DOI 10.1016/j.biocon.2004.09.013; Bergl RA, 2007, MOL ECOL, V16, P501, DOI 10.1111/j.1365-294X.2006.03159.x; Berry O, 2005, CONSERV BIOL, V19, P855, DOI 10.1111/j.1523-1739.2005.00161.x; Bonham KJ, 2002, FOREST ECOL MANAG, V158, P237, DOI 10.1016/S0378-1127(00)00717-9; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Clark RW, 2010, CONSERV BIOL, V24, P1059, DOI 10.1111/j.1523-1739.2009.01439.x; Coates Terry, 2008, Victorian Naturalist (Blackburn), V125, P128; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corlatti L, 2009, CONSERV BIOL, V23, P548, DOI 10.1111/j.1523-1739.2008.01162.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Cushman SA, 2010, LANDSCAPE ECOL, V25, P1613, DOI 10.1007/s10980-010-9534-6; Delaney KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012767; Department for Environment and Heritage, 2009, INF BIOD CONS AD MOU; Department of Environment and Conservation (DEC), 2006, REC PLAN SO BROWN BA; Dixo M, 2009, BIOL CONSERV, V142, P1560, DOI 10.1016/j.biocon.2008.11.016; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Fietz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088092; Fisher R. A., 1946, Statistical methods for research workers.; Fitzgibbon SI, 2011, AUSTRAL ECOL, V36, P722, DOI 10.1111/j.1442-9993.2010.02209.x; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Gugger P. F., 2012, REDUNDANCY ANAL TUTO; Haby NA, 2013, J MAMMAL, V94, P801, DOI 10.1644/12-MAMM-A-220.1; Heidinger IMM, 2013, CONSERV GENET, V14, P299, DOI 10.1007/s10592-013-0449-z; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Holderegger R, 2010, BASIC APPL ECOL, V11, P522, DOI 10.1016/j.baae.2010.06.006; Horn T, 2003, S E BIODIVERSITY COR; Jackson ND, 2011, BIOL CONSERV, V144, P3143, DOI 10.1016/j.biocon.2011.09.010; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen H, 2013, MOL ECOL, V22, P1792, DOI 10.1111/mec.12226; Johansson M, 2005, GLOBAL CHANGE BIOL, V11, P1664, DOI 10.1111/j.1365-2486.2005.1005.x; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Jones W, 1924, MAMMALS S AUSTR 2; Keller I, 2004, MOL ECOL, V13, P2983, DOI 10.1111/j.1365-294X.2004.02310.x; Lancaster ML, 2016, LANDSCAPE ECOL, V31, P655, DOI 10.1007/s10980-015-0271-8; Lancaster ML, 2011, MOL ECOL, V20, P2258, DOI 10.1111/j.1365-294X.2011.05072.x; Lecis R, 2006, MOL ECOL, V15, P119, DOI 10.1111/j.1365-294X.2005.02812.x; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Lesbarreres D, 2006, ECOSCIENCE, V13, P531, DOI 10.2980/1195-6860(2006)13[531:TEOYOH]2.0.CO;2; Levy E, 2010, MOL ECOL, V19, P4192, DOI 10.1111/j.1365-294X.2010.04810.x; Li Y, 2015, CONSERV GENET, V16, P331, DOI 10.1007/s10592-014-0661-5; Li Y, 2014, AUST J ZOOL, V62, P345, DOI 10.1071/ZO14038; Li Y, 2013, CONSERV GENET RESOUR, V5, P105, DOI 10.1007/s12686-012-9743-1; Lindenmayer D, 2006, HABITAT FRAGMENTATIO; Lindenmayer D, 2008, ECOL LETT, V11, P78, DOI 10.1111/j.1461-0248.2007.01114.x; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Lindenmayer DB, 2004, BIOL CONSERV, V119, P151, DOI 10.1016/j.biocon.2003.10.028; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Martin PR, 2004, EVOLUTION, V58, P938; McCulloch ES, 2013, MOL ECOL, V22, P4619, DOI 10.1111/mec.12418; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Moore JA, 2011, MOL ECOL, V20, P4858, DOI 10.1111/j.1365-294X.2011.05313.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; NEUMANN FG, 1979, AUST FOREST RES, V9, P277; Opie A, 1980, AUSTR MAMMALIAN SOC, P6; Packer JG, 2016, BIODIVERS CONSERV, V25, P503, DOI 10.1007/s10531-016-1059-0; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; PAULL D, 1995, WILDLIFE RES, V22, P585, DOI 10.1071/WR9950585; Paull D., 2003, HABITAT FRAGMENTATIO; Paull DJ, 1993, THESIS U ADELAIDE; Peacock MM, 1997, OECOLOGIA, V112, P524, DOI 10.1007/s004420050341; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Pritchard J.K., DOCUMENTATION STRUCT; Pritchard JK, 2000, GENETICS, V155, P945; Quemere E, 2010, MOL ECOL, V19, P1606, DOI 10.1111/j.1365-294X.2010.04581.x; QUIN D G, 1988, Australian Mammalogy, V11, P15; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; Reddy PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029827; Rees M, 2000, WILDLIFE RES, V27, P539, DOI 10.1071/WR99045; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SIMBERLOFF D, 1988, ANNU REV ECOL SYST, V19, P473, DOI 10.1146/annurev.ecolsys.19.1.473; Taylor AC, 2007, MOL ECOL, V16, P2655, DOI 10.1111/j.1365-294X.2007.03331.x; Taylor AM, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017069, 10.1371/journal.pone.0026651]; Vaha JP, 2006, MOL ECOL, V15, P63, DOI 10.1111/j.1365-294X.2005.02773.x; van der Grift EA, 2013, BIODIVERS CONSERV, V22, P425, DOI 10.1007/s10531-012-0421-0; van der Ree R, 2007, P INT C ECOLOGY TRAN, P423; van der Ree R, 2009, ECOL SOC, V14; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez-Dominguez E, 2004, ORYX, V38, P347, DOI 10.1017/S0030605304000602; Wagner H., 2013, PACKAGE VEGAN COMMUN, V2, P1; Wang J, 2007, GENET RES, V89, P135, DOI 10.1017/S0016672307008798; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x; Weeks AR, 2011, EVOL APPL, V4, P709, DOI 10.1111/j.1752-4571.2011.00192.x; Wilson GA, 2003, GENETICS, V163, P1177; Zenger KR, 2001, MOL ECOL NOTES, V1, P149, DOI 10.1046/j.1471-8278.2001.00055.x; Zhu LF, 2011, MOL ECOL, V20, P1122, DOI 10.1111/j.1365-294X.2011.04999.x	100	7	7	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152850	10.1371/journal.pone.0152850	http://dx.doi.org/10.1371/journal.pone.0152850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096952	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600018
J	Singh, NS; Rutkowska, E; Plazinska, A; Khadeer, M; Moaddel, R; Jozwiak, K; Bernier, M; Wainer, IW				Singh, Nagendra S.; Rutkowska, Ewelina; Plazinska, Anita; Khadeer, Mohammed; Moaddel, Ruin; Jozwiak, Krzysztof; Bernier, Michel; Wainer, Irving W.			Ketamine Metabolites Enantioselectively Decrease Intracellular D-Serine Concentrations in PC-12 Cells	PLOS ONE			English	Article							MAMMALIAN TARGET; NMDA RECEPTORS; RACEMASE; RELEASE; INHIBITION; GABAPENTIN; ACTIVATION; EXPRESSION; INDUCTION; RAPAMYCIN	D-Serine is an endogenous NMDA receptor co-agonist that activates synaptic NMDA receptors modulating neuronal networks in the cerebral cortex and plays a key role in long-term potentiation of synaptic transmission. D-serine is associated with NMDA receptor neurotoxicity and neurodegeneration and elevated D-serine concentrations have been associated with Alzheimer's and Parkinsons' diseases and amyotrophic lateral sclerosis. Previous studies have demonstrated that the ketamine metabolites (rac)-dehydronorketamine and (2S, 6S)-hydroxynorketamine decrease intracellular D-serine concentrations in a concentration dependent manner in PC-12 cells. In the current study, PC-12 cells were incubated with a series of ketamine metabolites and the IC50 values associated with attenuated intracellular D-serine concentrations were determined. The results demonstrate that structural and stereochemical features of the studied compounds contribute to the magnitude of the inhibitory effect with (2S, 6S)-hydroxynorketamine and (2R, 6R)-hydroxynorketamine displaying the most potent inhibition with IC50 values of 0.18 +/- 0.04 nM and 0.68 +/- 0.09 nM. The data was utilized to construct a preliminary 3D-QSAR/pharmacophore model for use in the design of new and more efficient modulators of D-serine.	[Singh, Nagendra S.; Khadeer, Mohammed; Moaddel, Ruin; Wainer, Irving W.] NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA; [Rutkowska, Ewelina; Plazinska, Anita; Jozwiak, Krzysztof] Med Univ Lublin, Dept Biopharm, Lublin, Poland; [Bernier, Michel] NIA, Translat Gerontol Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Medical University of Lublin; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wainer, IW (corresponding author), NIA, Clin Invest Lab, NIH, Baltimore, MD 21224 USA.	iwwainer@gmail.com	Moaddel, Ruin/AAE-3378-2020; Singh, Nagendra/B-6646-2018; Bernier, Michel/AAO-3983-2021; Bernier, Michel/Y-7139-2019; Singh, Nagendra S/K-8966-2015	Bernier, Michel/0000-0002-5948-368X; Jozwiak, Krzysztof/0000-0001-6018-5092; Plazinska, Anita/0000-0002-3698-2574; Moaddel, Ruin/0000-0002-6812-0127	Intramural Research Programs of the National Institute on Aging; Foundation for Polish Science [2009 - 4/5]; NATIONAL INSTITUTE ON AGING [ZIAAG000297] Funding Source: NIH RePORTER	Intramural Research Programs of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The work was funded by the Intramural Research Programs of the National Institute on Aging and by The Foundation for Polish Science (TEAM Programme 2009 - 4/5).	ADAMS JD, 1981, BIOMED MASS SPECTROM, V8, P527, DOI 10.1002/bms.1200081103; Balu DT, 2012, NEUROBIOL DIS, V45, P671, DOI 10.1016/j.nbd.2011.10.006; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; Crow JP, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/625245; Desta Z, 2012, XENOBIOTICA, V42, P1076, DOI 10.3109/00498254.2012.685777; Domino EF, 2010, ANESTHESIOLOGY, V113, P678, DOI 10.1097/ALN.0b013e3181ed09a2; Dwyer JM, 2013, BIOL PSYCHIAT, V73, P1189, DOI 10.1016/j.biopsych.2012.11.011; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Henneberger C, 2013, NEUROCHEM RES, V38, P1156, DOI 10.1007/s11064-013-0987-2; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirota K, 2011, BRIT J ANAESTH, V107, P123, DOI 10.1093/bja/aer221; Jiraskova-Vanickova J, 2011, CURR DRUG TARGETS, V12, P1037, DOI 10.2174/138945011795677755; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; LEUNG LY, 1986, J MED CHEM, V29, P2396, DOI 10.1021/jm00161a043; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Moaddel R, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.157; Moaddel R, 2015, PSYCHOPHARMACOLOGY, V232, P399, DOI 10.1007/s00213-014-3669-0; Moaddel R, 2013, EUR J PHARMACOL, V698, P228, DOI 10.1016/j.ejphar.2012.11.023; Moaddel R, 2010, TALANTA, V82, P1892, DOI 10.1016/j.talanta.2010.08.005; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Paul RK, 2014, ANESTHESIOLOGY, V121, P149, DOI 10.1097/ALN.0000000000000285; Sethuraman R, 2009, MINI-REV MED CHEM, V9, P813, DOI 10.2174/138955709788452630; Shleper M, 2005, J NEUROSCI, V25, P9413, DOI 10.1523/JNEUROSCI.3190-05.2005; Singh NS, 2015, BRIT J PHARMACOL, V172, P4546, DOI 10.1111/bph.13239; Singh NS, 2013, CELL SIGNAL, V25, P2634, DOI 10.1016/j.cellsig.2013.08.025; Singh NS, 2013, NEUROSCI LETT, V535, P90, DOI 10.1016/j.neulet.2012.12.024; Singh NS, 2012, ANAL BIOCHEM, V421, P460, DOI 10.1016/j.ab.2011.10.003; Taylor CP, 2009, PAIN, V142, P13, DOI 10.1016/j.pain.2008.11.019; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Wu SZ, 2007, CURR ALZHEIMER RES, V4, P243; Wu SZ, 2004, ANN NY ACAD SCI, V1035, P133, DOI 10.1196/annals.1332.009; Zarate CA, 2012, BIOL PSYCHIAT, V72, P331, DOI 10.1016/j.biopsych.2012.03.004	32	20	20	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0149499	10.1371/journal.pone.0149499	http://dx.doi.org/10.1371/journal.pone.0149499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096720	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600001
J	Brim, S; Groschup, MH; Kuczius, T				Brim, Svetlana; Groschup, Martin H.; Kuczius, Thorsten			Copper and Zinc Interactions with Cellular Prion Proteins Change Solubility of Full-Length Glycosylated Isoforms and Induce the Occurrence of Heterogeneous Phenotypes	PLOS ONE			English	Article							TRUNCATED FORMS; BINDING; OCTAREPEAT; COORDINATION; MEMBRANE; PEPTIDES; DOMAIN; PRP	Prion diseases are characterized biochemically by protein aggregation of infectious prion isoforms (PrPSc), which result from the conformational conversion of physiological prion proteins (PrPC). PrPC are variable post-translationally modified glycoproteins, which exist as full length and as aminoterminally truncated glycosylated proteins and which exhibit differential detergent solubility. This implicates the presence of heterogeneous phenotypes, which overlap as protein complexes at the same molecular masses. Although the biological function of PrPC is still enigmatic, evidence reveals that PrPC exhibits metal-binding properties, which result in structural changes and decreased solubility. In this study, we analyzed the yield of PrPC metal binding affiliated with low solubility and changes in protein banding patterns. By implementing a high-speed centrifugation step, the interaction of zinc ions with PrPC was shown to generate large quantities of proteins with low solubility, consisting mainly of full-length glycosylated PrPC; whereas unglycosylated PrPC remained in the supernatants as well as truncated glycosylated proteins which lack of octarepeat sequence necessary for metal binding. This effect was considerably lower when PrPC interacted with copper ions; the presence of other metals tested exhibited no effect under these conditions. The binding of zinc and copper to PrPC demonstrated differentially soluble protein yields within distinct PrPC subtypes. PrPC-Zn2+-interaction may provide a means to differentiate glycosylated and unglycosylated subtypes and offers detailed analysis of metal-bound and metal-free protein conversion assays.	[Brim, Svetlana; Kuczius, Thorsten] Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany; [Groschup, Martin H.] FLI, Inst Novel & Emerging Infect Dis, Boddenblick 5a, D-17493 Greifswald, Insel Riems, Germany	University of Munster; Friedrich Loeffler Institute	Kuczius, T (corresponding author), Univ Munster, Inst Hyg, Robert Koch Str 41, D-48149 Munster, Germany.	thorsten.kuczius@ukmuenster.de						Brown DR, 1999, BIOCHEM J, V344, P1, DOI 10.1042/0264-6021:3440001; Brown DR, 1997, EXP NEUROL, V146, P104, DOI 10.1006/exnr.1997.6505; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Estibeiro JP, 1996, TRENDS NEUROSCI, V19, P257, DOI 10.1016/S0166-2236(96)30010-6; Gaggelli E, 2005, J AM CHEM SOC, V127, P996, DOI 10.1021/ja045958z; Garnett AP, 2006, DALTON T, P509, DOI 10.1039/b511553a; GASSET M, 1993, P NATL ACAD SCI USA, V90, P1, DOI 10.1073/pnas.90.1.1; Gonzalez-Iglesias R, 2004, FEBS LETT, V556, P161, DOI 10.1016/S0014-5793(03)01397-8; HORNSHAW MP, 1995, BIOCHEM BIOPH RES CO, V207, P621, DOI 10.1006/bbrc.1995.1233; Hu W, 2008, J NEUROL SCI, V264, P1, DOI 10.1016/j.jns.2007.06.019; Jobling MF, 2001, BIOCHEMISTRY-US, V40, P8073, DOI 10.1021/bi0029088; Kenward AG, 2007, BIOCHEMISTRY-US, V46, P4261, DOI 10.1021/bi602473r; Kuczius T, 2007, EUR J NEUROSCI, V25, P2649, DOI 10.1111/j.1460-9568.2007.05518.x; Kuczius T, 2011, EXP NEUROL, V227, P188, DOI 10.1016/j.expneurol.2010.10.014; Lasmezas CI, 2003, BRIT MED BULL, V66, P61, DOI 10.1093/bmb/66.1.61; Leliveld SR, 2006, J BIOL CHEM, V281, P3268, DOI 10.1074/jbc.M510606200; Morante S, 2004, J BIOL CHEM, V279, P11753, DOI 10.1074/jbc.M312860200; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 1997, SCIENCE, V278, P245, DOI 10.1126/science.278.5336.245; Pushie MJ, 2007, ANAL CHEM, V79, P5659, DOI 10.1021/ac070312l; Pushie M, 2009, BIOMETALS, V22, P159, DOI 10.1007/s10534-008-9196-x; Qin KF, 2000, J BIOL CHEM, V275, P19121, DOI 10.1074/jbc.275.25.19121; Quaglio E, 2001, J BIOL CHEM, V276, P11432, DOI 10.1074/jbc.M009666200; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Stockel J, 1998, BIOCHEMISTRY-US, V37, P7185, DOI 10.1021/bi972827k; Viles JH, 1999, P NATL ACAD SCI USA, V96, P2042, DOI 10.1073/pnas.96.5.2042; Walter ED, 2007, J AM CHEM SOC, V129, P15440, DOI 10.1021/ja077146j; Watanabe Y, 2010, BIOCHEM BIOPH RES CO, V394, P522, DOI 10.1016/j.bbrc.2010.03.003; Whittal RM, 2000, PROTEIN SCI, V9, P332; Zhu F, 2008, BIOCHEMISTRY-US, V47, P2510, DOI 10.1021/bi7022893	37	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153931	10.1371/journal.pone.0153931	http://dx.doi.org/10.1371/journal.pone.0153931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093554	Green Submitted, gold, Green Published			2022-12-27	WOS:000374541200063
J	Guo, YJ; Qi, Y; Yang, XF; Zhao, LH; Wen, S; Liu, YH; Tang, L				Guo, Yanjie; Qi, Yane; Yang, Xuefei; Zhao, Lihui; Wen, Shu; Liu, Yinhui; Tang, Li			Association between Polycystic Ovary Syndrome and Gut Microbiota	PLOS ONE			English	Article							PERIODONTAL PATHOGENS; INSULIN SENSITIVITY; BARRIER FUNCTION; DISEASE; OBESITY; WOMEN; PCOS; SEX; DYSBIOSIS; ETIOLOGY	Polycystic ovary syndrome (PCOS) is the most frequent endocrinopathy in women of reproductive age. It is difficult to treat PCOS because of its complex etiology and pathogenesis. Here, we characterized the roles of gut microbiota on the pathogenesis and treatments in letrozole (a nonsteroidal aromatase inhibitor) induced PCOS rat model. Changes in estrous cycles, hormonal levels, ovarian morphology and gut microbiota by PCR-DGGE and real-time PCR were determined. The results showed that PCOS rats displayed abnormal estrous cycles with increasing androgen biosynthesis and exhibited multiple large cysts with diminished granulosa layers in ovarian tissues. Meanwhile, the composition of gut microbiota in letrozole-treated rats was different from that in the controls. Lactobacillus, Ruminococcus and Clostridium were lower while Prevotella was higher in PCOS rats when compared with control rats. After treating PCOS rats with Lactobacillus and fecal microbiota transplantation (FMT) from healthy rats, it was found that the estrous cycles were improved in all 8 rats in FMT group, and in 6 of the 8 rats in Lactobacillus transplantation group with decreasing androgen biosynthesis. Their ovarian morphologies normalized. The composition of gut microbiota restored in both FMT and Lactobacillus treated groups with increasing of Lactobacillus and Clostridium, and decreasing of Prevotella. These results indicated that dysbiosis of gut microbiota was associated with the pathogenesis of PCOS. Microbiota interventions through FMT and Lactobacillus transplantation were beneficial for the treatments of PCOS rats.	[Guo, Yanjie; Qi, Yane; Yang, Xuefei; Zhao, Lihui; Wen, Shu; Liu, Yinhui; Tang, Li] Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China	Dalian Medical University	Tang, L (corresponding author), Dalian Med Univ, Sch Basic Med Sci, Dept Microecol, Dalian, Liaoning, Peoples R China.	tangli_2015cn@sina.com			National Program on Key Basic Research Project (973 Program) [2013CB531405]; National Program on Key Basic Research Project (863 Program) [2014AA022200]; National Natural Science Foundation of China [81370113]; education Department of Liaoning Province [L2015143]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Program on Key Basic Research Project (863 Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); education Department of Liaoning Province	This study was supported by grants from the National Program on Key Basic Research Project (973 Program) ( NO. 2013CB531405), the National Program on Key Basic Research Project (863 Program) ( NO. 2014AA022200), the National Natural Science Foundation of China ( No. 81370113) and funds from education Department of Liaoning Province ( NO. L2015143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcali A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108074; Akkol EK, 2015, J ETHNOPHARMACOL, V168, P25, DOI 10.1016/j.jep.2015.03.029; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Balen A, 2004, BEST PRACT RES CL OB, V18, P685, DOI 10.1016/j.bpobgyn.2004.05.004; Brook I, 2005, J LARYNGOL OTOL, V119, P251, DOI 10.1258/0022215054020304; Chen J, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0139-1; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Corbin CJ, 1999, ENDOCRINOLOGY, V140, P5202, DOI 10.1210/en.140.11.5202; Diamanti-Kandarakis Evanthia, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000598; Dokras A, 2013, STEROIDS, V78, P773, DOI 10.1016/j.steroids.2013.04.009; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Flak MB, 2013, SCIENCE, V339, P1044, DOI 10.1126/science.1236226; Fox Robert, 2002, Hum Fertil (Camb), V5, pS28, DOI 10.1080/1464727022000199881; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222; Goodarzi MO, 2011, NAT REV ENDOCRINOL, V7, P219, DOI 10.1038/nrendo.2010.217; Haag LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035988; Homburg R, 2008, BEST PRACT RES CL OB, V22, P261, DOI 10.1016/j.bpobgyn.2007.07.009; Hsu MI, 2013, STEROIDS, V78, P761, DOI 10.1016/j.steroids.2013.04.005; Hulston CJ, 2015, BRIT J NUTR, V113, P596, DOI 10.1017/S0007114514004097; Johnson-Henry KC, 2008, INFECT IMMUN, V76, P1340, DOI 10.1128/IAI.00778-07; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kafali H, 2004, ARCH MED RES, V35, P103, DOI 10.1016/j.arcmed.2003.10.005; Kumar PS, 2013, PERIODONTOL 2000, V61, P103, DOI 10.1111/j.1600-0757.2011.00398.x; Lebbe M, 2013, MOL HUM REPROD, V19, P828, DOI 10.1093/molehr/gat065; Li M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00692; Lim SS, 2013, OBES REV, V14, P95, DOI 10.1111/j.1467-789X.2012.01053.x; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; McFarland LV, 2000, EUR J GASTROEN HEPAT, V12, P1069, DOI 10.1097/00042737-200012100-00001; MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338; Moran CP, 2014, BEST PRACT RES CL GA, V28, P585, DOI 10.1016/j.bpg.2014.07.005; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Oakley BB, 2008, APPL ENVIRON MICROB, V74, P4898, DOI 10.1128/AEM.02884-07; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; SOORY M, 1995, J PERIODONTAL RES, V30, P124, DOI 10.1111/j.1600-0765.1995.tb01261.x; Soory M, 1997, ARCH ORAL BIOL, V42; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079382; Tremellen K, 2012, MED HYPOTHESES, V79, P104, DOI 10.1016/j.mehy.2012.04.016; Umeda M, 1998, J PERIODONTOL, V69, P1111, DOI 10.1902/jop.1998.69.10.1111; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Yang S, AM J OBSTET GYNECOL, V211, p44 e1; ZAMBON JJ, 1981, INFECT IMMUN, V32, P198, DOI 10.1128/IAI.32.1.198-203.1981	45	62	81	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153196	10.1371/journal.pone.0153196	http://dx.doi.org/10.1371/journal.pone.0153196			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093642	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200015
J	Qian, C; Li, PC; Jiao, Y; Yao, HH; Chen, YC; Yang, J; Ding, J; Yang, XY; Teng, GJ				Qian, Cheng; Li, Pei-Cheng; Jiao, Yun; Yao, Hong-Hong; Chen, Yu-Chen; Yang, Jian; Ding, Jie; Yang, Xiang-Yu; Teng, Gao-Jun			Precise Characterization of the Penumbra Revealed by MRI: A Modified Photothrombotic Stroke Model Study	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; PERFUSION COMPUTED-TOMOGRAPHY; ISCHEMIC PENUMBRA; PLASMINOGEN-ACTIVATOR; TISSUE; BRAIN; VOLUME; REPERFUSION; MISMATCH; INJURY	Aims To precisely characterize the penumbra by MRI based on a modified photothrombotic stroke mouse model. Methods The proximal middle cerebral artery was occluded by a convenient laser system in conjunction with an intravenous injection of Rose Bengal in mice. And the suture MCAO model was performed in seven mice as a comparison of the reproducibility. One hour after occlusion, the penumbra was defined in six random photothrombotic stroke mice by mismatch between perfusion-weighted imaging and the apparent diffusion coefficient map on a home-made workstation. After imaging, three random mice of them were chosen to perform the reperfusion surgery. And the other three mice were sacrificed to stain for several potential penumbra markers, such as c-fos and heart shock protein 90. In the remaining mice, the evolution of the lesions was detected on the apparent diffusion coefficient map, diffusion-weighted imaging and T2-weighted imaging at 1, 3, 6, 12 and 24 hours. After evaluating the neurological deficit scores, the brains were sectioned and stained by triphenyltetrazolium chloride and Nissl. Results The mice subjected to photothrombosis showed significant behavioral deficits. One hour after occlusion, the low perfusion areas on the perfusion-weighted imaging interlaced with the hypointense areas on the apparent diffusion coefficient map, demonstrating that the penumbra was located both surrounding and inside the lesions. This phenomenon was subsequently confirmed by the c-fos and heart shock protein 90 staining. The final T2-weighted images of the mice subjected to the reperfusion surgery were also consistent with the penumbra images at one hour. At early stages, the lesions were clearly identified on the apparent diffusion coefficient map; the volumes of the lesions on the diffusion-weighted imaging and T2-weighted imaging did not reach a maximum until 12 hours. The coefficient of variation (CV) of the final lesions in the photothrombotic stroke mice was 21.7% (0.08 of 0.37) on T2-weighted imaging and 27.8%(0.10 of 0.35) on triphenyltetrazolium chloride, representing a high reproducibility (n = 7). While the CV of the lesions in the MCAO stroke mice was only 70% 0.24 of 0.34, n = 4). Conclusions This study has provided a precise imaging definition of the penumbra based on a reproducible photothrombotic stroke mouse model.	[Qian, Cheng; Li, Pei-Cheng; Jiao, Yun; Chen, Yu-Chen; Yang, Jian; Ding, Jie; Yang, Xiang-Yu; Teng, Gao-Jun] Southeast Univ, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol,Med Sch, Nanjing, Jiangsu, Peoples R China; [Yao, Hong-Hong] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China	Teng, GJ (corresponding author), Southeast Univ, Zhongda Hosp, Jiangsu Key Lab Mol & Funct Imaging, Dept Radiol,Med Sch, Nanjing, Jiangsu, Peoples R China.	gjteng@seu.edu.cn		Ding, Jie/0000-0001-9162-7850	National Key Basic Research Program of China (973 Program) [2013CB733800, 013CB733803]; National Natural Science Foundation of China [81230034]; Jiangsu Provincial Special Program of Medical Science [BL2013029]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Special Program of Medical Science	The National Key Basic Research Program of China (973 Program; 2013CB733800, 013CB733803, URLs: http://www.nsfc.gov.cn/), CQ PCL YJ HHY YCC JY JD XYY GJT; the National Natural Science Foundation of China (81230034, URLs: http://www.nsfc.gov.cn/), CQ PCL YJ YCC JY JD XYY GJT; the Jiangsu Provincial Special Program of Medical Science (BL2013029, URLs: www.jswst.gov.cn), CQ PCL YJ JY JD XYY GJT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulla J, 2014, THERANOSTICS, V4, P90, DOI 10.7150/thno.7088; Boehm-Sturm P, 2014, BIOMATERIALS, V35, P2218, DOI 10.1016/j.biomaterials.2013.11.085; Chemmanam T, 2010, NEUROLOGY, V75, P1040, DOI 10.1212/WNL.0b013e3181f39ab6; Chen F, 2007, RADIOLOGY, V244, P429, DOI 10.1148/radiol.2442061316; Chen XP, 2015, NAT CHEM BIOL, V11, P19, DOI 10.1038/nchembio.1657; Del Bene A, 2013, STROKE, V44, P3000, DOI 10.1161/STROKEAHA.113.002227; Ezura M, 2006, MINIMALLY INVASIVE NEUROSURGERY AND MULTIDISCIPLINARY NEUROTRAUMATOLOGY, P85, DOI 10.1007/4-431-28576-8_13; Ginsberg MD, 1996, ARCH NEUROL-CHICAGO, V53, P1065, DOI 10.1001/archneur.1996.00550100151024; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Jiang W, 2006, J CEREBR BLOOD F MET, V26, P927, DOI 10.1038/sj.jcbfm.9600245; Jung S, 2013, BRAIN, V136, P3554, DOI 10.1093/brain/awt246; Karatas H, 2011, J CEREBR BLOOD F MET, V31, P1452, DOI 10.1038/jcbfm.2011.8; Kidwell CS, 2003, STROKE, V34, P2729, DOI 10.1161/01.STR.0000097608.38779.CC; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Langer D, 2009, STROKE, V40, P2761, DOI 10.1161/STROKEAHA.108.544957; Li PY, 2014, STROKE, V45, P857, DOI 10.1161/STROKEAHA.113.004100; Markus R, 2004, BRAIN, V127, P1427, DOI 10.1093/brain/awh162; McCabe C, 2009, STROKE, V40, P3864, DOI 10.1161/STROKEAHA.109.559021; McLeod DD, 2015, INT J STROKE, V10, P553, DOI 10.1111/ijs.12147; McLeod DD, 2011, INT J STROKE, V6, P284, DOI 10.1111/j.1747-4949.2010.00564.x; Morris GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148503; Muir KW, 2006, J NEUROL NEUROSUR PS, V77, P334, DOI 10.1136/jnnp.2005.074179; Orset C, 2007, STROKE, V38, P2771, DOI 10.1161/STROKEAHA.107.487520; Ramos-Cabrer P, 2011, STROKE, V42, pS7, DOI 10.1161/STROKEAHA.110.596684; Reid E, 2012, J CEREBR BLOOD F MET, V32, P1765, DOI 10.1038/jcbfm.2012.69; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; Robertson CA, 2015, INT J STROKE, V10, P42, DOI 10.1111/ijs.12327; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Rosso C, 2014, CURR OPIN NEUROL, V27, P35, DOI 10.1097/WCO.0000000000000047; Rosso C, 2009, RADIOLOGY, V250, P184, DOI 10.1148/radiol.2493080107; Schaefer PW, 2008, STROKE, V39, P2986, DOI 10.1161/STROKEAHA.107.513358; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; Weinstein PR, 2004, STROKE, V35, P2666, DOI 10.1161/01.STR.0000144052.10644.ed; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Xu JH, 2003, STROKE, V34, P1287, DOI 10.1161/01.STR.0000066308.25088.64; Yang ST, 2015, NEUROLOGY, V84, P2381, DOI 10.1212/WNL.0000000000001669; Yao H, 2003, STROKE, V34, P2716, DOI 10.1161/01.STR.0000094730.38343.73; Yao H, 2002, NEUROREPORT, V13, P1005, DOI 10.1097/00001756-200206120-00004; Yao H, 1996, STROKE, V27, P333, DOI 10.1161/01.STR.27.2.333; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]	40	24	24	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153756	10.1371/journal.pone.0153756	http://dx.doi.org/10.1371/journal.pone.0153756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093556	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200043
J	Shen, TC; Lin, CL; Wei, CC; Chen, CH; Tu, CY; Hsia, TC; Shih, CM; Hsu, WH; Sung, FC; Kao, CH				Shen, Te-Chun; Lin, Cheng-Li; Wei, Chang-Ching; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei; Sung, Fung-Chang; Kao, Chia-Hung			Bidirectional Association between Asthma and Irritable Bowel Syndrome: Two Population-Based Retrospective Cohort Studies	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; GENERAL-POPULATION; BRONCHIAL-ASTHMA; PRIMARY-CARE; RISK; CRITERIA; DISEASES; ALLERGY; VALIDATION; DIAGNOSIS	Background There is a demonstrated association between asthma and irritable bowel syndrome (IBS). In this study, we examined the bidirectional association between asthma and IBS using a nationwide database. Methods We conducted two retrospective cohort studies using data obtained from the National Health Insurance of Taiwan. Study 1 included 29,648 asthma patients newly diagnosed between 2000 and 2010. Study 2 included 29,875 IBS patient newly diagnosed between 2000 and 2010. For each study, four subjects without asthma and IBS were selected, respectively, frequency-matched by sex, age, and the diagnosis date. All four cohorts were followed up until the end of 2011 to estimate incident IBS for Study 1 and incident asthma for study 2. Adjusted hazard ratios (aHRs) were estimated using the Cox proportional hazards model after controlling for sex, age and comorbidities. Results The incidence of IBS was 1.89 times higher in the asthma cohort than in the comparison cohort (8.26 vs. 4.36 per 1,000 person-years), with an aHR of 1.57 [95% confidence interval (CI) = 1.47-1.68]. The aHRs remained significant in all subgroups measured by sex, age and the presence of comorbidities. In contrast, the incidence of asthma was 1.76 times higher in the IBS cohort than the comparison cohort (7.09 vs. 4.03 per 1,000 person-years), with an aHR of 1.54 (95% CI = 1.44 -1.64). Similarly, aHRs remained significant in all subgroups measured by sex, age and the presence of comorbidities. Conclusion The present study suggests a bidirectional association between asthma and IBS. Atopy could be a shared pathophysiology underlying this association, deserving a further investigation.	[Shen, Te-Chun; Chen, Chia-Hung; Kao, Chia-Hung] China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan; [Shen, Te-Chun; Chen, Chia-Hung; Tu, Chih-Yen; Hsia, Te-Chun; Shih, Chuen-Ming; Hsu, Wu-Huei] China Med Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med, Taichung, Taiwan; [Lin, Cheng-Li; Sung, Fung-Chang; Kao, Chia-Hung] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ, China Med Univ Hosp, Childrens Hosp, Taichung, Taiwan; [Sung, Fung-Chang] China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan; [Sung, Fung-Chang] Mahidol Univ, Fac Publ Hlth, Bangkok 10700, Thailand; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Mahidol University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan	Kao, CH (corresponding author), China Med Univ, Coll Med, Grad Inst Clin Med Sci, Taichung, Taiwan.; Sung, FC; Kao, CH (corresponding author), China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan.; Sung, FC (corresponding author), China Med Univ, Dept Hlth Serv Adm, Taichung, Taiwan.; Sung, FC (corresponding author), Mahidol Univ, Fac Publ Hlth, Bangkok 10700, Thailand.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.	fcsung.tw@gmail.com; d10040@mail.cmuh.org.tw		Shen, Te-Chun/0000-0002-9427-1068	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039-005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital; Academia Sinica Taiwan Biobank; Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan	This study was supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039-005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan.	Amra B, 2006, RESP MED, V100, P110, DOI 10.1016/j.rmed.2005.03.036; Andersen ABT, 2015, CLIN EPIDEMIOL, V7, P37, DOI 10.2147/CLEP.S73662; Begum T, 2014, INT ARCH INTEGRATED, V1, P34; Boulet LP, 2009, EUR RESPIR J, V33, P897, DOI 10.1183/09031936.00121308; Brassard P, 2015, EUR RESPIR J, V45, P962, DOI 10.1183/09031936.00079414; Caffarelli C, 2007, EUR J PEDIATR, V166, P1245, DOI 10.1007/s00431-006-0410-y; Chao CH, 2013, ANDROLOGY-US, V1, P793, DOI 10.1111/j.2047-2927.2013.00120.x; Chung WS, 2014, EUR J INTERN MED, V25, P941, DOI 10.1016/j.ejim.2014.10.023; Cole JA, 2007, DIGEST DIS SCI, V52, P329, DOI 10.1007/s10620-006-9530-5; Cruz AA, 2007, ALLERGY, V62, P1, DOI 10.1111/j.1398-9995.2007.01551.x; Drossman DA, 2002, GASTROENTEROLOGY, V123, P2108, DOI 10.1053/gast.2002.37095; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Ekici A, 2005, DIGEST LIVER DIS, V37, P773, DOI 10.1016/j.dld.2005.05.006; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Ford AC, 2013, GASTROENTEROLOGY, V145, P1262, DOI 10.1053/j.gastro.2013.08.048; Ford AC, 2011, J GASTROENTEROL, V46, P421, DOI 10.1007/s00535-011-0379-9; Global Initiative for Asthma, 2015, GLOB STRAT ASTHM MAN; Goodwin RD, 2003, ARCH GEN PSYCHIAT, V60, P1125, DOI 10.1001/archpsyc.60.11.1125; Huerta C, 2002, PHARMACOEPIDEM DR S, V11, P31, DOI 10.1002/pds.666; Jellema P, 2009, ALIMENT PHARM THER, V30, P695, DOI 10.1111/j.1365-2036.2009.04087.x; Jones MP, 2014, ALIMENT PHARM THER, V40, P382, DOI 10.1111/apt.12846; Kennedy TM, 1998, GUT, V43, P770, DOI 10.1136/gut.43.6.770; Ludvigsson JF, 2011, J ALLERGY CLIN IMMUN, V127, DOI 10.1016/j.jaci.2010.12.1076; Magnusson J, 2003, J ALLERGY CLIN IMMUN, V112, P45, DOI 10.1067/mai.2003.1604; Olen O, 2014, ALIMENT PHARM THER, V40, P1349, DOI 10.1111/apt.12965; Ozol D, 2006, J ASTHMA, V43, P773, DOI 10.1080/02770900601031789; Panicker R, 2010, ANN THORAC MED, V5, P37, DOI 10.4103/1817-1737.58958; Pearson JS, 2015, THER ADV GASTROENTER, V8, P270, DOI 10.1177/1756283X15588875; PETITPIERRE M, 1985, ANN ALLERGY, V54, P538; Philpott H, 2011, ASIA PAC ALLERGY, V1, P36, DOI 10.5415/apallergy.2011.1.1.36; Roussos A, 2003, RESP MED, V97, P75, DOI 10.1053/rmed.2001.1409; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Shen TC, 2014, QJM-INT J MED, V107, P435, DOI 10.1093/qjmed/hcu008; Shen TC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116608; Tobin MC, 2008, ANN ALLERG ASTHMA IM, V100, P49, DOI 10.1016/S1081-1206(10)60404-8; Walker MM, 2014, EXPERT REV GASTROENT, V8, P289, DOI 10.1586/17474124.2014.881716; Westreich D, 2012, EPIDEMIOLOGY, V23, P159, DOI 10.1097/EDE.0b013e31823b6296; Whitehead WE, 2010, AM J GASTROENTEROL, V105, P814, DOI 10.1038/ajg.2010.56; Yang TY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000616; Yazar A, 2001, AM J GASTROENTEROL, V96, P1511, DOI 10.1111/j.1572-0241.2001.03748.x; Yilmaz A, 2011, CLINICS, V66, P591, DOI 10.1590/S1807-59322011000400012	41	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153911	10.1371/journal.pone.0153911	http://dx.doi.org/10.1371/journal.pone.0153911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093172	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200060
J	Yang, SH; Luo, C; Song, YJ; Wang, JH				Yang, Shaohui; Luo, Cui; Song, Yingjin; Wang, Jiehua			Two Groups of Thellungiella salsuginea RAVs Exhibit Distinct Responses and Sensitivity to Salt and ABA in Transgenic Arabidopsis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; DORMANCY RELEASE; DOMAIN; GENE; EVOLUTION; SEQUENCE; PROTEIN; EXPRESSION; DROUGHT; ANNOTATION	Containing both AP2 domain and B3 domain, RAV (Related to ABI3NP1) transcription factors are involved in diverse functions in higher plants. A total of eight TsRAV genes were isolated from the genome of Thellungiella salsuginea and could be divided into two groups (A and B-group) based on their sequence similarity. The mRNA abundance of all Thellungiella salsuginea TsRAVs followed a gradual decline during seed germination. In Thellungiella salsuginea seedling, transcripts of TsRAVs in the group A (A-TsRAVs) were gradually and moderately reduced by salt treatment but rapidly and severely repressed by ABA treatment. In comparison, with a barely detectable constitutive expression, the transcriptional level of TsRAVs in the group B (B-TsRAVs) exhibited a moderate induction in cotyledons when confronted with ABA. We then produced the "gain-of-function" transgenicArabidopsis plants for each TsRAV gene and found that only 35S:A-TsRAVs showed weak growth retardation including reduced root elongation, suggesting their roles in negatively controlling plant growth. Under normal conditions, the germination process of all TsRAVs overexpressing transgenic seeds was inhibited with a stronger effect observed in 35S:A-TsRAVs seeds than in 35S:B-TsRAVs seeds. With the presence of NaCI, seed germination and seedling root elongation of all plants including wild type and 35S:TsRAVs plants were retarded and a more severe inhibition occurred to the 35S:A-TsRAVtransgenic plants. ABA treatment only negatively affected the germination rates of 35S:A-TsRAV transgenic seeds but not those of 35S:B-TsRAV transgenic seeds. All 35S:TsRAVs transgenic plants showed a similar degree of reduction in root growth compared with untreated seedlings in the presence of ABA. Furthermore, the cotyledon greening/expansion was more severely inhibited 35S:A-TsRAVs than in 35S:B-TsRAVs seedlings. Upon water deficiency, with a wider opening of stomata, 35SA-TsRAVs plants experienced a faster transpirational water loss than wild type and 35S:B-TsRAVs lines. Taken together, our results suggest that two groups of TsRAVs perform distinct regulating roles during plant growth and abiotic defense including drought and salt, and A-TsRAVs are more likely than B-TsRAVs to act as negative regulators in the above -mentioned biological processes.	[Yang, Shaohui; Luo, Cui; Song, Yingjin; Wang, Jiehua] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China	Tianjin University	Wang, JH (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.	jiehuawang@tju.edu.cn			National Transgenic Major Project [2014ZX0800404B]; Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration [HYSYJ-HB-2010-BH-3]	National Transgenic Major Project; Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration	This work was supported by the National Transgenic Major Project (2014ZX0800404B) and Central Government Shared Marine Appropriation Expenditure by State Oceanic Administration (HYSYJ-HB-2010-BH-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali-Rachedi S, 2004, PLANTA, V219, P479, DOI 10.1007/s00425-004-1251-4; Amtmann A, 2009, MOL PLANT, V2, P3, DOI 10.1093/mp/ssn094; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Castillejo C, 2008, CURR BIOL, V18, P1338, DOI 10.1016/j.cub.2008.07.075; Chen XF, 2009, GENES GENET SYST, V84, P101, DOI 10.1266/ggs.84.101; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Feng CZ, 2014, PLANT J, V80, P654, DOI 10.1111/tpj.12670; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Finkelstein RR, 2000, PLANT PHYSIOL, V122, P1179, DOI 10.1104/pp.122.4.1179; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fu M, 2014, PLANT CELL PHYSIOL, V55, P1892, DOI 10.1093/pcp/pcu118; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Gubler F, 2005, CURR OPIN PLANT BIOL, V8, P183, DOI 10.1016/j.pbi.2005.01.011; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Ikeda M, 2009, PLANT CELL PHYSIOL, V50, P970, DOI 10.1093/pcp/pcp048; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Kang JY, 2002, PLANT CELL, V14, P343, DOI 10.1105/tpc.010362; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Lee D, 2005, NEW PHYTOL, V165, P429, DOI 10.1111/j.1469-8137.2004.01238.x; Li CW, 2011, PLANT PHYSIOL, V156, P213, DOI 10.1104/pp.111.174268; Li X, 2015, SHOCK VIB, V2015, DOI 10.1155/2015/431476; Liu ZN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083444; Lu QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089145; Magnani E, 2004, PLANT CELL, V16, P2265, DOI 10.1105/tpc.104.023135; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; Mittal A, 2012, THESIS TEXAS TU, P161; Mittal A, 2014, PLANT BIOTECHNOL J, V12, P578, DOI 10.1111/pbi.12162; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Osnato M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1810; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Suzuki M, 1997, PLANT CELL, V9, P799, DOI 10.1105/tpc.9.5.799; Taji T, 2004, PLANT PHYSIOL, V135, P1697, DOI 10.1104/pp.104.039909; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; Zhao L, 2008, PLANTA, V227, P1389, DOI 10.1007/s00425-008-0711-7; Zhao L, 2012, J EXP BOT, V63, P3257, DOI 10.1093/jxb/ers056; Zhuang J, 2011, MOL BIOL REP, V38, P3921, DOI 10.1007/s11033-010-0508-1	47	9	11	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153517	10.1371/journal.pone.0153517	http://dx.doi.org/10.1371/journal.pone.0153517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093611	Green Submitted, gold, Green Published			2022-12-27	WOS:000374541200024
J	Yang, SK; Zhang, JQ; Lu, D				Yang Shunkun; Zhang Jiaquan; Lu Dan			Prediction of Cascading Failures in Spatial Networks	PLOS ONE			English	Article							RELIABILITY	Cascading overload failures are widely found in large-scale parallel systems and remain a major threat to system reliability; therefore, they are of great concern to maintainers and managers of different systems. Accurate cascading failure prediction can provide useful information to help control networks. However, for a large, gradually growing network with increasing complexity, it is often impractical to explore the behavior of a single node from the perspective of failure propagation. Fortunately, overload failures that propagate through a network exhibit certain spatial-temporal correlations, which allows the study of a group of nodes that share common spatial and temporal characteristics. Therefore, in this study, we seek to predict the failure rates of nodes in a given group using machine-learning methods. We simulated overload failure propagations in a weighted lattice network that start with a center attack and predicted the failure percentages of different groups of nodes that are separated by a given distance. The experimental results of a feedforward neural network (FNN), a recurrent neural network (RNN) and support vector regression (SVR) all show that these different models can accurately predict the similar behavior of nodes in a given group during cascading overload propagation.	[Yang Shunkun; Zhang Jiaquan; Lu Dan] Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China	Beihang University	Yang, SK (corresponding author), Beihang Univ, Sch Reliabil & Syst Engn, Beijing 100191, Peoples R China.	ysk@buaa.edu.cn						Brandes U, 2008, SOC NETWORKS, V30, P136, DOI 10.1016/j.socnet.2007.11.001; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Helbing D, 2013, NATURE, V497, P51, DOI 10.1038/nature12047; HORNIK K, 1989, NEURAL NETWORKS, V2, P359, DOI 10.1016/0893-6080(89)90020-8; Jung-Hua Lo, 2010, Proceedings Second International Conference on Computer Research and Development (ICCRD 2010), P765, DOI 10.1109/ICCRD.2010.144; KARUNANITHI N, 1992, IEEE SOFTWARE, V9, P53, DOI 10.1109/52.143107; Kinney R, 2005, EUR PHYS J B, V46, P101, DOI 10.1140/epjb/e2005-00237-9; Li D, 2015, P NATL ACAD SCI, V112; Li D, 2008, PHYS REV LETT, V101, P3958; Li DQ, 2015, RELIAB ENG SYST SAFE, V142, P556, DOI 10.1016/j.ress.2015.05.021; Li DQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05381; Li DQ, 2011, NAT PHYS, V7, P481, DOI [10.1038/NPHYS1932, 10.1038/nphys1932]; Schaul T, 2010, J MACH LEARN RES, V11, P743; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Wei Z, 2013, RELIAB ENG SYST SAFE, V119, P109, DOI 10.1016/j.ress.2013.05.021; Williams RJ, 1989, NEURAL COMPUT, V1, P270, DOI 10.1162/neco.1989.1.2.270; Zhao JC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10094; Zheng J, 2009, EXPERT SYST APPL, V36, P2116, DOI 10.1016/j.eswa.2007.12.029	19	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153904	10.1371/journal.pone.0153904	http://dx.doi.org/10.1371/journal.pone.0153904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093054	Green Published, gold			2022-12-27	WOS:000374541200059
J	Enke, M; Meyer, P; Flor, H				Enke, Martin; Meyer, Patric; Flor, Herta			From Memory to Attitude: The Neurocognitive Process beyond Euthanasia Acceptance	PLOS ONE			English	Article							PHYSICIAN-ASSISTED SUICIDE; EMOTIONAL FACIAL EXPRESSIONS; OF-LIFE DECISIONS; AUTOMATIC ACTIVATION; IMPLICIT ATTITUDES; TRAIT ANXIETY; ELECTROPHYSIOLOGICAL EVIDENCE; SOCIAL COGNITION; SELF-ESTEEM; BRAIN	Numerous questionnaire studies on attitudes towards euthanasia produced conflicting results, precluding any general conclusion. This might be due to the fact that human behavior can be influenced by automatically triggered attitudes, which represent ingrained associations in memory and cannot be assessed by standard questionnaires, but require indirect measures such as reaction times (RT) or electroencephalographic recording (EEG). Event related potentials (ERPs) of the EEG and RT during an affective priming task were assessed to investigate the impact of automatically triggered attitudes and were compared to results of an explicit questionnaire. Explicit attitudes were ambivalent. Reaction time data showed neither positive nor negative associations towards euthanasia. ERP analyses revealed an N400 priming effect with lower mean amplitudes when euthanasia was associated with negative words. The euthanasia-related modulation of the N400 component shows an integration of the euthanasia object in negatively valenced associative neural networks. The integration of all measures suggests a bottom-up process of attitude activation, where automatically triggered negative euthanasia-relevant associations can become more ambiguous with increasing time in order to regulate the bias arising from automatic processes. These data suggest that implicit measures may make an important contribution to the understanding of euthanasia-related attitudes.	[Enke, Martin; Meyer, Patric; Flor, Herta] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Mannheim, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg	Enke, M (corresponding author), Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Mannheim, Dept Cognit & Clin Neurosci, Mannheim, Germany.	martin.enke@zi-mannheim.de		Flor, Herta/0000-0003-4809-5398	Marsilius-Kolleg, Heidelberg University, Germany	Marsilius-Kolleg, Heidelberg University, Germany	This work was funded by the Marsilius-Kolleg, Heidelberg University (http://www.marsilius-kolleg.uni-heidelberg.de/index_en.html), Germany (excellence initia-tive of the federal and state governments) to HF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2012, COGN AFFECT BEHAV NE; Allen Jen, 2006, J SOCIOLOGY SOCIAL W, V33, P5; Banaji MR, 2001, SCI CON SER, P117; Bartholow BD, 2009, J EXP SOC PSYCHOL, V45, P655, DOI 10.1016/j.jesp.2009.02.015; Berner MP, 2004, EXP PSYCHOL, V51, P180, DOI 10.1027/1618-3169.51.3.180; Blendon RJ, 2005, ARCH INTERN MED, V165, P2580, DOI 10.1001/archinte.165.22.2580; Bower GH, 2000, OXFORD HDB MEMORY, P135; Bridger EK, 2012, NEUROIMAGE, V63, P1334, DOI 10.1016/j.neuroimage.2012.07.047; Buiting HM, 2012, J MED ETHICS, V38, P267, DOI 10.1136/medethics-2011-100066; CACIOPPO JT, 1993, PSYCHOL SCI, V4, P108, DOI 10.1111/j.1467-9280.1993.tb00470.x; Chong AML, 2009, SOC WORK HEALTH CARE, V48, P119, DOI 10.1080/00981380802533298; Cohen J, 2006, EUR J PUBLIC HEALTH, V16, P663, DOI 10.1093/eurpub/ckl042; De Houwer J., 2009, ATTITUDES INSIGHTS N, P361; Duncan OD, 2006, J MED ETHICS, V32, P266, DOI 10.1136/jme.2004.011072; Eder AB, 2012, SOC COGN AFFECT NEUR, V7, P436, DOI 10.1093/scan/nsr033; Fazio RH, 2001, COGNITION EMOTION, V15, P115, DOI 10.1080/02699930125908; Fazio RH, 2003, ANNU REV PSYCHOL, V54, P297, DOI 10.1146/annurev.psych.54.101601.145225; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; FAZIO RH, 1982, J EXP SOC PSYCHOL, V18, P339, DOI 10.1016/0022-1031(82)90058-0; Federmeier KD, 2001, J EXP PSYCHOL LEARN, V27, P202, DOI 10.1037/0278-7393.27.1.202; Ganis G, 1996, J COGNITIVE NEUROSCI, V8, P89, DOI 10.1162/jocn.1996.8.2.89; Gielen J, 2008, J PALLIAT CARE, V24, P173, DOI 10.1177/082585970802400307; Glaser J, 1999, J PERS SOC PSYCHOL, V77, P669, DOI 10.1037/0022-3514.77.4.669; Greenwald AG, 2002, PSYCHOL REV, V109, P3, DOI 10.1037/0033-295X.109.1.3; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Hagemann D, 2001, PSYCHOPHYSIOLOGY, V38, P847, DOI 10.1111/1469-8986.3850847; Herring DR, 2011, EMOTION, V11, P794, DOI 10.1037/a0022804; Hinojosa JA, 2009, EMOTION, V9, P164, DOI 10.1037/a0014680; Ito TA, 2000, J EXP SOC PSYCHOL, V36, P660, DOI 10.1006/jesp.2000.1430; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Ivo K, 2012, J MED ETHICS, V38, P310, DOI 10.1136/medethics-2011-100153; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kissler J, 2011, BIOL PSYCHOL, V86, P254, DOI 10.1016/j.biopsycho.2010.12.006; Klauer KC, 2007, J EXP SOC PSYCHOL, V43, P648, DOI 10.1016/j.jesp.2006.06.003; Klauer KC, 2009, J PERS SOC PSYCHOL, V96, P265, DOI 10.1037/a0013248; Klauer KC, 2001, Q J EXP PSYCHOL-A, V54, P727, DOI 10.1080/02724980042000444; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Long SO, 2002, THEOR MED BIOETH, V23, P305, DOI 10.1023/A:1021243805657; Luck S.J., 2005, INTRO EVENT RELATED; Maier MA, 2003, EXP PSYCHOL, V50, P116, DOI 10.1026//1618-3169.50.2.116; Maitra Robin T, 2005, Eur J Gen Pract, V11, P94; Makeig S, 1996, ADV NEUR IN, V8, P145; McCormack R, 2012, PALLIATIVE MED, V26, P23, DOI 10.1177/0269216311397688; Moehring B, 2011, J PALLIAT MED, V14, P1206, DOI 10.1089/jpm.2011.0184; Morris JP, 2003, POLIT PSYCHOL, V24, P727, DOI 10.1046/j.1467-9221.2003.00349.x; Muller-Busch H C, 2004, Med Health Care Philos, V7, P333; Nilstun T, 2000, SCAND J PUBLIC HEALT, V28, P111, DOI 10.1080/713797391; Nosek BA, 2005, J EXP PSYCHOL GEN, V134, P565, DOI 10.1037/0096-3445.134.4.565; Okishiro N, 2009, AM J HOSP PALLIAT ME, V26, P98, DOI 10.1177/1049909108327027; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Silvoniemi M, 2010, PALLIATIVE MED, V24, P744, DOI 10.1177/0269216310376556; Slotnick SD, 2010, COGN NEUROSCI-UK, V1, P8, DOI 10.1080/17588920903474263; Spruyt A, 2007, MEM COGNITION, V35, P95, DOI 10.3758/BF03195946; Stanley D, 2008, CURR DIR PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-8721.2008.00568.x; Stocke V. C, 2007, SOCIAL METHODOLOGY, V3, P125, DOI DOI 10.1027/1614-2241.3.3.125; Storbeck J, 2004, PERS SOC PSYCHOL B, V30, P81, DOI 10.1177/0146167203258855; STORMARK KM, 1995, COGNITION EMOTION, V9, P507, DOI 10.1080/02699939508408978; Stronegger WJ, 2011, J MED ETHICS, V37, P227, DOI 10.1136/jme.2010.039792; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Tulving E., 2000, OXFORD HDB MEMORY, P33; Vo MLH, 2009, BEHAV RES METHODS, V41, P534, DOI 10.3758/BRM.41.2.534; Voss JL, 2011, PSYCHOPHYSIOLOGY, V48, P532, DOI 10.1111/j.1469-8986.2010.01085.x; Wang L, 2011, BRAIN RES, V1375, P103, DOI 10.1016/j.brainres.2010.12.021; Werheid K, 2005, INT J PSYCHOPHYSIOL, V55, P209, DOI 10.1016/j.ijpsycho.2004.07.006; White KR, 2009, SOC COGN AFFECT NEUR, V4, P191, DOI 10.1093/scan/nsp004; Whitney SN, 2001, J GEN INTERN MED, V16, P290, DOI 10.1046/j.1525-1497.2001.04159.x; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Zhang Q, 2006, BRAIN RES BULL, V71, P316, DOI 10.1016/j.brainresbull.2006.09.023; Zhang Q, 2012, BRAIN RES, V1474, P60, DOI 10.1016/j.brainres.2012.07.023; Zhang Q, 2010, BRAIN RES, V1329, P142, DOI 10.1016/j.brainres.2010.03.021	76	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153910	10.1371/journal.pone.0153910	http://dx.doi.org/10.1371/journal.pone.0153910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088244	Green Published, gold			2022-12-27	WOS:000374527000058
J	Jee, YH; Lebenthal, Y; Chaemsaithong, P; Yan, G; Peran, I; Wellstein, A; Romero, R; Baron, J				Jee, Youn Hee; Lebenthal, Yael; Chaemsaithong, Piya; Yan, Gai; Peran, Ivana; Wellstein, Anton; Romero, Roberto; Baron, Jeffrey			Midkine and Pleiotrophin Concentrations in Amniotic Fluid in Healthy and Complicated Pregnancies	PLOS ONE			English	Article							GROWTH-FACTOR PLEIOTROPHIN; ACID-RESPONSIVE GENE; PRETERM DELIVERY; ADULT-RAT; EXPRESSION; MK; DIFFERENTIATION; FETAL; PREDICTION; FAMILY	Background Midkine (MDK) and pleiotrophin (PTN) are heparin-binding growth factors that, in rodents, are highly expressed in early life and decrease to undetectable levels by adulthood. The potential roles of MDK and PTN in human growth and development are not completely elucidated. Method and Findings To delineate the role of MDK and PTN in human development, we developed high sensitivity assays to measure their concentrations in amniotic fluid (AF) at various gestational ages in both healthy and complicated pregnancies. We found that both of these growth factors could be readily measured in AF and that the concentrations were higher than most cytokines previously reported in AF. Conclusion The concentration of MDK but not that of PTN declined with gestational age. Both MDK and PTN concentrations were found to be lower in pregnancies that were complicated by chorioamnionitis at term, raising the possibility that these growth factors might be useful as markers for infection.	[Jee, Youn Hee; Lebenthal, Yael; Baron, Jeffrey] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA; [Lebenthal, Yael] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Chaemsaithong, Piya; Romero, Roberto] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Program Perinatal Res & Obstet, Div Intramural Res, Detroit, MI USA; [Yan, Gai; Peran, Ivana; Wellstein, Anton] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Yan, Gai; Peran, Ivana; Wellstein, Anton] Lombardi Comprehens Canc Ctr, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Tel Aviv University; Sackler Faculty of Medicine; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Georgetown University	Baron, J (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Growth & Dev, Program Dev Endocrinol & Genet, NIH, Bethesda, MD USA.	jeffrey.baron@nih.gov	Lebenthal, Yael/AAW-7891-2020; Lebenthal, Yael/AAZ-5216-2020; Peran, Ivana/AAL-7480-2020; Romero, Roberto/A-5268-2019	Lebenthal, Yael/0000-0001-5963-0574; Peran, Ivana/0000-0001-7399-7452; Chaemsaithong, piya/0000-0002-5398-6868; chaemsaithong, piya/0000-0003-1750-9834; Romero, Roberto/0000-0002-4448-5121	Thrasher Research Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000640, ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009686] Funding Source: NIH RePORTER	Thrasher Research Fund; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant from the Thrasher Research Fund and by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [https://www.thrasherresearch.org/default.aspx].	Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; BLOCH B, 1992, DEV BRAIN RES, V70, P267, DOI 10.1016/0165-3806(92)90206-C; Chaemsaithong P, 2016, J MATERN-FETAL NEO M, V29, P360, DOI 10.3109/14767058.2015.1006621; Erguven M, 2012, MIDKINE EMBRYOGENESI; Fan QW, 2000, DEV GROWTH DIFFER, V42, P113; Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; GIBBS RS, 1988, OBSTET GYNECOL, V72, P823, DOI 10.1097/00006250-198812000-00001; Goebel-Stengel M, 2011, ANAL BIOCHEM, V414, P38, DOI 10.1016/j.ab.2011.02.009; Hando Atsushi, 2008, Rinsho Byori, V56, P221; Heikkinen J, 2001, SCAND J IMMUNOL, V53, P310, DOI 10.1046/j.1365-3083.2001.00872.x; Hong SN, 2015, ARCH GYNECOL OBSTET, V291, P265, DOI 10.1007/s00404-014-3439-6; Ishimoto H, 2006, J CLIN ENDOCR METAB, V91, P4050, DOI 10.1210/jc.2006-1139; Jee YH, 2014, CLIN ENDOCR IN PRESS; Jones DR, 2014, BRIT J PHARMACOL, V171, P2925, DOI 10.1111/bph.12601; KADOMATSU K, 1990, J CELL BIOL, V110, P607, DOI 10.1083/jcb.110.3.607; Kadomatsu K, 2013, J BIOCHEM, V153, P511, DOI 10.1093/jb/mvt035; Liedert A, 2014, BRIT J PHARMACOL, V171, P870, DOI 10.1111/bph.12412; Lui JC, 2010, FASEB J, V24, P3083, DOI 10.1096/fj.09-152835; MATSUBARA S, 1990, J BIOL CHEM, V265, P9441; MITSIADIS TA, 1995, DEVELOPMENT, V121, P37; MURAMATSU H, 1993, DEV BIOL, V159, P392, DOI 10.1006/dbio.1993.1250; Muramatsu H, 2006, GENES CELLS, V11, P1405, DOI 10.1111/j.1365-2443.2006.01028.x; Muramatsu T, 2014, BRIT J PHARMACOL, V171, P814, DOI 10.1111/bph.12353; Muramatsu T, 2010, P JPN ACAD B-PHYS, V86, P410, DOI 10.2183/pjab.86.410; NAKAMOTO M, 1992, J BIOCHEM-TOKYO, V112, P346, DOI 10.1093/oxfordjournals.jbchem.a123903; OBAMA H, 1995, J BIOCHEM-TOKYO, V118, P88, DOI 10.1093/oxfordjournals.jbchem.a124896; Ozgu-Erdinc AS, 2014, J OBSTET GYNAECOL RE, V40, P1540, DOI 10.1111/jog.12371; Qi MS, 2000, J BIOCHEM, V127, P269, DOI 10.1093/oxfordjournals.jbchem.a022604; Redline RW, 2005, PLACENTA, V26, pS114, DOI 10.1016/j.placenta.2005.02.009; SATOH J, 1993, DEV BRAIN RES, V75, P201, DOI 10.1016/0165-3806(93)90024-5; Schulte AM, 1996, P NATL ACAD SCI USA, V93, P14759, DOI 10.1073/pnas.93.25.14759; Schulte AM, 1998, J VIROL, V72, P6065, DOI 10.1128/JVI.72.7.6065-6072.1998; Schulte AM, 2000, ONCOGENE, V19, P3988, DOI 10.1038/sj.onc.1203742; UEHARA K, 1992, J BIOCHEM-TOKYO, V111, P563, DOI 10.1093/oxfordjournals.jbchem.a123797; Underwood Mark A, 2005, J Perinatol, V25, P341, DOI 10.1038/sj.jp.7211290; VANDERWINDEN JM, 1992, ANAT EMBRYOL, V186, P387; Winkler C, 2014, BRIT J PHARMACOL, V171, P905, DOI 10.1111/bph.12462; Zou P, 2006, LAB INVEST, V86, P645, DOI 10.1038/labinvest.3700428	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153325	10.1371/journal.pone.0153325	http://dx.doi.org/10.1371/journal.pone.0153325			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089523	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000017
J	Liu, BJ; Chen, HL; Fang, F; Tillander, A; Wirdefeldt, K				Liu, Bojing; Chen, Honglei; Fang, Fang; Tillander, Annika; Wirdefeldt, Karin			Early-Life Factors and Risk of Parkinson's Disease: A Register-Based Cohort Study	PLOS ONE			English	Article							EXPOSURE; CHILDHOOD; INFLUENZA; EPIDEMIOLOGY; ASSOCIATION; INFECTIONS; SIBLINGS	Parkinson's disease (PD) may take decades to develop and early life exposures such as infection may be important. However, few epidemiological studies have evaluated early life risk factors in relation to PD risk. We therefore examined such associations in a prospective analysis of 3 545 612 individuals born in Sweden between 1932 and 1970 without PD on January 1, 2002. Incident PD cases were identified using the Swedish Patient Register during 2002-2010. Information on sibship size, number of older and younger siblings, multiple births, parental age, birth month and season was obtained from the Swedish Multi-Generation Register. Monthly data on national burden of influenza-like illness during 1932-1970 were obtained from the Swedish Public Health Agency. Hazard ratios with 95% confidence intervals (CI) were estimated using Cox proportional hazards regression. During the follow-up, 8779 incident PD cases were identified. As expected, older age, male sex, parental occupation as farmers, and family history of PD were associated with higher PD risk. Overall, early life factors, including flu burden in the year of birth, were not associated with PD risk, although we did find a lower PD risk among participants with older siblings than those without (HR = 0.93, 95% CI: 0.89, 0.98). Our study therefore provided little support for important etiological contributions of early life factors to the PD risk late in life. The finding of a lower PD risk among individuals with older siblings will need confirmation and further investigation.	[Liu, Bojing; Fang, Fang; Tillander, Annika; Wirdefeldt, Karin] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Chen, Honglei] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Wirdefeldt, Karin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Karolinska Institutet	Liu, BJ (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	bojing.liu@ki.se		Liu, Bojing/0000-0002-0366-6989; Chen, Honglei/0000-0003-3446-7779; Fang, Fang/0000-0002-3310-6456	Swedish Research Council for Health, Working Life and Welfare [2013-1350]; KI-NIH Doctoral Partnership Program in Neuroscience; Swedish Society for Medical Research; Karolinska Institutet; NIH, the National Institute of Environmental Health Sciences [Z01-ES-101986]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101986, Z01ES101986] Funding Source: NIH RePORTER	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); KI-NIH Doctoral Partnership Program in Neuroscience; Swedish Society for Medical Research; Karolinska Institutet(Karolinska Institutet); NIH, the National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	KW received funding from Swedish Research Council for Health, Working Life and Welfare (www.forte.se, 2013-1350), KI-NIH Doctoral Partnership Program in Neuroscience (www.ki.se). FF received funding from Swedish Society for Medical Research (www.ssmf.se) and Karolinska Institutet (www.ki.se). HC received funding from the intramural research program of the NIH, the National Institute of Environmental Health Sciences (www.niehs.nih.gov, Z01-ES-101986). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Cardwell CR, 2011, INT J EPIDEMIOL, V40, P363, DOI 10.1093/ije/dyq207; Crow JF, 1997, P NATL ACAD SCI USA, V94, P8380, DOI 10.1073/pnas.94.16.8380; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; EBMEIER KP, 1989, J NEUROL NEUROSUR PS, V52, P911, DOI 10.1136/jnnp.52.7.911; Fang F, 2008, AM J EPIDEMIOL, V167, P1281, DOI 10.1093/aje/kwn056; Feldman AL, 2012, NEUROEPIDEMIOLOGY, V38, P186, DOI 10.1159/000336356; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gronnesby J K, 1996, Lifetime Data Anal, V2, P315, DOI 10.1007/BF00127305; Harris MA, 2012, MOVEMENT DISORD, V27, P1111, DOI 10.1002/mds.25077; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Logroscino G, 2005, ENVIRON HEALTH PERSP, V113, P1234, DOI 10.1289/ehp.7573; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; MARTYN CN, 1995, J NEUROL SCI, V132, P201, DOI 10.1016/0022-510X(95)00148-U; MATTOCK C, 1988, J NEUROL NEUROSUR PS, V51, P753, DOI 10.1136/jnnp.51.6.753; Moceri VM, 2000, NEUROLOGY, V54, P415, DOI 10.1212/WNL.54.2.415; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Postuma RB, 2007, MOVEMENT DISORD, V22, P1097, DOI 10.1002/mds.21272; Skog L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-378; Statistics Sweden, 2009, MULT REG 2009 A DESC; Statistics Sweden, 2014, POP POP CHANG 1749 2; Statistics Sweden, 2015, NAT PAT REG; Statistics Sweden (SCB), 1982, MEDD SAM, P5; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Torrey EF, 2000, NEUROEPIDEMIOLOGY, V19, P177, DOI 10.1159/000026253; Westergaard T, 1999, ARCH GEN PSYCHIAT, V56, P993, DOI 10.1001/archpsyc.56.11.993; Wirdefeldt K, 2011, EUR J EPIDEMIOL, V26, pS1, DOI 10.1007/s10654-011-9581-6	29	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152841	10.1371/journal.pone.0152841	http://dx.doi.org/10.1371/journal.pone.0152841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082111	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800010
J	Niu, L; Luo, D; Liu, Y; Silenzio, VMB; Xiao, SY				Niu, Lu; Luo, Dan; Liu, Ying; Silenzio, Vincent M. B.; Xiao, Shuiyuan			The Mental Health of People Living with HIV in China, 1998-2014: A Systematic Review	PLOS ONE			English	Review							FORMER PLASMA DONORS; SOCIAL SUPPORT; NEUROCOGNITIVE IMPAIRMENT; PSYCHOLOGICAL STATUS; DEPRESSIVE SYMPTOMS; HIV/AIDS; INFECTION; DISORDERS; USERS; RISK	Background Understanding the mental health burdens faced by people living with HIV in China is instrumental in the development of successful targeted programs for psychological support and care. Methods Using multiple Chinese and English literature databases, we conducted a systematic review of observational research (cross-sectional, case-control, or cohort) published between 1998 and 2014 on the mental health of people living with HIV in China. Results We identified a total of 94 eligible articles. A broad range of instruments were used across studies. Depression was the most widely studied problem; the majority of studies reported prevalence greater than 60% across research settings, with indications of a higher prevalence among women than men. Rates of anxiety tended to be greater than 40%. Findings regarding the rates of suicidality, HIV-related neurocognitive disorders, and substance use were less and varied. Only one study investigated posttraumatic stress disorder and reported a prevalence of 46.2%. Conflicting results about health and treatment related factors of mental health were found across studies. Conclusions Despite limitations, this review confirmed that people living with HIV are vulnerable to mental health problems, and there is substantial need for mental health services among this population.	[Niu, Lu; Luo, Dan; Liu, Ying; Xiao, Shuiyuan] Cent South Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China; [Niu, Lu; Luo, Dan; Silenzio, Vincent M. B.] Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA	Central South University; University of Rochester	Luo, D (corresponding author), Cent South Univ, Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha, Hunan, Peoples R China.; Luo, D (corresponding author), Univ Rochester, Med Ctr, Dept Psychiat, Rochester, NY 14642 USA.	luodan_csu_2011@126.com	Silenzio, Vincent Michael Bernard/AAC-1466-2020	Silenzio, Vincent Michael Bernard/0000-0003-1408-7955	National Natural Science Foundation of China [81202290]; U.S. National Institutes of Health [D43 TW009101]; FOGARTY INTERNATIONAL CENTER [D43TW009101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI078498] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Natural Science Foundation of China (81202290) received by Dan Luo, and the U.S. National Institutes of Health (D43 TW009101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, CHINA NEWS      1201; Atkinson JH, 2011, J AFFECT DISORDERS, V130, P421, DOI 10.1016/j.jad.2010.10.039; Au A, 2008, J CLIN EXP NEUROPSYC, V30, P338, DOI 10.1080/13803390701416189; Bai GX, 2008, CHINESE REMEDIES CLI, V8, P20; Bai P, 2012, CHINESE FOREIGN MED, V10, P61; Bao MJ, 2009, P 5 CAACM CLIN MICR; Brandt R, 2009, AJAR-AFR J AIDS RES, V8, P123, DOI 10.2989/AJAR.2009.8.2.1.853; Catalan J, 2011, PSYCHOL HEALTH MED, V16, P588, DOI 10.1080/13548506.2011.582125; Chan I, 2006, AIDS CARE, V18, P977, DOI 10.1080/09540120500490093; Chen FQ, 2014, J DERMATOLOGY VENERE, V36, P110; [陈光 CHEN Guang], 2008, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V30, P1091; Chen J, 2007, MED SOC, V20, P50; [陈庆玲 Chen Qiangling], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P850; Chen X., 2008, J NURS SCI, V23, P21; Cheng X., 2014, THESIS NANCHANG U; Chinese Center for Disease Control and Prevention, 2015, 2014 NAT REP NOT INF; Chinese Center for Disease Control and Prevention, 2013, 2012 NAT REP NOT INF; Clucas C, 2011, PSYCHOL HEALTH MED, V16, P528, DOI 10.1080/13548506.2011.579989; Cysique LA, 2010, AIDS, V24, P983, DOI 10.1097/QAD.0b013e32833336c8; Dong W., 2011, CHINESE JOURNAL OF N, V4, P429; Dwyer R, 2014, J AFFECT DISORDERS, V162, P89, DOI 10.1016/j.jad.2014.03.038; Fang GX, 2007, CHIN J DIS CONTROL P, V11, P127; Fang LW, 2008, MATERN CHILD HLTH J, V23, P1525; Gao JH, 2014, POPULAR SCI TECHNOLO, V16, P107; Gao LL, 2010, CHIN J DIS CONTROL P, V14, P415; Greene MC, 2013, AIDS BEHAV, V17, P1775, DOI 10.1007/s10461-012-0396-6; Gully A, 2010, CHIN J MOD DRU APPL, V04, P213; Guo ZK, 2013, CHINESE FOREIGN MED, V11, P151; Hao Y, 2014, CHIN J DIS CONTROL P, V18, P369; Heaton RK, 2008, J NEUROVIROL, V14, P536, DOI 10.1080/13550280802378880; Hu JP, 2011, J MED FORUM, V32, P87; Hu JY, 2007, ZEAJIANG PREV MED, V19, P60; Hu JY, 2007, ZHEJIANG PREV MED, V19, P65; Huang CY, 2013, CHINA HLTH CARE NUTR, V23, P1475; Huang GG, 2004, CHINESE J HLTH PSYCH, V12, P464; Huang ZL, 2010, J MED FORUM, V31, P100; Jin C, 2010, HIV MED, V11, P253, DOI 10.1111/j.1468-1293.2009.00770.x; Jin H., 1986, CHIN J NERV MENT DIS, V12, P260; Jin H, 2013, JAIDS-J ACQ IMM DEF, V62, P311, DOI 10.1097/QAI.0b013e31827ce513; Kim HK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005486; [赖文红 Lai Wenhong], 2011, [中国公共卫生, China Public Health], V27, P1521; Lau JTF, 2010, AIDS CARE, V22, P946, DOI 10.1080/09540120903511016; Li BG, 2008, J KUNMING MED U, V29, P20; [李进 Li Jin], 2004, [中国心理卫生杂志, Chinese Mental Health Journal], V18, P530; Li K, 2008, CHIN J DIS CONTROL P, V12, P550; Li L, 2007, THESIS PEKING UNION; Li L, 2011, J FAM PSYCHOL, V25, P202, DOI 10.1037/a0022755; Li YL, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-11; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Liu Qing, 2011, Wuhan Daxue Xuebao (Yixue Ban), V32, P273; Liu TZ, 2010, PREV MED TRIB, V16, P228; Liu Yan, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P658, DOI 10.11817/j.issn.1672-7347.2014.07.002; Loney PL, 1998, CHRONIC DIS CANADA, V19, P170; Lu L, 2010, CHINA MODERN DOCTOR, V48, P85; Lu Si-Han, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P23; Lu SiPing, 2012, Medical Journal of National Defending Forces in Southwest China, V22, P580; Luo XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061660; Lv YH, 2007, THESIS PEKING UNION; Meade CS, 2010, AIDS BEHAV, V14, P328, DOI 10.1007/s10461-008-9494-x; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Health and Family Planning Commission of China, 2014, 2014 CHIN AIDS RESP; Orza L, 2015, J INT AIDS SOC, V18, P56, DOI 10.7448/IAS.18.6.20289; Pan CE, 2010, CHIN J MOD NURS, V16, P259; Pei XL, 2007, MED J CHINESE PEOPLE, V19, P511; Pei XL, 2007, MED J CHINESE PEOPLE, V19, P513; Qian ZZ, 2006, J PUB HLTH PREV MED, V17, P56; Qin XJ, 2014, S CHINA J PREV MED, V40, P208; Qiu Yangyang, 2014, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V39, P835, DOI 10.3969/j.issn.1672-7347.2014.08.014; Qu W., 2005, CHINA J AIDS STD, V2, P91; Rackstraw S, 2011, PSYCHOL HEALTH MED, V16, P548, DOI 10.1080/13548506.2011.579992; Rao D, 2012, INT J STD AIDS, V23, P481, DOI 10.1258/ijsa.2009.009428; Ren YX, 2009, THESIS GUANGDONG PHA; Shan JH, 2009, CHINESES J HLTH ED, V25, P366; Sherr L, 2011, PSYCHOL HEALTH MED, V16, P612, DOI 10.1080/13548506.2011.579991; Shi CR, 2008, CHINA J HLTH PSYCHOL, V16, P1409; Shi CR, 2010, CHIN J AIDS STD, V16, P10; Su Puyu, 2010, Wei Sheng Yan Jiu, V39, P739; Su XY, 2013, J AFFECT DISORDERS, V149, P108, DOI 10.1016/j.jad.2013.01.011; Sun HM, 2007, PUBLIC HEALTH NURS, V24, P132, DOI 10.1111/j.1525-1446.2007.00617.x; Sun W, 2014, INT J INFECT DIS, V28, P147, DOI 10.1016/j.ijid.2014.07.010; Sun YH, 2011, CHIN J PHM, V27, P314; Wang HH, 2014, J ASSOC NURSE AIDS C, V25, P568, DOI 10.1016/j.jana.2014.02.001; [王红红 WANG Honghong], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P881; Wang JN, 2010, CHIN J HLTH MANAGE, V04, P196; Wang Y, 2012, CHINA J HLTH PSYCHOL, V20, P23; Wang Y., 2010, CHINESE J FAMILY PLA, V18, P340, DOI [10.3969/i.issn.1004-8189.2010.06, DOI 10.3969/I.ISSN.1004-8189.2010.06]; Wright E, 2008, NEUROLOGY, V71, P50, DOI 10.1212/01.wnl.0000316390.17248.65; Wu HN, 2006, THESIS DALIAN MED U; Wu M, 2013, CHRONIC PATHEMATHOL, V14, P489; Wu WQ, 2011, CHINESE MED MODERN D, V9, P112; Wu WQ, 2011, CHINESE MED MODERN D, V9, P109; Wu X, 2014, THESIS CHINESE U HON; Wu Y., 2007, CHINESE J DIS CONTRO, V4, P342; Wu YC, 2007, J CLIN NEUROSCI, V14, P8, DOI 10.1016/j.jocn.2005.07.012; [谢世平 Xie Shiping], 2012, [中国病原生物学杂志, Journal of Pathogen Biology], V7, P781; Xie Z, 2012, CHINESE J PRACTICAL, V15, P56; [徐青 Xu Qing], 2014, [南京医科大学学报. 自然科学版, Journal of Nanjing Medical University. Natural Sciences Edition], V34, P834; Yang HX, 2011, THESIS KUMMING MED C; YANG Y, 2013, GUANGZHOU DAXUE XUEB, V12, P12; Yang YanJun, 2013, Journal of Tropical Medicine (Guangzhou), V13, P1381; Yang YJ, 2013, J TROP MED, V13, P1391; Yao HJ, 2014, CHINESE PRIMARY HLTH, V28, p[48, 54]; Yin YanTian, 2009, Modern Preventive Medicine, V36, P3913; Yu XN, 2009, AIDS CARE, V21, P645, DOI 10.1080/09540120802459770; Yuan D, 2012, THESIS NINGBO U; Zhang X, 2008, IMPACT GLOBAL FUND E; Zhang Y, 2005, J PUB HLTH PREV MED, V16, P24; Zhang YL, 2012, J NEUROVIROL, V18, P120, DOI 10.1007/s13365-012-0089-y; Zhao J, 2012, YUNNAN J TRADITIONAL, V33, P27; Zhen LF, 2013, J INTERN MED CONCEPT, V8, P111; Zhen LX, 2011, CHINESE J PRACTICAL, V14, P12; Zhou G, 2014, THESIS KUMMING MED U; Zhou ZH, 2014, CHINA J HLTH PSYCHOL, V22, P22; Zou P, 2014, FOR ALL HLTH, V8, P435; 赵婷婷, 2013, [广东医学, Guangdong Medical Journal], V34, P2506	115	61	71	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153489	10.1371/journal.pone.0153489	http://dx.doi.org/10.1371/journal.pone.0153489			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082749	Green Submitted, gold, Green Published			2022-12-27	WOS:000374291800023
J	Shen, KL; Xiong, TB; Tan, SC; Wu, JH				Shen, Kunling; Xiong, Tengbin; Tan, Seng Chuen; Wu, Jiuhong			Oseltamivir Treatment for Children with Influenza-Like Illness in China: A Cost-Effectiveness Analysis	PLOS ONE			English	Article							VIRUS; MORTALITY; TRIAL	Background Influenza is a common viral respiratory infection that causes epidemics and pandemics in the human population. Oseltamivir is a neuraminidase inhibitor-a new class of antiviral therapy for influenza. Although its efficacy and safety have been established, there is uncertainty regarding whether influenza-like illness (ILI) in children is best managed by oseltamivir at the onset of illness, and its cost-effectiveness in children has not been studied in China. Objective To evaluate the cost-effectiveness of post rapid influenza diagnostic test (RIDT) treatment with oseltamivir and empiric treatment with oseltamivir comparing with no antiviral therapy against influenza for children with ILI. Methods We developed a decision-analytic model based on previously published evidence to simulate and evaluate 1-year potential clinical and economic outcomes associated with three managing strategies for children presenting with symptoms of influenza. Model inputs were derived from literature and expert opinion of clinical practice and research in China. Outcome measures included costs and quality-adjusted life year (QALY). All the interventions were compared with incremental cost-effectiveness ratios (ICER). Results In base case analysis, empiric treatment with oseltamivir consistently produced the greatest gains in QALY. When compared with no antiviral therapy, the empiric treatment with oseltamivir strategy is very cost effective with an ICER of RMB 4,438. When compared with the post RIDT treatment with oseltamivir, the empiric treatment with oseltamivir strategy is dominant. Probabilistic sensitivity analysis projected that there is a 100% probability that empiric oseltamivir treatment would be considered as a very cost-effective strategy compared to the no antiviral therapy, according to the WHO recommendations for cost-effectiveness thresholds. The same was concluded with 99% probability for empiric oseltamivir treatment being a very cost-effective strategy compared to the post RIDT treatment with oseltamivir. Conclusion In the Chinese setting of current health system, our modelling based simulation analysis suggests that empiric treatment with oseltamivir to be a cost-saving and very cost-effective strategy in managing children with ILI.	[Shen, Kunling] Beijing Childrens Hosp, Dept Resp Care, Beijing, Peoples R China; [Xiong, Tengbin] IMS Hlth China, Hlth Econ & Outcomes Res, Shanghai, Peoples R China; [Tan, Seng Chuen] IMS Hlth Asia Pacific, Hlth Econ & Outcomes Res, Singapore, Singapore; [Wu, Jiuhong] 306th Hosp PLA, Dept Pharm, Beijing, Peoples R China	Capital Medical University	Xiong, TB (corresponding author), IMS Hlth China, Hlth Econ & Outcomes Res, Shanghai, Peoples R China.	tbxiong@cn.imshealth.com			HEC Pharm, a subsidiary of HEC Group	HEC Pharm, a subsidiary of HEC Group	This project was sponsored by HEC Pharm, a subsidiary of HEC Group. The funder provided support in the form of salaries for authors Tengbin Xiong and Seng Chuen Tan, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Cai J, 2013, THESIS FUDAN U SHANG; [CDC CDC], 2011, FLU VIEW; Chen HongYi, 2013, Modern Preventive Medicine, V40, P1560; Chen L, 2015, CONT MED, V10, P136; Chen L, 2005, CHINESE GEN PRACTICE, V13, P1088; Chen W, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001086; [陈旭岩 CHEN Xuyan], 2007, [中国全科医学, Chinese General Practice], V10, P272; Chen Y, 2013, HERALD MED, V32, P264; Chen Y, 2015, CHINA PHARM, V11, P101; Epperson S., 2008, Morbidity and Mortality Weekly Report, V57, P692; Gilbert SA, 2013, VALUE HEALTH, V16, P953, DOI 10.1016/j.jval.2013.06.014; Guan Wenda, 2014, Zhonghua Jie He He Hu Xi Za Zhi, V37, P16; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Holm MV, 2004, PHARM WORLD SCI, V26, P339, DOI 10.1007/s11096-004-0559-2; Huang Ting, 2014, Modern Preventive Medicine, V41, P1108; Huang WJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0317-1; Husereau DR, 2001, 212001 CAN COORD OFF; Lavelle TA, 2012, J PEDIATR-US, V160, P67, DOI 10.1016/j.jpeds.2011.07.001; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; Liu Z, 2013, MED J IND ENTERPRISE, V2, P150; Lu X. S., 2015, J PEDIAT PHARM, V21, P24; Luo C, 2007, CHINA PHARM, V32, P2486; Ma J, 2015, NINGXIA MED J, V37, P235, DOI 10.13621/j.1001-5949.2015.03.0235; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Nagase H, 2009, VALUE HEALTH, V12, pS62, DOI 10.1111/j.1524-4733.2009.00629.x; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Peters PH, 2001, J AM GERIATR SOC, V49, P1025, DOI 10.1046/j.1532-5415.2001.49204.x; Reisinger K, 2004, CLIN DRUG INVEST, V24, P395, DOI 10.2165/00044011-200424070-00003; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Wang B, 2008, HEALTH POLICY, V87, P223, DOI 10.1016/j.healthpol.2008.01.001; Wang C, 2014, CHINA PHARM, V24, P48; Wang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069035; Wang Q, 2012, QINGHAI MED J, V12, P63; Wang S, 2012, CHINESE J PHARMACOEP, V3, P140; Wang S, 2006, J PEDIAT PHARM, V2, P24; Wang Xiang-Shi, 2013, Zhonghua Er Ke Za Zhi, V51, P356; WHO Macroeconomics, 2001, HLTH INV HLTH EC DEV; Wilschut JC, 2011, RAPID REFERENCE INFL; Xing J, 2007, CHINA PHARM, V11, P806; Xing Yi, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P368; [杨景秀 Yang Jingxiu], 2013, [中国药房, China Pharmacy], V24, P3634; [杨婷婷 Yang Tingting], 2014, [中华传染病杂志, Chinese Journal of Infections Diseases], V32, P7; Yu G, 2014, J APPL PREVENTIVE ME, V20, P249; Yue Y, 2012, J N PHARM, V6, P91; Zheng H, 2010, MOD PREV MED, V2, P201; Zhong N, 2011, CHINESE J TUBERCULOS, V34, P725; Zhu Q, 2011, FUDAN U J MED SCI, V38; [邹丽容 Zou Lirong], 2011, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V34, P940	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153664	10.1371/journal.pone.0153664	http://dx.doi.org/10.1371/journal.pone.0153664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082431	Green Published, gold			2022-12-27	WOS:000374291800039
J	Boguta, P; Sokolowska, Z				Boguta, Patrycja; Sokolowska, Zofia			Interactions of Zn(II) Ions with Humic Acids Isolated from Various Type of Soils. Effect of pH, Zn Concentrations and Humic Acids Chemical Properties	PLOS ONE			English	Article							BUFFER CAPACITY; FLUORESCENCE SPECTROSCOPY; ORGANIC-LIGANDS; FULVIC-ACID; METAL-IONS; COMPLEXATION; SUBSTANCES; COPPER(II); MATTER; WATER	The main aim of this study was the analysis of the interaction between humic acids (HAs) from different soils and Zn(II) ions at wide concentration ranges and at two different pHs, 5 and 7, by using fluorescence and FTIR spectroscopy, as well as potentiometric measurements. The presence of a few areas of HAs structures responsible for Zn(II) complexing was revealed. Complexation at alpha-sites (low humified structures of low-molecular weight and aromatic polycondensation) and beta-sites (weakly humified structures) was stronger at pH 7 than 5. This trend was not observed for gamma-sites (structures with linearly-condensed aromatic rings, unsaturated bonds and large molecular weight). The amount of metal complexed at pH5 and 7 by alpha and gamma-structures increased with a decrease in humification and aromaticity of HAs, contrary to beta-areas where complexation increased with increasing content of carboxylic groups. The stability of complexes was higher at pH 7 and was the highest for gamma-structures. At pH 5, stability decreased with C/N increase for alpha-areas and -COOH content increase for beta-sites; stability increased with humification decrease for gamma-structures. The stability of complexes at a and beta-areas at pH 7 decreased with a drop in HAs humification. FTIR spectra at pH 5 revealed that the most-humified HAs tended to cause bidentate bridging coordination, while in the case of the least-humified HAs, Zn caused bidentate bridging coordination at low Zn additions and bidentate chelation at the highest Zn concentrations. Low Zn doses at pH 7 caused formation of unidentate complexes while higher Zn doses caused bidentate bridging. Such processes were noticed for HAs characterized by high oxidation degree and high oxygen functional group content; where these were low, HAs displayed bidentate bridging or even bidentate chelation. To summarize, the above studies have showed significant impact of Zn concentration, pH and some properties of HAs on complexation reactions of humic acids with zinc.	[Boguta, Patrycja; Sokolowska, Zofia] Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, PL-20236 Lublin, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences	Boguta, P (corresponding author), Polish Acad Sci, Inst Agrophys, Dept Phys Chem Porous Mat, PL-20236 Lublin, Poland.	p.boguta@ipan.lublin.pl	Boguta, Patrycja/AAL-9890-2020	Boguta, Patrycja/0000-0003-4996-8795; Sokolowska, Zofia/0000-0003-2309-0785	National Science Centre [DEC-2013/11/D/NZ9/02545]	National Science Centre(National Science Centre, Poland)	The studies were partly carried out within the framework of a research project. The project was financed from funds of National Science Centre on the base of decision number DEC-2013/11/D/NZ9/02545. Granted to PB (www: https://www.ncn.gov.pl/?language=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate G, 2001, J BRAZIL CHEM SOC, V12, P109, DOI 10.1590/S0103-50532001000100015; Aryal Rupak Kumar, 2014, Sustainable Environment Research, V24, P81; Baker BJ, 2012, THESIS FACULTY BOARD; Bednarek R, 2011, ECOLOGICAL SOIL SCI; Boguta P, 2012, INT AGROPHYS, V26, P7, DOI 10.2478/v10247-012-0002-1; Boguta P, 2013, ACTA AGROPH, V20, P253; Boguta P., 2013, ACTA AGROPHYS MONOGR, V2, P1; Boguta P, 2014, INT AGROPHYS, V28, P269, DOI 10.2478/intag-2014-0017; Cao J, 2004, CHEMOSPHERE, V54, P507, DOI 10.1016/j.chemosphere.2003.08.027; Chassapis K, 2010, FUEL, V89, P1480, DOI 10.1016/j.fuel.2009.10.005; Chen J, 2003, CHEMOSPHERE, V50, P639, DOI 10.1016/S0045-6535(02)00616-1; CHEN Y, 1977, SOIL SCI SOC AM J, V41, P352, DOI 10.2136/sssaj1977.03615995004100020037x; Dang-Vu T, 2009, COLLOID SURFACE A, V337, P80, DOI 10.1016/j.colsurfa.2008.11.055; Debska B, 2012, POL J ENVIRON STUD, V21, P603; Erdogan S, 2007, POL J ENVIRON STUD, V16, P671; Garcia-Gil JC, 2004, GEODERMA, V121, P135, DOI 10.1016/j.geoderma.2003.11.004; Golonka I, 2005, GEODERMA, V127, P237, DOI 10.1016/j.geoderma.2004.12.005; Guan XH, 2007, J ENVIRON SCI-CHINA, V19, P438, DOI 10.1016/S1001-0742(07)60073-4; He XS, 2014, ENVIRON SCI POLLUT R, V21, P7973, DOI 10.1007/s11356-014-2751-9; Kononova M.M., 1969, SOIL ORGANIC MATTER, DOI DOI 10.1016/B978-0-08-011470-5.50007-1; Korodi G., 2012, ACAD APPL RES MILIT, V11, P61; Kostic I, 2011, J SERB CHEM SOC, V76, P1325, DOI 10.2298/JSC110310115K; Lippold H, 2007, CHEMOSPHERE, V67, P1050, DOI 10.1016/j.chemosphere.2006.10.045; Ma MG, 2014, INT J ENV PROTECTION, V10, P230; Parvan L, 2013, ROM AGRIC RES, V30, P205; Pehlivan E, 2006, ENERG SOURCE PART A, V28, P1099, DOI 10.1080/009083190910451; Pertusatti J, 2007, J COLLOID INTERF SCI, V314, P484, DOI 10.1016/j.jcis.2007.06.006; Piccolo A, 2002, ADV AGRON, V75, P57, DOI 10.1016/S0065-2113(02)75003-7; Plaza C, 2006, ENVIRON SCI TECHNOL, V40, P917, DOI 10.1021/es051687w; Rahman MA, 2010, PAK J ANAL ENV CHEM, V11, P42; RYAN DK, 1982, ANAL CHEM, V54, P986, DOI 10.1021/ac00243a033; Sakellariadou F, 2006, MEDITERR MAR SCI, V7, P11, DOI 10.12681/mms.166; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; Swift RS, 1996, METHODS SOIL ANAL 3, V23, P1018, DOI [10.2136/sssabookser5.3.c35, DOI 10.2136/SSSABOOKSER5.3.C35]; Tipping E, 2004, CATION BINDING HUMIC; Wu FC, 2004, ANAL CHEM, V76, P110, DOI 10.1021/ac030005p; Wu FC, 2001, GEOCHEM J, V35, P333, DOI 10.2343/geochemj.35.333; Zheng YA, 2010, DESALINATION, V263, P170, DOI 10.1016/j.desal.2010.06.054; Zhou P, 2005, CHEMOSPHERE, V58, P1327, DOI 10.1016/j.chemosphere.2004.10.017	39	68	71	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153626	10.1371/journal.pone.0153626	http://dx.doi.org/10.1371/journal.pone.0153626			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077915	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700096
J	Braga Goncalves, I; Heistermann, M; Santema, P; Dantzer, B; Mausbach, J; Ganswindt, A; Manser, MB				Braga Goncalves, Ines; Heistermann, Michael; Santema, Peter; Dantzer, Ben; Mausbach, Jelena; Ganswindt, Andre; Manser, Marta B.			Validation of a Fecal Glucocorticoid Assay to Assess Adrenocortical Activity in Meerkats Using Physiological and Biological Stimuli	PLOS ONE			English	Article							CORTICOSTERONE METABOLITES; SUBORDINATE REPRODUCTION; SURICATA-SURICATTA; CORTISOL-LEVELS; ENVIRONMENTAL-CONDITIONS; COOPERATIVE BEHAVIOR; NONINVASIVE METHOD; ADRENAL ACTIVITY; STRESS HORMONES; SEX-DIFFERENCES	In mammals, glucocorticoid (i.e. GC) levels have been associated with specific life-history stages and transitions, reproductive strategies, and a plethora of behaviors. Assessment of adrenocortical activity via measurement of glucocorticoid metabolites in feces (FGCM) has greatly facilitated data collection from wild animals, due to its non-invasive nature, and thus has become an established tool in behavioral ecology and conservation biology. The aim of our study was to validate a fecal glucocorticoid assay for assessing adrenocortical activity in meerkats (Suricata suricatta), by comparing the suitability of three GC enzyme immunoassays (corticosterone, 11 beta-hydroxyetiocholanolone and 11oxo-etiocholanolone) in detecting FGCM increases in adult males and females following a pharmacological challenge with adrenocorticotropic hormone (ACTH) and biological stimuli. In addition, we investigated the time course characterizing FGCM excretion, the effect of age, sex and time of day on FGCM levels and assessed the potential effects of soil contamination (sand) on FGCM patterns. Our results show that the group specific 11 beta-hydroxyetiocholanolone assay was most sensitive to FGCM alterations, detecting significant and most distinctive elevations in FGCM levels around 25 h after ACTH administration. We found no age and sex differences in basal FGCM or on peak response levels to ACTH, but a marked diurnal pattern, with FGCM levels being substantially higher in the morning than later during the day. Soil contamination did not significantly affect FGCM patterns. Our results emphasize the importance of conducting assay validations to characterize species-specific endocrine excretion patterns, a crucial step to all animal endocrinology studies using a non-invasive approach.	[Braga Goncalves, Ines; Mausbach, Jelena; Manser, Marta B.] Univ Zurich, Dept Evolutionary Biol & Environm Studies, Anim Behav, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Heistermann, Michael] German Primate Ctr, Endocrinol Lab, D-37077 Gottingen, Germany; [Santema, Peter; Dantzer, Ben] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Ganswindt, Andre] Univ Pretoria, Dept Anat & Physiol, Endocrine Res Lab, ZA-0110 Onderstepoort, South Africa; [Santema, Peter] Max Planck Inst Ornithol, Dept Behav Ecol & Evolutionary Genet, D-82319 Seewiesen, Germany; [Dantzer, Ben] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA; [Dantzer, Ben] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	University of Zurich; Deutsches Primatenzentrum (DPZ); University of Cambridge; University of Pretoria; Max Planck Society; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Braga Goncalves, I (corresponding author), Univ Zurich, Dept Evolutionary Biol & Environm Studies, Anim Behav, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	inesvilargoncalves@gmail.com	Ganswindt, Andre/G-9856-2014; Goncalves, Ines Braga/F-5859-2012; Dantzer, Ben/E-9779-2011	Ganswindt, Andre/0000-0002-1474-7602; Goncalves, Ines Braga/0000-0003-0659-9029; Dantzer, Ben/0000-0002-3058-265X	Swiss National Science Foundation [31003A_13676]; University of Zurich; ERC [294494, THCB2011]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University of Zurich; ERC(European Research Council (ERC)European Commission)	This study was funded by the Swiss National Science Foundation (grant no. 31003A_13676) to Marta B. Manser, the University of Zurich, and by an ERC grant (no. 294494, THCB2011) to Tim H. Clutton-Brock at the University of Cambridge. The funding bodies played no role in the design, data collection, analysis or preparation of the manuscript.r We are grateful to David Jansen, Sabrina Engesser and Gabriela Gall for their help collecting the fecal samples. We are very thankful to Miriam Polten and, in particular, Andrea Heistermann for helping with fecal sample processing and extraction and for performing the hormone analyzes. We are also very grateful to Tim Clutton-Brock for financial support and helpful comments on the manuscript. This study was funded by the Swiss National Science Foundation (grant no. 31003A_13676) to Marta B. Manser, the University of Zurich, and by an ERC grant (No 294494, THCB2011) to Tim Clutton-Brock at the University of Cambridge.	Angelier F, 2007, HORM BEHAV, V52, P482, DOI 10.1016/j.yhbeh.2007.07.003; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Bahr NI, 2000, GEN COMP ENDOCR, V117, P427, DOI 10.1006/gcen.1999.7431; Beehner JC, 2008, PHYSIOL BEHAV, V95, P508, DOI 10.1016/j.physbeh.2008.07.022; Behie AM, 2010, AM J PRIMATOL, V72, P600, DOI 10.1002/ajp.20813; Blumstein DT, 2006, BIOL LETTERS, V2, P29, DOI 10.1098/rsbl.2005.0405; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; Boonstra R, 2005, J MAMMAL, V86, P236, DOI 10.1644/BHE-001.1; Carlson AA, 2006, P ROY SOC B-BIOL SCI, V273, P571, DOI 10.1098/rspb.2005.3087; Carlson AA, 2004, HORM BEHAV, V46, P141, DOI 10.1016/j.yhbeh.2004.01.009; Carlson AA, 2006, HORM BEHAV, V50, P94, DOI 10.1016/j.yhbeh.2006.01.009; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Clutton-Brock TH, 2008, ANIM BEHAV, V76, P689, DOI 10.1016/j.anbehav.2008.03.015; Clutton-Brock TH, 2002, SCIENCE, V297, P253, DOI 10.1126/science.1071412; Clutton-Brock TH, 2001, ANIM BEHAV, V61, P705, DOI 10.1006/anbe.2000.1631; Clutton-Brock TH, 1999, AFR J ECOL, V37, P69, DOI 10.1046/j.1365-2028.1999.00160.x; Clutton-Brock TH, 2010, AM NAT, V176, P664, DOI 10.1086/656492; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; Creel SF, 2005, J MAMMAL, V86, P255, DOI 10.1644/BHE-002.1; Dantzer B, 2011, GEN COMP ENDOCR, V174, P124, DOI 10.1016/j.ygcen.2011.08.010; DECATANZARO D, 1992, NEUROSCI BIOBEHAV R, V16, P43, DOI 10.1016/S0149-7634(05)80050-8; DOBSON H, 1995, J REPROD FERTIL, P451; Doolan SP, 1997, BEHAVIOUR, V134, P827, DOI 10.1163/156853997X00179; Doolan SP, 1999, ETHOLOGY, V105, P851, DOI 10.1046/j.1439-0310.1999.00461.x; Doolan SP, 1997, J ZOOL, V242, P309; Frigerio D, 2004, GEN COMP ENDOCR, V137, P29, DOI 10.1016/j.ygcen.2004.02.013; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganswindt A, 2012, PHYSIOL BIOCHEM ZOOL, V85, P194, DOI 10.1086/664591; Pereira RJG, 2010, GEN COMP ENDOCR, V166, P94, DOI 10.1016/j.ygcen.2009.12.012; Gesquiere LR, 2011, AM J PHYS ANTHROPOL, V144, P169, DOI 10.1002/ajpa.21374; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Goymann W, 2011, J BIOL RHYTHM, V26, P44, DOI 10.1177/0748730410388394; Hamalainen A, 2014, GEN COMP ENDOCR, V195, P68, DOI 10.1016/j.ygcen.2013.10.017; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; Harris BN, 2012, GEN COMP ENDOCR, V179, P436, DOI 10.1016/j.ygcen.2012.08.026; Heistermann M, 2006, AM J PRIMATOL, V68, P257, DOI 10.1002/ajp.20222; HEISTERMANN M, 1995, AM J PRIMATOL, V37, P275, DOI 10.1002/ajp.1350370402; Heistermann M, 2004, INT J PRIMATOL, V25, P689, DOI 10.1023/B:IJOP.0000023581.17889.0f; Heistermann M, 1995, NON INVASIVE ENDOCRI, P36; Hill SP, 2009, ZOO BIOL, V28, P531, DOI 10.1002/zoo.20276; Hodges J. Keith, 2011, P353; Hogan L. A., 2011, Australian Zoologist, V35, P649; Holekamp KE, 1998, HORM BEHAV, V33, P205, DOI 10.1006/hbeh.1998.1450; Hulsman A, 2011, ZOO BIOL, V30, P451, DOI 10.1002/zoo.20325; Kenagy GJ, 2000, GEN COMP ENDOCR, V117, P189, DOI 10.1006/gcen.1999.7397; Koren L, 2012, GEN COMP ENDOCR, V177, P113, DOI 10.1016/j.ygcen.2012.02.020; Lane J, 2006, ANIM WELFARE, V15, P331; Leclaire S, 2014, BEHAV ECOL, V25, P996, DOI 10.1093/beheco/aru074; Mares R, 2014, ANIM BEHAV, V88, P185, DOI 10.1016/j.anbehav.2013.11.025; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mohle U, 2002, GEN COMP ENDOCR, V129, P135, DOI 10.1016/S0016-6480(02)00525-7; Monfort SL, 1998, J ZOO WILDLIFE MED, V29, P129; Mostl E, 2005, ANN NY ACAD SCI, V1046, P17, DOI 10.1196/annals.1343.004; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Ohl F, 1999, COGNITIVE BRAIN RES, V7, P379, DOI 10.1016/S0926-6410(98)00042-1; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; Palme R, 1996, ANIM REPROD SCI, V43, P43, DOI 10.1016/0378-4320(95)01458-6; Palme R, 1997, Z SAUGETIERKD, V62, P192; Preis A, 2011, GEN COMP ENDOCR, V174, P335, DOI 10.1016/j.ygcen.2011.09.010; Pride RE, 2005, BIOL LETT-UK, V1, P60, DOI 10.1098/rsbl.2004.0245; Quispe R, 2014, GEN COMP ENDOCR, V197, P65, DOI 10.1016/j.ygcen.2013.12.007; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Reeder DM, 2004, GEN COMP ENDOCR, V136, P260, DOI 10.1016/j.ygcen.2003.12.020; Rimbach R, 2013, GEN COMP ENDOCR, V191, P13, DOI 10.1016/j.ygcen.2013.05.010; Romero LM, 2008, AM J PHYSIOL-REG I, V294, pR614, DOI 10.1152/ajpregu.00752.2007; Sanderson JL, 2014, FUNCT ECOL, V28, P1377, DOI 10.1111/1365-2435.12307; Santema P, 2013, BEHAV ECOL, V24, P1122, DOI 10.1093/beheco/art039; Sapolsky RM, 2004, P NATL ACAD SCI USA, V101, P17323, DOI 10.1073/pnas.0408041101; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Scarlata CD, 2013, ANIM WELFARE, V22, P357, DOI 10.7120/09627286.22.3.357; Schatz S, 2001, VET RES COMMUN, V25, P271, DOI 10.1023/A:1010626608498; SEYLE H, 1936, NATURE, V138, P32; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Shutt K, 2012, GEN COMP ENDOCR, V179, P167, DOI 10.1016/j.ygcen.2012.08.008; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Touma C, 2004, HORM BEHAV, V45, P10, DOI 10.1016/j.yhbeh.2003.07.002; Touma C, 2003, GEN COMP ENDOCR, V130, P267, DOI 10.1016/S0016-6480(02)00620-2; VANSCHAIK CP, 1991, PRIMATES, V32, P345, DOI 10.1007/BF02382675; Voellmy IK, 2014, HORM BEHAV, V66, P759, DOI 10.1016/j.yhbeh.2014.08.008; Washburn BE, 2002, GEN COMP ENDOCR, V127, P217, DOI 10.1016/S0016-6480(02)00056-4; Wells A, 2004, J ZOO WILDLIFE MED, V35, P8, DOI 10.1638/02-084; Wheeler BC, 2013, INT J PRIMATOL, V34, P879, DOI 10.1007/s10764-013-9703-y; Wingfield JC, 2003, J NEUROENDOCRINOL, V15, P711, DOI 10.1046/j.1365-2826.2003.01033.x; Young AJ, 2008, HORM BEHAV, V53, P131, DOI 10.1016/j.yhbeh.2007.09.005; Young AJ, 2006, P NATL ACAD SCI USA, V103, P12005, DOI 10.1073/pnas.0510038103; Young AJ, 2009, BIOL LETTERS, V5, P439, DOI 10.1098/rsbl.2009.0032	93	19	19	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153161	10.1371/journal.pone.0153161	http://dx.doi.org/10.1371/journal.pone.0153161			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077741	Green Published, gold			2022-12-27	WOS:000374131700025
J	Cottinet, D; Condamine, F; Bremond, N; Griffiths, AD; Rainey, PB; de Visser, JAGM; Baudry, J; Bibette, J				Cottinet, Denis; Condamine, Florence; Bremond, Nicolas; Griffiths, Andrew D.; Rainey, Paul B.; de Visser, J. Arjan G. M.; Baudry, Jean; Bibette, Jerome			Lineage Tracking for Probing Heritable Phenotypes at Single-Cell Resolution	PLOS ONE			English	Article							ESCHERICHIA-COLI K-12; LONG-TERM SURVIVAL; EXPERIMENTAL EVOLUTION; STATIONARY-PHASE; MICROBIAL-POPULATIONS; ADAPTIVE RADIATION; BACTERIAL-GROWTH; GENE-EXPRESSION; ADAPTATION; MUTATIONS	Determining the phenotype and genotype of single cells is central to understand microbial evolution. DNA sequencing technologies allow the detection of mutants at high resolution, but similar approaches for phenotypic analyses are still lacking. We show that a drop-based millifluidic system enables the detection of heritable phenotypic changes in evolving bacterial populations. At time intervals, cells were sampled and individually compartmentalized in 100 nL drops. Growth through 15 generations was monitored using a fluorescent protein reporter. Amplification of heritable changes-via growth-over multiple generations yields phenotypically distinct clusters reflecting variation relevant for evolution. To demonstrate the utility of this approach, we follow the evolution of Escherichia coli populations during 30 days of starvation. Phenotypic diversity was observed to rapidly increase upon starvation with the emergence of heritable phenotypes. Mutations corresponding to each phenotypic class were identified by DNA sequencing. This scalable lineage-tracking technology opens the door to large-scale phenotyping methods with special utility for microbiology and microbial population biology.	[Cottinet, Denis; Condamine, Florence; Bremond, Nicolas; Griffiths, Andrew D.; Rainey, Paul B.; Baudry, Jean; Bibette, Jerome] PSL Res Univ, Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, Chem Biol Innovat, CNRS,UMR 8231, Paris, France; [Rainey, Paul B.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Rainey, Paul B.] Max Planck Inst Evolutionary Biol, Plon, Germany; [de Visser, J. Arjan G. M.] Wageningen Univ, Genet Lab, NL-6700 AP Wageningen, Netherlands	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Massey University; Max Planck Society; Wageningen University & Research	Bibette, J (corresponding author), PSL Res Univ, Ecole Super Phys & Chim Ind Ville Paris ESPCI Par, Chem Biol Innovat, CNRS,UMR 8231, Paris, France.	denis.cottinet@espci.org; Jerome.bibette@espci.fr	Griffiths, Andrew D/A-1370-2010; Baudry, Jean/A-7344-2016; Rainey, Paul/A-3207-2008; de Visser, Arjan/GLU-3870-2022; Baudry, Jean/AAX-6267-2020	Griffiths, Andrew D/0000-0002-0808-3539; Baudry, Jean/0000-0002-5526-499X; Rainey, Paul/0000-0003-0879-5795; Baudry, Jean/0000-0002-5526-499X	European Community [225167]; Universite Pierre Marie Curie (Paris, France); French State; Ile-de-France	European Community(European Commission); Universite Pierre Marie Curie (Paris, France); French State; Ile-de-France	This work was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no. [225167] (eFlux), by a PhD grant from Universite Pierre Marie Curie (Paris, France). PBR holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure.; We thank C. Beloin (Institut Pasteur Paris), D. Schneider and T. Hindre (Universite Joseph Fourier, Grenoble) for useful discussions; J Vinh, Y. Verdier and I. Addad (Proteomic facility, Ecole Superieure de Physique et Chimie Industrielle, Paris, France) for their help in exploratory experiments, E. Mordret for his help in preliminary experiments; J. Garnica-Rodriquez for producing movies; and the Genomic facility of Institut Curie (Paris, France) for performing the sequencing. This work was supported by the European Community's Seventh Framework Programme (FP7/20072013) under grant agreement no. [225167] (eFlux), by a PhD grant from Universite Pierre Marie Curie (Paris, France). PBR holds an International Blaise Pascal Research Chair funded by the French State and the Ile-de-France, managed by the Fondation de l'Ecole Normale Superieure.	Bachmann H, 2013, P NATL ACAD SCI USA, V110, P14302, DOI 10.1073/pnas.1308523110; Baraban L, 2011, LAB CHIP, V11, P4057, DOI 10.1039/c1lc20545e; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Beaumont HJE, 2009, NATURE, V462, P90, DOI 10.1038/nature08504; BEISER SM, 1957, J BACTERIOL, V74, P303, DOI 10.1128/JB.74.3.303-307.1957; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Brenner N, 2006, PHYS BIOL, V3, P172, DOI 10.1088/1478-3975/3/3/002; Callahan BJ, 2014, EVOLUTION, V68, P3307, DOI 10.1111/evo.12512; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; Choi K, 2012, ANNU REV ANAL CHEM, V5, P413, DOI 10.1146/annurev-anchem-062011-143028; Clausell-Tormos J, 2008, CHEM BIOL, V15, P427, DOI 10.1016/j.chembiol.2008.04.004; Damodaran SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118987; de Visser JAGM, 2006, GENETICS, V172, P2093, DOI 10.1534/genetics.105.052373; Desai MM, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/01/P01003; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Gallie J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002109; Habets MGJL, 2006, ECOL LETT, V9, P1041, DOI 10.1111/j.1461-0248.2006.00955.x; Hansen SK, 2007, NATURE, V445, P533, DOI 10.1038/nature05514; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; Jakiela S, 2013, ANGEW CHEM INT EDIT, V52, P8908, DOI 10.1002/anie.201301524; Kawecki TJ, 2012, TRENDS ECOL EVOL, V27, P547, DOI 10.1016/j.tree.2012.06.001; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; Koch R., 1881, MITTHEILUNGEN KAISER, V2, P1; Koster S, 2008, LAB CHIP, V8, P1110, DOI 10.1039/b802941e; Kram KE, 2014, APPL ENVIRON MICROB, V80, P1732, DOI 10.1128/AEM.03150-13; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Levin-Reisman I, 2010, NAT METHODS, V7, P737, DOI 10.1038/nmeth.1485; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lind PA, 2015, ELIFE, V4, DOI 10.7554/eLife.07074; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Mukhopadhyay S, 2000, MOL MICROBIOL, V37, P371, DOI 10.1046/j.1365-2958.2000.01999.x; NAAS T, 1994, GENETICS, V136, P721; Obadia B, 2007, J MOL BIOL, V367, P42, DOI 10.1016/j.jmb.2006.12.048; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PIRT SJ, 1967, J GEN MICROBIOL, V47, P181, DOI 10.1099/00221287-47-2-181; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Poltak SR, 2011, ISME J, V5, P369, DOI 10.1038/ismej.2010.136; Prosser JI, 2007, NAT REV MICROBIOL, V5, P384, DOI 10.1038/nrmicro1643; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; Shimada T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020081; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Theberge AB, 2010, ANGEW CHEM INT EDIT, V49, P5846, DOI 10.1002/anie.200906653; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; WIMPENNY JWT, 1979, J GEN MICROBIOL, V114, P483, DOI 10.1099/00221287-114-2-483; ZAMBRANO MM, 1993, SCIENCE, V259, P1757, DOI 10.1126/science.7681219; Zinser ER, 2003, GENETICS, V164, P1271; Zinser ER, 2000, J BACTERIOL, V182, P4361, DOI 10.1128/JB.182.15.4361-4365.2000	53	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152395	10.1371/journal.pone.0152395	http://dx.doi.org/10.1371/journal.pone.0152395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077662	Green Published, gold			2022-12-27	WOS:000374131700004
J	Goncalves-de-Albuquerque, CF; Medeiros-de-Moraes, IM; Oliveira, FMD; Burth, P; Bozza, PT; Faria, MVC; Silva, AR; de Castro-Faria-Neto, HC				Goncalves-de-Albuquerque, Cassiano Felippe; Medeiros-de-Moraes, Isabel Matos; de Jesus Oliveira, Flora Magno; Burth, Patricia; Bozza, Patricia Torres; Castro Faria, Mauro Velho; Silva, Adriana Ribeiro; de Castro-Faria-Neto, Hugo Caire			Omega-9 Oleic Acid Induces Fatty Acid Oxidation and Decreases Organ Dysfunction and Mortality in Experimental Sepsis	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; CRITICALLY-ILL PATIENTS; OLIVE OIL; UNCOUPLING PROTEIN-2; LIPID-METABOLISM; ENDOTOXIC-SHOCK; MEDITERRANEAN DIET; SIGNALING PATHWAY; NUCLEAR RECEPTORS; CECAL LIGATION	Sepsis is characterized by inflammatory and metabolic alterations, which lead to massive cytokine production, oxidative stress and organ dysfunction. In severe systemic inflammatory response syndrome, plasma non-esterified fatty acids (NEFA) are increased. Several NEFA are deleterious to cells, activate Toll-like receptors and inhibit Na+/K+-ATPase, causing lung injury. A Mediterranean diet rich in olive oil is beneficial. The main component of olive oil is omega-9 oleic acid (OA), a monounsaturated fatty acid (MUFA). We analyzed the effect of OA supplementation on sepsis. OA ameliorated clinical symptoms, increased the survival rate, prevented liver and kidney injury and decreased NEFA plasma levels in mice subjected to cecal ligation and puncture (CLP). OA did not alter food intake and weight gain but diminished reactive oxygen species (ROS) production and NEFA plasma levels. Carnitine palmitoyltransferase IA (CPT1A) mRNA levels were increased, while uncoupling protein 2 (UCP2) liver expression was enhanced in mice treated with OA. OA also inhibited the decrease in 5' AMP-activated protein kinase (AMPK) expression and increased the enzyme expression in the liver of OA-treated mice compared to septic animals. We showed that OA pretreatment decreased NEFA concentration and increased CPT1A and UCP2 and AMPK levels, decreasing ROS production. We suggest that OA has a beneficial role in sepsis by decreasing metabolic dysfunction, supporting the benefits of diets high in monounsaturated fatty acids (MUFA).	[Goncalves-de-Albuquerque, Cassiano Felippe; Medeiros-de-Moraes, Isabel Matos; de Jesus Oliveira, Flora Magno; Bozza, Patricia Torres; Silva, Adriana Ribeiro; de Castro-Faria-Neto, Hugo Caire] Fiocruz MS, Inst Oswaldo Cruz, Lab Imunofarmacol, BR-21040900 Rio De Janeiro, RJ, Brazil; [Burth, Patricia] Univ Fed Fluminense, Inst Biol, Dept Biol Celular & Mol, BR-2402015 Niteroi, RJ, Brazil; [Castro Faria, Mauro Velho] Univ Estado Rio de Janeiro, Fac Ciencias Med, Dept Med Interna, BR-20550900 Rio De Janeiro, RJ, Brazil; [de Castro-Faria-Neto, Hugo Caire] Univ Estacio Sa, Programa Produtividade Cient, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; Universidade Estacio de Sa	de Castro-Faria-Neto, HC (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Imunofarmacol, BR-21040900 Rio De Janeiro, RJ, Brazil.	arsilva71@gmail.com; hugocfneto@gmail.com	Silva, Adriana R/C-5931-2014; Burth, Patricia/N-8180-2017; Bozza, Patricia T./AAM-4537-2021; Bozza, Patricia T./AAE-2933-2021; Gonçalves-de-Albuquerque, Cassiano Felippe/ABH-2409-2020; Gonçalves-de-Albuquerque, Cassiano Felippe/N-2815-2014; Silva, Adriana/U-7811-2019	Silva, Adriana R/0000-0002-5137-4251; Burth, Patricia/0000-0003-4433-9375; Bozza, Patricia T./0000-0001-8349-9529; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Gonçalves-de-Albuquerque, Cassiano Felippe/0000-0002-4458-3055; Silva, Adriana/0000-0002-5137-4251	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)-MVCF, PB, HCCFN; Programa Estrategico de Apoio a Pesquisa em Saude (PAPES)-FIOCRUZ- PTB, ARS, HCCFN; and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PB, PTB, ARS, MVCF, HCCFN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo CV, 2012, MICROVASC RES, V84, P218, DOI 10.1016/j.mvr.2012.05.006; Armstrong MB, 2001, AM J PHYSIOL-ENDOC M, V281, pE1197, DOI 10.1152/ajpendo.2001.281.6.E1197; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Burth P, 2005, J INFECT DIS, V191, P51, DOI 10.1086/426455; Canbay A, 2007, Z GASTROENTEROL, V45, P35, DOI 10.1055/s-2006-927368; Casanova E, 2014, J NUTR BIOCHEM, V25, P1003, DOI 10.1016/j.jnutbio.2014.05.003; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Djousse L, 2013, CIRC-HEART FAIL, V6, P964, DOI 10.1161/CIRCHEARTFAILURE.113.000521; Drechsler Susanne, 2015, Intensive Care Med Exp, V3, P48, DOI 10.1186/s40635-015-0048-z; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; Eisen DP, 2012, INTENS CARE MED, V38, P1249, DOI 10.1007/s00134-012-2570-8; Erlanson-Albertsson C, 2003, ACTA PHYSIOL SCAND, V178, P405, DOI 10.1046/j.1365-201X.2003.01159.x; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feingold KR, 2009, J LIPID RES, V50, P2055, DOI 10.1194/jlr.M800655-JLR200; Fink MP, 2002, CURR OPIN CLIN NUTR, V5, P167, DOI 10.1097/00075197-200203000-00009; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Foster DW, 2004, ANN NY ACAD SCI, V1033, P1, DOI 10.1196/annals.1320.001; Gaieski DF, 2013, CRIT CARE MED, V41, P1167, DOI 10.1097/CCM.0b013e31827c09f8; de Albuquerque CFG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/601032; Guerreiro MO, 2010, J TRAUMA, V69, pE102, DOI 10.1097/TA.0b013e3181dbb289; Guirgis FW, 2014, J CRIT CARE, V29, P320, DOI 10.1016/j.jcrc.2013.10.020; HALUSHKA PV, 1981, J PHARMACOL EXP THER, V218, P464; HALUSHKA PV, 1983, AM J MED, V74, P91, DOI 10.1016/0002-9343(83)90535-1; HOSTMARK AT, 1995, MED HYPOTHESES, V44, P539, DOI 10.1016/0306-9877(95)90520-0; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Hwang J, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-184; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2014.26371850096, DOI 10.1001/JAMA.2014.26371850096]; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kim YI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031317; Klenzak J, 2005, CRIT CARE CLIN, V21, P211, DOI 10.1016/j.ccc.2005.01.002; Krishan S, 2014, J CLIN PATHOL, V67, P758, DOI 10.1136/jclinpath-2014-202422; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Leite MS, 2005, SHOCK, V23, P173, DOI 10.1097/01.shk.0000148072.12094.77; Li XW, 2013, CELL BIOCHEM BIOPHYS, V67, P1157, DOI 10.1007/s12013-013-9629-1; Mailloux RJ, 2011, FREE RADICAL BIO MED, V51, P1106, DOI 10.1016/j.freeradbiomed.2011.06.022; Maitra U, 2009, MOL IMMUNOL, V47, P420, DOI 10.1016/j.molimm.2009.08.023; Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; Mattiasson G, 2006, ANTIOXID REDOX SIGN, V8, P1, DOI 10.1089/ars.2006.8.1; Mayer K, 2003, AM J RESP CRIT CARE, V167, P1321, DOI 10.1164/rccm.200207-674OC; Maynard ND, 1997, CHEST, V111, P180, DOI 10.1378/chest.111.1.180; Mori Yutaka, 2004, J Atheroscler Thromb, V11, P224; Munford RS, 2006, ANNU REV PATHOL-MECH, V1, P467, DOI 10.1146/annurev.pathol.1.110304.100200; Nakbi A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-80; Niu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030782; Nogueira AC, 2008, SHOCK, V29, P342, DOI 10.1097/SHK.0b013e31815abbc6; Ohhira M, 2007, J GASTROENTEROL, V42, P969, DOI 10.1007/s00535-007-2119-8; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Puertollano MA, 2007, BRIT J NUTR, V98, pS54, DOI 10.1017/S0007114507832934; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Rajaram S, 2010, BRIT J NUTR, V103, P907, DOI 10.1017/S0007114509992480; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Regueira T, 2011, MED INTENSIVA, V35, P424, DOI 10.1016/j.medin.2011.03.011; Reis PA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003099; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Ritter C, 2003, INTENS CARE MED, V29, P1782, DOI 10.1007/s00134-003-1789-9; Schwingshackl L, 2011, ANN NUTR METAB, V59, P176, DOI 10.1159/000334071; Schwingshackl L, 2011, ANN NUTR METAB, V58, P290, DOI 10.1159/000331214; Sofi F, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1344; Sztefko K, 2001, PANCREATOLOGY, V1, P230, DOI 10.1159/000055816; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Urpi-Sarda M, 2012, PHARMACOL RES, V65, P577, DOI 10.1016/j.phrs.2012.03.006; Varga T, 2011, BBA-MOL BASIS DIS, V1812, P1007, DOI 10.1016/j.bbadis.2011.02.014; Wang HP, 2010, AM J PHYSIOL-RENAL, V298, pF754, DOI 10.1152/ajprenal.00439.2009; Waterman E, 2007, ALTERN MED REV, V12, P331; Wood LG, 2009, PROG LIPID RES, V48, P27, DOI 10.1016/j.plipres.2008.10.001; Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0; Yang K, 2015, TOXICOL LETT, V234, P110, DOI 10.1016/j.toxlet.2015.01.021; Yang ZH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-16; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yoo SH, 2011, TOXICOL LETT, V202, P23, DOI 10.1016/j.toxlet.2011.01.013	74	48	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153607	10.1371/journal.pone.0153607	http://dx.doi.org/10.1371/journal.pone.0153607			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078880	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700092
J	Savers, A; Rasid, O; Parlato, M; Brock, M; Jouvion, G; Ryffel, B; Cavaillon, JM; Eberl, G; Ibrahim-Granet, O				Savers, Amelie; Rasid, Orhan; Parlato, Marianna; Brock, Matthias; Jouvion, Gregory; Ryffel, Bernhard; Cavaillon, Jean-Marc; Eberl, Gerard; Ibrahim-Granet, Oumaima			Infection-Mediated Priming of Phagocytes Protects against Lethal Secondary Aspergillus fumigatus Challenge	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; NEUTROPHIL RECRUITMENT; CXC CHEMOKINE; RECEPTOR; DEFENSE; CONIDIA	Phagocytes restrict the germination of Aspergillus fumigatus conidia and prevent the establishment of invasive pulmonary aspergillosis in immunecompetent mice. Here we report that immunecompetent mice recovering from a primary A. fumigatus challenge are protected against a secondary lethal challenge. Using RAG gamma c knock-out mice we show that this protection is independent of T, B and NK cells. In protected mice, lung phagocytes are recruited more rapidly and are more efficient in conidial phagocytosis and killing. Protection was also associated with an enhanced expression of CXCR2 and Dectin-1 on bone marrow phagocytes. We also show that protective lung cytokine and chemokine responses are induced more rapidly and with enhanced dynamics in protected mice. Our findings support the hypothesis that following a first encounter with a non-lethal dose of A. fumigatus conidia, the innate immune system is primed and can mediate protection against a secondary lethal infection.	[Savers, Amelie; Rasid, Orhan; Cavaillon, Jean-Marc; Ibrahim-Granet, Oumaima] Inst Pasteur, Unite Cytokines & Inflammat, Paris, France; [Savers, Amelie; Brock, Matthias] Univ Nottingham, Sch Life Sci, Fungal Genet & Biol, Nottingham NG7 2RD, England; [Parlato, Marianna] Inst Imagine, INSERM, UMR S1163, Lab Immun Intestinale, Paris, France; [Jouvion, Gregory] Inst Pasteur, Unite Histopathol Humaine & Modeles Animaux, Paris, France; [Ryffel, Bernhard] Univ Orleans, Inst Transgenose, Immunol Mol, INSERM,UMR 7355, Orleans, France; [Ryffel, Bernhard] CNRS, F-45071 Orleans, France; [Eberl, Gerard] Inst Pasteur, Lymphoid Tissue Dev Unit, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Nottingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ibrahim-Granet, O (corresponding author), Inst Pasteur, Unite Cytokines & Inflammat, Paris, France.	ogranet@pasteur.fr	Brock, Matthias/AAX-1430-2021; Jouvion, Grégory/AAL-2620-2021; Parlato, Marianna/H-9467-2017; Eberl, Gerard/A-1160-2013	Rasid, Orhan/0000-0002-7040-9587; Eberl, Gerard/0000-0002-1119-5638; Brock, Matthias/0000-0003-2774-1856	Institut Pasteur [PTR 468];  [Transregio 124]	Institut Pasteur(European Commission); 	This work was supported by funding from Institut Pasteur PTR 468 to OIG and AS, and the Transregio 124 "FungiNet" project A3 to AS and MB.	Bonnett CR, 2006, INFECT IMMUN, V74, P6528, DOI 10.1128/IAI.00909-06; Brock M, 2008, APPL ENVIRON MICROB, V74, P7023, DOI 10.1128/AEM.01288-08; Dubourdeau M AR, 2006, J IMMUNOLOGY; Dubourdeau M, 2006, J IMMUNOL, V177, P3994, DOI 10.4049/jimmunol.177.6.3994; Galiger C, 2013, ANTIMICROB AGENTS CH, V57, P3046, DOI 10.1128/AAC.01660-12; Ibrahim-Granet O, 2003, INFECT IMMUN, V71, P891, DOI 10.1128/IAI.71.2.891-903.2003; Ibrahim-Granet O, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-105; Mehrad B, 1999, J IMMUNOL, V163, P6086; Mircescu MM, 2009, J INFECT DIS, V200, P647, DOI 10.1086/600380; Philippe B, 2003, INFECT IMMUN, V71, P3034, DOI 10.1128/IAI.71.6.3034-3042.2003; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Roussel L, 2010, J IMMUNOL, V184, P4531, DOI 10.4049/jimmunol.0903162; Shepardson KM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004378; Shoham S, 2012, FUTURE MICROBIOL, V7, P639, DOI [10.2217/FMB.12.28, 10.2217/fmb.12.28]; Steele C, 2005, PLOS PATHOG, V1, P323, DOI 10.1371/journal.ppat.0010042; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Taylor PR, 2014, NAT IMMUNOL, V15, P143, DOI 10.1038/ni.2797; Werner JL, 2011, INFECT IMMUN, V79, P3966, DOI 10.1128/IAI.05493-11; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519	20	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153829	10.1371/journal.pone.0153829	http://dx.doi.org/10.1371/journal.pone.0153829			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078879	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700112
J	Wu, LZ; Chaudhary, SC; Atigadda, VR; Belyaeva, OV; Harville, SR; Elmets, CA; Muccio, DD; Athar, M; Kedishvili, NY				Wu, Lizhi; Chaudhary, Sandeep C.; Atigadda, Venkatram R.; Belyaeva, Olga V.; Harville, Steven R.; Elmets, Craig A.; Muccio, Donald D.; Athar, Mohammad; Kedishvili, Natalia Y.			Retinoid X Receptor Agonists Upregulate Genes Responsible for the Biosynthesis of All-Trans-Retinoic Acid in Human Epidermis	PLOS ONE			English	Article							LIGAND-BINDING DOMAIN; VITAMIN-A METABOLISM; T-CELL LYMPHOMA; SKIN-CANCER; SIGNALING PATHWAY; NUCLEAR RECEPTORS; 9-CIS-RETINOIC ACID; MAMMARY CANCERS; SYSTEMIC RETINOIDS; GROWTH-INHIBITION	UAB30 is an RXR selective agonist that has been shown to have potential cancer chemopreventive properties. Due to high efficacy and low toxicity, it is currently being evaluated in human Phase I clinical trials by the National Cancer Institute. While UAB30 shows promise as a low toxicity chemopreventive drug, the mechanism of its action is not well understood. In this study, we investigated the effects of UAB30 on gene expression in human organotypic skin raft cultures and mouse epidermis. The results of this study indicate that treatment with UAB30 results in upregulation of genes responsible for the uptake and metabolism of all-trans-retinol to all-trans-retinoic acid (ATRA), the natural agonist of RAR nuclear receptors. Consistent with the increased expression of these genes, the steady-state levels of ATRA are elevated in human skin rafts. In ultraviolet B (UVB) irradiated mouse skin, the expression of ATRA target genes is found to be reduced. A reduced expression of ATRA sensitive genes is also observed in epidermis of mouse models of UVB-induced squamous cell carcinoma and basal cell carcinomas. However, treatment of mouse skin with UAB30 prior to UVB irradiation prevents the UVB-induced decrease in expression of some of the ATRA-responsive genes. Considering its positive effects on ATRA signaling in the epidermis and its low toxicity, UAB30 could be used as a chemoprophylactic agent in the treatment of non-melanoma skin cancer, particularly in organ transplant recipients and other high risk populations.	[Wu, Lizhi; Belyaeva, Olga V.; Kedishvili, Natalia Y.] Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Chaudhary, Sandeep C.; Elmets, Craig A.; Athar, Mohammad] Univ Alabama Birmingham, Dept Dermatol, Sch Med, Birmingham, AL 35294 USA; [Atigadda, Venkatram R.; Harville, Steven R.; Muccio, Donald D.] Univ Alabama Birmingham, Dept Chem, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kedishvili, NY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	nkedishvili@uab.edu		Kedishvili, Natalia/0000-0001-6917-4891	National Institutes of Health [AA12153, P30AR050948, P30CA013148, CA138998, P50 CA089019]; NATIONAL CANCER INSTITUTE [R01CA138998, R01CA193885, P30CA013148, P50CA089019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES026219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA012153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the National Institutes of Health Grants AA12153 (N. Y. K.), P30AR050948 (N. Y. K. and C. A. E.), P30CA013148 (C. A. E.), CA138998 (M. A.), and P50 CA089019 (D. D. M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MK, 2014, J BIOL CHEM, V289, P14868, DOI 10.1074/jbc.M114.552257; Alvarez R, 2014, CHEM REV, V114, P1, DOI 10.1021/cr400126u; Arumugam A, 2012, BIOCHEM BIOPH RES CO, V425, P177, DOI 10.1016/j.bbrc.2012.07.062; ASSELINEAU D, 1989, DEV BIOL, V133, P322, DOI 10.1016/0012-1606(89)90037-7; Atigadda VR, 2015, J MED CHEM, V58, P7763, DOI 10.1021/acs.jmedchem.5b00829; Atigadda VR, 2003, J MED CHEM, V46, P3766, DOI 10.1021/jm030095q; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; BAVINCK JNB, 1995, J CLIN ONCOL, V13, P1933, DOI 10.1200/JCO.1995.13.8.1933; Boerma LJ, 2014, J BIOL CHEM, V289, P814, DOI 10.1074/jbc.M113.476861; Boorjian S, 2004, CLIN CANCER RES, V10, P3429, DOI 10.1158/1078-0432.CCR-03-0756; Campbell RM, 2006, DERMATOL THER, V19, P306, DOI 10.1111/j.1529-8019.2006.00088.x; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chapellier B, 2002, EMBO J, V21, P3402, DOI 10.1093/emboj/cdf331; Chaudhary SC, 2015, ONCOTARGET, V6, P36789, DOI 10.18632/oncotarget.5103; Chaudhary SC, 2014, CANCER PREV RES, V7, P186, DOI 10.1158/1940-6207.CAPR-13-0276; CHEN LC, 1994, CARCINOGENESIS, V15, P2383, DOI 10.1093/carcin/15.10.2383; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Desphande A, 2014, BIOORGAN MED CHEM, V22, P178, DOI 10.1016/j.bmc.2013.11.039; Di-Poi N, 2003, J STEROID BIOCHEM, V85, P257, DOI 10.1016/S0960-0760(03)00215-2; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Doldo E, 2014, ANTICANCER RES, V34, P3303; Dragnev KH, 2011, CANCER PREV RES, V4, P818, DOI 10.1158/1940-6207.CAPR-10-0376; Duvic M, 2001, ARCH DERMATOL, V137, P581; Elabdeen HRZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070838; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fu YS, 2012, MOL ONCOL, V6, P48, DOI 10.1016/j.molonc.2011.11.004; Fujimura S, 1998, LEUKEMIA RES, V22, P611, DOI 10.1016/S0145-2126(98)00049-6; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Germain P, 2006, PHARMACOL REV, V58, P760, DOI 10.1124/pr.58.4.7; Goverse G, 2015, EUR J IMMUNOL, V45, P89, DOI 10.1002/eji.201343340; Grubbs CJ, 2003, CANCER LETT, V201, P17, DOI 10.1016/S0304-3835(03)00461-0; Grubbs CJ, 2006, CARCINOGENESIS, V27, P1232, DOI 10.1093/carcin/bgi308; Guo XJ, 2002, CANCER RES, V62, P1654; Guo XJ, 2001, CANCER RES, V61, P2774; Guo XJ, 2000, CARCINOGENESIS, V21, P1925, DOI 10.1093/carcin/21.11.1925; Hsu SL, 1999, EXP CELL RES, V252, P332, DOI 10.1006/excr.1999.4625; Huang PX, 2014, CHEM REV, V114, P233, DOI 10.1021/cr400161b; Jiang W, 2009, CANCER BIOL THER, V8, P285, DOI 10.4161/cbt.8.3.7486; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kane MA, 2010, METHODS MOL BIOL, V652, P1, DOI 10.1007/978-1-60327-325-1_1; KANG SW, 1995, J INVEST DERMATOL, V105, P549, DOI 10.1111/1523-1747.ep12323445; Kawaguchi R, 2015, MEMBRANES, V5, P425, DOI 10.3390/membranes5030425; Kedishvili NY, 2013, J LIPID RES, V54, P1744, DOI 10.1194/jlr.R037028; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kitareewan S, 1996, MOL BIOL CELL, V7, P1153, DOI 10.1091/mbc.7.8.1153; Kolesar JM, 2010, CANCER PREV RES, V3, P1565, DOI 10.1158/1940-6207.CAPR-10-0149; KRAEMER KH, 1988, NEW ENGL J MED, V318, P1633, DOI 10.1056/NEJM198806233182501; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Langenfeld J, 1997, P NATL ACAD SCI USA, V94, P12070, DOI 10.1073/pnas.94.22.12070; Lansigan F, 2010, DRUGS, V70, P273, DOI 10.2165/11532190-000000000-00000; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Lee SA, 2011, J BIOL CHEM, V286, P13550, DOI 10.1074/jbc.M110.181065; Lemotte PK, 1996, EUR J BIOCHEM, V236, P328, DOI 10.1111/j.1432-1033.1996.00328.x; Li Y, 2013, J BIOL CHEM, V288, P10490, DOI 10.1074/jbc.M112.429852; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Matsuo T, 1998, ONCOGENE, V16, P3337, DOI 10.1038/sj.onc.1201830; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; McKenna DB, 1999, BRIT J DERMATOL, V140, P656; Mevorah B, 1996, J AM ACAD DERMATOL, V34, P379, DOI 10.1016/S0190-9622(07)80013-2; Mihaly J, 2011, EXP DERMATOL, V20, P326, DOI 10.1111/j.1600-0625.2010.01225.x; Miller VA, 1997, J CLIN ONCOL, V15, P790, DOI 10.1200/JCO.1997.15.2.790; Muccio DD, 1998, J MED CHEM, V41, P1679, DOI 10.1021/jm970635h; Napoli JL, 1998, METH MOL B, V89, P29; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; O'Byrne SM, 2013, J LIPID RES, V54, P1731, DOI 10.1194/jlr.R037648; Otley CC, 2006, DERMATOL SURG, V32, P562, DOI 10.1111/j.1524-4725.2006.32115.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reijntjes S, 2010, INT J DEV BIOL, V54, P1267, DOI 10.1387/ijdb.093009sr; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; Roos TC, 1998, PHARMACOL REV, V50, P315; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Saurat JH, 1999, J AM ACAD DERMATOL, V41, pS2, DOI 10.1016/S0190-9622(99)70358-0; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Strate I, 2009, DEVELOPMENT, V136, P461, DOI 10.1242/dev.024901; Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501; Szklenar M, 2013, J VASC RES, V50, P372, DOI 10.1159/000350865; Tang XH, 2009, CANCER BIOL THER, V8, P1214, DOI 10.4161/cbt.8.13.8630; Teixeira C, 1997, MOL ENDOCRINOL, V11, P1191, DOI 10.1210/me.11.9.1191; Vedell PT, 2013, MOL PHARMACOL, V83, P698, DOI 10.1124/mol.112.082404; Walsh SB, 2011, MOL CARCINOGEN, V50, P516, DOI 10.1002/mc.20744; Waters AM, 2015, MOL CANCER THER, V14, P1559, DOI 10.1158/1535-7163.MCT-14-1103; Wolf G, 2006, NUTR REV, V64, P532, DOI 10.1111/j.1753-4887.2006.tb00186.x; Xia G, 2011, BIOCHEMISTRY-US, V50, P93, DOI 10.1021/bi101288y; Xu J, 2011, BIOCHEM BIOPH RES CO, V408, P363, DOI 10.1016/j.bbrc.2011.02.039; XU XC, 1995, CANCER RES, V55, P5507	89	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153556	10.1371/journal.pone.0153556	http://dx.doi.org/10.1371/journal.pone.0153556			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078158	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700078
J	Nagasawa, Y; Okuzaki, D; Muso, E; Yamamoto, R; Shinzawa, M; Iwasaki, Y; Iwatani, H; Nakanishi, T; Isaka, Y; Nojima, H				Nagasawa, Yasuyuki; Okuzaki, Daisuke; Muso, Eri; Yamamoto, Ryohei; Shinzawa, Maki; Iwasaki, Yukako; Iwatani, Hirotsugu; Nakanishi, Takeshi; Isaka, Yoshitaka; Nojima, Hiroshi			IFI27 Is a Useful Genetic Marker for Diagnosis of Immunoglobulin A Nephropathy and Membranous Nephropathy Using Peripheral Blood	PLOS ONE			English	Article							INDUCIBLE PROTEIN-27 IFI27; IGA NEPHROPATHY; EXPRESSION; CELLS; MICROARRAY; RECEPTOR; ANTIGEN; SERUM; TLR9	Diagnosis of chronic glomerulonephritis (CGN) depends primarily on renal biopsy, which is expensive and requires hospitalization, creating a demand for noninvasive diagnostic method for this disease. We used DNA microarray analysis to search for genes whose expression levels in peripheral blood mononuclear cells (PBMCs) could distinguish between patients with CGN and healthy volunteers (HVs). We selected immunoglobulin A nephropathy (IgAN) and membranous nephropathy (MN) as typical forms of CGN. The mRNA level of the gene encoding interferon (IFN)-alpha-inducible protein 27, IFI27, which is preferentially expressed in podocytes of glomeruli, was lower in PBMCs of IgAN and MN patients than in those of HVs. This result was confirmed by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR). Moreover, qRT-PCR analysis revealed that the IFI27 mRNA level was reduced in PBMCs of patients with other types of chronic glomerulonephritis. IFI27 immunohistochemical staining of biopsied specimens also confirmed reduced expression of IFI27 protein in IgAN and MN patients. Based on these results, we propose that IFI27 could serve as a noninvasive diagnostic marker for CGNs using peripheral blood.	[Nagasawa, Yasuyuki; Yamamoto, Ryohei; Shinzawa, Maki; Iwatani, Hirotsugu; Isaka, Yoshitaka] Osaka Univ, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka, Japan; [Nagasawa, Yasuyuki; Nakanishi, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Kidney & Dialysis, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, 3-1 Yamadaoka, Suita, Osaka 565, Japan; [Okuzaki, Daisuke; Nojima, Hiroshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 565, Japan; [Muso, Eri; Iwasaki, Yukako] Kitano Hosp, Div Nephrol & Hemodialysis, Tazuke Kofukai Med Res Inst, Kita Ku, 2-4-20 Ohgimachi, Osaka, Japan	Osaka University; Hyogo College of Medicine; Osaka University; Osaka University; Kitano Hospital	Nojima, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, DNA Chip Dev Ctr Infect Dis, 3-1 Yamadaoka, Suita, Osaka 565, Japan.; Nojima, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Genet, 3-1 Yamadaoka, Suita, Osaka 565, Japan.	snj-0212@biken.osaka-u.ac.jp	Okuzaki, Daisuke/AAN-5641-2020; YAMAMOTO, Ryohei/AAU-3059-2021	Okuzaki, Daisuke/0000-0002-4552-783X; YAMAMOTO, Ryohei/0000-0003-2610-9824				Baek JE, 2008, NEPHRON CLIN PRACT, V108, pC35, DOI 10.1159/000112527; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; Chugh SS, 2012, AM J KIDNEY DIS, V59, P284, DOI 10.1053/j.ajkd.2011.07.024; Coppo R, 2010, J NEPHROL, V23, P626; Cuellar LM, 2009, NEPHROLOGY, V14, P94, DOI 10.1111/j.1440-1797.2008.01009.x; Hastings Margaret Colleen, 2013, Expert Opin Med Diagn, V7, P615, DOI 10.1517/17530059.2013.856878; Hsieh WL, 2015, CELL PROLIFERAT, V48, P187, DOI 10.1111/cpr.12168; Iio K, 2010, BIOCHEM BIOPH RES CO, V393, P565, DOI 10.1016/j.bbrc.2010.01.120; Ishii T, 2005, DNA RES, V12, P429, DOI 10.1093/dnares/dsi020; Iwatani H, 2015, CLIN EXP NEPHROL, V19, P216, DOI 10.1007/s10157-014-0968-z; Kiryluk K, 2014, J CLIN INVEST, V124, P2325, DOI 10.1172/JCI74475; Li SQ, 2015, J SURG RES, V193, P255, DOI 10.1016/j.jss.2014.06.055; Li WW, 2014, MOL MED REP, V10, P1469, DOI 10.3892/mmr.2014.2359; Mihalich A, 2012, GYNECOL ENDOCRINOL, V28, P216, DOI 10.3109/09513590.2011.588746; Misaki T, 2015, CLIN EXP NEPHROL, V19, P844, DOI 10.1007/s10157-014-1072-0; Moriyama T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091756; Muso E, 2013, AUTOIMMUNITY, V46, P513, DOI 10.3109/08916934.2013.822073; Nagasawa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081636; Nair R, 2006, KIDNEY INT, V69, P1455, DOI 10.1038/sj.ki.5000292; Okuzaki D, 2012, J MOL BIOMARK DIAGN, V3, P125; Okuzaki D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19456; Okuzaki D, 2010, DNA RES, V17, P369, DOI 10.1093/dnares/dsq025; Park KH, 2016, J INFECT IN PRESS; Pau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036761; Sallustio F, 2015, EUR J HUM GENET, V23, P940, DOI 10.1038/ejhg.2014.208; Serino G, 2012, J AM SOC NEPHROL, V23, P814, DOI 10.1681/ASN.2011060567; Shankland SJ, 2014, SEMIN NEPHROL, V34, P418, DOI 10.1016/j.semnephrol.2014.06.008; Sugimoto T, 2007, INTERNAL MED, V46, P1483, DOI 10.2169/internalmedicine.46.0200; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Suomela S, 2004, J INVEST DERMATOL, V122, P717, DOI 10.1111/j.0022-202X.2004.22322.x; Suzuki H, 2008, J AM SOC NEPHROL, V19, P2384, DOI 10.1681/ASN.2007121311; SUZUKI S, 1994, LANCET, V343, P12, DOI 10.1016/S0140-6736(94)90875-3; Tantawy MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106392; Tougan T, 2008, DNA RES, V15, P103, DOI 10.1093/dnares/dsm035; Uhrin P, 2013, IMMUNOBIOLOGY, V218, P1207, DOI 10.1016/j.imbio.2013.04.009; VanBeek C, 2015, CLIN NEPHROL, V84, P1, DOI 10.5414/CN108602; Wallace TA, 2014, CARCINOGENESIS, V35, P2074, DOI 10.1093/carcin/bgu114; Wilde B, 2011, KIDNEY INT, V79, P599, DOI 10.1038/ki.2010.472; Wyatt RJ, 2013, NEW ENGL J MED, V368, P2402, DOI 10.1056/NEJMra1206793; Yamamoto R, 2012, NEPHROL DIAL TRANSPL, V27, P1020, DOI 10.1093/ndt/gfr369	40	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153252	10.1371/journal.pone.0153252	http://dx.doi.org/10.1371/journal.pone.0153252			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100186	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500027
J	Abasht, B; Mutryn, MF; Michalek, RD; Lee, WR				Abasht, Behnam; Mutryn, Marie F.; Michalek, Ryan D.; Lee, William R.			Oxidative Stress and Metabolic Perturbations in Wooden Breast Disorder in Chickens	PLOS ONE			English	Article							PECTORALIS MAJOR MUSCLE; UDP-GLUCOSE DEHYDROGENASE; GLUTATHIONE CONSUMPTION; HYALURONAN SYNTHASE; ASCORBIC-ACID; PATHWAY; PROTEIN; LIVER; MEAT; OVEREXPRESSION	This study was conducted to characterize metabolic features of the breast muscle (pectoralis major) in chickens affected with the Wooden Breast myopathy. Live birds from two purebred chicken lines and one crossbred commercial broiler population were clinically examined by manual palpation of the breast muscle (pectoralis major) at 47-48 days of age. Metabolite abundance was determined by gas chromatography/mass spectrometry (GC/MS) and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) using breast muscle tissue samples from 16 affected and 16 unaffected chickens. Muscle glycogen content was also quantified in breast muscle tissue samples from affected and unaffected chickens. In total, levels of 140 biochemicals were significantly different (FDR < 0.1 and fold-change A/U > 1.3 or < 0.77) between affected and unaffected chickens. Glycogen content measurements were considerably lower (1.7-fold) in samples taken from Wooden Breast affected birds when compared with samples from unaffected birds. Affected tissues exhibited biomarkers related to increased oxidative stress, elevated protein levels, muscle degradation, and altered glucose utilization. Affected muscle also showed elevated levels of hypoxanthine, xanthine, and urate molecules, the generation of which can contribute to altered redox homeostasis. In conclusion, our findings show that Wooden Breast affected tissues possess a unique metabolic signature. This unique profile may identify candidate biomarkers for diagnostic utilization and provide mechanistic insight into altered biochemical processes contributing to tissue hardening associated with the Wooden Breast myopathy in commercial chickens.	[Abasht, Behnam; Mutryn, Marie F.] Univ Delaware, Dept Anim & Food Sci, Newark, DE USA; [Michalek, Ryan D.] Metabolon Inc, Durham, NC USA; [Lee, William R.] Maple Leaf Farms, Leesburg, IN USA	University of Delaware; Metabolon	Abasht, B (corresponding author), Univ Delaware, Dept Anim & Food Sci, Newark, DE USA.	abasht@UDel.edu			University of Delaware; Maple Leaf Farms; Metabolon Inc.	University of Delaware; Maple Leaf Farms; Metabolon Inc.	The study was financially supported by the University of Delaware. Maple Leaf Farms provided support in the form of salaries for William R. Lee, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Metabolon Inc. provided support in the form of salaries for Ryan D. Michalek and conducted metabolomics profiling of samples, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abasht B, P 22 EUR S QUAL POUL; Alexander D, 2011, EUR J CLIN INVEST, V41, P527, DOI 10.1111/j.1365-2362.2010.02441.x; Aschenbach WG, 2002, DIABETES, V51, P567, DOI 10.2337/diabetes.51.3.567; Bailey RA, 2015, POULTRY SCI, V94, P2870, DOI 10.3382/ps/pev304; Banhegyi G, 1996, FEBS LETT, V381, P39, DOI 10.1016/0014-5793(96)00077-4; Banhegyi G, 1997, FREE RADICAL BIO MED, V23, P793, DOI 10.1016/S0891-5849(97)00062-2; Berri C, 2007, J ANIM SCI, V85, P2005, DOI 10.2527/jas.2006-398; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; BRAUN L, 1994, FEBS LETT, V352, P4, DOI 10.1016/0014-5793(94)00905-8; Breiman L, 2001, MACH LEARN, V45, P261, DOI 10.1023/A:1017934522171; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bucciante G, G CLIN MED, V66, P451; BURG MB, 1988, J CLIN INVEST, V81, P635, DOI 10.1172/JCI113366; Cheng HT, 2014, ATLAS NEUROMUSCULAR, P37; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; DIMAURO S, 1987, J INHERIT METAB DIS, V10, P113, DOI 10.1007/BF01812852; Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fu WX, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0098-4; GIESECKE K, 1989, METABOLISM, V38, P1196, DOI 10.1016/0026-0495(89)90159-5; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; Ishikawa Y, 2013, BBA-MOL CELL RES, V1833, P2479, DOI 10.1016/j.bbamcr.2013.04.008; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; KINOSHIT.JH, 1974, INVEST OPHTH VISUAL, V13, P713; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Kuttappan VA, 2012, POULTRY SCI, V91, P3230, DOI 10.3382/ps.2012-02397; Li P, 2015, INT J CLIN EXP PATHO, V8, P12101; Liaw A., 2015, PACKAGE RANDOMFOREST; Lorentzen KA, 2016, ATHEROSCLEROSIS, V244, P195, DOI 10.1016/j.atherosclerosis.2015.11.016; Luptak I, 2007, J CLIN INVEST, V117, P1432, DOI 10.1172/JCI30658; Ma C, 2014, BRIT J PHARMACOL, V171, P3352, DOI 10.1111/bph.12594; Mazzoni M, 2015, POULTRY SCI, V94, P123, DOI 10.3382/ps/peu043; MEIJER AEFH, 1991, PROG HISTOCHEM CYTOC, V22, P1; Mudalal S, 2015, ANIMAL, V9, P728, DOI 10.1017/S175173111400295X; Mudalal S, 2014, POULTRY SCI, V93, P2108, DOI 10.3382/ps.2014-03911; Mutryn M, P 22 EUR S QUAL POUL; Mutryn MF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1623-0; Owens C.M, 2014, WATT POULTRY US, P42; Pongratz D, 1999, J MUSCULOSKELET PAIN, V7, P93, DOI 10.1300/J094v07n01_09; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Schuller-Levis GB, 2004, NEUROCHEM RES, V29, P117, DOI 10.1023/B:NERE.0000010440.37629.17; Sihvo HK, 2014, VET PATHOL, V51, P619, DOI 10.1177/0300985813497488; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; STIRPE F, 1965, BIOCHEM J, V97, P561, DOI 10.1042/bj0970561; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Velleman SG, 2015, HISTOPATHOLOGIC MYOG; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Viola M, 2015, GLYCOCONJUGATE J, V32, P93, DOI 10.1007/s10719-015-9586-6; Wasner G, 2004, EUR J PAIN, V8, P179, DOI 10.1016/S1090-3801(03)00099-5; Wilkinson TS, 2006, J CELL PHYSIOL, V206, P378, DOI 10.1002/jcp.20468	53	140	145	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153750	10.1371/journal.pone.0153750	http://dx.doi.org/10.1371/journal.pone.0153750			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097013	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600051
J	Costello, R; Winthrop, KL; Pye, SR; Brown, B; Dixon, WG				Costello, Ruth; Winthrop, Kevin L.; Pye, Stephen R.; Brown, Benjamin; Dixon, William G.			Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink	PLOS ONE			English	Article							AUDIT; INFECTION	Introduction Guidelines for the management of rheumatoid arthritis (RA) recommend using influenza and pneumococcal vaccinations to mitigate infection risk. The level of adherence to these guidelines is not well known in the UK. The aims of this study were to describe the uptake of influenza and pneumococcal vaccinations in patients with RA in the UK, to compare the characteristics of those vaccinated to those not vaccinated and to compare vaccination rates across regions of the UK. Methods A retrospective cohort study of adults diagnosed with incident RA and treated with non-biologic immunosuppressive therapy, using data from a large primary care database. For the influenza vaccination, patients were considered unvaccinated on 1st September each year and upon vaccination their status changed to vaccinated. For pneumococcal vaccination, patients were considered vaccinated after their first vaccination until the end of follow-up. Patients were stratified by age 65 at the start of follow-up, given differences in vaccination guidelines for the general population. Results Overall (N = 15,724), 80% patients received at least one influenza vaccination, and 50% patients received a pneumococcal vaccination, during follow-up (mean 5.3 years). Of those aged below 65 years (N = 9,969), 73% patients had received at least one influenza vaccination, and 43% patients received at least one pneumococcal vaccination. Of those aged over 65 years (N = 5,755), 91% patients received at least one influenza vaccination, and 61% patients had received at least one pneumococcal vaccination. Those vaccinated were older, had more comorbidity and visited the GP more often. Regional differences in vaccination rates were seen with the highest rates in Northern Ireland, and the lowest rates in London. Conclusions One in five patients received no influenza vaccinations and one in two patients received no pneumonia vaccine over five years of follow-up. There remains significant scope to improve uptake of vaccinations in patients with RA.	[Costello, Ruth; Pye, Stephen R.; Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England; [Winthrop, Kevin L.] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97201 USA; [Brown, Benjamin; Dixon, William G.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Hlth eRes Ctr, Manchester, Lancs, England	University of Manchester; Oregon Health & Science University; University of Manchester	Costello, R (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Inst Inflammat & Repair, Arthrit Res UK Ctr Epidemiol,Ctr Musculoskeletal, Manchester, Lancs, England.	ruth.costello@manchester.ac.uk	Dixon, William/L-8408-2019; Costello, Ruth/GWR-0357-2022; Pye, Stephen R/D-9236-2011	Dixon, William/0000-0001-5881-4857; Pye, Stephen R/0000-0002-7263-2897; Costello, Ruth/0000-0003-2709-6666	Arthritis Research UK Centre for Epidemiology [20380]; MRC [G0902272]; Wellcome Trust [104438/Z/14/Z]; MRC [MR/K006665/1] Funding Source: UKRI; Medical Research Council [MR/K006665/1, MC_PC_13042, G0902272] Funding Source: researchfish	Arthritis Research UK Centre for Epidemiology(Versus Arthritis); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Arthritis Research UK Centre for Epidemiology (20380). WD was supported by an MRC clinican scientist fellowship (G0902272). BB was supported by a Wellcome Trust Research Training fellowship (104438/Z/14/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, NHS IMM STAT 2013 14; Bennett Nancy M., 2012, Morbidity and Mortality Weekly Report, V61, P816; Bridges MJ, 2003, ANN RHEUM DIS, V62, P685, DOI 10.1136/ard.62.7.685; Clarke AJ, 2011, CLIN EXP RHEUMATOL, V29, P596; Desai SP, 2011, RHEUMATOLOGY, V50, P366, DOI 10.1093/rheumatology/keq297; Doe S, 2007, RHEUMATOLOGY, V46, P715, DOI 10.1093/rheumatology/kel410; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2294, DOI 10.1002/art.10529; Doran MF, 2002, ARTHRITIS RHEUM, V46, P2287, DOI 10.1002/art.10524; England : PH, 2014, INFLUENZA GREEN BOOK; England PH, 2013, PNEUMOCOCCAL GREEN B; England PH, 2014, SEASONAL FLU UPTAKE; Feuchtenberger M, 2012, RHEUMATOL INT, V32, P1533, DOI 10.1007/s00296-011-1808-z; Haroon M, 2011, JOINT BONE SPINE, V78, P374, DOI 10.1016/j.jbspin.2010.10.012; Hmamouchi I, 2015, VACCINE, V33, P1446, DOI 10.1016/j.vaccine.2015.01.065; Lanternier F, 2008, ANN RHEUM DIS, V67, P1047, DOI 10.1136/ard.2007.081703; McCarthy E M, 2011, Ir Med J, V104, P208; Moberley S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000422.pub3; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pradeep J, 2007, ANN RHEUM DIS, V66, P837, DOI 10.1136/ard.2006.060285; Saravana S, 2004, RHEUMATOLOGY, V43, P1055, DOI 10.1093/rheumatology/keh263; Sowden E, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-58; Thomas LM, 2005, RHEUMATOLOGY, V44, P131, DOI 10.1093/rheumatology/keh452; Thomas SL, 2008, ARTHRIT RHEUM-ARTHR, V59, P1314, DOI 10.1002/art.24015; van Assen S, 2011, ANN RHEUM DIS, V70, P414, DOI 10.1136/ard.2010.137216; Williams T, 2012, THER ADV DRUG SAF, V3, P89, DOI 10.1177/2042098611435911	25	33	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153848	10.1371/journal.pone.0153848	http://dx.doi.org/10.1371/journal.pone.0153848			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096429	Green Submitted, gold, Green Published			2022-12-27	WOS:000374543600063
J	Miller, S; Masuya, H; Zhang, J; Walsh, E; Zhang, N				Miller, Stephen; Masuya, Hayato; Zhang, Jian; Walsh, Emily; Zhang, Ning			Real-Time PCR Detection of Dogwood Anthracnose Fungus in Historical Herbarium Specimens from Asia	PLOS ONE			English	Article							DISCULA-DESTRUCTIVA; POPULATION-STRUCTURE; FLOWERING DOGWOOD; NORTH-AMERICA; ENDOPHYTES; PHYLOGENY; PATTERNS; DISEASE	Cornus species (dogwoods) are popular ornamental trees and important understory plants in natural forests of northern hemisphere. Dogwood anthracnose, one of the major diseases affecting the native North American Cornus species, such as C. florida, is caused by the fungal pathogen Discula destructiva. The origin of this fungus is not known, but it is hypothesized that it was imported to North America with its host plants from Asia. In this study, a TaqMan real-time PCR assay was used to detect D. destructiva in dried herbarium and fresh Cornus samples. Several herbarium specimens fromJapan and China were detected positive for D. destructiva, some of which were collected before the first report of the dogwood anthracnose in North America. Our findings further support that D. destructiva was introduced to North America from Asia where the fungus likely does not cause severe disease.	[Miller, Stephen; Walsh, Emily; Zhang, Ning] Rutgers State Univ, Dept Plant Biol & Pathol, 201 Foran Hall,59 Dudley Rd, New Brunswick, NJ 08901 USA; [Masuya, Hayato] Tohoku Res Ctr, Forestry & Forest Prod Res Inst, 92-25 Nabeyashiki, Morioka, Iwate 0200123, Japan; [Zhang, Jian] Chinese Med Hosp Gaomi, Weifang 261500, Shandong, Peoples R China; [Zhang, Ning] Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Forestry & Forest Products Research Institute - Japan; Rutgers State University New Brunswick	Zhang, N (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, 201 Foran Hall,59 Dudley Rd, New Brunswick, NJ 08901 USA.; Zhang, N (corresponding author), Rutgers State Univ, Dept Biochem & Microbiol, 76 Lipman Dr, New Brunswick, NJ 08901 USA.	zhang@aesop.rutgers.edu	Zhang, Ning/K-3046-2012; Masuya, Hayato/AAN-8998-2021	Zhang, Ning/0000-0002-2680-1354; 	Mycological Society of America; Rutgers University	Mycological Society of America; Rutgers University	This work was supported by the Clark T. Rogerson Student Research Award of the Mycological Society of America to Miller and a startup fund to Zhang from Rutgers University. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RL, 2001, 23 ANN TENN NURS SHO, P14; [Anonymous], 2004, NPS             0205; Arnold AE, 2001, MYCOL RES, V105, P1502, DOI 10.1017/S0953756201004956; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; BRASIER CM, 1995, CAN J BOT, V73, pS1213, DOI 10.1139/b95-381; Byther RS, 1979, ORNAMENTALS NW NEWSL, V3, P20; Caetano-Anolles G, 2001, CURR GENET, V39, P346, DOI 10.1007/s002940100223; CaetanoAnolles G, 1996, FEMS MICROBIOL LETT, V145, P377; Daughtrey ML, 1996, PLANT DIS, V80, P349, DOI 10.1094/PD-80-0349; DAUGHTREY ML, 1994, ANNU REV PHYTOPATHOL, V32, P61, DOI 10.1146/annurev.py.32.090194.000425; Davis EC, 2008, AM J BOT, V95, P914, DOI 10.3732/ajb.2006463; FARR DF, 1991, MYCOLOGIA, V83, P611, DOI 10.2307/3760216; Guo LD, 2001, MOL PHYLOGENET EVOL, V20, P1, DOI 10.1006/mpev.2001.0942; Lacap DC, 2003, FUNGAL DIVERS, V12, P53; Lay DW, 1961, P 15 ANN M SE GAM FI, P30; Pirone PP, 1980, NY TIMES, V24, P34; Pirone PP, 1980, NY TIMES NEW YO 0224, P37; REDLIN SC, 1991, MYCOLOGIA, V83, P633, DOI 10.2307/3760218; Rossell IM, 2001, AM MIDL NAT, V146, P379, DOI 10.1674/0003-0031(2001)146[0379:IODADD]2.0.CO;2; Schneeberger NF, 1989, PLANT DIAGNOSTICIANS, V10, P30; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Sherald JL, 1996, PLANT DIS, V80, P310, DOI 10.1094/PD-80-0310; Stinzing A, 2003, NACHRICHTENBL DEUT P, V55, pS1; Tantardini A, 2004, INFORM FITOPATOLOGIC, V12, P44; THOMAS WA, 1969, ECOL MONOGR, V39, P101, DOI 10.2307/1950739; Toofanee SB, 2002, FUNGAL DIVERS, V11, P169; TRIGIANO RN, 1995, MYCOLOGIA, V87, P490, DOI 10.2307/3760766; USDA, 2009, 2007 CENS AGR; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Xiang QYJ, 2006, TAXON, V55, P9, DOI 10.2307/25065525; Zhang N, 2002, PHYTOPATHOLOGY, V92, P1276, DOI 10.1094/PHYTO.2002.92.12.1276; Zhang N, 2001, MYCOLOGIA, V93, P355, DOI 10.2307/3761657; Zhang N, 2011, EUR J PLANT PATHOL, V130, P551, DOI 10.1007/s10658-011-9777-3	33	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154030	10.1371/journal.pone.0154030	http://dx.doi.org/10.1371/journal.pone.0154030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096929	gold, Green Published			2022-12-27	WOS:000374543600082
J	Cheung, MY; Almukhtar, A; Keeling, A; Hsung, TC; Ju, XY; McDonald, J; Ayoub, A; Khambay, BS				Cheung, Man Yan; Almukhtar, Anas; Keeling, Andrew; Hsung, Tai-Chiu; Ju, Xiangyang; McDonald, James; Ayoub, Ashraf; Khambay, Balvinder Singh			The Accuracy of Conformation of a Generic Surface Mesh for the Analysis of Facial Soft Tissue Changes	PLOS ONE			English	Article								Purpose Three dimensional analysis of the face is required for the assessment of complex changes following surgery, pathological conditions and to monitor facial growth. The most suitable method may be "dense surface correspondence". Materials and Methods This method utilizes a generic facial mesh and " conformation process" to establish anatomical correspondences between two facial images. The aim of this study was to validate the use of conformed meshes to measure simulated maxillary and mandibular surgical movements. The " simulation" was performed by deforming the actual soft tissues of the participant during image acquisition. The study was conducted on 20 volunteers and used 77 facial landmarks pre-marked over six anatomical regions; left cheek, right cheek, left upper lip, philtrum, right upper lip and chin region. Each volunteer was imaged at rest and after performing 5 different simulated surgical procedures using 3D stereophotogrammetry. The simulated surgical movement was determined by measuring the Euclidean distances and the mean absolute x, y and z distances of the landmarks making up the six regions following digitization. A generic mesh was then conformed to each of the aligned six facial 3D images. The same six regions were selected on the aligned conformed simulated meshes and the surgical movement determined by determining the Euclidean distances and the mean absolute x, y and z distances of the mesh points making up the six regions were determined. Results In all cases the mean Euclidian distance between the simulated movement and conformed region was less than 0.7mm. For the x, y and z directions the majority of differences in the mean absolute distances were less than 1.0mm except in the x-direction for the left and right cheek regions, which was above 2.0mm. Conclusions This concludes that the conformation process has an acceptable level of accuracy and is a valid method of measuring facial change between two images i.e. pre- and post-surgery. The conformation accuracy is higher toward the center of the face than the peripheral regions.	[Cheung, Man Yan; Hsung, Tai-Chiu; Khambay, Balvinder Singh] Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China; [Keeling, Andrew; Khambay, Balvinder Singh] Univ Leeds, Sch Dent, Leeds, W Yorkshire, England; [Almukhtar, Anas; Ju, Xiangyang; McDonald, James; Ayoub, Ashraf] Univ Glasgow, Glasgow Dent Sch, Glasgow, Lanark, Scotland	University of Hong Kong; University of Leeds; University of Glasgow	Khambay, BS (corresponding author), Univ Hong Kong, Fac Dent, Hong Kong, Hong Kong, Peoples R China.; Khambay, BS (corresponding author), Univ Leeds, Sch Dent, Leeds, W Yorkshire, England.	b.s.khambay@leeds.ac.uk	Keeling, Andrew/N-7794-2019; Almukhtar, Anas/G-4217-2019	Keeling, Andrew/0000-0003-4598-3744; Ju, Xiangyang/0000-0003-3471-7256; Hsung, Tai-Chiu/0000-0001-7699-1937; Ayoub, Ashraf/0000-0002-2760-6008; Almukhtar, Anas/0000-0003-3696-6424				Almukhtar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131540; Aynechi N, 2011, ANGLE ORTHOD, V81, P245, DOI 10.2319/041810-210.1; Baik HS, 2007, AM J ORTHOD DENTOFAC, V131, P759, DOI 10.1016/j.ajodo.2005.08.038; Baik HS, 2010, AM J ORTHOD DENTOFAC, V138, P167, DOI 10.1016/j.ajodo.2010.02.022; Bozic M, 2009, ANGLE ORTHOD, V79, P640, DOI 10.2319/081608-432.1; Claes P, 2012, INT J ORAL MAX SURG, V41, P324, DOI 10.1016/j.ijom.2011.10.019; Heymann GC, 2010, AM J ORTHOD DENTOFAC, V137, P274, DOI 10.1016/j.ajodo.2009.07.009; Kau CH, 2010, AM J ORTHOD DENTOFAC, V137, DOI [10.1016/j.ajodo.2009.04.022, 10.1016/j.ajodo.2010.01.022]; Luximon Y, 2010, P TMCE APR 12 16 AN, P1; Mao ZL, 2006, PATTERN RECOGN LETT, V27, P597, DOI 10.1016/j.patrec.2005.09.025; Miller L, 2007, EUR J ORTHODONT, V29, P14, DOI 10.1093/ejo/cjl037; Toma AM, 2008, ORTHOD CRANIOFAC RES, V11, P180, DOI 10.1111/j.1601-6343.2008.00428.x; Ullah R, 2015, BRIT J ORAL MAX SURG, V53, P153, DOI 10.1016/j.bjoms.2014.11.001; Verze L, 2012, J CRANIOFAC SURG, V23, P1448, DOI 10.1097/SCS.0b013e31824e25fc	14	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152381	10.1371/journal.pone.0152381	http://dx.doi.org/10.1371/journal.pone.0152381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093637	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000374541200005
J	Klein, H; Abu-Arish, A; Trinh, NTN; Luo, YS; Wiseman, PW; Hanrahan, JW; Brochiero, E; Sauve, R				Klein, Helene; Abu-Arish, Asmahan; Nguyen Thu Ngan Trinh; Luo, Yishan; Wiseman, Paul W.; Hanrahan, John W.; Brochiero, Emmanuelle; Sauve, Remy			Investigating CFTR and KCa3.1 Protein/Protein Interactions	PLOS ONE			English	Article							IMAGE CORRELATION SPECTROSCOPY; ACTIVATED PROTEIN-KINASE; CYSTIC-FIBROSIS; PLASMA-MEMBRANE; K+ CHANNELS; CHLORIDE SECRETION; AIRWAY; CONDUCTANCE; INHIBITION; IDENTIFICATION	In epithelia, Cl-channels play a prominent role in fluid and electrolyte transport. Of particular importance is the cAMP-dependent cystic fibrosis transmembrane conductance regulator Cl-channel (CFTR) with mutations of the CFTR encoding gene causing cystic fibrosis. The bulk transepithelial transport of Cl-ions and electrolytes needs however to be coupled to an increase in K+ conductance in order to recycle K+ and maintain an electrical driving force for anion exit across the apical membrane. In several epithelia, this r efflux is ensured by K+ channels, including KCa3.1, which is expressed at both the apical and basolateral membranes. We show here for the first time that CFTR and KCa3.1 can physically interact. We first performed a two -hybrid screen to identify which KCa3.1 cytosolic domains might mediate an interaction with CFTR. Our results showed that both the N-terminal fragment M1-M40 of KCa3.1 and part of the KCa3.1 calmodulin binding domain (residues L345-A400) interact with the NBD2 segment (G1237-Y1420) and C-region of CFTR (residues T1387 L1480), respectively. An association of CFTR and F508de1-CFTR with KCa3.1 was further confirmed in co-immunoprecipitation experiments demonstrating the formation of immunoprecipitable CFTR/KCa3.1 complexes in CFBE cells. Co-expression of KCa3.1 and CFTR in HEK cells did not impact CFTR expression at the cell surface, and KCa3.1 trafficking appeared independent of CFTR stimulation. Finally, evidence is presented through cross correlation spectroscopy measurements that KCa3.1 and CFTR colocalize at the plasma membrane and that KCa3.1 channels tend to aggregate consequent to an enhanced interaction with CFTR channels at the plasma membrane following an increase in intracellular Ca2+ concentration. Altogether, these results suggest 1) that the physical interaction KCa3.1/CFTR can occur early during the biogenesis of both proteins and 2) that KCa3.1 and CFTR form a dynamic complex, the formation of which depends on internal Ca2+.	[Klein, Helene; Sauve, Remy] Univ Montreal, Dept Physiol Mol & Integrat, Montreal, PQ H3C 3J7, Canada; [Klein, Helene; Sauve, Remy] Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada; [Abu-Arish, Asmahan; Luo, Yishan; Hanrahan, John W.] McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada; [Nguyen Thu Ngan Trinh; Brochiero, Emmanuelle] CRCHUM, 900 Rue St Denis, Montreal, PQ H2X 0A9, Canada; [Nguyen Thu Ngan Trinh; Brochiero, Emmanuelle] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Wiseman, Paul W.] McGill Univ, Chem & Phys, Montreal, PQ H3G 1Y6, Canada	Universite de Montreal; Universite de Montreal; McGill University; Universite de Montreal; Universite de Montreal; McGill University	Sauve, R (corresponding author), Univ Montreal, Dept Physiol Mol & Integrat, Montreal, PQ H3C 3J7, Canada.; Sauve, R (corresponding author), Univ Montreal, Membrane Prot Res Grp, Montreal, PQ H3C 3J7, Canada.	remy.sauve@umontreal.ca	Hanrahan, John/AGG-1926-2022	Hanrahan, John/0000-0001-9080-2039	Cystic Fibrosis Canada; Natural Science and Engineering Research Council; Canadian Institutes of Health Research; Groupe d'Etude des Proteines Membranaires (Universite de Montreal); Natural Sciences and Engineering Research Council	Cystic Fibrosis Canada; Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Groupe d'Etude des Proteines Membranaires (Universite de Montreal); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Cystic Fibrosis Canada (R.S. and E.B.), the Natural Science and Engineering Research Council (P.W.W.), the Canadian Institutes of Health Research (J.W.H.), and by a Projet novateur grant from the Groupe d'Etude des Proteines Membranaires (Universite de Montreal). A.A-A. was supported by postdoctoral fellowships from Cystic Fibrosis Canada and the Natural Sciences and Engineering Research Council. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Arish A, 2015, BIOPHYS J, V109, P85, DOI 10.1016/j.bpj.2015.04.042; Balghi H, 2011, FASEB J, V25, P4274, DOI 10.1096/fj.11-187682; Bardou O, 2009, AM J PHYSIOL-LUNG C, V296, pL145, DOI 10.1152/ajplung.90525.2008; Bates IR, 2006, BIOPHYS J, V91, P1046, DOI 10.1529/biophysj.106.084830; Bernard K, 2003, J MEMBRANE BIOL, V196, P15, DOI 10.1007/s00232-003-0621-3; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P581, DOI 10.1164/ajrccm.150.2.8049852; BOUCHER RC, 1994, AM J RESP CRIT CARE, V150, P271, DOI 10.1164/ajrccm.150.1.8025763; Cahill P, 2000, J BIOL CHEM, V275, P16697, DOI 10.1074/jbc.M910205199; COOK DI, 1989, J MEMBRANE BIOL, V110, P139, DOI 10.1007/BF01869469; Devor DC, 1996, AM J PHYSIOL-LUNG C, V271, pL775, DOI 10.1152/ajplung.1996.271.5.L775; Duffy SM, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0112-z; Frizzell RA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009563; Girault A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0263-x; Guggino WB, 2006, NAT REV MOL CELL BIO, V7, P426, DOI 10.1038/nrm1949; Hallows KR, 2003, J BIOL CHEM, V278, P998, DOI 10.1074/jbc.M210621200; Hebert B, 2005, BIOPHYS J, V88, P3601, DOI 10.1529/biophysj.104.054874; Hollenhorst MI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/174306; Klein H, 2009, AM J PHYSIOL-CELL PH, V296, pC285, DOI 10.1152/ajpcell.00418.2008; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Kolin DL, 2007, CELL BIOCHEM BIOPHYS, V49, P141, DOI 10.1007/s12013-007-9000-5; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Luo Y, 2009, BIOCHEM J, V419, P211, DOI 10.1042/BJ20081869; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Morales P, 2013, J GEN PHYSIOL, V142, P37, DOI 10.1085/jgp.201210933; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Nguyen TNT, 2012, EUR RESPIR J, V40, P1390, DOI 10.1183/09031936.00221711; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pilewski Joseph M., 1999, Physiological Reviews, V79, pS215; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Singh S, 2001, J PHARMACOL EXP THER, V296, P600; Sorensen JB, 2001, PFLUG ARCH EUR J PHY, V442, P1, DOI 10.1007/s004240000493; Thompson J, 2009, CHANNELS, V3, P194, DOI 10.4161/chan.3.3.9043; Treharne KJ, 2009, CELL PHYSIOL BIOCHEM, V24, P347, DOI 10.1159/000257427; Wang J, 2013, AM J PHYSIOL-CELL PH, V304, pC673, DOI 10.1152/ajpcell.00196.2012; Wu XY, 2000, MOL THER, V2, P47, DOI 10.1006/mthe.2000.0095	38	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153665	10.1371/journal.pone.0153665	http://dx.doi.org/10.1371/journal.pone.0153665			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092946	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200038
J	Prakash, S; Kuang, SQ; Regalado, E; Guo, DC; Milewicz, D				Prakash, Siddharth; Kuang, Shao-Qing; Regalado, Ellen; Guo, Dongchuan; Milewicz, Dianna		GenTAC Registry Investigators	Recurrent Rare Genomic Copy Number Variants and Bicuspid Aortic Valve Are Enriched in Early Onset Thoracic Aortic Aneurysms and Dissections	PLOS ONE			English	Article							GENETIC-BASIS; COARCTATION; RESOLUTION; PHENOTYPE; COMMUNITY; REGISTRY; MODEL; SNP	Thoracic Aortic Aneurysms and Dissections (TAAD) are a major cause of death in the United States. The spectrum of TAAD ranges from genetic disorders, such as Marfan syndrome, to sporadic isolated disease of unknown cause. We hypothesized that genomic copy number variants (CNVs) contribute causally to early onset TAAD (ETAAD). We conducted a genome-wide SNP array analysis of ETAAD patients of European descent who were enrolled in the National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (GenTAC). Genotyping was performed on the Illumina Omni -Express platform, using PennCNV, Nexus and CNVPartition for CNV detection. ETAAD patients (n = 108, 100% European American, 28% female, average age 20 years, 55% with bicuspid aortic valves) were compared to 7013 dbGAP controls without a history of vascular disease using downsampled Omni 2.5 data. For comparison, 805 sporadic TAAD patients with late onset aortic disease (STAAD cohort) and 192 affected probands from families with at least two affected relatives (FTAAD cohort) from our institution were screened for additional CNVs at these loci with SNP arrays. We identified 47 recurrent CNV regions in the ETAAD, FTAAD and STAAD groups that were absent or extremely rare in controls. Nine rare CNVs that were either very large (>1 Mb) or shared by ETAAD and STAAD or FTAAD patients were also identified. Four rare CNVs involved genes that cause arterial aneurysms when mutated. The largest and most prevalent of the recurrent CNVs were at Xq28 (two duplications and two deletions) and 17q25.1 (three duplications). The percentage of individuals harboring rare CNVs was significantly greater in the ETAAD cohort (32%) than in the FTAAD (23%) or STAAD (17%) cohorts. We identified multiple loci affected by rare CNVs in one-third of ETAAD patients, confirming the genetic heterogeneity of TAAD. Alterations of candidate genes at these loci may contribute to the pathogenesis of TAAD.	[Prakash, Siddharth; Kuang, Shao-Qing; Regalado, Ellen; Guo, Dongchuan; Milewicz, Dianna; GenTAC Registry Investigators] Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Prakash, S (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Med Genet, Dept Internal Med, Houston, TX 77030 USA.	Siddharth.K.Prakash@uth.tmc.edu	Asch, Federico/AAS-7653-2021	Asch, Federico/0000-0002-1744-5271; Regalado, Ellen/0000-0002-5859-218X; Morris, Shaine/0000-0002-8056-0934	US Federal Government from the National Heart Lung and Blood Institute [HHSN268200648199C, HHSN268201000048C]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD); National Institute on Aging [U01AG009740, RC2AG036495, RC4AG039029]; National Eye Institute; National Institutes of Health [HHSN268200782096C]; Collaborative Genetic Study of Nicotine Dependence (COGEND) [P01 CA089392]; University of Wisconsin Transdisciplinary Tobacco Use Research Center [P50 DA019706, P50 CA084724];  [1U54HD083092];  [5R01HD039056];  [5R01HL090506];  [5R01HL091771];  [5R01HL109758];  [R01EY016514];  [R01EY016482];  [1X01HG006619-01];  [1 X01HG005274-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083092] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039056] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA089392, P50CA084724] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000370, UL1TR000371] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016482, R01EY016514] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109758, R01HL091771, R01HL109942, P50HL083794] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036495, U01AG009740, RC4AG039029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA019706] Funding Source: NIH RePORTER	US Federal Government from the National Heart Lung and Blood Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Genetic Study of Nicotine Dependence (COGEND); University of Wisconsin Transdisciplinary Tobacco Use Research Center; ; ; ; ; ; ; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	John W. Belmont was supported by 1U54HD083092, 5R01HD039056, 5R01HL090506 and 5R01HL091771. Kim McBride was supported by 5R01HL109758. The GenTAC Registry has been supported by US Federal Government contracts HHSN268200648199C and HHSN268201000048C from the National Heart Lung and Blood Institute and the National Institute of Arthritis and Musculoskeletal and Skin Diseases (Bethesda, MD). FECD was primarily supported by grants R01EY016514 (DUEC, PI: Gordon Klintworth), R01EY016482 (CWRU, PI: Sudha Iyengar) and 1X01HG006619-01 (PI: Sudha Iyengar, Natalie Afshar). The HRS genetic data was sponsored by the National Institute on Aging (grants U01AG009740, RC2AG036495 and RC4AG039029) and was conducted by the University of Michigan. Funding support for NEIREC was provided by the National Eye Institute. Genotyping for the Genetic Architecture of Smoking and Smoking Cessation Study, which was performed at the Center for Inherited Disease Research (CIDR), was funded by 1 X01HG005274-01. CIDR is fully funded through a federal contract from the National Institutes of Health to The Johns Hopkins University, contract number HHSN268200782096C. Assistance with genotype cleaning, as well as with general study coordination for the Genetic Architecture of Smoking and Smoking Cessation Study was provided by the Gene Environment Association Studies (GENEVA) Coordinating Center (U01 HG004446). Funding support for collection of the Genetic Architecture of Smoking and Smoking Cessation Study datasets and samples was provided by the Collaborative Genetic Study of Nicotine Dependence (COGEND; P01 CA089392) and the University of Wisconsin Transdisciplinary Tobacco Use Research Center (P50 DA019706, P50 CA084724).	Beaton AZ, 2009, AM J CARDIOL, V103, P266, DOI 10.1016/j.amjcard.2008.09.062; Brandler WM, 2015, ANNU REV MED, V66, P487, DOI 10.1146/annurev-med-091113-024550; Carlson M, 2012, CIRCULATION, V126, P2220, DOI 10.1161/CIRCULATIONAHA.111.088633; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Costain G, 2013, HUM MOL GENET, V22, P4485, DOI 10.1093/hmg/ddt297; Dykes IM, 2014, CIRC RES, V115, P23, DOI 10.1161/CIRCRESAHA.115.303300; Elefteriades John A., 2008, Yale Journal of Biology and Medicine, V81, P175; Frieden LA, 2010, DEV DYNAM, V239, P3226, DOI 10.1002/dvdy.22458; GILLUM RF, 1995, J CLIN EPIDEMIOL, V48, P1289, DOI 10.1016/0895-4356(95)00045-3; Heegaard AM, 2007, CIRCULATION, V115, P2731, DOI 10.1161/CIRCULATIONAHA.106.653980; Hoebeeck J, 2005, LAB INVEST, V85, P24, DOI 10.1038/labinvest.3700209; Hooli BV, 2014, MOL PSYCHIATR, V19, P676, DOI 10.1038/mp.2013.77; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Jurecka A, 2013, AM J MED GENET A, V161A, P1291, DOI 10.1002/ajmg.a.35905; Kameda Y, 2009, CELL TISSUE RES, V336, P165, DOI 10.1007/s00441-009-0760-7; McBride KL, 2011, BIRTH DEFECTS RES A, V91, P162, DOI 10.1002/bdra.20764; McBride KL, 2009, EUR J HUM GENET, V17, P811, DOI 10.1038/ejhg.2008.255; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; Milewicz DM, 2008, ANNU REV GENOM HUM G, V9, P283, DOI 10.1146/annurev.genom.8.080706.092303; Milewicz DM, 1998, AM J CARDIOL, V82, P474, DOI 10.1016/S0002-9149(98)00364-6; Prakash SK, 2014, J AM COLL CARDIOL, V64, P832, DOI 10.1016/j.jacc.2014.04.073; Prakash SK, 2010, AM J HUM GENET, V87, P743, DOI 10.1016/j.ajhg.2010.09.015; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raychaudhuri S, 2010, PLOS GENET, V6; Schaefer BM, 2008, HEART, V94, P1634, DOI 10.1136/hrt.2007.132092; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Singh R, 2007, FRONT BIOSCI-LANDMRK, V12, P4504, DOI 10.2741/2405; Tadros TM, 2009, CIRCULATION, V119, P880, DOI 10.1161/CIRCULATIONAHA.108.795401; Tomatsu S, 2008, HUM MOL GENET, V17, P815, DOI 10.1093/hmg/ddm353; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weaver S, 2010, METHODS, V50, P271, DOI 10.1016/j.ymeth.2010.01.003; Wheeler E, 2013, NAT GENET, V45, P513, DOI 10.1038/ng.2607	32	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153543	10.1371/journal.pone.0153543	http://dx.doi.org/10.1371/journal.pone.0153543			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092555	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200026
J	Ren, JW; Chen, GG; Liu, Y; Su, XW; Hu, BG; Leung, BCS; Wang, Y; Ho, RLK; Yang, SL; Lu, G; Lee, CG; Lai, PBS				Ren, Jianwai; Chen, George G.; Liu, Yi; Su, Xianwei; Hu, Baoguang; Leung, Billy C. S.; Wang, Y.; Ho, Rocky L. K.; Yang, Shengli; Lu, Gang; Lee, C. G.; Lai, Paul B. S.			Cytochrome P450 1A2 Metabolizes 17 beta-Estradiol to Suppress Hepatocellular Carcinoma	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; HISTONE DEACETYLASES; GENDER DISPARITY; CANCER CELLS; GROWTH; 2-METHOXYESTRADIOL; EXPRESSION; APOPTOSIS; ACTIVATION; PROLIFERATION	Hepatocellular carcinoma (HCC) occurs more frequently in men than in women. It is commonly agreed that estrogen plays important roles in suppressing HCC development, however, the underlying mechanism remains largely unknown. Since estrogen is mainly metabolized in liver and its metabolites affect cell proliferation, we sought to investigate if the liver-specific cytochrome P450 1A2 (CYP1A2) mediated the inhibitory effect of estrogen on HCC. In this study, the expression of estrogen-metabolizing enzyme CYP1A2 was determined in HCC tissues and cell lines. Cell proliferation and apoptosis were assessed in cells with or without CYP1A2 overexpression. The levels of 17 beta-estradiol (E2) and its metabolite 2-methoxyestradiol (2-ME) were determined. A xenograft tumor model in mice was established to confirm the findings. It was found that CYP1A2 expression was greatly repressed in HCC. E2 suppressed HCC cell proliferation and xenograft tumor development by inducing apoptosis. The inhibitory effect was significantly enhanced in cells with CYP1A2 overexpression, which effectively conversed E2 to the cytotoxic 2-ME. E2 in combination with sorafenib showed an additive effect on HCC. The anti-HCC effect of E2 was not associated with estrogen receptors ER alpha and ER beta as well as tumor suppressor P53 but enhanced by the approved anti-HCC drug sorafenib. In addition, HDAC inhibitors greatly induced CYP1A2 promoter activities in cancer cells, especially liver cancer cells, but not in non-tumorigenic cells. Collectively, CYP1A2 metabolizes E2 to generate the potent anti-tumor agent 2-ME in HCC. The reduction of CYP1A2 significantly disrupts this metabolic pathway, contributing the progression and growth of HCC and the gender disparity of this malignancy.	[Ren, Jianwai; Chen, George G.; Liu, Yi; Su, Xianwei; Hu, Baoguang; Leung, Billy C. S.; Ho, Rocky L. K.; Yang, Shengli; Lu, Gang; Lai, Paul B. S.] Chinese Univ Hong Kong, Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Ren, Jianwai; Chen, George G.] CUHK Shenzhen Res Inst SZRI, Shenzhen 518057, Peoples R China; [Liu, Yi] Guangdong Med Univ, Guangdong Key Lab Res & Dev Nat Drugs, Zhanjiang, Guangdong, Peoples R China; [Wang, Y.; Lee, C. G.] Natl Canc Ctr, Div Med Sci, Singapore, Singapore	Chinese University of Hong Kong; Guangdong Medical University; National Cancer Centre Singapore (NCCS)	Chen, GG (corresponding author), Chinese Univ Hong Kong, Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China.; Chen, GG (corresponding author), CUHK Shenzhen Res Inst SZRI, Shenzhen 518057, Peoples R China.	gchen@cuhk.edu.hk; paulai@cuhk.edu.hk	Lai, Paul BS/K-8556-2015; Chen, George Gong/I-2757-2016; Lee, Caroline G/M-8918-2019	Lai, Paul BS/0000-0002-9469-6728; Lee, Caroline G/0000-0002-4323-3635; Hu, Baoguang/0000-0002-6065-7720	Shenzhen SZSIA foundation [JCYJ20140425184428469]; Chinese University of Hong Kong [4054222]	Shenzhen SZSIA foundation; Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by Shenzhen SZSIA foundation under grant No. JCYJ20140425184428469, and a direct grant ( Ref No 4054222) from the Chinese University of Hong Kong.	Balasubramanian S, 2008, LEUKEMIA, V22, P1026, DOI 10.1038/leu.2008.9; BARBIERI RL, 1978, STEROIDS, V32, P529, DOI 10.1016/0039-128X(78)90064-8; BATRA S, 1980, BIOL REPROD, V22, P430, DOI 10.1095/biolreprod22.3.430; Bertani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067756; Bigsby RM, 2011, CARCINOGENESIS, V32, P1162, DOI 10.1093/carcin/bgr094; Boniol M, 2010, EUR J CANCER, V46, P2534, DOI 10.1016/j.ejca.2010.07.049; Chan QKY, 2010, CELL DEATH DIFFER, V17, P1511, DOI 10.1038/cdd.2010.20; Chang I, 2012, CARCINOGENESIS, V33, P420, DOI 10.1093/carcin/bgr294; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Du B, 2011, TUMORI J, V97, P660, DOI 10.1700/989.10728; El Naga RNA, 2009, PHARMACOLOGY, V84, P9, DOI 10.1159/000221062; ElSaadany S, 2002, CAN J PUBLIC HEALTH, V93, P443, DOI 10.1007/BF03405035; Folkerd EJ, 2014, J CLIN ONCOL, V32, P1396, DOI 10.1200/JCO.2013.53.9411; Galmiche A, 2014, CANCER LETT, V346, P159, DOI 10.1016/j.canlet.2013.12.028; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Huang EJ, 2006, MOL CELL BIOCHEM, V290, P1, DOI 10.1007/s11010-005-9000-y; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kar S, 2008, CANCER CHEMOTH PHARM, V62, P831, DOI 10.1007/s00280-007-0670-x; LaVallee TM, 2002, CANCER RES, V62, P3691; Lee CGL, 2003, ONCOGENE, V22, P2592, DOI 10.1038/sj.onc.1206337; Li Z, 2012, CELL, V148, P72, DOI 10.1016/j.cell.2011.11.026; Lin YM, 2013, ONCOL REP, V30, P3027, DOI 10.3892/or.2013.2793; Liu Jun, 2004, Hepatobiliary Pancreat Dis Int, V3, P110; Miceli V, 2011, OMICS, V15, P313, DOI 10.1089/omi.2010.0108; Moser C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-206; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Park SJ, 2006, CANCER GENET CYTOGEN, V166, P56, DOI 10.1016/j.cancergencyto.2005.08.022; Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240; Ruggieri A, 2010, INT J CANCER, V127, P499, DOI 10.1002/ijc.25298; Seli E, 2006, J CLIN ENDOCR METAB, V91, P4995, DOI 10.1210/jc.2006-1225; Shi L, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-93; Shimizu I, 2007, WORLD J GASTROENTERO, V13, P4295, DOI 10.3748/wjg.v13.i32.4295; Verenich S, 2010, MOL PHARMACEUT, V7, P2030, DOI 10.1021/mp100190f; Wang CJ, 2014, MOL MED REP, V10, P3125, DOI 10.3892/mmr.2014.2595; Wang SH, 2012, GASTROENTEROLOGY, V142, P989, DOI 10.1053/j.gastro.2011.12.045; Wang YC, 2011, HEPATO-GASTROENTEROL, V58, P2032, DOI 10.5754/hge10685; Wang YC, 2012, INFLAMMATION, V35, P143, DOI 10.1007/s10753-011-9299-3; Wardell SE, 2011, BIOCHEM PHARMACOL, V82, P122, DOI 10.1016/j.bcp.2011.03.031; Wu MH, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001143; Xu HW, 2012, J PATHOL, V228, P216, DOI 10.1002/path.4009; Yang WW, 2012, J BIOL CHEM, V287, P40140, DOI 10.1074/jbc.M112.348763; Yeh SH, 2010, ONCOLOGY-BASEL, V78, P172, DOI 10.1159/000315247; Zhou SF, 2009, AAPS J, V11, P481, DOI 10.1208/s12248-009-9127-y; Zhu BT, 2005, STEROIDS, V70, P225, DOI 10.1016/j.steroids.2005.01.002; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1; Zoller AL, 2006, J IMMUNOL, V176, P7371, DOI 10.4049/jimmunol.176.12.7371	50	28	31	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153863	10.1371/journal.pone.0153863	http://dx.doi.org/10.1371/journal.pone.0153863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093553	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200053
J	Bertocchio, JP; Barbe, C; Lavaud, S; Toupance, O; Nazeyrollas, P; Jaisser, F; Rieu, P				Bertocchio, Jean-Philippe; Barbe, Coralie; Lavaud, Sylvie; Toupance, Olivier; Nazeyrollas, Pierre; Jaisser, Frederic; Rieu, Philippe			Safety of Eplerenone for Kidney-Transplant Recipients with Impaired Renal Function and Receiving Cyclosporine A	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR ANTAGONIST; RANDOMIZED ALDACTONE EVALUATION; SELECTIVE ALDOSTERONE BLOCKER; GLOMERULAR-FILTRATION-RATE; REDUCED EJECTION FRACTION; SEVERE HEART-FAILURE; MYOCARDIAL-INFARCTION; METABOLIC-ACIDOSIS; TUBULAR FUNCTION; SPIRONOLACTONE	Background Animal studies have highlighted the role of vascular mineralocorticoid receptor during Cyclosporine A-induced nephrotoxicity. Mineralocorticoid receptor antagonists could improve kidney survival but are not commonly used during renal impairment and in association with several immunosuppressive drugs due to a supposed higher risk of adverse events. We tested the tolerance of eplerenone according to its expected adverse events: hyperkalemia, metabolic acidosis, hypotension, acute kidney failure, or any other adverse event. Methods We conducted a single-center, prospective, open-label study in 31 kidney-transplant recipients with impaired renal function (30 and 50 mL/min/1.73m(2)) and receiving cyclosporine A. All patients received eplerenone 25 mg/d for 8 weeks. Serum potassium, renal function and expected adverse events were closely monitored. Results Eight patients experienced mild hyperkalemia (>5 mmol/L), one moderate hyperkalemia (>5.5 mmol/L) and had to receive potassium-exchange resin. No severe hyperkalemia (>6 mmol/L) occurred. One acute kidney failure was observed, secondary to diarrhea. Basal serum potassium and bicarbonate were independently associated with a higher risk of developing mild hyperkalemia (>5 mmol/L) under treatment (OR 6.5, p = 0.003 and 0.7, p = 0.007, respectively). A cut-off value of 4.35 mmol/L for basal serum potassium was the best factor to predict the risk of developing mild hyperkalemia (>5 mmol/L). Conclusions Until eGFR falls to 30 mL/min/1.73m(2), eplerenone could be safely given to kidney-transplant recipients receiving cyclosporine A, if kalemia is closely monitored. When renal function is impaired and if basal kalemia is >4.35 mmol/L, then clinicians should properly balance risk and benefit of eplerenone use and offer dietary advice. An adequately powered prospective randomized study is now needed to test its efficiency (and safety) in this population.	[Bertocchio, Jean-Philippe; Lavaud, Sylvie; Toupance, Olivier; Rieu, Philippe] Reims Univ Hosp, Nephrol Dialysis & Transplantat Unit, Ave Cognacq Jay, F-51092 Reims, France; [Barbe, Coralie; Nazeyrollas, Pierre] Reims Univ Hosp, Biostat & Methodol unit, Ave Cognacq Jay, F-51092 Reims, France; [Bertocchio, Jean-Philippe; Jaisser, Frederic] INSERM, UMRS 1138, Team 1, Res Ctr Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France	CHU de Reims; Universite de Reims Champagne-Ardenne; CHU de Reims; Universite de Reims Champagne-Ardenne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Bertocchio, JP (corresponding author), Reims Univ Hosp, Nephrol Dialysis & Transplantat Unit, Ave Cognacq Jay, F-51092 Reims, France.; Bertocchio, JP (corresponding author), INSERM, UMRS 1138, Team 1, Res Ctr Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.	jean-philippe.bertocchio@aphp.fr	Jaisser, Frederic/P-4287-2017; Bertocchio, Jean-Philippe/Q-1768-2016	Jaisser, Frederic/0000-0001-9051-1901; Bertocchio, Jean-Philippe/0000-0002-4104-702X	Reims University Hospital; Institut National de la Sante et de la Recherche Medicale	Reims University Hospital; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm))	Reims University Hospital and the Institut National de la Sante et de la Recherche Medicale funded the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LA, 2014, CIRC-HEART FAIL, V7, P43, DOI 10.1161/CIRCHEARTFAILURE.113.000709; Amador CA, 2016, KIDNEY INT, V89, P354, DOI 10.1038/ki.2015.312; Bertocchio JP, 2011, KIDNEY INT, V79, P1051, DOI 10.1038/ki.2011.48; Bobadilla NA, 2007, AM J PHYSIOL-RENAL, V293, pF2, DOI 10.1152/ajprenal.00072.2007; Cat AND, 2010, FASEB J, V24, P2454, DOI 10.1096/fj.09-147926; Danjuma MI, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0414-8; Dobre M, 2015, J AM SOC NEPHROL, V26, P515, DOI 10.1681/ASN.2014020205; Edwards NC, 2012, BRIT J CLIN PHARMACO, V73, P447, DOI 10.1111/j.1365-2125.2011.04102.x; ENGLISH J, 1987, TRANSPLANTATION, V44, P135, DOI 10.1097/00007890-198707000-00027; Feria I, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.2003.00707.x; Galmiche G, 2014, HYPERTENSION, V63, P520, DOI 10.1161/HYPERTENSIONAHA.113.01967; Monte EG, 2010, TRANSPL P, V42, P2899, DOI 10.1016/j.transproceed.2010.08.024; HEERING P, 1991, NEPHRON, V59, P66, DOI 10.1159/000186520; Henger A, 2000, J LAB CLIN MED, V136, P379, DOI 10.1067/mlc.2000.110371; Hernandez AF, 2012, JAMA-J AM MED ASSOC, V308, P2097, DOI 10.1001/jama.2012.14795; Hocherl K, 2004, KIDNEY INT, V65, P2071, DOI 10.1111/j.1523-1755.2004.00627.x; Hoorn EJ, 2011, NAT MED, V17, P1304, DOI 10.1038/nm.2497; Ito Y, 2014, J AM SOC NEPHROL, V25, P1094, DOI 10.1681/ASN.2013030273; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Kaplan B, 1996, TRANSPLANTATION, V62, P1174, DOI 10.1097/00007890-199610270-00025; Keven K, 2007, NEPHROL DIAL TRANSPL, V22, P906, DOI 10.1093/ndt/gfl714; Khosla N, 2009, AM J NEPHROL, V30, P418, DOI 10.1159/000237742; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsumoto Y, 2014, J AM COLL CARDIOL, V63, P529, DOI 10.1016/j.jacc.2013.09.056; McCurley A, 2012, NAT MED, V18, P1429, DOI 10.1038/nm.2891; Melnikov S, 2011, EUR J CLIN INVEST, V41, P1113, DOI 10.1111/j.1365-2362.2011.02517.x; Menon MC, 2013, CURR OPIN PHARMACOL, V13, P662, DOI 10.1016/j.coph.2013.05.004; Mitterbauer C, 2008, NEPHROL DIAL TRANSPL, V23, P1442, DOI 10.1093/ndt/gfm864; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nankivell Brian J., 2003, New England Journal of Medicine, V349, P2326, DOI 10.1056/NEJMoa020009; Nielsen FT, 2008, NEPHROL DIAL TRANSPL, V23, P2777, DOI 10.1093/ndt/gfn204; Perez-Rojas JM, 2005, AM J PHYSIOL-RENAL, V289, pF1020, DOI 10.1152/ajprenal.00166.2005; Pitt B, 1996, AM J CARDIOL, V78, P902; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rossignol P, 2014, CIRC-HEART FAIL, V7, P51, DOI 10.1161/CIRCHEARTFAILURE.113.000792; Rossignol P, 2011, J AM COLL CARDIOL, V58, P1958, DOI 10.1016/j.jacc.2011.04.049; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; SIMON R, 1989, CONTROL CLIN TRIALS, V10, P1, DOI 10.1016/0197-2456(89)90015-9; Smyth A, 2014, KIDNEY INT, V86, P1205, DOI 10.1038/ki.2014.214; STAHL RAK, 1986, CLIN NEPHROL, V25, P245; Sun QL, 2015, J RENIN-ANGIO-ALDO S, V16, P301, DOI 10.1177/1470320314561248; TUMLIN JA, 1993, KIDNEY INT, V43, P246, DOI 10.1038/ki.1993.38; Vardeny O, 2014, CIRC-HEART FAIL, V7, P573, DOI 10.1161/CIRCHEARTFAILURE.114.001104; Weinberger MH, 2002, AM J HYPERTENS, V15, P709, DOI 10.1016/S0895-7061(02)02957-6; Weir MR, 2015, NEW ENGL J MED, V372, P211, DOI 10.1056/NEJMoa1410853; Zannad F, 2012, EUR HEART J, V33, P2782, DOI 10.1093/eurheartj/ehs257; Zannad F, 2011, NEW ENGL J MED, V364, P11, DOI 10.1056/NEJMoa1009492; Zhang Y, 2008, AM J PHYSIOL-CELL PH, V294, pC765, DOI 10.1152/ajpcell.00528.2007	51	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153635	10.1371/journal.pone.0153635	http://dx.doi.org/10.1371/journal.pone.0153635			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088859	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000033
J	Tran, TB; Baek, C; Min, J				Trong Binh Tran; Baek, Changyoon; Min, Junhong			Electric Cell-Substrate Impedance Sensing (ECIS) with Microelectrode Arrays for Investigation of Cancer Cell - Fibroblasts Interaction	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; PROLIFERATION; DIFFERENTIATION; CYTOTOXICITY; INHIBITION; ATTACHMENT	The tumor microenvironment, including stromal cells, surrounding blood vessels and extracellular matrix components, has been defined as a crucial factor that influences the proliferation, drug-resistance, invasion and metastasis of malignant epithelial cells. Among other factors, the communications and interaction between cancer cells and stromal cells have been reported to play pivotal roles in cancer promotion and progression. To investigate these relationships, an on-chip co-culture model was developed to study the cellular interaction between A549-human lung carcinoma cells and MRC-5-human lung epithelial cells in both normal proliferation and treatment conditions. In brief, a co-culture device consisting of 2 individual fluidic chambers in parallel, which were separated by a 100 mu m fence was utilized for cell patterning. Microelectrodes arrays were installed within each chamber including electrodes at various distances away from the confrontation line for the electrochemical impedimetric sensing assessment of cell-to-cell influence. After the fence was removed and cell-to-cell contact occurred, by evaluating the impedance signal responses representing cell condition and behavior, both direct and indirect cell-to-cell interactions through conditioned media were investigated. The impact of specific distances that lead to different influences of fibroblast cells on cancer cells in the co-culture environment was also defined.	[Trong Binh Tran; Baek, Changyoon; Min, Junhong] Chung Ang Univ, Sch Integrat Engn, Seoul 156756, South Korea	Chung Ang University	Min, J (corresponding author), Chung Ang Univ, Sch Integrat Engn, Seoul 156756, South Korea.	junmin@cau.ac.kr			BioNano Health-Guard Research Center; Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project [H-GUARD 2015M3A6B2063548]; NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF); Korea government (MSIP) [NRF-2014M3A7B4051907]	BioNano Health-Guard Research Center; Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project; NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF); Korea government (MSIP)	This research was supported by the BioNano Health-Guard Research Center, funded by the Ministry of Science, ICT & Future Planning (MSIP) of Korea as Global Frontier Project (H-GUARD 2015M3A6B2063548) and was supported by the NanoMaterial Technology Development Program through the National Research Foundation of Korea (NRF), funded by the Korea government (MSIP) (NRF-2014M3A7B4051907).	Albini A, 2007, NAT REV CANCER, V7, P139, DOI 10.1038/nrc2067; Alexeyenko A, 2015, J EXP CLIN CANC RES, V18, P34; Alkasalias T, 2014, P NATL ACAD SCI USA, V111, P17188, DOI 10.1073/pnas.1419554111; Campbell CE, 2007, BIOSENS BIOELECTRON, V23, P536, DOI 10.1016/j.bios.2007.06.015; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Flaberg E, 2012, INT J CANCER, V131, P2274, DOI 10.1002/ijc.27521; Flaberg E, 2011, INT J CANCER, V128, P2793, DOI 10.1002/ijc.25612; Fukumura D, 2007, MICROVASC RES, V74, P72, DOI 10.1016/j.mvr.2007.05.003; Hadjout N, 2001, BIOTECHNIQUES, V31, P1130, DOI 10.2144/01315rr02; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Iacopino F, 2012, ANTICANCER RES, V32, P1579; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Mishra DK, 2015, ANN THORAC SURG, V100, P1167, DOI 10.1016/j.athoracsur.2015.05.014; MITRA P, 1991, BIOTECHNIQUES, V11, P504; Pillai GR, 2004, CANCER LETT, V208, P163, DOI 10.1016/j.canlet.2004.01.008; Raof NA, 2011, BIOMATERIALS, V32, P4130, DOI 10.1016/j.biomaterials.2011.02.035; Riahi R, 2012, JALA-J LAB AUTOM, V17, P59, DOI 10.1177/2211068211426550; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Spink BC, 2006, CELL BIOL INT, V30, P227, DOI 10.1016/j.cellbi.2005.11.006; STOKER MGP, 1966, J CELL SCI, V1, P297; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; Tlsty TD, 2001, CURR OPIN GENET DEV, V11, P54, DOI 10.1016/S0959-437X(00)00156-8; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tran TB, 2013, BIOSENS BIOELECTRON, V50, P453, DOI 10.1016/j.bios.2013.07.019; Tran TB, 2016, BIOSENS BIOELECTRON, V77, P631, DOI 10.1016/j.bios.2015.10.030; Wadlow RC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006888; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Xiao C, 2002, ANAL CHEM, V74, P1333, DOI 10.1021/ac011104a; Xie FB, 2012, ANALYST, V137, P1343, DOI 10.1039/c2an16141a; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Zeisberg M, 2000, J NEPHROL, V13, pS111; Zhang J, 2010, BIOCHEM BIOPH RES CO, V399, P1, DOI 10.1016/j.bbrc.2010.07.013	34	31	34	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153813	10.1371/journal.pone.0153813	http://dx.doi.org/10.1371/journal.pone.0153813			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088611	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000051
J	Brucks, D; Essler, JL; Marshall-Pescini, S; Range, F				Brucks, Desiree; Essler, Jennifer L.; Marshall-Pescini, Sarah; Range, Friederike			Inequity Aversion Negatively Affects Tolerance and Contact-Seeking Behaviours towards Partner and Experimenter	PLOS ONE			English	Article							MEASURING HEART-RATE; RATE MONITOR; DOGS; MONKEYS; APES	Inequity aversion has been proposed to act as a limiting factor for cooperation, thus preventing subjects from disadvantageous cooperative interactions. While a recent study revealed that also dogs show some sensitivity to inequity, the underlying mechanisms of this behaviour are still unclear. The aim of the current study was threefold: 1) to replicate the study by Range et al. (2009, PNAS, 106, 340-345); 2) to investigate the emotional mechanisms involved in the inequity response by measuring the heart rate and 3) to explore the link between inequity aversion and cooperation in terms of behaviours shown towards the partner dog and towards the experimenter who caused the inequity. Dog tested in dyads were alternately asked to give their paw and were either equally or unequally rewarded by the experimenter. After each social test condition, we conducted food tolerance tests and free interaction tests in which the subjects' social behaviour towards the partner and the experimenter were observed. As in the previous study, subjects refused to continue giving their paw when only the partner was rewarded, but not when both dogs were rewarded with rewards of different quality. Although subjects did not react to this quality inequity during the test, we did find reduced durations of food sharing in the subsequent tolerance test, indicating that dogs perceived the inequity but were not able to react to it in the test context. Moreover, subjects avoided their partner and the experimenter more during the free interaction time following unequal compared to equal treatment. Despite the clear behavioural reactions to inequity, we could not detect any changes in heart rate. Results suggest that inequity aversion might in fact be mediated by simple emotional mechanisms: sharing a negative experience, like inequity, might reduce future cooperation by decreasing the likelihood of proximity being maintained between partners.	[Brucks, Desiree; Essler, Jennifer L.; Marshall-Pescini, Sarah; Range, Friederike] Univ Vienna, Med Univ Vienna, Univ Vet Med, Comparat Cognit,Messerli Res Inst, Vienna, Austria	Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Brucks, D (corresponding author), Univ Vienna, Med Univ Vienna, Univ Vet Med, Comparat Cognit,Messerli Res Inst, Vienna, Austria.	desiree.brucks@vetmeduni.ac.at	Brucks, Désirée/AAF-6788-2020	Range, Friederike/0000-0003-3127-5536; Brucks, Desiree/0000-0003-3146-5110; Marshall-Pescini, Sarah/0000-0002-5944-4701	Austrian Science Fund (FWF) [P24840]; European Research Council under the European Union [311870]; Austrian Science Fund (FWF) [P 24840] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); European Research Council under the European Union(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	DB was funded by the Austrian Science Fund (FWF) project (P24840), JLE, SMP and FR by the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement n. [311870]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Bailey I, 2013, BEHAV ECOL SOCIOBIOL, V67, P1, DOI 10.1007/s00265-012-1423-3; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Bentosela M, 2009, J COMP PSYCHOL, V123, P125, DOI 10.1037/a0013340; Brauer J, 2012, SOC JUSTICE RES, V25, P256, DOI 10.1007/s11211-012-0159-6; Brauer J, 2006, P ROY SOC B-BIOL SCI, V273, P3123, DOI 10.1098/rspb.2006.3693; Brauer J, 2009, AM J PRIMATOL, V71, P175, DOI 10.1002/ajp.20639; Brosnan SF, 2006, AM J PRIMATOL, V68, P713, DOI 10.1002/ajp.20261; Brosnan SF, 2014, SCIENCE, V346, P314, DOI 10.1126/science.1251776; Brosnan SF, 2013, P NATL ACAD SCI USA, V110, P10416, DOI 10.1073/pnas.1301194110; Brosnan SF, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00043; Brosnan SF, 2010, EVOL HUM BEHAV, V31, P279, DOI 10.1016/j.evolhumbehav.2010.02.003; Brosnan SF, 2010, ANIM BEHAV, V79, P1229, DOI 10.1016/j.anbehav.2010.02.019; Brosnan SF, 2005, P ROY SOC B-BIOL SCI, V272, P253, DOI 10.1098/rspb.2004.2947; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; CREEL S, 1995, ANIM BEHAV, V50, P1325, DOI 10.1016/0003-3472(95)80048-4; Cronin KA, 2008, ANIM BEHAV, V75, P245, DOI 10.1016/j.anbehav.2007.04.032; Essner A, 2013, PHYSIOL BEHAV, V114, P1, DOI 10.1016/j.physbeh.2013.03.002; Hopper L. M., 2013, J PRIMATOL, V2, P109, DOI [10.4172/2167-6801.1000109, DOI 10.4172/2167-6801.1000109]; Horowitz A, 2012, SOC JUSTICE RES, V25, P195, DOI 10.1007/s11211-012-0158-7; Jonckheer-Sheehy VSM, 2012, J VET BEHAV, V7, P205, DOI 10.1016/j.jveb.2011.10.006; Lamb Allison P, 2010, J Vet Cardiol, V12, P107, DOI 10.1016/j.jvc.2010.04.001; MacNulty DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112884; Massen JJM, 2012, AM J PRIMATOL, V74, P145, DOI 10.1002/ajp.21014; Mech D., 2003, WOLVES BEHAV ECOLOGY; Melis AP, 2009, EVOL HUM BEHAV, V30, P381, DOI 10.1016/j.evolhumbehav.2009.05.003; Osumi T, 2009, INT J PSYCHOPHYSIOL, V74, P74, DOI 10.1016/j.ijpsycho.2009.07.007; Pillutla MM, 1996, ORGAN BEHAV HUM DEC, V68, P208, DOI 10.1006/obhd.1996.0100; Range F, 2009, P NATL ACAD SCI USA, V106, P340, DOI 10.1073/pnas.0810957105; Roma PG, 2006, J COMP PSYCHOL, V120, P67, DOI 10.1037/0735-7036.120.1.67; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Schoberl I, 2015, BEHAV RES METHODS, V47, P1356, DOI 10.3758/s13428-014-0546-z; Silberberg A, 2009, ANIM COGN, V12, P505, DOI 10.1007/s10071-009-0211-6; van Wolkenten M, 2007, P NATL ACAD SCI USA, V104, P18854, DOI 10.1073/pnas.0707182104; Wascher CAF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056885	35	23	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153799	10.1371/journal.pone.0153799	http://dx.doi.org/10.1371/journal.pone.0153799			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27081852	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800054
J	Hasanuzzaman, AM; Islam, MN; Zhang, Y; Zhang, CY; Liu, TX				Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian			Leaf Morphological Characters Can Be a Factor for Intra-Varietal Preference of Whitefly Bemisia tabaci (Hemiptera: Aleyrodidae) among Eggplant Varieties	PLOS ONE			English	Article							TRIALEURODES-VAPORARIORUM; ARGENTIFOLII HOMOPTERA; HOST PREFERENCE; B-BIOTYPE; TRAP CROP; RESISTANCE; COTTON; OVIPOSITION; ATTRACTION; ENEMIES	The sweetpotato whitefly, Bemisia tabaci (Hemiptera: Aleyrodidae) MEAM1, is considered a serious pest of horticultural and many other crops. While eggplant (Solanum melongena) is one of the most favored host plants, the whiteflies exhibit preferences among different varieties. We hypothesized that certain morphological leaf characteristics of different varieties, like leaf trichome density, trichome length, leaf lamina thickness and leaf color, may affect whitefly landing, feeding and oviposition. In this study, we investigated the variation in leaf morphological characters among selected eggplant varieties and evaluated the effect of these leaf characteristics in rendering eggplant varieties either susceptible or resistant to B. tabaci. We evaluated eight eggplant varieties in choice feeding tests, and we found that the varieties JinSheng Zilongchangqie (JSZ) and H149 were the highly preferred varieties with the highest numbers of whitefly adults and eggs. Significantly lower numbers of whitefly adult eggs were found on the resistant variety Tuo Lu Bamu (TLB). The varieties Jin-Guangbo Luqie (JGL), JinGuangbo Ziquanqie (JGZ), DaYang Ziguanqie (DYZ), QinXing Ziguanqie (QXZ), and QinXing Niuxinqie (QXN) were moderately favored by B. tabaci. Leaf trichome density, trichome length and leaf lamina thickness were positively correlated with numbers of whitefly adults and eggs. B. tabaci was less attracted to the leaves that reflect long and middle wavelength light (higher R and G values) than to the bright green leaves (medium G value), but the short wavelength light (higher B value) had no significant effect on whitefly preference. The degree of hue had a positive effect, and saturation and brightness had a negative effect on whitefly attraction.	[Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China; [Hasanuzzaman, Abu Tayeb Mohammad; Islam, Md Nazrul; Zhang, Yi; Zhang, Chen-Yang; Liu, Tong-Xian] Northwest A&F Univ, Minist Agr, Key Lab Integrated Pest Management Loess Plateau, Yangling 712100, Shaanxi, Peoples R China; [Hasanuzzaman, Abu Tayeb Mohammad] Bangladesh Agr Res Inst, Vertebrate Pest Div, Gazipur 1701, Bangladesh; [Islam, Md Nazrul] Atom Energy Res Estab, Inst Food & Radiat Biol, Agrochem & Environm Res Div, Dhaka, Bangladesh	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China; Bangladesh Agricultural Research Institute (BARI)	Liu, TX (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling 712100, Shaanxi, Peoples R China.; Liu, TX (corresponding author), Northwest A&F Univ, Minist Agr, Key Lab Integrated Pest Management Loess Plateau, Yangling 712100, Shaanxi, Peoples R China.	txliu@nwsuaf.edu.cn			National Natural Science Foundation of China [31272089]; National Basic Research Program of China (973 Project) [2013CB127600]; China Agriculture Research System [CARS-25-B-06]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Project)(National Basic Research Program of China); China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31272089), National Basic Research Program of China (973 Project No. 2013CB127600), and China Agriculture Research System (No. CARS-25-B-06).	Acharya VS, 2008, INDIAN J AGR SCI, V78, P818; Ayyasamy R., 2005, Journal of Food Agriculture & Environment, V3, P333; BERLINGER MJ, 1980, ENTOMOL EXP APPL, V27, P98, DOI 10.1007/BF00377246; BERLINGER MJ, 1986, AGR ECOSYST ENVIRON, V17, P69, DOI 10.1016/0167-8809(86)90028-9; Boykin LM, 2014, PEST MANAG SCI, V70, P1454, DOI 10.1002/ps.3709; BUTTER NS, 1989, PHYTOPARASITICA, V17, P251, DOI 10.1007/BF02980754; Byrne FJ, 2010, CROP PROT, V29, P260, DOI 10.1016/j.cropro.2009.11.007; Cavanagh A, 2009, J ECON ENTOMOL, V102, P1101, DOI 10.1603/029.102.0331; CHU CC, 1995, ENVIRON ENTOMOL, V24, P354, DOI 10.1093/ee/24.2.354; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Oriani MAD, 2011, SCI AGR, V68, P37, DOI 10.1590/S0103-90162011000100006; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Dharmendar Singh, 2002, Haryana Journal of Horticultural Sciences, V31, P289; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; ELSEY KD, 1994, HORTSCIENCE, V29, P814, DOI 10.21273/HORTSCI.29.7.814; Feng YT, 2010, PEST MANAG SCI, V66, P313, DOI 10.1002/ps.1877; Frisbie RE, 1994, INTRO INSECT PEST MA, P421; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Halitschke R, 2008, ECOL LETT, V11, P24, DOI 10.1111/j.1461-0248.2007.01123.x; HEINZ KM, 1995, J ECON ENTOMOL, V88, P1494, DOI 10.1093/jee/88.5.1494; Islam MT, 2010, ACTA AGR SCAND B-S P, V60, P320, DOI 10.1080/09064710902976974; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; KISHABA AN, 1992, HORTSCIENCE, V27, P1217, DOI 10.21273/HORTSCI.27.11.1217; Lakshminarayan S., 2008, Environment and Ecology, V26, P978; Lee DH, 2009, ENTOMOL EXP APPL, V133, P105, DOI 10.1111/j.1570-7458.2009.00920.x; Li SJ, 2011, INSECT SCI, V18, P101, DOI 10.1111/j.1744-7917.2010.01395.x; Lin Ke-Jian, 2003, Acta Ecologica Sinica, V23, P870; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Lu YH, 2009, CROP PROT, V28, P77, DOI 10.1016/j.cropro.2008.08.018; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; Maskato Y, 2014, ARTHROPOD-PLANT INTE, V8, P285, DOI 10.1007/s11829-014-9307-2; MISRA C. S., 1929, Bull. Agric. Res. Inst. Pusa; MOUND LAURENCE A., 1962, ENTOMOL EXPTL ET APPL, V5, P99, DOI 10.1111/j.1570-7458.1962.tb00571.x; Mouttet R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018840; Mumm R, 2010, CAN J ZOOL, V88, P628, DOI 10.1139/Z10-032; Oriani MAD, 2005, NEOTROP ENTOMOL, V34, P97, DOI 10.1590/S1519-566X2005000100014; Oriani MAD, 2010, NEOTROP ENTOMOL, V39, P1002, DOI 10.1590/S1519-566X2010000600024; OZGUR AF, 1986, AGR ECOSYST ENVIRON, V17, P83, DOI 10.1016/0167-8809(86)90029-0; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Petro L, 2002, PREFERENCE PERFORMAN; Petro LO, 2000, HOST PLANT PREFERENC; Polston JE, 1999, MANEJO INTEGRADO PLA, V53, P24; Rustamani M. A., 2014, Sindh University Research Journal -Science Series, V46, P351; Schuster DJ, 2010, PEST MANAG SCI, V66, P186, DOI 10.1002/ps.1853; Shah MMR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077368; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shepherd RW, 2005, PLANT CELL, V17, P1851, DOI 10.1105/tpc.105.031559; Shibuya T, 2009, J ECON ENTOMOL, V102, P2265, DOI 10.1603/029.102.0631; Silva GFD, 2012, CHIL J AGR RES, V72, P516; Soundararajan R. P., 2001, Madras Agricultural Journal, V88, P657; Taggar GK, 2012, PHYTOPARASITICA, V40, P461, DOI 10.1007/s12600-012-0247-z; Unsicker SB, 2009, CURR OPIN PLANT BIOL, V12, P479, DOI 10.1016/j.pbi.2009.04.001; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Wang ZY, 2009, PEST MANAG SCI, V65, P1189, DOI 10.1002/ps.1808; White J., 1998, CALIF AGR, V52, P6; Zhao L. R., 2000, XINJIANG AGR SCI, V1, P27; ZHOU Y, 1949, ENTOMOL SINICA, V3, P1	58	31	34	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153880	10.1371/journal.pone.0153880	http://dx.doi.org/10.1371/journal.pone.0153880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081849	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800063
J	Lin, WL; Quintero, A; Zhang, YX				Lin, Weilin; Quintero, Andres; Zhang, Yixin			Conformational Heterogeneity of Cyclosporin A in Cyclophilin 18 Binding	PLOS ONE			English	Article							PEPTIDE CONFORMATIONS; CRYSTAL-STRUCTURE; INHIBITION	The immunosuppressive drug cyclosporin A (CsA) binds to its receptor protein cyclophilin 18 (Cyp18) in two distinct kinetic phases, while the mechanism remains elusive. Stopped-flow measurements coupled with titration and competition experiments were used to investigate the puzzling two-phase process of CsA and Cyp18 interaction. This study leads to the dissection of different conformational fractions of either direct fast binding or slow binding with rate-limiting conformational inter-conversion and the real-time measurement of k(on) value (8.34 +/- 0.22 x10(6) M(-1)s(-1)) in solution. Furthermore, our study indicates that the structure of CsA during dissociation from the protein possesses a distribution of conformations different from those in solution under equilibrium condition.	[Lin, Weilin; Quintero, Andres; Zhang, Yixin] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany	Technische Universitat Dresden	Zhang, YX (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, Arnoldstr 18, D-01307 Dresden, Germany.	yixin.zhang@bcube-dresden.de		Lin, Weilin/0000-0002-2262-5859	German Bundesministerium fur Bildung und Forschung (BMBF) [03Z2EN12]	German Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work is supported by the German Bundesministerium fur Bildung und Forschung (BMBF) Grant 03Z2EN12.	Baumgrass R, 2004, J BIOL CHEM, V279, P2470, DOI 10.1074/jbc.M304754200; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2; Gaither LA, 2010, VIROLOGY, V397, P43, DOI 10.1016/j.virol.2009.10.043; Huai Q, 2002, P NATL ACAD SCI USA, V99, P12037, DOI 10.1073/pnas.192206699; Janowski B, 1997, BIOORGAN MED CHEM, V5, P179, DOI 10.1016/S0968-0896(96)00198-8; Jin L, 2002, P NATL ACAD SCI USA, V99, P13522, DOI 10.1073/pnas.212504399; KESSLER H, 1985, HELV CHIM ACTA, V68, P661, DOI 10.1002/hlca.19850680318; KESSLER H, 1990, HELV CHIM ACTA, V73, P1818, DOI 10.1002/hlca.19900730703; KOFRON JL, 1992, J AM CHEM SOC, V114, P2670, DOI 10.1021/ja00033a047; LIU J, 1991, BIOCHEMISTRY-US, V30, P2306, DOI 10.1021/bi00223a003; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; Macey R., 2000, BERKELEY MADONNA USE; Mallis RJ, 2002, NAT STRUCT BIOL, V9, P900, DOI 10.1038/nsb864; Zhang YX, 2009, NAT CHEM BIOL, V5, P724, DOI 10.1038/nchembio.214; Zhang YX, 2004, CHEMBIOCHEM, V5, P1006, DOI 10.1002/cbic.200400020	16	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153669	10.1371/journal.pone.0153669	http://dx.doi.org/10.1371/journal.pone.0153669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082870	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800042
J	Pedersen, MK; Andersen, AB; Andersen, PH; Svensson, E; Jensen, SG; Lillebaek, T				Pedersen, Mathias Klok; Andersen, Aase Bengaard; Andersen, Peter Henrik; Svensson, Erik; Jensen, Sidse Graff; Lillebaek, Troels			Occupational Tuberculosis in Denmark through 21 Years Analysed by Nationwide Genotyping	PLOS ONE			English	Article							HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; OUTBREAK; STRAIN; RISK	Tuberculosis (TB) is a well-known occupational hazard. Based on more than two decades (1992-2012) of centralized nationwide genotyping of all Mycobacterium tuberculosis culture-positive TB patients in Denmark, we compared M. tuberculosis genotypes from all cases notified as presumed occupational (N = 130) with M. tuberculosis genotypes from all TB cases present in the country (N = 7,127). From 1992 through 2006, the IS6110 Restriction Fragment Length Polymorphism (RFLP) method was used for genotyping, whereas from 2005 to present, the 24-locus-based Mycobacterial Interspersed Repetitive Unit-Variable Number of Tandem Repeat (MIRU-VNTR) was used. An occupational TB case was classified as clustered if the genotype was 100% identical to at least one other genotype. Subsequently, based on genotype, time period, smear positivity, geography, susceptibility pattern, and any reported epidemiological links between the occupational cases and any potential source cases, the occupational case was categorized as confirmed, likely, possible or unlikely occupationally infected. Among the 130 notified presumed occupational cases, 12 (9.2%) could be classified as confirmed and 46 (35.4%) as unlikely, accounting for nearly half of all cases (44.6%). The remaining 72 cases (55.4%) were categorized as possible. Within this group, 15 cases (11.5%) were assessed to be likely occupational. Our study shows that genotyping can serve as an important tool for disentangle occupational TB in high-income low incidence settings, but still needs to be combined with good epidemiological linkage information.	[Pedersen, Mathias Klok; Svensson, Erik; Lillebaek, Troels] Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark; [Andersen, Aase Bengaard] Copenhagen Univ Hosp, Dept Infect Dis, Copenhagen, Denmark; [Andersen, Peter Henrik] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen, Denmark; [Jensen, Sidse Graff] Gentofte Univ Hosp, Dept Pulm Med, Hellerup, Denmark	Statens Serum Institut; University of Copenhagen; Statens Serum Institut; University of Copenhagen; Herlev & Gentofte Hospital	Pedersen, MK (corresponding author), Statens Serum Inst, Int Reference Lab Mycobacteriol, DK-2300 Copenhagen, Denmark.	makp@ssi.dk	; Svensson, Erik/Q-5926-2018	Lillebaek, Troels/0000-0002-2601-2718; Svensson, Erik/0000-0003-0797-1080; Andersen, Aase Bengaard/0000-0003-4779-7603				BergmireSweat D, 1996, EPIDEMIOL INFECT, V117, P485, DOI 10.1017/S095026880005915X; Danish Health Authority, 2015, GUID PREV TUB; Danish Society of Respiratory Medicine Danish Society of Infectious Diseases Danish Paediatric Society Danish Society of Clinical Microbiology and Statens Serum Institut, 2010, TUB CONTR DENM NAT T; de Vries G, 2006, EUR RESPIR J, V28, P1216, DOI 10.1183/09031936.06.00039906; Diel R, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-35; Field MJ, 2001, TUBERCULOSIS IN THE WORKPLACE, P13; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Johnson KR, 2000, JAMA-J AM MED ASSOC, V284, P1683, DOI 10.1001/jama.284.13.1683; Jones TF, 1999, ANN INTERN MED, V131, P557, DOI 10.7326/0003-4819-131-8-199910190-00002; Kamper-Jorgensen Z, 2009, CLIN RESPIR J, V3, P55, DOI 10.1111/j.1752-699X.2008.00074.x; Lauzardo M, 2001, CHEST, V119, P640, DOI 10.1378/chest.119.2.640; Lillebaek T, 2013, J CLIN MICROBIOL, V51, P4040, DOI 10.1128/JCM.01916-13; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098; Statens Serum Institut, 2015, EPI NEWS NEWSL TUB; Sterling TR, 2000, NEW ENGL J MED, V342, P246, DOI 10.1056/NEJM200001273420404; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993	22	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153668	10.1371/journal.pone.0153668	http://dx.doi.org/10.1371/journal.pone.0153668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082745	Green Published, gold			2022-12-27	WOS:000374291800041
J	Zhu, R; Yang, TJ; Kobeissy, F; Mouhieddine, TH; Raad, M; Nokkari, A; Gold, MS; Wang, KK; Mechref, Y				Zhu, Rui; Yang, Tianjiao; Kobeissy, Firas; Mouhieddine, Tarek H.; Raad, Mohamad; Nokkari, Amaly; Gold, Mark S.; Wang, Kevin K.; Mechref, Yehia			The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; GRAY-MATTER VOLUME; NEURONAL APOPTOSIS; MOUSE-BRAIN; DOPAMINERGIC-NEURONS; MEDIATED PROTEOLYSIS; PARKINSONS-DISEASE; MOLECULAR-BASES; CELL-LINE; FETUIN-A	Nowadays, drug abuse and addiction are serious public health problems in the USA. Methamphetamine (METH) is one of the most abused drugs and is known to cause brain damage after repeated exposure. In this paper, we conducted a neuroproteomic study to evaluate METH-induced brain protein dynamics, following a two-week chronic regimen of an escalating dose of METH exposure. Proteins were extracted from rat brain hippocampal and olfactory bulb tissues and subjected to liquid chromatography-mass spectrometry (LCMS/MS) analysis. Both shotgun and targeted proteomic analysis were performed. Protein quantification was initially based on comparing the spectral counts between METH exposed animals and their control counterparts. Quantitative differences were further confirmed through multiple reaction monitoring (MRM) LC-MS/MS experiments. According to the quantitative results, the expression of 18 proteins (11 in the hippocampus and 7 in the olfactory bulb) underwent a significant alteration as a result of exposing rats to METH. 13 of these proteins were up-regulated after METH exposure while 5 were down-regulated. The altered proteins belonging to different structural and functional families were involved in processes such as cell death, inflammation, oxidation, and apoptosis.	[Zhu, Rui; Yang, Tianjiao; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Kobeissy, Firas; Gold, Mark S.; Wang, Kevin K.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA; [Mouhieddine, Tarek H.; Raad, Mohamad] Amer Univ Beirut, Med Ctr, Fac Med, Beirut, Lebanon; [Nokkari, Amaly] Amer Univ Beirut, Med Ctr, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon	Texas Tech University System; Texas Tech University; State University System of Florida; University of Florida; American University of Beirut; American University of Beirut	Mechref, Y (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.; Wang, KK (corresponding author), Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA.	kwang@psychiatry.ufl.edu; yehia.mechref@ttu.edu	Kobeissy, Firas/E-7042-2017; Mechref, Yehia/I-5126-2013	Kobeissy, Firas/0000-0002-5008-6944; Mechref, Yehia/0000-0002-6661-6073; Raad, Mohamad/0000-0002-5446-3786; Wang, Kevin/0000-0002-9343-6473; Mouhieddine, Tarek/0000-0002-1190-5978	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112490] Funding Source: NIH RePORTER; NCATS NIH HHS [UL1 TR001427] Funding Source: Medline; NIGMS NIH HHS [R01 GM112490] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adinoff B, 2004, HARVARD REV PSYCHIAT, V12, P305, DOI 10.1080/10673220490910844; Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; Akiyama K, 2008, PROG NEURO-PSYCHOPH, V32, P1957, DOI 10.1016/j.pnpbp.2008.09.021; Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; Cadet JL, 2003, FASEB J, V17, P1775, DOI 10.1096/fj.03-0073rev; Cecchi GA, 2001, J COMPUT NEUROSCI, V11, P175, DOI 10.1023/A:1012849801892; Chen Q, 2007, AM J PHYSIOL-CELL PH, V292, pC137, DOI 10.1152/ajpcell.00270.2006; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; Choi HJ, 2002, MOL CELLS, V13, P221; Crochemore C, 2009, MUSCLE NERVE, V39, P548, DOI 10.1002/mus.21260; Daulatzai MA, 2015, J NEURAL TRANSM, V122, P1475, DOI 10.1007/s00702-015-1404-6; Davidson C, 2001, BRAIN RES REV, V36, P1, DOI 10.1016/S0165-0173(01)00054-6; Deng XL, 2007, BIOL PSYCHIAT, V61, P1235, DOI 10.1016/j.biopsych.2006.09.010; Deng XL, 2002, MOL PHARMACOL, V62, P993, DOI 10.1124/mol.62.5.993; Deng XL, 2002, NEUROPHARMACOLOGY, V42, P837, DOI 10.1016/S0028-3908(02)00034-5; DEVITO MJ, 1989, NEUROPHARMACOLOGY, V28, P1145, DOI 10.1016/0028-3908(89)90130-5; Sanchez-Nino MD, 2010, J AM SOC NEPHROL, V21, P610, DOI 10.1681/ASN.2009020227; Elsas J, 2013, DEV NEUROBIOL, V73, P354, DOI 10.1002/dneu.22064; Ernst T, 2000, NEUROLOGY, V54, P1344, DOI 10.1212/WNL.54.6.1344; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Finnegan S, 2010, MOL VIS, V16, P7; Freese TE, 2000, J PSYCHOACTIVE DRUGS, V32, P177, DOI 10.1080/02791072.2000.10400226; Galinato MH, 2015, NEUROSCIENCE, V286, P97, DOI 10.1016/j.neuroscience.2014.11.042; Gluck MR, 2001, J NEUROCHEM, V79, P152, DOI 10.1046/j.1471-4159.2001.00549.x; Granado N, 2010, NEUROTOX RES, V18, P48, DOI 10.1007/s12640-009-9106-1; Groman SM, 2013, PSYCHOPHARMACOLOGY, V229, P527, DOI 10.1007/s00213-013-3159-9; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hanaya R, 2012, NEUROSCIENCE, V221, P12, DOI 10.1016/j.neuroscience.2012.06.058; Herrero-Mendez A, 2009, NAT CELL BIOL, V11, P747, DOI 10.1038/ncb1881; Huh GY, 2001, NEUROSCI LETT, V316, P41, DOI 10.1016/S0304-3940(01)02371-0; Huisman E, 2004, MOVEMENT DISORD, V19, P687, DOI 10.1002/mds.10713; Ivanova M, 2014, ACTA NEUROBIOL EXP, V74, P317; IWANAMI A, 1994, ACTA PSYCHIAT SCAND, V89, P428, DOI 10.1111/j.1600-0447.1994.tb01541.x; Jayanthi S, 2014, BIOL PSYCHIAT, V76, P47, DOI 10.1016/j.biopsych.2013.09.034; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1749, DOI 10.1136/jnnp.2003.035287; Keller CM, 2011, PSYCHOPHARMACOLOGY, V215, P513, DOI 10.1007/s00213-011-2301-9; Keverne EB, 2005, NAT NEUROSCI, V8, P1637, DOI 10.1038/nn1205-1637; Kitanaka N, 2010, NEUROCHEM RES, V35, P749, DOI 10.1007/s11064-010-0132-4; Kobeissy FH, 2008, EXPERT REV PROTEOMIC, V5, P293, DOI 10.1586/14789450.5.2.293; Kobeissy FH, 2012, METHODS MOL BIOL, V829, P269, DOI 10.1007/978-1-61779-458-2_17; Krasnova IN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008790; Kriebel M, 2011, J BIOL CHEM, V286, P24385, DOI 10.1074/jbc.M110.212191; Larsen KE, 2002, J NEUROSCI, V22, P8951; Lee DH, 2010, ANAT CELL BIOL, V43, P194, DOI 10.5115/acb.2010.43.3.194; Lee JM, 2000, J CLIN INVEST, V106, P723, DOI 10.1172/JCI11003; Lee KH, 2011, J NEUROSCI RES, V89, P96, DOI 10.1002/jnr.22525; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; Moberg Paul J, 2003, Curr Psychiatry Rep, V5, P311, DOI 10.1007/s11920-003-0061-x; Molz S, 2008, NEUROCHEM RES, V33, P27, DOI 10.1007/s11064-007-9402-1; Morales AM, 2015, MOL PSYCHIATR, V20, P764, DOI 10.1038/mp.2015.47; Morales AM, 2012, DRUG ALCOHOL DEPEN, V125, P230, DOI 10.1016/j.drugalcdep.2012.02.017; Moratalla R, 1996, P NATL ACAD SCI USA, V93, P14928, DOI 10.1073/pnas.93.25.14928; Negoias S, 2016, BRAIN IMAGING BEHAV, V10, P367, DOI 10.1007/s11682-015-9400-x; North A, 2013, SYNAPSE, V67, P245, DOI 10.1002/syn.21635; O'Callaghan JP, 2008, ANN NY ACAD SCI, V1139, P318, DOI 10.1196/annals.1432.032; Orikabe L, 2011, SCHIZOPHR RES, V132, P183, DOI 10.1016/j.schres.2011.07.006; OTMAKHOVA NA, 1992, PHYSIOL BEHAV, V52, P441, DOI 10.1016/0031-9384(92)90329-Z; Ramkissoon A, 2013, FREE RADICAL BIO MED, V65, P620, DOI 10.1016/j.freeradbiomed.2013.07.043; Riddle EL, 2002, EUR J PHARMACOL, V435, P181, DOI 10.1016/S0014-2999(01)01592-8; Robison AJ, 2011, NAT REV NEUROSCI, V12, P623, DOI 10.1038/nrn3111; Rodriguez-Rodriguez P, 2012, CELL DEATH DIFFER, V19, P1582, DOI 10.1038/cdd.2012.33; Romero L, 2006, BIOCHEM J, V400, P135, DOI 10.1042/BJ20060110; Ryoo K, 2004, J BIOL CHEM, V279, P43589, DOI 10.1074/jbc.M404359200; Sailasuta N, 2010, J CEREBR BLOOD F MET, V30, P950, DOI 10.1038/jcbfm.2009.261; Sapolsky RM, 2001, P NATL ACAD SCI USA, V98, P12320, DOI 10.1073/pnas.231475998; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Schwartz DL, 2010, NEUROIMAGE, V50, P1392, DOI 10.1016/j.neuroimage.2010.01.056; Schwendt M, 2009, J PHARMACOL EXP THER, V331, P555, DOI 10.1124/jpet.109.155770; Seo JY, 2009, J NEUROL SCI, V285, P88, DOI 10.1016/j.jns.2009.05.029; Sokolov BP, 2004, PHARMACOL BIOCHEM BE, V77, P319, DOI 10.1016/j.pbb.2003.11.006; Song C, 2005, NEUROSCI BIOBEHAV R, V29, P627, DOI 10.1016/j.neubiorev.2005.03.010; Stumm G, 1999, FASEB J, V13, P1065, DOI 10.1096/fasebj.13.9.1065; Sun KH, 2011, J NEUROCHEM, V118, P902, DOI 10.1111/j.1471-4159.2011.07343.x; Takaichi R, 2012, J NEUROSCI RES, V90, P21, DOI 10.1002/jnr.22740; Teodoro RO, 2013, EMBO J, V32, P2039, DOI 10.1038/emboj.2013.147; Tew KD, 2007, BIOCHEM PHARMACOL, V73, P1257, DOI 10.1016/j.bcp.2006.09.027; Thiriet N, 2001, MOL BRAIN RES, V90, P202, DOI 10.1016/S0169-328X(01)00093-6; Thompson PM, 2004, J NEUROSCI, V24, P6028, DOI 10.1523/JNEUROSCI.0713-04.2004; THORNE BM, 1993, ANN NY ACAD SCI, V702, P131, DOI 10.1111/j.1749-6632.1993.tb17245.x; Tokunaga I, 2008, J MED INVESTIG, V55, P241, DOI 10.2152/jmi.55.241; Turetsky BI, 2003, ARCH GEN PSYCHIAT, V60, P1193, DOI 10.1001/archpsyc.60.12.1193; Urbina A, 2004, CLIN INFECT DIS, V38, P890, DOI 10.1086/381975; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Volkow ND, 2001, AM J PSYCHIAT, V158, P377, DOI 10.1176/appi.ajp.158.3.377; Volkow ND, 2001, J NEUROSCI, V21, P9414, DOI 10.1523/JNEUROSCI.21-23-09414.2001; Wang HC, 2010, J CEREBR BLOOD F MET, V30, P493, DOI 10.1038/jcbfm.2009.247; Warren MW, 2007, ACTA NEUROPATHOL, V114, P277, DOI 10.1007/s00401-007-0259-9; Warren MW, 2005, LIFE SCI, V78, P301, DOI 10.1016/j.lfs.2005.04.058; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; Yamamoto H, 2006, ANN NY ACAD SCI, V1074, P97, DOI 10.1196/annals.1369.009; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Yuan TF, 2014, PROG NEURO-PSYCHOPH, V54, P26, DOI 10.1016/j.pnpbp.2014.05.013; Zhou P, 2012, J NEUROSCI, V32, P583, DOI 10.1523/JNEUROSCI.2849-11.2012; Zipfel GJ, 2000, J NEUROTRAUM, V17, P857, DOI 10.1089/neu.2000.17.857; Zuloaga DG, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00178	99	13	14	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0151034	10.1371/journal.pone.0151034	http://dx.doi.org/10.1371/journal.pone.0151034			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082425	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800003
J	Castro, NP; Merchant, AS; Saylor, KL; Anver, MR; Salomon, DS; Golubeva, YG				Castro, Nadia P.; Merchant, Anand S.; Saylor, Karen L.; Anver, Miriam R.; Salomon, David S.; Golubeva, Yelena G.			Adaptation of Laser Microdissection Technique for the Study of a Spontaneous Metastatic Mammary Carcinoma Mouse Model by NanoString Technologies	PLOS ONE			English	Article							GENE-EXPRESSION ANALYSIS; MICROCAPILLARY ELECTROPHORESIS TRACES; CAPTURE MICRODISSECTION; BREAST-CANCER; RNA QUALITY; TISSUE SAMPLES; IMPACT; TARGET	Laser capture microdissection (LCM) of tissue is an established tool in medical research for collection of distinguished cell populations under direct microscopic visualization for molecular analysis. LCM samples have been successfully analyzed in a number of genomic and proteomic downstream molecular applications. However, LCM sample collection and preparation procedure has to be adapted to each downstream analysis platform. In this present manuscript we describe in detail the adaptation of LCM methodology for the collection and preparation of fresh frozen samples for NanoString analysis based on a study of a model of mouse mammary gland carcinoma and its lung metastasis. Our adaptation of LCM sample preparation and workflow to the requirements of the NanoString platform allowed acquiring samples with high RNA quality. The NanoString analysis of such samples provided sensitive detection of genes of interest and their associated molecular pathways. NanoString is a reliable gene expression analysis platform that can be effectively coupled with LCM.	[Castro, Nadia P.; Saylor, Karen L.; Salomon, David S.] NCI, Tumor Growth Factor Sect, Mouse Canc Genet Program, Frederick, MD 21702 USA; [Merchant, Anand S.] NCI, CCRIFX Bioinformat Core, Bethesda, MD 20892 USA; [Anver, Miriam R.; Golubeva, Yelena G.] Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Castro, NP (corresponding author), NCI, Tumor Growth Factor Sect, Mouse Canc Genet Program, Frederick, MD 21702 USA.; Golubeva, YG (corresponding author), Leidos Biomed Res Inc, Pathol Histotechnol Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.	castron2@mail.nih.gov; yelena.golubeva@gmail.com			Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research; National Cancer Institute, National Institutes of Health [HHSN261200800001E]	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldelli E, 2015, PROTEOM CLIN APPL, V9, P928, DOI 10.1002/prca.201400056; Bidarimath M, 2015, METHODS MOL BIOL, V1219, P115, DOI 10.1007/978-1-4939-1661-0_10; Castro NP, 2015, ONCOTARGET, V6, P11910, DOI 10.18632/oncotarget.4182; Clement-Ziza M, 2008, RNA, V14, P2698, DOI 10.1261/rna.1261708; Copois V, 2007, J BIOTECHNOL, V127, P549, DOI 10.1016/j.jbiotec.2006.07.032; Ehrig T, 2001, J MOL DIAGN, V3, P22, DOI 10.1016/S1525-1578(10)60645-9; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Erickson HS, 2009, NAT PROTOC, V4, P902, DOI 10.1038/nprot.2009.61; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Golubeva Yelena, 2013, Methods Mol Biol, V931, P213, DOI 10.1007/978-1-62703-056-4_12; Golubeva Yelena, 2009, V511, P3, DOI 10.1007/978-1-59745-447-6_1; Golubeva YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066854; Huang LE, 2002, METHOD ENZYMOL, V356, P49; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Institute of Laboratory Animal Resources CoLS National Research Council, 1996, GUIDE CARE USE LAB A; Jacquet R, 2005, ANAL BIOCHEM, V337, P22, DOI 10.1016/j.ab.2004.09.033; Ma XJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2222; Melis M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0230-1; Nakazono M, 2003, PLANT CELL, V15, P583, DOI 10.1105/tpc.008102; Ojaniemi H, 2003, BIOTECHNIQUES, V35, P968, DOI 10.2144/03355st04; Strand C, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-38; Wang HY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-97; Wulfkuhle JD, 2008, J PROTEOME RES, V7, P1508, DOI 10.1021/pr7008127	24	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153270	10.1371/journal.pone.0153270	http://dx.doi.org/10.1371/journal.pone.0153270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077656	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700034
J	Hayashi, G; Cortopassi, G				Hayashi, Genki; Cortopassi, Gino			Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia	PLOS ONE			English	Article							FRATAXIN DEFICIENCY LEADS; SULFUR TRANSFER; EXPRESSION; NRF2; TRANSCRIPTION; CONTRIBUTES; MODELS; GROWTH; CELLS	There is no current approved therapy for the ultimately lethal neuro- and cardio-degenerative disease Friedreich's ataxia (FA). Finding minimally-invasive molecular biomarkers of disease progression and drug effect could support smaller, shorter clinical trials. Since we and others have noted a deficient oxidative stress response in FA, we investigated the expression of 84 genes involved in oxidative stress, signaling, and protection in control and FA lymphoblasts ranging from 460 to 1122 GAA repeats. Several antioxidant genes responded in a dose-dependent manner to frataxin expression at the mRNA and protein levels, which is inversely correlated with disease progression and severity. We tested the effect of experimental Friedreich's ataxia therapies dimethyl fumarate (DMF) and type 1 histone deacetylase inhibitor (HDACi) on biomarker mRNA expression. We observed that exposure of lymphoblasts to DMF and HDACi dose-dependently unsilenced frataxin expression and restored the potential biomarkers NCF2 and PDLIM1 expression to control levels. We suggest that in addition to frataxin expression, blood lymphoblast levels of NCF2 and PDLIM1 could be useful biomarkers for disease progression and drug effect in future clinical trials of Friedreich's ataxia.	[Hayashi, Genki; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis	Cortopassi, G (corresponding author), Univ Calif Davis, Dept Mol Biosci, Davis, CA 95616 USA.	gcortopassi@ucdavis.edu			NIH [R01 NS077777]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077777] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by NIH R01 NS077777. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeti R, 2015, PHARMACOL RES, V99, P344, DOI 10.1016/j.phrs.2015.05.015; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; Angeloni C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083283; Bradley J, 1999, HUM MOL GENET, V9, P8; Bridwell-Rabb J, 2014, BIOCHEMISTRY-US, V53, P4904, DOI 10.1021/bi500532e; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K., 2001, HUM MOL GENET, V10, P8; Cossee M, 1997, P NATL ACAD SCI USA, V94, P7452, DOI 10.1073/pnas.94.14.7452; Cox AG, 2010, BIOCHEM J, V425, P313, DOI 10.1042/BJ20091541; D'Oria V, 2013, INT J MOL SCI, V14, P7853, DOI 10.3390/ijms14047853; Durr A., 1996, NEW ENGL J MED, V335, P7; Durr A., 2000, CURR OPIN NEUROL, V13, P7; Emond M, 2000, INCREASED LEVELS PLA, V55, P2; Hasegawa T, 2010, NEUROSCI LETT, V476, P53, DOI 10.1016/j.neulet.2010.03.081; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Jain D, 2008, AM J RESP CRIT CARE, V178, P805, DOI 10.1164/rccm.200804-582OC; Kim E, 2011, NUCLEIC ACIDS RES, V39, P8366, DOI 10.1093/nar/gkr542; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kropotov A, 2006, FEBS J, V273, P2607, DOI 10.1111/j.1742-4658.2006.05265.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mine Y, 2015, MOL NUTR FOOD RES, V59, P303, DOI 10.1002/mnfr.201400381; Parent A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6686; Paupe V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004253; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Rotig A, 1997, NAT GENET, V17, P3; Sahdeo S, 2014, HUM MOL GENET, V23, P6848, DOI 10.1093/hmg/ddu408; Sandi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089488; Sandi C, 2011, NEUROBIOL DIS, V42, P496, DOI 10.1016/j.nbd.2011.02.016; Schulz J., 2000, NEUROLOGY, V55, P3; Seyer L, 2015, ACTA NEUROL SCAND, V132, P7, DOI 10.1111/ane.12337; Shan YX, 2013, ANTIOXID REDOX SIGN, V19, P1481, DOI 10.1089/ars.2012.4537; SMALL JR, 1993, NEUROSCI LETT, V163, P182, DOI 10.1016/0304-3940(93)90377-W; Soragni E, 2014, ANN NEUROL, V76, P489, DOI 10.1002/ana.24260; Strawser CJ, 2014, EXPERT REV NEUROTHER, V14, P949, DOI 10.1586/14737175.2014.939173; Tammariello SP, 2000, J NEUROSCI, V20; Thierbach R, 2005, HUM MOL GENET, V14, P3857, DOI 10.1093/hmg/ddi410; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Wong A, 1999, HUM MOL GENET, V8, P425, DOI 10.1093/hmg/8.3.425; Yuzawa S, 2009, J INNATE IMMUN, V1, P543, DOI 10.1159/000235656	44	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153574	10.1371/journal.pone.0153574	http://dx.doi.org/10.1371/journal.pone.0153574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078885	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700082
J	Lindbohm, JV; Kaprio, J; Korja, M				Lindbohm, Joni Valdemar; Kaprio, Jaakko; Korja, Miikka			Cholesterol as a Risk Factor for Subarachnoid Hemorrhage: A Systematic Review	PLOS ONE			English	Review							SERUM-LIPIDS; STROKE SUBTYPES; BLOOD-PRESSURE; ASSOCIATION; MORTALITY; DISEASE; ANEURYSMS; MEN	Background The role played by total cholesterol (TC) in risk for subarachnoid hemorrhage (SAH) is unclear because studies report both high and low TC each as a risk factor. We performed a systematic review to clarify associations between lipid profile and SAH. Methods Our literature search comprised Pubmed, Scopus, and Cochrane Library databases with no language, publication year, or study type limitations. The Preferred Reporting Items for Systematic reviews and Meta-analyses (PRISMA) checklist guided our reporting. Data forms adapted from the Critical Appraisal Skills Program (CASP), and Cochrane Collaboration guidelines provided a platform for risk-of-bias evaluation. We used a random effects model to calculate pooled estimates and assessed heterogeneity with I-2-statistics. Results Of the final 21 studies reviewed, 12 were prospective and 9 retrospective. All studies assessed TC, four assessed HDL, and none LDL in risk for SAH. Heterogeneity among all, retrospective, and Asian studies was high (I-2 = 79.5%, I-2 = 89.0%, and I-2 = 84.3%) and considerable in prospective (I-2 = 46.0%). We therefore focused on qualitative analysis and found that only two studies had a low risk of bias. According to these studies high TC increases risk for SAH in men, whereas the role of HDL remained unclear. Conclusion The low-risk-of-bias studies suggest that elevated TC levels elevate risk for SAH in men. Due to the high prevalence of hypercholesterolemia, population attributable risk (PAR) of hypercholesterolemia may exceed the PARs of smoking and hypertension in men. Apart from diabetes and obesity, the risk-factor profile of SAH seems to resemble that of other cerebrovascular diseases, at least in men.	[Lindbohm, Joni Valdemar; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, FI-00014 Helsinki, Finland; [Lindbohm, Joni Valdemar; Korja, Miikka] Univ Helsinki, Dept Neurosurg, FI-00029 Helsinki, Finland; Helsinki Univ Hosp, FI-00029 Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, FI-00271 Helsinki, Finland; [Kaprio, Jaakko] Inst Mol Med FIMM, FI-00014 Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare	Lindbohm, JV (corresponding author), Univ Helsinki, Dept Publ Hlth, POB 41, FI-00014 Helsinki, Finland.	joni.lindbohm@helsinki.fi	Korja, Miikka/E-4292-2016; Kaprio, Jaakko/A-1820-2008	Korja, Miikka/0000-0002-4463-6954; Kaprio, Jaakko/0000-0002-3716-2455				ADAMSON J, 1994, STROKE, V25, P963, DOI 10.1161/01.STR.25.5.963; Aull S, 1996, AM J MED, V101, P291, DOI 10.1016/S0002-9343(96)00199-4; Auro K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5708; Bekelis K, 2015, INT J STROKE, V10, P38, DOI 10.1111/ijs.12559; Borodulin K, 2015, EUR J PUBLIC HEALTH, V25, P539, DOI 10.1093/eurpub/cku174; Broderick JP, 2003, STROKE, V34, P1375, DOI 10.1161/01.STR.0000074572.91827.F4; Canhao P, 1994, J Cardiovasc Risk, V1, P155; Critical Appraisal Skills Programme (CASP), 2014, CASP CHECKL; Cui RZ, 2007, ATHEROSCLEROSIS, V194, P415, DOI 10.1016/j.atherosclerosis.2006.08.022; Evangelista O, 2009, GENDER MED, V6, P17, DOI 10.1016/j.genm.2009.02.004; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Frosen J, 2012, ACTA NEUROPATHOL, V123, P773, DOI 10.1007/s00401-011-0939-3; Gatchev O, 1993, Ann Epidemiol, V3, P403, DOI 10.1016/1047-2797(93)90068-F; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Haase CL, 2012, J CLIN ENDOCR METAB, V97, pE248, DOI 10.1210/jc.2011-1846; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Inagawa T, 2005, J NEUROSURG, V102, P60, DOI 10.3171/jns.2005.102.1.0060; Inagawa T, 2010, WORLD NEUROSURG, V73, P155, DOI 10.1016/j.surneu.2009.03.007; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; KNEKT P, 1991, J CLIN EPIDEMIOL, V44, P933, DOI 10.1016/0895-4356(91)90056-F; Korja M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073760; Korja M, 2013, NEUROLOGY, V80, P481, DOI 10.1212/WNL.0b013e31827f0fb5; Leppala JM, 1999, STROKE, V30, P2535, DOI 10.1161/01.STR.30.12.2535; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Neaton J D, 1993, Ann Epidemiol, V3, P493; Ohkuma H, 2003, STROKE, V34, P96, DOI 10.1161/01.STR.0000048161.57536.42; Park JK, 1998, YONSEI MED J, V39, P229, DOI 10.3349/ymj.1998.39.3.229; Sandvei MS, 2012, ACTA NEUROL SCAND, V125, P382, DOI 10.1111/j.1600-0404.2011.01578.x; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Suh I, 2001, LANCET, V357, P922, DOI 10.1016/S0140-6736(00)04213-6; Suzuki K, 2011, CEREBROVASC DIS, V31, P100, DOI 10.1159/000321506; Tan YY, 2010, MATURITAS, V65, P149, DOI 10.1016/j.maturitas.2009.09.023; Teunissen LL, 1996, STROKE, V27, P544, DOI 10.1161/01.STR.27.3.544; Tirschwell DL, 2004, NEUROLOGY, V63, P1868, DOI 10.1212/01.WNL.0000144282.42222.DA; Tokuda Y, 2005, J CLIN NEUROSCI, V12, P538, DOI 10.1016/j.jocn.2004.07.021; Vlak MHM, 2013, J NEUROL NEUROSUR PS, V84, P619, DOI 10.1136/jnnp-2012-303783; Voight Benjamin F, 2012, Lancet, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang X, 2013, STROKE; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WOO J, 1990, STROKE, V21, P1407, DOI 10.1161/01.STR.21.10.1407; Zhang YR, 2012, STROKE, V43, P1768, DOI 10.1161/STROKEAHA.111.646778	45	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152568	10.1371/journal.pone.0152568	http://dx.doi.org/10.1371/journal.pone.0152568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077917	Green Published, gold			2022-12-27	WOS:000374131700006
J	Schleicher, N; Tomkins, AJ; Kampschulte, M; Hyvelin, JM; Botteron, C; Juenemann, M; Yeniguen, M; Krombach, GA; Kaps, M; Spratt, NJ; Gerriets, T; Nedelmann, M				Schleicher, Nadine; Tomkins, Amelia J.; Kampschulte, Marian; Hyvelin, Jean-Marc; Botteron, Catherine; Juenemann, Martin; Yeniguen, Mesut; Krombach, Gabriele A.; Kaps, Manfred; Spratt, Neil J.; Gerriets, Tibo; Nedelmann, Max			Sonothrombolysis with BR38 Microbubbles Improves Microvascular Patency in a Rat Model of Stroke	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; ISCHEMIC-STROKE; ULTRASOUND; REPERFUSION; RECANALIZATION; THROMBOLYSIS; BLOOD; TOMOGRAPHY; TRIAL	Background Early recanalization of large cerebral vessels in ischemic stroke is associated with improved clinical outcome, however persisting hypoperfusion leads to poor clinical recovery despite large vessel recanalization. Limited experimental sonothrombolysis studies have shown that addition of microbubbles during treatment can improve microvascular patency. We aimed to determine the effect of two different microbubble formulations on microvascular patency in a rat stroke model. Methods We tested BR38 and SonoVue (R) microbubble-enhanced sonothrombolysis in Wistar rats submitted to 90-minute filament occlusion of the middle cerebral artery. Rats were randomized to treatment (n = 6/group): control, rt-PA, or rt-PA+3-MHz ultrasound insonation with BR38 or SonoVue (R) at full or 1/3 dose. Treatment duration was 60 minutes, beginning after withdrawal of the filament, and sacrifice was immediately after treatment. Vascular volumes were evaluated with microcomputed tomography. Results Total vascular volume of the ipsilateral hemisphere was reduced in control and rt-PA groups (p<0.05), but was not significantly different from the contralateral hemisphere in all microbubble-treated groups (p>0.1). Conclusions Microbubble-enhanced sonothrombolysis improves microvascular patency. This effect is not dose-or microbubble formulation-dependent suggesting a class effect of microbubbles promoting microvascular reopening. This study demonstrates that microbubble-enhanced sonothrombolysis may be a therapeutic strategy for patients with persistent hypoperfusion of the ischemic territory.	[Schleicher, Nadine; Tomkins, Amelia J.; Juenemann, Martin; Yeniguen, Mesut; Gerriets, Tibo] Univ Giessen, Heart & Brain Res Grp, D-35390 Giessen, Germany; [Schleicher, Nadine; Juenemann, Martin; Yeniguen, Mesut; Kaps, Manfred; Gerriets, Tibo] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Schleicher, Nadine] Kerckhoff Clin, Dept Cardiac Surg, Bad Nauheim, Germany; [Tomkins, Amelia J.; Spratt, Neil J.] Univ Newcastle, Sch Biomed Sci & Pharm, Newcastle, NSW 2300, Australia; [Tomkins, Amelia J.; Spratt, Neil J.] Hunter Med Res Inst, Newcastle, NSW, Australia; [Kampschulte, Marian; Krombach, Gabriele A.] Univ Giessen, Dept Diagnost & Intervent Radiol, D-35390 Giessen, Germany; [Hyvelin, Jean-Marc; Botteron, Catherine] Bracco Suisse SA, Geneva, Switzerland; [Spratt, Neil J.] Hunter New England Local Hlth Dist, New Lambton, NSW, Australia; [Gerriets, Tibo] Buergerhosp Friedberg, Dept Neurol, Friedberg, Germany; [Nedelmann, Max] Sana Regio Klinkum, Pinneberg, Germany; [Nedelmann, Max] Univ Hosp Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen; Kerckhoff Clinic; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; Justus Liebig University Giessen; Bracco; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nedelmann, M (corresponding author), Sana Regio Klinkum, Pinneberg, Germany.; Nedelmann, M (corresponding author), Univ Hosp Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.	max.nedelmann@sana.de	Spratt, Neil J/K-4208-2012	Spratt, Neil J/0000-0002-9023-6177; Botteron, Catherine/0000-0001-9525-1723	Heart Foundation Australia; Hunter Medical Research Institute Travel Scholarship; Australian National Health and Medical Research Council [APP1035465]; Bracco Suisse SA, Geneva, Switzerland; Faculty of Human Medicine, Justus-Liebig University, Giessen; German Research Foundation [NST 162/291-1 FUGG]	Heart Foundation Australia; Hunter Medical Research Institute Travel Scholarship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bracco Suisse SA, Geneva, Switzerland; Faculty of Human Medicine, Justus-Liebig University, Giessen; German Research Foundation(German Research Foundation (DFG))	Ms. Amelia Tomkins was supported by a Heart Foundation Australia post-graduate scholarship cofounded by the National Stroke Foundation Australia, and by a Hunter Medical Research Institute Travel Scholarship funded by Mrs. Jennie Thomas. Dr. Neil Spratt was supported by an Australian National Health and Medical Research Council Career Development Fellowship (APP1035465). The study was in part supported by Bracco Suisse SA, Geneva, Switzerland and in part from the Faculty of Human Medicine, Justus-Liebig University, Giessen and the German Research Foundation (NST 162/291-1 FUGG). The co-authors, Jean-Marc Hyvelin and Catherine Botteron, are employees of Bracco Suisse SA, Geneva, Switzerland. Their contribution was histology and histological analysis and manuscript preparation in conjunction with all other co-authors. All other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinder P, 2010, P NATL ACAD SCI USA, V107, P12670, DOI 10.1073/pnas.1007239107; Cho TH, 2015, STROKE, V46, P1582, DOI 10.1161/STROKEAHA.114.007964; Daffertshofer M, 2005, STROKE, V36, P1441, DOI 10.1161/01.STR.0000170707.86793.1a; Dalkara T, 2012, J CEREBR BLOOD F MET, V32, P2091, DOI 10.1038/jcbfm.2012.139; Dawson DA, 1997, BRAIN RES, V749, P200, DOI 10.1016/S0006-8993(96)01166-3; Eilaghi A, 2013, RADIOLOGY, V269, P240, DOI 10.1148/radiol.13122327; Kampschulte M, 2016, ROFO-FORTSCHR RONTG, V188, P146, DOI 10.1055/s-0041-106541; Langheinrich AC, 2004, RADIOLOGY, V233, P165, DOI 10.1148/radiol.2331031340; Langheinrich AC, 2010, NEURORADIOLOGY, V52, P815, DOI 10.1007/s00234-009-0617-5; Miller MW, 1996, ULTRASOUND MED BIOL, V22, P1131, DOI 10.1016/S0301-5629(96)00089-0; Molina CA, 2006, STROKE, V37, P425, DOI 10.1161/01.STR.0000199064.94588.39; Molina CA, 2009, ANN NEUROL, V66, P28, DOI 10.1002/ana.21723; Nedelmann M, 2010, J CEREBR BLOOD F MET, V30, P1712, DOI 10.1038/jcbfm.2010.82; Nedelmann M, 2008, ULTRASOUND MED BIOL, V34, P2019, DOI 10.1016/j.ultrasmedbio.2008.06.003; OKADA Y, 1994, STROKE, V25, P1847, DOI 10.1161/01.STR.25.9.1847; Perren F, 2008, J THROMB THROMBOLYS, V25, P219, DOI 10.1007/s11239-007-0044-6; Petit B, 2012, ULTRASOUND MED BIOL, V38, P1222, DOI 10.1016/j.ultrasmedbio.2012.02.023; Porter TR, 2001, PROG CARDIOVASC DIS, V44, P101, DOI 10.1053/pcad.2001.26441; Rubiera M, 2008, ULTRASOUND MED BIOL, V34, P1573, DOI 10.1016/j.ultrasmedbio.2008.02.011; Saqqur M, 2014, J NEUROIMAGING, V24, P209, DOI 10.1111/jon.12026; Schneider M, 2011, INVEST RADIOL, V46, P486, DOI 10.1097/RLI.0b013e318217b821; Soares BP, 2010, STROKE, V41, pE34, DOI 10.1161/STROKEAHA.109.568766; Soehle M, 2001, J NEUROSCI METH, V110, P91, DOI 10.1016/S0165-0270(01)00422-8; Tsivgoulis G, 2010, STROKE, V41, P280, DOI 10.1161/STROKEAHA.109.563304; Viguier A, 2005, J THROMB THROMBOLYS, V19, P55, DOI 10.1007/s11239-005-0940-6	25	23	25	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152898	10.1371/journal.pone.0152898	http://dx.doi.org/10.1371/journal.pone.0152898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077372	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700013
J	Todd, VLG; Warley, JC; Todd, IB				Todd, Victoria Louise Georgia; Warley, Jane Clare; Todd, Ian Boyer			Meals on Wheels? A Decade of Megafaunal Visual and Acoustic Observations from Offshore Oil & Gas Rigs and Platforms in the North and Irish Seas	PLOS ONE			English	Article							TO-REEFS; HARBOR PORPOISES; ECHOLOCATION SIGNALS; PHOCOENA-PHOCOENA; FISH	A decade of visual and acoustic detections of marine megafauna around offshore Oil & Gas (O&G) installations in the North and Irish Seas are presented. Marine megafauna activity was monitored visually and acoustically by Joint Nature Conservation Committee (JNCC) qualified and experienced Marine Mammal Observers (MMO) and Passive Acoustic Monitoring (PAM) Operators respectively, with real-time towed PAM in combination with industry standard software, PAMGuard. Monitoring was performed during routine O&G industrial operations for underwater noise mitigation purposes, and to ensure adherence to regulatory guidelines. Incidental sightings by off-effort MMOs and installation crew were also reported. Visual and acoustic monitoring spanned 55 non-consecutive days between 2004 and 2014. A total of 47 marine mammal sightings were recorded by MMOs on dedicated watch, and 10 incidental sightings of marine megafauna were reported over 10 years. Species included: harbour porpoise (Phocoena phocoena), Atlantic white-sided dolphin (Lagenorhynchus acutus), white beaked dolphin (Lagenorhynchus albirostris), common dolphin (Delphinus delphis), minke whale (Balaenoptera acutorostrata), common seal (Phoca vitulina), grey seal (Halichoerus grypus) and, basking shark (Cetorhinus maximus). Passive Acoustic Monitoring was conducted on two occasions in 2014; 160 PAM hours over 12 days recorded a total of 308 individual clicks identified as harbour porpoises. These appear to be the first such acoustic detections obtained from a North Sea drilling rig whilst using a typically configured hydrophone array designed for towing in combination with real-time PAMGuard software. This study provides evidence that marine megafauna are present around mobile and stationary offshore O&G installations during routine operational activities. On this basis, Environmental Impact Assessments (EIAs) for decommissioning O&G platforms should be carried-out on a case-by-case basis, and must include provisions for hitherto overlooked marine megafauna.	[Todd, Victoria Louise Georgia; Warley, Jane Clare; Todd, Ian Boyer] Ocean Sci Consulting, Ocean House,4 Brewery Lane, Dunbar, East Lothian, England; [Todd, Victoria Louise Georgia] Univ Southampton, Inst Sound & Vibrat Res, Highfield, Hants, England	University of Southampton	Todd, VLG (corresponding author), Ocean Sci Consulting, Ocean House,4 Brewery Lane, Dunbar, East Lothian, England.; Todd, VLG (corresponding author), Univ Southampton, Inst Sound & Vibrat Res, Highfield, Hants, England.	vt@osc.co.uk		Todd, Victoria/0000-0002-9639-1661; Warley, Jane/0000-0002-6813-0296	Ocean Science Consulting	Ocean Science Consulting	Funding was provided by Ocean Science Consulting. Ocean Science Consulting provided support in the form of salaries for authors [VLGT, JCW, IBT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au WWL, 1999, J ACOUST SOC AM, V106, P3699, DOI 10.1121/1.428221; Baine M, 2002, ICES J MAR SCI, V59, pS277, DOI 10.1006/jmsc.2002.1216; Baine M, 2003, AM FISHERIES SOC S; Bergmark P, 2014, MAR ECOL PROG SER, V516, P275, DOI 10.3354/meps10997; Bernstein BB, 2010, EVALUATING ALTERNATI; Callahan E, 2015, 1 INT C DEC OFFSH SU; Centre SP, 2016, BEAUF WIND SCAL NOAA; Cripps SJ, 2002, ICES J MAR SCI, V59, pS300, DOI 10.1006/jmsc.2002.1293; Evans PGH, 2004, MAMMAL REV, V34, P131, DOI 10.1046/j.0305-1838.2003.00027.x; Fowler AM, 2014, OCEAN COAST MANAGE, V87, P20, DOI 10.1016/j.ocecoaman.2013.10.019; Frumkes DR, 2002, ICES J MAR SCI, V59, pS272, DOI 10.1006/jmsc.2002.1289; Fujii T., 2014, SOC PETR ENG INT C H; Fujii T, 2015, MAR ENVIRON RES, V108, P69, DOI 10.1016/j.marenvres.2015.03.013; Goodson AD, 1996, ICES J MAR SCI, V53, P465, DOI 10.1006/jmsc.1996.0066; Guerin A., 2009, MARINE COMMUNITIES N; Guerin AJ, 2007, ARTIFICIAL REEF PROP, P795; HEINEMANN D, 1981, J WILDLIFE MANAGE, V45, P489, DOI 10.2307/3807930; Hume R, 2002, BIRDS BRITAIN EUROPE; IWindsurf, 2016, WIND OBS FOR; Jepson PU, 2001, DENMARK PROGR REPORT; JNCC, 2010, STAT NAT CONS AG PRO, P14; JNCC, 2010, JNCC GUID MIN RISK I; Jorgensen D, 2012, OCEAN COAST MANAGE, V58, P57, DOI 10.1016/j.ocecoaman.2011.12.012; Jorgensen D, 2009, HIST TECHNOL, V25, P343, DOI 10.1080/07341510903313030; Kastelein RA, 1997, FOOD CONSUMPTION BOD; Koopman HN, 1994, THESIS U GUELPH GUEL; Linnenschmidt M, 2013, MAR MAMMAL SCI, V29, pE77, DOI 10.1111/j.1748-7692.2012.00592.x; Macreadie PI, 2012, FRONT ECOL ENVIRON, V10, P179, DOI 10.1890/12.WB.013; Macreadie PI, 2011, FRONT ECOL ENVIRON, V9, P455, DOI 10.1890/100112; Offshore Technology, 2016, WING GAS FIELD; Oil and Gas UK, 2015, ACT SURV 2015; Otani S, 2000, MAR MAMMAL SCI, V16, P811, DOI 10.1111/j.1748-7692.2000.tb00973.x; Palka Debra, 1996, Report of the International Whaling Commission, V46, P575; Picken G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P331; Quantum GIS Development Team, 2014, 281 QUANT GIS DEV TE; Rigzone, 2016, PAR HZ1; Rijkswaterstaat, 2016, WAT RIJKSW; Robinson DP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058255; Rothbach D, 2007, ENV L POLY F, V17; Russell DJF, 2014, CURR BIOL, V24, pR638, DOI 10.1016/j.cub.2014.06.033; Sayer MDJ, 2002, UNDERWATER TECHNOL, V25, P93, DOI 10.3723/175605402783219181; Soldal AV, 2002, ICES J MAR SCI, V59, pS281, DOI 10.1006/jmsc.2002.1279; Systat Software Inc, 2011, SIGMPL 12 0 BUILD 12; Teilmann Jonas, 2003, Journal of Cetacean Research and Management, V5, P85; Teilmann Jonas, 2002, Aquatic Mammals, V28, P275; Todd V., 2015, MARINE MAMMAL OBSERV; Todd VLG, 2009, ICES J MAR SCI, V66, P734, DOI 10.1093/icesjms/fsp035; Triossi F, 2013, MAR ECOL-EVOL PERSP, V34, P373, DOI 10.1111/maec.12020; Twomey B, 2012, WORKSH END CONC DEC, P37; Villadsgaard A, 2007, J EXP BIOL, V210, P56, DOI 10.1242/jeb.02618; Wilson B, 2013, ENDANGER SPECIES RES, V22, P125, DOI 10.3354/esr00538; Zawawi N. A. W. A., 2012, 2012 IEEE Colloquium on Humanities, Science and Engineering Research (CHUSER 2012), P26, DOI 10.1109/CHUSER.2012.6504275	52	22	22	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153320	10.1371/journal.pone.0153320	http://dx.doi.org/10.1371/journal.pone.0153320			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078153	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700038
J	Dimitrov, L; Pedersen, D; Ching, KH; Yi, H; Collarini, EJ; Izquierdo, S; van de Lavoir, MC; Leighton, PA				Dimitrov, Lazar; Pedersen, Darlene; Ching, Kathryn H.; Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley; van de lavoir, Marie-Cecile; Leighton, Philip A.			Germline Gene Editing in Chickens by Efficient CRISPR-Mediated Homologous Recombination in Primordial Germ Cells	PLOS ONE			English	Article							KNOCKOUT; SYSTEM; BIRDS	The CRISPR/Cas9 system has been applied in a large number of animal and plant species for genome editing. In chickens, CRISPR has been used to knockout genes in somatic tissues, but no CRISPR-mediated germline modification has yet been reported. Here we use CRISPR to target the chicken immunoglobulin heavy chain locus in primordial germ cells (PGCs) to produce transgenic progeny. Guide RNAs were co-transfected with a donor vector for homology-directed repair of the double-strand break, and clonal populations were selected. All of the resulting drug-resistant clones contained the correct targeting event. The targeted cells gave rise to healthy progeny containing the CRISPR-targeted locus. The results show that gene-edited chickens can be obtained by modifying PGCs in vitro with the CRISPR/Cas9 system, opening up many potential applications for efficient genetic modification in birds.	[Dimitrov, Lazar; Pedersen, Darlene; Ching, Kathryn H.; Yi, Henry; Collarini, Ellen J.; Izquierdo, Shelley; van de lavoir, Marie-Cecile; Leighton, Philip A.] Crystal Biosci Inc, Emeryville, CA USA		Leighton, PA (corresponding author), Crystal Biosci Inc, Emeryville, CA USA.	pal@crystalbioscience.com		Ching, Kathryn/0000-0002-1932-1504	Crystal Bioscience	Crystal Bioscience	Crystal Bioscience provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Collarini E, 2015, POULTRY SCI, V94, P799, DOI [10.3382/ps.2014-04372, 10.3382/ps.2014-4372]; Doran TJ, 2016, TRANSGENIC RES, V25, P307, DOI 10.1007/s11248-016-9926-8; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Inui M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05396; Jordan BJ, 2014, J BIOTECHNOLOGY; Lai SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146562; Leighton PA, 2008, MOL REPROD DEV, V75, P1163, DOI 10.1002/mrd.20859; Leighton PA, 2016, TRANSGENIC RES, V25, P609, DOI 10.1007/s11248-016-9952-6; Lin S, 2014, ELIFE, V3, DOI 10.7554/eLife.04766; Love J., 1994, NAT BIOTECHNOL, V12, P60; Merkert S, 2016, STEM CELL RES, V16, P377, DOI 10.1016/j.scr.2016.02.027; Ni W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106718; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Schusser B, 2013, HARNESSING GENE CONV, V8, DOI [10.1371/journal.pone.0080108, DOI 10.1371/JOURNAL.PONE.0080108]; Schusser B, 2013, P NATL ACAD SCI USA, V110, P20170, DOI 10.1073/pnas.1317106110; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimada K, 2014, GEN COMP ENDOCR, V196, P100, DOI 10.1016/j.ygcen.2013.11.001; Song YH, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113381; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Tan WF, 2016, TRANSGENIC RES, V25, P273, DOI 10.1007/s11248-016-9932-x; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Veron N, 2015, DEV BIOL, V407, P68, DOI 10.1016/j.ydbio.2015.08.007; Wang XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13348	25	68	75	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154303	10.1371/journal.pone.0154303	http://dx.doi.org/10.1371/journal.pone.0154303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099923	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500181
J	McVeigh, J; Smith, A; Howie, E; Straker, L				McVeigh, Joanne; Smith, Anne; Howie, Erin; Straker, Leon			Trajectories of Television Watching from Childhood to Early Adulthood and Their Association with Body Composition and Mental Health Outcomes in Young Adults	PLOS ONE			English	Article							ANXIETY STRESS SCALES; PHYSICAL-ACTIVITY; VIEWING TIME; SEDENTARY BEHAVIOR; DEPRESSION; RISK; ADOLESCENCE; VALIDITY; VERSION; WEIGHT	Introduction Prior studies examining longitudinal patterns of television (TV) watching have tended to use analytical approaches which do not allow for heterogeneity in the variation of TV watching over time. In the current study, we used latent class analysis (LCA) to examine the relationships between television watching (from childhood to early adulthood) and body fat percentage (%) and mental health. Methods Data were collected from 2411 participants (50% female) from the Raine Study, a prospective birth cohort study in Australia. Participants were followed up over 15 years and answered questions about hours of TV watching per week at six time-points (5, 8, 10, 14, 17 and 20yrs). Trajectories of television watching were estimated using LCA and appropriate regression models used to test the association of television watching class with percentage body fat (measured by DXA) and mental health (DASS-21) at age 20. Physical activity was used as a covariate. Results Three distinct trajectories of TV watching were identified. Class 1 (47.4%) had consistently high (> 14 hrs/wk) levels of TV watching, Class 2 (37.9%) was characterised by an increase in TV watching over adolescence and Class 3 (14.7%) had consistently lower (< 14 hrs/wk) TV watching over 15 years. Sex was used as an active covariate in the latent class model and was significantly associated with class membership (p< 0.001), with females comprising 45%, 47% and 59% of Class 1, 2 and 3 respectively. In females, membership in Class 2 or 3 was associated with lower body fat % at age 20, compared to Class 1 (p< 0.001). For males, membership in Class 2 was associated with lower body fat % compared with males in Class 1 (p = 0.026). Membership of TV watching class and mental health were not related (p> 0.05). Conclusions TV watching from childhood to young adulthood appears to be a relatively stable behavior for around two thirds of participants, but not everyone tracks consistently. This study identified a subset of participants with low levels of TV watching in childhood and also that this group, despite an increase in TV watching over adolescence, maintained a lower level of body fat in young adulthood.	[McVeigh, Joanne; Smith, Anne; Howie, Erin; Straker, Leon] Curtin Univ, Dept Physiotherapy & Exercise Sci, Perth, WA 6845, Australia	Curtin University	McVeigh, J (corresponding author), Curtin Univ, Dept Physiotherapy & Exercise Sci, Perth, WA 6845, Australia.	Joanne.McVeigh@curtin.edu.au	McVeigh, Joanne/C-9363-2016; Straker, Leon M/B-2407-2013	McVeigh, Joanne/0000-0002-2446-3814; Straker, Leon M/0000-0002-7786-4128; Smith, Anne/0000-0002-4667-7389	University of Western Australia; Curtin University; Telethon Kids Institute; Women and Infants Research Foundation; Raine Medical Research Foundation; Edith Cowan University; NHMRC; CIHR(Canadian Institutes of Health Research) [MOP-82893]	University of Western Australia; Curtin University; Telethon Kids Institute; Women and Infants Research Foundation; Raine Medical Research Foundation; Edith Cowan University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); CIHR(Canadian Institutes of Health Research)(Canadian Institutes of Health Research (CIHR))	Core funding for the Raine Study is provided by the University of Western Australia; Curtin University; the Telethon Kids Institute; the Women and Infants Research Foundation; the Raine Medical Research Foundation and Edith Cowan University. The authors thank the NHMRC for their long term contribution to funding the study over the last 25 years. The DXA data in the Yr 20 follow up was funded by CIHR(Canadian Institutes of Health Research) MOP-82893.	Alberga AS, 2012, PEDIATR OBES, V7, P261, DOI 10.1111/j.2047-6310.2011.00046.x; Berkey CS, 2003, PEDIATRICS, V111, P836, DOI 10.1542/peds.111.4.836; Biddle SJH, 2010, PREV MED, V51, P345, DOI 10.1016/j.ypmed.2010.07.018; Boone JE, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-26; Borghese MM, 2014, APPL PHYSIOL NUTR ME, V39, P937, DOI 10.1139/apnm-2013-0551; Braithwaite I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074263; Certain LK, 2002, PEDIATRICS, V109, P634, DOI 10.1542/peds.109.4.634; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Wit L, 2011, PSYCHIAT RES, V186, P239, DOI 10.1016/j.psychres.2010.07.003; Feldman BJ, 2009, DEV PSYCHOL, V45, P652, DOI 10.1037/a0014851; Francis SL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-100; Gebremariam MK, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-104; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Hancox RJ, 2004, LANCET, V364, P257, DOI 10.1016/S0140-6736(04)16675-0; Hands BP, 2011, J SCI MED SPORT, V14, P397, DOI 10.1016/j.jsams.2011.03.011; Healy GN, 2008, DIABETES CARE, V31, P661, DOI 10.2337/dc07-2046; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Howie EK, 2016, MED SCI SPORTS EXERC; Jago R, 2005, INT J OBESITY, V29, P557, DOI 10.1038/sj.ijo.0802969; Kwon S, 2015, JAMA PEDIATR, V169, P666, DOI 10.1001/jamapediatrics.2015.0327; Lovibond S.H., 1996, MANUAL DEPRESSION AN, DOI DOI 10.1037/T01004-000; Lucas M, 2011, AM J EPIDEMIOL, V174, P1017, DOI 10.1093/aje/kwr218; Mekary RA, 2013, AM J EPIDEMIOL, V178, P474, DOI 10.1093/aje/kws590; Mitchell JA, 2013, INT J OBESITY, V37, P54, DOI 10.1038/ijo.2012.41; NEWNHAM JP, 1993, LANCET, V342, P887, DOI 10.1016/0140-6736(93)91944-H; Ng F, 2007, ACTA NEUROPSYCHIATR, V19, P304, DOI 10.1111/j.1601-5215.2007.00217.x; Proctor MH, 2003, INT J OBESITY, V27, P827, DOI 10.1038/sj.ijo.0802294; Rebar AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1088; Robinson M, 2011, J PAEDIATR CHILD H, V47, P54, DOI 10.1111/j.1440-1754.2010.01891.x; Sanchez-Villegas A, 2008, MED SCI SPORT EXER, V40, P827, DOI 10.1249/MSS.0b013e31816348b9; Smith L, 2014, J EPIDEMIOLOGY COMMU; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; Sui XM, 2015, MAYO CLIN PROC, V90, P184, DOI 10.1016/j.mayocp.2014.12.006; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Veerman JL, 2012, BRIT J SPORT MED, V46, P927, DOI [10.1136/bjsports-2011-085662, 10.1136/bjsm.2011.085662]; Viner RM, 2005, J PEDIATR-US, V147, P429, DOI 10.1016/j.jpeds.2005.05.005; Wennberg P, 2014, J EPIDEMIOL COMMUN H, V68, P928, DOI 10.1136/jech-2013-203504; Zick CD, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-84	39	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152879	10.1371/journal.pone.0152879	http://dx.doi.org/10.1371/journal.pone.0152879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097324	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600021
J	Van Schuerbeek, P; Baeken, C; De Mey, J				Van Schuerbeek, Peter; Baeken, Chris; De Mey, Johan			The Heterogeneity in Retrieved Relations between the Personality Trait 'Harm Avoidance' and Gray Matter Volumes Due to Variations in the VBM and ROI Labeling Processing Settings	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; TEMPERAMENT; SEGMENTATION; DIMENSIONS; DEPRESSION; MODEL	Concerns are raising about the large variability in reported correlations between gray matter morphology and affective personality traits as 'Harm Avoidance' (HA). A recent review study (Mincic 2015) stipulated that this variability could come from methodological differences between studies. In order to achieve more robust results by standardizing the data processing procedure, as a first step, we repeatedly analyzed data from healthy females while changing the processing settings (voxel-based morphology (VBM) or region-of-interest (ROI) labeling, smoothing filter width, nuisance parameters included in the regression model, brain atlas and multiple comparisons correction method). The heterogeneity in the obtained results clearly illustrate the dependency of the study outcome to the opted analysis settings. Based on our results and the existing literature, we recommended the use of VBM over ROI labeling for whole brain analyses with a small or intermediate smoothing filter (5-8mm) and a model variable selection step included in the processing procedure. Additionally, it is recommended that ROI labeling should only be used in combination with a clear hypothesis and that authors are encouraged to report their results uncorrected for multiple comparisons as supplementary material to aid review studies.	[Van Schuerbeek, Peter; De Mey, Johan] Vrije Univ VUB, UZ Brussel, Dept Radiol, Brussels, Belgium; [Baeken, Chris] Vrije Univ Brussel, UZ Brussel, Dept Psychiat, Brussels, Belgium; [Baeken, Chris] Univ Ghent, Dept Psychiat & Med Psychol, B-9000 Ghent, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; University Hospital Brussels; University Hospital Brussels; Vrije Universiteit Brussel; Ghent University	Van Schuerbeek, P (corresponding author), Vrije Univ VUB, UZ Brussel, Dept Radiol, Brussels, Belgium.	Peter.VanSchuerbeek@uzbrussel.be	de Mey, Johan/AAL-9312-2021; Baeken, Chris/D-6790-2013; de Mey, Johan/F-3602-2011	Van Schuerbeek, Peter/0000-0003-3647-4446; de Mey, Johan/0000-0002-3601-3212				Aleman-Gomez Y., 2006, 12 ANN M ORG HUM BRA; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bohland JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007200; Callaert DV, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00124; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1987, ARCH GEN PSYCHIAT, V44, P573; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; CLONINGER CR, 1986, PSYCHIAT DEV, V4, P167; De Fruyt F, 2000, PERS INDIV DIFFER, V29, P441, DOI 10.1016/S0191-8869(99)00204-4; de la Rie SM, 1998, J PERS DISORD, V12, P362, DOI 10.1521/pedi.1998.12.4.362; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Giuliani NR, 2005, SCHIZOPHR RES, V74, P135, DOI 10.1016/j.schres.2004.08.019; Hu XC, 2011, NEUROIMAGE, V54, P1994, DOI 10.1016/j.neuroimage.2010.10.024; Iidaka T, 2006, BRAIN RES, V1125, P85, DOI 10.1016/j.brainres.2006.09.015; Ioannidis JPA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001747; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jylha P, 2013, EUR PSYCHIAT, V28, P483, DOI 10.1016/j.eurpsy.2013.06.003; Jylha P, 2006, EUR PSYCHIAT, V21, P389, DOI 10.1016/j.eurpsy.2005.09.003; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; Miettunen J, 2008, PSYCHIAT RES, V160, P106, DOI 10.1016/j.psychres.2007.05.003; Mincic AM, 2015, NEUROPSYCHOLOGIA, V77, P97, DOI 10.1016/j.neuropsychologia.2015.08.007; Pujol J, 2002, NEUROIMAGE, V15, P847, DOI 10.1006/nimg.2001.1004; Ridgway GR, 2008, NEUROIMAGE, V40, P1429, DOI 10.1016/j.neuroimage.2008.01.003; Sacher J, 2013, MAGN RESON IMAGING, V31, P366, DOI 10.1016/j.mri.2012.06.007; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Shen S, 2013, J MAGN RESON IMAGING, V37, P1468, DOI 10.1002/jmri.23927; Takao H, 2013, J MAGN RESON IMAGING, V38, P1283, DOI 10.1002/jmri.24038; Tardif CL, 2009, NEUROIMAGE, V44, P827, DOI 10.1016/j.neuroimage.2008.09.053; Van Schuerbeek P, 2011, BRAIN RES, V1371, P32, DOI 10.1016/j.brainres.2010.11.073; VANSTRIEN JW, 2001, NEUROPRAXIS, V2, P10; Voormolen EHJ, 2010, NEUROIMAGE, V49, P587, DOI 10.1016/j.neuroimage.2009.07.018; Wood J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2215; World Medical Association General Assembly, 2004, J Int Bioethique, V15, P124; Yamasue H, 2008, CEREB CORTEX, V18, P46, DOI 10.1093/cercor/bhm030	40	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153865	10.1371/journal.pone.0153865	http://dx.doi.org/10.1371/journal.pone.0153865			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096608	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600064
J	Ailabouni, NJ; Nishtala, PS; Mangin, D; Tordoff, JM				Ailabouni, Nagham J.; Nishtala, Prasad S.; Mangin, Dee; Tordoff, June M.			Challenges and Enablers of Deprescribing: A General Practitioner Perspective	PLOS ONE			English	Article							PRIMARY-CARE; MULTIPLE CONDITIONS; OLDER-PEOPLE; MEDICATION; POLYPHARMACY; IMPACT; MULTIMORBIDITY; FEASIBILITY; GUIDELINES; BENEFITS	Aims Deprescribing is the process of reducing or discontinuing medicines that are unnecessary or deemed to be harmful. We aimed to investigate general practitioner (GP) perceived challenges to deprescribing in residential care and the possible enablers that support GPs to implement deprescribing. Methods A qualitative study was undertaken using semi-structured, face-to-face interviews from two cities in New Zealand and a purpose-developed pilot-tested interview schedule. Interviews were recorded with permission and transcribed verbatim. Transcripts were read and re-read and themes were identified with iterative building of a coding list until all data was accounted for. Interviews continued until saturation of ideas occurred. Analysis was carried out with the assistance of a Theoretical Domains Framework (TDF) and constant comparison techniques. Several themes were identified. Challenges and enablers of deprescribing were determined based on participants' answers. Results Ten GPs agreed to participate. Four themes were identified to define the issues around prescribing for older people, from the GPs' perspectives. Theme 1, the 'recognition of the problem', discusses the difficulties involved with prescribing for older people. Theme 2 outlines the identified behaviour change factors relevant to the problem. Deprescribing challenges were drawn from these factors and summarised in Theme 3 under three major headings; 'prescribing factors', 'social influences' and 'policy and processes'. Deprescribing enablers, based on the opinions and professional experience of GPs, were retrieved and summarised in Theme 4. Conclusion The process of deprescribing is laced with many challenges for GPs. The uncertainty of research evidence in older people and social factors such as specialists' and nurses' influences were among the major challenges identified. Deprescribing enablers encompassed support for GPs' awareness and knowledge, improvement of communication between multiple prescribers, adequate reimbursement and pharmacists being involved in the multidisciplinary team.	[Ailabouni, Nagham J.; Nishtala, Prasad S.; Tordoff, June M.] Univ Otago, Sch Pharm, Dunedin, New Zealand; [Mangin, Dee] McMaster Univ, David Braley Chair Family Med, Hamilton, ON, Canada; [Mangin, Dee] Univ Otago, Christchurch, New Zealand	University of Otago; McMaster University; University of Otago	Ailabouni, NJ (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	Nagham.ailabouni@otago.ac.nz	Nishtala, Prasad/B-6988-2012; Ailabouni, Nagham J/AAE-9720-2021	Nishtala, Prasad/0000-0002-4155-8540; Ailabouni, Nagham J/0000-0002-6732-745X; Tordoff, June/0000-0001-5571-7592; Mangin, Dee/0000-0003-2149-9376	New Zealand Lottery Health Research; New Zealand Pharmacy Education and Research Foundation (NZPERF)	New Zealand Lottery Health Research; New Zealand Pharmacy Education and Research Foundation (NZPERF)	New Zealand Lottery Health Research provided the scholarship for this PhD (http://www.communitymatters.govt.nz/Funding-and-grants-Lottery-grants-Lottery-Health-Research); and the New Zealand Pharmacy Education and Research Foundation (NZPERF) provided funding for the employment of a transcriber for the interviews in this study (http://www.psnz.org.nz/Category?Action=View&Category_id=155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006544; Betteridge TM, 2012, INTERN MED J, V42, P208, DOI 10.1111/j.1445-5994.2011.02690.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Cumming RG, 2003, CNS DRUGS, V17, P825, DOI 10.2165/00023210-200317110-00004; Farrell B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122246; Fried TR, 2011, ARCH INTERN MED, V171, P75, DOI 10.1001/archinternmed.2010.318; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gheewala PA, 2014, DRUG AGING, V31, P825, DOI 10.1007/s40266-014-0208-y; Gnjidic D, 2012, J CLIN EPIDEMIOL, V65, P989, DOI 10.1016/j.jclinepi.2012.02.018; Gnjidic D, 2012, CLIN GERIATR MED, V28, P237, DOI 10.1016/j.cger.2012.01.006; Guba E.G., 1994, HDB QUALITATIVE RES, P110; Herzog A, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0249-2; Lincoln YS, 1986, IS IT RIGOROUS TRUST; Luijks HD, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X652373; McLarin PE, 2015, CURR MED RES OPIN, V10, P1; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Ministry of Health, 2015, HEALTHCERT B INF SEC; Nishtala PS, 2009, DRUG AGING, V26, P677, DOI 10.2165/11316440-000000000-00000; Olazaran J, 2013, J AM MED DIR ASSOC, V14, P213, DOI 10.1016/j.jamda.2012.10.020; Reeve E, 2015, ANN PHARMACOTHER, V49, P29, DOI 10.1177/1060028014558290; Reeve E, 2014, MED J AUSTRALIA, V201, P386, DOI 10.5694/mja13.00200; Reeve E, 2014, INT J CLIN PHARM-NET, V36, P26, DOI 10.1007/s11096-013-9871-z; Schoen C, 2011, HEALTH AFFAIR, V30, P2437, DOI 10.1377/hlthaff.2011.0923; Schuling J, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-56; Scott IA, 2015, INTERN MED J, V45, P352, DOI 10.1111/imj.12693; Sinnott C, 2015, BRIT J GEN PRACT, V65, pE184, DOI 10.3399/bjgp15X684001; Sinnott C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003610; Sloane PD, 2004, ARCH INTERN MED, V164, P2031, DOI 10.1001/archinte.164.18.2031; Solomon J, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X636119; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458	31	104	105	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151066	10.1371/journal.pone.0151066	http://dx.doi.org/10.1371/journal.pone.0151066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093289	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200001
J	Garfield, S; Jheeta, S; Husson, F; Lloyd, J; Taylor, A; Boucher, C; Jacklin, A; Bischler, A; Norton, C; Hayles, R; Franklin, BD				Garfield, Sara; Jheeta, Seetal; Husson, Fran; Lloyd, Jill; Taylor, Alex; Boucher, Charles; Jacklin, Ann; Bischler, Anna; Norton, Christine; Hayles, Rob; Franklin, Bryony Dean			The Role of Hospital Inpatients in Supporting Medication Safety: A Qualitative Study	PLOS ONE			English	Article							PATIENT INVOLVEMENT; PRESCRIBING ERRORS	Background Inpatient medication errors are a significant concern. An approach not yet widely studied is to facilitate greater involvement of inpatients with their medication. At the same time, electronic prescribing is becoming increasingly prevalent in the hospital setting. In this study we aimed to explore hospital inpatients' involvement with medication safety-related behaviours, facilitators and barriers to this involvement, and the impact of electronic prescribing. Methods We conducted ethnographic observations and interviews in two UK hospital organisations, one with established electronic prescribing and one that changed from paper to electronic prescribing during our study. Researchers and lay volunteers observed nurses' medication administration rounds, pharmacists' ward rounds, doctor-led ward rounds and drug history taking. We also conducted interviews with healthcare professionals, patients and carers. Interviews were audio-recorded and transcribed. Observation notes and transcripts were coded thematically. Results Paper or electronic medication records were shown to patients in only 4 (2%) of 247 cases. However, where they were available during patient-healthcare professional interactions, healthcare professionals often viewed them in order to inform patients about their medicines and answer any questions. Interprofessional discussions about medicines seemed more likely to happen in front of the patient where paper or electronic drug charts were available near the bedside. Patients and carers had more access to paper-based drug charts than electronic equivalents. However, interviews and observations suggest there are potentially more significant factors that affect patient involvement with their inpatient medication. These include patient and healthcare professional beliefs concerning patient involvement, the way in which healthcare professionals operate as a team, and the underlying culture. Conclusion Patients appear to have more access to paper-based records than electronic equivalents. However, to develop interventions to increase patient involvement with medication safety behaviours, a wider range of factors needs to be considered.	[Garfield, Sara; Jheeta, Seetal; Husson, Fran; Lloyd, Jill; Taylor, Alex; Jacklin, Ann; Norton, Christine; Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, Ctr Medicat Safety & Serv Qual, London, England; [Garfield, Sara; Franklin, Bryony Dean] UCL Sch Pharm, Res Dept Practice & Policy, BMA House,Tavistock Sq, London, England; [Bischler, Anna] Chelsea & Westminster Healthcare NHS Fdn Trust, Dept Pharm, London, England; [Norton, Christine] Kings Coll London, Fac Nursing & Midwifery, London WC2R 2LS, England; [Norton, Christine] Imperial Coll Healthcare NHS Trust, London, England; [Boucher, Charles] Patients Participat Grp, Walm Lane Surg, London, England; [Hayles, Rob] Meeting Minds, London, England; [Hayles, Rob] Collaborat Leadership Appl Healthcare Res Northwe, London, England	Imperial College London; University of London; University College London; University of London; King's College London; Imperial College London	Garfield, S (corresponding author), Imperial Coll Healthcare NHS Trust, Ctr Medicat Safety & Serv Qual, London, England.; Garfield, S (corresponding author), UCL Sch Pharm, Res Dept Practice & Policy, BMA House,Tavistock Sq, London, England.	sara.garfield@imperial.nhs.uk	Garfield, Sara/F-9941-2019	Garfield, Sara/0000-0002-9980-0520	Health Foundation [7205]	Health Foundation	This study was funded by The Health Foundation (Grant number 7205). The Health Foundation is an independent charity working to continuously improve the quality of healthcare in the UK (http://www.health.org.uk). The Health Foundation funded the roles of SG, AJ, BDF, AB, CN, FH, JL, AT, CB and RH. The Centre for Medication Safety and Service Quality is affiliated with the National Institute for Health Research Imperial Patient Safety Translational Research Centre and the National Institute for Healthcare Research Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London in partnership with Public Health England (PHE). The views expressed are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, The PHE or the Department of Health. A member of the Health Foundation was on the patient and clinical engagement group, which met quarterly and provided general contextual information and advice to the research team. Neither the Health Foundation nor the National Institute for Health Research had any specific role in the design, data collection and analysis, decision to publish, or preparation of the manuscript.	Academy of Royal Medical Colleges, 2011, STAND DES HOSP IN PA; Ahmed Z, 2013, PLOS ONE, V8; [Anonymous], 2010, EQ EXC LIB NHS; Brock TP, 2007, AM J HEALTH-SYST PH, V64, P1541, DOI 10.2146/ajhp060444; Caldwell G., 2010, PHARM MANAGE, V26, P3; Cumbler E, 2010, J HOSP MED, V5, P83, DOI 10.1002/jhm.566; Davis RE, 2011, BMJ QUAL SAF, V20, P108, DOI 10.1136/bmjqs.2010.041871; Davis RE, 2012, J PATIENT SAF, V8, P182, DOI 10.1097/PTS.0b013e318267c4aa; de Lusignan S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006021; Entwistle VA, 2010, BMJ QUAL SAF, V19, P33; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Franklin BD, 2007, QUAL SAF HEALTH CARE, V16, P279, DOI 10.1136/qshc.2006.019497; Franklin BD, 2011, POSTGRAD MED J, V87, P739, DOI 10.1136/pgmj.2011.117879; Garfield Sara, 2015, Res Involv Engagem, V1, P8, DOI 10.1186/s40900-015-0006-7; Hall J, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2009.032748; Hibbard JH, 2005, MED CARE RES REV, V62, P601, DOI 10.1177/1077558705279313; Lawton R, 2012, ROLE PATIENT CLIN SA; Lee Lisa, 2015, J Innov Health Inform, V22, P391, DOI 10.14236/jhi.v22i4.176; Manias E, 2015, HEALTH EXPECT, V18, P850, DOI 10.1111/hex.12057; McLeod M, 2015, PLOSONE IN PRESS MAR; McLeod MC, 2013, BMJ QUAL SAF, V22, P278, DOI 10.1136/bmjqs-2012-001330; Milne H, 2016, HEALTH EXPECT, V19, P602, DOI 10.1111/hex.12320; Mohsin-Shaikh S, 2014, INT J CLIN PHARM-NET, V36, P657, DOI 10.1007/s11096-014-9951-8; O'Grady K., 2006, BJHC&IM-British Journal of Healthcare Computing & Information Management, V23, P15; Schwappach D. L., 2010, QUAL SAF HEALTH CARE, V19, P9; Schwappach DLB, 2011, ANN ONCOL, V22, P424, DOI 10.1093/annonc/mdq346; Schwappach DLB, 2010, ONCOLOGIST, V15, P903, DOI 10.1634/theoncologist.2010-0117; Schwappach DLB, 2010, J CLIN ONCOL, V28, P2896, DOI 10.1200/JCO.2009.27.6626; Vincent C., 2010, PATIENT SAFETY, V2nd Ed.; Watt I, 2009, REV STRATEGIES PROMO; Westbrook JI, 2015, INT J QUAL HEALTH C, V27, P1, DOI 10.1093/intqhc/mzu098	31	19	19	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153721	10.1371/journal.pone.0153721	http://dx.doi.org/10.1371/journal.pone.0153721			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093438	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200042
J	Wang, DF; Qin, YL; Fang, JJ; Yuan, SJ; Peng, LX; Zhao, JF; Li, XY				Wang, Daofeng; Qin, Yanling; Fang, Jingjing; Yuan, Shoujiang; Peng, Lixiang; Zhao, Jinfeng; Li, Xueyong			A Missense Mutation in the Zinc Finger Domain of OsCESA7 Deleteriously Affects Cellulose Biosynthesis and Plant Growth in Rice	PLOS ONE			English	Article							SYNTHASE CATALYTIC SUBUNITS; ENCODES; RESISTANCE; ISOXABEN; PROTEIN; GENES; FORM	Rice is a model plant species for the study of cellulose biosynthesis. We isolated a mutant, S1-24, from ethyl methanesulfonate (EMS)-treated plants of the japonica rice cultivar, Nipponbare. The mutant exhibited brittle culms and other pleiotropic phenotypes such as dwarfism and partial sterility. The brittle culms resulted from reduced mechanical strength due to a defect in thickening of the sclerenchyma cell wall and reduced cellulose content in the culms of the S1-24 mutant. Map-based gene cloning and a complementation assay showed that phenotypes of the S1-24 mutant were caused by a recessive point mutation in the OsCESA7 gene, which encodes cellulose synthase A subunit 7. The missense mutation changed the highly conserved C40 to Y in the zinc finger domain. The OsCESA7 gene is expressed predominantly in the culm at the mature stage, particularly in mechanical tissues such as vascular bundles and sclerenchyma cells, consistent with the brittle phenotype in the culm. These results indicate that OsCESA7 plays an important role in cellulose biosynthesis and plant growth.	[Wang, Daofeng; Qin, Yanling; Fang, Jingjing; Peng, Lixiang; Zhao, Jinfeng; Li, Xueyong] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China; [Yuan, Shoujiang] Shandong Rice Res Inst, Jinan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Li, XY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	lixueyong@caas.cn			Ministry of Agriculture of China [2016ZX08009-003]; Agricultural Science and Technology Innovation Program of China	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); Agricultural Science and Technology Innovation Program of China	This work was supported by grants from the Ministry of Agriculture of China (2016ZX08009-003) and the Agricultural Science and Technology Innovation Program of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aohara T, 2009, PLANT CELL PHYSIOL, V50, P1886, DOI 10.1093/pcp/pcp133; Arioli T, 1998, SCIENCE, V279, P717, DOI 10.1126/science.279.5351.717; Chu ZQ, 2007, PLANT PHYSIOL, V143, P213, DOI 10.1104/pp.106.088393; Cosgrove DJ, 2000, NATURE, V407, P321, DOI 10.1038/35030000; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Doblin MS, 2002, PLANT CELL PHYSIOL, V43, P1407, DOI 10.1093/pcp/pcf164; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fagard M, 2000, PLANT CELL, V12, P2409, DOI 10.1105/tpc.12.12.2409; Gardiner JC, 2003, PLANT CELL, V15, P1740, DOI 10.1105/tpc.012815; Hiei Y, 2008, NAT PROTOC, V3, P824, DOI 10.1038/nprot.2008.46; Kotake T, 2011, J EXP BOT, V62, P2053, DOI 10.1093/jxb/erq395; Kurek I, 2002, P NATL ACAD SCI USA, V99, P11109, DOI 10.1073/pnas.162077099; Li Shundai, 2014, Arabidopsis Book, V12, pe0169, DOI 10.1199/tab.0169; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Richmond TA, 2000, PLANT PHYSIOL, V124, P495, DOI 10.1104/pp.124.2.495; Saxena IM, 2005, ANN BOT-LONDON, V96, P9, DOI 10.1093/aob/mci155; Scheible WR, 2001, P NATL ACAD SCI USA, V98, P10079, DOI 10.1073/pnas.191361598; Somerville C, 2006, ANNU REV CELL DEV BI, V22, P53, DOI 10.1146/annurev.cellbio.22.022206.160206; Song XQ, 2013, MOL PLANT, V6, P768, DOI 10.1093/mp/sst025; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Taylor NG, 2004, CELLULOSE, V11, P329, DOI 10.1023/B:CELL.0000046405.11326.a8; Taylor NG, 1999, PLANT CELL, V11, P769, DOI 10.1105/tpc.11.5.769; Taylor NG, 2003, P NATL ACAD SCI USA, V100, P1450, DOI 10.1073/pnas.0337628100; Taylor NG, 2000, PLANT CELL, V12, P2529, DOI 10.1105/tpc.12.12.2529; Timmers J, 2009, FEBS LETT, V583, P978, DOI 10.1016/j.febslet.2009.02.035; Wang DF, 2012, PLANT SCI, V196, P117, DOI 10.1016/j.plantsci.2012.08.002; Yan Changjie, 2007, Journal of Genetics and Genomics, V34, P1019, DOI 10.1016/S1673-8527(07)60115-5; Zhang BC, 2011, J INTEGR PLANT BIOL, V53, P136, DOI 10.1111/j.1744-7909.2010.01011.x; Zhang BC, 2009, PLANT MOL BIOL, V71, P509, DOI 10.1007/s11103-009-9536-4; Zhong RQ, 2003, PLANT PHYSIOL, V132, P786, DOI 10.1104/pp.102.019331	32	20	23	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153993	10.1371/journal.pone.0153993	http://dx.doi.org/10.1371/journal.pone.0153993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092937	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200068
J	Kwok, MK; Leung, GM; Schooling, CM				Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary			Associations of Birth Order with Early Adolescent Growth, Pubertal Onset, Blood Pressure and Size: Evidence from Hong Kong's "Children of 1997" Birth Cohort	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; HEART-DISEASE; EARLY ORIGINS; FAMILY-SIZE; EARLY-LIFE; WEIGHT; CHILDHOOD; AGE; IMPUTATION; PATTERNS	Background Birth order has been proposed as a cardiovascular risk factor, because the lower birth weight and greater infant weight gain typical of firstborns could programme metabolism detrimentally. Methods We examined the associations of birth order (firstborn or laterborn) with birth weight-for-gestational age, length/height and body mass index (BMI) z-scores during infancy, childhood, and puberty using generalized estimating equations, with age at pubertal onset using interval-censored regression and with age-, sex-and height-standardized blood pressure, height and BMI z-scores at 13 years using linear regression in a population-representative Chinese birth cohort: "Children of 1997" (n = 8,327). Results Compared with laterborns, firstborns had lower birth weight-for-gestational age (mean difference = -0.18 z-score, 95% confidence interval (CI) -0.23, -0.14), lower infant BMI (-0.09 z-score, 95% CI -0.14, -0.04), greater childhood height (0.10 z-score, 95% CI 0.05, 0.14) and BMI (0.08 z-score, 95% CI 0.03, 0.14), but not greater pubertal BMI (0.05 z-score, 95% CI -0.02, 0.11), adjusted for sex, parental age, birthplace, education and income. Firstborns had earlier onset of pubic hair (time ratio = 0.988, 95% CI 0.980, 0.996), but not breast or genitalia, development. Firstborns had greater BMI (0.07 z-score, 95% CI 0.002, 0.15), but not height (0.05 z-score, 95% CI -0.01, 0.11), at 13 years, but similar blood pressure. Conclusions Differences by birth order continue into early adolescence with firstborns being heavier with earlier pubic hair development, which could indicate long-term cardiovascular risk.	[Kwok, Man Ki; Leung, Gabriel M.; Schooling, C. Mary] Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Schooling, C. Mary] CUNY, Sch Publ Hlth, New York, NY 10021 USA; [Schooling, C. Mary] CUNY Hunter Coll, New York, NY 10021 USA	University of Hong Kong; City University of New York (CUNY) System; City University of New York (CUNY) System; Hunter College (CUNY)	Schooling, CM (corresponding author), Univ Hong Kong, Sch Publ Hlth, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China.; Schooling, CM (corresponding author), CUNY, Sch Publ Hlth, New York, NY 10021 USA.; Schooling, CM (corresponding author), CUNY Hunter Coll, New York, NY 10021 USA.	cms1@hku.hk		Kwok, Man Ki/0000-0003-3777-4766; Leung, Gabriel/0000-0002-2503-6283	Health Care and Promotion Fund; Health and Welfare Bureau; Government of the Hong Kong SAR [HCPF] [216106]; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR [03040771, 07080841, 07080751, 08090761, 09101061]; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong	Health Care and Promotion Fund; Health and Welfare Bureau; Government of the Hong Kong SAR [HCPF]; Health and Health Services Research Fund [HHSRF], Government of the Hong Kong SAR; University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong(University of Hong Kong)	This work is a sub-study of the "Children of 1997" birth cohort which was initially supported by the Health Care and Promotion Fund, Health and Welfare Bureau, Government of the Hong Kong SAR [HCPF Grant # 216106] and re-established in 2005 funded by the Health and Health Services Research Fund [HHSRF Grant # 03040771] and the University Research Committee Strategic Research Theme (SRT) of Public Health, The University of Hong Kong. This sub-study was funded by the Health and Health Services Research Fund [HHSRF Grants # 07080841, # 07080751, # 08090761 and # 09101061], Government of the Hong Kong SAR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboderin I., 2002, LIFE COURSE PERSPECT; Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Adair LS, 1999, J NUTR, V129, P1140, DOI 10.1093/jn/129.6.1140; Apraiz AG, 1999, AM J HUM BIOL, V11, P779, DOI 10.1002/(SICI)1520-6300(199911/12)11:6<779::AID-AJHB8>3.0.CO;2-7; Barker DJP, 1997, BRIT MED BULL, V53, P96; Cheung YB, 2001, SOC SCI MED, V52, P1135, DOI 10.1016/S0277-9536(00)00228-8; D'Aloisio AA, 2013, EPIDEMIOLOGY, V24, P277, DOI 10.1097/EDE.0b013e31828062b7; Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D; Floyd B, 2005, J BIOSOC SCI, V37, P287, DOI 10.1017/S0021932004006674; Fok TF, 2003, ARCH DIS CHILD-FETAL, V88, P229, DOI 10.1136/fn.88.3.F229; Frejka T, 2010, POPUL DEV REV, V36, P579, DOI 10.1111/j.1728-4457.2010.00347.x; Harrell FE, 2001, REGRESSION MODELING; Haugaard LK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056357; Hemminki K, 2001, BRIT J CANCER, V84, P1466, DOI 10.1054/bjoc.2001.1811; Howe LD, 2013, INT J OBES LOND, DOI [10.1038/ijo.2013.189, DOI 10.1038/IJ0.2013.189]; Hui LL, 2012, ANN EPIDEMIOL, V22, P43, DOI 10.1016/j.annepidem.2011.10.003; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Jelenkovic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063361; Kamp GA, 2002, ARCH DIS CHILD, V87, P215, DOI 10.1136/adc.87.3.215; Karlberg J, 1989, Acta Paediatr Scand Suppl, V350, P70; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Koziel S, 2001, COLLEGIUM ANTROPOL, V25, P555; Kristensen P, 2007, SCIENCE, V316, P1717, DOI 10.1126/science.1141493; Kwok MK, 2013, J HYPERTENS, V31, P1785, DOI 10.1097/HJH.0b013e3283622ea0; Kwok MK, 2013, AM J EPIDEMIOL, V178, P928, DOI 10.1093/aje/kwt076; Kwok MK, 2013, ANN EPIDEMIOL, V23, P475, DOI 10.1016/j.annepidem.2013.05.016; Kwok MK, 2012, PEDIATRICS, V130, pE631, DOI 10.1542/peds.2011-3697; Lawlor DA, 2004, CIRCULATION, V110, P2417, DOI 10.1161/01.CIR.0000145165.80130.B5; Luo ZC, 2001, J PEDIATR ENDOCR MET, V14, P757; Mathai M, 1996, Indian Pediatr, V33, P203; Mongraw-Chaffin ML, 2015, LANCET DIABETES ENDO, V3, P437, DOI 10.1016/S2213-8587(15)00086-8; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ochiai H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-766; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Pang MW, 2000, AUST NZ J OBSTET GYN, V40, P161, DOI 10.1111/j.1479-828X.2000.tb01139.x; PETO R, 1973, ROY STAT SOC C-APP, V22, P86; PRENTICE A, 1987, HUM NUTR-CLIN NUTR, V41C, P319; Savage T, 2013, CLIN ENDOCRINOL, V79, P379, DOI 10.1111/cen.12156; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schooling CM, 2010, J EPIDEMIOL COMMUN H, V64, DOI 10.1136/jech.2008.086553; Schooling CM, 2012, INT J EPIDEMIOL, V41, P611, DOI 10.1093/ije/dyq243; Schooling CM, 2010, ARCH DIS CHILD, V95, P437, DOI 10.1136/adc.2009.168542; Siervo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013907; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Tu YK, 2010, EPIDEMIOLOGY, V21, P440, DOI 10.1097/EDE.0b013e3181d62123; Urquia ML, 2010, J EPIDEMIOL COMMUN H, V64, P243, DOI 10.1136/jech.2008.083535; Verropoulou G, 2014, J BIOSOC SCI, V46, P316, DOI 10.1017/S0021932013000321; Wells JCK, 2011, AM J EPIDEMIOL, V174, P1028, DOI 10.1093/aje/kwr232; WHINCUP PH, 1989, BMJ-BRIT MED J, V299, P587, DOI 10.1136/bmj.299.6699.587; Whiting S., 2011, POPULATION MATTERS; WHO, 2007, WHO GROWTH REF 5 19; Wilcox MA, 1996, ACTA OBSTET GYN SCAN, V75, P459, DOI 10.3109/00016349609033354; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Wong SN, 2006, BLOOD PRESS MONIT, V11, P281, DOI 10.1097/01.mbp.0000209082.09623.b4; World Health Organization, 2005, WHO CHILD GROWTH STA; World Health Organization (WHO), 2013, STRAT PRIOR WHO CARD; World Health Organization (WHO), 2015, CARD DIS CVDS 2015; Worthman CM, 2005, AM J HUM BIOL, V17, P95, DOI 10.1002/ajhb.20096	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153787	10.1371/journal.pone.0153787	http://dx.doi.org/10.1371/journal.pone.0153787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088360	gold, Green Published			2022-12-27	WOS:000374527000049
J	Ribeiro, BG; Alves, AN; dos Santos, LAD; Cantero, TM; Fernandes, KPS; Dias, DD; Bernardes, N; De Angelis, K; Mesquita-Ferrari, RA				Ribeiro, Beatriz Guimaraes; Alves, Agnelo Neves; Dias dos Santos, Lucas Andreo; Cantero, Tatiane Matarazzo; Santos Fernandes, Kristianne Porta; Dias, Danielle da Silva; Bernardes, Nathalia; De Angelis, Katia; Mesquita-Ferrari, Raquel Agnelli			Red and Infrared Low-Level Laser Therapy Prior to Injury with or without Administration after Injury Modulate Oxidative Stress during the Muscle Repair Process	PLOS ONE			English	Article							TIBIALIS ANTERIOR MUSCLE; INTENSITY LIGHT THERAPY; SKELETAL-MUSCLE; MAMMALIAN-CELLS; EXPRESSION; FIBROSIS; DAMAGE; MODEL	Introduction Muscle injury is common among athletes and amateur practitioners of sports. Following an injury, the production of reactive oxygen species (ROS) occurs, which can harm healthy muscle fibers (secondary damage) and delay the repair process. Low-level laser therapy (LLLT) administered prior to or following an injury has demonstrated positive and protective effects on muscle repair, but the combination of both administration times together has not been clarified. Aim To evaluate the effect of LLLT (660 nm and 780 nm, 10 J/cm(2), 40 mW, 3.2 J) prior to injury with or without the administration after injury on oxidative stress during the muscle repair process. Methods Wistar rats were divided into following groups: control; muscle injury alone; LLLT 660 nm + injury; LLLT 780 nm + injury; LLLT 660 nm before and after injury; and LLLT 780 nm before and after injury. The rats were euthanized on days 1, 3 and 7 following cryoinjury of the tibialis anterior (TA) muscle, which was then removed for analysis. Results Lipid peroxidation decreased in the 660+injury group after one day. Moreover, red and infrared LLLT employed at both administration times induced a decrease in lipid peroxidation after seven days. CAT activity was altered by LLLT in all periods evaluated, with a decrease after one day in the 780+injury+780 group and after seven days in the 780+injury group as well as an increase in the 780+injury and 780+injury+780 groups after three days. Furthermore, increases in GPx and SOD activity were found after seven days in the 780+injury+780 group. Conclusion The administration of red and infrared laser therapy at different times positively modulates the activity of antioxidant enzymes and reduces stress markers during the muscle repair process.	[Ribeiro, Beatriz Guimaraes; Alves, Agnelo Neves; Cantero, Tatiane Matarazzo; Dias, Danielle da Silva; De Angelis, Katia; Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Rehabil Dept, Sao Paulo, SP, Brazil; [Dias dos Santos, Lucas Andreo; Santos Fernandes, Kristianne Porta; Mesquita-Ferrari, Raquel Agnelli] Univ Nove de Julho UNINOVE, Biophoton Dept, Sao Paulo, SP, Brazil; [Bernardes, Nathalia] Univ Sao Paulo, Sch Med, Hypertens Unit, Heart Inst InCor, Sao Paulo, SP, Brazil; [De Angelis, Katia] Univ Nove de Julho UNINOVE, Dept Med, Sao Paulo, SP, Brazil	Universidade Nove de Julho; Universidade Nove de Julho; Universidade de Sao Paulo; Universidade Nove de Julho	Mesquita-Ferrari, RA (corresponding author), Univ Nove de Julho UNINOVE, Rehabil Dept, Sao Paulo, SP, Brazil.; Mesquita-Ferrari, RA (corresponding author), Univ Nove de Julho UNINOVE, Biophoton Dept, Sao Paulo, SP, Brazil.	raquel.mesquita@gmail.com	da Silva Dias, Danielle/AAN-7618-2020; Bernardes, Nathalia/L-7460-2015; Ferrari, Raquel/I-4419-2016; Alves, Agnelo N/C-2775-2013; Andreo, Lucas/GQB-0944-2022; Fernandes, Kristianne Porta Santos/I-4417-2016; DE ANGELIS, KATIA/I-6098-2016	da Silva Dias, Danielle/0000-0003-4152-0849; Bernardes, Nathalia/0000-0001-9555-4134; Ferrari, Raquel/0000-0001-5142-9526; Alves, Agnelo N/0000-0003-2586-4377; Fernandes, Kristianne Porta Santos/0000-0001-7156-9286; DE ANGELIS, KATIA/0000-0002-3640-9049	UNINOVE; National Council for Scientific and Technological Development [305739/2014 RAMF, 303662/2012 RAMF]; Coordination for the Improvement of Higher Education Personnel [1510536 BGR]; Sao Paulo Research Foundation [2013/21540-3 ANA, 2014/12381-1 RAMF]	UNINOVE; National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by UNINOVE and the Brazilian fostering agencies: National Council for Scientific and Technological Development (www.cnpq.br; process numbers: 305739/2014 RAMF, 303662/2012 RAMF); Coordination for the Improvement of Higher Education Personnel (www.capes.gov.br; process number: 1510536 BGR); Sao Paulo Research Foundation (www.fapesp.br; process numbers: 2013/21540-3 ANA; 2014/12381-1 RAMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida P, 2011, PHOTOCHEM PHOTOBIOL, V87, P1159, DOI DOI 10.1111/J.1751-1097.2011.00968.X; Alves AN, 2014, LASER MED SCI, V29, P813, DOI 10.1007/s10103-013-1428-9; Alves AN, 2014, AM J PHYS MED REHAB, V93, P1073, DOI 10.1097/PHM.0000000000000158; Assis L, 2013, LASER MED SCI, V28, P947, DOI 10.1007/s10103-012-1183-3; Assis L, 2012, LASER SURG MED, V44, P726, DOI 10.1002/lsm.22077; Baptista J, 2011, PHOTOMED LASER SURG, V29, P11, DOI 10.1089/pho.2009.2737; Barbieri Elena, 2012, J Signal Transduct, V2012, P982794, DOI 10.1155/2012/982794; Brunelli RM, 2014, LASER MED SCI, V29, P91, DOI 10.1007/s10103-013-1277-6; Conti FF, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-185; de Souza TOF, 2011, LASER MED SCI, V26, P803, DOI 10.1007/s10103-011-0951-9; Ferraresi Cleber, 2012, Photonics Lasers Med, V1, P267; FLECHA BG, 1991, FREE RADICAL BIO MED, V10, P93; Gao XJ, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-4; Garg K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00087; Gharaibeh B, 2012, BIRTH DEFECTS RES C, V96, P82, DOI 10.1002/bdrc.21005; Irigoyen MC, 2005, HYPERTENSION, V46, P998, DOI 10.1161/01.HYP.0000176238.90688.6b; Karu TI, 2008, PHOTOCHEM PHOTOBIOL, V84, P1091, DOI 10.1111/j.1751-1097.2008.00394.x; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Liu XG, 2009, PHOTOMED LASER SURG, V27, P863, DOI 10.1089/pho.2008.2443; Silveira PCL, 2013, LASER MED SCI, V28, P431, DOI 10.1007/s10103-012-1075-6; Luo L, 2013, LASER MED SCI, V28, P725, DOI 10.1007/s10103-012-1133-0; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Mesquita-Ferrari RA, 2011, LASER MED SCI, V26, P335, DOI 10.1007/s10103-010-0850-5; Leal ECP, 2015, LASER MED SCI, V30, P925, DOI 10.1007/s10103-013-1465-4; Pisoschi AM, 2015, EUR J MED CHEM, V97, P55, DOI 10.1016/j.ejmech.2015.04.040; Quinteiro H, 2015, MENOPAUSE, V22, P534, DOI [10.1097/GME.0000000000000344, 10.1097/gme.0000000000000344]; REZNICK AZ, 1994, METHOD ENZYMOL, V233, P357; Ribeiro BG, 2015, LASER SURG MED, DOI [10.1002/Ism.22381, DOI 10.1002/ISM.22381]; Rizzi CF, 2006, LASER SURG MED, V38, P704, DOI 10.1002/lsm.20371; Fernandes KPS, 2013, LASER MED SCI, V28, P1043, DOI 10.1007/s10103-012-1233-x; Schaur RJ, 2015, BIOMOLECULES, V5, P2247, DOI 10.3390/biom5042247; Tafur J, 2008, PHOTOMED LASER SURG, V26, P323, DOI 10.1089/pho.2007.2184; Tafur J, 2010, PHOTOMED LASER SURG, V28, P23, DOI 10.1089/pho.2008.2373; Urish KL, 2009, MOL BIOL CELL, V20, P509, DOI 10.1091/mbc.E08-03-0274; Vatansever Fatma, 2012, Photonics Lasers Med, V1, P287	35	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153618	10.1371/journal.pone.0153618	http://dx.doi.org/10.1371/journal.pone.0153618			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082964	Green Published, gold			2022-12-27	WOS:000374291800034
J	Schoot, L; Heyselaar, E; Hagoort, P; Segaert, K				Schoot, Lotte; Heyselaar, Evelien; Hagoort, Peter; Segaert, Katrien			Does Syntactic Alignment Effectively Influence How Speakers Are Perceived by Their Conversation Partner?	PLOS ONE			English	Article							SENTENCE PRODUCTION; LANGUAGE PRODUCTION; PERSISTENCE; DIALOGUE	The way we talk can influence how we are perceived by others. Whereas previous studies have started to explore the influence of social goals on syntactic alignment, in the current study, we additionally investigated whether syntactic alignment effectively influences conversation partners' perception of the speaker. To this end, we developed a novel paradigm in which we can measure the effect of social goals on the strength of syntactic alignment for one participant (primed participant), while simultaneously obtaining usable social opinions about them from their conversation partner (the evaluator). In Study 1, participants' desire to be rated favorably by their partner was manipulated by assigning pairs to a Control (i.e., primed participants did not know they were being evaluated) or Evaluation context (i.e., primed participants knew they were being evaluated). Surprisingly, results showed no significant difference in the strength with which primed participants aligned their syntactic choices with their partners' choices. In a follow-up study, we used a Directed Evaluation context (i.e., primed participants knew they were being evaluated and were explicitly instructed to make a positive impression). However, again, there was no evidence supporting the hypothesis that participants' desire to impress their partner influences syntactic alignment. With respect to the influence of syntactic alignment on perceived likeability by the evaluator, a negative relationship was reported in Study 1: the more primed participants aligned their syntactic choices with their partner, the more that partner decreased their likeability rating after the experiment. However, this effect was not replicated in the Directed Evaluation context of Study 2. In other words, our results do not support the conclusion that speakers' desire to be liked affects how much they align their syntactic choices with their partner, nor is there convincing evidence that there is a reliable relationship between syntactic alignment and perceived likeability.	[Schoot, Lotte; Heyselaar, Evelien; Hagoort, Peter; Segaert, Katrien] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Hagoort, Peter] Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Segaert, Katrien] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	Max Planck Society; Radboud University Nijmegen; University of Birmingham	Schoot, L (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	Lotte.Schoot@mpi.nl	Hagoort, Peter/B-7417-2012; Heyselaar, Evelien/AAG-7354-2021; Segaert, Katrien/AAT-9387-2021	Segaert, Katrien/0000-0002-3002-5837				[Anonymous], 2014, R LANG ENV STAT COMP; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2014, ARXIV14065823; Bernolet S, 2010, COGNITION, V114, P455, DOI 10.1016/j.cognition.2009.11.005; Bernolet S, 2009, COGNITION, V112, P300, DOI 10.1016/j.cognition.2009.05.013; BOCK JK, 1986, COGNITIVE PSYCHOL, V18, P355, DOI 10.1016/0010-0285(86)90004-6; BOCK K, 1990, COGNITION, V35, P1, DOI 10.1016/0010-0277(90)90035-I; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; CAPPELLA JN, 1981, HUM COMMUN RES, V7, P117, DOI 10.1111/j.1468-2958.1981.tb00564.x; Chang F, 2006, PSYCHOL REV, V113, P234, DOI 10.1037/0033-295X.113.2.234; Chang F, 2000, J PSYCHOLINGUIST RES, V29, P217, DOI 10.1023/A:1005101313330; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Coyle JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027971; Dale R, 2005, P 27 ANN M COGN SCI, P184; Ferreira VS, 2003, J MEM LANG, V48, P379, DOI 10.1016/S0749-596X(02)00523-5; Giles H, 1975, SPEECH STYLE SOCIAL, Vviii; Hartsuiker RJ, 1999, Q J EXP PSYCHOL-A, V52, P129, DOI 10.1080/027249899391250; Hartsuiker RJ, 1998, LANG SPEECH, V41, P143, DOI 10.1177/002383099804100202; Haselton MG, 2006, HUM NATURE-INT BIOS, V17, P50, DOI 10.1007/s12110-006-1020-0; Heyselaar E., 2014, P 36 ANN M COGN SCI, P2351; Heyselaar E, 2015, BEHAV RES       1216, P1; Jaeger TF, 2013, COGNITION, V127, P57, DOI 10.1016/j.cognition.2012.10.013; Lev-Ari S., 2015, DISCOURSE PROCESS, P1; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Pickering MJ, 1998, J MEM LANG, V39, P633, DOI 10.1006/jmla.1998.2592; Potter MC, 1998, J MEM LANG, V38, P265, DOI 10.1006/jmla.1997.2546; Reise SP, 2005, J PERS ASSESS, V84, P126, DOI 10.1207/s15327752jpa8402_02; Reitter D, 2011, COGNITIVE SCI, V35, P587, DOI 10.1111/j.1551-6709.2010.01165.x; Scheepers C, 2003, COGNITION, V89, P179, DOI 10.1016/S0010-0277(03)00119-7; Segaert K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024209; Weatherholtz K, 2014, LANG VAR CHANGE, V26, P387, DOI 10.1017/S0954394514000155; WEBB JT, 1969, LANG SPEECH, V12, P54, DOI 10.1177/002383096901200105; Weissgerber TL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002128	34	10	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153521	10.1371/journal.pone.0153521	http://dx.doi.org/10.1371/journal.pone.0153521			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27081856	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800027
J	Deligianni, F; Carmichael, DW; Zhang, GH; Clark, CA; Clayden, JD				Deligianni, Fani; Carmichael, David W.; Zhang, Gary H.; Clark, Chris A.; Clayden, Jonathan D.			NODDI and Tensor-Based Microstructural Indices as Predictors of Functional Connectivity	PLOS ONE			English	Article							CANONICAL CORRELATION-ANALYSIS; MULTISHELL DIFFUSION MRI; WHITE-MATTER; SPHERICAL-DECONVOLUTION; ORIENTATION DISPERSION; TISSUE-MICROSTRUCTURE; WATER DIFFUSION; BRAIN; TRACTOGRAPHY; ARTIFACT	In Diffusion Weighted MR Imaging (DWI), the signal is affected by the biophysical properties of neuronal cells and their relative placement, as well as extra-cellular tissue compartments. Typically, microstructural indices, such as fractional anisotropy (FA) and mean diffusivity (MD), are based on a tensor model that cannot disentangle the influence of these parameters. Recently, Neurite Orientation Dispersion and Density Imaging (NODDI) has exploited multi-shell acquisition protocols to model the diffusion signal as the contribution of three tissue compartments. NODDI microstructural indices, such as intra-cellular volume fraction (ICVF) and orientation dispersion index (ODI) are directly related to neuronal density and orientation dispersion, respectively. One way of examining the neurophysiological role of these microstructural indices across neuronal fibres is to look into how they relate to brain function. Here we exploit a statistical framework based on sparse Canonical Correlation Analysis (sCCA) and randomised Lasso to identify structural connections that are highly correlated with resting-state functional connectivity measured with simultaneous EEG-fMRI. Our results reveal distinct structural fingerprints for each microstructural index that also reflect their inter-relationships.	[Deligianni, Fani; Carmichael, David W.; Clark, Chris A.; Clayden, Jonathan D.] UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England; [Zhang, Gary H.] UCL, Dept Comp Sci, Ctr Med Image Comp, London, England	University of London; University College London; University of London; University College London	Deligianni, F (corresponding author), UCL, Inst Child Hlth, Dev Imaging & Biophys Sect, London, England.	f.deligianni@ucl.ac.uk	Clayden, Jonathan D/C-1894-2008; Carmichael, David/A-5391-2009; Deligianni, Fani/M-9116-2018	Clayden, Jonathan D/0000-0002-6608-0619; Carmichael, David/0000-0001-9972-0718; Deligianni, Fani/0000-0003-1306-5017	Engineering and Physical Sciences Research Council [EP/J016292/1]; EPSRC [EP/J016292/1]; MRC [G0701782] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Engineering and Physical Sciences Research Council, EP/J016292/1, JC (https://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this study comes from the EPSRC (EP/J016292/1).	Alexander DC, 2008, MAGN RESON MED, V60, P439, DOI 10.1002/mrm.21646; Allen PJ, 1998, NEUROIMAGE, V8, P229, DOI 10.1006/nimg.1998.0361; Allen PJ, 2000, NEUROIMAGE, V12, P230, DOI 10.1006/nimg.2000.0599; Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Chowdhury MEH, 2014, NEUROIMAGE, V84, P307, DOI 10.1016/j.neuroimage.2013.08.039; Clayden JD, 2013, FUNCT NEUROL, V28, P197, DOI 10.11138/FNeur/2013.28.3.197; Clayden JD, 2012, CEREB CORTEX, V22, P1738, DOI 10.1093/cercor/bhr243; Clayden JD, 2011, J STAT SOFTW, V44, P1; Deco G, 2013, J NEUROSCI, V33, P11239, DOI 10.1523/JNEUROSCI.1091-13.2013; Deco G, 2012, J NEUROSCI, V32, P3366, DOI 10.1523/JNEUROSCI.2523-11.2012; Deligianni Fani, 2013, Multimodal Brain Image Analysis. Third International Workshop, MBIA 2013. Held in Conjunction with MICCAI 2013. Proceedings: LNCS 8159, P211, DOI 10.1007/978-3-319-02126-3_21; Deligianni F, 2011, PROBABILISTIC FRAMEW, P296; Deligianni F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00258; Deligianni F, 2013, IEEE T MED IMAGING, V32, P2200, DOI 10.1109/TMI.2013.2276916; Deligianni F, 2010, I S BIOMED IMAGING, P1113, DOI 10.1109/ISBI.2010.5490188; Dell'Acqua F, 2013, HUM BRAIN MAPP, V34, P2464, DOI 10.1002/hbm.22080; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Horowitz A, 2014, BRAIN STRUCT FUNCT, P1; Jeurissen B, 2014, NEUROIMAGE, V103, P411, DOI 10.1016/j.neuroimage.2014.07.061; Jones D.K., 2010, IMAGING MED, V2, P341, DOI [10.2217/iim.10.21, DOI 10.2217/IIM.10.21]; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kunz N, 2014, NEUROIMAGE, V96, P288, DOI 10.1016/j.neuroimage.2014.03.057; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Ledoit O, 2004, J MULTIVARIATE ANAL, V88, P365, DOI 10.1016/S0047-259X(03)00096-4; Luo QF, 2012, MAGN RESON MED, V68, P807, DOI 10.1002/mrm.23299; LUTZ JG, 1994, EDUC PSYCHOL MEAS, V54, P666, DOI 10.1177/0013164494054003009; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Meinshausen N, 2010, J R STAT SOC B, V72, P417, DOI 10.1111/j.1467-9868.2010.00740.x; Messe A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003530; Mullinger K, 2008, INT J PSYCHOPHYSIOL, V67, P178, DOI 10.1016/j.ijpsycho.2007.06.008; Nilsson M, 2013, MAGN RESON MATER PHY, V26, P345, DOI 10.1007/s10334-013-0371-x; Parker CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111262; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; Reisert M, 2011, NEUROIMAGE, V54, P955, DOI 10.1016/j.neuroimage.2010.09.016; Reveley C, 2015, P NATL ACAD SCI USA, V112, pE2820, DOI 10.1073/pnas.1418198112; Roine T, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00028; Sagi Y, 2012, NEURON, V73, P1195, DOI 10.1016/j.neuron.2012.01.025; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sun Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096505; SZAFER A, 1995, MAGNET RESON MED, V33, P697, DOI 10.1002/mrm.1910330516; Szczepankiewicz F, 2015, NEUROIMAGE, V104, P241, DOI 10.1016/j.neuroimage.2014.09.057; Tewarie P, 2014, NEUROIMAGE, V97, P296, DOI 10.1016/j.neuroimage.2014.04.038; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; Varoquaux G, 2013, NEUROIMAGE, V80, P405, DOI 10.1016/j.neuroimage.2013.04.007; Wang ZQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126310; Wildie M, 2012, CHAOS, V22, DOI 10.1063/1.4766592; Wilkins B, 2015, NEUROIMAGE, V109, P341, DOI 10.1016/j.neuroimage.2014.12.060; Winston GP, 2014, EPILEPSY RES, V108, P336, DOI 10.1016/j.eplepsyres.2013.11.004; Witten DM, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1470; Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008; Yuan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045476; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang H, 2011, NEUROIMAGE, V56, P1301, DOI 10.1016/j.neuroimage.2011.01.084	65	35	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153404	10.1371/journal.pone.0153404	http://dx.doi.org/10.1371/journal.pone.0153404			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078862	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000374131700051
J	Simidjievski, N; Todorovski, L; Dzeroski, S				Simidjievski, Nikola; Todorovski, Ljupco; Dzeroski, Saso			Modeling Dynamic Systems with Efficient Ensembles of Process-Based Models	PLOS ONE			English	Article							POPULATION-DYNAMICS; LIBRARY; KNOWLEDGE; OPTIMIZATION; LAKES	Ensembles are a well established machine learning paradigm, leading to accurate and robust models, predominantly applied to predictive modeling tasks. Ensemble models comprise a finite set of diverse predictive models whose combined output is expected to yield an improved predictive performance as compared to an individual model. In this paper, we propose a new method for learning ensembles of process-based models of dynamic systems. The process-based modeling paradigm employs domain-specific knowledge to automatically learn models of dynamic systems from time-series observational data. Previous work has shown that ensembles based on sampling observational data (i.e., bagging and boosting), significantly improve predictive performance of process-based models. However, this improvement comes at the cost of a substantial increase of the computational time needed for learning. To address this problem, the paper proposes a method that aims at efficiently learning ensembles of process-based models, while maintaining their accurate long-term predictive performance. This is achieved by constructing ensembles with sampling domain-specific knowledge instead of sampling data. We apply the proposed method to and evaluate its performance on a set of problems of automated predictive modeling in three lake ecosystems using a library of process-based knowledge for modeling population dynamics. The experimental results identify the optimal design decisions regarding the learning algorithm. The results also show that the proposed ensembles yield significantly more accurate predictions of population dynamics as compared to individual process-based models. Finally, while their predictive performance is comparable to the one of ensembles obtained with the state-of-the-art methods of bagging and boosting, they are substantially more efficient.	[Simidjievski, Nikola; Dzeroski, Saso] Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia; [Simidjievski, Nikola; Dzeroski, Saso] Jozef Stefan Inst, Postgrad Sch, Ljubljana, Slovenia; [Todorovski, Ljupco] Univ Ljubljana, Fac Adm, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana	Simidjievski, N (corresponding author), Jozef Stefan Inst, Dept Knowledge Technol, Ljubljana, Slovenia.; Simidjievski, N (corresponding author), Jozef Stefan Inst, Postgrad Sch, Ljubljana, Slovenia.	nikola.simidjievski@ijs.si	Dzeroski, Saso/ABH-2758-2021	Dzeroski, Saso/0000-0003-2363-712X; Simidjievski, Nikola/0000-0003-3948-6370	Slovenian Research Agency [P2-0103, P5-0093(B)]; European Commission [ICT-2013-604102 HBP, ICT-2013-612944 MAESTRA]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); European Commission(European CommissionEuropean Commission Joint Research Centre)	NS received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P2-0103) and the European Commission (http://ec.europa.eu, Grant ICT-2013-604102 HBP). LT received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P5-0093(B)). SD received funding from the Slovenian Research Agency (https://www.arrs.gov.si, Grant P2-0103) and the European Commission (http://ec.europa.eu, Grants ICT-2013-612944 MAESTRA and ICT-2013-604102 HBP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040916; [Anonymous], 1963, DISTRIBUTION FREE MU; Atanasova N, 2006, ECOL MODEL, V194, P37, DOI 10.1016/j.ecolmodel.2005.10.029; Atanasova N, 2006, ECOL MODEL, V194, P14, DOI 10.1016/j.ecolmodel.2005.10.002; Atanasova N, 2006, ECOLOGICAL INFORM, P409; Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Blockeel H, 1998, ARTIF INTELL, V101, P285, DOI 10.1016/S0004-3702(98)00034-4; Borrett SR, 2007, ECOL COMPLEX, V4, P1, DOI 10.1016/j.ecocom.2007.02.017; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 1984, CLASSIFICATION REGRE; Bridewell W, 2005, P 22 INT C MACHINE L, P81, DOI DOI 10.1145/1102351.1102362; Bridewell W, 2008, MACH LEARN, V71, P1, DOI 10.1007/s10994-007-5042-6; Brown G., 2005, Information Fusion, V6, P5, DOI 10.1016/j.inffus.2004.04.004; Cao HQ, 2008, ECOL INFORM, V3, P181, DOI 10.1016/j.ecoinf.2008.02.001; Cerepnalkoski D., 2013, PROCESS BASED MODELS; Cerepnalkoski D, 2012, ECOL MODEL, V245, P136, DOI 10.1016/j.ecolmodel.2012.06.001; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; Cohen S. D., 1996, Computers in Physics, V10, P138; Demsar J, 2006, J MACH LEARN RES, V7, P1; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Dietzel A, 2013, FRESHWATER BIOL, V58, P10, DOI 10.1111/fwb.12031; Drucker H., 1997, P INT C MACH LEARN N, VVolume 97, P107; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Durillo JJ, 2011, ADV ENG SOFTW, V42, P760, DOI 10.1016/j.advengsoft.2011.05.014; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Ho TK, 2000, LECT NOTES COMPUT SC, V1857, P97; IMAN RL, 1980, COMMUN STAT A-THEOR, V9, P571, DOI 10.1080/03610928008827904; Knudby A, 2010, ECOL MODEL, V221, P503, DOI 10.1016/j.ecolmodel.2009.11.008; Kocev D, 2013, ECOL INFORM, V18, P79, DOI 10.1016/j.ecoinf.2013.06.003; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Langley P., 1987, SCI DISCOVERY COMPUT; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Okun O., 2011, ENSEMBLES MACHINE LE, V373; Opitz D., 1999, J ARTIF INTELL RES, V11, P169, DOI [10.1613/jair.614, DOI 10.1613/JAIR.614]; Panov P, 2007, LECT NOTES COMPUT SC, V4723, P118; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Schapire RE, 2003, LECT NOTES STAT, V171, P149, DOI 10.1007/978-0-387-21579-2_9; Schapire RE, 1999, IJCAI-99: PROCEEDINGS OF THE SIXTEENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 & 2, P1401; Simidjievski N, 2015, EXPERT SYST APPL, V42, P8484, DOI 10.1016/j.eswa.2015.07.004; Simidjievski N, 2015, ECOL MODEL, V306, P305, DOI 10.1016/j.ecolmodel.2014.08.019; Skerjanec M, 2014, ENVIRON MODELL SOFTW, V54, P60, DOI 10.1016/j.envsoft.2013.12.017; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Tanevski J, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0273-4; Tanevski J, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0175-x; Tashkova K, 2012, ECOL MODEL, V226, P36, DOI 10.1016/j.ecolmodel.2011.11.029; Tashkova K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-159; Todorovski Ljupco, 2007, Computational Discovery of Scientific Knowledge. Introduction, Techniques, and Applications in Environmental and Life Sciences, P69; Todorovski L, 2003, ECOL MODEL, V170, P141, DOI 10.1016/S0304-3800(03)00222-9; Todorovski L., 2005, P 20 NAT C ART INT, P892; Washio T, 2000, P 17 INT C MACH LEAR, P1127; Whigham PA, 2001, ECOL MODEL, V146, P243, DOI 10.1016/S0304-3800(01)00310-6; WOLPERT DH, 1992, NEURAL NETWORKS, V5, P241, DOI 10.1016/S0893-6080(05)80023-1	54	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153507	10.1371/journal.pone.0153507	http://dx.doi.org/10.1371/journal.pone.0153507			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078633	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700070
J	Zheng, ZT; Liu, XM; Li, B; Cai, YQ; Zhu, YY; Zhou, MG				Zheng, Zhitian; Liu, Xiumei; Li, Bin; Cai, Yiqiang; Zhu, Yuanye; Zhou, Mingguo			Myosins FaMyo2B and Famyo2 Affect Asexual and Sexual Development, Reduces Pathogenicity, and FaMyo2B Acts Jointly with the Myosin Passenger Protein FaSmy1 to Affect Resistance to Phenamacril in Fusarium asiaticum	PLOS ONE			English	Article							KINESIN-RELATED PROTEIN; HEAD BLIGHT; SACCHAROMYCES-CEREVISIAE; FUNGICIDE JS399-19; GRAMINEARUM CLADE; POLARIZED GROWTH; YEAST; WHEAT; GENE; CYTOSKELETON	We previously reported that mutations occurred in the gene myosin5 were responsible for resistance to the fungicide phenamacril in Fusarium graminearum. Here, we determined whether there is a functional link between phenamacril resistance and the myosin proteins FaMyo2B and Famyo2 in Fusarium asiaticum, which is the major causal agent of Fusarium head blight in China. We found that FaMyo2B acts jointly with FaSmy1 to affect resistance to phenamacril in F. asiaticum. We also found that FaMyo2B disruption mutant and Famyo2 deletion mutant were defective in hyphal branching, conidiation, and sexual reproduction. Delta Famyo2 also had an enhanced sensitivity to cell wall damaging agents and an abnormal distribution of septa and nuclei. In addition, the FaMyo2B and Famyo2 mutants had reduced pathogenicity on wheat coleoptiles and flowering wheat heads. Taken together, these results reveal that FaMyo2B and Famyo2 are required for several F. asiaticum developmental processes and activities, which help us better understand the resistance mechanism and find the most effective approach to control FHB.	[Zheng, Zhitian; Liu, Xiumei; Li, Bin; Cai, Yiqiang; Zhu, Yuanye; Zhou, Mingguo] Nanjing Agr Univ, Coll Plant Protect, Key Lab Pesticide, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, MG (corresponding author), Nanjing Agr Univ, Coll Plant Protect, Key Lab Pesticide, Nanjing 210095, Jiangsu, Peoples R China.	mgzhou@njau.edu.cn			Chinese 973 Program [2012CB114000]; National Science Foundation of China [31201543]; Ph.D. Programs Foundation of Ministry of Education of China [20120097120009]	Chinese 973 Program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by the Chinese 973 Program (2012CB114000), the National Science Foundation of China (31201543), and The Ph.D. Programs Foundation of Ministry of Education of China (no. 20120097120009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Bai GH, 2002, MYCOPATHOLOGIA, V153, P91, DOI 10.1023/A:1014419323550; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Chen Yu, 2007, Journal of Genetics and Genomics, V34, P469, DOI 10.1016/S1673-8527(07)60051-4; Chen Y, 2009, PHYTOPATHOLOGY, V99, P441, DOI 10.1094/PHYTO-99-4-0441; Chesarone-Cataldo M, 2011, DEV CELL, V21, P217, DOI 10.1016/j.devcel.2011.07.004; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Diaz-Blanco NL, 2007, YEAST, V24, P343, DOI 10.1002/yea.1481; Duan YB, 2013, MOL PLANT PATHOL, V14, P708, DOI 10.1111/mpp.12041; Fagarasanu A, 2010, NAT REV MOL CELL BIO, V11, P644, DOI 10.1038/nrm2960; Gale LR, 2007, PHYTOPATHOLOGY, V97, P1434, DOI 10.1094/PHYTO-97-11-1434; Geli MI, 1996, SCIENCE, V272, P533, DOI 10.1126/science.272.5261.533; Goswami RS, 2004, MOL PLANT PATHOL, V5, P515, DOI 10.1111/J.1364-3703.2004.00252.X; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Jenczmionka NJ, 2005, CURR GENET, V47, P29, DOI 10.1007/s00294-004-0547-z; Li HK, 2008, CROP PROT, V27, P90, DOI 10.1016/j.cropro.2007.04.010; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Lillie SH, 1992, SUPPRESSION MYOSIN D; Lu W. Z., 2001, RES WHEAT SCAB; Matsui Y, 2003, INT REV CYTOL, V229, P1, DOI 10.1016/S0074-7696(03)29001-X; Min K, 2012, FEMS MICROBIOL LETT, V334, P66, DOI 10.1111/j.1574-6968.2012.02620.x; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Niessen L, 2007, INT J FOOD MICROBIOL, V119, P38, DOI 10.1016/j.ijfoodmicro.2007.07.023; O'Donnell K, 2004, FUNGAL GENET BIOL, V41, P600, DOI 10.1016/j.fgb.2004.03.003; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Sebe-Pedros A, 2014, GENOME BIOL EVOL, V6, P290, DOI 10.1093/gbe/evu013; Song B, 2013, FUNGAL GENET BIOL, V54, P60, DOI 10.1016/j.fgb.2013.02.010; Starkey DE, 2007, FUNGAL GENET BIOL, V44, P1191, DOI 10.1016/j.fgb.2007.03.001; Sutton J. C., 1982, Canadian Journal of Plant Pathology, V4, P195; Toth B, 2005, EUR J PLANT PATHOL, V113, P35, DOI 10.1007/s10658-005-0296-y; Trail F, 2009, PLANT PHYSIOL, V149, P103, DOI 10.1104/pp.108.129684; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005; Wang Y, 2011, MOL PLANT MICROBE IN, V24, P118, DOI 10.1094/MPMI-06-10-0129; Wang YQ, 2012, MOL BIOL CELL, V23, P3911, DOI 10.1091/mbc.E12-05-0396; Weisman LS, 2006, NAT REV MOL CELL BIO, V7, P243, DOI 10.1038/nrm1892; Windels CE, 2000, PHYTOPATHOLOGY, V90, P17, DOI 10.1094/PHYTO.2000.90.1.17; Wu AB, 2005, MYCOPATHOLOGIA, V160, P75, DOI 10.1007/s11046-005-1153-4; Xu XM, 2008, EUR J PLANT PATHOL, V120, P21, DOI 10.1007/s10658-007-9189-6; Zhang CQ, 2015, ENVIRON MICROBIOL, V17, P2735, DOI 10.1111/1462-2920.12711; Zhang H, 2009, J MOL BIOL, V392, P228, DOI 10.1016/j.jmb.2009.07.006; Zhang JB, 2007, MYCOL RES, V111, P967, DOI 10.1016/j.mycres.2007.06.008; Zhang YJ, 2010, PESTIC BIOCHEM PHYS, V98, P151, DOI 10.1016/j.pestbp.2010.04.007; Zheng Z, 2015, SCI REPORTS, V5, P82; Zheng ZT, 2014, MOL PLANT PATHOL, V15, P488, DOI 10.1111/mpp.12108	49	9	9	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154058	10.1371/journal.pone.0154058	http://dx.doi.org/10.1371/journal.pone.0154058			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099966	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500133
J	Chelkowski, T; Gloor, P; Jemielniak, D				Chelkowski, Tadeusz; Gloor, Peter; Jemielniak, Dariusz			Inequalities in Open Source Software Development: Analysis of Contributor's Commits in Apache Software Foundation Projects	PLOS ONE			English	Article							OPEN COLLABORATION; PEER PRODUCTION; COMMUNITY; EMERGENCE; NETWORK; POWER	While researchers are becoming increasingly interested in studying OSS phenomenon, there is still a small number of studies analyzing larger samples of projects investigating the structure of activities among OSS developers. The significant amount of information that has been gathered in the publicly available open-source software repositories and mailing-list archives offers an opportunity to analyze projects structures and participant involvement. In this article, using on commits data from 263 Apache projects repositories (nearly all), we show that although OSS development is often described as collaborative, but it in fact predominantly relies on radically solitary input and individual, non-collaborative contributions. We also show, in the first published study of this magnitude, that the engagement of contributors is based on a power-law distribution.	[Chelkowski, Tadeusz] Kozminski Univ, Warsaw, Poland; [Gloor, Peter] MIT, Ctr Cognit Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Jemielniak, Dariusz] Kozminski Univ, New Res Digital Soc NeRDS Grp, Warsaw, Poland	Kozminski University; Massachusetts Institute of Technology (MIT); Kozminski University	Gloor, P (corresponding author), MIT, Ctr Cognit Intelligence, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	darekj@kozminski.edu.pl	Jemielniak, Dariusz/G-6434-2010; Jemielniak, Dariusz/M-9949-2019	Jemielniak, Dariusz/0000-0002-3745-7931; Jemielniak, Dariusz/0000-0002-3745-7931	Polish National Science Center [UMO-2012/05/E/HS4/01498]	Polish National Science Center	This research was conducted as a part of a research grant from the Polish National Science Center (no. UMO-2012/05/E/HS4/01498).	Arafat O., 2009, P 42 HAW INT C SYST, P1, DOI [DOI 10.1109/HICSS.2009.421, 10.1109/HICSS.2009.421]; Bauwens M, 2009, CAP CL, V33, P121, DOI 10.1177/030981680909700107; Baytiyeh H, 2010, COMPUT HUM BEHAV, V26, P1345, DOI 10.1016/j.chb.2010.04.008; Benkler Y, 2002, YALE LAW J, V112, P369, DOI 10.2307/1562247; BENKLER Y, 2006, WEALTH NETWORKS; Benkler Y, 2006, J POLIT PHILOS, V14, P394, DOI 10.1111/j.1467-9760.2006.00235.x; Bergquist M, 2001, INFORM SYST J, V11, P305, DOI 10.1046/j.1365-2575.2001.00111.x; Bird Christian, 2012, 2012 9th IEEE Working Conference on Mining Software Repositories (MSR 2012), P237, DOI 10.1109/MSR.2012.6224286; Bishop YM., 2007, DISCRETE MULTIVARIAT; Bitzer J, 2007, J COMP ECON, V35, P160, DOI 10.1016/j.jce.2006.10.001; Cheong K, 2000, SEOUL J EC, V13, P391; Ciesielska M, 2013, TAMARA J CRITICAL OR, V11, P5; Crowston K., 2006, Knowledge Technology & Policy, V18, P65, DOI 10.1007/s12130-006-1004-8; Crowston K, 2012, ACM COMPUT SURV, V44, DOI 10.1145/2089125.2089127; De Maio FG, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.052969; Demil B, 2006, ORGAN STUD, V27, P1447, DOI 10.1177/0170840606067250; Ducheneaut N., 2005, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V14, P323, DOI 10.1007/s10606-005-9000-1; Fielding RT, 1999, COMMUN ACM, V42, P42, DOI 10.1145/299157.299167; Fitzgerald B, 2006, MIS QUART, V30, P587; Forte A, 2013, AM BEHAV SCI, V57, P535, DOI 10.1177/0002764212469362; Gabbiadini A, 2013, CYBERPSYCH BEH SOC N, V16, P285, DOI 10.1089/cyber.2012.0412; Gala-Perez S, 2013, IEEE WORK CONF MIN S, P159, DOI 10.1109/MSR.2013.6624023; German D., 2003, P 3 WORKSH OP SOURC, P63; Gloor P. A., 2005, SWARM CREATIVITY COM; Gloor PA, 2007, MIT SLOAN MANAGE REV, V48, P81; Gonzalez-Barahona JM, 2008, INF ECON POLICY, V20, P356, DOI 10.1016/j.infoecopol.2008.07.001; Hahsler M, 2005, HICSS 05 P 38 ANN HA; Hargittai Eszter, 2008, Information Communication & Society, V11, P239, DOI 10.1080/13691180801946150; HEBB DO, 1946, PSYCHOL REV, V53, P259, DOI 10.1037/h0061690; Hill BM, 2013, AM BEHAV SCI, V57, P643, DOI 10.1177/0002764212469359; Howison J., 2004, P INT WORKSH MIN SOF; Jemielniak D., 2015, SAGE HDB ACTION RES; Jemielniak D., 2014, COMMON KNOWLEDGE ETH; Jemielniak D, 2009, INFORM ORGAN-UK, V19, P277, DOI 10.1016/j.infoandorg.2009.08.002; Johnson SL, 2014, MIS QUART, V38, P795, DOI 10.25300/MISQ/2014/38.3.08; Keen A., 2007, CULT AMATEUR TODAYS; Koch S, 2000, RESULTS SOFTWARE ENG; Kreiss D, 2011, NEW MEDIA SOC, V13, P243, DOI 10.1177/1461444810370951; Krishnamurthy S, 2002, 1 MONDAY, P2; Lakhani KR, 2003, RES POLICY, V32, P923, DOI 10.1016/S0048-7333(02)00095-1; Lanier Jaron, 2006, EDGE 3 CULTURE; LERMAN RI, 1989, J ECONOMETRICS, V42, P43, DOI 10.1016/0304-4076(89)90074-2; Ljungberg J, 2000, EUR J INFORM SYST, V9, P208, DOI 10.1057/palgrave/ejis/3000373; Luthiger Stoll B., 2005, P 1 INT C OP SOURC S, P273; MacLean AC, 2013, APACHE COMMIT HIST N; Matellan Olivera V, 2003, 3 WORKSH OP SOURC SO; McCandless Michael, 2010, LUCENE ACTION COVERS; Mockus A, 2002, ACM T SOFTW ENG METH, V11, P309, DOI 10.1145/567793.567795; Moon JY, 2002, 1 MONDAY, P5; O'Neil M, 2010, J SCI COMMUNICATION, V9, P1; O'Neil Mathieu, 2011, CRITICAL STUDIES PEE, V1, P1; Oliva Gustavo A., 2012, Collaboration and Technology. Proceedings of the 18th International Conference, CRIWG 2012, P97, DOI 10.1007/978-3-642-33284-5_8; Ostrom E, 2000, J ECON PERSPECT, V14, P137, DOI 10.1257/jep.14.3.137; Pomelse JA, 2008, TELECOMMUN POLICY, V32, P701, DOI 10.1016/j.telpol.2008.09.004; Raymond Eric, 1999, CATHEDRAL BAZAAR, DOI DOI 10.1007/S12130-999-1026-0; Riehle D, 2012, INF SYST E-BUS MANAG, V10, P5, DOI 10.1007/s10257-010-0149-x; Riehle D, 2009, IEEE SOFTWARE, V26, P52, DOI 10.1109/MS.2009.44; Ritzer G, 2010, J CONSUM CULT, V10, P13, DOI 10.1177/1469540509354673; Roth S., 2013, INT J ENTREPRENEURSH, V20, P272, DOI [DOI 10.1504/IJESB.2013.056890, 10.1504/IJESB.2013.056890]; SHALIT H, 1985, OXFORD B ECON STAT, V47, P185; Van Dijck J, 2009, NEW MEDIA SOC, V11, P855, DOI 10.1177/1461444809105356; von Hippel E, 2003, ORGAN SCI, V14, P209, DOI 10.1287/orsc.14.2.209.14992; Wasko MM, 2005, MIS QUART, V29, P35, DOI 10.2307/25148667; Weber Steven, 2004, SUCCESS OPEN SOURCE	64	13	13	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152976	10.1371/journal.pone.0152976	http://dx.doi.org/10.1371/journal.pone.0152976			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096157	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600022
J	del Cerro, P; Rolla-Santos, AAP; Valderrama-Fernandez, R; Gil-Serrano, A; Bellogin, RA; Gomes, DF; Perez-Montano, F; Megias, M; Hungria, M; Ollero, FJ				del Cerro, Pablo; Rolla-Santos, Amanda A. P.; Valderrama-Fernandez, Rocio; Gil-Serrano, Antonio; Bellogin, Ramon A.; Fabiano Gomes, Douglas; Perez-Montano, Francisco; Megias, Manuel; Hungria, Mariangela; Javier Ollero, Francisco			NrcR, a New Transcriptional Regulator of Rhizobium tropici CIAT 899 Involved in the Legume Root-Nodule Symbiosis	PLOS ONE			English	Article							BEAN PHASEOLUS-VULGARIS; BROAD-HOST-RANGE; NODULATION FACTORS; BRADYRHIZOBIUM-JAPONICUM; GENE-EXPRESSION; STRAINS; SIGNALS; NOLR; COMPETITIVENESS; IDENTIFICATION	The establishment of nitrogen-fixing rhizobium-legume symbioses requires a highly complex cascade of events. In this molecular dialogue the bacterial NodD transcriptional regulators in conjunction with plant inducers, mostly flavonoids, are responsible for the biosynthesis and secretion of Nod factors which are key molecules for successful nodulation. Other transcriptional regulators related to the symbiotic process have been identified in rhizobial genomes, including negative regulators such as NolR. Rhizobium tropici CIAT 899 is an important symbiont of common bean (Phaseolus vulgaris L.), and its genome encompasses intriguing features such as five copies of nodD genes, as well as other possible transcriptional regulators including the NolR protein. Here we describe and characterize a new regulatory gene located in the non-symbiotic plasmid pRtrCIAT899c, that shows homology (46% identity) with the nolR gene located in the chromosome of CIAT 899. The mutation of this gene, named nrcR (nolR-like plasmid c Regulator), enhanced motility and exopolysaccharide production in comparison to the wild-type strain. Interestingly, the number and decoration of Nod Factors produced by this mutant were higher than those detected in the wildtype strain, especially under salinity stress. The nrcR mutant showed delayed nodulation and reduced competitiveness with P. vulgaris, and reduction in nodule number and shoot dry weight in both P. vulgaris and Leucaena leucocephala. Moreover, the mutant exhibited reduced capacity to induce the nodC gene in comparison to the wild-type CIAT 899. The finding of a new nod-gene regulator located in a non-symbiotic plasmid may reveal the existence of even more complex mechanisms of regulation of nodulation genes in R. tropici CIAT 899 that may be applicable to other rhizobial species.	[del Cerro, Pablo; Bellogin, Ramon A.; Perez-Montano, Francisco; Megias, Manuel; Javier Ollero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Rolla-Santos, Amanda A. P.; Fabiano Gomes, Douglas; Hungria, Mariangela] Embrapa Soja, Cx Postal 231, BR-86001970 Londrina, Parana, Brazil; [Valderrama-Fernandez, Rocio; Gil-Serrano, Antonio] Univ Seville, Fac Quim, Dept Quim Organ, E-41071 Seville, Spain	University of Sevilla; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Sevilla	Ollero, FJ (corresponding author), Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain.	fjom@us.es	Pérez-Montaño, Francisco/K-8971-2014; del Cerro Sánhez, Pablo PdC/H-7198-2016; Gil-Serrano, Antonio M/L-2002-2014; del Cerro Sánchez, Pablo/ABG-1194-2020; Hungria, Mariangela/D-8540-2013; Ollero Marquez, Francisco Javier/G-3271-2015	Pérez-Montaño, Francisco/0000-0002-6272-2063; del Cerro Sánhez, Pablo PdC/0000-0002-8030-7226; Gil-Serrano, Antonio M/0000-0001-9503-0891; del Cerro Sánchez, Pablo/0000-0002-8030-7226; Ollero Marquez, Francisco Javier/0000-0002-3641-7946	Ministerio de Economia y Competitividad (Spanish Government) [AGL2012-38831, FPU14/00160]; CNPq (National Council for Scientific and Technological Development) [400205/2012-5]; VPP (University of Seville)	Ministerio de Economia y Competitividad (Spanish Government); CNPq (National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); VPP (University of Seville)	This work was supported by the Project AGL2012-38831 of the Ministerio de Economia y Competitividad (Spanish Government, www.mineco.gob.es), CNPq (National Council for Scientific and Technological Development, http://cnpq.br/, Science without Borders 400205/2012-5). AAPR-S acknowledges a postdoctoral fellowship from CNPq (National Council for Scientific and Technological Development, http://cnpq.br/, Science without Borders 400205/2012-5). MH a research fellow from CNPq (NPq (National Council for Scientific and Technological Development, http://cnpq.br/). FPM a postdoctoral fellowship from VPP (University of Seville, https://investigacion.us.es/secretariado-investigacion/plan-propio). PdC a FPU fellowship from Ministerio de Economia y Competitividad (FPU14/00160, Spanish Government, www.mineco.gob.es). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	[Anonymous], 2013, J PLANT BIOL SOIL HL; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Brencic A, 2005, MICROBIOL MOL BIOL R, V69, P155, DOI 10.1128/MMBR.69.1.155-194.2005; Chen HC, 2005, MOL PLANT MICROBE IN, V18, P1340, DOI 10.1094/MPMI-18-1340; Chen HC, 2000, ELECTROPHORESIS, V21, P3823, DOI 10.1002/1522-2683(200011)21:17&lt;3823::AID-ELPS3823&gt;3.0.CO;2-K; CREN M, 1995, MOL MICROBIOL, V15, P733, DOI 10.1111/j.1365-2958.1995.tb02381.x; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2033-z; del Cerro P, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1458-8; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Estevez J, 2009, FEMS MICROBIOL LETT, V293, P220, DOI 10.1111/j.1574-6968.2009.01540.x; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; GENIAUX E, 1995, INT J SYST BACTERIOL, V45, P392, DOI 10.1099/00207713-45-2-392; Geurts R, 2002, PLANT CELL, V14, pS239, DOI 10.1105/tpc.002451; GILSERRANO A, 1990, CARBOHYD RES, V204, P103, DOI 10.1016/0008-6215(90)84025-P; Gomes DF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-643; Guasch-Vidal B, 2013, MOL PLANT MICROBE IN, V26, P451, DOI 10.1094/MPMI-09-12-0213-R; HERNANDEZLUCAS I, 1995, APPL ENVIRON MICROB, V61, P2775, DOI 10.1128/AEM.61.7.2775-2779.1995; HUNGRIA M, 1993, MOL PLANT MICROBE IN, V6, P418, DOI 10.1094/MPMI-6-418; Hungria M, 2001, BIOL FERT SOILS, V33, P387, DOI 10.1007/s003740100338; HUNGRIA M, 1992, MOL PLANT MICROBE IN, V5, P199, DOI 10.1094/MPMI-5-199; Hungria M, 2000, SOIL BIOL BIOCHEM, V32, P1515, DOI 10.1016/S0038-0717(00)00063-8; Janczarek M, 2011, INT J MOL SCI, V12, P7898, DOI 10.3390/ijms12117898; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kiss E, 1998, MOL PLANT MICROBE IN, V11, P1186, DOI 10.1094/MPMI.1998.11.12.1186; KONDOROSI E, 1989, EMBO J, V8, P1331, DOI 10.1002/j.1460-2075.1989.tb03513.x; KONDOROSI E, 1991, J MOL BIOL, V222, P885, DOI 10.1016/0022-2836(91)90583-R; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; Lamrabet Y, 1999, MOL PLANT MICROBE IN, V12, P207, DOI 10.1094/MPMI.1999.12.3.207; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SG, 2014, P NATL ACAD SCI USA, V111, P6509, DOI 10.1073/pnas.1402243111; LIU RL, 1989, APPL ENVIRON MICROB, V55, P1895, DOI 10.1128/AEM.55.8.1895-1900.1989; Lopez-Baena FJ, 2008, MICROBIOL-SGM, V154, P1825, DOI 10.1099/mic.0.2007/016337-0; Marks BB, 2015, AMB EXPRESS, V5, DOI 10.1186/s13568-015-0154-z; MARTINEZROMERO E, 1991, INT J SYST BACTERIOL, V41, P417, DOI 10.1099/00207713-41-3-417; MCDERMOTT TR, 1990, APPL ENVIRON MICROB, V56, P3035, DOI 10.1128/AEM.56.10.3035-3039.1990; Mendes IC, 2004, BIOL FERT SOILS, V40, P28, DOI 10.1007/s00374-004-0739-1; Moron B, 2005, CHEM BIOL, V12, P1029, DOI 10.1016/j.chembiol.2005.06.014; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Ormen ~o-Orrillo E., 2013, PROKARYOTES, P427, DOI [10.1007/978-3-642-30141-4_72, DOI 10.1007/978-3-642-30141-4_72]; Ormeno-Orrillo E, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-735; Osman D, 2010, NAT PROD REP, V27, P668, DOI 10.1039/b906682a; Perez-Montano F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105901; POUPOT R, 1993, BIOCHEMISTRY-US, V32, P10430, DOI 10.1021/bi00090a019; Rodriguez-Navarro DN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115391; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schlaman H. R. M., 1998, The Rhizobiaceae: molecular biology of model plant-associated bacteria., P361; SHI WP, 1994, J BIOL CHEM, V269, P19826; Pinto FGS, 2007, SOIL BIOL BIOCHEM, V39, P1851, DOI 10.1016/j.soilbio.2007.01.001; SIMON R, 1984, MOL GEN GENET, V196, P413, DOI 10.1007/BF00436188; SPAINK HP, 1992, MOL PLANT MICROBE IN, V5, P72, DOI 10.1094/MPMI-5-072; SPAINK HP, 1992, PLANT MOL BIOL, V20, P977, DOI 10.1007/BF00027167; Spaink HP, 2000, ANNU REV MICROBIOL, V54, P257, DOI 10.1146/annurev.micro.54.1.257; STREETER JG, 1994, CAN J MICROBIOL, V40, P513, DOI 10.1139/m94-084; Sugawara M, 2014, MOL PLANT MICROBE IN, V27, P328, DOI 10.1094/MPMI-10-13-0312-R; Tomlinson AD, 2010, MICROBIOL-SGM, V156, P2670, DOI 10.1099/mic.0.039032-0; Toro N, 1996, WORLD J MICROB BIOT, V12, P157, DOI 10.1007/BF00364680; TRIPLETT EW, 1992, ANNU REV MICROBIOL, V46, P399, DOI 10.1146/annurev.mi.46.100192.002151; Vargas MAT, 2000, BIOL FERT SOILS, V32, P228, DOI 10.1007/s003740000240; Vinardell JM, 2004, MOL PLANT MICROBE IN, V17, P676, DOI 10.1094/MPMI.2004.17.6.676; Vincent JM, 1970, MANUAL PRACTICAL STU, P144	64	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154029	10.1371/journal.pone.0154029	http://dx.doi.org/10.1371/journal.pone.0154029			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096734	Green Published, gold			2022-12-27	WOS:000374543600081
J	Tossige-Gomes, R; Costa, KB; Ottone, VD; Magalhaes, FD; Amorim, FT; Rocha-Vieira, E				Tossige-Gomes, Rosalina; Costa, Karine Beatriz; Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel			Lymphocyte Redox Imbalance and Reduced Proliferation after a Single Session of High Intensity Interval Exercise	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; RESPIRATORY-TRACT INFECTIONS; TERM SPRINT INTERVAL; OXIDATIVE STRESS; IMMUNE FUNCTION; T-CELLS; RESPONSES; RECEPTOR; PERFORMANCE; SUBPOPULATIONS	This study investigated whether an acute session of high-intensity interval training (HIIT) is sufficient to alter lymphocyte function and redox status. Sixteen young healthy men underwent a HIIT session on a cycloergometer, consisting of eight bouts of 1 min at 90-100% of peak power, with 75 seconds of active recovery at 30 W between bouts. Venous blood was collected before, immediately after, and 30 minutes after the HIIT session. In response to Staphylococcus aureus superantigen B (SEB) stimulation, lymphocyte proliferation decreased and the IL-2 concentration increased after the HIIT session. However, the HIIT session had no effect on lymphocyte proliferation or IL-2 response to phytohemagglutinin stimulation. The HIIT session also induced lymphocyte redox imbalance, characterized by an increase in the concentration of thiobarbituric acid reactive substances and a decrease in the activity of the antioxidant enzyme catalase. Lymphocyte viability was not affected by the HIIT session. The frequencies of CD25(+) and CD69(+) T helper and B lymphocytes in response to superantigen stimulation were lower after exercise, suggesting that superantigen-induced lymphocyte activation was reduced by HIIT. However, HIIT also led to a reduction in the frequency of CD4(+) and CD19(+) cells, so the frequencies of CD25(+) and CD69(+) cells within the CD4 and CD19 cell populations were not affected by HIIT. These data indicate that the reduced lymphocyte proliferation observed after HIIT is not due to reduced early lymphocyte activation by superantigen. Our findings show that an acute HIIT session promotes lymphocyte redox imbalance and reduces lymphocyte proliferation in response to superantigenic, but not to mitogenic stimulation. This observation cannot be explained by alteration of the early lymphocyte activation response to superantigen. The manner in which lymphocyte function modulation by an acute HIIT session can affect individual immunity and susceptibility to infection is important and requires further investigation.	[Tossige-Gomes, Rosalina; Costa, Karine Beatriz; Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel] Univ Fed Vales Jequitinhonha & Mucuri, Soc Brasileira Fisiol, Programa Multictr Posgrad Ciencias Fisiol, Diamantina, MG, Brazil; [Magalhaes, Flavio de Castro; Amorim, Fabiano Trigueiro] Univ Fed Vales Jequitinhonha & Mucuri, Fac Ciencias Biol & Saude, Dept Educ Fis, Diamantina, MG, Brazil; [Rocha-Vieira, Etel] Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil	Sociedade Brasileira de Fisiologia; Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM)	Rocha-Vieira, E (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Soc Brasileira Fisiol, Programa Multictr Posgrad Ciencias Fisiol, Diamantina, MG, Brazil.; Rocha-Vieira, E (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Fac Med, Diamantina, MG, Brazil.	etelvieira@terra.com.br	Rocha-Vieira, Etel/A-2524-2017; de Castro Magalhaes, Flavio/AAB-5540-2022; Magalhães, Flávio/AAE-9680-2020	Rocha-Vieira, Etel/0000-0001-6908-7237; de Castro Magalhaes, Flavio/0000-0002-1963-982X; Amorim, Fabiano/0000-0003-2936-4484	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fapemig - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [PRI-00182-16]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [PRI-00182-16]	CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fapemig - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by CAPES - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; CNPq - Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Fapemig - Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (PRI-00182-16).; The authors acknowledge Dr. Dr. David Lee Nelson for reviewing the manuscript and the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (PRI-00182-16) for supporting this publication.	American College of Sports Medicine (ACSM), 2009, GUID EX TEST EX PRES; Angulo R, 1998, AM J OBSTET GYNECOL, V151, P143; Balady Gary J, 2003, DIRETRIZES ACSM TEST, P239; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BICALHO HMS, 1981, J IMMUNOL METHODS, V40, P115, DOI 10.1016/0022-1759(81)90087-9; Bogdanis GC, 2013, FOOD CHEM TOXICOL, V61, P171, DOI 10.1016/j.fct.2013.05.046; Burgomaster KA, 2006, J APPL PHYSIOL, V100, P2041, DOI 10.1152/japplphysiol.01220.2005; Castell LM, 1996, EUR J APPL PHYSIOL O, V73, P488, DOI 10.1007/BF00334429; Cemerski S, 2002, J BIOL CHEM, V277, P19585, DOI 10.1074/jbc.M111451200; Chen YJ, 2008, BRIT J NUTR, V100, P1260, DOI 10.1017/S0007114508975619; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; DOrazio JA, 1996, CLIN EXP IMMUNOL, V104, P366, DOI 10.1046/j.1365-2249.1996.08698.x; Ferrer MD, 2009, J SPORT SCI, V27, P49, DOI 10.1080/02640410802409683; Fisher G, 2011, J APPL PHYSIOL, V110, P730, DOI 10.1152/japplphysiol.00575.2010; Flescher E, 1998, CLIN EXP IMMUNOL, V112, P242; GABRIEL H, 1992, EUR J APPL PHYSIOL O, V65, P529, DOI 10.1007/BF00602360; Gaffen SL, 2001, CYTOKINE, V14, P63, DOI 10.1006/cyto.2001.0862; Ganguly T, 2001, PHYTOMEDICINE, V8, P431, DOI 10.1078/S0944-7113(04)70061-6; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Gillen JB, 2014, APPL PHYSIOL NUTR ME, V39, P409, DOI 10.1139/apnm-2013-0187; Gray P, 2012, BRAIN BEHAV IMMUN, V26, P1265, DOI 10.1016/j.bbi.2012.08.002; Green KJ, 2002, J APPL PHYSIOL, V92, P2390, DOI 10.1152/japplphysiol.00926.2001; HEEG K, 1995, J IMMUNOL, V155, P83; Ijichi S, 1996, CELL IMMUNOL, V173, P312, DOI 10.1006/cimm.1996.0283; Leggate M, 2010, CELL STRESS CHAPERON, V15, P827, DOI 10.1007/s12192-010-0192-z; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; LOHRMANN HP, 1974, J EXP MED, V139, P1553, DOI 10.1084/jem.139.6.1553; Lyons AB, 2001, METHOD CELL BIOL, V63, P375; Mandavilli BS, 2010, CURR PROTOC CYTOM, V9, P35, DOI [10.1002/0471142956.cy0935s53, DOI 10.1002/0471142956.CY0935S53]; Maranhao-Neto GA, 2011, VALIDADE EQUIVALENCI; Moholdt TT, 2009, AM HEART J, V158, P1031, DOI 10.1016/j.ahj.2009.10.003; Moreira A, 2009, BRIT MED BULL, V90, P111, DOI 10.1093/bmb/ldp010; MYERS J, 1994, AM J CARDIOL, V73, P591, DOI 10.1016/0002-9149(94)90340-9; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nieman DC, 2008, MED SCI SPORT EXER, V40, P1463, DOI 10.1249/MSS.0b013e31817057c2; Nieman DC, 2012, J INTERF CYTOK RES, V32, P12, DOI 10.1089/jir.2011.0038; NIEMAN DC, 1990, J SPORT MED PHYS FIT, V30, P316; NIEMAN DC, 1994, INT J SPORTS MED, V15, P199, DOI 10.1055/s-2007-1021047; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Otsuji M, 1996, P NATL ACAD SCI USA, V93, P13119, DOI 10.1073/pnas.93.23.13119; Peake JM, 2014, AM J PHYSIOL-ENDOC M, V307, pE539, DOI 10.1152/ajpendo.00276.2014; Pescatello LS, 2014, AMERICAN COLLEGE OF; Rodas G, 2000, EUR J APPL PHYSIOL, V82, P480, DOI 10.1007/s004210000223; Sandstad J, 2015, EUR J APPL PHYSIOL, V115, P2081, DOI 10.1007/s00421-015-3186-9; Santos VC, 2013, CELL BIOCHEM FUNCT, V31, P237, DOI 10.1002/cbf.2877; Sawka MN, 2007, MED SCI SPORT EXER, V39, P377, DOI 10.1249/mss.0b013e31802ca597; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Steensberg A, 2001, J APPL PHYSIOL, V91, P1708, DOI 10.1152/jappl.2001.91.4.1708; Sureda A, 2009, BRIT J SPORT MED, V43, P186, DOI 10.1136/bjsm.2007.043943; Tremblay MS, 2007, APPL PHYSIOL NUTR ME, V32, pS218, DOI 10.1139/H07-125; Turner JE, 2011, J APPL PHYSIOL, V111, P206, DOI 10.1152/japplphysiol.00051.2011; Vargas JA, 1996, CYTOMETRY, V26, P125; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Wisloff U, 2007, CIRCULATION, V115, P3086, DOI 10.1161/CIRCULATIONAHA.106.675041	54	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153647	10.1371/journal.pone.0153647	http://dx.doi.org/10.1371/journal.pone.0153647			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096389	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600047
J	Caverly, LJ; Carmody, LA; Haig, SJ; Kotlarz, N; Kalikin, LM; Raskin, L; LiPuma, JJ				Caverly, Lindsay J.; Carmody, Lisa A.; Haig, Sarah-Jane; Kotlarz, Nadine; Kalikin, Linda M.; Raskin, Lutgarde; LiPuma, John J.			Culture-Independent Identification of Nontuberculous Mycobacteria in Cystic Fibrosis Respiratory Samples	PLOS ONE			English	Article							AIRWAY MICROBIOTA; SPUTUM; DNA; TUBERCULOSIS; DIAGNOSIS; EFFICIENT; DYNAMICS	Respiratory tract infections with nontuberculous mycobacteria (NTM) are increasing in prevalence and are a significant cause of lung function decline in individuals with cystic fibrosis (CF). NTM have been detected in culture-independent analyses of CF airway microbiota at lower rates than would be expected based on published prevalence data, likely due to poor lysing of the NTM cell wall during DNA extraction. We compared a standard bacterial lysis protocol with a modified method by measuring NTM DNA extraction by qPCR and NTM detection with bacterial 16S rRNA gene sequencing. The modified method improved NTM DNA recovery from spiked CF sputum samples by a mean of 0.53 log10 copies/mL for M. abscessus complex and by a mean of 0.43 log10 copies/mL for M. avium complex as measured by qPCR targeting the atpE gene. The modified method also improved DNA sequence based NTM detection in NTM culture-positive CF sputum and bronchoalveolar lavage samples; however, both qPCR and 16S rRNA gene sequencing remained less sensitive than culture for NTM detection. We highlight the limitations of culture-independent identification of NTM from CF respiratory samples, and illustrate how alterations in the bacterial lysis and DNA extraction process can be employed to improve NTM detection with both qPCR and 16S rRNA gene sequencing.	[Caverly, Lindsay J.; Carmody, Lisa A.; Kalikin, Linda M.; LiPuma, John J.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA; [Haig, Sarah-Jane; Kotlarz, Nadine; Raskin, Lutgarde] Univ Michigan, Dept Civil & Environm Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Caverly, LJ (corresponding author), Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI USA.	caverlyl@med.umich.edu	Haig, Sarah/H-5986-2019	Haig, Sarah/0000-0002-0004-8894	National Institute of Child Heath and Human Development [HD 028820]; Cystic Fibrosis Foundation [CAVERL15I0]; University of Michigan Department of Pediatrics and Communicable Diseases; Elizabeth E. Kennedy Children's Research Fund Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD028820] Funding Source: NIH RePORTER	National Institute of Child Heath and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); University of Michigan Department of Pediatrics and Communicable Diseases; Elizabeth E. Kennedy Children's Research Fund Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institute of Child Heath and Human Development, https://www.nichd.nih.gov/Pages/index.aspx, grant number: HD 028820, to LJC; Cystic Fibrosis Foundation, https://www.cff.org/, grant number: CAVERL15I0 to LJC; University of Michigan Department of Pediatrics and Communicable Diseases, https://medicine.umich.edu/dept/pediatrics/, Elizabeth E. Kennedy Children's Research Fund Award to LJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaro A, 2008, LETT APPL MICROBIOL, V47, P8, DOI 10.1111/j.1472-765X.2008.02372.x; BERCOVIER H, 1986, BIOCHEM BIOPH RES CO, V136, P1136, DOI 10.1016/0006-291X(86)90452-3; Carmody LA, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0074-9; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Chakravorty S, 2001, FEMS MICROBIOL LETT, V205, P113, DOI 10.1111/j.1574-6968.2001.tb10933.x; Cheung MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054574; Clooney AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148028; Coenye T, 2003, FEMS MICROBIOL LETT, V228, P45, DOI 10.1016/S0378-1097(03)00717-1; Cui ZL, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-276; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Esther CR, 2005, PEDIATR PULM, V40, P39, DOI 10.1002/ppul.20222; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Johnson EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147643; Kaser M, 2009, APPL ENVIRON MICROB, V75, P414, DOI 10.1128/AEM.01358-08; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Madiraju MVVS, 2000, LETT APPL MICROBIOL, V30, P38, DOI 10.1046/j.1472-765x.2000.00619.x; Mahboubi MA, 2016, J CLIN MICROBIOL, V54, P613, DOI 10.1128/JCM.02299-15; Martiniano Stacey L, 2014, Ann Am Thorac Soc, V11, P36, DOI 10.1513/AnnalsATS.201309-310OC; MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Odumeru J, 2001, CAN J VET RES, V65, P201; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Plain KM, 2015, J CLIN MICROBIOL, V53, P1121, DOI 10.1128/JCM.03521-14; POLLOCK HM, 1977, J CLIN MICROBIOL, V5, P329; R Foundation for Statistical Computing, 2015, R LANG ENV STAT COMP; Radomski N, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-277; Radomski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078749; Rubin BK, 2009, RESP CARE, V54, P726, DOI 10.4187/002013209790983269; Salsgiver EL, 2016, CHEST, V149, P390, DOI 10.1378/chest.15-0676; Stressmann FA, 2011, J CYST FIBROS, V10, P357, DOI 10.1016/j.jcf.2011.05.002; Tell LA, 2003, AVIAN DIS, V47, P1486, DOI 10.1637/7070; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083445; Zhao JC, 2015, J CYST FIBROS, V14, P468, DOI 10.1016/j.jcf.2015.02.004; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	39	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153876	10.1371/journal.pone.0153876	http://dx.doi.org/10.1371/journal.pone.0153876			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093603	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200054
J	Mok, Y; Matsushita, K; Sang, YY; Ballew, SH; Grams, M; Shin, SY; Jee, SH; Coresh, J				Mok, Yejin; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.; Grams, Morgan; Shin, Sang Yop; Jee, Sun Ha; Coresh, Josef			Association of Kidney Disease Measures with Cause-Specific Mortality: The Korean Heart Study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; POOLED ANALYSIS; CYSTATIN-C; RISK; CANCER; ALBUMINURIA; DEATH; PREVALENCE	Background The link of low estimated glomerular filtration rate (eGFR) and high proteinuria to cardiovascular disease (CVD) mortality is well known. However, its link to mortality due to other causes is less clear. Methods We studied 367,932 adults (20-93 years old) in the Korean Heart Study (baseline between 1996-2004 and follow-up until 2011) and assessed the associations of creatinine-based eGFR and dipstick proteinuria with mortality due to CVD (1,608 cases), cancer (4,035 cases), and other (non-CVD/non-cancer) causes (3,152 cases) after adjusting for potential confounders. Results Although cancer was overall the most common cause of mortality, in participants with chronic kidney disease (CKD), non-CVD/non-cancer mortality accounted for approximately half of cause of death (47.0% for eGFR >= 60 ml/min/1.73m(2) and 54.3% for proteinuria >= 1+). Lower eGFR (< 60 vs. >= 60 ml/min/1.73m2) was significantly associated with mortality due to CVD (adjusted hazard ratio 1.49 [95% CI, 1.24-1.78]) and non-CVD/non-cancer causes (1.78 [1.54-2.05]). The risk of cancer mortality only reached significance at eGFR < 45 ml/min/1.73m2 when eGFR 45-59 ml/min/1.73m(2) was set as a reference (1.62 [1.10-2.39]). High proteinuria (dipstick >= 1+ vs. negative/trace) was consistently associated with mortality due to CVD (1.93 [1.66-2.25]), cancer (1.49 [1.32-1.68]), and other causes (2.19 [1.96-2.45]). Examining finer mortality causes, low eGFR and high proteinuria were commonly associated with mortality due to coronary heart disease, any infectious disease, diabetes, and renal failure. In addition, proteinuria was also related to death from stroke, cancers of stomach, liver, pancreas, and lung, myeloma, pneumonia, and viral hepatitis. Conclusion Low eGFR was associated with CVD and non-CVD/non-cancer mortality, whereas higher proteinuria was consistently related to mortality due to CVD, cancer, and other causes. These findings suggest the need for multidisciplinary prevention and management strategies in individuals with CKD, particularly when proteinuria is present.	[Mok, Yejin; Matsushita, Kunihiro; Sang, Yingying; Ballew, Shoshana H.; Grams, Morgan; Coresh, Josef] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Mok, Yejin; Jee, Sun Ha] Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Mok, Yejin; Jee, Sun Ha] Yonsei Univ, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea; [Shin, Sang Yop] Korea Med Inst, Dept Internal Med, Seoul, South Korea	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jee, SH (corresponding author), Yonsei Univ, Dept Epidemiol & Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea.; Jee, SH (corresponding author), Yonsei Univ, Inst Hlth Promot, Grad Sch Publ Hlth, Seoul 120749, South Korea.	jsunha@yuhs.ac	Matsushita, Kunihiro/AAJ-5817-2020; Matsushita, Kunihiro/B-1021-2018	Matsushita, Kunihiro/0000-0002-7179-718X; Matsushita, Kunihiro/0000-0002-7179-718X; Ballew, Shoshana/0000-0002-7547-3764; Jee, Sun Ha/0000-0001-9519-3068	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C0715]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100446] Funding Source: NIH RePORTER	Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C0715).	Aguilar MI, 2010, NEUROLOGY, V75, P1343, DOI 10.1212/WNL.0b013e3181f73638; Arora P, 2013, CAN MED ASSOC J, V185, pE417, DOI 10.1503/cmaj.120833; Chun JH, 2000, KOREAN J EPIDEMIOL, V22, P124; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Davis AM, 2014, JAMA-J AM MED ASSOC, V312, P1248, DOI 10.1001/jama.2014.12272; Di Angelantonio Emanuele, 2010, BMJ, V341, pc4986, DOI 10.1136/bmj.c4986; Franses JW, 2013, INT J CANCER, V133, P1334, DOI 10.1002/ijc.28146; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Gansevoort RT, 2013, LANCET, V382, P339, DOI 10.1016/S0140-6736(13)60595-4; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Harteloh P, 2010, EUR J EPIDEMIOL, V25, P531, DOI 10.1007/s10654-010-9445-5; Health NIo, 2013, HLTH NIO USRDS 2013; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; Herget-Rosenthal S, 2000, AM J NEPHROL, V20, P97, DOI 10.1159/000013564; Iff S, 2014, AM J KIDNEY DIS, V63, P23, DOI 10.1053/j.ajkd.2013.07.008; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Janus N, 2008, NEPHROL DIAL TRANSPL, V23, P800, DOI 10.1093/ndt/gfm851; Jee SH, 2014, EUR J PREV CARDIOL, V21, P1484, DOI 10.1177/2047487313497602; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Kidney Disease Improving Global Outcomes Working Group, 2013, KDIGO CLIN PRACT GUI; Lee DH, 2000, J KOREAN CANC ASS, V32, P210; Leung WK, 2008, LANCET ONCOL, V9, P279, DOI 10.1016/S1470-2045(08)70072-X; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lowrance WT, 2014, J AM SOC NEPHROL, V25, P2327, DOI 10.1681/ASN.2013060604; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Mahmoodi BK, 2014, STROKE, V45, P1925, DOI 10.1161/STROKEAHA.114.004900; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; Nagata M, 2013, AM J EPIDEMIOL, V178, P1, DOI 10.1093/aje/kws447; National Bureau of Statistics, 2010, RES 2010 POP HOUS CE; National Bureau of Statistics, 2012, ANN REP CAUS DEATH S; Navaneethan SD, 2015, J AM SOC NEPHROL, V26, P2512, DOI 10.1681/ASN.2014101034; Pedersen LM, 1998, EUR J CANCER, V34, P76, DOI 10.1016/S0959-8049(97)10003-X; SAWYER N, 1988, BMJ-BRIT MED J, V296, P1295, DOI 10.1136/bmj.296.6632.1295; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Song YM, 2001, EPIDEMIOLOGY, V12, P173, DOI 10.1097/00001648-200103000-00008; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273; Thompson S, 2015, J AM SOC NEPHROL, V26, P2504, DOI 10.1681/ASN.2014070714; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tonelli M, 2006, J AM SOC NEPHROL, V17, P2034, DOI 10.1681/ASN.2005101085; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Wang HE, 2011, AM J NEPHROL, V34, P330, DOI 10.1159/000330673; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Weng PH, 2011, CLIN J AM SOC NEPHRO, V6, P1121, DOI 10.2215/CJN.09011010; Winkler V, 2010, INT J PUBLIC HEALTH, V55, P43, DOI 10.1007/s00038-009-0053-7; World Health Organization, 2014, CAUS DEATH MORT HLTH; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	56	23	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153429	10.1371/journal.pone.0153429	http://dx.doi.org/10.1371/journal.pone.0153429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092943	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200018
J	El Mendili, MM; Lenglet, T; Stojkovic, T; Behin, A; Guimaraes-Costa, R; Salachas, F; Meininger, V; Bruneteau, G; Le Forestier, N; Laforet, P; Lehericy, S; Benali, H; Pradat, PF				El Mendili, Mohamed-Mounir; Lenglet, Timothee; Stojkovic, Tanya; Behin, Anthony; Guimaraes-Costa, Raquel; Salachas, Franois; Meininger, Vincent; Bruneteau, Gaelle; Le Forestier, Nadine; Laforet, Pascal; Lehericy, Stephane; Benali, Habib; Pradat, Pierre-Francois			Cervical Spinal Cord Atrophy Profile in Adult SMN1-Linked SMA	PLOS ONE			English	Article							KUGELBERG-WELANDER DISEASE; MUSCULAR-ATROPHY; MOTOR-NEURON; NEUROMUSCULAR-JUNCTIONS; MULTIPLE-SCLEROSIS; NATURAL-HISTORY; MOUSE MODELS; DEGENERATION; ALS; CONSTRUCTION	Purpose The mechanisms underlying the topography of motor deficits in spinal muscular atrophy (SMA) remain unknown. We investigated the profile of spinal cord atrophy (SCA) in SMN1-linked SMA, and its correlation with the topography of muscle weakness. Materials and Methods Eighteen SMN1-linked SMA patients type III/V and 18 age/gender-matched healthy volunteers were included. Patients were scored on manual muscle testing and functional scales. Spinal cord was imaged using 3T MRI system. Radial distance (RD) and cord cross-sectional area (CSA) measurements in SMA patients were compared to those in controls and correlated with strength and disability scores. Results CSA measurements revealed a significant cord atrophy gradient mainly located between C3 and C6 vertebral levels with a SCA rate ranging from 5.4% to 23% in SMA patients compared to controls. RD was significantly lower in SMA patients compared to controls in the anterior-posterior direction with a maximum along C4 and C5 vertebral levels (p-values < 10(-5)). There were no correlations between atrophy measurements, strength and disability scores. Conclusions Spinal cord atrophy in adult SMN1-linked SMA predominates in the segments innervating the proximal muscles. Additional factors such as neuromuscular junction or intrinsic skeletal muscle defects may play a role in more complex mechanisms underlying weakness in these patients.	[El Mendili, Mohamed-Mounir; Benali, Habib; Pradat, Pierre-Francois] Univ Paris 06, Sorbonne Univ, Lab Imagerie Biomed, CNRS,INSERM, F-75013 Paris, France; [Lenglet, Timothee; Salachas, Franois; Meininger, Vincent; Bruneteau, Gaelle; Le Forestier, Nadine; Pradat, Pierre-Francois] Hop La Pitie Salpetriere, APHP, Dept Malad Syst Nerveux, Ctr Referent SLA, Paris, France; [Lenglet, Timothee] Hop La Pitie Salpetriere, APHP, Serv Explorat Fonct, Paris, France; [Stojkovic, Tanya; Behin, Anthony; Guimaraes-Costa, Raquel; Laforet, Pascal] APHP, Ctr Reference Malad Neuromusculaires Paris Est, Inst Myol, Paris, France; [Lehericy, Stephane] Hop La Pitie Salpetriere, APHP, Serv Neuroradiol, Paris, France; [Lehericy, Stephane] Univ Paris 06, Ctr Rech Inst Cerveau & Moelle Epiniere CRICM, Ctr Neuroimagerie Rech CENIR, Sorbonne Univ,UMR S975,Inserm U975,CNRS UMR7225, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Pradat, PF (corresponding author), Univ Paris 06, Sorbonne Univ, Lab Imagerie Biomed, CNRS,INSERM, F-75013 Paris, France.; Pradat, PF (corresponding author), Hop La Pitie Salpetriere, APHP, Dept Malad Syst Nerveux, Ctr Referent SLA, Paris, France.	pierre-francois.pradat@psl.aphp.fr	STOJKOVIC, Tanya/AAA-3967-2021	GUIMARAES-COSTA, Raquel/0000-0001-6799-022X; Behin, Anthony/0000-0001-7179-5152; BRUNETEAU, GAELLE/0000-0002-1905-7985				Araki S, 2003, ACTA NEUROPATHOL, V106, P441, DOI 10.1007/s00401-003-0743-9; Bede P, 2014, J NEUROL, V261, P235, DOI 10.1007/s00415-013-7193-7; Bede P, 2012, AMYOTROPH LATERAL SC, V13, P407, DOI 10.3109/17482968.2011.649760; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; Boyer JG, 2014, HUM MOL GENET, V23, P4249, DOI 10.1093/hmg/ddu142; Cadotte DW, 2015, AM J NEURORADIOL, V36, P803, DOI 10.3174/ajnr.A4192; CARTER CT, 1995, AM J PHYS MED REHAB, V74, pS150, DOI 10.1097/00002060-199509001-00009; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Cohen-Adad J, 2013, AMYOTROPH LAT SCL FR, V14, P30, DOI 10.3109/17482968.2012.701308; d'Errico P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082654; Edgington E.S., 2007, RANDOMIZATION TESTS; El Mendili MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122224; El Mendili MM, 2015, J MAGN RESON IMAGING, V41, P454, DOI 10.1002/jmri.24571; El Mendili MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095516; GARDNERMEDWIN D, 1967, J NEUROL SCI, V5, P121, DOI 10.1016/0022-510X(67)90013-5; Hamilton G, 2013, TRENDS MOL MED, V19, P40, DOI 10.1016/j.molmed.2012.11.002; Hausmanowa-Petrusewicz I, 1984, PROGR SPINAL MUSCULA, P31; HIRAYAMA K, 1987, J NEUROL NEUROSUR PS, V50, P285, DOI 10.1136/jnnp.50.3.285; HUANG KW, 1983, J NEUROL SCI, V61, P249, DOI 10.1016/0022-510X(83)90009-6; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Kuru S, 2009, NEUROPATHOLOGY, V29, P63, DOI 10.1111/j.1440-1789.2008.00910.x; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Losseff NA, 1996, BRAIN, V119, P701, DOI 10.1093/brain/119.3.701; Lundell H, 2011, SPINAL CORD, V49, P70, DOI 10.1038/sc.2010.87; MEADOWS JC, 1969, J NEUROL SCI, V9, P527, DOI 10.1016/0022-510X(69)90093-8; Morra JH, 2009, NEUROIMAGE, V45, pS3, DOI 10.1016/j.neuroimage.2008.10.043; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Piepers S, 2008, J NEUROL, V255, P1400, DOI 10.1007/s00415-008-0929-0; Rutkove SB, 2012, MUSCLE NERVE, V45, P642, DOI 10.1002/mus.23233; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Sorenson EJ, 2003, NEUROLOGY, V61, P1503; Sproule DM, 2011, J CHILD NEUROL, V26, P309, DOI 10.1177/0883073810380457; Taso M, 2015, NEUROIMAGE, V117, P20, DOI 10.1016/j.neuroimage.2015.05.034; Taso M, 2014, MAGN RESON MATER PHY, V27, P257, DOI 10.1007/s10334-013-0403-6; Thompson PM, 2007, NEUROIMAGE, V36, P1397, DOI 10.1016/j.neuroimage.2007.04.019; Valsasina P, 2013, RADIOLOGY, V266, P853, DOI 10.1148/radiol.12120813; Van den Berg-Vos RM, 2003, J NEUROL, V250, P1279, DOI 10.1007/s00415-003-0235-9; Wadman RI, 2012, NEUROLOGY, V79, P2050, DOI 10.1212/WNL.0b013e3182749eca; Wakeling EN, 2012, J COMP NEUROL, V520, P1737, DOI 10.1002/cne.23010; Werlauff U, 2012, NEUROMUSCULAR DISORD, V22, P1069, DOI 10.1016/j.nmd.2012.06.352; WINDER TR, 1989, CAN J NEUROL SCI, V16, P67, DOI 10.1017/S0317167100028535; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	45	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152439	10.1371/journal.pone.0152439	http://dx.doi.org/10.1371/journal.pone.0152439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089520	Green Submitted, gold, Green Published			2022-12-27	WOS:000374527000007
J	Wang, L; Kang, S; Zou, DQ; Zhan, L; Li, ZX; Zhu, W; Su, H				Wang, Liang; Kang, Shuai; Zou, Dingquan; Zhan, Lei; Li, Zhengxi; Zhu, Wan; Su, Hua			Bone Fracture Pre-Ischemic Stroke Exacerbates Ischemic Cerebral Injury in Mice	PLOS ONE			English	Article							HIP FRACTURE; COGNITIVE DYSFUNCTION; TNF-ALPHA; NEUROINFLAMMATION; INFLAMMATION; RISK; SENSORIMOTOR; RECOVERY; DECLINE; DISEASE	Ischemic stroke is a devastating complication of bone fracture. Bone fracture shortly after stroke enhances stroke injury by augmenting inflammation. We hypothesize that bone fracture shortly before ischemic stroke also exacerbates ischemic cerebral injury. Tibia fracture was performed 6 or 24 hours before permanent middle cerebral artery occlusion (pMCAO) on C57BL/6J mice or Ccr2(RFP/+)Cx3cr1(GFP/+) mice that have the RFP gene knocked into one allele of Ccr2 gene and GFP gene knocked into one allele of Cx3cr1 gene. Behavior was tested 3 days after pMCAO. Infarct volume, the number of CD68(+) cells, apoptotic neurons, bone marrow-derived macrophages (RFP+), and microgila (GFP(+)) in the peri-infarct region were quantified. Compared to mice subjected to pMCAO only, bone fracture 6 or 24 hours before pMCAO increased behavioral deficits, the infarct volume, and the number of CD68(+) cells and apoptotic neurons in the peri-infarct area. Both bone marrow-derived macrophages (CCR2(+)) and microglia (CX3CR1(+)) increased in the peri-infarct regions of mice subjected to bone fracture before pMCAO compared to stroke-only mice. The mice subjected to bone fracture 6 hours before pMCAO had more severe injury than mice that had bone fracture 24 hours before pMCAO. Our data showed that bone fracture shortly before stroke also increases neuroinflammation and exacerbates ischemic cerebral injury. Our findings suggest that inhibition of neuroinflammation or management of stroke risk factors before major bone surgery would be beneficial for patients who are likely to suffer from stroke.	[Wang, Liang; Kang, Shuai; Zou, Dingquan; Zhan, Lei; Li, Zhengxi; Zhu, Wan; Su, Hua] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA; [Wang, Liang] Tianjin Fifth Ctr Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Kang, Shuai] Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Zhengxi] Shanghai Ninth Peoples Hosp, Dept Neurol, Shanghai, Peoples R China	University of California System; University of California San Francisco; Capital Medical University; Shanghai Jiao Tong University	Su, H (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, Ctr Cerebrovasc Res, San Francisco, CA 94143 USA.	hua.su@ucsf.edu			National Institutes of Health [R01 NS027713, R01 HL122774, R21 NS083788]; Michael Ryan Zodda Foundation; UCSF Research Evaluation and Allocation Committee (REAC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS083788, R01NS027713] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael Ryan Zodda Foundation; UCSF Research Evaluation and Allocation Committee (REAC); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health R01 NS027713, R01 HL122774 and R21 NS083788 (to HS); Michael Ryan Zodda Foundation (to HS); and UCSF Research Evaluation and Allocation Committee (REAC) (to HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti A, 2011, INTERN EMERG MED, V6, P119, DOI 10.1007/s11739-011-0675-7; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chamorro A, 2006, STROKE, V37, P291, DOI 10.1161/01.STR.0000200561.69611.f8; Chisholm NC, 2016, NEUROBIOL DIS, V85, P245, DOI 10.1016/j.nbd.2015.03.028; Choy FC, 2015, J CEREB BLOOD FLOW M, DOI [10.1177/0271678X15606146, DOI 10.1177/0271678X15606146]; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Cunningham C, 2009, BIOL PSYCHIAT, V65, P304, DOI 10.1016/j.biopsych.2008.07.024; Degos V, 2013, ANESTHESIOLOGY, V118, P1362, DOI 10.1097/ALN.0b013e31828c23f8; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Han ZY, 2014, J NEUROCHEM, V131, P498, DOI 10.1111/jnc.12817; Han ZY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105711; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Hayakawa K, 2010, ANN NY ACAD SCI, V1207, P50, DOI 10.1111/j.1749-6632.2010.05728.x; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Lakhan SE, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-97; Langdon KD, 2010, J CEREBR BLOOD F MET, V30, P1450, DOI 10.1038/jcbfm.2010.23; Lo EH, 2009, NAT MED, V15, P844, DOI 10.1038/nm0809-844; Mathew RO, 2013, AM J PHYS MED REHAB, V92, P686, DOI 10.1097/PHM.0b013e318282bc67; Nguyen ND, 2007, J BONE MINER RES, V22, P781, DOI 10.1359/JBMR.070315; Palan J, 2007, INJURY, V38, P1279, DOI 10.1016/j.injury.2007.05.014; Rosi S, 2009, BRAIN, V132, P2464, DOI 10.1093/brain/awp148; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sathiyakumar V, 2016, INT ORTHOP, V40, P439, DOI 10.1007/s00264-015-2832-5; Sennerby U, 2009, JAMA-J AM MED ASSOC, V302, P1666, DOI 10.1001/jama.2009.1463; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Terrando N, 2010, CRIT CARE, V14, DOI 10.1186/cc9019; Vidal Sarkis Morales, 2013, Hosp Pract (1995), V41, P108, DOI 10.3810/hp.2013.04.1060; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0	33	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153835	10.1371/journal.pone.0153835	http://dx.doi.org/10.1371/journal.pone.0153835			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089041	Green Published, gold			2022-12-27	WOS:000374527000054
J	Li, DY; Zhang, YW; Cui, ZL; He, LW; Chen, WB; Meng, QX; Ren, LP				Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping			Effects of Phytoecdysteroids (PEDS) Extracted from Cyanotis arachnoidea on Rumen Fermentation, Enzyme Activity and Microbial Efficiency in a Continuous-Culture System	PLOS ONE			English	Article							PLANT-EXTRACTS; METHANE PRODUCTION; GAS-PRODUCTION; AMINO-ACIDS; ECDYSTEROIDS; FEED; NITROGEN; PROTEIN; DIGESTIBILITY; METABOLISM	The objective of this study was to evaluate the effects of supplementation of phytoecdysteroids (PEDS) extracted from Cyanotis arachnoidea on rumen fermentation, enzymes activity and microbial efficiency in a dual flow continuous-culture system. A single-factor experimental design was used with twelve fermenters in 4 groups with 3 replicates each. Fermenters were incubated for a total of 7 days that included first 4 days for adaptation and last 3 days for sampling. PEDS was added at levels of zero (as control), 5, 10, and 15 mg/g of the substrate (DM). The results showed that increasing supplementation levels of PEDS resulted in incremental digestibility of dry matter (DMD) (quadratic, P = 0.001) and organic matter (OMD) (quadratic, P = 0.031), but unchanged digestibility of neutral detergent fiber (NDFD), crude protein (CPD) and acid detergent acid (ADFD). As supplementation levels of PEDS increased, there were decreased response in the concentration of ammonia nitrogen (NH3-N) (linear, P = 0.015) and increased response in molar proportions of butyrate (linear, P = 0.004), but unchanged response in total volatile fatty acid (TVFA) and the molar proportion of acetate and propionate, respectively. Increasing PEDS supplementation levels decreased the ratio of acetate to propionate (linear, P = 0.038), suggesting an alteration of rumen fermentation pattern occurring due to PEDS supplementation in the diet. Supplementation of PEDS significantly increased activities of glutamate dehydrogenase (quadratic, P = 0.001), alanine dehydrogenase (quadratic, P = 0.004), glutamate synthase (linear, P = 0.038), glutamine synthetase (quadratic, P = 0.011), respectively. There were no discernible differences in the activity of carboxymethyl cellulose (CMCase), xylanase and protease regardless of the treatments. The daily production of microbial nitrogen (linear, P = 0.002) and microbial efficiency (MOEEF) (linear, P = 0.001) increased linearly as supplementation levels of PEDS increased. The decreased response of fluid NH3-N and the increased response of MN indicated that PEDS positively increased the synthesis of microbial proteins.	[Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China; [Li, Deyong; Zhang, Yawei; Cui, Zhenliang; He, Liwen; Chen, Wanbao; Meng, Qingxiang; Ren, Liping] China Agr Univ, Coll Anim Sci & Technol, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China	China Agricultural University; China Agricultural University	Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, State Key Lab Anim Nutr, Beijing 100094, Peoples R China.; Ren, LP (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	lideyong200713@126.com	Meng, Q./GSI-6185-2022	Zhang, Yawei/0000-0002-0571-8383; He, Liwen/0000-0002-8578-710X	National Natural Science Foundation of China [31172231]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant No. 31172231) and the website is: http://www.nsfc.gov.cn/. The corresponding author LPR host the program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad V. U., 1996, Fitoterapia, V67, P88; Alexander G, 2008, ANIM FEED SCI TECH, V145, P229, DOI 10.1016/j.anifeedsci.2007.05.036; AOAC, 2007, OFFICIAL METHODS ANA, V18th; Appuhamy JADRN, 2013, J DAIRY SCI, V96, P5161, DOI 10.3168/jds.2012-5923; Baker SK, 1994, PCT Int. Appl, Patent No. [AU Appl. 93/ 7,397, 937397]; Baker SK, 1994, PCT Int. Appl, Patent No. [Wo 94 18, 984, 9418984, WO 94 18,984]; BENSADOUN A, 1962, J DAIRY SCI, V45, P1203, DOI 10.3168/jds.S0022-0302(62)89597-6; Blake JS, 1983, BR J NUTR, P769; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Broudiscou LP, 2002, ANIM FEED SCI TECH, V101, P183, DOI 10.1016/S0377-8401(02)00221-3; Casewell M, 2003, J ANTIMICROB CHEMOTH, V52, P159, DOI 10.1093/jac/dkg313; Chadin I, 2003, BIOCHEM SYST ECOL, V31, P407, DOI 10.1016/S0305-1978(02)00172-2; Chattopadhyay MK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00334; CHAUDHARY KD, 1969, EXPERIENTIA, V25, P250, DOI 10.1007/BF02034373; Dinan L, 2001, PHYTOCHEMISTRY, V57, P325, DOI 10.1016/S0031-9422(01)00078-4; Dinan L, 2001, PHYTOCHEMISTRY, V56, P569, DOI 10.1016/S0031-9422(00)00438-6; Dinan L, 2006, J ENDOCRINOL, V191, P1, DOI 10.1677/joe.1.06900; Golder HM, 2014, J DAIRY SCI, V97, P985, DOI 10.3168/jds.2013-7166; Hu J, 2014, PHYTOCHEM LETT, V8, P73, DOI 10.1016/j.phytol.2014.02.003; Kim JN, 2014, APPL ENVIRON MICROB, V80, P3095, DOI 10.1128/AEM.00029-14; Kratky F, 1997, ZIVOCISNA VYROBA, V42, P445; Kung L, 2014, J DAIRY SCI, V97, P1707, DOI 10.3168/jds.2013-7469; Le Bizec B, 2002, ANAL CHIM ACTA, V473, P89, DOI 10.1016/S0003-2670(02)00874-7; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mamadalieva NZ, 2012, B LATINOAM CARIBE PL, V11, P474; Meng QX, 2000, ASIAN AUSTRAL J ANIM, V13, P1399, DOI 10.5713/ajas.2000.1399; MENKE KH, 1979, J AGR SCI, V93, P217, DOI 10.1017/S0021859600086305; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Minato H., 1993, P MIE BIOF GEN BIOCH, P139; Morrison M, 1996, AUST J AGR RES, V47, P227, DOI 10.1071/AR9960227; NEWBOLD CJ, 1995, LETT APPL MICROBIOL, V21, P230, DOI 10.1111/j.1472-765X.1995.tb01048.x; ORKOV ER, 1994, LIVEST PROD SCI, V39, P53, DOI 10.1016/0301-6226(94)90153-8; Patil N, 2012, FEEDING MANAGEMENT L; Patra AK, 2006, ANIM FEED SCI TECH, V128, P276, DOI 10.1016/j.anifeedsci.2005.11.001; Patra AK, 2009, ANTON LEEUW INT J G, V96, P363, DOI 10.1007/s10482-009-9364-1; Shabi Z, 2000, J DAIRY SCI, V83, P2326, DOI 10.3168/jds.S0022-0302(00)75120-4; Shirshova T.I., 2006, PHARM CHEM J+, V40, P268; Slama K, 1996, EXPERIENTIA, V52, P702, DOI 10.1007/BF01925578; SLAMA K, 1995, EUR J ENTOMOL, V92, P355; STUMM CK, 1986, MICROBIOL SCI, V3, P100; Todorov I. N., 2000, Khimiko-Farmatsevticheskii Zhurnal, V34, P3; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Wall EH, 2014, J DAIRY SCI, V97, P5709, DOI 10.3168/jds.2014-7896; Wang PP, 2013, ANIM BIOTECHNOL, V24, P107, DOI 10.1080/10495398.2012.756402; Wei ML, 2012, J ANIM VET ADV, V11, P4304; WELLER RA, 1974, BRIT J NUTR, V32, P341, DOI 10.1079/BJN19740087; Wu N, 2010, ENVIRON SCI TECHNOL, V44, P6933, DOI 10.1021/es1007802; ZINN RA, 1986, CAN J ANIM SCI, V66, P157, DOI 10.4141/cjas86-017	48	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153584	10.1371/journal.pone.0153584	http://dx.doi.org/10.1371/journal.pone.0153584			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082647	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800031
J	Balint, R; Lowe, T; Shearer, T				Balint, Richard; Lowe, Tristan; Shearer, Tom			Optimal Contrast Agent Staining of Ligaments and Tendons for X-Ray Computed Tomography	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; STRAIN-ENERGY FUNCTION; PATELLAR TENDON; MICRO-CT; ARRANGEMENT; TOOL	X-ray computed tomography has become an important tool for studying the microstructures of biological soft tissues, such as ligaments and tendons. Due to the low X-ray attenuation of such tissues, chemical contrast agents are often necessary to enhance contrast during scanning. In this article, the effects of using three different contrast agents-iodine potassium iodide solution, phosphotungstic acid and phosphomolybdic acid-are evaluated and compared. Porcine anterior cruciate ligaments, patellar tendons, medial collateral ligaments and lateral collateral ligaments were used as the basis of the study. Three samples of each of the four ligament/tendon types were each assigned a different contrast agent (giving a total of twelve samples), and the progression of that agent through the tissue was monitored by performing a scan every day for a total period of five days (giving a total of sixty scans). Since the samples were unstained on day one, they had been stained for a total of four days by the time of the final scans. The relative contrast enhancement and tissue deformation were measured. It was observed that the iodine potassium iodide solution penetrated the samples fastest and caused the least sample shrinkage on average (although significant deformation was observed by the time of the final scans), whereas the phosphomolybdic acid caused the greatest sample shrinkage. Equations describing the observed behaviour of the contrast agents, which can be used to predict optimal staining times for ligament and tendon X-ray computed tomography, are presented.	[Balint, Richard; Shearer, Tom] Univ Manchester, Sch Mat, Manchester, Lancs, England; [Lowe, Tristan] Univ Manchester, Sch Mat, Henry Moseley Xray Imaging Facil, Manchester, Lancs, England; [Shearer, Tom] Univ Manchester, Sch Math, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Shearer, T (corresponding author), Univ Manchester, Sch Mat, Manchester, Lancs, England.	tom.shearer@manchester.ac.uk	Shearer, Tom/H-7048-2019	Shearer, Tom/0000-0001-7536-5547	Engineering and Physical Sciences Research Council (EPSRC) [EP/L017997/1]; EPSRC [EP/F007906/1, EP/F001452/1, EP/I02249X/1]; EPSRC [EP/L017997/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L017997/1, EP/F007906/1, EP/I02249X/1, EP/F001452/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	TS would like to thank the Engineering and Physical Sciences Research Council (EPSRC - https://www.epsrc.ac.uk/) for supporting this work via his Fellowship grant EP/L017997/1. All the authors would like to acknowledge the assistance provided by the Manchester X-ray Imaging Facility, which was funded in part by the EPSRC (grants EP/F007906/1, EP/F001452/1 and EP/I02249X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi OV, 2013, IEEE T MED IMAGING, V32, P8, DOI 10.1109/TMI.2012.2209183; Butters TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105552; de Crespigny A, 2008, J NEUROSCI METH, V171, P207, DOI 10.1016/j.jneumeth.2008.03.006; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dewulf W, 2012, CIRP ANN-MANUF TECHN, V61, P495, DOI 10.1016/j.cirp.2012.03.013; Eleswarapu SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026178; Elsheikh A, 2013, MED ENG PHYS, V35, P211, DOI 10.1016/j.medengphy.2012.09.006; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Kalson NS, 2012, J HAND SURG-EUR VOL, V37E, P550, DOI 10.1177/1753193411433228; KASTELIC J, 1978, CONNECT TISSUE RES, V6, P11, DOI 10.3109/03008207809152283; LIU SQ, 1988, J BIOMECH ENG-T ASME, V110, P82, DOI 10.1115/1.3108410; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Pauwels E, 2013, J MICROSC-OXFORD, V250, P21, DOI 10.1111/jmi.12013; Roberts N, 2012, AM J PATHOL, V180, P1835, DOI 10.1016/j.ajpath.2012.01.033; Screen HRC, 2004, STRAIN, V40, P157, DOI 10.1111/j.1475-1305.2004.00164.x; Shearer T, 2015, J BIOMECH, V48, P3017, DOI 10.1016/j.jbiomech.2015.07.032; Shearer T, 2015, J BIOMECH, V48, P290, DOI 10.1016/j.jbiomech.2014.11.031; Shearer Tom, 2014, Muscles Ligaments Tendons J, V4, P238; Stephenson RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035299; Vickerton P, 2013, J ANAT, V223, P185, DOI 10.1111/joa.12068; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084321; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; YAHIA LH, 1989, J ORTHOPAED RES, V7, P243, DOI 10.1002/jor.1100070212; YAHIA LH, 1988, J MATER SCI, V23, P3750, DOI 10.1007/BF00540523	25	36	36	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153552	10.1371/journal.pone.0153552	http://dx.doi.org/10.1371/journal.pone.0153552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078030	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700077
J	Tomas, D; Stanic, D; Chua, HK; White, K; Boon, WC; Horne, M				Tomas, D.; Stanic, D.; Chua, H. K.; White, K.; Boon, W. C.; Horne, M.			Restoration of the Dopamine Transporter through Cell Therapy Improves Dyskinesia in a Rat Model of Parkinson's Disease	PLOS ONE			English	Article							MOTOR FLUCTUATIONS; LEVODOPA; NEURONS; TERMINALS; EVOLUTION; LESIONS; PHARMACODYNAMICS; FRACTIONATOR; MICE; SNPC	The dyskinesia of Parkinson's Disease is most likely due to excess levels of dopamine in the striatum. The mechanism may be due to aberrant synthesis but also, a deficiency or absence of the Dopamine Transporter. In this study we have examined the proposition that reinstating Dopamine Transporter expression in the striatum would reduce dyskinesia. We transplanted c17.2 cells that stably expressed the Dopamine Transporter into dyskinetic rats. There was a reduction in dyskinesia in rats that received grafts expressing the Dopamine Transporter. Strategies designed to increase Dopamine Transporter in the striatum may be useful in treating the dyskinesia associated with human Parkinson's Disease.	[Tomas, D.; Stanic, D.; Chua, H. K.; White, K.; Boon, W. C.; Horne, M.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia; [Horne, M.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne	Horne, M (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3010, Australia.; Horne, M (corresponding author), Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia.	malcolm.horne@florey.edu.au	Horne, Malcolm/AAL-5214-2020	Horne, Malcolm/0000-0001-9427-2100; Stanic, Davor/0000-0002-4310-7030; White, Kylie/0000-0003-1963-6140				Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Cenci MA, 1999, NEUROSCIENCE, V94, P515, DOI 10.1016/S0306-4522(99)00294-8; Chen LN, 2008, J NEUROSCI, V28, P425, DOI 10.1523/JNEUROSCI.3602-07.2008; COTZIAS GC, 1967, NEW ENGL J MED, V276, P374, DOI 10.1056/NEJM196702162760703; Finkelstein DI, 2000, NEUROSCIENCE, V97, P99, DOI 10.1016/S0306-4522(00)00009-9; Grammatopoulos TN, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt36; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; HELY MA, 1994, J NEUROL NEUROSUR PS, V57, P903, DOI 10.1136/jnnp.57.8.903; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; McColl CD, 2002, MOVEMENT DISORD, V17, P1227, DOI 10.1002/mds.10244; Metman LV, 1997, NEUROLOGY, V49, P711, DOI 10.1212/WNL.49.3.711; MOURADIAN MM, 1988, ANN NEUROL, V24, P372, DOI 10.1002/ana.410240304; Nutt JG, 2002, ANN NEUROL, V51, P686, DOI 10.1002/ana.10189; Nutt JG, 2001, PARKINSONISM RELAT D, V8, P101, DOI 10.1016/S1353-8020(01)00024-4; NUTT JG, 1995, CLIN EXP PHARMACOL P, V22, P837, DOI 10.1111/j.1440-1681.1995.tb01946.x; NUTT JG, 1992, ARCH NEUROL-CHICAGO, V49, P1123, DOI 10.1001/archneur.1992.00530350037016; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Parish CL, 2005, NEUROBIOL DIS, V19, P301, DOI 10.1016/j.nbd.2005.01.009; Parish CL, 2001, J NEUROSCI, V21, P5147, DOI 10.1523/JNEUROSCI.21-14-05147.2001; Reardon KA, 1999, MOVEMENT DISORD, V14, P605, DOI 10.1002/1531-8257(199907)14:4<605::AID-MDS1009>3.0.CO;2-H; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sossi V, 2007, ANN NEUROL, V62, P468, DOI 10.1002/ana.21204; Stanic D, 2003, J NEUROCHEM, V86, P329, DOI 10.1046/j.1471-4159.2003.01843.x; Stanic D, 2003, EUR J NEUROSCI, V18, P1175, DOI 10.1046/j.1460-9568.2003.02800.x; Sui Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00013; Vinuela A, 2008, BRAIN, V131, P3361, DOI 10.1093/brain/awn192; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411	28	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153424	10.1371/journal.pone.0153424	http://dx.doi.org/10.1371/journal.pone.0153424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077649	gold, Green Published			2022-12-27	WOS:000374131700054
J	Zurawski, G; Zurawski, S; Flamar, AL; Richert, L; Wagner, R; Tomaras, GD; Montefiori, DC; Roederer, M; Ferrari, G; Lacabaratz, C; Bonnabau, H; Klucar, P; Wang, ZQ; Foulds, KE; Kao, SF; Yates, NL; LaBranche, C; Jacobs, BL; Kibler, K; Asbach, B; Kliche, A; Salazar, A; Reed, S; Self, S; Gottardo, R; Galmin, L; Weiss, D; Cristillo, A; Thiebaut, R; Pantaleo, G; Levy, Y				Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Richert, Laura; Wagner, Ralf; Tomaras, Georgia D.; Montefiori, David C.; Roederer, Mario; Ferrari, Guido; Lacabaratz, Christine; Bonnabau, Henri; Klucar, Peter; Wang, Zhiqing; Foulds, Kathryn E.; Kao, Shing-Fen; Yates, Nicole L.; LaBranche, Celia; Jacobs, Bertram L.; Kibler, Karen; Asbach, Benedikt; Kliche, Alexander; Salazar, Andres; Reed, Steve; Self, Steve; Gottardo, Raphael; Galmin, Lindsey; Weiss, Deborah; Cristillo, Anthony; Thiebaut, Rodolphe; Pantaleo, Giuseppe; Levy, Yves			Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques	PLOS ONE			English	Article							T-CELL RESPONSES; DENDRITIC CELLS; IMMUNOLOGICAL CHARACTERIZATION; EFFICACY TRIAL; VACCINE; ANTIBODIES; PROTEIN; ANTIGENS; PRIME; ALVAC	Improved antigenicity against HIV-1 envelope (Env) protein is needed to elicit vaccine-induced protective immunity in humans. Here we describe the first tests in non-human primates (NHPs) of Env gp140 protein fused to a humanized anti-LOX-1 recombinant antibody for delivering Env directly to LOX-1-bearing antigen presenting cells, especially dendritic cells (DC). LOX-1, or 1ectin-like oxidized low-density lipoprotein (LDL) receptor-1, is expressed on various antigen presenting cells and endothelial cells, and is involved in promoting humoral immune responses. The anti-LOX-1 Env gp140 fusion protein was tested for priming immune responses and boosting responses in animals primed with replication competent NYVAC-KC Env gp140 vaccinia virus. Anti-LOX-1 Env gp140 vaccination elicited robust cellular and humoral responses when used for either priming or boosting immunity. Co-administration with Poly ICLC, a TLR3 agonist, was superior to GLA, a TLR4 agonist. Both CD4(+) and CD8(+) Env-specific T cell responses were elicited by anti-LOX-1 Env gp140, but in particular the CD4(+) T cells were multifunctional and directed to multiple epitopes. Serum IgG and IgA antibody responses induced by anti-LOX-1 Env gp140 against various gp140 domains were cross-reactive across HIV-1 clades; however, the sera neutralized only HIV-1 bearing sequences most similar to the clade C 96ZM651 Env gp140 carried by the anti-LOX-1 vehicle. These data, as well as the safety of this protein vaccine, justify further exploration of this DC-targeting vaccine approach for protective immunity against HIV-1.	[Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Lacabaratz, Christine; Klucar, Peter; Wang, Zhiqing; Levy, Yves] Univ Paris Est, Vaccine Res Inst, Fac Med, INSERM,U955, Creteil, France; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Lacabaratz, Christine; Klucar, Peter; Wang, Zhiqing; Levy, Yves] Grp Henri Mondor Albert Chenevier, AP HP, Serv Immunol Clin, INRIA SISTM, Creteil, France; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Klucar, Peter; Wang, Zhiqing] Baylor Inst Immunol Res, Dallas, TX USA; [Zurawski, Gerard; Zurawski, Sandra; Flamar, Anne-Laure; Klucar, Peter; Wang, Zhiqing] INSERM, U955, Dallas, TX USA; [Richert, Laura; Bonnabau, Henri; Thiebaut, Rodolphe] Univ Bordeaux Segalen, INSERM, U897, INRIA SISTM, Bordeaux, France; [Wagner, Ralf; Asbach, Benedikt; Kliche, Alexander] Univ Regensburg, Inst Med Microbiol & Hyg, Mol Microbiol & Gene Therapy Unit, D-93053 Regensburg, Germany; [Tomaras, Georgia D.; Montefiori, David C.; Ferrari, Guido; Yates, Nicole L.; LaBranche, Celia] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Tomaras, Georgia D.; Montefiori, David C.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC USA; [Roederer, Mario; Foulds, Kathryn E.; Kao, Shing-Fen] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Jacobs, Bertram L.; Kibler, Karen] Arizona State Univ, Sch Life Sci, Ctr Infect Dis & Vaccinol, Tempe, AZ USA; [Self, Steve; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Self, Steve; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA; [Salazar, Andres] Oncovir, Washington, DC USA; [Reed, Steve] Infect Dis Res Inst, Seattle, WA USA; [Galmin, Lindsey; Weiss, Deborah; Cristillo, Anthony] Adv BioSci Labs Inc, Rockville, MD USA; [Pantaleo, Giuseppe] CHU Vaudois, CH-101 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Baylor Scott & White Health; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Regensburg; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Arizona State University; Arizona State University-Tempe; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Zurawski, G (corresponding author), Univ Paris Est, Vaccine Res Inst, Fac Med, INSERM,U955, Creteil, France.; Zurawski, G (corresponding author), Grp Henri Mondor Albert Chenevier, AP HP, Serv Immunol Clin, INRIA SISTM, Creteil, France.; Zurawski, G (corresponding author), Baylor Inst Immunol Res, Dallas, TX USA.	gerardz@baylorhealth.edu	Gottardo, Raphael/HCH-3169-2022; Thiebaut, Rodolphe/T-6803-2019; Ferrari, Guido/Z-2137-2019; Ferrari, Guido/A-6088-2015; Pantaleo, Giuseppe/K-6163-2016; Roederer, Mario/G-1887-2011; Richert, Laura/T-5801-2019; Tomaras, Georgia/J-5041-2016	Thiebaut, Rodolphe/0000-0002-5235-3962; Ferrari, Guido/0000-0001-7747-3349; Gottardo, Raphael/0000-0002-3867-0232; Richert, Laura/0000-0002-7682-2225; Zurawski, Gerard/0000-0002-0168-3523; Lacabaratz, Christine/0000-0001-6925-0225	Vaccine Research Institute HIV vaccine program (ANRS/INSERM); Vaccine Research Institute HIV vaccine program (Investissements d'Avenir program) [ANR-10-LABX-77]; Poxvirus T-cell Vaccine Consortium - Bill & Melinda Gates Foundation [OPP38599]; Vaccine Immune Monitoring Centers - Bill & Melinda Gates Foundation [OPP1032325, OPP1032144]; Vaccine Immunology Statistical Center - Bill & Melinda Gates Foundation [OPP1032317]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI005103, ZIAAI005021, ZIAAI005020] Funding Source: NIH RePORTER	Vaccine Research Institute HIV vaccine program (ANRS/INSERM)(French National Research Agency (ANR)); Vaccine Research Institute HIV vaccine program (Investissements d'Avenir program)(French National Research Agency (ANR)); Poxvirus T-cell Vaccine Consortium - Bill & Melinda Gates Foundation; Vaccine Immune Monitoring Centers - Bill & Melinda Gates Foundation; Vaccine Immunology Statistical Center - Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded within the Vaccine Research Institute HIV vaccine program (ANRS/INSERM and was supported by the Investissements d'Avenir program managed by the ANR under reference ANR-10-LABX-77). Support from the Poxvirus T-cell Vaccine Consortium funded by the Bill & Melinda Gates Foundation (OPP38599) for the development of NYVAC-KC vector. Support for the ICS and antibody immune monitoring assays was provided by the Vaccine Immune Monitoring Centers (OPP1032325 & OPP1032144), and support for the statistical analysis from the Vaccine Immunology Statistical Center (OPP1032317), all part of the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded within the Vaccine Research Institute HIV vaccine program (ANRS/INSERM and was supported by the Investissements d'Avenir program managed by the ANR under reference ANR-10-LABX-77). Support from the Poxvirus T-cell Vaccine Consortium funded by the Bill & Melinda Gates Foundation (OPP38599) for the development of NYVAC-KC vector. Support for the ICS and antibody immune monitoring assays was provided by the Vaccine Immune Monitoring Centers (OPP1032325 & OPP1032144), and support for the statistical analysis from the Vaccine Immunology Statistical Center (OPP1032317), all part of the Collaboration for AIDS Vaccine Discovery (CAVD) funded by the Bill & Melinda Gates Foundation. Alicia Sato (Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center) and Jason Skinner (BIIR) are thanked for valuable edits. Matthew Baker (Antitope, Ltd) provided humanization of the alpha LOX-1 15C4 mAb. Lauren Hudacik (ABL), Cecile Peltekian (INSERM U955) and Song Ding (EuroVacc Foundation) are thanked for excellent project coordination.	Donaldson MM, 2012, J IMMUNOL METHODS, V386, P10, DOI 10.1016/j.jim.2012.08.011; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Epaulard O, 2014, J IMMUNOL, V193, P2416, DOI 10.4049/jimmunol.1303339; Flamar AL, 2013, AIDS, V27, P2041, DOI 10.1097/QAD.0b013e3283624305; Flamar AL, 2012, J IMMUNOL, V189, P2645, DOI 10.4049/jimmunol.1102390; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008; Garcia-Arriaza J, 2015, J VIROL, V89, P8525, DOI 10.1128/JVI.01265-15; Gaschen B, 2002, SCIENCE, V296, P2354, DOI 10.1126/science.1070441; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Joo H, 2014, IMMUNITY, V41, P592, DOI 10.1016/j.immuni.2014.09.009; Kibler KV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025674; Lewis GK, 2010, EXPERT REV VACCINES, V9, P683, DOI [10.1586/erv.10.70, 10.1586/ERV.10.70]; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Liao HX, 2013, IMMUNITY, V38, P176, DOI 10.1016/j.immuni.2012.11.011; Lin L, 2015, NAT BIOTECHNOL, V33, P610, DOI 10.1038/nbt.3187; Lumsden JM, 2011, INFECT IMMUN, V79, P3492, DOI 10.1128/IAI.05257-11; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Nkolola JP, 2014, VACCINE, V32, P2109, DOI 10.1016/j.vaccine.2014.02.001; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Perdiguero B, 2015, J VIROL, V89, P970, DOI 10.1128/JVI.02469-14; Pitisuttithum P, 2006, J INFECT DIS, V194, P1661, DOI 10.1086/508748; Pollara J, 2014, J VIROL, V88, P7715, DOI 10.1128/JVI.00156-14; Pollara J, 2011, CYTOM PART A, V79A, P603, DOI 10.1002/cyto.a.21084; Reed SG, 2013, NAT MED, V19, P1597, DOI 10.1038/nm.3409; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Robb ML, 2012, LANCET INFECT DIS, V12, P531, DOI 10.1016/S1473-3099(12)70088-9; Rose R De, 2014, NOVEL APPROACHES STR; Schneider LP, 2012, VACCINE, V30, P4216, DOI 10.1016/j.vaccine.2012.04.051; Skinner JA, 2014, CLIN VACCINE IMMUNOL, V21, P1668, DOI 10.1128/CVI.00547-14; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Tomaras GD, 2013, P NATL ACAD SCI USA, V110, P9019, DOI 10.1073/pnas.1301456110; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Vaure C, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00316; Vingert B, 2010, PLOS PATHOG, V6; White SD, 2011, BIOTECHNIQUES, V50, P303, DOI 10.2144/000113667; Yates NL, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007730; Zolla-Pazner S, 2014, EBIOMEDICINE, V1, P37, DOI 10.1016/j.ebiom.2014.10.022; Zolla-Pazner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087572	43	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153484	10.1371/journal.pone.0153484	http://dx.doi.org/10.1371/journal.pone.0153484			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077384	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700063
J	Bergman, PS; Schumer, G; Blankenship, S; Campbell, E				Bergman, Paul S.; Schumer, Gregg; Blankenship, Scott; Campbell, Elizabeth			Detection of Adult Green Sturgeon Using Environmental DNA Analysis	PLOS ONE			English	Article							SURVEY TOOL; EDNA	Environmental DNA (eDNA) is an emerging sampling method that has been used successfully for detection of rare aquatic species. The Identification of sampling tools that are less stressful for target organisms has become increasingly important for rare and endangered species. A decline in abundance of the Southern Distinct Population Segment (DPS) of North American Green Sturgeon located in California's Central Valley has led to its listing as Threatened under the Federal Endangered Species Act in 2006. While visual surveys of spawning Green Sturgeon in the Central Valley are effective at monitoring fish densities in concentrated pool habitats, results do not scale well to the watershed level, providing limited spatial and temporal context. Unlike most traditional survey methods, environmental DNA analysis provides a relatively quick, inexpensive tool that could efficiently monitor the presence and distribution of aquatic species. We positively identified Green Sturgeon DNA at two locations of known presence in the Sacramento River, proving that eDNA can be effective for monitoring the presence of adult sturgeon. While further study is needed to understand uncertainties of the sampling method, our study represents the first documented detection of Green Sturgeon eDNA, indicating that eDNA analysis could provide a new tool for monitoring Green Sturgeon distribution in the Central Valley, complimenting traditional on-going survey methods.	[Bergman, Paul S.; Schumer, Gregg; Blankenship, Scott] Cramer Fish Sci, West Sacramento, CA USA; [Campbell, Elizabeth] US Fish & Wildlife Serv, Anadromous Fish Restorat Program, Lodi, CA USA	United States Department of the Interior; US Fish & Wildlife Service	Bergman, PS (corresponding author), Cramer Fish Sci, West Sacramento, CA USA.	pbergman@fishsciences.net		Blankenship, Scott/0000-0001-6371-9475	U.S. Fish and Wildlife (USFWS) Service grant [813329G011]	U.S. Fish and Wildlife (USFWS) Service grant	This study was funded exclusively through a U.S. Fish and Wildlife (USFWS) Service grant, award number 813329G011. Except for USFWS employee and author EB, no other funders played a role in the study to develop study design, conduct data collection and analysis, decision to publish, or prepare the manuscript. Cramer Fish Sciences provided support in the form of salaries for authors PB, SB, and GS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bergman PS, 2011, 813329G011 US FISH W; Brandl S, 2015, MOL ECOL RESOUR, V15, P278, DOI 10.1111/1755-0998.12305; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Fukumoto S, 2015, J APPL ECOL, V52, P358, DOI 10.1111/1365-2664.12392; Goldberg CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022746; Jane SF, 2015, MOL ECOL RESOUR, V15, P216, DOI 10.1111/1755-0998.12285; Janosik AM, 2015, ENVIRON BIOL FISH, V98, P1889, DOI 10.1007/s10641-015-0405-5; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Klymus KE, 2015, BIOL CONSERV, V183, P77, DOI 10.1016/j.biocon.2014.11.020; Laramie MB, 2015, BIOL CONSERV, V183, P29, DOI 10.1016/j.biocon.2014.11.025; Mora EA, 2009, J APPL ICHTHYOL, V25, P39, DOI 10.1111/j.1439-0426.2009.01297.x; National Marine Fisheries Service (NMFS), 2005, GREEN STURG AC MED S; NMFS (National Marine Fisheries Service), 2006, FED REGISTER, V71, P17757; NMFS (National Marine Fisheries Service), 2015, SO DIST POP SEGM N A; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; Poytress WR, 2008, ANN REPORT; Poytress WR, 2012, ANN REPORT; Poytress WR, 2010, ANN REPORT; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; SEESHOLTZ A, 2014, ENVIRON BIOL FISH, V98, P905; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x	23	29	30	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153500	10.1371/journal.pone.0153500	http://dx.doi.org/10.1371/journal.pone.0153500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096433	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600040
J	Hays, J; Shonkoff, SBC				Hays, Jake; Shonkoff, Seth B. C.			Toward an Understanding of the Environmental and Public Health Impacts of Unconventional Natural Gas Development: A Categorical Assessment of the Peer-Reviewed Scientific Literature, 2009-2015	PLOS ONE			English	Article							SHALE GAS; OIL; AIR; OPERATIONS; EXTRACTION; EMISSIONS; BASIN	The body of science evaluating the potential impacts of unconventional natural gas development (UNGD) has grown significantly in recent years, although many data gaps remain. Still, a broad empirical understanding of the impacts is beginning to emerge amidst a swell of research. The present categorical assessment provides an overview of the peer-reviewed scientific literature from 2009-2015 as it relates to the potential impacts of UNGD on public health, water quality, and air quality. We have categorized all available original research during this time period in an attempt to understand the weight and direction of the scientific literature. Our results indicate that at least 685 papers have been published in peer-reviewed scientific journals that are relevant to assessing the impacts of UNGD. 84% of public health studies contain findings that indicate public health hazards, elevated risks, or adverse health outcomes; 69% of water quality studies contain findings that indicate potential, positive association, or actual incidence of water contamination; and 87% of air quality studies contain findings that indicate elevated air pollutant emissions and/or atmospheric concentrations. This paper demonstrates that the weight of the findings in the scientific literature indicates hazards and elevated risks to human health as well as possible adverse health outcomes associated with UNGD. There are limitations to this type of assessment and it is only intended to provide a snapshot of the scientific knowledge based on the available literature. However, this work can be used to identify themes that lie in or across studies, to prioritize future research, and to provide an empirical foundation for policy decisions.	[Hays, Jake] PSE Hlth Energy, New York, NY USA; [Hays, Jake] Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA; [Shonkoff, Seth B. C.] PSE Hlth Energy, Oakland, CA USA; [Shonkoff, Seth B. C.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Shonkoff, Seth B. C.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA	Cornell University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Hays, J (corresponding author), PSE Hlth Energy, New York, NY USA.; Hays, J (corresponding author), Weill Cornell Med, Dept Healthcare Policy & Res, New York, NY USA.	hays@psehealthyenergy.org						Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Bunch AG, 2014, SCI TOTAL ENVIRON, V468, P832, DOI 10.1016/j.scitotenv.2013.08.080; de Melo-Martin I, 2014, SCI TOTAL ENVIRON, V470, P1114, DOI 10.1016/j.scitotenv.2013.10.088; Edwards PM, 2014, NATURE, V514, P351, DOI 10.1038/nature13767; Ethridge S, 2015, J UNCONV OIL GAS RES, V11, P95, DOI 10.1016/j.juogr.2015.06.001; Evensen D, 2014, EXTR IND SOC, V1, P130, DOI 10.1016/j.exis.2014.06.004; Finkel ML, 2016, J EPIDEMIOL COMMUN H, V70, P221, DOI 10.1136/jech-2015-205487; Finkel ML, 2015, MED J AUST, V203; Fry M, 2015, ECOL ECON, V117, P97, DOI 10.1016/j.ecolecon.2015.06.012; Hays J, 2015, SCI TOTAL ENVIRON, V512, P36, DOI 10.1016/j.scitotenv.2015.01.004; Macey GP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-82; Maryland Institute for Applied Environmental Health, 2014, POT PUBL HLTH IMP NA; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; MILLS PK, 1984, LANCET, V1, P207; New York State Department of Health, 2014, PUBL HLTH REV HIGH V; Paulik LB, 2015, ENVIRON SCI TECHNOL, V49, P5203, DOI 10.1021/es506095e; Petron G, 2014, J GEOPHYS RES-ATMOS, V119, P6836, DOI 10.1002/2013JD021272; Shonkoff SBC, 2014, ENVIRON HEALTH PERSP, V122, P787, DOI 10.1289/ehp.1307866; Werner AK, 2015, SCI TOTAL ENVIRON, V505, P1127, DOI 10.1016/j.scitotenv.2014.10.084	19	30	31	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154164	10.1371/journal.pone.0154164	http://dx.doi.org/10.1371/journal.pone.0154164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096432	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600087
J	Tabas, A; Siebert, A; Supek, S; Pressnitzer, D; Balaguer-Ballester, E; Rupp, A				Tabas, Alejandro; Siebert, Anita; Supek, Selma; Pressnitzer, Daniel; Balaguer-Ballester, Emili; Rupp, Andre			Insights on the Neuromagnetic Representation of Temporal Asymmetry in Human Auditory Cortex	PLOS ONE			English	Article							TIME-DOMAIN; VIRTUAL PITCH; SINGLE UNITS; GUINEA-PIG; RESPONSES; AMPLITUDE; LATENCY; SPEECH; MODEL; LATERALIZATION	Communication sounds are typically asymmetric in time and human listeners are highly sensitive to this short-term temporal asymmetry. Nevertheless, causal neurophysiological correlates of auditory perceptual asymmetry remain largely elusive to our current analyses and models. Auditory modelling and animal electrophysiological recordings suggest that perceptual asymmetry results from the presence of multiple time scales of temporal integration, central to the auditory periphery. To test this hypothesis we recorded auditory evoked fields (AEF) elicited by asymmetric sounds in humans. We found a strong correlation between perceived tonal salience of ramped and damped sinusoids and the AEFs, as quantified by the amplitude of the N100m dynamics. The N100m amplitude increased with stimulus half-life time, showing a maximum difference between the ramped and damped stimulus for a modulation half-life time of 4 ms which is greatly reduced at 0.5 ms and 32 ms. This behaviour of the N100m closely parallels psychophysical data in a manner that: i) longer half-life times are associated with a stronger tonal percept, and ii) perceptual differences between damped and ramped are maximal at 4 ms half-life time. Interestingly, differences in evoked fields were significantly stronger in the right hemisphere, indicating some degree of hemispheric specialisation. Furthermore, the N100m magnitude was successfully explained by a pitch perception model using multiple scales of temporal integration of auditory nerve activity patterns. This striking correlation between AEFs, perception, and model predictions suggests that the physiological mechanisms involved in the processing of pitch evoked by temporal asymmetric sounds are reflected in the N100m.	[Tabas, Alejandro; Balaguer-Ballester, Emili] Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England; [Siebert, Anita] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland; [Supek, Selma] Univ Zagreb, Fac Sci, Dept Phys, Zagreb 41000, Croatia; [Pressnitzer, Daniel] Ecole Normale Super, Dept Etud Cognit, 24 Rue Lhomond, F-75231 Paris, France; [Balaguer-Ballester, Emili] Bernstein Ctr Computat Neurosci Heidelberg Mannhe, Mannheim, Baden, Germany; [Rupp, Andre] Heidelberg Univ, Dept Neurol, Heidelberg, Baden Wur, Germany	Bournemouth University; University of Zurich; University of Zagreb; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Ruprecht Karls University Heidelberg	Tabas, A (corresponding author), Bournemouth Univ, Fac Sci & Technol, Bournemouth, Dorset, England.	atabas@bournemouth.ac.uk		Pressnitzer, Daniel/0000-0003-4744-5165; Balaguer-Ballester, Emili/0000-0002-0695-7191	Bournemouth University; Santander Research Mobility Award program; Deutsche Forschungsgemeinschaft [Ru-652/1-3]; Croatian Ministry of Science and Technology [0119265]	Bournemouth University; Santander Research Mobility Award program; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Croatian Ministry of Science and Technology(Ministry of Science, Education and Sports, Republic of Croatia)	AT receives funding from the Bournemouth University Doctoral Fund (bournemouth.ac.uk) and the Santander Research Mobility Award program (santander.co.uk). AR and AS were funded by the Deutsche Forschungsgemeinschaft (dfg.de) Grant Ru-652/1-3. SS was supported by the Croatian Ministry of Science and Technology (public.mzos.hr) Grant 0119265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 1997, EVOKED POTENTIAL, V104, P531, DOI 10.1016/S0168-5597(97)00057-9; Andermann M, 2011, NEUROIMAGE, V57, P1499, DOI 10.1016/j.neuroimage.2011.05.049; Balaguer-Ballester E, 2008, J ACOUST SOC AM, V124, P2186, DOI 10.1121/1.2967829; Balaguer-Ballester E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000301; Beagley H A, 1967, J Laryngol Otol, V81, P861, DOI 10.1017/S0022215100067815; Belin P, 1998, J COGNITIVE NEUROSCI, V10, P536, DOI 10.1162/089892998562834; Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; BERG P, 1994, ELECTROEN CLIN NEURO, V90, P229, DOI 10.1016/0013-4694(94)90094-9; Biermann S, 2000, J NEUROPHYSIOL, V84, P2426, DOI 10.1152/jn.2000.84.5.2426; Daunizeau J, 2009, NEUROIMAGE, V47, P590, DOI 10.1016/j.neuroimage.2009.04.062; David H. A, 1963, METHOD PAIRED COMP; de Cheveigne A, 2005, SPR HDB AUD, V24, P169; Fishbach A, 2003, J NEUROPHYSIOL, V90, P3663, DOI 10.1152/jn.00654.2003; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gerstner W, 2014, NEURONAL DYNAMICS: FROM SINGLE NEURONS TO NETWORKS AND MODELS OF COGNITION, P1, DOI 10.1017/CBO9781107447615; Gerstner W, 2002, SPIKING NEURON MODEL; GORDON JW, 1987, J ACOUST SOC AM, V82, P88, DOI 10.1121/1.395441; Grose JH, 2002, J ACOUST SOC AM, V112, P2956, DOI 10.1121/1.1514934; Gutschalk A, 2004, NEUROIMAGE, V22, P755, DOI 10.1016/j.neuroimage.2004.01.025; HALL JW, 1981, J ACOUST SOC AM, V69, P509, DOI 10.1121/1.385480; Happel MFK, 2014, J NEUROSCI, V34, P1234, DOI 10.1523/JNEUROSCI.1990-13.2014; HARTMANN WM, 1978, J ACOUST SOC AM, V63, P1105, DOI 10.1121/1.381818; Irino T, 1997, J ACOUST SOC AM, V101, P412, DOI 10.1121/1.417975; JACOBSON GP, 1992, EAR HEARING, V13, P300, DOI 10.1097/00003446-199210000-00007; Krumbholz K, 2003, CEREB CORTEX, V13, P765, DOI 10.1093/cercor/13.7.765; Kumar S, 2007, PLOS COMPUT BIOL, V3, P977, DOI 10.1371/journal.pcbi.0030100; Kumar S, 2011, J COGNITIVE NEUROSCI, V23, P3084, DOI 10.1162/jocn_a_00021; Lopez-Poveda EA, 2001, J ACOUST SOC AM, V110, P3107, DOI 10.1121/1.1416197; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; Meddis R, 1997, J ACOUST SOC AM, V102, P1811, DOI 10.1121/1.420088; Meddis R, 2006, J ACOUST SOC AM, V120, P3861, DOI 10.1121/1.2372595; MORTON J, 1976, PSYCHOL REV, V83, P405, DOI 10.1037/0033-295X.83.5.405; Neuert V, 2001, HEARING RES, V159, P36, DOI 10.1016/S0378-5955(01)00318-5; Okamoto H, 2011, J COGNITIVE NEUROSCI, V23, P1855, DOI 10.1162/jocn.2010.21521; Paquette C, 1997, CORTEX, V33, P689, DOI 10.1016/S0010-9452(08)70726-3; Patterson RD, 1998, J ACOUST SOC AM, V104, P2967, DOI 10.1121/1.423879; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Patterson RD, 2008, PHILOS T R SOC B, V363, P1023, DOI 10.1098/rstb.2007.2157; Penagos H, 2004, J NEUROSCI, V24, P6810, DOI 10.1523/JNEUROSCI.0383-04.2004; Plack CJ, 2000, J ACOUST SOC AM, V108, P1162, DOI 10.1121/1.1287022; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pressnitzer D, 2000, HEARING RES, V149, P155, DOI 10.1016/S0378-5955(00)00175-1; Ragot R, 1996, NEUROREPORT, V7, P905, DOI 10.1097/00001756-199603220-00014; RAPIN I, 1966, ELECTROEN CLIN NEURO, V21, P335, DOI 10.1016/0013-4694(66)90039-3; Ritter S, 2005, NEUROIMAGE, V27, P533, DOI 10.1016/j.neuroimage.2005.05.003; Roberts TPL, 1996, NEUROREPORT, V7, P1138, DOI 10.1097/00001756-199604260-00007; Roberts TPL, 2000, J CLIN NEUROPHYSIOL, V17, P114, DOI 10.1097/00004691-200003000-00002; Rosen S, 1982, PERCEPT PSYCHOPHYS, V31, P462, DOI [10.3758/BF03204856, DOI 10.3758/BF03204856]; Schlauch RS, 2001, J ACOUST SOC AM, V109, P2880, DOI 10.1121/1.1372913; Seither-Preisler A, 2003, AUDIOL NEURO-OTOL, V8, P322, DOI 10.1159/000073517; Seither-Preisler A, 2006, HEARING RES, V213, P88, DOI 10.1016/j.heares.2006.01.003; Stecker GC, 2000, J ACOUST SOC AM, V107, P3358, DOI 10.1121/1.429407; Suied C, 2014, J ACOUST SOC AM, V135, P1380, DOI 10.1121/1.4863659; Tailarach J., 1988, COPLANAR STEREOTAXIC; VOS J, 1981, PERCEPT PSYCHOPHYS, V29, P323, DOI 10.3758/BF03207341; Wang XG, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00114; Wiegrebe L, 2001, J ACOUST SOC AM, V109, P1082, DOI 10.1121/1.1348005; Winter IM, 2005, SPR HDB AUD, V24, P99; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593	62	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153947	10.1371/journal.pone.0153947	http://dx.doi.org/10.1371/journal.pone.0153947			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096960	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000374543600074
J	Wu, F; Wang, PY; Zhao, QL; Kang, LQ; Xia, DG; Qiu, ZY; Tang, SM; Li, MW; Shen, XJ; Zhang, GZ				Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng			Mutation of a Cuticle Protein Gene, BmCPG10, Is Responsible for Silkworm Non-Moulting in the 2nd Instar Mutant	PLOS ONE			English	Article							BOMBYX-MORI; ECDYSTEROID BIOSYNTHESIS; BEETLE TENEBRIO; NOPPERA-BO; WING DISCS; EXPRESSION; 20-HYDROXYECDYSONE; DROSOPHILA; SEQUENCE; METAMORPHOSIS	In the silkworm, metamorphosis and moulting are regulated by ecdysone hormone and juvenile hormone. The subject in the present study is a silkworm mutant that does not moult in the 2nd instar (nm2). Genetic analysis indicated that the nm2 mutation is controlled by a recessive gene and is homozygous lethal. Based on positional cloning, nm2 was located in a region approximately 275 kb on the 5th linkage group by eleven SSR polymorphism markers. In this specific range, according to the transcriptional expression of thirteen genes and cloning, the relative expression level of the BmCPG10 gene that encodes a cuticle protein was lower than the expression level of the wild-type gene. Moreover, this gene's structure differs from that of the wild-type gene: there is a deletion of 217 bp in its open reading frame, which resulted in a change in the protein it encoded. The BmCPG10 mRNA was detectable throughout silkworm development from the egg to the moth. This mRNA was low in the premoulting and moulting stages of each instar but was high in the gluttonous stage and in newly exuviated larvae. The BmCPG10 mRNA showed high expression levels in the epidermis, head and trachea, while the expression levels were low in the midgut, Malpighian tubule, prothoracic gland, haemolymph and ventral nerve cord. The ecdysone titre was determined by ELISA, and the results demonstrated that the ecdysone titre of nm2 larvae was lower than that of the wild-type larvae. The nm2 mutant could be rescued by feeding 20-hydroxyecdysone, cholesterol and 7-dehydrocholesterol (7dC), but the rescued nm2 only developed to the 4th instar and subsequently died. The moulting time of silkworms could be delayed by BmCPG10 RNAi. Thus, we speculated that the mutation of BmCPG10 was responsible for the silkworm mutant that did not moult in the 2nd instar.	[Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng] Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Peoples R China; [Wu, Fan; Wang, Pingyang; Zhao, Qiaoling; Kang, Lequn; Xia, Dingguo; Qiu, Zhiyong; Tang, Shunming; Li, Muwang; Shen, Xingjia; Zhang, Guozheng] Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang 212018, Peoples R China; [Wu, Fan] Hubei Acad Agr Sci, Ind Crops Inst, Wuhan 430064, Peoples R China	Jiangsu University of Science & Technology; Chinese Academy of Agricultural Sciences; Hubei Academy of Agricultural Sciences	Zhao, QL (corresponding author), Jiangsu Univ Sci & Technol, Sch Biotechnol, Zhenjiang 212018, Peoples R China.; Zhao, QL (corresponding author), Chinese Acad Agr Sci, Sericulture Res Inst, Zhenjiang 212018, Peoples R China.	qlzhao302@126.com		Wang, Pingyang/0000-0003-3908-6561	National Natural Science Foundation of China [31372378]; Graduate Student Innovation Program of Jiangsu province [KYLX15-1116]; Graduate Student Innovation Program of Jiangsu University of Science and Technology [YCX14B-03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Program of Jiangsu province; Graduate Student Innovation Program of Jiangsu University of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (No. 31372378), the Graduate Student Innovation Program of Jiangsu province (KYLX15-1116) and the Graduate Student Innovation Program of Jiangsu University of Science and Technology in 2014 (YCX14B-03).	ANDERSEN SO, 1979, ANNU REV ENTOMOL, V24, P29, DOI 10.1146/annurev.en.24.010179.000333; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; BANNO Y, 2005, GUIDE SILKWORM MUTAN, P29; Bouhin H., 1993, Insect Molecular Biology, V2, P81, DOI 10.1111/j.1365-2583.1993.tb00128.x; Braquart C, 1996, EUR J BIOCHEM, V240, P336, DOI 10.1111/j.1432-1033.1996.0336h.x; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Daimon T, 2015, P NATL ACAD SCI USA, V112, pE4226, DOI 10.1073/pnas.1506645112; DOIRA H, 1984, Journal of Sericultural Science of Japan, V53, P427; Enya S, 2015, INSECT BIOCHEM MOLEC, V61, P1, DOI 10.1016/j.ibmb.2015.04.001; Enya S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06586; Fujii T, 2013, INSECT BIOCHEM MOLEC, V43, P594, DOI 10.1016/j.ibmb.2013.03.009; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; HIRUMA K, 1991, DEV BIOL, V144, P369, DOI 10.1016/0012-1606(91)90429-7; HORODYSKI FM, 1989, DEV BIOL, V132, P292, DOI 10.1016/0012-1606(89)90226-1; Iconomidou VA, 1999, INSECT BIOCHEM MOLEC, V29, P285, DOI 10.1016/S0965-1748(99)00005-3; Kozlova T, 2003, SCIENCE, V301, P1911, DOI 10.1126/science.1087419; Lemoine A, 2004, INSECT MOL BIOL, V13, P481, DOI 10.1111/j.0962-1075.2004.00508.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mousavi A, 2005, APPL BIOCHEM BIOTECH, V120, P169, DOI 10.1385/ABAB:120:3:169; Nita M, 2009, COMP BIOCHEM PHYS B, V153, P101, DOI 10.1016/j.cbpb.2009.02.005; Niwa R, 2010, DEVELOPMENT, V137, P1991, DOI 10.1242/dev.045641; Noji T, 2003, INSECT BIOCHEM MOLEC, V33, P671, DOI 10.1016/S0965-1748(03)00048-1; Okamoto S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-396; Quan GX, 2002, INSECT MOL BIOL, V11, P217, DOI 10.1046/j.1365-2583.2002.00328.x; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; SHIMIZU K, 1980, Journal of Sericultural Science of Japan, V49, P7; Shimizu K, 1983, 53RD M JAP SOC SER S, P64; Shimizu K, 1983, J SERICULTURAL SCI J, V52, P348; Soares MPM, 2007, INSECT BIOCHEM MOLEC, V37, P1272, DOI 10.1016/j.ibmb.2007.07.014; Suzuki Y, 2002, INSECT BIOCHEM MOLEC, V32, P599, DOI 10.1016/S0965-1748(01)00136-9; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P624, DOI 10.1016/j.ibmb.2009.06.007; Wang HB, 2009, INSECT BIOCHEM MOLEC, V39, P615, DOI 10.1016/j.ibmb.2009.06.008; Willis Judith H., 1996, P253; Xiang Z., 2005, SILK BIOL, P374; Zhao QL, 2000, SCI SERICULTURE, V26, P63; Zhao QL, 2015, SCI SERIC, V41; Zhong YS, 2006, INSECT BIOCHEM MOLEC, V36, P99, DOI 10.1016/j.ibmb.2005.07.005	38	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153549	10.1371/journal.pone.0153549	http://dx.doi.org/10.1371/journal.pone.0153549			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096617	Green Published, gold			2022-12-27	WOS:000374543600041
J	Bayani, A; Tiwade, D; Dongre, A; Dongre, AP; Phatak, R; Watve, M				Bayani, Abhijeet; Tiwade, Dilip; Dongre, Ashok; Dongre, Aravind P.; Phatak, Rasika; Watve, Milind			Assessment of Crop Damage by Protected Wild Mammalian Herbivores on the Western Boundary of Tadoba-Andhari Tiger Reserve (TATR), Central India	PLOS ONE			English	Article							LOXODONTA-AFRICANA; LARGE CARNIVORES; ELEPHANTS; CONFLICT; PATTERNS; OVERCOMPENSATION; SUSCEPTIBILITY; CONSERVATION; PERCEPTIONS; LIVESTOCK	Crop raiding by wild herbivores close to an area of protected wildlife is a serious problem that can potentially undermine conservation efforts. Since there is orders of magnitude difference between farmers' perception of damage and the compensation given by the government, an objective and realistic estimate of damage was found essential. We employed four different approaches to estimate the extent of and patterns in crop damage by wild herbivores along the western boundary of Tadoba-Andhari Tiger Reserve in the state of Maharashtra, central India. These approaches highlight different aspects of the problem but converge on an estimated damage of over 50% for the fields adjacent to the forest, gradually reducing in intensity with distance. We found that the visual damage assessment method currently employed by the government for paying compensation to farmers was uncorrelated to and grossly underestimated actual damage. The findings necessitate a radical rethinking of policies to assess, mitigate as well as compensate for crop damage caused by protected wildlife species.	[Bayani, Abhijeet; Tiwade, Dilip; Dongre, Ashok; Dongre, Aravind P.; Watve, Milind] IISER, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India; [Phatak, Rasika] Abasaheb Garaware Coll, Dept Biodivers, Pune, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Watve, M (corresponding author), IISER, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	milind@iiserpune.ac.in			NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India; RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India; Rajeev Gandhi Science and Technology Commission, Maharashtra State, India	NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India(Department of Science & Technology (India)); RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India; Rajeev Gandhi Science and Technology Commission, Maharashtra State, India	Work was partly funded by NINA (Norwegian Institute for Nature Research); DST (Department of Science and Technology), Government of India; and RGSTC (Rajiv Gandhi Science and Technology Commission), State Government of Maharashtra, India.; We acknowledge all the farmers of TATR for their support throughout the study period. The study was partially funded by Rajeev Gandhi Science and Technology Commission, Maharashtra State, India. We also thank Kajol Patel, Manawa Diwekar and Dr. Neelesh Dahanukar from IISER, Pune for helping in manuscript preparation.	Adler PB, 2014, P NATL ACAD SCI USA, V111, P740, DOI 10.1073/pnas.1315179111; *AFESG, 2007, HUM EL CONFL WORK GR; Altrichter H., 2008, TEACHERS INVESTIGATE; Bagchi S, 2006, J ZOOL, V268, P217, DOI 10.1111/j.1469-7998.2005.00030.x; BELSKY AJ, 1993, EVOL ECOL, V7, P109, DOI 10.1007/BF01237737; Bogdan Robert., 2006, QUALITATIVE RES ED I; Buckle AP, 2015, RODENT PESTS AND THEIR CONTROL, 2ND EDITION, P1; Chauhan NPS, 1990, P 14 VERT PEST C U C, P218; Delger Joshua A., 2011, Human-Wildlife Interactions, V5, P32; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Fernando P, 2005, BIODIVERS CONSERV, V14, P2465, DOI 10.1007/s10531-004-0216-z; Galvin KA, 2006, HUM ECOL, V34, P155, DOI 10.1007/s10745-006-9012-6; Graham MD, 2008, ORYX, V42, P76, DOI 10.1017/S0030605308000677; Graham MD, 2010, SYST BIODIVERS, V8, P435, DOI 10.1080/14772000.2010.533716; Guerbois C, 2012, J APPL ECOL, V49, P1149, DOI 10.1111/j.1365-2664.2012.02192.x; Gureja N, 2002, 6 WILDL TRUST IND NE; Hussain S, 2002, MT RES DEV, V2, P224; INOUYE DW, 1982, OIKOS, V39, P269, DOI 10.2307/3544495; Jackson TR, 2008, ORYX, V42, P83, DOI 10.1017/S0030605308001117; Jayson EA, 1999, STUDY CROP DAMAGE WI, P48; Karanth KK, 2013, BIOL CONSERV, V166, P175, DOI 10.1016/j.biocon.2013.06.027; Karanth KK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050433; KEAR J, 1970, Biological Conservation, V2, P206, DOI 10.1016/0006-3207(70)90110-2; King LE, 2009, AFR J ECOL, V47, P131, DOI 10.1111/j.1365-2028.2009.01114.x; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Mathur V. B., 2015, 2015004 TR WILDL I I, P1; MCNAUGHTON SJ, 1983, OIKOS, V40, P329, DOI 10.2307/3544305; Mehta D., 2014, THESIS SAURASHTA U G; Milind W, 2016, GLOB ECOL CONSERV, V5, P58, DOI 10.1016/j.gecco.2015.11.012; Mishra C, 1997, ENVIRON CONSERV, V24, P338, DOI 10.1017/S0376892997000441; Naughton-Treves L, 1997, GEOGR REV, V87, P27, DOI 10.2307/215656; Nepal SK, AMBIO, V199, P238; Ogra M, 2008, HUM ECOL, V36, P717, DOI 10.1007/s10745-008-9189-y; Osborn FV, 2002, PACHYDERM, V33, P32; PAIGE KN, 1987, AM NAT, V129, P407, DOI 10.1086/284645; Rangarajan M, 2010, GAJAH SECURING FUTUR, P1; Schwerdtner K, 2007, BIOL CONSERV, V134, P354, DOI 10.1016/j.biocon.2006.08.010; Sethi N, 2003, BATTLE ZONE AFTERWAR; Sillero-Zubiri Claudio, 2006, P253; Sitati N.W., 2003, THESIS U KENT CANTER; Sitati NW, 2005, J APPL ECOL, V42, P1175, DOI 10.1111/j.1365-2664.2005.01091.x; Sukumar R., 1989, ASIAN ELEPHANT ECOLO; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Wagner KK, 1997, WILDLIFE SOC B, V25, P312; Woodroffe R., 2005, CONSERV BIOL; Woodroffe R, 2014, SCIENCE, V344, P46, DOI 10.1126/science.1246251; ZADOKS JC, 1985, ANNU REV PHYTOPATHOL, V23, P455, DOI 10.1146/annurev.py.23.090185.002323	48	17	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153854	10.1371/journal.pone.0153854	http://dx.doi.org/10.1371/journal.pone.0153854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093293	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200051
J	Habib, S; El Andaloussi, A; Hisham, A; Ismail, N				Habib, Samar; El Andaloussi, Abdeljabar; Hisham, Ahmed; Ismail, Nahed			NK Cell-Mediated Regulation of Protective Memory Responses against Intracellular Ehrlichial Pathogens	PLOS ONE			English	Article							SHOCK-LIKE-SYNDROME; INDUCED TOXIC-SHOCK; CD4 T-CELLS; MONOCYTOTROPIC EHRLICHIOSIS; ANIMAL-MODEL; CYTOMEGALOVIRUS-INFECTION; FATAL EHRLICHIOSIS; ADAPTIVE IMMUNITY; RECALL RESPONSES; IFN-GAMMA	Ehrlichiae are gram-negative obligate intracellular bacteria that cause potentially fatal human monocytic ehrlichiosis. We previously showed that natural killer (NK) cells play a critical role in host defense against Ehrlichia during primary infection. However, the contribution of NK cells to the memory response against Ehrlichia remains elusive. Primary infection of C57BL/6 mice with Ehrlichia muris provides long-term protection against a second challenge with the highly virulent Ixodes ovatus Ehrlichia (IOE), which ordinarily causes fatal disease in naive mice. Here, we show that the depletion of NK cells in E. muris-primed mice abrogates the protective memory response against IOE. Approximately, 80% of NK cell-depleted E. muris-primed mice succumbed to lethal IOE infection on days 8-10 after IOE infection, similar to naive mice infected with the same dose of IOE. The lack of a recall response in NK cell-depleted mice correlated with an increased bacterial burden, extensive liver injury, decreased frequency of Ehrlichia-specific IFN-gamma-producing memory CD4(+) and CD8(+) T-cells, and a low titer of Ehrlichia-specific antibodies. Intraperitoneal infection of mice with E. muris resulted in the production of IL-15, IL-12, and IFN-gamma as well as an expansion of activated NKG2D(+) NK cells. The adoptive transfer of purified E. muris-primed hepatic and splenic NK cells into Rag2(-/-)Il2rg(-/-) recipient mice provided protective immunity against challenge with E. muris. Together, these data suggest that E. muris-induced memory-like NK cells, which contribute to the protective, recall response against Ehrlichia.	[Hisham, Ahmed; Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Habib, Samar; El Andaloussi, Abdeljabar] Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University	Ismail, N (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.	ismailn@upmc.edu	Habib, Samar/AAM-1716-2021	Habib, Samar/0000-0002-0690-8277	NIH/NIAID, National Institute of Allergy and Infectious Diseases [1R56AI097679-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097679] Funding Source: NIH RePORTER	NIH/NIAID, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding provided by NIH/NIAID: 1R56AI097679-01, National Institute of Allergy and Infectious Diseases, PI; NI.	Achour A, 2014, J IMMUNOL, V192, P503, DOI 10.4049/jimmunol.1301951; Allen MB, 2014, J CLIN MICROBIOL, V52, P4102, DOI 10.1128/JCM.01670-14; Alsharifi M, 2008, IMMUNOL CELL BIOL, V86, P239, DOI 10.1038/sj.icb.7100159; Arase N, 2003, J IMMUNOL, V170, P3054, DOI 10.4049/jimmunol.170.6.3054; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bellora F, 2014, IMMUNOL LETT, V161, P168, DOI 10.1016/j.imlet.2013.12.009; Bigley AB, 2012, BRAIN BEHAV IMMUN, V26, P177, DOI 10.1016/j.bbi.2011.09.004; Bitsaktsis C, 2004, J IMMUNOL, V172, P6894, DOI 10.4049/jimmunol.172.11.6894; Bitsaktsis C, 2007, INFECT IMMUN, V75, P4933, DOI 10.1128/IAI.00705-07; Bitsaktsis C, 2006, J IMMUNOL, V177, P4644, DOI 10.4049/jimmunol.177.7.4644; Carbone T, 2010, J IMMUNOL, V184, P1102, DOI 10.4049/jimmunol.0902518; Chattoraj P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058514; Dou YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121258; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Ghose P, 2011, J IMMUNOL, V187, P1333, DOI 10.4049/jimmunol.1100092; Hendricks DW, 2015, CURR TOP MICROBIOL I; Ismail N, 2005, ANN NY ACAD SCI, V1063, P383, DOI 10.1196/annals.1355.070; Ismail N, 2006, INFECT IMMUN, V74, P1846, DOI 10.1128/IAI.74.3.1846-1856.2006; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2007, INFECT IMMUN, V75, P4608, DOI 10.1128/IAI.00198-07; Ismail N, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-26; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Kalia V, 2006, CURR OPIN IMMUNOL, V18, P255, DOI 10.1016/j.coi.2006.03.020; Lanier LL, 2013, NAT REV IMMUNOL, V13, P73, DOI 10.1038/nri3389; Lassen MG, 2010, J IMMUNOL, V184, P2693, DOI 10.4049/jimmunol.0901362; Leavy O, 2013, NAT REV IMMUNOL, V13, P848, DOI 10.1038/nri3571; Leavy O, 2013, NAT REV IMMUNOL, V13, P394, DOI 10.1038/nri3471; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Min-Oo G, 2014, J EXP MED, V211, P1289, DOI 10.1084/jem.20132459; Moraru M, 2015, J IMMUNOL, V195, P1676, DOI 10.4049/jimmunol.1500872; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Romee R, 2012, BLOOD, V120, P4751, DOI 10.1182/blood-2012-04-419283; Singh AK, 2014, INFECT IMMUN, V82, P4092, DOI 10.1128/IAI.02101-14; Stevenson HL, 2008, INFECT IMMUN, V76, P1434, DOI 10.1128/IAI.01242-07; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stevenson HL, 2010, AM J PATHOL, V177, P766, DOI 10.2353/ajpath.2010.091110; Strutt TM, 2011, ADV EXP MED BIOL, V780, P57, DOI 10.1007/978-1-4419-5632-3_6; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Thirumalapura NR, 2008, INFECT IMMUN, V76, P1920, DOI 10.1128/IAI.01293-07; Thirumalapura NR, 2009, INFECT IMMUN, V77, P5682, DOI 10.1128/IAI.00720-09; Walker David H, 2004, Trans Am Clin Climatol Assoc, V115, P375; Walker DH, 2008, MED CLIN N AM, V92, P1345, DOI 10.1016/j.mcna.2008.06.002; Yang Q, 2014, AM J PATHOL; Yang Q, 2015, AM J PATHOL, V185, P446, DOI 10.1016/j.ajpath.2014.10.005; Yang Q, 2013, INFECT IMMUN, V81, P1751, DOI 10.1128/IAI.01409-12; Zhang TX, 2013, J IMMUNOL, V190, P1402, DOI 10.4049/jimmunol.1203034; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153223	10.1371/journal.pone.0153223	http://dx.doi.org/10.1371/journal.pone.0153223			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092553	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200016
J	Krsulovic, FAM; Lima, M				Maurin Krsulovic, Felipe Augusto; Lima, Mauricio			Tuberculosis Epidemiology at the Country Scale: Self-Limiting Process and the HIV Effects	PLOS ONE			English	Article							DYNAMICS; HISTORY; AFRICA; AGE	Background The global spread of the human immunodeficiency virus (HIV) is the main hypothesis behind tuberculosis (TB) positive trends in the last decades, according to modeling studies and World Health Organization Reports (WHO). On one hand, TB (WHO) reports do not explicitly consider a modeling approach, but cover country and global TB trends. On the other hand, modeling studies usually do not cover the scale of WHO reports, because of the amount of parameters estimated to describe TB natural history. Here we combined these two principal sources of TB studies covering TB High Burden Countries (HBCs) dynamics. Our main goals were: (i) to detect the endogenous component of TB dynamics since 1974 for TB HBCs; and (ii) to explore the HIV exogenous effects on TB models' parameters. Methods and Findings We explored the relationship between the TB per capita population rate of change (R-I) and the infectious class size following an endogenous/exogenous framework. R-I can be affected by intra-population processes (i.e. competition, predation) and exogenous variables like HIV. We found that TB dynamics had always a strong endogenous component, represented by a negative correlation between TB population size and R-I, which was captured by the discrete logistic model. Moreover, we explored the HIV exogenous effects on TB models' parameters. We found that overall the TB+HIV logistic model was more parsimonious than TB model alone, principally in the African region. Our results showed that HIV affected principally TB carrying capacity, as expected by the known HIV effects on TB natural-history. We also tested if DOTS (Directly Observed Treatment Short-Course Strategy), poverty levels and BCG (Bacillus Calmette-Guerin) coverage explained the models' residuals variances, but they did not. Conclusions Since 1974, TB dynamics were categorized in distinct chronological domains, with different dynamics but nearly the same underlying mechanism: a negative relationship between RI and infected class size (i.e. self-limiting). In the last decades, not only HIV spread represented a new TB chronological domain, but it also has been pushing TB carrying capacity (K) to higher levels. TB has a complex natural-history and imposes real challenges to model its dynamics. Yet, we were able to explore and reveal the main drivers of TB dynamics for HBCs since 1974, through a simple approach. Based on our results, we suggest that the endogenous view should be considered as a plausible hypothesis to model and explain TB dynamics and that future World Health Organization reports could include the endogenous/exogenous framework as a supplement to help to decipher the main drivers of TB dynamics and other diseases.	[Maurin Krsulovic, Felipe Augusto; Lima, Mauricio] Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile	Pontificia Universidad Catolica de Chile	Krsulovic, FAM (corresponding author), Pontificia Univ Catolica Chile, Alameda 340, Santiago, Chile.	famk@globo.com	Krsulovic, Felipe Augusto/V-6337-2018; Lima, Mauricio/F-2722-2013	Krsulovic, Felipe Augusto/0000-0002-8260-1074; Lima, Mauricio/0000-0002-3700-2945	CONICYT; Pontificia Universidad Catolica de Chile; Fondo Basal-CONICYT grant [FB- 0002]; Proyecto Fondecyt Regular [1141164]	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Pontificia Universidad Catolica de Chile; Fondo Basal-CONICYT grant; Proyecto Fondecyt Regular(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	FAMK was supported by PhD scholarships from CONICYT and Pontificia Universidad Catolica de Chile. ML was supported by Fondo Basal-CONICYT grant FB- 0002 and Proyecto Fondecyt Regular 1141164.; FAMK was supported by PhD scholarships from CONICYT and Pontificia Universidad Catolica de Chile. Disease data and other variables were obtained from World Health Organization reports, World Bank, UNAIDS, Gapminder and UN web site. ML was supported by Fondo Basal-CONICYT grant FB- 0002 and Proyecto Fondecyt Regular 1141164.	Acemoglu D, 2010, ECON HIST DEV REG, V25, P21, DOI 10.1080/20780389.2010.505010; Allee CW, 1931, ANIMAL AGGREGATIONS; Anderson R, 1999, INFECT DIS HUMANS DY; [Anonymous], 1988, NONLINEAR REGRESSION, DOI DOI 10.1002/9780470316757; [Anonymous], 2013, UNAIDS REP GLOB AIDS; Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Banerjee A, 2005, AM ECON REV, V95, P1190, DOI 10.1257/0002828054825574; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; Berryman A., 1999, PRINCIPLES POPULATIO; Berryman AA, 1992, ECOLOGY, P73; Berryman A, 2006, AM NAT, V168, P784, DOI 10.1086/508670; BLOWER SM, 1995, NAT MED, V1, P815, DOI 10.1038/nm0895-815; Blower SM, 1996, SCIENCE, V273, P497, DOI 10.1126/science.273.5274.497; Broutin H, 2010, P R SOC B, P277; Castillo-Chavez C, 1997, J MATH BIOL, P35; Colijn C, 2006, P TRIM, V20; Croissant A., 2009, ASIEN, V110, P13; Davies PDO, 2003, ANN MED, V35, P235, DOI 10.1080/07853890310005713; DeRiemer K, 2007, AM J RESP CRIT CARE, P176; Dowdy DW, 2009, B WORLD HEALTH ORGAN, V87, P296, DOI 10.2471/BLT.08.054510; Dye C, 2003, SCIENCE, P328; Gupta R, 2010, SCIENCE, P293; Lima M, 2002, ECOL LETT, P5; Lima M, 2009, ECOL LETT, V12, P302, DOI 10.1111/j.1461-0248.2009.01289.x; Nico JD, 2002, B WORLD HEALTH ORGAN, P80; Pawlowski A, 2012, PLOS PATHOG, P8; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Perelson AS, 1997, REV MOD PHYS, V69, P1219, DOI 10.1103/RevModPhys.69.1219; Perelson AS, 2002, NATURE, P2; Royama T., 1992, ANAL POPULATION ECOL; Stenseth NC, 2004, P ROY SOC B-BIOL SCI, V271, P1985, DOI 10.1098/rspb.2004.2794; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Thorne C., 2011, ELIMINATION MOTHER T; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; *WHO, 2009, GLOB TUB CONTR SHORT; Wirth T., 2008, PLOS PATHOG, V4, P1; World Health Organization, 1995, BRIDG THE GAPS; World Health Organization, 2009, WHO HTM HIV; World Health Organization, 2009, GLOB TUB REP 2013; World Health Organization, 2009, GLOB PLAN STOP TB 20	43	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153710	10.1371/journal.pone.0153710	http://dx.doi.org/10.1371/journal.pone.0153710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093296	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200041
J	Zou, SM; Fei, C; Song, JM; Bao, YC; He, ML; Wang, CH				Zou, Shanmei; Fei, Cong; Song, Jiameng; Bao, Yachao; He, Meilin; Wang, Changhai			Combining and Comparing Coalescent, Distance and Character-Based Approaches for Barcoding Microalgaes: A Test with Chlorella-Like Species (Chlorophyta)	PLOS ONE			English	Article							PLANT DNA BARCODES; GEN. NOV TREBOUXIOPHYCEAE; COMPARATIVE PHYSIOLOGY; MITOCHONDRIAL GENOME; INTEGRATIVE APPROACH; EVOLUTIONARY TRENDS; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; SINGLE-LOCUS; TAXONOMY	Several different barcoding methods of distinguishing species have been advanced, but which method is the best is still controversial. Chlorella is becoming particularly promising in the development of second-generation biofuels. However, the taxonomy of Chlorella-like organisms is easily confused. Here we report a comprehensive barcoding analysis of Chlorella-like species from Chlorella, Chloroidium, Dictyosphaerium and Actinastrum based on rbcL, ITS, tufA and 16S sequences to test the efficiency of traditional barcoding, GMYC, ABGD, PTP, P ID and character-based barcoding methods. First of all, the barcoding results gave new insights into the taxonomic assessment of Chlorella-like organisms studied, including the clear species discrimination and resolution of potentially cryptic species complexes in C. sorokiniana, D. ehrenbergianum and C. Vulgaris. The tufA proved to be the most efficient barcoding locus, which thus could be as potential "specific barcode" for Chlorella-like species. The 16S failed in discriminating most closely related species. The resolution of GMYC, PTP, P ID, ABGD and character-based barcoding methods were variable among rbcL, ITS and tufA genes. The best resolution for species differentiation appeared in tufA analysis where GMYC, PTP, ABGD and character-based approaches produced consistent groups while the PTP method over-split the taxa. The character analysis of rbcL, ITS and tufA sequences could clearly distinguish all taxonomic groups respectively, including the potentially cryptic lineages, with many character attributes. Thus, the character-based barcoding provides an attractive complement to coalescent and distance-based barcoding. Our study represents the test that proves the efficiency of multiple DNA barcoding in species discrimination of microalgaes.	[Zou, Shanmei; Fei, Cong; Song, Jiameng; Bao, Yachao; He, Meilin; Wang, Changhai] Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Wang, CH (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Jiangsu Prov Key Lab Marine Biol, Nanjing 210095, Jiangsu, Peoples R China.	chwang@njau.edu.cn		Fei, Cong/0000-0002-7156-1230	China Postdoctoral Science Foundation [2014M561661, 2015T80558]; Natural Science Fund project in Jiangsu Province [BK20150680]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Fund project in Jiangsu Province	The financial support was from the China Postdoctoral Science Foundation ( 2014M561661, 2015T80558), and Natural Science Fund project in Jiangsu Province ( BK20150680). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen RA, 2005, ALGAL CULTURING TECH; Andreyeva VM, 1975, ROD CHLORELLA MORFOL; Ashfaq M, 2013, MOL ECOL RESOUR, V13, P573, DOI 10.1111/1755-0998.12089; Avise J.C., 1990, Oxford Surveys in Evolutionary Biology, V7, P45; AVISE JC, 1989, TRENDS ECOL EVOL, V4, P279, DOI 10.1016/0169-5347(89)90203-6; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bashan Y, 2015, J APPL PHYCOL, P1; BAUM D, 1992, TRENDS ECOL EVOL, V7, P1, DOI 10.1016/0169-5347(92)90187-G; BAUM DA, 1995, MONOG SYST BOTAN, V53, P289; BAUM DA, 1995, SYST BOT, V20, P560, DOI 10.2307/2419810; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Bock C, 2011, FOTTEA, V11, P293, DOI 10.5507/fot.2011.028; Bock C, 2011, J PHYCOL, V47, P638, DOI 10.1111/j.1529-8817.2011.00989.x; Bock C, 2010, EUR J PHYCOL, V45, P267, DOI 10.1080/09670262.2010.487920; Burja AM, 2001, FEMS MICROBIOL LETT, V202, P195, DOI 10.1016/S0378-1097(01)00306-8; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Chakraborty C, 2014, APPL MICROBIOL BIOT, V98, P3425, DOI 10.1007/s00253-014-5550-9; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Darienko T, 2010, EUR J PHYCOL, V45, P79, DOI 10.1080/09670260903362820; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Dong WP, 2014, MOL ECOL RESOUR, V14, P336, DOI 10.1111/1755-0998.12185; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Ezard T, 2009, PACKAGE SPLITS SPECI; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Ferri E, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-1; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Fontaneto D, 2014, MAR BIODIV UNPUB, P1; Fucikova K, 2013, NOVA HEDWIGIA, V96, P15, DOI 10.1127/0029-5035/2012/0067; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goldstein PZ, 2000, CLADISTICS, V16, P364, DOI 10.1111/j.1096-0031.2000.tb00356.x; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall JD, 2010, CRYPTOGAMIE ALGOL, V31, P529; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; HUSS VAR, 1990, J MOL EVOL, V31, P432, DOI 10.1007/BF02106057; HUSS VAR, 1989, ARCH MICROBIOL, V152, P512, DOI 10.1007/BF00446939; Huss VAR, 1999, J PHYCOL, V35, P587, DOI 10.1046/j.1529-8817.1999.3530587.x; Jaen-Molina R, 2015, MOL ECOL RESOUR, V15, P42, DOI 10.1111/1755-0998.12292; Jiang Y, 2011, J MED PLANTS RES, V5, P6413, DOI 10.5897/JMPR11.545; Joly S, 2014, MOL ECOL RESOUR, V14, P221, DOI 10.1111/1755-0998.12173; KAPAUN E, 1995, PLANTA, V197, P577; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KESSLER E, 1992, J PHYCOL, V28, P550, DOI 10.1111/j.0022-3646.1992.00550.x; KESSLER E, 1976, PLANT SYST EVOL, V125, P129, DOI 10.1007/BF00986146; Kessler E, 1982, PROGR PHYCOLOGICA RE, P111; Kessler E, 1984, SYSTEMATICS GREEN AL, V27, P391; Khaybullina LS, 2010, FOTTEA, V10, P201, DOI 10.5507/fot.2010.011; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Komarek J., 1983, PHYTOPLANKTON SUSSWA; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Krienitz L, 2004, PHYCOLOGIA, V43, P529, DOI 10.2216/i0031-8884-43-5-529.1; Krienitz L, 2015, TRENDS PLANT SCI, V20, P67, DOI 10.1016/j.tplants.2014.11.005; Krienitz L, 2012, FOTTEA, V12, P231, DOI 10.5507/fot.2012.017; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Kvist S, 2013, MOL PHYLOGENET EVOL, V69, P39, DOI 10.1016/j.ympev.2013.05.012; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Li XW, 2015, BIOL REV, V90, P157, DOI 10.1111/brv.12104; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Luo W, 2010, PLANT BIOLOGY, V12, P545, DOI 10.1111/j.1438-8677.2009.00221.x; Luo W, 2006, PROTIST, V157, P315, DOI 10.1016/j.protis.2006.05.006; Ma S, 2015, HYDROBIOLOGIA, P1; Maddison WP, 2005, MACCLADE ANAL PHYLOG; Masters BC, 2011, MOL ECOL RESOUR, V11, P154, DOI 10.1111/j.1755-0998.2010.02896.x; McDevit DC, 2010, PHYCOLOGIA, V49, P235, DOI 10.2216/PH09-36.1; Meier R, 2008, SYST ASSOC SPEC VOL, V76, P95; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Miralles A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068242; Nemcova Yvonne, 2000, Archiv fuer Hydrobiologie Supplement, V136, P95; Neustupa J, 2013, PHYCOLOGIA, V52, P411, DOI 10.2216/13-142.2; Neustupa J, 2013, INT J SYST EVOL MICR, V63, P377, DOI 10.1099/ijs.0.047944-0; Nozaki H, 1995, JSMRS, V11, P11; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Phukan MM, 2011, APPL ENERG, V88, P3307, DOI 10.1016/j.apenergy.2010.11.026; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Proschold T, 2011, ENVIRON MICROBIOL, V13, P350, DOI 10.1111/j.1462-2920.2010.02333.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rach J, 2008, PROY SOC LOND B, V275; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Safi C, 2014, RENEW SUST ENERG REV, V35, P265, DOI 10.1016/j.rser.2014.04.007; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; SIMPSON GG, 1951, EVOLUTION, V5, P285, DOI 10.2307/2405675; Skaloud P, 2014, FOTTEA, V14, P53, DOI 10.5507/fot.2014.004; Summerer M, 2008, J PHYCOL, V44, P77, DOI 10.1111/j.1529-8817.2007.00455.x; Sun Xue, 2009, Journal of Fisheries of China, V33, P565; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tokusoglu O, 2003, J FOOD SCI, V68, P1144, DOI 10.1111/j.1365-2621.2003.tb09615.x; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Watanabe S., 1996, P1; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Weiss M, 2014, HYDROBIOLOGIA, V721, P165, DOI 10.1007/s10750-013-1658-7; Xu H, 2006, J BIOTECHNOL, V126, P499, DOI 10.1016/j.jbiotec.2006.05.002; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Yu ZZ, 2015, MAR BIOTECHNOL, V17, P55, DOI 10.1007/s10126-014-9596-6; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zou S, 2010, PLOS ONE, V6; Zou S, 2012, PLOS ONE, V7, pe4727	127	30	30	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153833	10.1371/journal.pone.0153833	http://dx.doi.org/10.1371/journal.pone.0153833			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092945	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200048
J	Toth, R; Sperling, D; Madabhushi, A				Toth, Robert; Sperling, Dan; Madabhushi, Anant			Quantifying Post-Laser Ablation Prostate Therapy Changes on MRI via a Domain-Specific Biomechanical Model: Preliminary Findings	PLOS ONE			English	Article							DEFORMABLE REGISTRATION; FOCAL THERAPY; ACCURACY; RADIOTHERAPY; SENSITIVITY; SIMULATION; IMAGES; MOTION	Focal laser ablation destroys cancerous cells via thermal destruction of tissue by a laser. Heat is absorbed, causing thermal necrosis of the target region. It combines the aggressive benefits of radiation treatment (destroying cancer cells) without the harmful side effects (due to its precise localization). MRI is typically used pre-treatment to determine the targeted area, and post-treatment to determine efficacy by detecting necrotic tissue, or tumor recurrence. However, no system exists to quantitatively evaluate the post-treatment effects on the morphology and structure via MRI. To quantify these changes, the pre- and post-treatment MR images must first be spatially aligned. The goal is to quantify (a) laser-induced shape-based changes, and (b) changes in MRI parameters post-treatment. The shapebased changes may be correlated with treatment efficacy, and the quantitative effects of laser treatment over time is currently poorly understood. This work attempts to model changes in gland morphology following laser treatment due to (1) patient alignment, (2) changes due to surrounding organs such as the bladder and rectum, and (3) changes due to the treatment itself. To isolate the treatment-induced shape-based changes, the changes from (1) and (2) are first modeled and removed using a finite element model (FEM). A FEM models the physical properties of tissue. The use of a physical biomechanical model is important since a stated goal of this work is to determine the physical shape-based changes to the prostate from the treatment, and therefore only physical real deformations are to be allowed. A second FEM is then used to isolate the physical, shape-based, treatmentinduced changes. We applied and evaluated our model in capturing the laser induced changes to the prostate morphology on eight patients with 3.0 Tesla, T2-weighted MRI, acquired approximately six months following treatment. Our results suggest the laser treatment causes a decrease in prostate volume, which appears to manifest predominantly at the site of ablation. After spatially aligning the images, changes to MRI intensity values are clearly visible at the site of ablation. Our results suggest that our new methodology is able to capture and quantify the degree of laser-induced changes to the prostate. The quantitative measurements reflecting of the deformation changes can be used to track treatment response over time.	[Toth, Robert; Madabhushi, Anant] Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA; [Toth, Robert] Toth Technol LLC, Long Valley, NJ USA; [Sperling, Dan] Sperling Prostate Ctr, New York, NY USA	Case Western Reserve University	Toth, R (corresponding author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.; Toth, R (corresponding author), Toth Technol LLC, Long Valley, NJ USA.	robtoth@tothtechnology.com	Madabhushi, Anant/AAG-2908-2019	Madabhushi, Anant/0000-0002-5741-0399	National Cancer Institute of the National Institutes of Health [1U24CA199374-01, R21CA167811-01, R21CA179327-01, R21CA195152-01]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK098503-02]; DOD Prostate Cancer Synergistic Idea Development Award [PC120857]; DOD Lung Cancer Idea Development New Investigator Award [LC130463]; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE [R21CA179327, U24CA199374, R21CA195152, R01CA202752, R21CA167811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098503] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DOD Prostate Cancer Synergistic Idea Development Award; DOD Lung Cancer Idea Development New Investigator Award; DOD Prostate Cancer Idea Development Award; Ohio Third Frontier Technology development Grant; CTSC Coulter Annual Pilot Grant; Case Comprehensive Cancer Center Pilot Grant; VelaSano Grant from the Cleveland Clinic; Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award numbers 1U24CA199374-01, R21CA167811-01, R21CA179327-01; R21CA195152-01, the National Institute of Diabetes and Digestive and Kidney Diseases under award number R01DK098503-02, the DOD Prostate Cancer Synergistic Idea Development Award (PC120857); the DOD Lung Cancer Idea Development New Investigator Award (LC130463), the DOD Prostate Cancer Idea Development Award; the Ohio Third Frontier Technology development Grant, the CTSC Coulter Annual Pilot Grant, the Case Comprehensive Cancer Center Pilot Grant, VelaSano Grant from the Cleveland Clinic, the Wallace H. Coulter Foundation Program in the Department of Biomedical Engineering at Case Western Reserve University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benzley S., 1995, INT MESH ROUNDT, V17, P1; Boubaker MB, 2009, J BIOMECH, V42, P1862, DOI 10.1016/j.jbiomech.2009.05.022; Brock KK, 2008, MED PHYS, V35, P4019, DOI 10.1118/1.2965263; Chi Y, 2006, MED PHYS, V33, P421, DOI 10.1118/1.2163838; Colin P, 2012, ADV UROL, V2012, DOI 10.1155/2012/589160; Crouch JR, 2007, IEEE T MED IMAGING, V26, P1379, DOI 10.1109/TMI.2007.898810; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eggener S, 2010, EUR UROL, V58, P57, DOI 10.1016/j.eururo.2010.03.034; Foltz WD, 2013, J MAGN RESON IMAGING, V37, P909, DOI 10.1002/jmri.23885; Hensel JM, 2007, INT J RADIAT ONCOL, V68, P1522, DOI 10.1016/j.ijrobp.2007.04.004; Karacali B, 2006, IEEE T MED IMAGING, V25, P649, DOI 10.1109/TMI.2006.873221; Kitamura K, 2002, RADIOTHER ONCOL, V62, P275, DOI 10.1016/S0167-8140(02)00017-8; Kyriacou SK, 1999, IEEE T MED IMAGING, V18, P580, DOI 10.1109/42.790458; Lindner U, 2010, NAT REV UROL, V7, P562, DOI 10.1038/nrurol.2010.142; Lindner U, 2010, EUR UROL, V57, P1111, DOI 10.1016/j.eururo.2010.03.008; Mohamed A., 2002, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2002. 5th International Conference. Proceedings, Part II (Lecture Notes in Computer Science Vol.2489), P452; Oto A, 2013, RADIOLOGY, V267, P932, DOI 10.1148/radiol.13121652; Raz O, 2010, EUR UROL, V58, P173, DOI 10.1016/j.eururo.2010.03.006; Rusu M, 2014, MED PHYS, V41, DOI 10.1118/1.4881515; Seppenwoolde Y, 2002, INT J RADIAT ONCOL, V53, P822, DOI 10.1016/S0360-3016(02)02803-1; Toth R, 2014, NEUROCOMPUT IN PRESS; Toth R, 2013, COMPUT VIS IMAGE UND, V117, P1051, DOI 10.1016/j.cviu.2012.11.013; VANDERVORST HA, 1992, SIAM J SCI STAT COMP, V13, P631, DOI 10.1137/0913035; Viswanath S, 2014, NEUROCOMPUT IN PRESS; Yoo TS, 2002, P MED MEETS VIRTUAL; Zacharaki EI, 2009, NEUROIMAGE, V46, P762, DOI 10.1016/j.neuroimage.2009.01.051	26	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0150016	10.1371/journal.pone.0150016	http://dx.doi.org/10.1371/journal.pone.0150016			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088600	Green Published, gold			2022-12-27	WOS:000374527000001
J	Hernandez, D; Casane, D; Chevalier-Monteagudo, P; Bernatchez, L; Garcia-Machado, E				Hernandez, Damir; Casane, Didier; Chevalier-Monteagudo, Pedro; Bernatchez, Louis; Garcia-Machado, Erik			Go West: A One Way Stepping-Stone Dispersion Model for the Cavefish Lucifuga dentata in Western Cuba	PLOS ONE			English	Article							CRYPTIC DIVERSITY; PHYLOGEOGRAPHY; POPULATIONS; ASTYANAX; COLONIZATION; DIVERGENCE; HISTORY; FISHES; WATER; SPECIATION	Consistent with the limited dispersal capacity of most troglobitic animals, almost all Lucifuga cavefish species have very narrow geographic distribution in Cuba. However, one species, L. dentata, has a wide but disjointed distribution over 300 km in the west of the island. In order to estimate the relative role of vicariance and dispersal in the unexpected L. dentata distribution, we obtained partial sequences of the mitochondrial DNA (mtDNA) cytochrome b (cytb) gene and control region (CR), and then applied Approximate Bayesian Computation (ABC), based on the identification of five genetic and geographic congruent groups of populations. The process that best explains the distribution of genetic diversity in this species is sequential range expansion from east Matanzas to the western Pinar del Rio provinces, followed by isolation of groups of populations. We found relative high haplotype diversity and low nucleotide diversity in all but the Havana group, which has high values for both diversity parameters, suggesting that this group has been demographically stable over time. For two groups of populations (Cayuco and Bolondron), the mismatch distribution analyses suggests past demographic expansion. In the case of the Cayuco region, the star like relationships of haplotypes in the network suggests a recent founding event, congruent with other evidence indicating that this is the most recently colonized region. Over all, the results suggest that a combination of habitat availability, temporal interconnections, and possibly the biological properties of this species, may have enabled its dispersal and range expansion compared to other species of the genus, which are more geographically restricted.	[Hernandez, Damir; Garcia-Machado, Erik] Univ La Habana, Ctr Invest Marinas, Calle 16,114 Entre 1ra & 3ra, Havana 11300, Cuba; [Casane, Didier] Univ Paris 11, CNRS, Lab Evolut, Genomes,Comportement,Ecol,UMR 9191,IRD UMR 247, Gif Sur Yvette, France; [Casane, Didier] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Chevalier-Monteagudo, Pedro] Acuario Nacl Cuba, Calle 60, Havana 11300, Cuba; [Bernatchez, Louis] Univ Laval, IBIS, Pavillon Charles Eugene Marchand, Quebec City, PQ G1V 0A6, Canada	Universidad de la Habana; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite; Laval University	Garcia-Machado, E (corresponding author), Univ La Habana, Ctr Invest Marinas, Calle 16,114 Entre 1ra & 3ra, Havana 11300, Cuba.	egarcia@cim.uh.cu		Bernatchez, Louis/0000-0002-8085-9709	Centre National de la Recherche Scientifique; University of Havana; Acuario Nacional de Cuba; University of Paris-Sud; Embassy of France in Cuba	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University of Havana; Acuario Nacional de Cuba; University of Paris-Sud; Embassy of France in Cuba	This work was supported by institutional grants from Centre National de la Recherche Scientifique, University of Paris-Sud, Embassy of France in Cuba and University of Havana. Acuario Nacional de Cuba provided support in the form of salaries for authors [PCM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1972, EVOLUTION, V26, P1, DOI 10.1111/j.1558-5646.1972.tb00170.x; BARR TC, 1985, ANNU REV ECOL SYST, V16, P313, DOI 10.1146/annurev.es.16.110185.001525; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Borowsky RB, 2001, ENVIRON BIOL FISH, V62, P225, DOI 10.1023/A:1011857421818; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Buhay JE, 2005, MOL ECOL, V14, P4259, DOI 10.1111/j.1365-294X.2005.02755.x; Buhay JE, 2007, MOL PHYLOGENET EVOL, V42, P435, DOI 10.1016/j.ympev.2006.07.014; Burridge CP, 2008, EVOLUTION, V62, P1484, DOI 10.1111/j.1558-5646.2008.00377.x; CACCONE A, 1986, BIOCHEM SYST ECOL, V14, P215, DOI 10.1016/0305-1978(86)90066-9; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 2008, BIOINFORMATICS, V24, P2713, DOI 10.1093/bioinformatics/btn514; Culver DC, 2009, FRESHWATER BIOL, V54, P918, DOI 10.1111/j.1365-2427.2007.01856.x; Dowling TE, 2002, MOL BIOL EVOL, V19, P446, DOI 10.1093/oxfordjournals.molbev.a004100; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Espinasa L, 2001, ENVIRON BIOL FISH, V62, P233, DOI 10.1023/A:1011881921023; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagundes NJR, 2007, P NATL ACAD SCI USA, V104, P17614, DOI 10.1073/pnas.0708280104; Finston TL, 2007, MOL ECOL, V16, P355, DOI 10.1111/j.1365-294X.2006.03123.x; Fu YX, 1997, GENETICS, V147, P915; Garcia-Machado E, 2011, MOL PHYLOGENET EVOL, V61, P470, DOI 10.1016/j.ympev.2011.06.015; Guzik MT, 2009, MOL ECOL, V18, P3683, DOI 10.1111/j.1365-294X.2009.04296.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUDSON RR, 1992, MOL BIOL EVOL, V9, P138; Iturralde- Vinent M, 2003, INT GEOLOGY REV; Iturralde-Vinent MA, 2006, INT GEOL REV, V48, P791, DOI 10.2747/0020-6814.48.9.791; Ketmaier V, 2003, MOL ECOL, V12, P547, DOI 10.1046/j.1365-294X.2003.01734.x; LEE WJ, 1995, J MOL EVOL, V41, P54; Lefebure T, 2007, MOL PHYLOGENET EVOL, V42, P676, DOI 10.1016/j.ympev.2006.08.020; Lefebure T, 2006, MOL ECOL, V15, P1797, DOI 10.1111/j.1365-294X.2006.02888.x; Lejeusne C, 2006, MOL ECOL, V15, P4123, DOI 10.1111/j.1365-294X.2006.03101.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Martinsen L, 2009, HEREDITAS, V146, P33, DOI 10.1111/j.1601-5223.2008.02068.x; MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0; Neuenschwander S, 2008, MOL ECOL, V17, P757, DOI 10.1111/j.1365-294X.2007.03621.x; Palandacic Anja, 2012, Mol Ecol, V21, P1658, DOI 10.1111/j.1365-294X.2012.05507.x; Poey F, 1858, MEMORIAS HIST NATURA, P95; Ponce de Leon JL, 2012, LIB ROJO VERTEBRADOS, P33; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rosenblum EB, 2007, EVOLUTION, V61, P2971, DOI 10.1111/j.1558-5646.2007.00251.x; Schneider S, 1999, GENETICS, V152, P1079; Stepien CA, 2001, MOL ECOL, V10, P1873, DOI 10.1046/j.0962-1083.2001.01329.x; Strecker U, 2004, MOL PHYLOGENET EVOL, V33, P469, DOI 10.1016/j.ympev.2004.07.001; Strecker U, 2003, MOL ECOL, V12, P699, DOI 10.1046/j.1365-294X.2003.01753.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trontelj P, 2009, FRESHWATER BIOL, V54, P727, DOI 10.1111/j.1365-2427.2007.01877.x; Verovnik R, 2005, MOL ECOL, V14, P4355, DOI 10.1111/j.1365-294X.2005.02745.x; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Zaksek V, 2009, MOL ECOL, V18, P931, DOI 10.1111/j.1365-294X.2008.04061.x	50	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153545	10.1371/journal.pone.0153545	http://dx.doi.org/10.1371/journal.pone.0153545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082117	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800028
J	Hodges-Simeon, CR; Sobraske, KNH; Samore, T; Gurven, M; Gaulin, SJC				Hodges-Simeon, Carolyn R.; Sobraske, Katherine N. Hanson; Samore, Theodore; Gurven, Michael; Gaulin, Steven J. C.			Facial Width-To-Height Ratio (fWHR) Is Not Associated with Adolescent Testosterone Levels	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; DIGIT RATIO; SALIVARY TESTOSTERONE; TSIMANE AMERINDIANS; STRUCTURE PREDICTS; FACE; AGGRESSION; 2D-4D; GROWTH; SHAPE	Facial width-to-height ratio (fWHR) has been proposed as a sexually dimorphic signal in humans that develops under the influence of pubertal testosterone (T); however, no studies have examined the association between fWHR and T during the phase in which facial growth is canalized-adolescence. In a sample of adolescent Tsimane males, we evaluate the relationship between T, known T-derived traits (i.e. strength and voice pitch), and craniofacial measurements. If fWHR variation derives from T's effect on craniofacial growth during adolescence, several predictions should be supported: 1) fWHR should increase with age as T increases, 2) fWHR should reflect adolescent T (rather than adult T per se), 3) fWHR should exhibit velocity changes during adolescence in parallel with the pubertal spurt in T, 4) fWHR should correlate with T after controlling for age and other potential confounds, and 5) fWHR should show strong associations with other T-derived traits. Only prediction 4 was observed. Additionally, we examined three alternative facial masculinity ratios: facial width/lower face height, cheekbone prominence, and facial width/full face height. In contrast to fWHR, all three alternative measures show a strong age-related trend and are associated with both T and T-dependent traits. Overall, our results question the status of fWHR as a sexually-selected signal of pubertal T and T-linked traits.	[Hodges-Simeon, Carolyn R.; Samore, Theodore] Boston Univ, Dept Anthropol, Boston, MA 02215 USA; [Sobraske, Katherine N. Hanson; Gurven, Michael; Gaulin, Steven J. C.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Boston University; University of California System; University of California Santa Barbara	Hodges-Simeon, CR (corresponding author), Boston Univ, Dept Anthropol, Boston, MA 02215 USA.	crhodges@bu.edu		Gurven, Michael/0000-0002-5661-527X	NSF [BCS-0136761]; NIH/NIA [R01AG024119-01, R56AG024119-06, R01AG024119-07]; NATIONAL INSTITUTE ON AGING [R01AG024119, R56AG024119] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Wenner-Gren dissertation fieldwork grant to CRH (www.wennergren.org). The Tsimane Health and Life History project (MG) is supported by grants from NSF (BCS-0136761; www.nsf.gov) and NIH/NIA (R01AG024119-01, R56AG024119-06, R01AG024119-07; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrajih S, 2014, BRIT J PSYCHOL, V105, P153, DOI 10.1111/bjop.12035; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; Bailey AA, 2005, BIOL PSYCHOL, V68, P215, DOI 10.1016/j.biopsycho.2004.05.001; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Breedlove SM, 2010, ENDOCRINOLOGY, V151, P4116, DOI 10.1210/en.2010-0041; Bribiescas RG, 2010, AM J HUM BIOL, V22, P216, DOI 10.1002/ajhb.21012; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; BUTLER GE, 1989, CLIN ENDOCRINOL, V30, P587, DOI 10.1111/j.1365-2265.1989.tb01431.x; CAMERON N, 1981, PRACTICAL HUMAN BIOL, P25; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; COLLINS MA, 1995, J APPL SOC PSYCHOL, V25, P129, DOI 10.1111/j.1559-1816.1995.tb01588.x; Deaner RO, 2012, J RES PERS, V46, P235, DOI 10.1016/j.jrp.2012.01.005; Duffy DL, 2000, BEHAV ECOL, V11, P654, DOI 10.1093/beheco/11.6.654; Ellison PT, 2002, HUM REPROD, V17, P3251, DOI 10.1093/humrep/17.12.3251; Ellison PT, 2003, FERTILE GROUND NATUR; Enlow D. H., 1990, FACIAL GROWTH; Enlow DH, 1982, FACIAL GROWTH; Fink B, 2002, CURR DIR PSYCHOL SCI, V11, P154, DOI 10.1111/1467-8721.00190; Frisancho AR, 1990, ANTHROPOMETRIC STAND; Geniole SN, 2014, J EXP PSYCHOL HUMAN, V40, P1526, DOI 10.1037/a0036732; Godoy RA, 2006, ECON HUM BIOL, V4, P184, DOI 10.1016/j.ehb.2005.11.001; Gomez-Valdes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052317; GRAFEN A, 1990, J THEOR BIOL, V144, P517, DOI 10.1016/S0022-5193(05)80088-8; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; Gurven M, 2008, J GERONTOL A-BIOL, V63, P196, DOI 10.1093/gerona/63.2.196; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Haselhuhn MP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122637; Haselhuhn MP, 2012, P ROY SOC B-BIOL SCI, V279, P571, DOI 10.1098/rspb.2011.1193; Hilbe J., 2011, NEGATIVE BINOMIAL RE; Hodges-Simeon CR, 2015, EVOL HUM BEHAV, V36, P294, DOI 10.1016/j.evolhumbehav.2015.01.002; Hodges-Simeon CR, 2014, BEHAV ECOL, V25, P984, DOI 10.1093/beheco/aru081; Hodges-Simeon CR, 2013, ANN HUM BIOL, V40, P209, DOI 10.3109/03014460.2012.759622; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Kivlighan KT, 2004, HORM BEHAV, V46, P39, DOI 10.1016/j.yhbeh.2004.01.006; Kramer RSS, 2015, EVOL PSYCHOL-US, V13, P197, DOI 10.1177/147470491501300112; Kramer RSS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042705; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; Lefevre CE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0729; Lefevre CE, 2013, EVOL HUM BEHAV, V34, P273, DOI 10.1016/j.evolhumbehav.2013.03.005; Lefevre CE, 2012, EVOL HUM BEHAV, V33, P623, DOI 10.1016/j.evolhumbehav.2012.03.002; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Little AC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002106; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Mazur A, 1997, EVOL HUM BEHAV, V18, P317, DOI 10.1016/S1090-5138(97)00013-5; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; McCormick CM, 2010, J VIS, V10, P599, DOI [10.1167/10.7.599, DOI 10.1167/10.7.599]; McDade TW, 2008, AM J PHYS ANTHROPOL, V136, P478, DOI 10.1002/ajpa.20831; McIntyre MH, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-10; Meindl K, 2012, P ROY SOC B-BIOL SCI, V279, P2457, DOI 10.1098/rspb.2011.2351; Millet K, 2007, PERS INDIV DIFFER, V43, P289, DOI 10.1016/j.paid.2006.11.024; Mitteroecker P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118374; Muehlenbein MP, 2005, AM J HUM BIOL, V17, P527, DOI 10.1002/ajhb.20419; Mueller U, 1997, BEHAV ECOL, V8, P569; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Ozener B, 2012, EVOL HUM BEHAV, V33, P169, DOI 10.1016/j.evolhumbehav.2011.08.001; Penton-Voak IS, 2006, SOC COGNITION, V24, P607, DOI 10.1521/soco.2006.24.5.607; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Preece M, 1984, HUMAN GROWTH DEV; Puts DA, 2012, P ROY SOC B-BIOL SCI, V279, P601, DOI 10.1098/rspb.2011.0829; Rauch F, 2004, BONE, V34, P771, DOI 10.1016/j.bone.2004.01.022; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rogol AD, 2012, J ADOLESCENT HEALTH, V31, P192; Rohrich RJ, 2008, PLAST RECONSTR SURG, V121, P2107, DOI 10.1097/PRS.0b013e31817123c6; Schaefer K, 2005, COLLEGIUM ANTROPOL, V29, P415; Scott IM, 2014, P NATL ACAD SCI USA, V111, P14388, DOI 10.1073/pnas.1409643111; Searcy W.N.S, 2005, EVOLUTION ANIMAL COM; Sell A, 2009, P R SOC B, V276, P575, DOI 10.1098/rspb.2008.1177; Shirtcliff EA, 2002, HORM BEHAV, V42, P62, DOI 10.1006/hbeh.2002.1798; Short LA, 2012, EVOL HUM BEHAV, V33, P121, DOI 10.1016/j.evolhumbehav.2011.07.002; Shoup ML, 2008, EVOL PSYCHOL-US, V6, P469; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; SNODELL SF, 1993, AM J ORTHOD DENTOFAC, V104, P471, DOI 10.1016/0889-5406(93)70073-W; Stirrat M, 2012, PSYCHOL SCI, V23, P718, DOI 10.1177/0956797611435133; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Swaddle JP, 2001, P BIOL SCI, V269, P2285; Takakura M, 1998, Int J Adult Orthodon Orthognath Surg, V13, P277; Tanner S, 2009, AM J HUM BIOL, V21, P651, DOI 10.1002/ajhb.20944; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; Trivers R, 2006, HORM BEHAV, V49, P150, DOI 10.1016/j.yhbeh.2005.05.023; Tsujimura H, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0140; Valentine KA, 2014, PSYCHOL SCI, V25, P806, DOI 10.1177/0956797613511823; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Verdonck A, 1999, EUR J ORTHODONT, V21, P137, DOI 10.1093/ejo/21.2.137; Weinberg SM, 2015, ORTHOD CRANIOFAC RES, V18, P21, DOI 10.1111/ocr.12055; Welker KM, 2015, ADAPT HUM BEHAV PHYS, V1, P17, DOI 10.1007/s40750-014-0003-3; Weston EM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000710; Weston EM, 2004, P ROY SOC B-BIOL SCI, V271, pS416, DOI 10.1098/rsbl.2004.0203; Whitehouse AJO, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1351; Wong EM, 2011, PSYCHOL SCI, V22, P1478, DOI 10.1177/0956797611418838; Zahavi A., 1997, HANDICAP PRINCIPLE; Zebrowitz LA, 1998, J PERS SOC PSYCHOL, V75, P1300, DOI 10.1037/0022-3514.75.5.1300; Zebrowitz LA, 2015, PERS INDIV DIFFER, V86, P312, DOI 10.1016/j.paid.2015.06.036; Zilioli S, 2015, AGGRESSIVE BEHAV, V41, P322, DOI 10.1002/ab.21544	99	64	65	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153083	10.1371/journal.pone.0153083	http://dx.doi.org/10.1371/journal.pone.0153083			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078636	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700020
J	Tiwari, S; Sl, K; Kumar, V; Singh, B; Rao, AR; Mithra, SVA; Rai, V; Singh, AK; Singh, NK				Tiwari, Sushma; Sl, Krishnamurthy; Kumar, Vinod; Singh, Balwant; Rao, A. R.; Mithra, Amitha S., V; Rai, Vandna; Singh, Ashok K.; Singh, Nagendra K.			Mapping QTLs for Salt Tolerance in Rice (Oryza sativa L.) by Bulked Segregant Analysis of Recombinant Inbred Lines Using 50K SNP Chip	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SALINITY TOLERANCE; SEEDLING STAGE; STRESS INDEXES; IDENTIFICATION; GENES; REGIONS; MARKERS; POOLS; NA+	Soil salinity is a major constraint to rice production in large inland and coastal areas around the world. Modern high yielding rice varieties are particularly sensitive to high salt stress. There are salt tolerant landraces and traditional varieties of rice but with limited information on genomic regions (QTLs) and genes responsible for their tolerance. Here we describe a method for rapid identification of QTLs for reproductive stage salt tolerance in rice using bulked segregant analysis (BSA) of bi-parental recombinant inbred lines (RIL). The number of RILs required for the creation of two bulks with extreme phenotypes was optimized to be thirty each. The parents and bulks were genotyped using a 50K SNP chip to identify genomic regions showing homogeneity for contrasting alleles of polymorphic SNPs in the two bulks. The method was applied to 'CSR11/MI48' RILs segregating for reproductive stage salt tolerance. Genotyping of the parents and RIL bulks, made on the basis of salt sensitivity index for grain yield, revealed 6,068 polymorphic SNPs and 21 QTL regions showing homogeneity of contrasting alleles in the two bulks. The method was validated further with 'CSR27/MI48' RILs used earlier for mapping salt tolerance QTLs using low-density SSR markers. BSA with 50K SNP chip revealed 5,021 polymorphic loci and 34 QTL regions. This not only confirmed the location of previously mapped QTLs but also identified several new QTLs, and provided a rapid way to scan the whole genome for mapping QTLs for complex agronomic traits in rice.	[Tiwari, Sushma; Singh, Balwant; Mithra, Amitha S., V; Rai, Vandna; Singh, Nagendra K.] Natl Res Ctr Plant Biotechnol, New Delhi, India; [Sl, Krishnamurthy; Kumar, Vinod] Cent Soil Salin Res Inst, Karnal, India; [Rao, A. R.] Indian Agr Res Inst, New Delhi, India; [Singh, Ashok K.] Indian Agr Res Inst, Div Genet, New Delhi 110012, India	Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB); Indian Council of Agricultural Research (ICAR); ICAR - Central Soil Salinity Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Singh, NK (corresponding author), Natl Res Ctr Plant Biotechnol, Pusa Campus, New Delhi, India.	nksingh4@gmail.com	Singh, Ashok/HGF-2506-2022; Singh, Nouratan/N-9377-2017; Rai, Vandna/AAF-1030-2020	Singh, Nouratan/0000-0002-8063-8375; Singh, Ashok Kumar/0000-0002-9777-8163; Rao, Atmakuri Ramakrishna/0000-0002-3914-6248; Singh, Balwant/0000-0002-4958-4540; Rai, Vandna/0000-0002-6734-3169; Saraswathipura L., Krishnamurthy/0000-0002-9389-2997	Indian Council of Agriculture Research;  [NPTC 2001-3001]	Indian Council of Agriculture Research; 	Funded by Grant number is NPTC 2001-3001. All the funding or sources of support received for this work were taken by Indian Council of Agriculture Research funded in-house NPTC project "Functional genomics for salt stress in rice". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Ali S, 2013, FIELD CROP RES, V154, P65, DOI 10.1016/j.fcr.2013.06.011; Ammar MHM, 2009, J PLANT BIOCHEM BIOT, V18, P139, DOI 10.1007/BF03263312; [Anonymous], 2004, GENETIC IMPROVEMENT; Austin RS, 2011, PLANT J, V67, P715, DOI 10.1111/j.1365-313X.2011.04619.x; Becker A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015993; Bonilla P, 2002, PHILIPP AGRIC SCI, V85, P68; Brauer MJ, 2006, GENETICS, V173, P1813, DOI 10.1534/genetics.106.057927; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; FERNANDEZ GCJ, 1993, ADAPTATION OF FOOD CROPS TO TEMPERATURE AND WATER STRESS, P257; FISCHER RA, 1978, AUST J AGR RES, V29, P897, DOI 10.1071/AR9780897; Flowers TJ, 2000, J EXP BOT, V51, P99, DOI 10.1093/jexbot/51.342.99; Gautam RK, 2000, CEREAL RES COMMUN, V28, P117; Ghomi K, 2013, OMICS, V17, P242, DOI 10.1089/omi.2012.0097; GIOVANNONI JJ, 1991, NUCLEIC ACIDS RES, V19, P6553, DOI 10.1093/nar/19.23.6553; Gomez A., 1984, STAT PROCEDURES AGR, V2nd edn, P97; Gong JM, 1999, CHINESE SCI BULL, V44, P68, DOI 10.1007/BF03182889; Hossain H, 2015, J AGRON CROP SCI, V201, P17, DOI 10.1111/jac.12086; Koyama ML, 2001, PLANT PHYSIOL, V125, P406, DOI 10.1104/pp.125.1.406; Krishnamurthy SL, 2014, CEREAL RES COMMUN, V42, P474, DOI 10.1556/CRC.2013.0067; Lee SY, 2006, MOL CELLS, V21, P192; Lin HongXuan, 1998, Chinese Journal of Rice Science, V12, P72; Lin HX, 2004, THEOR APPL GENET, V108, P253, DOI 10.1007/s00122-003-1421-y; Magwene PM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002255; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; MCINTOSH MS, 1983, AGRON J, V75, P153, DOI 10.2134/agronj1983.00021962007500010041x; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; MILLER P. A., 1958, AGRON JOUR, V50, P126; Mokry M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-256; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; OECD/FAO, 2012, OECD FAO AGRICULTURA, DOI 10.1787/agr_outlook-2012-en; Pandit A, 2010, MOL GENET GENOMICS, V284, P121, DOI 10.1007/s00438-010-0551-6; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Porch TG, 2006, J AGRON CROP SCI, V192, P390, DOI 10.1111/j.1439-037X.2006.00229.x; Prasad SR, 2000, CURR SCI INDIA, V78, P162; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Reza M, 2013, J GENET, V92, P433; Sabesan T., 2009, Electronic Journal of Plant Breeding, V1, P56; Sabouri H, 2009, BIOL PLANTARUM, V53, P657, DOI 10.1007/s10535-009-0119-7; Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803; Schneeberger K, 2009, NAT METHODS, V6, P550, DOI 10.1038/nmeth0809-550; SEDCOLE JR, 1977, CROP SCI, V17, P667, DOI 10.2135/cropsci1977.0011183X001700040052x; Singh N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11600; Singh R. K., 2007, Physiology and Molecular Biology of Plants, V13, P87; Supriyo Chakraborty, 2010, Notulae Scientia Biologicae, V2, P117; Swinnen S, 2012, GENOME RES, V22, P975, DOI 10.1101/gr.131698.111; Takagi H, 2013, PLANT J, DOI [10.1111/tpj_12105, DOI 10.1111/TPJ_12105]; Takagi H, 2013, NEW PHYTOL, V200, P276, DOI 10.1111/nph.12369; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Thomson MJ, 2010, RICE, V3, P148, DOI 10.1007/s12284-010-9053-8; Trick M, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-14; Wenger JW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000942; Wolyn DJ, 2004, GENETICS, V167, P907, DOI 10.1534/genetics.103.024810; Yan CJ, 2007, THEOR APPL GENET, V115, P1093, DOI 10.1007/s00122-007-0635-9; Yang ZM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068433; Zeng LH, 2001, AGR WATER MANAGE, V48, P191, DOI 10.1016/S0378-3774(00)00146-3; Zheng K., 1995, RICE GENET NEWSLETT, V12, P255; Zhou Y, 2009, GENETICS, V183, P315, DOI 10.1534/genetics.109.102681	60	82	87	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153610	10.1371/journal.pone.0153610	http://dx.doi.org/10.1371/journal.pone.0153610			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077373	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700093
J	Mohan, CD; Srinivasa, V; Rangappa, S; Mervin, L; Mohan, S; Paricharak, S; Baday, S; Li, F; Shanmugam, MK; Chinnathambi, A; Zayed, ME; Alharbi, SA; Bender, A; Sethi, G; Basappa; Rangappa, KS				Mohan, Chakrabhavi Dhananjaya; Srinivasa, V.; Rangappa, Shobith; Mervin, Lewis; Mohan, Surender; Paricharak, Shardul; Baday, Sefer; Li, Feng; Shanmugam, Muthu K.; Chinnathambi, Arunachalam; Zayed, M. E.; Alharbi, Sulaiman Ali; Bender, Andreas; Sethi, Gautam; Basappa; Rangappa, Kanchugarakoppal S.			Trisubstituted-Imidazoles Induce Apoptosis in Human Breast Cancer Cells by Targeting the Oncogenic PI3K/Akt/mTOR Signaling Pathway	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; CARCINOMA IN-VITRO; INHIBITS GROWTH; ANTICANCER ACTIVITY; PROMOTES APOPTOSIS; SUPPRESSION; ACTIVATION; KINASE; ANGIOGENESIS; DERIVATIVES	Overactivation of PI3K/Akt/mTOR is linked with carcinogenesis and serves a potential molecular therapeutic target in treatment of various cancers. Herein, we report the synthesis of trisubstituted-imidazoles and identified 2-chloro-3-(4, 5-diphenyl-1H-imidazol-2-yl) pyridine (CIP) as lead cytotoxic agent. Naive Base classifier model of in silico target prediction revealed that CIP targets RAC-beta serine/threonine-protein kinase which comprises the Akt. Furthermore, CIP downregulated the phosphorylation of Akt, PDK and mTOR proteins and decreased expression of cyclin D1, Bcl-2, survivin, VEGF, procaspase-3 and increased cleavage of PARP. In addition, CIP significantly downregulated the CXCL12 induced motility of breast cancer cells and molecular docking calculations revealed that all compounds bind to Akt2 kinase with high docking scores compared to the library of previously reported Akt2 inhibitors. In summary, we report the synthesis and biological evaluation of imidazoles that induce apoptosis in breast cancer cells by negatively regulating PI3K/Akt/mTOR signaling pathway.	[Mohan, Chakrabhavi Dhananjaya; Rangappa, Kanchugarakoppal S.] Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India; [Srinivasa, V.; Basappa] Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India; [Rangappa, Shobith] Hokkaido Univ, Frontier Res Ctr Postgenome Sci & Technol, Sapporo, Hokkaido 0600808, Japan; [Mervin, Lewis; Paricharak, Shardul; Baday, Sefer; Bender, Andreas] Univ Cambridge, Dept Chem, Ctr Mol Informat, Lensfield Rd, Cambridge CB2 1EW, England; [Mohan, Surender] Jawaharlal Nehru Univ, Lab Mol Biol & Genet Engn, Sch Biotechnol, New Delhi 110067, India; [Paricharak, Shardul] Leiden Univ, Div Med Chem, Leiden Acad Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands; [Baday, Sefer] Istanbul Tech Univ, Appl Informat Dept, Inst Informat, TR-34469 Istanbul, Turkey; [Li, Feng; Shanmugam, Muthu K.; Sethi, Gautam] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Chinnathambi, Arunachalam; Zayed, M. E.; Alharbi, Sulaiman Ali; Sethi, Gautam] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia; [Sethi, Gautam] Curtin Univ, Sch Biomed Sci, CHIRI Biosci Res Precinct, Perth, WA 6009, Australia	University of Mysore; Bangalore University; Hokkaido University; University of Cambridge; Jawaharlal Nehru University, New Delhi; Leiden University; Leiden University - Excl LUMC; Istanbul Technical University; National University of Singapore; King Saud University; Curtin University	Rangappa, KS (corresponding author), Univ Mysore, Dept Studies Chem, Mysore 570006, Karnataka, India.; Basappa (corresponding author), Bangalore Univ, Dept Chem, Biol Chem Lab, Cent Coll Campus,Palace Rd, Bangalore 560001, Karnataka, India.	salundibasappa@gmail.com; rangappaks@yahoo.com	Sethi, Gautam/F-2372-2011; Bender, Andreas/C-6942-2009; Mohan, Chakrabhavi Dhananjaya/AGO-1276-2022; Rangappa, Shobith/AAI-2169-2020; baday, sefer/ABA-9111-2020; Mervin, Lewis/B-3759-2016	Sethi, Gautam/0000-0002-8677-8475; Bender, Andreas/0000-0002-6683-7546; Rangappa, Shobith/0000-0002-9800-7192; baday, sefer/0000-0002-2913-6687; Mohan, Chakrabhavi Dhananjaya/0000-0002-6810-9219; Chinnathambi, Arunachalam/0000-0001-5075-5901; Basappa, Basappa/0000-0002-8844-468X; Mervin, Lewis/0000-0002-7271-0824	University Grants Commission [41-257-2012-SR]; Vision Group Science and Technology; Department of Science and Technology [SR/FT/LS-142/2012]; Department of Science and Technology Indo-Korea [INT/Indo-Korea/122/2011-12]; Institution of Excellence, University of Mysore; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; NUHS Bench-to-Bedside-to-Product grant; Netherlands Organisation for Scientific Research (NWO) [NWO-017.009-065]; Prins Bernhard Cultuurfonds; Biotechnology and Biological Sciences Research Council [1372344] Funding Source: researchfish	University Grants Commission(University Grants Commission, India); Vision Group Science and Technology; Department of Science and Technology(Department of Science & Technology (India)); Department of Science and Technology Indo-Korea(Department of Science & Technology (DOST), Philippines); Institution of Excellence, University of Mysore; University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship; NUHS Bench-to-Bedside-to-Product grant; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Prins Bernhard Cultuurfonds; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by University Grants Commission (41-257-2012-SR), Vision Group Science and Technology, and Department of Science and Technology (NO. SR/FT/LS-142/2012) to Basappa. KSR thanks Department of Science and Technology Indo-Korea [INT/Indo-Korea/122/2011-12] and Institution of Excellence, University of Mysore for financial support and instrumentation facility. CDM thanks the University of Mysore for Department of Science and Technology-Promotion of University Research and Scientific Excellence (DST-PURSE) Research Associate fellowship. This work was supported by NUHS Bench-to-Bedside-to-Product grant to GS. Deanship of Scientific Research, College of Science Research Centre, King Saud University, Kingdom of Saudi Arabia is also acknowledged. SP thanks the Netherlands Organisation for Scientific Research (NWO, grant number NWO-017.009-065) and the Prins Bernhard Cultuurfonds for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2018, NUCLEIC ACIDS RES, V46, pD8, DOI [10.1093/nar/gkx1095, 10.1093/nar/gkv1290]; Amaravadi R, 2005, J CLIN INVEST, V115, P2618, DOI 10.1172/JCI26273; Anusha S, 2016, BIOORG MED CHEM LETT, V26, P1056, DOI 10.1016/j.bmcl.2015.12.026; Anusha S, 2014, RSC ADV, V4, P52181, DOI 10.1039/c4ra07839j; Arcaro A, 2007, CURR GENOMICS, V8, P271, DOI 10.2174/138920207782446160; Ashwini N, 2015, BIOORGAN MED CHEM, V23, P6157, DOI 10.1016/j.bmc.2015.07.069; Basappa, 2004, INDIAN J CHEM B, V43, P1954; Basappa, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039444; Baviskar AT, 2011, J MED CHEM, V54, P5013, DOI 10.1021/jm200235u; Bharathkumar H, 2015, ORGANIC BIOMOLECULAR; Bharathkumar H, 2015, BIOORG MED CHEM LETT, V25, P1804, DOI 10.1016/j.bmcl.2015.01.030; Bharathkumar H, 2014, RSC ADV, V4, P45143, DOI 10.1039/c4ra08713e; Brader S, 2004, TUMORI J, V90, P2, DOI 10.1177/030089160409000102; Bratulescu G, 2009, SYNTHESIS-STUTTGART, P2319, DOI 10.1055/s-0029-1216841; Ching CB, 2010, LAB INVEST, V90, P1406, DOI 10.1038/labinvest.2010.133; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Fongmoon D, 2007, J BIOL CHEM, V282, P36895, DOI 10.1074/jbc.M707082200; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Kannaiyan R, 2011, APOPTOSIS, V16, P1028, DOI 10.1007/s10495-011-0629-6; Keane KN, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/181643; Keerthy HK, 2014, J BIOL CHEM, V289, P31879, DOI 10.1074/jbc.M114.593855; Kim H.-S., 2013, J NANOMATER, V2013, P4, DOI [10.1155/2013/679758, DOI 10.12826/18333575.2013.0016.KIM]; Kim SW, 2013, PROSTATE, V73, P296, DOI 10.1002/pros.22574; Kumar CA, 2007, MED CHEM, V3, P269; Kumar CA, 2007, INVEST NEW DRUG, V25, P343, DOI 10.1007/s10637-006-9033-4; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; LoPiccolo J, 2008, DRUG RESIST UPDATE, V11, P32, DOI 10.1016/j.drup.2007.11.003; Ludwig Joseph A, 2011, Cancers (Basel), V3, P3029, DOI 10.3390/cancers3033029; Makinoshima H, 2015, J BIOL CHEM, V290, P17495, DOI 10.1074/jbc.M115.660498; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martelli AM, 2009, EXPERT OPIN INV DRUG, V18, P1333, DOI 10.1517/14728220903136775; McAuliffe PF, 2010, CLIN BREAST CANCER, V10, pS59, DOI 10.3816/CBC.2010.s.013; Mervin LH, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0098-y; Mohan CD, 2014, J BIOL CHEM, V289, P34296, DOI 10.1074/jbc.M114.601104; Neelgundmath M, 2015, BIOORG MED CHEM LETT, V25, P893, DOI 10.1016/j.bmcl.2014.12.065; Park KR, 2011, CANCER LETT, V312, P178, DOI 10.1016/j.canlet.2011.08.001; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Priya BS, 2007, BIOORG MED CHEM LETT, V17, P2775, DOI 10.1016/j.bmcl.2007.02.074; Rademaker-Lakhai JM, 2004, CLIN CANCER RES, V10, P3717, DOI 10.1158/1078-0432.CCR-03-0746; Rakesh KS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107182; Rangappa KS, 2005, J PHYS ORG CHEM, V18, P773, DOI 10.1002/poc.936; Roopashree R, 2015, BIOORG MED CHEM LETT, V25, P2589, DOI 10.1016/j.bmcl.2015.04.010; Sadashiva Maralinganadoddi Panchegowda, 2012, BMC Chemical Biology, V12, P5, DOI 10.1186/1472-6769-12-5; Siddharth S, 2013, ONCOL RES, V21, P1, DOI 10.3727/096504013X13786659070190; Subramaniam A, 2013, BRIT J PHARMACOL, V170, P807, DOI 10.1111/bph.12302; Sun YN, 2014, TUMOR BIOL, V35, P7765, DOI 10.1007/s13277-014-1816-1; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Thimmegowda NR, 2008, BIOORG MED CHEM LETT, V18, P432, DOI 10.1016/j.bmcl.2007.08.078; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Zhao S, 2004, LEUKEMIA, V18, P267, DOI 10.1038/sj.leu.2403220	56	93	95	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153155	10.1371/journal.pone.0153155	http://dx.doi.org/10.1371/journal.pone.0153155			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097161	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000374543600028
J	Watts, A; Walters, RW; Hoffman, L; Templin, J				Watts, Amber; Walters, Ryan W.; Hoffman, Lesa; Templin, Jonathan			Intra-Individual Variability of Physical Activity in Older Adults With and Without Mild Alzheimer's Disease	PLOS ONE			English	Article							LOCATION SCALE-MODEL; MOMENTARY ASSESSMENT; SEDENTARY BEHAVIOR; EXERCISE; RISK; DEMENTIA; HEALTH; METAANALYSIS; PATTERNS; PEOPLE	Physical activity shows promise for protection against cognitive decline in older adults with and without Alzheimer's disease (AD). To better understand barriers to adoption of physical activity in this population, a clear understanding of daily and weekly activity patterns is needed. Most accelerometry studies report average physical activity over an entire wear period without considering the potential importance of the variability of physical activity. This study evaluated individual differences in the amount and intra-individual variability of physical activity and determined whether these differences could be predicted by AD status, day of wear, age, gender, education, and cardiorespiratory capacity. Physical activity was measured via accelerometry (Actigraph GT3X+) over one week in 86 older adults with and without AD (n = 33 and n = 53, respectively). Mixed-effects location-scale models were estimated to evaluate and predict individual differences in the amount and intra-individual variability of physical activity. Results indicated that compared to controls, participants with AD averaged 21% less activity, but averaged non-significantly greater intra-individual variability. Women and men averaged similar amounts of physical activity, but women were significantly less variable. The amount of physical activity differed significantly across days of wear. Increased cardiorespiratory capacity was associated with greater average amounts of physical activity. Investigation of individual differences in the amount and intra-individual variability of physical activity provided insight into differences by AD status, days of monitor wear, gender, and cardiovascular capacity. All individuals regardless of AD status were equally consistent in their physical activity, which may have been due to a highly sedentary sample and/or the early disease stage of those participants with AD. These results highlight the value of considering individual differences in both the amount and intra-individual variability of physical activity.	[Watts, Amber] Univ Kansas, Dept Clin Psychol, KU Alzheimers Dis Ctr, Lawrence, KS 66045 USA; [Walters, Ryan W.] Creighton Univ, Dept Med, Omaha, NE 68178 USA; [Hoffman, Lesa] Univ Kansas, Schiefelbusch Inst Lifespan Studies, Res Design & Anal Unit, Lawrence, KS 66045 USA; [Templin, Jonathan] Univ Kansas, Dept Educ Psychol, Lawrence, KS 66045 USA	University of Kansas; Creighton University; University of Kansas; University of Kansas	Watts, A (corresponding author), Univ Kansas, Dept Clin Psychol, KU Alzheimers Dis Ctr, Lawrence, KS 66045 USA.	amberwatts@ku.edu	Watts, Amber/AAL-5754-2020	Watts, Amber/0000-0002-8385-1091; Walters, Ryan/0000-0002-8801-9886; Templin, Jonathan/0000-0001-7616-0973	National Institute on Aging of the National Institutes of Health [NIA 5P30AG035982-3]; Clinical Translational Science Award grant from National Center for Advancing Translational Sciences [UL1TR000001, UL1RR033179]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000001] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG035982] Funding Source: NIH RePORTER	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Clinical Translational Science Award grant from National Center for Advancing Translational Sciences; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging of the National Institutes of Health (NIA 5P30AG035982-3) and a Clinical Translational Science Award grant from National Center for Advancing Translational Sciences awarded to the University of Kansas Medical Center for Frontiers: The Heartland Institute for Clinical and Translational Research (#UL1TR000001; formerly #UL1RR033179). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH or NCATS.	Actigraph, 2012, ACTILIFE 6 US MAN; Ainsworth BE, 2000, RES Q EXERCISE SPORT, V71, pS37, DOI 10.1080/02701367.2000.11082784; Bellettiere J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136161; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Cavanaugh JT, 2007, J AM GERIATR SOC, V55, P120, DOI 10.1111/j.1532-5415.2006.00997.x; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Dunton GF, 2014, HEALTH PSYCHOL, V33, P255, DOI 10.1037/a0032640; Evenson KR, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.110109; Gando Y, 2015, PHYS ACTIVITY EXERCI, P51; Grant PM, 2010, J AGING PHYS ACTIV, V18, P171, DOI 10.1123/japa.18.2.171; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Harvey JA, 2013, INT J ENV RES PUB HE, V10, P6645, DOI 10.3390/ijerph10126645; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Healy GN, 2010, REV ESP CARDIOL, V63, P261, DOI 10.1016/S0300-8932(10)70083-X; Hedeker D, 2008, BIOMETRICS, V64, P627, DOI 10.1111/j.1541-0420.2007.00924.x; Heyn P, 2004, ARCH PHYS MED REHAB, V85, P1694, DOI 10.1016/j.apmr.2004.03.019; Hilleras PK, 1999, AGE AGEING, V28, P147, DOI 10.1093/ageing/28.2.147; Hollenberg M, 1998, J GERONTOL A-BIOL, V53, pB259, DOI 10.1093/gerona/53A.4.B259; Hultsch D.F., 2004, NEW FRONTIERS COGNIT, P65, DOI DOI 10.1093/ACPROF:OSO/9780198525691.003.0004; James BD, 2012, ALZ DIS ASSOC DIS, V26, P238, DOI 10.1097/WAD.0b013e31822fc3cb; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lee YS, 2005, J WOMEN AGING, V17, P55, DOI 10.1300/J074v17n01_05; Li X, 2012, STAT MED, V31, P3192, DOI 10.1002/sim.5393; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Owings TM, 2004, GAIT POSTURE, V20, P26, DOI 10.1016/S0966-6362(03)00088-2; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rast P, 2011, J GERONTOPSYCHOLOGY, V24, P169; Sisson SB, 2009, METAB SYNDR RELAT D, V7, P529, DOI 10.1089/met.2009.0023; Sofi F, 2011, J INTERN MED, V269, P107, DOI 10.1111/j.1365-2796.2010.02281.x; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Thune-Boyle ICV, 2012, INT PSYCHOGERIATR, V24, P1046, DOI 10.1017/S1041610211002365; Thyfault JP, 2011, CURR OPIN CLIN NUTR, V14, P374, DOI 10.1097/MCO.0b013e3283468e69; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Vidoni ED, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131647; Wang LJ, 2012, PSYCHOL METHODS, V17, P567, DOI 10.1037/a0029317; Watts AS, 2013, CLIN GERONTOLOGIST, V36, P356, DOI 10.1080/07317115.2013.788116; Westerterp MR, 2008, PHYSIOL BEHAV, V93, P1039, DOI 10.1016/j.physbeh.2008.01.021; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	41	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153898	10.1371/journal.pone.0153898	http://dx.doi.org/10.1371/journal.pone.0153898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097226	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600068
J	Iakovleva, I; Begum, A; Brannstrom, K; Wijsekera, A; Nilsson, L; Zhang, J; Andersson, PL; Sauer-Eriksson, AE; Olofsson, A				Iakovleva, Irina; Begum, Afshan; Brannstrom, Kristoffer; Wijsekera, Alexandra; Nilsson, Lina; Zhang, Jin; Andersson, Patrik L.; Sauer-Eriksson, A. Elisabeth; Olofsson, Anders			Tetrabromobisphenol A Is an Efficient Stabilizer of the Transthyretin Tetramer	PLOS ONE			English	Article							BROMINATED FLAME RETARDANTS; AMYLOID FIBRIL FORMATION; THYROID-HORMONE-BINDING; INHIBITION PROPERTIES; NATIVE-STATE; POTENT; DIFLUNISAL; AMYLOIDOGENESIS; POLYNEUROPATHY; DISEASE	Amyloid formation of the human plasma protein transthyretin (TTR) is associated with several human disorders, including familial amyloidotic polyneuropathy (FAP) and senile systemic amyloidosis. Dissociation of TTR's native tetrameric assembly is the rate-limiting step in the conversion into amyloid, and this feature presents an avenue for intervention because binding of an appropriate ligand to the thyroxin hormone binding sites of TTR stabilizes the native tetrameric assembly and impairs conversion into amyloid. The desired features for an effective TTR stabilizer include high affinity for TTR, high selectivity in the presence of other proteins, no adverse side effects at the effective concentrations, and a long half-life in the body. In this study we show that the commonly used flame retardant tetrabromobisphenol A (TBBPA) efficiently stabilizes the tetrameric structure of TTR. The X-ray crystal structure shows TBBPA binding in the thyroxine binding pocket with bromines occupying two of the three halogen binding sites. Interestingly, TBBPA binds TTR with an extremely high selectivity in human plasma, and the effect is equal to the recently approved drug tafamidis and better than diflunisal, both of which have shown therapeutic effects against FAP. TBBPA consequently present an interesting scaffold for drug design. Its absorption, metabolism, and potential side-effects are discussed.	[Iakovleva, Irina; Brannstrom, Kristoffer; Wijsekera, Alexandra; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Begum, Afshan; Nilsson, Lina; Zhang, Jin; Andersson, Patrik L.; Sauer-Eriksson, A. Elisabeth] Umea Univ, Dept Chem, Umea, Sweden	Umea University; Umea University	Olofsson, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@umu.se	Brännström, Kristoffer/AAC-1204-2020	BEGUM, AFSHAN/0000-0001-5047-5168; Sauer-Eriksson, Elisabeth/0000-0003-0124-0199	Swedish Research Council; Parkinsofonden; Insamlingsstiftelsen at Umea University; Alzheimerfonden; Ahlen-stiftelsen; J.C. Kempes stiftelse; Hjarnfonden; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Parkinsofonden; Insamlingsstiftelsen at Umea University; Alzheimerfonden; Ahlen-stiftelsen; J.C. Kempes stiftelse; Hjarnfonden; O.E. och Edlas stiftelse; Torsten Soderbergs stiftelse; Vasterbottens Lans lasting (ALF-medel); Patientforeningen FAMY/AMYL; Medical Faculty of Umea University	We thank the Swedish Research Council, Parkinsofonden, Insamlingsstiftelsen at Umea University, Alzheimerfonden, Ahlen-stiftelsen, J.C. Kempes stiftelse, Hjarnfonden, O.E. och Edlas stiftelse, Torsten Soderbergs stiftelse, Vasterbottens Lans lasting (ALF-medel), Patientforeningen FAMY/AMYL, and the Medical Faculty of Umea University for funding.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski-Werner SL, 2004, J MED CHEM, V47, P355, DOI 10.1021/jm030347n; Addison RS, 2000, EUR J CLIN PHARMACOL, V56, P715, DOI 10.1007/s002280000211; Alhamadsheh MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002473; Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076; Alshehri B, 2015, J NEUROENDOCRINOL, V27, P303, DOI 10.1111/jne.12271; Arvidsson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143456; Belluti F, 2014, EUR J MED CHEM, V78, P157, DOI 10.1016/j.ejmech.2014.03.042; Berk JL, 2013, JAMA-J AM MED ASSOC, V310, P2658, DOI 10.1001/jama.2013.283815; Bromine Science and Environmental Forum (BSEF), BSEF POST TBBPA; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Carvalho A, 2015, LIVER TRANSPLANT, V21, P282, DOI 10.1002/lt.24058; Cheng SB, 2015, AM J REPROD IMMUNOL; CHENG SY, 1977, BIOCHEMISTRY-US, V16, P3707, DOI 10.1021/bi00635a031; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Cope RB, 2015, TOXICOLOGY, V329, P49, DOI 10.1016/j.tox.2014.12.013; Cotrina EY, 2013, J MED CHEM, V56, P9110, DOI 10.1021/jm401061w; Cruz MW, 2015, NEUROL THER, V4, P61, DOI 10.1007/s40120-015-0031-3; de Wit CA, 2010, SCI TOTAL ENVIRON, V408, P2885, DOI 10.1016/j.scitotenv.2009.08.037; Dunnick JK, 2015, TOXICOL PATHOL, V43, P464, DOI 10.1177/0192623314557335; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; European Medicines Agency, 2011, VYND ASS REP EUR MED; Ferreira N, 2013, BBA-MOL BASIS DIS, V1832, P39, DOI 10.1016/j.bbadis.2012.10.007; Ferreira N, 2012, AMYLOID, V19, P39, DOI 10.3109/13506129.2012.668502; Ferreira N, 2011, FEBS LETT, V585, P2424, DOI 10.1016/j.febslet.2011.06.030; Fromme H, 2014, ENVIRON INT, V64, P61, DOI 10.1016/j.envint.2013.11.017; Gales L, 2005, BIOCHEM J, V388, P615, DOI 10.1042/BJ20042035; Gales L, 2008, BBA-PROTEINS PROTEOM, V1784, P512, DOI 10.1016/j.bbapap.2007.11.014; Gertz MA, 2015, J AM COLL CARDIOL, V66, P2451, DOI 10.1016/j.jacc.2015.09.075; Hamers T, 2006, TOXICOL SCI, V92, P157, DOI 10.1093/toxsci/kfj187; Hornberg A, 2000, J MOL BIOL, V302, P649, DOI 10.1006/jmbi.2000.4078; Iakovleva I, 2015, J MED CHEM, V58, P6507, DOI 10.1021/acs.jmedchem.5b00544; Iakovleva I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128222; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Johnson SM, 2009, J MED CHEM, V52, P1115, DOI 10.1021/jm801347s; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalkunte SS, 2013, AM J PATHOL, V183, P1425, DOI 10.1016/j.ajpath.2013.07.022; Kang MJ, 2009, J TOXICOL ENV HEAL A, V72, P1439, DOI 10.1080/15287390903212907; Klabunde T, 2000, NAT STRUCT BIOL, V7, P312; Knudsen GA, 2014, TOXICOL REP, V1, P214, DOI 10.1016/j.toxrep.2014.03.005; Lai DY, 2015, FOOD CHEM TOXICOL, V80, P206, DOI 10.1016/j.fct.2015.03.023; Lindhagen-Persson M, 2008, AMYLOID, V15, P240, DOI 10.1080/13506120802524916; Maetzler W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048042; Mairal T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004124; Manral P, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20140155; Marchesini GR, 2006, ANAL CHEM, V78, P1107, DOI 10.1021/ac051399i; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Meerts IATM, 2000, TOXICOL SCI, V56, P95, DOI 10.1093/toxsci/56.1.95; Miller SR, 2004, LAB INVEST, V84, P545, DOI 10.1038/labinvest.3700059; Miroy GJ, 1996, P NATL ACAD SCI USA, V93, P15051, DOI 10.1073/pnas.93.26.15051; Morais-de-Sa E, 2004, J BIOL CHEM, V279, P53483, DOI 10.1074/jbc.M408053200; Moreira L, 2015, AMYLOID, V22, P93, DOI 10.3109/13506129.2015.1007497; Mu YS, 2015, FEBS LETT, V589, P849, DOI 10.1016/j.febslet.2015.02.020; National Toxicology Program, 2014, 587 NTP; Nencetti S, 2013, CHEMMEDCHEM, V8, P1617, DOI 10.1002/cmdc.201300245; Nyholm JR, 2010, ENVIRON POLLUT, V158, P2235, DOI 10.1016/j.envpol.2010.02.010; Palaninathan SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006290; Patel KS, 2015, J INTERN MED, V278, P126, DOI 10.1111/joim.12383; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Raghu P, 2002, ARCH BIOCHEM BIOPHYS, V400, P43, DOI 10.1006/abbi.2002.2779; Reixach N, 2004, P NATL ACAD SCI USA, V101, P2817, DOI 10.1073/pnas.0400062101; Reixach N, 2006, BIOCHEM BIOPH RES CO, V348, P889, DOI 10.1016/j.bbrc.2006.07.109; Ruberg FL, 2012, CIRCULATION, V126, P1286, DOI 10.1161/CIRCULATIONAHA.111.078915; Sant'Anna RO, 2013, INT J MOL SCI, V14, P5284, DOI 10.3390/ijms14035284; Saraiva MJ, 2012, CURR MED CHEM, V19, P2304; Schauer UMD, 2006, TOXICOL SCI, V91, P49, DOI 10.1093/toxsci/kfj132; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Sorgjerd K, 2008, BIOCHEM BIOPH RES CO, V377, P1072, DOI 10.1016/j.bbrc.2008.10.121; Sousa MM, 2001, AM J PATHOL, V159, P1993; Sousa MM, 2002, AM J PATHOL, V161, P1935, DOI 10.1016/S0002-9440(10)64469-0; Suhr OB, 2015, TRANSPLANTATION; Sun FF, 2014, ENVIRON SCI TECHNOL, V48, P14291, DOI 10.1021/es503383h; Tojo K, 2006, NEUROSCI RES, V56, P441, DOI 10.1016/j.neures.2006.08.014; Trivella DBB, 2012, J STRUCT BIOL, V180, P143, DOI 10.1016/j.jsb.2012.07.008; Trivella DBB, 2011, J STRUCT BIOL, V173, P323, DOI 10.1016/j.jsb.2010.10.003; Vaidya B, 2014, DIAGNOSIS MANAGEMENT; Viberg H, 2011, TOXICOLOGY, V289, P59, DOI 10.1016/j.tox.2011.07.010; Vilaro M, 2015, ACS COMB SCI, V17, P32, DOI 10.1021/co5001234; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Wilce JA, 2001, J BIOL CHEM, V276, P25997, DOI 10.1074/jbc.M101228200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yanagisawa A, 2015, MODERN PATHOL, V28, P201, DOI 10.1038/modpathol.2014.102; Yokoyama T, 2014, J MED CHEM, V57, P8928, DOI 10.1021/jm500997m	86	12	12	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153529	10.1371/journal.pone.0153529	http://dx.doi.org/10.1371/journal.pone.0153529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093678	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200025
J	Ouedraogo, N; Kaplon, J; Bonkoungou, IJO; Traore, AS; Pothier, P; Barro, N; Ambert-Balay, K				Ouedraogo, Nafissatou; Kaplon, Jerome; Bonkoungou, Isidore Juste O.; Traore, Alfred Sababenedjo; Pothier, Pierre; Barro, Nicolas; Ambert-Balay, Katia			Prevalence and Genetic Diversity of Enteric Viruses in Children with Diarrhea in Ouagadougou, Burkina Faso	PLOS ONE			English	Article							GROUP-A ROTAVIRUS; MOLECULAR EPIDEMIOLOGY; ACUTE GASTROENTERITIS; VIRAL GASTROENTERITIS; GENOMIC CHARACTERIZATION; NOROVIRUS INFECTIONS; HUMAN ASTROVIRUSES; UNITED-KINGDOM; YOUNG-CHILDREN; AICHI VIRUSES	Enteric viruses are a major cause of diarrhea in children, especially those under five years old. Identifying the viral agents is critical to the development of effective preventive measures. This study aimed to determine the prevalence and genetic diversity of common enteric viruses in children under five years old in Burkina Faso. Stool samples from children with (n = 263) and without (n = 50) diarrhea disorders were collected in Ouagadougou, Burkina Faso from November 2011 to September 2012. Rotavirus, norovirus, sapovirus, astrovirus, adenovirus and Aichivirus A were detected using real-time or end-point (RT-)PCR. Rotavirus strains were G and P genotyped by multiplex RT-PCR and other viral strains were characterized by sequencing of viral subgenomic segements. At least one viral agent was detected in 85.6% and 72% of the symptomatic and asymptomatic patients, respectively. Rotavirus (63.5%), adenovirus (31.2%) and genogroup II norovirus (18.2%) were the most prevalent viruses in symptomatic patients, but only rotavirus and genogroup II norovirus were significantly associated with diarrhea (OR: 7.9, 95`)/X1: 3.7-17; OR: 3.5, 95`)/X1: 1-11.7, respectively). Sapovirus (10.3%), astrovirus (4.9%), genogroup I norovirus (2.7%) and Aichivirus A (0.8%) were less prevalent. The predominant genotype of rotavirus was G9P[8] (36.5%), and the predominant norovirus strain was GII.4 variant 2012 (71.4%). Among sapovirus, the genogroup II (87.5%) predominated. Astrovirus type 1 (41.7%) was the most frequent astrovirus identified. Aichivirus A belonged to the three genotypes (A, B and C). Enteric adenoviruses type 40 and 41 were identified in 10.2% and 5.1% respectively. Several cases of co -infections were detected. The results highlight the high prevalence and the high diversity of enteric viruses in Burkinabe children.	[Ouedraogo, Nafissatou; Bonkoungou, Isidore Juste O.; Traore, Alfred Sababenedjo; Barro, Nicolas] Univ Ouagadougou, Lab Biol Mol Epidemiol & Surveillance Bacteries &, CRSBAN, Ouagadougou, Burkina Faso; [Kaplon, Jerome; Pothier, Pierre; Ambert-Balay, Katia] Univ Hosp Dijon, Natl Reference Ctr Enter Viruses, Dijon, France; [Bonkoungou, Isidore Juste O.] DBM, Lab Natl Sante Publ, Ouagadougou, Burkina Faso	CHU Dijon Bourgogne	Ouedraogo, N (corresponding author), Univ Ouagadougou, Lab Biol Mol Epidemiol & Surveillance Bacteries &, CRSBAN, Ouagadougou, Burkina Faso.	nafissatouedraogo@yahoo.fr	Bonkoungou, Isidore/ABC-3889-2020; Kaplon, Jerome/E-1707-2013	Bonkoungou, Isidore/0000-0002-8622-662X; Ambert-Balay, Katia/0000-0002-2624-712X; Kaplon, Jerome/0000-0002-8180-4152				Allard A, 2001, J CLIN MICROBIOL, V39, P498, DOI 10.1128/JCM.39.2.498-505.2001; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Armah GE, 2006, J MED VIROL, V78, P1480, DOI 10.1002/jmv.20722; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Bini J C, 2007, Bull Soc Pathol Exot, V100, P243; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bonkoungou IJO, 2011, J MED VIROL, V83, P1485, DOI 10.1002/jmv.22137; Bonkoungou IJO, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-94; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Boschi-Pinto C, 2008, B WORLD HEALTH ORGAN, V86, P710, DOI 10.2471/BLT.07.050054; Bull RA, 2006, J CLIN MICROBIOL, V44, P327, DOI 10.1128/JCM.44.2.327-333.2006; Chhabra P, 2009, J MED VIROL, V81, P922, DOI 10.1002/jmv.21458; Cunliffe NA, 2010, EMERG INFECT DIS, V16, P55, DOI 10.3201/eid1601.090401; Estes MK, 2007, FIELDS VIROLOGY, P1917; Fang Zhao-yin, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P673; Flahault A, 2010, B ACAD NAT MED PARIS, V194, P1415, DOI 10.1016/S0001-4079(19)32172-7; Fukuda S, 2008, J MED VIROL, V80, P921, DOI 10.1002/jmv.21151; Galeano ME, 2013, J CLIN VIROL, V58, P378, DOI 10.1016/j.jcv.2013.07.008; Gallimore CI, 2006, J MED VIROL, V78, P673, DOI 10.1002/jmv.20592; Gomara MI, 2004, J CLIN MICROBIOL, V42, P2541, DOI 10.1128/JCM.42.6.2541-2547.2004; Guntapong R, 2004, JPN J INFECT DIS, V57, P276; Gutierrez-Aguirre I, 2008, J CLIN MICROBIOL, V46, P2547, DOI 10.1128/JCM.02428-07; Hansman GS, 2006, EMERG INFECT DIS, V12, P141, DOI 10.3201/eid1201.050846; Huynen P, 2013, J CLIN VIROL, V58, P515, DOI 10.1016/j.jcv.2013.08.013; Iturriza-Gomara M, 2000, J CLIN MICROBIOL, V38, P4394; Japhet MO, 2012, J MED VIROL, V84, P1489, DOI 10.1002/jmv.23343; Jeong AY, 2011, CLIN MICROBIOL INFEC, V17, P404, DOI 10.1111/j.1469-0691.2010.03263.x; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Kaplon J, 2015, J CLIN MICROBIOL, V53, P3670, DOI 10.1128/JCM.01984-15; Kiulia NM, 2014, PEDIATR INFECT DIS J, V33, pS85, DOI 10.1097/INF.0000000000000059; Kojima S, 2002, J VIROL METHODS, V100, P107, DOI 10.1016/S0166-0934(01)00404-9; Kroneman A, 2011, J CLIN VIROL, V51, P121, DOI 10.1016/j.jcv.2011.03.006; Le Cann P, 2004, RES MICROBIOL, V155, P11, DOI 10.1016/j.resmic.2003.09.013; Lekana-Douki SE, 2015, INT J INFECT DIS, V34, P90, DOI 10.1016/j.ijid.2015.03.009; Liu XN, 2015, J MED VIROL, V87, P2048, DOI 10.1002/jmv.24283; Loisy F, 2005, J VIROL METHODS, V123, P1, DOI 10.1016/j.jviromet.2004.08.023; Lyman WH, 2009, J PEDIATR-US, V154, P253, DOI 10.1016/j.jpeds.2008.07.057; Malasao R, 2008, J MED VIROL, V80, P1749, DOI 10.1002/jmv.21244; Martella V, 2010, VET MICROBIOL, V140, P246, DOI 10.1016/j.vetmic.2009.08.028; Matsushima Y, 2011, J GEN VIROL, V92, P2770, DOI 10.1099/vir.0.034744-0; Matussek A, 2015, INFECT GENET EVOL, V32, P396, DOI 10.1016/j.meegid.2015.03.039; Mayindou G, 2016, J MED VIROL, V88, P596, DOI 10.1002/jmv.24382; Meyer CT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0299-z; Mihalov-Kovacs E, 2015, EMERG INFECT DIS, V21, P660, DOI 10.3201/eid2104.141370; Moreno-Espinosa Sarbelio, 2004, Semin Pediatr Infect Dis, V15, P237, DOI 10.1053/j.spid.2004.07.004; Mukherjee A, 2010, ARCH VIROL, V154, P33; Mustafa H, 2000, J CLIN MICROBIOL, V38, P1058, DOI 10.1128/JCM.38.3.1058-1062.2000; Mwenda JM, 2010, J INFECT DIS, V202, pS5, DOI 10.1086/653557; Nguyen TA, 2007, J MED VIROL, V79, P582, DOI 10.1002/jmv.20857; Nitiema LW, 2011, INT J INFECT DIS, V15, pE646, DOI 10.1016/j.ijid.2011.05.009; Noel JS, 1997, J MED VIROL, V52, P173, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;173::AID-JMV10&gt;3.0.CO;2-M; NOEL JS, 1995, J CLIN MICROBIOL, V33, P797, DOI 10.1128/JCM.33.4.797-801.1995; Nordgren J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069557; Nordgren J, 2012, EMERG INFECT DIS, V18, P589, DOI 10.3201/eid1804.110973; Oh DY, 2006, ARCH VIROL, V151, P1199, DOI 10.1007/s00705-005-0706-7; Oh DY, 2003, J MED VIROL, V71, P82, DOI 10.1002/jmv.10449; Oka T, 2006, J MED VIROL, V78, P1347, DOI 10.1002/jmv.20699; Oka T, 2015, CLIN MICROBIOL REV, V28, P32, DOI 10.1128/CMR.00011-14; Okitsu-Negishi S, 2004, PEDIATR INT, V46, P245, DOI 10.1046/j.1442-200x.2004.01896.x; Ouyang YB, 2012, ARCH VIROL, V157, P881, DOI 10.1007/s00705-012-1235-9; Page AL, 2014, EMERG INFECT DIS, V20, P573, DOI 10.3201/eid2004.131328; Patel MM, 2009, J CLIN VIROL, V44, P1, DOI 10.1016/j.jcv.2008.10.009; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Rackoff LA, 2013, LANCET, V8; Ren ZZ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-412; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Sdiri-Loulizi K, 2008, J CLIN MICROBIOL, V46, P1349, DOI 10.1128/JCM.02438-07; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P2275, DOI 10.1128/JCM.00913-09; Sdiri-Loulizi K, 2009, J CLIN MICROBIOL, V47, P421, DOI 10.1128/JCM.01852-08; Simpson R, 2003, J MED VIROL, V70, P258, DOI 10.1002/jmv.10386; Steele AD, 2010, J INFECT DIS, V202, pS225, DOI 10.1086/653574; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tcheremenskaia O, 2007, J CLIN MICROBIOL, V45, P2197, DOI 10.1128/JCM.00484-07; Trojnar E, 2013, J GEN VIROL, V94, P136, DOI 10.1099/vir.0.047381-0; Vinje J, 1996, J INFECT DIS, V174, P610, DOI 10.1093/infdis/174.3.610; Vinje J, 2015, J CLIN MICROBIOL, V53, P373, DOI 10.1128/JCM.01535-14; Wu FT, 2015, J MED VIROL, V87, P1462, DOI 10.1002/jmv.24208; Yamashita T, 2000, J CLIN MICROBIOL, V38, P2955, DOI 10.1128/JCM.38.8.2955-2961.2000; Yang XL, 2008, INT J INFECT DIS, V12, pE11, DOI 10.1016/j.ijid.2008.03.022	81	60	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153652	10.1371/journal.pone.0153652	http://dx.doi.org/10.1371/journal.pone.0153652			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092779	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200037
J	Perez, T; Zamora, J; Eguiluz, VM				Perez, Toni; Zamora, Jordi; Eguiluz, Victor M.			Collective Intelligence: Aggregation of Information from Neighbors in a Guessing Game	PLOS ONE			English	Article							HETEROGENEOUS NETWORKS; PROMOTE COOPERATION; SOCIAL-INFLUENCE; DECISION-MAKING; ADVANTAGE; EVOLUTION; DYNAMICS; BEHAVIOR; HUMANS	Complex systems show the capacity to aggregate information and to display coordinated activity. In the case of social systems the interaction of different individuals leads to the emergence of norms, trends in political positions, opinions, cultural traits, and even scientific progress. Examples of collective behavior can be observed in activities like the Wikipedia and Linux, where individuals aggregate their knowledge for the benefit of the community, and citizen science, where the potential of collectives to solve complex problems is exploited. Here, we conducted an online experiment to investigate the performance of a collective when solving a guessing problem in which each actor is endowed with partial information and placed as the nodes of an interaction network. We measure the performance of the collective in terms of the temporal evolution of the accuracy, finding no statistical difference in the performance for two classes of networks, regular lattices and random networks. We also determine that a Bayesian description captures the behavior pattern the individuals follow in aggregating information from neighbors to make decisions. In comparison with other simple decision models, the strategy followed by the players reveals a suboptimal performance of the collective. Our contribution provides the basis for the micro -macro connection between individual based descriptions and collective phenomena.	[Perez, Toni; Zamora, Jordi; Eguiluz, Victor M.] UIB, CSIC, IFISC, E-07122 Palma De Mallorca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC)	Perez, T (corresponding author), UIB, CSIC, IFISC, E-07122 Palma De Mallorca, Spain.	toni@ifisc.uib-csic.es	Eguíluz, Víctor M./B-9655-2008	Eguíluz, Víctor M./0000-0003-1133-1289	Spanish Ministry of Economy and Competitiveness (MINECO); FEDER (EU) [FIS2011-24785, FIS2012-30634]; MINECO	Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); FEDER (EU)(European Commission); MINECO(Spanish Government)	The authors acknowledge support from Spanish Ministry of Economy and Competitiveness (MINECO) and FEDER (EU) through the projects MODASS (FIS2011-24785) (VME) and INTENSE@COSYP (FIS2012-30634). TP acknowledges support from the program Juan de la Cierva of MINECO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arganda S, 2012, P NATL ACAD SCI USA, V109, P20508, DOI 10.1073/pnas.1210664109; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; Easley D, 2010, NETWORKS CROWDS MARK; Eguiluz VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121332; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Fontanari L, 2014, P NATL ACAD SCI USA, V111, P17075, DOI 10.1073/pnas.1410583111; Galton F, 1907, NATURE, V75, P450, DOI 10.1038/075450a0; Gowers T, 2009, NATURE, V461, P879, DOI 10.1038/461879a; Goyal S., 2011, HDB SOCIAL EC; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Harvey D., 2013, PREPRINT; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Lambiotte R, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/18007; Lazer D, 2007, ADMIN SCI QUART, V52, P667, DOI 10.2189/asqu.52.4.667; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mason W, 2012, P NATL ACAD SCI USA, V109, P764, DOI 10.1073/pnas.1110069108; Mason WA, 2008, J EXP PSYCHOL GEN, V137, P422, DOI 10.1037/a0012798; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Mavrodiev P, 2013, SCI REP-UK, V3, DOI 10.1038/srep01360; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; Meunier H, 2006, BEHAVIOUR, V143, P1511, DOI 10.1163/156853906779366982; Miller N, 2013, P NATL ACAD SCI USA, V110, P5263, DOI 10.1073/pnas.1217513110; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Nishi R, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.062123; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Pacheco JM, 2006, PLOS COMPUT BIOL, V2, P1634, DOI 10.1371/journal.pcbi.0020178; Perc M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0997; Rand DG, 2011, P NATL ACAD SCI USA, V108, P19193, DOI 10.1073/pnas.1108243108; Sumpter DJT, 2009, PHILOS T R SOC B, V364, P743, DOI 10.1098/rstb.2008.0204; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Surowiecki J., 2004, WISDOM CROWDS WHY MA, VXXI, P295; Valone TJ, 2006, OIKOS, V112, P252	37	5	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153586	10.1371/journal.pone.0153586	http://dx.doi.org/10.1371/journal.pone.0153586			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9NW	27093274	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200031
J	Sundstrom, A; Grabocka, E; Bar-Sagi, D; Mishra, B				Sundstrom, Andrew; Grabocka, Elda; Bar-Sagi, Dafna; Mishra, Bud			Histological Image Processing Features Induce a Quantitative Characterization of Chronic Tumor Hypoxia	PLOS ONE			English	Article							OXYGEN-TRANSPORT; CANCER; FIBROBLASTS; TISSUES; IMPACT; CELLS; MODEL	Hypoxia in tumors signifies resistance to therapy. Despite a wealth of tumor histology data, including anti-pimonidazole staining, no current methods use these data to induce a quantitative characterization of chronic tumor hypoxia in time and space. We use image-processing algorithms to develop a set of candidate image features that can formulate just such a quantitative description of xenographed colorectal chronic tumor hypoxia. Two features in particular give low-variance measures of chronic hypoxia near a vessel: intensity sampling that extends radially away from approximated blood vessel centroids, and multithresholding to segment tumor tissue into normal, hypoxic, and necrotic regions. From these features we derive a spatiotemporal logical expression whose truth value depends on its predicate clauses that are grounded in this histological evidence. As an alternative to the spatiotemporal logical formulation, we also propose a way to formulate a linear regression function that uses all of the image features to learn what chronic hypoxia looks like, and then gives a quantitative similarity score once it is trained on a set of histology images.	[Sundstrom, Andrew] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Grabocka, Elda; Bar-Sagi, Dafna] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY USA; [Sundstrom, Andrew; Mishra, Bud] NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA	Icahn School of Medicine at Mount Sinai; New York University; New York University	Sundstrom, A (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.; Sundstrom, A (corresponding author), NYU, Courant Inst Math Sci, Dept Comp Sci, New York, NY 10012 USA.	andrew.sundstrom@mssm.edu	Sundstrom, Andrew/AAI-3621-2021	Sundstrom, Andrew/0000-0002-3378-4513; Grabocka, E/0000-0001-7196-8498; Bar-Sagi, Dafna/0000-0003-2597-8948	National Science Foundation [DGE-0333389, CNS-0926166]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation - DGE-0333389 - IGERT: Program in Computation (http.//www.nsf.gov/) (AS), and National Science Foundation - CNS-0926166 - Collaborative Research: Next-Generation Model Checking and Abstract Interpretation with a Focus on Embedded Control and Systems Biology (http://www.nsf.gov) (BM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, CELL; BEATON AE, 1974, TECHNOMETRICS, V16, P147, DOI 10.2307/1267936; Cardenas-Navia LI, 2008, CANCER RES, V68, P5812, DOI 10.1158/0008-5472.CAN-07-6387; Cirri P, 2011, AM J CANCER RES, V1, P482; Giaccia AJ, 2010, CURR TOP MICROBIOL, V345, P31, DOI 10.1007/82_2010_73; Goldman D, 2008, MICROCIRCULATION, V15, P795, DOI 10.1080/10739680801938289; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Green DR, 2011, MEANS END APOPTOSIS; Grosu R, 2009, COMMUN ACM, V52, P97, DOI 10.1145/1467247.1467271; Guderlei R, 2007, IMAGE VISION COMPUT, V25, P464, DOI 10.1016/j.imavis.2006.07.019; Haijun Gong, 2010, Algebraic and Numeric Biology. 4th International Conference, ANB 2010. Revised Selected Papers, P117, DOI 10.1007/978-3-642-28067-2_7; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hockel M, 1996, CANCER RES, V56, P4509; Hutterer S., 2012, 2012 IEEE Symposium on Computational Intelligence in Bioinformatics and Computational Biology (CIBCB), P105, DOI 10.1109/CIBCB.2012.6217218; James W, 1961, P BERK S MATH STAT P, P316; Jha SK, 2009, LECT N BIOINFORMAT, V5688, P218, DOI 10.1007/978-3-642-03845-7_15; Kang K A, 1988, Adv Exp Med Biol, V222, P747; Kavanagh BD, 2002, INT J RADIAT ONCOL, V53, P172, DOI 10.1016/S0360-3016(02)02740-2; Kirkpatrick JP, 2003, RADIAT RES, V159, P336, DOI 10.1667/0033-7587(2003)159[0336:AMMOTO]2.0.CO;2; Kleinberg J., 2006, ALGORITHM DESIGN, P261; Krogh A, 1919, J PHYSIOL-LONDON, V52, P391, DOI 10.1113/jphysiol.1919.sp001838; Krogh A, 1919, J PHYSIOL-LONDON, V52, P457, DOI 10.1113/jphysiol.1919.sp001844; Krogh A, 1919, J PHYSIOL-LONDON, V52, P409, DOI 10.1113/jphysiol.1919.sp001839; Legland David, 2007, Image Analysis & Stereology, V26, P83, DOI 10.5566/ias.v26.p83-92; Michielsen K, 2001, PHYS REP, V347, P462; Osinsky S, 2011, CLIN TRANSL ONCOL, V13, P133, DOI 10.1007/s12094-011-0630-0; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Rath C, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/12/125010; Roque WL, 2009, BRAZILIAN J RHEUMATO, V49, P146; SECOMB TW, 1993, INT J RADIAT ONCOL, V25, P481, DOI 10.1016/0360-3016(93)90070-C; Sen A, 1990, REGRESSION ANAL THEO, P253; Simon M.C, 2010, DIVERSE EFFECTS HYPO, V345; Sundstrom A, 2012, IEEE T INF TECHNOL B, V16, P1200, DOI 10.1109/TITB.2012.2206819; TANNOCK IF, 1970, CANCER RES, V30, P2470; THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Wang CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015818; Weibel ER, 2013, J EXP BIOL, V216, P4135, DOI 10.1242/jeb.076497; Zuliani P, 2010, HSSC 10: PROCEEDINGS OF THE 13TH ACM INTERNATIONAL CONFERENCE ON HYBRID SYSTEMS: COMPUTATION AND CONTROL, P243	39	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153623	10.1371/journal.pone.0153623	http://dx.doi.org/10.1371/journal.pone.0153623			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093539	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200033
J	Findlay, SD; Vincent, KM; Berman, JR; Postovit, LM				Findlay, Scott D.; Vincent, Krista M.; Berman, Jennifer R.; Postovit, Lynne-Marie			A Digital PCR-Based Method for Efficient and Highly Specific Screening of Genome Edited Cells	PLOS ONE			English	Article							EFFECTOR NUCLEASES; KNOCKOUT; GENERATION; TALENS; DESIGN; SYSTEM; TOOLS	The rapid adoption of gene editing tools such as CRISPRs and TALENs for research and eventually therapeutics necessitates assays that can rapidly detect and quantitate the desired alterations. Currently, the most commonly used assay employs "mismatch nucleases" T7E1 or "Surveyor" that recognize and cleave heteroduplexed DNA amplicons containing mismatched base-pairs. However, this assay is prone to false positives due to cancer-associated mutations and/or SNPs and requires large amounts of starting material. Here we describe a powerful alternative wherein droplet digital PCR (ddPCR) can be used to decipher homozygous from heterozygous mutations with superior levels of both precision and sensitivity. We use this assay to detect knockout inducing alterations to stem cell associated proteins, NODAL and SFRP1, generated using either TALENs or an "all-in-one" CRISPR/Cas plasmid that we have modified for one-step cloning and blue/white screening of transformants. Moreover, we highlight how ddPCR can be used to assess the efficiency of varying TALEN-based strategies. Collectively, this work highlights how ddPCR-based screening can be paired with CRISPR and TALEN technologies to enable sensitive, specific, and streamlined approaches to gene editing and validation.	[Findlay, Scott D.; Vincent, Krista M.] Univ Western Ontario, Dept Anat & Cell Biol, Fac Med & Dent, London, ON, Canada; [Findlay, Scott D.; Vincent, Krista M.; Postovit, Lynne-Marie] Univ Alberta, Dept Oncol, Fac Med & Dent, Edmonton, AB, Canada; [Berman, Jennifer R.] Biorad Labs, Digital Biol Ctr, Pleasanton, CA USA	Western University (University of Western Ontario); University of Alberta	Postovit, LM (corresponding author), Univ Alberta, Dept Oncol, Fac Med & Dent, Edmonton, AB, Canada.	postovit@ualberta.ca	Findlay, Scott D/AAP-9554-2021	Findlay, Scott D/0000-0002-0393-1623; Postovit, Lynne-Marie/0000-0002-8088-4197	Canadian Institutes for Health Research [PLS 9538, PLS 95381]; Alberta Cancer Foundation; Women and Children's Health Research Institute; Alberta Innovates Health Solutions; Natural Sciences and Engineering Research Council of Canada; Ontario Graduate Scholarship; CIHR; Sawin-Baldwin Chair in Ovarian Cancer; Dr. Anthony Noujaim Legacy Oncology Chair; AIHS translational health chair in cancer; Canadian Foundation for Innovation Leaders Opportunity Fund [32351]; Alberta Innovates [201300495] Funding Source: researchfish	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Cancer Foundation; Women and Children's Health Research Institute; Alberta Innovates Health Solutions; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Graduate Scholarship(Ontario Graduate Scholarship); CIHR(Canadian Institutes of Health Research (CIHR)); Sawin-Baldwin Chair in Ovarian Cancer; Dr. Anthony Noujaim Legacy Oncology Chair; AIHS translational health chair in cancer; Canadian Foundation for Innovation Leaders Opportunity Fund(Canada Foundation for Innovation); Alberta Innovates	This work was supported by the Canadian Institutes for Health Research (PLS 9538 and PLS 95381), the Alberta Cancer Foundation, the Women and Children's Health Research Institute and Alberta Innovates Health Solutions. SDF has been supported by a doctoral scholarship from the Natural Sciences and Engineering Research Council of Canada, and an Ontario Graduate Scholarship. KMV is a Vanier scholar. LMP is the recipient of the premier new investigator award from the CIHR, the Sawin-Baldwin Chair in Ovarian Cancer, the Dr. Anthony Noujaim Legacy Oncology Chair and the AIHS translational health chair in cancer. The droplet digital PCR platform was funded by the Canadian Foundation for Innovation Leaders Opportunity Fund (project 32351) awarded to LMP. JRB is an employee of Bio-Rad Laboratories. Funders provided support in terms of salaries for authors and grants for research materials, but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Bell CC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1002; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Cong L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1962; Corbisier P, 2015, ANAL BIOANAL CHEM, V407, P1831, DOI 10.1007/s00216-015-8458-z; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Doyle EL, 2012, NUCLEIC ACIDS RES, V40, pW117, DOI 10.1093/nar/gks608; Flemr M, 2015, CELL REP, V12, P709, DOI 10.1016/j.celrep.2015.06.051; Frank S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-773; Hendel A, 2015, TRENDS BIOTECHNOL, V33, P132, DOI 10.1016/j.tibtech.2014.12.001; Jankele R, 2014, BRIEF FUNCT GENOMICS, V13, P409, DOI 10.1093/bfgp/elu013; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kim Y, 2013, NAT METHODS, V10, P185, DOI [10.1038/nmeth.2364, 10.1038/NMETH.2364]; Lin YN, 2014, METHODS MOL BIOL, V1114, P203, DOI 10.1007/978-1-62703-761-7_13; Miyaoka Y, 2014, NAT METHODS, V11, P291, DOI 10.1038/nmeth.2840; Mock U, 2015, NUCLEIC ACIDS RES, V43, P5560, DOI 10.1093/nar/gkv469; Quail DF, 2013, INT J BIOCHEM CELL B, V45, P885, DOI 10.1016/j.biocel.2012.12.021; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Streubel J, 2012, NAT BIOTECHNOL, V30, P593, DOI 10.1038/nbt.2304; Sun N, 2013, BIOTECHNOL BIOENG, V110, P1811, DOI 10.1002/bit.24890; Sung YH, 2014, GENOME RES, V24, P125, DOI 10.1101/gr.163394.113; Surana R, 2014, BBA-REV CANCER, V1845, P53, DOI 10.1016/j.bbcan.2013.11.004; Vouillot L, 2015, G3-GENES GENOM GENET, V5, P407, DOI 10.1534/g3.114.015834; Wang K, 2015, J BIOTECHNOL, V214, P128, DOI 10.1016/j.jbiotec.2015.09.029; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Yang Z, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv126; Yu C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098282	28	47	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153901	10.1371/journal.pone.0153901	http://dx.doi.org/10.1371/journal.pone.0153901			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089539	gold, Green Submitted, Green Published			2022-12-27	WOS:000374527000057
J	Tzekov, R; Dawson, C; Orlando, M; Mouzon, B; Reed, J; Evans, J; Crynen, G; Mullan, M; Crawford, F				Tzekov, Radouil; Dawson, Clint; Orlando, Megan; Mouzon, Benoit; Reed, Jon; Evans, James; Crynen, Gogce; Mullan, Michael; Crawford, Fiona			Sub-Chronic Neuropathological and Biochemical Changes in Mouse Visual System after Repetitive Mild Traumatic Brain Injury	PLOS ONE			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; MICROTUBULE-ASSOCIATED PROTEINS; RETINAL GANGLION-CELLS; HEAT-SHOCK PROTEINS; OPTIC-NERVE LESION; AXONAL-TRANSPORT; BASIC-PROTEIN; ALTERED EXPRESSION; APOLIPOPROTEIN-E; CATHEPSIN-D	Repetitive mild traumatic brain injury (r-mTBI) results in neuropathological and biochemical consequences in the human visual system. Using a recently developed mouse model of r-mTBI, with control mice receiving repetitive anesthesia alone (r-sham) we assessed the effects on the retina and optic nerve using histology, immunohistochemistry, proteomic and lipidomic analyses at 3 weeks post injury. Retina tissue was used to determine retinal ganglion cell (RGC) number, while optic nerve tissue was examined for cellularity, myelin content, protein and lipid changes. Increased cellularity and areas of demyelination were clearly detectable in optic nerves in r-mTBI, but not in r-sham. These changes were accompanied by a similar to 25% decrease in the total number of Brn3a-positive RGCs. Proteomic analysis of the optic nerves demonstrated various changes consistent with a negative effect of r-mTBI on major cellular processes like depolymerization of microtubules, disassembly of filaments and loss of neurons, manifested by decrease of several proteins, including neurofilaments (NEFH, NEFM, NEFL), tubulin (TUBB2A, TUBA4A), microtubule-associated proteins (MAP1A, MAP1B), collagen (COL6A1, COL6A3) and increased expression of other proteins, including heat shock proteins (HSP90B1, HSPB1), APOE and cathepsin D. Lipidomic analysis showed quantitative changes in a number of phospholipid species, including a significant increase in the total amount of lysophosphatidylcholine (LPC), including the molecular species 16:0, a known demyelinating agent. The overall amount of some ether phospholipids, like ether LPC, ether phosphatidylcholine and ether lysophosphatidylethanolamine were also increased, while the majority of individual molecular species of ester phospholipids, like phosphatidylcholine and phosphatidylethanolamine, were decreased. Results from the biochemical analysis correlate well with changes detected by histological and immunohistochemical methods and indicate the involvement of several important molecular pathways. This will allow future identification of therapeutic targets for improving the visual consequences of r-mTBI.	[Tzekov, Radouil; Dawson, Clint; Orlando, Megan; Mouzon, Benoit; Reed, Jon; Evans, James; Crynen, Gogce; Mullan, Michael; Crawford, Fiona] Roskamp Inst, Sarasota, FL USA; [Tzekov, Radouil] Univ S Florida, Dept Ophthalmol, Tampa, FL USA; [Tzekov, Radouil; Mouzon, Benoit; Evans, James; Crawford, Fiona] James A Haley Vet Adm, Tampa, FL USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Tzekov, R (corresponding author), Roskamp Inst, Sarasota, FL USA.; Tzekov, R (corresponding author), Univ S Florida, Dept Ophthalmol, Tampa, FL USA.; Tzekov, R (corresponding author), James A Haley Vet Adm, Tampa, FL USA.	rtzekov@roskampinstitute.net	Dawson, Clint/AAH-3213-2021	Dawson, Clint/0000-0001-7273-0684; Tzekov, Radouil/0000-0002-3662-9818	Department of Defense [W81XWH-10-1-0759]; Roskamp Foundation	Department of Defense(United States Department of Defense); Roskamp Foundation	This work was supported by Department of Defense award W81XWH-10-1-0759 (to Fiona Crawford), and the Roskamp Foundation.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; ADAMCZEWSKAGONCERZEWICZ Z, 1981, J NEUROCHEM, V36, P1378, DOI 10.1111/j.1471-4159.1981.tb00575.x; Agudo-Barriuso M, 2011, MYSTERY GLAUCOMA, P91; Aquino DA, 1997, J NEUROPATH EXP NEUR, V56, P664; Atkins Edward J, 2008, Rev Neurol Dis, V5, P73; Beaulieu JM, 1999, BIOCHEM CELL BIOL, V77, P41, DOI 10.1139/bcb-77-1-41; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilyk J R, 1994, Semin Ophthalmol, V9, P200, DOI 10.3109/08820539409060016; Blondeau N, 2002, J CEREBR BLOOD F MET, V22, P821, DOI 10.1097/00004647-200207000-00007; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; CAMMER W, 1986, BRAIN RES, V364, P91, DOI 10.1016/0006-8993(86)90990-X; Carroll W M, 1983, Clin Exp Neurol, V19, P17; Chen H, 2014, SURV OPHTHALMOL, V59, P64, DOI 10.1016/j.survophthal.2013.02.005; Chidlow G, 2005, MOL VIS, V11, P387; Chidlow G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114838; Cho Y, 2015, J BIOL CHEM, V290, P22759, DOI 10.1074/jbc.M115.638445; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cwiklinska H, 2003, INT IMMUNOL, V15, P241, DOI 10.1093/intimm/dxg022; DAS SK, 1978, LIPIDS, V13, P679, DOI 10.1007/BF02533745; de Monasterio-Schrader P, 2012, CELL MOL LIFE SCI, V69, P2879, DOI 10.1007/s00018-012-0958-9; Dieterich DC, 2002, EUR J NEUROSCI, V15, P1433, DOI 10.1046/j.1460-9568.2002.01977.x; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GOTO K, 1990, NEUROSCI LETT, V117, P269, DOI 10.1016/0304-3940(90)90675-Y; Greenwald BD, 2012, BRAIN INJURY, V26, P1338, DOI 10.3109/02699052.2012.706356; Grzelczyk A, 2013, BIOCHIMIE, V95, P667, DOI 10.1016/j.biochi.2012.10.009; Gupta R, 2005, J ORTHOP RES, V23, P1232, DOI 10.1016/j.orthres.2004.12.010; Hensley K, 2011, MOL NEUROBIOL, V43, P180, DOI 10.1007/s12035-011-8166-4; HERRMANN H, 1985, J BIOL CHEM, V260, P5797; Hsieh CC, 2000, ATHEROSCLEROSIS, V151, P481, DOI 10.1016/S0021-9150(00)00453-6; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; Ikeno Y, 2009, J NEUROSCI RES, V87, P190, DOI 10.1002/jnr.21821; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Joachim SC, 2011, INVEST OPHTH VIS SCI, V52, P3468, DOI 10.1167/iovs.10-5763; Johnson EC, 2007, INVEST OPHTH VIS SCI, V48, P3161, DOI 10.1167/iovs.06-1282; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kubo T, 2002, J NEUROCHEM, V82, P1129, DOI 10.1046/j.1471-4159.2002.01060.x; Kuhlmann T, 2002, J NEUROSCI RES, V67, P185, DOI 10.1002/jnr.10104; Lachapelle F, 2005, BRAIN PATHOL, V15, P198; Lavi S, 2007, CIRCULATION, V115, P2715, DOI 10.1161/CIRCULATIONAHA.106.671420; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Li Y, 2011, J CELL BIOCHEM, V112, P1930, DOI 10.1002/jcb.23113; Lin PC, 2011, J BIOL CHEM, V286, P41466, DOI 10.1074/jbc.M111.283580; LIU KM, 1985, CELL TISSUE RES, V242, P245; Martin A, 2003, J NEUROSCI, V23, P5416; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; MCKERRACHER L, 1990, J NEUROSCI, V10, P2834; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nagai J, 2011, J NEUROCHEM, V118, P256, DOI 10.1111/j.1471-4159.2011.07297.x; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; NIXON RA, 1984, J NEUROCHEM, V43, P507, DOI 10.1111/j.1471-4159.1984.tb00928.x; NIXON RA, 1990, J CELL BIOL, V110, P437, DOI 10.1083/jcb.110.2.437; Padilla ND, 2003, IMMUNOLOGY, V109, P564, DOI 10.1046/j.1365-2567.2003.01681.x; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Prilloff S, 2012, INVEST OPHTH VIS SCI, V53, P1460, DOI 10.1167/iovs.11-8306; Raasakka A, 2014, NEUROSCI BULL, V30, P956, DOI 10.1007/s12264-013-1437-5; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Rosenberger TA, 2002, J LIPID RES, V43, P59; Saab S, 2014, BIOCHIMIE, V107, P58, DOI 10.1016/j.biochi.2014.07.023; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Saunders LL, 2009, ARCH PHYS MED REHAB, V90, P1853, DOI 10.1016/j.apmr.2009.05.020; Schilling T, 2009, J CELL PHYSIOL, V221, P325, DOI 10.1002/jcp.21857; SCHMIDTKASTNER R, 1994, RESTOR NEUROL NEUROS, V6, P145, DOI 10.3233/RNN-1994-6208; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SCHOENFELD TA, 1989, J NEUROSCI, V9, P1712; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Sherafat MA, 2011, NEUROCHEM RES, V36, P1887, DOI 10.1007/s11064-011-0510-6; SNYDER DS, 1985, J NEUROCYTOL, V14, P579, DOI 10.1007/BF01200799; STOLL G, 1989, GLIA, V2, P170, DOI 10.1002/glia.440020306; Surgucheva I, 2002, J NEUROSCI RES, V68, P97, DOI 10.1002/jnr.10198; Surguchov A, 2001, J NEUROSCI RES, V65, P68, DOI 10.1002/jnr.1129; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Teigler A, 2009, HUM MOL GENET, V18, P1897, DOI 10.1093/hmg/ddp110; Thukkani AK, 2003, CIRCULATION, V108, P3128, DOI 10.1161/01.CIR.0000104564.01539.6A; Tytell M, 2005, INT J HYPERTHER, V21, P445, DOI 10.1080/02656730500041921; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Wang JQ, 2013, J NEUROPATH EXP NEUR, V72, P768, DOI 10.1097/NEN.0b013e31829d8d9d; Wender M, 1981, Acta Neuropathol Suppl, V7, P36; Wong EV, 2003, J NEUROSCI, V23, P3112; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; You YY, 2011, INVEST OPHTH VIS SCI, V52, P6911, DOI 10.1167/iovs.11-7434; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497; Yuan AD, 2006, J NEUROSCI, V26, P10006, DOI 10.1523/JNEUROSCI.2580-06.2006; Zhao J, 2016, METHOD ENZYMOL, V568, P477, DOI 10.1016/bs.mie.2015.09.012; Zhou ZG, 2011, LIPIDS, V46, P879, DOI 10.1007/s11745-011-3575-8; Zhu XD, 2007, AM J RESP CELL MOL, V36, P585, DOI 10.1165/rcmb.2006-0391OC	92	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153608	10.1371/journal.pone.0153608	http://dx.doi.org/10.1371/journal.pone.0153608			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088355	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000029
J	Costantini, R; Affaitati, G; Massimini, F; Tana, C; Innocenti, P; Giamberardino, MA				Costantini, Raffaele; Affaitati, Giannapia; Massimini, Francesca; Tana, Claudio; Innocenti, Paolo; Giamberardino, Maria Adele			Laparoscopic Cholecystectomy for Gallbladder Calculosis in Fibromyalgia Patients: Impact on Musculoskeletal Pain, Somatic Hyperalgesia and Central Sensitization	PLOS ONE			English	Article							POSTOPERATIVE OPIOID CONSUMPTION; SURVEY CRITERIA; REFERRED PAIN; RISK-FACTORS; ARTHROPLASTY; WOMEN	Fibromyalgia, a chronic syndrome of diffuse musculoskeletal pain and somatic hyperalgesia from central sensitization, is very often comorbid with visceral pain conditions. In fibromyalgia patients with gallbladder calculosis, this study assessed the short and long-term impact of laparoscopic cholecystectomy on fibromyalgia pain symptoms. Fibromyalgia pain (VAS scale) and pain thresholds in tender points and control areas (skin, subcutis and muscle) were evaluated 1 week before (basis) and 1 week, 1,3,6 and 12 months after laparoscopic cholecystectomy in fibromyalgia patients with symptomatic calculosis (n = 31) vs calculosis patients without fibromyalgia (n. 26) and at comparable time points in fibromyalgia patients not undergoing cholecystectomy, with symptomatic (n = 27) and asymptomatic (n = 28) calculosis, and no calculosis (n = 30). At basis, fibromyalgia+symptomatic calculosis patients presented a significant linear correlation between the number of previously experienced biliary colics and fibromyalgia pain (direct) and muscle thresholds (inverse) (p<0.0001). After cholecystectomy, fibromyalgia pain significantly increased and all thresholds significantly decreased at 1 week and 1 month (1-way ANOVA, p<0.01-p<0.001), the decrease in muscle thresholds correlating linearly with the peak postoperative pain at surgery site (p<0.003-p<0.0001). Fibromyalgia pain and thresholds returned to preoperative values at 3 months, then pain significantly decreased and thresholds significantly increased at 6 and 12 months (p<0.05-p<0.0001). Over the same 12-month period: in non-fibromyalgia patients undergoing cholecystectomy thresholds did not change; in all other fibromyalgia groups not undergoing cholecystectomy fibromyalgia pain and thresholds remained stable, except in fibromyalgia+symptomatic calculosis at 12 months when pain significantly increased and muscle thresholds significantly decreased (p<0.05-p<0.0001). The results of the study show that biliary colics from gallbladder calculosis represent an exacerbating factor for fibromyalgia symptoms and that laparoscopic cholecystectomy produces only a transitory worsening of these symptoms, largely compensated by the long-term improvement/desensitization due to gallbladder removal. This study provides new insights into the role of visceral pain comorbidities and the effects of their treatment on fibromyalgia pain/hypersensitivity.	[Costantini, Raffaele; Innocenti, Paolo] Univ G dAnnunzio, Inst Surg Pathol, Chieti, Italy; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, Dept Med & Sci Aging, Fibromyalgia & Musculoskeletal Pain Ctr, Chieti, Italy; [Affaitati, Giannapia; Giamberardino, Maria Adele] Univ G dAnnunzio, CeSI, Chieti, Italy; [Massimini, Francesca] Univ G dAnnunzio, Inst Clin Pathol, Chieti, Italy; [Tana, Claudio] AUSL Reggio Emilia, Guastalla Hosp, Internal Med Unit, Reggio Emilia, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Costantini, R (corresponding author), Univ G dAnnunzio, Inst Surg Pathol, Chieti, Italy.	r.costantini@unich.it	Tana, Claudio/L-5576-2019	Tana, Claudio/0000-0002-9162-7866				Abeles AM, 2007, ANN INTERN MED, V146, P726, DOI 10.7326/0003-4819-146-10-200705150-00006; Ablin JN, 2015, BEST PRACT RES CL RH, V29, P20, DOI 10.1016/j.berh.2015.04.018; Affaitati G, 2011, EUR J PAIN, V15, P61, DOI 10.1016/j.ejpain.2010.09.002; Blichfeldt-Eckhardt MR, 2014, PAIN, V155, P2400, DOI 10.1016/j.pain.2014.09.019; Brummett CM, 2013, ANESTHESIOLOGY, V119, P1434, DOI 10.1097/ALN.0b013e3182a8eb1f; Brummett CM, 2011, CURR OPIN ANESTHESIO, V24, P532, DOI 10.1097/ACO.0b013e32834a1091; Caldarella MP, 2006, AM J GASTROENTEROL, V101, P2782, DOI 10.1111/j.1572-0241.2006.00823.x; Clauw DJ, 2015, MAYO CLIN PROC, V90, P680, DOI 10.1016/j.mayocp.2015.03.014; Costantini R, 2005, J GASTROINTEST SURG, V9, P822, DOI 10.1016/j.gassur.2005.01.286; Costantini R, 2011, INT J CLIN PHARM TH, V49, P116, DOI 10.5414/CP201401; Costantini R, 2012, ANN ITAL CHIR, V83, P245; D'Apuzzo MR, 2012, ORTHOPEDICS, V35, pE175, DOI 10.3928/01477447-20120123-18; Drewes AM, 2015, POSTOPERATIVE PAIN S, P35; Fischer AA, 1998, J MUSCULOSKELET PAIN, V6, P1, DOI 10.1300/J094v06n01_01; Gerwin R, 2013, PAIN MED, V14, P777, DOI 10.1111/pme.12169; Giamberardino MA, 2005, PAIN, V114, P239, DOI 10.1016/j.pain.2004.12.024; Giamberardino MA, 2014, CURR OPIN OBSTET GYN, V26, P253, DOI 10.1097/GCO.0000000000000083; Giamberardino MA, 2011, BEST PRACT RES CL RH, V25, P185, DOI 10.1016/j.berh.2011.01.002; Giamberardino MA, 2011, CURR PAIN HEADACHE R, V15, P393, DOI 10.1007/s11916-011-0205-3; Giamberardino MA, 2010, J MUSCULOSKELET PAIN, V18, P403, DOI 10.3109/10582452.2010.502624; Giamberardino MA, 2010, PAIN, V151, P307, DOI 10.1016/j.pain.2010.06.023; Giamberardino MA, 2006, HAND CLINIC, V81, P343, DOI 10.1016/S0072-9752(06)80028-X; Janda AM, 2015, ANESTHESIOLOGY, V122, P1103, DOI 10.1097/ALN.0000000000000637; Kato K, 2006, ARCH INTERN MED, V166, P1649, DOI 10.1001/archinte.166.15.1649; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kehlet H, 2015, POSTOPERATIVE PAIN S, P1; Kjaer DW, 2006, WORLD J GASTROENTERO, V12, P7522, DOI 10.3748/wjg.v12.i46.7522; Obrosova IG, 2009, NEUROTHERAPEUTICS, V6, P638, DOI 10.1016/j.nurt.2009.07.004; Parkman HP, 2013, DIGEST DIS SCI, V58, P1062, DOI 10.1007/s10620-013-2596-y; Pogatzki-Zahn EM, 2009, CURR OPIN ANESTHESIO, V22, P627, DOI 10.1097/ACO.0b013e32833037d2; Souto MM, 2015, SURG LAPAROSC ENDOSC; Stawowy M, 2006, SCAND J GASTROENTERO, V41, P833, DOI 10.1080/00365520500463332; VECCHIET L, 1994, PROG PAIN RES MANAG, V2, P177; Viggiano A, 2009, PAIN PRACT, V9, P260, DOI 10.1111/j.1533-2500.2009.00287.x; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140	36	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153408	10.1371/journal.pone.0153408	http://dx.doi.org/10.1371/journal.pone.0153408			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081848	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800018
J	Klenk, J; Dallmeier, D; Denkinger, MD; Rapp, K; Koenig, W; Rothenbacher, D				Klenk, Jochen; Dallmeier, Dhayana; Denkinger, Michael Dieter; Rapp, Kilian; Koenig, Wolfgang; Rothenbacher, Dietrich		ActiFE Study Grp	Objectively Measured Walking Duration and Sedentary Behaviour and Four-Year Mortality in Older People	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; VIGOROUS PHYSICAL-ACTIVITY; CORONARY-HEART-DISEASE; QUALITY-OF-LIFE; METAANALYSIS; ADULTS; TIME; INTENSITY; EPIDEMIOLOGY; ASSOCIATIONS	Background Physical activity is an important component of health. Recommendations based on sensor measurements are sparse in older people. The aim of this study was to analyse the effect of objectively measured walking and sedentary duration on four-year mortality in community-dwelling older people. Methods Between March 2009 and April 2010, physical activity of 1271 participants (>= 65 years, 56.4% men) from Southern Germany was measured over one week using a thigh-worn uni-axial accelerometer (activPAL; PAL Technologies, Glasgow, Scotland). Mortality was assessed during a four-year follow-up. Cox-proportional-hazards models were used to estimate the associations between walking (including low to high intensity) and sedentary duration with mortality. Models were adjusted for age and sex, additional epidemiological variables, and selected biomarkers. Results An inverse relationship between walking duration and mortality with a minimum risk for the 3rd quartile (102.2 to 128.4 minutes walking daily) was found even after multivariate adjustment with HRs for quartiles 2 to 4 compared to quartile 1 of 0.45 (95%-CI: 0.26; 0.76), 0.18 (95%-CI: 0.08; 0.41), 0.39 (95%-CI: 0.19; 0.78), respectively. For sedentary duration an age-and sex-adjusted increased mortality risk was observed for the 4th quartile (daily sedentary duration >= 1137.2 min.) (HR 2.05, 95%-CI: 1.13; 3.73), which diminished, however, after full adjustment (HR 1.63, 95%-CI: 0.88; 3.02). Furthermore, our results suggest effect modification between walking and sedentary duration, such that in people with low walking duration a high sedentary duration was noted as an independent factor for increased mortality. Conclusions In summary, walking duration was clearly associated with four-year overall mortality in community-dwelling older people.	[Klenk, Jochen; Rapp, Kilian; Rothenbacher, Dietrich] Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany; [Klenk, Jochen; Rapp, Kilian] Robert Bosch Krankenhaus, Dept Geriatr & Geriatr Rehabil, Stuttgart, Germany; [Dallmeier, Dhayana; Koenig, Wolfgang] Univ Ulm, Med Ctr, Dept Internal Med Cardiol 2, D-89069 Ulm, Germany; [Dallmeier, Dhayana; Denkinger, Michael Dieter] Univ Ulm, Geriatr Res Unit, Agaples Bethesda Hosp, D-89069 Ulm, Germany; [Dallmeier, Dhayana; Denkinger, Michael Dieter] Geriatr Ctr Ulm Alb Donau, Ulm, Germany; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Koenig, Wolfgang] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany	Ulm University; Bosch; Robert Bosch Krankenhaus; Ulm University; Ulm University; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Klenk, J (corresponding author), Univ Ulm, Inst Epidemiol & Med Biometry, D-89069 Ulm, Germany.; Klenk, J (corresponding author), Robert Bosch Krankenhaus, Dept Geriatr & Geriatr Rehabil, Stuttgart, Germany.	jochen.klenk@uni-ulm.de	Klenk, Jochen/C-2164-2012; Rapp, Kilian/AAJ-3370-2020; Denkinger, Michael D/E-1814-2013; Stingl, Julia C./ABA-7201-2020; Dallmeier, Dhayana/A-1169-2015; Klenk, Jochen/R-3614-2019; Steinacker, Juergen M. M/E-6876-2015	Rapp, Kilian/0000-0003-1625-2571; Denkinger, Michael D/0000-0002-8097-060X; Stingl, Julia C./0000-0002-1566-8156; Dallmeier, Dhayana/0000-0003-3665-7023; Klenk, Jochen/0000-0002-5987-447X; Steinacker, Juergen M. M/0000-0001-8901-9450; Rothenbacher, Dietrich/0000-0002-3563-2791; Koenig, Wolfgang/0000-0002-2064-9603	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University; "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany	The study was funded by a grant from the Ministry of Science, Research and Arts, state of Baden-Wuerttemberg, Germany, as part of the Geriatric Competence Center, Ulm University. Dhayana Dallmeier was supported by the "Hertha-Nathorff" Program at Ulm University for the professional development of female physicians in research. Kilian Rapp and Michael Denkinger were supported by a "Forschungskolleg Geriatrie" grant from the Robert Bosch Foundation, Stuttgart, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, NUTR REV, V67, P114, DOI 10.1111/j.1753-4887.2008.00136.x; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bellavia A, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-94; Bembom O, 2009, EPIDEMIOLOGY, V20, P424, DOI 10.1097/EDE.0b013e31819e3f28; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Davis MG, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-116; Denkinger MD, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-50; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fried LP, 1996, J GERONTOL A-BIOL, V51, pM206, DOI 10.1093/gerona/51A.5.M206; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Hamer M, 2008, BRIT J SPORT MED, V42, P238, DOI 10.1136/bjsm.2007.039974; Hamer M, 2008, SCAND J MED SCI SPOR, V18, P736, DOI 10.1111/j.1600-0838.2007.00747.x; Healy GN, 2008, DIABETES CARE, V31, P369, DOI 10.2337/dc07-1795; Janz KF, 2006, BRIT J SPORT MED, V40, P191, DOI 10.1136/bjsm.2005.023036; Jefferis BJ, 2015, MED SCI SPORT EXER, V47, P343, DOI 10.1249/MSS.0000000000000410; Jefferis BJ, 2014, J AM GERIATR SOC, V62, P599, DOI 10.1111/jgs.12748; Kelly P, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0132-x; Klenk J, 2013, J EPIDEMIOL COMMUN H, V67, P194, DOI 10.1136/jech-2012-201312; Klenk J, 2012, J EPIDEMIOL COMMUN H, V66, P474, DOI 10.1136/jech.2010.128090; Koster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037696; Landi F, 2008, PREV MED, V47, P422, DOI 10.1016/j.ypmed.2008.06.020; Lee IM, 2000, AM J EPIDEMIOL, V151, P293, DOI 10.1093/oxfordjournals.aje.a010205; Lord S, 2011, AGE AGEING, V40, P205, DOI 10.1093/ageing/afq166; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Motl RW, 2010, PHYS MED REH CLIN N, V21, P299, DOI 10.1016/j.pmr.2009.12.006; Murphy MH, 2007, PREV MED, V44, P377, DOI 10.1016/j.ypmed.2006.12.008; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI [10.1249/mss.0b013e3180616aa2, 10.1161/CIRCULATIONAHA.107.185650]; Ortlieb S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111206; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Rothenbacher D, 2003, ARCH INTERN MED, V163, P1200, DOI 10.1001/archinte.163.10.1200; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; Samitz G, 2011, INT J EPIDEMIOL, V40, P1382, DOI 10.1093/ije/dyr112; Schnohr P, 2007, EUR J CARDIOV PREV R, V14, P72, DOI 10.1097/HJR.0b013e3280144470; Spirduso WW, 2001, MED SCI SPORT EXER, V33, pS598, DOI 10.1097/00005768-200106001-00028; Taraldsen K, 2012, MATURITAS, V71, P13, DOI 10.1016/j.maturitas.2011.11.003; Varo JJ, 2003, INT J EPIDEMIOL, V32, P138, DOI 10.1093/ije/dyg116; VERBRUGGE LM, 1994, SOC SCI MED, V38, P1, DOI 10.1016/0277-9536(94)90294-1; Voukelatos A, 2015, AGE AGEING, V44, P377, DOI 10.1093/ageing/afu186; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; Woodcock J, 2011, INT J EPIDEMIOL, V40, P121, DOI 10.1093/ije/dyq104	41	33	34	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153779	10.1371/journal.pone.0153779	http://dx.doi.org/10.1371/journal.pone.0153779			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082963	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800052
J	Mugo, PM; Wahome, EW; Gichuru, EN; Mwashigadi, GM; Thiong'o, AN; Prins, HAB; de Wit, TFR; Graham, SM; Sanders, EJ				Mugo, Peter M.; Wahome, Elizabeth W.; Gichuru, Evanson N.; Mwashigadi, Grace M.; Thiong'o, Alexander N.; Prins, Henrieke A. B.; de Wit, Tobias F. Rinke; Graham, Susan M.; Sanders, Eduard J.			Effect of Text Message, Phone Call, and In-Person Appointment Reminders on Uptake of Repeat HIV Testing among Outpatients Screened for Acute HIV Infection in Kenya: A Randomized Controlled Trial	PLOS ONE			English	Article							ADULTS SEEKING CARE; FOLLOW-UP; SMS REMINDERS; COASTAL KENYA; RISK; TRANSMISSION; PREVALENCE; ATTENDANCE; DIAGNOSIS; MALARIA	Background Following HIV-1 acquisition, many individuals develop an acute retroviral syndrome and a majority seek care. Available antibody testing cannot detect an acute HIV infection, but repeat testing after 2-4 weeks may detect seroconversion. We assessed the effect of appointment reminders on attendance for repeat HIV testing. Methods We enrolled, in a randomized controlled trial, 18-29 year old patients evaluated for acute HIV infection at five sites in Coastal Kenya (ClinicalTrials.gov NCT01876199). Participants were allocated 1:1 to either standard appointment (a dated appointment card) or enhanced appointment (a dated appointment card plus SMS and phone call reminders, or in-person reminders for participants without a phone). The primary outcome was visit attendance, i.e., the proportion of participants attending the repeat test visit. Factors associated with attendance were examined by bivariable and multivariable logistic regression. Principal Findings Between April and July 2013, 410 participants were randomized. Attendance was 41% (85/207) for the standard group and 59%(117/199) for the enhanced group, for a relative risk of 1.4 [95% Confidence Interval, CI, 1.2-1.7]. Higher attendance was independently associated with older age, study site, and report of transactional sex in past month. Lower attendance was associated with reporting multiple partners in the past two months. Conclusions Appointment reminders through SMS, phone calls and in-person reminders increased the uptake of repeat HIV test by forty percent. This low-cost intervention could facilitate detection of acute HIV infections and uptake of recommended repeat testing.	[Mugo, Peter M.; Wahome, Elizabeth W.; Gichuru, Evanson N.; Mwashigadi, Grace M.; Thiong'o, Alexander N.; Prins, Henrieke A. B.; Graham, Susan M.; Sanders, Eduard J.] Kenya Govt Med Res Ctr, CGMR C, Kilifi, Kenya; [de Wit, Tobias F. Rinke; Sanders, Eduard J.] Univ Amsterdam, Acad Med Ctr, Dept Global Hlth, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [de Wit, Tobias F. Rinke] AIGHD, Amsterdam, Netherlands; [Graham, Susan M.] Univ Washington, Dept Med, Seattle, WA USA; [Graham, Susan M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Graham, Susan M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Sanders, Eduard J.] Univ Oxford, Nuffield Dept Med, Headington, England	Kenya Medical Research Institute; University of Amsterdam; Academic Medical Center Amsterdam; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Oxford	Mugo, PM (corresponding author), Kenya Govt Med Res Ctr, CGMR C, Kilifi, Kenya.	PMugo@kemri-wellcome.org	Prins, Henrieke/AAA-5247-2021	Prins, Henrieke/0000-0002-1452-7271	International AIDS Vaccine Initiative (IAVI); NIH [P30 AI027757, 1R34MH099946-01]; Wellcome Trust [077092]; United States Agency for International Development (USAID); NIH (NIAID); NIH (NCI); NIH (NIMH); NIH (NIDA); NIH (NICHD); NIH (NHLBI); NIH (NIA); NIH (NIGMS); NIH (NIDDK); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH099946] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); NIH (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the International AIDS Vaccine Initiative (IAVI) for funding this study. IAVI's work is made possible by generous support from many donors, (www.iavi.org). The authors thank the University of Washington Center for AIDS Research, an NIH funded program (P30 AI027757) supported by the following NIH Institutes and Centers (NIAID, NCI, NIMH, NIDA, NICHD, NHLBI, NIA, NIGMS, NIDDK) for supporting the high-risk cohort studies in Kilifi. The Centre for Geographic Medicine Research-Coast is supported by core funding from the Wellcome Trust (#077092). SMG was supported by NIH grant 1R34MH099946-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID, the NIH, or the US Government. This report was published with permission from KEMRI.	[Anonymous], 2014, HLTH SERVICES DELIVE; Bourne C, 2011, SEX TRANSM INFECT, V87, P229, DOI 10.1136/sti.2010.048397; Burton J, 2014, SEX TRANSM INFECT, V90, P11, DOI 10.1136/sextrans-2013-051228; Cohen MS, 2013, LANCET, V382, P1515, DOI 10.1016/S0140-6736(13)61998-4; Downer Sean R, 2006, Aust Health Rev, V30, P389; Downing SG, 2013, SEX TRANSM INFECT, V89, P16, DOI 10.1136/sextrans-2011-050454; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Guy R, 2013, SEX TRANSM INFECT, V89, P11, DOI 10.1136/sextrans-2011-050370; Kimanga DO, 2014, JAIDS-J ACQ IMM DEF, V66, pS13, DOI 10.1097/QAI.0000000000000124; Leong KC, 2006, FAM PRACT, V23, P699, DOI 10.1093/fampra/cml044; Liew SM, 2009, BRIT J GEN PRACT, V59, P916, DOI 10.3399/bjgp09X472250; Lindback S, 2000, AIDS, V14, P2333, DOI 10.1097/00002030-200010200-00014; NASCOP, 2010, OP MAN IMPL PROV IN; NASCOP, 2010, NAT GUID HIV TEST CO; National AIDS Control Council (NACC), 2014, KEN HIV EST REP; Odeny TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043832; Perron NJ, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-79; Pettifor A, 2011, AIDS BEHAV, V15, P1243, DOI 10.1007/s10461-010-9839-0; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Powers KA, 2011, LANCET, V378, P256, DOI 10.1016/S0140-6736(11)60842-8; Prins HAB, 2014, INT HEALTH, V6, P82, DOI 10.1093/inthealth/ihu024; Sanders EJ, 2014, AIDS, V28, P1357, DOI 10.1097/QAD.0000000000000245; Sanders EJ, 2011, AIDS, V25, P1219, DOI 10.1097/QAD.0b013e3283474ed5; Sanders EJ, 2015, AIDS IN PRESS, V29; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Serna-Bolea C, 2010, AIDS, V24, P603, DOI 10.1097/QAD.0b013e328335cda3; Smith MK, 2013, JAIDS-J ACQ IMM DEF, V63, pS187, DOI 10.1097/QAI.0b013e31829871e0; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963; UNAIDS, 2014, GAP REP 2014; Yeatman SE, 2015, JAIDS-J ACQ IMM DEF, V69, P126, DOI 10.1097/QAI.0000000000000536	31	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153612	10.1371/journal.pone.0153612	http://dx.doi.org/10.1371/journal.pone.0153612			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077745	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700095
J	Kirschner, F; Reppe, K; Andresen, N; Witzenrath, M; Ebstein, F; Kloetzel, PM				Kirschner, Felicia; Reppe, Katrin; Andresen, Nadine; Witzenrath, Martin; Ebstein, Frederic; Kloetzel, Peter-Michael			Proteasome beta 5i Subunit Deficiency Affects Opsonin Synthesis and Aggravates Pneumococcal Pneumonia	PLOS ONE			English	Article							DIFFERENT ENZYMATIC-PROPERTIES; COMMUNITY-ACQUIRED PNEUMONIA; RECOGNITION MOLECULE PTX3; INNATE IMMUNE-RESPONSES; C-REACTIVE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; 20S PROTEASOME; EXPERIMENTAL COLITIS; COMPLEMENT-SYSTEM; LUNG INFECTION	Immunoproteasomes, harboring the active site subunits beta 5i/LMP7, beta 1i/LMP2, and beta 2i/MECL1 exert protective, regulatory or modulating functions during infection-induced immune responses. Immunoproteasomes are constitutively expressed in hematopoietic derived cells, constituting the first line of defense against invading pathogens. To clarify the impact of immunoproteasomes on the innate immune response against Streptococcus pneumoniae, we characterized the progression of disease and analyzed the systemic immune response in beta 5i/LMP7(-/-) mice. Our data show that beta 5i/LMP7 deficiency, which affected the subunit composition of proteasomes in murine macrophages and liver, was accompanied by reduced transcription of genes encoding immune modulating molecules such as pentraxins, ficolins, and collectins. The diminished opsonin expression suggested an impaired humoral immune response against invading pneumococci resulting in an aggravated systemic dissemination of S. pneumoniae in beta 5i/LMP7(-/-) mice. The impaired bacterial elimination in beta 5i/LMP7(-/-) mice was accompanied by an aggravated course of pneumonia with early mortality as a consequence of critical illness during the late phase of disease. In summary our results highlight an unsuspected role for immuno-subunits in modulating the innate immune response to extracellular bacterial infections.	[Kirschner, Felicia; Andresen, Nadine; Ebstein, Frederic; Kloetzel, Peter-Michael] Charite, Inst Biochem, D-13353 Berlin, Germany; [Reppe, Katrin; Witzenrath, Martin] Charite, Dept Infect Dis & Pulm Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kloetzel, PM (corresponding author), Charite, Inst Biochem, D-13353 Berlin, Germany.	p-m.kloetzel@charite.de			German Research Foundation [SFB-TR 84]; German Ministry for Education and Research: CAPSyS	German Research Foundation(German Research Foundation (DFG)); German Ministry for Education and Research: CAPSyS	This study received financial support from the German Research Foundation: SFB-TR 84 TP C3, C4, C6 (www.dfg.de/) and the German Ministry for Education and Research: CAPSyS and TP4 (https://www.bmbf.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdein JD, 2013, CLIN EXP IMMUNOL, V174, P193, DOI 10.1111/cei.12170; Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Braun JS, 1999, INFECT IMMUN, V67, P3750, DOI 10.1128/IAI.67.8.3750-3756.1999; Brehm A, 2015, SEMIN IMMUNOPATHOL, V37, P323, DOI 10.1007/s00281-015-0486-4; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Castellheim A, 2009, SCAND J IMMUNOL, V69, P479, DOI 10.1111/j.1365-3083.2009.02255.x; Cole J, 2014, ADV MICROB PHYSIOL, V65, P125, DOI 10.1016/bs.ampbs.2014.08.004; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Cuschieri J, 2004, CELL IMMUNOL, V227, P140, DOI 10.1016/j.cellimm.2004.03.005; Dahlmann B, 2000, J MOL BIOL, V303, P643, DOI 10.1006/jmbi.2000.4185; Dames C, 2014, AM J RESP CELL MOL, V51, P730, DOI 10.1165/rcmb.2014-0052MA; Doni A, 2012, IMMUNOBIOLOGY, V217, P1122, DOI 10.1016/j.imbio.2012.07.004; Ebstein F, 2012, CELL MOL LIFE SCI, V69, P2543, DOI 10.1007/s00018-012-0938-0; Gerber A, 2004, EUR RESPIR J, V24, P40, DOI 10.1183/09031936.04.00079203; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gohlke S, 2014, ANN HEPATOL, V13, P429, DOI 10.1016/S1665-2681(19)30850-6; Griffin TA, 1998, J EXP MED, V187, P97, DOI 10.1084/jem.187.1.97; Guillaume B, 2010, P NATL ACAD SCI USA, V107, P18599, DOI 10.1073/pnas.1009778107; Henriques-Normark B, 2013, COLD SPRING HARB PER, V3; Hensley SE, 2010, J IMMUNOL, V184, P4115, DOI 10.4049/jimmunol.0903003; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Inforzato A, 2013, SEMIN IMMUNOL, V25, P79, DOI 10.1016/j.smim.2013.05.002; Kadioglu A, 2000, INFECT IMMUN, V68, P492, DOI 10.1128/IAI.68.2.492-501.2000; Kerr AR, 2004, MICROB PATHOGENESIS, V36, P303, DOI 10.1016/j.micpath.2004.02.001; Kitamura A, 2011, J CLIN INVEST, V121, P4150, DOI 10.1172/JCI58414; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Mishto M, 2014, EUR J IMMUNOL, V44, P3508, DOI 10.1002/eji.201444902; Moalli F, 2011, J IMMUNOL, V186, P5425, DOI 10.4049/jimmunol.1002035; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Olfert E D, 2000, ILAR J, V41, P99; Opitz E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002233; Ortiz-Lazareno PC, 2008, IMMUNOLOGY, V124, P534, DOI 10.1111/j.1365-2567.2008.02806.x; Pfaller MA, 2012, CLIN INFECT DIS, V55, pS187, DOI 10.1093/cid/cis561; Reis J, 2011, CELL BIOCHEM BIOPHYS, V60, P119, DOI 10.1007/s12013-011-9183-7; Remington LT, 2014, CURR OPIN PULM MED, V20, P215, DOI 10.1097/MCP.0000000000000052; Ring A, 1998, J CLIN INVEST, V102, P347, DOI 10.1172/JCI2406; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Said MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060273; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Schmidt F, 2006, PROTEOMICS, V6, P4622, DOI 10.1002/pmic.200500920; Schmidt N, 2010, GUT, V59, P896, DOI 10.1136/gut.2009.203554; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sijts EJAM, 2011, CELL MOL LIFE SCI, V68, P1491, DOI 10.1007/s00018-011-0657-y; Stohwasser R, 1996, FEBS LETT, V383, P109, DOI 10.1016/0014-5793(96)00110-X; Strehl B, 2006, J IMMUNOL, V177, P6238, DOI 10.4049/jimmunol.177.9.6238; Suresh MV, 2007, J IMMUNOL, V178, P1158, DOI 10.4049/jimmunol.178.2.1158; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; WATSON DA, 1993, CLIN INFECT DIS, V17, P913, DOI 10.1093/clinids/17.5.913; Weber SE, 2011, J IMMUNOL, V186, P432, DOI 10.4049/jimmunol.1001963; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Yamada T, 1999, CLIN CHEM LAB MED, V37, P381, DOI 10.1515/CCLM.1999.063	57	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153847	10.1371/journal.pone.0153847	http://dx.doi.org/10.1371/journal.pone.0153847			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100179	Green Published, Green Submitted, gold			2022-12-27	WOS:000374898500075
J	Cebey-Lopez, M; Herberg, J; Pardo-Seco, J; Gomez-Carballa, A; Martinon-Torres, N; Salas, A; Martinon-Sanchez, JM; Justicia, A; Rivero-Calle, I; Sumner, E; Fink, C; Martinon-Torres, F				Cebey-Lopez, Miriam; Herberg, Jethro; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Sumner, Edward; Fink, Colin; Martinon-Torres, Federico		GENDRES Network	Does Viral Co-Infection Influence the Severity of Acute Respiratory Infection in Children?	PLOS ONE			English	Article							INCREASED DISEASE SEVERITY; LENGTH-OF-STAY; HOSPITALIZED CHILDREN; SYNCYTIAL VIRUS; HUMAN METAPNEUMOVIRUS; STREPTOCOCCUS-PNEUMONIAE; PROSPECTIVE MULTICENTER; BOCAVIRUS INFECTION; TRACT INFECTIONS; ETIOLOGY	Background Multiple viruses are often detected in children with respiratory infection but the significance of co-infection in pathogenesis, severity and outcome is unclear. Objectives To correlate the presence of viral co-infection with clinical phenotype in children admitted with acute respiratory infections (ARI). Methods We collected detailed clinical information on severity for children admitted with ARI as part of a Spanish prospective multicenter study (GENDRES network) between 2011-2013. A nested polymerase chain reaction (PCR) approach was used to detect respiratory viruses in respiratory secretions. Findings were compared to an independent cohort collected in the UK. Results 204 children were recruited in the main cohort and 97 in the replication cohort. The number of detected viruses did not correlate with any markers of severity. However, bacterial superinfection was associated with increased severity (OR: 4.356; P-value = 0.005), PICU admission (OR: 3.342; P-value = 0.006), higher clinical score (1.988; P-value = 0.002) respiratory support requirement (OR: 7.484; P-value < 0.001) and longer hospital length of stay (OR: 1.468; P-value < 0.001). In addition, pneumococcal vaccination was found to be a protective factor in terms of degree of respiratory distress (OR: 2.917; P-value = 0.035), PICU admission (OR: 0.301; P-value = 0.011), lower clinical score (-1.499; P-value = 0.021) respiratory support requirement (OR: 0.324; P-value = 0.016) and oxygen necessity (OR: 0.328; P-value = 0.001). All these findings were replicated in the UK cohort. Conclusion The presence of more than one virus in hospitalized children with ARI is very frequent but it does not seem to have a major clinical impact in terms of severity. However bacterial superinfection increases the severity of the disease course. On the contrary, pneumococcal vaccination plays a protective role.	[Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Salas, Antonio; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Univ Santiago de Compostela, Galicia, Spain; [Cebey-Lopez, Miriam; Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Martinon-Torres, Nazareth; Maria Martinon-Sanchez, Jose; Justicia, Antonio; Rivero-Calle, Irene; Martinon-Torres, Federico] Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain; [Herberg, Jethro] Univ London Imperial Coll Sci Technol & Med, Div Infect Dis, Paediat Sect, South Kensington Campus, London, England; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Dept Anat Patol & Ciencias Forenses, Unidade Xenet, Fac Med, Galicia, Spain; [Pardo-Seco, Jacobo; Gomez-Carballa, Alberto; Salas, Antonio] Univ Santiago de Compostela, Inst Ciencias Forenses, Grp Med Xenom, Fac Med, Galicia, Spain; [Sumner, Edward; Fink, Colin] Univ Warwick, Micropathol Ltd, Sci Pk, Coventry CV4 7AL, W Midlands, England	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Imperial College London; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; University of Warwick	Cebey-Lopez, M (corresponding author), Hosp Clin Univ, Grp Invest Genet Vacunas Infecc & Pediat, Galicia, Spain.; Cebey-Lopez, M (corresponding author), Univ Santiago de Compostela, Galicia, Spain.; Cebey-Lopez, M (corresponding author), Hosp Clin Univ Santiago, Dept Pediat, Translat Pediat & Infect Dis Sect, Santiago De Compostela, Galicia, Spain.	Miriam.cebey.lopez@sergas.es	Pardo-Seco, Jacobo J/G-3752-2016; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012; Gómez-Carballa, Alberto/I-4610-2014; Cebey, Miriam/K-9347-2014; rivero, irene/ABC-9006-2020; Martinon-Torres, Federico/E-4982-2016	Pardo-Seco, Jacobo J/0000-0002-8059-8908; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X; Gómez-Carballa, Alberto/0000-0003-0927-1272; Cebey, Miriam/0000-0003-0599-7519; Martinon-Torres, Federico/0000-0002-9023-581X; Rivero Calle, Irene/0000-0002-3678-9264; Justicia Grande, Antonio/0000-0002-0410-3328; Herberg, Jethro/0000-0001-6941-6491	Spanish Government (Research Program Health Research Fund (FIS)) [PI10/00540]; Spanish Government (FEDER funds); Regional Galician funds [10 PXIB 918 184 PR]; Ministerio de Ciencia e Innovacion [SAF2011-26983]; Plan Galego IDT, Xunta de Galicia [EM 2012/045]; Sistema Universitario Gallego Modalidad REDES from Xunta de Galicia [2014-PG139]; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora); European Union [279185]; Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College [DMPED P26077]; Micropathology Ltd.	Spanish Government (Research Program Health Research Fund (FIS)); Spanish Government (FEDER funds)(Spanish Government); Regional Galician funds; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Plan Galego IDT, Xunta de Galicia; Sistema Universitario Gallego Modalidad REDES from Xunta de Galicia; Instituto de Investigacion Sanitaria de Santiago de Compostela; Instituto Carlos III (Intensificacion de la actividad investigadora)(Instituto de Salud Carlos III); European Union(European Commission); Imperial College Comprehensive Biomedical Research Centre; Wellcome Trust Centre for Respiratory Infection at Imperial College; Micropathology Ltd.	This work was supported by the Spanish Government (Research Program Health Research Fund (FIS; PI10/00540) National Plan I + D + I and FEDER funds), by Regional Galician funds (Promotion of Research Project 10 PXIB 918 184 PR) (FMT), by Ministerio de Ciencia e Innovacion (SAF2011-26983), and by the Plan Galego IDT, Xunta de Galicia (EM 2012/045) (AS). A grant was received from the Sistema Universitario Gallego Modalidad REDES (2014-PG139) from the Xunta de Galicia (to AS and FMT). MCL research activities have been supported by grants from Instituto de Investigacion Sanitaria de Santiago de Compostela. FMT research activities have been supported by grants from Instituto Carlos III (Intensificacion de la actividad investigadora). Investigators received funding from the European Union's seventh Framework program under ECGA no. 279185 (EUCLIDS) during the production of this paper. JH was supported by the Imperial College Comprehensive Biomedical Research Centre and the Wellcome Trust Centre for Respiratory Infection at Imperial College (DMPED P26077 to JH). Micropathology Ltd. provided support in the form of salaries for authors ES and CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aberle JH, 2005, PEDIATR INFECT DIS J, V24, P605, DOI 10.1097/01.inf.0000168741.59747.2d; Advani S, 2012, PEDIATR INFECT DIS J, V31, P1221, DOI 10.1097/INF.0b013e318265a804; Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; Asner SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099392; Azzari C, 2014, PEDIATR INFECT DIS J, V33, P858, DOI 10.1097/INF.0000000000000328; Bonzel L, 2008, PEDIATR INFECT DIS J, V27, P589, DOI 10.1097/INF.0b013e3181694fb9; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Brand HK, 2012, PEDIATR PULM, V47, P393, DOI 10.1002/ppul.21552; Cebey-Lopez M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136526; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Chorazy ML, 2013, PEDIATR INFECT DIS J, V32, P460, DOI 10.1097/INF.0b013e31828683ce; Chung JY, 2006, EMERG INFECT DIS, V12, P1254, DOI 10.3201/eid1708.060261; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Garcia-Garcia ML, 2006, PEDIATR PULM, V41, P863, DOI 10.1002/ppul.20456; Hasegawa K, 2014, PEDIATR INFECT DIS J, V33, P809, DOI 10.1097/INF.0000000000000293; Huijskens EG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-276; Jartti T, 2014, PEDIATR INFECT DIS J, V33, P829, DOI 10.1097/INF.0000000000000313; Kahn JS, 2007, CURR OPIN PHARMACOL, V7, P478, DOI 10.1016/j.coph.2007.07.004; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Mansbach JM, 2008, ACAD EMERG MED, V15, P111, DOI 10.1111/j.1553-2712.2007.00034.x; Mansbach JM, 2012, ARCH PEDIAT ADOL MED, V166, P700, DOI 10.1001/archpediatrics.2011.1669; Nicoli EJ, 2013, J INFECTION, V66, P512, DOI 10.1016/j.jinf.2013.02.007; Papadopoulos NG, 2002, AM J RESP CRIT CARE, V165, P1285, DOI 10.1164/rccm.200112-118BC; Peng D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-155; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Richard N, 2008, PEDIATR INFECT DIS J, V27, P213, DOI 10.1097/INF.0b013e31815b4935; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Semple MG, 2005, J INFECT DIS, V191, P382, DOI 10.1086/426457; Smith CM, 2014, AM J RESP CRIT CARE, V190, P196, DOI 10.1164/rccm.201311-2110OC; Suryadevara M, 2011, CLIN PEDIATR, V50, P513, DOI 10.1177/0009922810394834; Tan BH, 2009, J MED VIROL, V81, P82, DOI 10.1002/jmv.21361; van der Zalm MM, 2009, J PEDIATR-US, V154, P396, DOI 10.1016/j.jpeds.2008.08.036; Weinberger DM, 2013, EMERG INFECT DIS, V19, P1084, DOI 10.3201/eid1907.121625; Wolf DG, 2006, PEDIATR INFECT DIS J, V25, P320, DOI 10.1097/01.inf.0000207395.80657.cf; Yoshida LM, 2013, EUR RESPIR J, V42, P461, DOI 10.1183/09031936.00101812	35	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152481	10.1371/journal.pone.0152481	http://dx.doi.org/10.1371/journal.pone.0152481			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096199	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600014
J	Chueca, N; Rivadulla, I; Lovatti, R; Reina, G; Blanco, A; Fernandez-Caballero, JA; Cardenoso, L; Rodriguez-Granjer, J; Fernandez-Alonso, M; Aguilera, A; Alvarez, M; Galan, JC; Garcia, F				Chueca, Natalia; Rivadulla, Isidro; Lovatti, Ruben; Reina, Gabriel; Blanco, Ana; Angel Fernandez-Caballero, Jose; Cardenoso, Laura; Rodriguez-Granjer, Javier; Fernandez-Alonso, Miriam; Aguilera, Antonio; Alvarez, Marta; Carlos Galan, Juan; Garcia, Federico			Using NS5B Sequencing for Hepatitis C Virus Genotyping Reveals Discordances with Commercial Platforms	PLOS ONE			English	Article							ASSAY; PREVALENCE; INFECTION; LIPA	We aimed to evaluate the correct assignment of HCV genotypes by three commercial methods-Trugene HCV genotyping kit (Siemens), VERSANT HCV Genotype 2.0 assay (Siemens), and Real-Time HCV genotype II (Abbott)-compared to NS5B sequencing. We studied 327 clinical samples that carried representative HCV genotypes of the most frequent geno/subtypes in Spain. After commercial genotyping, the sequencing of a 367 bp fragment in the NS5B gene was used to assign genotypes. Major discrepancies were defined, e.g. differences in the assigned genotype by one of the three methods and NS5B sequencing, including misclassification of subtypes 1a and 1b. Minor discrepancies were considered when differences at subtype levels, other than 1a and 1b, were observed. The overall discordance with the reference method was 34% for Trugene and 15% for VERSANT HCV2.0. The Abbott assay correctly identified all 1a and 1b subtypes, but did not subtype all the 2, 3, 4 and 5 (34%) genotypes. Major discordances were found in 16% of cases for Trugene HCV, and the majority were 1b-to 1a-related discordances; major discordances were found for VERSANT HCV 2.0 in 6% of cases, which were all but one 1b to 1a cases. These results indicated that the Trugene assay especially, and to a lesser extent, Versant HCV 2.0, can fail to differentiate HCV subtypes 1a and 1b, and lead to critical errors in clinical practice for correctly using directly acting antiviral agents.	[Chueca, Natalia; Angel Fernandez-Caballero, Jose; Alvarez, Marta; Garcia, Federico] Complejo Hosp Univ Granada, Hosp San Cecilio, Inst Invest Biosanitaria IBS, Microbiol Serv, Granada, Spain; [Rivadulla, Isidro; Aguilera, Antonio] Hosp Conxo CHUS Santiago de Compostela, Microbiol Serv, Dept Microbiol & Parasitol USC, La Coruna, Spain; [Lovatti, Ruben; Carlos Galan, Juan] Hosp Ramon & Cajal, Microbiol Serv, IRYCIS, E-28034 Madrid, Spain; [Lovatti, Ruben; Carlos Galan, Juan] CIBERESP, Madrid, Spain; [Reina, Gabriel; Fernandez-Alonso, Miriam] Univ Navarra Clin, Navarra Inst Hlth Res IdiSNA, Microbiol Serv, Pamplona, Spain; [Blanco, Ana; Cardenoso, Laura] Hosp Princesa, Microbiol Serv, Madrid, Spain; [Rodriguez-Granjer, Javier] Complejo Hosp Univ Granada, Hosp Virgen Nieves, Microbiol Serv, Granada, Spain	Hospital Universitario San Cecilio; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; Complejo Hospitalario Universitario A Coruna; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Navarra; Hospital de La Princesa; Hospital Universitario Virgen de las Nieves; University of Granada	Garcia, F (corresponding author), Complejo Hosp Univ Granada, Hosp San Cecilio, Inst Invest Biosanitaria IBS, Microbiol Serv, Granada, Spain.	fegarcia@ugr.es	Garcia, Federico/AAA-3175-2020; Reina, Gabriel/F-2709-2017; Fernández-Alonso, Mirian/Q-4471-2016; Aguilera, Antonio/L-6586-2018; Chueca, Natalia/T-9734-2019; Chueca, Natalia/K-5225-2014	Garcia, Federico/0000-0001-7611-781X; Reina, Gabriel/0000-0003-4079-9753; Fernández-Alonso, Mirian/0000-0001-8047-2734; Aguilera, Antonio/0000-0001-6940-241X; Chueca, Natalia/0000-0002-3420-3290; Chueca, Natalia/0000-0002-3420-3290; Blanco, Ana/0000-0002-3435-7919	Fondo de Investigacion Sanitaria [PI12/01053, PI15/00713]; Plan Nacional de I+D+I [RD12/0017/006]; Fundacion Progreso y salud, Junta de Andalucia [PI-0411-2014]; Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud; Fondo Europeo de Desarrollo Regional-FEDER [RD12/0017/006]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Plan Nacional de I+D+I; Fundacion Progreso y salud, Junta de Andalucia(Junta de Andalucia); Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud; Fondo Europeo de Desarrollo Regional-FEDER(European Commission)	This work was supported in part by grants from Fondo de Investigacion Sanitaria (PI12/01053, PI15/00713), RD12/0017/006 (Plan Nacional de I+D+I and Fondo Europeo de Desarrollo Regional-FEDER), and PI-0411-2014, Fundacion Progreso y salud, Junta de Andalucia. Federico Garcia has received a research extension grant from the Programa de Intensificacion de la Actividad de Investigacion del Servicio Andaluz de Salud.	[Anonymous], 2015, DOCUMENTO CONSENSO G; Avo AP, 2013, J MED VIROL, V85, P815, DOI 10.1002/jmv.23545; Belmonte P, 2019, SEGURO SALUD 5G; Benedet M, 2014, J CLIN VIROL, V60, P301, DOI 10.1016/j.jcv.2014.04.005; Berenguer Marina, 2014, Gastroenterol Hepatol, V37 Suppl 1, P23, DOI 10.1016/S0210-5705(15)30004-2; Buti M, 2015, J HEPATOL, V63, P1511, DOI 10.1016/j.jhep.2015.08.010; Cento V, 2013, ANTIVIR THER, V18, P645, DOI 10.3851/IMP2529; Chen ZY, 2002, J CLIN MICROBIOL, V40, P3127, DOI 10.1128/JCM.40.9.3127-3134.2002; Chevaliez S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008209; Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Garcia F, 2015, AIDS REV S1, V17, P8; Gonzalez V, 2013, J CLIN VIROL, V58, P249, DOI 10.1016/j.jcv.2013.05.005; Guelfo JR, 2014, J CLIN MICROBIOL, V52, P4027, DOI 10.1128/JCM.02209-14; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Hedskog C, 2015, HEPATOLOGY, V61, P471, DOI 10.1002/hep.27361; Hngtyszyn HJ, 2005, ANTIVIR THER, V10, P1; Larrat S, 2013, J CLIN MICROBIOL, V51, P2815, DOI 10.1128/JCM.00586-13; Lontok E, 2015, HEPATOLOGY, V62, P1623, DOI 10.1002/hep.27934; McCormick AL, 2015, J CLIN VIROL, V66, P56, DOI 10.1016/j.jcv.2015.03.006; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Navarro D, 2015, AIDS REV S1, V17, P7; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Pawlotsky JM, 2015, J HEPATOL, V62, pS87, DOI 10.1016/j.jhep.2015.02.006; Quer J, 2015, J CLIN MICROBIOL, V53, P219, DOI 10.1128/JCM.02093-14; Rein DB, 2015, CLIN INFECT DIS, V61, P157, DOI 10.1093/cid/civ220; Rosen HR, 2011, NEW ENGL J MED, V364, P2429, DOI 10.1056/NEJMcp1006613; Sarrazin C, 2016, J HEPATOL, V64, P486, DOI 10.1016/j.jhep.2015.09.011; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Silberstein FC, 2016, HEPATOLOGY, V63, P1058, DOI 10.1002/hep.27895; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Soriano V, 2016, ANTIVIR THER, V21, P1, DOI 10.3851/IMP2975; Wyles D, 2015, HEPATOLOGY, V61, P1793, DOI 10.1002/hep.27814	33	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153754	10.1371/journal.pone.0153754	http://dx.doi.org/10.1371/journal.pone.0153754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097040	Green Published, gold			2022-12-27	WOS:000374543600052
J	Mitchell, BI; Byron, MM; Ng, RC; Chow, DC; Ndhlovu, LC; Shikuma, CM				Mitchell, Brooks I.; Byron, Mary Margaret; Ng, Roland C.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.			Elevation of Non-Classical (CD14(+/low)CD16(++)) Monocytes Is Associated with Increased Albuminuria and Urine TGF-beta(1) in HIV-Infected Individuals on Stable Antiretroviral Therapy	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; CHRONIC KIDNEY-DISEASE; TGF-BETA; MICROALBUMINURIA; INFLAMMATION; EXPRESSION; HYPERTENSION; ACTIVATION; MARKERS; MONOCYTES/MACROPHAGES	Objective High rates of albuminuria are observed among HIV-infected individuals on stable antiretroviral therapy (ART). Though pro-inflammatory and pro-fibrotic responses are described as components of albuminuria in the general population, it is unclear how these responses are associated to albuminuria in ART-treated chronic HIV. We investigated the relationship of monocyte subsets and urine inflammatory and fibrotic biomarkers to albuminuria in ART-treated HIV-infected participants. Design and Methods Cross-sectional analyses were performed on Hawaii Aging with HIV-cardiovascular disease study cohort participants who were required at entry to be >= 40 years old and on ART >= 3 months. Monocyte subpopulations were determined in banked peripheral blood mononuclear cells (PBMC) using multi-parametric flow-cytometry. Entry random urine samples were assessed for albumin-to-creatinine ratios (UACR). Urine samples were measured for inflammatory and fibrotic biomarkers using Luminex technology. Results Among 96 HIV-infected subjects with measured UACR (87% male, 59% Caucasian, and 89% undetectable HIV RNA with median CD4 of 495.5 cells/mu L), 18 patients (19%) had albuminuria. Non-classical (CD14(low/+)CD16(++)) monocytes were significantly elevated in subjects with albuminuria (p = 0.034) and were correlated to UACR (r = 0.238, p = 0.019). Elevated non-classical monocyte counts were significant predictors of worsening albuminuria, independent of traditional-and ART-associated risk factors (beta = 0.539, p = 0.007). Urine TGF-beta 1 and collagen-IV were significantly higher in albuminuric compared to non-albuminuric participants (TGF-beta 1; p = 0.039 and collagen-IV; p = 0.042). Urine TGF-beta 1 was significantly correlated with non-classical monocyte counts (r = 0.464, p = 0.017). Conclusion Alterations in monocyte subpopulations and urine pro-fibrotic factors may play a role in kidney dysfunction during chronic HIV infection and warrants further study.	[Mitchell, Brooks I.; Byron, Mary Margaret; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.] Univ Hawaii, Dept Trop Med, Honolulu, HI 96822 USA; [Mitchell, Brooks I.; Chow, Dominic C.; Ndhlovu, Lishomwa C.; Shikuma, Cecilia M.] Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA; [Ng, Roland C.; Chow, Dominic C.; Shikuma, Cecilia M.] Univ Hawaii, Dept Med, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii System; University of Hawaii System	Mitchell, BI (corresponding author), Univ Hawaii, Dept Trop Med, Honolulu, HI 96822 USA.; Mitchell, BI (corresponding author), Univ Hawaii, Hawaii Ctr AIDS, Honolulu, HI 96822 USA.	brooksim@hawaii.edu	n, l/AAX-3992-2020	Ndhlovu, Lishomwa/0000-0001-5427-4187; Chow, Dominic/0000-0001-7395-038X	National Heart, Lung, and Blood Institute [R01HL095135]; National Institute on Minority Health and Health Disparities [8G12MD7601-27]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095135] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [U54MD007584, G12MD007601] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by Grant Number R01HL095135 from the National Heart, Lung, and Blood Institute awarded to C.M.S. and Grant Number 8G12MD7601-27 from the National Institute on Minority Health and Health Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1991, J CLIN INVEST, V87, P1773, DOI 10.1172/JCI115196; Ando M, 2012, CLIN EXP NEPHROL, V16, P363, DOI 10.1007/s10157-012-0585-7; Ando M, 2011, NEPHROL DIAL TRANSPL, V26, P3923, DOI 10.1093/ndt/gfr129; Audoy-Remus J, 2008, J NEUROSCI, V28, P10187, DOI 10.1523/JNEUROSCI.3510-08.2008; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Baekken M, 2008, NEPHROL DIAL TRANSPL, V23, P3130, DOI 10.1093/ndt/gfn236; Barbour JD, 2014, ATHEROSCLEROSIS, V232, P52, DOI 10.1016/j.atherosclerosis.2013.10.021; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Branton MH, 1999, MICROBES INFECT, V1, P1349, DOI 10.1016/S1286-4579(99)00250-6; Campbell LJ, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-85; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Chang A, 2014, CURR OPIN NEPHROL HY, V23, P204, DOI 10.1097/01.mnh.0000444814.49755.90; Choi A, 2010, AM J KIDNEY DIS, V56, P872, DOI 10.1053/j.ajkd.2010.05.019; Choi AI, 2010, CIRCULATION, V121, P651, DOI 10.1161/CIRCULATIONAHA.109.898585; Comper WD, 2008, AM J PHYSIOL-RENAL, V295, pF1589, DOI 10.1152/ajprenal.00142.2008; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Frankenberger M, 1996, BLOOD, V87, P373; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Funderburg NT, 2012, BLOOD, V120, P4599, DOI 10.1182/blood-2012-05-433946; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gupta D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091569; Gupta SK, 2009, J INFECT DIS, V200, P614, DOI 10.1086/600890; Hadigan C, 2013, AM J NEPHROL, V37, P443, DOI 10.1159/000350384; Jalbert E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075500; Kawanaka N, 2002, ARTHRITIS RHEUM, V46, P2578, DOI 10.1002/art.10545; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kim PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024610; Krishnan S, 2014, J INFECT DIS, V209, P931, DOI 10.1093/infdis/jit581; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Lampropoulou IT, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/394206; LOTZ M, 1993, ANN NY ACAD SCI, V685, P501, DOI 10.1111/j.1749-6632.1993.tb35912.x; Ma J, 2014, INT J CLIN EXP PATHO, V7, P481; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Mizuno K, 2005, CLIN EXP IMMUNOL, V142, P461, DOI 10.1111/j.1365-2005.02932.x; Nadkarni GN, 2014, CURR OPIN HIV AIDS, V9, P340, DOI 10.1097/COH.0000000000000067; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; O-charoen P, 2014, AIDS RES HUM RETROV, V30, P1185, DOI [10.1089/aid.2014.0072, 10.1089/AID.2014.0072]; Patel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088934; Russo LM, 2007, DIABETES, V56, P380, DOI 10.2337/db06-1018; Russo LM, 2002, HYPERTENSION, V39, P281, DOI 10.1161/hy0202.104266; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Shikuma CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090330; Shikuma CM, 2014, JAIDS-J ACQ IMM DEF, V65, P151, DOI 10.1097/01.qai.0000435599.27727.6c; Shikuma CM, 2012, AIDS RES HUM RETROV, V28, P793, DOI [10.1089/aid.2011.0086, 10.1089/AID.2011.0086]; SHUKLA RR, 1993, KIDNEY INT, V44, P1022, DOI 10.1038/ki.1993.344; Szaflarska A, 2004, EXP HEMATOL, V32, P748, DOI 10.1016/j.exphem.2004.05.027; Szczech LA, 2010, HIV MED, V11, P419, DOI 10.1111/j.1468-1293.2009.00805.x; Szczech LA, 2004, KIDNEY INT, V66, P1145, DOI 10.1111/j.1523-1755.2004.00865.x; Szczech LA, 2007, AIDS, V21, P1003, DOI 10.1097/QAD.0b013e3280d3587f; Tsujioka H, 2009, J AM COLL CARDIOL, V54, P130, DOI 10.1016/j.jacc.2009.04.021; Ucciferri C, 2012, EUR REV MED PHARMACO, V16, P491; WAHL SM, 1991, J EXP MED, V173, P981, DOI 10.1084/jem.173.4.981; Westhorpe CLV, 2014, IMMUNOL CELL BIOL, V92, P133, DOI 10.1038/icb.2013.84; Wilson EMP, 2014, J INFECT DIS, V210, P1396, DOI 10.1093/infdis/jiu275; Winston JA, 1999, KIDNEY INT, V55, P1036, DOI 10.1046/j.1523-1755.1999.0550031036.x; Yamamoto T, 1999, KIDNEY INT, V55, P579, DOI 10.1046/j.1523-1755.1999.00296.x; Yoshimoto S, 2007, AM J KIDNEY DIS, V50, P47, DOI 10.1053/j.ajkd.2007.04.012; Zidar DA, 2015, JAIDS-J ACQ IMM DEF, V69, P154, DOI 10.1097/QAI.0000000000000566; Ziegler-Heitbrock L, 2007, J LEUKOCYTE BIOL, V81, P584, DOI 10.1189/jlb.0806510; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558; Zimmermann AE, 2006, CLIN INFECT DIS, V42, P283, DOI 10.1086/499048	69	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153758	10.1371/journal.pone.0153758	http://dx.doi.org/10.1371/journal.pone.0153758			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097224	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600053
J	Koo, DL; Lee, JY; Joo, EY; Hong, SB; Nam, H				Koo, Dae Lim; Lee, Jee Young; Joo, Eun Yeon; Hong, Seung Bong; Nam, Hyunwoo			Acoustic Characteristics of Stridor in Multiple System Atrophy	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; VOCAL CORD MOTION; LARYNGEAL STRIDOR; SLEEP DISORDERS; SURVIVAL	Nocturnal stridor is a breathing disorder prevalent in patients with multiple system atrophy (MSA). An improved understanding of this breathing disorder is essential since nocturnal stridor carries a poor prognosis (an increased risk of sudden death). In this study, we aimed to classify types of stridor by sound analysis and to reveal their clinical significance. Patients who met the criteria for probable MSA and had undergone polysomnography (PSG) were recruited. Patients were then assessed clinically with sleep questionnaires, including the Pittsburgh Sleep Quality Index, and the Hoehn and Yahr scale. Nocturnal stridor and snoring were analyzed with the Multi-Dimensional Voice Program. Nocturnal stridor was recorded in 22 patients and snoring in 18 patients using the PSG. Waveforms of stridors were classified into rhythmic or semirhythmic after analysis of the oscillogram. Formants and harmonics were observed in both types of stridor, but not in snoring. Of the 22 patients diagnosed with stridor during the present study, fifteen have subsequently died, with the time to death after the PSG study being 1.9 +/- 1.4 years (range 0.8 to 5.0 years). The rhythmic waveform group presented higher scores on the Hoehn and Yahr scale and the survival outcome of this group was lower compared to the semirhythmic waveform group (p = 0.030, p = 0.014). In the Kaplan Meier's survival curve, the outcome of patients with rhythmic waveform was significantly less favorable than the outcome of patients with semirhythmic waveform (log-rank test, p < 0.001). Stridor in MSA can be classified into rhythmic and semirhythmic types and the rhythmic component signifies a poorer outcome.	[Koo, Dae Lim; Lee, Jee Young; Nam, Hyunwoo] Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea; [Joo, Eun Yeon; Hong, Seung Bong] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea; [Joo, Eun Yeon] Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU)	Nam, H (corresponding author), Seoul Natl Univ, Boramae Hosp, Dept Neurol, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol,Samsung Biomed Res Inst, Seoul, South Korea.; Joo, EY (corresponding author), Sungkyunkwan Univ, SAIHST, Dept Hlth Sci & Technol, Seoul, South Korea.	ejoo@skku.edu; hwnam85@gmail.com		Lee, Jee-Young/0000-0002-9120-2075	Clinical Research Grant of Boramae Medical Center [03-2014-1]; Samsung Biomedical Research Institute [OTX0002111]	Clinical Research Grant of Boramae Medical Center; Samsung Biomedical Research Institute(Samsung)	This research was supported by the Clinical Research Grant of Boramae Medical Center (03-2014-1) and Samsung Biomedical Research Institute grant (#OTX0002111).	American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS, V3rd; BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Figueroa JJ, 2014, MOVEMENT DISORD, V29, P1151, DOI 10.1002/mds.25927; Ghorayeb I, 2005, SLEEP MED, V6, P359, DOI 10.1016/j.sleep.2004.10.002; Ghorayeb I, 2002, J NEUROL NEUROSUR PS, V72, P798, DOI 10.1136/jnnp.72.6.798; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Iranzo A, 2004, NEUROLOGY, V63, P930, DOI 10.1212/01.WNL.0000137043.76383.A4; Iranzo Alex, 2007, Curr Treat Options Neurol, V9, P347, DOI 10.1007/BF02938541; Iriarte J, 2011, SLEEP BREATH, V15, P229, DOI 10.1007/s11325-010-0420-x; Isono S, 2001, J PHYSIOL-LONDON, V536, P237, DOI 10.1111/j.1469-7793.2001.t01-1-00237.x; Kakitsuba N, 1997, ANN OTO RHINOL LARYN, V106, P380; Koo DL, 2012, SLEEP MED, V13, P961, DOI 10.1016/j.sleep.2012.04.002; Lalich IJ, 2014, LARYNGOSCOPE, V124, P730, DOI 10.1002/lary.24402; Medicine AAoS, 2007, AASM MANUAL SCORING; Ozawa T, 2016, J NEUROL SCI, V361, P243, DOI 10.1016/j.jns.2016.01.007; Ozawa T, 2010, MOVEMENT DISORD, V25, P1418, DOI 10.1002/mds.23090; SAITO Y, 1994, INTERNAL MED, V33, P321, DOI 10.2169/internalmedicine.33.321; SCHULZ JB, 1994, J NEUROL NEUROSUR PS, V57, P1047, DOI 10.1136/jnnp.57.9.1047; Shiba K, 2007, AURIS NASUS LARYNX, V34, P443, DOI 10.1016/j.anl.2007.03.006; Shimohata T, 2014, SLEEP MED, V15, P1147, DOI 10.1016/j.sleep.2014.04.013; Silber MH, 2000, MOVEMENT DISORD, V15, P699, DOI 10.1002/1531-8257(200007)15:4<699::AID-MDS1015>3.0.CO;2-L; Testa D, 1996, J NEUROL, V243, P401, DOI 10.1007/BF00868999; Vetrugno R, 2004, SLEEP MED, V5, P21, DOI 10.1016/j.sleep.2003.07.002; Vetrugno R, 2007, MOVEMENT DISORD, V22, P673, DOI 10.1002/mds.21384; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117; Wenning GK, 1997, MOVEMENT DISORD, V12, P133, DOI 10.1002/mds.870120203; Yamaguchi M, 2003, EUR NEUROL, V49, P154, DOI 10.1159/000069077; YANAGIHARA N, 1967, J SPEECH HEAR RES, V10, P531, DOI 10.1044/jshr.1003.531	29	8	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153935	10.1371/journal.pone.0153935	http://dx.doi.org/10.1371/journal.pone.0153935			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093692	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200065
J	Wen, AP; Li, Z; Yu, JX; Li, R; Cheng, S; Duan, ML; Bai, J				Wen, Aiping; Li, Zhe; Yu, Junxian; Li, Ren; Cheng, Sheng; Duan, Meili; Bai, Jing			Clinical Validation of Therapeutic Drug Monitoring of Imipenem in Spent Effluent in Critically Ill Patients Receiving Continuous Renal Replacement Therapy: A Pilot Study	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; CONTINUOUS VENOVENOUS HEMOFILTRATION; INADEQUATE ANTIMICROBIAL TREATMENT; SEPTIC SHOCK; SEVERE SEPSIS; LIQUID-CHROMATOGRAPHY; HOSPITAL MORTALITY; ANTIBIOTIC-THERAPY; BETA-LACTAMS; HUMAN PLASMA	Objectives The primary objective of this pilot study was to investigate whether the therapeutic drug monitoring of imipenem could be performed with spent effluent instead of blood sampling collected from critically ill patients under continuous renal replacement therapy. Methods A prospective open-label study was conducted in a real clinical setting. Both blood and effluent samples were collected pairwise before imipenem administration and 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h after imipenem administration. Plasma and effluent imipenem concentrations were determined by reversed-phase high-performance liquid chromatography with ultraviolet detection. Pharmacokinetic and pharmacodynamic parameters of blood and effluent samples were calculated. Results Eighty-three paired plasma and effluent samples were obtained from 10 patients. The Pearson correlation coefficient of the imipenem concentrations in plasma and effluent was 0.950 (P<0.0001). The average plasma-to-effluent imipenem concentration ratio was 1.044 (95% confidence interval, 0.975 to 1.114) with Bland-Altman analysis. No statistically significant difference was found in the pharmacokinetic and pharmacodynamic parameters tested in paired plasma and effluent samples with Wilcoxon test. Conclusion Spent effluent of continuous renal replacement therapy could be used for therapeutic drug monitoring of imipenem instead of blood sampling in critically ill patients.	[Wen, Aiping; Yu, Junxian; Li, Ren; Cheng, Sheng] Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China; [Li, Zhe] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Beijing, Peoples R China; [Duan, Meili; Bai, Jing] Capital Med Univ, Beijing Friendship Hosp, Dept Crit Care Med, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Wen, AP (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Pharm, Beijing, Peoples R China.; Bai, J (corresponding author), Capital Med Univ, Beijing Friendship Hosp, Dept Crit Care Med, Beijing, Peoples R China.	wenaiping@126.com; alex_white@126.com			Research Program of the Beijing Pharmaceutical Association	Research Program of the Beijing Pharmaceutical Association	This study was funded by a grant from the Research Program of the Beijing Pharmaceutical Association.	Arzuaga A, 2005, J CLIN PHARMACOL, V45, P168, DOI 10.1177/0091270004269796; Bouman CSC, 2006, INTENS CARE MED, V32, P2013, DOI 10.1007/s00134-006-0397-x; CLARK WR, 1995, KIDNEY INT, V48, P481, DOI 10.1038/ki.1995.317; Connor MJ, 2011, ANTIMICROB AGENTS CH, V55, P557, DOI 10.1128/AAC.00548-10; Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284; Craig WA, 2003, INFECT DIS CLIN N AM, V17, P479, DOI 10.1016/S0891-5520(03)00065-5; Deepa C, 2012, J Anaesthesiol Clin Pharmacol, V28, P386, DOI 10.4103/0970-9185.98357; Dolman HS, 2015, SURGERY, V158, P1083, DOI 10.1016/j.surg.2015.05.018; Fish DN, 2005, ANTIMICROB AGENTS CH, V49, P2421, DOI 10.1128/AAC.49.6.2421-2428.2005; Galvagno SM, 2013, J CRIT CARE, V28, P1019, DOI 10.1016/j.jcrc.2013.05.018; Garnacho-Montero J, 2003, CRIT CARE MED, V31, P2742, DOI 10.1097/01.CCM.0000098031.24329.10; Garnacho-Montero J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1000-z; Harbarth S, 2003, AM J MED, V115, P529, DOI 10.1016/j.amjmed.2003.07.005; Hayashi Y, 2013, INT J ANTIMICROB AG, V41, P162, DOI 10.1016/j.ijantimicag.2012.10.002; Hayashi Y, 2010, EXPERT OPIN DRUG MET, V6, P1017, DOI 10.1517/17425255.2010.506187; Heintz BH, 2009, PHARMACOTHERAPY, V29, P562, DOI 10.1592/phco.29.5.562; Huang CT, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002136; Ibrahim EH, 2000, CHEST, V118, P146, DOI 10.1378/chest.118.1.146; Jaramillo-Bustamante JC, 2012, PEDIATR CRIT CARE ME, V13, P501, DOI 10.1097/PCC.0b013e31823c980f; Jiao Y, 2007, J PHARMACEUT BIOMED, V43, P1804, DOI 10.1016/j.jpba.2006.11.040; Joukhadar C, 2001, CRIT CARE MED, V29, P385, DOI 10.1097/00003246-200102000-00030; Kollef MH, 1999, CHEST, V115, P462, DOI 10.1378/chest.115.2.462; Legrand T, 2008, J CHROMATOGR B, V875, P551, DOI 10.1016/j.jchromb.2008.09.020; Lipman J, 2001, INTENS CARE MED, V27, P363, DOI 10.1007/s001340000741; Lopez KJV, 2007, J CHROMATOGR B, V860, P241, DOI 10.1016/j.jchromb.2007.10.041; Marshall MR, 2006, NEPHROLOGY, V11, P181, DOI 10.1111/j.1440-1797.2006.00581.x; Mouton JW, 2000, CLIN PHARMACOKINET, V39, P185, DOI 10.2165/00003088-200039030-00002; MYERS CM, 1984, ANTIMICROB AGENTS CH, V26, P78, DOI 10.1128/AAC.26.1.78; Ogura H, 2014, J INFECT CHEMOTHER, V20, P157, DOI 10.1016/j.jiac.2013.07.006; Pannu Neesh, 2005, Ther Clin Risk Manag, V1, P141, DOI 10.2147/tcrm.1.2.141.62908; Pasko DA, 2011, BLOOD PURIFICAT, V32, P82, DOI 10.1159/000324191; Pea F, 2007, CLIN PHARMACOKINET, V46, P997, DOI 10.2165/00003088-200746120-00003; Roberts JA, 2014, CRIT CARE, V18, DOI 10.1186/cc13939; Roberts JA, 2012, BRIT J CLIN PHARMACO, V73, P27, DOI 10.1111/j.1365-2125.2011.04080.x; Roberts JA, 2010, INT J ANTIMICROB AG, V36, P332, DOI 10.1016/j.ijantimicag.2010.06.008; Roberts JA, 2010, INT J ANTIMICROB AG, V35, P419, DOI 10.1016/j.ijantimicag.2010.01.022; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff; Rodloff AC, 2006, J ANTIMICROB CHEMOTH, V58, P916, DOI 10.1093/jac/dkl354; Shiber S, 2015, J ANTIMICROB CHEMOTH, V70, P41, DOI 10.1093/jac/dku351; Sime FB, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-35; Sinnollareddy MG, 2012, CLIN EXP PHARMACOL P, V39, P489, DOI 10.1111/j.1440-1681.2012.05715.x; SMITH GB, 1990, J PHARM SCI, V79, P732, DOI 10.1002/jps.2600790816; Tegeder I, 1997, ANTIMICROB AGENTS CH, V41, P2640, DOI 10.1128/AAC.41.12.2640; Tegeder I, 1999, CLIN PHARMACOL THER, V65, P50, DOI 10.1016/S0009-9236(99)70121-9; Thalhammer F, 2000, CLIN PHARMACOKINET, V39, P271, DOI 10.2165/00003088-200039040-00003; Tian Q, 2008, ANTIMICROB AGENTS CH, V52, P1009, DOI 10.1128/AAC.00858-07; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Ulldemolins M, 2014, CRIT CARE, V18, DOI 10.1186/cc13938; Ulldemolins M, 2011, CLIN PHARMACOKINET, V50, P99, DOI 10.2165/11539220-000000000-00000; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Yamamoto T, 2011, ANTIMICROB AGENTS CH, V55, P5804, DOI 10.1128/AAC.01758-10; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181	53	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153927	10.1371/journal.pone.0153927	http://dx.doi.org/10.1371/journal.pone.0153927			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093294	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200061
J	Belluco, S; Mancin, M; Conficoni, D; Simonato, G; Pietrobelli, M; Ricci, A				Belluco, Simone; Mancin, Marzia; Conficoni, Daniele; Simonato, Giulia; Pietrobelli, Mario; Ricci, Antonia			Investigating the Determinants of Toxoplasma gondii Prevalence in Meat: A Systematic Review and Meta-Regression	PLOS ONE			English	Review							SAO-PAULO STATE; GENETIC-CHARACTERIZATION; TISSUE CYSTS; MOLECULAR CHARACTERIZATION; HUMAN CONSUMPTION; NEOSPORA-CANINUM; SLAUGHTERED PIGS; RISK-ASSESSMENT; FINISHING PIGS; PORK MEAT	Background Toxoplasma gondii is one of the most widespread parasites in humans and can cause severe illness in immunocompromised individuals. However, its role in healthy people is probably under-appreciated. The complex epidemiology of this protozoan recognizes several infection routes but consumption of contaminated food is likely to be the predominant one. Among food, consumption of raw and undercooked meat is a relevant route of transmission, but the role of different meat producing animal species and meats thereof is controversial. Objectives The aim of the present work is to summarize and analyse literature data reporting prevalence estimates of T. gondii in meat animals/meats. Data Sources We searched Medline, Web of Science, Science Direct (last update 31/03/2015). Eligibility Criteria Relevant papers should report data from primary studies dealing with the prevalence of T. gondii in meat from livestock species as obtained through direct detection methods. Meta-analysis and meta-regression were performed. Results Of 1915 papers screened, 69 papers were included, dealing mainly with cattle, pigs and sheep. Pooled prevalences, based on random-effect models, were 2.6% (CI95 [0.5-5.8]) for cattle, 12.3% (CI95 [7.6-17.8]) for pigs and 14.7%(CI95 [8.9-21.5]) for sheep. Due to the high heterogeneity observed, univariable and multivariable meta-regression models were fitted showing that the geographic area for cattle (p = 0.032), the farming type for pigs (p = 0.0004) and the sample composition for sheep (p = 0.03) had significant effects on the prevalences of Toxoplasma detected/estimated. Moreover, the role of different animal species was dependent on the geographic location of animals' origin. Limitations Limitations were due mainly to a possible publication bias. Conclusions and Implications The present work confirms the role of meat, including beef, as T. gondii sources, and highlights the need for a control system for this parasite to be implemented along the meat production chain. Moreover, consumer knowledge should be strengthened in order to reduce the impact of disease.	[Belluco, Simone; Mancin, Marzia; Ricci, Antonia] Ist Zooprofilatt Sperimentale Venezie, Food Safety Dept, Viale Univ 10, I-35020 Legnaro, PD, Italy; [Belluco, Simone; Conficoni, Daniele; Simonato, Giulia; Pietrobelli, Mario] Univ Padua, Dept Anim Med Prod & Hlth, Viale Univ, I-35020 Legnaro, PD, Italy	IZS delle Venezie; University of Padua	Belluco, S (corresponding author), Ist Zooprofilatt Sperimentale Venezie, Food Safety Dept, Viale Univ 10, I-35020 Legnaro, PD, Italy.; Belluco, S (corresponding author), Univ Padua, Dept Anim Med Prod & Hlth, Viale Univ, I-35020 Legnaro, PD, Italy.	sbelluco@izsvenezie.it	Belluco, Simone/L-8107-2019; Ricci, Antonia/AAA-9473-2019	Belluco, Simone/0000-0002-3764-4040; Ricci, Antonia/0000-0002-4774-9655; CONFICONI, DANIELE/0000-0003-1975-6716; mancin, marzia/0000-0002-7260-6031				ALKHALIDI NW, 1979, J PARASITOL, V65, P331, DOI 10.2307/3280181; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3266; Andreoletti O, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3265; [Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; ARIAS ML, 1994, VET PARASITOL, V55, P133, DOI 10.1016/0304-4017(94)90063-9; Asgari Q, 2011, TROP ANIM HEALTH PRO, V43, P389, DOI 10.1007/s11250-010-9704-1; Aspinall TV, 2002, INT J PARASITOL, V32, P1193, DOI 10.1016/S0020-7519(02)00070-X; Azizi H, 2014, IRAN J PARASITOL, V9, P429; Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104; Belbacha I, 2004, SCHWEIZ ARCH TIERH, V146, P561, DOI 10.1024/0036-7281.146.12.561; Belfort-Neto R, 2007, AN ACAD BRAS CIENC, V79, P111, DOI 10.1590/S0001-37652007000100013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger-Schoch AE, 2011, VET PARASITOL, V177, P290, DOI 10.1016/j.vetpar.2010.11.046; Bezerra RA, 2012, PARASITOL RES, V110, P509, DOI 10.1007/s00436-011-2514-1; Boughattas S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085044; Bowie WR, 1997, LANCET, V350, P173, DOI 10.1016/S0140-6736(96)11105-3; Cademartori BG, 2014, VET PARASITOL, V203, P207, DOI 10.1016/j.vetpar.2014.02.009; Campo-Portacio DM, 2014, ASOCIACION COLOMBIAN, V18, P93; Camus D., 1990, MED MALADIES INFECT, V20, P551; CATAR G, 1969, J PARASITOL, V55, P952, DOI 10.2307/3277157; Andrade MMC, 2013, RES VET SCI, V94, P587, DOI 10.1016/j.rvsc.2013.01.006; Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142; da Silva AV, 2001, VET PARASITOL, V97, P191, DOI 10.1016/S0304-4017(01)00404-6; da Silva RC, 2009, VET PARASITOL, V165, P332, DOI 10.1016/j.vetpar.2009.07.016; de Sousa S, 2006, VET PARASITOL, V135, P133, DOI 10.1016/j.vetpar.2005.08.012; DESMONTS G, 1965, REV FR ETUD CLIN BIO, V10, P952; Dias Rafael André Ferreira, 2005, Rev. Inst. Med. trop. S. Paulo, V47, P185, DOI 10.1590/S0036-46652005000400002; dos Santos CBD, 2005, VET PARASITOL, V131, P207, DOI 10.1016/j.vetpar.2005.04.039; Dubey JP, 2008, INT J PARASITOL, V38, P999, DOI 10.1016/j.ijpara.2007.11.012; Dubey JP, 2012, VET PARASITOL, V188, P14, DOI 10.1016/j.vetpar.2012.03.008; Dubey JP, 2011, INT J PARASITOL, V41, P827, DOI 10.1016/j.ijpara.2011.03.006; DUBEY JP, 1986, J AM VET MED ASSOC, V188, P1035; DUBEY JP, 1993, AM J VET RES, V54, P270; Dubey JP, 2005, J PARASITOL, V91, P1082, DOI 10.1645/GE-683.1; DUBEY JP, 1976, J AM VET MED ASSOC, V169, P1197; Dubey JP, 2002, J PARASITOL, V88, P1234, DOI 10.1645/0022-3395(2002)088[1234:HPOVTG]2.0.CO;2; DUBEY JP, 1995, J PARASITOL, V81, P48, DOI 10.2307/3284004; Dumetre A, 2006, VET PARASITOL, V142, P376, DOI 10.1016/j.vetpar.2006.07.005; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Ergin S, 2009, B VET I PULAWY, V53, P657; Esteves F, 2014, VET PARASITOL, V200, P8, DOI 10.1016/j.vetpar.2013.12.017; Evers F, 2013, REV BRAS PARASITOL V, V22, P58, DOI 10.1590/S1984-29612013005000009; Fabiani S, 2015, J NEUROL SCI, V351, P3, DOI 10.1016/j.jns.2015.02.028; Feitosa TF, 2014, VET PARASITOL, V202, P305, DOI 10.1016/j.vetpar.2014.03.015; Frazao-Teixeira E, 2011, VET PARASITOL, V175, P33, DOI 10.1016/j.vetpar.2010.09.030; Frazao-teixeira E, 2006, BRAZIALIAN J VET PAR, V36, P33; Gajadhar AA, 1998, J PARASITOL, V84, P759, DOI 10.2307/3284584; Galvan-Ramirez ML, 2010, J FOOD PROTECT, V73, P1121, DOI 10.4315/0362-028X-73.6.1121; Gharbi M, 2013, Bull Soc Pathol Exot, V106, P184, DOI 10.1007/s13149-013-0290-4; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Gomez-Samblas M, 2015, FOOD MICROBIOL, V46, P107, DOI 10.1016/j.fm.2014.07.003; Guo M, 2015, J FOOD PROTECT, V78, P457, DOI 10.4315/0362-028X.JFP-14-328; Halos L, 2010, INT J PARASITOL, V40, P193, DOI 10.1016/j.ijpara.2009.06.009; Halova D, 2013, ZOONOSES PUBLIC HLTH, V60, P168, DOI 10.1111/j.1863-2378.2012.01514.x; Havelaar AH, 2012, INT J FOOD MICROBIOL, V156, P231, DOI 10.1016/j.ijfoodmicro.2012.03.029; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; JACOBS L, 1960, J PARASITOL, V46, P23, DOI 10.2307/3275327; Jacobs L, 1963, AM J VET RES; JAMRA L F, 1969, Revista do Instituto de Medicina Tropical de Sao Paulo, V11, P169; Khayeche M, 2013, B SOC PATHOL EXOT; Maciel BM, 2014, PARASITOL INT, V63, P567, DOI 10.1016/j.parint.2014.03.001; Martins C, 1989, REV I MED TROP S PAU; MCCABE RE, 1987, REV INFECT DIS, V9, P754; Mendonca A. de O., 2004, Parasitologia Latinoamericana, V59, P42; Miao Q, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0673-0; Montoya JG, 1997, CLIN INFECT DIS, V24, P676, DOI 10.1093/clind/24.4.676; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Navarro IT, 1992, CIENC AGR; Opsteegh M, 2011, INT J FOOD MICROBIOL, V150, P103, DOI 10.1016/j.ijfoodmicro.2011.07.022; Opsteegh M, 2011, INT J PARASITOL, V41, P343, DOI 10.1016/j.ijpara.2010.10.006; Opsteegh M, 2010, INT J FOOD MICROBIOL, V139, P193, DOI 10.1016/j.ijfoodmicro.2010.02.027; PASSOS L M F, 1984, Arquivo Brasileiro de Medicina Veterinaria e Zootecnia, V36, P581; R Core Team, 2012, R LANG ENV STAT COMP; Ragozo AMA, 2008, J PARASITOL, V94, P1259, DOI 10.1645/GE-1641.1; Rahdar M, 2012, JUNDISHAPUR J MICROB, V5, P570, DOI 10.5812/jjm.4280; Raudenbush S.W., 2009, HDB RES SYNTHESIS ME, P295; ROTHE J, 1985, PATHOLOGY, V17, P497, DOI 10.3109/00313028509105508; Fernandes EFTS, 2012, J PARASITOL, V98, P690, DOI 10.1645/GE-3032.1; Santos SL, 2010, PARASITOL RES, V106, P457, DOI 10.1007/s00436-009-1686-4; Shaapan R M, 2007, Pak J Biol Sci, V10, P174, DOI 10.3923/pjbs.2007.174.177; Siam M A, 1979, J Egypt Public Health Assoc, V54, P163; Silva MSA, 2009, VET PARASITOL, V162, P156, DOI 10.1016/j.vetpar.2009.02.007; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; Thomas J., 2010, EPPI REV 4 SOFTWARE; Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732; Turcekova L, 2013, ACTA PARASITOL, V58, P361, DOI 10.2478/s11686-013-0154-6; van der Giessen J, 2007, VET PARASITOL, V148, P371, DOI 10.1016/j.vetpar.2007.06.009; Viechtbauer W, 2005, J EDUC BEHAV STAT, V30, P261, DOI 10.3102/10769986030003261; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vostalova E, 2000, ACTA VET BRNO, V69, P209, DOI 10.2754/avb200069030209; Wang H, 2012, INT J FOOD MICROBIOL, V157, P393, DOI 10.1016/j.ijfoodmicro.2012.06.011; Wang L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-273; Warnekulasuriya MR, 1998, INT J FOOD MICROBIOL, V45, P211, DOI 10.1016/S0168-1605(98)00158-5; Yildiz K, 2014, TURK J VET ANIM SCI, V38, P169, DOI 10.3906/vet-1308-49; Young NS, 2008, PLOS MED, V5, P1418, DOI 10.1371/journal.pmed.0050201	97	68	70	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153856	10.1371/journal.pone.0153856	http://dx.doi.org/10.1371/journal.pone.0153856			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082633	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800058
J	Li, DD; Liu, ZC; Gao, L; Wang, LF; Gao, MJ; Jiao, ZJ; Qiao, HL; Yang, JW; Chen, M; Yao, LG; Liu, RY; Kan, YC				Li, Dandan; Liu, Zongcai; Gao, Lei; Wang, Lifang; Gao, Meijuan; Jiao, Zhujin; Qiao, Huili; Yang, Jianwei; Chen, Min; Yao, Lunguang; Liu, Renyi; Kan, Yunchao			Genome-Wide Identification and Characterization of microRNAs in Developing Grains of Zea mays L.	PLOS ONE			English	Article							COMBINED SMALL RNA; GENE-EXPRESSION; TRANSCRIPTION FACTOR; REGULATORY ROLES; LEAF POLARITY; MAIZE EMBRYO; TARGET GENES; ENDOSPERM; ROOT; MIRNAS	The development and maturation of maize kernel involves meticulous and fine gene regulation at transcriptional and post-transcriptional levels, and miRNAs play important roles during this process. Although a number of miRNAs have been identified in maize seed, the ones involved in the early development of grains and in different lines of maize have not been well studied. Here, we profiled four small RNA libraries, each constructed from groups of immature grains of Zea mays inbred line Chang 7-2 collected 4-6, 7-9, 12-14, and 18-23 days after pollination (DAP). A total of 40 known (containing 111 unique miRNAs) and 162 novel (containing 196 unique miRNA candidates) miRNA families were identified. For conserved and novel miRNAs with over 100 total reads, 44% had higher accumulation before the 9th DAP, especially miR166 family members. 42% of miRNAs had highest accumulation during 12-14 DAP (which is the transition stage from embryogenesis to nutrient storage). Only 14% of miRNAs had higher expression 18-23 DAP. Prediction of potential targets of all miRNAs showed that 165 miRNA families had 377 target genes. For miR164 and miR166, we showed that the transcriptional levels of their target genes were significantly decreased when co-expressed with their cognate miRNA precursors in vivo. Further analysis shows miR159, miR164, miR166, miR171, miR390, miR399, and miR529 families have putative roles in the embryogenesis of maize grain development by participating in transcriptional regulation and morphogenesis, while miR167 and miR528 families participate in metabolism process and stress response during nutrient storage. Our study is the first to present an integrated dynamic expression pattern of miRNAs during maize kernel formation and maturation.	[Li, Dandan; Liu, Zongcai; Wang, Lifang; Gao, Meijuan; Jiao, Zhujin; Qiao, Huili; Yang, Jianwei; Chen, Min; Yao, Lunguang; Kan, Yunchao] Nanyang Normal Univ, China UK NYNU RRes Joint Libratory Insect Biol, Nanyang, Henan, Peoples R China; [Gao, Lei; Liu, Renyi] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	Nanyang Normal College; University of California System; University of California Riverside	Kan, YC (corresponding author), Nanyang Normal Univ, China UK NYNU RRes Joint Libratory Insect Biol, Nanyang, Henan, Peoples R China.; Liu, RY (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	renyi.liu@ucr.edu; yckan1974@nynu.edu.cn	Liu, Renyi/AAA-6449-2020; Gao, Lei/I-4159-2013	Gao, Lei/0000-0002-6488-0292	Key Research Projects of Science and Technology Department of Henan Province [112102110158]	Key Research Projects of Science and Technology Department of Henan Province	This work is supported by the Key Research Projects of Science and Technology Department of Henan Province (112102110158).	Adam H, 2011, MOL BIOL EVOL, V28, P1439, DOI 10.1093/molbev/msq328; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Bao ML, 2014, PLANT CELL PHYSIOL, V55, P1343, DOI 10.1093/pcp/pcu058; Barrera-Figueroa BE, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-132; Barrera-Figueroa BE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-127; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bommert P, 2001, GENE, V271, P131, DOI 10.1016/S0378-1119(01)00503-0; Boualem A, 2008, PLANT J, V54, P876, DOI 10.1111/j.1365-313X.2008.03448.x; Carraro N, 2006, PLANT MOL BIOL, V60, P811, DOI 10.1007/s11103-005-2761-6; Chen J, 2014, PLANT PHYSIOL, V166, P252, DOI 10.1104/pp.114.240689; Chen Jie, 2010, Yichuan, V32, P1175, DOI 10.3724/SP.J.1005.2010.01175; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Cheng XF, 2012, NEW PHYTOL, V195, P71, DOI 10.1111/j.1469-8137.2012.04147.x; Chitwood DH, 2007, DEVELOPMENT, V134, P813, DOI 10.1242/dev.000497; Chuck G, 2007, NAT GENET, V39, P1517, DOI 10.1038/ng.2007.20; Chuck GS, 2011, P NATL ACAD SCI USA, V108, P17550, DOI 10.1073/pnas.1113971108; Consonni G, 2005, ANN BOT-LONDON, V96, P353, DOI 10.1093/aob/mci187; CREECH RG, 1965, GENETICS, V52, P1175; Curaba J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-120; Ding D, 2014, PLANT BIOLOGY, V16, P9, DOI 10.1111/plb.12013; Ding D, 2009, ANN BOT-LONDON, V103, P29, DOI 10.1093/aob/mcn205; Ding D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039578; Ding YF, 2009, BIOCHEM BIOPH RES CO, V386, P6, DOI 10.1016/j.bbrc.2009.05.137; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Feng H, 2014, MOL PLANT PATHOL, V15, P284, DOI 10.1111/mpp.12089; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gu Y, 2013, GENOMICS, V102, P472, DOI 10.1016/j.ygeno.2013.08.007; Guo HS, 2005, PLANT CELL, V17, P1376, DOI 10.1105/tpc.105.030841; Huang SQ, 2009, J INORG BIOCHEM, V103, P282, DOI 10.1016/j.jinorgbio.2008.10.019; Jiao YP, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-141; Jin XN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125800; Jin XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059353; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kamthan A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00208; Kang MM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-360; Kang Z, 2014, APPL MICROBIOL BIOT, V98, P3413, DOI 10.1007/s00253-014-5569-y; Kanjanawattanawong S, 2014, MOL GENET GENOMICS, V289, P921, DOI 10.1007/s00438-014-0862-0; Kantar M, 2011, PLANTA, V233, P471, DOI 10.1007/s00425-010-1309-4; Kidner CA, 2004, NATURE, V428, P81, DOI 10.1038/nature02366; Kim CS, 2004, PLANT PHYSIOL, V134, P380, DOI 10.1104/pp.103.031310; Knauer S, 2013, DEV CELL, V24, P125, DOI 10.1016/j.devcel.2012.12.009; KODRZYCKI R, 1989, PLANT CELL, V1, P105, DOI 10.1105/tpc.1.1.105; Kong XP, 2014, PLANT BIOTECHNOL J, V12, P1108, DOI 10.1111/pbi.12218; LAFEMINA RL, 1988, J GEN VIROL, V69, P355, DOI 10.1099/0022-1317-69-2-355; Li De-Bing, 2013, Journal of Fisheries International, V8, P1; Li GS, 2014, P NATL ACAD SCI USA, V111, P7582, DOI 10.1073/pnas.1406383111; Li J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-220; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li XM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072852; Lin X, 2007, CELL RES, V17, P512, DOI 10.1038/cr.2007.45; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Liu QK, 2014, PLANT CELL, V26, P741, DOI 10.1105/tpc.113.120972; Liu Q, 2009, FEBS LETT, V583, P723, DOI 10.1016/j.febslet.2009.01.020; Liu XH, 2008, GENOMICS, V91, P378, DOI 10.1016/j.ygeno.2007.12.002; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu XD, 2013, PLANT PHYSIOL, V162, P440, DOI 10.1104/pp.113.214874; Luan MD, 2015, GENE, V555, P178, DOI 10.1016/j.gene.2014.11.001; Maitz M, 2000, PLANT J, V23, P29, DOI 10.1046/j.1365-313x.2000.00747.x; Mallory AC, 2004, CURR BIOL, V14, P1035, DOI 10.1016/j.cub.2004.06.022; Meng FD, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-110; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Paul S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00232; Pei LM, 2013, PLANT PHYSIOL BIOCH, V70, P221, DOI 10.1016/j.plaphy.2013.05.043; Peng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054148; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shen Y, 2013, BIOCHEM BIOPH RES CO, V441, P425, DOI 10.1016/j.bbrc.2013.10.113; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Sunkar Ramanjulu, 2008, BMC Plant Biol, V8, P25, DOI 10.1186/1471-2229-8-25; Szittya G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-593; Teoh KT, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-19; Teotia S, 2015, MOL PLANT, V8, P359, DOI 10.1016/j.molp.2014.12.018; Thiebaut F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-766; Trevisan S, 2012, PLANT SIGNAL BEHAV, V7, P822, DOI 10.4161/psb.20462; Trevisan S, 2012, PLANT CELL ENVIRON, V35, P1137, DOI 10.1111/j.1365-3040.2011.02478.x; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; Wang B, 2014, PLANT PHYSIOL BIOCH, V80, P90, DOI 10.1016/j.plaphy.2014.03.020; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang LW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-154; Wang PF, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1204-7; Wang YG, 2014, BIOCHEM GENET, V52, P474, DOI 10.1007/s10528-014-9661-x; Wu FQ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085754, 10.1371/journal.pone.0087251]; Xin MM, 2013, PLANT CELL, V25, P3212, DOI 10.1105/tpc.113.115592; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Xu ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028009; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhai LH, 2013, PHYSIOL PLANTARUM, V147, P181, DOI 10.1111/j.1399-3054.2012.01653.x; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhao BT, 2007, BIOCHEM BIOPH RES CO, V354, P585, DOI 10.1016/j.bbrc.2007.01.022; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhou XF, 2008, BBA-GENE REGUL MECH, V1779, P780, DOI 10.1016/j.bbagrm.2008.04.005; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	101	36	40	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153168	10.1371/journal.pone.0153168	http://dx.doi.org/10.1371/journal.pone.0153168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082634	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800013
J	Steinacher, A; Bates, DG; Akman, OE; Soyer, OS				Steinacher, Arno; Bates, Declan G.; Akman, Ozgur E.; Soyer, Orkun S.			Nonlinear Dynamics in Gene Regulation Promote Robustness and Evolvability of Gene Expression Levels	PLOS ONE			English	Article							NETWORKS; EVOLUTION; ADAPTATION; FLUCTUATIONS; CAPACITANCE; FEEDBACK; DESIGN; NOISE; CELL	Cellular phenotypes underpinned by regulatory networks need to respond to evolutionary pressures to allow adaptation, but at the same time be robust to perturbations. This creates a conflict in which mutations affecting regulatory networks must both generate variance but also be tolerated at the phenotype level. Here, we perform mathematical analyses and simulations of regulatory networks to better understand the potential trade-off between robustness and evolvability. Examining the phenotypic effects of mutations, we find an inverse correlation between robustness and evolvability that breaks only with nonlinearity in the network dynamics, through the creation of regions presenting sudden changes in phenotype with small changes in genotype. For genotypes embedding low levels of nonlinearity, robustness and evolvability correlate negatively and almost perfectly. By contrast, genotypes embedding nonlinear dynamics allow expression levels to be robust to small perturbations, while generating high diversity (evolvability) under larger perturbations. Thus, nonlinearity breaks the robustness-evolvability trade-off in gene expression levels by allowing disparate responses to different mutations. Using analytical derivations of robustness and system sensitivity, we show that these findings extend to a large class of gene regulatory network architectures and also hold for experimentally observed parameter regimes. Further, the effect of nonlinearity on the robustness-evolvability trade-off is ensured as long as key parameters of the system display specific relations irrespective of their absolute values. We find that within this parameter regime genotypes display low and noisy expression levels. Examining the phenotypic effects of mutations, we find an inverse correlation between robustness and evolvability that breaks only with nonlinearity in the network dynamics. Our results provide a possible solution to the robustness-evolvability trade-off, suggest an explanation for the ubiquity of nonlinear dynamics in gene expression networks, and generate useful guidelines for the design of synthetic gene circuits.	[Steinacher, Arno] MRC Biostat Unit, Cambridge, England; [Bates, Declan G.] Univ Warwick, Sch Engn, Warwick, England; [Akman, Ozgur E.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England; [Soyer, Orkun S.] Univ Warwick, Sch Life Sci, Warwick, England	MRC Biostatistics Unit; University of Warwick; University of Exeter; University of Warwick	Akman, OE (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter, Devon, England.; Soyer, OS (corresponding author), Univ Warwick, Sch Life Sci, Warwick, England.	O.E.Akman@exeter.ac.uk; O.Soyer@warwick.ac.uk			UK Engineering and Physical Sciences Research Council [EP/I017445/1]; BBSRC [BB/M017982/1] Funding Source: UKRI; EPSRC [EP/I007563/1, EP/I017445/1, EP/I017445/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M017982/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I017445/2, EP/I017445/1, EP/I007563/1] Funding Source: researchfish	UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the UK Engineering and Physical Sciences Research Council, grant number EP/I017445/1.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Akman OE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-88; Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Brookfield JFY, 2009, BIOL LETTERS, V5, P44, DOI 10.1098/rsbl.2008.0639; Buchler NE, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.30; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Draghi JA, 2010, NATURE, V463, P353, DOI 10.1038/nature08694; Elf J, 2003, GENOME RES, V13, P2475, DOI 10.1101/gr.1196503; EMANCIPATOR K, 1993, CLIN CHEM, V39, P766; Garfield DA, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001696; Hayden EJ, 2011, NATURE, V474, P92, DOI 10.1038/nature10083; Huang CYF, 1996, P NATL ACAD SCI USA, V93, P10078, DOI 10.1073/pnas.93.19.10078; Huynen MA, 1996, J MOL EVOL, V43, P165; Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaneko K, 2009, J BIOSCIENCES, V34, P529, DOI 10.1007/s12038-009-0072-9; Kauffman S.A., 1993, ORIGINS ORDER; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kuwahara H, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.98; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; Lomnitz JG, 2013, CHAOS, V23, DOI 10.1063/1.4809776; Marciano DC, 2014, CELL REP, V7, P1789, DOI 10.1016/j.celrep.2014.05.018; Masel J, 2010, TRENDS GENET, V26, P406, DOI 10.1016/j.tig.2010.06.002; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Oyarzun DA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0671; Pechenick DA, 2013, J THEOR BIOL, V330, P26, DOI 10.1016/j.jtbi.2013.03.019; Pigliucci M, 2008, NAT REV GENET, V9, P75, DOI 10.1038/nrg2278; Polev D, 2012, J THEOR BIOL, V293, P27, DOI 10.1016/j.jtbi.2011.10.001; Raman K, 2011, MOL BIOSYST, V7, P1081, DOI 10.1039/c0mb00165a; Rand DA, 2006, J THEOR BIOL, V238, P616, DOI 10.1016/j.jtbi.2005.06.026; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Samal A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-30; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Steiner CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052204; Stelling J, 2004, P NATL ACAD SCI USA, V101, P13210, DOI 10.1073/pnas.0401463101; Ten Tusscher K. H., 2011, PLOS COMPUT BIOL, V7, DOI [DOI 10.1371/JOURNAL.PCBI.1002208, 10.1371/journal.pcbi.1002208]; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Torres-Sosa C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002669; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Woods RJ, 2011, SCIENCE, V331, P1433, DOI 10.1126/science.1198914; Zhang Q, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130031	49	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153295	10.1371/journal.pone.0153295	http://dx.doi.org/10.1371/journal.pone.0153295			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082741	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800014
J	Bhattacharyya, S; Feferman, L; Tobacman, JK				Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.			Inhibition of Phosphatase Activity Follows Decline in Sulfatase Activity and Leads to Transcriptional Effects through Sustained Phosphorylation of Transcription Factor MITF	PLOS ONE			English	Article							GLYCOPROTEIN NONMETASTATIC B; MELANOMA PROTEIN-B; FORMYLGLYCINE-GENERATING ENZYME; P38 MAP KINASE; ARYLSULFATASE-B; CHONDROITIN SULFATE; THERAPEUTIC TARGET; HEPARAN-SULFATE; BREAST-CANCER; PROGNOSTIC INDICATOR	Arylsulfatase B (B-acetylgalactosamine 4-sulfatase; ARSB) is the enzyme that removes 4-sulfate groups from the non-reducing end of the glycosaminoglycans chondroitin 4-sulfate and dermatan sulfate. Decline in ARSB has been shown in malignant prostate, colonic, and mammary cells and tissues, and decline in ARSB leads to transcriptional events mediated by galectin-3 with AP-1 and Sp1. Increased mRNA expression of GPNMB (transmembrane glycoprotein NMB) in HepG2 cells and in hepatic tissue from ARSB-deficient mice followed decline in expression of ARSB and was mediated by the microphthalmia-associated transcription factor (MITF), but was unaffected by silencing galectin-3. Since GPNMB is increased in multiple malignancies, studies were performed to determine how decline in ARSB increased GPNMB expression. The mechanism by which decline in ARSB increased nuclear phospho-MITF was due to reduced activity of SHP2, a protein tyrosine phosphatase with Src homology (SH2) domains that regulates multiple cellular processes. SHP2 activity declined due to increased binding with chondroitin 4-sulfate when ARSB was reduced. When SHP2 activity was inhibited, phosphorylations of p38 mitogen-associated phosphokinase (MAPK) and of MITF increased, leading to GPNMB promoter activation. A dominant negative SHP2 construct, the SHP2 inhibitor PHSP1, and silencing of ARSB increased phospho-p38, nuclear MITF, and GPNMB. In contrast, constitutively active SHP2 and overexpression of ARSB inhibited GPNMB expression. The interaction between chondroitin 4-sulfate and SHP2 is a novel intersection between sulfation and phosphorylation, by which decline in ARSB and increased chondroitin 4-sulfation can inhibit SHP2, thereby regulating downstream tyrosine phosphorylations by sustained phosphorylations with associated activation of signaling and transcriptional events.	[Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Bhattacharyya, Sumit; Feferman, Leo; Tobacman, Joanne K.] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Tobacman, JK (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60612 USA.; Tobacman, JK (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	jkt@uic.edu						Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Bard-Chapeau EA, 2011, CANCER CELL, V19, P629, DOI 10.1016/j.ccr.2011.03.023; Bhattacharyya S, 2014, ONCOGENE, V33, P5467, DOI 10.1038/onc.2013.483; Bhattacharyya S, 2008, J BIOL CHEM, V283, P9523, DOI 10.1074/jbc.M707967200; Bhattacharyya S, 2008, J NUTR, V138, P469, DOI 10.1093/jn/138.3.469; Bhattacharyya S, 2007, J STEROID BIOCHEM, V103, P20, DOI 10.1016/j.jsbmb.2006.08.002; Bhattacharyya S, 2015, BBA-GENE REGUL MECH, V1849, P342, DOI 10.1016/j.bbagrm.2014.12.009; Bhattacharyya S, 2014, J BIOL CHEM, V289, P17564, DOI 10.1074/jbc.M114.561589; Bhattacharyya S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033250; Bhattacharyya S, 2010, BBA-MOL BASIS DIS, V1802, P472, DOI 10.1016/j.bbadis.2010.01.014; Bhattacharyya S, 2010, AM J RESP CELL MOL, V42, P51, DOI 10.1165/rcmb.2008-0482OC; Bhattacharyya S, 2009, CLIN EXP METASTAS, V26, P535, DOI 10.1007/s10585-009-9253-z; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Chong ZZ, 2003, CELL MOL NEUROBIOL, V23, P561, DOI 10.1023/A:1025158314016; Feferman L, 2013, PROSTATE CANCER P D, V16, P277, DOI 10.1038/pcan.2013.18; Fiorentini C, 2014, EXP CELL RES, V323, P100, DOI 10.1016/j.yexcr.2014.02.025; Frevert CW, 2003, AM J RESP CELL MOL, V28, P464, DOI 10.1165/rcmb.2002-0084OC; Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5; He Z, 2013, P NATL ACAD SCI USA, V110, pE79, DOI 10.1073/pnas.1213000110; Hellmuth K, 2008, P NATL ACAD SCI USA, V105, P7275, DOI 10.1073/pnas.0710468105; Jia XL, 2012, WORLD J GASTROENTERO, V18, P3962, DOI 10.3748/wjg.v18.i30.3962; Kim SO, 1998, J BIOL CHEM, V273, P2344, DOI 10.1074/jbc.273.4.2344; Kotlo K, 2013, GLYCOCONJUGATE J, V30, P667, DOI 10.1007/s10719-013-9468-8; Kuan CT, 2006, CLIN CANCER RES, V12, P1970, DOI 10.1158/1078-0432.CCR-05-2797; Li YN, 2014, APMIS, V122, P140, DOI 10.1111/apm.12107; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Maric G, 2015, ONCOGENE, V34, P5494, DOI 10.1038/onc.2015.8; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Martina JA, 2014, CELL MOL LIFE SCI, V71, P2483, DOI 10.1007/s00018-014-1565-8; Mitsunaga-Nakatsubo K, 2009, MED MOL MORPHOL, V42, P63, DOI 10.1007/s00795-009-0447-x; Mizumoto S, 2013, FEBS J, V280, P2462, DOI 10.1111/febs.12156; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Okamoto I, 2005, NEOPLASIA, V7, P303, DOI 10.1593/neo.04514; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Phillips JJ, 2012, J CLIN INVEST, V122, P911, DOI 10.1172/JCI58215; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; Ploper D, 2015, P NATL ACAD SCI USA, V112, pE420, DOI 10.1073/pnas.1424576112; Prabhu SV, 2011, J HISTOCHEM CYTOCHEM, V59, P328, DOI 10.1369/0022155410395511; Prince RN, 2010, J CELL SCI, V123, P2308, DOI 10.1242/jcs.058321; Qin CP, 2014, MOL MED REP, V9, P851, DOI 10.3892/mmr.2014.1896; Rao GJ, 1994, BIOCHIM BIOPHYS ACTA, V788, P58; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Roeser D, 2006, P NATL ACAD SCI USA, V103, P81, DOI 10.1073/pnas.0507592102; Roeser D, 2007, ACTA CRYSTALLOGR D, V63, P621, DOI 10.1107/S0907444907009961; Rose AAN, 2010, CLIN CANCER RES, V16, P2147, DOI 10.1158/1078-0432.CCR-09-1611; Ruan WM, 2014, INT J CLIN EXP MED, V7, P4857; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Tian F, 2012, ONCOL RES, V20, P341, DOI 10.3727/096504013X13657689382851; Tse KF, 2006, CLIN CANCER RES, V12, P1373, DOI 10.1158/1078-0432.CCR-05-2018; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; WOJCZYK B, 1986, BIOL CELL, V57, P147, DOI 10.1111/j.1768-322X.1986.tb00471.x; Yamashita H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092904; Yardley DA, 2015, J CLIN ONCOL, V33, P1609, DOI 10.1200/JCO.2014.56.2959; Yee AS, 2004, GENE, V336, P1, DOI 10.1016/j.gene.2004.04.004; Zhang TY, 2015, J CELL SCI, V128, P2938, DOI 10.1242/jcs.173807; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200	58	15	15	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153463	10.1371/journal.pone.0153463	http://dx.doi.org/10.1371/journal.pone.0153463			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078017	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700057
J	Majewska, R; Convey, P; De Stefano, M				Majewska, Roksana; Convey, Peter; De Stefano, Mario			Summer Epiphytic Diatoms from Terra Nova Bay and Cape Evans (Ross Sea, Antarctica) - A Synthesis and Final Conclusions	PLOS ONE			English	Article							KING-GEORGE-ISLAND; BENTHIC DIATOMS; PHYLLOPHORA-ANTARCTICA; WEDDELL SEA; ICE-EDGE; MICROBIAL COMMUNITIES; MARINE MACROALGAE; SURFACE SEDIMENTS; MCMURDO SOUND; POTTER COVE	Despite recent advances in polar marine biology and related fields, many aspects of the ecological interactions that are crucial for the functioning of Antarctic shallow water habitats remain poorly understood. Although epiphytic diatoms play an essential role in the Antarctic marine food web, basic information regarding their ecology, biodiversity and biogeography is largely unavailable. Here, we synthesise studies on Ross Sea epiphytic diatoms collected during 11 summer Antarctic expeditions between the years 1989/90 and 2011/12, presenting a full list of diatom taxa associated with three macroalgal species (Iridaea cordata, Phyllophora antarctica, and Plocamium cartilagineum) and their epiphytic sessile fauna. Diatom communities found during the three summer months at various depths and sampling stations differed significantly in terms of species composition, growth form structure and abundances. Densities ranged from 21 to >8000 cells mm(-2), and were significantly higher on the surface of epiphytic micro-fauna than on any of the macroalgal species examined. Generally, host organisms characterized by higher morphological heterogeneity (sessile micro-fauna, ramified Plocamium) supported richer diatom communities than those with more uniform surfaces (Iridaea). Differences between epiphytic communities associated with different macroalgae were reflected better in species composition than in growth form structure. The latter changed significantly with season, which was related strongly to the changing ice conditions. A general trend towards an increasing number of erect forms in deeper waters and tube-dwelling diatoms in the shallowest sites (2-5 m) was also observed. This study explores further important and largely previously unknown aspects of relationships and interactions between Antarctic epiphytic diatoms and their micro-and macro-environments.	[Majewska, Roksana; De Stefano, Mario] Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy; [Majewska, Roksana] Magna Graecia Univ Catanzaro, BioNEM Lab, Dept Expt & Clin Med, I-88100 Catanzaro, Italy; [Convey, Peter] British Antarctic Survey, Nat Environm Res Council, High Cross, Madingley Rd, Cambridge CB3 0ET, England	Universita della Campania Vanvitelli; Magna Graecia University of Catanzaro; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Majewska, R (corresponding author), Univ Naples 2, Dept Environm Biol & Pharmaceut Sci & Technol, I-81100 Caserta, Italy.; Majewska, R (corresponding author), Magna Graecia Univ Catanzaro, BioNEM Lab, Dept Expt & Clin Med, I-88100 Catanzaro, Italy.	roksana.majewska@unina2.it	Convey, Peter/AAV-5728-2020; Majewska, Roksana/P-1280-2015	Convey, Peter/0000-0001-8497-9903; Majewska, Roksana/0000-0003-2681-4304	Second University of Naples; Italian National Program of Research in Antarctica (PNRA) [2010/A1.02]; NERC; Natural Environment Research Council; NERC [bas0100036] Funding Source: UKRI; Natural Environment Research Council [bas0100036] Funding Source: researchfish	Second University of Naples; Italian National Program of Research in Antarctica (PNRA)(Ministry of Education, Universities and Research (MIUR)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Second University of Naples (www.unina2.it) and the Italian National Program of Research in Antarctica (PNRA) co-ordinated by the Italian National Research Council (www.cnr.it/sitocnr/home.html) [grant ID: 2010/A1.02, MD]. PC is supported by the Natural Environment Research Council (www.nerc.ac.uk) core funding to the British Antarctic Survey (www.bas.ac.uk) Biodiversity, Evolution and Adaptation Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Second University of Naples and the Italian National Program of Research in Antarctica (PNRA) co-ordinated by the Italian National Research Council [2010/A1.02]. PC is supported by NERC core funding to the BAS Biodiversity, Evolution and Adaptation Team. We thank Lukasz Polanski, who kindly provided the sampling site map (Fig 1). This paper also contributes to the SCAR 'State of the Antarctic Ecosystem' (AntEco) research programme.	Al-Handal AY, 2008, DIATOM RES, V23, P269; Al-Handal AY, 2008, BOT MAR, V51, P411, DOI 10.1515/BOT.2008.053; Al-Handal AY, 2008, BOT MAR, V51, P51, DOI 10.1515/BOT.2008.007; Al-Handal AY, 2010, DIATOM RES, V25, P1; Amsler CD, 2005, MAR ECOL PROG SER, V294, P141, DOI 10.3354/meps294141; Amsler CD, 1998, J PHYCOL, V34, P53, DOI 10.1046/j.1529-8817.1998.340053.x; ANDERSEN OGN, 1977, OPHELIA, V16, P205; Anderson M.J, 2008, PERMANOVA1 PRIMER GU; ANDREOLI C, 1995, POLAR BIOL, V15, P465; ARRIGO KR, 1994, SCIENCE, V266, P261, DOI 10.1126/science.266.5183.261; BATHMANN U, 1991, POLAR BIOL, V11, P185; Blackburn N, 1998, SCIENCE, V282, P2254, DOI 10.1126/science.282.5397.2254; BOHATY SM, 1998, TERRA ANTARTICA, V0005; BOOTH JA, 1984, ARCTIC, V37, P234; Bouma TJ, 2009, HELGOLAND MAR RES, V63, P95, DOI 10.1007/s10152-009-0146-y; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Bradshaw C, 2003, MAR BIOL, V143, P783, DOI 10.1007/s00227-003-1115-7; Buffen A, 2007, MAR MICROPALEONTOL, V62, P7, DOI 10.1016/j.marmicro.2006.07.002; CAMPANA G.L., 2008, BER POLARFORSCH MEER, V571, P302; Cardinale BJ, 2006, J ECOL, V94, P609, DOI 10.1111/j.1365-2745.2006.01107.x; CARPENTER E J, 1970, Phycologia, V9, P269, DOI 10.2216/i0031-8884-9-3-269.1; Catalano G, 1997, DEEP-SEA RES PT I, V44, P97, DOI 10.1016/S0967-0637(97)85248-X; Cefarelli AO, 2010, POLAR BIOL, V33, P1463, DOI 10.1007/s00300-010-0794-z; Cermeno P, 2009, SCIENCE, V325, P1539, DOI 10.1126/science.1174159; Chung Mi Hee, 2008, Algae, V23, P75; Clark GF, 2011, POLAR BIOL, V34, P781, DOI 10.1007/s00300-010-0931-8; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; Convey P, 2014, ECOL MONOGR, V84, P203, DOI 10.1890/12-2216.1; Cremer H, 2003, BOT MAR, V46, P82, DOI 10.1515/BOT.2003.010; Cunningham WL, 1998, ANTARCT SCI, V10, P134, DOI 10.1017/S0954102098000182; DEACON GER, 1982, DEEP-SEA RES, V29, P1, DOI 10.1016/0198-0149(82)90058-9; DURBIN EG, 1975, MAR BIOL, V32, P271, DOI 10.1007/BF00399206; Ehrenberg C. G., 1843, ABHANDLUNGEN KONIGLI, V1841, P291; El-Sayed S.Z., 1971, ANTARCT RES SER, V17, P301; EMINSON D, 1980, BRIT PHYCOL J, V15, P429, DOI 10.1080/00071618000650431; EVERITT DA, 1986, HYDROBIOLOGIA, V139, P3, DOI 10.1007/BF00770237; Fabiano M, 2000, ROSS SEA ECOLOGY ITA, P503; Fernandes LF, 2007, DIATOM RES, V22, P45; FLOWER RJ, 1993, HYDROBIOLOGIA, V269, P473, DOI 10.1007/BF00028045; Frenguelli J., 1960, REV ALGOL, V5, P1; Frenguelli J, 1958, PUBLICATION I ANTARC, V5; FRITSEN CH, 1994, SCIENCE, V266, P782, DOI 10.1126/science.266.5186.782; Fukushima H, 1966, ANTARCTIC RECORD, V27, P99; Gambi M.C., 2000, P527; GAMBI MC, 1994, ANTARCT SCI, V6, P449, DOI 10.1017/S0954102094000696; Garrison D.L., 1985, European Marine Biology Symposium, V18, P103; GARRISON DL, 1986, BIOSCIENCE, V36, P243, DOI 10.2307/1310214; GARRISON DL, 1989, ANTARCT SCI, V1, P313, DOI 10.1017/S0954102089000477; Gili JM, 1995, OCEANOGR MAR BIOL, V33, P351; Gili JM, 1996, POLAR BIOL, V16, P507; Gili JM, 2001, POLAR BIOL, V24, P473, DOI 10.1007/s003000100257; Goffart A, 2000, J MARINE SYST, V27, P161, DOI 10.1016/S0924-7963(00)00065-8; Grotti M, 2001, MAR CHEM, V76, P189, DOI 10.1016/S0304-4203(01)00063-9; Harper James T., 1994, Diatom Research, V9, P329; Harwood DM, 2000, ANTARCT SCI, V12, P443; HASLE G R, 1968, Journal of the Royal Microscopical Society, V88, P357; Hasle G. R., 1965, SKR NOR VIDENSK AKAD, V21, P1; HASLE GR, 1994, PHYCOLOGIA, V33, P248, DOI 10.2216/i0031-8884-33-4-248.1; Heiden H., 1928, DTSCH SUDPOLAR EXPED, P447; HORNER R, 1982, ARCTIC, V35, P485; Huang YSM, 2006, J EXP MAR BIOL ECOL, V329, P55, DOI 10.1016/j.jembe.2005.08.013; Hustedt F., 1958, DSCH ANTARKT EXPED 1, P103; HUSTON M, 1979, AM NAT, V113, P81, DOI 10.1086/283366; JOHN J, 1993, PHYCOLOGIA, V32, P388, DOI 10.2216/i0031-8884-32-5-388.1; KAMATANI A, 1982, MAR BIOL, V68, P91, DOI 10.1007/BF00393146; KELLOGG TB, 1979, MAR MICROPALEONTOL, V4, P137, DOI 10.1016/0377-8398(79)90011-2; KREBS WN, 1983, MICROPALEONTOLOGY, V29, P267, DOI 10.2307/1485734; Lannuzel D, 2013, POLAR BIOL, V36, P1483, DOI 10.1007/s00300-013-1368-7; Campana GL, 2009, BOT MAR, V52, P655, DOI 10.1515/BOT.2009.076; Leventer A, 1996, J GEOPHYS RES-OCEANS, V101, P18489, DOI 10.1029/96JC00204; LEVINTON J, 1972, AM NAT, V106, P472, DOI 10.1086/282788; LEWIN JC, 1961, GEOCHIM COSMOCHIM AC, V21, P182, DOI 10.1016/S0016-7037(61)80054-9; Ligowski R, 2000, POLAR BIOL, V23, P619, DOI 10.1007/s003000000131; Liu J, 2013, J BIOGEOGR, V40, P2238, DOI 10.1111/jbi.12160; Lotter AF, 2000, AQUAT SCI, V62, P125, DOI 10.1007/s000270050002; Majewska R, 2015, ANTARCT SCI, V27, P44, DOI 10.1017/S0954102014000327; Majewska R, 2015, POLAR BIOL, V38, P189, DOI 10.1007/s00300-014-1578-7; Majewska R, 2013, ANTARCT SCI, V25, P501, DOI 10.1017/S0954102012001101; Majewska R, 2013, POLAR BIOL, V36, P73, DOI 10.1007/s00300-012-1240-1; Mangin L, 1915, PHYTOPLANCTON ANTARC; Manguin E., 1960, ANN SCI NAT BOT BIOL, V12, P223; Manguin E., 1957, REV ALGOLOGIQUE, V3, P111; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Mazzella L., 1992, GIORN BOT ITAL, V126, P752; MCCORMICK PV, 1991, OECOLOGIA, V86, P287, DOI 10.1007/BF00317542; McLachlan DH, 2009, J PHYCOL, V45, P592, DOI 10.1111/j.1529-8817.2009.00681.x; Michalchuk BR, 2009, QUATERNARY SCI REV, V28, P3049, DOI 10.1016/j.quascirev.2009.08.012; Michels J, 2005, MAR BIOL, V146, P483, DOI 10.1007/s00227-004-1452-1; MILLER KA, 1991, AM ZOOL, V31, P35; MILLIE DF, 1983, HYDROBIOLOGIA, V99, P7, DOI 10.1007/BF00013712; MONTGOMERY WL, 1980, ENVIRON BIOL FISH, V5, P143, DOI 10.1007/BF02391621; NELSON DM, 1986, DEEP-SEA RES, V33, P1389, DOI 10.1016/0198-0149(86)90042-7; Norkko A, 2004, POLAR BIOL, V27, P482, DOI 10.1007/s00300-004-0610-8; NOWELL ARM, 1984, ANNU REV ECOL SYST, V15, P303, DOI 10.1146/annurev.es.15.110184.001511; ORTH RJ, 1984, AQUAT BOT, V18, P43, DOI 10.1016/0304-3770(84)90080-9; Pancic M, 2015, BIOGEOSCIENCES, V12, P4235, DOI 10.5194/bg-12-4235-2015; PEARSE JS, 1966, BIOL BULL, V130, P387, DOI 10.2307/1539745; PERAGALLO M, 1921, DEUXIEME EXPEDITION, P1, DOI DOI 10.1159/000511890; PEROVICH DK, 1990, J GEOPHYS RES-OCEANS, V95, P9557, DOI 10.1029/JC095iC06p09557; POFF NL, 1990, J N AM BENTHOL SOC, V9, P303, DOI 10.2307/1467898; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P275; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P45; POULIN M, 1984, Naturaliste Canadien (Quebec), V111, P349; Povero P, 2001, POLAR BIOL, V24, P875; Rajanahally MA, 2014, J EXP MAR BIOL ECOL, V461, P516, DOI 10.1016/j.jembe.2014.10.005; Reichardt W., 1985, ANTARCTIC NUTR CYCLE, P115; Riaux-Gobin C, 2011, DIATOM RES, V26, P325, DOI 10.1080/0269249X.2011.639559; ROBINSON CT, 1987, HYDROBIOLOGIA, V154, P49, DOI 10.1007/BF00026830; Romeo Oscar E., 1996, Diatom Research, V11, P317; Round F.E., 1981, ECOLOGY ALGAE; Ryan KG, 2006, ANTARCT SCI, V18, P583, DOI 10.1017/S0954102006000629; Schmidt K, 2011, LIMNOL OCEANOGR, V56, P1411, DOI 10.4319/lo.2011.56.4.1411; Schwarz AM, 2003, POLAR BIOL, V26, P789, DOI 10.1007/s00300-003-0556-2; Scott F.J., 2005, ANTARCTIC MARINE PRO, P13, DOI DOI 10.1017/S0954102005242906; SHEMESH A, 1989, QUATERNARY RES, V31, P288, DOI 10.1016/0033-5894(89)90010-0; Sicinski J, 2011, DEEP-SEA RES PT II, V58, P30, DOI 10.1016/j.dsr2.2010.09.005; SMETACEK V, 1992, DEEP-SEA RES, V39, P153, DOI 10.1016/0198-0149(92)90102-Y; SMITH WO, 1985, SCIENCE, V227, P163, DOI 10.1126/science.227.4683.163; Snoeijs Pauli, 1994, Diatom Research, V9, P189; STERRENBURG F A S, 1989, Diatom Research, V4, P143; Stickley CE, 2005, PALAEOGEOGR PALAEOCL, V227, P290, DOI 10.1016/j.palaeo.2005.05.021; SULLIVAN MJ, 1979, B MAR SCI, V29, P459; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sutherland DL, 2008, POLAR BIOL, V31, P879, DOI 10.1007/s00300-008-0426-z; Sutton JN, 2013, GEOCHIM COSMOCHIM AC, V104, P300, DOI 10.1016/j.gca.2012.10.057; Taylor F, 2001, MAR MICROPALEONTOL, V41, P25, DOI 10.1016/S0377-8398(00)00049-9; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; THOMAS DP, 1986, HYDROBIOLOGIA, V140, P193, DOI 10.1007/BF00007435; Totti C, 2011, CELL ORIG LIFE EXTRE, V16, P327; UNDERWOOD GJC, 1993, J MAR BIOL ASSOC UK, V73, P25, DOI 10.1017/S002531540003263X; Van Heurck H., 1909, RAPP SCI BOT, P1; Venables H, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005361; VILLAREAL TA, 1983, POLAR BIOL, V2, P163, DOI 10.1007/BF00448966; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Zacher K, 2007, POLAR BIOL, V30, P1203, DOI 10.1007/s00300-007-0278-y; ZIELINSKI K, 1990, Polish Polar Research, V11, P95	137	21	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153254	10.1371/journal.pone.0153254	http://dx.doi.org/10.1371/journal.pone.0153254			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078637	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000374131700030
J	Pasztor, D; Kolozsvari, BL; Csutak, A; Berta, A; Hassan, Z; Ujhelyi, B; Gogolak, P; Fodor, M				Pasztor, Dorottya; Kolozsvari, Bence Lajos; Csutak, Adrienne; Berta, Andras; Hassan, Ziad; Ujhelyi, Bernadett; Gogolak, Peter; Fodor, Mariann			Tear Mediators in Corneal Ectatic Disorders	PLOS ONE			English	Article							PELLUCID MARGINAL DEGENERATION; CONTACT-LENS WEAR; INFLAMMATORY MOLECULES; MATRIX-METALLOPROTEINASES; THINNING DISORDERS; KERATOCONUS; EXPRESSION; TOPOGRAPHY; MANAGEMENT; INDEXES	Purpose To compare the concentrations of 11 tear mediators in order to reveal the biochemical difference between pellucid marginal degeneration (PMD) and keratoconus (KC). Methods We have designed a cross-sectional study in which patients with corneal ectasia based on slit-lamp biomicroscopy and Pentacam HR (keratometry values (K1, K2, Kmax), astigmatism, minimal radius of curvature (Rmin), corneal thickness (Apex and Min), indices (surface variation, vertical asymmetry, keratoconus, central keratoconus, height asymmetry and decentration)) were enrolled. Eyes of keratoconic patients were similar to the PMD patients in age and severity (K2, Kmax and Rmin). Non-stimulated tear samples were collected from nine eyes of seven PMD patients, 55 eyes of 55 KC patients and 24 eyes of 24 healthy controls. The mediators' (interleukin -6, -10, chemokine ligand 5, -8, -10, matrix metalloproteinase (MMP) -9, -13, tissue inhibitor of metalloproteinases (TIMP)-1, tissue plasminogen activator, plasminogen activator inhibitor, nerve growth factor) concentrations were measured using Cytometric Bead Array. Results MMP-9 was the only mediator which presented relevant variances between the two patient groups (p = 0.005). The ratios of MMP-9 and TIMP-1 were 2.45, 0.40 and 0.23 in PMD, KC and the controls, respectively. Conclusion As far as we are aware, this is the first study that aims to reveal the biochemical differences between PMD and KC. Further studies of biomarkers to investigate the precise role of these mediators need to be defined, and it is important to confirm the observed changes in a larger study to gain further insights into the molecular alterations in PMD.	[Pasztor, Dorottya; Kolozsvari, Bence Lajos; Csutak, Adrienne; Berta, Andras; Ujhelyi, Bernadett; Fodor, Mariann] Univ Debrecen, Dept Ophthalmol, Fac Med, Debrecen, Hungary; [Hassan, Ziad] Orbident Refract Surg & Med Ctr, Debrecen, Hungary; [Gogolak, Peter] Univ Debrecen, Dept Immunol, Fac Med, Debrecen, Hungary	University of Debrecen; University of Debrecen	Fodor, M (corresponding author), Univ Debrecen, Dept Ophthalmol, Fac Med, Debrecen, Hungary.	mfodor@med.unideb.hu		Fodor, Mariann/0000-0002-1089-3899				Acera A, 2013, INVEST OPHTH VIS SCI, V54, P8285, DOI 10.1167/iovs.13-12235; Alhayek A, 2015, INT J OPHTHALMOL-CHI, V8, P407, DOI 10.3980/j.issn.2222-3959.2015.02.35; Ambrosio R, 2002, J REFRACT SURG, V18, P86; Ambrosio R, 2003, J REFRACT SURG, V19, P24; Balasubramanian SA, 2012, ACTA OPHTHALMOL, V90, pE303, DOI 10.1111/j.1755-3768.2011.02369.x; Belin MW, 2011, AM J OPHTHALMOL, V152, P157, DOI 10.1016/j.ajo.2011.03.028; Belin MW, 2011, AM J OPHTHALMOL, V151, P558, DOI 10.1016/j.ajo.2010.10.037; Belin MW, 2012, ELEVATION BASED CORN; Brookes NH, 2003, EXP EYE RES, V77, P515, DOI 10.1016/S0014-4835(03)00148-9; Cao Xiaoguang, 2011, J Med Case Rep, V5, P398, DOI 10.1186/1752-1947-5-398; Collier SA, 2001, CLIN EXP OPHTHALMOL, V29, P340, DOI 10.1046/j.1442-9071.2001.d01-17.x; Fodor M, 2013, EYE CONTACT LENS, V39, P147, DOI 10.1097/ICL.0b013e318273b35f; Fodor M, 2009, J INTERF CYTOK RES, V29, P375, DOI 10.1089/jir.2008.0116; Galvis V, 2015, EYE, V29, P843, DOI 10.1038/eye.2015.63; Jinabhai A, 2012, CORNEA, V31, P500, DOI 10.1097/ICO.0b013e31820f777b; Jinabhai A, 2011, CONTACT LENS ANTERIO, V34, P56, DOI 10.1016/j.clae.2010.11.007; Jun AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016437; Karabatsas CH, 1996, EYE, V10, P451, DOI 10.1038/eye.1996.99; KAYAZAWA F, 1984, ARCH OPHTHALMOL-CHIC, V102, P895; Kenney MC, 2005, INVEST OPHTH VIS SCI, V46, P823, DOI 10.1167/iovs.04-0549; Kolozsvari BL, 2014, OPHTHALMIC RES, V51, P46, DOI 10.1159/000351626; Kolozsvari BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076333; KRACHMER JH, 1984, SURV OPHTHALMOL, V28, P293, DOI 10.1016/0039-6257(84)90094-8; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P1217; Lambiase A, 2005, P NATL ACAD SCI USA, V102, P16795, DOI 10.1073/pnas.0508516102; Lema I, 2005, OPHTHALMOLOGY, V112, P654, DOI 10.1016/j.ophtha.2004.11.050; Lema I, 2009, BRIT J OPHTHALMOL, V93, P820, DOI 10.1136/bjo.2008.144253; Lema I, 2008, CORNEA, V27, P758, DOI 10.1097/ICO.0b013e31816a3591; Liu Q, 2009, EYE CONTACT LENS, V35, P232, DOI 10.1097/ICL.0b013e3181b3e87f; Mackiewicz Z, 2006, CORNEA, V25, P603, DOI 10.1097/01.ico.0000208820.32614.00; MAGUIRE LJ, 1987, OPHTHALMOLOGY, V94, P519, DOI 10.1016/S0161-6420(87)33416-5; Maharana PK, 2016, BRIT J OPHTHALMOL, V100, P34, DOI 10.1136/bjophthalmol-2015-307059; Matthews FJ, 2007, EXP EYE RES, V84, P1125, DOI 10.1016/j.exer.2007.02.013; Moshirfar M, 2014, J REFRACT SURG, V30, P474, DOI 10.3928/1081597X-20140429-02; Pannebaker C, 2010, MOL VIS, V16, P1949; RABINOWITZ YS, 1995, J REFRACT SURG, V11, P371; Rabinowitz YS, 1998, SURV OPHTHALMOL, V42, P297, DOI 10.1016/S0039-6257(97)00119-7; Rao SK, 1999, CORNEA, V18, P265, DOI 10.1097/00003226-199905000-00004; Rasheed K, 2000, OPHTHALMOLOGY, V107, P1836, DOI 10.1016/S0161-6420(00)00346-8; Rebenitsch RL, 2011, AM J OPHTHALMOL, V151, P768, DOI 10.1016/j.ajo.2010.10.034; Saghizadeh M, 2001, EXP EYE RES, V73, P179, DOI 10.1006/exer.2001.1028; Sakimoto Tohru, 2012, Cornea, V31 Suppl 1, pS50, DOI 10.1097/ICO.0b013e318269ccd0; Schmitt-Bernard CFM, 2000, J REFRACT SURG, V16, P368; Sorkhabi R, 2015, INT OPHTHALMOL, V35, P467, DOI 10.1007/s10792-014-9971-3; Sridhar MS, 2004, OPHTHALMOLOGY, V111, P1102, DOI 10.1016/j.ophtha.2003.09.035; Tummanapalli SS, 2013, J CATARACT REFR SURG, V39, P56, DOI 10.1016/j.jcrs.2012.08.053; Walker RN, 2008, CORNEA, V27, P963, DOI 10.1097/ICO.0b013e318170ae98; Wisse RPL, 2015, OCUL SURF, V13, P272, DOI 10.1016/j.jtos.2015.04.006; Zhou LL, 1998, INVEST OPHTH VIS SCI, V39, P1117	49	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153186	10.1371/journal.pone.0153186	http://dx.doi.org/10.1371/journal.pone.0153186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074131	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131200058
J	Braun, C; Rehdanz, K; Schmidt, U				Braun, Carola; Rehdanz, Katrin; Schmidt, Ulrich			Validity of Willingness to Pay Measures under Preference Uncertainty	PLOS ONE			English	Article							CONTINGENT VALUATION METHOD; DISCRETE-CHOICE; COHERENT ARBITRARINESS; RESPONDENT UNCERTAINTY; STATED PREFERENCE; IMPRECISION; RELIABILITY; ELICITATION; MECHANISMS; QUESTION	Recent studies in the marketing literature developed a new method for eliciting willingness to pay (WTP) with an open-ended elicitation format: the Range-WTP method. In contrast to the traditional approach of eliciting WTP as a single value (Point-WTP), Range-WTP explicitly allows for preference uncertainty in responses. The aim of this paper is to apply Range-WTP to the domain of contingent valuation and to test for its theoretical validity and robustness in comparison to the Point-WTP. Using data from two novel large-scale surveys on the perception of solar radiation management (SRM), a little-known technique for counteracting climate change, we compare the performance of both methods in the field. In addition to the theoretical validity (i.e. the degree to which WTP values are consistent with theoretical expectations), we analyse the test-retest reliability and stability of our results over time. Our evidence suggests that the Range-WTP method clearly outperforms the Point-WTP method.	[Braun, Carola; Rehdanz, Katrin; Schmidt, Ulrich] Kiel Inst World Econ, Kiel, Germany; [Rehdanz, Katrin; Schmidt, Ulrich] Univ Kiel, Dept Econ, Kiel, Germany; [Schmidt, Ulrich] Univ Johannesburg, Dept Econ & Econometr, Johannesburg, South Africa	Institut fur Weltwirtschaft an der Universitat Kiel (IFW); University of Kiel; University of Johannesburg	Braun, C (corresponding author), Kiel Inst World Econ, Kiel, Germany.	carola.kniebes@ifw-kiel.de		Rehdanz, Katrin/0000-0002-5336-0582	German Federal Ministry for Education and Research [01LA1112A]; Leibniz Association	German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Leibniz Association	This paper is part of the project ACCEPT, which is funded by the German Federal Ministry for Education and Research (grant number 01LA1112A). The publication of this article was funded by the Open Access fund of the Leibniz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter S, 2013, APPL ECON, V45, P2107, DOI 10.1080/00036846.2012.654914; Ariely D, 2003, Q J ECON, V118, P73, DOI 10.1162/00335530360535153; Arrow Kenneth., 1993, FED REGISTER, V58, P4601, DOI DOI 10.1002/QJ.49703213905; BATEMAN I, 1994, REG STUD, V28, P457, DOI 10.1080/00343409412331348396; Bateman IJ, 2005, ENVIRON RESOUR ECON, V31, P47, DOI 10.1007/s10640-004-6978-7; BATEMAN IJ, 1995, ECOL ECON, V12, P161, DOI 10.1016/0921-8009(94)00044-V; BOYLE KJ, 1988, AM J AGR ECON, V70, P20, DOI 10.2307/1241972; Broberg T, 2008, RESOUR ENERGY ECON, V30, P555, DOI 10.1016/j.reseneeco.2008.09.001; Brown TC, 1996, LAND ECON, V72, P152, DOI 10.2307/3146963; Butler D, 2011, J ECON BEHAV ORGAN, V80, P511, DOI 10.1016/j.jebo.2011.05.008; Butler DJ, 2007, AM ECON REV, V97, P277, DOI 10.1257/aer.97.1.277; Cai BL, 2010, ENVIRON RESOUR ECON, V46, P429, DOI 10.1007/s10640-010-9348-7; Carson R. T., 2011, CONTINGENT VALUATION; Champ PA, 1997, J ENVIRON ECON MANAG, V33, P151, DOI 10.1006/jeem.1997.0988; Corrigan JR, 2009, AM J AGR ECON, V91, P837, DOI 10.1111/j.1467-8276.2009.01267.x; Crutzen PJ, 2006, CLIMATIC CHANGE, V77, P211, DOI 10.1007/s10584-006-9101-y; Cubitt RP, 2015, J RISK UNCERTAINTY, V50, P1, DOI 10.1007/s11166-015-9207-6; Damschroder LJ, 2007, JUDGM DECIS MAK, V2, P96; Diener A, 1998, HEALTH ECON, V7, P313, DOI 10.1002/(SICI)1099-1050(199806)7:4<313::AID-HEC350>3.3.CO;2-2; Donaldson C, 1997, APPL ECON, V29, P79, DOI 10.1080/000368497327425; Dost F, 2012, INT J RES MARK, V29, P148, DOI 10.1016/j.ijresmar.2011.09.003; Dubourg WR, 1997, ECONOMICA, V64, P681; Ellingson L, 2009, VALUATION UNCERTAINT; Frew EJ, 2003, MED DECIS MAKING, V23, P150, DOI 10.1177/0272989X03251245; Green D, 1998, RESOUR ENERGY ECON, V20, P85, DOI 10.1016/S0928-7655(97)00031-6; GREGORY R, 1993, J RISK UNCERTAINTY, V7, P177, DOI 10.1007/BF01065813; Hakansson C, 2008, ENVIRON RESOUR ECON, V39, P175, DOI 10.1007/s10640-007-9102-y; Hanley N, 2009, LAND ECON, V85, P41, DOI 10.3368/le.85.1.41; IPCC, 2012, M REP INT PAN CLIM C; JACOWITZ KE, 1995, PERS SOC PSYCHOL B, V21, P1161, DOI 10.1177/01461672952111004; Jorgensen BS, 2004, J ECON PSYCHOL, V25, P41, DOI 10.1016/S0167-4870(02)00167-8; KAHNEMAN D, 1994, J RISK UNCERTAINTY, V9, P5, DOI 10.1007/BF01073401; KANNINEN BJ, 1995, J ENVIRON ECON MANAG, V28, P114, DOI 10.1006/jeem.1995.1008; KEALY MJ, 1993, AM J AGR ECON, V75, P321, DOI 10.2307/1242916; KEALY MJ, 1990, J ENVIRON ECON MANAG, V19, P244, DOI 10.1016/0095-0696(90)90072-7; Klepper G, 2014, REV ENV ECON POLICY, V8, P270, DOI 10.1093/reep/reu010; Klose T, 1999, HEALTH POLICY, V47, P97, DOI 10.1016/S0168-8510(99)00010-X; LI CZ, 1995, J ENVIRON ECON MANAG, V28, P256, DOI 10.1006/jeem.1995.1017; Lienhoop N, 2011, ECOL ECON, V70, P1250, DOI 10.1016/j.ecolecon.2011.02.014; LOOMES G, 1988, THEOR DECIS, V25, P1, DOI 10.1007/BF00129167; Loomis J, 1998, ECOL ECON, V27, P29, DOI 10.1016/S0921-8009(97)00126-2; LOOMIS JB, 1990, J ENVIRON ECON MANAG, V18, P78, DOI 10.1016/0095-0696(90)90053-2; Mahieu PA, 2012, J ENVIRON PLANN MAN, V55, P753, DOI 10.1080/09640568.2011.626524; MARCH JG, 1978, BELL J ECON, V9, P587, DOI 10.2307/3003600; Mentzakis E, 2010, WORKING PAPER; Mercer AM, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044006; Merk C, 2015, CLIMATIC CHANGE, V130, P299, DOI 10.1007/s10584-014-1317-7; Mitchell R.C., 1989, USING SURVEYS VALUE; Poe GL, 2002, ENVIRON RESOUR ECON, V23, P105, DOI 10.1023/A:1020242907259; Ready RC, 1996, LAND ECON, V72, P397, DOI 10.2307/3147205; READY RC, 1995, J ENVIRON ECON MANAG, V29, P181, DOI 10.1006/jeem.1995.1040; Ressurreicao A, 2011, ECOL ECON, V70, P729, DOI 10.1016/j.ecolecon.2010.11.009; SELLER C, 1985, LAND ECON, V61, P156, DOI 10.2307/3145808; Shaikh SL, 2007, ECOL ECON, V62, P115, DOI 10.1016/j.ecolecon.2006.05.016; Smith RD, 2000, MED DECIS MAKING, V20, P194, DOI 10.1177/0272989X0002000205; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Venkatachalam L, 2004, ENVIRON IMPACT ASSES, V24, P89, DOI 10.1016/S0195-9255(03)00138-0; Voltaire L, 2013, ECOL ECON, V88, P76, DOI 10.1016/j.ecolecon.2013.01.009; Wang T, 2007, J MARKETING RES, V44, P200, DOI 10.1509/jmkr.44.2.200; Welsh MP, 1998, J ENVIRON ECON MANAG, V36, P170, DOI 10.1006/jeem.1998.1043; Whitehead JC, 1998, ENVIRON RESOUR ECON, V11, P107, DOI 10.1023/A:1008231430184; Whynes DK, 2005, HEALTH ECON, V14, P1191, DOI 10.1002/hec.1001; Whynes DK, 2004, HEALTH ECON, V13, P183, DOI 10.1002/hec.809; Yeung RYT, 2006, HEALTH ECON, V15, P1077, DOI 10.1002/hec.1107	65	7	8	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154078	10.1371/journal.pone.0154078	http://dx.doi.org/10.1371/journal.pone.0154078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096163	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600086
J	Fujiwara, S; Araki, K; Matsuo, T; Yagi, H; Yamada, T; Shibata, K; Mochizuki, H				Fujiwara, Satoru; Araki, Katsuya; Matsuo, Tatsuhito; Yagi, Hisashi; Yamada, Takeshi; Shibata, Kaoru; Mochizuki, Hideki			Dynamical Behavior of Human alpha-Synuclein Studied by Quasielastic Neutron Scattering	PLOS ONE			English	Article							PROTEIN DYNAMICS; PARKINSONS-DISEASE; INTERNAL DYNAMICS; CONFORMATIONAL ENTROPY; STRUCTURAL DYNAMICS; DISORDERED PROTEIN; AMYLOID FIBRILS; FIBRILLATION; AGGREGATION; DIFFUSION	alpha-synuclein (alpha Syn) is a protein consisting of 140 amino acid residues and is abundant in the presynaptic nerve terminals in the brain. Although its precise function is unknown, the filamentous aggregates (amyloid fibrils) of alpha Syn have been shown to be involved in the pathogenesis of Parkinson's disease, which is a progressive neurodegenerative disorder. To understand the pathogenesis mechanism of this disease, the mechanism of the amyloid fibril formation of alpha Syn must be elucidated. Purified alpha Syn from bacterial expression is monomeric but intrinsically disordered in solution and forms amyloid fibrils under various conditions. As a first step toward elucidating the mechanism of the fibril formation of alpha Syn, we investigated dynamical behavior of the purified alpha Syn in the monomeric state and the fibril state using quasielastic neutron scattering (QENS). We prepared the solution sample of 9.5 mg/ml purified alpha Syn, and that of 46 mg/ml alpha Syn in the fibril state, both at pD 7.4 in D2O. The QENS experiments on these samples were performed using the near-backscattering spectrometer, BL02 (DNA), at the Materials and Life Science Facility at the Japan Accelerator Research Complex, Japan. Analysis of the QENS spectra obtained shows that diffusive global motions are observed in the monomeric state but largely suppressed in the fibril state. However, the amplitude of the side chain motion is shown to be larger in the fibril state than in the monomeric state. This implies that significant solvent space exists within the fibrils, which is attributed to the alpha Syn molecules within the fibrils having a distribution of conformations. The larger amplitude of the side chain motion in the fibril state than in the monomeric state implies that the fibril state is entropically favorable.	[Fujiwara, Satoru; Matsuo, Tatsuhito] Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan; [Araki, Katsuya; Mochizuki, Hideki] Osaka Univ, Dept Neurol, Grad Sch Med, Suita, Osaka, Japan; [Yagi, Hisashi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori 680, Japan; [Yamada, Takeshi] CROSS Tokai, Res Ctr Neutron Sci & Technol, Tokai, Ibaraki, Japan; [Shibata, Kaoru] J PARC Ctr, Neutron Sci Sect, Tokai, Ibaraki, Japan; [Fujiwara, Satoru; Matsuo, Tatsuhito] Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan	Japan Atomic Energy Agency; Osaka University; Tottori University; National Institutes for Quantum Science & Technology	Fujiwara, S (corresponding author), Japan Atom Energy Agcy, Quantum Beam Sci Ctr, Tokai, Ibaraki, Japan.; Fujiwara, S (corresponding author), Natl Inst Quantum & Radiol Sci & Technol, Tokai, Ibaraki, Japan.	fujiwara.satoru@qst.go.jp		Araki, Katsuya/0000-0001-5493-2178	Japan Society for the Promotion of Science (JSPS KAKENHI Grant) [26293210]; Takeda Science Foundation; CROSS-Tokai [2012P0502, 2013P0502, 2014P0502]	Japan Society for the Promotion of Science (JSPS KAKENHI Grant)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); CROSS-Tokai	This study is supported in part by the Grant-in-Aid for Scientific Research (B) from Japan Society for the Promotion of Science (JSPS KAKENHI Grant No. 26293210) (to HM, SF), and from Takeda Science Foundation (to HY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript" should not be changed. It is because the statement "The QENS experiments using BL02 (DNA) at MLF/J-PARC were carried out under the research project organized by J-PARC Center and CROSS-Tokai (Proposal No. 2012P0502, 2013P0502, and 2014P0502)" is not regarding funding but regarding the experimental proposals for requesting the beam time at the experiments at J-PARC.; We thank Dr. R. Inoue and Prof. M. Sugiyama for their help in the DLS measurements. The QENS experiments using BL02 (DNA) atMLF/J-PARC were carried out under the research project organized by J-PARC Center and CROSS-Tokai (Proposal No. 2012P0502, 2013P0502, and 2014P0502).	Baxa MC, 2014, P NATL ACAD SCI USA, V111, P15396, DOI 10.1073/pnas.1407768111; Bee M, 1988, QUASIELASTIC NEUTRON; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Borreguero JM, 2011, J PHYS CHEM B, V115, P8925, DOI 10.1021/jp201346x; Bousset L, 2014, BBA-PROTEINS PROTEOM, V1844, P1307, DOI 10.1016/j.bbapap.2014.04.010; Bu ZM, 2000, J MOL BIOL, V301, P525, DOI 10.1006/jmbi.2000.3978; Bu ZM, 2001, J MOL BIOL, V312, P865, DOI 10.1006/jmbi.2001.5006; Caronna C, 2005, BIOPHYS CHEM, V116, P219, DOI 10.1016/j.bpc.2005.02.004; Dee DR, 2011, BIOPHYS J, V101, P1699, DOI 10.1016/j.bpj.2011.08.002; Del Mar C, 2005, P NATL ACAD SCI USA, V102, P15477, DOI 10.1073/pnas.0507405102; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Fichou Y, 2015, P NATL ACAD SCI USA, V112, P6365, DOI 10.1073/pnas.1422824112; Fink AL, 2006, ACCOUNTS CHEM RES, V39, P628, DOI 10.1021/ar050073t; Fitter J, 2003, BIOPHYS J, V84, P3924, DOI 10.1016/S0006-3495(03)75120-0; Fujiwara S, 2008, BIOPHYS J, V94, P4880, DOI 10.1529/biophysj.107.125302; Fujiwara S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJS.82SA.SA019; Fujiwara S, 2011, EUR BIOPHYS J BIOPHY, V40, P661, DOI 10.1007/s00249-011-0669-4; Gabel F, 2002, Q REV BIOPHYS, V35, P327, DOI 10.1017/S0033583502003840; Gallat FX, 2012, BIOPHYS J, V103, P129, DOI 10.1016/j.bpj.2012.05.027; Gaspar AM, 2008, EUR BIOPHYS J BIOPHY, V37, P573, DOI 10.1007/s00249-008-0266-3; Gaspar AM, 2010, BBA-PROTEINS PROTEOM, V1804, P76, DOI 10.1016/j.bbapap.2009.06.024; Gibrat G, 2008, BIOPHYS J, V95, P5247, DOI 10.1529/biophysj.107.120147; Greenwald J, 2010, STRUCTURE, V18, P1244, DOI 10.1016/j.str.2010.08.009; Grimaldo M, 2015, PHYS CHEM CHEM PHYS, V17, P4645, DOI 10.1039/c4cp04944f; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Ikenoue T, 2014, ANGEW CHEM INT EDIT, V53, P7799, DOI 10.1002/anie.201403815; Inamura Y, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJS.82SA.SA031; Jansson H, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2943199; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lv GH, 2012, J MOL BIOL, V420, P99, DOI 10.1016/j.jmb.2012.04.009; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Parigi G, 2014, J AM CHEM SOC, V136, P16201, DOI 10.1021/ja506820r; Perez J, 1999, BIOPHYS J, V77, P454, DOI 10.1016/S0006-3495(99)76903-1; Perticaroli S, 2014, J PHYS CHEM B, V118, P7317, DOI 10.1021/jp503788r; Pieper J, 2009, BIOCHEMISTRY-US, V48, P6111, DOI 10.1021/bi900414k; Pieper J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.228103; PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Roosen-Runge F, 2011, P NATL ACAD SCI USA, V108, P11815, DOI 10.1073/pnas.1107287108; Sacquin-Mora S, 2007, BIOCHEMISTRY-US, V46, P14960, DOI 10.1021/bi7004416; Schiro G, 2012, J PHYS CHEM LETT, V3, P992, DOI 10.1021/jz300082x; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Shibata K., 2015, J PARC JPS C PROC, V8, DOI DOI 10.7566/JPSCP.8.036022; SMITH JC, 1991, Q REV BIOPHYS, V24, P227, DOI 10.1017/S0033583500003723; Stadler AM, 2008, BIOPHYS J, V95, P5449, DOI 10.1529/biophysj.108.138040; Stadler AM, 2015, J PHYS CHEM B, V119, P72, DOI 10.1021/jp509732q; Stadler AM, 2014, J AM CHEM SOC, V136, P6987, DOI 10.1021/ja502343b; Stadler AM, 2013, BIOPHYS J, V105, P2157, DOI 10.1016/j.bpj.2013.09.039; TEIXEIRA J, 1985, PHYS REV A, V31, P1913, DOI 10.1103/PhysRevA.31.1913; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; Uversky VN, 2005, CURR PROTEIN PEPT SC, V10, P482; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; VOLINO F, 1980, MOL PHYS, V41, P271, DOI 10.1080/00268978000102761; Vrandecic K, 2015, J PHYS CHEM B, V119, P3920, DOI 10.1021/jp5112873; Wang YQ, 2012, J PHYS CHEM LETT, V3, P2703, DOI 10.1021/jz3010915; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yasuda T, 2013, MOL NEUROBIOL, V47, P466, DOI 10.1007/s12035-012-8327-0; Zaccai G, 2000, SCIENCE, V288, P1604, DOI 10.1126/science.288.5471.1604; Zanotti JM, 1999, BIOPHYS J, V76, P2390, DOI 10.1016/S0006-3495(99)77395-9	63	24	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151447	10.1371/journal.pone.0151447	http://dx.doi.org/10.1371/journal.pone.0151447			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097022	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600003
J	Kim, DH; Choi, BH; Ku, SK; Park, JH; Oh, E; Kwak, MK				Kim, Dong-hyun; Choi, Bo-hyun; Ku, Sae-Kwang; Park, Jeong-hyeon; Oh, Euichaul; Kwak, Mi-Kyoung			Beneficial Effects of Sarpogrelate and Rosuvastatin in High Fat Diet/Streptozotocin-Induced Nephropathy in Mice	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; CARDIOVASCULAR-DISEASE; MOLECULAR-MECHANISMS; RECEPTOR ANTAGONIST; RENAL FIBROSIS; RISK-FACTOR; CYSTATIN-C	Chronic kidney disease (CKD) is a major complication of metabolic disorders such as diabetes mellitus, obesity, and hypertension. Comorbidity of these diseases is the factor exacerbating CKD progression. Statins are commonly used in patients with metabolic disorders to decrease the risk of cardiovascular complications. Sarpogrelate, a selective antagonist of 5-hydroxytryptamine (5-HT) 2A receptor, inhibits platelet aggregation and is used to improve peripheral circulation in diabetic patients. Here, we investigated the effects of sarpogrelate and rosuvastatin on CKD in mice that were subjected to a high fat diet (HFD) for 22 weeks and a single low dose of streptozotocin (STZ, 40 mg/kg). When mice were administrated sarpogrelate (50 mg/kg, p.o.) for 13 weeks, albuminuria and urinary cystatin C excretion were normalized and histopathological changes such as glomerular mesangial expansion, tubular damage, and accumulations in lipid droplets and collagen were significantly improved. Sarpogrelate treatment repressed the HFD/STZ-induced CD31 and vascular endothelial growth factor receptor-2 expressions, indicating the attenuation of glomerular endothelial proliferation. Additionally, sarpogrelate inhibited interstitial fibrosis by suppressing the increases in transforming growth factor-beta 1 (TGF-beta 1) and plasminogen activator inhibitor-1 (PAI-1). All of these functional and histological improvements were also seen in rosuvastatin (20 mg/kg) group and, notably, the combinatorial treatment with sarpogrelate and rosuvastatin showed additive beneficial effects on histopathological changes by HFD/STZ. Moreover, sarpogrelate reduced circulating levels of PAI-1 that were elevated in the HFD/STZ group. As supportive in vitro evidence, sarpogrelate incubation blocked TGF-beta 1/5-HT-inducible PAI-1 expression in murine glomerular mesangial cells. Taken together, sarpogrelate and rosuvastatin may be advantageous to control the progression of CKD in patients with comorbid metabolic disorders, and particularly, the use of sarpogrelate as adjunctive therapy with statins may provide additional benefits on CKD.	[Kim, Dong-hyun; Choi, Bo-hyun; Park, Jeong-hyeon; Oh, Euichaul; Kwak, Mi-Kyoung] Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea; [Ku, Sae-Kwang] Daegu Haany Univ, Coll Korean Med, Gyongsan 712715, Gyeonsangbuk Do, South Korea	Catholic University of Korea; Daegu Haany University	Kwak, MK (corresponding author), Catholic Univ Korea, Coll Pharm, Bucheon 420743, Gyeonggi Do, South Korea.	mkwak@catholic.ac.kr			National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2013M3A9B5075839, NRF-2013R1A2A2A01015497]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2013M3A9B5075839 and NRF-2013R1A2A2A01015497).	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; Adly AAM, 2014, J DIABETES COMPLICAT, V28, P340, DOI 10.1016/j.jdiacomp.2014.01.011; Alessi MC, 2006, ARTERIOSCL THROM VAS, V26, P2200, DOI 10.1161/01.ATV.0000242905.41404.68; Athyrost VG, 2015, EXPERT OPIN PHARMACO, V16, P1449, DOI 10.1517/14656566.2015.1053464; BARRADAS MA, 1988, EUR J CLIN INVEST, V18, P399, DOI 10.1111/j.1365-2362.1988.tb01030.x; Bottinger EP, 2007, SEMINARS NEPHROLOGY; Braun L, 2012, INT J NEPHROL RENOV, V5, P151, DOI 10.2147/IJNRD.S37766; Campese VM, 2014, CLIN EXP NEPHROL, V18, P291, DOI 10.1007/s10157-014-0934-9; Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Zeeuw D, 2015, LANCET DIABETES ENDO, V3, P181, DOI 10.1016/S2213-8587(14)70246-3; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P865, DOI 10.1517/13543784.13.7.865; Doggreu SA, 2003, EXPERT OPIN INV DRUG, V12, P805, DOI 10.1517/eoid.12.5.805.22158; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Eddy AA, 1996, J AM SOC NEPHROL, V7, P2495; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fraser SDS, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0189-z; Gelber RP, 2005, AM J KIDNEY DIS, V46, P871, DOI 10.1053/j.ajkd.2005.08.015; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Giunti S, 2010, AM J PHYSIOL-RENAL, V299, pF528, DOI 10.1152/ajprenal.00127.2010; Hamasaki Y, 2013, AM J PHYSIOL-RENAL, V305, pF1796, DOI 10.1152/ajprenal.00151.2013; HAMSTEN A, 1987, LANCET, V2, P3; Hasegawa Y, 2002, THROMB RES, V107, P319, DOI 10.1016/S0049-3848(02)00348-1; Herget-Rosenthal S, 2004, KIDNEY INT, V66, P1115, DOI 10.1111/j.1523-1755.2004.00861.x; Herget-Rosenthal S, 2004, ANN CLIN BIOCHEM, V41, P111, DOI 10.1258/000456304322879980; Hovind P, 2001, KIDNEY INT, V59, P702, DOI 10.1046/j.1523-1755.2001.059002702.x; Ito M, 2001, ENVIRON TOXICOL PHAR, V9, P71, DOI 10.1016/S1382-6689(00)00064-8; Jafar T, 2006, CHRONIC KIDNEY DIS D; Jagroop IA, 2001, J HUM HYPERTENS, V15, P203, DOI 10.1038/sj.jhh.1001146; Kasahara M, 2014, CLIN EXP NEPHROL, V18, P282, DOI 10.1007/s10157-013-0928-z; Kasho M, 1998, KIDNEY INT, V54, P1083, DOI 10.1046/j.1523-1755.1998.00114.x; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kobayashi S, 2008, CLIN EXP NEPHROL, V12, P119, DOI 10.1007/s10157-007-0011-8; Kohler HP, 2000, NEW ENGL J MED, V342, P1792, DOI 10.1056/NEJM200006153422406; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Kuwabara T, 2012, DIABETOLOGIA, V55, P2256, DOI 10.1007/s00125-012-2578-1; Landray MJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1793; Lee HS, 2008, J MED FOOD, V11, P294, DOI 10.1089/jmf.2007.578; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Malgorzewicz S, 2013, INT J MOL MED, V31, P503, DOI 10.3892/ijmm.2013.1234; MANTTARI M, 1995, HYPERTENSION, V26, P670, DOI 10.1161/01.HYP.26.4.670; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Ogawa S, 2008, CLIN J AM SOC NEPHRO, V3, P362, DOI 10.2215/CJN.03450807; Pakala R, 1997, CIRCULATION, V96, P2280; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Ryoo IG, 2015, ARCH PHARM RES, V38, P272, DOI 10.1007/s12272-014-0380-y; Saini HK, 2004, CARDIOVASC DRUG REV, V22, P27; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Sirtori CR, 2014, PHARMACOL RES, V88, P3, DOI 10.1016/j.phrs.2014.03.002; Son JY, 2014, TOX RESEARCH, V30, P99, DOI 10.5487/TR.2014.30.2.099; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Suh DC, 2010, COMPLICATIONS, V24, P382, DOI DOI 10.1016/J.JDIAC0MP.2009.07.001; Takahashi T, 2002, DIABETES RES CLIN PR, V58, P123, DOI 10.1016/S0168-8227(02)00105-5; Tamura Y, 2011, INT J MOL MED, V28, P683, DOI 10.3892/ijmm.2011.769; Tsuchida K, 1999, DIABETOLOGIA, V42, P579, DOI 10.1007/s001250051198; Wasung ME, 2015, CLIN CHIM ACTA, V438, P350, DOI 10.1016/j.cca.2014.08.039	62	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153965	10.1371/journal.pone.0153965	http://dx.doi.org/10.1371/journal.pone.0153965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097221	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600076
J	Frankis, J; Young, I; Flowers, P; McDaid, L				Frankis, Jamie; Young, Ingrid; Flowers, Paul; McDaid, Lisa			Who Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK - A Mixed Methods Study	PLOS ONE			English	Article							AUSTRALIAN GAY; BISEXUAL MEN; CONDOM USE; HIV; WILLINGNESS	Background Recent clinical trials suggest that pre-exposure prophylaxis (PrEP) may reduce HIV transmission by up to 86% for men who have sex with men (MSM), whilst relatively high levels of PrEP acceptability have been reported to date. This study examines PrEP awareness amongst sub-groups of MSM communities and acceptability amongst MSM in a low prevalence region (Scotland, UK), using a mixed methods design. Methods Quantitative surveys of n = 690 MSM recruited online via social and sociosexual media were analysed using descriptive statistics and multivariate logistic regression. In addition, n = 10 in-depth qualitative interviews with MSM were analysed thematically. Results Under one third (29.7%) of MSM had heard of PrEP, with awareness related to living in large cities, degree level education, commercial gay scene use and reporting an HIV test in the last year. Just under half of participants (47.8%) were likely to use PrEP if it were available but there was no relationship between PrEP acceptability and previous PrEP awareness. Younger men (18-25 years) and those who report higher risk UAI were significantly more likely to say they would use PrEP. Qualitative data described specific PrEP scenarios, illustrating how risk, patterns of sexual practice and social relationships could affect motivation for and nature of PrEP use. Conclusion These findings suggest substantial interest PrEP amongst MSM reporting HIV risk behaviours in Scotland. Given the Proud results, there is a strong case to investigate PrEP implementation within the UK. However, it appears that disparities in awareness have already emerged along traditional indicators of inequality. Our research identifies the need for comprehensive support when PrEP is introduced, including a key online component, to ensure equity of awareness across diverse MSM communities (e.g. by geography, education, gay scene use and HIV proximity), as well as to responding to the diverse informational and sexual health needs of all MSM communities.	[Frankis, Jamie; Flowers, Paul] Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland; [Young, Ingrid; McDaid, Lisa] Univ Glasgow, MRC CSO Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland	Glasgow Caledonian University; MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of Glasgow	Frankis, J (corresponding author), Glasgow Caledonian Univ, Sch Hlth & Life Sci, Glasgow G4 0BA, Lanark, Scotland.	j.frankis@gcu.ac.uk	Flowers, Paul/H-5174-2019	Flowers, Paul/0000-0001-6239-5616; McDaid, Lisa/0000-0002-7711-8723; Frankis, Jamie/0000-0003-3350-5892; Young, Ingrid/0000-0002-1242-5992	Glasgow Caledonian University (GCU); NHS Lanarkshire Blood Bourne Viruses; UK Medical Research Council (MRC), Social Relationships and Health Improvement programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow [MC_U130031238/MC_UU_12017/2]; Chief Scientist Office (CSO) fellowship [PDF/14/02]; MRC [MC_UU_12017/11]; CSO [SPHSU11]; MRC [MC_UU_12017/2, MC_U130031238] Funding Source: UKRI; Medical Research Council [MC_UU_12017/2, MC_U130031238, MC_UU_12017/11] Funding Source: researchfish; Chief Scientist Office [PDF/14/02, SPHSU11] Funding Source: researchfish	Glasgow Caledonian University (GCU); NHS Lanarkshire Blood Bourne Viruses; UK Medical Research Council (MRC), Social Relationships and Health Improvement programme at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow; Chief Scientist Office (CSO) fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CSO; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	This work was supported by Glasgow Caledonian University (GCU) funds to JF and PF. NHS Lanarkshire Blood Bourne Viruses and GCU funded the Social Media, Men who have sex with men and Sexual Health (SMMASH) study, the quantitative research component of this paper, as part of the Sexual Health and Blood Borne Viruses Theme, at the Institute for Applied Health Research, GCU. HIV & the Biomedical, the qualitative research component, was funded by the UK Medical Research Council (MRC) (MC_U130031238/MC_UU_12017/2), as part of core-funding for the Sexual Health Programme (now the Social Relationships and Health Improvement programme) at the MRC/CSO Social and Public Health Sciences Unit, University of Glasgow. IY is funded by a Chief Scientist Office (CSO) fellowship (PDF/14/02). LM is funded by the MRC (MC_UU_12017/11) and CSO (SPHSU11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaizu A, 2013, SEX TRANSM INFECT, V89, P207, DOI 10.1136/sextrans-2012-050648; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Beyrer C, 2015, LANCET, V385, P1482, DOI 10.1016/S0140-6736(15)60724-3; Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Dolling D, 2014, HIV MED, V15, P15; FDA, 2012, FDA APPR 1 DRUG RED; Flowers P, 1997, PSYCHOL HEALTH, V12, P197, DOI 10.1080/08870449708407400; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Haberer JE, 2015, AIDS; Health Protection Scotland, 2015, HIV INF AIDS Q REP 3; Health Protection Scotland, 2015, HIV INF AIDS Q REP 3; Holt M, 2014, JAIDS-J ACQ IMM DEF, V67, P222, DOI 10.1097/QAI.0000000000000287; Holt M, 2014, SEX HEALTH, V11, P166, DOI 10.1071/SH13060; Holt M, 2012, SEX TRANSM INFECT, V88, P258, DOI 10.1136/sextrans-2011-050312; Kirby T, 2014, LANCET, V383, P399, DOI 10.1016/S0140-6736(14)60137-9; Krakower DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033119; Leonardi M, 2011, INT J STD AIDS, V22, P738, DOI 10.1258/ijsa.2011.011057; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Lorimer K, TRANSITIONS AP UNPUB; Mason J., 1996, QUALITATIVE RES; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Molina J-M, 2015, DEMAND PREP ORAL TDF, V23LB; Okwundu CI, 2012, COCHRANE DATABASE SY; Saberi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050061; Sigma Research, 2015, GAY MENS SEX SURV 20; Silverman D., 2017, DOING QUALITATIVE RE, V5th; Wallace LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090805; Young I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005717; Young I, 2014, AIDS BEHAV, V18, P195, DOI 10.1007/s10461-013-0560-7; Young I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064038; Zhou F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032329; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	33	37	38	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0151385	10.1371/journal.pone.0151385	http://dx.doi.org/10.1371/journal.pone.0151385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093430	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000374541200002
J	Drake, T; Keating, M; Summers, R; Yochikawa, A; Pitman, T; Dodd, AN				Drake, Tiffany; Keating, Mia; Summers, Rebecca; Yochikawa, Aline; Pitman, Tom; Dodd, Antony N.			The Cultivation of Arabidopsis for Experimental Research Using Commercially Available Peat-Based and Peat-Free Growing Media	PLOS ONE			English	Article							THALIANA; GROWTH; TRANSCRIPTION; CONSERVATION; SOIL; COMPOSTS	Experimental research involving Arabidopsis thaliana often involves the quantification of phenotypic traits during cultivation on compost or other growing media. Many commercially-available growing media contain peat, but peat extraction is not sustainable due to its very slow rate of formation. Moreover, peat extraction reduces peatland biodiversity and releases stored carbon and methane into the atmosphere. Here, we compared the experimental performance of Arabidopsis on peat-based and several types of commercially-available peat-free growing media (variously formed from coir, composted bark, wood-fibre, and domestic compost), to provide guidance for reducing peat use in plant sciences research with Arabidopsis. Arabidopsis biomass accumulation and seed yield were reduced by cultivation on several types of peat-free growing media. Arabidopsis performed extremely poorly on coir alone, presumably because this medium was completely nitrate-free. Some peatfree growing media were more susceptible to fungal contamination. We found that autoclaving of control (peat-based) growing media had no effect upon any physiological parameters that we examined, compared with non-autoclaved control growing media, under our experimental conditions. Overall, we conclude that Arabidopsis performs best when cultivated on peat-based growing media because seed yield was almost always reduced when peat-free media were used. This may be because standard laboratory protocols and growth conditions for Arabidopsis are optimized for peat-based media. However, during the vegetative growth phase several phenotypic traits were comparable between plants cultivated on peat-based and some peat-free media, suggesting that under certain circumstances peat-free media can be suitable for phenotypic analysis of Arabidopsis.	[Drake, Tiffany; Keating, Mia; Summers, Rebecca; Yochikawa, Aline; Pitman, Tom; Dodd, Antony N.] Univ Bristol, Sch Biol Sci, Bristol Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Dodd, Antony N.] Univ Bristol, Cabot Inst, Bristol BS8 1UJ, Avon, England; [Yochikawa, Aline] Univ Estadual Campinas, Cidade Univ Zeferino Vaz, Sao Paulo, Brazil	University of Bristol; University of Bristol; Universidade Estadual de Campinas	Dodd, AN (corresponding author), Univ Bristol, Sch Biol Sci, Bristol Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.; Dodd, AN (corresponding author), Univ Bristol, Cabot Inst, Bristol BS8 1UJ, Avon, England.	antony.dodd@bristol.ac.uk		Drake, Tiffany/0000-0001-9690-9689	UK Biotechnology and Biological Sciences Research Council [BB/I005811/2]; Royal Society [UF120033]; University of Bristol; National Council of Technological and Scientific Development (CNPq) Brazil [249210/2012-6]; University of Bristol Santander Scholarship; Kyoto University (Joint Usage/Research Program of the Center for Ecological Research)	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); University of Bristol; National Council of Technological and Scientific Development (CNPq) Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Bristol Santander Scholarship; Kyoto University (Joint Usage/Research Program of the Center for Ecological Research)	This work was supported by the UK Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk, grant BB/I005811/2), The Royal Society (royalsociety.org; University Research Fellowship, grant UF120033), The University of Bristol's BSc and MSci (Biological Sciences) programmes, no grant number (www.bristol.ac.uk/biology/), National Council of Technological and Scientific Development (CNPq) Brazil (www.cnpq.br) Science without Borders Program (studentship 249210/2012-6), University of Bristol Santander Scholarship, no grant number (www.bristol.ac.uk) and the Kyoto University (Joint Usage/Research Program of the Center for Ecological Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrios G., 2004, PLANT PATHOLOGY; Alexander P.D., 2008, MIRES PEAT, V3, P1; BARBER KE, 1993, BIODIVERS CONSERV, V2, P474, DOI 10.1007/BF00056743; BARKHAM JP, 1993, BIODIVERS CONSERV, V2, P556, DOI 10.1007/BF00056749; Billett MF, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002058; BUCKLAND PC, 1993, BIODIVERS CONSERV, V2, P513, DOI 10.1007/BF00056745; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Dennis RLH, 1999, BIOL CONSERV, V87, P295, DOI 10.1016/S0006-3207(98)00080-9; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fain GB, 2008, HORTTECHNOLOGY, V18, P13, DOI 10.21273/HORTTECH.18.1.13; Garcia-Gomez A, 2002, BIORESOURCE TECHNOL, V83, P81, DOI 10.1016/S0960-8524(01)00211-5; Gruda N, 2004, SCI HORTIC-AMSTERDAM, V100, P333, DOI 10.1016/j.scienta.2003.09.004; Hicklenton PR, 2001, SCI HORTIC-AMSTERDAM, V91, P365, DOI 10.1016/S0304-4238(01)00251-5; Holden J, 2005, PHILOS T R SOC A, V363, P2891, DOI 10.1098/rsta.2005.1671; Lindsay R, 2010, PEATBOGS CARBON CRIT; LINDSAY RA, 1993, BIODIVERS CONSERV, V2, P528, DOI 10.1007/BF00056746; Masclaux-Daubresse C, 2011, J EXP BOT, V62, P2131, DOI 10.1093/jxb/erq405; MEEROW AW, 1994, HORTSCIENCE, V29, P1484, DOI 10.21273/HORTSCI.29.12.1484; MEYEROWITZ EM, 1985, SCIENCE, V229, P1214, DOI 10.1126/science.229.4719.1214; MOORE PD, 1989, INT J COAL GEOL, V12, P89, DOI 10.1016/0166-5162(89)90048-7; Noordally ZB, 2013, SCIENCE, V339, P1316, DOI 10.1126/science.1230397; Ostle NJ, 2009, LAND USE POLICY, V26, pS274, DOI 10.1016/j.landusepol.2009.08.006; Pannu R, 2014, ENVIRON POLLUT, V193, P138, DOI 10.1016/j.envpol.2014.06.023; Penfield S, 2005, CURR BIOL, V15, P1998, DOI 10.1016/j.cub.2005.11.010; POWLSON DS, 1976, SOIL BIOL BIOCHEM, V8, P179, DOI 10.1016/0038-0717(76)90002-X; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; SALONIUS PO, 1967, PLANT SOIL, V27, P239, DOI 10.1007/BF01373392; Schmilewski G., 2008, MIRES PEAT, V3, P2; Shaw LJ, 1999, APPL SOIL ECOL, V11, P217, DOI 10.1016/S0929-1393(98)00149-8; Turunen J, 2001, GLOBAL BIOGEOCHEM CY, V15, P285, DOI 10.1029/2000GB001312; UK Department for Environment, 2013, GOV RESP SUST GROW M; Vidal EA, 2014, J EXP BOT, V65, P5611, DOI 10.1093/jxb/eru326; Wilson PJ, 2003, P ROY SOC B-BIOL SCI, V270, P881, DOI 10.1098/rspb.2002.2324	33	7	7	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153625	10.1371/journal.pone.0153625	http://dx.doi.org/10.1371/journal.pone.0153625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088495	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000030
J	Hall, JA; MacLeay, J; Yerramilli, M; Obare, E; Yerramilli, M; Schiefelbein, H; Paetau-Robinson, I; Jewell, DE				Hall, Jean A.; MacLeay, Jennifer; Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.			Positive Impact of Nutritional Interventions on Serum Symmetric Dimethylarginine and Creatinine Concentrations in Client-Owned Geriatric Dogs	PLOS ONE			English	Article							L-CARNITINE SUPPLEMENTATION; KIDNEY-FUNCTION BIOMARKERS; OXIDATIVE STRESS; VITAMIN-C; FISH-OIL; INCREASE; DISEASE; CATS; SDMA	A prospective study was conducted in client-owned geriatric dogs to evaluate the short-term effects of a test food on serum symmetric dimethylarginine (SDMA) and creatinine (Cr) concentrations. Test food contained functional lipids (fish oil), antioxidants (lipoic acid, vitamins C and E), L-carnitine, botanicals (fruits and vegetables), controlled sodium concentration, and high quality protein sources (high bioavailability and an ideal amino acid composition). Dogs (n = 210) were fed either test food or owner's-choice foods (non-nutritionally controlled cohort). Dogs were included based on age and body weight: small (6.8 to 11.4 kg) and medium dogs (11.5 to 22.7 kg) were >= 9 years, whereas dogs >22.7 kg were >= 7 years at baseline. At baseline, all dogs had to have serum Cr concentrations within the reference interval and be free of chronic disease. Renal function biomarkers and urinalysis results at baseline, and after consuming test food or owner's-choice foods for 3 and 6 months, were evaluated. Only dogs consuming test food showed significant decreases in serum SDMA and Cr concentrations (both P <= 0.05) across time. At baseline or during the 6-month feeding trial, 18 dogs (8.6%) had increased serum SDMA, but normal serum Cr, consistent with IRIS Stage 1 chronic kidney disease. This included 9 dogs fed test food and 9 dogs fed owner's-choice foods. Compared with baseline, after feeding 9 dogs test food for 6 months, serum SDMA decreased in 8 dogs and increased in 1 dog. After feeding 9 dogs owner's-choice foods for 6 months, serum SDMA decreased in 4 dogs and increased in 4 dogs (remained stable in 1 dog). The decreases in serum SDMA and Cr concentrations were significant (both P = 0.03) only for dogs fed test food. These results suggest that nonazotemic dogs with elevated serum SDMA (early renal insufficiency) when fed a test food designed to promote healthy aging are more likely to demonstrate improved renal function compared with dogs fed owner's-choice foods.	[Hall, Jean A.] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [MacLeay, Jennifer; Schiefelbein, Heidi; Paetau-Robinson, Inke; Jewell, Dennis E.] Hills Pet Nutr Inc, Pet Nutr Ctr, Topeka, KS USA; [Yerramilli, Maha; Obare, Edward; Yerramilli, Murthy] IDEXX Labs Inc, One IDEXX Dr, Westbrook, ME USA	Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu	Jewell, Dennis/AAS-8563-2020	Jewell, Dennis/0000-0003-2305-1014	Hill's Pet Nutrition, Inc.; IDEXX Laboratories, Inc.; Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	Hill's Pet Nutrition, Inc.; IDEXX Laboratories, Inc.; Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS	The work presented in this study was funded by and performed at the Pet Nutrition Center, Hill's Pet Nutrition, Inc., Topeka, KS (http://www.hillspet.com/our-company.html). Hill's Pet Nutrition, Inc. and IDEXX Laboratories, Inc. provided support in the form of salaries for authors [JM, HS, IP-R, DEJ] and [Maha Y, EO, Murthy Y], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Boonsanit D, 2006, NEPHROLOGY, V11, P313, DOI 10.1111/j.1440-1797.2006.00592.x; Boudouris G, 2013, INT UROL NEPHROL, V45, P1137, DOI 10.1007/s11255-012-0334-6; Brown SA, 1998, J LAB CLIN MED, V131, P447, DOI 10.1016/S0022-2143(98)90146-9; Brown SA, 2000, J LAB CLIN MED, V135, P275, DOI 10.1067/mlc.2000.105178; Brown SA, 2008, VET CLIN N AM-SMALL, V38, P157, DOI 10.1016/j.cvsm.2007.11.001; Calder PC, 2009, POSTGRAD MED, V121, P148, DOI 10.3810/pgm.2009.11.2083; Chade AR, 2004, J AM SOC NEPHROL, V15, P958, DOI 10.1097/01.ASN.0000117774.83396.E9; Fletcher AE, 2003, AM J CLIN NUTR, V78, P999, DOI 10.1093/ajcn/78.5.999; Hall JA, 2014, VET J, V202, P588, DOI 10.1016/j.tvjl.2014.10.021; Hall JA, 2014, J VET INTERN MED, V28, P1676, DOI 10.1111/jvim.12445; Hall JA, 2016, J VET INTERN MED; Hall JA, 2015, J VET INTERN MED, V29, P808, DOI 10.1111/jvim.12607; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; Hall JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049510; Hall JA, 2011, VET IMMUNOL IMMUNOP, V144, P355, DOI 10.1016/j.vetimm.2011.08.007; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; International Renal Interest Society, 2009, IRIS 2009 STAG CKD; Jain N, 2014, NAT REV NEPHROL, V10, P712, DOI 10.1038/nrneph.2014.192; Juliet PAR, 2003, J GERONTOL A-BIOL, V58, P970; Kadkhodaee M, 2005, EXP PHYSIOL, V90, P571, DOI 10.1113/expphysiol.2004.029728; Karamouzis I, 2008, AM J NEPHROL, V28, P397, DOI 10.1159/000112413; Kielstein JT, 2006, NEPHROL DIAL TRANSPL, V21, P2446, DOI 10.1093/ndt/gfl292; Kielstein JT, 2002, J AM SOC NEPHROL, V13, P170, DOI 10.1681/ASN.V131170; Kovesdy CP, 2012, NEPHROL DIAL TRANSPL, V27, P891, DOI 10.1093/ndt/gfs038; Lin JL, 2011, AM J KIDNEY DIS, V57, P245, DOI 10.1053/j.ajkd.2010.09.027; Moffitt TA, 2013, J NEPHROL, V26, P403, DOI 10.5301/jn.5000135; Owen L, 2011, NUTRIENTS, V3, P735, DOI 10.3390/nu3080735; Polzin DJ, 2013, J VET EMERG CRIT CAR, V23, P205, DOI 10.1111/vec.12034; Reckelhoff JF, 1998, AM J PHYSIOL-REG I, V274, pR767, DOI 10.1152/ajpregu.1998.274.3.R767; Rentko V, 2013, J VET INTERN MED, V27, P750; Ringseis R, 2013, EUR J NUTR, V52, P1421, DOI 10.1007/s00394-013-0511-0; Sahebkar A, 2015, J MED BIOCHEM, V34, P151, DOI 10.2478/jomb-2014-0030; Schwedhelm E, 2011, NAT REV NEPHROL, V7, P275, DOI 10.1038/nrneph.2011.31; Small DM, 2012, NEPHROLOGY, V17, P311, DOI 10.1111/j.1440-1797.2012.01572.x; Sung CC, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/301982; Takahashi N, 2011, NEPHROL DIAL TRANSPL, V26, P1252, DOI 10.1093/ndt/gfq547; Thangasamy T, 2008, CLIN CHIM ACTA, V389, P19, DOI 10.1016/j.cca.2007.11.013; Veldink H, 2013, NEPHROL DIAL TRANSPL, V28, P1434, DOI 10.1093/ndt/gfs554; Vlassara H, 2009, KIDNEY INT, V76, pS3, DOI 10.1038/ki.2009.401; Xu H, 2015, J NUTR, V145, P729, DOI 10.3945/jn.114.205187	40	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153653	10.1371/journal.pone.0153653	http://dx.doi.org/10.1371/journal.pone.0153653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088214	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000038
J	Kuo, IY; Duong, SL; Nguyen, L; Ehrlich, BE				Kuo, Ivana Y.; Duong, Sophie L.; Nguyen, Lily; Ehrlich, Barbara E.			Decreased Polycystin 2 Levels Result in Non-Renal Cardiac Dysfunction with Aging	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; KIDNEY-DISEASE; DILATED CARDIOMYOPATHY; HEART-FAILURE; SIGNALING PATHWAYS; BLOOD-PRESSURE; RECEPTOR; MUTATIONS; BLOCKADE; RELEASE	Mutations in the gene for polycystin 2 (Pkd2) lead to polycystic kidney disease, however the main cause of mortality in humans is cardiac related. We previously showed that 5 month old Pkd2+/- mice have altered calcium-contractile activity in cardiomyocytes, but have preserved cardiac function. Here, we examined 1 and 9 month old Pkd2+/- mice to determine if decreased amounts of functional polycystin 2 leads to impaired cardiac function with aging. We observed changes in calcium handling proteins in 1 month old Pkd2+/- mice, and these changes were exacerbated in 9 month old Pkd2+/- mice. Anatomically, the 9 month old Pkd2+/- mice had thinner left ventricular walls, consistent with dilated cardiomyopathy, and the left ventricular ejection fraction was decreased. Intriguingly, in response to acute isoproterenol stimulation to examine beta-adrenergic responses, the 9 month old Pkd2+/- mice exhibited a stronger contractile response, which also coincided with preserved localization of the beta 2 adrenergic receptor. Importantly, the Pkd2+/- mice did not have any renal impairment. We conclude that the cardiac-related impact of decreased polycystin 2 progresses over time towards cardiac dysfunction and altered adrenergic signaling. These results provide further evidence that polycystin 2 provides a critical function in the heart, independent of renal involvement.	[Kuo, Ivana Y.; Duong, Sophie L.; Nguyen, Lily; Ehrlich, Barbara E.] Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA; [Ehrlich, Barbara E.] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA	Yale University; Yale University	Ehrlich, BE (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06510 USA.; Ehrlich, BE (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT USA.	Barbara.ehrlich@yale.edu	/AAX-8408-2021	/0000-0001-9657-9704; Kuo, Ivana/0000-0002-9867-2408; Nguyen, Lily/0000-0003-4425-2536	National Institutes of Health [K99DK101585, 5P01DK057751, P30DK090744]; Yale Imaging Core [5P30DK034989, OD020142]; Studienstiftung des deutschen Volkes (German National Academic Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK090744, K99DK101585, P30DK034989, P01DK057751] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD020142] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Imaging Core; Studienstiftung des deutschen Volkes (German National Academic Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health: K99DK101585 (IYK), 5P01DK057751 and P30DK090744 (BEE), Yale Imaging Core (5P30DK034989 and OD020142) and the Studienstiftung des deutschen Volkes (German National Academic Foundation, SLD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anyatonwu GI, 2007, P NATL ACAD SCI USA, V104, P6454, DOI 10.1073/pnas.0610324104; Bers DM, 2006, PHYSIOLOGY, V21, P380, DOI 10.1152/physiol.00019.2006; Cai ZQ, 1999, J BIOL CHEM, V274, P28557, DOI 10.1074/jbc.274.40.28557; Chapman AB, 2010, CLIN J AM SOC NEPHRO, V5, P102, DOI 10.2215/CJN.04310709; Ecder T, 2009, NAT REV NEPHROL, V5, P221, DOI 10.1038/nrneph.2009.13; Geng L, 2006, J CELL SCI, V119, P1383, DOI 10.1242/jcs.02818; Harding SE, 2004, CONGEST HEART FAIL, V10, P6; Harding Sian E, 2004, Congest Heart Fail, V10, P181, DOI 10.1111/j.1527-5299.2004.02052.x; Helal I, 2012, AM J NEPHROL, V36, P362, DOI 10.1159/000343281; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kuo IY, 2014, P NATL ACAD SCI USA, V111, P16604, DOI 10.1073/pnas.1415933111; Li Y, 2005, J BIOL CHEM, V280, P41298, DOI 10.1074/jbc.M510082200; Martinez-Vea A, 2000, AM J NEPHROL, V20, P193, DOI 10.1159/000013583; McNally EM, 2013, J CLIN INVEST, V123, P19, DOI 10.1172/JCI62862; Mekahli D, 2012, CELL CALCIUM, V51, P452, DOI 10.1016/j.ceca.2012.03.002; Paavola J, 2013, J MOL CELL CARDIOL, V58, P199, DOI 10.1016/j.yjmcc.2013.01.015; Pedrozo Z, 2015, CIRCULATION, V131, P2131, DOI 10.1161/CIRCULATIONAHA.114.013537; Plank DM, 2003, AM J PHYSIOL-HEART C, V285, pH305, DOI 10.1152/ajpheart.00425.2002; Pott C, 2011, CURR DRUG TARGETS, V12, P737, DOI 10.2174/138945011795378559; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Qian Q, 2007, J AM SOC NEPHROL, V18, P485, DOI 10.1681/ASN.2006050501; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; Reinecke H, 1996, CARDIOVASC RES, V31, P48, DOI 10.1016/0008-6363(95)00176-X; Rowell J, 2014, PHYSIOL GENOMICS, V46, P779, DOI 10.1152/physiolgenomics.00054.2014; Schrier RW, 2014, NEW ENGL J MED, V371, P2255, DOI 10.1056/NEJMoa1402685; Schrier RW, 2009, J AM SOC NEPHROL, V20, P1888, DOI 10.1681/ASN.2008080882; Schutzer WE, 2003, AGEING RES REV, V2, P169, DOI 10.1016/S1568-1637(02)00063-6; Stypmann J, 2007, INT J CARDIOL, V120, P158, DOI 10.1016/j.ijcard.2006.09.013; Torres VE, 2014, NEW ENGL J MED, V371, P2267, DOI 10.1056/NEJMoa1402686; Xiao RP, 1998, J CLIN INVEST, V101, P1273, DOI 10.1172/JCI1335	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153632	10.1371/journal.pone.0153632	http://dx.doi.org/10.1371/journal.pone.0153632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081851	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800036
J	Mei, H; Johansson, E; Hagstromer, M; Xiong, YL; Zhang, LL; Zhang, JD; Marcus, C				Mei, Hong; Johansson, Elin; Hagstromer, Maria; Xiong, Yuelin; Zhang, Lanlan; Zhang, Jianduan; Marcus, Claude			Physical Activity Levels in Chinese One-Year-Old Children and Their Parents, an Early STOPP China Study	PLOS ONE			English	Article							BODY-MASS INDEX; PRESCHOOL-CHILDREN; ACCELEROMETER; CHILDHOOD; OBESITY; WORN; VALIDATION; BMI; ASSOCIATIONS; ADOLESCENTS	Background Physical activity (PA) is associated with health benefits, already in childhood. However, little is known about actual levels, patterns and gender differences in PA level in very young children. This study examines Chinese one-year-old children and their parents' PA levels and patterns, and assesses the correlations between children's PA level and gender, body mass index standard deviation score (BMI SDS), parental BMI and parental PA level. Methods Data from 123 families participating in the Early STOPP China study were used. Families were recruited based on parental BMI and were classified as either high-risk or low-risk of obesity. Parents and children wore an ActiGraph GT3X+ to assess the average PA levels. PA levels and hourly patterns during weekdays and weekends were examined as were correlations with gender, BMI SDS, parental BMI and parental PA levels. Results There were no significant differences in children's averaged PA between risk groups, genders, or between weekdays and weekends. Children's peak average activity level was at 7 pm and they were least active at 3 pm (p<0.001). Both mothers and fathers demonstrated a similar PA pattern as their children, although paternal PA level was consistently lower than that of mothers and children. No significant association was found between children's PA and their gender, BMI SDS, parental BMI or paternal PA levels. Maternal PA was found positively associated with child PA (p<0.05). Conclusion PA in one-year-old Chinese children vary over the day but weekdays and weekends are similar. At this age, children's PA is not related to gender, BMI SDS, parental BMI or paternal PA. Larger scale studies with more contextual information are needed to improve the understanding of our findings.	[Mei, Hong; Zhang, Jianduan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Wuhan 430074, Hubei, Peoples R China; [Johansson, Elin; Xiong, Yuelin; Zhang, Lanlan; Marcus, Claude] Karolinska Inst, Dept Clin Sci Technol & Intervent, Div Pediat, Stockholm, Sweden; [Hagstromer, Maria] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Physiotherapy, Stockholm, Sweden	Huazhong University of Science & Technology; Karolinska Institutet; Karolinska Institutet	Marcus, C (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Maternal & Child Hlth Care, Wuhan 430074, Hubei, Peoples R China.	jd_zh@hust.edu.cn; claude.marcus@ki.se	Marcus, Claude/ABE-1177-2020; Xiong, Yuelin/D-9988-2019	Marcus, Claude/0000-0003-0890-2650; Xiong, Yuelin/0000-0002-6204-4733	Swedish Council for Working Life and Social Research; Swedish Research Council, Karolinska Institutet; Swedish Heart-Lung Foundation; Sven Jerring Foundation; Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China [30800917]; Special Fund for Basic Scientific Research of Central Colleges [2013TS009]	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council, Karolinska Institutet(Swedish Research Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Sven Jerring Foundation; Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Central Colleges	The sources of funding are as follows: The Swedish Council for Working Life and Social Research; The Swedish Research Council, Karolinska Institutet; The Swedish Heart-Lung Foundation; The Sven Jerring Foundation and Stockholm Free Masons' Foundation for Children's Welfare; National Natural Science Fund of China (30800917); The Special Fund for Basic Scientific Research of Central Colleges (2013TS009). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; Baquet G, 2007, PREV MED, V44, P143, DOI 10.1016/j.ypmed.2006.10.004; Baur LA, 2004, CLIN DERMATOL, V22, P338, DOI 10.1016/j.clindermatol.2004.01.005; BENDEL RB, 1977, J AM STAT ASSOC, V72, P46, DOI 10.2307/2286904; Bonvin A, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-23; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; Dieu O., 2016, CLIN PHYSL FUNCT IMA; Dossegger A, 2014, MED SCI SPORT EXER, V46, P1140, DOI 10.1249/MSS.0000000000000215; Du HD, 2013, AM J CLIN NUTR, V97, P487, DOI 10.3945/ajcn.112.046854; Ekstedt M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-82; Fairclough SJ, 2015, MED SCI SPORTS EXERC; Felix JF, 2016, HUM MOL GENET, V25, P389, DOI 10.1093/hmg/ddv472; Finn K, 2002, J PEDIATR-US, V140, P81, DOI 10.1067/mpd.2002.120693; Freedman DS, 2004, INT J OBESITY, V28, P10, DOI 10.1038/sj.ijo.0802544; Galland BC, 2012, SLEEP MED, V13, P743, DOI 10.1016/j.sleep.2012.01.018; Hesketh KR, 2014, PEDIATRICS, V133, pE973, DOI 10.1542/peds.2013-3153; Hinkley T, 2012, AM J PREV MED, V43, P159, DOI 10.1016/j.amepre.2012.04.020; Hnatiuk J, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-123; Hnatiuk J, 2012, MED SCI SPORT EXER, V44, P1715, DOI 10.1249/MSS.0b013e31825825c4; Hussey J, 2007, BRIT J SPORT MED, V41, P311, DOI 10.1136/bjsm.2006.032045; Johansson E, 2015, PEDIATR OBES, V10, P1, DOI 10.1111/j.2047-6310.2013.00213.x; Johansson E, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0161-0; Mackintosh KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036919; Maffeis C, 2000, EUR J PEDIATR, V159, pS35, DOI 10.1007/PL00014361; Mattocks C, 2008, BMJ-BRIT MED J, V336, P26, DOI 10.1136/bmj.39385.443565.BE; Ng SW, 2014, OBES REV, V15, P27, DOI 10.1111/obr.12127; Nyberg GA, 2009, MED SCI SPORT EXER, V41, P1842, DOI 10.1249/MSS.0b013e3181a48ee6; Rowlands AV, 2014, MED SCI SPORT EXER, V46, P2308, DOI 10.1249/MSS.0000000000000365; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Senso MM, 2014, J PHYS ACT HLTH; Shen Ma BW, 2013, MODERN PREVENTIVE ME, P1065; Shiroma EJ, 2015, MED SCI SPORT EXER, V47, P2558, DOI 10.1249/MSS.0000000000000725; Sobko T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-336; Syvaoja HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103559; Tremblay MS, 2012, APPL PHYSIOL NUTR ME, V37, P357, DOI [10.1139/h2012-026, 10.1139/H2012-026, 10.1139/H2012-018, 10.1139/h2012-018]; Vale S, 2011, INT J PEDIATR OBES, V6, P37, DOI 10.3109/17477166.2011.613663; Cauwenberghe E, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-67; Vanhelst J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-690; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; Worobey J, 2014, AM J CLIN NUTR, V99, p729S, DOI 10.3945/ajcn.113.072397; Xiao Y, 2015, PLOS ONE, P10; Yang W, 2012, BMC PUBLIC HEALTH, V12, DOI [10.1186/1471-2458-12-1127, 10.1186/1471-2458-12-804]; Ying Huang SPWC, 2015, MED REV, P1409; Zong XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046942	45	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153605	10.1371/journal.pone.0153605	http://dx.doi.org/10.1371/journal.pone.0153605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078684	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700090
J	Perlado, S; Bustamante-Aragones, A; Donas, M; Lorda-Sanchez, I; Plaza, J; de Alba, MR				Perlado, Sara; Bustamante-Aragones, Ana; Donas, Marta; Lorda-Sanchez, Isabel; Plaza, Javier; Rodriguez de Alba, Marta			Fetal Genotyping in Maternal Blood by Digital PCR: Towards NIPD of Monogenic Disorders Independently of Parental Origin	PLOS ONE			English	Article							NONINVASIVE PRENATAL-DIAGNOSIS; SEX DETERMINATION; HUNTINGTON DISEASE; BETA-THALASSEMIA; DOWN-SYNDROME; DNA; PLASMA; MUTATION; RELIABILITY; IMPROVEMENT	Purpose To date, non-invasive prenatal diagnosis (NIPD) of monogenic disorders has been limited to cases with a paternal origin. This work shows a validation study of the Droplet Digital PCR (ddPCR) technology for analysis of both paternally and maternally inherited fetal alleles. For the purpose, single nucleotide polymorphisms (SNPs) were studied with the only intention to mimic monogenic disorders. Methods NIPD SNP genotyping was performed by ddPCR in 55 maternal plasma samples. In 19 out of 55 cases, inheritance of the paternal allele was determined by presence/absence criteria. In the remaining 36, determination of the maternally inherited fetal allele was performed by relative mutation dosage (RMD) analysis. Results ddPCR exhibited 100% accuracy for detection of paternal alleles. For diagnosis of fetal alleles with maternal origin by RMD analysis, the technology showed an accuracy of 96%. Twenty-nine out of 36 were correctly diagnosed. There was one FP and six maternal plasma samples that could not be diagnosed. Discussion In this study, ddPCR has shown to be capable to detect both paternal and maternal fetal alleles in maternal plasma. This represents a step forward towards the introduction of NIPD for all pregnancies independently of the parental origin of the disease.	[Perlado, Sara; Bustamante-Aragones, Ana; Donas, Marta; Lorda-Sanchez, Isabel; Rodriguez de Alba, Marta] IIS Fdn Jimenez Diaz UAM, CIBERER, Dept Genet, Madrid, Spain; [Plaza, Javier] Fdn Jimenez Diaz IIS, Dept Obstet & Gynecol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Fundacion Jimenez Diaz; Fundacion Jimenez Diaz	Bustamante-Aragones, A (corresponding author), IIS Fdn Jimenez Diaz UAM, CIBERER, Dept Genet, Madrid, Spain.	abustamante@fjd.es			Fundacion Mutua Madrilena [12114/01]; Instituto de Salud Carlos III [PI11/01014, EC11/260, II14/00015]; Fundacion Conchita Rabago de Jimenez Diaz; Fundacion Conchita Rabago	Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Conchita Rabago de Jimenez Diaz; Fundacion Conchita Rabago	This work has been supported by Fundacion Mutua Madrilena (12114/01) and Instituto de Salud Carlos III (PI11/01014; EC11/260; II14/00015). Sara Perlado has been supported by Fundacion Conchita Rabago de Jimenez Diaz.; This work has been supported by Fundacion Mutua Madrilena (12114/01) and Instituto de Salud Carlos III (PI11/01014; EC11/260; II14/00015). Sara Perlado has been supported by Fundacion Conchita Rabago. Thanks to Oliver Shaw for his collaboration with the language.	Akolekar R, 2015, ULTRASOUND OBST GYN, V45, P16, DOI 10.1002/uog.14636; Amicucci P, 2000, CLIN CHEM, V46, P301; [Anonymous], 1996, WHO SCI M; Barrett AN, 2012, CLIN CHEM, V58, P1026, DOI 10.1373/clinchem.2011.178939; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bustamante-Aragones A, 2008, EUR J NEUROL, V15, P1338, DOI 10.1111/j.1468-1331.2008.02312.x; Bustamante-Aragones A, 2008, HAEMOPHILIA, V14, P593, DOI 10.1111/j.1365-2516.2008.01670.x; Bustamante-Aragones A, 2008, MOL GENET METAB, V95, P101, DOI 10.1016/j.ymgme.2008.05.006; Bustamante-Aragones A, 2012, GENE, V504, P144, DOI 10.1016/j.gene.2012.04.045; Bustamante-Aragones A, 2008, J CYST FIBROS, V7, P505, DOI 10.1016/j.jcf.2008.05.006; Chan KCA, 2006, CLIN CHEM, V52, P2211, DOI 10.1373/clinchem.2006.074997; Chan K, 2010, EUR J OBSTET GYN R B, V150, P28, DOI 10.1016/j.ejogrb.2010.02.016; Chitty LS, 2011, ULTRASOUND OBST GYN, V37, P283, DOI 10.1002/uog.8893; Chitty LS, 2015, PRENATAL DIAG, V35, P656, DOI 10.1002/pd.4583; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Chiu RWK, 2002, LANCET, V360, P998, DOI 10.1016/S0140-6736(02)11086-5; Gonzalez-Gonzalez MC, 2008, J ASSIST REPROD GEN, V25, P477, DOI 10.1007/s10815-008-9256-8; Debrand E, 2015, NONINVASIVE DROPLET, V10, DOI [10.1371/journal.pone.0142729, DOI 10.1371/JOURNAL.PONE.0142729]; Debrand E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142729; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Finning K, 2008, BRIT MED J, V336, P816, DOI 10.1136/bmj.39518.463206.25; Finning KM, 2008, SEMIN FETAL NEONAT M, V13, P69, DOI 10.1016/j.siny.2007.12.007; Gonzalez-Gonzalez MC, 2002, PRENATAL DIAG, V22, P946, DOI 10.1002/pd.439; Hill M, 2015, PRENATAL DIAG, V35, P950, DOI 10.1002/pd.4585; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Lim JH, 2011, J ASSIST REPROD GEN, V28, P167, DOI 10.1007/s10815-010-9489-1; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lun FMF, 2008, P NATL ACAD SCI USA, V105, P19920, DOI 10.1073/pnas.0810373105; Manokhina I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101500; Meaney C, 2009, PRENATAL DIAG, V29, P1218, DOI 10.1002/pd.2385; Nasis O, 2004, CLIN CHEM, V50, P694, DOI 10.1373/clinchem.2003.025981; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; de Alba MR, 2012, EXPERT OPIN BIOL TH, V12, pS171, DOI 10.1517/14712598.2012.674509; Saito H, 2000, LANCET, V356, P1170, DOI 10.1016/S0140-6736(00)02767-7; Scheffer PG, 2010, OBSTET GYNECOL, V115, P117, DOI 10.1097/AOG.0b013e3181c3c938; Tsui NBY, 2011, BLOOD, V117, P3684, DOI 10.1182/blood-2010-10-310789; van den Oever JME, 2015, PRENATAL DIAG, V35, P945, DOI 10.1002/pd.4593; Vogelstein B, 1999, P NATL ACAD SCI USA, V96, P9236, DOI 10.1073/pnas.96.16.9236; Wulff CB, 2016, ULTRASOUND OBST GYN, V47, P38, DOI 10.1002/uog.15820	40	32	34	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153258	10.1371/journal.pone.0153258	http://dx.doi.org/10.1371/journal.pone.0153258			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078875	gold, Green Published			2022-12-27	WOS:000374131700032
J	Derraik, JGB; Lundgren, M; Cutfield, WS; Ahlsson, F				Derraik, Jose G. B.; Lundgren, Maria; Cutfield, Wayne S.; Ahlsson, Fredrik			Maternal Height and Preterm Birth: A Study on 192,432 Swedish Women	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; BODY-MASS INDEX; STATURE; LENGTH; LABOR; RISK; GESTATION; DELIVERY; AGE	Background There is increasing evidence that lower maternal stature is associated with shorter gestational length in the offspring. We examined the association between maternal height and the likelihood of delivering preterm babies in a large and homogeneous cohort of Swedish women. Methods This study covers antenatal data from the Swedish Medical Birth Register on 192,432 women (aged 26.0 years on average) born at term, from singleton pregnancies, and of Nordic ethnicity. Continuous associations between women's heights and the likelihood of preterm birth in the offspring were evaluated. Stratified analyses were also carried out, separating women into different height categories. Results Every cm decrease in maternal stature was associated with 0.2 days shortening of gestational age in the offspring (p<0.0001) and increasing odds of having a child born preterm (OR 1.03), very preterm (OR 1.03), or extremely preterm (OR 1.04). Besides, odds of all categories of preterm birth were highest among the shortest women but lowest among the tallest mothers. Specifically, women of short stature (<= 155 cm or <=-2.0 SDS below the population mean) had greater odds of having preterm (OR 1.65) or very preterm (OR 1.47) infants than women of average stature (-0.5 to 0.5 SDS). When compared to women of tall stature (>= 19 cm), mothers of short stature had even greater odds of giving birth to preterm (OR 2.07) or very preterm (OR 2.16) infants. Conclusions Among Swedish women, decreasing height was associated with a progressive increase in the odds of having an infant born preterm. Maternal short stature is a likely contributing factor to idiopathic preterm births worldwide, possibly due to maternal anatomical constraints.	[Derraik, Jose G. B.; Cutfield, Wayne S.] Univ Auckland, Liggins Inst, Auckland 1, New Zealand; [Lundgren, Maria; Ahlsson, Fredrik] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden	University of Auckland; Uppsala University	Derraik, JGB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	j.derraik@auckland.ac.nz	Derraik, José Guilherme Behrensdorf/A-1925-2008	Derraik, José Guilherme Behrensdorf/0000-0003-1226-1956; Ahlsson, Fredrik/0000-0002-8413-9274				Behrman RE, 2007, PRETERM BIRTH CAUSES; Beta J, 2011, PRENATAL DIAG, V31, P75, DOI 10.1002/pd.2662; Chan BCP, 2009, AUST NZ J OBSTET GYN, V49, P388, DOI 10.1111/j.1479-828X.2009.01006.x; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Dahl AK, 2010, AGE AGEING, V39, P445, DOI 10.1093/ageing/afq038; Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154; Derraik JGB, 2016, J OBSTET GYNAECOL, V36, P1, DOI 10.3109/01443615.2015.1006595; Gagel CK, 2010, AM J PERINAT, V27, P691, DOI 10.1055/s-0030-1253100; Han Z, 2012, J OBSTET GYNAECOL CA, V34, P721, DOI 10.1016/S1701-2163(16)35337-3; Kozuki N, 2015, J NUTR, V145, P2542, DOI 10.3945/jn.115.216374; KRAMER MS, 1995, OBSTET GYNECOL, V86, P744, DOI 10.1016/0029-7844(95)00267-U; March of Dimes PMNCH Save The Children WHO, 2012, GLOB ACT REP PRET BI, DOI DOI 10.1016/S0140-6736(12)61970-9; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Myklestad K, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-33; Ozaltin E, 2010, JAMA-J AM MED ASSOC, V303, P1507, DOI 10.1001/jama.2010.450; Patel RR, 2004, INT J EPIDEMIOL, V33, P107, DOI 10.1093/ije/dyg238; Porter TF, 1997, OBSTET GYNECOL, V90, P63, DOI 10.1016/S0029-7844(97)00215-9; Sharples H, 2012, NEW ZEAL MED J, V125, P60; Sorkin JD, 1999, AM J EPIDEMIOL, V150, P969, DOI 10.1093/oxfordjournals.aje.a010106; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865; Zhang X, 2007, J PEDIATR-US, V150, P603, DOI 10.1016/j.jpeds.2007.01.048	22	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154304	10.1371/journal.pone.0154304	http://dx.doi.org/10.1371/journal.pone.0154304			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100080	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500182
J	Thompson, A; Stephens, JW; Bain, SC; Kanamarlapudi, V				Thompson, Aiysha; Stephens, Jeffrey W.; Bain, Stephen C.; Kanamarlapudi, Venkateswarlu			Molecular Characterisation of Small Molecule Agonists Effect on the Human Glucagon Like Peptide-1 Receptor Internalisation	PLOS ONE			English	Article							ALLOSTERIC MODULATION; INSULIN-SECRETION; N-TERMINUS; CYTOPLASMIC DOMAIN; GLP-1 RECEPTOR; ACTIVATION; EXPRESSION; MEMBRANE; EXENDIN-(9-39); TRAFFICKING	The glucagon-like peptide receptor (GLP-1R), which is a G-protein coupled receptor (GPCR), signals through both G alpha s and G alpha q coupled pathways and ERK phosphorylation to stimulate insulin secretion. The aim of this study was to determine molecular details of the effect of small molecule agonists, compounds 2 and B, on GLP-1R mediated cAMP production, intracellular Ca2+ accumulation, ERK phosphorylation and its internalisation. In human GLP-1R (hGLP-1R) expressing cells, compounds 2 and B induced cAMP production but caused no intracellular Ca2+ accumulation, ERK phosphorylation or hGLP-1R internalisation. GLP-1 antagonists Ex(9-39) and JANT-4 and the orthosteric binding site mutation (V36A) in hGLP-1R failed to inhibit compounds 2 and B induced cAMP production, confirming that their binding site distinct from the GLP-1 binding site on GLP-1R. However, K334A mutation of hGLP-1R, which affects G alpha(s) coupling, inhibited GLP-1 as well as compounds 2 and B induced cAMP production, indicating that GLP-1, compounds 2 and B binding induce similar conformational changes in the GLP-1R for G alpha(s) coupling. Additionally, compound 2 or B binding to the hGLP-1R had significantly reduced GLP-1 induced intracellular Ca2+ accumulation, ERK phosphorylation and hGLP-1R internalisation. This study illustrates pharmacology of differential activation of GLP-1R by GLP-1 and compounds 2 and B.	[Thompson, Aiysha; Stephens, Jeffrey W.; Bain, Stephen C.; Kanamarlapudi, Venkateswarlu] Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales	Swansea University	Kanamarlapudi, V (corresponding author), Swansea Univ, Sch Med, Inst Life Sci 1, Singleton Pk, Swansea, W Glam, Wales.	k.venkateswarlu@swansea.ac.uk	Kanamarlapudi, Venkateswarlu/A-9864-2011	Kanamarlapudi, Venkateswarlu/0000-0002-8739-1483	Biotechnology and Biological Sciences Research Council UK [BB/C515455/2]; Medical Research Council UK [G0401232]; Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship [BB/F017596/1]; MRC [G0401232] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C515455/2, 1095087] Funding Source: researchfish; Medical Research Council [G0401232] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council UK (BB/C515455/2) and Medical Research Council UK (G0401232) (VK). AT was recipient of a Biotechnology and Biological Sciences Research Council UK-Nova Nordisk studentship (BB/F017596/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bond Aaron, 2006, Proc (Bayl Univ Med Cent), V19, P281; Bridges TM, 2008, ACS CHEM BIOL, V3, P530, DOI 10.1021/cb800116f; Cheong YH, 2012, BIOCHEM BIOPH RES CO, V417, P558, DOI 10.1016/j.bbrc.2011.12.004; Chung LTK, 2009, BIOCHEM BIOPH RES CO, V390, P613, DOI 10.1016/j.bbrc.2009.10.015; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Davies JCB, 2014, BIOCHEM PHARMACOL, V92, P651, DOI 10.1016/j.bcp.2014.09.023; Davies JCB, 2014, BIOCHEM PHARMACOL, V90, P406, DOI 10.1016/j.bcp.2014.06.012; de Maturana RL, 2002, FEBS LETT, V530, P244, DOI 10.1016/S0014-5793(02)03492-0; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; DRUCKER DJ, 1987, P NATL ACAD SCI USA, V84, P3434, DOI 10.1073/pnas.84.10.3434; Edavalath M, 2010, PATIENT PREFER ADHER, V4, P61; GOKE R, 1993, J BIOL CHEM, V268, P19650; Green BD, 2006, EUR J PHARMACOL, V547, P192, DOI 10.1016/j.ejphar.2006.07.043; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Holz GG, 1999, J BIOL CHEM, V274, P14147, DOI 10.1074/jbc.274.20.14147; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Kanamarlapudi V, 2014, J BIOL CHEM, V289, P33378, DOI 10.1074/jbc.M113.534156; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Li NC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047936; Ma L, 2009, P NATL ACAD SCI USA, V106, P15950, DOI 10.1073/pnas.0900903106; Mathi SK, 1997, MOL ENDOCRINOL, V11, P424, DOI 10.1210/me.11.4.424; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; Nolte WM, 2014, NAT CHEM BIOL, V10, P629, DOI 10.1038/nchembio.1581; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; Patterson JT, 2011, ACS CHEM BIOL, V6, P135, DOI 10.1021/cb1002015; Price MR, 2005, MOL PHARMACOL, V68, P1484, DOI 10.1124/mol.105.016162; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Serre V, 1998, ENDOCRINOLOGY, V139, P4448, DOI 10.1210/en.139.11.4448; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Takhar S, 1996, ENDOCRINOLOGY, V137, P2175, DOI 10.1210/en.137.5.2175; Thomas RL, 2009, J PHARMACOL EXP THER, V331, P1086, DOI 10.1124/jpet.109.160242; Thompson A, 2013, CLIN EXP PHARMACOL P, V3, P2161, DOI [DOI 10.4172/2161-1459.1000138, 10.4172/2161-1459.1000138]; Thompson A, 2015, MOL CELL ENDOCRINOL, V413, P66, DOI 10.1016/j.mce.2015.06.012; Thompson A, 2015, BIOCHEM PHARMACOL, V93, P72, DOI 10.1016/j.bcp.2014.10.015; Thompson A, 2014, SCI REP-UK, V4, DOI 10.1038/srep07410; THORENS B, 1993, DIABETES, V42, P1678, DOI 10.2337/diabetes.42.11.1678; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Vahl TP, 2003, J CLIN ENDOCR METAB, V88, P1772, DOI 10.1210/jc.2002-021479; Vazquez P, 2005, J ENDOCRINOL, V186, P221, DOI 10.1677/joe.1.06179; Venkateswarlu K, 2007, J CELL SCI, V120, P792, DOI 10.1242/jcs.03373; Willard Francis S, 2012, Exp Diabetes Res, V2012, P709893, DOI 10.1155/2012/709893; Wootten D, 2013, MOL PHARMACOL, V83, P822, DOI 10.1124/mol.112.084525; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	47	9	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154229	10.1371/journal.pone.0154229	http://dx.doi.org/10.1371/journal.pone.0154229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100083	Green Submitted, gold, Green Published			2022-12-27	WOS:000374898500170
J	Csosz, S; Fisher, BL				Csosz, Sandor; Fisher, Brian L.			Toward Objective, Morphology-Based Taxonomy: A Case Study on the Malagasy Nesomyrmex sikorai Species Group (Hymenoptera: Formicidae)	PLOS ONE			English	Article							CLUSTERS	Madagascar is one of the world's greatest biodiversity hotspots, meriting special attention from biodiversity scientists. It is an excellent testing ground for novel techniques in taxonomy that aim to increase classification objectivity and yield greater taxonomic resolving power. Here we reveal the diversity of a unique and largely unexplored fragment of the Malagasy ant fauna using an advanced combination of exploratory analyses on quantitative morphological data allowing for increased objectivity in taxonomic workflow. The diversity of the Nesomyrmex sikorai species-group was assessed via hypothesis-free nest-centroid-clustering combined with recursive partitioning to estimate the number of morphological clusters and determine the most probable boundaries between them. This combination of methods provides a highly automated and objective species delineation protocol based on continuous morphometric data. Delimitations of clusters recognized by these exploratory analyses were tested via confirmatory Linear Discriminant Analysis (LDA) and Multivariate Ratio Analysis (MRA). The final species hypotheses are corroborated by many qualitative characters, and the recognized species exhibit different spatial distributions and occupy different ecological regions. We describe and redescribe eight morphologically distinct species including six new species: Nesomyrmex excelsior sp. n., N. modestus sp. n., N. reticulatus sp. n., N. retusispinosus (Forel, 1892), N. rugosus sp. n., N. sikorai (Emery, 1896), N. striatus sp. n., and N. tamatavensis sp. n. An identification key for their worker castes using morphometric data is provided.	[Csosz, Sandor; Fisher, Brian L.] Calif Acad Sci, Dept Entomol, 55 Mus Concourse Dr, San Francisco, CA 94118 USA	California Academy of Sciences	Csosz, S (corresponding author), Calif Acad Sci, Dept Entomol, 55 Mus Concourse Dr, San Francisco, CA 94118 USA.	sandorcsosz2@gmail.com			National Science Foundation [DEB-0072713, DEB-0344731, DEB-0842395]; Schlinger Fellowship at the California Academy of Sciences; Museum of Comparative Zoology, Harvard University	National Science Foundation(National Science Foundation (NSF)); Schlinger Fellowship at the California Academy of Sciences; Museum of Comparative Zoology, Harvard University	This study was supported by the National Science Foundation under Grant No. DEB-0072713, DEB-0344731, and DEB-0842395 (http://www.nsf.gov/). SC was supported by the Schlinger Fellowship at the California Academy of Sciences and an Ernst Mayr Travel Grants (Museum of Comparative Zoology, Harvard University), http://www.mcz.harvard.edu/grants_and_funding/ernst-mayr-travel.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur H, 2014, SYST ENTOMOL, V39, P691, DOI 10.1111/syen.12081; Baur H, 2011, SYST BIOL, V60, P813, DOI 10.1093/sysbio/syr061; Beleites C, 2012, J STAT SOFTWAR UNPUB; Brown JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6046; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Cornet A., 1974, NOTICE EXPLICATIVE, V55; Csosz S, 2007, ZOOTAXA, P1; Csosz S, 2016, PEERJ, V4, DOI 10.7717/peerj.1796; Csosz S, 2014, ORG DIVERS EVOL, V14, P75, DOI 10.1007/s13127-013-0153-3; Csoz S, 2015, ZOOKEYS, P19, DOI 10.3897/zookeys.526.6037; Derkarabetian S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104982; Ezard THG, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-175; Guillem RM, 2014, CURR ZOOL, V60, P62, DOI 10.1093/czoolo/60.1.62; Harris RA, 1979, OCC PAP ENT, V28, P1; Klingenberg CP, 2005, SYST BIOL, V54, P678, DOI 10.1080/10635150590947258; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Maechler M, 2014, CLUSTER CLUSTER ANAL; Miko I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094056; Nilsen G., 2013, **DATA OBJECT**; Nilsen G, 2013, STAT APPL GENET MOL, V12, P637, DOI 10.1515/sagmb-2013-0016; R Core Team, R LANG ENV STAT COMP; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Richmond MP, 2012, ECOL EVOL, V2, P397, DOI 10.1002/ece3.93; Schatz GE., 2000, MEMOIRES SOC BIOGEOG, V1, P1, DOI DOI 10.1002/14356007; Seifert B, 2015, ZOOKEYS, P37, DOI 10.3897/zookeys.479.8510; Seifert B, 2014, MYRMECOL NEWS, V19, P1; Seltmann KC, 2012, J HYMENOPT RES, V27, P67, DOI 10.3897/JHR.27.2961; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Venables WN, 2002, RIPLEY BD MODERN APP; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wachter GA, 2015, MOL ECOL, V24, P863, DOI 10.1111/mec.13077; Yoder MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015991	32	10	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152454	10.1371/journal.pone.0152454	http://dx.doi.org/10.1371/journal.pone.0152454			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097219	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600012
J	Latronico, T; Depalo, N; Valente, G; Fanizza, E; Laquintana, V; Denora, N; Fasano, A; Striccoli, M; Colella, M; Agostiano, A; Curri, ML; Liuzzi, GM				Latronico, Tiziana; Depalo, Nicoletta; Valente, Gianpiero; Fanizza, Elisabetta; Laquintana, Valentino; Denora, Nunzio; Fasano, Anna; Striccoli, Marinella; Colella, Matilde; Agostiano, Angela; Curri, M. Lucia; Liuzzi, Grazia Maria			Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; QUANTUM DOTS; CELL-CULTURES; IN-VITRO; NANOPARTICLES; APOPTOSIS; NEURONS; CDSE; SURVIVAL; DELIVERY	Luminescent colloidal nanocrystals (NCs) are emerging as a new tool in neuroscience field, representing superior optical probes for cellular imaging and medical diagnosis of neurological disorders with respect to organic fluorophores. However, only a limited number of studies have, so far, explored NC applications in primary neurons, glia and related cells. Indeed astrocytes, as resident cells in the central nervous system (CNS), play an important pathogenic role in several neurodegenerative and neuroinflammatory diseases, therefore enhanced imaging tools for their thorough investigation are strongly amenable. Here, a comprehensive and systematic study on the in vitro toxicological effect of core-shell type luminescent CdSe@ZnS NCs incorporated in polyethylene glycol (PEG) terminated phospholipid micelles on primary cultures of rat astrocytes was carried out. Cytotoxicity response of empty micelles based on PEG modified phospholipids was compared to that of their NC containing counterpart, in order to investigate the effect on cell viability of both inorganic NCs and micelles protecting NC surface. Furthermore, since the surface charge and chemistry influence cell interaction and toxicity, effect of two different functional groups terminating PEG-modified phospholipid micelles, namely amine and carboxyl group, respectively, was evaluated against bare micelles, showing that carboxyl group was less toxic. The ability of PEG-lipid micelles to be internalized into the cells was qualitatively and quantitatively assessed by fluorescence microscopy and photoluminescence (PL) assay. The results of the experiments clearly demonstrate that, once incorporated into the micelles, a low, not toxic, concentration of NCs is sufficient to be distinctly detected within cells. The overall study provides essential indications to define the optimal experimental conditions to effectively and profitably use the proposed luminescent colloidal NCs as optical probe for future in vivo experiments.	[Latronico, Tiziana; Fasano, Anna; Colella, Matilde; Liuzzi, Grazia Maria] Univ Bari Aldo Moro, Dipartimento Biosci Biotecnol & Biofarmaceut, Bari, Italy; [Depalo, Nicoletta; Valente, Gianpiero; Striccoli, Marinella; Agostiano, Angela; Curri, M. Lucia] CNR, Ist Proc Chim Fis, I-70126 Bari, Italy; [Depalo, Nicoletta; Valente, Gianpiero; Striccoli, Marinella; Agostiano, Angela; Curri, M. Lucia] Univ Bari, Dipartimento Chim, Bari, Italy; [Valente, Gianpiero; Fanizza, Elisabetta; Agostiano, Angela] Univ Bari Aldo Moro, Dipartimento Chim, Bari, Italy; [Laquintana, Valentino; Denora, Nunzio] Univ Bari Aldo Moro, Dipartimento Farm Sci Farmaco, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Processi Chimico-Fisici (IPCF-CNR); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Curri, ML (corresponding author), CNR, Ist Proc Chim Fis, I-70126 Bari, Italy.; Curri, ML (corresponding author), Univ Bari, Dipartimento Chim, Bari, Italy.	lucia.curri@ba.ipcf.cnr.it	Depalo, Nicoletta/AAD-9489-2020; Striccoli, Marinella/C-5456-2009; Curri, Maria Lucia/C-5360-2009; Liuzzi, Grazia Maria/GVR-7164-2022; Colella, Matilde/G-9246-2011; DENORA, Nunzio/J-6881-2018; agostiano, angela/E-2579-2015	Striccoli, Marinella/0000-0002-5366-691X; Colella, Matilde/0000-0002-9584-7030; DENORA, Nunzio/0000-0002-7756-7828; Valente, Gianpiero/0000-0002-6721-4180; agostiano, angela/0000-0003-1938-9944; Latronico, Tiziana/0000-0001-6971-5416; Liuzzi, Grazia Maria/0000-0001-5692-9335	PRIN [2010C4R8M8]; PON R&C MAAT-Molecular Nanotechnology for Health and Environment [PON02 00563 3316357]; FIRB Futuro in Ricerca [RBFR122HFZ]; Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM); National and Sens&Micro LAB (POFESR)	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); PON R&C MAAT-Molecular Nanotechnology for Health and Environment; FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM); National and Sens&Micro LAB (POFESR)	This work was supported by PRIN 2010-2011 (2010C4R8M8), PON R&C 2007-2013 MAAT-Molecular Nanotechnology for Health and Environment (Project number: PON02 00563 3316357), FIRB Futuro in Ricerca (RBFR122HFZ), Nanomax-integrable sensors for pathological biomarkers diagnosis (N-CHEM), National and Sens&Micro LAB (POFESR 2007-2013) projects.	Al-Ali A, 2015, TOXICOL RES-UK, V4, P623, DOI 10.1039/c4tx00175c; Arizono Misa, 2014, Curr Protoc Neurosci, V66, DOI 10.1002/0471142301.ns0221s66; Calvo P, 2002, EUR J NEUROSCI, V15, P1317, DOI 10.1046/j.1460-9568.2002.01967.x; Cardone A, 2012, BBA-BIOMEMBRANES, V1818, P2808, DOI 10.1016/j.bbamem.2012.06.011; Chan WH, 2006, TOXICOL LETT, V167, P191, DOI 10.1016/j.toxlet.2006.09.007; Chen N, 2012, BIOMATERIALS, V33, P1238, DOI 10.1016/j.biomaterials.2011.10.070; Damalakiene L, 2013, INT J NANOMED, V8, P555, DOI 10.2147/IJN.S39658; De Jong WH, 2008, INT J NANOMED, V3, P133, DOI 10.2147/ijn.s596; Denora N, 2013, J CONTROL RELEASE, V172, P1111, DOI 10.1016/j.jconrel.2013.09.024; Depalo N, 2008, J COLLOID INTERF SCI, V325, P558, DOI 10.1016/j.jcis.2008.06.018; Depalo N, 2011, LANGMUIR, V27, P6962, DOI 10.1021/la200822b; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Fanizza E, 2010, LANGMUIR, V26, P14294, DOI 10.1021/la1023339; Frohlich E, 2012, INT J NANOMED, V7, P5577, DOI 10.2147/IJN.S36111; Gerbino A, 2012, CELL CALCIUM, V51, P393, DOI 10.1016/j.ceca.2012.01.002; Giancaspero TA, 2013, J BIOL CHEM, V288, P29069, DOI 10.1074/jbc.M113.500066; Gobe G, 2010, TOXICOL LETT, V198, P49, DOI 10.1016/j.toxlet.2010.04.013; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Kondoh M, 2002, TOXICOLOGY, V170, P111, DOI 10.1016/S0300-483X(01)00536-4; Latronico T, 2013, TOXICOL SCI, V135, P218, DOI 10.1093/toxsci/kft146; Latronico T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049656; Li KG, 2009, TOXICOL IN VITRO, V23, P1007, DOI 10.1016/j.tiv.2009.06.020; Lockman PR, 2004, J DRUG TARGET, V12, P635, DOI 10.1080/10611860400015936; Maysinger D, 2007, NANO LETT, V7, P2513, DOI 10.1021/nl071611t; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagy A, 2011, CHEM RES TOXICOL, V24, P2176, DOI 10.1021/tx2003195; Ni DL, 2014, ACS NANO, V8, P1231, DOI 10.1021/nn406197c; Pathak S, 2006, J NEUROSCI, V26, P1893, DOI 10.1523/JNEUROSCI.3847-05.2006; Pinkernelle J, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-32; Rivet CJ, 2012, CHEM RES TOXICOL, V25, P153, DOI 10.1021/tx200369s; Romoser A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022079; Shilo M, 2014, NANOSCALE, V6, P2146, DOI 10.1039/c3nr04878k; Singh A V, 2012, THERANOSTIC IMPLICAT; Srikanth M, 2012, NAT REV NEUROL, V8, P307, DOI 10.1038/nrneurol.2012.76; Walters R, 2012, ASN NEURO, V4, DOI 10.1042/AN20120042; Wang J, 2012, ACS NANO, V6, P5018, DOI 10.1021/nn300571c; Wang J, 2012, J CONTROL RELEASE, V160, P637, DOI 10.1016/j.jconrel.2012.02.021; Xu G, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00140; Yan L, 2013, CHEM-ASIAN J, V8, P2342, DOI 10.1002/asia.201300542; Yong KT, 2010, INTEGR BIOL-UK, V2, P121, DOI 10.1039/b916663g; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhao YL, 2015, TOXICOL RES-UK, V4, P399, DOI 10.1039/c4tx00207e	44	17	17	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153451	10.1371/journal.pone.0153451	http://dx.doi.org/10.1371/journal.pone.0153451			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097043	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600035
J	Tanmoy, AM; Ahmed, ASMNU; Arumugam, R; Hossain, B; Marzan, M; Saha, S; El Arifeen, S; Baqui, AH; Black, RE; Kang, G; Saha, SK				Tanmoy, Arif Mohammad; Ahmed, A. S. M. Nawshad Uddin; Arumugam, Rajesh; Hossain, Belal; Marzan, Mahfuza; Saha, Shampa; El Arifeen, Shams; Baqui, Abdullah H.; Black, Robert E.; Kang, Gagandeep; Saha, Samir Kumar			Rotavirus Surveillance at a WHO-Coordinated Invasive Bacterial Disease Surveillance Site in Bangladesh: A Feasibility Study to Integrate Two Surveillance Systems	PLOS ONE			English	Article							CHILDREN LESS-THAN-5 YEARS; DOUBLE-BLIND; VACCINE; GENOTYPES; DIARRHEA; GASTROENTERITIS; EFFICACY; AGE; STRAINS; INFANTS	The World Health Organization (WHO) currently coordinates rotavirus diarrhea and invasive bacterial disease (IBD) surveillance at 178 sentinel sites in 60 countries. However, only 78 sites participate in both surveillance systems using a common sentinel site. Here, we explored the feasibility of extending a WHO-IBD surveillance platform to generate data on the burden of rotaviral diarrhea and its epidemiological characteristics to prepare the countries to measure the impact of rotaviral vaccine. A six-month (July to December, 2012) surveillance, managed by IBD team, collected stool samples and clinical data from underfive children with acute watery diarrhea at an IBD sentinel site. Samples were tested for rotavirus antigen by ELISA and genotyped by PCR at the regional reference laboratory (RRL). Specimens were collected from 79% (n = 297) of eligible cases (n = 375); 100% of which were tested for rotavirus by ELISA and 54% (159/297) of them were positive. At RRL, all the cases were confirmed by PCR and genotyped (99%; 158/159). The typing results revealed the predominance of G12 (40%; 64/159) genotype, followed by G1 (31%; 50/159) and G9 (19%; 31/159). All in all, this exploratory surveillance collected the desired demographic and epidemiological data and achieved almost all the benchmark indicators of WHO, starting from enrollment number to quality assurance through a number of case detection, collection, and testing of specimens and genotyping of strains at RRL. The success of thisWHO-IBD site in achieving these benchmark indicators of WHO can be used by WHO as a proof-of-concept for considering integration of rotavirus surveillance with WHO-IBD platforms, specifically in countries with well performing IBD site and no ongoing rotavirus surveillance.	[Tanmoy, Arif Mohammad; Ahmed, A. S. M. Nawshad Uddin; Hossain, Belal; Marzan, Mahfuza; Saha, Shampa; El Arifeen, Shams; Baqui, Abdullah H.; Saha, Samir Kumar] Dhaka Shishu Hosp, Dept Microbiol, Child Hlth Res Fdn, Dhaka, Bangladesh; [Ahmed, A. S. M. Nawshad Uddin] Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Pediat, Dhaka, Bangladesh; [Arumugam, Rajesh; Kang, Gagandeep] Christian Med Coll & Hosp, Dept Gastrointestinal Sci, Vellore, Tamil Nadu, India; [El Arifeen, Shams] Int Ctr Diarrhoeal Dis Res, Dept Child & Adolescent Hlth, GPO Box 128, Dhaka 1000, Bangladesh; [Baqui, Abdullah H.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Saha, Samir Kumar] Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh	Christian Medical College & Hospital (CMCH) Vellore; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Saha, SK (corresponding author), Dhaka Shishu Hosp, Dept Microbiol, Child Hlth Res Fdn, Dhaka, Bangladesh.; Saha, SK (corresponding author), Dhaka Shishu Hosp, Bangladesh Inst Child Hlth, Dept Microbiol, Dhaka, Bangladesh.	samirk.sks@gmail.com	Tanmoy, Arif Mohammad/V-8340-2019	Marzan, Mahfuza/0000-0003-4568-412X; Saha, Shampa/0000-0001-7185-9232; Tanmoy, Arif Mohammad/0000-0002-7769-8035	WHO [201233523]; World Health Organization, Geneva	WHO(World Health Organization); World Health Organization, Geneva(World Health Organization)	WHO funded the IBD project, no. 201233523.; The study was partially supported by World Health Organization, Geneva. We gratefully acknowledge the generous technical support from Mr. Zakaria M Emran, Mr. Md. Hasanuzzaman, Dr. Mohammad Anowar Uddin and Ms. Maksuda Islam.	Afrad MH, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-320; Agocs MM, 2014, MMWR-MORBID MORTAL W, V63, P634; Alkoshi S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1400-7; [Anonymous], 2012, ROT SURV PERF IND; Babji S, 2014, VACCINE, V32, pA10, DOI 10.1016/j.vaccine.2014.03.001; Banerjee I, 2007, J MED VIROL, V79, P1413, DOI 10.1002/jmv.20872; Bhutta ZA, 2013, LANCET, V381, P1417, DOI 10.1016/S0140-6736(13)60648-0; Boom JA, 2010, PEDIATRICS, V125, pE199, DOI 10.1542/peds.2009-1021; Ciarlet M, 2009, VACCINE, V27, pG72, DOI 10.1016/j.vaccine.2009.09.107; Dennehy PH, 2000, PEDIATR INFECT DIS J, V19, pS103, DOI 10.1097/00006454-200010001-00003; Dey SK, 2009, EMERG INFECT DIS, V15, P91, DOI 10.3201/eid1501.080883; Hasing ME, 2009, J MED VIROL, V81, P2109, DOI 10.1002/jmv.21632; Giaquinto C, 2010, SCAND J INFECT DIS, V42, P142, DOI 10.3109/00365540903380495; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iturriza-Gomara M, 1999, J VIROL METHODS, V78, P93, DOI 10.1016/S0166-0934(98)00168-2; Kang G, 2013, VACCINE, V31, P2879, DOI 10.1016/j.vaccine.2013.04.030; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Matthijnssens J, 2010, MOL BIOL EVOL, V27, P2431, DOI 10.1093/molbev/msq137; Mullick S, 2014, VACCINE, V32, pA20, DOI 10.1016/j.vaccine.2014.03.018; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nelson EAS, 2008, VACCINE, V26, P3192, DOI 10.1016/j.vaccine.2008.03.073; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Patel M, 2009, JAMA-J AM MED ASSOC, V301, P2243, DOI 10.1001/jama.2009.756; Patel MM, 2011, PEDIATR INFECT DIS J, V30, pS1, DOI 10.1097/INF.0b013e3181fefa1f; Rahman M, 2007, EMERG INFECT DIS, V13, P18, DOI 10.3201/eid1301.060910; Tapisiz A, 2011, CURR MICROBIOL, V63, P517, DOI 10.1007/s00284-011-0014-2; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Ward RL, 2009, CLIN INFECT DIS, V48, P222, DOI 10.1086/595702; Widdowson MA, 2009, J INFECT DIS, V200, pS1, DOI 10.1086/605061; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153582	10.1371/journal.pone.0153582	http://dx.doi.org/10.1371/journal.pone.0153582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096958	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600043
J	Mas, S; Gasso, P; Morer, A; Calvo, A; Bargallo, N; Lafuente, A; Lazaro, L				Mas, Sergi; Gasso, Patricia; Morer, Astrid; Calvo, Anna; Bargallo, Nuria; Lafuente, Amalia; Lazaro, Luisa			Integrating Genetic, Neuropsychological and Neuroimaging Data to Model Early-Onset Obsessive Compulsive Disorder Severity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SYMPTOM DIMENSIONS; WHITE-MATTER; ADOLESCENT PATIENTS; CHILD; ABNORMALITIES; METAANALYSIS; RELIABILITY; NAIVE; DTI	We propose an integrative approach that combines structural magnetic resonance imaging data (MRI), diffusion tensor imaging data (DTI), neuropsychological data, and genetic data to predict early-onset obsessive compulsive disorder (OCD) severity. From a cohort of 87 patients, 56 with complete information were used in the present analysis. First, we performed a multivariate genetic association analysis of OCD severity with 266 genetic polymorphisms. This association analysis was used to select and prioritize the SNPs that would be included in the model. Second, we split the sample into a training set (N = 38) and a validation set (N = 18). Third, entropy-based measures of information gain were used for feature selection with the training subset. Fourth, the selected features were fed into two supervised methods of class prediction based on machine learning, using the leave-one-out procedure with the training set. Finally, the resulting model was validated with the validation set. Nine variables were used for the creation of the OCD severity predictor, including six genetic polymorphisms and three variables from the neuropsychological data. The developed model classified child and adolescent patients with OCD by disease severity with an accuracy of 0.90 in the testing set and 0.70 in the validation sample. Above its clinical applicability, the combination of particular neuropsychological, neuroimaging, and genetic characteristics could enhance our understanding of the neurobiological basis of the disorder.	[Mas, Sergi; Gasso, Patricia; Lafuente, Amalia] Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain; [Morer, Astrid; Lazaro, Luisa] Hosp Clin Barcelona, Inst Neurosci, Dept Child & Adolescent Psychiat & Psychol, Barcelona, Spain; [Lazaro, Luisa] Univ Barcelona, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Calvo, Anna] IDIBAPS, Magnet Resonance Image Core Facil, Barcelona, Spain; [Bargallo, Nuria] Hosp Clin Barcelona, Ctr Diagnost Imatge, Dept Radiol, Barcelona, Spain; [Mas, Sergi; Morer, Astrid; Lafuente, Amalia; Lazaro, Luisa] Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain; [Mas, Sergi; Gasso, Patricia; Morer, Astrid; Calvo, Anna; Bargallo, Nuria; Lafuente, Amalia; Lazaro, Luisa] IDIBAPS, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Hospital Clinic de Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Mas, S (corresponding author), Univ Barcelona, Dept Anat Pathol Pharmacol & Microbiol, Barcelona, Spain.; Mas, S (corresponding author), Ctr Invest Biomed Red Salud Mental CIBERSAM, Barcelona, Spain.; Mas, S (corresponding author), IDIBAPS, Barcelona, Spain.	sergimash@ub.edu	mas, sergi/AAD-1996-2019; Bargallo, Nuria/G-6854-2016; Morer, Astrid/J-5113-2017	Gasso, Patricia/0000-0001-6930-3454; Bargallo, Nuria/0000-0001-6284-5402; Lazaro, Luisa/0000-0002-8425-5750; Mas, Sergi/0000-0003-3336-6298; Morer, Astrid/0000-0001-8109-7008	Fundacio la Marato de TV3 [091710]; Agencia de Gestio d'Ajuts Universitaris i Recerca (AGAUR) of the Generalitat de Catalunya [2009 SGR 1119, 2009 SGR 1295, 2009 SGR 1501]	Fundacio la Marato de TV3; Agencia de Gestio d'Ajuts Universitaris i Recerca (AGAUR) of the Generalitat de Catalunya	This research was funded by the "Fundacio la Marato de TV3" (Grant 091710). Support was also given by the "Agencia de Gestio d'Ajuts Universitaris i Recerca" (AGAUR) of the "Generalitat de Catalunya" to the "Child Psychiatry and Psychology Group" (2009 SGR 1119), to the "Schizophrenia Research Group" (2009 SGR 1295) and to the "Clinical Pharmacology and Pharmacogenetics Group" (2009 SGR 1501).	Abramovitch A, 2013, CLIN PSYCHOL REV, V33, P1163, DOI 10.1016/j.cpr.2013.09.004; Alonso P, 2013, J ANXIETY DISORD, V27, P321, DOI 10.1016/j.janxdis.2013.02.012; Alvarenga PG, 2012, J PSYCHIATR RES, V46, P1635, DOI 10.1016/j.jpsychires.2012.09.002; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Atmaca M, 2009, PSYCHIAT CLIN NEUROS, V63, P486, DOI 10.1111/j.1440-1819.2009.01993.x; Birmaher B, 1997, J AM ACAD CHILD PSY, V36, P545, DOI 10.1097/00004583-199704000-00018; Curk T, 2005, BIOINFORMATICS, V21, P396, DOI 10.1093/bioinformatics/bth474; Fan R, 2011, GENET EPIDEMIOL, V35, P706, DOI 10.1002/gepi.20621; Gasso P, 2015, J AFFECT DISORDERS, V186, P284, DOI 10.1016/j.jad.2015.07.035; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Greene CS, 2014, J CELL PHYSIOL, V229, P1896, DOI 10.1002/jcp.24662; Hoexter MQ, 2013, J AFFECT DISORDERS, V150, P1213, DOI 10.1016/j.jad.2013.05.041; Jakulin A, 2003, LECT NOTES ARTIF INT, V2838, P229; Ko S, 2005, J NEUROSCI, V25, P977, DOI 10.1523/JNEUROSCI.4059-04.2005; Koch K, 2014, J PSYCHIATR RES, V54, P26, DOI 10.1016/j.jpsychires.2014.03.006; Koch K, 2012, J PSYCHIATR RES, V46, P264, DOI 10.1016/j.jpsychires.2011.10.016; Koo CL, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/432375; KOVACS M, 1985, PSYCHOPHARMACOL BULL, V21, P995; Lazaro L, 2014, PROG NEURO-PSYCHOPH, V54, P249, DOI 10.1016/j.pnpbp.2014.06.009; Lazaro L, SUBGROUPING IN PRESS; Lazaro L, 2014, DEPRESS ANXIETY, V31, P1007, DOI 10.1002/da.22330; Li F, 2014, HUM BRAIN MAPP, V35, P2643, DOI 10.1002/hbm.22357; Mas S, 2014, GENES BRAIN BEHAV, V13, P409, DOI 10.1111/gbb.12128; Mataix-Cols D, 2004, ARCH GEN PSYCHIAT, V61, P564, DOI 10.1001/archpsyc.61.6.564; Mattheisen M, 2015, MOL PSYCHIATR, V20, P337, DOI 10.1038/mp.2014.43; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Moritz Steffen, 2003, Cogn Neuropsychiatry, V8, P261; Nakao T, 2014, PSYCHIAT CLIN NEUROS, V68, P587, DOI 10.1111/pcn.12195; Ortiz AE, 2016, WORLD J BIOL PSYCHIA, V17, P394, DOI 10.3109/15622975.2015.1111524; Pauls DL, 2014, NAT REV NEUROSCI, V15, P410, DOI 10.1038/nrn3746; Pettersson-Yeo W, 2013, PSYCHOL MED, V43, P2547, DOI 10.1017/S003329171300024X; Salomoni G, 2009, J CLIN PSYCHOPHARM, V29, P343, DOI 10.1097/JCP.0b013e3181aba68f; Scahill L, 1997, J AM ACAD CHILD PSY, V36, P844, DOI 10.1097/00004583-199706000-00023; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Soriano-Mas C, 2007, NEUROIMAGE, V35, P1028, DOI 10.1016/j.neuroimage.2007.01.011; Stewart SE, 2013, AM J MED GENET B, V162B, P367, DOI 10.1002/ajmg.b.32137; Taylor S, 2013, MOL PSYCHIATR, V18, P799, DOI 10.1038/mp.2012.76; Tukel R, 2014, J CLIN NEUROSCI, V21, P790, DOI 10.1016/j.jocn.2013.07.037; Ulloa RE, 2006, ACTAS ESP PSIQUIATRI, V34, P36; Venkatasubramanian G, 2012, J PSYCHIATR RES, V46, P1161, DOI 10.1016/j.jpsychires.2012.06.003; Veronese E, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/867924; Winham SJ, 2013, J CHILD PSYCHOL PSYC, V54, P1120, DOI 10.1111/jcpp.12114; Wu M, 2012, PHARMACOL BIOCHEM BE, V100, P726, DOI 10.1016/j.pbb.2011.10.007; Zhang ZM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00260	44	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153846	10.1371/journal.pone.0153846	http://dx.doi.org/10.1371/journal.pone.0153846			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9NW	27093171	gold, Green Submitted, Green Published			2022-12-27	WOS:000374541200050
J	Huber, W; Fuchs, S; Minning, A; Kuchle, C; Braun, M; Beitz, A; Schultheiss, C; Mair, S; Phillip, V; Schmid, S; Schmid, RM; Lahmer, T				Huber, Wolfgang; Fuchs, Stephan; Minning, Andreas; Kuechle, Claudius; Braun, Marlena; Beitz, Analena; Schultheiss, Caroline; Mair, Sebastian; Phillip, Veit; Schmid, Sebastian; Schmid, Roland M.; Lahmer, Tobias			Transpulmonary thermodilution (TPTD) before, during and after Sustained Low Efficiency Dialysis (SLED). A Prospective Study on Feasibility of TPTD and Prediction of Successful Fluid Removal	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; RENAL REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; PULSE PRESSURE VARIATION; CARDIAC POWER INDEX; BLOOD-VOLUME; RESPONSIVENESS; HEMODIALYSIS; RESUSCITATION; APPLICABILITY	Background Acute kidney injury (AKI) is common in critically ill patients. AKI requires renal replacement therapy (RRT) in up to 10% of patients. Particularly during connection and fluid removal, RRT frequently impairs haemodyamics which impedes recovery from AKI. Therefore, "acute" connection with prefilled tubing and prolonged periods of RRT including sustained low efficiency dialysis (SLED) has been suggested. Furthermore, advanced haemodynamic monitoring using trans-pulmonary thermodilution (TPTD) and pulse contour analysis (PCA) might help to define appropriate fluid removal goals. Objectives, Methods Since data on TPTD to guide RRT are scarce, we investigated the capabilities of TPTD-and PCA-derived parameters to predict feasibility of fluid removal in 51 SLED-sessions (Genius; Fresenius, Germany; blood-flow 150mL/min) in 32 patients with PiCCO-monitoring (Pulsion Medical Systems, Germany). Furthermore, we sought to validate the reliability of TPTD during RRT and investigated the impact of "acute" connection and of disconnection with re-transfusion on haemodynamics. TPTDs were performed immediately before and after connection as well as disconnection. Results Comparison of cardiac index derived from TPTD (CItd) and PCA (CIpc) before, during and after RRT did not give hints for confounding of TPTD by ongoing RRT. Connection to RRT did not result in relevant changes in haemodynamic parameters including CItd. However, disconnection with re-transfusion of the tubing volume resulted in significant increases in CItd, CIpc, CVP, global end-diastolic volume index GEDVI and cardiac power index CPI. Feasibility of the pre-defined ultrafiltration goal without increasing catecholamines by >10% (primary endpoint) was significantly predicted by baseline CPI ( ROC-AUC 0.712; p = 0.010) and CItd (ROC-AUC 0.662; p = 0.049). Conclusions TPTD is feasible during SLED. "Acute" connection does not substantially impair haemodynamics. Disconnection with re-transfusion increases preload, CI and CPI. The extent of these changes might be used as a "post-RRT volume change" to guide fluid removal during subsequent RRTs. CPI is the most useful marker to guide fluid removal by SLED.	[Huber, Wolfgang; Fuchs, Stephan; Minning, Andreas; Kuechle, Claudius; Braun, Marlena; Beitz, Analena; Schultheiss, Caroline; Mair, Sebastian; Phillip, Veit; Schmid, Roland M.; Lahmer, Tobias] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany; [Schmid, Sebastian] Tech Univ Munich, Klinikum Rechts Isar, Klin Anaesthesiol, D-80290 Munich, Germany	Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technical University of Munich; University of Munich	Huber, W (corresponding author), Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, D-80290 Munich, Germany.	wolfgang.huber@lrz.tu-muenchen.de	Phillip, Veit/ABE-4899-2021; Lahmer, Tobias/AAD-3838-2021; Schmid, Sebastian/AAW-3026-2021	Phillip, Veit/0000-0002-0921-2523; Schmid, Sebastian/0000-0002-1232-5350				Benes J, 2014, J CLIN MONIT COMPUT, V28, P225, DOI 10.1007/s10877-013-9524-8; Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Chew MS, 2012, CRIT CARE, V16, DOI 10.1186/cc10599; Citerio G, 2014, INTENS CARE MED, V40, P147, DOI 10.1007/s00134-013-3184-5; Compton F, 2015, THER APHER DIAL, V19, P23, DOI 10.1111/1744-9987.12193; Compton Friederike, 2007, Hemodial Int, V11, P231, DOI 10.1111/j.1542-4758.2007.00174.x; De Laet I, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-S1-S20; Druml W, 2015, INTENS CARE MED, V41, P1941, DOI 10.1007/s00134-015-3989-5; Dufour N, 2012, INTENS CARE MED, V38, P1162, DOI 10.1007/s00134-012-2573-5; Fincke R, 2004, J AM COLL CARDIOL, V44, P340, DOI 10.1016/j.jacc.2004.03.060; Grodin JL, 2015, EUR J HEART FAIL, V17, P689, DOI 10.1002/ejhf.268; Guinot PG, 2015, EUR J ANAESTH, V32, P645, DOI 10.1097/EJA.0000000000000175; Heise D, 2012, MINERVA ANESTESIOL, V78, P315; Huber W, 2008, INTENS CARE MED, V34, P181; Huber W, 2008, CRIT CARE MED, V36, P2348, DOI 10.1097/CCM.0b013e3181809928; Huber W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103854; Kellum JA, 2013, CRIT CARE, V17, DOI 10.1186/cc11454; Kuhn Christian, 2006, Hemodial Int, V10, P68, DOI 10.1111/j.1542-4758.2006.01177.x; Maguire S, 2011, ANESTH ANALG, V112, P94, DOI 10.1213/ANE.0b013e318200366b; Mahjoub Y, 2014, BRIT J ANAESTH, V112, P681, DOI 10.1093/bja/aet442; Metnitz PGH, 2003, INTENS CARE MED, V29, P241, DOI 10.1007/s00134-002-1584-z; Muller L, 2011, ANESTHESIOLOGY, V115, P541, DOI 10.1097/ALN.0b013e318229a500; Oeyen S, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1004-8; Pathil A, 2013, EUR J ANAESTH, V30, P16, DOI 10.1097/EJA.0b013e328358543a; Popovic B, 2014, SHOCK, V42, P22, DOI 10.1097/SHK.0000000000000170; Poukkanen M, 2013, CRIT CARE, V17, DOI 10.1186/cc13161; Sakka SG, 2007, ANESTH ANALG, V105, P1079, DOI 10.1213/01.ane.0000280440.08530.fb; Salzwedel C, 2013, CRIT CARE, V17, DOI 10.1186/cc12885; Sanchez M, 2013, CRIT CARE, V17, DOI 10.1186/cc12855; Sun Y, 2015, PANCREATOLOGY, V15, P497, DOI 10.1016/j.pan.2015.06.006; Tagami T, 2014, CRIT CARE MED, V42, P1348, DOI 10.1097/CCM.0000000000000163; Thijssen S, 2013, BLOOD PURIFICAT, V35, P63, DOI 10.1159/000345484; Venkatachalam MA, 2015, J AM SOC NEPHROL, V26, P1765, DOI 10.1681/ASN.2015010006; Zhang L, 2015, AM J KIDNEY DIS, V66, P322, DOI 10.1053/j.ajkd.2015.02.328	35	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153430	10.1371/journal.pone.0153430	http://dx.doi.org/10.1371/journal.pone.0153430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088612	Green Published, gold			2022-12-27	WOS:000374527000021
J	Rast, TJ; Kullas, AL; Southern, PJ; Davis, DA				Rast, Timothy J.; Kullas, Amy L.; Southern, Peter J.; Davis, Dana A.			Human Epithelial Cells Discriminate between Commensal and Pathogenic Interactions with Candida albicans	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTHELIAL-CELLS; PATHWAY; INFECTIONS; ADHERENCE; PROMOTER; BINDING; GENES; SHOCK; LINE	The commensal fungus, Candida albicans, can cause life-threatening infections in at risk individuals. C. albicans colonizes mucosal surfaces of most people, adhering to and interacting with epithelial cells. At low concentrations, C. albicans is not pathogenic nor does it cause epithelial cell damage in vitro; at high concentrations, C. albicans causes mucosal infections and kills epithelial cells in vitro. Here we show that while there are quantitative dose-dependent differences in exposed epithelial cell populations, these reflect a fundamental qualitative difference in host cell response to C. albicans. Using transcriptional profiling experiments and real time PCR, we found that wild-type C. albicans induce dose-dependent responses from a FaDu epithelial cell line. However, real time PCR and Western blot analysis using a high dose of various C. albicans strains demonstrated that these dose-dependent responses are associated with ability to promote host cell damage. Our studies support the idea that epithelial cells play a key role in the immune system by monitoring the microbial community at mucosal surfaces and initiating defensive responses when this community is dysfunctional. This places epithelial cells at a pivotal position in the interaction with C. albicans as epithelial cells themselves promote C. albicans stimulated damage.	[Rast, Timothy J.; Kullas, Amy L.; Southern, Peter J.; Davis, Dana A.] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA; [Rast, Timothy J.] Univ Arizona, Dept Ecol & Evolutionary Biol, Tucson, AZ USA; [Kullas, Amy L.] NIH, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Arizona; National Institutes of Health (NIH) - USA	Davis, DA (corresponding author), Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA.	dadavis@umn.edu		Kullas, Amy/0000-0003-2429-4691	University of Minnesota [18805]; National Institutes of Health [1R01 AI064054-01]; Burroughs Wellcome Fund [1004419]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064054] Funding Source: NIH RePORTER	University of Minnesota(University of Minnesota System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by University of Minnesota (http://www.research.umn.edu): #18805, National Institutes of Health (http://www.niaid.nih.gov/Pages/default.aspx): 1R01 AI064054-01, and Burroughs Wellcome Fund (http://www.bwfund.org): #1004419. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams A, 1997, METHODS YEAST GENETI; Barker KS, 2008, J INFECT DIS, V198, P193, DOI 10.1086/589516; Calderone RA., 2002, CANDIDA CANDIDIASIS; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Davis DA, 2009, CURR OPIN MICROBIOL, V12, P365, DOI 10.1016/j.mib.2009.05.006; Deng WG, 2007, ARTERIOSCL THROM VAS, V27, P1752, DOI 10.1161/ATVBAHA.107.144352; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edmond MB, 1999, CLIN INFECT DIS, V29, P239, DOI 10.1086/520192; Enache E, 1996, MICROBIOL-UK, V142, P2741, DOI 10.1099/13500872-142-10-2741; Fidel Paul L Jr, 2005, Curr Opin Infect Dis, V18, P107; FILLER SG, 1995, INFECT IMMUN, V63, P976, DOI 10.1128/IAI.63.3.976-983.1995; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Hammer M, 2006, J EXP MED, V203, P15, DOI 10.1084/jem.20051753; Howie HL, 2005, PLOS BIOL, V3, P627, DOI 10.1371/journal.pbio.0030100; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaiser P, 2011, CURR OPIN IMMUNOL, V23, P456, DOI 10.1016/j.coi.2011.06.004; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lakshminarayanan V, 1998, J BIOL CHEM, V273, P32670, DOI 10.1074/jbc.273.49.32670; Levitz SA, 2004, MICROBES INFECT, V6, P1351, DOI 10.1016/j.micinf.2004.08.014; Liu YP, 2015, GENOME RES, V25, P679, DOI 10.1101/gr.187427.114; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Gil ML, 2009, FRONT BIOSCI-LANDMRK, V14, P570, DOI 10.2741/3263; Moyes DL, 2010, CELL HOST MICROBE, V8, P225, DOI 10.1016/j.chom.2010.08.002; Nobile CJ, 2008, CELLULAR MICROBIOLOG; Park H, 2005, CELL MICROBIOL, V7, P499, DOI 10.1111/j.1462-5822.2004.00476.x; Phan QT, 2000, INFECT IMMUN, V68, P3485, DOI 10.1128/IAI.68.6.3485-3490.2000; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Rossi O, 2013, CURR TOP MICROBIOL, V358, P291, DOI 10.1007/82_2011_191; Southern P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002067; Villar CC, 2007, INFECT IMMUN, V75, P2126, DOI 10.1128/IAI.00054-07; Wolf JM, 2010, EUKARYOT CELL, V9, P1203, DOI 10.1128/EC.00056-10; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	33	10	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153165	10.1371/journal.pone.0153165	http://dx.doi.org/10.1371/journal.pone.0153165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088599	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000011
J	Yergeau, E; Masson, L; Elias, M; Xiang, SR; Madey, E; Huang, HS; Brooks, B; Beaudette, LA				Yergeau, Etienne; Masson, Luke; Elias, Miria; Xiang, Shurong; Madey, Ewa; Huang, Hongsheng; Brooks, Brian; Beaudette, Lee A.			Comparison of Methods to Identify Pathogens and Associated Virulence Functional Genes in Biosolids from Two Different Wastewater Treatment Facilities in Canada	PLOS ONE			English	Article							ANAEROBICALLY DIGESTED BIOSOLIDS; TIME QUANTITATIVE PCR; BACTERIAL PATHOGENS; OLIGONUCLEOTIDE MICROARRAY; PROPIDIUM MONOAZIDE; LAND APPLICATION; SALMONELLA; INDICATORS; SOIL; QUANTIFICATION	The use of treated municipal wastewater residues (biosolids) as fertilizers is an attractive, inexpensive option for growers and farmers. Various regulatory bodies typically employ indicator organisms (fecal coliforms, E. coli and Salmonella) to assess the adequacy and efficiency of the wastewater treatment process in reducing pathogen loads in the final product. Molecular detection approaches can offer some advantages over culture-based methods as they can simultaneously detect a wider microbial species range, including non-cultivable microorganisms. However, they cannot directly assess the viability of the pathogens. Here, we used bacterial enumeration methods together with molecular methods including qPCR, 16S rRNA and cpn60 gene amplicon sequencing and shotgun metagenomic sequencing to compare pre-and post-treatment biosolids from two Canadian wastewater treatment plants (WWTPs). Our results show that an anaerobic digestion WWTP was unsuccessful at reducing the live indicator organism load (coliforms, generic E. coli and Salmonella) below acceptable regulatory criteria, while biosolids from a dewatering/pelletization WWTP met these criteria. DNA from other pathogens was detected by the molecular methods, but these species were considered less abundant. Clostridium DNA increased significantly following anaerobic digestion treatments. In addition to pathogen DNA, genes related to virulence and antibiotic resistance were identified in treated biosolids. Shotgun metagenomics revealed the widest range of pathogen DNA and, among the approaches used here, was the only approach that could access functional gene information in treated biosolids. Overall, our results highlight the potential usefulness of amplicon sequencing and shotgun metagenomics as complementary screening methods that could be used in parallel with culture-based methods, although more detailed comparisons across a wider range of sites would be needed.	[Yergeau, Etienne; Elias, Miria] Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada; [Masson, Luke] Natl Res Council Canada, Human Hlth Therapeut, Montreal, PQ, Canada; [Xiang, Shurong; Beaudette, Lee A.] Environm Canada, Biol Assessment & Standardizat Sect, Ottawa, ON K1A 0H3, Canada; [Madey, Ewa] Canadian Food Inspect Agcy, Fertilizer Safety Off, Plant Hlth & Biosecur Directorate, Ottawa, ON, Canada; [Huang, Hongsheng; Brooks, Brian] Canadian Food Inspect Agcy, Ottawa Lab Fallowfield, Ottawa, ON, Canada	National Research Council Canada; National Research Council Canada; Environment & Climate Change Canada; Canadian Food Inspection Agency; Canadian Food Inspection Agency	Yergeau, E (corresponding author), Natl Res Council Canada, Energy Min & Environm, Montreal, PQ, Canada.	Etienne.Yergeau@iaf.inrs.ca	Yergeau, Etienne/AAZ-6145-2020; Yergeau, Etienne/B-5344-2008	Yergeau, Etienne/0000-0002-7112-3425; 	Canadian Food Inspection Agency; Canadian Food Inspection Agency (CFIA)	Canadian Food Inspection Agency; Canadian Food Inspection Agency (CFIA)	This study was funded by the Canadian Food Inspection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully acknowledge the Canadian Food Inspection Agency (CFIA) for the collaboration and funding of this research. We gratefully acknowledge the assistance of Ms. B. Phipps-Todds for her research efforts with the bacterial enumeration and DNA extraction of biosolid samples, and CFIA for collection of biosolids samples.	Ademe E., 2001, BOUES EPURATION MUNI; [Anonymous], 2010, 1446 PN CAN COUNC MI; Bell TH, 2014, TRENDS BIOTECHNOL, V32, P271, DOI 10.1016/j.tibtech.2014.02.008; Bell TH, 2013, ENCY METAGENOMICS; Bibby K, 2010, WATER RES, V44, P4252, DOI 10.1016/j.watres.2010.05.039; Brown JG, 1996, IMMUNOL INVEST, V25, P369, DOI 10.3109/08820139609059318; Champagne P, 2007, RESOUR CONSERV RECY, V50, P211, DOI 10.1016/j.resconrec.2006.09.003; Chen YC, 2011, WATER RES, V45, P2616, DOI 10.1016/j.watres.2011.02.014; Cheng HWA, 2009, PARASITOL RES, V105, P689, DOI 10.1007/s00436-009-1440-y; City_ of_ Toronto, 2003, BIOSOLIDS RESIDUALS; Fey A, 2004, APPL ENVIRON MICROB, V70, P3618, DOI 10.1128/aem.70.6.3618-3623.2004; Garcia-Orenes F, 2005, SOIL TILL RES, V82, P65, DOI 10.1016/j.still.2004.06.004; Gerba CP, 2011, WASTE MANAGE RES, V29, P781, DOI 10.1177/0734242X10397968; Gerba CP, 2005, J ENVIRON QUAL, V34, P42; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Health_Canada, 2002, MFHPB19 HLTH CAN; Health_Canada, 2004, MFLP75 HLTH CAN; Higgins MJ, 2007, WATER RES, V41, P665, DOI 10.1016/j.watres.2006.09.017; Hill JE, 2004, GENOME RES, V14, P1669, DOI 10.1101/gr.2649204; Horswell J, 2010, J APPL MICROBIOL, V108, P104, DOI 10.1111/j.1365-2672.2009.04416.x; Huson DH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S12; Ishii S, 2006, APPL ENVIRON MICROB, V72, P4545, DOI 10.1128/AEM.00131-06; Lee DY, 2008, SCI TOTAL ENVIRON, V398, P203, DOI 10.1016/j.scitotenv.2008.03.004; Lee DY, 2006, J MICROBIOL METH, V65, P453, DOI 10.1016/j.mimet.2005.09.008; Lewis DL, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-11; Loschinkohl C, 2001, HORTSCIENCE, V36, P790, DOI 10.21273/HORTSCI.36.4.790; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Nocker A, 2007, APPL ENVIRON MICROB, V73, P5111, DOI 10.1128/AEM.02987-06; Nocker A, 2009, J MICROBIOL METH, V76, P253, DOI 10.1016/j.mimet.2008.11.004; Oksanen J., 2007, COMMUN ECOL PACK, P631; Oleszkiewicz J. A., 2002, Journal of Environmental Engineering and Science, V1, P75, DOI 10.1139/s02-010; Pillai SD, 2007, WATER ENVIRON RES, V79, P270, DOI 10.2175/106143007X156763; R Core Team, 2021, R LANGUAGE ENV STAT; Rogers M, 2007, WATER ENVIRON J, V21, P34, DOI 10.1111/j.1747-6593.2006.00043.x; Sanschagrin Sylvie, 2014, J Vis Exp, DOI 10.3791/51709; Shannon KE, 2007, SCI TOTAL ENVIRON, V382, P121, DOI 10.1016/j.scitotenv.2007.02.039; Sidhu JPS, 2009, ENVIRON INT, V35, P187, DOI 10.1016/j.envint.2008.07.006; Sopper WE, 1982, LAND RECLAMATION BIO; Tanner BD, 2008, J ENVIRON QUAL, V37, P2311, DOI 10.2134/jeq2007.0193; Viau E, 2009, WATER RES, V43, P4878, DOI 10.1016/j.watres.2009.09.016; Viau E, 2009, APPL ENVIRON MICROB, V75, P164, DOI 10.1128/AEM.01331-08; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wong K, 2010, APPL ENVIRON MICROB, V76, P6441, DOI 10.1128/AEM.02685-09; Yergeau E, 2015, APPL ENVIRON MICROB, V81, P5855, DOI 10.1128/AEM.01470-15; Yergeau E, 2014, ISME J, V8, P344, DOI 10.1038/ismej.2013.163; Yergeau E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030058; Yergeau E, 2010, ISME J, V4, P1206, DOI 10.1038/ismej.2010.41	48	15	15	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153554	10.1371/journal.pone.0153554	http://dx.doi.org/10.1371/journal.pone.0153554			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089040	Green Published, gold			2022-12-27	WOS:000374527000024
J	Deep, SN; Baitharu, I; Sharma, A; Gurjar, AKS; Prasad, D; Singh, SB				Deep, Satya Narayan; Baitharu, Iswar; Sharma, Apurva; Gurjar, Anoop Kishor Singh; Prasad, Dipti; Singh, Shashi Bala			Neuroprotective Role of L-N-G-Nitroarginine Methyl Ester (L-NAME) against Chronic Hypobaric Hypoxia with Crowding Stress (CHC) Induced Depression-Like Behaviour	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED MEMORY IMPAIRMENT; ANTIDEPRESSANT-LIKE; MAJOR DEPRESSION; ANXIOLYTIC-LIKE; MICROGLIA; INHIBITION; ACTIVATION; PATHWAY; MODEL	Improper neuroimmune responses following chronic stress exposure have been reported to cause neuronal dysfunctions leading to memory impairment, anxiety and depression like behaviours. Though several factors affecting microglial activation and consequent alteration in neuro-inflammatory responses have been well studied, role of NO and its association with microglia in stress induced depression model is yet to be explored. In the present study, we validated combination of chronic hypobaric hypoxia and crowding (CHC) as a stress model for depression and investigated the role of chronic stress induced elevated nitric oxide (NO) level in microglia activation and its effect on neuro-inflammatory responses in brain. Further, we evaluated the ameliorative effect of L-N-G-Nitroarginine Methyl Ester (L-NAME) to reverse the stress induced depressive mood state. Four groups of male Sprague Dawley rat were taken and divided into control and CHC stress exposed group with and without treatment of L-NAME. Depression like behaviour and anhedonia in rats were assessed by Forced Swim Test (FST) and Sucrose Preference Test (SPT). Microglial activation was evaluated using Iba-1 immunohistochemistry and proinflammatory cytokines were assessed in the hippocampal region. Our result showed that exposure to CHC stress increased the number of active microglia with corresponding increase in inflammatory cytokines and altered behavioural responses. The inhibition of NO synthesis by L-NAME during CHC exposure decreased the number of active microglia in hippocampus as evident from decreased Iba-1 positive cells. Further, L-NAME administration decreased pro-inflammatory cytokines in hippocampus and improved behaviour of rats. Our study demonstrate that stress induced elevation of NO plays pivotal role in altered microglial activation and consequent neurodegenerative processes leading to depression like behaviour in rat.	[Deep, Satya Narayan; Prasad, Dipti; Singh, Shashi Bala] Def Inst Physiol & Allied Sci, Div Neurobiol, Lucknow Rd, Delhi 54, India; [Baitharu, Iswar] Sambalpur Univ, Post Grad Dept Environm Sci, Sambalpur, Odisha, India; [Sharma, Apurva] Punjab Tech Univ, Dept Pharmacol, Chandigarh, Punjab, India; [Gurjar, Anoop Kishor Singh] Bundelkhand Univ, Jhansi, Uttar Pradesh, India	Defence Research & Development Organisation (DRDO); Defence Institute of Physiology & Allied Sciences (DIPAS); Sambalpur University; I. K. Gujral Punjab Technical University; Bundelkhand University	Prasad, D (corresponding author), Def Inst Physiol & Allied Sci, Div Neurobiol, Lucknow Rd, Delhi 54, India.	drdiptinprasad@gmail.com	Singh, Shashi Bala/AAS-9889-2021; Baitharu, Iswar/AAM-3530-2021	Baitharu, Iswar/0000-0002-3046-2076	Defence Research and Development Organisation, Ministry of Defence, Government of India [DIP-13-254]; Council of Scientific and Industrial Research, New Delhi	Defence Research and Development Organisation, Ministry of Defence, Government of India(Defence Research & Development Organisation (DRDO)); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by DIP-13-254, www.drdo.gov.in. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by Defence Research and Development Organisation (Grant No. DIP-13-254), Ministry of Defence, Government of India. We are also thankful to Council of Scientific and Industrial Research, New Delhi for providing fellowship for conduction of the study smoothly.	Aloisi F., 2005, NEUROGLIA, V2nd, P285; Amiri S, 2015, PHYSIOL BEHAV, V145, P38, DOI 10.1016/j.physbeh.2015.03.032; Anisman H, 2008, PROG NEUROBIOL, V85, P1, DOI 10.1016/j.pneurobio.2008.01.004; Baitharu I, 2013, J BEHAV BRAIN SCI, V3, P591, DOI 10.4236/jbbs.2013.38063; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Baitharu I, 2012, BEHAV BRAIN RES, V228, P53, DOI 10.1016/j.bbr.2011.11.030; Barhwal K, 2009, NEUROBIOL DIS, V34, P230, DOI 10.1016/j.nbd.2009.01.008; Bodet D, 2004, IMMUNO-ANAL BIOL SPE, V19, P138, DOI DOI 10.1016/J.IMMBI0.2004.03.007; Chaudhari UP, 2010, INT J PHARMACOL, V6, P183; De Vente J, 1998, NEUROSCIENCE, V87, P207, DOI 10.1016/S0306-4522(98)00171-7; Dhir A, 2007, EUR J PHARMACOL, V568, P177, DOI 10.1016/j.ejphar.2007.04.028; Faria MS, 1997, EUR J PHARMACOL, V323, P37, DOI 10.1016/S0014-2999(97)00027-7; Felger JC, 2007, BIOL PSYCHIAT, V62, P1324, DOI 10.1016/j.biopsych.2007.05.026; Garcia-Bueno B, 2008, ENDOCRINOLOGY, V149, P1969, DOI 10.1210/en.2007-0482; Gu HF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/613879; Guillemin GJ, 2004, J LEUKOCYTE BIOL, V75, P388, DOI 10.1189/jlb.0303114; Hemmerle AM, 2012, EXP NEUROL, V233, P79, DOI 10.1016/j.expneurol.2011.09.035; Hota SK, 2009, NEUROBIOL DIS, V34, P23, DOI 10.1016/j.nbd.2008.12.006; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Jain V, 2012, CELL MOL NEUROBIOL, V32, P599, DOI 10.1007/s10571-012-9807-5; Joca SRL, 2006, PSYCHOPHARMACOLOGY, V185, P298, DOI 10.1007/s00213-006-0326-2; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kubera M, 2011, PROG NEURO-PSYCHOPH, V35, P744, DOI 10.1016/j.pnpbp.2010.08.026; Kumar B, 2012, PHYTOTHER RES, V26, P488, DOI 10.1002/ptr.3584; Leonard BE, 2006, NEUROTOX RES, V10, P149; Levine J, 1999, NEUROPSYCHOBIOLOGY, V40, P171, DOI 10.1159/000026615; Licinio J, 1999, MOL PSYCHIATR, V4, P317, DOI 10.1038/sj.mp.4000586; Maes M, 1999, ADV EXP MED BIOL, V461, P25; Maes M, 1993, Rev Neurosci, V4, P407; MAES M, 1991, NEUROPSYCHOBIOLOGY, V24, P115, DOI 10.1159/000119472; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P313; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P664, DOI 10.1016/j.pnpbp.2010.06.014; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Maiti P, 2010, ACTA HISTOCHEM, V112, P222, DOI 10.1016/j.acthis.2008.10.005; Muthuraju S, 2010, EXP BRAIN RES, V203, P583, DOI 10.1007/s00221-010-2266-7; Nadjar A, 2005, NEUROPSYCHOPHARMACOL, V30, P1492, DOI 10.1038/sj.npp.1300755; Nakajima K, 1998, Hum Cell, V11, P141; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; O'Connor JC, 2009, MOL PSYCHIATR, V14, P511, DOI 10.1038/sj.mp.4002148; Peng YL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-75; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Rock RB, 2004, CLIN MICROBIOL REV, V17, P942, DOI 10.1128/CMR.17.4.942-964.2004; Sevgi S, 2006, METHOD FIND EXP CLIN, V28, P95, DOI 10.1358/mf.2006.28.2.977840; Shukitt-Hale B, 1998, INT J AVIAT PSYCHOL, V8, P319, DOI 10.1207/s15327108ijap0804_1; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; SINGH SB, 1993, INT J BIOMETEOROL, V37, P200, DOI 10.1007/BF01387523; Skalisz LL, 2002, PROG NEURO-PSYCHOPH, V26, P879, DOI 10.1016/S0278-5846(01)00333-5; Sluzewska A, 1995, ANN NY ACAD SCI, V762, P474; SmithSwintosky VL, 1996, J CEREBR BLOOD F MET, V16, P585, DOI 10.1097/00004647-199607000-00008; Spiacci A, 2008, PHARMACOL BIOCHEM BE, V88, P247, DOI 10.1016/j.pbb.2007.08.008; Stefano GB, 2004, MED SCI MONITOR, V10, pBR17; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Tilleux S, 2007, J NEUROIMMUNOL, V189, P23, DOI 10.1016/j.jneuroim.2007.06.011; Tomaz VS, 2014, NEUROSCIENCE, V268, P236, DOI 10.1016/j.neuroscience.2014.03.025; Volke V, 2003, BEHAV BRAIN RES, V140, P141, DOI 10.1016/S0166-4328(02)00312-1; VOLKE V, 1995, NEUROREPORT, V6, P1413, DOI 10.1097/00001756-199507100-00013; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Wang XM, 2006, CLIN PHARMACOL THER, V79, P303, DOI 10.1016/j.clpt.2005.12.306; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WONG YN, 1994, J CHROMATOGR B, V661, P211, DOI 10.1016/0378-4347(94)00346-7; Wuwongse S, 2010, PROG NEUROBIOL, V91, P362, DOI 10.1016/j.pneurobio.2010.04.005	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153371	10.1371/journal.pone.0153371	http://dx.doi.org/10.1371/journal.pone.0153371			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082990	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800017
J	Vaulet, LG; Entrocassi, C; Portu, AI; Castro, E; Di Bartolomeo, S; Ruettger, A; Sachse, K; Fermepin, MR				Gallo Vaulet, Lucia; Entrocassi, Carolina; Portu, Ana I.; Castro, Erica; Di Bartolomeo, Susana; Ruettger, Anke; Sachse, Konrad; Rodriguez Fermepin, Marcelo			High Frequency of Chlamydia trachomatis Mixed Infections Detected by Microarray Assay in South American Samples	PLOS ONE			English	Article							DNA MICROARRAY; HYBRIDIZATION ASSAY; OMPA GENOTYPES; IDENTIFICATION; PCR; EPIDEMIOLOGY; SEROVARS	Chlamydia trachomatis is one of the most common sexually transmitted infections worldwide. Based on sequence variation in the ompA gene encoding the major outer membrane protein, the genotyping scheme distinguishes 17 recognized genotypes, i.e. A, B, Ba, C, D, Da, E, F, G, H, I, Ia, J, K, L1, L2, and L3. Genotyping is an important tool for epidemiological tracking of C. trachomatis infections, including the revelation of transmission pathways and association with tissue tropism and pathogenicity. Moreover, genotyping can be useful for clinicians to establish the correct treatment when LGV strains are detected. Recently a microarray assay was described that offers several advantages, such as rapidity, ease of standardization and detection of mixed infections. The aim of this study was to evaluate the performance of the DNA microarray-based assay for C. trachomatis genotyping of clinical samples already typed by PCR-RFLP from South America. The agreement between both typing techniques was 90.05% and the overall genotype distribution obtained with both techniques was similar. Detection of mixed-genotype infections was significantly higher using the microarray assay (8.4% of cases) compared to PCR-RFLP (0.5%). Among 178 samples, the microarray assay identified 10 ompA genotypes, i.e. D, Da, E, F, G, H, I, J, K and L2. The most predominant type was genotype E, followed by D and F.	[Gallo Vaulet, Lucia; Entrocassi, Carolina; Portu, Ana I.; Rodriguez Fermepin, Marcelo] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol Clin, RA-1113 Buenos Aires, DF, Argentina; [Castro, Erica] Univ San Sebastian, Fac Med, Concepcion, Chile; [Di Bartolomeo, Susana] Hosp Nacl Prof A Posadas, Serv Bioquim, Secc Bioquim Microbiol, Buenos Aires, DF, Argentina; [Ruettger, Anke; Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Pathogenesis, Jena, Germany	University of Buenos Aires; Universidad San Sebastian; University of Buenos Aires; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Loeffler Institute	Vaulet, LG (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Catedra Microbiol Clin, RA-1113 Buenos Aires, DF, Argentina.	lgvaulet@ffyb.uba.ar	Sachse, Konrad/GWC-4999-2022; RODRIGUEZ FERMEPIN, Marcelo/AAY-7762-2021	Sachse, Konrad/0000-0003-1230-1786; RODRIGUEZ FERMEPIN, Marcelo/0000-0003-2543-4262	Universidad de Buenos Aires [UBACyT B810, UBACyT 20020090200460]; national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals"; Federal Ministry of Education and Research (BMBF) of Germany [01KI0720]	Universidad de Buenos Aires(University of Buenos Aires); national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals"; Federal Ministry of Education and Research (BMBF) of Germany(Federal Ministry of Education & Research (BMBF))	The study was financed in part by a grant of the Universidad de Buenos Aires UBACyT B810 and UBACyT 20020090200460 awarded to MRF. KS acknowledges financial support by the national research network "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals," which was funded by the Federal Ministry of Education and Research (BMBF) of Germany under grant 01KI0720. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	BEbEar C, 2009, CLIN MICROBIOL INFEC, V15, P4, DOI 10.1111/j.1469-0691.2008.02647.x; Borel N, 2008, MOL CELL PROBE, V22, P55, DOI 10.1016/j.mcp.2007.06.003; Centers for Disease Control and Prevention [CDC], 2010, MORB MORT WKLY REP, V58, P26; Dean D, 2008, PLOS MED, V5, P57, DOI 10.1371/journal.pmed.0050014; Gallo Vaulet Lucia, 2010, BMC Res Notes, V3, P34, DOI 10.1186/1756-0500-3-34; Geisler WM, 2008, SEX TRANSM INFECT, V84, P541, DOI 10.1136/sti.2008.030825; Gharsallah H, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-333; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Jalal H, 2007, J CLIN MICROBIOL, V45, P2649, DOI 10.1128/JCM.00451-07; Jonsdottir K, 2003, SEX TRANSM DIS, V30, P249, DOI 10.1097/00007435-200303000-00015; Joseph SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099290; Kapil R, 2015, J CLIN MICROBIOL, V53, P546, DOI 10.1128/JCM.02483-14; Klint M, 2006, J CLIN MICROBIOL, V44, P4066, DOI 10.1128/JCM.00574-06; Leinberger DM, 2005, J CLIN MICROBIOL, V43, P4943, DOI 10.1128/JCM.43.10.4943-4953.2005; Lysen M, 2004, J CLIN MICROBIOL, V42, P1641, DOI 10.1128/JCM.42.4.1641-1647.2004; Molano M, 2004, J CLIN MICROBIOL, V42, P2935, DOI 10.1128/JCM.42.7.2935-2939.2004; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Pedersen LN, 2009, FEMS IMMUNOL MED MIC, V55, P120, DOI 10.1111/j.1574-695X.2008.00526.x; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Psarrakos P, 2011, MOL CELL PROBE, V25, P168, DOI 10.1016/j.mcp.2011.04.003; Quint KD, 2007, J MOL DIAGN, V9, P631, DOI 10.2353/jmoldx.2007.070011; Ruettger A, 2011, MOL CELL PROBE, V25, P19, DOI 10.1016/j.mcp.2010.09.004; Ryabinin VA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017529; Sachse K, 2005, MOL CELL PROBE, V19, P41, DOI 10.1016/j.mcp.2004.09.005; Sachse K, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-63; Stevens MP, 2010, J CLIN MICROBIOL, V48, P2060, DOI 10.1128/JCM.02308-09; Stothard DR, 2001, J CLIN MICROBIOL, V39, P2655, DOI 10.1128/JCM.39.7.2655-2659.2001; White JA, 2009, CURR OPIN INFECT DIS, V22, P57, DOI 10.1097/QCO.0b013e328320a8ae; Wright HR, 2008, LANCET, V371, P1945, DOI 10.1016/S0140-6736(08)60836-3; Wylie JL, 2005, J INFECT DIS, V191, P899, DOI 10.1086/427661; Xiong LK, 2006, J CLIN MICROBIOL, V44, P1413, DOI 10.1128/JCM.44.4.1413-1418.2006; YUAN Y, 1989, INFECT IMMUN, V57, P1040, DOI 10.1128/IAI.57.4.1040-1049.1989	32	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153511	10.1371/journal.pone.0153511	http://dx.doi.org/10.1371/journal.pone.0153511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082962	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800025
J	Saad, NS; Floyd, K; Ahmed, AAE; Mohler, PJ; Janssen, PML; Elnakish, MT				Saad, Nancy S.; Floyd, Kyle; Ahmed, Amany A. E.; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.			The Effect of Sorafenib, Tadalafil and Macitentan Treatments on Thyroxin-Induced Hemodynamic Changes and Cardiac Abnormalities	PLOS ONE			English	Article							EXPERIMENTAL PULMONARY-HYPERTENSION; ENDOTHELIN RECEPTOR ANTAGONIST; ACUTE HEART-FAILURE; PROTEIN-KINASE; ANGIOTENSIN-II; BLOOD-PRESSURE; PHOSPHODIESTERASE-5 INHIBITOR; HYPERTROPHIC RESPONSE; VENTRICULAR-FUNCTION; UP-REGULATION	Multikinase inhibitors (e.g. Sorafenib), phosphodiesterase-5 inhibitors (e.g. Tadalafil), and endothelin-1 receptor blockers (e.g. Macitentan) exert influential protection in a variety of animal models of cardiomyopathy; however, their effects on thyroxin-induced cardiomyopathy have never been investigated. The goal of the present study was to assess the functional impact of these drugs on thyroxin-induced hemodynamic changes, cardiac hypertrophy and associated altered responses of the contractile myocardium both in-vivo at the whole heart level and ex-vivo at the cardiac tissue level. Control and thyroxin (500 mu g/kg/day)-treated mice with or without 2-week treatments of sorafenib (10 mg/kg/day; I.P), tadalafil (1 mg/kg/day; I.P or 4 mg/kg/day; oral), macitentan (30 and 100 mg/kg/day; oral), and their vehicles were studied. Blood pressure, echocardiography and electrocardiogram were non-invasively evaluated, followed by ex-vivo assessments of isolated multicellular cardiac preparations. Thyroxin increased blood pressure, resulted in cardiac hypertrophy and left ventricular dysfunction in-vivo. Also, it caused contractile abnormalities in right ventricular papillary muscles ex-vivo. None of the drug treatments were able to significantly attenuate theses hemodynamic changes or cardiac abnormalities in thyroxin-treated mice. We show here for the first time that multikinase (raf1/b, VEGFR, PDGFR), phosphodiesterase-5, and endothelin-1 pathways have no major role in thyroxin-induced hemodynamic changes and cardiac abnormalities. In particular, our data show that the involvement of endothelin-1 pathway in thyroxine-induced cardiac hypertrophy/dysfunction seems to be model-dependent and should be carefully interpreted.	[Saad, Nancy S.; Floyd, Kyle; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Saad, Nancy S.; Floyd, Kyle; Mohler, Peter J.; Janssen, Paul M. L.; Elnakish, Mohammad T.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Saad, Nancy S.; Ahmed, Amany A. E.; Elnakish, Mohammad T.] Helwan Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Egyptian Knowledge Bank (EKB); Helwan University	Elnakish, MT (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.; Elnakish, MT (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Elnakish, MT (corresponding author), Helwan Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt.	elnakish.1@osu.edu	Ahmed, Amany Ali Eissa/T-2497-2019	Janssen, Paul/0000-0002-9682-3014; Saad, Nancy/0000-0002-5194-7515	Ohio State University; NINDS [P30 NS045758-06]; American Heart Association [16POST27760155]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045758] Funding Source: NIH RePORTER	Ohio State University(Ohio State University); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided in part through start-up funds to PMLJ from The Ohio State University, and by P30 core grant NINDS P30 NS045758-06 (PI: C. Beattie). MTE is supported by the American Heart Association Great Rivers Affiliate Post-doctoral Fellowship 16POST27760155.	Adamo CM, 2010, P NATL ACAD SCI USA, V107, P19079, DOI 10.1073/pnas.1013077107; Adiarto S, 2012, LIFE SCI, V91, P651, DOI 10.1016/j.lfs.2012.02.006; Al Husseini A, 2013, EUR RESPIR J, V41, P104, DOI 10.1183/09031936.00196511; Anand I, 2004, LANCET, V364, P347, DOI 10.1016/S0140-6736(04)16723-8; Andersen A, 2008, EUR J HEART FAIL, V10, P1158, DOI 10.1016/j.ejheart.2008.09.016; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Araujo ASR, 2007, MOL CELL BIOCHEM, V303, P89, DOI 10.1007/s11010-007-9459-9; Araujo ASR, 2011, MOL CELL ENDOCRINOL, V333, P78, DOI 10.1016/j.mce.2010.12.018; Araujo ASR, 2008, J MOL ENDOCRINOL, V41, P423, DOI 10.1677/JME-08-0024; Biondi B, 2012, EUR J ENDOCRINOL, V167, P609, DOI 10.1530/EJE-12-0627; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; Brandt F, 2011, EUR J ENDOCRINOL, V165, P491, DOI 10.1530/EJE-11-0299; CAMPBELL SE, 1988, J MOL CELL CARDIOL, V20, P379, DOI 10.1016/S0022-2828(88)80129-9; Araujo ASD, 2010, J CARDIOVASC PHARM, V56, P513, DOI 10.1097/FJC.0b013e3181f50a70; Dai WD, 2012, CIRCULATION, V125, P1341, DOI 10.1161/CIRCULATIONAHA.112.094912; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Dias AT, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0250-x; Dishy V, 2004, BRIT J CLIN PHARMACO, V57, P209, DOI 10.1046/j.1365-2125.2003.01974.x; Duran JM, 2014, CIRC RES, V114, P1700, DOI 10.1161/CIRCRESAHA.114.303200; ECKER T, 1989, CIRC RES, V65, P1361, DOI 10.1161/01.RES.65.5.1361; Elnakish MT, 2015, FREE RADICAL BIO MED, V83, P252, DOI 10.1016/j.freeradbiomed.2015.02.035; Elnakish MT, 2013, J CARDIOVASC PHARM, V61, P536, DOI 10.1097/FJC.0b013e31828d4b9d; Elnakish MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042500; Elnakish MT, ROLE OXIDATIVE STRES; Engel S, 2001, EUR J PHARMACOL, V421, P23, DOI 10.1016/S0014-2999(01)00993-1; Feng Y, 2007, PHARMACOL REP, V59, P306; Frey Maria Klara, 2012, Expert Opin Pharmacother, V13, P747, DOI 10.1517/14656566.2012.662220; Ghofrani HA, 2005, NEW ENGL J MED, V353, P1412, DOI 10.1056/NEJMc051946; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; Hassan Madiha A. H., 2005, BMC Pharmacology, V5, P10, DOI 10.1186/1471-2210-5-10; Heiden S, 2014, PLOS ONE, V9; Ho David, 2011, Curr Protoc Mouse Biol, V1, P123, DOI 10.1002/9780470942390.mo100159; Hocher B, 1999, HYPERTENSION, V33, P816, DOI 10.1161/01.HYP.33.3.816; Iglarz M, 2015, J CARDIOVASC PHARM, V66, P457, DOI 10.1097/FJC.0000000000000296; Iglarz M, 2014, LIFE SCI, V118, P333, DOI 10.1016/j.lfs.2014.02.018; ITO H, 1993, J CLIN INVEST, V92, P398, DOI 10.1172/JCI116579; Jin Z, 2013, J CARDIOL, V62, P110, DOI 10.1016/j.jjcc.2013.03.018; Kaddoura S, 1996, CIRCULATION, V93, P2068, DOI 10.1161/01.CIR.93.11.2068; Katz E, 2006, PEPTIDES, V27, P2276, DOI 10.1016/j.peptides.2006.04.011; Kedzierski RM, 2003, MOL CELL BIOL, V23, P8226, DOI 10.1128/MCB.23.22.8226-8232.2003; Klein M, 2008, CIRCULATION, V118, P2081, DOI 10.1161/CIRCULATIONAHA.108.779751; Kojonazarov B, 2013, INT J CARDIOL, V167, P2630, DOI 10.1016/j.ijcard.2012.06.129; Koka S, 2010, J PHARMACOL EXP THER, V334, P1023, DOI 10.1124/jpet.110.170191; Kuczynski EA, 2015, CANC RES; Kunita-Takanezawa M, 2014, J CARDIOVASC PHARM, V64, P473, DOI 10.1097/FJC.0000000000000141; Kuzman JA, 2005, J APPL PHYSIOL, V99, P1428, DOI 10.1152/japplphysiol.00515.2005; Kuzman JA, 2005, J MOL CELL CARDIOL, V39, P251, DOI 10.1016/j.yjmcc.2005.03.020; Li JS, 1996, AM J PHYSIOL-HEART C, V271, pH88, DOI 10.1152/ajpheart.1996.271.1.H88; Mahmud A, 2001, J HUM HYPERTENS, V15, P707, DOI 10.1038/sj.jhh.1001244; Maitland M, 2006, ASCO ANN M P; Milani-Nejad N, 2014, J MUSCLE RES CELL M, V35, P225, DOI 10.1007/s10974-014-9386-9; Moreno-Vinasco L, 2008, PHYSIOL GENOMICS, V33, P278, DOI 10.1152/physiolgenomics.00169.2007; Mortara L, 2014, J ENDOCRINOL INVEST, V37, P1099, DOI 10.1007/s40618-014-0177-3; Nagayama T, 2009, J AM COLL CARDIOL, V53, P207, DOI 10.1016/j.jacc.2008.08.069; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; O'Connor CM, 2003, J AM COLL CARDIOL, V41, P1452, DOI 10.1016/S0735-1097(03)00194-3; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Picard P, 1998, J CARDIOVASC PHARM, V31, pS294, DOI 10.1097/00005344-199800001-00082; Pieske B, 1999, CIRCULATION, V99, P1802, DOI 10.1161/01.CIR.99.14.1802; Pulido T, 2013, NEW ENGL J MED, V369, P809, DOI 10.1056/NEJMoa1213917; RODRIGUEZ EK, 1992, AM J PHYSIOL, V263, pH293, DOI 10.1152/ajpheart.1992.263.1.H293; Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212; Sakai S, 1996, CIRCULATION, V93, P1214, DOI 10.1161/01.CIR.93.6.1214; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Salloum FN, 2014, CARDIOVASC DRUG THER, V28, P493, DOI 10.1007/s10557-014-6559-0; Salloum FN, 2009, CIRCULATION, V120, pS31, DOI 10.1161/CIRCULATIONAHA.108.843979; Salonia A, 2003, CURR MED RES OPIN, V19, P241, DOI 10.1185/030079903125001839; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Schwartz BG, 2012, J AM COLL CARDIOL, V59, P9, DOI 10.1016/j.jacc.2011.07.051; Shohet RV, 2004, P NATL ACAD SCI USA, V101, P2088, DOI 10.1073/pnas.0307159101; Stanley JL, 2012, HYPERTENSION, V59, P1021, DOI 10.1161/HYPERTENSIONAHA.111.186270; STEWART DJ, 1992, CIRCULATION, V85, P510, DOI 10.1161/01.CIR.85.2.510; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Tang XY, 2008, PHARMACOL REP, V60, P524; TSE J, 1980, ENDOCRINOLOGY, V107, P6, DOI 10.1210/endo-107-1-6; Varma A, 2012, ANTIINFLAMMATORY CAR, DOI [10.1371/journal.pone.0045243 PMID: 23028874, DOI 10.1371/JOURNAL.PONE.0045243]; Wang YY, 2010, MOL CELL ENDOCRINOL, V320, P67, DOI 10.1016/j.mce.2010.01.031; Wangensteen R, 2006, AM J PHYSIOL-REG I, V291, pR1376, DOI 10.1152/ajpregu.00722.2005; WEISS HR, 1995, AM J PHYSIOL-HEART C, V268, pH686, DOI 10.1152/ajpheart.1995.268.2.H686; Xie YP, 2012, HYPERTENSION, V59, P355, DOI 10.1161/HYPERTENSIONAHA.111.180968; Yan L, 2003, CLIN EXP PHARMACOL P, V30, P943, DOI 10.1111/j.1440-1681.2003.03936.x; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang LL, 2004, CIRCULATION, V109, P255, DOI 10.1161/01.CIR.0000105701.98663.D4; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; Zhang Y, 2008, INT J CARDIOL, V130, P463, DOI 10.1016/j.ijcard.2008.05.018; ZIERHUT W, 1989, J MOL CELL CARDIOL, V21, P617, DOI 10.1016/0022-2828(89)90827-4	86	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153694	10.1371/journal.pone.0153694	http://dx.doi.org/10.1371/journal.pone.0153694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082116	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800046
J	Buell, KG; Puri, A; Demontis, MA; Short, CL; Adonis, A; Haddow, J; Martin, F; Dhasmana, D; Taylor, GP				Buell, Kevin G.; Puri, Aiysha; Demontis, Maria Antonietta; Short, Charlotte L.; Adonis, Adine; Haddow, Jana; Martin, Fabiola; Dhasmana, Divya; Taylor, Graham P.			Effect of Pulsed Methylprednisolone on Pain, in Patients with HTLV-1-Associated Myelopathy	PLOS ONE			English	Article							I-ASSOCIATED MYELOPATHY; TROPICAL SPASTIC PARAPARESIS; VIRUS TYPE-I; T-CELL LEUKEMIA; HTLV-I; DOUBLE-BLIND; THERAPY; LYMPHOCYTES; FREQUENCIES; PREDNISONE	HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immune mediated myelopathy caused by the human T-lymphotropic virus type 1 (HTLV-1). The efficacy of treatments used for patients with HAM/TSP is uncertain. The aim of this study is to document the efficacy of pulsed methylprednisolone in patients with HAM/TSP. Data from an open cohort of 26 patients with HAM/TSP was retrospectively analysed. 1g IV methylprednisolone was infused on three consecutive days. The outcomes were pain, gait, urinary frequency and nocturia, a range of inflammatory markers and HTLV-1 proviral load. Treatment was well tolerated in all but one patient. Significant improvements in pain were: observed immediately, unrelated to duration of disease and maintained for three months. Improvement in gait was only seen on Day 3 of treatment. Baseline cytokine concentrations did not correlate to baseline pain or gait impairment but a decrease in tumour necrosis factor-alpha (TNF-alpha) concentration after pulsed methylprednisolone was associated with improvements in both. Until compared with placebo, treatment with pulsed methylprednisolone should be offered to patients with HAM/TSP for the treatment of pain present despite regular analgesia.	[Buell, Kevin G.; Puri, Aiysha; Demontis, Maria Antonietta; Short, Charlotte L.; Taylor, Graham P.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Norfolk Pl, London W2 1PG, England; [Adonis, Adine; Haddow, Jana; Dhasmana, Divya; Taylor, Graham P.] St Marys Hosp, Natl Ctr Human Retrovirol, Imperial Coll Healthcare NHS Trust, Praed St, London W2 1NY, England; [Martin, Fabiola] Univ York, Ctr Immunol & Infect, Hull York Med Sch, Dept Biol, York YO10 5DD, N Yorkshire, England	Imperial College London; Imperial College London; University of Hull; University of York - UK	Taylor, GP (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Virol Sect, Norfolk Pl, London W2 1PG, England.; Taylor, GP (corresponding author), St Marys Hosp, Natl Ctr Human Retrovirol, Imperial Coll Healthcare NHS Trust, Praed St, London W2 1NY, England.	g.p.taylor@imperial.ac.uk	Adonis, Adine/AFR-0710-2022	Martin, Fabiola/0000-0003-4487-8803; Short, Charlotte-Eve/0000-0002-4974-8824; Buell, Kevin/0000-0001-5718-3328; Adonis, Adine/0000-0002-5372-8025				Araujo A Q, 1993, Arq Neuropsiquiatr, V51, P325; Carod-Artal FJ, 2000, REV NEUROLOGIA, V31, P32, DOI 10.33588/rn.3101.2000004; Coral LC, 1998, ARQ NEURO-PSIQUIAT, V56, P120, DOI 10.1590/S0004-282X1998000100020; Croda MG, 2008, J NEUROL SCI, V269, P133, DOI 10.1016/j.jns.2008.01.004; Daenke S, 1996, VIROLOGY, V217, P139, DOI 10.1006/viro.1996.0101; De Castro-Costa CM, 2006, AIDS RES HUM RETROV, V22, P931, DOI 10.1089/aid.2006.22.931; de Castro-Costa CM, 2009, ARQ NEURO-PSIQUIAT, V67, P866, DOI 10.1590/S0004-282X2009000500016; Demontis MA, 2013, AIDS RES HUM RETROV, V29, P359, DOI [10.1089/AID.2012.0132, 10.1089/aid.2012.0132]; ELOVAARA I, 1993, J EXP MED, V177, P1567, DOI 10.1084/jem.177.6.1567; European Centre for Disease Prevention and Control, 2015, GEOGR DISTR AR HIGH; FAUCI AS, 1976, CLIN EXP IMMUNOL, V24, P54; FAUCI AS, 1975, J CLIN INVEST, V55, P22, DOI 10.1172/JCI107914; FAUCI AS, 1975, BLOOD, V46, P235; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; FURUKAWA K, 1994, J CLIN INVEST, V94, P1830, DOI 10.1172/JCI117532; GARIN EH, 1986, EUR J PEDIATR, V145, P380, DOI 10.1007/BF00439243; GESSAIN A, 1985, LANCET, V2, P407; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Goon PKC, 2003, J VIROL, V77, P9716, DOI 10.1128/JVI.77.17.9716-9722.2003; Goon PKC, 2002, BLOOD, V99, P3335, DOI 10.1182/blood.V99.9.3335; Gotuzzo E, 2004, CLIN INFECT DIS, V39, P939, DOI 10.1086/423957; Greten TF, 1998, P NATL ACAD SCI USA, V95, P7568, DOI 10.1073/pnas.95.13.7568; HARRINGTON WJ, 1991, AIDS RES HUM RETROV, V7, P1031, DOI 10.1089/aid.1991.7.1031; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; Hirahara K, 2013, J AM ACAD DERMATOL, V69, P496, DOI 10.1016/j.jaad.2013.04.007; Hollsberg P, 1997, ACTA NEUROL SCAND, V95, P86; IWASAKI Y, 1992, AM J PATHOL, V140, P1003; Izumo S, 1996, NEUROLOGY, V46, P1016, DOI 10.1212/WNL.46.4.1016; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; KATAOKA A, 1993, J NEUROL NEUROSUR PS, V56, P1213, DOI 10.1136/jnnp.56.11.1213; KIRA J, 1991, J NEUROL SCI, V106, P41, DOI 10.1016/0022-510X(91)90192-A; Maloney EM, 1998, J ACQ IMMUN DEF SYND, V17, P167, DOI 10.1097/00042560-199802010-00011; Martin F, 2014, RETROVIROLOGY, V11, P31; Martin F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001675; Martin F, 2010, J NEUROL NEUROSUR PS, V81, P1336, DOI 10.1136/jnnp.2009.191239; MILLIGAN NM, 1987, J NEUROL NEUROSUR PS, V50, P511, DOI 10.1136/jnnp.50.5.511; Murphy EL, 1997, NEUROLOGY, V48, P315, DOI 10.1212/WNL.48.2.315; Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225; NAKAGAWA M, 1995, J NEUROVIROL, V1, P50, DOI 10.3109/13550289509111010; Nakagawa M, 1996, J NEUROVIROL, V2, P345, DOI 10.3109/13550289609146899; Netto EC, 2011, CLIN J PAIN, V27, P131, DOI 10.1097/AJP.0b013e3181f195d3; Olindo S, 2006, ARCH NEUROL-CHICAGO, V63, P1560, DOI 10.1001/archneur.63.11.1560; Oliveira P, 2007, CLINICS, V62, P191, DOI 10.1590/S1807-59322007000200015; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Tanajura D, 2015, CLIN INFECT DIS, V61, P49, DOI 10.1093/cid/civ229; Tavares IR, 2010, SPINAL CORD, V48, P134, DOI 10.1038/sc.2009.83; Taylor GP, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-63; UMEHARA F, 1993, J NEUROPATH EXP NEUR, V52, P424, DOI 10.1097/00005072-199307000-00010; *WHO, 1989, WHO WKLY EPIDEMIOL R, V49, P382; WILLIAMS IA, 1988, ANN RHEUM DIS, V47, P930, DOI 10.1136/ard.47.11.930	51	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152557	10.1371/journal.pone.0152557	http://dx.doi.org/10.1371/journal.pone.0152557			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077747	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700005
J	Kotsou, I; Leys, C				Kotsou, Ilios; Leys, Christophe			Self-Compassion Scale (SCS): Psychometric Properties of The French Translation and Its Relations with Psychological Well-Being, Affect and Depression	PLOS ONE			English	Article							DISORDER; ADULTS; ASSOCIATIONS; ADOLESCENTS; VALIDATION; AVOIDANCE; BEHAVIORS; ANHEDONIA; EMOTIONS; CRITERIA	Over the past few years, the topic of self-compassion has attracted increasing attention from both scientific and clinical fields. The Self-Compassion Scale (SCS) was created to specifically capture this way of being kind and understanding towards oneself in moments of turmoil. In this article, we present a French adaptation of the SCS. We first explore the psychometric properties of this adaptation and then investigate its relation to psychological well-being. As in the original version of the SCS, the French adaptation has a strong 6-factor structure but a weaker hierarchical second order structure. However the bi-factor model yields a good omega index suggesting the relevance of a single score accounting for self-compassion. Moreover, there was a relation between the SCS and classical outcomes such as a positive relation with psychological well-being and negative relation with depressive symptoms. We then hypothesized that self-compassion would have a moderating role on the relation between affect and depression. This hypothesis was confirmed: expressing negative affect is correlated with depressive symptoms; however, being kind with oneself lowers depressive symptoms even when expressing negative affect. In conclusion, this research presents a valid self-compassion measure for French-speaking researchers and clinicians and outlines the need for further research on the concept of self-compassion.	[Kotsou, Ilios; Leys, Christophe] Univ Libre Bruxelles, Brussels, Belgium	Universite Libre de Bruxelles	Kotsou, I (corresponding author), Univ Libre Bruxelles, Brussels, Belgium.	ilios.kotsou@ulb.ac.be		Leys, Christophe/0000-0002-3832-3097; Kotsou, Ilios/0000-0003-0101-3797				ABRAMSON LY, 1978, J ABNORM PSYCHOL, V87, P49, DOI 10.1037/0021-843X.87.1.49; Allen AB, 2012, SELF IDENTITY, V11, P428, DOI 10.1080/15298868.2011.595082; Beck AT, 2009, DEPRESSION: CAUSES AND TREATMENT, SECOND EDITION, P1; BENTLER PM, 1992, PSYCHOL BULL, V112, P400, DOI 10.1037/0033-2909.112.3.400; BLAIS MR, 1989, CAN J BEHAV SCI, V21, P210, DOI 10.1037/h0079854; Bollen K.A, 2014, STRUCTURAL EQUATIONS, P210; BOURQUE P, 1982, CAN J BEHAV SCI, V14, P211, DOI 10.1037/h0081254; Brion JM, 2014, J HEALTH PSYCHOL, V19, P218, DOI 10.1177/1359105312467391; Byrne Barbara M., 2013, STRUCTURAL EQUATION; CRONBACH LJ, 1956, ANNU REV PSYCHOL, V7, P173, DOI 10.1146/annurev.ps.07.020156.001133; Diener ML, 2004, J CROSS CULT PSYCHOL, V35, P525, DOI 10.1177/0022022104268387; Fry CL, 2005, J MED ETHICS, V31, P542, DOI 10.1136/jme.2004.009290; Gilbert P, 2006, J COGN PSYCHOTHER, V20, P183, DOI 10.1891/jcop.20.2.183; Gilbert P, 2006, CLIN PSYCHOL PSYCHOT, V13, P353, DOI 10.1002/cpp.507; GORDON BF, 1966, J EXP SOC PSYCHOL, V2, P55; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Hayes SC, 2013, BEHAV THER, V44, P180, DOI 10.1016/j.beth.2009.08.002; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jacobs RH, 2008, CLIN PSYCHOL REV, V28, P759, DOI 10.1016/j.cpr.2007.10.006; Jermann F, 2009, PSYCHOL ASSESSMENT, V21, P506, DOI 10.1037/a0017032; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Krieger T, 2013, BEHAV THER, V44, P501, DOI 10.1016/j.beth.2013.04.004; Leary MR, 2007, J PERS SOC PSYCHOL, V92, P887, DOI 10.1037/0022-3514.92.5.887; Linehan MM, 2002, DRUG ALCOHOL DEPEN, V67, P13, DOI 10.1016/S0376-8716(02)00011-X; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Neff K.D., 2015, HDB MINDFULNESS SELF, DOI [https://doi.org/10.1007/978-1-4939-2263-5_10, DOI 10.1007/978-1-4939-2263-5_10]; Neff KD, 2007, J RES PERS, V41, P908, DOI 10.1016/j.jrp.2006.08.002; Neff KD, 2003, SELF IDENTITY, V2, P223, DOI 10.1080/15298860390209035; Neff KD, 2013, J CLIN PSYCHOL, V69, P28, DOI 10.1002/jclp.21923; Neff KD, 2011, SOC PERSONAL PSYCHOL, V5, P1, DOI 10.1111/j.1751-9004.2010.00330.x; Neff KD, 2010, SELF IDENTITY, V9, P225, DOI 10.1080/15298860902979307; Olson K, 2015, J EVID BASED COMPLEM; Schermelleh-Engel K., 2003, METHODS PSYCHOL RES; Sirois FM, 2015, HEALTH PSYCHOL, V34, P661, DOI 10.1037/hea0000158; Thompson BL, 2008, J TRAUMA STRESS, V21, P556, DOI 10.1002/jts.20374; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Werner KH, 2012, ANXIETY STRESS COPIN, V25, P543, DOI 10.1080/10615806.2011.608842; White JB, 2006, J ADULT DEV, V13, P36, DOI 10.1007/s10804-006-9005-0; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0	40	45	50	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152880	10.1371/journal.pone.0152880	http://dx.doi.org/10.1371/journal.pone.0152880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078886	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700012
J	Yilmaz, FM; Kahveci, R; Aksoy, A; Kucuk, EO; Akin, T; Mathew, JL; Meads, C; Zengin, N				Yilmaz, Fatma Meric; Kahveci, Rabia; Aksoy, Altan; Kucuk, Emine Ozer; Akin, Tezcan; Mathew, Joseph Lazar; Meads, Catherine; Zengin, Nurullah			Impact of Laboratory Test Use Strategies in a Turkish Hospital	PLOS ONE			English	Article							TEST-ORDERING BEHAVIOR; EDUCATION-PROGRAM; CARE; MANAGEMENT; INTERVENTION; PHYSICIANS; RESIDENTS; IMPROVE	Objectives Eliminating unnecessary laboratory tests is a good way to reduce costs while maintain patient safety. The aim of this study was to define and process strategies to rationalize laboratory use in Ankara Numune Training and Research Hospital (ANH) and calculate potential savings in costs. Methods A collaborative plan was defined by hospital managers; joint meetings with ANHTA and laboratory professors were set; the joint committee invited relevant staff for input, and a laboratory efficiency committee was created. Literature was reviewed systematically to identify strategies used to improve laboratory efficiency. Strategies that would be applicable in local settings were identified for implementation, processed, and the impact on clinical use and costs assessed for 12 months. Results Laboratory use in ANH differed enormously among clinics. Major use was identified in internal medicine. The mean number of tests per patient was 15.8. Unnecessary testing for chloride, folic acid, free prostate specific antigen, hepatitis and HIV testing were observed. Test panel use was pinpointed as the main cause of overuse of the laboratory and the Hospital Information System test ordering page was reorganized. A significant decrease (between 12.6-85.0%) was observed for the tests that were taken to an alternative page on the computer screen. The one year study saving was equivalent to 371,183 US dollars. Conclusion Hospital-based committees including laboratory professionals and clinicians can define hospital based problems and led to a standardized approach to test use that can help clinicians reduce laboratory costs through appropriate use of laboratory tests.	[Yilmaz, Fatma Meric] Yildirim Bayezid Univ, Dept Biochem, Ankara, Turkey; [Kahveci, Rabia; Kucuk, Emine Ozer] Ankara Numune Training & Res Hosp, Hlth Technol Assessment Unit, Ankara, Turkey; [Aksoy, Altan] Ankara Numune Training & Res Hosp, Dept Microbiol, Ankara, Turkey; [Akin, Tezcan] Ankara Numune Training & Res Hosp, Dept Gen Surg, Ankara, Turkey; [Mathew, Joseph Lazar] Postgrad Inst Med Educ & Res, Adv Pediat Ctr, Chandigarh 160012, India; [Meads, Catherine] Brunel Univ, Hlth Econ Res Grp, Uxbridge UB8 3PH, Middx, England; [Zengin, Nurullah] Ankara Numune Training & Res Hosp, Dept Oncol, Ankara, Turkey	Ankara Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; Ankara Numune Training & Research Hospital; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Brunel University; Ankara Numune Training & Research Hospital	Yilmaz, FM (corresponding author), Yildirim Bayezid Univ, Dept Biochem, Ankara, Turkey.	fatmamericyilmaz@hotmail.com	akın, tezcan/HHS-5457-2022; kucuk, emine ozer/AAC-3873-2019	Meads, Catherine/0000-0002-2368-0665; Akin, Tezcan/0000-0001-8786-6269				Aguilar I, 2011, ARCH INTERN MED, V171, P1385, DOI 10.1001/archinternmed.2011.231; [Anonymous], 2013, CLIN EVIDENCE; Ashton CM, 1999, NEW ENGL J MED, V340, P32, DOI 10.1056/NEJM199901073400106; Astion ML, 2005, LAB ERRORS PATIENT S, V2, P5; Becich M J, 2000, Clin Leadersh Manag Rev, V14, P296; BENSON ES, 1980, HUM PATHOL, V11, P440, DOI 10.1016/S0046-8177(80)80052-9; BILLI JE, 1987, J GEN INTERN MED, V2, P306, DOI 10.1007/BF02596163; Calderon-Margalit R, 2005, INT J QUAL HEALTH C, V17, P243, DOI 10.1093/intqhc/mzi025; Canadian Agency for Drugs and Technologies in Health, 2010, HLTH TECHN INQ SERV; DANIELS M, 1977, MED CARE, V15, P482, DOI 10.1097/00005650-197706000-00004; DOWLING PT, 1989, ACAD MED, V64, P410, DOI 10.1097/00001888-198907000-00017; DuBose Jr TD, 2008, BRENNER RECTORS KIDN; FERRARO MJ, 1986, DIAGN MICR INFEC DIS, V4, pS135, DOI 10.1016/S0732-8893(86)80051-7; Holladay EB, 2012, CRITICAL VALUES, V5, P3; Institut national d'excellence en sante et en services (INESSS), 2013, PORTR STRAT IMPL OPT; Kim JY, 2011, AM J CLIN PATHOL, V135, P108, DOI 10.1309/AJCP4GS7KSBDBACF; Kumwilaisak K, 2008, CRIT CARE MED, V36, P2993, DOI 10.1097/CCM.0b013e31818b3a9d; LEELEWANDROWSKI E, 1994, AM J MED, V97, P222, DOI 10.1016/0002-9343(94)90004-3; Levick DL, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-43; MARTIN AR, 1980, NEW ENGL J MED, V303, P1330, DOI 10.1056/NEJM198012043032304; Neilson EG, 2004, ANN INTERN MED, V141, P196, DOI 10.7326/0003-4819-141-3-200408030-00008; Powell EC, 2003, ARCH PEDIAT ADOL MED, V157, P978, DOI 10.1001/archpedi.157.10.978; ROBINSON A, 1994, CLIN MICROBIOL REV, V7, P185, DOI 10.1128/CMR.7.2.185-199.1994; SMITH ADS, 1982, ANN CLIN BIOCHEM, V19, P325, DOI 10.1177/000456328201900501; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153693	10.1371/journal.pone.0153693	http://dx.doi.org/10.1371/journal.pone.0153693			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077653	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000374131700104
J	Zhang, NN; Liu, HJ; Yue, GJ; Zhang, Y; You, JF; Wang, H				Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua			Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing	PLOS ONE			English	Article							CELL LUNG-CANCER; PEUTZ-JEGHERS-SYNDROME; SOMATIC MUTATIONS; GROWTH-FACTOR; TUMOR; GENE; EXPRESSION; CHEMOTHERAPY; FAMILY; BONE	Ewing sarcoma (ES) is the second most common malignant bone and soft tissue tumor in children and adolescents. Despite advances in comprehensive treatment, patients with ES metastases still suffer poor outcomes, thus, emphasizing the need for detailed genetic profiles of ES patients to identify suitable molecular biomarkers for improved prognosis and development of effective and targeted therapies. In this study, the next generation sequencing Ion AmpliSeq (TM) Cancer Hotspot Panel v2 was used to identify cancer-related gene mutations in the tissue samples from 20 ES patients. This platform targeted 207 amplicons of 2800 loci in 50 cancer-related genes. Among the 20 tissue specimens, 62 nonsynonymous hotspot mutations were identified in 26 cancer-related genes, revealing the molecular heterogeneity of ES. Among these, five novel mutations in cancer-related genes (KDR, STK11, MLH1, KRAS, and PTPN11) were detected in ES, and these mutations were confirmed with traditional Sanger sequencing. ES patients with KDR, STK11, and MLH1 mutations had higher Ki-67 proliferation indices than the ES patients lacking such mutations. Notably, more than half of the ES patients harbored one or two possible 'druggable' mutations that have been previously linked to a clinical cancer treatment option. Our results provided the foundation to not only elucidate possible mechanisms involved in ES pathogenesis but also indicated the utility of Ion Torrent sequencing as a sensitive and cost-effective tool to screen key oncogenes and tumor suppressors in order to develop personalized therapy for ES patients.	[Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China; [Zhang, Nana; Liu, Haijing; Yue, Guanjun; Zhang, Yan; You, Jiangfeng; Wang, Hua] Peking Univ, Hosp 3, Dept Pathol, Beijing 100871, Peoples R China	Peking University; Peking University	Wang, H (corresponding author), Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Pathol, Beijing 100871, Peoples R China.; Wang, H (corresponding author), Peking Univ, Hosp 3, Dept Pathol, Beijing 100871, Peoples R China.	huawanghw@163.com			National Natural Science Foundation of China [81272945]; Beijing Natural Science Foundation of China [7122100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation of China(Beijing Natural Science Foundation)	This work was supported by the National Natural Science Foundation of China (Grant No. 81272945) and the Beijing Natural Science Foundation of China (Grant No. 7122100). Hua Wang, as a project leader of the above grand, was responsible for the study design, decision to publish and manuscript revise. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ab Mutalib Nurul-Syakima, 2014, BMC Res Notes, V7, P805, DOI 10.1186/1756-0500-7-805; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Atak ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038463; Bacci G, 2002, EUR J CANCER, V38, P2243, DOI 10.1016/S0959-8049(02)00148-X; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Brohl AS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004475; Chen H, 2010, EJSO-EUR J SURG ONC, V36, P657, DOI 10.1016/j.ejso.2010.05.014; Chernoguz A, 2012, J SURG RES, V173, P1, DOI 10.1016/j.jss.2011.04.041; Di Nicolantonio F, 2010, J CLIN INVEST, V120, P2858, DOI 10.1172/JCI37539; Dong GL, 2012, CANCER SCI, V103, P561, DOI 10.1111/j.1349-7006.2011.02194.x; Dong SM, 1998, CANCER RES, V58, P3787; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Forcet C, 2005, HUM MOL GENET, V14, P1283, DOI 10.1093/hmg/ddi139; Furcht CM, 2013, ONCOGENE, V32, P2346, DOI 10.1038/onc.2012.240; Gao Y, 2015, MOL NEUROBIOLOGY; Glubb DM, 2011, CLIN CANCER RES, V17, P5257, DOI 10.1158/1078-0432.CCR-11-0379; Hadd AG, 2013, J MOL DIAGN, V15, P234, DOI 10.1016/j.jmoldx.2012.11.006; Haluska P, 2008, MOL CANCER THER, V7, P2589, DOI 10.1158/1535-7163.MCT-08-0493; Herrero-Martin David, 2011, Sarcoma, V2011, P352580, DOI 10.1155/2011/352580; Hezel AF, 2008, ONCOGENE, V27, P6908, DOI 10.1038/onc.2008.342; Hu ZQ, 2014, ONCOL REP, V32, P205, DOI 10.3892/or.2014.3201; Huang HY, 2005, J CLIN ONCOL, V23, P548, DOI 10.1200/JCO.2005.02.081; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Jiang J, 2013, WORLD J GASTROENTERO, V19, P575, DOI 10.3748/wjg.v19.i4.575; Kanagal-Shamanna R, 2014, MODERN PATHOL, V27, P314, DOI 10.1038/modpathol.2013.122; Kastritis E, 2009, INT J CANCER, V124, P103, DOI 10.1002/ijc.23917; Kim YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099451; Kolb EA, 2003, J CLIN ONCOL, V21, P3423, DOI 10.1200/JCO.2003.10.033; KOVAR H, 1993, ONCOGENE, V8, P2683; Kreuter M, 2006, EUR J CANCER, V42, P1904, DOI 10.1016/j.ejca.2006.01.063; Kushner BH, 2001, J CLIN ONCOL, V19, P870, DOI 10.1200/JCO.2001.19.3.870; Lee SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090459; Lee YC, 2015, MOL CLIN ONCOL, V3, P1375, DOI 10.3892/mco.2015.642; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Loman NJ, 2012, NAT BIOTECHNOL, V30, P434, DOI 10.1038/nbt.2198; Ordonez JL, 2009, CANCER RES, V69, P7140, DOI 10.1158/0008-5472.CAN-08-4041; Murray S, 2006, LUNG CANCER, V52, P225, DOI 10.1016/j.lungcan.2005.12.015; Naing A, 2012, CLIN CANCER RES, V18, P2625, DOI 10.1158/1078-0432.CCR-12-0061; Nathke I, 2004, J CELL SCI, V117, P4873, DOI 10.1242/jcs.01313; Ohsawa T, 2009, MOL MED REP, V2, P887, DOI 10.3892/mmr_00000187; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Ross Keir A, 2013, ISRN Oncol, V2013, P759725, DOI 10.1155/2013/759725; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Sand LGL, 2015, INT J MOL SCI, V16, P16176, DOI 10.3390/ijms160716176; Su GH, 1999, AM J PATHOL, V154, P1835, DOI 10.1016/S0002-9440(10)65440-5; Subbiah V, 2009, CURR TREAT OPTION ON, V10, P126, DOI 10.1007/s11864-009-0104-6; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Takyar S, 2016, ANTICANCER DRUGS; Terrier P, 1996, SEMIN DIAGN PATHOL, V13, P250; Whitehall VLJ, 2014, EPIGENETICS-US, V9, P1454, DOI 10.4161/15592294.2014.971624; Xu RF, 2011, BIOMED PHARMACOTHER, V65, P22, DOI 10.1016/j.biopha.2010.06.009; Yang F, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004147; Zhang J, 2011, DISCRETE DYN NAT SOC, V2011, DOI [10.1155/2011/958381, 10.1093/database/bar026]	54	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153546	10.1371/journal.pone.0153546	http://dx.doi.org/10.1371/journal.pone.0153546			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077911	gold, Green Published			2022-12-27	WOS:000374131700076
J	Zhang, Y; Xu, C; Zheng, H; Loh, HH; Law, PY				Zhang, Yue; Xu, Chi; Zheng, Hui; Loh, Horace H.; Law, Ping-Yee			Morphine Modulates Adult Neurogenesis and Contextual Memory by Impeding the Maturation of Neural Progenitors	PLOS ONE			English	Article							HIPPOCAMPAL NEUROGENESIS; CELL-PROLIFERATION; PLACE PREFERENCE; DENTATE GYRUS; GRANULE CELLS; NEURONS; SURVIVAL; COCAINE; EXPRESSION; MARKER	The regulation of adult neurogenesis by opiates has been implicated in modulating different addiction cycles. At which neurogenesis stage opiates exert their action remains unresolved. We attempt to define the temporal window of morphine's inhibition effect on adult neurogenesis by using the POMC-EGFP mouse model, in which newborn granular cells (GCs) can be visualized between days 3-28 post-mitotic. The POMC-EGFP mice were trained under the 3-chambers conditioned place preference (CPP) paradigm with either saline or morphine. We observed after 4 days of CPP training with saline, the number of EGFP-labeled newborn GCs in sub-granular zone (SGZ) hippocampus significantly increased compared to mice injected with saline in their homecage. CPP training with morphine significantly decreased the number of EGFP-labeled GCs, whereas no significant difference in the number of EGFP-labeled GCs was observed with the homecage mice injected with the same dose of morphine. Using cell-type selective markers, we observed that morphine reduced the number of late stage progenitors and immature neurons such as Doublecortin (DCX) and beta III Tubulin (TuJ1) positive cells in the SGZ but did not reduce the number of early progenitors such as Nestin, SOX2, or neurogenic differentiation-1 (NeuroD1) positive cells. Analysis of co-localization between different cell markers shows that morphine reduced the number of adult-born GCs by interfering with differentiation of early progenitors, but not by inducing apoptosis. In addition, when NeuroD1 was over-expressed in DG by stereotaxic injection of lentivirus, it rescued the loss of immature neurons and prolonged the extinction of morphine-trained CPP. These results suggest that under the condition of CPP training paradigm, morphine affects the transition of neural progenitor/stem cells to immature neurons via a mechanism involving NeuroD1.	[Zhang, Yue; Xu, Chi; Zheng, Hui; Loh, Horace H.; Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA; [Zheng, Hui] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China	University of Minnesota System; University of Minnesota Twin Cities; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Zhang, Y (corresponding author), Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	zhan0975@umn.edu	Zhang, Yue/AAC-7170-2021; Xu, Chi/N-5249-2014	Xu, Chi/0000-0001-5470-7376; Zhang, Yue/0000-0003-2128-8472	National Institutes of Health, National Institute of Drug Abuse [DA031442-02]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA031442] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health, National Institute of Drug Abuse (Grant DA031442-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello AA, 2008, NEUROSCIENCE, V157, P70, DOI 10.1016/j.neuroscience.2008.08.064; Arguello AA, 2009, NEUROSCIENCE, V159, P1003, DOI 10.1016/j.neuroscience.2009.01.020; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Chae JH, 2004, MOL CELLS, V18, P271; Cunningham CL, 2006, BEHAV NEUROSCI, V120, P1115, DOI 10.1037/0735-7044.120.5.1115; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fischer SJ, 2008, NEUROSCIENCE, V151, P1217, DOI 10.1016/j.neuroscience.2007.11.035; Gao ZL, 2009, NAT NEUROSCI, V12, P1090, DOI 10.1038/nn.2385; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Harburg GC, 2007, NEUROSCIENCE, V144, P77, DOI 10.1016/j.neuroscience.2006.09.018; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Hicks MP, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/283829; Hodge RD, 2008, J NEUROSCI, V28, P3707, DOI 10.1523/JNEUROSCI.4280-07.2008; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kobilo T, 2011, LEARN MEMORY, V18, P605, DOI 10.1101/lm.2283011; Lai KO, 2009, CURR OPIN NEUROBIOL, V19, P275, DOI 10.1016/j.conb.2009.04.009; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Liu M, 2000, P NATL ACAD SCI USA, V97, P865, DOI 10.1073/pnas.97.2.865; Miyachi T, 1999, MOL BRAIN RES, V69, P223, DOI 10.1016/S0169-328X(99)00112-6; Mustroph ML, 2011, EUR J NEUROSCI, V34, P1161, DOI 10.1111/j.1460-9568.2011.07828.x; Noonan MA, 2008, J NEUROSCI, V28, P2516, DOI 10.1523/JNEUROSCI.4661-07.2008; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Nugent FS, 2007, NATURE, V446, P1086, DOI 10.1038/nature05726; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Preston KL, 2011, PSYCHOPHARMACOLOGY, V218, P29, DOI 10.1007/s00213-011-2183-x; Recinto P, 2012, NEUROPSYCHOPHARMACOL, V37, P1275, DOI 10.1038/npp.2011.315; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Sastry L, 2002, GENE THER, V9, P1155, DOI 10.1038/sj.gt.3301731; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539; Seo S, 2007, EMBO J, V26, P5093, DOI 10.1038/sj.emboj.7601923; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sommer L, 2002, PROG NEUROBIOL, V66, P1, DOI 10.1016/S0301-0082(01)00022-3; Teuchert-Noodt G, 2000, J NEURAL TRANSM, V107, P133, DOI 10.1007/s007020050012; van Hooijdonk LWA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-2; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Willner D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103043; Xu C., 2014, SPRINGER BRIEFS COMP, P1; Xu C, 2014, STEM CELLS, V32, P2961, DOI 10.1002/stem.1774; Yang G, 2009, NATURE, V462, P920, DOI 10.1038/nature08577; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng H, 2013, NEUROPSYCHOPHARMACOL, V38, P770, DOI 10.1038/npp.2012.242; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010	50	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153628	10.1371/journal.pone.0153628	http://dx.doi.org/10.1371/journal.pone.0153628			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078155	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700098
J	James, P; Sadler, K; Wondafrash, M; Argaw, A; Luo, HQ; Geleta, B; Kedir, K; Getnet, Y; Belachew, T; Bahwere, P				James, Philip; Sadler, Kate; Wondafrash, Mekitie; Argaw, Alemayehu; Luo, Hanqi; Geleta, Benti; Kedir, Kiya; Getnet, Yilak; Belachew, Tefera; Bahwere, Paluku			Children with Moderate Acute Malnutrition with No Access to Supplementary Feeding Programmes Experience High Rates of Deterioration and No Improvement: Results from a Prospective Cohort Study in Rural Ethiopia	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; MANAGEMENT; HEALTH; UNDERNUTRITION; GROWTH; ISSUES; BLEND	Background Children with moderate acute malnutrition (MAM) have an increased risk of mortality, infections and impaired physical and cognitive development compared to well-nourished children. In parts of Ethiopia not considered chronically food insecure there are no supplementary feeding programmes (SFPs) for treating MAM. The short-term outcomes of children who have MAM in such areas are not currently described, and there remains an urgent need for evidence-based policy recommendations. Methods We defined MAM as mid-upper arm circumference (MUAC) of >= 11.0cm and < 12.5cm with no bilateral pitting oedema to include Ethiopian government and World Health Organisation cut-offs. We prospectively surveyed 884 children aged 6-59 months living with MAM in a rural area of Ethiopia not eligible for a supplementary feeding programme. Weekly home visits were made for seven months (28 weeks), covering the end of peak malnutrition through to the post-harvest period (the most food secure window), collecting anthropometric, socio-demographic and food security data. Results By the end of the study follow up, 32.5% (287/884) remained with MAM, 9.3% (82/884) experienced at least one episode of SAM (MUAC < 11cm and/or bilateral pitting oedema), and 0.9% (8/884) died. Only 54.2% of the children recovered with no episode of SAM by the end of the study. Of those who developed SAM half still had MAM at the end of the follow up period. The median (interquartile range) time to recovery was 9 (4-15) weeks. Children with the lowest MUAC at enrolment had a significantly higher risk of remaining with MAM and a lower chance of recovering. Conclusions Children with MAM during the post-harvest season in an area not eligible for SFP experience an extremely high incidence of SAM and a low recovery rate. Not having a targeted nutrition-specific intervention to address MAM in this context places children with MAM at excessive risk of adverse outcomes. Further preventive and curative approaches should urgently be considered.	[James, Philip; Sadler, Kate; Luo, Hanqi; Bahwere, Paluku] Valid Int, Oxford, England; [Wondafrash, Mekitie; Argaw, Alemayehu; Belachew, Tefera] Jimma Univ, Populat & Family Hlth Dept, Coll Publ Hlth & Med Sci, Jimma, Ethiopia; [Wondafrash, Mekitie; Argaw, Alemayehu] Univ Ghent, Dept Food Safety & Food Qual, Fac Biosci Engn, B-9000 Ghent, Belgium; [Geleta, Benti; Kedir, Kiya; Getnet, Yilak] Save Children Int, Addis Ababa, Ethiopia; [Bahwere, Paluku] Free Univ Brussels, Res Ctr Epidemiol Biostat & Clin Res, Sch Publ Hlth, Brussels, Belgium	Jimma University; Ghent University; Save the Children; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Bahwere, P (corresponding author), Valid Int, Oxford, England.; Bahwere, P (corresponding author), Free Univ Brussels, Res Ctr Epidemiol Biostat & Clin Res, Sch Publ Hlth, Brussels, Belgium.	paluku@validinternational.org	Belachew, Tefera/AAO-5877-2020; Luo, Hanqi/AAZ-9394-2020; James, Philip/AAG-4618-2020	Luo, Hanqi/0000-0001-6253-5818; James, Philip/0000-0001-5448-8193; Buli, Benti Geleta/0000-0003-1315-9603; Argaw, Alemayehu/0000-0003-3982-5408; Wondafrash, Mekitie/0000-0002-8320-6244	U.S. Agency for International Development (USAID), Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE) [AID-663-A-11-00017]	U.S. Agency for International Development (USAID), Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE)(United States Agency for International Development (USAID))	The research was funded by the U.S. Agency for International Development (USAID) under Cooperative Agreement No. AID-663-A-11-00017, Empowering New Generations to Improve Nutrition and Economic opportunities (ENGINE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P. D., 1995, SURVIVAL ANAL USING; Annan R., 2015, MANAGEMENT MODERATE; Arimond M, 2003, GENERATING INDICATOR; Ashworth A, 2009, FOOD NUTR BULL, V30, pS405, DOI 10.1177/15648265090303S304; Bahwere P., 2012, Journal of Public Health and Epidemiology, V4, P215; BECKER S, 1986, ECOL FOOD NUTR, V18, P251, DOI 10.1080/03670244.1986.9990930; Berhane Y, 2001, SOC SCI MED, V53, P1525, DOI 10.1016/S0277-9536(00)00441-X; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Black RE, 2013, LANCET, V382, P1551, DOI 10.1016/S0140-6736(13)62320-X; Briend A, 2006, FOOD NUTR BULL, V27, pS3, DOI 10.1177/15648265060273S301; Briend A, 2015, FOOD NUTR BULL, V36, pS15, DOI 10.1177/15648265150361S103; Briend A, 2009, FOOD NUTR BULL, V30, pS265, DOI 10.1177/15648265090303S301; Central Statistical Agency,, 2012, ETH DEM HLTH SURV 20; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; Dale NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055404; de Pee S, 2015, FOOD NUTR BULL, V36, pS24, DOI 10.1177/15648265150361S104; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Egata G, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-91; Emergency Nutrition Coordination Unit, 2012, GUID MAN MOD AC MALN; Forsen E, 2015, MATERN CHILD NUTR, V11, P962, DOI 10.1111/mcn.12076; Gebremariam A, 2005, East Afr Med J, V82, P554; Getahun Z, 2011, ETHIOP J HEALTH DEV, V15, P55; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Global Nutrition Cluster MAM Task Force, 2014, MOD AC MALN DEC TOOL; Golden MH, 2009, FOOD NUTR BULL, V30, pS267, DOI 10.1177/15648265090303S302; Goossens S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049320; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Guevarra E., 2014, Field Exchange - Emergency Nutrition Network ENN, P60; Haidar J, 1999, S AFR MED J, V89, P181; Humphrey JH, 2009, LANCET, V374, P1032, DOI 10.1016/S0140-6736(09)60950-8; Hyder Adnan A, 2005, Afr Health Sci, V5, P328; Ibnouf O.F., 2009, J INT WOMENS STUDIES, V10, P144; Karakochuk C, 2012, AM J CLIN NUTR, V96, P911, DOI 10.3945/ajcn.111.029744; Kebebew Z., 2011, RES J APPL SCI, V6, P38; Kennedy E, 2015, FOOD NUTR BULL, V36, pS9, DOI 10.1177/15648265150361S102; LaGrone LN, 2012, AM J CLIN NUTR, V95, P212, DOI 10.3945/ajcn.111.022525; Langendorf C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001714; Lauritsen JM, 2003, EPIDATA ENTRY COMPRE; Lazzerini M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009584.pub2; Lenters LM, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S23; Leroy J, 2011, ZSCORE06 STATA COMMA; LOHMAN TJ, 1992, MEDICINE SCIENCE IN, V24, P1; Mason JB, 2012, INT J ENV RES PUB HE, V9, P791, DOI 10.3390/ijerph9030791; Matilsky DK, 2009, J NUTR, V139, P773, DOI 10.3945/jn.108.104018; Maust A, 2015, J NUTR, V145, P2604, DOI 10.3945/jn.115.214957; Mucha N., 2014, PREVENTING MODERATE; Myatt M, 2000, RAPID ASSESSMENT MET; Myatt M, 2010, NOTES REGARDING MUAC; Nackers F, 2010, J TROP PEDIATRICS, V56, P407, DOI 10.1093/tropej/fmq019; Navarro-Colorado C, 2008, 63 OV DEV I HUM PRAC; Nikiema L, 2014, AM J CLIN NUTR, V100, P241, DOI 10.3945/ajcn.113.072538; Odunayo SI, 2006, ASIA PAC J CLIN NUTR, V15, P491; Puett C, 2013, HEALTH POLICY PLANN, V28, P386, DOI 10.1093/heapol/czs070; Puett C, 2013, MATERN CHILD NUTR, V9, P130, DOI 10.1111/j.1740-8709.2012.00409.x; Richard SA, 2012, J NUTR, V142, P1291, DOI 10.3945/jn.111.154922; Roberfroid D, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0074-4; Roy SK, 2005, J HEALTH POPUL NUTR, V23, P320; Skau J., 2009, OUTCOME EVALUATION S; StataCorp, 2013, STATA STAT SOFTW REL; Stevens B, 2015, MATERN CHILD NUTR, V11, P415, DOI 10.1111/mcn.12183; Teshome B, 2009, ETHIOP J HEALTH DEV, V23, P98; The Sphere Project, 2011, HUM CHART MIN STAND; United Nations Children Fund (UNICEF), 2007, WAT ENV SAN CHILDR W; Vittinghoff E, 2011, REGRESSION METHODS B; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Webb P, 2015, FOOD NUTR BULL, V36, pS65, DOI 10.1177/15648265150361S111; WHO, 2013, GUID UPD MAN SEV AC; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2012, TECHN NOT SUPPL FOOD; Zotor FB, 2008, P NUTR SOC, V67, P98, DOI 10.1017/S0029665108006071	71	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153530	10.1371/journal.pone.0153530	http://dx.doi.org/10.1371/journal.pone.0153530			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100177	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000374898500039
J	Liao, YL; Zhang, Y; He, L; Wang, JF; Liu, X; Zhang, NX; Xu, B				Liao, Yilan; Zhang, Yan; He, Lei; Wang, Jinfeng; Liu, Xin; Zhang, Ningxu; Xu, Bing			Temporal and Spatial Analysis of Neural Tube Defects and Detection of Geographical Factors in Shanxi Province, China	PLOS ONE			English	Article							HIGH PREVALENCE; TRACE-ELEMENTS; FOLIC-ACID; RISK; AREA; POPULATION; EXPOSURE; RATES; SOIL	Background Neural tube defects (NTDs) are congenital birth defects that occur in the central nervous system, and they have the highest incidence among all birth defects. Shanxi Province in China has the world's highest rate of NTDs. Since the 1990s, China's government has worked on many birth defect prevention programs to reduce the occurrence of NTDs, such as pregnancy planning, health education, genetic counseling, antenatal ultrasonography and serological screening. However, the rate of NTDs in Shanxi Province is still higher than the world's average morbidity rate after intervention. In addition, Shanxi Province has abundant coal reserves, and is the largest coal production province in China. The objectives of this study are to determine the temporal and spatial variation of the NTD rate in rural areas of Shanxi Province, China, and identify geographical environmental factors that were associated with NTDs in the risk area. Methods In this study, Heshun County and Yuanping County in Shanxi Province, which have high incidence of NTDs, were selected as the study areas. Two paired sample T test was used to analyze the changes in the risk of NTDs from the time dimension. Ripley's k function and spatial filtering were combined with geographic information system (GIS) software to study the changes in the risk of NTDs from the spatial dimension. In addition, geographical detectors were used to identify the risk geographical environmental factors of NTDs in the study areas, especially the areas close to the coal sites and main roads. Results In both Heshun County and Yuanping County, the incidence of NTDs was significantly (P<0.05) reduced after intervention. The results from spatial analysis showed that significant spatial heterogeneity existed in both counties. NTD clusters were still identified in areas close to coal sites and main roads after interventions. This study also revealed that the elevation, fault and soil types always had a larger influence on the incidence of NTDs in our study areas. In addition, distance to the river was a risk factor of NTDs in areas close to the coal sites and main roads. Conclusion The existing interventions may have played an important role to reduce the incidence of NTDs. However, there is still spatial heterogeneity in both counties after using the traditional intervention methods. The government needs to take more measures to strengthen the environmental restoration to prevent the occurrence of NTDs, especially those areas close to coal sites and main roads. The outcome of this research provides an important theoretical basis and technical support for the government to prevent the occurrence of NTDs.	[Liao, Yilan; Wang, Jinfeng; Zhang, Ningxu] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China; [Liao, Yilan; Wang, Jinfeng; Zhang, Ningxu] Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China; [Zhang, Yan] Henan Acad Agr Sci, Inst Agr Econ & Informat, Zhengzhou 450002, Peoples R China; [He, Lei] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Liu, Xin] Curtin Univ, Dept Spatial Sci, Bentley, WA 6845, Australia; [Xu, Bing] Changan Univ, Xian 710054, Peoples R China; [Xu, Bing] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Center for Disease Control & Prevention; Henan Academy of Agricultural Sciences; University of California System; University of California Berkeley; Curtin University; Chang'an University	Liao, YL; Wang, JF (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, State Key Lab Resources & Environm Informat Syst, Beijing 100101, Peoples R China.; Liao, YL; Wang, JF (corresponding author), Chinese Ctr Dis Control & Prevent, Key Lab Surveillance & Early Warning Infect Dis, Beijing 102206, Peoples R China.	liaoyl@lreis.ac.cn; wangjf@lreis.ac.cn	Liu, Xin/AGH-0829-2022	Liu, Xin/0000-0003-4513-3395; Wang, Jinfeng/0000-0002-6687-9420	National Natural Science Foundation of China [41471377, 41101431]; Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS [2012RC201]; Youth Innovation Promotion Association of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS; Youth Innovation Promotion Association of the Chinese Academy of Sciences	This study was supported by the National Natural Science Foundation of China, http://www.nsfc.gov.cn/publish/portal1/ (Nos. 41471377, 41101431), and the Young Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS, http://english.igsnrr.cas.cn/ (2012RC201).; This study was supported by the National Natural Science Foundation of China http://www.nsfc.gov.cn/publish/portal1/ (Nos. 41471377, 41101431), and the Yong Talent Fund of the Institute of Geographic Sciences and Natural Resources Research, CAS http://english.igsnrr.cas.cn/ (2012RC201). We would like to thank all the staff enrolled in this study for their excellent cooperation. We also thank the Youth Innovation Promotion Association of the Chinese Academy of Sciences for their support.	An HX, 2010, J SHANXI MED U, V41, P1090; Araneta MRG, 2000, TERATOLOGY, V62, P195, DOI 10.1002/1096-9926(200010)62:4<195::AID-TERA5>3.0.CO;2-5; Box J. F., 1987, STAT SCI, V2, P45, DOI [10.1214/ss/1177013437, DOI 10.1214/SS/1177013437]; Brender JD, 2006, ENVIRON RES, V101, P132, DOI 10.1016/j.envres.2005.08.003; Castilla EE, 1999, AM J MED GENET, V86, P9, DOI 10.1002/(SICI)1096-8628(19990903)86:1<9::AID-AJMG3>3.0.CO;2-X; Dai Li, 2002, Zhonghua Yufang Yixue Zazhi, V36, P402; Durbeck H, 2002, CLUSTERSEER SOFTWARE; Frey L, 2003, EPILEPSIA, V44, P4, DOI 10.1046/j.1528-1157.44.s3.2.x; Gu X, 2007, BIRTH DEFECTS RES A, V79, P702, DOI 10.1002/bdra.20397; Hu Y, 2011, PLOS ONE, V6, P214; Huang J, 2011, BIOMED ENVIRON SCI, V24, P94, DOI 10.3967/0895-3988.2011.02.002; Kafadar K, 1996, STAT MED, V15, P2539, DOI 10.1002/(SICI)1097-0258(19961215)15:23<2539::AID-SIM379>3.0.CO;2-B; Li XinHu, 2007, Research of Environmental Sciences, V20, P21; Li Xinhu, 2006, Toxicological and Environmental Chemistry, V88, P551, DOI 10.1080/00222930600803282; Li ZW, 2011, AM J EPIDEMIOL, V174, P451, DOI 10.1093/aje/kwr108; Li ZW, 2006, BIRTH DEFECTS RES A, V76, P237, DOI 10.1002/bdra.20248; Liao YL, 2010, INT J ENVIRON HEAL R, V20, P439, DOI 10.1080/09603123.2010.491854; Liao YL, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-391; Liu XX, SHANXI PROVINCE HAD; Milunsky A., 2010, GENETIC DISORDERS FE; Ozdenerol Esra, 2005, Int J Health Geogr, V4, P19, DOI 10.1186/1476-072X-4-19; Ren Y, 2014, LANDSCAPE ECOL; Ren ZP, 2013, STOCH ENV RES RISK A, V27, P1695, DOI 10.1007/s00477-013-0707-0; Rushton G, 1996, STAT MED, V15, P717, DOI 10.1002/(SICI)1097-0258(19960415)15:7/9<717::AID-SIM243>3.0.CO;2-0; Rushton G, 1989, SPATIAL ANAL INFANT; Talbot TO, 2000, STAT MED, V19, P2399, DOI 10.1002/1097-0258(20000915/30)19:17/18<2399::AID-SIM577>3.3.CO;2-I; Wang GH, 2009, WORK PROGRAM FULL IM; Wang JF, 2012, ENVIRON MODELL SOFTW, V33, P114, DOI 10.1016/j.envsoft.2012.01.015; Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457; Wang JF, 2010, INT J GEOGR INF SCI, V24, P523, DOI 10.1080/13658810902873512; Wu JL, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-23; Yi YN, 2011, EUR J PEDIATR, V170, P1391, DOI 10.1007/s00431-011-1492-8; Zhang BG, 2001, SHANXI SCI TECH COMM, V143, P60; Zhang JY, 2004, FUEL, V83, P129, DOI 10.1016/S0016-2361(03)00221-7; Zhang L, 2004, CHIN J REPROD HLTH, V15, P293; Zhang SL, 2012, SHANXI COAL, V32, P41	36	27	32	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0150332	10.1371/journal.pone.0150332	http://dx.doi.org/10.1371/journal.pone.0150332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100082	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500002
J	Farmer, H; Carr, EW; Svartdal, M; Winkielman, P; Hamilton, AFD				Farmer, Harry; Carr, Evan W.; Svartdal, Marita; Winkielman, Piotr; Hamilton, Antonia F. de C.			Status and Power Do Not Modulate Automatic Imitation of Intransitive Hand Movements	PLOS ONE			English	Article							AVOIDANCE MOTOR ACTIONS; INTERPERSONAL POWER; BEHAVIORAL MIMICRY; PREFRONTAL CORTEX; EMOTIONAL MIMICRY; SOCIAL HIERARCHY; EYE CONTACT; MIRROR; PERCEPTION; ATTENTION	The tendency to mimic the behaviour of others is affected by a variety of social factors, and it has been argued that such "mirroring" is often unconsciously deployed as a means of increasing affiliation during interpersonal interactions. However, the relationship between automatic motor imitation and status/power is currently unclear. This paper reports five experiments that investigated whether social status (Experiments 1, 2, and 3) or power (Experiments 4 and 5) had a moderating effect on automatic imitation (AI) in finger-movement tasks, using a series of different manipulations. Experiments 1 and 2 manipulated the social status of the observed person using an associative learning task. Experiment 3 manipulated social status via perceived competence at a simple computer game. Experiment 4 manipulated participants' power (relative to the actors) in a card-choosing task. Finally, Experiment 5 primed participants using a writing task, to induce the sense of being powerful or powerless. No significant interactions were found between congruency and social status/power in any of the studies. Additionally, Bayesian hypothesis testing indicated that the null hypothesis should be favoured over the experimental hypothesis in all five studies. These findings are discussed in terms of their implications for AI tasks, social effects on mimicry, and the hypothesis of mimicry as a strategic mechanism to promote affiliation.	[Farmer, Harry; Svartdal, Marita; Hamilton, Antonia F. de C.] UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England; [Winkielman, Piotr] Univ Calif San Diego, Dept Psychol, 9500 Gilman Dr,0109, La Jolla, CA 92093 USA; [Winkielman, Piotr] Univ Warwick, Warwick Business Sch, Behav Sci Grp, Coventry CV4 7AL, W Midlands, England; [Winkielman, Piotr] SWPS Univ Social Sci & Humanities, Dept Psychol, Ul Chodakowska 19-31, PL-03815 Warsaw, Poland	University of London; University College London; University of California System; University of California San Diego; University of Warwick; SWPS University of Social Sciences & Humanities	Farmer, H (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	h.farmer@ucl.ac.uk	Hamilton, Antonia/AAC-6648-2019; Farmer, Harry/AAA-3603-2020; Winkielman, Piotr/AAT-6275-2020; Hamilton, Antonia/ABC-4196-2021	Hamilton, Antonia/0000-0001-8000-0219; Winkielman, Piotr/0000-0003-2330-1802; 	European Research Council [509573]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council (http://erc.europa.eu/) grant 509573 (CTHN) INTERACT to AH funded experiments 1,2,3 and 4. The author(s) received no specific funding for experiment 5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2006, J RES PERS, V40, P440, DOI 10.1016/j.jrp.2005.03.002; Andreoni J, 2008, J ECON PSYCHOL, V29, P73, DOI 10.1016/j.joep.2007.07.008; Ashton-James CE, 2013, SOC PSYCHOL PERS SCI, V4, P643, DOI 10.1177/1948550613476097; Autodesk, 2013, MOT 14 0; Ball S, 2001, Q J ECON, V116, P161, DOI 10.1162/003355301556374; Belot M, 2013, P NATL ACAD SCI USA, V110, P2763, DOI 10.1073/pnas.1209981110; Bourgeois P, 2008, BIOL PSYCHOL, V77, P343, DOI 10.1016/j.biopsycho.2007.11.008; Brass M, 2000, BRAIN COGNITION, V44, P124, DOI 10.1006/brcg.2000.1225; Brass M, 2001, ACTA PSYCHOL, V106, P3, DOI 10.1016/S0001-6918(00)00024-X; Carli LL, 1999, J SOC ISSUES, V55, P81, DOI 10.1111/0022-4537.00106; Carr EW, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00505; Carr EW, 2014, J EXP PSYCHOL GEN, V143, P997, DOI 10.1037/a0034972; Chartrand TL, 2013, ANNU REV PSYCHOL, V64, P285, DOI 10.1146/annurev-psych-113011-143754; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Cheng CM, 2003, J PERS SOC PSYCHOL, V85, P1170, DOI 10.1037/0022-3514.85.6.1170; Chiao JY, 2010, CURR OPIN NEUROBIOL, V20, P803, DOI 10.1016/j.conb.2010.08.006; Cloutier J, 2013, BIOL PSYCHOL, V92, P301, DOI 10.1016/j.biopsycho.2012.09.006; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cook J, 2011, EXP BRAIN RES, V211, P601, DOI 10.1007/s00221-011-2584-4; Cook JL, 2012, J AUTISM DEV DISORD, V42, P1045, DOI 10.1007/s10803-011-1341-7; Cook JE, 2011, PERS SOC PSYCHOL B, V37, P165, DOI 10.1177/0146167210390389; Cook R, 2012, P ROY SOC B-BIOL SCI, V279, P780, DOI 10.1098/rspb.2011.1024; Cuddy AJC, 2007, J PERS SOC PSYCHOL, V92, P631, DOI 10.1037/0022-3514.92.4.631; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Dalton AN, 2010, J PERS SOC PSYCHOL, V98, P605, DOI 10.1037/a0017629; Dienes Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00781; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Donne CM, 2011, NEUROSCI LETT, V489, P57, DOI 10.1016/j.neulet.2010.11.067; DOOB AN, 1968, J SOC PSYCHOL, V76, P213, DOI 10.1080/00224545.1968.9933615; Eaves DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046728; Fiske ST, 2002, J PERS SOC PSYCHOL, V82, P878, DOI 10.1037//0022-3514.82.6.878; Fiske ST, 1999, J SOC ISSUES, V55, P473, DOI 10.1111/0022-4537.00128; Fiske ST., 1996, EUR REV SOC PSYCHOL, V7, P31, DOI DOI 10.1080/14792779443000094; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Friedman RS, 2002, J EXP SOC PSYCHOL, V38, P41, DOI 10.1006/jesp.2001.1488; Friedman RS, 2000, J PERS SOC PSYCHOL, V79, P477, DOI 10.1037//0022-3514.79.4.477; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Guinote A., 2015, APA HDB PERSONALITY, V1, P547, DOI DOI 10.1037/14341-017; Guinote A, 2008, J PERS SOC PSYCHOL, V95, P237, DOI 10.1037/a0012518; Guinote A, 2007, J EXP SOC PSYCHOL, V43, P685, DOI 10.1016/j.jesp.2006.06.008; HALPERIN K, 1976, J APPL PSYCHOL, V61, P85, DOI 10.1037/0021-9010.61.1.85; Hess U, 2014, SOC PERSONAL PSYCHOL, V8, P45, DOI 10.1111/spc3.12083; Hess U, 2013, PERS SOC PSYCHOL REV, V17, P142, DOI 10.1177/1088868312472607; Heyes C, 2011, PSYCHOL BULL, V137, P463, DOI 10.1037/a0022288; Heyes C, 2010, NEUROSCI BIOBEHAV R, V34, P575, DOI 10.1016/j.neubiorev.2009.11.007; Hogeveen J, 2014, J EXP PSYCHOL GEN, V143, P755, DOI 10.1037/a0033477; Hogeveen J, 2013, EXP BRAIN RES, V224, P613, DOI 10.1007/s00221-012-3339-6; Huang L, 2011, PSYCHOL SCI, V22, P95, DOI 10.1177/0956797610391912; Iacoboni M, 2009, ANNU REV PSYCHOL, V60, P653, DOI 10.1146/annurev.psych.60.110707.163604; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; Kavanagh LC, 2011, PSYCHOL SCI, V22, P1274, DOI 10.1177/0956797611418678; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Keutmann MK, 2015, BEHAV RES METHODS, V47, P228, DOI 10.3758/s13428-014-0464-0; Lakin JL, 2008, PSYCHOL SCI, V19, P816, DOI 10.1111/j.1467-9280.2008.02162.x; Lakin JL, 2003, J NONVERBAL BEHAV, V27, P145, DOI 10.1023/A:1025389814290; Lakin JL, 2003, PSYCHOL SCI, V14, P334, DOI 10.1111/1467-9280.14481; LARSEN KS, 1979, J SOC PSYCHOL, V108, P259, DOI 10.1080/00224545.1979.9711639; LEFFLER A, 1982, SOC PSYCHOL QUART, V45, P153, DOI 10.2307/3033648; Leighton J, 2010, J EXP SOC PSYCHOL, V46, P905, DOI 10.1016/j.jesp.2010.07.001; Leotti LA, 2011, PSYCHOL SCI, V22, P1310, DOI 10.1177/0956797611417005; Liepelt R, 2010, COGNITION, V115, P426, DOI 10.1016/j.cognition.2010.03.003; Liepelt R, 2010, EXP PSYCHOL, V57, P221, DOI 10.1027/1618-3169/a000028; Likowski KU, 2008, J EXP SOC PSYCHOL, V44, P1065, DOI 10.1016/j.jesp.2007.10.007; Longo MR, 2008, J EXP PSYCHOL HUMAN, V34, P489, DOI 10.1037/0096-1523.34.2.489; Longo MR, 2009, EXP BRAIN RES, V192, P739, DOI 10.1007/s00221-008-1649-5; Ly M, 2011, CURR BIOL, V21, P794, DOI 10.1016/j.cub.2011.03.050; MacCann C., 2003, INT J ORG ANAL, V11, P247, DOI DOI 10.1108/EB028975; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Maner JK, 2008, PERS SOC PSYCHOL B, V34, P488, DOI 10.1177/0146167207311910; Marsh AA, 2009, J COGNITIVE NEUROSCI, V21, P713, DOI 10.1162/jocn.2009.21052; Mast MS, 2010, EUR REV SOC PSYCHOL, V21, P1, DOI 10.1080/10463283.2010.486942; Mathworks, 2015, MATL R2015B; McIntosh D.N., 2006, POL PSYCHOL BULL, V37, P31; Microsoft, 2008, VIS STUD 2008; Naef M, 2009, REPORT NO 167; Obhi SS, 2014, J EXP PSYCHOL HUMAN, V40, P920, DOI 10.1037/a0034056; Over H, 2009, DEVELOPMENTAL SCI, V12, pF1, DOI 10.1111/j.1467-7687.2008.00820.x; Pan XN, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00790; Psychology Software Tools Inc, 2012, E PRIM 2 0; Ratcliff NJ, 2012, SOC COGNITION, V30, P631, DOI 10.1521/soco.2012.30.5.631; Ratcliff NJ, 2011, PERS SOC PSYCHOL B, V37, P1003, DOI 10.1177/0146167211407210; Rauchbauer B, 2015, DISTINCT NEURAL PROC; Rouder JN, 2009, PSYCHON B REV, V16, P225, DOI 10.3758/PBR.16.2.225; Rudman LA, 2000, PERS SOC PSYCHOL B, V26, P1315, DOI 10.1177/0146167200263001; Russell AMT, 2008, EUR J SOC PSYCHOL, V38, P1193, DOI 10.1002/ejsp.539; Ruys KI, 2010, J EXP SOC PSYCHOL, V46, P1130, DOI 10.1016/j.jesp.2010.05.016; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Smith PK, 2015, CURR OPIN BEHAV SCI, V3, P152, DOI 10.1016/j.cobeha.2015.04.007; SNYDER M, 1974, J PERS SOC PSYCHOL, V30, P526, DOI 10.1037/h0037039; SPECTOR PE, 1994, J ORGAN BEHAV, V15, P385, DOI 10.1002/job.4030150503; Spengler S, 2010, CONSCIOUS COGN, V19, P98, DOI 10.1016/j.concog.2009.12.014; Stel M, 2010, EXP PSYCHOL, V57, P412, DOI 10.1027/1618-3169/a000050; Sturmer B, 2000, J EXP PSYCHOL HUMAN, V26, P1746, DOI 10.1037//0096-1523.26.6.1746; Tiedens LZ, 2003, J PERS SOC PSYCHOL, V84, P558, DOI 10.1037/0022-3514.84.3.558; Tomasello Michael, 1996, P319, DOI 10.1016/B978-012273965-1/50016-9; Tops M, 2006, PSYCHON B REV, V13, P229, DOI 10.3758/BF03193835; van Baaren R, 2009, PHILOS T R SOC B, V364, P2381, DOI 10.1098/rstb.2009.0057; WANG Y, 2013, PLOS ONE, V2013; Wang Y, 2012, CONTROL MIMICRY SOCI; Wang Y, 2015, SOC COGN AFFECT NEUR, V10, P486, DOI 10.1093/scan/nsu076; Wang Y, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00153; Wang Y, 2011, J NEUROSCI, V31, P12001, DOI 10.1523/JNEUROSCI.0845-11.2011; Wang Y, 2011, BIOL LETTERS, V7, P7, DOI 10.1098/rsbl.2010.0279; Wieser MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102937; Yabar Y, 2006, J NONVERBAL BEHAV, V30, P97, DOI 10.1007/s10919-006-0010-6; Zink CF, 2008, NEURON, V58, P273, DOI 10.1016/j.neuron.2008.01.025	107	10	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151835	10.1371/journal.pone.0151835	http://dx.doi.org/10.1371/journal.pone.0151835			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096167	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000374543600006
J	Foo, J; Landis, SH; Maskell, J; Oh, YM; van der Molen, T; Han, MK; Mannino, DM; Ichinose, M; Punekar, Y				Foo, Jason; Landis, Sarah H.; Maskell, Joe; Oh, Yeon-Mok; van der Molen, Thys; Han, MeiLan K.; Mannino, David M.; Ichinose, Masakazu; Punekar, Yogesh			Continuing to Confront COPD International Patient Survey: Economic Impact of COPD in 12 Countries	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NONCOMMUNICABLE DISEASES; GLOBAL IMPACT; COSTS; BURDEN; PRODUCTIVITY; DISABILITY; LIFE	Background The Continuing to Confront COPD International Patient Survey estimated the prevalence and burden of COPD across 12 countries. Using data from this survey we evaluated the economic impact of COPD. Methods This cross-sectional, population-based survey questioned 4,343 subjects aged 40 years and older, fulfilling a case definition of COPD based on self-reported physician diagnosis or symptomatology. Direct cost measures were based on exacerbations of COPD (treated and those requiring emergency department visits and/or hospitalisation), contacts with healthcare professionals, and COPD medications. Indirect costs were calculated from work loss values using the Work Productivity and Activity Impairment scale. Combined direct and indirect costs estimated the total societal costs per patient. Results The annual direct costs of COPD ranged from $504 (South Korea) to $9,981 (USA), with inpatient hospitalisations (5 countries) and home oxygen therapy (3 countries) being the key drivers of direct costs. The proportion of patients completely prevented from working due to their COPD ranged from 6% (Italy) to 52% (USA and UK) with 8 countries reporting this to be >= 20%. Total societal costs per patient varied widely from $1,721 (Russia) to $30,826 (USA) but a consistent pattern across countries showed greater costs among those with increased burden of COPD (symptoms, health status and more severe disease) and a greater number of comorbidities. Conclusions The economic burden of COPD is considerable across countries, and requires targeted resources to optimise COPD management encompassing the control of symptoms, prevention of exacerbations and effective treatment of comorbidities. Strategies to allow COPD patients to remain in work are important for addressing the substantial wider societal costs.	[Foo, Jason] GlaxoSmithKline, Hlth Outcomes, Uxbridge, Middx, England; [Landis, Sarah H.; Maskell, Joe] GlaxoSmithKline, Real World Evidence, Uxbridge, Middx, England; [Oh, Yeon-Mok] Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea; [van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Han, MeiLan K.] Univ Michigan, Div Pulm & Crit Care, Ann Arbor, MI 48109 USA; [Mannino, David M.] Univ Kentucky, Coll Publ Hlth, Lexington, KY USA; [Ichinose, Masakazu] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Punekar, Yogesh] GlaxoSmithKline, Value Evidence Outcomes, Uxbridge, Middx, England	GlaxoSmithKline; GlaxoSmithKline; University of Ulsan; University of Groningen; University of Michigan System; University of Michigan; University of Kentucky; Tohoku University; GlaxoSmithKline	Punekar, Y (corresponding author), GlaxoSmithKline, Value Evidence Outcomes, Uxbridge, Middx, England.	yogesh.q.punekar@gsk.com		Mannino, David/0000-0003-3646-7828	GlaxoSmithKline; GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	This study was funded in full by GlaxoSmithKline. The survey was conducted by Abt SRBI, a global survey research firm that specializes in health surveys on behalf of GlaxoSmithKline. Authors were not paid for their contribution to the manuscript development. GSK provided support in the form of salaries for authors JF, SHL, JM and YP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agusti AGN, 2005, RESP MED, V99, P670, DOI 10.1016/j.rmed.2004.11.006; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Chaker L, 2015, EUR J EPIDEMIOL, V30, P357, DOI 10.1007/s10654-015-0026-5; Chapman KR, 2006, EUR RESPIR J, V27, P188, DOI 10.1183/09031936.06.00024505; de Miguel-Diez J, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-8; Fletcher MJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-612; Ford ES, 2015, CHEST, V147, P31, DOI 10.1378/chest.14-0972; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kigozi J, 2016, EUR J HEALTH ECON, V17, P31, DOI 10.1007/s10198-014-0652-y; Kim C, 2014, INT J TUBERC LUNG D, V18, P737, DOI 10.5588/ijtld.13.0634; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Landis SH, 2014, INT J CHRONIC OBSTR, V9, P597, DOI 10.2147/COPD.S61854; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Miravitlles M, 2003, CHEST, V123, P784, DOI 10.1378/chest.123.3.784; Muka T, 2015, EUR J EPIDEMIOL, V30, P251, DOI 10.1007/s10654-014-9984-2; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nishimura S, 2004, RESPIROLOGY, V9, P466, DOI 10.1111/j.1440-1843.2004.00617.x; Polatli M, 2012, RESP MED, V106, pS75, DOI 10.1016/S0954-6111(12)70016-1; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Rennard S, 2002, EUR RESPIR J, V20, P799, DOI 10.1183/09031936.02.03242002; Seuring T, 2015, PHARMACOECONOMICS, V33, P811, DOI 10.1007/s40273-015-0268-9; Srivastava K, 2015, PHARMACOECONOMICS, V33, P467, DOI 10.1007/s40273-015-0252-4; World Health Organization, BURD OF COPD; Wouters EFM, 2003, RESP MED, V97, pS3, DOI 10.1016/S0954-6111(03)80020-3	24	77	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0152618	10.1371/journal.pone.0152618	http://dx.doi.org/10.1371/journal.pone.0152618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092775	gold, Green Submitted, Green Published			2022-12-27	WOS:000374541200007
J	Mirmonsef, P; Hotton, AL; Gilbert, D; Gioia, CJ; Maric, D; Hope, TJ; Landay, AL; Spear, GT				Mirmonsef, Paria; Hotton, Anna L.; Gilbert, Douglas; Gioia, Casey J.; Maric, Danijela; Hope, Thomas J.; Landay, Alan L.; Spear, Gregory T.			Glycogen Levels in Undiluted Genital Fluid and Their Relationship to Vaginal pH, Estrogen, and Progesterone	PLOS ONE			English	Article							PEROXIDE-PRODUCING LACTOBACILLI; SIMPLEX-VIRUS TYPE-2; BACTERIAL VAGINOSIS; ACQUISITION; COLONIZATION; TRANSMISSION; FLORA	Background Colonization of the female lower genital tract with Lactobacillus provides protection against STIs and adverse pregnancy outcomes. Growth of genital Lactobacillus is postulated to depend on epithelial cell -produced glycogen. However, the amount of cell -free glycogen in genital fluid available for utilization by Lactobacillus is not known. Methods Eighty-five genital fluid samples from 7 pre -menopausal women taken over 4-6 weeks were obtained using the Instead SoftCupg (EvoFem, Inc., San Diego, CA, USA) by consented donors. Cell -free glycogen and glucose in genital fluids and estrogen and progesterone in blood were quantified. Findings Glycogen ranged from 0.1-32 fag/pl. There were significant differences between women in glycogen over the observation period. There was a strong negative correlation between glycogen and vaginal pH (r = -0.542, p<0.0001). In multivariable analysis, free glycogen levels were significantly negatively associated with both vaginal pH and progesterone (p < 0.001 and p = 0.004, respectively). Estrogen, glucose, age, sexual intercourse 24 hours prior to visit, and days after the initial visit were not significantly associated with free glycogen levels. Conclusion Cell -free glycogen concentrations can be very high, up to 3% of genital fluid, and are strongly associated with acidic vaginal pH. However, the fluctuations in glycogen levels in individuals and differences between individuals do not appear to be associated with estrogen.	[Mirmonsef, Paria; Gilbert, Douglas; Landay, Alan L.; Spear, Gregory T.] Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA; [Hotton, Anna L.] Cook Cty Hlth & Hosp Syst, CORE Ctr, Chicago, IL USA; [Gioia, Casey J.; Maric, Danijela; Hope, Thomas J.] Northwestern Univ, Robert H Lurie Med Res Ctr, Feinberg Sch Med, Chicago, IL 60611 USA	Rush University; John H Stroger Junior Hospital Cook County; Northwestern University; Feinberg School of Medicine	Mirmonsef, P (corresponding author), Rush Univ, Med Ctr, Dept Immunol Microbiol, Chicago, IL 60612 USA.	Paria_Mirmonsef@rush.edu			Bill and Melinda Gates Foundation [OPP1031734]; National Institutes of Health [R33AI094584]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI094584] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by https://www.cavd.org/Pages/default.aspx; Collaboration for AIDS Vaccine Discovery grant from the Bill and Melinda Gates Foundation (OPP1031734) to TJH and http://www.nih.gov/; National Institutes of Health (R33AI094584) to TJH.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Boskey ER, 1999, INFECT IMMUN, V67, P5170, DOI 10.1128/IAI.67.10.5170-5175.1999; Cherpes TL, 2008, SEX TRANSM DIS, V35, P78, DOI 10.1097/OLQ.0b013e318156a5d0; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cruickshank R SA, 1934, J OBSTET GYN BR COMM, V41, P208, DOI DOI 10.1111/J.1471-0528; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hickey RJ, 2015, MBIO, V6, DOI 10.1128/mBio.00097-15; Hild-Petito S, 1998, AIDS RES HUM RETROV, V14, pS125; Krause Megan, 2009, J Pelvic Med Surg, V15, P105; Martin R, 2009, INT MICROBIOL, V11, P261, DOI 10.2436/20.1501.01.70; Marx PA, 1996, NAT MED, V2, P1084, DOI 10.1038/nm1096-1084; Miller L, 2000, OBSTET GYNECOL, V96, P431, DOI 10.1016/S0029-7844(00)00906-6; MIRMONSEF P, 2014, MENOPAUSE, V22, P1, DOI DOI 10.1097/GME.0000000000000397; Mirmonsef P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102467; Mirmonsef P, 2014, AM J REPROD IMMUNOL, V71, P531, DOI 10.1111/aji.12232; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Patton DL, 2000, AM J OBSTET GYNECOL, V183, P967, DOI 10.1067/mob.2000.108857; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Spear GT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132646; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; STEWARTT.DE, 1964, AM J OBSTET GYNECOL, V88, P676, DOI 10.1016/0002-9378(64)90898-1; Vallor AC, 2001, J INFECT DIS, V184, P1431, DOI 10.1086/324445; Wiesenfeld HC, 2003, CLIN INFECT DIS, V36, P663, DOI 10.1086/367658; WYLIE JG, 1969, J MED MICROBIOL, V2, P363, DOI 10.1099/00222615-2-3-363; Zendjabil M CZ, 2016, ANN ENDOCRINOL PARIS, V77	27	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153553	10.1371/journal.pone.0153553	http://dx.doi.org/10.1371/journal.pone.0153553			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093050	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200029
J	Singh, K; Samant, MA; Tom, MT; Prasad, NG				Singh, Karan; Samant, Manas Arun; Tom, Megha Treesa; Prasad, Nagaraj Guru			Evolution of Pre- and Post-Copulatory Traits in Male Drosophila melanogaster as a Correlated Response to Selection for Resistance to Cold Stress	PLOS ONE			English	Article							HEAT-STRESS; MATING SUCCESS; MALE SIZE; SPERM; TEMPERATURES; POPULATIONS; BEHAVIOR; HISTORY; REPRODUCTION; SPERMATOZOA	Background In Drosophila melanogaster the fitness of males depends on a broad array of reproductive traits classified as pre- and post-copulatory traits. Exposure to cold stress, can reduce sperm number, male mating ability and courtship behavior. Therefore, it is expected that the adaptation to cold stress will involve changes in pre- and post -copulatory traits. Such evolution of reproductive traits in response to cold stress is not well studied. Methods We selected replicate populations of D. melanogaster for resistance to cold shock. Over 37-46 generations of selection, we investigated pre- and post -copulatory traits such as mating latency, copulation duration, mating frequency, male fertility, fitness (progeny production) and sperm competitive ability in male flies subjected to cold shock and those not subjected to cold shock. Results We found that post cold shock, the males from the selected populations had a significantly lower mating latency along with, higher mating frequency, fertility, sperm competitive ability and number of progeny relative to the control populations. Conclusion While most studies of experimental evolution of cold stress resistance have documented the evolution of survivorship in response to selection, our study clearly shows that adaptation to cold stress involves rapid changes in the pre- and post -copulatory traits. Additionally, improved performances under stressful conditions need not necessarily trade-off with performance under benign conditions.	[Singh, Karan; Samant, Manas Arun; Tom, Megha Treesa; Prasad, Nagaraj Guru] Indian Inst Sci Educ & Res Mohali, Sect 81, Po Manauli 140306, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Prasad, NG (corresponding author), Indian Inst Sci Educ & Res Mohali, Sect 81, Po Manauli 140306, Punjab, India.	prasad@iisermohali.ac.in	Singh, Karan/AAH-3752-2022	Singh, Karan/0000-0002-2496-028X; Prasad, N G/0000-0002-0410-5518; Geeta Arun, Manas/0000-0002-4433-4913	Indian Institute of Science Education and Research Mohali, Govt. of India; IISER Mohali, Govt. of India; Department of Science and Technology, Govt. of India	Indian Institute of Science Education and Research Mohali, Govt. of India; IISER Mohali, Govt. of India; Department of Science and Technology, Govt. of India(Department of Science & Technology (India))	This work was supported by the Indian Institute of Science Education and Research Mohali, Govt. of India. Karan Singh thanks IISER Mohali, Govt. of India for financial support in the form of a Senior Research Fellowship. Manas Arun Samant and Megha Treesa Tom thank the Department of Science and Technology, Govt. of India for INSPIRE Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AR, 2005, GENET RES, V85, P15, DOI 10.1017/S0016672304007281; [Anonymous], 2010, LOW TEMPERATURE BIOL; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; Barrios B, 2000, BIOL REPROD, V63, P1531, DOI 10.1095/biolreprod63.5.1531; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; CAMPBELL PM, 1992, BIOL REPROD, V47, P1140, DOI 10.1095/biolreprod47.6.1140; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; CHEN CP, 1994, J INSECT PHYSIOL, V40, P661, DOI 10.1016/0022-1910(94)90093-0; CHIHRANE J, 1994, ENTOMOPHAGA, V39, P11, DOI 10.1007/BF02373490; Chippindale AK, 1998, EVOLUTION, V52, P1342, DOI 10.2307/2411304; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; DENLINGER DL, 1998, TEMPERATURE SENSITIV; Fischer K, 2003, ECOLOGY, V84, P3138, DOI 10.1890/02-0733; Froman DP, 2002, P ROY SOC B-BIOL SCI, V269, P607, DOI 10.1098/rspb.2001.1925; Gage MJG, 2003, CURR BIOL, V13, P754, DOI 10.1016/S0960-9822(03)00282-3; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Hance T, 2007, ANNU REV ENTOMOL, V52, P107, DOI 10.1146/annurev.ento.52.110405.091333; Hansen PJ, 2009, PHILOS T R SOC B, V364, P3341, DOI 10.1098/rstb.2009.0131; IYENGAR SV, 1962, GENETICS, V47, P963; Kingsolver JG, 2009, AM NAT, V174, P755, DOI 10.1086/648310; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; KVELLAND I, 1965, HEREDITAS-GENETISK A, V54, P88; Lefevre GJ., 1962, DROS INFORM SERV, V1962, P86; MacMillan HA, 2009, INSECT SCI, V16, P263, DOI 10.1111/j.1744-7917.2009.01251.x; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MARKOW TA, 1985, ANIM BEHAV, V33, P775, DOI 10.1016/S0003-3472(85)80010-5; MARKOW TA, 1992, HEREDITY, V69, P122, DOI 10.1038/hdy.1992.104; MARKOW TA, 1992, J INSECT BEHAV, V5, P375, DOI 10.1007/BF01049845; MARKOW TA, 1988, J COMP PSYCHOL, V102, P169, DOI 10.1037/0735-7036.102.2.169; Marshall KE, 2010, P ROY SOC B-BIOL SCI, V277, P963, DOI 10.1098/rspb.2009.1807; Mockett RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092228; MOORE HDM, 1977, J REPROD FERTIL, V50, P349, DOI 10.1530/jrf.0.0500349; Nandy B, 2013, EVOLUTION, V67, P2133, DOI 10.1111/evo.12076; Nicolson SW, 2004, INSECT PHYSL ECOLOGY; Overgaard Johannes, 2010, P276, DOI 10.1017/CBO9780511675997.012; PARTRIDGE L, 1987, ANIM BEHAV, V35, P555, DOI 10.1016/S0003-3472(87)80281-6; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Patton ZJ, 2001, PHYSIOL BIOCHEM ZOOL, V74, P783, DOI 10.1086/323327; Perez-Crespo M, 2008, MOL REPROD DEV, V75, P40, DOI 10.1002/mrd.20759; Prasad NG, 2007, AM NAT, V169, P29, DOI 10.1086/509941; Rinehart JP, 2000, PHYSIOL ENTOMOL, V25, P330, DOI 10.1046/j.1365-3032.2000.00201.x; Rohmer C, 2004, J EXP BIOL, V207, P2735, DOI 10.1242/jeb.01087; ROSE MR, 1984, EVOLUTION, V38, P1004, DOI 10.1111/j.1558-5646.1984.tb00370.x; SANTOS M, 1988, HEREDITY, V61, P255, DOI 10.1038/hdy.1988.113; Schmidt PS, 2008, EVOLUTION, V62, P1204, DOI 10.1111/j.1558-5646.2008.00351.x; SCHNEBEL EM, 1984, EVOLUTION, V38, P1296, DOI 10.1111/j.1558-5646.1984.tb05651.x; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2012, REPRODUCTION, V144, P519, DOI 10.1530/REP-12-0285; Singh K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129992; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Nguyen TM, 2013, J INSECT PHYSIOL, V59, P248, DOI 10.1016/j.jinsphys.2012.12.001; van Lieshout E, 2013, ECOL EVOL, V3, P2859, DOI 10.1002/ece3.667; WALES RG, 1959, J ENDOCRINOL, V19, P211, DOI 10.1677/joe.0.0190211; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Yenisetti SC, 2006, KOREAN J GENETIC, V28, P395; Zizzari ZV, 2011, J INSECT PHYSIOL, V57, P421, DOI 10.1016/j.jinsphys.2011.01.002	58	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153629	10.1371/journal.pone.0153629	http://dx.doi.org/10.1371/journal.pone.0153629			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093599	gold, Green Published			2022-12-27	WOS:000374541200034
J	Janssens, KAM; Riese, H; Van Roon, AM; Hunfeld, JAM; Groot, PFC; Oldehinkel, AJ; Rosmalen, JGM				Janssens, Karin A. M.; Riese, Harriette; Van Roon, Arie M.; Hunfeld, Joke A. M.; Groot, Paul F. C.; Oldehinkel, Albertine J.; Rosmalen, Judith G. M.			Are Cardiac Autonomic Nervous System Activity and Perceived Stress Related to Functional Somatic Symptoms in Adolescents? The TRAILS Study	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; MEDICALLY UNEXPLAINED SYMPTOMS; SOCIAL STRESS; CHRONIC PAIN; CHILDREN; METAANALYSIS; POPULATION; RESPONSES; ASSOCIATIONS; DISORDERS	Objective Stressors have been related to medically insufficiently explained or functional somatic symptoms (FSS). However, the underlying mechanism of this association is largely unclear. In the current study, we examined whether FSS are associated with different perceived stress and cardiac autonomic nervous system (ANS) levels during a standardized stressful situation, and whether these associations are symptom-specific. Methods We examined 715 adolescents (16.1 years, 51.3% girls) from the Dutch cohort study Tracking Adolescents' Individual Lives Sample during the Groningen Social Stress Test (GSST). FSS were assessed by the Youth Self-Report, and clustered into a cluster of overtiredness, dizziness and musculoskeletal pain and a cluster of headache and gastrointestinal symptoms. Perceived stress levels (i.e. unpleasantness and arousal) were assessed by the SelfAssessment Manikin, and cardiac ANS activity by assessing heart rate variability (HRV-HF) and pre-ejection period (PEP). Perceived stress and cardiac ANS levels before, during, and after the GSST were studied as well as cardiac ANS reactivity. Linear regression analyses were used to examine the associations. Results Perceived arousal levels during (beta = 0.09, p = 0.04) and after (beta = 0.07, p = 0.047) the GSST, and perceived unpleasantness levels before (beta = 0.07, p = 0.048) and during (beta = 0.12, p = 0.001) the GSST were related to FSS during the past couple of months. The association between perceived stress and FSS was stronger for the FSS cluster of overtiredness, dizziness and musculoskeletal pain than for the cluster of headache and gastrointestinal symptoms. Neither ANS activity levels before, during, and after the GSST, nor maximal HF-HRV and PEP reactivity were related to FSS. Conclusions This study suggests that perceived stress levels during social stress are related to FSS, whereas cardiac ANS activity and reactivity are not related to FSS.	[Janssens, Karin A. M.; Riese, Harriette; Oldehinkel, Albertine J.; Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Van Roon, Arie M.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Groningen, Netherlands; [Hunfeld, Joke A. M.] Erasmus MC, Dept Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Groot, Paul F. C.] Univ Amsterdam, Acad Med Ctr, Dept Radiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	University of Groningen; University of Groningen; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam	Janssens, KAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	k.a.m.janssens@umcg.nl	Rosmalen, Judith G.M./F-5375-2011; Riese, Harriëtte/E-7234-2012	Rosmalen, Judith G.M./0000-0002-6393-0032; Riese, Harriëtte/0000-0003-3661-3151	Netherlands Organization for Scientific Research NWO (Medical Research Council) [GB-MW 940-38-011]; Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant) [100-001-004]; Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants) [60-60600-98-018, 60-60600-97-118]; Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant) [261-98-710]; Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants) [GB-MaGW 480-01-006, GB-MaGW 480-07-001]; Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants) [GB-MaGW 457-03-018, GB-MaGW 452-04-314, GB-MaGW 452-06-004]; Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant) [175.010.2003.005]; Sophia Foundation for Medical Research [301, 393]; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project) [FP-006]	Netherlands Organization for Scientific Research NWO (Medical Research Council)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research NWO (ZonMW Brainpower grant); Netherlands Organization for Scientific Research NWO (ZonMw Risk Behavior and Dependence grants); Netherlands Organization for Scientific Research NWO (ZonMw Culture and Health grant); Netherlands Organization for Scientific Research NWO (Social Sciences Council medium-sized investment grants); Netherlands Organization for Scientific Research NWO (Social Sciences Council project grants); Netherlands Organization for Scientific Research NWO (NWO large-sized investment grant); Sophia Foundation for Medical Research; Dutch Ministry of Justice (WODC); European Science Foundation (EuroSTRESS project)	This research is part of the TRacking Adolescents' Individual Lives Survey. Participating centers of the Tracking adolescents' individual lives survey include various departments of the University Medical Center and University of Groningen, the Erasmus University Medical Center Rotterdam, the University of Utrecht, the Radboud Medical Center Nijmegen, and the Parnassia Bavo group, all in the Netherlands. The Tracking adolescents' individual lives survey has been financially supported by various grants from the Netherlands Organization for Scientific Research NWO (Medical Research Council program grant GB-MW 940-38-011; ZonMW Brainpower grant 100-001-004; ZonMw Risk Behavior and Dependence grants 60-60600-98-018 and 60-60600-97-118; ZonMw Culture and Health grant 261-98-710; Social Sciences Council medium-sized investment grants GB-MaGW 480-01-006 and GB-MaGW 480-07-001; Social Sciences Council project grants GB-MaGW 457-03-018, GB-MaGW 452-04-314, and GB-MaGW 452-06-004; NWO large-sized investment grant 175.010.2003.005); the Sophia Foundation for Medical Research (projects 301 and 393), the Dutch Ministry of Justice (WODC), the European Science Foundation (EuroSTRESS project FP-006), and the participating universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Alfven G, 2008, J PSYCHOSOM RES, V65, P381, DOI 10.1016/j.jpsychores.2008.07.004; [Anonymous], ASSESSMENT CARDIOVAS; Bernardi L, 2000, J AM COLL CARDIOL, V35, P1462, DOI 10.1016/S0735-1097(00)00595-7; Bjorling EA, 2009, HEADACHE, V49, P1186, DOI 10.1111/j.1526-4610.2009.01406.x; Bouma EMC, 2009, PSYCHONEUROENDOCRINO, V34, P884, DOI 10.1016/j.psyneuen.2009.01.003; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Connelly M, 2011, J PEDIATR PSYCHOL, V36, P852, DOI 10.1093/jpepsy/jsr017; de Winter AF, 2005, EUR J EPIDEMIOL, V20, P173, DOI 10.1007/s10654-004-4948-6; Dietrich A, 2007, AUTONOMIC NERVOUS SY; Dietrich A, 2011, PSYCHOTHER PSYCHOSOM, V80, P62, DOI 10.1159/000318781; Ebinger F, 2006, CEPHALALGIA, V26, P295, DOI 10.1111/j.1468-2982.2005.01039.x; Gini G, 2009, PEDIATRICS, V123, P1059, DOI 10.1542/peds.2008-1215; Houtveen JH, 2007, BIOL PSYCHOL, V76, P239, DOI 10.1016/j.biopsycho.2007.08.005; Houtveen JH, 2010, PSYCHOPHYSIOLOGY, V47, P570, DOI 10.1111/j.1469-8986.2009.00951.x; Hunfeld JAM, 2002, PSYCHOL PSYCHOTHER-T, V75, P251, DOI 10.1348/147608302320365172; Janssens KAM, 2014, J PEDIATR-US, V164, P900, DOI 10.1016/j.jpeds.2013.12.003; Janssens KAM, 2012, PSYCHONEUROENDOCRINO, V37, P332, DOI 10.1016/j.psyneuen.2011.06.016; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Janssens KAM, 2009, J PEDIATR-US, V154, P918, DOI 10.1016/j.jpeds.2008.12.023; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Larsson B, 1996, J PEDIATR PSYCHOL, V21, P603, DOI 10.1093/jpepsy/21.5.603; Olafsdottir E, 2001, ACTA PAEDIATR, V90, P632, DOI 10.1080/080352501750258685; Oldehinkel AJ, 2011, PSYCHOPHYSIOLOGY, V48, P441, DOI 10.1111/j.1469-8986.2010.01118.x; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Puzanovova M, 2009, J PSYCHOSOM RES, V67, P235, DOI 10.1016/j.jpsychores.2009.02.007; Riese H, 2003, BEHAV RES METH INS C, V35, P467, DOI 10.3758/BF03195525; ROBBE HWJ, 1987, HYPERTENSION, V10, P538, DOI 10.1161/01.HYP.10.5.538; SLOAN RP, 1991, PHYSIOL BEHAV, V50, P1039, DOI 10.1016/0031-9384(91)90434-P; Stults-Kolehmainen MA, 2014, J STRENGTH COND RES, V28, P2007, DOI 10.1519/JSC.0000000000000335; Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002; Tak LM, 2010, J PSYCHOSOM RES, V68, P461, DOI 10.1016/j.jpsychores.2009.12.004; Tak LM, 2010, PSYCHOTHER PSYCHOSOM, V79, P179, DOI 10.1159/000296136; Tak LM, 2009, BIOL PSYCHOL, V82, P101, DOI 10.1016/j.biopsycho.2009.05.002; van Tilburg MAL, 2009, PEDIATRICS, V124, pE890, DOI 10.1542/peds.2009-0028; Varni JW, 1996, J BEHAV MED, V19, P515, DOI 10.1007/BF01904901; VU-DAMS, 2013, DATA ANAL MANAGEMENT; Willemsen GHM, 1996, PSYCHOPHYSIOLOGY, V33, P184, DOI 10.1111/j.1469-8986.1996.tb02122.x; Wyller VB, 2008, ANN NONINVAS ELECTRO, V13, P67, DOI 10.1111/j.1542-474X.2007.00202.x	39	1	1	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153318	10.1371/journal.pone.0153318	http://dx.doi.org/10.1371/journal.pone.0153318			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089394	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000016
J	Klausberger, M; Tscheliessnig, R; Neff, S; Nachbagauer, R; Wohlbold, TJ; Wilde, M; Palmberger, D; Krammer, F; Jungbauer, A; Grabherr, R				Klausberger, Miriam; Tscheliessnig, Rupert; Neff, Silke; Nachbagauer, Raffael; Wohlbold, Teddy John; Wilde, Monika; Palmberger, Dieter; Krammer, Florian; Jungbauer, Alois; Grabherr, Reingard			Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus	PLOS ONE			English	Article							IN-VIVO; MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; INTERSUBUNIT REGION; CELL EPITOPE; INFECTION; VACCINE; MICE; CHALLENGE; RESPONSES	Significant genetic variability in the head region of the influenza A hemagglutinin, the main target of current vaccines, makes it challenging to develop a long-lived seasonal influenza prophylaxis. Vaccines based on the conserved hemagglutinin stalk domain might provide broader cross-reactive immunity. However, this region of the hemagglutinin is immunosub-dominant to the head region. Peptide-based vaccines have gained much interest as they allow the immune system to focus on relevant but less immunogenic epitopes. We developed a novel influenza A hemagglutinin-based display platform for H1 hemagglutinin stalk peptides that we identified in an epitope mapping assay using human immune sera and synthetic HA peptides. Flow cytometry and competition assays suggest that the identified stalk sequences do not recapitulate the epitopes of already described broadly neutralizing stalk antibodies. Vaccine constructs displaying 25-mer stalk sequences provided up to 75% protection from lethal heterologous virus challenge in BALB/c mice and induced antibody responses against the H1 hemagglutinin. The developed platform based on a vaccine antigen has the potential to be either used as stand-alone or as prime-vaccine in combination with conventional seasonal or pandemic vaccines for the amplification of stalk-based cross-reactive immunity in humans or as platform to evaluate the relevance of viral peptides/epitopes for protection against influenza virus infection.	[Klausberger, Miriam; Tscheliessnig, Rupert; Neff, Silke; Wilde, Monika; Palmberger, Dieter; Jungbauer, Alois; Grabherr, Reingard] Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria; [Tscheliessnig, Rupert] Austrian Ctr Ind Biotechnol, Vienna, Austria; [Nachbagauer, Raffael] Univ Vienna, Fac Life Sci, Vienna, Austria; [Nachbagauer, Raffael; Wohlbold, Teddy John; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Wohlbold, Teddy John] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Vienna; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Grabherr, R (corresponding author), Univ Nat Resources & Life Sci Vienna, Dept Biotechnol, Vienna, Austria.	reingard.grabherr@boku.ac.at	Krammer, Florian/H-3237-2019; Nachbagauer, Raffael/H-7798-2019; Klausberger, Miriam/C-7885-2017	Krammer, Florian/0000-0003-4121-776X; Nachbagauer, Raffael/0000-0001-5568-5420; Klausberger, Miriam/0000-0001-8409-454X; Grabherr, Reingard/0000-0002-4501-927X; Jungbauer, Alois/0000-0001-8182-7728	Austrian Science Foundation FWF [W1224]; FWF [P 25092-B13]; Austrian Centre of Industrial Biotechnology (ACIB); Federal Ministry of Economy, Family and Youth (BMWJF); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Syrian Business Promotion Agency SFG; Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program; Erwin Schrodinger fellowship from the Austrian Science Fund [J 3232]; NIH (National Institutes of Health) [1P01AI097092-01A1]; PATH (Program for Appropriate Technology in Health); Austrian Centre of Industrial Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI097092] Funding Source: NIH RePORTER	Austrian Science Foundation FWF(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Austrian Centre of Industrial Biotechnology (ACIB); Federal Ministry of Economy, Family and Youth (BMWJF); Federal Ministry of Traffic, Innovation and Technology (BMVIT); Syrian Business Promotion Agency SFG; Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program; Erwin Schrodinger fellowship from the Austrian Science Fund; NIH (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PATH (Program for Appropriate Technology in Health); Austrian Centre of Industrial Biotechnology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	MK and MW received funding from the Austrian Science Foundation FWF Doctoral program BioToP-Molecular Technology of Proteins W1224 and DP also was funded by the FWF (P 25092-B13). RT was funded by the Austrian Centre of Industrial Biotechnology (ACIB). ACIB is a non-profit research centre supported by the Federal Ministry of Economy, Family and Youth (BMWJF), the Federal Ministry of Traffic, Innovation and Technology (BMVIT), the Syrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT - Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. FK was supported by an Erwin Schrodinger fellowship (J 3232) from the Austrian Science Fund. This work was partially supported by NIH (National Institutes of Health) program project grant 1P01AI097092-01A1 and PATH (Program for Appropriate Technology in Health). The Austrian Centre of Industrial Biotechnology provided support in the form of salaries for authors [RT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Atsmon J, 2012, J CLIN IMMUNOL, V32, P595, DOI 10.1007/s10875-011-9632-5; Berglund L, 2008, PROTEIN SCI, V17, P606, DOI 10.1110/ps.073347208; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Condron M M, 2008, Open Biotechnol J, V2, P87, DOI 10.2174/1874070700802010087; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Crowe JE, 2012, Patent publication number, Patent No. [WO2012045001 A2, 2012045001]; DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.bi.59.070190.002255; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Dreyfus C, 2013, J VIROL, V87, P7149, DOI 10.1128/JVI.02975-12; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ferko B, 1998, J INFECT DIS, V178, P1359, DOI 10.1086/314445; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Gogolak P, 2000, BIOCHEM BIOPH RES CO, V270, P190, DOI 10.1006/bbrc.2000.2384; Heaton NS, 2013, J VIROL, V87, P8272, DOI 10.1128/JVI.00969-13; Horvath A, 1998, IMMUNOL LETT, V60, P127, DOI 10.1016/S0165-2478(97)00137-5; Huang Q, 2003, BBA-BIOMEMBRANES, V1614, P3, DOI 10.1016/S0005-2736(03)00158-5; JACKSON DC, 1986, VIROLOGY, V155, P625, DOI 10.1016/0042-6822(86)90222-9; JERRY DJ, 1993, BIOTECHNIQUES, V14, P464; Klausberger M, 2014, VACCINE, V32, P355, DOI 10.1016/j.vaccine.2013.11.036; Knittelfelder R, 2009, EXPERT OPIN BIOL TH, V9, P493, DOI [10.1517/14712590902870386, 10.1517/14712590902870386 ]; Krammer F, 2015, CURR TOP MICROBIOL, V386, P301, DOI 10.1007/82_2014_408; Krammer F, 2013, J VIROL, V87, P6542, DOI [10.1128/JVI.00641-13, 10.1128/JVI.03183-13]; Krammer F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043603; Krammer F, 2010, J VIROL METHODS, V167, P17, DOI 10.1016/j.jviromet.2010.03.003; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Margine I, 2013, J VIROL, V87, P4728, DOI 10.1128/JVI.03509-12; Moody MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025797; Mullarkey CE, 2013, EUR J IMMUNOL, V43, P1940, DOI 10.1002/eji.201242922; MULLER GM, 1982, P NATL ACAD SCI-BIOL, V79, P569, DOI 10.1073/pnas.79.2.569; MUSTER T, 1994, J VIROL, V68, P4031, DOI 10.1128/JVI.68.6.4031-4034.1994; NAGY Z, 1994, SCAND J IMMUNOL, V40, P281, DOI 10.1111/j.1365-3083.1994.tb03464.x; Nakamura G, 2013, CELL HOST MICROBE, V14, P93, DOI 10.1016/j.chom.2013.06.004; NESTOROWICZ A, 1985, MOL IMMUNOL, V22, P145, DOI 10.1016/S0161-5890(85)80008-0; Pflegerl K, 2002, J PEPT RES, V59, P174, DOI 10.1034/j.1399-3011.2002.1o965.x; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Prabhu N, 2009, J VIROL, V83, P2553, DOI 10.1128/JVI.02165-08; RAJNAVOLGYI E, 1994, MOL IMMUNOL, V31, P1403, DOI 10.1016/0161-5890(94)90156-2; Sivalingam GN, 2012, MOL IMMUNOL, V51, P304, DOI 10.1016/j.molimm.2012.03.030; Staczek J, 1998, INFECT IMMUN, V66, P3990, DOI 10.1128/IAI.66.8.3990-3994.1998; Stanekova Z, 2012, INFLUENZA OTHER RESP, V6, P389, DOI 10.1111/j.1750-2659.2011.00328.x; STYK B, 1979, ACTA VIROL, V23, P1; Sui J, 2011, CLIN INFECT DIS, V52, P1003, DOI 10.1093/cid/cir121; Tan GS, 2012, J VIROL, V86, P6179, DOI 10.1128/JVI.00469-12; TANG XL, 1988, J VIROL, V62, P4745, DOI 10.1128/JVI.62.12.4745-4751.1988; Terajima M, 2011, J VIROL, V85, P13463, DOI 10.1128/JVI.05193-11; Tharakaraman K, 2014, CELL HOST MICROBE, V15, P644, DOI 10.1016/j.chom.2014.04.009; Wacheck V, 2010, J INFECT DIS, V201, P354, DOI 10.1086/649428; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; Wohlbold TJ, 2015, VACCINE, V33, P3314, DOI 10.1016/j.vaccine.2015.05.038	52	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153579	10.1371/journal.pone.0153579	http://dx.doi.org/10.1371/journal.pone.0153579			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088239	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000028
J	Valmasoni, M; Pierobon, ES; Ruol, A; De Pasqual, CA; Zanchettin, G; Moletta, L; Salvador, R; Costantini, M; Merigliano, S				Valmasoni, Michele; Pierobon, Elisa Sefora; Ruol, Alberto; De Pasqual, Carlo Alberto; Zanchettin, Gianpietro; Moletta, Lucia; Salvador, Renato; Costantini, Mario; Merigliano, Stefano			Endoscopic Tumor Length Should Be Reincluded in the Esophageal Cancer Staging System: Analyses of 662 Consecutive Patients	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LONG-TERM SURVIVAL; PROGNOSTIC-FACTOR; LYMPHATIC SPREAD; LOCATION; IMPACT; GRADE; ADENOCARCINOMA; PREDICT	Esophageal cancer represents the 6th cause of cancer mortality in the World. New treatments led to outcome improvements, but patient selection and prognostic stratification is a critical aspect to gain maximum benefit from therapies. Today, patients are stratified into 9 prognostic groups, according to a staging system developed by the American Joint Committee on Cancer. Recently, trying to better select patients with curing possibilities several authors are reconsidering tumor length as a valuable prognostic parameter. Specifically, endoscopic tumor length can be easily measured with an esophageal endoscopy and, if its utility in esophageal cancer staging is demonstrated, it may represent a simple method to identify high risk patients and an easy-to-obtain variable in prognostic stratification. In this study we retrospectively analyzed 662 patients treated for esophageal cancer, stratified according to cancer histology and current staging system, to assess the possible role of endoscopic tumor length. We found a significant correlation between endoscopic tumor length, current staging parameters and 5-year survival, proving that endoscopic tumor length may be used as a simple risk stratification tool. Our results suggest a possible indication for preoperative therapy in early stage squamocellular carcinoma patients without lymph nodes involvement, who are currently treated with surgery alone.	[Valmasoni, Michele; Pierobon, Elisa Sefora; Ruol, Alberto; De Pasqual, Carlo Alberto; Zanchettin, Gianpietro; Moletta, Lucia; Salvador, Renato; Costantini, Mario; Merigliano, Stefano] Univ Hosp Padova, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 3, Ctr Esophageal Dis, I-35128 Padua, Italy	University of Padua; Azienda Ospedaliera - Universita di Padova	Valmasoni, M (corresponding author), Univ Hosp Padova, Dept Surg Oncol & Gastroenterol Sci, Surg Clin 3, Ctr Esophageal Dis, I-35128 Padua, Italy.	michele.valmasoni@unipd.it	Pierobon, Elisa Sefora/AAS-9267-2021; Merigliano, Stefano/AAY-3023-2021; Valmasoni, Michele/C-7574-2014; Pierobon, Elisa Sefora/AAE-5150-2021; Moletta, Lucia/ABD-7200-2020; De Pasqual, Carlo Alberto/AAF-3368-2020	Pierobon, Elisa Sefora/0000-0002-5836-1197; Valmasoni, Michele/0000-0002-1462-8275; De Pasqual, Carlo Alberto/0000-0001-7719-258X				Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bhutani MS, 2002, ENDOSCOPY, V34, P461, DOI 10.1055/s-2002-31996; Bollschweiler E, 2006, J SURG ONCOL, V94, P355, DOI 10.1002/jso.20569; Bolton WD, 2009, J THORAC CARDIOV SUR, V138, P831, DOI 10.1016/j.jtcvs.2009.02.003; Cense HA, 2006, BEST PRACT RES CL GA, V20, P893, DOI 10.1016/j.bpg.2006.03.010; Chang WL, 2011, DIS ESOPHAGUS, V24, P590, DOI 10.1111/j.1442-2050.2011.01195.x; Cohen DJ, 2015, J CLIN ONCOL, V33, P1754, DOI 10.1200/JCO.2014.59.7765; Cools-Lartigue J, 2015, J GASTROINTEST SURG, V19, P964, DOI 10.1007/s11605-014-2701-3; Dhupar R, 2014, DIS ESOPHAGUS, V27, P770, DOI 10.1111/dote.12154; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Feng JF, 2013, UPSALA J MED SCI, V118, P145, DOI 10.3109/03009734.2013.792887; Gaur P., 2010, CANCER, V117, P63, DOI [10.1002/cncr.25373, DOI 10.1002/CNCR.25373]; Griffiths EA, 2006, J SURG ONCOL, V93, P258, DOI 10.1002/jso.20449; Hu W, 2013, EUR SURG, V45, P200, DOI 10.1007/s10353-013-0223-y; HUTTER RVP, 1987, ARCH SURG-CHICAGO, V122, P1235; Jeon HW, 2015, THORAC CARDIOV SURG, V63, P341, DOI 10.1055/s-0034-1384787; Karashima R, 2015, SURG TODAY, V45, P471, DOI 10.1007/s00595-014-0965-6; Kato H, 2013, GEN THORAC CARDIOVAS, V61, P330, DOI 10.1007/s11748-013-0246-0; Khanna LG, 2015, BEST PRACT RES CL GA, V29, P179, DOI 10.1016/j.bpg.2014.12.005; Kidane B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001556.pub3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mirinezhad SK, 2014, ASIAN PAC J CANCER P, V15, P691, DOI 10.7314/APJCP.2014.15.2.691; Qumseya BJ, 2015, GASTROINTEST ENDOSC, V81, P865, DOI 10.1016/j.gie.2014.08.025; Rice TW, 2013, THORAC SURG CLIN, V23, P461, DOI 10.1016/j.thorsurg.2013.07.004; Rubenstein J. H., 2015, GASTROENTEROLOGY; Schmidt T, 2015, J NATL COMPR CANC NE, V13, P239, DOI 10.6004/jnccn.2015.0030; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Situ DR, 2013, J THORAC CARDIOV SUR, V146, P45, DOI 10.1016/j.jtcvs.2013.01.034; Situ D, 2013, ANN SURG ONCOL, V20, P580, DOI 10.1245/s10434-012-2656-0; Song Zhengbo, 2012, World J Surg Oncol, V10, P273, DOI 10.1186/1477-7819-10-273; Stein HJ, 2005, ANN SURG, V242, P566, DOI 10.1097/01.sla.0000184211.75970.85; Suh YS, 2012, ANN SURG, V255, P908, DOI 10.1097/SLA.0b013e31824beb95; Tekola Bezawit D, 2014, J Gastrointest Cancer, V45, P342, DOI 10.1007/s12029-014-9616-9; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Visbal AL, 2001, ANN THORAC SURG, V71, P1803, DOI 10.1016/S0003-4975(01)02601-7; Wang BY, 2012, ANN SURG ONCOL, V19, P2149, DOI 10.1245/s10434-012-2273-y; Wang BY, 2011, ANN THORAC SURG, V91, P887, DOI 10.1016/j.athoracsur.2010.11.011; Wang J, 2014, WORLD J GASTROENTERO, V20, P18397, DOI 10.3748/wjg.v20.i48.18397; Wijnhoven BPL, 2007, ANN SURG, V245, P717, DOI 10.1097/01.sla.0000251703.35919.02; Williams B. A., 2006, MAYO CLIN TECHNICAL, V79; Worrell SG, 2014, J GASTROINTEST SURG, V18, P318, DOI 10.1007/s11605-013-2398-8; Wu N, 2012, CHINESE MED J-PEKING, V125, P4445, DOI 10.3760/cma.j.issn.0366-6999.2012.24.022; Yendamuri S, 2009, CANCER-AM CANCER SOC, V115, P508, DOI 10.1002/cncr.24062; Zeybek A, 2013, INT SURG, V98, P234, DOI 10.9738/INTSURG-D-13-00075.1	44	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153068	10.1371/journal.pone.0153068	http://dx.doi.org/10.1371/journal.pone.0153068			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088503	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000010
J	Weiss-Gayet, M; Starck, J; Chaabouni, A; Chazaud, B; Morle, F				Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois			Notch Stimulates Both Self-Renewal and Lineage Plasticity in a Subset of Murine CD9(High) Committed Megakaryocytic Progenitors	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VIVO; ERYTHROLEUKEMIA-CELLS; IMMUNE-SYSTEM; EX-VIVO; DIFFERENTIATION; MAINTENANCE; COMMITMENT; HIERARCHY; LEUKEMIA	This study aimed at reinvestigating the controversial contribution of Notch signaling to megakaryocytic lineage development. For that purpose, we combined colony assays and single cells progeny analyses of purified megakaryocyte-erythroid progenitors (MEP) after short-term cultures on recombinant Notch ligand rDLL1. We showed that Notch activation stimulated the SCF-dependent and preferential amplification of Kit(+) erythroid and bipotent progenitors while favoring commitment towards the erythroid at the expense of megakaryocytic lineage. Interestingly, we also identified a CD9(High) MEP subset that spontaneously generated almost exclusively megakaryocytic progeny mainly composed of single megakaryocytes. We showed that Notch activation decreased the extent of polyploidization and maturation of megakaryocytes, increased the size of megakaryocytic colonies and surprisingly restored the generation of erythroid and mixed colonies by this CD9(High) MEP subset. Importantly, the size increase of megakaryocytic colonies occurred at the expense of the production of single megakaryocytes and the restoration of colonies of alternative lineages occurred at the expense of the whole megakaryocytic progeny. Altogether, these results indicate that Notch activation is able to extend the number of divisions of MK-committed CD9(High) MEPs before terminal maturation while allowing a fraction of them to generate alternative lineages. This unexpected plasticity of MK-committed progenitors revealed upon Notch activation helps to better understand the functional promiscuity between megakaryocytic lineage and hematopoietic stem cells.	[Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] Univ Lyon 1, Inst NeuroMyoGene INMG, F-69622 Villeurbanne, France; [Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] INSERM, U1217, Villeurbanne, France; [Weiss-Gayet, Michele; Starck, Joelle; Chaabouni, Azza; Chazaud, Benedicte; Morle, Francois] CNRS, UMR 5310, Villeurbanne, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Morle, F (corresponding author), Univ Lyon 1, Inst NeuroMyoGene INMG, F-69622 Villeurbanne, France.; Morle, F (corresponding author), INSERM, U1217, Villeurbanne, France.; Morle, F (corresponding author), CNRS, UMR 5310, Villeurbanne, France.	francois.morle@univ-lyon1.fr	Chazaud, Benedicte/N-9291-2017	Chazaud, Benedicte/0000-0002-1262-502X	CNRS; Universite Claude Bernard Lyon1; Ligue Nationale contre le Cancer (Equipe labellisee); Ligue Nationale contre le Cancer (Comites du Rhone, de la Drome et du Cantal); Ligue Nationale contre le Cancer; Societe Francaise d'Hematologie	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon1; Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Ligue Nationale contre le Cancer (Comites du Rhone, de la Drome et du Cantal); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Societe Francaise d'Hematologie	This work has been supported by grants from the CNRS and Universite Claude Bernard Lyon1 and by specific grants from the Ligue Nationale contre le Cancer (Equipe labellisee 2009-2012 and Comites du Rhone, de la Drome et du Cantal). MW and JS are permanent employees of CNRS while FM and BC are permanent employees of INSERM. AC PhD student has been supported by a three years salary from the Ligue Nationale contre le Cancer (2011-2014) and by a 6 months salary from the Societe Francaise d'Hematologie (2014-2015).	Alderton GK, 2011, NAT REV CANCER, V11, P385, DOI 10.1038/nrc3071; Benveniste P, 2014, BLOOD, V123, P1167, DOI 10.1182/blood-2013-07-505099; Besancenot R, 2014, BLOOD, V124, P2104, DOI 10.1182/blood-2014-03-559815; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Carlesso N, 1999, BLOOD, V93, P838, DOI 10.1182/blood.V93.3.838.403k29_838_848; Cornejo MG, 2011, BLOOD, V118, P1264, DOI 10.1182/blood-2011-01-328567; Dahlberg A, 2011, BLOOD, V117, P6083, DOI 10.1182/blood-2011-01-283606; Danahay H, 2015, CELL REP, V10, P239, DOI 10.1016/j.celrep.2014.12.017; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; Dore LC, 2011, BLOOD, V118, P231, DOI 10.1182/blood-2011-04-285981; Elagib KE, 2004, MOLECULAR AND CELLUL, V24, P7779, DOI [10.1128/MCB.24.17.7779-7794.2004, DOI 10.1128/MCB.24.17.7779-7794.2004]; Falk R, 2012, METHODS, V58, P69, DOI 10.1016/j.ymeth.2012.07.008; Goldenson B, 2015, BLOOD, V125, P2141, DOI 10.1182/blood-2014-12-615401; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Jang MS, 2004, J CELL PHYSIOL, V199, P418, DOI 10.1002/jcp.10467; Kageyama R, 2015, CELL TISSUE RES, V359, P125, DOI 10.1007/s00441-014-1888-7; Kalaitzidis D, 2011, NATURE, V473, P159, DOI 10.1038/473159a; Karanu FN, 2003, LEUKEMIA, V17, P1366, DOI 10.1038/sj.leu.2402973; Klinakis A, 2011, NATURE, V473, P230, DOI 10.1038/nature09999; Koch U, 2011, TRENDS IMMUNOL, V32, P434, DOI 10.1016/j.it.2011.06.005; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Lauret E, 2004, LEUKEMIA, V18, P788, DOI 10.1038/sj.leu.2403288; Leysi-Derilou Y, 2010, CELL CYCLE, V9, P2589, DOI 10.4161/cc.9.13.12078; Lobry C, 2011, J EXP MED, V208, P1931, DOI 10.1084/jem.20111855; Lordier L, 2012, CELL CYCLE, V11, P4385, DOI 10.4161/cc.22712; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malinge S, 2010, BLOOD, V116, P5438, DOI 10.1182/blood-2010-09-308395; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mercher T, 2008, CELL STEM CELL, V3, P314, DOI 10.1016/j.stem.2008.07.010; Ng AP, 2012, P NATL ACAD SCI USA, V109, P2364, DOI 10.1073/pnas.1121385109; Nishikii H, 2015, STEM CELLS, V33, P2196, DOI 10.1002/stem.1985; Oh P, 2013, CELL STEM CELL, V13, P190, DOI 10.1016/j.stem.2013.05.015; Ohishi K, 2002, J CLIN INVEST, V110, P1165, DOI 10.1172/JCI200216167; Pajcini KV, 2011, LEUKEMIA, V25, P1525, DOI 10.1038/leu.2011.127; Poirault-Chassac S, 2010, BLOOD, V116, P5670, DOI 10.1182/blood-2010-05-285957; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Rieger MA, 2009, BRIT J HAEMATOL, V144, P448, DOI 10.1111/j.1365-2141.2008.07419.x; Roch A, 2015, STEM CELLS, V33, P3152, DOI 10.1002/stem.2106; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Shelly LL, 1999, J CELL BIOCHEM, V73, P164, DOI 10.1002/(SICI)1097-4644(19990501)73:2<164::AID-JCB3>3.0.CO;2-0; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Starck J, 2010, BLOOD, V116, P4795, DOI 10.1182/blood-2010-02-270405; Varnum-Finney B, 1998, BLOOD, V91, P4084, DOI 10.1182/blood.V91.11.4084.411k05_4084_4091; Varnum-Finney B, 2011, J CLIN INVEST, V121, P1207, DOI 10.1172/JCI43868; Walkley CR, 2011, CELL STEM CELL, V8, P602, DOI 10.1016/j.stem.2011.04.010; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Zeuner A, 2011, CELL DEATH DIFFER, V18, P371, DOI 10.1038/cdd.2010.110	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153860	10.1371/journal.pone.0153860	http://dx.doi.org/10.1371/journal.pone.0153860			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089435	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000056
J	Lefeuvre, D; Delmas, MC; Marguet, C; Chauvin, P; Vandentorren, S				Lefeuvre, Delphine; Delmas, Marie-Christine; Marguet, Christophe; Chauvin, Pierre; Vandentorren, Stephanie			Asthma-Like Symptoms in Homeless Children in the Greater Paris Area in 2013: Prevalence, Associated Factors and Utilization of Healthcare Services in the ENFAMS Survey	PLOS ONE			English	Article							YOUNG-CHILDREN; ATOPIC ECZEMA; DISPARITIES; CHILDHOOD; ALLERGIES; BIRTH; ENVIRONMENT; DISORDERS; RISK	Introduction Asthma remains poorly studied in homeless children. We sought to estimate the prevalence of asthma-like symptoms (ALS) and to identify the factors associated with ALS and healthcare service utilisation. Materials and Methods A cross-sectional survey of a random sample of sheltered homeless families was conducted by interviewing 801 parents of children (0-12 years) in 17 languages. ALS were defined as wheezing or night cough without fever during the previous year. Poisson regression models with robust error variance were used to compute prevalence ratios (PR) for factors associated with ALS and healthcare service utilisation for ALS. Results The prevalence of ALS among the children was 19.9%. Poor housing sanitation was significantly associated with ALS, as being born in the European Union. Most of the children with ALS had used healthcare services (85.4%). The main barriers to accessing such services were having lived in France for less than 49 months, having difficulties in French and living in poor housing conditions. Conclusion ALS prevalence seemed lower than in the general child population, possibly because of the children's origins. Environmental factors associated with ALS point to the need to improve the indoor environment of family shelters. The relatively high rate of healthcare service utilisation should not overshadow existing barriers.	[Lefeuvre, Delphine; Chauvin, Pierre; Vandentorren, Stephanie] Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France; [Delmas, Marie-Christine; Vandentorren, Stephanie] French Inst Publ Hlth Surveillance, St Maurice, France; [Marguet, Christophe] Univ Hosp Rouen, Rouen, France; [Vandentorren, Stephanie] Observ Samusocial Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institute of Public Health Surveillance; CHU de Rouen	Vandentorren, S (corresponding author), Univ Paris 06, Sorbonne Univ, INSERM,Dept Social Epidemiol, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France.; Vandentorren, S (corresponding author), French Inst Publ Hlth Surveillance, St Maurice, France.; Vandentorren, S (corresponding author), Observ Samusocial Paris, Paris, France.	Stephanie.VANDENTORREN@ars.sante.fr	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; VANDENTORREN, Stephanie/0000-0003-4269-8286	Agence regionale de sante d'Ile-de-France (ARS); Canceropole Ile-de-France; Caisse nationale des allocations familiales (CNAF); Fondation de France; Fondation Macif; Fondation Sanofi Espoir; Institut national de prevention et deducation pour la sante (INPES); Institut de recherche en sante publique (IReSP); Institut de veille sanitaire (InVS); Ministere de l'Interieur; Observatoire national de l'enfance en danger (ONED); Procter et Gamble; State Street	Agence regionale de sante d'Ile-de-France (ARS); Canceropole Ile-de-France(Region Ile-de-France); Caisse nationale des allocations familiales (CNAF); Fondation de France(Fondation de France); Fondation Macif; Fondation Sanofi Espoir; Institut national de prevention et deducation pour la sante (INPES); Institut de recherche en sante publique (IReSP); Institut de veille sanitaire (InVS); Ministere de l'Interieur; Observatoire national de l'enfance en danger (ONED); Procter et Gamble; State Street	This survey was supported by the Agence regionale de sante d'Ile-de-France (ARS), Canceropole Ile-de-France, Caisse nationale des allocations familiales (CNAF), Fondation de France, Fondation Macif, Fondation Sanofi Espoir, Institut national de prevention et deducation pour la sante (INPES), Institut de recherche en sante publique (IReSP), Institut de veille sanitaire (InVS), Ministere de l'Interieur, Observatoire national de l'enfance en danger (ONED), Procter et Gamble and State Street. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia SK, 2011, CURR OPIN ALLERGY CL, V11, P137, DOI 10.1097/ACI.0b013e3283445921; Akinbami LJ, 2011, NATL HLTH STAT REPOR; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Berchet C., 2012, BEH, P17; Braaback L, 2011, CLIN EXP ALLERGY, V41, P1108, DOI 10.1111/j.1365-2222.2011.03744.x; Buu MC, 2014, J ASTHMA, V51, P142, DOI 10.3109/02770903.2013.857682; Cabieses B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105347; Cantarero-Arevalo L, 2013, J EPIDEMIOL COMMUN H, V67, P912, DOI 10.1136/jech-2012-202135; Chen E, 2007, BRAIN BEHAV IMMUN, V21, P993, DOI 10.1016/j.bbi.2007.03.009; Crocker D, 2009, CHEST, V136, P1063, DOI 10.1378/chest.09-0013; Currie A, 2007, J HEALTH ECON, V26, P213, DOI 10.1016/j.jhealeco.2006.08.003; Cutuli JJ, 2014, J HEALTH CARE POOR U, V25, P717, DOI 10.1353/hpu.2014.0099; Cutuli JJ, 2010, PEDIATRICS, V125, P145, DOI 10.1542/peds.2009-0103; Delmas MC, 2012, REV MAL RESPIR, V29, P688, DOI 10.1016/j.rmr.2011.11.016; Delmas MC, 2010, REV MAL RESPIR, V27, P151, DOI 10.1016/j.rmr.2009.09.001; Delmas MC, 2009, ARCH PEDIATRIE, V16, P1261, DOI 10.1016/j.arcped.2009.06.009; Delmas MC, 2014, B EPIDEMIOL HEBD, V20, P360; Flores G, 2009, J ASTHMA, V46, P392, DOI 10.1080/02770900802712971; Fung V, 2014, JAMA PEDIATR, V168, P649, DOI 10.1001/jamapediatrics.2014.79; Garcia-Marcos L, 2014, INT J EPIDEMIOL, V43, P1846, DOI 10.1093/ije/dyu145; Gehring U, 2006, EUR RESPIR J, V27, P95, DOI 10.1183/09031936.06.00017205; Grant R, 2007, AM J PUBLIC HEALTH, V97, P448, DOI 10.2105/AJPH.2005.070482; Guyavarch E, 2014, INFORM SOCIALES, V182, P142; Hammer-Helmich L, 2014, SCAND J PUBLIC HEALT, V42, P120, DOI 10.1177/1403494813505727; Herr M, 2012, REV MAL RESPIR, V29, P52, DOI 10.1016/j.rmr.2011.05.016; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Kelley CF, 2005, PEDIATRICS, V115, P726, DOI 10.1542/peds.2004-0529; McLean DE, 2004, ARCH PEDIAT ADOL MED, V158, P244, DOI 10.1001/archpedi.158.3.244; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Samuels J., 2010, HOMELESS CHILDREN UP; Simoni M, 2005, OCCUP ENVIRON MED, V62, P616, DOI 10.1136/oem.2004.018291; Societe Pediatrique de Pneumologie et Allergologie, 2009, ASTHM ENF MOINS 36 M; Stingone JA, 2006, ANN ALLERG ASTHMA IM, V97, P244, DOI 10.1016/S1081-1206(10)60021-X; Strunk RC, 2002, PEDIATRICS, V109, P357; Sun YX, 2007, SCI TOTAL ENVIRON, V387, P276, DOI 10.1016/j.scitotenv.2007.07.001; Sun YX, 2011, SCI TOTAL ENVIRON, V409, P4229, DOI 10.1016/j.scitotenv.2011.07.011; van der Hulst AE, 2007, J ALLERGY CLIN IMMUN, V120, P565, DOI 10.1016/j.jaci.2007.05.042; Vandentorren S, 2016, EUR J PUBLIC HEALTH, V26, P71, DOI 10.1093/eurpub/ckv187; Venn AJ, 2003, THORAX, V58, P955, DOI 10.1136/thorax.58.11.955; Victorino CC, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-53; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	43	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153872	10.1371/journal.pone.0153872	http://dx.doi.org/10.1371/journal.pone.0153872			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082960	gold, Green Submitted, Green Published			2022-12-27	WOS:000374291800061
J	Mor, V; Farnoud, AM; Singh, A; Rella, A; Tanno, H; Ishii, K; Kawakami, K; Sato, T; Del Poeta, M				Mor, Visesato; Farnoud, Amir M.; Singh, Ashutosh; Rella, Antonella; Tanno, Hiromasa; Ishii, Keiko; Kawakami, Kazuyoshi; Sato, Toshiya; Del Poeta, Maurizio			Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis	PLOS ONE			English	Article							TOXOID CONJUGATE VACCINE; ALPHA-GALACTOSYLCERAMIDE; PROTECTIVE IMMUNITY; LIVER-INJURY; CELL LIGAND; NEOFORMANS; MECHANISMS; PATHOGENICITY; ANTIBODIES; INFECTION	Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in conditions of immune deficiency disseminates to the blood stream and central nervous system, resulting in life-threatening meningoencephalitis. A number of studies have focused on the development of a vaccine against Cryptococcus, primarily utilizing protein-conjugated components of the Cryptococcus polysaccharide capsule as antigen. However, there is currently no vaccine against Cryptococcus in the clinic. Previous studies have shown that the glycosphingolipid, glucosylceramide (GlcCer), is a virulence factor in C. neoformans and antibodies against this lipid inhibit fungal growth and cell division. In the present study, we have investigated the possibility of using GlcCer as a therapeutic agent against C. neoformans infections in mouse models of cryptococcosis. GlcCer purified from a non-pathogenic fungus, Candida utilis, was administered intraperitoneally, prior to infecting mice with a lethal dose of C. neoformans. GlcCer administration prevented the dissemination of C. neoformans from the lungs to the brain and led to 60% mouse survival. GlcCer administration did not cause hepatic injury and elicited an anti-GlcCer antibody response, which was observed independent of the route of administration and the strains of mouse. Taken together, our results suggest that fungal GlcCer can protect mice against lethal doses of C. neoformans infection and can provide a viable vaccination strategy against Cryptococcus.	[Mor, Visesato; Farnoud, Amir M.; Singh, Ashutosh; Rella, Antonella; Del Poeta, Maurizio] SUNY Stony Brook, Dept Mol Genet & Microbiol, 145 Life Sci Bldg, Stony Brook, NY 11794 USA; [Tanno, Hiromasa] Tohoku Univ, Grad Sch Med, Dept Sci Nursing Practice, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Ishii, Keiko; Kawakami, Kazuyoshi] Tohoku Univ, Grad Sch Med, Dept Med Microbiol Mycol & Immunol, Aoba Ku, 2-1 Seiryo Cho, Sendai, Miyagi 9808575, Japan; [Sato, Toshiya] Kohjin Life Sci Co Ltd, Chiyoda Ku, 1-3 Yurakucho 1 Chome, Tokyo 1000006, Japan; [Del Poeta, Maurizio] Vet Adm Med Ctr, Northport, NY 11768 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Tohoku University; Tohoku University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Del Poeta, M (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, 145 Life Sci Bldg, Stony Brook, NY 11794 USA.; Del Poeta, M (corresponding author), Vet Adm Med Ctr, Northport, NY 11768 USA.	maurizio.delpoeta@stonybrook.edu	SINGH, ASHUTOSH/AAR-1283-2021	SINGH, ASHUTOSH/0000-0002-0995-6696	NIH [AI56168, AI100631, AI116420]; Veterans Affairs Program in Biomedical Laboratory Research and Development [I01BX002624]; Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056168, R21AI100631, R01AI116420] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002624] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Program in Biomedical Laboratory Research and Development; Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH grants AI56168, AI100631, AI116420 and by a Merit Review grant I01BX002624 from the Veterans Affairs Program in Biomedical Laboratory Research and Development to MDP. This work was also supported by the Research Program on Emerging and Reemerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED. MDP is a Burroughs Wellcome Investigator in Infectious Diseases. The funder provided support in the form of salaries for authors [VM, AF, AR, and MD], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. TS is an employee of Kohjin Life Sciences Co., Ltd and contributed in analyzing the data.	Biburger M, 2005, J IMMUNOL, V175, P1540, DOI 10.4049/jimmunol.175.3.1540; Biondo C, 2002, INFECT IMMUN, V70, P2383, DOI 10.1128/IAI.70.5.2383-2391.2002; Casadevall A, 2005, CURR MOL MED, V5, P421, DOI 10.2174/1566524054022567; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Chaturvedi AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104316; Chow SK, 2011, VACCINE, V29, P1891, DOI 10.1016/j.vaccine.2010.12.134; Datta K, 2008, CLIN VACCINE IMMUNOL, V15, P1176, DOI 10.1128/CVI.00130-08; Datta K, 2006, FEMS YEAST RES, V6, P525, DOI 10.1111/j.1567-1364.2006.00073.x; Del Poeta M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003832; Devi SJN, 1996, VACCINE, V14, P841, DOI 10.1016/0264-410X(95)00256-Z; Fleuridor R, 2001, J IMMUNOL, V166, P1087, DOI 10.4049/jimmunol.166.2.1087; Fujii H, 2005, VIRCHOWS ARCH, V446, P663, DOI 10.1007/s00428-005-1265-8; Gonzalez-Aseguinolaza G, 2002, J EXP MED, V195, P617, DOI 10.1084/jem.20011889; Hirata M, 2012, J AGR FOOD CHEM, V60, P11473, DOI 10.1021/jf303117e; Huang YX, 2008, VACCINE, V26, P1807, DOI 10.1016/j.vaccine.2008.02.002; Inafuku M, 2012, LIPIDS, V47, P581, DOI 10.1007/s11745-012-3666-1; Kechichian TB, 2007, INFECT IMMUN, V75, P4792, DOI 10.1128/IAI.00587-07; Ko SY, 2005, J IMMUNOL, V175, P3309, DOI 10.4049/jimmunol.175.5.3309; Kopecky-Bromberg SA, 2009, VACCINE, V27, P3766, DOI 10.1016/j.vaccine.2009.03.090; Levery SB, 2002, FEBS LETT, V525, P59, DOI 10.1016/S0014-5793(02)03067-3; Murphy JW, 1998, INFECT IMMUN, V66, P2632, DOI 10.1128/IAI.66.6.2632-2639.1998; Nakagawa R, 2001, J IMMUNOL, V166, P6578, DOI 10.4049/jimmunol.166.11.6578; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Rella A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00836; Rhome R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015572; Rittershaus PC, 2006, J CLIN INVEST, V116, P1651, DOI 10.1172/JCI27890; Rodrigues ML, 2000, INFECT IMMUN, V68, P7049, DOI 10.1128/IAI.68.12.7049-7060.2000; Saito K, 2006, APPL MICROBIOL BIOT, V71, P515, DOI 10.1007/s00253-005-0187-3; Savelkoul HFJ, 2015, VACCINES-BASEL, V3, P148, DOI 10.3390/vaccines3010148; Singh A, 2012, CELL MICROBIOL, V14, P500, DOI 10.1111/j.1462-5822.2011.01735.x; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006854	32	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153853	10.1371/journal.pone.0153853	http://dx.doi.org/10.1371/journal.pone.0153853			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082428	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800057
J	Shao, J; Gao, F; Lin, HJ; Mao, QY; Chen, P; Wu, X; Yao, X; Kong, W; Liang, ZL				Shao, Jie; Gao, Fan; Lin, Hui-Juan; Mao, Qun-Ying; Chen, Pan; Wu, Xing; Yao, Xin; Kong, Wei; Liang, Zheng-Lun			Short-Fragment DNA Residue from Vaccine Purification Processes Promotes Immune Response to the New Inactivated EV71 Vaccine by Upregulating TLR9 mRNA	PLOS ONE			English	Article							CELL RABIES VACCINE; ANTIBODY-RESPONSES; SOLUTION ASSAY; IMMUNOGENICITY; SAFETY; ADJUVANT; ANTIGEN; REAGENT	To reduce potential oncogenic long genomic DNA in vaccines, nuclease treatment has been applied in the purification processes. However, this action increased the residue of short-fragment DNA and its effect on vaccine potency was still elusive. In this study, we found residual sf-DNA in an inactivated EV71 vaccine could enhance humoral immune response in mice. Ag stimulation in vitro and vaccine injection in vivo revealed that TLR9 transcription level was elevated, indicating that sf-DNA could activate TLR9. These new findings will help us to understand the molecular mechanism induced by vero-cell culture-derived vaccines.	[Shao, Jie; Kong, Wei] Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China; [Shao, Jie; Gao, Fan; Lin, Hui-Juan; Mao, Qun-Ying; Chen, Pan; Wu, Xing; Yao, Xin; Liang, Zheng-Lun] Natl Inst Food & Drug Control, Beijing, Peoples R China	Jilin University; National Institute of Food & Drug Control - China	Kong, W (corresponding author), Jilin Univ, Sch Life Sci, Changchun 130023, Peoples R China.; Liang, ZL (corresponding author), Natl Inst Food & Drug Control, Beijing, Peoples R China.	weikong@jlu.edu.cn; lzhenglun@126.com			National 12th Five Major Special Projects Funding Program from the Ministry of Science and Technology of the People's Republic of China [2012ZX10004701]	National 12th Five Major Special Projects Funding Program from the Ministry of Science and Technology of the People's Republic of China	This work was supported by the National 12th Five Major Special Projects Funding Program (No. 2012ZX10004701) from the Ministry of Science and Technology of the People's Republic of China, URL: http://www.nmp.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichinger G, 2011, VACCINE, V29, P9376, DOI 10.1016/j.vaccine.2011.09.125; [Anonymous], 1998, DEV BIOL STAND, V93, P136; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Cannella F, 2015, IMMUNOBIOLOGY, V220, P363, DOI 10.1016/j.imbio.2014.10.012; Cao SC, 2013, HUM VACC IMMUNOTHER, V9, P413, DOI 10.4161/hv.22699; Chen J, 2011, VACCINE, V29, P706, DOI 10.1016/j.vaccine.2010.11.023; Cooper CL, 2004, VACCINE, V22, P3136, DOI 10.1016/j.vaccine.2004.01.058; Dhiman N, 2008, VACCINE, V26, P1731, DOI 10.1016/j.vaccine.2008.01.017; European Medicines Agency, 2009, ASS REP CELV; FERGUSON M, 1982, J GEN VIROL, V59, P197, DOI 10.1099/0022-1317-59-1-197; Hagen AJ, 1996, BIOTECHNOL APPL BIOC, V23, P209; Hsiao HB, 2014, J VIROL, V88, P11658, DOI 10.1128/JVI.00867-14; Iqbal J, 2013, PROTEOMICS, V13, P2455, DOI 10.1002/pmic.201300073; JOHANSSON HJ, 1990, J CHEM TECHNOL BIOT, V49, P233; Jones LJ, 1998, ANAL BIOCHEM, V265, P368, DOI 10.1006/abio.1998.2914; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Knezevic I, 2010, BIOLOGICALS, V38, P162, DOI 10.1016/j.biologicals.2009.08.019; Kulkarni PS, 2013, VACCINE, V31, P2719, DOI [10.1016/j.vaccine.2013.03.050, 10.1016/j.vaccine.201]; Kumar AAP, 2002, J BIOSCI BIOENG, V94, P375, DOI 10.1263/jbb.94.375; Lagler H, 2011, VACCINE, V29, P6888, DOI 10.1016/j.vaccine.2011.07.050; Li SM, 2014, BIOLOGICALS, V42, P271, DOI 10.1016/j.biologicals.2014.06.005; Liang ZL, 2013, HUM VACC IMMUNOTHER, V9, P1701, DOI 10.4161/hv.24949; Liang ZL, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.24; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Lin YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111496; Liu ZY, 2013, BIOMACROMOLECULES, V14, P1711, DOI 10.1021/bm400426f; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599; Pichon S, 2013, VACCINE, V31, P2295, DOI 10.1016/j.vaccine.2013.02.058; Pohar J, 2015, J IMMUNOL, V194, P3901, DOI 10.4049/jimmunol.1402755; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Rallabhandi P, 2012, MBIO, V3, DOI 10.1128/mBio.00218-12; Rassa JC, 2002, P NATL ACAD SCI USA, V99, P2281, DOI 10.1073/pnas.042355399; ROUMIANTZEFF M, 1988, Southeast Asian Journal of Tropical Medicine and Public Health, V19, P549; Sehgal Saraljit, 1994, Journal of Communicable Diseases, V26, P139; Singer VL, 1997, ANAL BIOCHEM, V249, P228, DOI 10.1006/abio.1997.2177; Tambyah PA, 2012, VACCINE, V30, P329, DOI 10.1016/j.vaccine.2011.10.088; Thoelen S, 1998, VACCINE, V16, P708, DOI 10.1016/S0264-410X(97)00254-5; van der Velden MVW, 2014, J INFECT DIS, V209, P12, DOI 10.1093/infdis/jit498; WHO Expert Committee On Biological Standardization, 1998, WHO TECH REP SER, V878, P1; Yip Cyril C Y, 2013, Emerg Health Threats J, V6, P19780, DOI 10.3402/ehtj.v6i0.19780	41	2	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153867	10.1371/journal.pone.0153867	http://dx.doi.org/10.1371/journal.pone.0153867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082865	Green Published, gold			2022-12-27	WOS:000374291800060
J	Cerritelli, S; Hirschberg, S; Hill, R; Balthasar, N; Pickering, AE				Cerritelli, Serena; Hirschberg, Stefan; Hill, Rob; Balthasar, Nina; Pickering, Anthony E.			Activation of Brainstem Pro-opiomelanocortin Neurons Produces Opioidergic Analgesia, Bradycardia and Bradypnoea	PLOS ONE			English	Article							NUCLEUS-TRACTUS-SOLITARIUS; VAGUS NERVE-STIMULATION; CARDIAC VAGAL NEURONS; STRESS-INDUCED ANALGESIA; BETA-ENDORPHIN; RETICULARIS-VENTRALIS; AFFERENT MODULATION; MEDULLA-OBLONGATA; POMC NEURONS; IN-VIVO	Opioids are widely used medicinally as analgesics and abused for hedonic effects, actions that are each complicated by substantial risks such as cardiorespiratory depression. These drugs mimic peptides such as beta-endorphin, which has a key role in endogenous analgesia. The beta-endorphin in the central nervous system originates from pro-opiomelanocortin (POMC) neurons in the arcuate nucleus and nucleus of the solitary tract (NTS). Relatively little is known about the NTSPOMC neurons but their position within the sensory nucleus of the vagus led us to test the hypothesis that they play a role in modulation of cardiorespiratory and nociceptive control. The NTSPOMC neurons were targeted using viral vectors in a POMC-Cre mouse line to express either opto-genetic (channelrhodopsin-2) or chemo-genetic (Pharmacologically Selective Actuator Modules). Opto-genetic activation of the NTSPOMC neurons in the working heart brainstem preparation (n = 21) evoked a reliable, titratable and time-locked respiratory inhibition (120% increase in inter-breath interval) with a bradycardia (125 +/- 26 beats per minute) and augmented respiratory sinus arrhythmia (58% increase). Chemo-genetic activation of NTSPOMC neurons in vivo was anti-nociceptive in the tail flick assay (latency increased by 126 +/- 65%, p<0.001; n = 8). All effects of NTSPOMC activation were blocked by systemic naloxone (opioid antagonist) but not by SHU9119 (melanocortin receptor antagonist). The NTSPOMC neurons were found to project to key brainstem structures involved in cardiorespiratory control (nucleus ambiguus and ventral respiratory group) and endogenous analgesia (periaqueductal gray and midline raphe). Thus the NTSPOMC neurons may be capable of tuning behaviour by an opioidergic modulation of nociceptive, respiratory and cardiac control.	[Cerritelli, Serena; Hirschberg, Stefan; Hill, Rob; Balthasar, Nina; Pickering, Anthony E.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England; [Pickering, Anthony E.] Univ Hosp Bristol, Dept Anaesthesia, Bristol BS2 8HW, Avon, England	University of Bristol; University of Bristol	Pickering, AE (corresponding author), Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci Bldg, Bristol BS8 1TD, Avon, England.; Pickering, AE (corresponding author), Univ Hosp Bristol, Dept Anaesthesia, Bristol BS2 8HW, Avon, England.	Tony.Pickering@bristol.ac.uk	Pickering, Anthony E/A-9929-2011; Core, Vector/CAF-4832-2022	Pickering, Anthony/0000-0003-0345-0456; Hirschberg, Stefan/0000-0002-4297-9224; Hill, Rob/0000-0003-3859-8506	Wellcome Trust [gr088373]; Medical Research Council	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Wellcome Trust, gr088373, AEP; http://www.wellcome.ac.uk/ and Medical Research Council, in vivo PhD studentship, SC; http://www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AICHER SA, 1990, PAIN, V42, P103, DOI 10.1016/0304-3959(90)91096-2; Anseloni VCZ, 2005, NEUROSCIENCE, V133, P231, DOI 10.1016/j.neuroscience.2005.01.055; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Appleyard SM, 2003, ENDOCRINOLOGY, V144, P1753, DOI 10.1210/en.2002-221096; Appleyard SM, 2005, J NEUROSCI, V25, P3578, DOI 10.1523/JNEUROSCI.4177-04.2005; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; Barraco IRA, 1994, NUCL SOLITARY TRACT; Benarroch EE, 2012, NEUROLOGY, V79, P807, DOI 10.1212/WNL.0b013e3182662098; Bicknell AB, 2008, J NEUROENDOCRINOL, V20, P692, DOI 10.1111/j.1365-2826.2008.01709.x; BIEGER D, 1987, J COMP NEUROL, V262, P546, DOI 10.1002/cne.902620408; Bohotin C, 2003, PAIN, V101, P3, DOI 10.1016/S0304-3959(02)00301-9; Boscan P, 2002, EXP PHYSIOL, V87, P259, DOI 10.1113/eph8702353; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Busch V, 2013, BRAIN STIMUL, V6, P202, DOI 10.1016/j.brs.2012.04.006; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Cardin JA, 2010, NAT PROTOC, V5, P247, DOI 10.1038/nprot.2009.228; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Corbett AD, 2006, BRIT J PHARMACOL, V147, pS153, DOI 10.1038/sj.bjp.0706435; COX BM, 1976, P NATL ACAD SCI USA, V73, P1821, DOI 10.1073/pnas.73.6.1821; DUM J, 1984, PHARMACOL BIOCHEM BE, V21, P259, DOI 10.1016/0091-3057(84)90224-7; Dutschmann M, 2009, PHILOS T R SOC B, V364, P2611, DOI 10.1098/rstb.2009.0076; FANG FG, 1989, BRAIN RES, V501, P116, DOI 10.1016/0006-8993(89)91033-0; Farmer D, 2015, FASEB J, V29; Fields H, 2004, NAT REV NEUROSCI, V5, P565, DOI 10.1038/nrn1431; Frank JG, 2009, J NEUROPHYSIOL, V101, P1755, DOI 10.1152/jn.91134.2008; Griffioen KJS, 2004, BRAIN RES, V1007, P109, DOI 10.1016/j.brainres.2004.02.010; Harrison D, 2012, PEDIATRICS, V130, P918, DOI 10.1542/peds.2011-3848; Hickey L, 2014, J NEUROSCI, V34, P4148, DOI 10.1523/JNEUROSCI.4835-13.2014; HOLADAY JW, 1983, ANNU REV PHARMACOL, V23, P541, DOI 10.1146/annurev.pa.23.040183.002545; Howorth PW, 2009, J COMP NEUROL, V512, P141, DOI 10.1002/cne.21879; Irnaten M, 2003, NEUROSCIENCE, V116, P573, DOI 10.1016/S0306-4522(02)00657-7; IZZO PN, 1993, J COMP NEUROL, V327, P572, DOI 10.1002/cne.903270408; JOSEPH SA, 1983, NEUROSCI LETT, V38, P221, DOI 10.1016/0304-3940(83)90372-5; Kirchner A, 2000, NEUROLOGY, V55, P1167, DOI 10.1212/WNL.55.8.1167; Kirchner A, 2006, EUR J PAIN, V10, P449, DOI 10.1016/j.ejpain.2005.06.005; Lalley PM, 2014, J PHYSIOL-LONDON, V592, P1163, DOI 10.1113/jphysiol.2013.258830; Lalley PM, 2008, RESP PHYSIOL NEUROBI, V164, P160, DOI 10.1016/j.resp.2008.02.004; LEVINE JD, 1980, BRAIN RES, V201, P129, DOI 10.1016/0006-8993(80)90780-5; LEWIS JW, 1987, BRAIN RES, V424, P65, DOI 10.1016/0006-8993(87)91193-0; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; Marsh DJ, 1999, NAT GENET, V21, P119, DOI 10.1038/5070; Mason P, 2009, ANN NY ACAD SCI, V1170, P399, DOI 10.1111/j.1749-6632.2009.04368.x; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; MILLAN MJ, 1986, PAIN, V27, P303, DOI 10.1016/0304-3959(86)90158-2; Mogil JS, 2000, NEUROSCIENCE, V101, P709, DOI 10.1016/S0306-4522(00)00422-X; Montandon G, 2014, J PHYSIOL-LONDON, V592, P1159, DOI 10.1113/jphysiol.2013.261974; Montandon G, 2011, J NEUROSCI, V31, P1292, DOI 10.1523/JNEUROSCI.4611-10.2011; MORGAN MM, 1989, BRAIN RES, V486, P175, DOI 10.1016/0006-8993(89)91291-2; Mountjoy KG, 2010, ADV EXP MED BIOL, V681, P29, DOI 10.1007/978-1-4419-6354-3_3; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; PALKOVITS M, 1987, BRAIN RES, V436, P323, DOI 10.1016/0006-8993(87)91676-3; Paton JFR, 1996, J NEUROSCI METH, V65, P63, DOI 10.1016/0165-0270(95)00147-6; Pattinson KTS, 2008, BRIT J ANAESTH, V100, P747, DOI 10.1093/bja/aen094; Prkic I, 2012, J NEUROPHYSIOL, V108, P2430, DOI 10.1152/jn.00185.2012; RANDICH A, 1988, J NEUROSCI, V8, P4675; RANDICH A, 1992, BRAIN RES REV, V17, P77, DOI 10.1016/0165-0173(92)90009-B; REN K, 1988, BRAIN RES, V446, P285, DOI 10.1016/0006-8993(88)90887-6; Richardson J, 2013, J NEUROSCI, V33, P13286, DOI 10.1523/JNEUROSCI.0780-13.2013; Rubinstein M, 1996, P NATL ACAD SCI USA, V93, P3995, DOI 10.1073/pnas.93.9.3995; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHWARTZBERG DG, 1983, BRAIN RES, V276, P351, DOI 10.1016/0006-8993(83)90746-1; Stannard CF, 2013, OPIOIDS BRIEF HIST O, P1; SUH HH, 1990, J PHARMACOL EXP THER, V253, P981; Sutton AK, 2014, J NEUROSCI, V34, P15306, DOI 10.1523/JNEUROSCI.0226-14.2014; TSENG LF, 1992, EUR J PHARMACOL, V214, P59, DOI 10.1016/0014-2999(92)90096-M; Vaughan CW, 1997, NATURE, V390, P611, DOI 10.1038/37610; Venkatesan P, 2003, J NEUROPHYSIOL, V90, P1581, DOI 10.1152/jn.01117.2002; Wan S, 2008, J NEUROSCI, V28, P4957, DOI 10.1523/JNEUROSCI.5398-07.2008; Wang DQ, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00040; WATSON SJ, 1978, NATURE, V275, P226, DOI 10.1038/275226a0; Yang YL, 2011, CELL, V146, P991, DOI 10.1016/j.cell.2011.07.039; Zhan C, 2013, J NEUROSCI, V33, P3624, DOI 10.1523/JNEUROSCI.2742-12.2013; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936	74	24	25	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153187	10.1371/journal.pone.0153187	http://dx.doi.org/10.1371/journal.pone.0153187			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077912	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700026
J	Ingram, NT; Khankan, RR; Phelps, PE				Ingram, Norianne T.; Khankan, Rana R.; Phelps, Patricia E.			Olfactory Ensheathing Cells Express alpha 7 Integrin to Mediate Their Migration on Laminin	PLOS ONE			English	Article							DIRECT CELLULAR CONTACT; NERVE GROWTH-FACTOR; SCHWANN-CELLS; SPINAL-CORD; NEURITE OUTGROWTH; GENE-EXPRESSION; IN-VITRO; GLIA TRANSPLANTATION; VASCULAR DEVELOPMENT; FUNCTIONAL RECOVERY	The unique glia located in the olfactory system, called olfactory ensheathing cells (OECs), are implicated as an attractive choice for transplantation therapy following spinal cord injury because of their pro-regenerative characteristics. Adult OECs are thought to improve functional recovery and regeneration after injury by secreting neurotrophic factors and making cell-to-cell contacts with regenerating processes, but the mechanisms are not well understood. We show first that alpha 7 integrin, a laminin receptor, is highly expressed at the protein level by OECs throughout the olfactory system, i.e., in the olfactory mucosa, olfactory nerve, and olfactory nerve layer of the olfactory bulb. Then we asked if OECs use the alpha 7 integrin receptor directly to promote neurite outgrowth on permissive and neutral substrates, in vitro. We co-cultured alpha 7(+/+) and alpha 7(lacZ/lacZ) postnatal cerebral cortical neurons with alpha 7(+/+) or alpha 7(lacZ/lacZ) OECs and found that genotype did not effect the ability of OECs to enhance neurite outgrowth by direct contact. Loss of alpha 7 integrin did however significantly decrease the motility of adult OECs in transwell experiments. Twice as many alpha 7(+/+) OECs migrated through laminin-coated transwells compared to alpha 7(+/+) OECs on poly-L-lysine (PLL). This is in contrast to alpha 7(lacZ/lacZ) OECs, which showed no migratory preference for laminin substrate over PLL. These results demonstrate that OECs express alpha 7 integrin, and that laminin and its alpha 7 integrin receptor contribute to adult OEC migration in vitro and perhaps also in vivo.	[Ingram, Norianne T.; Khankan, Rana R.; Phelps, Patricia E.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA	University of California System; University of California Los Angeles	Phelps, PE (corresponding author), Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA.	pphelps@physci.ucla.edu			National Institutes of Health, National Institute of General Medical Sciences [2T32GM065823]; National Institutes of Health, National Institute of Neurological Disorders and Stroke [RO1NS076976]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD087101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076976] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Support was provided by the National Institutes of Health, National Institute of General Medical Sciences, Grant number: 2T32GM065823 (NTI); National Institutes of Health, National Institute of Neurological Disorders and Stroke; Grant number: RO1NS076976 (RKK and PEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadesco AD, 2014, EUR J NEUROSCI, V39, P579, DOI 10.1111/ejn.12416; Au WW, 2002, J COMP NEUROL, V446, P68, DOI 10.1002/cne.10182; Barnett SC, 2004, TRENDS NEUROSCI, V27, P54, DOI 10.1016/j.tins.2003.10.011; Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107; Cao L, 2007, GLIA, V55, P897, DOI 10.1002/glia.20511; Chernousov MA, 2007, GLIA, V55, P1134, DOI 10.1002/glia.20536; Choi D, 2008, BRIT J NEUROSURG, V22, P301, DOI 10.1080/02688690701883442; Chung RS, 2004, CELL MOL LIFE SCI, V61, P1238, DOI 10.1007/s00018-004-4026-y; DOUCETTE R, 1990, GLIA, V3, P433, DOI 10.1002/glia.440030602; Flintoff-Dye NL, 2005, DEV DYNAM, V234, P11, DOI 10.1002/dvdy.20462; Forni PE, 2011, J NEUROSCI, V31, P6915, DOI 10.1523/JNEUROSCI.6087-10.2011; Franceschini IA, 1996, DEV BIOL, V173, P327, DOI 10.1006/dbio.1996.0027; Franssen EHP, 2008, GLIA, V56, P1285, DOI 10.1002/glia.20697; Gardiner NJ, 2005, MOL CELL NEUROSCI, V28, P229, DOI 10.1016/j.mcn.2004.08.017; Granger N, 2012, BRAIN, V135, P3227, DOI 10.1093/brain/aws268; Guerout N, 2010, GLIA, V58, P1570, DOI 10.1002/glia.21030; Hultgardh-Nilsson A, 2007, CURR OPIN LIPIDOL, V18, P540, DOI 10.1097/MOL.0b013e3282ef77e9; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Khankan RR, 2015, EXP NEUROL, V269, P93, DOI 10.1016/j.expneurol.2015.03.025; Khialeeva E, 2011, DEVELOPMENT, V138, P767, DOI 10.1242/dev.057588; Kostidou E, 2007, CLIN BIOCHEM, V40, P671, DOI 10.1016/j.clinbiochem.2007.03.011; LIESI P, 1985, EMBO J, V4, P2505, DOI 10.1002/j.1460-2075.1985.tb03963.x; Lipson AC, 2003, EXP NEUROL, V180, P167, DOI 10.1016/S0014-4886(02)00058-4; Liu QA, 2010, NEUROSCI LETT, V478, P37, DOI 10.1016/j.neulet.2010.04.065; Mercado MLT, 2004, J NEUROSCI, V24, P238, DOI 10.1523/JNEUROSCI.4519-03.2004; Monti-Graziadei G A, 1977, J Histochem Cytochem, V25, P1311; Murdoch B, 2008, J NEUROSCI, V28, P4271, DOI 10.1523/JNEUROSCI.5566-07.2008; Previtali SC, 2003, MOL CELL NEUROSCI, V23, P210, DOI 10.1016/S1044-7431(03)00014-9; Ramon-Cueto A, 2000, NEURON, V25, P425, DOI 10.1016/S0896-6273(00)80905-8; Ramon-Cueto A, 2000, PROG BRAIN RES, V128, P265; Roet KCD, 2013, J NEUROSCI, V33, P11116, DOI 10.1523/JNEUROSCI.1002-13.2013; Roet KCD, 2011, EXP NEUROL, V229, P10, DOI 10.1016/j.expneurol.2011.03.001; Rooney JE, 2006, J CELL SCI, V119, P2185, DOI 10.1242/jcs.02952; Ruitenberg MJ, 2003, J NEUROSCI, V23, P7045, DOI 10.1523/JNEUROSCI.23-18-07045.2003; Runyan SA, 2009, EXP NEUROL, V216, P95, DOI 10.1016/j.expneurol.2008.11.015; Shields SD, 2010, J COMP NEUROL, V518, P4329, DOI 10.1002/cne.22459; Su ZD, 2013, GLIA, V61, P490, DOI 10.1002/glia.22450; Tabakow P, 2014, CELL TRANSPLANT, V23, P1631, DOI 10.3727/096368914X685131; Takatoh J, 2008, EXP NEUROL, V213, P36, DOI 10.1016/j.expneurol.2008.04.041; Takeoka A, 2011, J NEUROSCI, V31, P4298, DOI 10.1523/JNEUROSCI.4967-10.2011; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Velling T, 1996, DEV DYNAM, V207, P355, DOI 10.1002/(SICI)1097-0177(199612)207:4<355::AID-AJA1>3.0.CO;2-G; Wanner IB, 2008, GLIA, V56, P1691, DOI 10.1002/glia.20721; Werner A, 2000, J NEUROSCI, V20, P1822; Wewetzer K, 2002, CELL TISSUE RES, V309, P337, DOI 10.1007/s00441-002-0607-y; Whitley M, 2005, J NEUROCYTOL, V34, P81, DOI 10.1007/s11068-005-5049-5; Windus LCE, 2007, GLIA, V55, P1708, DOI 10.1002/glia.20586; Windus LCE, 2010, CELL MOL LIFE SCI, V67, P1735, DOI 10.1007/s00018-010-0280-3; Woodhall E, 2001, MOL BRAIN RES, V88, P203, DOI 10.1016/S0169-328X(01)00044-4; Yao CC, 1997, J CELL SCI, V110, P1477; Ziegler MD, 2011, EXP NEUROL, V229, P109, DOI 10.1016/j.expneurol.2011.01.007	51	9	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153394	10.1371/journal.pone.0153394	http://dx.doi.org/10.1371/journal.pone.0153394			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078717	gold, Green Published			2022-12-27	WOS:000374131700050
J	Kong, XY; Yang, ST; Gong, F; Lu, CF; Zhang, SP; Lu, GX; Lin, G				Kong, Xiangyi; Yang, Shuting; Gong, Fei; Lu, Changfu; Zhang, Shuoping; Lu, Guangxiu; Lin, Ge			The Relationship between Cell Number, Division Behavior and Developmental Potential of Cleavage Stage Human Embryos: A Time-Lapse Study	PLOS ONE			English	Article							MORPHOLOGY; PREDICTOR; PROGNOSIS; CULTURE; QUALITY	Day 3 cleavage embryo transfer is routine in many assisted reproductive technology centers today. Embryos are usually selected according to cell number, cell symmetry and fragmentation for transfer. Many studies have showed the relationship between cell number and embryo developmental potential. However, there is limited understanding of embryo division behavior and their association with embryo cell number and developmental potential. A retrospective and observational study was conducted to investigate how different division behaviors affect cell number and developmental potential of day 3 embryos by time-lapse imaging. Based on cell number at day 3, the embryos (from 104 IVF/intracytoplasmic sperm injection (ICSI) treatment cycles, n = 799) were classified as follows: less than 5 cells (<5C; n = 111); 5-6 cells (5-6C; n = 97); 7-8 cells (7-8C; n = 442), 9-10 cells (9-10C; n = 107) and more than 10 cells (>10C; n = 42). Division behavior, morphokinetic parameters and blastocyst formation rate were analyzed in 5 groups of day 3 embryos with different cell numbers. In <5C and 5-6C embryos, fragmentation (FR; 62.2% and 30.9%, respectively) was the main cause for low cell number. The majority of 7-8C embryos exhibited obvious normal behaviors (NB; 85.7%) during development. However, the incidence of DC in 9-10C and >10C embryos increased compared to 7-8C embryos (45.8%, 33.3% vs. 11.1%, respectively). In >= 5C embryos, FR and DC significantly reduced developmental potential, whereas <5C embryos showed little potential irrespective of division behaviors. In NB embryos, the blastocyst formation rate increased with cell number from 7.4% (<5C) to 89.3% (>10C). In NB embryos, the cell cycle elongation or shortening was the main cause for abnormally low or high cell number, respectively. After excluding embryos with abnormal division behaviors, the developmental potential, implantation rate and live birth rate of day 3 embryos increased with cell number.	[Kong, Xiangyi; Yang, Shuting; Gong, Fei; Lu, Changfu; Zhang, Shuoping; Lu, Guangxiu; Lin, Ge] Cent South Univ, Coll Basic Med, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Kong, Xiangyi; Yang, Shuting; Gong, Fei; Lu, Changfu; Zhang, Shuoping; Lu, Guangxiu; Lin, Ge] Minist Hlth, Key Lab Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Gong, Fei; Lu, Changfu; Zhang, Shuoping; Lu, Guangxiu; Lin, Ge] CITIC Xiangya, Reprod & Genet Hosp, Changsha, Hunan, Peoples R China; [Lu, Guangxiu; Lin, Ge] Natl Engn & Res Ctr Human Stem Cells, Changsha, Hunan, Peoples R China	Central South University; Central South University	Lin, G (corresponding author), Cent South Univ, Coll Basic Med, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.; Lin, G (corresponding author), Minist Hlth, Key Lab Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China.; Lin, G (corresponding author), CITIC Xiangya, Reprod & Genet Hosp, Changsha, Hunan, Peoples R China.; Lin, G (corresponding author), Natl Engn & Res Ctr Human Stem Cells, Changsha, Hunan, Peoples R China.	linggf@hotmail.com			National Natural Science Foundation of China [81222007, 81471510]; Major State Basic Research Development Program of China [2012CB944901]; Program for New Century Excellent Talents in University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The work was supported by the following: National Natural Science Foundation of China (No. 81222007, No.81471510), GLin; Major State Basic Research Development Program of China (No. 2012CB944901), GLu; and Program for New Century Excellent Talents in University, GLin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AH S, 1982, MICRON, V13, P193; Alikani M, 2000, HUM REPROD, V15, P2634, DOI 10.1093/humrep/15.12.2634; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; Azzarello A, 2012, HUM REPROD, V27, P2649, DOI 10.1093/humrep/des210; Buehler N, 2008, FERTIL STERIL, V90, P243, DOI 10.1016/j.fertnstert.2008.05.023; Check JH, 2011, CLIN EXP OBSTET GYN, V38, P201; Chen AA, 2013, FERTIL STERIL, V99, P1035, DOI 10.1016/j.fertnstert.2013.01.143; Chi HJ, 2011, FERTIL STERIL, V96, P187, DOI 10.1016/j.fertnstert.2011.04.020; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; CUMMINS J M, 1986, Journal of In Vitro Fertilization and Embryo Transfer, V3, P284, DOI 10.1007/BF01133388; Desai NN, 2000, HUM REPROD, V15, P2190, DOI 10.1093/humrep/15.10.2190; Escrich L, 2010, FERTIL STERIL, V93, P2557, DOI 10.1016/j.fertnstert.2009.05.077; Gardner DK, 1999, TOWARDS REPRODUCTIVE CERTAINTY, P378; Hashimoto S, 2012, FERTIL STERIL, V97, P332, DOI 10.1016/j.fertnstert.2011.11.042; Hlinka D, 2012, PHYSIOL RES, V61, P513, DOI 10.33549/physiolres.932287; Hnida C, 2004, HUM REPROD, V19, P288, DOI 10.1093/humrep/deh070; Kasterstein E, 2013, J ASSIST REPROD GEN, V30, P1073, DOI 10.1007/s10815-013-0032-z; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; Luna M, 2008, FERTIL STERIL, V89, P358, DOI 10.1016/j.fertnstert.2007.03.030; Magli MC, 1998, J ASSIST REPROD GEN, V15, P297, DOI 10.1023/A:1022596528036; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Rubio I, 2012, LIMITED IMPLANTATION, P1458; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Stylianou C, 2012, HUM FERTIL, V15, P11, DOI 10.3109/14647273.2011.652251; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050; Wong CC, 2010, NAT BIOTECHNOL, V28, P1115, DOI 10.1038/nbt.1686; Yang S. T., 2015, REPROD BIOMED ONLINE; Ziebe S, 1997, HUM REPROD, V12, P1545, DOI 10.1093/humrep/12.7.1545	28	28	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153697	10.1371/journal.pone.0153697	http://dx.doi.org/10.1371/journal.pone.0153697			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077739	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700105
J	Maggio, M; Ceda, GP; Ticinesi, A; De Vita, F; Gelmini, G; Costantino, C; Meschi, T; Kressig, RW; Cesari, M; Fabi, M; Lauretani, F				Maggio, Marcello; Ceda, Gian Paolo; Ticinesi, Andrea; De Vita, Francesca; Gelmini, Giovanni; Costantino, Cosimo; Meschi, Tiziana; Kressig, Reto W.; Cesari, Matteo; Fabi, Massimo; Lauretani, Fulvio			Instrumental and Non-Instrumental Evaluation of 4-Meter Walking Speed in Older Individuals	PLOS ONE			English	Article							PHYSICAL PERFORMANCE-MEASURES; GAIT SPEED; CONTROLLED-TRIAL; SARCOPENIA; ADULTS; DISABILITY; MOBILITY; HEALTH; IDENTIFICATION; VALIDATION	Background Manual measurement of 4-meter gait speed by a stopwatch is the gold standard test for functional assessment in older adults. However, the accuracy of this technique may be biased by several factors, including intra-and inter-operator variability. Instrumental techniques of measurement using accelerometers may have a higher accuracy. Studies addressing the concordance between these two techniques are missing. The aim of the present community-based observational study was to compare manual and instrumental measurements of 4-meter gait speed in older individuals and to assess their relationship with other indicators of physical performance. Methods One-hundred seventy-two (69 men, 103 women) non-disabled community-dwellers aged >= 65 years were enrolled. They underwent a comprehensive geriatric assessment including physical function by Short Physical Performance Battery (SPPB), hand grip strength, and 6-minute walking test (6MWT). Timed usual walking speed on a 4-meter course was assessed by using both a stopwatch (4-meter manual measurement, 4-MM) and a tri-axial accelerometer (4-meter automatic measurement, 4-MA). Correlations between these performance measures were evaluated separately in men and women by partial correlation coefficients. Results In both genders, 4-MA was associated with 4-MM (men r = 0.62, p<0.001; women r = 0.73, p<0.001), handgrip strength (men r = 0.40, p = 0.005; women r = 0.29, p = 0.001) and 6MWT (men r = 0.50, p = 0.0004; women r = 0.22, p = 0.048). 4-MM was associated with handgrip strength and 6MWT in both men and women. Considering gait speed <0.6 m/s as diagnostic of dismobility syndrome, the two methods of assessment disagreed, with a different categorization of subjects, in 19% of men and 23% of women. The use of accelerometer resulted in 29 (13 M, 16 F) additional diagnoses of dismobility, compared with the 4-MM. Conclusions In an older population, the concordance of gait speeds manually or instrumentally assessed is not optimal. The results suggest that manual measures might lead to misclassification of a substantial number of subjects. However, longitudinal studies using standardized and validated procedures aimed at the comparison of different techniques are needed before recommending the use of accelerometers in comprehensive geriatric assessment.	[Maggio, Marcello; Ceda, Gian Paolo; Ticinesi, Andrea; De Vita, Francesca; Costantino, Cosimo; Meschi, Tiziana; Lauretani, Fulvio] Univ Hosp Parma, Geriatr Rehabil Dept, Parma, Italy; [Maggio, Marcello; Ceda, Gian Paolo; Ticinesi, Andrea; De Vita, Francesca; Costantino, Cosimo; Meschi, Tiziana] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Gelmini, Giovanni] Azienda USL Parma, Dist Valli Taro & Ceno, Parma, Italy; [Kressig, Reto W.] Univ Basel, Felix Platter Hosp, Univ Ctr Med Aging Basel UAB, Memory Clin, CH-4003 Basel, Switzerland; [Cesari, Matteo] Ctr Hosp Univ Toulouse, Gerontopole, Toulouse, France; [Cesari, Matteo] Univ Toulouse 3, F-31062 Toulouse, France; [Fabi, Massimo] Univ Hosp Parma, Gen Direct, Parma, Italy	University of Parma; University Hospital of Parma; University of Parma; University Hospital of Parma; University of Basel; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Parma; University Hospital of Parma	Maggio, M (corresponding author), Univ Hosp Parma, Geriatr Rehabil Dept, Parma, Italy.; Maggio, M (corresponding author), Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy.	marcellomaggio2001@yahoo.it	Costantino, Cosimo/Q-1606-2016; Cesari, Matteo/A-4649-2008; Lauretani, Fulvio/K-5115-2016; Meschi, Tiziana/K-5032-2016; Ticinesi, Andrea/K-5017-2016	Costantino, Cosimo/0000-0003-0563-5235; Cesari, Matteo/0000-0002-0348-3664; Lauretani, Fulvio/0000-0002-5287-9972; Meschi, Tiziana/0000-0002-7538-6863; Ticinesi, Andrea/0000-0001-9171-8592; Ceda, Gian Paolo/0000-0002-9648-8295	Nutricia Research, Nutricia Advanced Medical Nutrition	Nutricia Research, Nutricia Advanced Medical Nutrition	Data presented in this paper are from the MED&SANO study, a population-based epidemiological study conducted in a representative sample of non-disabled older persons living in Medesano geographic area (Emilia Romagna Region, Italy). This is an ancillary project of the Provide multicenter European study. The current analysis used cross-sectional data from the baseline comprehensive geriatric assessment conducted between November 2012 and April 2013. The study was financially supported by Nutricia Research, Nutricia Advanced Medical Nutrition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The final interpretation of the study results, review, and decision to submit the manuscript was performed by independent researchers with no affiliation to the funding source. None of the authors received financial compensation or grants by the funding source.	Bandinelli S, 2006, AM J PHYS MED REHAB, V85, P986, DOI 10.1097/01.phm.0000233210.69400.d4; Bauer JM, 2015, J AM MED DIR ASSOC, V16, P740, DOI 10.1016/j.jamda.2015.05.021; Brooks D, 2003, AM J RESP CRIT CARE, V167, P1287, DOI 10.1164/ajrccm.167.9.950; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Culhane KM, 2005, AGE AGEING, V34, P556, DOI 10.1093/ageing/afi192; Cummings SR, 2014, JAMA-J AM MED ASSOC, V311, P2061, DOI 10.1001/jama.2014.3033; Dam TT, 2014, J GERONTOL A-BIOL, V69, P584, DOI 10.1093/gerona/glu013; Eyler AA, 2003, MED SCI SPORT EXER, V35, P1529, DOI 10.1249/01.MSS.0000084622.39122.0C; Fazio P, 2013, NEUROL SCI, V34, P435, DOI 10.1007/s10072-012-1017-x; Fitzhugh EC, 2009, J PHYS ACT HEALTH, V6, P393, DOI 10.1123/jpah.6.4.393; Gill TM, 2010, J AM GERIATR SOC, V58, pS308, DOI 10.1111/j.1532-5415.2010.02914.x; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Kaiser MJ, 2009, J NUTR HEALTH AGING, V13, P782, DOI 10.1007/s12603-009-0214-7; Kalyani RR, 2013, J AM GERIATR SOC, V61, P769, DOI 10.1111/jgs.12204; Kasper JD, 1999, ANN EPIDEMIOL, V9, P498, DOI 10.1016/S1047-2797(99)00026-5; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lauretani F, 2014, AGING MALE, V17, P199, DOI 10.3109/13685538.2014.958457; Lord S, 2013, MOVEMENT DISORD, V28, P1534, DOI 10.1002/mds.25545; Minneci C, 2015, J AM GERIATR SOC, V63, P136, DOI 10.1111/jgs.13195; Montero-Odasso M, 2005, J GERONTOL A-BIOL, V60, P1304, DOI 10.1093/gerona/60.10.1304; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Murphy SL, 2009, PREV MED, V48, P108, DOI 10.1016/j.ypmed.2008.12.001; Patil R, 2015, J AM GERIATR SOC, V63, P1306, DOI 10.1111/jgs.13489; Rydwik E., 2012, Physiotherapy Theory and Practice, V28, P238, DOI 10.3109/09593985.2011.601804; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Studenski S, 2003, J AM GERIATR SOC, V51, P314, DOI 10.1046/j.1532-5415.2003.51104.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Vinkers DJ, 2004, INT J GERIATR PSYCH, V19, P80, DOI 10.1002/gps.1043	30	52	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153583	10.1371/journal.pone.0153583	http://dx.doi.org/10.1371/journal.pone.0153583			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077744	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700085
J	Sarzani, R; Spannella, F; Giulietti, F; Fedecostante, M; Giordano, P; Gattafoni, P; Espinosa, E; Busco, F; Piccinini, G; Dessi-Fulgheri, P				Sarzani, Riccardo; Spannella, Francesco; Giulietti, Federico; Fedecostante, Massimiliano; Giordano, Piero; Gattafoni, Pisana; Espinosa, Emma; Busco, Franco; Piccinini, Gina; Dessi-Fulgheri, Paolo			NT-proBNP and Its Correlation with In-Hospital Mortality in the Very Elderly without an Admission Diagnosis of Heart Failure	PLOS ONE			English	Article							NATRIURETIC PEPTIDE LEVELS; QUALITY-OF-CARE; PREDICTIVE-VALUE; OLDER-ADULTS; VALIDATION; GUIDELINES; DEATH; BNP	Background The diagnosis of heart failure (HF) is often difficult and underestimated in very elderly comorbid patients, especially when an echocardiographic evaluation is not available or feasible. Aim: to evaluate NT-proBNP values and their correlation with in-hospital mortality in a population of very elderly hospitalized for medical conditions other than HF. Methods We performed a prospective observational study on 403 very elderly admitted to an Internal Medicine and Geriatrics Department. Exclusion criterion was an admission diagnosis of HF. Patients with at least one symptom or sign compatible with HF were tested for NT-proBNP. NT-proBNP values < 300 pg/ml were considered as an age-independent exclusion criterion for HF (high negative predictive value), while NT-proBNP values >= 1800 pg/ml were considered as a diagnostic criterion. Main comorbidities and laboratory parameters were considered to adjust regression analyses between NT-proBNP and in-hospital mortality. Results NT-proBNP values >= 1800 pg/ml were present in 61.0% of patients and 32.8% of patients laid between 300 <= NT-proBNP < 1800 pg/ml values. NT-proBNP values were associated with the main indices of disease severity/organ failure considered such as reduced eGFR, reduced albumin and elevated CRP. NT-proBNP values >= 1800 pg/ml and ln(NT-proBNP) values were significantly associated with in-hospital mortality independently from the main comorbidities and lab parameters considered. The patients, who were already taking ACE inhibitors/Angiotensin Receptor Blockers before admission, showed lower in-hospital mortality. Conclusions Testing for NT-proBNP should be strongly recommended in the hospitalized very elderly, because of the very high prevalence of underlying HF and its impact on in-hospital mortality, to identify an underlying cardiac involvement that requires appropriate treatment.	[Sarzani, Riccardo; Spannella, Francesco; Giulietti, Federico; Fedecostante, Massimiliano; Giordano, Piero; Gattafoni, Pisana; Espinosa, Emma; Busco, Franco; Dessi-Fulgheri, Paolo] IRCCS INRCA, Italian Natl Res Ctr Aging U Sestilli, Ancona, Italy; [Sarzani, Riccardo; Spannella, Francesco; Giulietti, Federico; Giordano, Piero; Gattafoni, Pisana; Espinosa, Emma; Dessi-Fulgheri, Paolo] Univ Politecn Marche, Dept Clin & Mol Sci, Internal Med & Geriatr, Ancona, Italy; [Busco, Franco; Piccinini, Gina] IRCCS INRCA, Italian Natl Res Ctr Aging U Sestilli, Clin Anal Lab, Ancona, Italy	IRCCS INRCA; Marche Polytechnic University; IRCCS INRCA	Sarzani, R (corresponding author), IRCCS INRCA, Italian Natl Res Ctr Aging U Sestilli, Ancona, Italy.; Sarzani, R (corresponding author), Univ Politecn Marche, Dept Clin & Mol Sci, Internal Med & Geriatr, Ancona, Italy.	r.sarzani@univpm.it	Spannella, Francesco/AAB-2960-2021; Fedecostante, Massimiliano/K-1789-2018; Sarzani, Riccardo/AAB-3110-2021	Spannella, Francesco/0000-0002-1846-7819; Fedecostante, Massimiliano/0000-0002-0130-5805; Sarzani, Riccardo/0000-0002-5159-0181				Abete P, 2013, HEART FAIL REV, V18, P529, DOI 10.1007/s10741-012-9363-6; Ahmed A, 2004, ARCH GERONTOL GERIAT, V38, P297, DOI 10.1016/j.archger.2003.12.001; Blonde-Cynober F, 2011, ARCH GERONTOL GERIAT, V52, P106, DOI 10.1016/j.archger.2010.02.010; Bombelli M, 2015, ARCH GERONTOL GERIAT, V61, P296, DOI 10.1016/j.archger.2015.05.001; Borson S, 2003, J AM GERIATR SOC, V51, P1451, DOI 10.1046/j.1532-5415.2003.51465.x; Brocco S, 2010, AGING CLIN EXP RES, V22, P243, DOI 10.1007/BF03324803; Di Somma S, 2015, CLIN CHEM LAB MED, V53, P507, DOI 10.1515/cclm-2013-0927; Di Somma S, 2010, CRIT CARE, V14, DOI 10.1186/cc9067; Di Somma Salvatore, 2008, Congest Heart Fail, V14, P245, DOI 10.1111/j.1751-7133.2008.00002.x; Doust JA, 2005, BRIT MED J, V330, P625, DOI 10.1136/bmj.330.7492.625; Fonarow GC, 2007, J AM COLL CARDIOL, V49, P1943, DOI 10.1016/j.jacc.2007.02.037; Januzzi JL, 2008, AM J CARDIOL, V101, p1A, DOI 10.1016/j.amjcard.2007.11.011; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Oudejans I, 2011, EUR J HEART FAIL, V13, P518, DOI 10.1093/eurjhf/hfr021; Rozzini R, 2002, AGE AGEING, V31, P277, DOI 10.1093/ageing/31.4.277; Samala RV, 2011, CLEV CLIN J MED, V78, P837, DOI 10.3949/ccjm.78a.11085; Sanders-van Wijk S, 2013, EUR J HEART FAIL, V15, P910, DOI 10.1093/eurjhf/hft079; Schocken DD, 2008, CIRCULATION, V117, P2544, DOI 10.1161/CIRCULATIONAHA.107.188965; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Testa G, 2013, J AM GERIATR SOC, V61, P1827, DOI 10.1111/jgs.12475; Vaes B, 2010, BMC GERIATR, V10, DOI 10.1186/1471-2318-10-85; Vaes B, 2009, J AM GERIATR SOC, V57, P823, DOI 10.1111/j.1532-5415.2009.02218.x	27	23	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153759	10.1371/journal.pone.0153759	http://dx.doi.org/10.1371/journal.pone.0153759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077910	Green Published, gold			2022-12-27	WOS:000374131700106
J	Depardieu, C; Premont, V; Boily, C; Caron, J				Depardieu, Claire; Premont, Valerie; Boily, Carole; Caron, Jean			Sawdust and Bark-Based Substrates for Soilless Strawberry Production: Irrigation and Electrical Conductivity Management	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY; CHEMICAL-PROPERTIES; GROWING MEDIA; PEAT MOSS; COIR; GROWTH; YIELD; AERATION; ELSANTA; QUALITY	The objective of this work was to optimize a soilless growing system for producing bare-root strawberry transplants in three organic substrates. Three trials were conducted in the Quebec City area to determine the productivity potential of a peat-sawdust mixture (PS25) and an aged bark (AB) material compared to conventional coconut fiber (CF) substrate. A first experiment was carried out to define appropriate irrigation set points for each substrate that allowed optimal plant growth and fruit yields. For all substrates, wetter conditions (irrigation started at -1.0 kPa for CF; -1.5 kPa for AB and PS25, relative to -1.5 kPa for CF; -2.5 kPa for AB and PS25) enhanced plant growth and fruit production. The second trial was carried out to test the productivity potential for commercial production of the three substrates using high-tunnels. After the addition of an initial fertilizer application to PS25, we successfully established bare-root plants that gave similar fruit yields than those in CF and AB. The productivity potential of PS25 and AB were further confirmed during a third trial under greenhouse conditions. The critical factor for plant establishment in PS25 was attributed to consistent N, P and S immobilization by microorganisms, as well as the retention of other elements (Mg2+, K+) in the growth media. Taken together, our results showed that PS25 and AB are promising alternative substrates to coconut coir dust for strawberry cultivation. This paper also provides a useful guide for strawberry cultivation in Quebec, and suggests future research that might be conducted to optimize soilless systems for cold-climate strawberry production in Northern America.	[Depardieu, Claire; Premont, Valerie; Boily, Carole; Caron, Jean] Univ Laval, Dept Sols & Genie Agroalimentaire, 2480 Blvd Hochelaga, Quebec City, PQ G1V 0A6, Canada	Laval University	Depardieu, C (corresponding author), Univ Laval, Dept Sols & Genie Agroalimentaire, 2480 Blvd Hochelaga, Quebec City, PQ G1V 0A6, Canada.	calima45@hotmail.fr			Natural Sciences and Engineering Research Council of Canada (NSERC); Ferme Onesime Pouliot; Hortau	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ferme Onesime Pouliot; Hortau	The authors acknowledge the financial and collaboration of the Natural Sciences and Engineering Research Council of Canada (NSERC), Ferme Onesime Pouliot and Hortau to have funded and collaborated in this study. NSERC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2002, BIORESOURCE TECHNOL, V82, P241, DOI 10.1016/S0960-8524(01)00189-4; Abu-Hamdeh NH, 1999, SOIL TILL RES, V52, P113, DOI 10.1016/S0167-1987(99)00064-1; Allaire SE, 2005, CAN J SOIL SCI, V85, P67, DOI 10.4141/S04-026; Andriolo JL, 2011, HORTIC BRAS, V29, P516, DOI 10.1590/S0102-05362011000400012; Arenas M, 2002, HORTSCIENCE, V37, P309, DOI 10.21273/HORTSCI.37.2.309; Ballington JR, 2008, HORTSCIENCE, V43, P1982, DOI 10.21273/HORTSCI.43.7.1982; Bradley D., 2007, CANADA SUSTAINABLE F; Cantliffe DJ, 2007, PROC FL STATE HORTIC, V120, P157; Caron J, 2005, SOIL SCI SOC AM J, V69, P783, DOI 10.2136/sssaj2004.0107; Caron J, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2014.10.0146; Caron J, 2002, SOIL SCI SOC AM J, V66, P373, DOI 10.2136/sssaj2002.0373; Caron J, 2010, CAN J SOIL SCI, V90, P481, DOI 10.4141/CJSS09015; Clark GA, 1993, FINAL REPORT TO THE; Collette L, 2011, SAVE AND GROW A POLI; Conseil des productions vegetales du Quebec, 1997, PLANTES FOURRAGERES; Conseil des Productions Vegetales du Quebec (CPVQ), 1988, METHODES DANALYSE DE; CTIFL, 1990, CER, P361; D'Anna F, 2003, ACTA HORTIC, P355, DOI 10.17660/ActaHortic.2003.609.53; Darnell RL, 2001, J AM SOC HORTIC SCI, V126, P560, DOI 10.21273/JASHS.126.5.560; Davis AS, 2009, EVALUATION OF THREE, P58; Di Benedetto A., 2012, PEAT FORMATION USES, P1; Domeno I, 2009, SCI HORTIC-AMSTERDAM, V122, P269, DOI 10.1016/j.scienta.2009.05.006; Dorais M, 2007, ACTA HORTIC, P589, DOI 10.17660/ActaHortic.2007.761.82; Fennimore SA, 2013, CALIF AGR, V67, P139, DOI 10.3733/ca.v067n03p139; Morillo JG, 2015, AGR WATER MANAGE, V151, P43, DOI 10.1016/j.agwat.2014.09.021; Grattan J, 2002, PUBLICATION, V8066; Hartz T. K., 1996, HortTechnology, V6, P168; Hochmuth G, 2006, HORTTECHNOLOGY, V16, P205, DOI 10.21273/HORTTECH.16.2.0205; Hoffman GJ, 2007, DEV AGR ENG, V13, P131, DOI 10.1016/S0167-4137(07)80007-2; Hoppula KI, 2007, IRRIGATION SCI, V25, P401, DOI 10.1007/s00271-006-0055-7; Jackson BE, 2009, HORTSCIENCE, V44, P1983, DOI 10.21273/HORTSCI.44.7.1983; Jarosz Z, 2010, ACTA SCI POL-HORTORU, V9, P87; Jensen MH, 1997, HORTSCIENCE, V32, P1018, DOI 10.21273/HORTSCI.32.6.1018; Jung JiYoung, 2014, African Journal of Biotechnology, V13, P1541; Kadir S, 2006, HORTSCIENCE, V41, P329, DOI 10.21273/HORTSCI.41.2.329; Kruistum G van, 2014, PROCEEDINGS OF THE 2; Landis TD, 2009, NAT P FOR CONS NURS, P26; Lemay I, 2012, HORTSCIENCE, V47, P1141, DOI 10.21273/HORTSCI.47.8.1141; Letourneau G, 2009, THESIS; Lieten P, 2013, INT J FRUIT SCI, V13, P84, DOI 10.1080/15538362.2012.697024; Marinou E, 2013, PLANT SOIL ENVIRON, V59, P452, DOI 10.17221/297/2013-PSE; Mattner SW, 2014, ISHS ACTA HORTICULTU, V1044; Medina Y, 2009, ISHS ACTA HORTIC 893, V893; Morgan L, 2005, THE BEST OF THE GROW, P23; Naasz R, 2009, SOIL SCI SOC AM J, V73, P780, DOI 10.2136/sssaj2008.0058; Noguera P, 2003, COMMUN SOIL SCI PLAN, V34, P593, DOI 10.1081/CSS-120017842; Noguera P, 2000, ACTA HORTIC, P279, DOI 10.17660/ActaHortic.2000.517.34; Poling EB, 2000, ACTA HORTIC, P393; Raviv M., 2002, HYDROPONIC PRODUCTIO, P25; Raynal-Lacroix C, 2005, FERTIRRIGATION DES V; Rowley D, 2011, HORTSCIENCE, V46, P1480, DOI 10.21273/HORTSCI.46.11.1480; Saied AS, 2005, SCI HORTIC-AMSTERDAM, V103, P289, DOI 10.1016/j.scienta.2004.06.015; Sawan OMM, 1996, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.1996.434.14; Smith R., 2009, PROC 2009 IRRIGATION, P1; Statistics Canada, 2012, FRUIT AND VEGETABLE; Takeda F, 2003, PROC XXVI IHC BERRY, P626; Thomas GV, 2013, CURR SCI INDIA, V104, P245; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vano I, 2011, SOIL SCI PLANT NUTR, V57, P348, DOI 10.1080/00380768.2011.574596; Wilkinson K, 2014, AGR HDB, V732, P376; Yuan BZ, 2004, BIOSYST ENG, V87, P237, DOI 10.1016/j.biosystemseng.2003.10.014	61	17	17	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154104	10.1371/journal.pone.0154104	http://dx.doi.org/10.1371/journal.pone.0154104			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099949	Green Published, gold, Green Submitted			2022-12-27	WOS:000374898500145
J	Herry, CL; Cortes, M; Wu, HT; Durosier, LD; Cao, MJ; Burns, P; Desrochers, A; Fecteau, G; Seely, AJE; Frasch, MG				Herry, Christophe L.; Cortes, Marina; Wu, Hau-Tieng; Durosier, Lucien D.; Cao, Mingju; Burns, Patrick; Desrochers, Andre; Fecteau, Gilles; Seely, Andrew J. E.; Frasch, Martin G.			Temporal Patterns in Sheep Fetal Heart Rate Variability Correlate to Systemic Cytokine Inflammatory Response: A Methodological Exploration of Monitoring Potential Using Complex Signals Bioinformatics	PLOS ONE			English	Article							NEAR-TERM; WEIGHT; BIRTH	Fetal inflammation is associated with increased risk for postnatal organ injuries. No means of early detection exist. We hypothesized that systemic fetal inflammation leads to distinct alterations of fetal heart rate variability (fHRV). We tested this hypothesis deploying a novel series of approaches from complex signals bioinformatics. In chronically instrumented near-term fetal sheep, we induced an inflammatory response with lipopolysaccharide (LPS) injected intravenously (n = 10) observing it over 54 hours; seven additional fetuses served as controls. Fifty-one fHRV measures were determined continuously every 5minutes using Continuous Individualized Multi-organ Variability Analysis (CIMVA). CIMVA creates an fHRV measures matrix across five signal-analytical domains, thus describing complementary properties of fHRV. We implemented, validated and tested methodology to obtain a subset of CIMVA fHRV measures that matched best the temporal profile of the inflammatory cytokine IL-6. In the LPS group, IL-6 peaked at 3 hours. For the LPS, but not control group, a sharp increase in standardized difference in variability with respect to baseline levels was observed between 3 h and 6 h abating to baseline levels, thus tracking closely the IL-6 inflammatory profile. We derived fHRV inflammatory index (FII) consisting of 15 fHRV measures reflecting the fetal inflammatory response with prediction accuracy of 90%. Hierarchical clustering validated the selection of 14 out of 15 fHRV measures comprising FII. We developed methodology to identify a distinctive subset of fHRV measures that tracks inflammation over time. The broader potential of this bioinformatics approach is discussed to detect physiological responses encoded in HRV measures.	[Herry, Christophe L.; Seely, Andrew J. E.] Ottawa Hosp, Clin Epidemiol Program, Res Inst, Ottawa, ON, Canada; [Durosier, Lucien D.; Cao, Mingju; Frasch, Martin G.] Univ Montreal, Dept OBGYN, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Durosier, Lucien D.; Cao, Mingju; Frasch, Martin G.] Univ Montreal, Dept Neurosci, CHU Ste Justine Res Ctr, Montreal, PQ, Canada; [Burns, Patrick; Desrochers, Andre; Fecteau, Gilles] Univ Montreal, CHUV, Clin Sci, St Hyacinthe, PQ, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Thorac Surg, Ottawa, ON, Canada; [Seely, Andrew J. E.] Univ Ottawa, Div Crit Care Med, Ottawa, ON, Canada; [Cortes, Marina; Frasch, Martin G.] Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada; [Wu, Hau-Tieng] Univ Toronto, Dept Math, Toronto, ON M5S 1A1, Canada	University of Ottawa; Ottawa Hospital Research Institute; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of Ottawa; University of Ottawa; Universite de Montreal; University of Toronto	Frasch, MG (corresponding author), Univ Montreal, Dept OBGYN, CHU Ste Justine Res Ctr, Montreal, PQ, Canada.; Frasch, MG (corresponding author), Univ Montreal, Dept Neurosci, CHU Ste Justine Res Ctr, Montreal, PQ, Canada.; Frasch, MG (corresponding author), Univ Montreal, Ctr Rech Reprod Anim, St Hyacinthe, PQ, Canada.	mfrasch@uw.edu	Cortes, Marina/O-3291-2013; Desrochers, Andre/E-7634-2019; Burns, Patrick/C-5943-2013; Frasch, Martin/AAN-8507-2020; Herry, Christophe/AAF-2086-2020	Cortes, Marina/0000-0002-4710-6334; Burns, Patrick/0000-0001-5229-3886; Frasch, Martin/0000-0003-3159-6321; Herry, Christophe/0000-0003-1863-5920; Wu, Hau-Tieng/0000-0002-0253-3156; Cao, Mingju/0000-0003-3380-7620	Canadian Institutes of Health Research, CIHR; fonds de recherche du Quebec en sante, FRQS; MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet; Molly Towell Perinatal Research Foundation; CHU Ste-Justine Research Center; CIHR; NeuroDevNet/MITACS	Canadian Institutes of Health Research, CIHR(Canadian Institutes of Health Research (CIHR)); fonds de recherche du Quebec en sante, FRQS; MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet; Molly Towell Perinatal Research Foundation; CHU Ste-Justine Research Center; CIHR(Canadian Institutes of Health Research (CIHR)); NeuroDevNet/MITACS	Funding was provided by the Canadian Institutes of Health Research, CIHR (to MGF and AJES); fonds de recherche du Quebec en sante, FRQS, MATHEMATICS OF INFORMATION TECHNOLOGY AND COMPLEX SYSTEMS, MITACS/NeuroDevNet, Molly Towell Perinatal Research Foundation and CHU Ste-Justine Research Center (to MGF); CIHR-funded Quebec Training Network in Perinatal Research, QTNPR and NeuroDevNet/MITACS (to LDD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuchee A, 2012, SLEEP, V35, P1541, DOI 10.5665/sleep.2206; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Durosier LD, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/2089; Frasch MG, 2007, J PHYSIOL-LONDON, V579, P893, DOI 10.1113/jphysiol.2006.124800; Frasch MG, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00378; Frasch MG, 2014, PHYSIOL MEAS, V35, pL1, DOI 10.1088/0967-3334/35/12/L1; Frasch MG, 2008, REPROD SCI, V15, P863, DOI 10.1177/1933719108324894; Frasch MG, 2009, AM J PHYSIOL-REG I, V296, pR702, DOI 10.1152/ajpregu.90474.2008; Garite TJ, 2001, CLIN PERINATOL, V28, P837, DOI 10.1016/S0095-5108(03)00081-2; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Grether JK, 1997, JAMA-J AM MED ASSOC, V278, P207, DOI 10.1001/jama.278.3.207; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Johnstone IM, 2009, PHILOS T R SOC A, V367, P4237, DOI 10.1098/rsta.2009.0159; Liu HL, 2016, PEDIATR CRIT CARE ME, V17, pE165, DOI 10.1097/PCC.0000000000000643; Ratcliffe SJ, 2008, J STAT SOFTW, V25, P1; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566	17	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153515	10.1371/journal.pone.0153515	http://dx.doi.org/10.1371/journal.pone.0153515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100089	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500038
J	Seim, A; Omurova, G; Azisov, E; Musuraliev, K; Aliev, K; Tulyaganov, T; Nikolyai, L; Botman, E; Helle, G; Linan, ID; Jivcov, S; Linderholm, HW				Seim, Andrea; Omurova, Gulzar; Azisov, Erlan; Musuraliev, Kanaat; Aliev, Kumar; Tulyaganov, Timur; Nikolyai, Lyutsian; Botman, Evgeniy; Helle, Gerd; Dorado Linan, Isabel; Jivcov, Sandra; Linderholm, Hans W.			Climate Change Increases Drought Stress of Juniper Trees in the Mountains of Central Asia	PLOS ONE			English	Article							WATER-USE EFFICIENCY; TIEN-SHAN; GROWTH; RESPONSES; TEMPERATURES; IMPACTS; REGION; SPRUCE; SHIFT; RIVER	Assessments of climate change impacts on forests and their vitality are essential for semi-arid environments such as Central Asia, where the mountain regions belong to the globally important biodiversity hotspots. Alterations in species distribution or drought-induced tree mortality might not only result in a loss of biodiversity but also in a loss of other ecosystem services. Here, we evaluate spatial trends and patterns of the growth-climate relationship in a tree-ring network comprising 33 juniper sites from the northern Pamir-Alay and Tien Shan mountain ranges in eastern Uzbekistan and across Kyrgyzstan for the common period 1935-2011. Junipers growing at lower elevations are sensitive to summer drought, which has increased in intensity during the studied period. At higher elevations, juniper growth, previously favored by warm summer temperatures, has in the recent few decades become negatively affected by increasing summer aridity. Moreover, response shifts are observed during all seasons. Rising temperatures and alterations in precipitation patterns during the past eight decades can account for the observed increase in drought stress of junipers at all altitudes. The implications of our findings are vital for the application of adequate long-term measures of ecosystem conservation, but also for paleo-climatic approaches and coupled climate-vegetation model simulations for Central Asia.	[Seim, Andrea; Linderholm, Hans W.] Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden; [Omurova, Gulzar; Azisov, Erlan] CAIAG, Bishkek, Kyrgyzstan; [Omurova, Gulzar; Musuraliev, Kanaat] KNAU, Bishkek, Kyrgyzstan; [Musuraliev, Kanaat] Natl Acad Sci Republ Kyrgyzstan, Innovat Ctr Phytotechnol, Bishkek, Kyrgyzstan; [Aliev, Kumar] Univ Cent Asia, Bishkek, Kyrgyzstan; [Tulyaganov, Timur; Nikolyai, Lyutsian; Botman, Evgeniy] RSPCDGF, Tashkent, Uzbekistan; [Helle, Gerd] Helmholtz Ctr Potsdam, German Ctr Geosci Climate Dynam & Landscape Evolu, Potsdam, Germany; [Dorado Linan, Isabel] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Forest Res Ctr, Madrid, Spain; [Jivcov, Sandra] Univ Cologne, Inst Geol & Mineral, D-50931 Cologne, Germany	University of Gothenburg; Central-Asian Institute for Applied Geosciences (CAIAG); Kyrgyz National Agrarian University; National Academy of Sciences of the Kyrgyz Republic (NAS KR); American University of Central Asia; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); University of Cologne	Seim, A (corresponding author), Univ Gothenburg, Dept Earth Sci, Reg Climate Grp, Gothenburg, Sweden.	andrea.seim@gvc.gu.se	Linderholm, Hans W/N-1020-2013; Botman, Evgeniy/AAC-3857-2021; Dorado Liñán, Isabel/B-4393-2017; Liñán, Isabel Dorado/AAR-1539-2020	Linderholm, Hans W/0000-0002-1522-8919; Dorado Liñán, Isabel/0000-0002-8913-0420; Liñán, Isabel Dorado/0000-0002-8913-0420; Seim, Andrea/0000-0002-7201-8010; Helle, Gerhard/0000-0001-9988-6638; Omurova, Gulzar/0000-0002-9951-3628	Kungliga Vetenskapsakademien (KVA, Margit Althins Stipendiefond); Svenska Sallskapet for Antropologi och Geografi (SSAG); Wilhelm och Martina Lundgrens Vetenskapsfond; Swedish International Development Cooperation Agency SIDA [SWE-2009-245]	Kungliga Vetenskapsakademien (KVA, Margit Althins Stipendiefond); Svenska Sallskapet for Antropologi och Geografi (SSAG); Wilhelm och Martina Lundgrens Vetenskapsfond; Swedish International Development Cooperation Agency SIDA	The study was partially funded by Kungliga Vetenskapsakademien (KVA, including the Margit Althins Stipendiefond), Svenska Sallskapet for Antropologi och Geografi (SSAG), Wilhelm och Martina Lundgrens Vetenskapsfond and Swedish International Development Cooperation Agency SIDA (project SWE-2009-245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen VB, 1997, J CLIMATE, V10, P1393, DOI 10.1175/1520-0442(1997)010<1393:CAHCIT>2.0.CO;2; Aizen VB, 2007, GLOBAL PLANET CHANGE, V56, P328, DOI 10.1016/j.gloplacha.2006.07.016; Allen CD, 1998, P NATL ACAD SCI USA, V95, P14839, DOI 10.1073/pnas.95.25.14839; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Andreu-Hayles L, 2011, GLOBAL CHANGE BIOL, V17, P2095, DOI 10.1111/j.1365-2486.2010.02373.x; Beniston M, 2003, CLIMATIC CHANGE, V59, P5, DOI 10.1023/A:1024458411589; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Boisvenue C, 2006, GLOBAL CHANGE BIOL, V12, P862, DOI 10.1111/j.1365-2486.2006.01134.x; Botman E., 2008, CLIMATE CHANGE CONSE; Brauning A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020793; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Buntgen U, 2006, TREES-STRUCT FUNCT, V20, P99, DOI 10.1007/s00468-005-0017-3; Buntgen U, 2005, CLIM DYNAM, V25, P141, DOI 10.1007/s00382-005-0028-1; Buntgen U, 2006, J CLIMATE, V19, P5606, DOI 10.1175/JCLI3917.1; Burrough PA, 2011, PRINCIPLES GEOGRAPHI; Linares JC, 2012, GLOBAL CHANGE BIOL, V18, P1000, DOI 10.1111/j.1365-2486.2011.02566.x; Carrer M, 2006, NEW PHYTOL, V170, P861, DOI 10.1111/j.1469-8137.2006.01703.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Cook E.R., 2005, PROGRAM ARSTAN TREE; Cook ER, 1997, HOLOCENE, V7, P361, DOI 10.1177/095968369700700314; Edenhofer O., 2014, CONTRIBUTION WORKING; Esper J, 2003, CLIM DYNAM, V21, P699, DOI 10.1007/s00382-003-0356-y; Esper J, 2002, HOLOCENE, V12, P267, DOI 10.1191/0959683602hl543rp; ESRI, 2011, ARCGIS DESKT REL 10; Fisher M, 1997, GLOBAL ECOL BIOGEOGR, V6, P379, DOI 10.2307/2997338; Fritts H.C, 1976, TREE RINGS CLIMATE; Galvan JD, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084001; Glazirin GE, 2005, NIGMI P, V5, P24; Granda E, 2014, OECOLOGIA, V174, P307, DOI 10.1007/s00442-013-2742-4; Graybill D, 1992, RECENT DENDROCHRONOL; Harris I, 2014, INT J CLIMATOL, V34, P623, DOI 10.1002/joc.3711; Hessl A, 2007, PROF GEOGR, V59, P87, DOI 10.1111/j.1467-9272.2007.00593.x; HOLMES R L, 1983, Tree-Ring Bulletin, V43, P69; Horton DE, 2015, NATURE, V522, P465, DOI 10.1038/nature14550; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Kyrgyzstan N., 2009, 2 NATL COMMUNICATION; Levesque M, 2014, NEW PHYTOL, V203, P94, DOI 10.1111/nph.12772; Liang EY, 2008, GLOBAL PLANET CHANGE, V61, P313, DOI 10.1016/j.gloplacha.2007.10.008; Liang E, 2016, CLIMATIC CHANGE, V134, P163, DOI 10.1007/s10584-015-1531-y; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; Liu HY, 2013, GLOBAL CHANGE BIOL, V19, P2500, DOI 10.1111/gcb.12217; Liu Y, 2009, SCI CHINA SER D, V52, P348, DOI 10.1007/s11430-009-0025-z; Lutgens F.K., 2001, ATMOSPHERE INTRO MET; Melvin Thomas M., 2007, Dendrochronologia, V25, P65, DOI 10.1016/j.dendro.2007.01.004; Merzlyakova I., 2002, MOUNTAINS CENTRAL AS, P377; Mittermeier RA., 2005, HOTSPOTS REVISITED E, DOI DOI 10.1111/j.1471-8286.2007.01678.x; Mosello B, 2008, J PUBLIC INT AFFAIRS, V19; Mukhamedshin KD, 1977, TIEN SHAN JUNIPER FO; Osborn T, 1997, DENDROCHRONOLOGIA, V15, pe99; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Penuelas J, 2011, GLOBAL ECOL BIOGEOGR, V20, P597, DOI 10.1111/j.1466-8238.2010.00608.x; Saiko TA, 2000, APPL GEOGR, V20, P349, DOI 10.1016/S0143-6228(00)00014-X; Salzer MW, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/11/114007; Savitskiy AG, 2008, ADAPTIVE AND INTEGRATED WATER MANAGEMENT: COPING WITH COMPLEXITY AND UNCERTAINTY, P323, DOI 10.1007/978-3-540-75941-6_17; Seim A, 2015, TREES-STRUCT FUNCT, P1, DOI [10.1007/s00468-015-1316-y, DOI 10.1007/S00468-015-1316-Y]; Solomina Olga, 2014, [Geography, Environment, Sustainability, Geography, Environment, Sustainability], V7, P66; Sorg A, 2014, ENVIRON SCI POLICY, V43, P68, DOI 10.1016/j.envsci.2013.11.003; Spaargaren OC, 1998, WORLD REFERENCE BASE; Stokes M.A., 1996, INTRO TREE RING DATI; Uzbekistan N., 2009, 2 NATL COMMUNICATION; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Williams M.W., 2008, CENTRAL ASIA TEMPERA, DOI [10.7265/N5NK3BZ8, DOI 10.7265/N5NK3BZ8]; Wilmking M, 2004, GLOBAL CHANGE BIOL, V10, P1724, DOI 10.1111/j.1365-2486.2004.00826.x; Winter MB, 2009, EUR J FOREST RES, V128, P531, DOI 10.1007/s10342-009-0295-1; Zhang TW, 2014, DENDROCHRONOLOGIA, V32, P230, DOI 10.1016/j.dendro.2014.03.002	66	21	22	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153888	10.1371/journal.pone.0153888	http://dx.doi.org/10.1371/journal.pone.0153888			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100092	Green Published, gold			2022-12-27	WOS:000374898500086
J	Elwood, PC; Morgan, G; Pickering, JE; Galante, J; Weightman, AL; Morris, D; Kelson, M; Dolwani, S				Elwood, Peter C.; Morgan, Gareth; Pickering, Janet E.; Galante, Julieta; Weightman, Alison L.; Morris, Delyth; Kelson, Mark; Dolwani, Sunil			Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies	PLOS ONE			English	Review							LOW-DOSE ASPIRIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BREAST-CANCER; COLORECTAL-CANCER; VENOUS THROMBOEMBOLISM; POST-DIAGNOSIS; NSAID USE; SURVIVAL; RISK; COHORT	Background Low-dose aspirin has been shown to reduce the incidence of cancer, but its role in the treatment of cancer is uncertain. Objectives We conducted a systematic search of the scientific literature on aspirin taken by patients following a diagnosis of cancer, together with appropriate meta-analyses. Methods Searches were completed in Medline and Embase in December 2015 using a pre-defined search strategy. References and abstracts of all the selected papers were scanned and expert colleagues were contacted for additional studies. Two reviewers applied pre-determined eligibility criteria (cross-sectional, cohort and controlled studies, and aspirin taken after a diagnosis of cancer), assessed study quality and extracted data on cancer cause-specific deaths, overall mortality and incidence of metastases. Random effects meta-analyses and planned sub-group analyses were completed separately for observational and experimental studies. Heterogeneity and publication bias were assessed in sensitivity analyses and appropriate omissions made. Papers were examined for any reference to bleeding and authors of the papers were contacted and questioned. Results Five reports of randomised trials were identified, together with forty two observational studies: sixteen on colorectal cancer, ten on breast and ten on prostate cancer mortality. Pooling of eleven observational reports of the effect of aspirin on cause-specific mortality from colon cancer, after the omission of one report identified on the basis of sensitivity analyses, gave a hazard ratio (HR) of 0.76 (95% CI 0.66, 0.88) with reduced heterogeneity (P = 0.04). The cause specific mortality in five reports of patients with breast cancer showed significant heterogeneity (P< 0.0005) but the omission of one outlying study reduced heterogeneity (P = 0.19) and led to an HR = 0.87 (95% CI 0.69, 1.09). Heterogeneity between nine studies of prostate cancer was significant, but again, the omission of one study led to acceptable homogeneity (P = 0.26) and an overall HR = 0.89 (95% CI 0.79-0.99). Six single studies of other cancers suggested reductions in cause specific mortality by aspirin, and in five the effect is statistically significant. There were no significant differences between the pooled HRs for the three main cancers and after the omission of three reports already identified in sensitivity analyses heterogeneity was removed and revealed an overall HR of 0.83 (95% CI 0.76-0.90). A mutation of PIK3CA was present in about 20% of patients, and appeared to explain most of the reduction in colon cancer mortality by aspirin. Data were not adequate to examine the importance of this or any other marker in the effect of aspirin in the other cancers. On bleeding attributable to aspirin two reports stated that there had been no side effect or bleeding attributable to aspirin. Authors on the other reports were written to and 21 replied stating that no data on bleeding were available. Conclusions and Implications The study highlights the need for randomised trials of aspirin treatment in a variety of cancers. While these are awaited there is an urgent need for evidence from observational studies of aspirin and the less common cancers, and for more evidence of the relevance of possible bio-markers of the aspirin effect on a wide variety of cancers. In the meantime it is urged that patients in whom a cancer is diagnosed should be given details of this research, together with its limitations, to enable each to make an informed decision as to whether or not to take low-dose aspirin.	[Elwood, Peter C.; Morgan, Gareth; Pickering, Janet E.; Weightman, Alison L.; Morris, Delyth; Kelson, Mark; Dolwani, Sunil] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [Morgan, Gareth] Hywel Dda Univ Hlth Board, Llanelli SA14 8QF, England; [Galante, Julieta] Univ Cambridge, Dept Psychiat, Cambridge, England; [Weightman, Alison L.] Cardiff Univ, Specialist Unit Review Evidence, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; University of Cambridge; Cardiff University	Elwood, PC (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales.	ElwoodPC@cf.ac.uk	Dolwani, Sunil/M-4241-2016; Galante, Julieta/C-3151-2016; Weightman, Alison/A-4680-2010; Kelson, Mark/E-6753-2016	Galante, Julieta/0000-0002-4108-5341; Weightman, Alison/0000-0001-5210-3798; Kelson, Mark/0000-0001-7744-3780				Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Assayag J, 2015, J UROLOGY, V193, P1220, DOI 10.1016/j.juro.2014.11.018; Bains S, 2015, J CLIN ONCOLOGY; Baron JA, 1998, LANCET, V351, P1077, DOI 10.1016/S0140-6736(97)10018-6; Barron TI, 2015, CANCER EPIDEM BIOMAR, V24, P898, DOI 10.1158/1055-9965.EPI-14-1415; Barron TI, 2014, CANCER RES, V74, P4065, DOI 10.1158/0008-5472.CAN-13-2679; Barron TI, 2012, J CLIN ONCOL S; Bastiaannet E, 2012, BRIT J CANCER, V106, P1564, DOI 10.1038/bjc.2012.101; Basu GD, 2014, J CLIN ONCOL S3, V32, P2014; Battistoni A, 2015, CLIN CARDIOL, DOI [10.1002/cic.22394, DOI 10.1002/CIC.22394]; Blair CK, 2007, BREAST CANCER RES TR, V101, P191, DOI 10.1007/s10549-006-9277-x; Bowers LW, 2014, CANCER RES, V74, P4446, DOI 10.1158/0008-5472.CAN-13-3603; Burn J, 2011, LANCET, V378, P2081, DOI 10.1016/S0140-6736(11)61049-0; Caon J, 2014, PROSTATE CANCER, V2014, DOI 10.1155/2014/184297; Cardwell CR, 2014, GASTROENTEROLOGY, V146, P700, DOI 10.1053/j.gastro.2013.11.005; Chae Y, 2013, POSTER EPIDEMIOLOGY; Chae YK, 2014, BLOOD, V123, P1424, DOI 10.1182/blood-2013-07-517102; Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112; Choe KS, 2012, J CLIN ONCOL, V30, P3540, DOI 10.1200/JCO.2011.41.0308; Cizkova M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3113; Coghill AE, 2011, GUT, V60, P491, DOI 10.1136/gut.2010.221143; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; CREAGAN ET, 1991, J CLIN ONCOL, V9, P2104, DOI 10.1200/JCO.1991.9.12.2104; Cronin-Fenton D, PHARM DRUG SAF C BOS; Curigliano G, 2007, SUPPORT CARE CANCER, V15, P1213, DOI 10.1007/s00520-007-0277-0; Daugherty SER, 2013, LB15 POSTER AM ASS C; Dhillon PK, 2012, CANCER PREV RES, V5, P1223, DOI 10.1158/1940-6207.CAPR-12-0171; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322; Egger Matthias, 2009, SYSTEMATIC REV HLTH; Elwood P, 2014, EDITORIAL GASTROENTE, V10, P61; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Flahavan EM, 2014, ANN ONCOL, V25, P154, DOI 10.1093/annonc/mdt428; Fontaine E, 2010, EUR J CARDIO-THORAC, V38, P21, DOI 10.1016/j.ejcts.2010.01.015; Fraser DM, 2014, BRIT J CANCER, V111, P623, DOI 10.1038/bjc.2014.264; Fuchs C, 2005, J CLIN ONCOL, V23, p253S; Goh HH, 2014, ANTICANCER RES, V34, P7407; Gorelick PB, 2005, STROKE, V36, P1801, DOI 10.1161/01.STR.0000174189.81153.85; Grytli HH, 2014, EUR UROL, V65, P635, DOI 10.1016/j.eururo.2013.01.007; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Holmes MD, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-391; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang XZ, 2015, CANCER CAUSE CONTROL, V26, P589, DOI 10.1007/s10552-015-0539-y; Jacobs CD, 2014, CANCER BIOL THER, V15, P699, DOI 10.4161/cbt.28554; Jacobs EJ, 2014, J CLIN ONCOL, V32, P3716, DOI 10.1200/JCO.2013.54.8875; KASSIRER JP, 1994, NEW ENGL J MED, V330, P1895, DOI 10.1056/NEJM199406303302611; Kaufman DW, 1999, AM J GASTROENTEROL, V94, P3189, DOI 10.1111/j.1572-0241.1999.01517.x; Kothari N, 2015, ACTA ONCOL, V54, P487, DOI 10.3109/0284186X.2014.990158; Kwan ML, 2007, CANCER CAUSE CONTROL, V18, P613, DOI 10.1007/s10552-007-9003-y; Langley RE, 2011, BRIT J CANCER, V105, P1107, DOI 10.1038/bjc.2011.289; Langley RE, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.297; LEBEAU B, 1993, CANCER, V71, P1741, DOI 10.1002/1097-0142(19930301)71:5<1741::AID-CNCR2820710507>3.0.CO;2-Q; Li PW, 2015, GUT, V64, P1419, DOI 10.1136/gutjnl-2014-308260; Liao X, 2012, NEW ENGL J MED, V367, P1597; LIPTON A, 1982, J MED, V13, P419; Liu JF, 2009, ANN SURG ONCOL, V16, P1397, DOI 10.1245/s10434-009-0382-z; Liu YQ, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-55; Ljung R, 2014, INT J CANCER, V135, P238, DOI 10.1002/ijc.28671; Lyman GH, 2007, J CLIN ONCOL, V25, P5490, DOI 10.1200/JCO.2007.14.1283; Macfarlane TV, 2015, CANCER EPIDEMIOL, V39, P1015, DOI 10.1016/j.canep.2015.10.030; McCowan C, 2013, EUR J CANCER, V49, P1049, DOI 10.1016/j.ejca.2012.10.024; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mills EJ, 2012, AM J MED, V125, P560, DOI 10.1016/j.amjmed.2012.01.017; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Murray LJ, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3638; Nagle CM, 2015, CANCER EPIDEMIOL, V39, P196, DOI 10.1016/j.canep.2014.12.010; Ng K, 2015, JNCI-J NATL CANCER I, DOI [10.1093/jmci/dju345, DOI 10.1093/JMCI/DJU345]; O'Brien J, 2000, LANCET, V355, P1295; Office for National Statistics, 2008, CANC INC MORT UK 200; Paleari L, 2015, CLIN ONCOL; Pastore AL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1152-x; Patrono C, 2005, NEW ENGL J MED, V353, P2373, DOI 10.1056/NEJMra052717; Reimers MS, 2014, JAMA INTERN MED, V174, P732, DOI 10.1001/jamainternmed.2014.511; Rodriguez LAG, 2001, BRIT J CLIN PHARMACO, V52, P563, DOI 10.1046/j.0306-5251.2001.01476.x; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Stock DC, 2008, PROSTATE, V68, P1655, DOI 10.1002/pros.20834; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Sun R, 2013, CANCER EPIDEM BIOMAR, V22, P472, DOI 10.1158/1055-9965.EPI-13-0067; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valkhoff VE, 2013, CAN J GASTROENTEROL, V27, P159, DOI 10.1155/2013/596015; Walker AJ, 2012, BRIT J CANCER, V107, P1602, DOI 10.1038/bjc.2012.427; Wang YQ, 2010, CELL ADHES MIGR, V4, P7, DOI 10.4161/cam.4.1.10497; Wehbeh A, 2015, DIGEST DIS SCI, V60, P2077, DOI 10.1007/s10620-015-3604-1; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wernli KJ, 2011, PHARMACOEPIDEM DR S, V20, P131, DOI 10.1002/pds.2064; Ye XF, 2014, BRIT J CANCER, V111, P2172, DOI 10.1038/bjc.2014.481; Zanders MMJ, 2015, BRIT J CANCER, V113, P403, DOI 10.1038/bjc.2015.259; Zhong SL, 2015, BREAST CANCER RES TR, V150, P199, DOI 10.1007/s10549-015-3300-z	91	99	102	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152402	10.1371/journal.pone.0152402	http://dx.doi.org/10.1371/journal.pone.0152402			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096951	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000374543600010
J	Yazdani, S; Yusof, R; Karimian, A; Mitsukira, Y; Hematian, A				Yazdani, Sepideh; Yusof, Rubiyah; Karimian, Alireza; Mitsukira, Yasue; Hematian, Amirshahram			Automatic Region-Based Brain Classification of MRI-T1 Data	PLOS ONE			English	Article							SEGMENTATION; IMAGE; HYBRID; MODEL; EXTRACTION	Image segmentation of medical images is a challenging problem with several still not totally solved issues, such as noise interference and image artifacts. Region-based and histogram-based segmentation methods have been widely used in image segmentation. Problems arise when we use these methods, such as the selection of a suitable threshold value for the histogram-based method and the over-segmentation followed by the time-consuming merge processing in the region-based algorithm. To provide an efficient approach that not only produce better results, but also maintain low computational complexity, a new region dividing based technique is developed for image segmentation, which combines the advantages of both regions-based and histogram-based methods. The proposed method is applied to the challenging applications: Gray matter (GM), White matter (WM) and cerebrospinal fluid (CSF) segmentation in brain MR Images. The method is evaluated on both simulated and real data, and compared with other segmentation techniques. The obtained results have demonstrated its improved performance and robustness.	[Yazdani, Sepideh; Yusof, Rubiyah] Univ Technol Malaysia, Ctr Artificial Intelligence & Robot, MJIIT, Kuala Lumpur, Malaysia; [Karimian, Alireza] Univ Isfahan, Dept Biomed Engn, Fac Engn, Esfahan, Iran; [Mitsukira, Yasue] Keio Univ, Dept Syst Design Engn, Fac Sci & Technol, Kyoto, Japan; [Hematian, Amirshahram] Towson Univ, Dept Comp & Informat Sci, Towson, MD USA	Universiti Teknologi Malaysia; University of Isfahan; Keio University; University System of Maryland; Towson University	Yusof, R (corresponding author), Univ Technol Malaysia, Ctr Artificial Intelligence & Robot, MJIIT, Kuala Lumpur, Malaysia.	rubiyah.kl@utm.my	yusof, rubiyah/AAV-9212-2020; Karimian, Alireza/AAW-3501-2021	Karimian, Alireza/0000-0003-2543-4772	Ministry of Higher Education of Malaysia (MOHE) [4L659]	Ministry of Higher Education of Malaysia (MOHE)	The authors would like to acknowledge the financial support from Ministry of Higher Education of Malaysia (MOHE) under Research Grant 4L659.; The authors would like to acknowledge the financial support from Ministry of Higher Education of Malaysia (MOHE) under Research Grant 4L659. Also, thanks are due to Research Management Center (RMC) of Universiti Teknologi Malaysia (UTM) for a great research environment to complete this work.	Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338; Ayman A, 2010, NEW REGION GROWING S, V110, P71; Bricq S, 2008, MED IMAGE ANAL, V12, P639, DOI 10.1016/j.media.2008.03.001; Caldairou B, 2011, PATTERN RECOGN, V44, P1916, DOI 10.1016/j.patcog.2010.06.006; Cocosco C.A., 1997, NEUROIMAGE; Cocosco CA, 2003, MED IMAGE ANAL, V7, P513, DOI 10.1016/S1361-8415(03)00037-9; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; del Fresno M, 2009, COMPUT MED IMAG GRAP, V33, P369, DOI 10.1016/j.compmedimag.2009.03.002; Fan JP, 2001, IEEE T IMAGE PROCESS, V10, P1454, DOI 10.1109/83.951532; Galdames FJ, 2012, J NEUROSCI METH, V206, P103, DOI 10.1016/j.jneumeth.2012.02.017; Hao M, 2014, IEEE GEOSCI REMOTE S, V11, P210, DOI 10.1109/LGRS.2013.2252879; Kato T., 2002, Structural, Syntactic, and Statistical Pattern Recognition. Joint IAPR International Workshops SSPR 2002 and SPR 2002 (Lecture Notes in Computer Science Vol. 2396), P405; Kwan RKS, 1999, IEEE T MED IMAGING, V18, P1085, DOI 10.1109/42.816072; Lan K, 2001, J CHROMATOGR A, V915, P1, DOI 10.1016/S0021-9673(01)00594-5; Lee JD, 2009, IEEE T MED IMAGING, V28, P894, DOI 10.1109/TMI.2009.2012896; Liew AWC, 2006, CURR MED IMAGING, V2, P91, DOI 10.2174/157340506775541604; Lui D, 2014, IEEE T BIO-MED ENG, V61, P368, DOI 10.1109/TBME.2013.2279635; Mansourvar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138493; Murgasova M, 2007, P 23 SPRING C COMP G; Ortiz A., 2013, COMPUTATIONAL MATH M, V2013; Rajapakse JC, 1998, IMAGE VISION COMPUT, V16, P165, DOI 10.1016/S0262-8856(97)00067-X; Roy S, 2014, LECT NOTES COMPUT SC, V8679, P248, DOI 10.1007/978-3-319-10581-9_31; Shan ZY, 2002, NEUROIMAGE, V17, P1587, DOI 10.1006/nimg.2002.1287; Shattuck DW, 2001, NEUROIMAGE, V13, P856, DOI 10.1006/nimg.2000.0730; Singh WJ, 2013, COMPUT METHOD BIOMEC, V16, P758, DOI 10.1080/10255842.2011.639015; Wehner WS, 2014, INT J PATTERN RECOGN, V28, DOI 10.1142/S0218001414550088; Weizman L, 2012, MED IMAGE ANAL, V16, P177, DOI 10.1016/j.media.2011.07.001; Wells WM, 1996, IEEE T MED IMAGING, V15, P429, DOI 10.1109/42.511747; Xie M, 2015, MED BIOL ENG COMPUT, V53, P23, DOI 10.1007/s11517-014-1198-y; Yazdani S, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/829893; Yazdani S, 2015, IETE TECHNICAL REV, P1; Yazdani S, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0207-7; Yu ZQ, 2006, COMPUT MED IMAG GRAP, V30, P197, DOI 10.1016/j.compmedimag.2006.03.006; Zanaty EA, 2013, CONNECT SCI, V25, P179, DOI 10.1080/09540091.2013.854736	34	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151326	10.1371/journal.pone.0151326	http://dx.doi.org/10.1371/journal.pone.0151326			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096925	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600002
J	Hwang, JJ; Park, H; Jeong, HG; Han, SS				Hwang, Jae Joon; Park, Hyok; Jeong, Ho-Gul; Han, Sang-Sun			Change in Image Quality According to the 3D Locations of a CBCT Phantom	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; TO-NOISE RATIO; CONE-BEAM; ROOT FRACTURES; CT; RADIATION; DENSITY; SIZE; ACQUISITION; PARAMETERS	A patient's position changes in every CBCT scan despite patient alignment protocols. However, there have been studies to determine image quality differences when an object is located at the center of the field of view (FOV). To evaluate changes in the image quality of the CBCT scan according to different object positions, the image quality indexes of the Alphard 3030 (Alphard Roentgen Ind., Ltd., Kyoto, Japan) and the Rayscan Symphony (RAY Ind., Ltd., Suwon, Korea) were measured using the Quart DVT_AP phantom at the center of the FOV and 6 peripheral positions under four types of exposure conditions. Anterior, posterior, right, left, upper, and lower positions 1 cm offset from the center of the FOV were used for the peripheral positions. We evaluated and compared the voxel size, homogeneity, contrast to noise ratio (CNR), and the 10% point of the modulation transfer function (MTF10%) of the center and periphery. Because the voxel size, which is determined by the Nyquist frequency, was within tolerance, other image quality indexes were not influenced by the voxel size. For the CNR, homogeneity, and MTF10%, there were peripheral positions which showed considerable differences with statistical significance. The average difference between the center and periphery was up to 31.27% (CNR), 70.49% (homogeneity), and 13.64% (MTF10%). Homogeneity was under tolerance at some of the peripheral locations. Because the CNR, homogeneity, and MTF10% were significantly affected by positional changes of the phantom, an object's position can influence the interpretation of follow up CBCT images. Therefore, efforts to locate the object in the same position are important.	[Hwang, Jae Joon; Park, Hyok; Jeong, Ho-Gul; Han, Sang-Sun] Yonsei Univ, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System	Han, SS (corresponding author), Yonsei Univ, Coll Dent, Dept Oral & Maxillofacial Radiol, Seoul 120749, South Korea.	sshan@yuhs.ac		Han, Sang-Sun/0000-0003-1775-7862				[Anonymous], 2011, CON BEAM CT DENT MAX; [Anonymous], 2013, 6868161 DIN; Bamba J, 2013, DENTOMAXILLOFAC RAD, V42, DOI 10.1259/dmfr.20120445; Blendl C, 2012, ROFO-FORTSCHR RONTG, V184, P24, DOI 10.1055/s-0031-1281818; Brullmann D, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140204; Choi JW, 2015, OR SURG OR MED OR PA, V119, P357, DOI 10.1016/j.oooo.2014.11.010; Commision E, 1999, EUR GUID QUAL CRIT C; Costa FF, 2012, J ENDODONT, V38, P856, DOI 10.1016/j.joen.2012.03.011; Cronin CG, 2008, AM J ROENTGENOL, V191, P502, DOI 10.2214/AJR.07.2338; Dunfee BL, 2006, RADIOGRAPHICS, V26, P1751, DOI 10.1148/rg.266055189; Endo M, 2001, MED PHYS, V28, P469, DOI 10.1118/1.1357457; Eskandarloo Amir, 2012, Dent Res J (Isfahan), V9, pS81; Farquhar TH, 2000, J NUCL MED, V41, P745; Garayoa J, 2013, J APPL CLIN MED PHYS, V14, P239, DOI 10.1120/jacmp.v14i1.3888; Gkanatsios NA, 2002, MED PHYS, V29, P1643, DOI 10.1118/1.1493213; Gu K, 2016, KOREAN J RADIOL, V17, P111, DOI 10.3348/kjr.2016.17.1.111; Guzinski M, 2016, EUROPEAN RADIOLOGY, P1, DOI [10.1007/s00330-015-4183-4, DOI 10.1007/S00330-015-4183-4:1-6]; Hakim CM, 2015, RADIOLOGY, V276, P65, DOI 10.1148/radiol.15142009; Hirokawa Y, 2009, RADIOLOGY, V251, P388, DOI 10.1148/radiol.2512081360; Hofmann E, 2014, J OROFAC ORTHOP, V75, P384, DOI 10.1007/s00056-014-0232-x; Hofmann E, 2014, CLIN ORAL INVEST, V18, P301, DOI 10.1007/s00784-013-0948-9; Huda W, 2006, ACAD RADIOL, V13, P1355, DOI 10.1016/j.acra.2006.07.011; Iacobellis F, 2016, GASTROENT RES PRACT, V2016, P12; Katsumata A, 2009, ORAL SURG ORAL MED O, V107, P420, DOI 10.1016/j.tripleo.2008.05.049; Klintstrom E, 2014, DENTOMAXILLOFAC RAD, V43, DOI 10.1259/dmfr.20140196; Lagravere MO, 2008, DENTOMAXILLOFAC RAD, V37, P305, DOI 10.1259/dmfr/65993482; Martin CJ, 1999, APPL RADIAT ISOTOPES, V50, P21, DOI 10.1016/S0969-8043(98)00022-0; Masafumi Kanoto K K, 2015, J NEUROLOGY NEUROSCI; Molteni R, 2013, OR SURG OR MED OR PA, V116, P105, DOI 10.1016/j.oooo.2013.04.013; Moore CS, 2015, PHYS MED BIOL, V60, P9047, DOI 10.1088/0031-9155/60/23/9047; Moore CS, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130077; Nackaerts O, 2011, CLIN ORAL IMPLAN RES, V22, P873, DOI 10.1111/j.1600-0501.2010.02076.x; Neves FS, 2014, J ENDODONT, V40, P1530, DOI 10.1016/j.joen.2014.06.012; Nguyen-Huynh MN, 2008, STROKE, V39, P1184, DOI 10.1161/STROKEAHA.107.502906; Park HJ, 2009, KOREAN J RADIOL, V10, P490, DOI 10.3348/kjr.2009.10.5.490; Pauwels R, 2015, DENTOMAXILLOFAC RAD, V44, DOI 10.1259/dmfr.20140224; Pauwels R, 2012, OR SURG OR MED OR PA, V114, P127, DOI 10.1016/j.oooo.2012.01.020; Pauwels R, 2011, J APPL CLIN MED PHYS, V12, P245, DOI 10.1120/jacmp.v12i4.3478; Plachtovics M, 2014, OR SURG OR MED OR PA, V117, P760, DOI 10.1016/j.oooo.2014.02.024; Scholtz JE, 2015, NEURORADIOLOGY, V57, P645, DOI 10.1007/s00234-015-1512-x; Sherwood IA, 2012, DENTOMAXILLOFAC RAD, V41, P43, DOI 10.1259/dmfr/26466415; Sunitha V Raja, 2008, J Conserv Dent, V11, P54, DOI 10.4103/0972-0707.44046; Suomalainen A, 2009, DENTOMAXILLOFAC RAD, V38, P367, DOI 10.1259/dmfr/15779208; Tanaka C, 2006, AM J NEURORADIOL, V27, P40; van Asch CJJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5762; Varela C, 2005, EUR J RADIOL, V56, P248, DOI 10.1016/j.ejrad.2005.04.007; Veldkamp WJH, 2009, EUR J RADIOL, V72, P209, DOI 10.1016/j.ejrad.2009.05.039; Wang P, 2011, DENTOMAXILLOFAC RAD, V40, P290, DOI 10.1259/dmfr/84907460; White S.C., 2009, ORAL RADIOLOGY PRINC; Yeh ED, 2014, RADIOGRAPHICS, V34, pE1, DOI 10.1148/rg.341125193; Zarb F, 2010, RADIOGRAPHY, V16, P147, DOI 10.1016/j.radi.2009.10.002	51	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153884	10.1371/journal.pone.0153884	http://dx.doi.org/10.1371/journal.pone.0153884			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093639	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200055
J	Wang, XM; Fu, JJ; Li, QX; Zeng, DY				Wang, Xingmin; Fu, Jinjian; Li, Qianxi; Zeng, Dingyuan			Geographical and Ethnic Distributions of the MTHFR C677T, A1298C and MTRR A66G Gene Polymorphisms in Chinese Populations: A Meta-Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE MTHFR; METHIONINE SYNTHASE; HIGH PREVALENCE; FOLATE STATUS; HOMOCYSTEINE; ASSOCIATION; MUTATION; WOMEN; HYPERHOMOCYSTEINEMIA; ADULTS	Background The geographical and ethnic distributions of the polymorphic methylenetetrahydrofolate reductase (MTHFR) mutations (C677T and A1298C) and methionine synthase reductase (MTRR) mutation (A66G) remain heterogeneous in China. The goal of this study was to estimate the pooled frequencies of the alleles and associated genotypes of these gene polymorphisms among healthy populations in Mainland China. Objective and Methods We systematically reviewed published epidemiological studies on the distributions of 3 genetic variants in Chinese healthy populations living in Mainland China through a meta-analysis. The relevant electronic databases were searched. All of the raw data of the eligible citations were extracted. The frequency estimates were stratified by geography, ethnicity and sex. Results Sixty-six studies were identified with a total of 92277 study participants. The meta-analysis revealed that the frequencies of the MTHFR C677T, A1298C, and MTRR A66G gene polymorphisms varied significantly between different ethnic groups and along geographical gradients. The frequencies of the 677T allele and 677TT genotype increased along the southern-central-northern direction across Mainland China (all P values <= 0.001). The frequencies of the 1298C, 1298CC, 66G and 66GG genotypes decreased along the southcentral- north direction across the country (all P values <= 0.001). Conclusions Our meta-analysis strongly indicates significant geographical and ethnic variations in the frequencies of the C677T, A1298C, and A66G gene polymorphisms in the folate metabolism pathway among Chinese populations.	[Wang, Xingmin; Fu, Jinjian; Li, Qianxi; Zeng, Dingyuan] Liuzhou Municipal Matern & Child Healthcare Hosp, Dept Gynecol, Liuzhou, Guangxi, Peoples R China		Zeng, DY (corresponding author), Liuzhou Municipal Matern & Child Healthcare Hosp, Dept Gynecol, Liuzhou, Guangxi, Peoples R China.	zdylzsfy@126.com		Zeng, Dingyuan/0000-0002-4271-5632	Guangxi Medical and Health Self-funding Project [Z2014373]	Guangxi Medical and Health Self-funding Project	This manuscript was funded by Guangxi Medical and Health Self-funding Project (No Z2014373). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amouzou EK, 2004, AM J CLIN NUTR, V79, P619; Angeline T, 2004, EXP MOL PATHOL, V77, P85, DOI 10.1016/j.yexmp.2004.04.006; Barbosa PR, 2008, CLIN CHIM ACTA, V388, P139, DOI 10.1016/j.cca.2007.10.023; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Brustolin S, 2010, BRAZ J MED BIOL RES, V43, P1, DOI 10.1590/S0100-879X2009007500021; Cai BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089609; Callejon G, 2007, HUM REPROD, V22, P3249, DOI 10.1093/humrep/dem337; Chen F, 2009, ZHENG ZHOU DA XUEXUE, V44, P317; Chen PL, 2015, GENET MOL RES, V14, P19191, DOI 10.4238/2015.December.29.29; Chen SQ, 2002, ZHONGGUO YOU SHENG Y, V10, P22; Chen XL, 2014, CHINESE J WOMEN CHIL, V5, P17; Chen YX, 2010, ZHONGGUO GONG GONG W, V26, P958; Chen YX, 2013, SHAN XI YI KE DA XUE, V44, P130; Cheng HB, 2012, CHANG ZHI YI XUE YUA, V26, P401; Cong YY, 2012, XIAN DAI FU CHAN KEJ, V21, P779; Cui Huiling, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P710, DOI 10.11817/j.issn.1672-7347.2015.07.002; Dai XJ, 2008, NING XIA YI XUE YUAN, V30, P152; Du LL, 2013, ZHONGGUO DONG MAI ZH, V24, P325; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferretti A, 2013, MED HYPOTHESES, V81, P524, DOI 10.1016/j.mehy.2013.06.025; Gao LJ, 2013, ZHONG SHAN DA XUEXUE, V34, P140; Gao X, 2014, ZHONGGUO YOU SHENG Y, V22, P35; Gaughan DJ, 2001, ATHEROSCLEROSIS, V157, P451, DOI 10.1016/S0021-9150(00)00739-5; GOYETTE P, 1994, NAT GENET, V7, P195, DOI 10.1038/ng0694-195; Gueant-Rodriguez RM, 2006, AM J CLIN NUTR, V83, P701, DOI 10.1093/ajcn.83.3.701; Guo H, 2013, JIAN YAN YI XUE YU L, V10, P1655; Hao L, 2003, J NUTR, V133, P3630, DOI 10.1093/jn/133.11.3630; Hao YY, 2014, ZHONGGUO FU YOU BAO, V29, P3495; He XM, 2010, ZHONGGUOJI HUA SHENG, V1, P13; He YX, 2012, SHI YONG JIAN YAN YI, V4, P6; Higgins JP, 2002, STAT MED, V21; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hogeveen M, 2012, AM J CLIN NUTR, V95, P130, DOI 10.3945/ajcn.111.016212; Hu XW, 2015, ZHONGGUO FU YOU BAO, V25, P4336; Huang GuiXiang, 2013, China Tropical Medicine, V13, P1446; Huang QH, 2015, CHIN J FAM PLANN, V23, P15; Jia XP, 2015, J WANNAN MED COLL, V34, P317; Jiang HO, 2010, ZHONGGUO YOU SHENG Y, V18, P18; Jiang W, 2014, GUANG XI YI XUE, V36, P1517; Jiao FY, 2014, MOLDIAGNTHER, V6, P105; Lange LA, 2010, HUM MOL GENET, V19, P2050, DOI 10.1093/hmg/ddq062; Lao HH, 2011, ZHONGGUOJI HUA SHENG, V19, P655; Li AF, 2007, ZHONGGUO YOU SHENG Y, V15, P19; Li JH, 2014, BASIC CLIN MED, V11, P1564; [李欣欣 Li Xinxin], 2015, [基础医学与临床, Basic & Clinical Medicine], V35, P1228; Liang JN, 2002, GUANGZHOU YI XUE YUA, V30, P38; Liu XL, 2014, J NINGXIA MED U, V36, P1216; Lu GR, 2014, HENAN MED RES, V23, P7; Luo SQ, 2015, ZHONGGUO YOU SHENG Y, V23, P20; Luo XL, 2014, J PUB HLTH PREV MED, V25, P29; Ma LM, 2015, PRACTPREV MED, V22, P289; Mao RF, 2008, CELL BIOCHEM FUNCT, V26, P352, DOI 10.1002/cbf.1450; Mao WC, 2015, CHIN J FAMPLANN, V23, P310; Markan S, 2007, MOL CELL BIOCHEM, V302, P125, DOI 10.1007/s11010-007-9434-5; Marti-Carvajal AJ, 2013, COCHRANE DB SYST REV, V31; Ott J., 1988, UTILITY PROGRAMS ANA; Ouyang QQ, 2014, ZHONGGUO YOU SHENG Y, V22, P6; Pei Li-jun, 2000, HEREDITAS BEIJING, V22, P369; Rady PL, 2002, AM J MED GENET, V107, P162, DOI 10.1002/ajmg.10122; Rai Vandana, 2013, Indian J Hum Genet, V19, P183, DOI 10.4103/0971-6866.116123; Rai Vandana, 2012, Indian J Med Sci, V66, P136; Reyes-Engel A, 2002, MOL HUM REPROD, V8, P952, DOI 10.1093/molehr/8.10.952; Sabbagh AS, 2008, GENET TEST, V12, P75, DOI 10.1089/gte.2007.0064; Saraswathy KN, 2012, MOL BIOL REP, V39, P5025, DOI 10.1007/s11033-011-1299-8; Shan KR, 2009, ZHONGGUO YOU SHENG Y, V17, P16; Shen LP, 2005, ZHONGGUO LIN CHUANG, V9, P8; Sun WP, 2003, DI SI JUN YI DA XUEX, V24, P634; Szvetko AL, 2007, J NEUROL SCI, V252, P49, DOI 10.1016/j.jns.2006.10.006; Tang HY, 2014, CHINA MED HERALD, V11, P8; Tian Y, 2014, XIN YI XUE, V45, P253; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wang FeiXia, 2014, Journal of Modern Laboratory Medicine, V29, P35; Wang Li-na, 2012, Zhonghua Pifuke Zazhi, V45, P178, DOI 10.3760/cma.j.issn.0412-4030.2012.03.010; Wang SY, 2015, TIANJIN MED J, V42, P1205; Wang WP, 2013, ZHONGGUO FU YOU BAO, V28, P140; Wilcken B, 2003, J MED GENET, V40, P619, DOI 10.1136/jmg.40.8.619; Wu HZ, 2011, BAOTOU YI XUE YUAN X, V27, P4; Wu WQ, 2015, JIANGSU MED J, V41, P71; Xiang CG, 2015, SHAN DONG YI YAO, V55, P22; Xiao Y, 2005, ZHONGGUO YOU SHENG Y, V13, P14; Xiao Yan, 2005, Zhonghua Yixue Yichuanxue Zazhi, V22, P219; [肖雁 Xiao Yan], 2005, [人类学学报, Acta Anthropologica Sinica], V24, P315; Xing JF, 2014, J MED FORUM, V35, P10; Xiu X, 2013, SHAN DONG YI YAO, V53, P31; Xue Y, 2000, Anthropol Anz, V58, P253; Yakub M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033222; Yamada K, 2006, P NATL ACAD SCI USA, V103, P9476, DOI 10.1073/pnas.0603694103; Yan Q, 2014, J SHANDONG U HLTH SC, V52, P79; Yan ZM, 2013, HAI NAN YI XUE YUAN, V19, P18; Yang BH, 2001, WAN NAN YI XUE YUAN, V20, P308; Yang BY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057917; Yang Y, 2012, NAN JING YI KE DA XU, V32, P1250; Yu JM, 2000, HUM HERED, V50, P268, DOI 10.1159/000022929; Yu YH, 2015, CHIN J FAMPLANN, V23, P591; Zhang CS, 2005, QI LU YI XUEZAZHI, V30, P310; Zhang L, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-123; Zhang QF, 2010, ZHONGGUO RE DAI YI X, V10, P1346; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059570; [张婷 Zhang Ting], 2013, [重庆医学, Chongqing Medicine], V42, P3413; Zhang Y, 2012, ZHONGGUOXUN ZHENG YI, V12, P631; Zhang Yan-li, 2012, Zhonghua Yixue Yichuanxue Zazhi, V29, P705, DOI 10.3760/cma.j.issn.1003-9406.2012.06.018; Zhu HP, 2000, ZHONGGUO YOU SHENG Y, V11, P51	102	31	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152414	10.1371/journal.pone.0152414	http://dx.doi.org/10.1371/journal.pone.0152414			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089387	Green Submitted, Green Published, gold			2022-12-27	WOS:000374527000006
J	Najafian, B; Tondel, C; Svarstad, E; Sokolovkiy, A; Smith, K; Mauer, M				Najafian, Behzad; Tondel, Camilla; Svarstad, Einar; Sokolovkiy, Alexey; Smith, Kelly; Mauer, Michael			One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; AGALSIDASE-BETA THERAPY; FOOT PROCESS EFFACEMENT; CHOLESTEROL ACCUMULATION; ALPHA-GALACTOSIDASE; ALBUMIN FILTRATION; MEMBRANE REPAIR; LAMELLAR BODIES; EXOCYTOSIS; RAT	Fabry nephropathy is associated with progressive accumulation of globotriaosylceramide (GL3) in podocytes. Reducing this GL3 burden may reduce podocyte injury. Sensitive methods to quantify podocyte GL3 content may determine whether a given strategy can benefit podocytes in Fabry disease. We developed an unbiased electron microscopic stereological method to estimate the average volume of podocytes and their GL3 inclusions in 6 paired pre- and post-enzyme replacement therapy (ERT) biopsies from 5 men with Fabry disease. Podocyte GL3 content was regularly reduced (average 73%) after 11-12 months of ERT. This was not detectable using a semi-quantitative approach. Parallel to GL3 reduction, podocytes became remarkably smaller (average 63%). These reductions in podocyte GL3 content or size were not significantly correlated with changes in foot process width (FPW). However, FPWafter ERT was significantly correlated with the magnitude of the decrease in podocyte GL3 content from baseline to 11-12 months of ERT. Also podocytes exocytosed GL3 inclusions, a phenomenon correlated with their reduction in their GL3 content. Demonstrable after11-12 months, reduction in podocyte GL3 content allows for early assessment of treatment efficacy and shorter clinical trials in Fabry disease.	[Najafian, Behzad; Sokolovkiy, Alexey; Smith, Kelly] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Tondel, Camilla; Svarstad, Einar] Univ Bergen, Dept Clin Med, Bergen, Norway; [Tondel, Camilla] Haukeland Hosp, Dept Pediat, N-5021 Bergen, Norway; [Svarstad, Einar] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Mauer, Michael] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Mauer, Michael] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Washington; University of Washington Seattle; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Najafian, B (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	najafian@uw.edu	Mauer, Michael/ABD-5415-2020	Najafian, Behzad/0000-0002-0904-6721	National Institutes of Health Lysosomal Disease Network, NCATS Rare Diseases Clinical Research Network (RDCRN) [U54NS065768]; Genzyme (a Sanofi company); NCATS; National Institute of Neurological Disorders and Stroke (NINDS); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS065768] Funding Source: NIH RePORTER	National Institutes of Health Lysosomal Disease Network, NCATS Rare Diseases Clinical Research Network (RDCRN); Genzyme (a Sanofi company)(Sanofi-AventisGenzyme Corporation); NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant (MM) from the National Institutes of Health Lysosomal Disease Network [(U54NS065768), a part of the NCATS Rare Diseases Clinical Research Network (RDCRN). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)], no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, and by an investigator initiated grant from Genzyme (a Sanofi company) to MM. Genzyme provided five paired biopsies with associated clinical information, but had no role in study design, research data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Ms. Frida Meiers and Karen Zaruba for electron microscopy studies and Ms. Cathy Bagne for research coordination. This work was supported by a grant from the National Institutes of Health Lysosomal Disease Network [(U54NS065768), a part of the NCATS Rare Diseases Clinical Research Network (RDCRN). RDCRN is an initiative of the Office of Rare Diseases Research (ORDR), NCATS, funded through a collaboration between NCATS and the National Institute of Neurological Disorders and Stroke (NINDS), and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)] and by an investigator initiated grant from Genzyme (a Sanofi company). Sanofi Genzyme provided the biopsy material and corresponding clinical data for 5 cases from the Fabrazyme (R) phase III clinical trial.	Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; BRAENDGAARD H, 1986, J NEUROSCI METH, V18, P39, DOI 10.1016/0165-0270(86)90112-3; Brinkkoetter PT, 2013, NAT REV NEPHROL, V9, P328, DOI 10.1038/nrneph.2013.78; Cao Y, 2006, J BIOL CHEM, V281, P20483, DOI 10.1074/jbc.M602180200; Chavez RA, 1996, J CELL BIOL, V133, P1177, DOI 10.1083/jcb.133.6.1177; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Deegens JKJ, 2008, KIDNEY INT, V74, P1568, DOI 10.1038/ki.2008.413; DESNICK RJ, 1973, J LAB CLIN MED, V81, P157; ELLIS EN, 1987, KIDNEY INT, V32, P736, DOI 10.1038/ki.1987.268; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Fogo AB, 2010, NEPHROL DIAL TRANSPL, V25, P2168, DOI 10.1093/ndt/gfp528; Fraldi A, 2010, EMBO J, V29, P3607, DOI 10.1038/emboj.2010.237; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Gerasimenko JV, 2001, CURR BIOL, V11, pR971, DOI 10.1016/S0960-9822(01)00577-2; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; GUBLER MC, 1978, KIDNEY INT, V13, P223, DOI 10.1038/ki.1978.32; GUNDERSEN HJG, 1985, J MICROSC-OXFORD, V138, P127, DOI 10.1111/j.1365-2818.1985.tb02607.x; Hodgin JB, 2015, J AM SOC NEPHROL; Kinugasa S, 2010, MED MOL MORPHOL, V43, P218, DOI 10.1007/s00795-010-0500-9; Kukic I, 2014, J CELL SCI, V127, P3094, DOI 10.1242/jcs.145318; Lee SH, 2015, APOPTOSIS, V20, P1056, DOI 10.1007/s10495-015-1134-0; LESAGE GD, 1993, GASTROENTEROLOGY, V105, P889, DOI 10.1016/0016-5085(93)90909-V; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; MacDermot KD, 2001, J MED GENET, V38, P750, DOI 10.1136/jmg.38.11.750; Mauer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112188; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; Miklavc P, 2009, ANN NY ACAD SCI, V1152, P43, DOI 10.1111/j.1749-6632.2008.03989.x; Najafian B, 2013, PEDIATR NEPHROL, V28, P679, DOI 10.1007/s00467-012-2222-9; Najafian B, 2011, KIDNEY INT, V79, P663, DOI 10.1038/ki.2010.484; Ogasawara R, 2009, CELL TISSUE RES, V335, P397, DOI 10.1007/s00441-008-0717-2; Patel V, 2015, HEART, V101, P961, DOI 10.1136/heartjnl-2014-306782; Pena K, 2015, CELL CALCIUM, V57, P257, DOI 10.1016/j.ceca.2015.01.005; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; REHDER V, 1992, NEUROSCIENCE, V51, P565, DOI 10.1016/0306-4522(92)90296-E; Schiffmann R, 2006, VIRCHOWS ARCH, V448, P337, DOI 10.1007/s00428-005-0089-x; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Sheppard MN, 2010, CARDIOVASC PATHOL, V19, P293, DOI 10.1016/j.carpath.2009.05.003; SILVERSTEIN RL, 1992, BLOOD, V80, P1470; TAPPER H, 1990, BIOCHEM J, V272, P407, DOI 10.1042/bj2720407; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Tondel C, 2008, AM J KIDNEY DIS, V51, P767, DOI 10.1053/j.ajkd.2007.12.032; Tondel C, 2013, J AM SOC NEPHROL, V24, P137, DOI 10.1681/ASN.2012030316; van den Berg JG, 2004, KIDNEY INT, V66, P1901, DOI 10.1111/j.1523-1755.2004.00964.x; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Weibel E, 1979, PRACTICAL METHODS BI, P9; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222	50	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152812	10.1371/journal.pone.0152812	http://dx.doi.org/10.1371/journal.pone.0152812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27081853	Green Published, gold			2022-12-27	WOS:000374291800009
J	Ong, QX; Guo, SL; Duan, LT; Zhang, K; Collier, EA; Cui, BX				Ong, Qunxiang; Guo, Shunling; Duan, Liting; Zhang, Kai; Collier, Eleanor Ann; Cui, Bianxiao			The Timing of Raf/ERK and AKT Activation in Protecting PC12 Cells against Oxidative Stress	PLOS ONE			English	Article							OPTOGENETIC CONTROL; ISCHEMIC-INJURY; BRAIN-INJURY; OXYGEN; MECHANISMS; DYNAMICS; TIME; REQUIREMENT; EXPRESSION; INDUCTION	Acute brain injuries such as ischemic stroke or traumatic brain injury often cause massive neural death and irreversible brain damage with grave consequences. Previous studies have established that a key participant in the events leading to neural death is the excessive production of reactive oxygen species. Protecting neuronal cells by activating their endogenous defense mechanisms is an attractive treatment strategy for acute brain injuries. In this work, we investigate how the precise timing of the Raf/ERK and the AKT pathway activation affects their protective effects against oxidative stress. For this purpose, we employed optogenetic systems that use light to precisely and reversibly activate either the Raf/ERK or the AKT pathway. We find that preconditioning activation of the Raf/ERK or the AKT pathway immediately before oxidant exposure provides significant protection to cells. Notably, a 15-minute transient activation of the Raf/ERK pathway is able to protect PC12 cells against oxidant strike that is applied 12 hours later, while the transient activation of the AKT pathway fails to protect PC12 cells in such a scenario. On the other hand, if the pathways are activated after the oxidative insult, i.e. postconditioning, the AKT pathway conveys greater protective effect than the Raf/ERK pathway. We find that postconditioning AKT activation has an optimal delay period of 2 hours. When the AKT pathway is activated 30min after the oxidative insult, it exhibits very little protective effect. Therefore, the precise timing of the pathway activation is crucial in determining its protective effect against oxidative injury. The optogenetic platform, with its precise temporal control and its ability to activate specific pathways, is ideal for the mechanistic dissection of intracellular pathways in protection against oxidative stress.	[Ong, Qunxiang; Guo, Shunling; Duan, Liting; Collier, Eleanor Ann; Cui, Bianxiao] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Zhang, Kai] Univ Illinois, Sch Mol & Cellular Biol, Dept Biochem, Urbana, IL 61801 USA	Stanford University; University of Illinois System; University of Illinois Urbana-Champaign	Cui, BX (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	bcui@stanford.edu	Zhang, Kai/ABD-1498-2021	Zhang, Kai/0000-0002-6687-4558	US National Institute of Health [DP2-NS082125]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP2NS082125] Funding Source: NIH RePORTER	US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institute of Health (www.nih.gov) DP2-NS082125 to BC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHULAIFI AM, 1993, CARDIOSCIENCE, V4, P163; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barone FC, 1998, STROKE, V29, P1937, DOI 10.1161/01.STR.29.9.1937; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bugaj LJ, 2013, NAT METHODS, V10, P249, DOI 10.1038/nmeth.2360; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Choi YS, 2007, EXP MOL MED, V39, P556, DOI 10.1038/emm.2007.61; Cohen MV, 2015, BRIT J PHARMACOL, V172, P1913, DOI 10.1111/bph.12903; DeRosa MC, 2002, COORDIN CHEM REV, V233, P351, DOI 10.1016/S0010-8545(02)00034-6; Dijkmans TF, 2008, J NEUROCHEM, V105, P2388, DOI 10.1111/j.1471-4159.2008.05338.x; Duan LT, 2015, CHEM BIOL, V22, P671, DOI 10.1016/j.chembiol.2015.04.014; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FOOTE CS, 1968, ACCOUNTS CHEM RES, V1, P104, DOI 10.1021/ar50004a002; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hausenloy DJ, 2016, NAT REV CARDIOL, V13, P193, DOI 10.1038/nrcardio.2016.5; Idevall-Hagren O, 2012, P NATL ACAD SCI USA, V109, pE2316, DOI 10.1073/pnas.1211305109; Jiang H, 2005, J MOL NEUROSCI, V25, P133, DOI 10.1385/JMN:25:2:133; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Katsura Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep14589; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kim SY, 2011, ONCOL REP, V26, P1561, DOI 10.3892/or.2011.1439; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Kokona D, 2015, EXP EYE RES, V136, P45, DOI 10.1016/j.exer.2015.05.007; Lee JM, 1999, NATURE, V399, pA7, DOI 10.1038/399a007; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Loukogeorgakis SP, 2006, CIRCULATION, V113, P1015, DOI 10.1161/CIRCULATIONAHA.105.590398; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Marinho HS, 2013, METHOD ENZYMOL, V526, P159, DOI 10.1016/B978-0-12-405883-5.00010-7; Martin KR, 2002, HUM EXP TOXICOL, V21, P71, DOI 10.1191/0960327102ht213oa; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Moreira JBN, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0444-x; Muller K, 2013, MOL BIOSYST, V9, P596, DOI 10.1039/c3mb25590e; Neumann JT, 2015, J CEREBR BLOOD F MET, V35, P121, DOI 10.1038/jcbfm.2014.185; Noh MY, 2013, MOL NEUROBIOL, V47, P757, DOI 10.1007/s12035-012-8382-6; Ong Q, 2015, OPTOGENETIC CO UNPUB; Ong QX, 2015, ACS CHEM NEUROSCI, V6, P130, DOI 10.1021/cn500288n; Perez-Pinzon MA, 2005, ANTIOXID REDOX SIGN, V7, P1150, DOI 10.1089/ars.2005.7.1150; SACK S, 1993, CARDIOVASC RES, V27, P551, DOI 10.1093/cvr/27.4.551; Salinas M, 2003, J BIOL CHEM, V278, P13898, DOI 10.1074/jbc.M209164200; Schulz R, 2001, CARDIOVASC RES, V52, P181, DOI 10.1016/S0008-6363(01)00384-4; Shahzad T, 2013, J MOL CELL CARDIOL, V58, P209, DOI 10.1016/j.yjmcc.2013.01.003; Shamloo M, 1999, NEUROSCIENCE, V93, P81, DOI 10.1016/S0306-4522(99)00137-2; STEEVES G, 1994, ANN NY ACAD SCI, V723, P116, DOI 10.1111/j.1749-6632.1994.tb36721.x; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Tischer D, 2014, NAT REV MOL CELL BIO, V15, P551, DOI 10.1038/nrm3837; Toettcher JE, 2013, CELL, V155, P1422, DOI 10.1016/j.cell.2013.11.004; Wang XT, 2000, J BIOL CHEM, V275, P14624, DOI 10.1074/jbc.275.19.14624; Wauson EM, 2013, BIOCHEMISTRY-US, V52, P5164, DOI 10.1021/bi4007644; Wegener S, 2004, STROKE, V35, P616, DOI 10.1161/01.STR.0000115767.17923.6A; Weitzman M, 2014, CURR OPIN CELL BIOL, V30, P112, DOI 10.1016/j.ceb.2014.08.004; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; YOUNGMAN RJ, 1981, FEBS LETT, V129, P265, DOI 10.1016/0014-5793(81)80180-9; Zhang K, 2015, TRENDS BIOTECHNOL, V33, P92, DOI 10.1016/j.tibtech.2014.11.007; Zhang KW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098215; Zhao H, 2009, J CEREBR BLOOD F MET, V29, P873, DOI 10.1038/jcbfm.2009.13; Zipper LM, 2003, TOXICOL SCI, V73, P124, DOI 10.1093/toxsci/kfg083	61	21	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153487	10.1371/journal.pone.0153487	http://dx.doi.org/10.1371/journal.pone.0153487			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082641	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800022
J	Patterson, BR; Mills, KJ; Middel, KR; Benson, JF; Obbard, ME				Patterson, Brent R.; Mills, Kenneth J.; Middel, Kevin R.; Benson, John F.; Obbard, Martyn E.			Does Predation Influence the Seasonal and Diel Timing of Moose Calving in Central Ontario, Canada?	PLOS ONE			English	Article							VAGINAL IMPLANT TRANSMITTERS; WHITE-TAILED DEER; ALCES-ALCES; ACTIVITY PATTERNS; BLACK BEARS; URSUS-AMERICANUS; CALF MORTALITY; WOLF ACTIVITY; SYNCHRONY; SURVIVAL	Birth synchrony is well documented among ungulates and is hypothesised to maximize neonate survival, either by minimizing the risk of predation through predator swamping or by synchronising birthing with increased seasonal food availability. We used encapsulated vaginal implant transmitters to locate and capture neonatal moose calves and document the seasonal and diel timing of parturition in two adjacent study areas with different predation pressure in central Ontario, Canada. We tested the hypothesis that predation promotes earlier and more synchronous birth of moose calves. Across both areas, proportionately more births occurred during the afternoon and fewer than expected occurred overnight. Mean date of calving averaged 1.5 days earlier and calving was also more synchronous in the study area with heavier predation pressure, despite average green-up date and peak Normalized Difference Vegetation Index date occurring 2 days later in this study area than in the area receiving lighter predation pressure. We encourage analysis of data on timing of parturition from additional study areas experiencing varying degrees of predation pressure to better clarify the influence of predation in driving seasonal and diel timing of parturition in temperate ungulates.	[Patterson, Brent R.; Mills, Kenneth J.; Middel, Kevin R.; Obbard, Martyn E.] Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON K9J 7B8, Canada; [Benson, John F.] Trent Univ, Environm & Life Sci Grad Program, Peterborough, ON K9J 7B8, Canada; [Mills, Kenneth J.] Wyoming Game & Fish Dept, Pinedale, WY USA; [Benson, John F.] Calif State Univ Los Angeles, Inst Environm & Sustainabil, La Kretz Ctr Calif Conservat Sci, Los Angeles, CA 90032 USA	Ministry of Natural Resources & Forestry; Trent University; Trent University; California State University System; California State University Los Angeles	Patterson, BR (corresponding author), Trent Univ, Ontario Minist Nat Resources & Forestry, Wildlife Res & Monitoring Sect, Peterborough, ON K9J 7B8, Canada.	brent.patterson@ontario.ca	Obbard, Martyn/AFU-0326-2022	Obbard, Martyn/0000-0003-2064-0155	Ontario Ministry of Natural Resources & Forestry through Ontario Parks; Wildlife Research and Monitoring Section; Natural Sciences & Research Council of Canada [STPGP 321950-05]; Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant; Canadian Foundation for Innovation (CFI); Ontario Ministry of Natural Resources & Forestry, through Ontario Parks	Ontario Ministry of Natural Resources & Forestry through Ontario Parks; Wildlife Research and Monitoring Section; Natural Sciences & Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant; Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Ontario Ministry of Natural Resources & Forestry, through Ontario Parks	Major funding for this work was provided by the Ontario Ministry of Natural Resources & Forestry through Ontario Parks and the Wildlife Research and Monitoring Section. Additional funding was provided by the Natural Sciences & Research Council of Canada (STPGP 321950-05 awarded to Dennis Murray). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was part of a larger assessment of moose viability funded primarily by a Strategic Natural Sciences and Engineering Research Council of Canada (NSERC) grant, and an equipment grant from the Canadian Foundation for Innovation (CFI), both granted to Dennis Murray, Trent University, Peterborough, Ontario. Primary funding for the work described here was provided by the Ontario Ministry of Natural Resources & Forestry, through Ontario Parks and the Wildlife Research and Monitoring Section. Andrew Silver and Mark Gibson assisted greatly with logistical arrangements related to calf captures. Erica Newton assisted with the calculation of NDVI values for our study areas and Sarah Jamieson assisted with the literature search regarding onset of labor. We further thank the many students, volunteers and technicians who participated in field searches for moose calves. Art Rodgers and J. Ward Testa provided useful comments on a previous draft of the manuscript.	ADAMS LG, 1995, J WILDLIFE MANAGE, V59, P584, DOI 10.2307/3802467; Addison E.M., 1990, Alces, V26, P142; ADDISON EM, 1993, ALCES N AM, V29, P27; AUSTIN MA, 1994, CAN FIELD NAT, V108, P236; Ballard W. B., 1979, ALCES, V15, P362; BENSON JF, 2013, CAN J ZOOL, V91, P1; Benson JF, 2012, MOL ECOL, V21, P5934, DOI 10.1111/mec.12045; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Berger J, 2007, BIOL LETTERS, V3, P620, DOI 10.1098/rsbl.2007.0415; BERGERUD AT, 1975, CAN J ZOOL, V53, P1213, DOI 10.1139/z75-145; Bertram MR, 2002, J WILDLIFE MANAGE, V66, P747, DOI 10.2307/3803140; Bishop CJ, 2007, J WILDLIFE MANAGE, V71, P945, DOI 10.2193/2006-123; Boer A.H., 1992, ALCES, V1, P1; Bowman JL, 1998, WILDLIFE SOC B, V26, P295; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Bridges AS, 2004, WILDLIFE BIOL, V10, P277, DOI 10.2981/wlb.2004.033; BRONSON EH, 1989, MAMMALIAN REPROD BIO; BUNNELL FL, 1982, CAN J ZOOL, V60, P1, DOI 10.1139/z82-001; Canadian Association of Zoo and Wildlife Veterinarians, 2009, CHEM IMM WILDL; Crins WJ, 2008, ECOSYSTEMS ONTANO 2; EDWARDS R. Y., 1958, JOUR WILDLIFE MANAGEMENT, V22, P261, DOI 10.2307/3796458; Environment Canada, 2008, NAT CLIM DAT INF ARC; Eriksen A, 2011, ANIM BEHAV, V81, P423, DOI 10.1016/j.anbehav.2010.11.011; ESTES R D, 1976, East African Wildlife Journal, V14, P135; ESTES RD, 1979, Z TIERPSYCHOL, V50, P45; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; Finnegan LA, 2012, EUR J WILDLIFE RES, V58, P415, DOI 10.1007/s10344-011-0590-2; FULLER TK, 1991, CAN J ZOOL, V69, P283, DOI 10.1139/z91-044; Griffin KA, 2011, J ANIM ECOL, V80, P1246, DOI 10.1111/j.1365-2656.2011.01856.x; GUNTHER KA, 1990, INT C BEAR, V8, P329; Hegel TM, 2010, J ANIM ECOL, V79, P471, DOI 10.1111/j.1365-2656.2009.01647.x; Hogg JT, 2006, P ROY SOC B-BIOL SCI, V273, P1491, DOI 10.1098/rspb.2006.3477; Howe EJ, 2013, POPUL ECOL, V55, P595, DOI 10.1007/s10144-013-0389-y; Jacoby ME, 1999, J WILDLIFE MANAGE, V63, P921, DOI 10.2307/3802806; Johnson DS, 2004, J MAMMAL, V85, P932, DOI 10.1644/BFW-009; Johnstone-Yellin TL, 2006, WILDLIFE SOC B, V34, P338, DOI 10.2193/0091-7648(2006)34[338:EOVITF]2.0.CO;2; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Keech MA, 2011, J WILDLIFE MANAGE, V75, P1361, DOI 10.1002/jwmg.188; LARIVIERE S, 1994, J MAMMAL, V75, P613, DOI 10.2307/1382508; LARSEN DG, 1989, J WILDLIFE MANAGE, V53, P548, DOI 10.2307/3809175; Laurian C, 2000, J APPL ECOL, V37, P515, DOI 10.1046/j.1365-2664.2000.00520.x; Lowe SJ, 2010, CAN J ZOOL, V88, P1032, DOI 10.1139/Z10-071; Marshall FHA, 1937, PROC R SOC SER B-BIO, V122, P413, DOI 10.1098/rspb.1937.0034; McLaren M., 2009, 127 ONT MIN NAT RES; McLoughlin PD, 2011, BASIC APPL ECOL, V12, P654, DOI 10.1016/j.baae.2011.09.001; Murray DL, 2012, CAN J ZOOL, V90, P422, DOI 10.1139/Z2012-002; Nathanielsz PW, 1998, EUR J OBSTET GYN R B, V78, P127, DOI 10.1016/S0301-2115(98)00058-X; Obbard Martyn E., 2000, Northeast Wildlife, V55, P57; Patterson BR, 2004, WILDLIFE SOC B, V32, P938, DOI 10.2193/0091-7648(2004)032[0938:EWDIFA]2.0.CO;2; Patterson BR, 2013, J WILDLIFE MANAGE, V77, P832, DOI 10.1002/jwmg.516; Quinn NWS, 2005, CAN FIELD NAT, V119, P330, DOI 10.22621/cfn.v119i3.142; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAWLINGS NC, 1976, J REPROD FERTIL, V48, P355, DOI 10.1530/jrf.0.0480355; Rowe J.S., 1972, CANADIAN FOREST SERV, V1300; RUTBERG AT, 1987, AM NAT, V130, P692, DOI 10.1086/284739; Saether BE, 2003, J WILDLIFE MANAGE, V67, P455, DOI 10.2307/3802703; SCHWARTZ CC, 1993, J WILDLIFE MANAGE, V57, P454, DOI 10.2307/3809270; Schwartz Charles C., 1998, P141; Sigouin D, 1997, ALCES N AM, V33, P85; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Solberg EJ, 2007, OECOLOGIA, V154, P259, DOI 10.1007/s00442-007-0833-9; Testa JW, 2002, J MAMMAL, V83, P699, DOI 10.1644/1545-1542(2002)083<0699:DPONIS>2.0.CO;2; Testa JW, 2000, J MAMMAL, V81, P162, DOI 10.1644/1545-1542(2000)081<0162:TPITSO>2.0.CO;2; Theuerkauf J, 2003, J MAMMAL, V84, P243, DOI 10.1644/1545-1542(2003)084<0243:DPADOW>2.0.CO;2; United States Geological Survey EROS Centre, 2014, USGS CONT US 1 KM AV; Welch Ian D., 2000, Alces, V36, P93; White KS, 2001, J MAMMAL, V82, P422, DOI 10.1644/1545-1542(2001)082<0422:BAEEOD>2.0.CO;2; Whiting JC, 2011, J MAMMAL, V92, P213, DOI 10.1644/10-MAMM-A-145.1; [No title captured]	69	8	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0150730	10.1371/journal.pone.0150730	http://dx.doi.org/10.1371/journal.pone.0150730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082234	Green Published, gold			2022-12-27	WOS:000374291800002
J	Trakman, L; Hewson, C; Burdach, J; Morris, KV				Trakman, Laura; Hewson, Chris; Burdach, Jon; Morris, Kevin V.			RNA Directed Modulation of Phenotypic Plasticity in Human Cells	PLOS ONE			English	Article							ANTISENSE RNA; TRANSCRIPTION	Natural selective processes have been known to drive phenotypic plasticity, which is the emergence of different phenotypes from one genome following environmental stimulation. Long non-coding RNAs (lncRNAs) have been observed to modulate transcriptional and epigenetic states of genes in human cells. We surmised that lncRNAs are governors of phenotypic plasticity and drive natural selective processes through epigenetic modulation of gene expression. Using heat shocked human cells as a model we find several differentially expressed transcripts with the top candidates being lncRNAs derived from retro-elements. One particular retro-element derived transcripts, Retro-EIF2S2, was found to be abundantly over-expressed in heat shocked cells. Over-expression of Retro-EIF2S2 significantly enhanced cell viability and modulated a predisposition for an adherent cellular phenotype upon heat shock. Mechanistically, we find that this retro-element derived transcript interacts directly with a network of proteins including 40S ribosomal protein S30 (FAU), Eukaryotic translation initiation factor 5A (EIF5A), and Ubiquitin-60S ribosomal protein L40 (UBA52) to affect protein modulated cell adhesion pathways. We find one motif in Retro-EIF2S2 that exhibits binding to FAU and modulates phenotypic cell transitions from adherent to suspension states. The observations presented here suggest that retroviral derived transcripts actively modulate phenotypic plasticity in human cells in response to environmental selective pressures and suggest that natural selection may play out through the action of retro-elements in human cells.	[Trakman, Laura; Hewson, Chris; Burdach, Jon; Morris, Kevin V.] Univ New S Wales, Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia; [Morris, Kevin V.] City Hope Beckman Res Inst, Ctr Gene Therapy, Duarte, CA 91010 USA	University of New South Wales Sydney; City of Hope; Beckman Research Institute of City of Hope	Morris, KV (corresponding author), Univ New S Wales, Biotechnol & Biomed Sci, Sydney, NSW 2052, Australia.; Morris, KV (corresponding author), City Hope Beckman Res Inst, Ctr Gene Therapy, Duarte, CA 91010 USA.	kmorris@coh.org		Morris, Kevin/0000-0002-0157-0553	NIAID [P01 AI099783-01]; ARC [FT130100572]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI099783, R01AI111139] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ARC(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by the following: NIAID P01 AI099783-01 and ARC Future Fellow FT130100572.	Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; BARSACCHI G, 1972, J CELL BIOL, V54, P580, DOI 10.1083/jcb.54.3.580; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Johnsson P, 2013, NAT STRUCT MOL BIOL, V20, P440, DOI 10.1038/nsmb.2516; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2009, EPIGENETICS, P4; Rossman TG, 2003, ONCOGENE, V22, P1817, DOI 10.1038/sj.onc.1206283; Saayman S, 2014, MOL THER, V22, P1164, DOI 10.1038/mt.2014.29; Thanaphum S, 1998, INSECT MOL BIOL, V7, P63, DOI 10.1046/j.1365-2583.1998.71051.x; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vadie N, 2015, RNA BIOL, V12, P893, DOI 10.1080/15476286.2015.1063773; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468	19	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152424	10.1371/journal.pone.0152424	http://dx.doi.org/10.1371/journal.pone.0152424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082860	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800006
J	Wipfli, R; Dubois-Ferriere, V; Budry, S; Hoffmeyer, P; Lovis, C				Wipfli, Rolf; Dubois-Ferriere, Victor; Budry, Sylvain; Hoffmeyer, Pierre; Lovis, Christian			Gesture-Controlled Image Management for Operating Room: A Randomized Crossover Study to Compare Interaction Using Gestures, Mouse, and Third Person Relaying	PLOS ONE			English	Article							USER-INTERFACE; TOUCH	Objective In this work, we aim at comparing formally three different interaction modes for image manipulation that are usable in a surgery setting: 1) A gesture-controlled approach using Kinect (R); 2) oral instructions to a third part dedicated to manipulate the images; and 3) direct manipulation using a mouse. Materials and Methods Each participant used the radiology image viewer Weasis with the three interaction modes. In a crossover randomized controlled trial participants were attributed block wise to six experimental groups. For each group, the order for testing the three modes was randomly assigned. Nine standardized scenarios were used. Results 30 physicians and senior medical students participated in the experiment. Efficiency, measured as time used to pass the scenario, was best when using the mouse (M=109.10s, SD = 25.96), followed by gesture-controlled (M=214.97s, SD = 46.29) and oral instructions (M = 246.33s, SD = 76.50). Satisfaction, measured by a questionnaire, was rated highest in the condition mouse (M=6.63, SD = 0.56), followed by gesture-controlled (M=5.77, SD = 0.93) and oral instructions (M = 4.40, SD = 1.71). Differences in efficiency and satisfaction rating were significant. No significant difference in effectiveness, measured with error rates, was found. Discussion The study shows with formal evaluation that the use of gestures is advantageous over instructions to a third person. In particular, the use of gestures is more efficient than verbalizing instructions. The given gestures could be learned easily and reliability of the tested gesture-control system is good. Conclusion Under the premise that mouse cannot be used directly during surgery, gesture-controlled approaches demonstrate to be superior to oral instructions for image manipulation.	[Wipfli, Rolf; Lovis, Christian] Univ Hosp Geneva, Div Med Informat Sci, Geneva, Switzerland; [Dubois-Ferriere, Victor; Hoffmeyer, Pierre] Univ Hosp Geneva, Div Orthopaed & Trauma Surg, Geneva, Switzerland; [Budry, Sylvain; Hoffmeyer, Pierre; Lovis, Christian] Univ Geneva, Fac Med, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Dubois-Ferriere, V (corresponding author), Univ Hosp Geneva, Div Orthopaed & Trauma Surg, Geneva, Switzerland.	victor.dubois-ferriere@hcuge.ch	Lovis, Christian/D-2634-2012; Hoffmeyer, Pierre/X-4491-2019; hoffmeyer, pierre/AAY-1392-2021; Lovis, Christian/T-5364-2019	Lovis, Christian/0000-0002-2681-8076; Lovis, Christian/0000-0002-2681-8076; Hoffmeyer, Pierre/0000-0001-9736-828X				[Anonymous], 2014, INTERACTIONS, DOI DOI https://doi.org/10.1145/2591689; Bigdelou A., 2012, 2012 IEEE Symposium on 3D User Interfaces (3DUI), P53, DOI 10.1109/3DUI.2012.6184184; Carifio J., 2007, J SOCIAL SCI, V3, P106, DOI DOI 10.3844/JSSP.2007.106.116; Ebert LC, 2012, SURG INNOV, V19, P301, DOI 10.1177/1553350611425508; Gallo L, 2011, COMP MED SY, DOI 10.1109/CBMS.2011.5999138; Graetzel C, 2014, TECHNOLOGY HEALTHCAR, V12; Hartmann Bernd, 2004, J Clin Monit Comput, V18, P7, DOI 10.1023/B:JOCM.0000025279.27084.39; Hotker AM, 2013, INT J COMPUT ASS RAD, V8, P997, DOI 10.1007/s11548-013-0841-7; ISO, 1998, 9241 ISO EN 11; Jacob MG, 2013, J AM MED INFORM ASSN, V20, pE183, DOI 10.1136/amiajnl-2012-001212; Johnson R, 2011, 29TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, P3323; Kipshagen T, 2009, IFMBE PROC, V25, P75, DOI 10.1007/978-3-642-03906-5_21; LEWIS JR, 1995, INT J HUM-COMPUT INT, V7, P57, DOI 10.1080/10447319509526110; Nacenta Miguel A., 2013, P SIGCHI C HUMAN FAC, P1099, DOI [DOI 10.1145/2470654.2466142, 10.1145/2470654.2466142]; Punt MM, 2005, MINIM INVASIV THER, V14, P181, DOI 10.1080/13645700510033967; Ruppert GCS, 2012, WORLD J UROL, V30, P687, DOI 10.1007/s00345-012-0879-0; Strickland M, 2013, CAN J SURG, V56, pE1, DOI 10.1503/cjs.035311; Tan JH, 2013, RADIOGRAPHICS, V33, pE61, DOI 10.1148/rg.332125101; Tuntakurn A, 2012, BIOMED ENG INT CONF, P28; Wachs JP, 2008, J AM MED INFORM ASSN, V15, P321, DOI 10.1197/jamia.M241; Wipfli R, JMIR HUMAN FAC UNPUB	21	24	24	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153596	10.1371/journal.pone.0153596	http://dx.doi.org/10.1371/journal.pone.0153596			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082758	Green Published, Green Submitted, gold			2022-12-27	WOS:000374291800032
J	Cury, DP; Dias, FJ; Miglino, MA; Watanabe, IS				Cury, Diego Pulzatto; Jose Dias, Fernando; Miglino, Maria Angelica; Watanabe, Ii-sei			Structural and Ultrastructural Characteristics of Bone-Tendon Junction of the Calcaneal Tendon of Adult and Elderly Wistar Rats	PLOS ONE			English	Article							AGE-RELATED-CHANGES; ACHILLES-TENDON; COLLAGEN-FIBERS; III COLLAGEN; ELECTRON-MICROSCOPY; INSERTION; TISSUE; METABOLISM; MORPHOLOGY; OSTEOCYTE	Tendons are transition tissues that transfer the contractile forces generated by the muscles to the bones, allowing movement. The region where the tendon attaches to the bone is called bone-tendon junction or enthesis and may be classified as fibrous or fibrocartilaginous. This study aims to analyze the collagen fibers and the cells present in the bone-tendon junction using light microscopy and ultrastructural techniques as scanning electron microscopy and transmission electron microscopy. Forty male Wistar rats were used in the experiment, being 20 adult rats at 4 months-old and 20 elderly rats at 20 months-old. The hind limbs of the rats were removed, dissected and prepared to light microscopy, transmission electron microscopy and scanning electron microscopy. The aging process showed changes in the collagen fibrils, with a predominance of type III fibers in the elderly group, in addition to a decrease in the amount of the fibrocartilage cells, fewer and shorter cytoplasmic processes and a decreased synthetic capacity due to degradation of the organelles involved in synthesis.	[Cury, Diego Pulzatto; Watanabe, Ii-sei] Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil; [Cury, Diego Pulzatto; Miglino, Maria Angelica; Watanabe, Ii-sei] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Surg, Sao Paulo, Brazil; [Jose Dias, Fernando] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Surg & Anat, BR-14049 Ribeirao Preto, Brazil; [Jose Dias, Fernando] Univ La Frontera, Sch Dent, CICO Res Ctr, Temuco, Chile	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad de La Frontera	Watanabe, IS (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Anat, Sao Paulo, Brazil.	watanabe@icb.usp.br	Miglino, Maria Angelica/B-9519-2012; Cury, Diego Pulzatto/N-9870-2015; Cury, Diego Pulzatto/AAS-5015-2021; Dias, Fernando Jose/AAP-7420-2020; Dias, Fernando Jose/D-8228-2014	Miglino, Maria Angelica/0000-0003-4979-115X; Cury, Diego Pulzatto/0000-0002-8571-7144; Dias, Fernando Jose/0000-0001-9945-9185; Watanabe, Ii-sei/0000-0002-1000-1467	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation) [2012/03280-1]; FAPESP [2012/03280-1]	FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Sao Paulo Research Foundation), http://www.fapesp.br/, Grant #2012/03280-1.; The authors would like to thank FAPESP grant #2012/03280-1 for financial support and Sonia Regina Yokomizo de Almeida, Marta Maria da Silva Righetti, Kelly Patricia Nery Borges, Sebastiao Aparecido Boleta for the technical assistance and reviewers of the Plos One for all suggestions and comments.	Alves A, 2015, MICROSC RES TECHNIQ, V78, P900, DOI 10.1002/jemt.22553; Alves LC, 2008, CAD SAUDE PUBLICA, V24, P535, DOI 10.1590/S0102-311X2008000300007; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2000, INT REV CYTOL, V196, P85; BENJAMIN M, 1986, J ANAT, V149, P89; Benjamin M, 2002, COMP BIOCHEM PHYS A, V133, P931, DOI 10.1016/S1095-6433(02)00138-1; BENJAMIN M, 1991, J ANAT, V179, P127; Biancalana A, 2012, MICRON, V43, P463, DOI 10.1016/j.micron.2011.11.002; BOSCO C, 1980, EUR J APPL PHYSIOL O, V45, P209, DOI 10.1007/BF00421329; Buckley MR, 2013, CONNECT TISSUE RES, V54, P374, DOI 10.3109/03008207.2013.847096; Burger EH, 1999, FASEB J, V13, pS101, DOI 10.1096/fasebj.13.9001.s101; Claudepierre P, 2005, JOINT BONE SPINE, V72, P32, DOI 10.1016/j.jbspin.2004.02.010; CONSTANTINE VS, 1968, J INVEST DERMATOL, V50, P419, DOI 10.1038/jid.1968.68; Dapson RW, 2011, BIOTECH HISTOCHEM, V86, P133, DOI 10.3109/10520295.2011.570277; del Sol M, 2011, INT J MORPHOL, V29, P918, DOI 10.4067/S0717-95022011000300042; Dias FJ, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/597863; Dias FJ, 2012, MICRON, V43, P237, DOI 10.1016/j.micron.2011.08.005; Dressler MR, 2005, J ORTHOP RES, V23, P287, DOI 10.1016/j.orthres.2004.06.017; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Everts V, 2012, METHODS MOL BIOL, V816, P351, DOI 10.1007/978-1-61779-415-5_23; FLORIDI A, 1981, CONNECT TISSUE RES, V9, P95, DOI 10.3109/03008208109160246; Ganestam A, 2016, KNEE SURG SPORT TR A, V24, P3730, DOI 10.1007/s00167-015-3544-5; Geary MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136351; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Gopinathan PA, 2015, SCIENTIFICA, V2015, DOI 10.1155/2015/802980; IPPOLITO E, 1980, J BONE JOINT SURG AM, V62, P583, DOI 10.2106/00004623-198062040-00014; Jarvinen TAH, 2004, J ORTHOP RES, V22, P1303, DOI 10.1016/j.orthres.2004.04.003; JOZSA L, 1989, AM J SPORT MED, V17, P338, DOI 10.1177/036354658901700305; JOZSA L, 1984, ARCH ORTHOP TRAUM SU, V103, P47, DOI 10.1007/BF00451318; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kannus P, 2000, SCAND J MED SCI SPOR, V10, P312, DOI 10.1034/j.1600-0838.2000.010006312.x; Kannus P, 2005, TENDON INJURIES: BASIC SCIENCE AND CLINICAL MEDICINE, P25, DOI 10.1007/1-84628-050-8_4; Kostrominova TY, 2013, AGE, V35, P2203, DOI 10.1007/s11357-013-9514-2; Lantto I, 2015, SCAND J MED SCI SPOR, V25, pE133, DOI 10.1111/sms.12253; Lattouf R, 2014, J HISTOCHEM CYTOCHEM, V62, P751, DOI 10.1369/0022155414545787; Lavagnino M, 2013, CONNECT TISSUE RES, V54, P70, DOI 10.3109/03008207.2012.744973; Maffulli N, 2000, AM J SPORT MED, V28, P499, DOI 10.1177/03635465000280040901; Manjunatha BS, 2015, J CANCER RES THER, V11, P272, DOI 10.4103/0973-1482.154061; Mendes M, 2010, KAFKAS UNIV VET FAK, V16, P711; Milz S, 2004, ANN RHEUM DIS, V63, P1015, DOI 10.1136/ard.2003.016378; MONTES GS, 1991, MEM I OSWALDO CRUZ, V86, P1; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Oegema TR, 1997, MICROSC RES TECHNIQ, V37, P324, DOI 10.1002/(SICI)1097-0029(19970515)37:4<324::AID-JEMT7>3.0.CO;2-K; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; Ritchie RO, 2006, STRAIN, V42, P225, DOI 10.1111/j.1475-1305.2006.00282.x; Rochefort GY, 2010, OSTEOPOROSIS INT, V21, P1457, DOI 10.1007/s00198-010-1194-5; Singh Harkanwal Preet, 2012, Natl J Maxillofac Surg, V3, P15, DOI 10.4103/0975-5950.102142; SQUIER CA, 1983, CELL TISSUE RES, V234, P17; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2006, J BIOMECH, V39, P1842, DOI 10.1016/j.jbiomech.2005.05.021; van Hove RP, 2009, BONE, V45, P321, DOI 10.1016/j.bone.2009.04.238; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; WATANABE I, 1983, ARCH HISTOL JAPON, V46, P173, DOI 10.1679/aohc.46.173; Watanabe I., 1998, SCANNING ELECTRON MI; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P727, DOI 10.1083/jcb.4.6.727; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wopenka B, 2008, APPL SPECTROSC, V62, P1285, DOI 10.1366/000370208786822179; Yanagisawa H, 2012, J ELECTRON MICROSC, V61, P237, DOI 10.1093/jmicro/dfs044; Yang G, 2013, BIRTH DEFECTS RES C, V99, P203, DOI 10.1002/bdrc.21041; Yu TY, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-2; Zhao L, 2014, J ANAT, V224, P624, DOI 10.1111/joa.12174; Zhou ZP, 2010, AGING CELL, V9, P911, DOI 10.1111/j.1474-9726.2010.00598.x	64	18	19	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153568	10.1371/journal.pone.0153568	http://dx.doi.org/10.1371/journal.pone.0153568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078690	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700080
J	Kawamoto, R; Ninomiya, D; Kasai, Y; Kusunoki, T; Ohtsuka, N; Kumagi, T; Abe, M				Kawamoto, Ryuichi; Ninomiya, Daisuke; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki; Kumagi, Teru; Abe, Masanori			Serum Uric Acid Is Positively Associated with Handgrip Strength among Japanese Community-Dwelling Elderly Women	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INDUCED OXIDATIVE STRESS; J-SHAPED ASSOCIATION; OLDER PERSONS; METABOLIC SYNDROME; MUSCLE STRENGTH; INFLAMMATORY MARKERS; PHYSICAL FUNCTION; BLOOD-PRESSURE; ALL-CAUSE	Serum uric acid (UA) has strong anti-oxidant properties. Muscle strength and mass decrease with age, and recently, this decrease has been defined as sarcopenia. Sarcopenia may be triggered by oxidative stress. We investigated whether serum UA is associated with handgrip strength (HGS), which is a useful indicator of sarcopenia, among Japanese community-dwelling elderly persons. The present study included 602 men aged 72 +/- 7 years and 847 women aged 71 +/- 6 years from a rural village. We examined the cross-sectional relationship between serum UA and HGS. In both genders, HGS increased significantly with increased serum UA levels. A multiple linear regression analysis using HGS as an objective variable and various confounding factors as explanatory variables showed that in men age, drinking status, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), and estimated glomerular filtration ratio (eGFR(CKDEPI)) were independently and significantly associated with HGS, and in women, serum UA as well as age, body mass index, drinking status, diastolic blood pressure, and eGFR(CKDEPI) were independently and significantly associated with HGS. In women, age and multivariate-adjusted HGS were significantly higher in the Quartile-3 (4.8-5.4 mg/dL) and Quartile-4 groups (5.5-9.3 mg/dL) of serum UA than in the lower groups (0.7-4.7 mg/dL). These results suggest that serum UA may have a protective role in aging-associated decline in muscle strength in community-dwelling elderly women.	[Kawamoto, Ryuichi; Ninomiya, Daisuke; Kumagi, Teru; Abe, Masanori] Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 7910295, Japan; [Kawamoto, Ryuichi; Ninomiya, Daisuke; Kasai, Yoshihisa; Kusunoki, Tomo; Ohtsuka, Nobuyuki] Seiyo Municipal Nomura Hosp, Dept Internal Med, Matsuyama, Ehime 7971212, Japan	Ehime University	Kawamoto, R (corresponding author), Ehime Univ, Grad Sch Med, Dept Community Med, Matsuyama, Ehime 7910295, Japan.; Kawamoto, R (corresponding author), Seiyo Municipal Nomura Hosp, Dept Internal Med, Matsuyama, Ehime 7971212, Japan.	rykawamo@m.ehime-u.ac.jp	Kumagi, Teru/AAS-7427-2021	Kumagi, Teru/0000-0002-2292-7750	Foundation for Development of Community	Foundation for Development of Community	This work was supported in part by a grant-in-aid for Scientific Research from the Foundation for Development of Community (2014). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Beavers KM, 2009, J NUTR HEALTH AGING, V13, P177, DOI 10.1007/s12603-009-0054-5; Brinkley TE, 2009, J GERONTOL A-BIOL, V64, P455, DOI 10.1093/gerona/gln038; Cesari M, 2004, J GERONTOL A-BIOL, V59, P242; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Derbre F, 2014, EUR J SPORT SCI, V14, pS98, DOI 10.1080/17461391.2011.654268; Fulle S, 2004, EXP GERONTOL, V39, P17, DOI 10.1016/j.exger.2003.09.012; Glantzounis GK, 2005, CURR PHARM DESIGN, V11, P4145, DOI 10.2174/138161205774913255; GORDON T, 1983, ARCH INTERN MED, V143, P1366, DOI 10.1001/archinte.143.7.1366; Howard C, 2007, J APPL PHYSIOL, V103, P17, DOI 10.1152/japplphysiol.00133.2007; Hsu SP, 2004, NEPHROL DIAL TRANSPL, V19, P457, DOI 10.1093/ndt/gfg563; Huang C, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-258; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kawamoto R, 2013, ENDOCRINE, V44, P132, DOI 10.1007/s12020-013-9912-3; Kawamoto R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065886; Kawamoto R, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-87; Kim Tae Nyun, 2013, J Bone Metab, V20, P1, DOI 10.11005/jbm.2013.20.1.1; Kohara K, 2014, ENDOCRINE, V45, P15, DOI 10.1007/s12020-013-9992-0; Llull L, 2015, STROKE, V46, P2162, DOI 10.1161/STROKEAHA.115.009960; Lyngdoh T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019901; Macchi C, 2008, MECH AGEING DEV, V129, P522, DOI 10.1016/j.mad.2008.04.008; Mazzali M, 2001, HYPERTENSION, V38, P1101, DOI 10.1161/hy1101.092839; Meisinger C, 2008, ARTERIOSCL THROM VAS, V28, P1186, DOI 10.1161/ATVBAHA.107.160184; Nakagawa T, 2005, NAT CLIN PRACT NEPHR, V1, P80, DOI 10.1038/ncpneph0019; Richette P, 2010, LANCET, V375, P318, DOI 10.1016/S0140-6736(09)60883-7; Romanos E, 2007, J CEREBR BLOOD F MET, V27, P14, DOI 10.1038/sj.jcbfm.9600312; Ruggiero C, 2006, EUR HEART J, V27, P1174, DOI 10.1093/eurheatj/ehi879; Ruggiero C, 2007, J AM GERIATR SOC, V55, P1206, DOI 10.1111/j.1532-5415.2007.01260.x; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; Schaap LA, 2009, J GERONTOL A-BIOL, V64, P1183, DOI 10.1093/gerona/glp097; Suliman ME, 2006, AM J KIDNEY DIS, V48, P761, DOI 10.1053/j.ajkd.2006.08.019; Sundstrom J, 2005, HYPERTENSION, V45, P28, DOI 10.1161/01.HYP.0000150784.92944.9a; Waring WS, 2003, CLIN SCI, V105, P425, DOI 10.1042/CS20030149; Wu YL, 2013, GERIATR GERONTOL INT, V13, P672, DOI 10.1111/j.1447-0594.2012.00962.x; Yu ZF, 1998, J NEUROSCI RES, V53, P613, DOI 10.1002/(SICI)1097-4547(19980901)53:5<613::AID-JNR11>3.0.CO;2-1; Zoccali C, 2006, J AM SOC NEPHROL, V17, P1466, DOI 10.1681/ASN.2005090949	38	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0151044	10.1371/journal.pone.0151044	http://dx.doi.org/10.1371/journal.pone.0151044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078883	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700002
J	Lipkin, E; Strillacci, MG; Eitam, H; Yishay, M; Schiavini, F; Soller, M; Bagnato, A; Shabtay, A				Lipkin, Ehud; Strillacci, Maria Giuseppina; Eitam, Harel; Yishay, Moran; Schiavini, Fausta; Soller, Morris; Bagnato, Alessandro; Shabtay, Ariel			The Use of Kosher Phenotyping for Mapping QTL Affecting Susceptibility to Bovine Respiratory Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INNATE IMMUNE-RESPONSES; SOMATIC-CELL SCORE; FEEDLOT CATTLE; PROTEIN PERCENTAGE; TREATMENT RECORDS; HOLSTEIN CATTLE; CARCASS TRAITS; MAREKS-DISEASE; BEEF-CALVES	Bovine respiratory disease (BRD) is the leading cause of morbidity and mortality in feedlot cattle, caused by multiple pathogens that become more virulent in response to stress. As clinical signs often go undetected and various preventive strategies failed, identification of genes affecting BRD is essential for selection for resistance. Selective DNA pooling (SDP) was applied in a genome wide association study (GWAS) to map BRD QTLs in Israeli Holstein male calves. Kosher scoring of lung adhesions was used to allocate 122 and 62 animals to High (Glatt Kosher) and Low (Non-Kosher) resistant groups, respectively. Genotyping was performed using the Illumina BovineHD BeadChip according to the Infinium protocol. Moving average of -logP was used to map QTLs and Log drop was used to define their boundaries (QTLRs). The combined procedure was efficient for high resolution mapping. Nineteen QTLRs distributed over 13 autosomes were found, some overlapping previous studies. The QTLRs contain polymorphic functional and expression candidate genes to affect kosher status, with putative immunological and wound healing activities. Kosher phenotyping was shown to be a reliable means to map QTLs affecting BRD morbidity.	[Lipkin, Ehud; Soller, Morris] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Strillacci, Maria Giuseppina; Schiavini, Fausta; Bagnato, Alessandro] Univ Milano UNIMI, Milan, Italy; [Eitam, Harel; Yishay, Moran; Shabtay, Ariel] Agr Res Org, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel	Hebrew University of Jerusalem; University of Milan; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Lipkin, E (corresponding author), Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel.; Shabtay, A (corresponding author), Agr Res Org, Dept Ruminant Sci, IL-50250 Bet Dagan, Israel.	ehud.lipkin@mail.huji.ac.il; shabtay@volcani.agri.gov.il	Lipkin, Ehud/AAE-9034-2020; Bagnato, Alessandro/L-1817-2017; strillacci, maria/M-7605-2013	Bagnato, Alessandro/0000-0003-2087-1287; Lipkin, Ehud/0000-0003-2624-6765; strillacci, maria/0000-0002-8972-1730				Agbeniga B, 2013, S AFR J ANIM SCI, V43, pS98, DOI 10.4314/sajas.v43i5.18; Aich P, 2007, J GEN VIROL, V88, P2749, DOI 10.1099/vir.0.82861-0; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; BISHOP SC, 2005, ENCY ANIMAL SCI, P288; Bishop SC, 2011, BREEDING DIS RESISTA; Brickner AG, J EXPT MED, V193, P195; Bryant Lonty K., 1999, Bovine Practitioner, V33, P163; Burgner D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000319; Busby D., 2014, CATTLE FEEDER CLIN, P24; Casas E, 2011, ANIM GENET, V42, P571, DOI 10.1111/j.1365-2052.2011.02189.x; Catz SD, 2014, CELL MICROBIOL, V16, P1301, DOI 10.1111/cmi.12328; Cheng H, 2008, DEV BIOLOGICALS, V132, P365, DOI 10.1159/000317187; Cobb JMT, 1996, PSYCHOSOM MED, V58, P404, DOI 10.1097/00006842-199609000-00003; Danilowicz E, 2010, ANIM GENET, V41, P424, DOI 10.1111/j.1365-2052.2009.02012.x; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Duff GC, 2007, J ANIM SCI, V85, P823, DOI 10.2527/jas.2006-501; Eitam H, 2010, CELL STRESS CHAPERON, V15, P865, DOI 10.1007/s12192-010-0195-9; Fernando RL, 2004, GENETICS, V166, P611, DOI 10.1534/genetics.166.1.611; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Fulton JE, 2012, ANIM GENET, V43, P102, DOI 10.1111/j.1365-2052.2012.02384.x; Galyean ML, 1999, J ANIM SCI, V77, P1120; Gardner BA, 1999, J ANIM SCI, V77, P3168; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Hanotte O, 2003, P NATL ACAD SCI USA, V100, P7443, DOI 10.1073/pnas.1232392100; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Hayes NS, 2015, MEAT SCI, V100, P134, DOI 10.1016/j.meatsci.2014.09.145; Heifetz EM, 2007, GENETICS, V177, P2417, DOI 10.1534/genetics.107.080002; Hodgson PD, 2005, COMP FUNCT GENOM, V6, P244, DOI 10.1002/cfg.474; Hoglund JK, 2009, J DAIRY SCI, V92, P2136, DOI 10.3168/jds.2008-1104; Howard JT, 2014, INT J BIOMETEOROL, V58, P1665, DOI 10.1007/s00484-013-0773-5; John LB, 2009, J IMMUNOL, V182, P4792, DOI 10.4049/jimmunol.0802372; LEKEUX P, 1984, AM J VET RES, V45, P2003; Lipkin E, 2013, P PLANT AN GEN 21 C; Liu ML, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-253; Ma YT, 2013, IMMUNITY, V39, P211, DOI 10.1016/j.immuni.2013.07.017; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Moiseeva EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061579; Mosig MO, 2001, GENETICS, V157, P1683; MUGGLICOCKETT NE, 1992, J ANIM SCI, V70, P2013, DOI 10.2527/1992.7072013x; Neibergs H, 2011, J ANIM SCI, V89, P907, DOI 10.2527/jas.2010-3330; Neibergs HL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1164; Nicolazzi EL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-123; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Regenstein J M, 2003, Compr Rev Food Sci Food Saf, V2, P111, DOI 10.1111/j.1541-4337.2003.tb00018.x; Roeber D. L., 2001, Professional Animal Scientist, V17, P39; Ruteshouser EC, 2001, ONCOGENE, V20, P2050, DOI 10.1038/sj.onc.1204301; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-442; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; Sakata D, 2010, IUBMB LIFE, V62, P591, DOI 10.1002/iub.356; Schneider MJ, 2010, J ANIM SCI, V88, P1220, DOI 10.2527/jas.2008-1755; Schneider MJ, 2009, J ANIM SCI, V87, P1821, DOI 10.2527/jas.2008-1283; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Snowder GD, 2007, J ANIM SCI, V85, P1885, DOI 10.2527/jas.2007-0008; Snowder GD, 2005, J ANIM SCI, V83, P1247; Sporer KRB, 2007, VET IMMUNOL IMMUNOP, V118, P19, DOI 10.1016/j.vetimm.2007.04.002; Steinfelder S, 2011, BLOOD, V117, P2839, DOI 10.1182/blood-2010-06-293027; Strillacci MG, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0106-7; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Tal-Stein R, 2010, J DAIRY SCI, V93, P4913, DOI 10.3168/jds.2010-3254; Thompson PN, 2006, J ANIM SCI, V84, P488, DOI 10.2527/2006.842488x; Tizioto PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131459; Vannahme C, 2003, BIOCHEM J, V373, P805, DOI 10.1042/BJ20030532; Weller JI, 2009, QUANTITATIVE TRAIT LOCI ANALYSIS IN ANIMALS, 2ND EDITION, P1; Whitaker HC, 2014, ONCOGENE, V33, P5274, DOI 10.1038/onc.2013.464; Wittum TE, 1996, J AM VET MED ASSOC, V209, P814; Wu SM, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-115; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Zanella Ricardo, 2011, Frontiers in Genetics, V2, P82, DOI 10.3389/fgene.2011.00082	71	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153423	10.1371/journal.pone.0153423	http://dx.doi.org/10.1371/journal.pone.0153423			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077383	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700053
J	Peng, YF; Tang, JH; Fu, YC; Fan, IC; Hor, MK; Chan, TC				Peng, Yi-Fan; Tang, Jia-Hong; Fu, Yang-chih; Fan, I-chun; Hor, Maw-Kae; Chan, Ta-Chien			Analyzing Personal Happiness from Global Survey and Weather Data: A Geospatial Approach	PLOS ONE			English	Article							GENDER-DIFFERENCES; HEALTH; MOOD; CLIMATE; LIFE	Past studies have shown that personal subjective happiness is associated with various macro- and micro-level background factors, including environmental conditions, such as weather and the economic situation, and personal health behaviors, such as smoking and exercise. We contribute to this literature of happiness studies by using a geospatial approach to examine both macro and micro links to personal happiness. Our geospatial approach incorporates two major global datasets: representative national survey data from the International Social Survey Program (ISSP) and corresponding world weather data from the National Oceanic and Atmospheric Administration (NOAA). After processing and filtering 55,081 records of ISSP 2011 survey data from 32 countries, we extracted 5,420 records from China and 25,441 records from 28 other countries. Sensitivity analyses of different intervals for average weather variables showed that macro-level conditions, including temperature, wind speed, elevation, and GDP, are positively correlated with happiness. To distinguish the effects of weather conditions on happiness in different seasons, we also adopted climate zone and seasonal variables. The micro-level analysis indicated that better health status and eating more vegetables or fruits are highly associated with happiness. Never engaging in physical activity appears to make people less happy. The findings suggest that weather conditions, economic situations, and personal health behaviors are all correlated with levels of happiness.	[Peng, Yi-Fan; Hor, Maw-Kae] Natl Chengchi Univ, Dept Comp Sci, 64 Chihnan Rd,Sec 2 Wenshan, Taipei 11623, Taiwan; [Peng, Yi-Fan; Tang, Jia-Hong; Fan, I-chun; Chan, Ta-Chien] Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan; [Fu, Yang-chih] Acad Sinica, Inst Sociol, Taipei 115, Taiwan; [Fan, I-chun] Acad Sinica, Inst Hist & Philol, Taipei 115, Taiwan; [Hor, Maw-Kae] Kainan Univ, Sch Informat, Taoyuan, Taiwan	National Chengchi University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Nan Kai University Technology	Chan, TC (corresponding author), Acad Sinica, Res Ctr Humanities & Social Sci, Taipei 115, Taiwan.; Fu, YC (corresponding author), Acad Sinica, Inst Sociol, Taipei 115, Taiwan.	fuyc@sinica.edu.tw; dachianpig@gmail.com						Adan A, 2001, CHRONOBIOL INT, V18, P491, DOI 10.1081/CBI-100103971; [Anonymous], 2015, GLOBAL SURFACE SUMMA; Behr D, 2014, QUAL QUANT, V48, P127, DOI 10.1007/s11135-012-9754-8; Beute F, 2013, J ENVIRON PSYCHOL, V36, P162, DOI 10.1016/j.jenvp.2013.07.016; Chan TC, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4315; Ciucci E, 2013, INT J BIOMETEOROL, V57, P845, DOI 10.1007/s00484-012-0612-0; Connolly M, 2013, J HAPPINESS STUD, V14, P457, DOI 10.1007/s10902-012-9338-2; Drehmer JE, 2017, J SMOK CESS, V12, P6, DOI 10.1017/jsc.2015.6; Fung HH, 2008, PSYCHOL AGING, V23, P440, DOI 10.1037/0882-7974.23.2.440; Goetzmann WN, 2015, REV FINANC STUD, V28, P73, DOI 10.1093/rfs/hhu063; Graham C, 2008, HEALTH AFFAIR, V27, P72, DOI 10.1377/hlthaff.27.1.72; Green C, 2000, PHARMACOECONOMICS, V17, P151, DOI 10.2165/00019053-200017020-00004; Hagerty MR, 2003, SOC INDIC RES, V64, P1, DOI 10.1023/A:1024790530822; Holopainen J, 2014, INT J BIOMETEOROL, V58, P1039, DOI 10.1007/s00484-013-0689-0; International Social Survey Programme, 2015, HLTH HLTH CAR ISSP 2; Isaacowitz DM, 2012, PERSPECT PSYCHOL SCI, V7, P3, DOI 10.1177/1745691611424750; Khazaee-Pool M, 2015, J PSYCHIATR MENT HLT, V22, P47, DOI 10.1111/jpm.12168; Kohsaka M, 1999, PSYCHIAT CLIN NEUROS, V53, P239, DOI 10.1046/j.1440-1819.1999.00539.x; Lu L, 2006, ASIAN J SOC PSYCHOL, V9, P36, DOI 10.1111/j.1467-839X.2006.00183.x; Maddison D, 2011, ECOL ECON, V70, P2437, DOI 10.1016/j.ecolecon.2011.07.027; Rehdanz K, 2005, ECOL ECON, V52, P111, DOI 10.1016/j.ecolecon.2004.06.015; Richards J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1391-4; Stranges S, 2006, ADDICTION, V101, P1265, DOI 10.1111/j.1360-0443.2006.01517.x; Stranges S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005878; Tesch-Romer C, 2008, SOC INDIC RES, V85, P329, DOI 10.1007/s11205-007-9133-3; Tsutsui Y, 2013, WEATHER CLIM SOC, V5, P70, DOI 10.1175/WCAS-D-11-00052.1; Veenhoven R, 2006, SOC INDIC RES, V79, P421, DOI 10.1007/s11205-005-5074-x; Zhang X, 2015, SOCIAL SCI RES NETWO	28	3	3	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153638	10.1371/journal.pone.0153638	http://dx.doi.org/10.1371/journal.pone.0153638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27078263	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700099
J	Xu, YX; Richlen, ML; Liefer, JD; Robertson, A; Kulis, D; Smith, TB; Parsons, ML; Anderson, DM				Xu, Yixiao; Richlen, Mindy L.; Liefer, Justin D.; Robertson, Alison; Kulis, David; Smith, Tyler B.; Parsons, Michael L.; Anderson, Donald M.			Influence of Environmental Variables on Gambierdiscus spp. (Dinophyceae) Growth and Distribution	PLOS ONE			English	Article							CIGUATERA-ENDEMIC AREA; NE ATLANTIC-OCEAN; GULF-OF-MEXICO; TOXIC DINOFLAGELLATE; SP-NOV; BENTHIC DINOFLAGELLATE; GENUS GAMBIERDISCUS; FRENCH-POLYNESIA; COASTAL AREAS; TEMPERATURE	Benthic dinoflagellates in the genus Gambierdiscus produce the ciguatoxin precursors responsible for the occurrence of ciguatera toxicity. The prevalence of ciguatera toxins in fish has been linked to the presence and distribution of toxin-producing species in coral reef ecosystems, which is largely determined by the presence of suitable benthic habitat and environmental conditions favorable for growth. Here using single factor experiments, we examined the effects of salinity, irradiance, and temperature on growth of 17 strains of Gambierdiscus representing eight species/phylotypes (G. belizeanus, G. caribaeus, G. carolinianus, G. carpenteri, G. pacificus, G. silvae, Gambierdiscus sp. type 4-5), most of which were established from either Marakei Island, Republic of Kiribati, or St. Thomas, United States Virgin Island (USVI). Comparable to prior studies, growth rates fell within the range of 0-0.48 divisions day(-1). In the salinity and temperature studies, Gambierdiscus responded in a near Gaussian, non-linear manner typical for such studies, with optimal and suboptimal growth occurring in the range of salinities of 25 and 45 and 21.0 and 32.5 degrees C. In the irradiance experiment, no mortality was observed; however, growth rates at 55 mu mol photons . m(-2) . s(-1) were lower than those at 110-400 mu mol photons . m(-2). s(-1). At the extremes of the environmental conditions tested, growth rates were highly variable, evidenced by large coefficients of variability. However, significant differences in intraspecific growth rates were typically found only at optimal or near-optimal growth conditions. Polynomial regression analyses showed that maximum growth occurred at salinity and temperature levels of 30.1-38.5 and 23.8-29.2 degrees C, respectively. Gambierdiscus growth patterns varied among species, and within individual species: G. belizeanus, G. caribaeus, G. carpenteri, and G. pacificus generally exhibited a wider range of tolerance to environmental conditions, which may explain their broad geographic distribution. In contrast, G. silvae and Gambierdiscus sp. types 4-5 all displayed a comparatively narrow range of tolerance to temperature, salinity, and irradiance.	[Xu, Yixiao] Guangxi Teachers Educ Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning, Guangxi, Peoples R China; [Xu, Yixiao] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China; [Xu, Yixiao; Richlen, Mindy L.; Kulis, David; Anderson, Donald M.] Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA; [Liefer, Justin D.] Mt Allison Univ, Dept Geog & Environm, Sackville, NB E0A 3C0, Canada; [Robertson, Alison] Univ S Alabama, Dept Marine Sci, Dauphin Isl, AL USA; [Robertson, Alison] Dauphin Isl Sea Lab, Dauphin Isl, AL USA; [Smith, Tyler B.] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Parsons, Michael L.] Florida Gulf Coast Univ, Coastal Watershed Inst, Ft Myers, FL USA	Nanning Normal University; Nanjing University; Woods Hole Oceanographic Institution; Mount Allison University; University of South Alabama; Dauphin Island Sea Lab; University of the Virgin Islands; State University System of Florida; Florida Gulf Coast University	Xu, YX (corresponding author), Guangxi Teachers Educ Univ, Key Lab Environm Change & Resources Use Beibu Gul, Minist Educ, Nanning, Guangxi, Peoples R China.; Xu, YX (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing, Jiangsu, Peoples R China.; Xu, YX (corresponding author), Woods Hole Oceanog Inst, Dept Biol, Woods Hole, MA 02543 USA.	xuyixiao_77@163.com		Parsons, Michael/0000-0003-4268-567X; Robertson, Alison/0000-0002-2537-0943; Liefer, Justin/0000-0001-5161-940X	National Natural Science Foundation of China [41506137]; Guangxi Natural Science Foundation [2015GXNSFCA139003]; Centers for Disease Control and Prevention [U01 EH000421]; USFDA [F223201000060C]; NOAA NOS through the CiguaHAB program [NA11NOS4780060, NA11NOS4780028]; VI-EPSCoR Program (NSF) [346483, 081441]; System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education [2014BGERLXT01]; Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF) [OCE-1314642]; National Institute of Environmental Health Sciences (NIEHS) [1-P01-ES021923-014]; China Scholarship Council; Lana Vento Trust; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES021923] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USFDA; NOAA NOS through the CiguaHAB program; VI-EPSCoR Program (NSF)(National Science Foundation (NSF)NSF - Office of the Director (OD)); System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education; Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF)(National Science Foundation (NSF)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); China Scholarship Council(China Scholarship Council); Lana Vento Trust; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was funded by the National Natural Science Foundation of China (41506137); Guangxi Natural Science Foundation (2015GXNSFCA139003), Centers for Disease Control and Prevention (U01 EH000421); USFDA (F223201000060C); NOAA NOS through the CiguaHAB program (Cooperative Agreement NA11NOS4780060, NA11NOS4780028); the Lana Vento Trust and VI-EPSCoR Program (NSF award # 346483 & 081441); and a System Fund from Key Laboratory of Environment Change and Resources Use in Beibu Gulf, Ministry of Education (2014BGERLXT01). Support was also provided by the Woods Hole Center for Oceans and Human Health through National Science Foundation (NSF) Grant OCE-1314642, National Institute of Environmental Health Sciences (NIEHS) Grant 1-P01-ES021923-014, as well as the China Scholarship Council. This is contribution #145 from the Center for Marine and Environmental Studies, University of the Virgin Islands, and ECOHAB publication #840.	ADACHI R, 1979, B JPN SOC SCI FISH, V45, P67; BOMBER JW, 1988, J EXP MAR BIOL ECOL, V115, P53, DOI 10.1016/0022-0981(88)90189-X; BOMBER JW, 1988, B MAR SCI, V43, P204; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Burkholder JM, 2006, AFR J MAR SCI, V28, P177, DOI 10.2989/18142320609504143; Carlson R.D., 1985, P171; Catania D, 2012, PREVALENCE BENTHIC D; Chateau-Degat ML, 2005, HARMFUL ALGAE, V4, P1053, DOI 10.1016/j.hal.2005.03.003; Chinain M, 1999, MAR BIOL, V135, P259, DOI 10.1007/s002270050623; Chinain M, 1999, J PHYCOL, V35, P1282, DOI 10.1046/j.1529-8817.1999.3561282.x; Chinain M, 2010, TOXICON, V56, P739, DOI 10.1016/j.toxicon.2009.06.013; Delgado G, 2006, REV BIOL TROP, V54, P299; Doblin MA, 2006, HARMFUL ALGAE, V5, P665, DOI 10.1016/j.hal.2006.02.002; Faust MA, 1995, J PHYCOL, V31, P996, DOI 10.1111/j.0022-3646.1995.00996.x; Faust Maria A., 2009, Atoll Research Bulletin, P1; Fraga S, 2010, GEOHAB OP SCI M HABS, P5; Fraga S, 2014, PROTIST, V165, P839, DOI 10.1016/j.protis.2014.09.003; Fraga S, 2011, HARMFUL ALGAE, V11, P10, DOI 10.1016/j.hal.2011.06.013; Gomez F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119676; Guillard R.R.L., 1984, P391; Guillard R.R.L., 1973, HDB PHYCOLOGICAL MET, P289; Hallegraeff GM, 2010, J PHYCOL, V46, P220, DOI 10.1111/j.1529-8817.2010.00815.x; HEIL CA, 1993, DEV MAR BIO, V3, P501; Holmes MJ, 1998, J PHYCOL, V34, P661, DOI 10.1046/j.1529-8817.1998.340661.x; Ishikawa A, 2011, ORAL PRESENTATION NO; Jeong HJ, 2012, J EUKARYOT MICROBIOL, V59, P637, DOI 10.1111/j.1550-7408.2012.00645.x; Kibler SR, 2015, ECOL MODEL, V316, P194, DOI 10.1016/j.ecolmodel.2015.08.020; Kibler SR, 2012, HARMFUL ALGAE, V19, P1, DOI 10.1016/j.hal.2012.04.007; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Kuno S, 2010, PHYCOL RES, V58, P44, DOI 10.1111/j.1440-1835.2009.00557.x; Lartigue J, 2009, HARMFUL ALGAE, V8, P781, DOI 10.1016/j.hal.2008.05.006; Laurion I, 2009, J PHYCOL, V45, P16, DOI 10.1111/j.1529-8817.2008.00618.x; Lehane L, 2000, INT J FOOD MICROBIOL, V61, P91, DOI 10.1016/S0168-1605(00)00382-2; Litaker RW, 2010, TOXICON, V56, P711, DOI 10.1016/j.toxicon.2010.05.017; Litaker RW, 2009, PHYCOLOGIA, V48, P344, DOI 10.2216/07-15.1; Llewellyn LE, 2010, TOXICON, V56, P691, DOI 10.1016/j.toxicon.2009.08.011; MORTON SL, 1992, J EXP MAR BIOL ECOL, V157, P79, DOI 10.1016/0022-0981(92)90076-M; Morton SL, 2010, GEOHAB OP SCI M HABS, P5; Nakahara Hiroyhuki, 1996, Phycological Research, V44, P113, DOI 10.1111/j.1440-1835.1996.tb00385.x; Nishimura T, 2014, J PHYCOL, V50, P506, DOI 10.1111/jpy.12175; Nishimura T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060882; Parsons ML, 2012, HARMFUL ALGAE, V14, P107, DOI 10.1016/j.hal.2011.10.017; Parsons ML, 2010, HARMFUL ALGAE, V10, P71, DOI 10.1016/j.hal.2010.07.002; RICHARDSON K, 1983, NEW PHYTOL, V93, P157, DOI 10.1111/j.1469-8137.1983.tb03422.x; Richlen ML, 2011, MAR ECOL PROG SER, V421, P51, DOI 10.3354/meps08854; Rodriguez F, 2010, GEOHAB OP SCI M HABS, P17; Saburova Maria, 2013, Marine Biodiversity Records, V6, pe91, DOI 10.1017/S1755267213000675; Stocker T. F., 2013, CLIMATE CHANGE 2013; Tester PA, 2013, HARMFUL ALGAE, V29, P1, DOI 10.1016/j.hal.2013.07.001; Tester PA, 2010, TOXICON, V56, P698, DOI 10.1016/j.toxicon.2010.02.026; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Tindall Donald R., 1998, NATO ASI Series Series G Ecological Sciences, V41, P293; Vega-Cendejas ME, 2004, ESTUAR COAST SHELF S, V60, P285, DOI 10.1016/j.ecss.2004.01.005; WATRAS CJ, 1982, J EXP MAR BIOL ECOL, V62, P25, DOI 10.1016/0022-0981(82)90214-3; Withers N.W., 1981, P 4 INT COR REEF S P, P449; Xu YX, 2014, HARMFUL ALGAE, V34, P56, DOI 10.1016/j.hal.2014.02.007; Yanez-Arancibia A, 2004, OCEAN COAST MANAGE, V47, P727, DOI 10.1016/j.ocecoaman.2004.12.010; YASUMOTO T, 1980, B JPN SOC SCI FISH, V46, P1397; Yoshimatsu T, 2014, HARMFUL ALGAE, V35, P29, DOI 10.1016/j.hal.2014.03.007	59	89	90	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153197	10.1371/journal.pone.0153197	http://dx.doi.org/10.1371/journal.pone.0153197			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074134	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200059
J	Reniers, RLEP; Murphy, L; Lin, A; Bartolome, SP; Wood, SJ				Reniers, Renate L. E. P.; Murphy, Laura; Lin, Ashleigh; Bartolome, Sandra Para; Wood, Stephen J.			Risk Perception and Risk-Taking Behaviour during Adolescence: The Influence of Personality and Gender	PLOS ONE			English	Article							DECISION-MAKING; SENSATION SEEKING; AGE-DIFFERENCES; SOCIAL ANXIETY; PEER INFLUENCE; INHIBITION; ACTIVATION; REWARD; MODEL; TASK	This study investigated the influence of personality characteristics and gender on adolescents' perception of risk and their risk-taking behaviour. Male and female participants (157 females: 116 males, aged 13-20) completed self-report measures on risk perception, risk-taking and personality. Male participants perceived behaviours as less risky, reportedly took more risks, were less sensitive to negative outcomes and less socially anxious than female participants. Path analysis identified a model in which age, behavioural inhibition and impulsiveness directly influenced risk perception, while age, social anxiety, impulsiveness, sensitivity to reward, behavioural inhibition and risk perception itself were directly or indirectly associated with risk-taking behaviour. Age and behavioural inhibition had direct relationships with social anxiety, and reward sensitivity was associated with impulsiveness. The model was representative for the whole sample and male and female groups separately. The observed relationship between age and social anxiety and the influence this may have on risk-taking behaviour could be key for reducing adolescent risk-taking behaviour. Even though adolescents may understand the riskiness of their behaviour and estimate their vulnerability to risk at a similar level to adults, factors such as anxiety regarding social situations, sensitivity to reward and impulsiveness may exert their influence and make these individuals prone to taking risks. If these associations are proven causal, these factors are, and will continue to be, important targets in prevention and intervention efforts.	[Reniers, Renate L. E. P.; Murphy, Laura; Bartolome, Sandra Para; Wood, Stephen J.] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England; [Lin, Ashleigh] Univ Western Australia, Telethon Kids Inst, Perth, WA 6009, Australia; [Wood, Stephen J.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia; [Wood, Stephen J.] Melbourne Hlth, Melbourne, Vic, Australia	University of Birmingham; Telethon Kids Institute; University of Western Australia; University of Melbourne	Reniers, RLEP (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	R.L.E.P.Reniers@bham.ac.uk	Lin, Ashleigh/AHC-6262-2022; Reniers, Renate/ABH-5726-2020; Wood, Stephen J/M-8652-2014; Wood, Stephen/ABF-4086-2020	Lin, Ashleigh/0000-0002-4054-0242; Reniers, Renate/0000-0003-4119-2486; Wood, Stephen J/0000-0003-4186-5919; Wood, Stephen/0000-0003-4186-5919				Amstadter AB, 2012, J PSYCHIATR RES, V46, P940, DOI 10.1016/j.jpsychires.2012.04.010; Anokhin AP, 2009, TWIN RES HUM GENET, V12, P366, DOI 10.1375/twin.12.4.366; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Avants SK, 1998, J CONSULT CLIN PSYCH, V66, P924, DOI 10.1037/0022-006X.66.6.924; Barkley-Levenson EE, 2013, DEV COGN NEUROS-NETH, V3, P72, DOI 10.1016/j.dcn.2012.09.007; Barr GC, 2015, J EMERG MED, V48, P366, DOI 10.1016/j.jemermed.2014.09.055; Boyer TW, 2006, DEV REV, V26, P291, DOI 10.1016/j.dr.2006.05.002; Burnett S, 2010, COGNITIVE DEV, V25, P183, DOI 10.1016/j.cogdev.2009.11.003; Burnham K. P., 1998, MODEL SELECTION INFE; Byrne B. M., 2001, STRUCTURAL EQUATION; Carlsson M, 2002, QUAL LIFE RES, V11, P415, DOI 10.1023/A:1015670628990; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Casey BJ, 2011, J RES ADOLESCENCE, V21, P21, DOI 10.1111/j.1532-7795.2010.00712.x; Cauffman E, 2010, DEV PSYCHOL, V46, P193, DOI 10.1037/a0016128; Chein J., 2010, DEVELOPMENTAL SCI, V14, P1; Collins HR, 2012, BRAIN RES, V1481, P1, DOI 10.1016/j.brainres.2012.08.004; Conrod PJ, 2013, JAMA PSYCHIAT, V70, P334, DOI 10.1001/jamapsychiatry.2013.651; Daughters SB, 2013, J ABNORM CHILD PSYCH, V41, P749, DOI 10.1007/s10802-013-9713-4; Deckman T, 2011, PERS INDIV DIFFER, V51, P674, DOI 10.1016/j.paid.2011.06.004; Education Df, 2014, SCH PUPILS THEIR CHA; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Field A, 2013, DISCOVERING STAT USI; Galvan A, 2007, DEVELOPMENTAL SCI, V10, pF8, DOI 10.1111/j.1467-7687.2006.00579.x; Gardner M, 2005, DEV PSYCHOL, V41, P625, DOI 10.1037/0012-1649.41.4.625; Gullone E, 2000, J ADOLESCENT RES, V15, P231, DOI 10.1177/0743558400152003; Gullone E, 2000, J ADOLESCENCE, V23, P393, DOI 10.1006/jado.2000.0327; Heitland I, 2012, COGN AFFECT BEHAV NE, V12, P678, DOI 10.3758/s13415-012-0108-8; Jackson-Newsom J, 2010, DEV PSYCHOBIOL, V52, P295, DOI 10.1002/dev.20458; Joseph JE, 2009, PSYCHOL SCI, V20, P215, DOI 10.1111/j.1467-9280.2009.02283.x; Kellam SG, 2014, PREV SCI, V15, pS6, DOI 10.1007/s11121-012-0296-z; Kupper N, 2012, J AFFECT DISORDERS, V136, P90, DOI 10.1016/j.jad.2011.08.014; Lauriola M, 2001, PERS INDIV DIFFER, V31, P215, DOI 10.1016/S0191-8869(00)00130-6; Lee TMC, 2009, CEREB CORTEX, V19, P1303, DOI 10.1093/cercor/bhn172; Lejuez CW, 2002, J EXP PSYCHOL-APPL, V8, P75, DOI 10.1037//1076-898X.8.2.75; Leone L, 2001, EUR J PERSONALITY, V15, P373, DOI 10.1002/per.415; Mata R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039135; Mattick RP, 1998, BEHAV RES THER, V36, P455, DOI 10.1016/S0005-7967(97)10031-6; Mehta PH, 2015, PSYCHONEUROENDOCRINO, V56, P88, DOI 10.1016/j.psyneuen.2015.02.023; Millstein SG, 2002, J ADOLESCENT HEALTH, V31, P10, DOI 10.1016/S1054-139X(02)00412-3; Mitchell SH, 2008, PSYCHON B REV, V15, P272, DOI 10.3758/PBR.15.2.272; Moeller FG, 2001, AM J PSYCHIAT, V158, P1783, DOI 10.1176/appi.ajp.158.11.1783; Nicholson N, 2005, J RISK RES, V8, P157, DOI 10.1080/1366987032000123856; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Pfeifer JH, 2011, NEURON, V69, P1029, DOI 10.1016/j.neuron.2011.02.019; Reniers RLEP, 2017, BRIT J PSYCHOL, V108, P276, DOI 10.1111/bjop.12195; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Robbins RN, 2004, J ADOLESCENT RES, V19, P428, DOI 10.1177/0743558403258860; Rosenthal R, 1991, METAANALYTIC PROCEDU; Scott-Parker B, 2012, BRIT J PSYCHOL, V103, P248, DOI 10.1111/j.2044-8295.2011.02069.x; Sercombe H, 2014, BRAIN COGNITION, V89, P61, DOI 10.1016/j.bandc.2014.01.001; Stanford MS, 2009, PERS INDIV DIFFER, V47, P385, DOI 10.1016/j.paid.2009.04.008; Steinberg L, 1996, LAW HUMAN BEHAV, V20, P249, DOI 10.1007/BF01499023; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2007, DEV PSYCHOL, V43, P1531, DOI 10.1037/0012-1649.43.6.1531; Steinberg L, 2010, DEV PSYCHOBIOL, V52, P216, DOI 10.1002/dev.20445; Strang NM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00223; Tabachnick B. G., 2001, USING MULTIVARIATE S; Tymula A, 2012, P NATL ACAD SCI USA, V109, P17135, DOI 10.1073/pnas.1207144109; Ullman S., 2001, USING MULTIVARIATE S, P653; van den Bos R, 2013, BEHAV BRAIN RES, V238, P95, DOI 10.1016/j.bbr.2012.10.002; Van Leijenhorst L, 2008, DEV NEUROPSYCHOL, V33, P179, DOI 10.1080/87565640701884287; Van Leijenhorst L, 2010, NEUROIMAGE, V51, P345, DOI 10.1016/j.neuroimage.2010.02.038; Victor EC, 2015, J NEUROSCI, V35, P8896, DOI 10.1523/JNEUROSCI.0737-15.2015; Waldeck TL, 1997, J SUBST ABUSE, V9, P269, DOI 10.1016/S0899-3289(97)90021-3; Wortman J, 2012, PSYCHOL AGING, V27, P867, DOI 10.1037/a0029322	66	81	85	7	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153842	10.1371/journal.pone.0153842	http://dx.doi.org/10.1371/journal.pone.0153842			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100081	Green Published, gold			2022-12-27	WOS:000374898500074
J	Darbyshire, JL; Greig, PR; Vollam, S; Young, JD; Hinton, L				Darbyshire, Julie L.; Greig, Paul R.; Vollam, Sarah; Young, J. Duncan; Hinton, Lisa			"I Can Remember Sort of Vivid People ... but to Me They Were Plasticine." Delusions on the Intensive Care Unit: What Do Patients Think Is Going On?	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; POSTTRAUMATIC-STRESS-DISORDER; MECHANICALLY VENTILATED PATIENTS; RANDOMIZED CONTROLLED-TRIAL; CONFUSION ASSESSMENT METHOD; TERM COGNITIVE IMPAIRMENT; CRITICAL ILLNESS; QUALITATIVE DATA; FOLLOW-UP; DELIRIUM ASSESSMENT	Introduction Patients who develop intensive care unit (ICU) acquired delirium stay longer in the ICU, and hospital, and are at risk of long-term mental and physical health problems. Despite guidelines for patient assessment, risk limitation, and treatment in the ICU population, delirium and associated delusions remain a relatively common occurrence on the ICU. There is considerable information in the literature describing the incidence, suspected causes of, and discussion of the benefits and side-effects of the various treatments for delirium in the ICU. But peer-reviewed patient-focused research is almost non-existent. There is therefore a very limited understanding of the reality of delusions in the intensive care unit from the patient's point of view. Method A secondary analysis of the original interviews conducted by the University of Oxford Health Experiences Research Group was undertaken to explore themes relating specifically to sleep and delirium. Results Patients describe a liminal existence on the ICU. On the threshold of consciousness their reality is uncertain and their sense of self is exposed. Lack of autonomy in an unfamiliar environment prompts patients to develop explanations and understandings for themselves with no foothold in fact. Conclusion Patients on the ICU are perhaps more disoriented than they appear and early psychological intervention in the form of repeated orientation whilst in the ICU might improve the patient experience and defend against development of side-effects.	[Darbyshire, Julie L.; Greig, Paul R.; Vollam, Sarah; Young, J. Duncan] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Young, J. Duncan] Oxford Univ Hosp Natl Hlth Serv Fdn Trust, Oxford, England; [Hinton, Lisa] Univ Oxford, Dept Primary Care, Oxford, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Darbyshire, JL (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England.	Julie.Darbyshire@ndcn.ox.ac.uk	Young, John D/M-9756-2016; Darbyshire, Julie/O-7932-2019; Hinton, Lisa/AAA-2266-2019	Darbyshire, Julie/0000-0002-7655-1963; Greig, Paul Robert/0000-0003-3161-5641; Vollam, Sarah/0000-0003-2835-6271; Hinton, Lisa/0000-0002-6082-3151; Young, John Duncan/0000-0002-6838-4835	ICNARC	ICNARC	We are grateful to the Health Experiences Research Group, Department of Primary Care Health Sciences, University of Oxford for permission to conduct a secondary analysis of interviews collected for their study of experiences of intensive care, which was funded by ICNARC. Summarised findings from the original study are available on the www.healthtalk.org website run by the DIPEx Charity.	Aaronovitch D., 2001, TIMES MAGAZINE  1112; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], 2011, ANN INDIAN ACAD SS1, V14, P16; Azoulay E, 2005, AM J RESP CRIT CARE, V171, P987, DOI 10.1164/rccm.200409-1295OC; Backman CG, 2001, INTENS CARE MED, V27, P426, DOI 10.1007/s001340000692; Ballenger JC, 2000, J CLIN PSYCHIAT, V61, P60; Borowski M, 2011, COMPUT MATH METHOD M, V2011, DOI 10.1155/2011/143480; Borowski M, 2011, BIOMED TECH, V56, P73, DOI 10.1515/BMT.2011.005; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; BRADY KT, 1991, J CLIN PSYCHIAT, V52, P509; Broomhead LR, 2002, CRIT CARE, V6, P411, DOI 10.1186/cc1532; Corbett A, 2014, DONT USE ANTIPSYCHOT; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Cuthbertson BH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3723; Daly J, 2007, J CLIN EPIDEMIOL, V60, P43, DOI 10.1016/j.jclinepi.2006.03.014; de Man FR, 2014, ANAESTHESIA, V69, P598, DOI 10.1111/anae.12640; Dedert EA, 2010, ANN BEHAV MED, V39, P61, DOI 10.1007/s12160-010-9165-9; Devlin JW, 2007, INTENS CARE MED, V33, P929, DOI 10.1007/s00134-007-0603-5; Dubois MJ, 2001, INTENS CARE MED, V27, P1297, DOI 10.1007/s001340101017; Elias N., 2000, CIVILIZING PROCESS; Ely EW, 2001, CRIT CARE MED, V29, P1370, DOI 10.1097/00003246-200107000-00012; Ely EW, 2001, SEMIN RESP CRIT CARE, V22, P115, DOI 10.1055/s-2001-13826; Field K, 2008, CRIT CARE, V12, DOI 10.1186/cc6795; Flacker JM, 1998, AM J GERIAT PSYCHIAT, V6, P31; Flannery AH, 2014, NEW ENGL J MED, V370, P1566, DOI 10.1056/NEJMc1402402; Frank AW, 2004, QUAL HEALTH RES, V14, P430, DOI 10.1177/1049732303261955; Freeman D, 2002, BRIT J CLIN PSYCHOL, V41, P331, DOI 10.1348/014466502760387461; Gamache K, 2012, NEUROPSYCHOPHARMACOL, V37, P2789, DOI 10.1038/npp.2012.145; Gaudreau JD, 2005, MED HYPOTHESES, V64, P471, DOI 10.1016/j.mehy.2004.08.007; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Goldstein D. M., 2003, J MED HUMANITIES, V24, P229; Gosden E., 2014, TELEGRAPH; Green J, 2014, QUALITATIVE METHODS; Griffiths JA, 2004, CONTIN ED ANAESTH CR, V4, P202, DOI DOI 10.1093/BJACEACCP/MKH054; Grof S., 1975, REALMS OF THE HUMAN; Heaton, 1998, SECONDARY ANAL QUALI, P22; Hinds PS, 1997, QUAL HEALTH RES, V7, P408, DOI 10.1177/104973239700700306; Hintzen A., 2010, PHARM LSD; Jackson DL, 2009, CRIT CARE, V13, DOI 10.1186/cc8212; Jackson JC, 2010, AM J RESP CRIT CARE, V182, P183, DOI 10.1164/rccm.200903-0442OC; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Johansson Lotta, 2012, Open Nurs J, V6, P108, DOI 10.2174/1874434601206010108; Johns A, 2001, BRIT J PSYCHIAT, V178, P116, DOI 10.1192/bjp.178.2.116; Kress JP, 2003, AM J RESP CRIT CARE, V168, P1457, DOI 10.1164/rccm.200303-455OC; Lawton J, 1998, SOCIOL HEALTH ILL, V20, P121, DOI 10.1111/1467-9566.00094; Lawton J, 2003, PARTICIPATING UK PRO, P394; Mac Sweeney R, 2010, QJM-INT J MED, V103, P243, DOI 10.1093/qjmed/hcp194; MANSCHRECK TC, 1988, YALE J BIOL MED, V61, P115; Mason J, 2007, SOCIOL RES ONLINE, V12; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Mauthner NS, 1998, SOCIOLOGY, V32, P733, DOI 10.1177/0038038598032004006; Milbrandt EB, 2004, CRIT CARE MED, V32, P955, DOI 10.1097/01.CCM.0000119429.16055.92; MILLER NS, 1991, INT J ADDICT, V26, P1077, DOI 10.3109/10826089109058942; Moore N., 2006, METHODOLOGICAL INNOV, V1; National Institute for Health and Care Excellence, 2010, DEL DIAGN PREV MAN G; National Institute for Health and Care Excellence, 2013, POSTTR STRESS DIS PT; Ouimet S, 2007, INTENS CARE MED, V33, P66, DOI 10.1007/s00134-006-0399-8; Page V., 2011, DELIRIUM CRITICAL CA; Pandharipande P, 2006, ANESTHESIOLOGY, V104, P21, DOI 10.1097/00000542-200601000-00005; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Picchioni MM, 2007, BMJ-BRIT MED J, V335, P91, DOI 10.1136/bmj.39227.616447.BE; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Pratchett T, 2013, JUDGEMENT DAY SCI DI; Prinjha S, 2009, CRIT CARE, V13, DOI 10.1186/cc7769; Rasmussen KG, 2014, ACTA NEUROPSYCHIATR, V26, P230, DOI 10.1017/neu.2013.61; Reynolds GP, 2004, J PSYCHOPHARMACOL, V18, P340, DOI 10.1177/026988110401800303; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Rozmovits L, 2004, QUAL HEALTH RES, V14, P187, DOI 10.1177/1049732303260874; Salluh J, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h3129, 10.1136/bmj.h2538]; Salluh JI, 2010, CRIT CARE, V14, DOI 10.1186/cc9333; SATEL SL, 1991, AM J PSYCHIAT, V148, P495; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Seery J, 2008, AM I CRAZY IT IS ICU; Shauna, 1934, ON PAT ICU PSYCH STO; SIEGEL RK, 1982, J PSYCHOACTIVE DRUGS, V14, P271; Strom T, 2011, CRIT CARE, V15, DOI 10.1186/cc10586; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Trzepacz PT, 1996, PSYCHIAT CLIN N AM, V19, P429, DOI 10.1016/S0193-953X(05)70299-9; TRZEPACZ PT, 1994, PSYCHOSOMATICS, V35, P374, DOI 10.1016/S0033-3182(94)71759-X; Trzepacz PT, 1999, DEMENT GERIATR COGN, V10, P330, DOI 10.1159/000017164; van den Berg H, 2015, REANALYZING QUALITAT, V2005; van Eijk MM, 2011, AM J RESP CRIT CARE, V184, P340, DOI 10.1164/rccm.201101-0065OC; van Eijk MMJ, 2009, CRIT CARE MED, V37, P1881, DOI 10.1097/CCM.0b013e3181a00118; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Various, 2015, I SURV ICU PSYCH 200; Vidan MT, 2009, J AM GERIATR SOC, V57, P2029, DOI 10.1111/j.1532-5415.2009.02485.x; Wade D, 2013, MINERVA ANESTESIOL, V79, P944; Williams Teresa A, 2008, Aust Crit Care, V21, P6, DOI 10.1016/j.aucc.2007.11.001; Ziebland S, 2006, MED EDUC, V40, P405, DOI 10.1111/j.1365-2929.2006.02467.x	90	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153775	10.1371/journal.pone.0153775	http://dx.doi.org/10.1371/journal.pone.0153775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096605	Green Published, gold			2022-12-27	WOS:000374543600056
J	Gigli, CC; Scaramuzza, L; Gandaglia, A; Bellini, E; Gabaglio, M; Parolaro, D; Kilstrup-Nielsen, C; Landsberger, N; Bedogni, F				Gigli, Clementina Cobolli; Scaramuzza, Linda; Gandaglia, Anna; Bellini, Elisa; Gabaglio, Marina; Parolaro, Daniela; Kilstrup-Nielsen, Charlotte; Landsberger, Nicoletta; Bedogni, Francesco			MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background	PLOS ONE			English	Article							RETT-SYNDROME; MOUSE MODEL; MUTANT MICE; SOCIAL INTERACTIONS; DEFICIENCY; EXPRESSION; NEURONS; ABNORMALITIES; MORPHOLOGY; DELIVERY	MECP2 mutations cause a number of neurological disorders of which Rett syndrome (RTT) represents the most thoroughly analysed condition. Many Mecp2 mouse models have been generated through the years; their validity is demonstrated by the presence of a broad spectrum of phenotypes largely mimicking those manifested by RTT patients. These mouse models, between which the C57BL/6 Mecp2(tm1.1Bird) strain probably represents the most used, enabled to disclose much of the roles of Mecp2. However, small litters with little viability and poor maternal care hamper the maintenance of the colony, thus limiting research on such animals. For this reason, past studies often used Mecp2 mouse models on mixed genetic backgrounds, thus opening questions on whether modifier genes could be responsible for at least part of the described effects. To verify this possibility, and facilitate the maintenance of the Mecp2 colony, we transferred the Mecp2(tm1.1Bird) allele on the stronger CD1 background. The CD1 strain is easier to maintain and largely recapitulates the phenotypes already described in Mecp2-null mice. We believe that this mouse model will foster the research on RTT.	[Gigli, Clementina Cobolli; Scaramuzza, Linda; Gandaglia, Anna; Bellini, Elisa; Landsberger, Nicoletta; Bedogni, Francesco] Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy; [Bellini, Elisa] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Gabaglio, Marina; Parolaro, Daniela; Kilstrup-Nielsen, Charlotte] Univ Insubria, Dept Biotechnol & Life Sci, Busto Arsizio, Italy; [Parolaro, Daniela] ZardiGori Fdn, Milan, Italy; [Landsberger, Nicoletta] Univ Milan, Dept Med Biotechnol & Translat Med, LITA, Segrate, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Zurich; University Zurich Hospital; University of Insubria; University of Milan	Landsberger, N; Bedogni, F (corresponding author), Ist Sci San Raffaele, Div Neurosci, San Raffaele Rett Res Unit, I-20132 Milan, Italy.; Landsberger, N (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med, LITA, Segrate, Italy.	nicoletta.landsberger@unimi.it; bedogni.francesco@hsr.it		Landsberger, Nicoletta/0000-0003-0820-3155; bedogni, francesco/0000-0002-6651-0041; Kilstrup-Nielsen, Charlotte/0000-0003-4977-4077	Jerome Lejeune Foundation; proRETT Ricerca	Jerome Lejeune Foundation; proRETT Ricerca	This work was supported by Jerome Lejeune Foundation to Francesco Bedogni, Jerome Lejeune Foundation to Nicoletta Landsberger, and proRETT Ricerca to Nicoletta Landsberger.	Aldinger KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004729; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Armstrong DD, 1999, PEDIATR NEUROL, V20, P125, DOI 10.1016/S0887-8994(98)00124-6; Bedogni F, 2016, CEREB CORTEX, V26, P2517, DOI 10.1093/cercor/bhv078; Bedogni F, 2014, NEUROSCI BIOBEHAV R, V46, P187, DOI 10.1016/j.neubiorev.2014.01.011; Belichenko NP, 2008, J COMP NEUROL, V508, P184, DOI 10.1002/cne.21673; Buchovecky CM, 2013, NAT GENET, V45, P1013, DOI 10.1038/ng.2714; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cohen S, 2011, NEURON, V72, P72, DOI 10.1016/j.neuron.2011.08.022; Conti V, 2015, PLOS ONE IN PRESS; Fischer M, 2009, J NEUROPHYSIOL, V101, P1016, DOI 10.1152/jn.91124.2008; Garg SK, 2013, J NEUROSCI, V33, P13612, DOI 10.1523/JNEUROSCI.1854-13.2013; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Goffin D, 2012, NAT NEUROSCI, V15, P274, DOI 10.1038/nn.2997; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Jugloff DGM, 2008, HUM MOL GENET, V17, P1386, DOI 10.1093/hmg/ddn026; Jugloff DGM, 2006, J NEUROSCI METH, V154, P89, DOI 10.1016/j.jneumeth.2005.12.002; Justice MJ, 2013, RARE DIS, V1, DOI 10.4161/rdis.27265; Katz DM, 2012, DIS MODEL MECH, V5, P733, DOI 10.1242/dmm.011007; Kerr B, 2008, HUM MOL GENET, V17, P1707, DOI 10.1093/hmg/ddn061; Kilstrup-Nielsen C, 2015, NEUROBIOLOGY OF BRAIN DISORDERS: BIOLOGICAL BASIS OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS, P98, DOI 10.1016/B978-0-12-398270-4.00007-0; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Neul JL, 2010, ANN NEUROL, V68, P944, DOI 10.1002/ana.22124; Panighini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064863; Park MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109527; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Pitcher MR, 2013, HUM MOL GENET, V22, P2626, DOI 10.1093/hmg/ddt111; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; Ricciardi S, 2011, HUM MOL GENET, V20, P1182, DOI 10.1093/hmg/ddq563; Rietveld L, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00145, 10.3389/fnel.2015.00145]; Roceri M, 2004, BIOL PSYCHIAT, V55, P708, DOI 10.1016/j.biopsych.2003.12.011; Roceri M, 2002, MOL PSYCHIATR, V7, P609, DOI 10.1038/sj.mp.4001036; Samaco RC, 2013, HUM MOL GENET, V22, P96, DOI 10.1093/hmg/dds406; Schaevitz LR, 2013, GENES BRAIN BEHAV, V12, P732, DOI 10.1111/gbb.12070; Segatto M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104834; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Stearns NA, 2007, NEUROSCIENCE, V146, P907, DOI 10.1016/j.neuroscience.2007.02.009	42	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153473	10.1371/journal.pone.0153473	http://dx.doi.org/10.1371/journal.pone.0153473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097329	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000374543600037
J	Lin, SF; Chen, YC; Chen, RN; Chen, LC; Ho, HO; Tsung, YH; Sheu, MT; Liu, DZ				Lin, Shen-Fu; Chen, Ying-Chen; Chen, Ray-Neng; Chen, Ling-Chun; Ho, Hsiu-O; Tsung, Yu-Han; Sheu, Ming-Thau; Liu, Der-Zen			Improving the Stability of Astaxanthin by Microencapsulation in Calcium Alginate Beads	PLOS ONE			English	Article							HAEMATOCOCCUS-PLUVIALIS; FOOD INGREDIENTS; ENCAPSULATION; EMULSIFICATION; CHITOSAN; MATRIX; GEL	There has been considerable interest in the biological functions of astaxanthin and its potential applications in the nutraceutical, cosmetics, food, and feed industries in recent years. However, the unstable structure of astaxanthin considerably limits its application. Therefore, this study reports the encapsulation of astaxanthin in calcium alginate beads using the extrusion method to improve its stability. This study also evaluates the stability of the encapsulated astaxanthin under different storage conditions. The evaluation of astaxanthin stability under various environmental factors reveals that temperature is the most influential environmental factor in astaxanthin degradation. Stability analysis shows that, regardless of the formulation used, the content of astaxanthin encapsulated in alginate beads remains above 90% of the original amount after 21 days of storage at 25 degrees C. These results suggest that the proposed technique is a promising way to enhance the stability of other sensitive compounds.	[Lin, Shen-Fu; Liu, Der-Zen] Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan; [Chen, Ying-Chen; Chen, Ling-Chun; Ho, Hsiu-O; Tsung, Yu-Han; Sheu, Ming-Thau] Taipei Med Univ, Sch Pharm, Coll Pharm, Taipei, Taiwan; [Chen, Ray-Neng] Mackay Med Nursing & Management Coll, Dept Cosmet Sci & Management, Taipei, Taiwan; [Liu, Der-Zen] Hsuan Chuang Univ, Ctr Gen Educ, Hsinchu, Taiwan	Taipei Medical University; Taipei Medical University; Mackay Junior College of Medicine, Nursing & Management; Hsuan Chuang University	Liu, DZ (corresponding author), Taipei Med Univ, Coll Biomed Engn, Grad Inst Biomed Mat & Tissue Engn, Taipei, Taiwan.	tonyliu@tmu.edu.tw						Ausich RL, 1997, PURE APPL CHEM, V69, P2169, DOI 10.1351/pac199769102169; Bhosale P, 2005, APPL MICROBIOL BIOT, V68, P445, DOI 10.1007/s00253-005-0032-8; Desai KGH, 2005, DRY TECHNOL, V23, P1361, DOI 10.1081/DRT-200063478; Gouin S, 2004, TRENDS FOOD SCI TECH, V15, P330, DOI 10.1016/j.tifs.2003.10.005; Higuera-Ciapara I, 2006, CRIT REV FOOD SCI, V46, P185, DOI 10.1080/10408690590957188; Higuera-Ciapara I, 2004, CARBOHYD POLYM, V56, P41, DOI 10.1016/j.carbpol.2003.11.012; Kim S, 2010, J KOREAN SOC APPL BI, V53, P559, DOI 10.3839/jksabc.2010.086; Kittikaiwan P, 2007, CARBOHYD POLYM, V70, P378, DOI 10.1016/j.carbpol.2007.04.021; MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111; NISHIGAKI I, 1994, J CLIN BIOCHEM NUTR, V16, P161; Nishino H, 2005, ONCOLOGY-BASEL, V69, P38, DOI 10.1159/000086631; Ribeiro HS, 2005, J FOOD SCI, V70, pE117, DOI 10.1111/j.1365-2621.2005.tb07083.x; Santocono M, 2006, J PHOTOCH PHOTOBIO B, V85, P205, DOI 10.1016/j.jphotobiol.2006.07.009; SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032; SHAHIDI F, 1993, CRIT REV FOOD SCI, V33, P501, DOI 10.1080/10408399309527645; Shilpa A, 2003, J MACROMOL SCI-POL R, VC43, P187, DOI 10.1081/MC-120020160; Shu B, 2006, J FOOD ENG, V76, P664, DOI 10.1016/j.jfoodeng.2005.05.062; SUGAWARA S, 1994, PHARMACEUT RES, V11, P272, DOI 10.1023/A:1018963626248; WAN LSC, 1992, J MICROENCAPSUL, V9, P309, DOI 10.3109/02652049209021245; Yuan C, 2008, FOOD CHEM, V109, P264, DOI 10.1016/j.foodchem.2007.07.051; Yuan JP, 2000, FOOD CHEM, V68, P443, DOI 10.1016/S0308-8146(99)00219-8	21	44	45	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153685	10.1371/journal.pone.0153685	http://dx.doi.org/10.1371/journal.pone.0153685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093175	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200040
J	Xu, QF; Zhang, XG				Xu, Qifeng; Zhang, Xuegong			The Influence of the Global Gene Expression Shift on Downstream Analyses	PLOS ONE			English	Article							CDNA MICROARRAY EXPERIMENTS; C-MYC; CLASSIFICATION; CANCER; NORMALIZATION; PREDICTION; DISCOVERY; SELECTION; ADENOCARCINOMA; PROFILES	The assumption that total abundance of RNAs in a cell is roughly the same in different cells is underlying most studies based on gene expression analyses. But experiments have shown that changes in the expression of some master regulators such as c-MYC can cause global shift in the expression of almost all genes in some cell types like cancers. Such shift will violate this assumption and can cause wrong or biased conclusions for standard data analysis practices, such as detection of differentially expressed (DE) genes and molecular classification of tumors based on gene expression. Most existing gene expression data were generated without considering this possibility, and are therefore at the risk of having produced unreliable results if such global shift effect exists in the data. To evaluate this risk, we conducted a systematic study on the possible influence of the global gene expression shift effect on differential expression analysis and on molecular classification analysis. We collected data with known global shift effect and also generated data to simulate different situations of the effect based on a wide collection of real gene expression data, and conducted comparative studies on representative existing methods. We observed that some DE analysis methods are more tolerant to the global shift while others are very sensitive to it. Classification accuracy is not sensitive to the shift and actually can benefit from it, but genes selected for the classification can be greatly affected.	[Xu, Qifeng; Zhang, Xuegong] Tsinghua Univ, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Xu, Qifeng; Zhang, Xuegong] Tsinghua Univ, TNLIST, Dept Automat, Bioinformat Div, Beijing 100084, Peoples R China; [Xu, Qifeng] Air Force Logist Coll, Dept Aircraft Spare Management, Xuzhou, Jiangsu, Peoples R China	Tsinghua University; Tsinghua University	Zhang, XG (corresponding author), Tsinghua Univ, MOE, Key Lab Bioinformat, Beijing 100084, Peoples R China.; Zhang, XG (corresponding author), Tsinghua Univ, TNLIST, Dept Automat, Bioinformat Div, Beijing 100084, Peoples R China.	zhangxg@tsinghua.edu.cn			National Basic Research Program of China [2012CB316504]	National Basic Research Program of China(National Basic Research Program of China)	This work is supported in part by the National Basic Research Program of China (2012CB316504). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Ben-Dor A, 2000, J COMPUT BIOL, V7, P559, DOI 10.1089/106652700750050943; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Coate JE, 2015, CHROMOSOMA, V124, P27, DOI 10.1007/s00412-014-0496-3; Cui HF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-641; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Dang CV, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a014217; Dudoit S, 2002, STAT SINICA, V12, P111; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2012, CELL, V151, P476, DOI 10.1016/j.cell.2012.10.012; Marshall E, 2012, SCIENCE, V338, P593, DOI 10.1126/science.338.6107.593; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Onskog J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-390; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Quackenbush J, 2001, NAT REV GENET, V2, P418, DOI 10.1038/35076576; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Zhang XG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-197	34	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153903	10.1371/journal.pone.0153903	http://dx.doi.org/10.1371/journal.pone.0153903			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092944	Green Submitted, gold, Green Published			2022-12-27	WOS:000374541200058
J	Freiberg, MS; Bebu, I; Tracy, R; So-Armah, K; Okulicz, J; Ganesan, A; Armstrong, A; O'Bryan, T; Rimland, D; Justice, AC; Agan, BK				Freiberg, Matthew S.; Bebu, Ionut; Tracy, Russell; So-Armah, Kaku; Okulicz, Jason; Ganesan, Anuradha; Armstrong, Adam; O'Bryan, Thomas; Rimland, David; Justice, Amy C.; Agan, Brian K.		Infect Dis Clinical Res	D-Dimer Levels before HIV Seroconversion Remain Elevated Even after Viral Suppression and Are Associated with an Increased Risk of Non-AIDS Events	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MYOCARDIAL-INFARCTION; INFLAMMATORY BIOMARKERS; ANTIRETROVIRAL THERAPY; INFECTED PATIENTS; ALCOHOL-PROBLEMS; DISEASE; INTERLEUKIN-6; COAGULATION; MARKERS	The mechanism underlying the excess risk of non-AIDS diseases among HIV infected people is unclear. HIV associated inflammation/hypercoagulability likely plays a role. While antiretroviral therapy (ART) may return this process to pre-HIV levels, this has not been directly demonstrated. We analyzed data/specimens on 249 HIV+ participants from the US Military HIV Natural History Study, a prospective, multicenter observational cohort of >5600 active duty military personnel and beneficiaries living with HIV. We used stored blood specimens to measure D-dimer and Interleukin-6 (IL-6) at three time points: pre-HIV seroconversion, >= 6 months post-HIV seroconversion but prior to ART initiation, and >= 6 months post-ART with documented HIV viral suppression on two successive evaluations. We evaluated the changes in biomarker levels between time points, and the association between these biomarker changes and future non-AIDS events. During a median follow-up of 3.7 years, there were 28 incident non-AIDS diseases. At ART initiation, the median CD4 count was 361cells/mm(3); median duration of documented HIV infection 392 days; median time on ART was 354 days. Adjusted mean percent increase in D-dimer levels from pre-seroconversion to post-ART was 75.1% (95% confidence interval 24.6-148.0, p = 0.002). This increase in D-dimer was associated with a significant 22% increase risk of future non-AIDS events (p = 0.03). Changes in IL-6 levels across time points were small and not associated with future non-AIDS events. In conclusion, ART initiation and HIV viral suppression does not eliminate HIV associated elevation in D-dimer levels. This residual pathology is associated with an increased risk of future non-AIDS diseases.	[Freiberg, Matthew S.] Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA; [Freiberg, Matthew S.] Vet Affairs Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr, Nashville, TN USA; [Okulicz, Jason; Ganesan, Anuradha; Armstrong, Adam; O'Bryan, Thomas; Agan, Brian K.] Uniformed Serv Univ Hlth Sci, IDCRP, Dept Prevent Med & Biostat, Bethesda, MD 20814 USA; [Okulicz, Jason; O'Bryan, Thomas] San Antonio Mil Med Ctr, Infect Dis Serv, San Antonio, TX USA; [Ganesan, Anuradha] Walter Reed Natl Mil Med Ctr, Infect Dis Clin, Bethesda, MD USA; [Tracy, Russell] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Bebu, Ionut] George Washington Univ, Biostat Ctr, Milken Inst Sch Publ Hlth, Rockville, MD USA; [Armstrong, Adam] US Naval Med Res Unit 6 Peru, Lima, Peru; [So-Armah, Kaku] Boston Univ, Div Gen Internal Med, Boston, MA 02215 USA; [Rimland, David] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA; [Rimland, David] VA Med Ctr, Atlanta, GA USA; [Justice, Amy C.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06510 USA; [Justice, Amy C.] VA Connecticut Healthcare Syst West Haven Affilia, New Haven, CT USA; [Ganesan, Anuradha; O'Bryan, Thomas; Agan, Brian K.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA	Vanderbilt University; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Uniformed Services University of the Health Sciences - USA; San Antonio Military Medical Center; Walter Reed National Military Medical Center; University of Vermont; George Washington University; Boston University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Freiberg, MS (corresponding author), Vanderbilt Univ, Sch Med, Div Cardiovasc Med, Nashville, TN 37212 USA.; Freiberg, MS (corresponding author), Vet Affairs Tennessee Valley Healthcare Syst, Geriatr Res Educ & Clin Ctr, Nashville, TN USA.	matthew.s.freiberg@vanderbilt.edu		Agan, Brian/0000-0002-5114-1669; Justice, Amy/0000-0003-0139-5502; So-Armah, Kaku/0000-0003-1505-6384	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program through the Uniformed Services University of the Health Sciences [IDCRP-000-33]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program through the Uniformed Services University of the Health Sciences [IDCRP-000-33]; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) [Y1-AI-5072]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI005072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA020794, U13AA022864, U01AA020790] Funding Source: NIH RePORTER	Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program through the Uniformed Services University of the Health Sciences; National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Support for this work (IDCRP-000-33) was provided by the Infectious Disease Clinical Research Program (IDCRP), a Department of Defense (DoD) program executed through the Uniformed Services University of the Health Sciences. This project has been funded in whole, or in part, with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), under Inter-Agency Agreement Y1-AI-5072.	Althoff KN, 2015, CLIN INFECT DIS, V60, P627, DOI 10.1093/cid/ciu869; Armah KA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-399; Armah KA, 2012, CLIN INFECT DIS, V55, P126, DOI 10.1093/cid/cis406; Baker JV, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000264; Borges AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090978; Brodine SK, 1999, ANN INTERN MED, V131, P502, DOI 10.7326/0003-4819-131-7-199910050-00004; Dawson DA, 2010, ALCOHOL CLIN EXP RES, V34, P364, DOI 10.1111/j.1530-0277.2009.01098.x; Deeks SG, 2013, LANCET, V382, P1525, DOI 10.1016/S0140-6736(13)61809-7; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Delvaeye M, 2009, BLOOD, V114, P2367, DOI 10.1182/blood-2009-05-199208; Dooko CBA, 2014, JAIDS-J ACQ IMM DEF, V67, P538, DOI 10.1097/QAI.0000000000000354; Duprez DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044454; Efron B., 1994, INTRO BOOTSTRAP; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; Freiberg MS, 2013, JAMA INTERN MED, V173, P614, DOI 10.1001/jamainternmed.2013.3728; Fuster D, 2013, AIDS RES HUM RETROV, V29, P1110, DOI [10.1089/aid.2012.0348, 10.1089/AID.2012.0348]; Justice AC, 2006, MED CARE, V44, pS52, DOI 10.1097/01.mlr.0000228003.08925.8c; Koethe JR, 2013, AIDS RES HUM RETROV, V29, P1019, DOI [10.1089/aid.2013.0016, 10.1089/AID.2013.0016]; Kuller L, 2008, C RETR OPP INF 2008; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Nordell AD, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000844; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Palella FJ, 2010, AIDS, V24, P1657, DOI 10.1097/QAD.0b013e3283389dfa; Peters L, 2014, J CLIN VIROL, V60, P295, DOI 10.1016/j.jcv.2014.03.017; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Wada NI, 2015, AIDS, V29, P463, DOI 10.1097/QAD.0000000000000545; Wannamethee SG, 2009, J THROMB HAEMOST, V7, P1605, DOI 10.1111/j.1538-7836.2009.03574.x	32	33	33	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0152588	10.1371/journal.pone.0152588	http://dx.doi.org/10.1371/journal.pone.0152588			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088215	gold, Green Published, Green Submitted			2022-12-27	WOS:000374527000008
J	Lee, M; San Martin, A; Valdivia, A; Martin-Garrido, A; Griendling, KK				Lee, Minyoung; San Martin, Alejandra; Valdivia, Alejandra; Martin-Garrido, Abel; Griendling, Kathy K.			Redox-Sensitive Regulation of Myocardin-Related Transcription Factor (MRTF-A) Phosphorylation via Palladin in Vascular Smooth Muscle Cell Differentiation Marker Gene Expression	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; NUCLEAR-LOCALIZATION; PROTEIN PALLADIN; ACTIN; NOX4; POLDIP2; FAMILY	Vascular smooth muscle cells (VSMCs) undergo a phenotypic switch from a differentiated to synthetic phenotype in cardiovascular diseases such as atherosclerosis and restenosis. Our previous studies indicate that transforming growth factor-beta (TGF-beta) helps to maintain the differentiated phenotype by regulating expression of pro-differentiation genes such as smooth muscle a-actin (SMA) and Calponin (CNN) through reactive oxygen species (ROS) derived from NADPH oxidase 4 (Nox4) in VSMCs. In this study, we investigated the relationship between Nox4 and myocardin-related transcription factor-A (MRTF-A), a transcription factor known to be important in expression of smooth muscle marker genes. Previous work has shown that MRTF-A interacts with the actin-binding protein, palladin, although how this interaction affects MRTF-A function is unclear, as is the role of phosphorylation in MRTF-A activity. We found that Rho kinase (ROCK)-mediated phosphorylation of MRTF-A is a key event in the regulation of SMA and CNN in VSMCs and that this phosphorylation depends upon Nox4-mediated palladin expression. Knockdown of Nox4 using siRNA decreases TGF-beta-induced palladin expression and MRTF-A phosphorylation, suggesting redox-sensitive regulation of this signaling pathway. Knockdown of palladin also decreases MRTF-A phosphorylation. These data suggest that Nox4-dependent palladin expression and ROCK regulate phosphorylation of MRTF-A, a critical factor in the regulation of SRF responsive gene expression.	[Lee, Minyoung; San Martin, Alejandra; Valdivia, Alejandra; Martin-Garrido, Abel; Griendling, Kathy K.] Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Emory University	Griendling, KK (corresponding author), Emory Univ, Dept Med, Div Cardiol, Atlanta, GA 30322 USA.	kgriend@emory.edu	San Martin, Alejandra/HDN-0012-2022	Griendling, Kathy/0000-0002-9456-8582; Valdivia, Alejandra/0000-0003-1492-5066	NIH [P01HL095070, R01HL38206, R01HL113167]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL038206, R01HL038206, R01HL113167, P01HL095070] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH grants P01HL095070 (KKG and ASM), R01HL38206 (KKG), and R01HL113167 (ASM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boggy GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012355; Boukhelifa M, 2001, MOL BIOL CELL, V12, P2721, DOI 10.1091/mbc.12.9.2721; Brentnall TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030219; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; DalleDonne I, 1995, BIOPHYS J, V69, P2710, DOI 10.1016/S0006-3495(95)80142-6; Datla SR, 2014, AM J PHYSIOL-HEART C, V307, pH945, DOI 10.1152/ajpheart.00918.2013; Dixon RDS, 2008, J BIOL CHEM, V283, P6222, DOI 10.1074/jbc.M707694200; Du KL, 2004, J BIOL CHEM, V279, P17578, DOI 10.1074/jbc.M400961200; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Hautmann MB, 1997, J BIOL CHEM, V272, P10948; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Jin L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012823; Jin L, 2009, J MUSCLE RES CELL M, V30, P41, DOI 10.1007/s10974-009-9173-1; Jin L, 2009, J BIOL CHEM, V284, P2121, DOI 10.1074/jbc.M806095200; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lee CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066964; Liu XS, 2007, J CELL BIOCHEM, V100, P1288, DOI 10.1002/jcb.21126; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Mykkanen OM, 2001, MOL BIOL CELL, V12, P3060, DOI 10.1091/mbc.12.10.3060; Otey CA, 2005, INT REV CYTOL, V246, P31, DOI 10.1016/S0074-7696(05)46002-7; Otey CA, 2009, CELL MOTIL CYTOSKEL, V66, P618, DOI 10.1002/cm.20385; Parast MM, 2000, J CELL BIOL, V150, P643, DOI 10.1083/jcb.150.3.643; Qian XJ, 2013, ENDOCRINOLOGY, V154, P1907, DOI 10.1210/en.2012-2269; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Ronty MJ, 2006, J INVEST DERMATOL, V126, P2387, DOI 10.1038/sj.jid.5700427; Vattepu R, 2015, PROTEIN SCI, V24, P70, DOI 10.1002/pro.2588; Wang DZ, 2002, P NATL ACAD SCI USA, V99, P14855, DOI 10.1073/pnas.222561499; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang HV, 2008, DEV DYNAM, V237, P3342, DOI 10.1002/dvdy.21755	34	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153199	10.1371/journal.pone.0153199	http://dx.doi.org/10.1371/journal.pone.0153199			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088725	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000012
J	Perez-Zepeda, MU; Belanger, E; Zunzunegui, MV; Phillips, S; Ylli, A; Guralnik, J				Perez-Zepeda, Mario U.; Belanger, Emmanuelle; Zunzunegui, Maria-Victoria; Phillips, Susan; Ylli, Alban; Guralnik, Jack			Assessing the Validity of Self-Rated Health with the Short Physical Performance Battery: A Cross-Sectional Analysis of the International Mobility in Aging Study	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; MAINTAINING MOBILITY; MORTALITY RISK; WALKING SPEED; OLDER-ADULTS; LATE-LIFE; PREDICTOR; ASSOCIATION; COMMUNITY; POPULATIONS	Objective The aim of this study was to explore the validity of self-rated health across different populations of older adults, when compared to the Short Physical Performance Battery. Design Cross-sectional analysis of the International Mobility in Aging Study. Setting Five locations: Saint-Hyacinthe and Kingston (Canada), Tirana (Albania), Manizales (Colombia), and Natal (Brazil). Participants Older adults between 65 and 74 years old (n = 1,995). Methods The Short Physical Performance Battery (SPPB) was used to measure physical performance. Self-rated health was assessed with one single five-point question. Linear trends between SPPB scores and self-rated health were tested separately for men and women at each of the five international study sites. Poor physical performance (independent variable) (SPPB less than 8) was used in logistic regression models of self-rated health (dependent variable), adjusting for potential covariates. All analyses were stratified by gender and site of origin. Results A significant linear association was found between the mean scores of the Short Physical Performance Battery and ordinal categories of self-rated health across research sites and gender groups. After extensive control for objective physical and mental health indicators and socio-demographic variables, these graded associations became non-significant in some research sites. Conclusion These findings further confirm the validity of SRH as a measure of overall health status in older adults.	[Perez-Zepeda, Mario U.] Inst Nacl Geriatria, Div Res, Geriatr & Epidemiol Res Dept, Mexico City, DF, Mexico; [Belanger, Emmanuelle; Zunzunegui, Maria-Victoria] Univ Montreal, Dept Social & Prevent Med, Publ Hlth Res Inst IRSPUM, Montreal, PQ, Canada; [Phillips, Susan] Queens Univ, Ctr Studies Primary Care, Kingston, ON, Canada; [Ylli, Alban] Univ Tirana, Fac Med, Tirana, Albania; [Guralnik, Jack] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA	Universite de Montreal; Queens University - Canada; University of Tirana (UT); University System of Maryland; University of Maryland Baltimore	Perez-Zepeda, MU (corresponding author), Inst Nacl Geriatria, Div Res, Geriatr & Epidemiol Res Dept, Mexico City, DF, Mexico.	mperez@inger.gob.mx	PEREZ-ZEPEDA, MARIO Ulises/B-7265-2011	PEREZ-ZEPEDA, MARIO Ulises/0000-0003-4374-976X; Phillips, Susan/0000-0003-4798-1742; Belanger, Emmanuelle/0000-0001-7301-0451; Zunzunegui, Maria-Victoria/0000-0003-0827-2804	Education, Loisir et Sport-Quebec grant [177395]; Institute of Aging, Canadian Institutes of Heal Research [AAM108]	Education, Loisir et Sport-Quebec grant; Institute of Aging, Canadian Institutes of Heal Research	Dr. Perez-Zepeda was supported by an Education, Loisir et Sport-Quebec grant (2013-2014, Programme 3M, dossier 177395; http://www.education.gouv.qc.ca/). The IMIAS project is funded by the Institute of Aging, Canadian Institutes of Heal Research. Project number: AAM108 (http://www.cihr-irsc.gc.ca/e/8671.html). There was no sponsor's role in the design, methods, subject recruitment, data collections, analysis and preparation of paper.	da Camara SMA, 2013, GERIATR GERONTOL INT, V13, P421, DOI 10.1111/j.1447-0594.2012.00920.x; Babones SJ, 2009, PUBLIC HEALTH, V123, P199, DOI 10.1016/j.puhe.2008.12.016; Bardage Carola, 2005, Eur J Ageing, V2, P149, DOI 10.1007/s10433-005-0032-7; Benyamini Y, 1999, RES AGING, V21, P392, DOI 10.1177/0164027599213002; Borrell C, 2009, INT J HEALTH SERV, V39, P321, DOI 10.2190/HS.39.2.f; Burstrom B, 2001, J EPIDEMIOL COMMUN H, V55, P836, DOI 10.1136/jech.55.11.836; Cesari M, 2009, GERONTOLOGY, V55, P194, DOI 10.1159/000174824; Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x; de Yebenes MJG, 2003, INT J GERIATR PSYCH, V18, P925, DOI 10.1002/gps.947; Gomez JF, 2013, COLOMB MEDICA, V44, P165; Fielding RA, 2011, J GERONTOL A-BIOL, V66, P1226, DOI 10.1093/gerona/glr123; Freire AN, 2012, J AGING HEALTH, V24, P863, DOI 10.1177/0898264312438551; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Guralnik JM, 2003, AM J PREV MED, V25, P112, DOI 10.1016/S0749-3797(03)00174-0; GURALNIK JM, 1993, AM J EPIDEMIOL, V137, P845, DOI 10.1093/oxfordjournals.aje.a116746; Guralnik JM, 1997, MUSCLE NERVE, pS14; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jylha M, 2006, J CLIN EPIDEMIOL, V59, P465, DOI 10.1016/j.jclinepi.2005.12.004; Jylha M, 2001, J GERONTOL A-BIOL, V56, pM609, DOI 10.1093/gerona/56.10.M609; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; KRAUSE NM, 1994, MED CARE, V32, P930, DOI 10.1097/00005650-199409000-00004; LACROIX AZ, 1993, AM J EPIDEMIOL, V137, P858, DOI 10.1093/oxfordjournals.aje.a116747; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Lourenco RA, 2015, AGE AGEING, V44, P334, DOI 10.1093/ageing/afu192; Lyyra TM, 2006, ARCH GERONTOL GERIAT, V42, P277, DOI 10.1016/j.archger.2005.08.001; Mangani I, 2008, AGING CLIN EXP RES, V20, P234; McDowell I., 2006, MEASURING HLTH GUIDE, P617; Miller TR, 2007, J GERONTOL B-PSYCHOL, V62, pS22, DOI 10.1093/geronb/62.1.S22; MOSSEY JM, 1982, AM J PUBLIC HEALTH, V72, P800, DOI 10.2105/AJPH.72.8.800; RADLOFF LS, 1991, J YOUTH ADOLESCENCE, V20, P149, DOI 10.1007/BF01537606; Rolland Y, 2006, EUR J EPIDEMIOL, V21, P113, DOI 10.1007/s10654-005-5458-x; Sen A, 2002, BRIT MED J, V324, P860, DOI 10.1136/bmj.324.7342.860; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Sanchez-Santos MT, 2011, EUR J AGEING, V8, P281, DOI 10.1007/s10433-011-0198-0; Vasunilashorn S, 2009, J GERONTOL A-BIOL, V64, P223, DOI 10.1093/gerona/gln022; Wang A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150070; WEINBERGER M, 1986, AM J PUBLIC HEALTH, V76, P457, DOI 10.2105/AJPH.76.4.457; Zunzunegui MV, 2004, SOC SCI MED, V58, P2069, DOI 10.1016/j.socscimed.2003.08.005	39	43	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153855	10.1371/journal.pone.0153855	http://dx.doi.org/10.1371/journal.pone.0153855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27089219	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000055
J	Sharma, M; Iyer, JK; Shih, N; Majumder, M; Mattaparthi, VSK; Mukhopadhyay, R; Doley, R				Sharma, Maitreyee; Iyer, Janaki Krishnamurthy; Shih, Norrapat; Majumder, Munmi; Mattaparthi, Venkata Satish Kumar; Mukhopadhyay, Rupak; Doley, Robin			Daboxin P, a Major Phospholipase A2 Enzyme from the Indian Daboia russelii russelii Venom Targets Factor X and Factor Xa for Its Anticoagulant Activity	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; SNAKE-VENOM; PROTEASE INHIBITOR; CAROTID-ARTERY; BINDING-SITE; I-TASSER; A(2); COAGULATION; COMPLEX; PROTEINS	In the present study a major protein has been purified from the venom of Indian Daboia russelii russelii using gel filtration, ion exchange and Rp-HPLC techniques. The purified protein, named daboxin P accounts for similar to 24% of the total protein of the crude venom and has a molecular mass of 13.597 kDa. It exhibits strong anticoagulant and phospholipase A(2) activity but is devoid of any cytotoxic effect on the tested normal or cancerous cell lines. Its primary structure was deduced by N-terminal sequencing and chemical cleavage using Edman degradation and tandem mass spectrometry. It is composed of 121 amino acids with 14 cysteine residues and catalytically active His48 -Asp49 pair. The secondary structure of daboxin P constitutes 42.73% of alpha-helix and 12.36% of beta-sheet. It is found to be stable at acidic (pH 3.0) and neutral pH (pH 7.0) and has a Tm value of 71.59 +/- 0.46 degrees C. Daboxin P exhibits anticoagulant effect under in-vitro and in-vivo conditions. It does not inhibit the catalytic activity of the serine proteases but inhibits the activation of factor X to factor Xa by the tenase complexes both in the presence and absence of phospholipids. It also inhibits the tenase complexes when active site residue (His48) was alkylated suggesting its non-enzymatic mode of anticoagulant activity. Moreover, it also inhibits prothrombinase complex when pre-incubated with factor Xa prior to factor Va addition. Fluorescence emission spectroscopy and affinity chromatography suggest the probable interaction of daboxin P with factor X and factor Xa. Molecular docking analysis reveals the interaction of the Ca+2 binding loop; helix C; anticoagulant region and C-terminal region of daboxin P with the heavy chain of factor Xa. This is the first report of a phospholipase A(2) enzyme from Indian viper venom which targets both factor X and factor Xa for its anticoagulant activity.	[Sharma, Maitreyee; Majumder, Munmi; Mattaparthi, Venkata Satish Kumar; Mukhopadhyay, Rupak; Doley, Robin] Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India; [Iyer, Janaki Krishnamurthy; Shih, Norrapat] Natl Univ Singapore, Dept Biol Sci, Fac Sci, Singapore 117548, Singapore	Tezpur University; National University of Singapore	Doley, R (corresponding author), Tezpur Univ, Dept Mol Biol & Biotechnol, Tezpur 784028, Assam, India.	doley@tezu.ernet.in	Kumar, M.Venkata Satish/M-1379-2017; Mukhopadhyay, Rupak/Q-9168-2017	Kumar, M.Venkata Satish/0000-0002-5238-753X; Mukhopadhyay, Rupak/0000-0001-5211-1413; Majumder, Munmi/0000-0002-6545-3217	DBT, Govt. of India [BT/43/NE/TBP/2010]; DST Inspire fellowship; India Research Initiative, NUS	DBT, Govt. of India(Department of Biotechnology (DBT) India); DST Inspire fellowship; India Research Initiative, NUS	This work was supported by a grant to RD by DBT, Govt. of India under the twinning programme to NER region (BT/43/NE/TBP/2010), and also DBT, DST, and UGC for various projects to the department. MS is a recipient of DST Inspire fellowship and thanks India Research Initiative, NUS for the short term financial support to carry out part of this work in Protein Science Laboratory, Department of Biological Sciences, NUS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atanasov VN, 2009, BIOCHEMISTRY-MOSCOW+, V74, P276, DOI 10.1134/S0006297909030055; Atoda H, 1998, BIOCHEMISTRY-US, V37, P17361, DOI 10.1021/bi981177x; Banerjee Y, 2005, J BIOL CHEM, V280, P42601, DOI 10.1074/jbc.M508987200; BOFFA MC, 1976, BIOCHIM BIOPHYS ACTA, V429, P839, DOI 10.1016/0005-2744(76)90330-2; Borensztajn K, 2008, TRENDS MOL MED, V14, P429, DOI 10.1016/j.molmed.2008.08.001; Cheng AC, 2012, J BIOL CHEM, V287, P15739, DOI 10.1074/jbc.M111.323063; Crimmins DL, 2005, CURRENT PROTOCOLS PR, P1; DAVIDSON FF, 1990, J MOL EVOL, V31, P228, DOI 10.1007/BF02109500; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Dutta S, 2015, BIOCHIMIE, V110, P93, DOI 10.1016/j.biochi.2014.12.020; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; FAURE G, 1988, BIOCHEMISTRY-US, V27, P730, DOI 10.1021/bi00402a036; FAURE G, 1987, TOXICON, V25, P229, DOI 10.1016/0041-0101(87)90246-7; Faure G, 2011, ACTA CHIM SLOV, V58, P671; Faure G, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-82; FLEER EAM, 1981, EUR J BIOCHEM, V113, P283, DOI 10.1111/j.1432-1033.1981.tb05064.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Girish V, 2012, EXACTIN A SPECIFIC I; GOWDA VT, 1994, TOXICON, V32, P665, DOI 10.1016/0041-0101(94)90336-0; GUTIERREZ JM, 1995, TOXICON, V33, P1405, DOI 10.1016/0041-0101(95)00085-Z; HEINRIKSON RL, 1977, J BIOL CHEM, V252, P4913; Joseph JS, 1999, BLOOD, V94, P621, DOI 10.1182/blood.V94.2.621.414k25_621_631; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kini R. M., 1997, VENOM PHOSPHOLIPASE, P1; Kini RM, 2005, TOXICON, V45, P1147, DOI 10.1016/j.toxicon.2005.02.018; Kini RM, 1999, J MOL EVOL, V48, P125, DOI 10.1007/PL00006450; KINI RM, 1987, J BIOL CHEM, V262, P14402; Kini RM, 1995, TOXICON, V33, P1585, DOI 10.1016/0041-0101(95)00103-4; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Kruger DM, 2010, NUCLEIC ACIDS RES, V38, pW480, DOI 10.1093/nar/gkq471; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Laskowski RA, 2001, NUCLEIC ACIDS RES, V29, P221, DOI 10.1093/nar/29.1.221; Ledizet Michel, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P1, DOI 10.2174/1568016052773315; Louis-Jeune C, 2011, PROTEINS STRUCTURE F, V80; Lu QM, 2002, J NAT TOXINS, V11, P25; Maduwage K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003220; Maduwage Kalana, 2011, J Venom Res, V2, P17; Mathus A, 1999, J BIOL CHEM, V274, P18477, DOI 10.1074/jbc.274.26.18477; Milner SJ, 1996, BIOTECHNOL BIOENG, V50, P265, DOI 10.1002/(SICI)1097-0290(19960505)50:3<265::AID-BIT5>3.0.CO;2-E; Mukherjee AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101334; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; OUYANG C, 1976, BIOCHIM BIOPHYS ACTA, V420, P298, DOI 10.1016/0005-2795(76)90321-4; Prasad BN, 1996, TOXICON, V34, P1173, DOI 10.1016/0041-0101(96)00033-5; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Rudolph AE, 2001, J BIOL CHEM, V276, P5123, DOI 10.1074/jbc.M006961200; Saikia D, 2011, TOXICON, V57, P841, DOI 10.1016/j.toxicon.2011.02.018; Sajevic T, 2011, TOXICON, V57, P627, DOI 10.1016/j.toxicon.2011.01.006; Saul FA, 2010, J STRUCT BIOL, V169, P360, DOI 10.1016/j.jsb.2009.10.010; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Sharma M, 2015, TOXICON, V107, P266, DOI 10.1016/j.toxicon.2015.06.027; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; STEFANSSON S, 1990, BIOCHEMISTRY-US, V29, P7742, DOI 10.1021/bi00485a024; STEFANSSON S, 1989, THROMB RES, V55, P481, DOI 10.1016/0049-3848(89)90056-X; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thakur R, 2014, BIOCHIMIE, V105, P149, DOI 10.1016/j.biochi.2014.07.006; Tsai IH, 2011, TOXICON, V57, P332, DOI 10.1016/j.toxicon.2010.12.012; VANDELOOSDRECHT AA, 1994, J IMMUNOL METHODS, V174, P311, DOI 10.1016/0022-1759(94)90034-5; VERHEIJ HM, 1980, EUR J BIOCHEM, V112, P25, DOI 10.1111/j.1432-1033.1980.tb04982.x; Wang X, 2005, J THROMB HAEMOST, V3, P695, DOI 10.1111/j.1538-7836.2005.01236.x; Wang YM, 2010, TOXICON, V56, P93, DOI 10.1016/j.toxicon.2010.03.015; Ward M, 2002, PROTEIN PROTOCOLS HD, P461; Wu WM, 2012, BLOOD, V120, P671, DOI 10.1182/blood-2012-03-419523; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang C, 1997, J MOL BIOL, V267, P707, DOI 10.1006/jmbi.1996.0859; Zhang Y, 1998, BIOCHEMISTRY-US, V37, P10681, DOI 10.1021/bi973050y; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	67	19	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153770	10.1371/journal.pone.0153770	http://dx.doi.org/10.1371/journal.pone.0153770			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089306	gold, Green Published, Green Submitted			2022-12-27	WOS:000374527000046
J	Wang, L; Huang, BQ; Chiang, KP; Liu, X; Chen, BZ; Xie, YY; Xu, YP; Hu, JY; Dai, MH				Wang, Lei; Huang, Bangqin; Chiang, Kuo-Ping; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan; Xu, Yanping; Hu, Jianyu; Dai, Minhan			Physical-Biological Coupling in the Western South China Sea: The Response of Phytoplankton Community to a Mesoscale Cyclonic Eddy	PLOS ONE			English	Article							SUBTROPICAL NORTH-ATLANTIC; PHOTOSYNTHETIC RATES; CLASS ABUNDANCES; EDDIES; DYNAMICS; EXPORT; OCEANOGRAPHY; VARIABILITY; SEPARATION; PIGMENTS	It is widely recognized that the mesoscale eddies play an important part in the biogeochemical cycle in ocean ecosystem, especially in the oligotrophic tropical zones. So here a heterogeneous cyclonic eddy in its flourishing stage was detected using remote sensing and in situ biogeochemical observation in the western South China Sea (SCS) in early September, 2007. The high-performance liquid chromatography method was used to identify the photosynthetic pigments. And the CHEMical TAXonomy (CHEMTAX) was applied to calculate the contribution of nine phytoplankton groups to the total chlorophyll a (TChl a) biomass. The deep chlorophyll a maximum layer (DCML) was raised to form a dome structure in the eddy center while there was no distinct enhancement for TChl a biomass. The integrated TChl a concentration in the upper 100 m water column was also constant from the eddy center to the surrounding water outside the eddy. However the TChl a biomass in the surface layer (at 5 m) in the eddy center was promoted 2.6-fold compared to the biomass outside the eddy (p < 0.001). Thus, the slight enhancement of TChl a biomass of euphotic zone integration within the eddy was mainly from the phytoplankton in the upper mixed zone rather than the DCML. The phytoplankton community was primarily contributed by diatoms, prasinophytes, and Synechococcus at the DCML within the eddy, while less was contributed by haptophytes_8 and Prochlorococcus. The TChl a biomass for most of the phytoplankton groups increased at the surface layer in the eddy center under the effect of nutrient pumping. The doming isopycnal within the eddy supplied nutrients gently into the upper mixing layer, and there was remarkable enhancement in phytoplankton biomass at the surface layer with 10.5% TChl a biomass of water column in eddy center and 3.7% at reference stations. So the slight increasing in the water column integrated phytoplankton biomass might be attributed to the stimulated phytoplankton biomass at the surface layer.	[Wang, Lei; Huang, Bangqin; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan] Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China; [Wang, Lei; Huang, Bangqin; Liu, Xin; Chen, Bingzhang; Xie, Yuyuan; Xu, Yanping; Hu, Jianyu; Dai, Minhan] Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China; [Chiang, Kuo-Ping] Natl Taiwan Ocean Univ, Inst Marine Environm Chem & Ecol, Keelung, Taiwan	Xiamen University; Xiamen University; National Taiwan Ocean University	Huang, BQ (corresponding author), Xiamen Univ, Minist Educ, Key Lab Coastal & Wetland Ecosyst, Xiamen, Peoples R China.; Huang, BQ (corresponding author), Xiamen Univ, State Key Lab Marine Environm Sci, Xiamen, Peoples R China.	bqhuang@xmu.edu.cn	Dai, Minhan/G-3343-2010; Chen, Bingzhang/AAH-6784-2020; Xie, Yuyuan/CAF-6420-2022; DAI, M/GPS-8291-2022; 许, 艳苹/E-3860-2013; Liu, Xin/D-6312-2019	Dai, Minhan/0000-0003-0550-0701; Chen, Bingzhang/0000-0002-1573-7473; Liu, Xin/0000-0002-7925-9618; Huang, Bangqin/0000-0003-2279-6241; Xie, Yuyuan/0000-0001-9134-3604	Natural Science Foundation of China [41330961, 41406158]; National Programme on Global Change and Air-Sea Interaction [GASI-03-01-02-03]; Specialized Research Fund for the Doctoral Program of Higher Education [20130121110031]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Programme on Global Change and Air-Sea Interaction; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by: (1) the Natural Science Foundation of China through grants No. 41330961 and 41406158 (http://www.nsfc.gov.cn/publish/portal1/); (2) the National Programme on Global Change and Air-Sea Interaction through grant No. GASI-03-01-02-03 (http://www.soa.gov.cn/); (3) the Specialized Research Fund for the Doctoral Program of Higher Education through grant No. 20130121110031 (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm).	Allen CB, 1996, DEEP-SEA RES PT I, V43, P917, DOI 10.1016/0967-0637(96)00022-2; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Benitez-Nelson CR, 2007, SCIENCE, V316, P1017, DOI 10.1126/science.1136221; Bibby TS, 2011, BIOGEOSCIENCES, V8, P657, DOI 10.5194/bg-8-657-2011; Bidigare RR, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL016393; Brown SL, 2008, DEEP-SEA RES PT II, V55, P1321, DOI 10.1016/j.dsr2.2008.02.012; Chelton DB, 2011, SCIENCE, V334, P328, DOI 10.1126/science.1208897; Chen BZ, 2009, LIMNOL OCEANOGR, V54, P1084, DOI 10.4319/lo.2009.54.4.1084; Chen GX, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006716; Chen GX, 2010, CONT SHELF RES, V30, P715, DOI 10.1016/j.csr.2009.11.013; Chen WF, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006460; Chen YFL, 2005, DEEP-SEA RES PT I, V52, P319, DOI 10.1016/j.dsr.2004.11.001; Chen YLL, 2007, J OCEANOGR, V63, P671, DOI 10.1007/s10872-007-0059-9; Chu P. C., 2001, J OCEANOGR, V57, P549, DOI DOI 10.1023/A:1021251519067; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P685, DOI 10.4319/lo.1967.12.4.0685; FALKOWSKI PG, 1991, NATURE, V352, P55, DOI 10.1038/352055a0; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; Gan J, 2008, DEEP-SEA RES PT I, V55, P1, DOI 10.1016/j.dsr.2007.09.008; GOERICKE R, 1993, MAR ECOL PROG SER, V101, P307, DOI 10.3354/meps101307; Hu JY, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006810; Jeffrey S.W., 1994, Systematics Association Special Volume Series, V51, P111; Landry MR, 2008, DEEP-SEA RES PT II, V55, P1348, DOI 10.1016/j.dsr2.2008.02.001; Latasa M, 2007, MAR ECOL PROG SER, V329, P13, DOI 10.3354/meps329013; LETELIER RM, 1993, LIMNOL OCEANOGR, V38, P1420, DOI 10.4319/lo.1993.38.7.1420; Li WKW, 2002, NATURE, V419, P154, DOI 10.1038/nature00994; Mackey MD, 1996, MAR ECOL PROG SER, V144, P265, DOI 10.3354/meps144265; Martin AP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001841; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 2011, SCIENCE, V334, P318, DOI 10.1126/science.1208892; McGillicuddy DJ, 1997, DEEP-SEA RES PT I, V44, P1427, DOI 10.1016/S0967-0637(97)00024-1; Mendes CR, 2007, LIMNOL OCEANOGR-METH, V5, P363, DOI 10.4319/lom.2007.5.363; Mizobata K, 2006, J GEOPHYS RES-OCEANS, V111, DOI [10.1029/2005JC003335, 10.1029/2005JC003314]; Ning X, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002365; OLAIZOLA M, 1993, MAR BIOL, V116, P533, DOI 10.1007/BF00355471; Parsons T. R., 1973, BIOL OCEANOGRAPHIC P; Raven JA, 1998, FUNCT ECOL, V12, P503, DOI 10.1046/j.1365-2435.1998.00233.x; Rii YM, 2008, DEEP-SEA RES PT II, V55, P1275, DOI 10.1016/j.dsr2.2008.01.013; Seki MP, 2001, GEOPHYS RES LETT, V28, P1583, DOI 10.1029/2000GL012439; SHERR EB, 1994, MICROBIAL ECOL, V28, P223, DOI 10.1007/BF00166812; TURPIN DH, 1979, J EXP MAR BIOL ECOL, V39, P151, DOI 10.1016/0022-0981(79)90011-X; Vaillancourt RD, 2003, DEEP-SEA RES PT I, V50, P829, DOI 10.1016/S0967-0637(03)00059-1; Wang GH, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018532; Williams RG, 2011, NAT GEOSCI, V4, P739, DOI 10.1038/ngeo1307; Wong GTF, 2007, DEEP-SEA RES PT II, V54, P1434, DOI 10.1016/j.dsr2.2007.05.012; Wong GTF, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015796; Wu CR, 1999, J GEOPHYS RES-OCEANS, V104, P29987, DOI 10.1029/1999JC900260; Zapata M, 2004, MAR ECOL PROG SER, V270, P83, DOI 10.3354/meps270083; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	50	32	35	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153735	10.1371/journal.pone.0153735	http://dx.doi.org/10.1371/journal.pone.0153735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088991	Green Published, gold, Green Accepted			2022-12-27	WOS:000374527000044
J	Van Doesum, NJ; Van Prooijen, JW; Verburgh, L; Van Lange, PAM				Van Doesum, Niels J.; Van Prooijen, Jan-Willem; Verburgh, Lot; Van Lange, Paul A. M.			Social Hostility in Soccer and Beyond	PLOS ONE			English	Article							VALUE ORIENTATION; DECISION-MAKING; HOT SAUCE; BIAS MAP; AGGRESSION; CHOICE; SELF; EXPRESSION; RESPONSES; DONATIONS	Social hostility is seldom expressed overtly. More often than not, individuals try to get their hostile message across without risking violent altercations. However, subtle and relatively covert hostility is not easy to research. We suggest a novel way with the SoMi paradigm, a social decision making task that offers participants the opportunity to be socially mindful or socially hostile by leaving or limiting choice to others. Sampling a general population we find that, relative to friends and strangers, foes are indeed met with greater social hostility (Study 1). Focusing on the highly competitive environment of youth soccer, we find that rival team members elicit social hostility, whereas teammates elicit social mindfulness (Study 2). We conclude that social mindfulness and social hostility play a subtle role in the dynamics of interpersonal and/or intergroup relationships, in which leaving or limiting choice is one of the subtle ways to express benevolent versus hostile intentions; the SoMi paradigm may thus be helpful in identifying which way the ball rolls.	[Van Doesum, Niels J.; Van Prooijen, Jan-Willem; Van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands; [Verburgh, Lot] Vrije Univ Amsterdam, Dept Clin Neuropsychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Van Doesum, NJ (corresponding author), Vrije Univ Amsterdam, Dept Expt & Appl Psychol, Amsterdam, Netherlands.	n.j.van.doesum@vu.nl		van Prooijen, Jan-Willem/0000-0001-6236-0819; Van Lange, Paul/0000-0001-7774-6984	Netherlands Organization for Scientific Research (NWO) [022.003.040]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	The research was supported in part by the Netherlands Organization for Scientific Research (NWO) Grant 022.003.040, awarded to the Kurt Lewin Institute, with Paul Van Lange (PVL) as the applicant representing the Department of Experimental and Applied Psychology at VU Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2002, ANNU REV PSYCHOL, V53, P27, DOI 10.1146/annurev.psych.53.100901.135231; Arriaga XB, 2015, PERS SOC PSYCHOL B, V41, P1332, DOI 10.1177/0146167215594123; Bandura A, 2006, PERSPECT PSYCHOL SCI, V1, P164, DOI 10.1111/j.1745-6916.2006.00011.x; BAREFOOT JC, 1992, HOSTILITY, COPING & HEALTH, P13, DOI 10.1037/10105-001; Batson CD, 2001, CURR DIR PSYCHOL SCI, V10, P54, DOI 10.1111/1467-8721.00114; Batson CD, 2003, PERS SOC PSYCHOL B, V29, P1190, DOI 10.1177/0146167203254600; Bown NJ, 2003, J BEHAV DECIS MAKING, V16, P297, DOI 10.1002/bdm.447; BREDEMEIER BJ, 1986, J SPORT EXERCISE PSY, V8, P304, DOI 10.1123/jsp.8.4.304; Bushman BJ, 1998, J PERS SOC PSYCHOL, V75, P219, DOI 10.1037/0022-3514.75.1.219; BUSS AH, 1992, J PERS SOC PSYCHOL, V63, P452, DOI 10.1037/0022-3514.63.3.452; BUSS AH, 1957, J CONSULT PSYCHOL, V21, P343, DOI 10.1037/h0046900; CAHOON DD, 1984, B PSYCHONOMIC SOC, V22, P305; Chantal Y, 2005, PSYCHOL SPORT EXERC, V6, P233, DOI 10.1016/j.psychsport.2003.10.010; Chernyak N, 2013, PSYCHOL SCI, V24, P1971, DOI 10.1177/0956797613482335; COSTIN F, 1969, EDUC PSYCHOL MEAS, V29, P461, DOI 10.1177/001316446902900224; Crockett MJ, 2014, P NATL ACAD SCI USA, V111, P17320, DOI 10.1073/pnas.1408988111; Cuddy AJC, 2008, ADV EXP SOC PSYCHOL, V40, P61, DOI 10.1016/S0065-2601(07)00002-0; Cuddy AJC, 2007, J PERS SOC PSYCHOL, V92, P631, DOI 10.1037/0022-3514.92.4.631; Dane S, 2005, PERCEPT MOTOR SKILL, V100, P743, DOI 10.2466/PMS.100.3.743-746; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DeWall CN, 2013, AGGRESSIVE BEHAV, V39, P419, DOI 10.1002/ab.21496; DODGE KA, 1990, SCIENCE, V250, P1678, DOI 10.1126/science.2270481; Dodge KA, 2015, P NATL ACAD SCI USA, V112, P9310, DOI 10.1073/pnas.1418572112; Elias Norbert, 1982, POWER CIVILITY VOL 2, VII; Elson M, 2014, PSYCHOL ASSESSMENT, V26, P419, DOI 10.1037/a0035569; EPSTEIN N, 1974, PERCEPT MOTOR SKILL, V39, P215, DOI 10.2466/pms.1974.39.1.215; Follingstad Diane R, 2005, Violence Vict, V20, P25, DOI 10.1891/088667005780927674; Geers AL, 2013, J PERS SOC PSYCHOL, V105, P549, DOI 10.1037/a0034005; GURTMAN MB, 1992, J PERS SOC PSYCHOL, V62, P989, DOI 10.1037/0022-3514.62.6.989; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harvey J H, 1997, Pers Soc Psychol Rev, V1, P224, DOI 10.1207/s15327957pspr0103_3; Harvey JH, 2006, MINDING CLOSE RELATI; Isberg L., 2000, EMOTIONS SPORT, V1, P13; Leotti LA, 2010, TRENDS COGN SCI, V14, P457, DOI 10.1016/j.tics.2010.08.001; Lewicki RJ, 1998, ACAD MANAGE REV, V23, P438, DOI 10.2307/259288; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; Markova I, 2008, ADV CULT PSYCHOL CON, P1; Messick DM, 1999, J ECON BEHAV ORGAN, V39, P11, DOI 10.1016/S0167-2681(99)00023-2; Murphy RO, 2014, PERS SOC PSYCHOL REV, V18, P13, DOI 10.1177/1088868313501745; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Pierce JR, 2013, PSYCHOL SCI, V24, P1986, DOI 10.1177/0956797613482144; Ritter D, 2005, AGGRESSIVE BEHAV, V31, P407, DOI 10.1002/ab.20066; Sanders E., 2005, NRC HANDELSBLAD; Shaver PR, 2011, HUMAN AGGRESSION VIO, P3; Smith TW, 1994, ANGER HOSTILITY HEAR, P23; Tedeschi James T, 1994, VIOLENCE AGGRESSION; Van Doesum NJ, 2013, J PERS SOC PSYCHOL, V105, P86, DOI 10.1037/a0032540; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Van Lange Paul, 2014, SOCIAL DILEMMAS PSYC; Van Lange PAM, 2007, BASIC APPL SOC PSYCH, V29, P375, DOI 10.1080/01973530701665223; Van Lange PAM, 2015, CURR OPIN BEHAV SCI, V3, P18, DOI 10.1016/j.cobeha.2014.12.009; van Prooijen JW, 2012, PERS SOC PSYCHOL B, V38, P1247, DOI 10.1177/0146167212448826; van Prooijen JW, 2009, J EXP SOC PSYCHOL, V45, P392, DOI 10.1016/j.jesp.2008.10.008; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Weingart LR, 2015, ACAD MANAGE REV, V40, P235, DOI 10.5465/amr.2013-0124; Wilson J, 2000, ANNU REV SOCIOL, V26, P215, DOI 10.1146/annurev.soc.26.1.215	57	12	12	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153577	10.1371/journal.pone.0153577	http://dx.doi.org/10.1371/journal.pone.0153577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27077379	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700083
J	Huang, ZQ; Li, ML; Zhou, YX; Ao, Y; Xin, W; Jia, Y; Yang, Y; Cai, Y; Xu, CC; Yang, YF; Lin, HT				Huang, Zheqian; Li, Miaoling; Zhou, Yuxian; Ao, Yong; Xin, Wei; Jia, Yu; Yang, Ying; Cai, Yu; Xu, Chaochao; Yang, Yangfan; Lin, Haotian			Modified Team-Based Learning in an Ophthalmology Clerkship in China	PLOS ONE			English	Article							MEDICAL GROSS-ANATOMY; CURRICULUM; EXPERIENCE; ATTITUDES; IMPACT; GAIN	Objective Team-based learning (TBL) is an increasingly popular teaching method in medical education. However, TBL hasn't been well-studied in the ophthalmology clerkship context. This study was to examine the impact of modified TBL in such context and to assess the student evaluations of TBL. Methods Ninety-nine students of an 8-year clinical medicine program from Zhongshan Ophthalmic Centre, Sun Yat-sen University, were randomly divided into four sequential units and assigned to six teams with the same faculty. The one-week ophthalmology clerkship module included traditional lectures, gross anatomy and a TBL module. The effects of the TBL module on student performance were measured by the Individual Readiness Assurance Test (IRAT), the Group Readiness Assurance Test (GRAT), the Group Application Problem (GAP) and final examination scores (FESs). Students' evaluations of TBL were measured by a 16-item questionnaire. IRAT and GRAT scores were compared using a paired t-test. One-way analysis of variance (ANOVA) and subgroup analysis compared the effects among quartiles that were stratified by the Basic Ophthalmology Levels (BOLs). The BOLs were evaluated before the ophthalmology clerkship. Results In TBL classes, the GRAT scores were significantly higher than the IRAT scores in both the full example and the BOL-stratified groups. It highlighted the advantages of TBL compared to the individual learning. Quartile-stratified ANOVA comparisons showed significant differences at FES scores (P < 0.01). In terms to IRAT, GRAT and GAP scores, there was no significant result. Moreover, IRAT scores only significantly differed between the first and fourth groups. The FES scores of the first three groups are significantly higher than the fourth group. Gender-specific differences were significant in FES but not the IRAT. Overall, 57.65% of student respondents agreed that TBL was helpful. Male students tended to rate TBL higher than female students. Conclusion The application of modified TBL to the ophthalmology clerkship curriculum improved students' performance and increased students' engagement and satisfaction. TBL should be further optimized and developed to enhance the educational outcomes among multi-BOLs medical students.	[Huang, Zheqian; Li, Miaoling; Zhou, Yuxian; Ao, Yong; Xin, Wei; Jia, Yu; Yang, Ying; Cai, Yu; Xu, Chaochao; Yang, Yangfan; Lin, Haotian] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Yang, YF; Lin, HT (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	Yangyangfan23@126.com; haot.lin@hotmail.com		Yang, Yangfan/0000-0002-0007-6481; Ao, Yingfang/0000-0002-8909-2022; Lin, Haotian/0000-0003-4672-9721	Undergraduate Teaching Reform Research Program of Sun Yat-sen University; Outstanding Young Teacher Cultivation Projects in Guangdong Province [YQ2015006]; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China [2014A030306030]; Youth Science and Technology Innovation Talents Funds in Special Support Plan for High Level Talents in Guangdong Province [2014TQ01R573]; Fundamental Research Funds for the Central Universities [12ykpy61, 2015ykzd11]; Fundamental Research Funds of the State Key Laboratory of Ophthalmology [2015QN01]	Undergraduate Teaching Reform Research Program of Sun Yat-sen University; Outstanding Young Teacher Cultivation Projects in Guangdong Province; Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China; Youth Science and Technology Innovation Talents Funds in Special Support Plan for High Level Talents in Guangdong Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Fundamental Research Funds of the State Key Laboratory of Ophthalmology	This study was supported by the Undergraduate Teaching Reform Research Program of Sun Yat-sen University (2014-33-Haotian Lin, 2015-16-Yong Ao), the Outstanding Young Teacher Cultivation Projects in Guangdong Province(No. YQ2015006), the Guangdong Provincial Natural Science Foundation for Distinguished Young Scholars of China (Grant No. 2014A030306030), Youth Science and Technology Innovation Talents Funds in Special Support Plan for High Level Talents in Guangdong Province (Grant No. 2014TQ01R573), the Cultivation Projects (12ykpy61) and Intensive Cultivation Projects (2015ykzd11) for Young Teaching Staff at Sun Yat-sen University from the Fundamental Research Funds for the Central Universities, and the Fundamental Research Funds of the State Key Laboratory of Ophthalmology (Grant No. 2015QN01). The sponsors of the study played no role in the study protocol design, data collection, data analysis, data interpretation, manuscript preparation, or the decision to submit the manuscript for publication.	Altintas L, 2014, ADV PHYSIOL EDUC, V38, P46, DOI 10.1152/advan.00129.2013; Blanch DC, 2008, PATIENT EDUC COUNS, V72, P374, DOI 10.1016/j.pec.2008.05.021; Blanch-Hartigan D, 2011, PATIENT EDUC COUNS, V84, P3, DOI 10.1016/j.pec.2010.06.037; Bosner S, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0346-x; BOSMAN FT, 1989, J PATHOL, V159, P175, DOI 10.1002/path.1711590214; Chung EK, 2009, MED TEACH, V31, P1013, DOI 10.3109/01421590802590553; Davidson LK, 2011, MED TEACH, V33, P750, DOI 10.3109/0142159X.2011.558948; Emke AR, 2015, MED TEACH, V38, P1; Goldberg HR, 2007, ADV PHYSIOL EDUC, V31, P261, DOI 10.1152/advan.00125.2006; Jelsing EJ, 2007, ANN ACAD MED SINGAP, V36, P713; Koles PG, 2010, ACAD MED, V85, P1739, DOI 10.1097/ACM.0b013e3181f52bed; Levine RE, 2004, TEACH LEARN MED, V16, P270, DOI 10.1207/s15328015tlm1603_9; Levine RE, 2007, ACAD PSYCHIATR, V31, P19, DOI 10.1176/appi.ap.31.1.19; Nieder GL, 2005, CLIN ANAT, V18, P56, DOI 10.1002/ca.20040; Parmelee Dean X, 2009, Med Educ Online, V14, P1, DOI 10.3885/meo.2009.Res00280; Parmelee DX, 2010, MED TEACH, V32, P118, DOI 10.3109/01421590903548562; Pawlina W, 2006, ANN ACAD MED SINGAP, V35, P609; Shellenberger S, 2009, ACAD MED, V84, P340, DOI 10.1097/ACM.0b013e3181972855; Tan NCK, 2011, BMC MED EDUC, V11, DOI 10.1186/1472-6920-11-91; Thompson BM, 2007, MED EDUC, V41, P250, DOI 10.1111/j.1365-2929.2006.02684.x; Vasan NS, 2008, ANAT SCI EDUC, V1, P3, DOI 10.1002/ase.5; Warrier KS, 2013, TEACH LEARN MED, V25, P300, DOI 10.1080/10401334.2013.827975; Wiener H, 2009, CROAT MED J, V50, P69, DOI 10.3325/cmj.2009.50.69; Yang LH, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-98	24	15	16	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154250	10.1371/journal.pone.0154250	http://dx.doi.org/10.1371/journal.pone.0154250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK4OR	27100286	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500172
J	Lee, AH; Fidock, DA				Lee, Andrew H.; Fidock, David A.			Evidence of a Mild Mutator Phenotype in Cambodian Plasmodium falciparum Malaria Parasites	PLOS ONE			English	Article							CATION ATPASE PFATP4; DRUG-RESISTANCE; SACCHAROMYCES-CEREVISIAE; SPIROINDOLONE KAE609; WEAK MUTATORS; MUTATIONS; FREQUENCIES; EVOLUTION; ANTIMALARIALS; SENSITIVITY	Malaria control efforts have been continuously stymied by drug-resistant strains of Plasmodium falciparum, which typically originate in Southeast Asia prior to spreading into high-transmission settings in Africa. One earlier proposed explanation for Southeast Asia being a hotbed of resistance has been the hypermutability or "Accelerated Resistance to Multiple Drugs" (ARMD) phenotype, whereby multidrug-resistant Southeast Asian parasites were reported to exhibit 1,000-fold higher rates of resistance to unrelated antimalarial agents when compared to drug-sensitive parasites. However, three recent studies do not recapitulate this hypermutability phenotype. Intriguingly, genome sequencing of recently derived multidrug-resistant Cambodian isolates has identified a high proportion of DNA repair gene mutations in multidrug-resistant parasites, suggesting their potential role in shaping local parasite evolution. By adapting fluctuation assays for use in P. falciparum, we have examined the in vitro mutation rates of five recent Cambodian isolates and three reference laboratory strains. For these studies we also generated a knockout parasite line lacking the DNA repair factor Exonuclease I. In these assays, parasites were typed for their ability to acquire resistance to KAE609, currently in advanced clinical trials, yielding 13 novel mutations in the Na+/H+-ATPase PfATP4, the primary resistance determinant. We observed no evidence of hypermutability. Instead, we found evidence of a mild mutator (up to a 3.4-fold increase in mutation rate) phenotype in two artemisinin-resistant Cambodian isolates, which carry DNA repair gene mutations. We observed that one such mutation in the Mismatch Repair protein Mlh1 contributes to the mild mutator phenotype when modeled in yeast (scmlh1-P157S). Compared to basal rates of mutation, a mild mutator phenotype may provide a greater overall benefit for parasites in Southeast Asia in terms of generating drug resistance without incurring detrimental fitness costs.	[Lee, Andrew H.; Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, New York, NY USA; [Fidock, David A.] Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA	Columbia University; Columbia University	Fidock, DA (corresponding author), Columbia Univ, Dept Microbiol & Immunol, New York, NY USA.; Fidock, DA (corresponding author), Columbia Univ, Dept Med, Div Infect Dis, New York, NY USA.	df2260@cumc.columbia.edu		Fidock, David/0000-0001-6753-8938	National Institutes of Health [R01 AI109023, R01 AI50234, T32 AI106711]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050234, R37AI050234, T32AI106711, R01AI109023] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (https://www.nih.gov/) R01 AI109023, R01 AI50234, T32 AI106711 to DAF. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaratunga C, 2012, LANCET INFECT DIS, V12, P851, DOI 10.1016/S1473-3099(12)70181-0; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baquero MR, 2004, J BACTERIOL, V186, P5538, DOI 10.1128/JB.186.16.5538-5542.2004; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Boiteux S, 2013, GENETICS, V193, P1025, DOI 10.1534/genetics.112.145219; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Brown TS, 2015, INFECT GENET EVOL, V30, P318, DOI 10.1016/j.meegid.2014.12.010; Claessens A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004812; Demogines A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000103; Denamur E, 2006, MOL MICROBIOL, V60, P820, DOI 10.1111/j.1365-2958.2006.05150.x; Denamur E, 2005, GENETICS, V171, P825, DOI 10.1534/genetics.105.045526; Diagana TT, 2015, DRUG DISCOV TODAY, V20, P1265, DOI 10.1016/j.drudis.2015.06.009; Dondorp Arjen M, 2011, N Engl J Med, V365, P1073, DOI 10.1056/NEJMp1108322; Ekland EH, 2011, FASEB J, V25, P3583, DOI 10.1096/fj.11-187401; Fidock DA, 1998, MOL PHARMACOL, V54, P1140, DOI 10.1124/mol.54.6.1140; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Gabryszewski SJ, 2016, MOL BIOL EVOL IN PRE; Goodyer ID, 1997, EXP PARASITOL, V86, P158, DOI 10.1006/expr.1997.4156; Greene CN, 2001, GENETICS, V159, P65; Gueneau E, 2013, NAT STRUCT MOL BIOL, V20, P461, DOI 10.1038/nsmb.2511; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Lehane AM, 2014, MOL MICROBIOL, V94, P327, DOI 10.1111/mmi.12765; Leong FJ, 2014, ANTIMICROB AGENTS CH, V58, P6209, DOI 10.1128/AAC.03393-14; Luria SE, 1943, GENETICS, V28, P491; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; Orlen H, 2006, ANTIMICROB AGENTS CH, V50, P3454, DOI 10.1128/AAC.00783-06; Rathod PK, 1997, P NATL ACAD SCI USA, V94, P9389, DOI 10.1073/pnas.94.17.9389; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Sa JM, 2011, ESSAYS BIOCHEM, V51, P137, DOI [10.1042/BSE0510137, 10.1042/bse0510137]; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Sokolsky T, 2000, GENETICS, V155, P589; Spillman NJ, 2013, CELL HOST MICROBE, V13, P227, DOI 10.1016/j.chom.2012.12.006; Spillman NJ, 2015, INT J PARASITOL-DRUG, V5, P149, DOI 10.1016/j.ijpddr.2015.07.001; Srivastava IK, 1999, MOL MICROBIOL, V33, P704, DOI 10.1046/j.1365-2958.1999.01515.x; Straimer J, 2015, SCIENCE, V347, P428, DOI 10.1126/science.1260867; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; Takala-Harrison S, 2015, ANN NY ACAD SCI, V1342, P62, DOI 10.1111/nyas.12766; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4; Vaidya AB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6521; Venkatesan M, 2013, TRENDS PARASITOL, V29, P497, DOI 10.1016/j.pt.2013.07.008; Vinayak S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000830; Wang TF, 1999, P NATL ACAD SCI USA, V96, P13914, DOI 10.1073/pnas.96.24.13914; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; WHO, 2012, GLOB PLAN INSECTICID; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yuthavong Y, 2012, P NATL ACAD SCI USA, V109, P16823, DOI 10.1073/pnas.1204556109; Zakharyevich K, 2012, CELL, V149, P334, DOI 10.1016/j.cell.2012.03.023	58	26	26	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154166	10.1371/journal.pone.0154166	http://dx.doi.org/10.1371/journal.pone.0154166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100094	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500158
J	Marzolf, G; Sabou, M; Lannes, B; Cotton, F; Meyronet, D; Galanaud, D; Cottier, JP; Grand, S; Desal, H; Kreutz, J; Schenck, M; Meyer, N; Schneider, F; Dietemann, JL; Koob, M; Herbrecht, R; Kremer, S				Marzolf, Guillaume; Sabou, Marcela; Lannes, Beatrice; Cotton, Francois; Meyronet, David; Galanaud, Damien; Cottier, Jean-Philippe; Grand, Sylvie; Desal, Hubert; Kreutz, Julie; Schenck, Maleka; Meyer, Nicolas; Schneider, Francis; Dietemann, Jean-Louis; Koob, Meriam; Herbrecht, Raoul; Kremer, Stephane			Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; BONE-MARROW-TRANSPLANTATION; INVASIVE ASPERGILLOSIS; FUNGAL-INFECTIONS; INTRACRANIAL ASPERGILLOSIS; IMMUNOCOMPROMISED PATIENTS; BRAIN ASPERGILLOSIS; MYCOTIC-ANEURYSM; ACUTE-LEUKEMIA; MR	Cerebral aspergillosis is associated with a significant morbidity and mortality rate. The imaging data present different patterns and no full consensus exists on typical imaging characteristics of the cerebral lesions. We reviewed MRI findings in 21 patients with cerebral aspergillosis and correlated them to the immune status of the patients and to neuropathological findings when tissue was available. The lesions were characterized by their number, topography, and MRI signal. Dissemination to the brain resulted from direct spread from paranasal sinuses in 8 patients, 6 of them being immunocompetent. Hematogenous dissemination was observed in 13 patients, all were immunosuppressed. In this later group we identified a total of 329 parenchymal abscesses involving the whole brain with a predilection for the corticomedullary junction. More than half the patients had a corpus callosum lesion. Hemorrhagic lesions accounted for 13% and contrast enhancement was observed in 61% of the lesions. Patients with hematogenous dissemination were younger (p = 0.003), had more intracranial lesions (p = 0.0004) and had a higher 12-week mortality rate (p = 0.046) than patients with direct spread from paranasal sinuses. Analysis of 12 aneurysms allowed us to highlight two distinct situations. In case of direct spread from the paranasal sinuses, aneurysms are saccular and located on the proximal artery portions, while the hematogenous dissemination in immunocompromised patients is more frequently associated with distal and fusiform aneurysms. MRI is the exam of choice for cerebral aspergillosis. Number and type of lesions are different according to the mode of dissemination of the infection.	[Marzolf, Guillaume; Dietemann, Jean-Louis; Koob, Meriam; Kremer, Stephane] Hop Univ Strasbourg, Dept Neuroradiol, Strasbourg, France; [Sabou, Marcela] Hop Univ Strasbourg, Lab Parasitol & Mycol Med, Strasbourg, France; [Lannes, Beatrice] Hop Univ Strasbourg, Serv Pathol, Strasbourg, France; [Cotton, Francois] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Neuroradiol, Lyon, France; [Meyronet, David] Hosp Civils Lyon, Dept Neuropathol, Lyon, France; [Galanaud, Damien] Hop Paris, Hop La Pitie Salpetriere, Dept Neuroradiol, Paris, France; [Cottier, Jean-Philippe] CHU Tours, Dept Neuroradiol, Tours, France; [Grand, Sylvie] CHU Grenoble, Dept Neuroradiol, F-38043 Grenoble, France; [Desal, Hubert] CHU Nantes, Hop Nord Laennec, Dept Neuroradiol, F-44035 Nantes 01, France; [Kreutz, Julie] Ctr Hosp Univ Liege, Dept Radiol, Liege, Belgium; [Schenck, Maleka; Schneider, Francis] Hop Univ Strasbourg, Serv Reanimat Med, Strasbourg, France; [Meyer, Nicolas] Fac Med Strasbourg, Lab Biostat, Strasbourg, France; [Herbrecht, Raoul] Hop Univ Strasbourg, Dept Hematol & Oncol, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Lyon; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Tours; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Nantes Universite; CHU de Nantes; University of Liege; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Marzolf, G (corresponding author), Hop Univ Strasbourg, Dept Neuroradiol, Strasbourg, France.	guillaume.marzolf@chru-strasbourg.fr	Cottier, Jean-Philippe/AAZ-6005-2021; Herbrecht, Raoul/AAT-1763-2021; cotton, francois/F-4762-2013; Herbrecht, Raoul/GVU-1333-2022; Desal, Hubert/T-2089-2019	Herbrecht, Raoul/0000-0002-9381-4876; cotton, francois/0000-0003-0046-2478; Cottier, Jean-Philippe/0000-0001-9166-212X	Pfizer; Basilea; Gilead; Merck; Schering-Plough	Pfizer(Pfizer); Basilea; Gilead(Gilead Sciences); Merck(Merck & Company); Schering-Plough(Merck & CompanySchering Plough Corporation)	Raoul Herbrecht, M.D., PhD, holds a consultancy with Pfizer including a grant from Pfizer; payment for lectures at Basilea, Gilead, Merck, Schering-Plough; travel/accomodation/meetings at Gilead, Pfizer, Merck. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ADLER CH, 1989, MOVEMENT DISORD, V4, P333, DOI 10.1002/mds.870040407; Almutairi BM, 2009, RADIOGRAPHICS, V29, P375, DOI 10.1148/rg.292075143; ASHDOWN BC, 1994, AM J ROENTGENOL, V162, P155, DOI 10.2214/ajr.162.1.8273655; Boes B, 1994, J Neuroimaging, V4, P123; Charlot M, 2007, EUR J NEUROL, V14, P912, DOI 10.1111/j.1468-1331.2007.01874.x; COX J, 1992, AM J NEURORADIOL, V13, P1489; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; DeLone DR, 1999, AM J NEURORADIOL, V20, P1597; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dietrich U, 2001, EUR RADIOL, V11, P1242, DOI 10.1007/s003300000756; Finelli PF, 2014, NEURORADIOL J, V27, P280, DOI 10.15274/NRJ-2014-10036; Gabelmann A, 2007, EUR J NEUROL, V14, P548, DOI 10.1111/j.1468-1331.2007.01755.x; Gaviani P, 2005, AM J NEURORADIOL, V26, P1115; Guermazi A, 2003, EUR RADIOL, V13, P377, DOI 10.1007/s00330-002-1480-5; Harris DE, 1997, NEUROIMAG CLIN N AM, V7, P187; Herbrecht R, 2002, NEW ENGL J MED, V347, P408, DOI 10.1056/NEJMoa020191; Hirschi S, 2012, J CLIN MICROBIOL, V50, P4168, DOI 10.1128/JCM.01928-12; Hurst RW, 2001, AM J NEURORADIOL, V22, P858; Kami M, 1999, INTERNAL MED, V38, P45, DOI 10.2169/internalmedicine.38.45; Kornienko VN., 2008, DIAGNOSTIC NEURORADI; Lee GJ, 2013, J KOREAN NEUROSURG S, V53, P312, DOI 10.3340/jkns.2013.53.5.312; MIAUX Y, 1995, AM J NEURORADIOL, V16, P555; Negoro E, 2013, INT J HEMATOL, V98, P4, DOI 10.1007/s12185-013-1369-x; Okafuji T, 2003, COMPUT MED IMAG GRAP, V27, P489, DOI 10.1016/S0895-6111(03)00033-8; Osborn AG., 1999, DIAGNOSTIC CEREBRAL, V2nd ed; Pagano L, 1996, CLIN INFECT DIS, V23, P628, DOI 10.1093/clinids/23.3.628; Pollack E, 2007, J NEUROIMAGING, V17, P361, DOI 10.1111/j.1552-6569.2007.00105.x; Schwartz S, 2005, BLOOD, V106, P2641, DOI 10.1182/blood-2005-02-0733; SPARANO JA, 1992, J NEURO-ONCOL, V13, P91; Starkey J, 2014, CLIN NEURORADIOL, V24, P217, DOI 10.1007/s00062-014-0305-7; Tempkin AD, 2006, RADIOGRAPHICS, V26, P1239, DOI 10.1148/rg.264055152; Yamada K, 2002, ACAD RADIOL, V9, P163, DOI 10.1016/S1076-6332(03)80166-6; YOUNG RC, 1970, MEDICINE, V49, P147, DOI 10.1097/00005792-197003000-00002; ZINREICH SJ, 1988, RADIOLOGY, V169, P439, DOI 10.1148/radiology.169.2.3174990	34	44	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152475	10.1371/journal.pone.0152475	http://dx.doi.org/10.1371/journal.pone.0152475			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097323	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600013
J	Oh, IH; Choi, EY; Park, JS; Lee, CH				Oh, Il Hwan; Choi, Eun Young; Park, Joon-Sung; Lee, Chang Hwa			Association of Serum Ferritin and Kidney Function with Age-Related Macular Degeneration in the General Population	PLOS ONE			English	Article							METABOLIC SYNDROME; RISK-FACTORS; IRON; PATHOGENESIS; DISEASE; HEALTH	Ferritin is considered to be a marker of the body's iron stores and has a potential relationship with the systemic manifestations of inflammatory reactions. Data on the association between increased levels of serum ferritin and ocular problems are limited, particularly in relation to age-related macular degeneration (AMD). Serum ferritin levels, as a possible clinical parameter for predicting AMD, were analyzed in anthropometric, biochemical, and ophthalmologic data from a nation-wide, population-based, case-control study (KNHNES IV and V). All native Koreans aged >= 20 years and who had no medical illness were eligible to participate. Among them, 2.9% had AMD, and its prevalence was found to increase in the higher ferritin quintile groups (P-trend < 0.0001). In multiple linear regression analysis, serum ferritin level was closely related to conventional risk factors for AMD. Comparison of early AMD with a control group showed that serum ferritin levels were closely associated with AMD (OR = 1.004, 95% CI = 1.002-1.006), and further adjustment for age, gender, serum iron, and kidney function did not reduce this association (OR = 1.003, 95% CI = 1.001-1.006). Furthermore, the relationship between ferritin quintile and early AMD was dose-dependent. Thus, an increased level of serum ferritin in a healthy person may be a useful indicator of neurodegenerative change in the macula. A large population-based prospective clinical study is needed to confirm these findings.	[Oh, Il Hwan; Choi, Eun Young; Park, Joon-Sung; Lee, Chang Hwa] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea	Hanyang University	Park, JS; Lee, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea.	sjpjoon@hanyang.ac.kr; changhwa@hanyang.ac.kr						Aoki A, 2015, INVEST OPHTH VIS SCI, V56, P2580, DOI 10.1167/iovs.14-16339; Batista-Nascimento L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/128647; Cho E, 2001, AM J CLIN NUTR, V73, P209; Friedman A, 2011, PARKINSONISM RELAT D, V17, P423, DOI 10.1016/j.parkreldis.2011.03.016; Friedman E, 2000, AM J OPHTHALMOL, V130, P658, DOI 10.1016/S0002-9394(00)00643-7; Gao JY, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/690243; Ghosh A, 2007, EUR J CLIN NUTR, V61, P412, DOI 10.1038/sj.ejcn.1602534; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Jehn M, 2004, DIABETES CARE, V27, P2422, DOI 10.2337/diacare.27.10.2422; Kauppinen A, 2012, IMMUNOL LETT, V147, P29, DOI 10.1016/j.imlet.2012.05.005; Kell DB, 2014, METALLOMICS, V6, P748, DOI 10.1039/c3mt00347g; Kim EC, 2014, INVEST OPHTH VIS SCI, V55, P4823, DOI 10.1167/iovs.14-14763; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; Krenn MA, 2015, FREE RADICAL BIO MED, V80, P48, DOI 10.1016/j.freeradbiomed.2014.12.007; Lederman M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087751; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin SC, 2014, JAMA OPHTHALMOL, V132, P1414, DOI 10.1001/jamaophthalmol.2014.2876; Loh A, 2009, BBA-GEN SUBJECTS, V1790, P637, DOI 10.1016/j.bbagen.2008.11.001; Mainous AG, 2004, AM J CARDIOL, V93, P559, DOI 10.1016/j.amjcard.2003.11.018; Maralani HG, 2015, RETINA-J RET VIT DIS, V35, P459, DOI 10.1097/IAE.0000000000000338; Moore C, 2013, JCR-J CLIN RHEUMATOL, V19, P324, DOI 10.1097/RHU.0b013e31829ce01f; Nowak JZ, 2006, PHARMACOL REP, V58, P353; Park SJ, 2014, OPHTHALMOLOGY, V121, P1756, DOI 10.1016/j.ophtha.2014.03.022; Peeters A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1554, DOI 10.1001/archopht.126.11.1554; Richer Stuart, 2002, Am J Ther, V9, P25, DOI 10.1097/00045391-200201000-00006; Schipper HM, 2012, BBA-MOL BASIS DIS, V1822, P350, DOI 10.1016/j.bbadis.2011.06.016; Smith W, 1998, ARCH OPHTHALMOL-CHIC, V116, P583, DOI 10.1001/archopht.116.5.583; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159	30	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153624	10.1371/journal.pone.0153624	http://dx.doi.org/10.1371/journal.pone.0153624			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096155	gold, Green Published			2022-12-27	WOS:000374543600046
J	Cheung, KW; Peng, QL; He, LF; Cai, KR; Jiang, Q; Zhou, BP; To, SWC; Yam, WC; Liu, L; Chen, ZW; Wang, H				Cheung, Ka-Wai; Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; To, Sabrina Wai-Chi; Yam, Wing-Cheong; Liu, Li; Chen, Zhiwei; Wang, Hui			Rapid and Simultaneous Detection of Major Drug Resistance Mutations in Reverse Transcriptase Gene for HIV-1 CRF01_AE, CRF07_BC and Subtype B in China Using Sequenom MassARRAY (R) System	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; ANTIRETROVIRAL THERAPY; GENOTYPING ASSAY; PREVALENCE; IDENTIFICATION; MORTALITY; VARIANTS; PROTEASE	`The development of a rapid, high -throughput and cost-effective HIV-1 drug resistance (HIV DR) testing system is a challenge for areas consisting different HIV-1 strains. In this study, we established a broadly reactive multiplex assay that could simultaneously detect major drug resistance mutations at 8 loci, which are associated with resistance to commonly used nucleoside reverse transcriptase inhibitors (NRTIs) and Non -nucleoside reverse transcriptase inhibitors (NNRTIs), in specimens of HIV-1 CRF01_AE, CRF07_BC and subtype B, the three major circulating strains in China, using the matrix -assisted laser desorption ionization -time of flight mass spectrometry (MALDI-TOF MS) provided by Sequenom MassARRAY system. To establish the assay, pol gene fragments were prepared from the plasma viral RNA of 159 patients by nested PCR and the presence of wild type and mutant alleles at the 8 loci were analyzed by MALDI-TOF MS. In terms of loci, the detection rate of the alleles was greater than 97% for M41L, K65R, M184V and G190A, 91.2% for K101E/Q/P, 91.2% for T215FN, 89.9% for K103N/S and 80.5% for L210W. In terms of individuals, 80% of the alleles were detected in 95.4% CRF01_AE patients, 100% CRF07_BC patients and 83.3% subtype B patients. Importantly, the MALDI-TOF MS results were concordant to the drug resistance profiles of patients obtained from conventional sequencing analysis after excluded the failed detections. Using plasmid templates, the assay was estimated to be sensitive to detect drug resistant variants at level about 20% of the circulating viral population. The capability of this assay to detect mixed viral populations was further verified by two different patient specimens. In conclusion, this study evaluated the use of Sequenom MassARRAY (R) system for high-throughput detection of HIV-DR mutations towards the commonly used reverse transcriptase inhibitors in China.	[Cheung, Ka-Wai; Liu, Li; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Cheung, Ka-Wai; Liu, Li; Chen, Zhiwei] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, HKU AIDS Inst Shenzhen Res Lab, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, AIDS Clin Res Lab, Shenzhen Peoples Hosp 3, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China; [Peng, Qiaoli; He, Liufen; Cai, Kanru; Jiang, Qiang; Zhou, Boping; Wang, Hui] Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China; [To, Sabrina Wai-Chi; Yam, Wing-Cheong] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; University of Hong Kong	Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, AIDS Inst, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Chen, ZW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Infect & Immun, Dept Microbiol, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, HKU AIDS Inst Shenzhen Res Lab, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, AIDS Clin Res Lab, Shenzhen Peoples Hosp 3, Guangdong Key Lab Emerging Infect Dis, Shenzhen, Peoples R China.; Wang, H (corresponding author), Guangdong Med Coll, Shenzhen Key Lab Infect & Immun, Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China.	zchenai@hku.hk; huiwang98@yahoo.com	Liu, Li/ABA-8315-2020; Chen, Zhiwei/B-7793-2019	Liu, Li/0000-0003-2566-7357; Chen, Zhiwei/0000-0002-4511-2888	Hong Kong AIDS Trust Fund [MSS183R, MSS227R]; Science and Technology key projects [201001010]; University Development Fund (HKU-UDF); Li Ka Shing Faculty of Medicine Matching Fund; Shenzhen San-Ming Program	Hong Kong AIDS Trust Fund; Science and Technology key projects; University Development Fund (HKU-UDF); Li Ka Shing Faculty of Medicine Matching Fund; Shenzhen San-Ming Program	This work was supported by Hong Kong AIDS Trust Fund (MSS183R) to ZC (www.atf.gov.hk) and Science and Technology key projects (201001010) to HW. The authors thank the University Development Fund (HKU-UDF) and Li Ka Shing Faculty of Medicine Matching Fund (www.hku.hk) for financial supports to AIDS Institute. The authors also thank for the support of Hong Kong AIDS Trust Fund (MSS227R) to ZC and Shenzhen San-Ming Program to HW. KWC, supported by the fellowship from MSS183R and MSS227R, played a role in study design, data collection and analysis as well as preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MANUAL NATL FREE ANT; Bouakaze C, 2011, J CLIN MICROBIOL, V49, P3292, DOI 10.1128/JCM.00744-11; Cao YZ, 2005, CELL RES, V15, P883, DOI 10.1038/sj.cr.7290363; Chinese Center for Disease Control and Prevention, 2012, AN HIV STD EP 2012; Dudley DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036494; Eshleman SH, 2005, J CLIN MICROBIOL, V43, P813, DOI 10.1128/JCM.43.2.813-817.2005; Grant RM, 2003, J CLIN MICROBIOL, V41, P1586, DOI 10.1128/JCM.41.4.1586-1593.2003; He X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047289; Hong SP, 2008, NAT PROTOC, V3, P1476, DOI 10.1038/nprot.2008.136; Lee JH, 2013, CLIN MICROBIOL INFEC, V19, pE263, DOI 10.1111/1469-0691.12167; Liao LJ, 2013, AIDS, V27, P1815, DOI 10.1097/QAD.0b013e3283611931; Liao LJ, 2012, CLIN INFECT DIS, V54, pS320, DOI 10.1093/cid/cir1016; Luan J, 2009, CLIN CHEM, V55, P1503, DOI 10.1373/clinchem.2009.124859; Luo MQ, 2009, JAIDS-J ACQ IMM DEF, V50, P1, DOI 10.1097/QAI.0b013e31818ffcdc; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; Russell JS, 2009, COMMUN DIS INTELL, V33, P216; Rybicka M, 2014, J CLIN MICROBIOL, V52, P9, DOI 10.1128/JCM.01891-13; Schuurman R, 1999, J CLIN MICROBIOL, V37, P2291, DOI 10.1128/JCM.37.7.2291-2296.1999; Shafer RW, 2009, J INFECT DIS, V199, P610, DOI 10.1086/596737; Stenman J, 2003, BIOTECHNIQUES, V34, P172, DOI 10.2144/03341dd05; Thompson MA, 2012, JAMA-J AM MED ASSOC, V308, P387, DOI 10.1001/jama.2012.7961; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Wang CL, 2007, GENOME RES, V17, P1195, DOI 10.1101/gr.6468307; Wang X, 2012, AIDS RES HUM RETROV, V28, P1637, DOI [10.1089/aid.2012.0164, 10.1089/AID.2012.0164]; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062408; Xing H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054917; Yang CF, 2010, J CLIN MICROBIOL, V48, P3158, DOI 10.1128/JCM.00564-10; Zhang FJ, 2008, CLIN INFECT DIS, V47, P825, DOI 10.1086/590945; Zhang F, 2007, JAIDS-J ACQ IMM DEF, V44, P429, DOI 10.1097/QAI.0b013e31803133ac; Zhang FJ, 2011, LANCET INFECT DIS, V11, P516, DOI 10.1016/S1473-3099(11)70097-4; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006; Zhang GQ, 2013, J CLIN MICROBIOL, V51, P3666, DOI 10.1128/JCM.01669-13; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443; Zhou ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028184	36	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153641	10.1371/journal.pone.0153641	http://dx.doi.org/10.1371/journal.pone.0153641			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092551	Green Published, gold, Green Submitted			2022-12-27	WOS:000374541200036
J	Hao, Q; Du, PC; Zhang, W; Hou, XX; Zhang, L; Zhang, YY; Liu, HX; Liu, W; Chen, C; Wan, KL				Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin			Genomic Characteristics of Chinese Borrelia burgdorferi Isolates	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; LYME-DISEASE SPIROCHETE; SENSU-LATO; SP NOV.; IDENTIFICATION	In China, B. burgdorferi, B. garinii, B. afzelii and B. yangtze sp. nov have been reported; B. garinii and B. afzelii are the main pathogenic genotypes. But until now only one Chinese strain was reported with whole genome sequence. In order to further understand the genomic characteristics and diversity of Chinese Borrelia strains, 5 isolates from China were sequenced and compared with the whole genome sequences of strains in other areas. The results showed a high degree of conservation within the linear chromosome of Chinese strains, whereas plasmid showed a much larger diversity according to the majority genomic information of plasmids. The genome sequences of the five Chinese strains were compared with the corresponding reference strains, respectively, according to the genospecies. Pair-wise analysis demonstrates that there are only 70 SNPs between the genomes of CS4 and B31. However, there are many more SNPs between the genomes of QX-S13 and VS116, PD91 and PBi, FP1 and PKo, R9 and Pko, respectively. Gene comparison showed some important different genes. OspA was one of the important different genes. Comparative genomic studies have found that OspA gene sequences of PD91 and R9 had great differences compared with the sequence of B31. OspA gene sequence of R9 had a 96bp deletion; OspA gene of PD91 had two deletions: 9bp and 10 bp. To conclude, we showed the genomic characteristics of four genotype Chinese B. burgdorferi strains. The genomic sequence of B. yangtze sp. nov and differences from B. valaisiana were first reported. Comparative analysis of Chinese strains with the different Borrelia species from other areas will help us to understand evolution and pathogenesis of Chinese Borrelia burgdorferi strains.	[Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin] Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China; [Hao, Qin; Du, Pengcheng; Zhang, Wen; Hou, Xuexia; Zhang, Lin; Zhang, Yuanyuan; Liu, Huixin; Liu, Wei; Chen, Chen; Wan, Kanglin] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Chen, C; Wan, KL (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing 102206, Peoples R China.; Chen, C; Wan, KL (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310003, Zhejiang, Peoples R China.	chenchen@celloud.cn; wankanglin@icdc.cn	chen, chen/AAQ-1805-2021; CHEN, CHEN/HDM-6657-2022	chen, chen/0000-0003-1765-8899; Du, Pengcheng/0000-0002-2930-9920	Natural Science foundation [31100105]; National Key Science and Technology Projects of China [2013ZX10004-215, 2013ZX10004001]	Natural Science foundation(National Natural Science Foundation of China (NSFC)); National Key Science and Technology Projects of China	This study was funded by Natural Science foundation ( Grant No. 31100105) and National Key Science and Technology Projects of China (2013ZX10004-215 and 2013ZX10004001).	Casjens S, 2000, MOL MICROBIOL, V35, P490, DOI 10.1046/j.1365-2958.2000.01698.x; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; Casjens SR, 2011, J BACTERIOL, V193, P1489, DOI 10.1128/JB.01521-10; Chu CY, 2008, J CLIN MICROBIOL, V46, P3130, DOI 10.1128/JCM.01195-08; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Fukunaga M, 1996, INT J SYST BACTERIOL, V46, P898, DOI 10.1099/00207713-46-4-898; Glockner G, 2004, NUCLEIC ACIDS RES, V32, P6038, DOI 10.1093/nar/gkh953; Glockner G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-211; Hao Q, 2011, J CLIN MICROBIOL, V49, P647, DOI 10.1128/JCM.00725-10; Huang WM, 2004, J BACTERIOL, V186, P4134, DOI 10.1128/JB.186.13.4134-4141.2004; Jiang BG, 2012, J BACTERIOL, V194, P6660, DOI 10.1128/JB.01844-12; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Masuzawa T, 2001, INT J SYST EVOL MICR, V51, P1817, DOI 10.1099/00207713-51-5-1817; Nau R, 2009, DTSCH ARZTEBL INT, V106, P72, DOI 10.3238/arztebl.2009.0072; Pavan WO, 2009, INT J MED SCI, V6, P123; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Rudenko N, 2009, J CLIN MICROBIOL, V47, P134, DOI 10.1128/JCM.01183-08; Schutzer SE, 2011, J BACTERIOL, V193, P1018, DOI 10.1128/JB.01158-10; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; WILSKE B, 1992, RES MICROBIOL, V143, P583, DOI 10.1016/0923-2508(92)90116-6; Zhang Z F, 1997, Zhonghua Liu Xing Bing Xue Za Zhi, V18, P8	26	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153149	10.1371/journal.pone.0153149	http://dx.doi.org/10.1371/journal.pone.0153149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093540	gold, Green Published, Green Submitted			2022-12-27	WOS:000374541200013
J	White, PA; Ikanda, D; Ferrante, L; Chardonnet, P; Mesochina, P; Cameriere, R				White, Paula A.; Ikanda, Dennis; Ferrante, Luigi; Chardonnet, Philippe; Mesochina, Pascal; Cameriere, Roberto			Age Estimation of African Lions Panthera leo by Ratio of Tooth Areas	PLOS ONE			English	Article							POPULATION-DYNAMICS; CANINES; SAMPLE	Improved age estimation of African lions Panthera leo is needed to address a number of pressing conservation issues. Here we present a formula for estimating lion age to within six months of known age based on measuring the extent of pulp closure from X-rays, or Ratio Of tooth AReas (ROAR). Derived from measurements taken from lions aged 3-13 years for which exact ages were known, the formula explains 92% of the total variance. The method of calculating the pulp/ tooth area ratio, which has been used extensively in forensic science, is novel in the study of lion aging. As a quantifiable measure, ROAR offers improved lion age estimates for population modeling and investigations of age-related mortality, and may assist national and international wildlife authorities in judging compliance with regulatory measures involving age.	[White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA; [Ikanda, Dennis] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Ferrante, Luigi] Polytech Univ Marche, Ctr Epidemiol Biostat & Med Informat Technol, Dept Biomed Sci & Publ Hlth, Ancona, Italy; [Chardonnet, Philippe; Mesochina, Pascal] IGF Int Fdn Wildlife Management, Paris, France; [Cameriere, Roberto] Univ Macerata, Inst Legal Med, AgEstimat Project, Macerata, Italy	University of California System; University of California Los Angeles; Marche Polytechnic University; University of Macerata	White, PA (corresponding author), Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA.	paw@carnivoreconservation.com		FERRANTE, LUIGI/0000-0001-9444-972X; White, Paula/0000-0002-1814-6265; cameriere, roberto/0000-0002-3775-2244	Safari Club International Foundation; IGF-Foundation	Safari Club International Foundation; IGF-Foundation	Field research was funded in part by Safari Club International Foundation (PAW, DI) and IGF-Foundation (DI, PC, PM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adobe Systems Incorporated, 2015, AD PHOT CS4 V 11 0 1; Angerbjorn A, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P163; Baldus RD, 2004, TOURIST HUNTING ITS; Barthold JA, 2016, J APPL ECOL, V53, P295, DOI 10.1111/1365-2664.12594; Cameriere R, 2009, FORENSIC SCI INT, V193, DOI 10.1016/j.forsciint.2009.09.011; Cameriere R, 2012, FORENSIC SCI INT, V214, P105, DOI 10.1016/j.forsciint.2011.07.028; Cameriere R, 2007, J FORENSIC SCI, V52, P166, DOI 10.1111/j.1556-4029.2006.00336.x; Cheater A., 2006, USE UPPER 2 PREMOLAR; Conover M., 2002, RESOLVING HUMAN WILD; Creel S, 2004, BIOLOGY AND CONSERVATION OF WILD CANIDS, P337; De Luca S, 2011, J FORENSIC SCI, V56, P1302, DOI 10.1111/j.1556-4029.2011.01784.x; Delahay RJ, 2011, J ZOOL, V284, P183, DOI 10.1111/j.1469-7998.2011.00796.x; Efron B., 1982, CBMS NSF REGIONAL C; European Commission. Commission Regulation (EU), 2015, OFFICIAL J EUROPEAN; Fabbri PF, 2015, AM J PHYS ANTHROPOL, V158, P423, DOI 10.1002/ajpa.22796; Foresman KR, 2012, TECH ECOL CONSERVAT, P130; Frank LG, 2005, CONSERV BIOL SER, V9, P286; Groom RJ, 2014, ORYX, V48, P385, DOI 10.1017/S0030605312001457; Klevezal G.A., 1967, TRANSLATION SERIES, V1024; Lindsey PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073808; Lindsey PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029332; Loveridge AJ, 2007, BIOL CONSERV, V134, P548, DOI 10.1016/j.biocon.2006.09.010; Matson G.M., 1981, WORKBOOK CEMENTUM AN; MORRIS P, 1972, Mammal Review, V2, P69, DOI 10.1111/j.1365-2907.1972.tb00160.x; Niassa Carnivore Project, 2014, ANN REPORT; Packer C, 2005, SCIENCE, V307, P390, DOI 10.1126/science.1105122; Packer C, 2011, CONSERV BIOL, V25, P142, DOI 10.1111/j.1523-1739.2010.01576.x; PENNYCUICK CJ, 1970, J ZOOL, V160, P497; R Development Core Team, R A LANG ENV STAT CO; Schaller G. B., 1972, SERENGETI LION STUDY; Skalski J.R., 2005, WILDLIFE DEMOGRAPHY; SMUTS GL, 1978, J ZOOL, V185, P115, DOI 10.1111/j.1469-7998.1978.tb03317.x; SPINAGE C A, 1973, East African Wildlife Journal, V11, P165; Tanzania Wildlife Division, 2012, COMM ESA STAT REV AF; USFWS, 2015, FED REGISTER, V80, P80000; USFWS, 2000, FACTS FED WILDL LAWS; White PA, 2007, AFRICAN INDABA, V5, P12; White PA, WILDL BIOL IN PRESS; White PA, 2010, AFRICAN INDABA, V8, P10; Whitman K, 2004, NATURE, V428, P175, DOI 10.1038/nature02395; Whitman K. L., 2007, HUNTERS GUIDE AGING; Williams VL., 2015, BONES CONTENTION ASS; Yamazaki K, 1996, J WILDLIFE MANAGE, V60, P490, DOI 10.2307/3802066	43	11	12	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153648	10.1371/journal.pone.0153648	http://dx.doi.org/10.1371/journal.pone.0153648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089506	gold, Green Published			2022-12-27	WOS:000374527000037
J	Han, SS; Yang, SH; Kim, MC; Cho, JY; Min, SI; Lee, JP; Kim, DK; Ha, J; Kim, YS				Han, Seung Seok; Yang, Seung Hee; Kim, Min Chang; Cho, Joo-Youn; Min, Sang-Il; Lee, Jung Pyo; Kim, Dong Ki; Ha, Jongwon; Kim, Yon Su			Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; RENAL-TRANSPLANTATION; ACUTE REJECTION; PHARMACOKINETICS; POLYMORPHISMS	Although monitoring the intracellular concentration of immunosuppressive agents may be a promising approach to individualizing the therapy after organ transplantation, additional studies on this issue are needed prior to its clinical approval. We investigated the relationship between intracellular and whole blood concentrations of tacrolimus (IC-TAC and WB-TAC, respectively), the factors affecting this relationship, and the risk of rejection based upon IC-TAC in stable kidney recipients. Both IC-TAC and WB-TAC were measured simultaneously in 213 kidney recipients with stable graft function using LC-MS/MS. The tacrolimus ratio was defined as IC-TAC per WB-TAC. The genetic polymorphism of ABCB1 gene and flow cytometric analyses were conducted to probe the correlation between tacrolimus concentrations and the immunoreactivity status as a potential risk of rejection, respectively. The correlation between IC-TAC and WB-TAC was relatively linear (r = 0.67; P<0.001). The factors affecting the tacrolimus ratio were sex, hematocrit, and the transplant duration, as follows: a high tacrolimus ratio was noted in female patients, patients with a low hematocrit, and patients with a short transplant period. However, the tacrolimus ratio did not reflect the prior clinical outcomes (e.g., rejection) or the genetic polymorphism of ABCB1. After stimulation with phorbol-12-myristate 13-acetate and ionomycin, the proportion of T cells producing interferon-gamma or interleukin-2 was higher in the low-IC-TAC group than in the high-IC-TAC group. Further studies are required to evaluate the value of the intracellular tacrolimus concentrations in several clinical settings, such as rejection, infection, and drug toxicity.	[Han, Seung Seok; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea; [Yang, Seung Hee; Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea; [Kim, Min Chang; Cho, Joo-Youn] Seoul Natl Univ, Coll Med, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Min, Sang-Il; Ha, Jongwon] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Jung Pyo; Kim, Dong Ki; Kim, Yon Su] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, Seoul, South Korea.; Kim, YS (corresponding author), Seoul Natl Univ, Kidney Res Inst, Seoul, South Korea.; Kim, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea.	yonsukim@snu.ac.kr	Cho, Joo-Youn/J-5672-2012; Cho, Joo-Youn/ABC-2044-2021; Kim, Dong Ki/J-5389-2012; Han, Seung Seok/HGD-2825-2022	Cho, Joo-Youn/0000-0001-9270-8273; Cho, Joo-Youn/0000-0001-9270-8273; Kim, Dong Ki/0000-0002-5195-7852; 	Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI13C1964]; Ministry of Health and Welfare, Republic of Korea	Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	The current study was supported by grants from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1964).; Based on the present study, Dr. Seung Seok Han was chosen to be a member of the training program of advanced translational and clinical researcher of Korea. Thus, the current study was supported by grants from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (HI13C1964). The biospecimens were provided by the Seoul National University Hospital Human Biobank, a member of the National Biobank of Korea, which is supported by the Ministry of Health and Welfare, Republic of Korea.	Capron A, 2012, TRANSPL INT, V25, P41, DOI 10.1111/j.1432-2277.2011.01365.x; Capron A, 2010, PHARMACOGENOMICS, V11, P703, DOI [10.2217/pgs.10.43, 10.2217/PGS.10.43]; Capron A, 2009, THER DRUG MONIT, V31, P178, DOI 10.1097/FTD.0b013e3181905aaa; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Gheorghian A, 2012, TRANSPLANTATION, V94, P241, DOI 10.1097/TP.0b013e318255f839; Hodges LM, 2011, PHARMACOGENET GENOM, V21, P152, DOI 10.1097/FPC.0b013e3283385a1c; JUSKO WJ, 1995, CLIN PHARMACOL THER, V57, P281, DOI 10.1016/0009-9236(95)90153-1; Kerb R, 2001, PHARMACOGENOMICS, V2, P51, DOI 10.1517/14622416.2.1.51; Lemaitre F, 2013, CLIN BIOCHEM, V46, P1538, DOI 10.1016/j.clinbiochem.2013.02.011; Matas AJ, 2014, AM J TRANSPLANT, V14, P11, DOI 10.1111/ajt.12579; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P1098, DOI 10.1097/00007890-200010150-00018; Najafian N, 2006, J AM SOC NEPHROL, V17, P2652, DOI 10.1681/ASN.2005070707; Raviv Y, 2000, FASEB J, V14, P511, DOI 10.1096/fasebj.14.3.511; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Vafadari R, 2013, THER DRUG MONIT, V35, P459, DOI 10.1097/FTD.0b013e31828c1581; van Gelder T, 2002, DRUG SAFETY, V25, P707, DOI 10.2165/00002018-200225100-00003; Velickovic-Radovanovic R, 2011, GENDER MED, V8, P23, DOI 10.1016/j.genm.2011.01.003; Webster A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003961.pub2; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303	21	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153491	10.1371/journal.pone.0153491	http://dx.doi.org/10.1371/journal.pone.0153491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082871	Green Published, gold			2022-12-27	WOS:000374291800024
J	Ward-Caviness, CK; Neas, LM; Blach, C; Haynes, CS; LaRocque-Abramson, K; Grass, E; Dowdy, E; Devlin, RB; Diaz-Sanchez, D; Cascio, WE; Miranda, ML; Gregory, SG; Shah, SH; Kraus, WE; Hauser, ER				Ward-Caviness, Cavin K.; Neas, Lucas M.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Elaine; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.; Miranda, Marie Lynn; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.			Genetic Variants in the Bone Morphogenic Protein Gene Family Modify the Association between Residential Exposure to Traffic and Peripheral Arterial Disease	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; AIR-POLLUTION; DNA METHYLATION; CARDIOVASCULAR-DISEASE; VASCULAR CALCIFICATION; RISK-FACTOR; ATHEROSCLEROSIS; SPERMATOGENESIS; PROGRESSION; INHIBITION	There is a growing literature indicating that genetic variants modify many of the associations between environmental exposures and clinical outcomes, potentially by increasing susceptibility to these exposures. However, genome-scale investigations of these interactions have been rarely performed particularly in the case of air pollution exposures. We performed race-stratified genome-wide gene-environment interaction association studies on European-American (EA, N = 1623) and African-American (AA, N = 554) cohorts to investigate the joint influence of common single nucleotide polymorphisms (SNPs) and residential exposure to traffic ("traffic exposure")-a recognized vascular disease risk factor-on peripheral arterial disease (BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.PAD). Traffic exposure was estimated via the distance from the primary residence to the nearest major roadway, defined as the nearest limited access highways or major arterial. The rs755249-traffic exposure interaction was associated with PAD at a genome-wide significant level (P = 2.29x10(-8)) in European-Americans. Rs755249 is located in the 3' untranslated region of BMP8A, a member of the bone morphogenic protein (BMP) gene family. Further investigation revealed several variants in BMP genes associated with PAD via an interaction with traffic exposure in both the EA and AA cohorts; this included interactions with non-synonymous variants in BMP2, which is regulated by air pollution exposure. The BMP family of genes is linked to vascular growth and calcification and is a novel gene family for the study of PAD pathophysiology. Further investigation of BMP8A using the Genotype Tissue Expression Database revealed multiple variants with nominally significant (P < 0.05) interaction P-values in our EA cohort were significant BMP8A eQTLs in tissue types highlight relevant for PAD such as rs755249 (tibial nerve, eQTL P = 3.6x10(-6)) and rs1180341 (tibial artery, eQTL P = 5.3x10(-6)). Together these results reveal a novel gene, and possibly gene family, associated with PAD via an interaction with traffic air pollution exposure. These results also highlight the potential for interactions studies, particularly at the genome scale, to reveal novel biology linking environmental exposures to clinical outcomes.	[Ward-Caviness, Cavin K.; Blach, Colette; Haynes, Carol S.; LaRocque-Abramson, Karen; Grass, Elizabeth; Dowdy, Elaine; Gregory, Simon G.; Shah, Svati H.; Kraus, William E.; Hauser, Elizabeth R.] Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA; [Ward-Caviness, Cavin K.] Helmholtz Ctr Munich, Inst Epidemiol 2, D-85764 Neuherberg, Germany; [Neas, Lucas M.; Devlin, Robert B.; Diaz-Sanchez, David; Cascio, Wayne E.] US Environm Protect Agcy, Natl Hlth & Environm Effects Res Lab, Chapel Hill, NC 27514 USA; [Miranda, Marie Lynn] Rice Univ, Natl Ctr Geospatial Med, Houston, TX 77005 USA; [Shah, Svati H.; Kraus, William E.] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA; [Hauser, Elizabeth R.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA; [Hauser, Elizabeth R.] Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA	Duke University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; United States Environmental Protection Agency; Rice University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Hauser, ER (corresponding author), Duke Univ, Med Ctr, Duke Mol Physiol Inst, Durham, NC 27710 USA.; Hauser, ER (corresponding author), Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC 27710 USA.; Hauser, ER (corresponding author), Vet Affairs Med Ctr, Cooperat Studies Program, Epidemiol Ctr Durham, Durham, NC 27701 USA.	elizabeth.hauser@gmail.com	Cascio, Wayne Eugene/GPG-0840-2022	Cascio, Wayne Eugene/0000-0003-1360-8093; Gregory, Simon/0000-0002-7805-1743; Miranda, Marie Lynn/0000-0002-5670-0837; Neas, Lucas/0000-0002-9377-8334; Hauser, Elizabeth/0000-0003-0367-9189	NIH [HL095987, HL10621, HL36587]; United States Environmental Protection Agency (EPA) [R-82811201]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095987, P01HL036587] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the following NIH grants: HL095987, HL10621, and HL36587. This project was supported in part by an appointment to the Research Participation Program at the Office of Research and Development, U.S. Environmental Protection Agency. Research described in this article was conducted under contract to the Health Effects Institute (HEI), and organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201) and certain motor vehicle and engine manufacturers. The contents of this article do not necessarily reflect the views of HEI, or its sponsors, nor do they necessarily reflect the view and policies of the EPA or motor vehicle and engine manufacturers.; This work was supported by the following NIH grants: HL095987, HL10621, and HL36587. This project was supported in part by an appointment to the Research Participation Program at the Office of Research and Development, U.S. Environmental Protection Agency. The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the EPA. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The contents of this article do not necessarily reflect the views of the Health Effects Institute (HEI), an organization jointly funded by the United States Environmental Protection Agency (EPA) (Assistance Award No. R-82811201) and certain motor vehicle and engine manufacturers, nor do they necessarily reflect the views and policies of its sponsors.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163; Baccarelli A, 2009, AM J RESP CRIT CARE, V179, P572, DOI 10.1164/rccm.200807-1097OC; Bera AK, 2001, J STAT PLAN INFER, V97, P9, DOI 10.1016/S0378-3758(00)00343-8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brunekreef B, 2009, RES REP HLTH EFF I, V139, P73; Brunekreef Bert, 2009, Res Rep Health Eff Inst, P5; Castro R, 2003, CLIN CHEM, V49, P1292, DOI 10.1373/49.8.1292; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Chung JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029100; Criqui MH, 2008, J AM COLL CARDIOL, V52, P1736, DOI 10.1016/j.jacc.2008.07.060; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DeJarnett N, 2015, ARTERIOSCL THROM VAS, V35, P2468, DOI 10.1161/ATVBAHA.115.305724; Derwall M, 2012, ARTERIOSCL THROM VAS, V32, P613, DOI 10.1161/ATVBAHA.111.242594; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Dong CM, 2002, J NUTR, V132, p2406S, DOI 10.1093/jn/132.8.2406S; Eraso LH, 2014, EUR J PREV CARDIOL, V21, P704, DOI 10.1177/2047487312452968; ESRI, 2011, ARCGIS DESKT REL 10; Federal Highway Administration, 2015, HIGHW STAT SER; Hagler GSW, 2009, ATMOS ENVIRON, V43, P1229, DOI 10.1016/j.atmosenv.2008.11.024; Hoek G, 2002, LANCET, V360, P1203, DOI 10.1016/S0140-6736(02)11280-3; Hoffmann B, 2007, EPIDEMIOLOGY, V18, pS75; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hoffmann B, 2009, BIOMARKERS, V14, P74, DOI 10.1080/13547500902965096; Hoffmann B, 2009, EPIDEMIOLOGY, V20, P280, DOI 10.1097/EDE.0b013e3181961ac2; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Jamaluddin MS, 2007, CLIN CHEM LAB MED, V45, P1660, DOI 10.1515/CCLM.2007.350; Jardim MJ, 2011, MUTAT RES-FUND MOL M, V717, P38, DOI 10.1016/j.mrfmmm.2011.03.014; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1463, DOI 10.1289/ehp.11290; Kim J, 2015, ARTERIOSCLEROSIS THR; Kim JH, 2015, ARTERIOSCL THROM VAS, V35, P2384, DOI 10.1161/ATVBAHA.115.306102; Knowles JW, 2007, ARTERIOSCL THROM VAS, V27, P2068, DOI 10.1161/01.ATV.0000282199.66398.8c; Kraus WE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005553; Kraus WE, 2015, J CARDIOVASC TRANSL, V8, P449, DOI 10.1007/s12265-015-9648-y; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Liberman M, 2011, BIOCHEM BIOPH RES CO, V413, P436, DOI 10.1016/j.bbrc.2011.08.114; London Stephanie J, 2007, Proc Am Thorac Soc, V4, P217, DOI 10.1513/pats.200701-031AW; Loveland KL, 2007, INT J ANDROL, V30, P377, DOI 10.1111/j.1365-2605.2007.00785.x; Madrigano J, 2011, ENVIRON HEALTH PERSP, V119, P977, DOI 10.1289/ehp.1002773; Mahoney SE, 2012, EPIGENETICS-US, V7, P400, DOI 10.4161/epi.19463; McGuinn LA, 2016, ENVIRON RES, V145, P9, DOI 10.1016/j.envres.2015.10.026; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Nawrot TS, 2009, AM J RESP CRIT CARE, V179, P523, DOI 10.1164/rccm.200812-1900ED; NCDOT (North Carolina Department of Transportation), 2015, GIS DAT LAYERS STAT; Novack DV, 2011, CELL RES, V21, P169, DOI 10.1038/cr.2010.159; OTTMAN R, 1990, GENET EPIDEMIOL, V7, P177, DOI 10.1002/gepi.1370070302; Polfus LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074642; Pollard KS, 2008, HUM GENET, V122, P625, DOI 10.1007/s00439-007-0440-1; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; R Core Development Team, 2009, R LANG ENV STAT COMP; Radhakrishna Rao C, 1948, LARGE SAMPLE TESTS S, P50; Rivas MA, 2015, SCIENCE, V348, P666, DOI 10.1126/science.1261877; Rostama B, 2015, ARTERIOSCL THROM VAS, V35, P2626, DOI 10.1161/ATVBAHA.115.306541; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sheffield NC, 2013, GENOME RES, V23, P777, DOI 10.1101/gr.152140.112; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smadja DM, 2008, ARTERIOSCL THROM VAS, V28, P2137, DOI 10.1161/ATVBAHA.108.168815; Smith FB, 2000, BLOOD COAGUL FIBRIN, V11, P43, DOI 10.1097/00001721-200011010-00005; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Townley-Tilson WHD, 2010, INT J BIOCHEM CELL B, V42, P1252, DOI 10.1016/j.biocel.2009.03.002; U.S. Census Bureau, 2013, TIGER LIN SHAP TIGER; Wahlgren CM, 2011, ARTERIOSCL THROM VAS, V31, P678, DOI 10.1161/ATVBAHA.110.210385; Ward-Caviness CK, 2015, ENV HLTH PERSPECT, V123, P8; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Yamawaki H, 2006, CIRC J, V70, P129, DOI 10.1253/circj.70.129; Yan MS, 2015, ARTERIOSCL THROM VAS, V35, P2297, DOI 10.1161/ATVBAHA.115.305043; Yao YC, 2010, CIRC RES, V107, P485, DOI 10.1161/CIRCRESAHA.110.219071; Zanobetti A, 2011, PROG CARDIOVASC DIS, V53, P344, DOI 10.1016/j.pcad.2011.01.001; Zhao GQ, 1998, DEVELOPMENT, V125, P1103	72	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0152670	10.1371/journal.pone.0152670	http://dx.doi.org/10.1371/journal.pone.0152670			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082954	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800007
J	Armstrong, MH; Tepole, AB; Kuhl, E; Simon, BR; Vande Geest, JP				Armstrong, Michelle Hine; Tepole, Adrian Buganza; Kuhl, Ellen; Simon, Bruce R.; Vande Geest, Jonathan P.			A Finite Element Model for Mixed Porohyperelasticity with Transport, Swelling, and Growth	PLOS ONE			English	Article							SMOOTH-MUSCLE CONTRACTION; INTERSTITIAL GROWTH; VOLUMETRIC GROWTH; BIOLOGICAL TISSUE; RESIDUAL-STRESS; ARTERIAL GROWTH; MASS-TRANSPORT; MIXTURE MODEL; SOFT-TISSUES; MECHANICS	The purpose of this manuscript is to establish a unified theory of porohyperelasticity with transport and growth and to demonstrate the capability of this theory using a finite element model developed in MATLAB. We combine the theories of volumetric growth and mixed porohyperelasticity with transport and swelling (MPHETS) to derive a new method that models growth of biological soft tissues. The conservation equations and constitutive equations are developed for both solid-only growth and solid/fluid growth. An axisymmetric finite element framework is introduced for the new theory of growing MPHETS (GMPHETS). To illustrate the capabilities of this model, several example finite element test problems are considered using model geometry and material parameters based on experimental data from a porcine coronary artery. Multiple growth laws are considered, including time-driven, concentrationdriven, and stress-driven growth. Time-driven growth is compared against an exact analytical solution to validate the model. For concentration-dependent growth, changing the diffusivity (representing a change in drug) fundamentally changes growth behavior. We further demonstrate that for stress-dependent, solid-only growth of an artery, growth of an MPHETS model results in a more uniform hoop stress than growth in a hyperelastic model for the same amount of growth time using the same growth law. This may have implications in the context of developing residual stresses in soft tissues under intraluminal pressure. To our knowledge, this manuscript provides the first full description of an MPHETS model with growth. The developed computational framework can be used in concert with novel in-vitro and in-vivo experimental approaches to identify the governing growth laws for various soft tissues.	[Armstrong, Michelle Hine; Vande Geest, Jonathan P.] Univ Arizona, Grad Interdisciplinary Program Appl Math, Tucson, AZ USA; [Tepole, Adrian Buganza; Kuhl, Ellen] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Simon, Bruce R.; Vande Geest, Jonathan P.] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ USA; [Vande Geest, Jonathan P.] Univ Arizona, Inst Biocollaborat Res BIO5, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA; [Vande Geest, Jonathan P.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA	University of Arizona; Stanford University; University of Arizona; University of Arizona; University of Arizona; University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vande Geest, JP (corresponding author), Univ Arizona, Grad Interdisciplinary Program Appl Math, Tucson, AZ USA.; Vande Geest, JP (corresponding author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Arizona, Grad Interdisciplinary Program Biomed Engn, Tucson, AZ USA.; Vande Geest, JP (corresponding author), Univ Arizona, Inst Biocollaborat Res BIO5, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.; Vande Geest, JP (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA.	jpv20@pitt.edu	Kuhl, Ellen/G-4444-2011; Geest, Jonathan Vande/L-8136-2016	Kuhl, Ellen/0000-0002-6283-935X; Geest, Jonathan Vande/0000-0003-2444-1751; Buganza Tepole, Adrian/0000-0001-8531-0603; Armstrong, Michelle/0000-0003-2736-8107	National Eye Institute [1R01EY020890]; National Heart, Lung, and Blood Institute [1R21HL111990]; Whitaker International Summer Grant; National Science Foundation [0841234]; ARCS Foundation; NATIONAL EYE INSTITUTE [R01EY020890] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL111990] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Whitaker International Summer Grant; National Science Foundation(National Science Foundation (NSF)); ARCS Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Eye Institute 1R01EY020890 (http://www.nih.gov/, JPVG); National Heart, Lung, and Blood Institute 1R21HL111990 (http://www.nih.gov/, JPVG); Whitaker International Summer Grant (http://www.whitaker.org/, MHA); National Science Foundation 0841234 (http://www.nsf.gov/); and ARCS Foundation (https://www.arcsfoundation.org/, MHA). Support for MHA was partly provided by the National Science Foundation under award No 0841234.	Alford PW, 2008, COMPUT METHOD BIOMEC, V11, P525, DOI 10.1080/10255840801930710; Almeida EDGARD S., 1997, Comput Methods Biomech Biomed Engin, V1, P25, DOI 10.1080/01495739708936693; Almeida EDGARD S., 1998, Comput Methods Biomech Biomed Engin, V1, P151, DOI 10.1080/01495739708936700; Ambrosi D, 2011, J MECH PHYS SOLIDS, V59, P863, DOI 10.1016/j.jmps.2010.12.011; Ambrosi D, 2002, INT J ENG SCI, V40, P1297, DOI 10.1016/S0020-7225(02)00014-9; Armstrong MAH, 2015, THESIS U ARIZONA; Ateshian GA, 2014, BIOMECH MODEL MECHAN, V13, P1105, DOI 10.1007/s10237-014-0560-1; BIOT MA, 1972, INDIANA U MATH J, V21, P597, DOI 10.1512/iumj.1972.21.21048; Biot MA, 1941, J APPL PHYS, V12, P155, DOI 10.1063/1.1712886; BOWEN RM, 1982, INT J ENG SCI, V20, P697, DOI 10.1016/0020-7225(82)90082-9; CHUONG CJ, 1986, J BIOMECH ENG-T ASME, V108, P189, DOI 10.1115/1.3138600; Eriksson TSE, 2014, J MECH PHYS SOLIDS, V73, P134, DOI 10.1016/j.jmps.2014.09.003; Fung YC, 1990, BIOMECHANICS MOTION; Garikipati K, 2004, J MECH PHYS SOLIDS, V52, P1595, DOI 10.1016/j.jmps.2004.01.004; Gleason RL, 2004, J BIOMECH ENG-T ASME, V126, P371, DOI 10.1115/1.1762899; Gleason RL, 2004, J VASC RES, V41, P352, DOI 10.1159/000080699; Goktepe S, 2010, J MECH PHYS SOLIDS, V58, P1661, DOI 10.1016/j.jmps.2010.07.003; Grytz R, 2012, MECH MATER, V44, P99, DOI 10.1016/j.mechmat.2011.07.004; Harper JL, 2014, J MECH BEHAV BIOMED, V29, P663, DOI 10.1016/j.jmbbm.2013.04.019; Harper JL, 2012, THESIS U ARIZONA; Himpel G, 2005, CMES-COMP MODEL ENG, V8, P119; Homer RJ, 2005, PHYSIOLOGY, V20, P28, DOI 10.1152/physiol.00035.2004; Humphrey JD, 2002, MATH MOD METH APPL S, V12, P407, DOI 10.1142/S0218202502001714; Huyghe JM, 2007, J BIOMECH ENG-T ASME, V129, P776, DOI 10.1115/1.2768379; Hwang CW, 2001, CIRCULATION, V104, P600, DOI 10.1161/hc3101.092214; Kaufmann MV, 1996, THESIS U ARIZONA; Keyes JT, 2013, PHARM RES-DORDR, V30, P1147, DOI 10.1007/s11095-012-0950-y; Keyes JT, 2013, J MECH BEHAV BIOMED, V17, P296, DOI 10.1016/j.jmbbm.2012.10.002; Kuhl E, 2007, BIOMECH MODEL MECHAN, V6, P321, DOI 10.1007/s10237-006-0062-x; LAI WM, 1991, J BIOMECH ENG-T ASME, V113, P245, DOI 10.1115/1.2894880; LEE EH, 1969, J APPL MECH, V36, P1, DOI 10.1115/1.3564580; Logan DL, 1993, 1 COURSE FINITE ELEM; Lubarda VA, 2002, INT J SOLIDS STRUCT, V39, P4627, DOI 10.1016/S0020-7683(02)00352-9; Matsumoto T, 1996, AM J PHYSIOL-HEART C, V271, pH1711, DOI 10.1152/ajpheart.1996.271.4.H1711; Myers K, 2014, J MECH BEHAV BIOMED, V29, P544, DOI 10.1016/j.jmbbm.2013.03.003; Nagarajan S., 1974, Computers and Structures, V4, P1117, DOI 10.1016/0045-7949(74)90028-5; Narayanan H, 2009, BIOMECH MODEL MECHAN, V8, P167, DOI 10.1007/s10237-008-0126-1; Owen D. R. J., 1980, FINITE ELEMENT PLAST; Rachev A, 2003, J BIOMECH, V36, P661, DOI 10.1016/S0021-9290(02)00444-X; Rachev A, 1998, J BIOMECH ENG-T ASME, V120, P9, DOI 10.1115/1.2834313; Rachev A, 1999, ANN BIOMED ENG, V27, P459, DOI 10.1114/1.191; RODRIGUEZ EK, 1994, J BIOMECH, V27, P455, DOI 10.1016/0021-9290(94)90021-3; Sengers BG, 2004, J BIOMECH ENG-T ASME, V126, P82, DOI 10.1115/1.1645526; Simon BR, 1998, INT J SOLIDS STRUCT, V35, P5021, DOI 10.1016/S0020-7683(98)00107-3; Simon BR, 1996, J BIOMECH ENG-T ASME, V118, P1, DOI 10.1115/1.2795941; SIMON BR, 1984, INT J NUMER ANAL MET, V8, P381, DOI 10.1002/nag.1610080406; Simon BR, 2001, BIOMECHANICAL SYSTEM, VIV; Simon BR., 1992, APPL MECH REV, V45, P191, DOI [DOI 10.1115/1.3121397, 10.1115/1.3121397]; Skalak R, 1997, J MATH BIOL, V35, P869, DOI 10.1007/s002850050081; Skalak R, 1996, J MATH BIOL, V34, P889, DOI 10.1007/s002850050036; Skalak R, 1981, P IUTAM S FINITE ELA, P347, DOI DOI 10.1007/978-94-009-7538-5_23; SUH JK, 1991, INT J NUMER METH ENG, V32, P1411, DOI 10.1002/nme.1620320704; Sun DN, 1999, INT J NUMER METH ENG, V45, P1375, DOI 10.1002/(SICI)1097-0207(19990810)45:10<1375::AID-NME635>3.0.CO;2-7; Taber LA, 2001, J BIOMECH ENG-T ASME, V123, P528, DOI 10.1115/1.1412451; Tepole AB, 2011, J MECH PHYS SOLIDS, V59, P2177, DOI 10.1016/j.jmps.2011.05.004; TERZAGHI K, 1967, SOIL MECH ENG PRACTI; Valentin A, 2009, PHILOS T R SOC A, V367, P3585, DOI 10.1098/rsta.2009.0113; Valentin A, 2009, J R SOC INTERFACE, V6, P293, DOI 10.1098/rsif.2008.0254; Vande Geest JP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003489; Vernerey FJ, 2015, BIOMECH MODEL MECHAN, P1; Zeller PJ, 1998, J VASC RES, V35, P8, DOI 10.1159/000025560; Zienkiewicz O. C., 1977, FINITE ELEMENT METHO, V3 rd; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1; Zollner AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045661	64	13	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152806	10.1371/journal.pone.0152806	http://dx.doi.org/10.1371/journal.pone.0152806			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078495	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000374131700009
J	Beck, G; Shinzawa, K; Hayakawa, H; Baba, K; Sumi-Akamaru, H; Tsujimoto, Y; Mochizuki, H				Beck, Goichi; Shinzawa, Koei; Hayakawa, Hideki; Baba, Kousuke; Sumi-Akamaru, Hisae; Tsujimoto, Yoshihide; Mochizuki, Hideki			Progressive Axonal Degeneration of Nigrostriatal Dopaminergic Neurons in Calcium-Independent Phospholipase A(2)beta Knockout Mice	PLOS ONE			English	Article							NEUROAXONAL DYSTROPHY; DOCOSAHEXAENOIC ACID; PLA2G6 MUTATION; MODEL; PARKINSONISM; DEFICIENCY	Calcium-independent phospholipase A(2)beta (iPLA(2)beta, PLA2G6) is essential for the remodeling of membrane glycerophospholipids. Mutations in this gene are responsible for autosomal recessive, young onset, L-dopa-responsive parkinsonism (PARK14), suggesting a neurodegenerative condition in the nigrostriatal dopaminergic system in patients with PLA2G6 mutations. We previously observed slowly progressive motor deficits in iPLA(2)beta-knockout (KO) mice. To clarify whether a deficiency of iPLA(2)beta leads to the degeneration of nigrostriatal dopaminergic neurons, we analyzed the striatum of iPLA(2)beta-KO mice. At all clinical stages, nerve terminals in the striatum were immunopositive for tyrosine hydroxylase (TH) and dopamine transporter (DAT) in wild-type (WT) control mice. In iPLA(2)beta-KO mice, focal loss of nerve terminals positive for TH and DAT was found from 56 weeks (early clinical stage), although iPLA(2)beta-KO mice at 56 weeks showed no significant decrease in the number of dopaminergic neurons in the substantia nigra compared with age-matched WT mice, as reported previously. At 100 weeks (late clinical stage), greater decreases in DAT immunoreactivity were observed in the striatum of iPLA(2)beta-KO mice. Moreover, strongly TH-positive structures, presumed to be deformed axons, were observed in the neuropils of the striatum of iPLA(2)beta-KO mice starting at 15 weeks (preclinical stage) and increased with age. These results suggest that the degeneration of dopaminergic neurons occurs mainly in the distal region of axons in iPLA(2)beta-KO mice.	[Beck, Goichi; Hayakawa, Hideki; Baba, Kousuke; Sumi-Akamaru, Hisae; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan; [Shinzawa, Koei; Tsujimoto, Yoshihide] Osaka Univ, Grad Sch Med, Dept Med Genet, Suita, Osaka, Japan; [Tsujimoto, Yoshihide] Osaka Med Ctr Canc & Cardiovasc Dis, Osaka, Japan	Osaka University; Osaka University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mochizuki, H (corresponding author), Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka, Japan.	hmochizuki@neurol.med.osaka-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [24591294, 24591295]; JSPS [22790314]; Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan [H26 intractable disease 037]; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED); MEXT [15H01558]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research on Rare and Intractable Diseases from the Ministry of Health, Labour and Welfare of Japan; Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS, https://www.jsps.go.jp) (Grant Number 24591294 to GB and Grant Number 24591295 to HSA) and a Grant-in-Aid for Young Scientists (B) (Grant Number 22790314 to KS) from JSPS, and was also partially supported by the Research on Rare and Intractable Diseases (H26 intractable disease 037 to HM) from the Ministry of Health, Labour and Welfare of Japan, the Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS) from Japan Agency for Medical Research and development (AMED) (to HM), and Grant-in-Aid for Scientific Research on Innovative Areas (Brain Protein Aging and Dementia Control) (15H01558 to HM) from MEXT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Balsinde J, 1997, J BIOL CHEM, V272, P29317, DOI 10.1074/jbc.272.46.29317; Beck G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141629; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Blesa J, 2012, NEUROBIOL DIS, V48, P79, DOI 10.1016/j.nbd.2012.05.018; COWEN D, 1963, J NEUROPATH EXP NEUR, V22, P175, DOI 10.1097/00005072-196304000-00001; Gai WP, 1995, BRAIN, V118, P1447, DOI 10.1093/brain/118.6.1447; Green JT, 2008, J LIPID RES, V49, P939, DOI 10.1194/jlr.R700017-JLR200; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Karkheiran S, 2015, TREMOR OTHER HYPERK, V5, DOI 10.7916/D84Q7T4W; Knab AM, 2010, INT J BIOL SCI, V6, P133; Malaguti MC, 2015, PARKINSONISM RELAT D, V21, P337, DOI 10.1016/j.parkreldis.2015.01.001; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nandhagopal R, 2011, BRAIN, V134, P3290, DOI 10.1093/brain/awr233; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Peters A., 1991, FINE STRUCTURE NERVO; Picconi B, 2012, ADV EXP MED BIOL, V970, P553, DOI 10.1007/978-3-7091-0932-8_24; Plowey ED, 2011, NEUROBIOL DIS, V43, P60, DOI 10.1016/j.nbd.2010.10.011; Schulz-Schaeffer WJ, 2010, ACTA NEUROPATHOL, V120, P131, DOI 10.1007/s00401-010-0711-0; Shi CH, 2011, NEUROLOGY, V77, P75, DOI 10.1212/WNL.0b013e318221acd3; Shinzawa K, 2003, J CELL BIOL, V163, P1219, DOI 10.1083/jcb.200306159; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Sina F, 2009, EUR J NEUROL, V16, P101, DOI 10.1111/j.1468-1331.2008.02356.x; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Toomey JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039041; Wilson JM, 1996, NEUROLOGY, V47, P718, DOI 10.1212/WNL.47.3.718; Yoshino H, 2010, NEUROLOGY, V75, P1356, DOI 10.1212/WNL.0b013e3181f73649	30	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153789	10.1371/journal.pone.0153789	http://dx.doi.org/10.1371/journal.pone.0153789			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078024	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700107
J	Dupervil, B; Grosse, S; Burnett, A; Parker, C				Dupervil, Brandi; Grosse, Scott; Burnett, Arthur; Parker, Christopher			Emergency Department Visits and Inpatient Admissions Associated with Priapism among Males with Sickle Cell Disease in the United States, 2006-2010	PLOS ONE			English	Article							MANAGEMENT; HEMOLYSIS	People with sickle cell disease (SCD) suffer from numerous acute complications that can result in multiple hospitalizations and emergency department (ED) and outpatient care visits. Priapism, a prolonged unwanted erection of the penis not due to sexual stimulation, is a serious complication among males with SCD. Variations in estimates of prevalence make it difficult to accurately assess the burden of this complication of SCD. We analyzed data from the Nationwide Emergency Department Sample (NEDS), a product of the Healthcare Cost and Utilization Project, for the years 2006 through 2010 to measure the numbers of ED visits and to examine patterns of subsequent hospitalizations associated with priapism among male patients with SCD. We find that among ED visits associated with males with SCD, those prompted by priapism are more likely to result in hospitalization than are those associated with pain.	[Dupervil, Brandi; Grosse, Scott; Parker, Christopher] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA; [Burnett, Arthur] Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Baltimore, MD 21205 USA	Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Medicine	Dupervil, B (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.	inm4@cdc.gov	Dupervil, Brandi/AAR-1471-2021	Grosse, Scott/0000-0003-1078-6855				Addis G, 2007, CHRONIC ILLN, V3, P145, DOI 10.1177/1742395307081505; Adeyoju AB, 2002, BJU INT, V90, P898, DOI 10.1046/j.1464-410X.2002.03022.x; Ashley-Koch A, 2000, AM J EPIDEMIOL, V151, P839; Boulet SL, 2010, AM J PREV MED, V38, pS528, DOI 10.1016/j.amepre.2010.01.003; Broderick GA, 2010, J SEX MED, V7, P476, DOI 10.1111/j.1743-6109.2009.01625.x; Burnett AL, 2013, J SEX MED, V10, P180, DOI 10.1111/j.1743-6109.2012.02707.x; Burnett AL, 2011, UROL CLIN N AM, V38, P185, DOI 10.1016/j.ucl.2011.02.005; Chrouser KL, 2011, AM J SURG, V201, P468, DOI 10.1016/j.amjsurg.2010.03.017; Crane G, 2011, ANEMIA, V2011, DOI 10.1155/2011/297364; Diggs LW, 1934, SOUTH MED J, V27, P839; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KULMALA RV, 1995, SCAND J UROL NEPHROL, V29, P93, DOI 10.3109/00365599509180545; National Heart Lung and Blood Institute, 2009, SICKL CELL AN WHO IS; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; Reeves S, 2014, ACAD PEDIATR, V14, pS61, DOI 10.1016/j.acap.2014.02.008; Roghmann F, 2013, J UROLOGY, V190, P1275, DOI 10.1016/j.juro.2013.03.118; Stein DM, 2013, J SEX MED, V10, P2418, DOI 10.1111/jsm.12251; Wolfson JA, 2011, PEDIATR BLOOD CANCER, V56, P413, DOI 10.1002/pbc.22792	20	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153257	10.1371/journal.pone.0153257	http://dx.doi.org/10.1371/journal.pone.0153257			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078839	Green Published, gold			2022-12-27	WOS:000374131700031
J	Fehrholz, M; Glaser, K; Seidenspinner, S; Ottensmeier, B; Curstedt, T; Speer, CP; Kunzmann, S				Fehrholz, Markus; Glaser, Kirsten; Seidenspinner, Silvia; Ottensmeier, Barbara; Curstedt, Tore; Speer, Christian P.; Kunzmann, Steffen			Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4(+) Lymphocytes	PLOS ONE			English	Article							PULMONARY SURFACTANT; IMMUNOREGULATORY PROPERTIES; SYNTHETIC SURFACTANT; BOVINE SURFACTANT; HUMAN MONOCYTES; MESSENGER-RNA; T-CELLS; IMMUNOSUPPRESSION; PROLIFERATION; INFLAMMATION	Background Natural surfactant preparations, commonly isolated from porcine or bovine lungs, are used to treat respiratory distress syndrome in preterm infants. Besides biophysical effectiveness, several studies have documented additional immunomodulatory properties. Within the near future, synthetic surfactant preparations may be a promising alternative. CHF5633 is a new generation reconstituted synthetic surfactant preparation with defined composition, containing dipalmitoyl-phosphatidylcholine, palmitoyl-oleoyl-phosphatidylglycerol and synthetic analogs of surfactant protein (SP-) B and SP-C. While its biophysical effectiveness has been demonstrated in vitro and in vivo, possible immunomodulatory abilities are currently unknown. Aim The aim of the current study was to define a potential impact of CHF5633 and its single components on pro-and anti-inflammatory cytokine responses in human CD4(+) lymphocytes. Methods Purified human CD4(+) T cells were activated using anti CD3/CD28 antibodies and exposed to CHF5633, its components, or to the well-known animal-derived surfactant Poractant alfa (Curosurf (R)). Proliferative response and cell viability were assessed using flow cytometry and a methylthiazolyldiphenyltetrazolium bromide colorimetric assay. The mRNA expression of IFN gamma, IL-2, IL-17A, IL-22, IL-4, and IL-10 was measured by quantitative PCR, while intracellular protein expression was assessed by means of flow cytometry. Results Neither CHF5633 nor any of its phospholipid components with or without SP-B or SP-C analogs had any influence on proliferative ability and viability of CD4(+) lymphocytes under the given conditions. IFN gamma, IL-2, IL-17A, IL-22, IL-4, and IL-10 mRNA as well as IFN gamma, IL-2, IL-4 and IL-10 protein levels were unaffected in both non-activated and activated CD4(+) lymphocytes after exposure to CHF5633 or its constituents compared to non-exposed controls. However, in comparison to Curosurf (R), expression levels of anti-inflammatory IL-4 and IL-10 mRNA were significantly increased in CHF5633 exposed CD4(+) lymphocytes. Conclusion For the first time, the immunomodulatory capacity of CHF5633 on CD4(+) lymphocytes was evaluated. CHF5633 did not show any cytotoxicity on CD4(+) cells. Moreover, our in vitro data indicate that CHF5633 does not exert unintended pro-inflammatory effects on non-activated and activated CD4(+) T cells. As far as anti-inflammatory cytokines are concerned, it might lack an overall reductive ability in comparison to animal-derived surfactants, potentially leaving pro- and anti-inflammatory cytokine response in balance.	[Fehrholz, Markus; Glaser, Kirsten; Seidenspinner, Silvia; Ottensmeier, Barbara; Speer, Christian P.; Kunzmann, Steffen] Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany; [Curstedt, Tore] Karolinska Inst, Karolinska Univ Hosp, Dept Mol Med & Surg, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Karolinska Institutet; Karolinska University Hospital	Fehrholz, M (corresponding author), Univ Wurzburg, Univ Childrens Hosp, D-97070 Wurzburg, Germany.	markus.fehrholz@uni-wuerzburg.de			Chiesi Farmaceutici S.p.A.; Open Access Publication Fund of the University of Wuerzburg	Chiesi Farmaceutici S.p.A.(Chiesi Pharmaceuticals Inc); Open Access Publication Fund of the University of Wuerzburg	This project was supported by Chiesi Farmaceutici S.p.A., supplying CHF5633, its single components and Curosurf (R). Chiesi Farmaceutici S.p.A. participated in the review of the manuscript, but otherwise had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This publication was supported by the Open Access Publication Fund of the University of Wuerzburg.	ALLEN JN, 1995, J LAB CLIN MED, V125, P356; [Anonymous], 2015, NEONATOLOGY, V107, P372; ANSFIELD MJ, 1979, AM REV RESPIR DIS, V120, P949; ANSFIELD MJ, 1980, J IMMUNOL, V125, P1093; Antal JM, 1996, AM J RESP CELL MOL, V14, P374, DOI 10.1165/ajrcmb.14.4.8600942; Trivella DBB, 2010, CELL MOL LIFE SCI, V67, P2909, DOI 10.1007/s00018-010-0380-0; BARTMANN P, 1992, J PERINAT MED, V20, P189, DOI 10.1515/jpme.1992.20.3.189; BARTMANN P, 1992, ACTA PAEDIATR, V81, P383, DOI 10.1111/j.1651-2227.1992.tb12254.x; Baur FM, 1998, PEDIATR RES, V44, P32, DOI 10.1203/00006450-199807000-00005; Bersani I, 2013, EXPERT REV ANTI-INFE, V11, P99, DOI [10.1586/ERI.12.156, 10.1586/eri.12.156]; Bersani I, 2012, EXPERT REV ANTI-INFE, V10, P573, DOI [10.1586/eri.12.34, 10.1586/ERI.12.34]; Borger P, 1999, IMMUNOLOGY, V96, P207; CATANZARO A, 1988, J LAB CLIN MED, V112, P727; Chatterjee P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00253; Curstedt T, 2015, NEONATOLOGY, V107, P321, DOI 10.1159/000381117; Curstedt T, 2013, NEONATOLOGY, V103, P327, DOI 10.1159/000349942; GEERTSMA MF, 1994, IMMUNOLOGY, V82, P450; Glaser K, 2015, IMMUNOL LETT, V166, P19, DOI 10.1016/j.imlet.2015.05.003; Hidalgo A, 2015, EUR J PHARM BIOPHARM; Israel-Assayag E, 1997, AM J PHYSIOL-LUNG C, V273, pL1258, DOI 10.1152/ajplung.1997.273.6.L1258; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kemp MW, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.09.076; Kolls JK, 2013, IMMUNOL REV, V252, P156, DOI 10.1111/imr.12030; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Lin SM, 2014, INT J CLIN EXP PATHO, V7, P474; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; ROTH MD, 1993, AM J RESP CELL MOL, V9, P652, DOI 10.1165/ajrcmb/9.6.652; Salvesen B, 2014, NEONATOLOGY, V105, P128, DOI 10.1159/000356065; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Seehase M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047631; Speer CR, 2013, EARLY HUM DEV, V89, pS22, DOI 10.1016/S0378-3782(13)70008-2; SPEER CP, 1991, PEDIATR RES, V30, P69, DOI 10.1203/00006450-199107000-00015; Speer CP., 2012, NEWBORN LUNG, V2nd edn, P283; Teijaro JR, 2011, J IMMUNOL, V187, P5510, DOI 10.4049/jimmunol.1102243; THOMASSEN MJ, 1992, AM J RESP CELL MOL, V7, P257, DOI 10.1165/ajrcmb/7.3.257; THOMASSEN MJ, 1994, AM J RESP CELL MOL, V10, P399, DOI 10.1165/ajrcmb.10.4.8136155; van Helden HPM, 1998, EUR RESPIR J, V12, P533, DOI 10.1183/09031936.98.12030533; Vreugdenhil HA, 2006, EXP LUNG RES, V32, P1, DOI 10.1080/01902140600575006; Walti H, 1997, PEDIATR RES, V41, P114, DOI 10.1203/00006450-199701000-00018; Weaver TE, 2001, ANNU REV PHYSIOL, V63, P555, DOI 10.1146/annurev.physiol.63.1.555; Wemhoner A, 2009, METHOD FIND EXP CLIN, V31, P317, DOI [10.1358/mf.2009.31.5.1386592, 10.1358/mf.2009.31.5.1380462]; WILSHER ML, 1988, CLIN EXP IMMUNOL, V74, P465; WILSHER ML, 1988, THORAX, V43, P354, DOI 10.1136/thx.43.5.354; WILSHER ML, 1990, THORAX, V45, P3, DOI 10.1136/thx.45.1.3; WILSHER ML, 1988, CLIN EXP IMMUNOL, V73, P117; WOERNDLE S, 1994, J PERINAT MED, V22, P119, DOI 10.1515/jpme.1994.22.2.119; Xu S, 2010, CELL MOL IMMUNOL, V7, P164, DOI 10.1038/cmi.2010.21; Yao LJ, 2001, BBA-MOL BASIS DIS, V1535, P266, DOI 10.1016/S0925-4439(01)00023-0; Zhang H, 2011, BIOCHIM BIOPHYS ACTA, V7, P23; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	57	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153578	10.1371/journal.pone.0153578	http://dx.doi.org/10.1371/journal.pone.0153578			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077658	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700084
J	Kelsey, TW; Miles, A; Mitchell, RT; Anderson, RA; Wallace, WHB				Kelsey, Thomas W.; Miles, Amy; Mitchell, Rod T.; Anderson, Richard A.; Wallace, W. Hamish B.			A Normative Model of Serum Inhibin B in Young Males	PLOS ONE			English	Article							FOLLICLE-STIMULATING-HORMONE; ANTI-MULLERIAN HORMONE; SERTOLI-CELLS; LUTEINIZING-HORMONE; DIMERIC INHIBINS; BOYS; TESTOSTERONE; MEN; PUBERTY; AGE	Inhibin B has been identified as a potential marker of Sertoli cell function in males. The aim of this study is to produce a normative model of serum inhibin B in males from birth to seventeen years. We used a well-defined search strategy to identify studies containing data that can contribute to a larger approximation of the healthy population. We combined data from four published studies (n = 709) and derived an internally validated model with high goodness-of-fit and normally distributed residuals. Our results show that inhibin B increases following birth to a post-natal peak of 270 pg/mL (IQR 210-335 pg/mL) and then decreases during childhood followed by a rise at around 8 years, peaking at a mean 305 pg/mL (IQR 240-445 pg/mL) at around age 17. Following this peak there is a slow decline to the standard mature adult normal range of 170 pg/mL (IQR 125-215 pg/mL). This normative model suggests that 35% of the variation in Inhibin B levels in young males is due to age alone, provides an age-specific reference range for inhibin B in the young healthy male population, and will be a powerful tool in evaluating the potential of inhibin B as a marker of Sertoli cell function in pre-pubertal boys.	[Kelsey, Thomas W.] Univ St Andrews, Sch Comp Sci, St Andrews KY16 9SX, Fife, Scotland; [Miles, Amy] Univ Edinburgh, Sch Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Mitchell, Rod T.; Anderson, Richard A.] Univ Edinburgh, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland; [Wallace, W. Hamish B.] Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland	University of St Andrews; University of Edinburgh; University of Edinburgh	Wallace, WHB (corresponding author), Royal Hosp Sick Children, Dept Haematol Oncol, Edinburgh EH9 1LF, Midlothian, Scotland.	hamish.wallace@nhs.net	Kelsey, Thomas W/H-3727-2019	Kelsey, Thomas W/0000-0002-8091-1458; Mitchell, Rod/0000-0003-4650-3765; Miles, Amy/0000-0002-9008-4599	Wellcome Trust [098522]	Wellcome Trust(Wellcome TrustEuropean Commission)	RTM is supported by a Wellcome Trust Intermediate Clinical Fellowship (Grant No: 098522), http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/Fellowships/Clinical-fellowships/wtd004402.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RA, 2000, INT J ANDROL, V23, P136, DOI 10.1046/j.1365-2605.2000.00229.x; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P2873, DOI 10.1210/jc.2003-032148; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Barbotin AL, 2015, EUR J ENDOCRINOL, V172, P669, DOI 10.1530/EJE-14-0932; Bergada I, 1999, CLIN ENDOCRINOL, V51, P455; Bergada I, 2006, J CLIN ENDOCR METAB, V91, P4092, DOI 10.1210/jc.2006-1079; Byrd W, 1998, J CLIN ENDOCR METAB, V83, P2849, DOI 10.1210/jc.83.8.2849; Carlsen E, 1999, J CLIN ENDOCR METAB, V84, P1664, DOI 10.1210/jc.84.5.1664; Chada M, 2003, PHYSIOL RES, V52, P45; CORTES D, 1987, INT J ANDROL, V10, P589, DOI 10.1111/j.1365-2605.1987.tb00358.x; Crofton PM, 2003, CLIN ENDOCRINOL, V58, P296, DOI 10.1046/j.1365-2265.2003.01712.x; Crofton PM, 2002, CLIN ENDOCRINOL, V56, P215, DOI 10.1046/j.0300-0664.2001.01448.x; Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203; Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jcem.81.4.8636341; Hafez M, 2014, J PEDIATR ENDOCR MET, V27, P891, DOI 10.1515/jpem-2013-0355; Hipler UC, 2001, ARCH ANDROLOGY, V46, P217; HRA, 2013, DOES MY PROJ REQ REV; Johansen ML, 2014, REPRODUCTION, V147, P529, DOI 10.1530/REP-13-0435; Kelsey TW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109346; Kelsey TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071465; Kelsey TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022024; Mahmoud AM, 2000, CLIN ENDOCRINOL, V53, P141; MULLER J, 1983, INT J ANDROL, V6, P143, DOI 10.1111/j.1365-2605.1983.tb00333.x; NIELSEN CT, 1986, J CLIN ENDOCR METAB, V62, P532, DOI 10.1210/jcem-62-3-532; Radicioni AF, 2005, EUR J ENDOCRINOL, V152, P403, DOI 10.1530/eje.1.01855; Rey RA, 2013, ANDROLOGY-US, V1, P3, DOI 10.1111/j.2047-2927.2012.00008.x; Rohatgi A., 2011, WEBPLOTDIGITIZER 201; Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769; van Beek RD, 2007, HUM REPROD, V22, P3215, DOI 10.1093/humrep/dem313; Wallace EM, 1997, J CLIN ENDOCR METAB, V82, P218, DOI 10.1210/jc.82.1.218; Wallace EM, 1997, J CLIN ENDOCR METAB, V82, P3111, DOI 10.1210/jc.82.9.3111; Wallace WHB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008772; Wohlfahrt-Veje C, 2016, J CLIN ENDOCR METAB, V101, P2667, DOI 10.1210/jc.2016-1073	34	17	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153843	10.1371/journal.pone.0153843	http://dx.doi.org/10.1371/journal.pone.0153843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077369	Green Published, gold			2022-12-27	WOS:000374131700113
J	Traag, VA				Traag, Vincent A.			Complex Contagion of Campaign Donations	PLOS ONE			English	Article							SOCIAL-INFLUENCE; RECRUITMENT; VIABILITY; DIFFUSION; CASCADES; BEHAVIOR; ELITES	Money is central in US politics, and most campaign contributions stem from a tiny, wealthy elite. Like other political acts, campaign donations are known to be socially contagious. We study how campaign donations diffuse through a network of more than 50000 elites and examine how connectivity among previous donors reinforces contagion. We find that the diffusion of donations is driven by independent reinforcement contagion: people are more likely to donate when exposed to donors from different social groups than when they are exposed to equally many donors from the same group. Counter-intuitively, being exposed to one side may increase donations to the other side. Although the effect is weak, simultaneous cross-cutting exposure makes donation somewhat less likely. Finally, the independence of donors in the beginning of a campaign predicts the amount of money that is raised throughout a campaign. We theorize that people infer population-wide estimates from their local observations, with elites assessing the viability of candidates, possibly opposing candidates in response to local support. Our findings suggest that theories of complex contagions need refinement and that political campaigns should target multiple communities.	[Traag, Vincent A.] Royal Netherlands Inst Southeast Asian & Caribbea, Leiden, Netherlands; [Traag, Vincent A.] Royal Netherlands Acad Arts & Sci, E Humanities Grp, Amsterdam, Netherlands; [Traag, Vincent A.] Leiden Univ, CWTS, Leiden, Netherlands	Royal Netherlands Academy of Arts & Sciences; Royal Netherlands Institute of Southeast Asian & Caribbean Studies (KITLV-KNAW); Leiden University; Leiden University - Excl LUMC	Traag, VA (corresponding author), Royal Netherlands Inst Southeast Asian & Caribbea, Leiden, Netherlands.; Traag, VA (corresponding author), Royal Netherlands Acad Arts & Sci, E Humanities Grp, Amsterdam, Netherlands.; Traag, VA (corresponding author), Leiden Univ, CWTS, Leiden, Netherlands.	v.a.traag@cwts.leidenuniv.nl	Traag, V.A./Q-5171-2019	Traag, V.A./0000-0003-3170-3879	Royal Netherlands Academy of Arts and Sciences (KNAW) through its eHumanities project	Royal Netherlands Academy of Arts and Sciences (KNAW) through its eHumanities project	This work is supported by the Royal Netherlands Academy of Arts and Sciences (KNAW) through its eHumanities project.; This work is supported by the Royal Netherlands Academy of Arts and Sciences (KNAW) through its eHumanities project. We are grateful to LittleSis for making its data available for analysis.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095140; Anderson A, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P66, DOI 10.1145/2736277.2741672; Anderson CL, 2013, POLIT RES QUART, V66, P61, DOI 10.1177/1065912911430669; [Anonymous], 2000, PRES STUD Q, DOI [10.1111/j.0360-4918.2000.00141.x, DOI 10.1111/J.0360-4918.2000.00141.X]; Aral S, 2009, P NATL ACAD SCI USA, V106, P21544, DOI 10.1073/pnas.0908800106; Bakshy E., 2015, SCIENCE; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Balkundi P, 2006, ACAD MANAGE J, V49, P49, DOI [10.2307/20159745, 10.5465/AMJ.2006.20785500]; Banerjee A, 2013, SCIENCE, V341, P363, DOI 10.1126/science.1236498; Battiston F, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.032804; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bond RM, 2012, NATURE, V489, P295, DOI 10.1038/nature11421; Brady HE, 1999, AM POLIT SCI REV, V93, P153, DOI 10.2307/2585767; Burris V, 2005, AM J SOCIOL, V111, P249, DOI 10.1086/428817; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Centola D, 2011, SCIENCE, V334, P1269, DOI 10.1126/science.1207055; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cho WKT, 2003, AM J POLIT SCI, V47, P368, DOI 10.2307/3186145; Christenson DP, 2011, J POLITICAL MARKETIN, V10, P4, DOI 10.1080/15377857.2011.540189; Coviello L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090315; de Montjoye YA, 2014, SCI REP-UK, V4, DOI 10.1038/srep05277; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Dowdle AJ, 2009, POLIT RES QUART, V62, P77, DOI 10.1177/1065912908317032; Easley D, 2010, CROWDS MARKETS REASO; Elias Norbert, 1965, ESTABLISHED OUTSIDER; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fowler JH, 2010, P NATL ACAD SCI USA, V107, P5334, DOI 10.1073/pnas.0913149107; Friedkin NE, 2001, SOC NETWORKS, V23, P167, DOI 10.1016/S0378-8733(01)00036-3; Gilens M, 2014, PERSPECT POLIT, V12, P564, DOI 10.1017/S1537592714001595; Gimpel JG, 2006, J POLIT, V68, P626, DOI 10.1111/j.1468-2508.2006.00450.x; Gonzalez-Bailon S, 2011, SCI REP-UK, V1, DOI 10.1038/srep00197; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Grant JT, 2002, POLIT BEHAV, V24, P31, DOI 10.1023/A:1020994921777; HARKINS SG, 1987, J PERS SOC PSYCHOL, V52, P260, DOI 10.1037/0022-3514.52.2.260; HARKINS SG, 1981, J PERS SOC PSYCHOL, V40, P401, DOI 10.1037/0022-3514.40.3.401; Hassell HJG, 2014, POLIT BEHAV, V36, P359, DOI 10.1007/s11109-013-9230-8; Hassell HJG, 2011, J POLITICAL MARKETIN, V10, P27, DOI 10.1080/15377857.2011.540192; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Hodas NO, 2014, SCI REP-UK, V4, DOI 10.1038/srep04343; Karsai M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0694; KATZ ML, 1985, AM ECON REV, V75, P424; Kearns M, 2009, P NATL ACAD SCI USA, V106, P1347, DOI 10.1073/pnas.0808147106; Konstas I, 2009, PROCEEDINGS 32ND ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P195, DOI 10.1145/1571941.1571977; Kramer J., 2007, JOHNS J LEG COMMENT, V22, P261; Lerman K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147617; Lim C, 2010, SOC SCI RES, V39, P341, DOI 10.1016/j.ssresearch.2009.05.005; Lipsitz K, 2011, J POLITICAL MARKETIN, V10, P43, DOI 10.1080/15377857.2011.540193; MCADAM D, 1986, AM J SOCIOL, V92, P64, DOI 10.1086/228463; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Meirowitz A, 2005, ECON POLIT-OXFORD, V17, P77, DOI [10.1111/j.1468-0343.2005.00147.x, DOI 10.1111/J.1468-0343.2005.00147.X]; Mills C. Wright, 1956, POWER ELITE; Muchnik L, 2013, SCIENCE, V341, P647, DOI 10.1126/science.1240466; Mutz DC, 2002, AM J POLIT SCI, V46, P838, DOI 10.2307/3088437; NEMATZADEH A, 2014, PHYS REV LETT, V113, DOI DOI 10.1103/PHYSREVLETT.113.088701; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nickerson DW, 2008, AM POLIT SCI REV, V102, P49, DOI 10.1017/S0003055408080039; Norrander B, 2006, BRIT J POLIT SCI, V36, P487, DOI 10.1017/S0007123406000251; Omodei E, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00059; Panagopoulos C, 2006, PRES STUD Q, V36, P155, DOI 10.1111/j.1741-5705.2006.00296.x; Rand DG, 2014, P NATL ACAD SCI USA, V111, P17093, DOI 10.1073/pnas.1400406111; Scholman K., 1999, CIVIC ENGAGEMENT AM, P427; Schussman A, 2005, SOC FORCES, V84, P1083, DOI 10.1353/sof.2006.0034; Shalizi CR, 2011, SOCIOL METHOD RES, V40, P211, DOI 10.1177/0049124111404820; Sherif M., 1936, PSYCHOL SOCIAL NORMS; Sole-Ribalta A, 2015, FRONT PHYS-LAUSANNE, V3, DOI 10.3389/fphy.2015.00061; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Tsvetkova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087275; Ugander J, 2012, P NATL ACAD SCI USA, V109, P5962, DOI 10.1073/pnas.1116502109; Verba S., 1995, VOICE EQUALITY CIVIC; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weiss CH, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041008; Weng L, 2013, SCI REP-UK, V3, DOI [10.1038/srep02304, 10.1038/srep02522]; WILDER DA, 1978, US SOC PSYCHOL, V41, P13, DOI 10.2307/3033593; WILDER DA, 1977, J EXP SOC PSYCHOL, V13, P253, DOI 10.1016/0022-1031(77)90047-6	77	8	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153539	10.1371/journal.pone.0153539	http://dx.doi.org/10.1371/journal.pone.0153539			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27077742	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700075
J	Yin, XY; Pang, SC; Huang, J; Cui, YH; Yan, B				Yin, Xiaoyun; Pang, Shuchao; Huang, Jian; Cui, Yinghua; Yan, Bo			Genetic and Functional Sequence Variants of the SIRT3 Gene Promoter in Myocardial Infarction	PLOS ONE			English	Article							FATTY-ACID OXIDATION; SIRT3-MEDIATED DEACETYLATION; MITOCHONDRIAL-FUNCTION; REPERFUSION INJURY; SIRTUINS; STRESS; ACETYLATION; HOMOLOG; DEFICIENCY; ACTIVATION	Coronary artery disease (CAD), including myocardial infarction (MI), is a common complex disease that is caused by atherosclerosis. Although a large number of genetic variants have been associated with CAD, only 10% of CAD cases could be explained. It has been proposed that low frequent and rare genetic variants may be main causes for CAD. SIRT3, a mitochondrial deacetylase, plays important roles in mitochondrial function and metabolism. Lack of SIRT3 in experimental animal leads to several age-related diseases, including cardiovascular diseases. Therefore, SIRT3 gene variants may contribute to the MI development. In this study, SIRT3 gene promoter was genetically and functionally analyzed in large cohorts of MI patients (n = 319) and ethnic-matched controls (n = 322). Total twenty-three DNA sequence variants (DSVs) were identified, including 10 single-nucleotide polymorphisms (SNPs). Six novel heterozygous DSVs, g.237307A>G, g.237270G>A, g.237023_25del, g. 236653C>A, g.236628G>C, g.236557T>C, and two SNPs g.237030C>T (rs12293349) and g. 237022C>G (rs369344513), were identified in nine MI patients, but in none of controls. Three SNPs, g.236473C>T (rs11246029), g.236380_81ins (rs71019893) and g.236370C>G (rs185277566), were more significantly frequent in MI patients than controls (P < 0.05). These DSVs and SNPs, except g. 236557T>C, significantly decreased the transcriptional activity of the SIRT3 gene promoter in cultured HEK-293 cells and H9c2 cells. Therefore, these DSVs identified in MI patients may change SIRT3 level by affecting the transcriptional activity of SIRT3 gene promoter, contributing to the MI development as a risk factor.	[Yin, Xiaoyun] Shandong Univ, Sch Med, Dept Med, Jinan 250100, Shandong, Peoples R China; [Pang, Shuchao; Huang, Jian; Yan, Bo] Jining Med Univ, Affiliated Hosp, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Jining, Shandong, Peoples R China; [Cui, Yinghua] Jining Med Univ, Affiliated Hosp, Div Cardiol, Jining, Shandong, Peoples R China; [Yan, Bo] Jining Med Univ, Affiliated Hosp, Shandong Prov Sino US Cooperat Res Ctr Translat M, Jining, Shandong, Peoples R China	Shandong University; Jining Medical University; Jining Medical University; Jining Medical University	Yan, B (corresponding author), Jining Med Univ, Affiliated Hosp, Shandong Prov Key Lab Cardiac Dis Diag & Treatmen, Jining, Shandong, Peoples R China.; Yan, B (corresponding author), Jining Med Univ, Affiliated Hosp, Shandong Prov Sino US Cooperat Res Ctr Translat M, Jining, Shandong, Peoples R China.	yanbo@mail.jnmc.edu.cn	Pang, Shuchao/H-7951-2013	Pang, Shuchao/0000-0003-0495-4250; Huang, Jian/0000-0003-0149-1799	National Natural Science Foundation of China [81370271]; Taishan Scholar Program of Shandong, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Taishan Scholar Program of Shandong, China	This study was supported by National Natural Science Foundation of China (No. 81370271) and Taishan Scholar Program of Shandong, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albani D, 2014, AGE, V36, P469, DOI 10.1007/s11357-013-9559-2; Alhazzazi TY, 2011, BBA-REV CANCER, V1816, P80, DOI 10.1016/j.bbcan.2011.04.004; Alrob OA, 2014, CARDIOVASC RES, V103, P485, DOI 10.1093/cvr/cvu156; Barger JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120738; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bellizzi D, 2007, GENOMICS, V89, P143, DOI 10.1016/j.ygeno.2006.09.004; Ben-Avraham D, 2015, ADV EXP MED BIOL, V847, P179, DOI 10.1007/978-1-4939-2404-2_9; Bochaton T, 2015, J MOL CELL CARDIOL, V84, P61, DOI 10.1016/j.yjmcc.2015.03.017; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chen CJ, 2013, BIOCHEM BIOPH RES CO, V430, P798, DOI 10.1016/j.bbrc.2012.11.066; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Choudhury M, 2011, AGING-US, V3, P175, DOI 10.18632/aging.100289; de Moura MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106028; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Giblin W, 2014, TRENDS GENET, V30, P271, DOI 10.1016/j.tig.2014.04.007; Goncharov NV, 2015, CURR PHARM DESIGN, V21, P1134, DOI 10.2174/1381612820666141014142557; Gounden S, 2015, METAB SYNDR RELAT D, V13, P255, DOI 10.1089/met.2014.0140; Hafner AV, 2010, AGING-US, V2, P914, DOI 10.18632/aging.100252; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Kathiresan S, 2012, CELL, V148, P1242, DOI 10.1016/j.cell.2012.03.001; Kumari S, 2015, J BIOL CHEM, V290, P12290, DOI 10.1074/jbc.M114.615948; Li HG, 2014, ATHEROSCLEROSIS, V237, P208, DOI 10.1016/j.atherosclerosis.2014.09.001; Liang QL, 2013, BIOCHEM J, V454, P249, DOI 10.1042/BJ20130414; Liu GD, 2015, INT J CLIN EXP PATHO, V8, P353; Lombard DB, 2014, GERONTOLOGY, V60, P56, DOI 10.1159/000354382; Lu ZP, 2015, J BIOL CHEM, V290, P2466, DOI 10.1074/jbc.M114.606228; Luo X, 2017, CELL BIOL INT, V41, P932, DOI 10.1002/cbin.10291; Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, pH1375, DOI 10.1152/ajpheart.00053.2015; McDonnell E, 2015, TRENDS ENDOCRIN MET, V26, P486, DOI 10.1016/j.tem.2015.06.001; Mei Y, 2015, BBA-MOL BASIS DIS, V1852, P243, DOI 10.1016/j.bbadis.2014.05.005; Merksamer PI, 2013, AGING-US, V5, P144, DOI 10.18632/aging.100544; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Ozaki K, 2016, J HUM GENET, V61, P71, DOI 10.1038/jhg.2015.70; Paulin R, 2014, CELL METAB, V20, P827, DOI 10.1016/j.cmet.2014.08.011; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Roberts R, 2014, CIRC RES, V114, P1890, DOI 10.1161/CIRCRESAHA.114.302692; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Samant SA, 2014, MOL CELL BIOL, V34, P807, DOI 10.1128/MCB.01483-13; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Shi T, 2010, J DIGEST DIS, V11, P55, DOI 10.1111/j.1751-2980.2009.00416.x; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Tseng AHH, 2014, BIOCHEM J, V464, P157, DOI 10.1042/BJ20140213; Tseng AHH, 2013, FREE RADICAL BIO MED, V63, P222, DOI 10.1016/j.freeradbiomed.2013.05.002; Winnik S, 2015, EUR HEART J, V36, P3404, DOI 10.1093/eurheartj/ehv290; Wu T, 2014, ANN CLIN LAB SCI, V44, P410; Xue L, 2012, FEBS LETT, V586, P137, DOI 10.1016/j.febslet.2011.11.031; Zeng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107011; Zhang B, 2013, AGE, V35, P2237, DOI 10.1007/s11357-013-9520-4; Zhang YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122297	58	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153815	10.1371/journal.pone.0153815	http://dx.doi.org/10.1371/journal.pone.0153815			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078640	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700110
J	Kitaoka, K; Kawata, S; Yoshida, T; Kadoriku, F; Kitamura, M				Kitaoka, Kazuyoshi; Kawata, Shiyori; Yoshida, Tomohiro; Kadoriku, Fumiya; Kitamura, Mitsuo			Exposure to an Extremely-Low-Frequency Magnetic Field Stimulates Adrenal Steroidogenesis via Inhibition of Phosphodiesterase Activity in a Mouse Adrenal Cell Line	PLOS ONE			English	Article							ELECTROMAGNETIC-FIELD; INTENSITY; PATHWAYS; CAMP	Extremely low-frequency magnetic fields (ELF-MFs) are generated by power lines and household electrical devices. In the last several decades, some evidence has shown an association between ELF-MF exposure and depression and/or anxiety in epidemiological and animal studies. The mechanism underlying ELF-MF-induced depression is considered to involve adrenal steroidogenesis, which is triggered by ELF-MF exposure. However, how ELF-MFs stimulate adrenal steroidogenesis is controversial. In the current study, we investigated the effect of ELF-MF exposure on the mouse adrenal cortex-derived Y-1 cell line and the human adrenal cortex-derived H295R cell line to clarify whether the ELF-MF stimulates adrenal steroidogenesis directly. ELF-MF exposure was found to significantly stimulate adrenal steroidogenesis (p < 0.01-0.05) and the expression of adrenal steroid synthetic enzymes (p < 0.05) in Y-1 cells, but the effect was weak in H295R cells. Y-1 cells exposed to an ELF-MF showed significant decreases in phosphodiesterase activity (p < 0.05) and intracellular Ca2+ concentration (p < 0.01) and significant increases in intracellular cyclic adenosine monophosphate (cAMP) concentration (p < 0.001-0.05) and cAMP response element-binding protein phosphorylation (p < 0.05). The increase in cAMP was not inhibited by treatment with NF449, an inhibitor of the Gs alpha subunit of G protein. Our results suggest that ELF-MF exposure stimulates adrenal steroidogenesis via an increase in intracellular cAMP caused by the inhibition of phosphodiesterase activity in Y-1 cells. The same mechanism may trigger the increase in adrenal steroid secretion in mice observed in our previous study.	[Kitaoka, Kazuyoshi] Univ Tokushima, Inst Liberal Arts & Sci, Tokushima 770, Japan; [Kawata, Shiyori; Yoshida, Tomohiro; Kadoriku, Fumiya] Univ Tokushima, Student Lab, Fac Med, Tokushima 770, Japan; [Kitamura, Mitsuo] Univ Tokushima, Grad Sch, Inst Biomed Sci, Support Ctr Adv Med Sci, Tokushima 770, Japan	Tokushima University; Tokushima University; Tokushima University	Kitaoka, K (corresponding author), Univ Tokushima, Inst Liberal Arts & Sci, Tokushima 770, Japan.	kitaoka@tokushima-u.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI Grant [25870475]	JSPS (Japan Society for the Promotion of Science) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by 25870475 JSPS (Japan Society for the Promotion of Science) KAKENHI Grant (https://www.jsps.go.jp/j-grantsinaid/).	Afework M, 1999, CELL TISSUE RES, V298, P449, DOI 10.1007/s004419900103; Martinez MA, 2012, CELL PHYSIOL BIOCHEM, V29, P675, DOI 10.1159/000178457; Chen CC, 2000, LIFE SCI, V67, P2045, DOI 10.1016/S0024-3205(00)00790-6; Chen L, 2015, EUR UROL, V68, P674, DOI 10.1016/j.eururo.2015.03.031; Cook CM, 2006, BIOELECTROMAGNETICS, V27, P613, DOI 10.1002/bem.20247; Di Lazzaro V, 2013, BRAIN STIMUL, V6, P469, DOI 10.1016/j.brs.2013.01.004; Fan WX, 2015, INT J CLIN EXP MED, V8, P7394; Gallo-Payet N, 2014, COMPR PHYSIOL, V4, P889, DOI 10.1002/cphy.c130050; Gerits N, 2008, CELL SIGNAL, V20, P1592, DOI 10.1016/j.cellsig.2008.02.022; Goodman R, 2009, INT J RADIAT BIOL, V85, P851, DOI [10.3109/09553000903072488, 10.1080/09553000903072488]; Nguyen H, 2014, REV CARDIOVASC MED, V15, P158, DOI 10.3909/ricm0679; Hulsmann M, 2003, EUR J PHARMACOL, V470, P1, DOI 10.1016/S0014-2999(03)01761-8; Int Commission Non-Ionizing, 2010, HEALTH PHYS, V99, P818, DOI 10.1097/HP.0b013e3181f06c86; Kaneda T, 1997, JPN J PHARMACOL, V75, P77, DOI 10.1254/jjp.75.77; Kitaoka K, 2013, NEUROPHARMACOLOGY, V72, P58, DOI 10.1016/j.neuropharm.2013.04.009; Kitaoka K, 2013, BIOELECTROMAGNETICS, V34, P43, DOI 10.1002/bem.21743; Liu TT, 2008, NEUROSCI LETT, V434, P12, DOI 10.1016/j.neulet.2008.01.019; Mattsson MO, 2012, TOXICOLOGY, V301, P1, DOI 10.1016/j.tox.2012.06.011; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; Mostafa RM, 2002, PHYSIOL BEHAV, V76, P589, DOI 10.1016/S0031-9384(02)00730-8; Okamoto M, 2005, BIOCHEM BIOPH RES CO, V338, P325, DOI 10.1016/j.bbrc.2005.07.187; POOLE C, 1993, AM J EPIDEMIOL, V137, P318, DOI 10.1093/oxfordjournals.aje.a116679; Razavi Shahnaz, 2014, Adv Biomed Res, V3, P25, DOI 10.4103/2277-9175.124668; Soda A, 2008, J MED INVESTIG, V55, P267, DOI 10.2152/jmi.55.267; Spiga F, 2011, J NEUROENDOCRINOL, V23, P136, DOI 10.1111/j.1365-2826.2010.02096.x; Szemerszky R, 2010, BRAIN RES BULL, V81, P92, DOI 10.1016/j.brainresbull.2009.10.015; Tsai LCL, 2012, HORM METAB RES, V44, P790, DOI 10.1055/s-0032-1321861; Tsai LCL, 2011, CURR OPIN PHARMACOL, V11, P670, DOI 10.1016/j.coph.2011.09.003; Tsai LCL, 2011, MOL PHARMACOL, V79, P639, DOI 10.1124/mol.110.069104; WILSON BW, 1988, BIOELECTROMAGNETICS, V9, P195, DOI 10.1002/bem.2250090211	30	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154167	10.1371/journal.pone.0154167	http://dx.doi.org/10.1371/journal.pone.0154167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100201	Green Submitted, Green Published, gold			2022-12-27	WOS:000374898500159
J	Kugino, K; Tamaru, S; Hisatomi, Y; Sakaguchi, T				Kugino, Kenji; Tamaru, Shizuka; Hisatomi, Yuko; Sakaguchi, Tadashi			Long-Duration Carbon Dioxide Anesthesia of Fish Using Ultra Fine (Nano-Scale) Bubbles	PLOS ONE			English	Article							TRANSPORTATION; CARP	Introduction: We investigated whether adding ultrafine (nano-scale) oxygen-carrying bubbles to water concurrently with dissolved carbon-dioxide (CO2) could result in safe, long-duration anesthesia for fish. Results: To confirm the lethal effects of CO2 alone, fishes were anesthetized with dissolved CO2 in 20 degrees C seawater. Within 30 minutes, all fishes, regardless of species, died suddenly due to CO2-induced narcosis, even when the water was saturated with oxygen. Death was attributed to respiration failure caused by hypoxemia. When ultrafine oxygen-carrying bubbles were supplied along with dissolved CO2, five chicken grunts were able to remain anesthetized for 22 hours and awoke normally within 2-3 hours after cessation of anesthesia. Conclusions: The high internal pressures and oxygen levels of the ultrafine bubbles enabled efficient oxygen diffusion across the branchia and permitted the organismal oxygen demands of individual anesthetized fish to be met. Thus, we demonstrated a method for safe, long-duration carbon dioxide anesthesia in living fish under normal water temperatures.	[Kugino, Kenji; Tamaru, Shizuka] Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutrit Sci, Nagasaki 8512195, Japan; [Hisatomi, Yuko] Nishikyushu Univ, Dept Hlth & Nutr Sci, Fac Hlth & Social Welf Sci, Saga 8420015, Japan; [Sakaguchi, Tadashi] Marine Biotechnol Inc, Inst Marine Sci & Technol, Fukuoka 8113501, Japan	Nagasaki University	Tamaru, S (corresponding author), Nagasaki Univ, Grad Sch Human Hlth Sci, Div Nutrit Sci, Nagasaki 8512195, Japan.	tamaru@sun.ac.jp			Institute of Marine Sciences and Technologies, Marine Biotechnology Inc.	Institute of Marine Sciences and Technologies, Marine Biotechnology Inc.	The authors received no specific funding for this paper. The Institute of Marine Sciences and Technologies, Marine Biotechnology Inc. provided support in the form of laboratory facilities for this for study. TS was employed by the Institute of Marine Sciences and Technologies, Marine Biotechnology Inc. at the time this research was conducted but participated in this study using holiday time.	Blessing JJ, 2010, J FISH BIOL, V76, P2571, DOI 10.1111/j.1095-8649.2010.02633.x; CHALON J, 1983, ACTA ANAESTH SCAND, V27, P361, DOI 10.1111/j.1399-6576.1983.tb01968.x; Chen K, 2014, ZEBRAFISH, V11, P71, DOI 10.1089/zeb.2012.0858; Collymore C, 2014, J AM ASSOC LAB ANIM, V53, P198; Gomes L. C., 2006, Braz. J. Biol., V66, P493, DOI 10.1590/S1519-69842006000300015; Grottum JA, 1996, COMP BIOCHEM PHYS A, V115, P323, DOI 10.1016/S0300-9629(96)00100-4; Kugino K, 2014, International Applications under the Patent Cooperation Treaty Patent, Patent No. [PCT/JP2014/053673, 2014053673]; Laplace P. S., 1805, TRAITE MECH CELESTE, V10, P349; Mi HB, 2012, FISH PHYSIOL BIOCHEM, V38, P1721, DOI 10.1007/s10695-012-9669-2; MITSUDA H, 1982, J NUTR SCI VITAMINOL, V28, P35, DOI 10.3177/jnsv.28.35; Mitsuda H, 1991, JPN J FREEZING DRYIN, V37, P54; Stokes G.G., 1845, T CAMBRIDGE PHILOS S, V8, P287; TAKEDA T, 1983, B JPN SOC SCI FISH, V49, P725; Talley L., 2006, OCEANOGR, V19, P32, DOI [10.5670/oceanog.2006.42, DOI 10.5670/OCEANOG.2006.42]; Watanabe K., 2006, AQUACULTURE SCI, V54, P255, DOI [10.11233/aquaculturesci1953.54.255, DOI 10.11233/AQUACULTURESCI1953.54.255]; Watanabe K, 2007, NIPPON SUISAN GAKK, V73, P287, DOI 10.2331/suisan.73.287; Young T., 1805, PHILOS T R SOC LONDO, V95, P65, DOI [10.1098/rstl.1805.0005, DOI 10.1098/RSTL.1805.0005]	17	13	14	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153542	10.1371/journal.pone.0153542	http://dx.doi.org/10.1371/journal.pone.0153542			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100285	gold, Green Submitted, Green Published			2022-12-27	WOS:000374898500040
J	Salas-Gismondi, R; Flynn, JJ; Baby, P; Tejada-Lara, JV; Claude, J; Antoine, PO				Salas-Gismondi, Rodolfo; Flynn, John J.; Baby, Patrice; Tejada-Lara, Julia V.; Claude, Julien; Antoine, Pierre-Olivier			A New 13 Million Year Old Gavialoid Crocodylian from Proto-Amazonian Mega-Wetlands Reveals Parallel Evolutionary Trends in Skull Shape Linked to Longirostry	PLOS ONE			English	Article							MIOCENE; PALEOCENE; BASIN; CONNECTIONS; DIVERSITY; OLIGOCENE; GHARIAL; URUMACO	Gavialoid crocodylians are the archetypal longirostrine archosaurs and, as such, understanding their patterns of evolution is fundamental to recognizing cranial rearrangements and reconstructing adaptive pathways associated with elongation of the rostrum (longirostry). The living Indian gharial Gavialis gangeticus is the sole survivor of the group, thus providing unique evidence on the distinctive biology of its fossil kin. Yet phylogenetic relationships and evolutionary ecology spanning similar to 70 million-years of longirostrine crocodylian diversification remain unclear. Analysis of cranial anatomy of a new proto-Amazonian gavialoid, Gryposuchus pachakamue sp. nov., from the Miocene lakes and swamps of the Pebas Mega-Wetland System reveals that acquisition of both widely separated and protruding eyes (telescoped orbits) and riverine ecology within South American and Indian gavialoids is the result of parallel evolution. Phylogenetic and morphometric analyses show that, in association with longirostry, circumorbital bone configuration can evolve rapidly for coping with trends in environmental conditions and may reflect shifts in feeding strategy. Our results support a long-term radiation of the South American forms, with taxa occupying either extreme of the gavialoid morphospace showing preferences for coastal marine versus fluvial environments. The early biogeographic history of South American gavialoids was strongly linked to the northward drainage system connecting proto-Amazonian wetlands to the Caribbean region.	[Salas-Gismondi, Rodolfo; Claude, Julien; Antoine, Pierre-Olivier] Univ Montpellier, Inst Sci eVOLUT, CNRS, IRD,EPHE, F-34095 Montpellier, France; [Salas-Gismondi, Rodolfo; Tejada-Lara, Julia V.] Univ Nacl Mayor San Marcos, Dept Paleontol Vertebrados, Museo Hist Nat, Ave Arenales 1256, Lima 14, Peru; [Flynn, John J.; Tejada-Lara, Julia V.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Baby, Patrice] Univ Toulouse, Geoscie Environm Toulouse, UPS SVT OMP, CNRS,IRD, 14 Ave Edouard Belin, F-31400 Toulouse, France; [Baby, Patrice] Convenio IRD PeruPetro, Ave Luis Aldana 320, Lima, Peru; [Tejada-Lara, Julia V.] Columbia Univ, Dept Earth & Environm Sci, New York, NY USA	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universidad Nacional Mayor de San Marcos; American Museum of Natural History (AMNH); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Columbia University	Salas-Gismondi, R (corresponding author), Univ Montpellier, Inst Sci eVOLUT, CNRS, IRD,EPHE, F-34095 Montpellier, France.; Salas-Gismondi, R (corresponding author), Univ Nacl Mayor San Marcos, Dept Paleontol Vertebrados, Museo Hist Nat, Ave Arenales 1256, Lima 14, Peru.	rodolfo.salas-gismondi@univ-montp2.fr	Baby, Patrice/D-2936-2009; Baby, Patrice/AAL-6640-2021; claude, julien/G-7411-2016	Baby, Patrice/0000-0001-6142-5174; Baby, Patrice/0000-0001-6142-5174; claude, julien/0000-0002-9267-1228; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	Frick Fund, Division of Paleontology, American Museum of Natural History; Escuela Doctoral Franco-Peruana en Ciencias de la Vida; Frick Fund (American Museum of Natural History)	Frick Fund, Division of Paleontology, American Museum of Natural History; Escuela Doctoral Franco-Peruana en Ciencias de la Vida; Frick Fund (American Museum of Natural History)	The study was financially supported by the Frick Fund, Division of Paleontology, American Museum of Natural History. RS-G benefitted from a Doctoral grant of the Escuela Doctoral Franco-Peruana en Ciencias de la Vida, and from financial support of the Frick Fund (American Museum of Natural History) and the Projects-Sud of the ISEM for visiting collections, Institut de Recherche pour le Developpement, and from CampusFrance.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; Aguilera O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076202; Blakey RC, 2008, GEOL SOC AM SPEC PAP, V441, P1, DOI 10.1130/2008.2441(01); Bocquentin Villanueva J., 1981, Geobios (Villeurbanne), V14, P415; Boonstra M, 2015, PALAEOGEOGR PALAEOCL, V417, P176, DOI 10.1016/j.palaeo.2014.10.032; Brochu CA, 2004, J VERTEBR PALEONTOL, V24, P610, DOI 10.1671/0272-4634(2004)024[0610:ANLCGC]2.0.CO;2; Brochu CA, 2006, J PALEONTOL, V80, P162, DOI 10.1666/0022-3360(2006)080[0162:OAPSOE]2.0.CO;2; Brochu CA, 2004, SPEC PAP PALAEONTOL, P61; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; Brochu CA, 2011, ZOOL J LINN SOC-LOND, V163, pS228, DOI 10.1111/j.1096-3642.2011.00716.x; Buffetaut E, 1982, GEOBIOS MEMOIRE SPEC, V15, P127, DOI DOI 10.1016/S0016-6995(82)80107-1; CLARK JM, 1994, IN THE SHADOW OF THE DINOSAURS, P84; Claude J, 2008, MORPHOMETRICS R; Cozzuol MA, 2006, J S AM EARTH SCI, V21, P185, DOI 10.1016/j.jsames.2006.03.005; Gasparini Z, 1968, AMEGHINIANA, V8, P299; Gatesy J, 2003, SYST BIOL, V52, P403, DOI 10.1080/10635150390197037; Gingras MK, 2002, J SEDIMENT RES, V72, P871, DOI 10.1306/052002720871; Gmelin J., 1789, LINNEI SYSTEMA NATUR; Goloboff P, 2008, CLADISTICS, V24, P91; Gurich GJE, 1912, JB HAMBURG WISE ANAT, VXXIX, P59; Harshman J, 2003, SYST BIOL, V52, P386, DOI 10.1080/10635150390197028; Hass CA, 1992, MOL PHYLOGENET EVOL, V1, P193, DOI 10.1016/1055-7903(92)90015-9; Hay O.P., 1930, CARNEGIE I WASHINGTO, V390, P1; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1994, PALAEOGEOGR PALAEOCL, V112, P187, DOI 10.1016/0031-0182(94)90074-4; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2010, AMAZONIA: LANDSCAPE AND SPECIES EVOLUTION: A LOOK INTO THE PAST, P123; Hovikoski J, 2001, THESIS U TURKU FINLA; Hua S, 2004, J VERTEBR PALEONTOL, V24, P341, DOI 10.1671/1104; Huxley T.H., 1875, Q J GEOLOGICAL SOC, V41, P423, DOI DOI 10.1144/GSL.JGS.1875.031.01-04.29; Jouve S, 2008, J VERTEBR PALEONTOL, V28, P409, DOI 10.1671/0272-4634(2008)28[409:TOACPP]2.0.CO;2; Jouve S, 2006, GEOBIOS-LYON, V39, P817, DOI 10.1016/j.geobios.2005.07.003; KALIN JOSEF ALOIS, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P535; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Kraus R., 1998, PALAONTOLOGISCHE Z, V72, P389, DOI DOI 10.1007/BF02988368; Langston W., 1965, U CALIFORNIA PUBLICA, V52, P1; Langston Wann Jr., 1997, P113; Lovejoy NR, 1998, NATURE, V396, P421, DOI 10.1038/24757; Lundberg John G., 1998, P13; Martin JE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5658; Martin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044541; Mook CC, 1921, B AM MUS NAT HIST, V44, P51; Moraes-Santos H, 2011, ZOOL J LINN SOC-LOND, V163, pS132, DOI 10.1111/j.1096-3642.2011.00710.x; Moreno F, 2015, SWISS J PALAEONTOL, V134, P5, DOI 10.1007/s13358-015-0071-4; Munoz-Torres FA, 2006, J S AM EARTH SCI, V21, P75, DOI 10.1016/j.jsames.2005.08.005; NORELL MA, 1989, J HERPETOL, V23, P325, DOI 10.2307/1564042; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Quiroz L, 2010, URUMACO VENEZUELAN P, P153; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rebata LA, 2006, J S AM EARTH SCI, V21, P116, DOI [10.10116/ jsames.2005.07.011, DOI 10.10116/JSAMES.2005.07]; Riff D, 2008, PALAEONTOL Z, V82, P178, DOI 10.1007/BF02988408; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; Rohlf FJ, 1999, J CLASSIF, V16, P197, DOI 10.1007/s003579900054; Salas-Gismondi R., 2007, Cuadernos del Museo Geominero, V8, P355; Salas-Gismondi R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2490; Sanchez-Villagra MR, 2006, J SYST PALAEONTOL, V4, P213, DOI 10.1017/S1477201906001829; Scheyer TM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2940; SILL W D, 1970, Ameghiniana, V7, P151; Tejada-Lara JV, 2015, PALAEONTOLOGY, V58, P341, DOI 10.1111/pala.12147; THORBJARNARSON JB, 1990, J HERPETOL, V24, P99, DOI 10.2307/1564301; Vargas-Llosa M, 1987, EL HABLADOR; Velez-Juarbe J, 2007, P ROY SOC B-BIOL SCI, V274, P1245, DOI 10.1098/rspb.2006.0455; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P291; Wesselingh FP, 2006, J S AM EARTH SCI, V21, P49, DOI 10.1016/j.jsames.2005.07.013; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Whitaker R., 1983, J BOMBAY NAT HIST SO, V79, P531; Wilberg EW, 2015, SYST BIOL, V64, P621, DOI 10.1093/sysbio/syv020	69	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152453	10.1371/journal.pone.0152453	http://dx.doi.org/10.1371/journal.pone.0152453			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097031	Green Published, Green Accepted, gold			2022-12-27	WOS:000374543600011
J	Spitz, A; Gimmler, A; Stoeck, T; Zweig, KA; Horvat, EA				Spitz, Andreas; Gimmler, Anna; Stoeck, Thorsten; Zweig, Katharina Anna; Horvat, Emoke-Agnes			Assessing Low-Intensity Relationships in Complex Networks	PLOS ONE			English	Article							LINK-PREDICTION	Many large network data sets are noisy and contain links representing low-intensity relationships that are difficult to differentiate from random interactions. This is especially relevant for high-throughput data from systems biology, large-scale ecological data, but also for Web 2.0 data on human interactions. In these networks with missing and spurious links, it is possible to refine the data based on the principle of structural similarity, which assesses the shared neighborhood of two nodes. By using similarity measures to globally rank all possible links and choosing the top-ranked pairs, true links can be validated, missing links inferred, and spurious observations removed. While many similarity measures have been proposed to this end, there is no general consensus on which one to use. In this article, we first contribute a set of benchmarks for complex networks from three different settings (e-commerce, systems biology, and social networks) and thus enable a quantitative performance analysis of classic node similarity measures. Based on this, we then propose a new methodology for link assessment called z* that assesses the statistical significance of the number of their common neighbors by comparison with the expected value in a suitably chosen random graph model and which is a consistently top-performing algorithm for all benchmarks. In addition to a global ranking of links, we also use this method to identify the most similar neighbors of each single node in a local ranking, thereby showing the versatility of the method in two distinct scenarios and augmenting its applicability. Finally, we perform an exploratory analysis on an oceanographic plankton data set and find that the distribution of microbes follows similar biogeographic rules as those of macroorganisms, a result that rejects the global dispersal hypothesis for microbes.	[Horvat, Emoke-Agnes] Northwestern Univ, NICO, Evanston, IL USA; [Spitz, Andreas] Heidelberg Univ, Inst Comp Sci, Heidelberg, BW, Germany; [Gimmler, Anna; Stoeck, Thorsten] Univ Kaiserslautern, Dept Ecol, D-67663 Kaiserslautern, RP, Germany; [Zweig, Katharina Anna] Univ Kaiserslautern, Dept Comp Sci, D-67663 Kaiserslautern, RP, Germany	Northwestern University; Ruprecht Karls University Heidelberg; University of Kaiserslautern; University of Kaiserslautern	Zweig, KA (corresponding author), Univ Kaiserslautern, Dept Comp Sci, D-67663 Kaiserslautern, RP, Germany.	zweig@cs.uni-kl.de			Deutsche Forschungsgemeinschaft [STO414/11-1]; BioComp	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioComp	This work was supported by Deutsche Forschungsgemeinschaft, grant No. STO414/11-1 to TS (http://www.dfg.de), and BioComp, no specific grant number, granted to TS, AG, and KZ (http://www.uni-kl.de/en/vorlage-einrichtung/home/).	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Bascompte J, 2009, SCIENCE, V325, P416, DOI 10.1126/science.1170749; Berger A, 2010, LECT NOTES COMPUT SC, V6410, P220; Cobb GW, 2003, AM MATH MON, V110, P265, DOI 10.2307/3647877; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; de Vargas C, 2015, SCIENCE, V348, DOI 10.1126/science.1261605; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Geng LQ, 2006, ACM COMPUT SURV, V38, DOI 10.1145/1132960.1132963; Getoor L., 2005, ACM SIGKDD EXPLORATI, V7, P3, DOI DOI 10.1145/1117454.1117456; Goldberg DS, 2003, P NATL ACAD SCI USA, V100, P4372, DOI 10.1073/pnas.0735871100; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Hanczar B, 2010, BIOINFORMATICS, V26, P822, DOI 10.1093/bioinformatics/btq037; Horvat EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073413; Jaccard P., 1901, B SOC VAUD SCI N, V37, P241, DOI DOI 10.5169/SEALS-266450; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leicht EA, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026120; Li MH, 2005, PHYSICA A, V350, P643, DOI 10.1016/j.physa.2004.11.039; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Linden G, 2003, IEEE INTERNET COMPUT, V7, P76, DOI 10.1109/MIC.2003.1167344; Lorrain F., 1971, J MATH SOCIOL, V1, P49, DOI [10.1080/0022250X.1971.9989788, DOI 10.1080/0022250X.1971.9989788, 10.1080/0022250x.1971.9989788]; Lozier MS, 2010, SCIENCE, V328, P1507, DOI 10.1126/science.1189250; Lu LY, 2012, PHYS REP, V519, P1, DOI 10.1016/j.physrep.2012.02.006; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Malumbres M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.2; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; PRICE JF, 1993, SCIENCE, V259, P1277, DOI 10.1126/science.259.5099.1277; RODGERS JL, 1988, AM STAT, V42, P59, DOI 10.2307/2685263; Salton G., 1986, INTRO MODERN INFORM; Schlauch WE, 2015, SOC NETW ANAL MIN, V5, DOI 10.1007/s13278-015-0267-z; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Uhlmann S, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.100; Vega-Redondo F., 2007, COMPLEX SOCIAL NETWO, P268; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wolf YI, 2002, BIOESSAYS, V24, P105, DOI 10.1002/bies.10059; Yang J., 2012, P ACM SIGKDD WORKSH, P3, DOI DOI 10.1145/2350190.2350193; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8; Zweig KA, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P200, DOI 10.1109/ASONAM.2010.24; Zweig KA, 2011, SOC NETW ANAL MIN, V1, P187, DOI 10.1007/s13278-011-0021-0	49	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152536	10.1371/journal.pone.0152536	http://dx.doi.org/10.1371/journal.pone.0152536			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096435	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600015
J	El-Mallawany, NK; Kamiyango, W; Slone, JS; Villiera, J; Kovarik, CL; Cox, CM; Dittmer, DP; Ahmed, S; Schutze, GE; Scheurer, ME; Kazembe, PN; Mehta, PS				El-Mallawany, Nader Kim; Kamiyango, William; Slone, Jeremy S.; Villiera, Jimmy; Kovarik, Carrie L.; Cox, Carrie M.; Dittmer, Dirk P.; Ahmed, Saeed; Schutze, Gordon E.; Scheurer, Michael E.; Kazembe, Peter N.; Mehta, Parth S.			Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study	PLOS ONE			English	Article							MULTICENTRIC CASTLEMAN DISEASE; MOTHER-TO-CHILD; HUMAN-HERPESVIRUS-8 INFECTION; UGANDAN CHILDREN; HERPESVIRUS KSHV; ENDEMIC REGION; TRANSMISSION; CANCER; AIDS; SEROPREVALENCE	Kaposi sarcoma (KS) is the most common HIV-associated malignancy in children and adolescents in Africa. Pediatric KS is distinct from adult disease. We evaluated the clinical characteristics associated with long-term outcomes. We performed a retrospective observational analysis of 70 HIV-infected children and adolescents with KS less than 18 years of age diagnosed between 8/2010 and 6/2013 in Lilongwe, Malawi. Local first-line treatment included bleomycin and vincristine plus nevirapine-based highly active anti-retroviral therapy (HAART). Median age was 8.6 years (range 1.7-17.9); there were 35 females (50%). Most common sites of presentation were: lymph node (74%), skin (59%), subcutaneous nodules (33%), oral (27%), woody edema (24%), and visceral (16%). Eighteen (26%) presented with lymphadenopathy only. Severe CD4 suppression occurred in 28%. At time of KS diagnosis, 49% were already on HAART. Overall, 28% presented with a platelet count < 100 x 10(9)/L and 37% with hemoglobin < 8 g/dL. The 2-year event-free (EFS) and overall survival (OS) were 46% and 58% respectively (median follow-up 29 months, range 15-50). Multivariable analysis of risk of death and failure to achieve EFS demonstrated that visceral disease (odds ratios [OR] 19.08 and 11.61, 95% CI 2.22-163.90 and 1.60-83.95 respectively) and presenting with more than 20 skin/oral lesions (OR 9.57 and 22.90, 95% CI 1.01-90.99 and 1.00-524.13 respectively) were independent risk factors for both. Woody edema was associated with failure to achieve EFS (OR 7.80, 95% CI 1.84-33.08) but not death. Univariable analysis revealed that lymph node involvement was favorable for EFS (OR 0.28, 95% CI 0.08-0.99), while T-1 TIS staging criteria, presence of cytopenias, and severe immune suppression were not associated with increased mortality. Long-term complete remission is achievable in pediatric KS, however outcomes vary according to clinical presentation. Based on clinical heterogeneity, treatment according to risk-stratification is necessary to improve overall outcomes.	[El-Mallawany, Nader Kim] New York Med Coll, Dept Pediat, Div Hematol Oncol & Hematopoiet Stem Cell Transpl, Valhalla, NY 10595 USA; [El-Mallawany, Nader Kim; Slone, Jeremy S.; Scheurer, Michael E.; Mehta, Parth S.] Baylor Coll Med, Dept Pediat, Sect Hematol & Oncol, Houston, TX 77030 USA; [Kamiyango, William; Villiera, Jimmy; Ahmed, Saeed; Kazembe, Peter N.] Baylor Coll Med Childrens Fdn Malawi, Lilongwe, Malawi; [Slone, Jeremy S.; Scheurer, Michael E.; Mehta, Parth S.] Texas Childrens Canc Ctr, Houston, TX USA; [Slone, Jeremy S.; Scheurer, Michael E.; Mehta, Parth S.] Texas Childrens Hematol Ctr, Houston, TX USA; [Kovarik, Carrie L.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Cox, Carrie M.] Loyola Univ Chicago, Stritch Sch Med, Dept Pediat, Maywood, IL USA; [Dittmer, Dirk P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ahmed, Saeed; Schutze, Gordon E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	New York Medical College; Baylor College of Medicine; Texas Children's Cancer Center; University of Pennsylvania; Loyola University Chicago; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine	El-Mallawany, NK (corresponding author), New York Med Coll, Dept Pediat, Div Hematol Oncol & Hematopoiet Stem Cell Transpl, Valhalla, NY 10595 USA.; El-Mallawany, NK (corresponding author), Baylor Coll Med, Dept Pediat, Sect Hematol & Oncol, Houston, TX 77030 USA.	nader.el-mallawany@bcm.edu	Dittmer, Dirk/AAH-3535-2021; Dittmer, Dirk/GPW-7423-2022; Slone, Jeremy S./AAW-5762-2021	Dittmer, Dirk/0000-0003-4968-5656; Slone, Jeremy S./0000-0002-0700-7104; Kovarik, Carrie/0000-0002-3258-3605; Scheurer, Michael/0000-0002-8379-6088; El-Mallawany, Nader/0000-0001-6115-1046	United States Agency for International Development through the Tingathe Program [674-A-00-10-00093-00]; ConocoPhillips; public health service [CA019014, CA190152, CA192744]; NATIONAL CANCER INSTITUTE [P30CA016086, P01CA019014, U54CA190152, R01CA163217, R21CA192744] Funding Source: NIH RePORTER	United States Agency for International Development through the Tingathe Program(United States Agency for International Development (USAID)); ConocoPhillips; public health service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for the pediatric HIV-associated malignancy and oncology program was provided by a grant from the United States Agency for International Development through the Tingathe Program via cooperative agreement number 674-A-00-10-00093-00 and philanthropic contributions to purchase chemotherapy from ConocoPhillips. The Kamuzu Central Hospital pathology laboratory and Kaposi sarcoma research at the University of North Carolina Project-Malawi are supported by public health service grants CA019014, CA190152, and CA192744. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni M, 2002, JAMA-J AM MED ASSOC, V287, P1295, DOI 10.1001/jama.287.10.1295; Anglemyer A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000034.pub2; [Anonymous], 2009, WHO CHILD GROWTH STA; Arkin LM, 2009, PEDIATR INFECT DIS J, V28, P426, DOI 10.1097/INF.0b013e318193ee21; Biggar RJ, 2000, JAMA-J AM MED ASSOC, V284, P205, DOI 10.1001/jama.284.2.205; Bourboulia D, 1998, JAMA-J AM MED ASSOC, V280, P31, DOI 10.1001/jama.280.1.31-a; Caselli D, 2000, J CLIN ONCOL, V18, P3854, DOI 10.1200/JCO.2000.18.22.3854; Chagaluka G, 2014, EUR J CANCER, V50, P1472, DOI 10.1016/j.ejca.2014.02.019; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatlynne LG, 1999, SEMIN CANCER BIOL, V9, P175, DOI 10.1006/scbi.1998.0089; Cox CM, 2013, PEDIATR BLOOD CANCER, V60, P1274, DOI 10.1002/pbc.24516; DeSantis Stacia M., 2002, International Journal of Infectious Diseases, V6, P266, DOI 10.1016/S1201-9712(02)90159-1; Dollard SC, 2010, INT J CANCER, V127, P2395, DOI 10.1002/ijc.25235; Dow DE, 2014, J PEDIATR INFECT DIS, V3, P66, DOI 10.1093/jpids/pit051; Evans JA, 1997, ARCH DIS CHILD, V76, P330, DOI 10.1136/adc.76.4.330; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Gantt S, 2010, PEDIATR BLOOD CANCER, V54, P670, DOI 10.1002/pbc.22369; Gopal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070361; Granovsky MO, 1998, J CLIN ONCOL, V16, P1729, DOI 10.1200/JCO.1998.16.5.1729; Herce ME, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19929; Hosseinipour MC, 2014, MBIO, V5, DOI 10.1128/mBio.01633-14; Kasolo FC, 2007, J MED VIROL, V79, P1555, DOI 10.1002/jmv.20952; Kest H, 2005, PEDIATR INFECT DIS J, V24, P237, DOI 10.1097/01.inf.0000154324.59426.8d; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Martro E, 2004, J MED VIROL, V72, P126, DOI 10.1002/jmv.10548; Mayama S, 1998, INT J CANCER, V77, P817, DOI 10.1002/(SICI)1097-0215(19980911)77:6&lt;817::AID-IJC2&gt;3.0.CO;2-X; Mbulaiteye SM, 2003, J INFECT DIS, V187, P1780, DOI 10.1086/374973; Olsen SJ, 1998, AIDS, V12, P1921, DOI 10.1097/00002030-199814000-00024; OLWENY CLM, 1976, BRIT J CANCER, V33, P555, DOI 10.1038/bjc.1976.88; Orem J, 2004, CURR OPIN ONCOL, V16, P468, DOI 10.1097/00001622-200409000-00010; Pfeiffer RM, 2010, ANN EPIDEMIOL, V20, P958, DOI 10.1016/j.annepidem.2010.07.098; Plancoulaine S, 2000, LANCET, V356, P1062, DOI 10.1016/S0140-6736(00)02729-X; Polizzotto MN, 2013, BLOOD, V122, P4189, DOI 10.1182/blood-2013-08-519959; Polizzotto MN, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00073; Pollock BH, 2003, JAMA-J AM MED ASSOC, V289, P2393, DOI 10.1001/jama.289.18.2393; Reddy-Holdcraft S, 2014, AIDS, V28, P800, DOI 10.1097/QAD.0000000000000157; Rohner E, 2016, INT J CANCER, V138, P45, DOI 10.1002/ijc.29687; Sarmati Loredana, 2004, Herpes, V11, P50; SLAVIN G, 1970, J PATHOL, V100, P187, DOI 10.1002/path.1711000307; Stefan DC, 2011, PEDIATR BLOOD CANCER, V56, P392, DOI 10.1002/pbc.22903; Tobin NH, 2013, IMMUNOL REV, V254, P143, DOI 10.1111/imr.12074; Tweya H, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-183; Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798; Vaz P, 2011, PEDIATR INFECT DIS J, V30, P891, DOI 10.1097/INF.0b013e318228fb04; Venkataraman G, 2013, AM J CLIN PATHOL, V139, P651, DOI 10.1309/AJCPKGF7U8AWQBVG	46	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153335	10.1371/journal.pone.0153335	http://dx.doi.org/10.1371/journal.pone.0153335			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082863	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800015
J	Gore, ML; Lute, ML; Ratsimbazafy, JH; Rajaonson, A				Gore, Meredith L.; Lute, Michelle L.; Ratsimbazafy, Jonah H.; Rajaonson, Andry			Local Perspectives on Environmental Insecurity and Its Influence on Illegal Biodiversity Exploitation	PLOS ONE			English	Article							WILDLIFE; CONSERVATION; SECURITY; MADAGASCAR; CONFLICT; TRADE	Environmental insecurity is a source and outcome of biodiversity declines and social conflict. One challenge to scaling insecurity reduction policies is that empirical evidence about local attitudes is overwhelmingly missing. We set three objectives: determine how local people rank risk associated with different sources of environmental insecurity; assess perceptions of environmental insecurity, biodiversity exploitation, myths of nature and risk management preferences; and explore relationships between perceptions and biodiversity exploitation. We conducted interviews (N = 88) with residents of Madagascar's Torotorofotsy Protected Area, 2014. Risk perceptions had a moderate effect on perceptions of environmental insecurity. We found no effects of environmental insecurity on biodiversity exploitation. Results offer one if not the first exploration of local perceptions of illegal biodiversity exploitation and environmental security. Local people's perception of risk seriousness associated with illegal biodiversity exploitation such as lemur hunting (low overall) may not reflect perceptions of policy-makers (considered to be high). Discord is a key entry point for attention.	[Gore, Meredith L.] Michigan State Univ, Dept Fisheries & Wildlife, Sch Criminal Justice, E Lansing, MI 48824 USA; [Lute, Michelle L.] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Ratsimbazafy, Jonah H.] Grp Etud & Rech Primates Madagascar GERP, Antananarivo, Madagascar; [Rajaonson, Andry] Malagasy Biologist Assoc, Antananarivo, Madagascar	Michigan State University; University of Nebraska System; University of Nebraska Lincoln	Gore, ML (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, Sch Criminal Justice, E Lansing, MI 48824 USA.	gorem@msu.edu	Gore, Meredith/AAY-4350-2020	Gore, Meredith/0000-0002-2613-4715				Barrett MA, 2009, NATURE, V461, P470, DOI 10.1038/461470a; Becker HS, 2001, CONT FIELD RES PERSP, V2nd, P317; Brashares JS, 2014, SCIENCE, V345, P376, DOI 10.1126/science.1256734; Brisman A, 2015, GREEN CRIMINOL, P1; Buzan B, 1995, 10 CTR PEACH CONFL R; Denzin N.K., 2013, LANDSCAPE QUALITATIV; DEUDNEY D, 1991, B ATOM SCI, V47, P22, DOI 10.1080/00963402.1991.11459957; Douglas M., 1978, 35 ROY ANTHR I GREAT; Douglas M., 1982, RISK CULTURE ESSAY S; Duffy R., 2010, NATURE CRIME WERE GE; Environmental Investigation Agency, 2015, HIGH PROF LOW RISK R; Erickson F., 1984, 81 MICH STAT U; Forsyth T., 2002, CRITICAL POLITICAL E, DOI 10.4324/9780203017562; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Gore M.L., 2007, HUMAN DIMENSIONS WIL, V12, P133, DOI DOI 10.1080/10871200701195985; Gore ML, 2006, WILDLIFE SOC B, V34, P36, DOI 10.2193/0091-7648(2006)34[36:SPORAW]2.0.CO;2; Gore ML, 2015, HUM DIMENS WILDL, V20, P159, DOI 10.1080/10871209.2014.992501; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Gore ML, 2011, CONSERV BIOL, V25, P659, DOI 10.1111/j.1523-1739.2011.01701.x; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Graeger N, 1996, J PEACE RES, V33, P109, DOI 10.1177/0022343396033001008; Hanisch-Kirkbride SL, 2013, J WILDLIFE DIS, V49, P841, DOI 10.7589/2013-02-031; Harvey CA, 2014, CONSERV LETT, V7, P77, DOI 10.1111/conl.12066; Heberlein T.A., 2012, NAVIGATING ENV ATTIT; Kahler JS, 2015, BIOL CONSERVATION; Lidskog R, 2013, ESSENTIALS RISK THEO, P75; Lodgaard S, 1992, ENV INT SECURITY, P11; Lonergan S, 1999, GLOBAL ENV CHANGE HU; Masse F., 2015, GEOFORUM, DOI http://doi.org/10.1016/j.geoforum.2015.03.005; Muter BA, 2012, RISK ANAL, DOI [10.1111/j.15396924.2012.01936.x, DOI 10.1111/J.15396924.2012.01936.X]; Nellemann C., 2014, ENV CRISIS THREATS S; O'Donoghue P, 2015, J APPL ECOL, DOI [10.1111/13652664.12452, DOI 10.1111/13652664.12452]; Obama B, 2013, EXECUTIVE ORDER 1364; Peng CYJ, 2002, J EDUC RES, V96, P3, DOI 10.1080/00220670209598786; Randrianja S., 2009, MADAGASCAR SHORT HIS; Ratsimbazafy J, 2013, COMMUNITY POLICING IN INDIGENOUS COMMUNITIES, P31; Robinson JE, 2015, BIOL CONSERV, V184, P42, DOI 10.1016/j.biocon.2014.12.019; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Solomon JN, 2015, BIOL CONSERV, V189, P1, DOI 10.1016/j.biocon.2015.04.028; Swart R, 1996, GLOBAL ENVIRON CHANG, V6, P187, DOI 10.1016/0959-3780(96)00014-3; Swart R, 1996, GLOBAL ENV CHANGE; Transparency International, 2002, CORR PERC IND 2002; Trochim William M. K, 2001, RES METHODS KNOWLEDG, V2nd; Tschakert P, 2007, GLOBAL ENVIRON CHANG, V17, P381, DOI 10.1016/j.gloenvcha.2006.11.008; Tyson P., 2002, 8 CONTINENT LIFE DEA; Vaske J., 2008, SURVEY RES ANAL APPL; White R, 2014, INT AFF, V90, P835, DOI 10.1111/1468-2346.12143; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104; World Bank, MAD DAT PROF 2007; Wyatt T., 2014, WILDLIFE TRAFFICKING	50	15	15	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0150337	10.1371/journal.pone.0150337	http://dx.doi.org/10.1371/journal.pone.0150337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082106	Green Published, gold			2022-12-27	WOS:000374291800001
J	Hidaka, T; Hayakawa, T; Kakamu, T; Kumagai, T; Hiruta, Y; Hata, J; Tsuji, M; Fukushima, T				Hidaka, Tomoo; Hayakawa, Takehito; Kakamu, Takeyasu; Kumagai, Tomohiro; Hiruta, Yuhei; Hata, Junko; Tsuji, Masayoshi; Fukushima, Tetsuhito			Prevalence of Metabolic Syndrome and Its Components among Japanese Workers by Clustered Business Category	PLOS ONE			English	Article							LONG-TERM PREDICTION; CARDIOVASCULAR MORTALITY; CLINICAL-VALUE; POPULATION; OBESITY; HEALTH; DISEASE; AREA; RISK; AGE	The present study was a cross-sectional study conducted to reveal the prevalence of metabolic syndrome and its components and describe the features of such prevalence among Japanese workers by clustered business category using big data. The data of approximately 120,000 workers were obtained from a national representative insurance organization, and the study analyzed the health checkup and questionnaire results according to the field of business of each subject. Abnormalities found during the checkups such as excessive waist circumference, hypertension or glucose intolerance, and metabolic syndrome, were recorded. All subjects were classified by business field into 18 categories based on The North American Industry Classification System. Based on the criteria of the Japanese Committee for the Diagnostic Criteria of Metabolic Syndrome, the standardized prevalence ratio (SPR) of metabolic syndrome and its components by business category was calculated, and the 95% confidence interval of the SPR was computed. Hierarchical cluster analysis was then performed based on the SPR of metabolic syndrome components, and the 18 business categories were classified into three clusters for both males and females. The following business categories were at significantly high risk of metabolic syndrome: among males, Construction, Transportation, Professional Services, and Cooperative Association; and among females, Health Care and Cooperative Association. The results of the cluster analysis indicated one cluster for each gender with a higher prevalence of metabolic syndrome components; among males, a cluster consisting of Manufacturing, Transportation, Finance, and Cooperative Association, and among females, a cluster consisting of Mining, Transportation, Finance, Accommodation, and Cooperative Association. These findings reveal that, when providing health guidance and support regarding metabolic syndrome, consideration must be given to its components and the variety of its prevalence rates by business category and gender.	[Hidaka, Tomoo; Hayakawa, Takehito; Kakamu, Takeyasu; Kumagai, Tomohiro; Fukushima, Tetsuhito] Fukushima Med Univ, Sch Med, Dept Hyg & Prevent Med, Fukushima, Fukushima, Japan; [Hiruta, Yuhei; Hata, Junko] Japan Hlth Insurance Assoc, Fukushima Branch Off, Fukushima, Fukushima, Japan; [Tsuji, Masayoshi] Fukuoka Univ, Fac Med, Dept Prevent Med & Publ Hlth, Fukuoka, Fukuoka 81401, Japan	Fukushima Medical University; Fukuoka University	Hidaka, T (corresponding author), Fukushima Med Univ, Sch Med, Dept Hyg & Prevent Med, Fukushima, Fukushima, Japan.	thidaka@fmu.ac.jp	PAN, ZEQIANG/X-6341-2018; Kakamu, Takeyasu/AAP-7766-2020	Hidaka, Tomoo/0000-0003-2987-4804; Kakamu, Takeyasu/0000-0001-6920-8457	Japan Health Insurance Association	Japan Health Insurance Association	The authors received no specific funding for this work. Japan Health Insurance Association provided support in the form of salaries for authors YH and JH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adeoye AM, 2015, J CLIN HYPERTENS, V17, P880, DOI 10.1111/jch.12595; Al-Daghri NM, 2014, BMC CARDIOVASC DISOR, V14, DOI [10.1186/1471-2261-14-51, 10.1186/1471-2458-14-391]; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Cheserek MJ, 2014, J CLIN DIAGN RES, V8, P65, DOI 10.7860/JCDR/2014/6515.4010; Dunning KK, 2010, AM J IND MED, V53, P276, DOI 10.1002/ajim.20774; Farmer A, 2006, BRIT MED J, V332, P882, DOI 10.1136/bmj.332.7546.882; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Kuzuya M, 2007, ATHEROSCLEROSIS, V191, P305, DOI 10.1016/j.atherosclerosis.2006.05.043; Luckhaupt SE, 2014, AM J PREV MED, V46, P237, DOI 10.1016/j.amepre.2013.11.002; Matsuzawa Y, 2005, J ATHEROSCLER THROMB, V12, P301, DOI 10.5551/jat.12.301; Nakao YM, 2012, P JPN ACAD B-PHYS, V88, P454, DOI 10.2183/pjab.88.454; Pathania D, 2014, J FAM COMMUNITY MED, V21, P130, DOI 10.4103/2230-8229.134774; Pokharel DR, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/s40200-014-0104-3; Poulsen K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103425; Shin SY, 2013, ANN OCCUP ENVIRON ME, V25, DOI 10.1186/2052-4374-25-34; Sieber WK, 2014, AM J IND MED, V57, P615, DOI 10.1002/ajim.22293; Sundstrom J, 2006, BMJ-BRIT MED J, V332, P878, DOI 10.1136/bmj.38766.624097.1F; Tabatabaie AH, 2015, DIABETES METAB SYND, V9, P153, DOI 10.1016/j.dsx.2015.04.012; Takeuchi H, 2005, HYPERTENS RES, V28, P203, DOI 10.1291/hypres.28.203; U.S. Department of Commerce, 2015, INTR NAICS; Wild SH, 2011, METABOLIC SYNDROME, 2ND EDITION, P1; Zimmet P, 2005, J ATHEROSCLER THROMB, V12, P295, DOI 10.5551/jat.12.295	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153368	10.1371/journal.pone.0153368	http://dx.doi.org/10.1371/journal.pone.0153368			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082961	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800016
J	Daoud, A; Hallerod, B; Guha-Sapir, D				Daoud, Adel; Hallerod, Bjorn; Guha-Sapir, Debarati			What Is the Association between Absolute Child Poverty, Poor Governance, and Natural Disasters? A Global Comparison of Some of the Realities of Climate Change	PLOS ONE			English	Article							POLITICAL-ECONOMY; GOVERNMENT; INCOME; FLOOD	The paper explores the degree to which exposure to natural disasters and poor governance (quality of governance) is associated with absolute child poverty in sixty-seven middle-and low-income countries. The data is representative for about 2.8 billion of the world's population. Institutionalist tend to argue that many of society's ills, including poverty, derive from fragile or inefficient institutions. However, our findings show that although increasing quality of government tends to be associated with less poverty, the negative effects of natural disasters on child poverty are independent of a country's institutional efficiency. Increasing disaster victims (killed and affected) is associated with higher rates of child poverty. A child's estimated odds ratio to be in a state of absolute poverty increases by about a factor of 5.7 [95% CI: 1.7 to 18.7] when the average yearly toll of disasters in the child's country increases by one on a log-10 scale. Better governance correlates with less child poverty, but it does not modify the correlation between child poverty and natural disasters. The results are based on hierarchical regression models that partition the variance into three parts: child, household, and country. The models were cross-sectional and based on observational data from the Demographic Health Survey and the Multiple Indicator Cluster Survey, which were collected at the beginning of the twenty-first millennium. The Sustainable Development Goals are a principle declaration to halt climate change, but they lack a clear plan on how the burden of this change should be shared by the global community. Based on our results, we suggest that the development agencies should take this into account and to articulate more equitable global policies to protect the most vulnerable, specifically children.	[Daoud, Adel; Hallerod, Bjorn] Univ Cambridge, Dept Sociol, Cambridge, England; [Daoud, Adel] Univ Gothenburg, Dept Sociol & Work Sci, Gothenburg, Sweden; [Guha-Sapir, Debarati] Ctr Res Epidemiol Disasters CRED, Brussels, Belgium; [Guha-Sapir, Debarati] Univ Louvain, Sch Publ Hlth, Brussels, Belgium	University of Cambridge; University of Gothenburg; Universite Catholique Louvain	Daoud, A (corresponding author), Univ Cambridge, Dept Sociol, Cambridge, England.; Daoud, A (corresponding author), Univ Gothenburg, Dept Sociol & Work Sci, Gothenburg, Sweden.	Adel.daoud@sociology.gu.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funded by Swedish Research Council. Project name is "poor governance and poor children".	Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; Agnafors M, 2013, AM POLIT SCI REV, V107, P433, DOI 10.1017/S0003055413000191; Alkire S., 2007, COUNTING MULTIDIMENS; Anbarci N, 2005, J PUBLIC ECON, V89, P1907, DOI 10.1016/j.jpubeco.2004.08.002; Aneshensel C. S, 2013, THEORY BASED DATA AN; [Anonymous], 2013, QUALITY GOVT DATASET; [Anonymous], 2009, RELATIONSHIP NATURAL; Arndt C, 2008, INT PUBLIC MANAG J, V11, P275, DOI 10.1080/10967490802301278; Arndt Christiane., 2006, USES ABUSES GOVERNAN; Banerjee S., 2014, HIERARCHICAL MODELIN; Benson C., 2004, UNDERSTANDING EC FIN; Benson C., 2003, THESIS U LONDON LOND; Berry WD, 2012, J POLIT, V74, P653, DOI 10.1017/S0022381612000199; Blaikie P., 2014, RISK NATURAL HAZARDS, DOI DOI 10.4324/9780203714775; Blakely TA, 2000, J EPIDEMIOL COMMUN H, V54, P367, DOI 10.1136/jech.54.5.367; Boerma JT, 1996, CHILD SURIVIAL DEV C; Brambor T, 2006, POLIT ANAL, V14, P63, DOI 10.1093/pan/mpi014; Cannon T., 1994, DISASTERS DEV ENV, P13; Carter MR, 2007, WORLD DEV, V35, P835, DOI 10.1016/j.worlddev.2006.09.010; Daoud A, 2015, J S ASIAN DEV, V10, P148, DOI 10.1177/0973174115588844; Daoud A, 2011, BRIT J SOCIOL EDUC, V32, P603, DOI 10.1080/01425692.2011.578440; Daoud A, 2007, J CRIT REALISM, V6, P199, DOI 10.1558/jocr.v6i2.199; Daoud A, 2010, AM J ECON SOCIOL, V69, P1206, DOI 10.1111/j.1536-7150.2010.00741.x; Dobkowski M., 1998, COMING AGE SCARCITY; Goldstein H., 2011, MULTILEVEL STAT MODE, V4th; Gordon D., 2003, CHILD POVERTY DEV WO; Gordon D, 2010, MEASURING CHILD POVE; Grindle MS, 2007, DEV POLICY REV, V25, P553; Guha-Sapir D., 2004, 30 YEARS NATURAL DIS; Hallerod B, 2013, WORLD DEV, V48, P19, DOI 10.1016/j.worlddev.2013.03.007; Holmberg S, 2012, GOOD GOVERNMENT: THE RELEVANCE OF POLITICAL SCIENCE, P1; Holmberg S, 2010, HLTH EC POLICY LAW; Holmberg S, 2011, HEALTH ECON POLICY L, V6, P529, DOI 10.1017/S174413311000023X; Kahn ME, 2005, REV ECON STAT, V87, P271, DOI 10.1162/0034653053970339; Kam CD, 2013, MODELING INTERPRETIN, V44, P51; Kaufmann D, 2010, 1682130 SOC SCI RES; Kaufmann D, 1424591 SOC SCI RES; Keefer P, 2011, WORLD DEV, V39, P1530, DOI 10.1016/j.worlddev.2011.02.010; Kenny C, 2009, WHY DO PEOPLE DIE EA; Kim JJ, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.18481; Klomp J, 2014, GLOBAL ENVIRON CHANG, V26, P183, DOI 10.1016/j.gloenvcha.2014.02.006; Kron W, 2012, NAT HAZARD EARTH SYS, V12, P535, DOI 10.5194/nhess-12-535-2012; Lopez-Calva L F., 2009, EVIDENCE POLICY LESS; Luke DA, 2019, MULTILEVEL MODELING; Malthus Thomas Robert, 1826, ESSAY PRINCIPLE POPU, V6th; Masters A., 2003, J HUMAN DEV, V4, P379, DOI DOI 10.1080/1464988032000125755; Minujin A, 2006, ENVIRON URBAN, V18, P481, DOI 10.1177/0956247806069627; Nandy S, 2016, SOC SCI MED, V149, P153, DOI 10.1016/j.socscimed.2015.11.036; Neumayer E, 2007, ANN ASSOC AM GEOGR, V97, P551, DOI 10.1111/j.1467-8306.2007.00563.x; Neumayer E, 2014, GLOBAL ENVIRON CHANG, V24, P8, DOI 10.1016/j.gloenvcha.2013.03.011; Paul BK, 2011, ENVIRONMENTAL HAZARDS AND DISASTERS: CONTEXTS, PERSPECTIVES AND MANAGEMENT, P1, DOI 10.1002/9781119979616; Pogge T, 2009, INITIATIVE POLICY DI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ravallion M, 2010, DEBATES MEASUREMENT, P86; Reddy SG, 2015, FINANCIAL TIMES; Reddy SG, 2015, REDDYTOREAD; Richardson LF., 1960, STAT DEADLY QUARRELS, Vxlvi; Rodriguez-Oreggia E, 2010, WORKING PAPERS CTR I; Roelen K, 2008, MEASURING CHILD POVE; Rothstein B., 2011, QUALITY GOVT CORRUPT; Rowhani P, 2011, AGR FOREST METEOROL, V151, P449, DOI 10.1016/j.agrformet.2010.12.002; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; SEN A, 1991, INTERDISCIPL SCI REV, V16, P324; Skoufias E, 2003, WORLD DEV, V31, P1087, DOI 10.1016/S0305-750X(03)00069-X; Stallings RA, 2006, SAGE DICT SOCIAL RES; Steele F, 2014, MULTILEVEL MODELLING, p[15, 1]; Stormberg D, 2007, J ECON PERSPECT, V21, P199; Sudaryo MK, 2012, GLOBAL HEALTH ACTION, V5, P1, DOI 10.3402/gha.v5i0.11816; Toya H., 2005, EC DEV IMPACTS NATUR; Bich TH, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.6356; UNDP, 2015, UNDP CLIM CHANG; UNICEF, 2004, STAT WORLDS CHILDR G; United N, 1995, COP DECL PROGR ACT W; Weiss TG, 2000, THIRD WORLD Q, V21, P795, DOI 10.1080/713701075; Zhang Z, 2013, R2MLWIN V0 1 7	75	23	23	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153296	10.1371/journal.pone.0153296	http://dx.doi.org/10.1371/journal.pone.0153296			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ3UH	27077913	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700036
J	Kwai, NCG; Nigole, W; Poynten, AM; Brown, C; Krishnan, AV				Kwai, Natalie C. G.; Nigole, William; Poynten, Ann M.; Brown, Christopher; Krishnan, Arun V.			The Relationship between Dyslipidemia and Acute Axonal Function in Type 2 Diabetes Mellitus In Vivo	PLOS ONE			English	Article							HUMAN PERIPHERAL-NERVE; QUALITY-OF-LIFE; INTENSIVE TREATMENT; NEUROPATHY; DYSFUNCTION; HYPERGLYCEMIA; EXCITABILITY; MEMBRANE; HYPERLIPIDEMIA; COMPLICATIONS	Objectives Diabetic peripheral neuropathy (DPN) is a common and debilitating complication of diabetes mellitus. Treatment largely consists of symptom alleviation and there is a need to identify therapeutic targets for prevention and treatment of DPN. The objective of this study was to utilise novel neurophysiological techniques to investigate axonal function in patients with type 2 diabetes and to prospectively determine their relationship to serum lipids in type 2 diabetic patients. Methods Seventy-one patients with type 2 diabetes were consecutively recruited and tested. All patients underwent thorough clinical neurological assessments including nerve conduction studies, and median motor axonal excitability studies. Studies were also undertaken in age matched normal control subjects(n = 42). Biochemical studies, including serum lipid levels were obtained in all patients. Patient excitability data was compared to control data and linear regression analysis was performed to determine the relationship between serum triglycerides and low density lipoproteins and excitability parameters typically abnormal in type 2 diabetic patients. Results Patient mean age was 64.2 +/- 2.3 years, mean glycosylated haemoglobin (HbA1c%) was 7.8 +/- 0.3%, mean triglyceride concentration was 1.6 +/- 0.1 mmol/L and mean cholesterol concentration was 4.1 +/- 0.2 mmol/L. Compared to age matched controls, median motor axonal excitability studies indicated axonal dysfunction in type 2 diabetic patients as a whole (T2DM) and in a subgroup of the patients without DPN (T2DM-NN). These included reduced percentage threshold change during threshold electrotonus at 10-20ms depolarising currents (TEd10-20ms)(controls 68.4 +/- 0.8, T2DM63.9 +/- 0.8, T2DM-NN64.8 +/- 1.6%, P<0.05) and superexcitability during the recovery cycle (controls-22.5 +/- 0.9, T2DM-17.5 +/- 0.8, T2DM-NN-17.3 +/- 1.6%, P<0.05). Linear regression analysis revealed no associations between changes in axonal function and either serum triglyceride or low density lipoprotein concentration when adjusted for renal function, a separate risk factor for neuropathy development. Our findings indicate that acutely, serum lipids do not exert an acute effect on axonal function in type 2 diabetic patients: TEd(10-20ms)(1.2(-1.4,3.8); P = 0.4) and superexcitability (2.4 (-0.05, 4.8); P = 0.06). Conclusions These findings suggest that serum triglyceride levels are not related to axonal function in type 2 diabetic patients. Additional pathogenic mechanisms may play a more substantial role in axonal dysfunction prior to DPN development.	[Kwai, Natalie C. G.; Nigole, William; Krishnan, Arun V.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia; [Poynten, Ann M.] Prince Wales Hosp, Dept Endocrinol, Sydney, NSW, Australia; [Brown, Christopher] Univ Sydney, Natl Hlth & Med Res Council Clin Trials Ctr, Sydney, NSW 2006, Australia	University of New South Wales Sydney; University of Sydney	Krishnan, AV (corresponding author), Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW, Australia.	arun.krishnan@unsw.edu.au	Brown, Chris/H-2797-2019	Brown, Chris/0000-0003-2506-4871; Krishnan, Arun/0000-0001-8883-8825; Kwai, Natalie/0000-0003-2934-570X	Australian Government's Department of Education and Training; Australian Government's National Health and Medical Research Council of Australia [1065663]; Australian Postgraduate Award scholarship; National Health and Medical Research Council of Australia [1065663]	Australian Government's Department of Education and Training(Australian Government); Australian Government's National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	NK was supported by an Australian Postgraduate Award scholarship from the Australian Government's Department of Education and Training, https://education.gov.au/australian-postgraduate-awards. AK was supported by a Career Development Fellowship from the Australian Government's National Health and Medical Research Council of Australia (#1065663), https://www.nhmrc.gov.au/grants-funding/apply-funding/career-development-fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; N. K. was supported by an Australian Postgraduate Award scholarship. A. K. was supported by a Career Development Fellowship of the National Health and Medical Research Council of Australia (#1065663). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold R, 2014, CLIN NEUROPHYSIOL, V125, P179, DOI 10.1016/j.clinph.2013.06.022; Arnold R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059055; Arnold R, 2013, DIABETES-METAB RES, V29, P53, DOI 10.1002/dmrr.2360; Bae JS, 2007, J NEUROL, V254, P53, DOI 10.1007/s00415-006-0261-5; Bae JS, 2011, DIABETES RES CLIN PR, V91, P183, DOI 10.1016/j.diabres.2010.11.008; Becker M, 2014, J MOL NEUROSCI, V54, P704, DOI 10.1007/s12031-014-0424-2; Bierhaus A, 2004, J CLIN INVEST, V114, P1741, DOI 10.1172/JCI200418058; BOSTOCK H, 1983, J PHYSIOL-LONDON, V341, P59, DOI 10.1113/jphysiol.1983.sp014792; Bostock H, 1997, J PHYSIOL-LONDON, V498, P277, DOI 10.1113/jphysiol.1997.sp021857; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Bril V, 2012, J PERIPHER NERV SYST, V17, P22, DOI 10.1111/j.1529-8027.2012.00391.x; Burke D, 2001, CLIN NEUROPHYSIOL, V112, P1575, DOI 10.1016/S1388-2457(01)00595-8; Callaghan BC, 2012, LANCET NEUROL, V11, P521, DOI 10.1016/S1474-4422(12)70065-0; Charles M, 2013, DIABETOLOGIA, V56, P101, DOI 10.1007/s00125-012-2744-5; Cornblath DR, 1999, NEUROLOGY, V53, P1660, DOI 10.1212/WNL.53.8.1660; Davis TME, 2008, DIABETOLOGIA, V51, P562, DOI 10.1007/s00125-007-0919-2; Devaraj S, 2008, J CLIN ENDOCR METAB, V93, P578, DOI 10.1210/jc.2007-2185; Duksal T, 2016, ACTA NEUROL SCAND, V133, P384, DOI 10.1111/ane.12474; Fernyhough P, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0671-9; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; GREENE DA, 1984, AM J PHYSIOL, V246, pE311, DOI 10.1152/ajpendo.1984.246.4.E311; Huang TJ, 2003, DIABETES, V52, P2129, DOI 10.2337/diabetes.52.8.2129; Ismail-Beigi F, 2010, LANCET, V376, P419, DOI 10.1016/S0140-6736(10)60576-4; Kiernan MC, 2000, MUSCLE NERVE, V23, P399, DOI 10.1002/(SICI)1097-4598(200003)23:3<399::AID-MUS12>3.0.CO;2-G; Kiernan MC, 2000, BRAIN, V123, P2542, DOI 10.1093/brain/123.12.2542; Kikkawa Y, 2005, CLIN NEUROPHYSIOL, V116, P270, DOI 10.1016/j.clinph.2004.08.011; Krishnan AV, 2008, BRAIN, V131, P1209, DOI 10.1093/brain/awn052; Krishnan AV, 2009, PROG NEUROBIOL, V89, P288, DOI 10.1016/j.pneurobio.2009.08.002; Kwai NCG, 2013, DIABETES CARE, V36, P1272, DOI 10.2337/dc12-1310; Lupachyk S, 2012, FREE RADICAL BIO MED, V52, P1255, DOI 10.1016/j.freeradbiomed.2012.01.029; Misawa S, 2004, CLIN NEUROPHYSIOL, V115, P2525, DOI 10.1016/j.clinph.2004.06.008; Mogyoros I, 1996, BRAIN, V119, P439, DOI 10.1093/brain/119.2.439; O'Connor AB, 2009, PHARMACOECONOMICS, V27, P95, DOI 10.2165/00019053-200927020-00002; Padilla A, 2011, BRAIN RES, V1370, P64, DOI 10.1016/j.brainres.2010.11.013; Purwata Thomas Eko, 2011, J Pain Res, V4, P169, DOI 10.2147/JPR.S21751; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Smith AG, 2013, J DIABETES COMPLICAT, V27, P436, DOI 10.1016/j.jdiacomp.2013.04.003; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; Sung JY, 2012, DIABETES, V61, P1592, DOI 10.2337/db11-1509; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Van Acker K, 2009, DIABETES METAB, V35, P206, DOI 10.1016/j.diabet.2008.11.004; Vas PRJ, 2015, MUSCLE NERVE, V52, P113, DOI 10.1002/mus.24504; Viader A, 2013, NEURON, V77, P886, DOI 10.1016/j.neuron.2013.01.012; Vincent AM, 2011, NAT REV NEUROL, V7, P573, DOI 10.1038/nrneurol.2011.137; Vincent AM, 2009, J PERIPHER NERV SYST, V14, P257, DOI 10.1111/j.1529-8027.2009.00237.x; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Wiggin TD, 2009, DIABETES, V58, P1634, DOI 10.2337/db08-1771	48	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153389	10.1371/journal.pone.0153389	http://dx.doi.org/10.1371/journal.pone.0153389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078166	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700048
J	Lee, DW; Chung, S; Yoo, HJ; Kim, SJ; Woo, CW; Kim, ST; Lee, DH; Kim, KW; Kim, JK; Lee, JS; Choi, CG; Shim, WH; Choi, Y; Woo, DC				Lee, Do-Wan; Chung, Seockhoon; Yoo, Hyun Ju; Kim, Su Jung; Woo, Chul-Woong; Kim, Sang-Tae; Lee, Dong-Hoon; Kim, Kyung Won; Kim, Jeong-Kon; Lee, Jin Seong; Choi, Choong Gon; Shim, Woo Hyun; Choi, Yoonseok; Woo, Dong-Cheol			Neurochemical Changes Associated with Stress-Induced Sleep Disturbance in Rats: In Vivo and In Vitro Measurements	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; H-1-NMR SPECTROSCOPY; PRIMARY INSOMNIA; GLUTAMATE LEVELS; MOUSE-BRAIN; SEROTONIN; GABA; EUTHANASIA; DISORDERS	The goal of this study was to quantitatively assess the changes in the cerebral neurochemical profile and to identify those factors that contribute to the alteration of endogenous biomolecules when rats are subjected to stress-induced sleep disturbance. We exposed Sprague-Dawley rats (controls: n = 9; stress-induced sleep perturbation rats: n = 11) to a psychological stressor (cage exchange method) to achieve stress-induced sleep perturbation. In vivo magnetic resonance imaging assessments were carried out using a high-resolution 9.4 T system. For in vivo neurochemical analysis, a single voxel was localized in the right dorsal hippocampal region, and in vivo spectra were quantified for 17 cerebral neurochemical signals. Rats were sacrificed upon completion of the magnetic resonance spectroscopy protocol, and whole-brain tissue was harvested from twenty subjects. The dopamine and serotonin signals were obtained by performing in vitro liquid chromatography-tandem mass spectrometry on the harvested tissue. In the right dorsal hippocampal region, the gamma-aminobutyric-acid (GABA) and glutamine (Gln) concentrations were significantly higher in the sleep-perturbed rats than in the sham controls. The ratios of Gln/Glu (glutamate), Gln/tCr (total-creatine), and GABA/Glu were also significantly higher in the sleep-perturbed group, while serotonin concentrations were significantly lower in the sleep-perturbed rats. Pearson correlation results among individual rat data indicate that concentrations of dopamine (DA) and serotonin (5-HT) were significantly higher in SSP rats. A larger correlation coefficient was also observed for the SSP rats. Analysis of the correlation between the in vivo and in vitro signals indicated that the concentrations of Gln, 5-HT, and DA exhibited a significant negative correlation in the SSP rat data but not in that of control rats. The authors propose that the altered and correlated GABA, Gln, 5-HT, and DA concentrations/ratios could be considered key markers of neurological function in animal models of stress-induced sleep perturbation.	[Lee, Do-Wan; Lee, Dong-Hoon] Johns Hopkins Univ, Sch Med, Dept Radiol, Div MR Res, Baltimore, MD 21205 USA; [Lee, Do-Wan; Woo, Chul-Woong; Kim, Sang-Tae; Choi, Yoonseok; Woo, Dong-Cheol] Asan Med Ctr, Asan Inst Life Sci, MR Core Lab, Seoul, South Korea; [Chung, Seockhoon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Psychiat, Seoul, South Korea; [Yoo, Hyun Ju; Kim, Su Jung] Univ Ulsan, Coll Med, Biomed Res Ctr, Asan Inst Life Sci,Asan Med Ctr, Seoul, South Korea; [Kim, Kyung Won; Kim, Jeong-Kon; Lee, Jin Seong; Choi, Choong Gon; Shim, Woo Hyun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea	Johns Hopkins University; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Asan Medical Center	Woo, DC (corresponding author), Asan Med Ctr, Asan Inst Life Sci, MR Core Lab, Seoul, South Korea.	dcwoo@amc.seoul.kr	Chung, Seockhoon/AAS-6676-2021; Lee, Dong-Hoon/G-4959-2016	Chung, Seockhoon/0000-0002-9798-3642; Lee, Dong-Hoon/0000-0002-5013-4440	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, Korea [NRF-2015R1C1A1A02036526]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI] - Ministry of Health & Welfare, Republic of Korea [HI14C1090]	Basic Science Research Program through the National Research Foundation of Korea [NRF] - Ministry of Science, Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI] - Ministry of Health & Welfare, Republic of Korea	This study was supported by grants of Basic Science Research Program through the National Research Foundation of Korea funded [NRF (www.nrf.re.kr): NRF-2015R1C1A1A02036526], by the Ministry of Science, Korea (DCW), and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute [KHIDI (www.khidi.or.kr): HI14C1090], funded by the Ministry of Health & Welfare, Republic of Korea (DCW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA GB, 1994, NEUROSCI LETT, V176, P29, DOI 10.1016/0304-3940(94)90863-X; Bekris S, 2005, BEHAV BRAIN RES, V161, P45, DOI 10.1016/j.bbr.2005.01.005; BLACKSHAW JK, 1988, LAB ANIM, V22, P67, DOI 10.1258/002367788780746674; Bonnet MH, 2010, SLEEP MED REV, V14, P9, DOI 10.1016/j.smrv.2009.05.002; Brady KT, 2005, AM J PSYCHIAT, V162, P1483, DOI 10.1176/appi.ajp.162.8.1483; Bremner JD, 1999, BIOL PSYCHIAT, V45, P797, DOI 10.1016/S0006-3223(99)00009-8; Broman J, 2000, HDB CHEM NEUROANATOM; Cano G, 2008, J NEUROSCI, V28, P10167, DOI 10.1523/JNEUROSCI.1809-08.2008; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Close B, 1996, LAB ANIM-UK, V30, P293, DOI 10.1258/002367796780739871; Deuschle M, 2010, SLEEP, V33, P343, DOI 10.1093/sleep/33.3.343; Espie CA, 2002, ANNU REV PSYCHOL, V53, P215, DOI 10.1146/annurev.psych.53.100901.135243; Fu Y, 2012, APPL MAGN RESON, V43, P385, DOI 10.1007/s00723-012-0370-5; GILAD GM, 1990, BRAIN RES, V525, P335, DOI 10.1016/0006-8993(90)90886-G; HARTMANN E, 1971, PSYCHOPHARMACOLOGIA, V19, P114, DOI 10.1007/BF00402635; Hartmann E, 1967, PSYCHON SCI, V8, P295; Jemal M, 2000, BIOMED CHROMATOGR, V14, P422, DOI 10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO;2-I; JOUVET M, 1969, SCIENCE, V163, P32, DOI 10.1126/science.163.3862.32; Kakeda S, 2011, PSYCHIAT RES-NEUROIM, V192, P55, DOI 10.1016/j.pscychresns.2010.10.011; Kim SY, 2012, NEUROCHEM RES, V37, P740, DOI 10.1007/s11064-011-0668-y; Leach MC, 2002, COMPARATIVE MED, V52, P249; Lee DW, 2013, NEUROCHEM INT, V62, P502, DOI 10.1016/j.neuint.2013.02.007; Levy LM, 2013, AM J NEURORADIOL, V34, P259, DOI 10.3174/ajnr.A2902; Lichstein KL, 2000, PSYCHOL AGING, V15, P232, DOI 10.1037/0882-7974.15.2.232; Luders JW, 1999, WILDLIFE SOC B, V27, P666; Machado RB, 2008, PSYCHONEUROENDOCRINO, V33, P1211, DOI 10.1016/j.psyneuen.2008.06.007; McCrae CS, 2001, SLEEP MED REV, V5, P47, DOI 10.1053/smrv.2000.0146; MELIA KR, 1994, J NEUROSCI, V14, P5929; Mokler DJ, 2007, BRAIN RES, V1148, P226, DOI 10.1016/j.brainres.2007.02.031; Monti JM, 2011, SLEEP MED REV, V15, P269, DOI 10.1016/j.smrv.2010.11.003; Monti JM, 2008, PROG BRAIN RES, V172, P625, DOI 10.1016/S0079-6123(08)00929-1; Moore CM, 2007, J AM ACAD CHILD PSY, V46, P524, DOI 10.1097/chi.0b013e31802f5f2c; Morgan PT, 2012, SLEEP, V35, P807, DOI 10.5665/sleep.1880; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Pawlyk AC, 2008, NEUROSCI BIOBEHAV R, V32, P99, DOI 10.1016/j.neubiorev.2007.06.001; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Pfeuffer J, 1999, J MAGN RESON, V141, P104, DOI 10.1006/jmre.1999.1895; Plante DT, 2012, NEUROPSYCHOPHARMACOL, V37, P1548, DOI 10.1038/npp.2012.4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; Riemann D, 2010, SLEEP MED REV, V14, P19, DOI 10.1016/j.smrv.2009.04.002; Rothman DL, 1999, PHILOS T R SOC B, V354, P1165, DOI 10.1098/rstb.1999.0472; Rothman DL, 2003, ANNU REV PHYSIOL, V65, P401, DOI 10.1146/annurev.physiol.65.092101.142131; Sanacora G, 1999, ARCH GEN PSYCHIAT, V56, P1043, DOI 10.1001/archpsyc.56.11.1043; Stewart MG, 2005, NEUROSCIENCE, V131, P43, DOI 10.1016/j.neuroscience.2004.10.031; Tkac I, 2005, APPL MAGN RESON, V29, P139, DOI 10.1007/BF03166960; Tkac I, 2004, MAGN RESON MED, V52, P478, DOI 10.1002/mrm.20184; Tzika AA, 2002, J NEUROSURG, V96, P1023, DOI 10.3171/jns.2002.96.6.1023; Winkelman JW, 2008, SLEEP, V31, P1499, DOI 10.1093/sleep/31.11.1499; Woo DC, 2014, ACAD RADIOL, V21, P1072, DOI 10.1016/j.acra.2014.04.003; WYATT RJ, 1970, LANCET, V2, P840; Zarate CA, 2003, ANN NY ACAD SCI, V1003, P273, DOI 10.1196/annals.1300.017; Zhang G, 2007, J CHROMATOGR B, V858, P276, DOI 10.1016/j.jchromb.2007.08.007	53	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153346	10.1371/journal.pone.0153346	http://dx.doi.org/10.1371/journal.pone.0153346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078855	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700041
J	Ferrell, PB; Diggins, KE; Polikowsky, HG; Mohan, SR; Seegmiller, AC; Irish, JM				Ferrell, Paul Brent, Jr.; Diggins, Kirsten Elizabeth; Polikowsky, Hannah Grace; Mohan, Sanjay Ram; Seegmiller, Adam C.; Irish, Jonathan Michael			High-Dimensional Analysis of Acute Myeloid Leukemia Reveals Phenotypic Changes in Persistent Cells during Induction Therapy	PLOS ONE			English	Article							PERIPHERAL-BLOOD; HEMATOLYMPHOID NEOPLASIA; MASS CYTOMETRY; FLOW-CYTOMETRY; STEM-CELLS; CLEARANCE; HETEROGENEITY; EXPRESSION; PREDICTS; IMMUNOPHENOTYPE	The plasticity of AML drives poor clinical outcomes and confounds its longitudinal detection. However, the immediate impact of treatment on the leukemic and non-leukemic cells of the bone marrow and blood remains relatively understudied. Here, we conducted a pilot study of high dimensional longitudinal monitoring of immunophenotype in AML. To characterize changes in cell phenotype before, during, and immediately after induction treatment, we developed a 27-antibody panel for mass cytometry focused on surface diagnostic markers and applied it to 46 samples of blood or bone marrow tissue collected over time from 5 AML patients. Central goals were to determine whether changes in AML phenotype would be captured effectively by cytomic tools and to implement methods for describing the evolving phenotypes of AML cell subsets. Mass cytometry data were analyzed using established computational techniques. Within this pilot study, longitudinal immune monitoring with mass cytometry revealed fundamental changes in leukemia phenotypes that occurred over time during and after induction in the refractory disease setting. Persisting AML blasts became more phenotypically distinct from stem and progenitor cells due to expression of novel marker patterns that differed from pre-treatment AML cells and from all cell types observed in healthy bone marrow. This pilot study of single cell immune monitoring in AML represents a powerful tool for precision characterization and targeting of resistant disease.	[Ferrell, Paul Brent, Jr.; Mohan, Sanjay Ram] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Diggins, Kirsten Elizabeth; Polikowsky, Hannah Grace; Irish, Jonathan Michael] Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Seegmiller, Adam C.; Irish, Jonathan Michael] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Irish, JM (corresponding author), Vanderbilt Univ, Dept Canc Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Irish, JM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA.	jonathan.irish@vanderbilt.edu	Irish, Jonathan M/E-1180-2013	Irish, Jonathan M/0000-0001-9428-8866	NIH/NCI [K12 CA090625, R25 CA136440-04, R00 CA143231-03]; Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI [P30 CA68485]; VICC Hematology Helping Hands award; NATIONAL CANCER INSTITUTE [R25CA136440, K12CA090625, R00CA143231, P30CA068485] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI; VICC Hematology Helping Hands award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI K12 CA090625 (PBF), NIH/NCI R25 CA136440-04 (KED), NIH/NCI R00 CA143231-03 (JMI), Vanderbilt-Ingram Cancer Center (VICC) NIH/NCI P30 CA68485 (JMI), and a VICC Hematology Helping Hands award (JMI, PBF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Arellano M, 2012, CANCER-AM CANCER SOC, V118, P5278, DOI 10.1002/cncr.27494; Baer MR, 2001, BLOOD, V97, P3574, DOI 10.1182/blood.V97.11.3574; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111; Diggins KE, 2015, METHODS, V82, P55, DOI 10.1016/j.ymeth.2015.05.008; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Elliott MA, 2007, BLOOD, V110, P4172, DOI 10.1182/blood-2007-07-104091; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Gianfaldoni G, 2006, BRIT J HAEMATOL, V134, P54, DOI 10.1111/j.1365-2141.2006.06100.x; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Irish JM, 2006, NAT REV CANCER, V6, P146, DOI 10.1038/nrc1804; Irish JM, 2014, NATURE IMMUNOLOGY; Klco JM, 2014, CANCER CELL, V25, P379, DOI 10.1016/j.ccr.2014.01.031; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Marusyk A, 2014, NATURE, V514, P54, DOI 10.1038/nature13556; Mason KD, 2006, BLOOD REV, V20, P71, DOI 10.1016/j.blre.2005.08.002; McCarthy N, 2013, NAT REV CANCER, V13, P439, DOI 10.1038/nrc3549; National Cancer Institute, 2013, SURV EP END RES SEER; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Nicholas KJ, 2016, CYTOM PART A, V89A, P271, DOI 10.1002/cyto.a.22799; Ornatsky OI, 2008, ANAL CHEM, V80, P2539, DOI 10.1021/ac702128m; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Qiu P, 2011, NAT BIOTECHNOL, V29, P886, DOI 10.1038/nbt.1991; Sarry JE, 2011, J CLIN INVEST, V121, P384, DOI 10.1172/JCI41495; Shekhar K, 2014, P NATL ACAD SCI USA, V111, P202, DOI 10.1073/pnas.1321405111; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Stein EM, 2012, INT J HEMATOL, V96, P164, DOI 10.1007/s12185-012-1121-y; Stetler-Stevenson M, 2007, CYTOM PART B-CLIN CY, V72B, pS3, DOI 10.1002/cyto.b.20362; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Dongen JJM, 2012, LEUKEMIA, V26, P1899, DOI 10.1038/leu.2012.121; van Dongen JJM, 2012, LEUKEMIA, V26, P1908, DOI 10.1038/leu.2012.120; Walter MJ, 2012, NEW ENGL J MED, V366, P1090, DOI 10.1056/NEJMoa1106968; Wood BL, 2007, CYTOM PART B-CLIN CY, V72B, pS14, DOI 10.1002/cyto.b.20363	39	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0153207	10.1371/journal.pone.0153207	http://dx.doi.org/10.1371/journal.pone.0153207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074138	Green Published, gold			2022-12-27	WOS:000374131200060
J	van der Valk, ME; Mangen, MJJ; Severs, M; van der Have, M; Dijkstra, G; van Bodegraven, AA; Fidder, HH; de Jong, DJ; van der Woude, CJ; Romberg-Camps, MJL; Clemens, CHM; Jansen, JM; de Meeberg, PCV; Mahmmod, N; van der Meulen-de Jong, AE; Ponsioen, CY; Bolwerk, C; Vermeijden, JR; Siersema, PD; Leenders, M; Oldenburg, B				van der Valk, Mirthe E.; Mangen, Marie-Josee J.; Severs, Mirjam; van der Have, Mike; Dijkstra, Gerard; van Bodegraven, Ad A.; Fidder, Herma H.; de Jong, Dirk J.; van der Woude, C. Janneke; Romberg-Camps, Marielle J. L.; Clemens, Cees H. M.; Jansen, Jeroen M.; de Meeberg, Paul C. van; Mahmmod, Nofel; van der Meulen-de Jong, Andrea E.; Ponsioen, Cyriel Y.; Bolwerk, Clemens; Vermeijden, J. Reinoud; Siersema, Peter D.; Leenders, Max; Oldenburg, Bas		COIN Study Grp; Dutch Initiative Crohn Colitis	Evolution of Costs of Inflammatory Bowel Disease over Two Years of Follow-Up	PLOS ONE			English	Article							POPULATION-BASED COHORT; HEALTH-CARE COSTS; CROHNS-DISEASE; ULCERATIVE-COLITIS; RHEUMATOID-ARTHRITIS; INCEPTION COHORT; CLINICAL-COURSE; ILLNESS; PREDICTORS; SWEDEN	Background With the increasing use of anti-TNF therapy in inflammatory bowel disease (IBD), a shift of costs has been observed with medication costs replacing hospitalization and surgery as major cost driver. We aimed to explore the evolution of IBD-related costs over two years of follow-up. Methods and Findings In total 1,307 Crohn's disease (CD) patients and 915 ulcerative colitis (UC) patients were prospectively followed for two years by three-monthly web-based questionnaires. Changes of healthcare costs, productivity costs and out-of-pocket costs over time were assessed using mixed model analysis. Multivariable logistic regression analysis was used to identify costs drivers. In total 737 CD patients and 566 UC were included. Total costs were stable over two years of follow-up, with annual total costs of (sic)7,835 in CD and (sic)3,600 in UC. However, within healthcare costs, the proportion of anti-TNF therapy-related costs increased from 64% to 72% in CD (p<0.01) and from 31% to 39% in UC (p < 0.01). In contrast, the proportion of hospitalization costs decreased from 19% to 13% in CD (p<0.01), and 22% to 15% in UC (p < 0.01). Penetrating disease course predicted an increase of healthcare costs (adjusted odds ratio (adj. OR) 1.95 (95% CI 1.02-3.37) in CD and age <40 years in UC (adj. OR 4.72 (95% CI 1.61-13.86)). Conclusions BD-related costs remained stable over two years. However, the proportion of anti-TNF-related healthcare costs increased, while hospitalization costs decreased. Factors associated with increased costs were penetrating disease course in CD and age <40 in UC.	[van der Valk, Mirthe E.; Severs, Mirjam; van der Have, Mike; Fidder, Herma H.; Siersema, Peter D.; Leenders, Max; Oldenburg, Bas] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Mangen, Marie-Josee J.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Dijkstra, Gerard] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9713 AV Groningen, Netherlands; [van Bodegraven, Ad A.] Vrije Univ Amsterdam, Dept Gastroenterol & Hepatol, Med Ctr, Amsterdam, Netherlands; [van Bodegraven, Ad A.; Romberg-Camps, Marielle J. L.] Atrium Orbis Med Ctr, Dept Internal Med Gastroenterol & Geriatr, Heerlen Sittard Geleen, Netherlands; [de Jong, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Gastroenterol & Hepatol, NL-6525 ED Nijmegen, Netherlands; [van der Woude, C. Janneke] Erasmus Univ, Med Ctr, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [Clemens, Cees H. M.] Diaconessenhuis, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Jansen, Jeroen M.] Onze Lieve Vrouw Hosp, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands; [de Meeberg, Paul C. van] Slingeland Hosp, Dept Gastroenterol & Hepatol, Doetinchem, Netherlands; [Mahmmod, Nofel] Antonius Hosp, Dept Gastroenterol & Hepatol, Nieuwegein, Netherlands; [van der Meulen-de Jong, Andrea E.] Leiden Univ, Med Ctr, Dept Gastroenterol & Hepatol, Leiden, Netherlands; [Ponsioen, Cyriel Y.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Bolwerk, Clemens] Reinier de Graaf Grp, Dept Gastroenterol & Hepatol, Delft, Netherlands; [Vermeijden, J. Reinoud] Meander Med Ctr, Dept Gastroenterol & Hepatol, Amersfoort, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of Groningen; Vrije Universiteit Amsterdam; Atrium Medical Center; Orbis Medical Center; Radboud University Nijmegen; Erasmus University Rotterdam; Erasmus MC; Onze Lieve Vrouwe Gasthuis Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Reinier de Graaf Hospital; Meander Medisch Centrum	Oldenburg, B (corresponding author), Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.	boldenbu@umcutrecht.nl	van Bodegraven, Ad/ABG-4367-2020; van Bodegraven, Ad A/L-3180-2013; van der Meulen, Andrea/AAU-9430-2020; Siersema, Peter/V-1636-2019	van der Meulen, Andrea/0000-0001-9353-5431; van der Woude, C.Janneke/0000-0003-3875-6957; Mangen, Marie-Josee J./0000-0001-8914-2045; /0000-0003-4563-7462	Abbvie	Abbvie(AbbVie)	This study was funded by an unrestricted grant of Abbvie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassi A, 2004, GUT, V53, P1471, DOI 10.1136/gut.2004.041616; Beaugerie L, 2006, GASTROENTEROLOGY, V130, P650, DOI 10.1053/j.gastro.2005.12.019; Bernstein CN, 2012, GUT, V61, P622, DOI 10.1136/gutjnl-2011-301397; Bitton A, 2001, GASTROENTEROLOGY, V120, P13, DOI 10.1053/gast.2001.20912; Blomqvist P, 1997, SCAND J GASTROENTERO, V32, P1134, DOI 10.3109/00365529709002993; Bodger K, 2002, PHARMACOECONOMICS, V20, P639, DOI 10.2165/00019053-200220100-00001; Burisch J, 2015, INFLAMM BOWEL DIS, V21, P121, DOI 10.1097/MIB.0000000000000250; Drummond M, 2005, INT J TECHNOL ASSESS, V21, P165, DOI 10.1017/S0266462305050221; Gibson TB, 2008, J OCCUP ENVIRON MED, V50, P1261, DOI 10.1097/JOM.0b013e318181b8ca; Hoie O, 2007, AM J GASTROENTEROL, V102, P1692, DOI 10.1111/j.1572-0241.2007.01265.x; Huscher D, 2015, ANN RHEUM DIS, V74, P738, DOI 10.1136/annrheumdis-2013-204311; Etchevers MJ, 2009, INFLAMM BOWEL DIS, V15, P1320, DOI 10.1002/ibd.20897; Juan J, 2003, DIGEST LIVER DIS, V35, P853, DOI 10.1016/j.dld.2003.07.002; Kalkan A, 2014, RHEUMATOLOGY, V53, P153, DOI 10.1093/rheumatology/ket290; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Loly C, 2008, SCAND J GASTROENTERO, V43, P948, DOI 10.1080/00365520801957149; Mesterton J, 2009, INFLAMM BOWEL DIS, V15, P1882, DOI 10.1002/ibd.20939; Moum B, 1997, SCAND J GASTROENTERO, V32, P1005, DOI 10.3109/00365529709011217; Odes S, 2006, GASTROENTEROLOGY, V131, P719, DOI 10.1053/j.gastro.2006.05.052; Prenzler A, 2011, EUR J HEALTH ECON, V12, P273, DOI 10.1007/s10198-010-0281-z; Solberg IC, 2007, CLIN GASTROENTEROL H, V5, P1430, DOI 10.1016/j.cgh.2007.09.002; Stark R, 2006, PHARMACOECONOMICS, V24, P797, DOI 10.2165/00019053-200624080-00006; Targownik LE, 2012, AM J GASTROENTEROL, V107, P1228, DOI 10.1038/ajg.2012.127; van der Have M, 2014, INFLAMM BOWEL DIS, V20, P637, DOI 10.1097/01.MIB.0000442677.55051.03; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376	25	74	75	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0142481	10.1371/journal.pone.0142481	http://dx.doi.org/10.1371/journal.pone.0142481			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099937	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500001
J	Yang, LC; Zhang, YH; Wang, J; Huang, ZW; Gou, LY; Wang, ZL; Ren, TX; Piao, JH; Yang, XG				Yang, Lichen; Zhang, Yuhui; Wang, Jun; Huang, Zhengwu; Gou, Lingyan; Wang, Zhilin; Ren, Tongxiang; Piao, Jianhua; Yang, Xiaoguang			Non-Heme Iron Absorption and Utilization from Typical Whole Chinese Diets in Young Chinese Urban Men Measured by a Double-Labeled Stable Isotope Technique	PLOS ONE			English	Article							ERYTHROCYTE INCORPORATION; FERRITIN CONCENTRATIONS; REFERENCE VALUES; HAN POPULATION; BIOAVAILABILITY; WOMEN; MEAL; ZINC; VITAMIN; C282Y	Background This study was to observe the non-heme iron absorption and biological utilization from typical whole Chinese diets in young Chinese healthy urban men, and to observe if the iron absorption and utilization could be affected by the staple food patterns of Southern and Northern China. Materials and Methods Twenty-two young urban men aged 18-24 years were recruited and randomly assigned to two groups in which the staple food was rice and steamed buns, respectively. Each subject received 3 meals containing approximately 3.25 mg stable (FeSO4)-Fe-57 (the ratio of Fe-57 content in breakfast, lunch and dinner was 1: 2: 2) daily for 2 consecutive days. In addition, approximately 2.4 mg (FeSO4)-Fe-58 was administered intravenously to each subject at 30-60 min after dinner each day. Blood samples were collected from each subject to measure the enrichment of the Fe-57 and Fe-58. Fourteen days after the experimental diet, non-heme iron absorption was assessed by measuring Fe-57 incorporation into red blood cells, and absorbed iron utilization was determined according to the red blood cell incorporation of intravenously infused Fe-58 SO4. Results Non-heme iron intake values overall, and in the rice and steamed buns groups were 12.8 +/- 2.1, 11.3 +/- 1.3 and 14.3 +/- 1.5 mg, respectively; the mean Fe-57 absorption rates were 11 +/- 7%, 13 +/- 7%, and 8 +/- 4%, respectively; and the mean infused Fe-58 utilization rates were 85 +/- 8%, 84 +/- 6%, and 85 +/- 10%, respectively. There was no significantly difference in the iron intakes, and Fe-57 absorption and infused Fe-58 utilization rates between rice and steamed buns groups (all P>0.05). Conclusion We present the non-heme iron absorption and utilization rates from typical whole Chinese diets among young Chinese healthy urban men, which was not affected by the representative staple food patterns of Southern and Northern China. This study will provide a basis for the setting of Chinese iron DRIs.	[Yang, Lichen; Huang, Zhengwu; Piao, Jianhua; Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr Hlth, Minist Hlth, Key Lab Trace Element Nutr, Beijing 100050, Peoples R China; [Zhang, Yuhui; Gou, Lingyan; Wang, Zhilin] Bethune Mil Med Coll, Shijiazhuang 050081, Hebei, Peoples R China; [Wang, Jun; Ren, Tongxiang] Natl Res Ctr Certified Reference Mat, Natl Inst Metrol, Beijing 100029, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Metrology China	Yang, XG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Nutr Hlth, Minist Hlth, Key Lab Trace Element Nutr, Beijing 100050, Peoples R China.	xyangcdc@sina.com	ren, tongxiang/AAB-9919-2019		National Science & Technology Pillar Program [2008BA158B02]	National Science & Technology Pillar Program	This project was supported by the Key Projects in the National Science & Technology Pillar Program during the Eleventh Five-Year Plan Period (www.nsfc.gov.cn, grant no.: 2008BA158B02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abizari AR, 2012, J NUTR, V142, P1950, DOI 10.3945/jn.112.164095; ACOSTA A, 1984, AM J CLIN NUTR, V39, P953, DOI 10.1093/ajcn/39.6.953; [Anonymous], 2012, 2 NAT REP BIOCH IND; Ashmore JH, 2013, EUR J CANCER PREV, V22, P506, DOI 10.1097/CEJ.0b013e32836056f8; Atkinson SA, 2011, AM J CLIN NUTR, V94, p655S, DOI 10.3945/ajcn.110.005728; BARRETT JFR, 1992, CLIN SCI, V83, P213, DOI 10.1042/cs0830213; Bavbek N, 2014, RENAL FAILURE, V36, P187, DOI 10.3109/0886022X.2013.836750; CARLSEN O, 1990, SCAND J CLIN LAB INV, V50, P63, DOI 10.3109/00365519009091566; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; Cheung CL, 2013, CLIN NUTR, V32, P1055, DOI 10.1016/j.clnu.2012.11.024; Chinese Nutrition Society, 2013, CHIN DIET REF INT; Cockell KA, 2009, AM J CLIN NUTR, V90, P1023, DOI 10.3945/ajcn.2009.27561; Collings R, 2013, AM J CLIN NUTR, V98, P65, DOI 10.3945/ajcn.112.050609; Cook JD, 2001, AM J CLIN NUTR, V73, P93; Dainty JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111824; Davidsson L, 2000, BRIT J NUTR, V84, P847; DellaValle DM, 2015, J NUTR, V145, P2253, DOI 10.3945/jn.115.217273; Diaz M, 2003, AM J CLIN NUTR, V78, P436, DOI 10.1093/ajcn/78.3.436; Etcheverry P, 2006, J AM COLL NUTR, V25, P34, DOI 10.1080/07315724.2006.10719512; Fairweather-Tait SJ, 2010, INT J VITAM NUTR RES, V80, P249, DOI 10.1024/0300-9831/a000031; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gropper S., 2005, ADV NUTR HUMAN METAB; Harvey LJ, 2013, CRIT REV FOOD SCI, V53, P1064, DOI 10.1080/10408398.2012.742860; Hunt JR, 2004, AM J CLIN NUTR, V80, P924, DOI 10.1093/ajcn/80.4.924; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Institute of Medicine (US) Subcommittee on Interpretation and Uses of Dietary Reference Intakes; Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes, 2000, DRI DIET REF INT APP; Kalasuramath S, 2013, INDIAN J MED RES, V137, P324; Kristensen MB, 2005, BRIT J NUTR, V94, P78, DOI 10.1079/BJN20051417; Lin A, 2007, TISSUE ANTIGENS, V70, P252, DOI 10.1111/j.1399-0039.2007.00877.x; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Moretti D, 2006, AM J CLIN NUTR, V83, P632, DOI 10.1093/ajcn.83.3.632; Nair KM, 2013, J NUTR, V143, P852, DOI 10.3945/jn.112.171702; National Health and Family Planning Commission of the People' Republic of China, 2012, STAND US NUTR FORT S; Navas-Carretero S, 2008, J AM COLL NUTR, V27, P96, DOI 10.1080/07315724.2008.10719680; NELSON R, 1978, SOUTHERN MED J, V71, P1482, DOI 10.1097/00007611-197812000-00011; Nie L, 2010, ANN HEMATOL, V89, P1249, DOI 10.1007/s00277-010-1016-z; Paik HY, 2008, ASIA PAC J CLIN NUTR, V17, P416; Patterson KY, 2001, EXP BIOL MED, V226, P271, DOI 10.1177/153537020122600403; Petry N, 2014, J NUTR, V144, P1681, DOI 10.3945/jn.114.192989; Pietrangelo A, 2010, GASTROENTEROLOGY, V139, P393, DOI 10.1053/j.gastro.2010.06.013; Pizarro F, 2006, AM J CLIN NUTR, V84, P830, DOI 10.1093/ajcn/84.4.830; Reddy MB, 2006, J NUTR, V136, P576, DOI 10.1093/jn/136.3.576; Reddy MB, 2000, AM J CLIN NUTR, V71, P937; Roe MA, 2005, AM J CLIN NUTR, V81, P814, DOI 10.1093/ajcn/81.4.814; Sasaki S, 2008, ASIA PAC J CLIN NUTR, V17, P420; SHARMA JC, 1984, AGE AGEING, V13, P248, DOI 10.1093/ageing/13.4.248; Sun L, 2008, J CLIN ENDOCR METAB, V93, P4690, DOI 10.1210/jc.2008-1159; Thankachan P, 2012, EUR J CLIN NUTR, V66, P481, DOI 10.1038/ejcn.2011.169; Trumbo P, 2001, J AM DIET ASSOC, V101, P294, DOI 10.1016/S0002-8223(01)00078-5; Turin TC, 2010, J EPIDEMIOL, V20, pS557, DOI 10.2188/jea.JE20090225; TURNLUND JR, 1991, CRIT REV FOOD SCI, V30, P387, DOI 10.1080/10408399109527549; van den Heuvel EGHM, 1998, CLIN CHEM, V44, P649; Whittaker PG, 2001, BRIT J NUTR, V86, P323, DOI 10.1079/BJN2001390; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Yang LC, 2005, J TRACE ELEM MED BIO, V19, P159, DOI 10.1016/j.jtemb.2005.09.001; Yu Dan, 2013, Wei Sheng Yan Jiu, V42, P228; Yu XY, 2012, ASIAN J ANDROL, V14, P599, DOI 10.1038/aja.2012.1; Zhang B, 2014, OBES REV, V15, P2, DOI 10.1111/obr.12119; Zhou Ji-Chang, 2006, Wei Sheng Yan Jiu, V35, P66; Zhou T, 2008, RAPID COMMUN MASS SP, V22, P717, DOI 10.1002/rcm.3406	60	5	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0153885	10.1371/journal.pone.0153885	http://dx.doi.org/10.1371/journal.pone.0153885			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27099954	gold, Green Published, Green Submitted			2022-12-27	WOS:000374898500085
J	Cheng, EH; Liu, JY; Lee, TH; Huang, CC; Chen, CI; Huang, LS; Lee, MS				Cheng, En-Hui; Liu, Jer-Yuh; Lee, Tsung-Hsein; Huang, Chun-Chia; Chen, Chung-I; Huang, Lii-Sheng; Lee, Maw-Sheng			Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways	PLOS ONE			English	Article							DEVELOPMENT IN-VITRO; MOUSE EMBRYOS; FACTOR EXPRESSION; STAT3 ACTIVATION; FACTOR-RECEPTOR; CELLS; EGFR; IMPLANTATION; COMPETENCE; CULTURE	Leukemia inhibitory factor (LIF) plays a key role in the survivability of mouse embryos during pre-implantation. In this study, we verified the role of LIF by detecting gene expression in morula stage embryos through DNA microarray. Our results showed that LIF knockdown affected expression of 369 genes. After LIF supplementation, the epidermal growth factor (EGF) is most affected by LIF expression. To observe the correlation between LIF and EGF, the LIF knockdown embryos were supplemented with various growth factors, including LIF, EGF, GM-CSF, TGF, and IGF II. Only LIF and EGF caused the rate of blastocyst development to recover significantly from 52% of control to 83% and 93%, respectively. All of the variables, including the diameter of blastocysts, the number of blastomeres, and cells in ICM and TE, were almost restored. Moreover, EGF knockdown also impaired blastocyst development, which was reversed by LIF or EGF supplementation. The treatment with various signaling suppressors revealed that both EGF and LIF promoted embryonic development through the JAK/STAT3 signaling pathway. These data suggest that the EGF and LIF can be compensatory to each other during early embryonic development, and at least one of them is necessary for sustaining the normal development of pre-implantation embryos.	[Cheng, En-Hui; Huang, Chun-Chia; Chen, Chung-I; Huang, Lii-Sheng; Lee, Maw-Sheng] Lee Womens Hosp, Div Infertil Clin, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liu, Jer-Yuh] China Med Univ Hosp, Ctr Mol Med, Taichung, Taiwan; [Lee, Tsung-Hsein; Lee, Maw-Sheng] Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40201, Taiwan; [Lee, Tsung-Hsein; Lee, Maw-Sheng] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Huang, Lii-Sheng] Chung Shan Med Univ, Dept Nursing, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University	Lee, MS (corresponding author), Lee Womens Hosp, Div Infertil Clin, Taichung, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ Hosp, Dept Obstet & Gynecol, Taichung 40201, Taiwan.; Lee, MS (corresponding author), Chung Shan Med Univ, Inst Med, Taichung, Taiwan.	msleephd@gmail.com		Lee, Tsung-Hsien/0000-0001-8858-0916	Ministry of Science and Technology, Taiwan [NSC-94-2314-B-039-013, NSC 96-2314-B-040-039, NSC 98-2314-B-040 -010 -MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by a research grant from the Ministry of Science and Technology, Taiwan (NSC-94-2314-B-039-013, NSC 96-2314-B-040-039 and NSC 98-2314-B-040 -010 -MY3).	Aghajanova L, 2010, CURR OPIN OBSTET GYN, V22, P213, DOI 10.1097/GCO.0b013e32833848e5; Amiri I, 2009, IRAN J REPROD MED, V7, P189; Attar Erkut, 2003, Reprod Biomed Online, V7, P71; Chan KS, 2004, CANCER RES, V64, P2382, DOI 10.1158/0008-5472.CAN-03-3197; Cheng Jr-Gang, 2002, Rev Endocr Metab Disord, V3, P119, DOI 10.1023/A:1015402811650; Cheng TC, 2004, BIOL REPROD, V70, P1270, DOI 10.1095/biolreprod.103.023283; Cheung LP, 2003, FERTIL STERIL, V80, P727, DOI 10.1016/S0015-0282(03)00772-6; Colomiere M, 2009, BRIT J CANCER, V100, P134, DOI 10.1038/sj.bjc.6604794; Dadi TD, 2009, COMPARATIVE MED, V59, P331; De la Fuente R, 1999, HUM REPROD, V14, P3060, DOI 10.1093/humrep/14.12.3060; Dunglison GF, 1996, HUM REPROD, V11, P191; FRY RC, 1992, BIOL REPROD, V46, P470, DOI 10.1095/biolreprod46.3.470; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GEARING DP, 1993, ADV IMMUNOL, V53, P31, DOI 10.1016/S0065-2776(08)60497-6; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; Hogan B, 1994, MANIPULATING MOUSE E; Hsieh YY, 2000, J ASSIST REPROD GEN, V17, P131, DOI 10.1023/A:1009426303742; Kou XJ, 2013, ONCOL LETT, V5, P1053, DOI 10.3892/ol.2012.1098; Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x; Lavranos TC, 1995, J REPROD FERTIL, V105, P331, DOI 10.1530/jrf.0.1050331; Lee GS, 2005, MOL REPROD DEV, V71, P45, DOI 10.1002/mrd.20098; Marquant-Le GB, 1993, J REPROD FERTIL, V12, P61; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MITCHELL MH, 1994, J SOC GYNECOL INVEST, V1, P215, DOI 10.1177/107155769400100307; Perkins J, 2002, MOL MED, V8, P847, DOI 10.1007/BF03402090; ROBINSON RC, 1994, CELL, V77, P1101, DOI 10.1016/0092-8674(94)90449-9; SMITH AG, 1992, DEV BIOL, V151, P339, DOI 10.1016/0012-1606(92)90174-F; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Terada A, 1997, J ASSIST REPROD GEN, V14, P404, DOI 10.1007/BF02766149; Viti J, 2003, J NEUROSCI, V23, P3385; Wanggren K, 2007, MOL HUM REPROD, V13, P391, DOI 10.1093/molehr/gam013; Wei ZX, 2001, MOL REPROD DEV, V60, P457, DOI 10.1002/mrd.1110; Xu JS, 2003, FERTIL STERIL, V80, P178, DOI 10.1016/S0015-0282(03)00570-3; Xu JS, 2001, BIOL REPROD, V65, P1481, DOI 10.1095/biolreprod65.5.1481; Xu JS, 2000, FERTIL STERIL, V74, P1215, DOI 10.1016/S0015-0282(00)01618-6; YAMAMORI T, 1992, NEUROSCI RES, V12, P545, DOI 10.1016/0168-0102(92)90064-J; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou P, 2008, ANIM REPROD SCI, V104, P370, DOI 10.1016/j.anireprosci.2007.02.024	40	9	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153086	10.1371/journal.pone.0153086	http://dx.doi.org/10.1371/journal.pone.0153086			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096934	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600026
J	Li, ZQ; Zhang, JL; Li, JX; Li, HJ; Zhang, GF				Li, Zeqin; Zhang, Jilong; Li, Jingxiao; Li, Hongjie; Zhang, Genfa			The Functional and Regulatory Mechanisms of the Thellungiella salsuginea Ascorbate Peroxidase 6 (TsAPX6) in Response to Salinity and Water Deficit Stresses	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; OXYGEN GENE NETWORK; ANTIOXIDANT SYSTEMS; DROUGHT TOLERANCE; ABIOTIC STRESS; SALT-TOLERANCE; ARABIDOPSIS; EXPRESSION; PLANTS; RICE	Soil salinization is a resource and ecological problem in the world. Thellungiella salsuginea is becoming a new model plant because it resembles its relative species, Arabidopsis thaliana, in small genome and short life cycle. It is highly tolerant to salinity and drought stresses. Ascorbate peroxidase (APX) is an enzyme that clears H2O2 in plants. The function and molecular and regulation mechanisms of APX in T. salsuginea have rarely been reported. In this study, an APX gene, TsApx6, was cloned from T. salsuginea and its responses to abiotic stresses in transgenic Arabidopsis were studied. Under high salinity treatment, the expression of TsApx6 was significantly induced. Under drought treatment, overexpression of TsApx6 increased the survival rate and reduced leaf water loss rate in Arabidopsis. Compared to the wild type plants, high salinity treatment reduced the concentrations of MDA, H2O2 and proline but elevated the activities of APX, GPX, CAT and SOD in the TsApx6-overexpressing plants. Meanwhile, germination rate, cotyledon greening, and root length were improved in the transgenic plants compared to the wild type plants under salt and water deficit conditions. Based on these findings, TsApx6 has an important function in the resistance of plants to certain abiotic stresses. The TsApx6 promoter sequence was obtained using Genome Walking technology. Bioinformatics analysis indicated that it contains some cis-acting elements related to stress response. The treatments of salt, dehydration, and ABA induced the expression of Gus gene under the regulation of the TsApx6 promoter. Mutation analysis showed that the MBS motif present in the TsApx6 promoter might be a key negative regulatory element which has an important effect on the growth and developmental process of plants.	[Li, Zeqin; Zhang, Jilong; Li, Jingxiao; Zhang, Genfa] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China; [Li, Hongjie] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China	Beijing Normal University; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zhang, GF (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Gene Resource & Mol Dev, Beijing 100875, Peoples R China.; Li, HJ (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resources & Genet Improv, Beijing 100193, Peoples R China.	lihongjie@caas.cn; gfzh@bnu.edu.cn			National Natural Science Foundation of China [31070289, 31270365]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) Grant No. 31070289 and 31270365. GZ received the funding. The funders had been used in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailey-Serres J, 2006, PLANT PHYSIOL, V141, P311, DOI 10.1104/pp.104.900191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CM, 2014, PLANT PHYSIOL, V166, P370, DOI 10.1104/pp.114.245324; Chen XH, 2014, BBA-PROTEINS PROTEOM, V1844, P818, DOI 10.1016/j.bbapap.2014.02.010; Cho SK, 2008, PLANT CELL, V20, P1899, DOI 10.1105/tpc.108.060699; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Deinlein U, 2014, TRENDS PLANT SCI, V19, P371, DOI 10.1016/j.tplants.2014.02.001; Frank G, 2009, J EXP BOT, V60, P3891, DOI 10.1093/jxb/erp234; Hernandez JA, 2002, PHYSIOL PLANTARUM, V115, P251, DOI 10.1034/j.1399-3054.2002.1150211.x; Higashi Y, 2013, MOL PLANT, V6, P411, DOI 10.1093/mp/sst024; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang LY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129932; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Li SJ, 2009, PLANT CELL REP, V28, P683, DOI 10.1007/s00299-008-0666-y; Li XY, 2013, INT J MOL SCI, V14, P12827, DOI 10.3390/ijms140612827; Li ZQ, 2015, BIOL PLANTARUM, V59, P497, DOI 10.1007/s10535-015-0533-y; [苗雨晨 Miao Yuchen], 2005, [植物学通报, Chinese Bulletin of Botany], V22, P350; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Mittler R, 2011, TRENDS PLANT SCI, V16, P300, DOI 10.1016/j.tplants.2011.03.007; Naliwajski MR, 2014, BIOL PLANTARUM, V58, P47, DOI 10.1007/s10535-013-0378-1; Nounjan N, 2012, J PLANT PHYSIOL, V169, P596, DOI 10.1016/j.jplph.2012.01.004; Panchuk II, 2002, PLANT PHYSIOL, V129, P838, DOI 10.1104/pp.001362; Pnueli L, 2003, PLANT J, V34, P187, DOI 10.1046/j.1365-313X.2003.01715.x; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rossel JB, 2006, PLANT CELL ENVIRON, V29, P269, DOI 10.1111/j.1365-3040.2005.01419.x; Shim D, 2009, PLANT CELL, V21, P4031, DOI 10.1105/tpc.109.066902; Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1; Suzuki N, 2005, PLANT PHYSIOL, V139, P1313, DOI 10.1104/pp.105.070110; Suzuki N, 2013, J EXP BOT, V64, P253, DOI 10.1093/jxb/ers335; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Torres MA, 2005, CURR OPIN PLANT BIOL, V8, P397, DOI 10.1016/j.pbi.2005.05.014; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Xu LH, 2014, BIOL PLANTARUM, V58, P751, DOI 10.1007/s10535-014-0442-5; Xu XJ, 2009, MOL CELLS, V27, P423, DOI 10.1007/s10059-009-0060-9; Zhang YY, 2008, J INTEGR PLANT BIOL, V50, P1327, DOI 10.1111/j.1744-7909.2008.00740.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	40	13	16	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154042	10.1371/journal.pone.0154042	http://dx.doi.org/10.1371/journal.pone.0154042			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097028	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600083
J	Reuter, KE; Wills, AR; Lee, RW; Cordes, EE; Sewall, BJ				Reuter, Kim E.; Wills, Abigail R.; Lee, Raymond W.; Cordes, Erik E.; Sewall, Brent J.			Using Stable Isotopes to Infer the Impacts of Habitat Change on the Diets and Vertical Stratification of Frugivorous Bats in Madagascar	PLOS ONE			English	Article							FEEDING ECOLOGY; PTEROPUS-RUFUS; SEED DISPERSAL; FLYING-FOXES; NECTARIVOROUS BATS; FRUIT BATS; FOREST; CONSERVATION; PTEROPODIDAE; SELECTION	Human-modified habitats are expanding rapidly; many tropical countries have highly fragmented and degraded forests. Preserving biodiversity in these areas involves protecting species-like frugivorous bats-that are important to forest regeneration. Fruit bats provide critical ecosystem services including seed dispersal, but studies of how their diets are affected by habitat change have often been rather localized. This study used stable isotope analyses (delta N-15 and delta C-13 measurement) to examine how two fruit bat species in Madagascar, Pteropus rufus (n = 138) and Eidolon dupreanum (n = 52) are impacted by habitat change across a large spatial scale. Limited data for Rousettus madagascariensis are also presented. Our results indicated that the three species had broadly overlapping diets. Differences in diet were nonetheless detectable between P. rufus and E. dupreanum, and these diets shifted when they co-occurred, suggesting resource partitioning across habitats and vertical strata within the canopy to avoid competition. Changes in diet were correlated with a decrease in forest cover, though at a larger spatial scale in P. rufus than in E. dupreanum. These results suggest fruit bat species exhibit differing responses to habitat change, highlight the threats fruit bats face from habitat change, and clarify the spatial scales at which conservation efforts could be implemented.	[Reuter, Kim E.; Cordes, Erik E.; Sewall, Brent J.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Wills, Abigail R.] Mpingo Conservat & Dev Initiat, Kilwa Masoko, Tanzania; [Lee, Raymond W.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Washington State University	Reuter, KE (corresponding author), Temple Univ, Dept Biol, Philadelphia, PA 19122 USA.	kimeleanorreuter@gmail.com	Cordes, Erik E/B-3293-2009	Cordes, Erik E/0000-0002-6989-2348	National Science Foundation Graduate Research Fellowship [DGE-1144462]; National Science Foundation [DEB-1257916]; Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology [1257916] Funding Source: National Science Foundation	National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); Explorers Club Grant; Temple University Faculty Senate grant; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship (https://www.nsfgrfp.org/) under Grant No. (DGE-1144462) to KER, a National Science Foundation grant (DEB-1257916) to BJS (http://www.nsf.gov/div/index.jsp?div=DEB), an Explorers Club Grant to KER (https://explorers.org/expeditions/funding/expedition_grants), and a Temple University Faculty Senate grant to BJS (https://www.temple.edu/research/facinitiatives/facini_int_funding.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2013, TROP CONSERV SCI, V6, P1, DOI 10.1177/194008291300600101; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Andriafidison D, 2006, BIOTROPICA, V38, P85, DOI 10.1111/j.1744-7429.2006.00112.x; Andrianaivoarivelo RA, 2011, MAMMALIA, V75, P69, DOI 10.1515/MAMM.2010.071; Asner GP, 2009, J APPL REMOTE SENS, V3, DOI 10.1117/1.3223675; BAUM DA, 1995, ANN MO BOT GARD, V82, P322, DOI 10.2307/2399883; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bollen A, 2002, ACTA CHIROPTEROL, V4, P33, DOI 10.3161/001.004.0105; Bravo A, 2010, BIOTROPICA, V42, P276, DOI 10.1111/j.1744-7429.2010.00639.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cabanellas-Reboredo M, 2009, J MOLLUS STUD, V75, P343, DOI 10.1093/mollus/eyp021; Cardiff SG, 2009, AFR J ECOL, V47, P640, DOI 10.1111/j.1365-2028.2008.01015.x; Cosson JF, 1999, J TROP ECOL, V15, P515, DOI 10.1017/S026646749900098X; Crawford K, 2008, MAMMAL REV, V38, P87, DOI 10.1111/j.1365-2907.2008.00120.x; Crowley BE, 2011, J BIOGEOGR, V38, P2106, DOI 10.1111/j.1365-2699.2011.02551.x; Dammhahn M, 2014, J TROP ECOL, V30, P97, DOI 10.1017/S0266467413000825; Dethier MN, 2013, MAR ECOL PROG SER, V478, P1, DOI 10.3354/meps10310; Deudero S, 2009, J EXP MAR BIOL ECOL, V368, P181, DOI 10.1016/j.jembe.2008.10.008; ESRI, 2011, ARCGIS DESKT REL 10; Fisher R. A., 1946, Statistical methods for research workers.; Fraser EE, 2013, CAN J ZOOL, V91, P533, DOI 10.1139/cjz-2013-0072; Garbutt N, 2007, MAMMALS MADAGASCAR C; Goodman SM, 2005, ANIM CONSERV, V8, P153, DOI 10.1017/S136794300500199X; GORCHOV DL, 1993, VEGETATIO, V108, P339; Herrera LG, 2008, J MAMMAL, V89, P1184, DOI 10.1644/07-MAMM-A-263.1; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IUCN Red List of Threatened Species, 2013, IUCN RED LIST THREAT; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jenkins RKB, 2007, ORYX, V41, P263, DOI 10.1017/S0030605307001883; Jenkins Richard K.B., 2008, Madagascar Conservation & Development, V3, P22; Kunz TH, 2011, ANN NY ACAD SCI, V1223, P1, DOI 10.1111/j.1749-6632.2011.06004.x; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; llo Program, 2003, REC COMM 2001; Long E, 2007, J TROP ECOL, V23, P397, DOI 10.1017/S0266467407004178; Luskin MS, 2010, BIOTROPICA, V42, P246, DOI 10.1111/j.1744-7429.2009.00577.x; MacKinnon J., 2003, NATURAL HIST MADAGAS, P1299; MARSHALL AG, 1985, ZOOL J LINN SOC-LOND, V83, P351, DOI 10.1111/j.1096-3642.1985.tb01181.x; Medellin RA, 1999, BIOTROPICA, V31, P478, DOI 10.1111/j.1744-7429.1999.tb00390.x; Mildenstein TL, 2005, BIOL CONSERV, V126, P93, DOI 10.1016/j.biocon.2005.05.001; Moat J., 2007, ATLAS VEGETATION MAD; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Oleksy R, 2015, GLOB ECOL CONSERV, V3, P678, DOI 10.1016/j.gecco.2015.02.012; Ossa G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045729; Owens J. R., 2013, THESIS DREXEL U; Picot M, 2007, AFR J ECOL, V45, P645, DOI 10.1111/j.1365-2028.2007.00788.x; Reuter KE, 2015, THESIS TEMPLE U; Reuter KE, 2015, ORYX, V1; Rex K, 2011, J TROP ECOL, V27, P211, DOI 10.1017/S0266467411000022; Scanlon AT, 2013, AUST J ZOOL, V61, P342, DOI 10.1071/ZO13047; Sewall BJ, 2003, ORYX, V37, P344, DOI 10.1017/S0030605303000607; Sewall BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068657; Soto-Centeno JA, 2006, J MAMMAL, V87, P19, DOI 10.1644/05-MAMM-041R1.1; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; U.S. Department of the Interior, 2014, USGS EARTH EXPL; Voigt CC, 2004, J EXP BIOL, V207, P1741, DOI 10.1242/jeb.00929; Voigt CC, 2012, J TROP ECOL, V28, P181, DOI 10.1017/S0266467411000666; WINTER K, 1979, OECOLOGIA, V40, P103, DOI 10.1007/BF00388814; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009; Yohannes E, 2008, OECOLOGIA, V158, P299, DOI 10.1007/s00442-008-1138-3	62	10	10	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153192	10.1371/journal.pone.0153192	http://dx.doi.org/10.1371/journal.pone.0153192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097316	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600029
J	Unkovic, C; Sen, M; Quinn, KM				Unkovic, Cait; Sen, Maya; Quinn, Kevin M.			Does Encouragement Matter in Improving Gender Imbalances in Technical Fields? Evidence from a Randomized Controlled Trial	PLOS ONE			English	Article							ROLE-MODELS; SCIENCE; STUDENTS; CHOICE	Does encouragement help address gender imbalances in technical fields? We present the results of one of the first and largest randomized controlled trials on the topic. Using an applied statistics conference in the social sciences as our context, we randomly assigned half of a pool of 3,945 graduate students to receive two personalized emails encouraging them to apply (n = 1,976) and the other half to receive nothing (n = 1,969). We find a robust, positive effect associated with this simple intervention and suggestive evidence that women responded more strongly than men. However, we find that women's conference acceptance rates are higher within the control group than in the treated group. This is not the case for men. The reason appears to be that female applicants in the treated group solicited supporting letters at lower rates. Our findings therefore suggest that "low dose" interventions may promote diversity in STEM fields but may also have the potential to expose underlying disparities when used alone or in a non-targeted way.	[Unkovic, Cait; Quinn, Kevin M.] Univ Calif Berkeley, UC Berkeley Sch Law, Berkeley, CA 94720 USA; [Sen, Maya] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	University of California System; University of California Berkeley; Harvard University	Sen, M (corresponding author), Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA.	maya_sen@hks.harvard.edu						Achen CH, 2014, POLITICAL METHODOLOG, V21, P25; American Political Science Association, 2015, 6 YEARS POL SCI DOCT; Ashworth J, 2001, J ECON EDUC, V32, P311; Bettinger EP, 2005, AM ECON REV, V95, P152, DOI 10.1257/000282805774670149; CANES BJ, 1995, IND LABOR RELAT REV, V48, P486, DOI 10.2307/2524777; Castleman BL, 2015, J ECON BEHAV ORGAN, V115, P144, DOI 10.1016/j.jebo.2014.12.008; Ferreira MM, 2003, INT J SCI EDUC, V25, P969, DOI 10.1080/09500690305026; Goulden, 2013, BABIES MATTER GENDER; Goulden M, 2011, ANN AM ACAD POLIT SS, V638, P141, DOI 10.1177/0002716211416925; Hinkelmann K., 2007, DESIGN ANAL EXPT INT, V1; Hoxby C, 2014, STANFORD I EC POL RE; King G, 2013, PS-POLIT SCI POLIT, V46, P621, DOI 10.1017/S1049096513000619; Kraft MA, 2015, ECON EDUC REV, V47, P49, DOI 10.1016/j.econedurev.2015.04.001; Long J.S., 2001, SCARCITY VISIBILITY; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Academy of Sciences, 2010, GEND DIFF CRIT TRANS; Nosek BA, 2009, P NATL ACAD SCI USA, V106, P10593, DOI 10.1073/pnas.0809921106; Rask KN, 2002, J ECON EDUC, V33, P99, DOI 10.1080/00220480209596461; Shannon M, 2014, POLITICAL METHODOLOG, V21, P2; Sunstein C. R., 2008, NUDGE; [No title captured]	21	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0151714	10.1371/journal.pone.0151714	http://dx.doi.org/10.1371/journal.pone.0151714			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097315	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600005
J	Heneberg, P				Heneberg, Petr			From Excessive Journal Self-Cites to Citation Stacking: Analysis of Journal Self-Citation Kinetics in Search for Journals, Which Boost Their Scientometric Indicators	PLOS ONE			English	Article							INFORMATION-SCIENCE; IMPACT FACTORS; RATES	Bibliometric indicators increasingly affect careers, funding, and reputation of individuals, their institutions and journals themselves. In contrast to author self-citations, little is known about kinetics of journal self-citations. Here we hypothesized that they may show a generalizable pattern within particular research fields or across multiple fields. We thus analyzed self-cites to 60 journals from three research fields (multidisciplinary sciences, parasitology, and information science). We also hypothesized that the kinetics of journal self-citations and citations received from other journals of the same publisher may differ from foreign citations. We analyzed the journals published the American Association for the Advancement of Science, Nature Publishing Group, and Editura Academiei Romane. We found that although the kinetics of journal self-cites is generally faster compared to foreign cites, it shows some field-specific characteristics. Particularly in information science journals, the initial increase in a share of journal self-citations during post-publication year 0 was completely absent. Self-promoting journal self-citations of top-tier journals have rather indirect but negligible direct effects on bibliometric indicators, affecting just the immediacy index and marginally increasing the impact factor itself as long as the affected journals are well established in their fields. In contrast, other forms of journal self-citations and citation stacking may severely affect the impact factor, or other citation-based indices. We identified here a network consisting of three Romanian physics journals Proceedings of the Romanian Academy, Series A, Romanian Journal of Physics, and Romanian Reports in Physics, which displayed low to moderate ratio of journal self-citations, but which multiplied recently their impact factors, and were mutually responsible for 55.9%, 64.7% and 63.3% of citations within the impact factor calculation window to the three journals, respectively. They did not receive nearly any network self-cites prior impact factor calculation window, and their network self-cites decreased sharply after the impact factor calculation window. Journal self-citations and citation stacking requires increased attention and elimination from citation indices.	[Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic	Charles University Prague	Heneberg, P (corresponding author), Charles Univ Prague, Fac Med 3, Prague, Czech Republic.	petr.heneberg@lf3.cuni.cz	Heneberg, Petr/C-1881-2012	Heneberg, Petr/0000-0002-0703-951X	Charles University in Prague [P31/2012]	Charles University in Prague	The access to the databases used was supported by the project PRVOUK P31/2012 from Charles University in Prague. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2003, SCIENTOMETRICS, V56, P235, DOI 10.1023/A:1021919228368; Anseel F, 2004, AM PSYCHOL, V59, P49, DOI 10.1037/0003.066X.59.1.49; Costas R, 2010, SCIENTOMETRICS, V82, P517, DOI 10.1007/s11192-010-0187-7; Davis P, EMERGENCE CITATION C; DeMaria AN, 2003, J AM COLL CARDIOL, V42, P952, DOI 10.1016/S0735-1097(03)01001-5; Fassoulaki A, 2000, BRIT J ANAESTH, V84, P266, DOI 10.1093/oxfordjournals.bja.a013418; Franck G, 1999, SCIENCE, V286, P53, DOI 10.1126/science.286.5437.53; Frandsen TF, 2007, J INFORMETR, V1, P47, DOI 10.1016/j.joi.2006.09.002; Garfield E, 2006, JAMA-J AM MED ASSOC, V295, P90, DOI 10.1001/jama.295.1.90; GARFIELD E, 1963, AM DOC, V14, P195, DOI 10.1002/asi.5090140304; Glanzel W, 2006, SCIENTOMETRICS, V67, P263, DOI 10.1556/Scient.67.2006.2.8; Glanzel W, 2004, SCIENTOMETRICS, V59, P63, DOI 10.1023/B:SCIE.0000013299.38210.74; Hendrix D, 2009, SCIENTOMETRICS, V81, P321, DOI 10.1007/s11192-008-2160-2; Heneberg P, 2014, J ASSOC INF SCI TECH, V65, P635, DOI 10.1002/asi.22997; HOLUB HW, 1991, SOUTH ECON J, V58, P317, DOI 10.2307/1060176; Huggett S, IMPACT FACTOR ETHICS; Ioannidis JPA, J PSYCHOSOMAT RES, V78, P7; Krauss J, 2007, SCIENTOMETRICS, V73, P79, DOI 10.1007/s11192-007-1727-7; LAWANI SM, 1982, J AM SOC INFORM SCI, V33, P281; Leydesdorff L, 2008, J AM SOC INF SCI TEC, V59, P278, DOI 10.1002/asi.20743; Lynch JG, 2012, SCIENCE, V335, P1169, DOI 10.1126/science.335.6073.1169-a; McVeigh M.E., 2002, J SELF CITATION JOUR; Motamed M, 2002, CLIN OTOLARYNGOL, V27, P318, DOI 10.1046/j.1365-2273.2002.00574.x; Nisonger TE, 2000, COLL RES LIBR, V61, P263, DOI 10.5860/crl.61.3.263; Opthof T, 2013, NETH HEART J, V21, P163, DOI 10.1007/s12471-013-0384-0; Rennie D., 2003, PEER REV HLTH SCI, V2nd, P118; Rousseau R, 1999, SCIENTOMETRICS, V44, P521, DOI 10.1007/BF02458493; Shibayama S, 2015, RES POLICY, V44, P936, DOI 10.1016/j.respol.2015.01.012; Smith R, 1997, BRIT MED J, V314, P461; Straub DW, 2009, COMMUN ASSOC INF SYS, V25, P57; Thombs BD, 2015, J PSYCHOSOM RES, V78, P1, DOI 10.1016/j.jpsychores.2014.09.015; VanNoorden R, RECORD NUMBER J BANN; Wilhite AW, 2012, SCIENCE, V335, P542, DOI 10.1126/science.1212540	33	57	58	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153730	10.1371/journal.pone.0153730	http://dx.doi.org/10.1371/journal.pone.0153730			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9IK	27088862	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000043
J	Marion, T; Elbahesh, H; Thomas, PG; DeVincenzo, JP; Webby, R; Schughart, K				Marion, Tony; Elbahesh, Husni; Thomas, Paul G.; DeVincenzo, John P.; Webby, Richard; Schughart, Klaus			Respiratory Mucosal Proteome Quantification in Human Influenza Infections	PLOS ONE			English	Article							LYMPHOCYTE CHEMOATTRACTANT FACTOR; T-CELLS; VIRUS; H5N1; IDENTIFICATION; CHEMOKINE; EXPRESSION; PROTEINS; PHOSPHORYLATION; DIFFERENTIATION	Respiratory influenza virus infections represent a serious threat to human health. Underlying medical conditions and genetic make-up predispose some influenza patients to more severe forms of disease. To date, only a few studies have been performed in patients to correlate a selected group of cytokines and chemokines with influenza infection. Therefore, we evaluated the potential of a novel multiplex micro-proteomics technology, SOMAscan, to quantify proteins in the respiratory mucosa of influenza A and B infected individuals. The analysis included but was not limited to quantification of cytokines and chemokines detected in previous studies. SOMAscan quantified more than 1,000 secreted proteins in small nasal wash volumes from infected and healthy individuals. Our results illustrate the utility of micro-proteomic technology for analysis of proteins in small volumes of respiratory mucosal samples. Furthermore, when we compared nasal wash samples from influenza-infected patients with viral load >= 2(8) and increased IL-6 and CXCL10 to healthy controls, we identified 162 differentially-expressed proteins between the two groups. This number greatly exceeds the number of DEPs identified in previous studies in human influenza patients. Most of the identified proteins were associated with the host immune response to infection, and changes in protein levels of 151 of the DEPs were significantly correlated with viral load. Most important, SOMAscan identified differentially expressed proteins heretofore not associated with respiratory influenza infection in humans. Our study is the first report for the use of SOMAscan to screen nasal secretions. It establishes a precedent for micro-proteomic quantification of proteins that reflect ongoing response to respiratory infection.	[Marion, Tony; Elbahesh, Husni; DeVincenzo, John P.; Schughart, Klaus] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Thomas, Paul G.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Thomas, Paul G.; DeVincenzo, John P.] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [DeVincenzo, John P.] Le Bonheur Childrens Hosp, Childrens Fdn Res Ctr, Memphis, TN USA; [Webby, Richard] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany; [Schughart, Klaus] Univ Vet Med Hannover, Hannover, Germany	University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation	Schughart, K (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA.; Schughart, K (corresponding author), Helmholtz Ctr Infect Res, Dept Infect Genet, Braunschweig, Germany.; Schughart, K (corresponding author), Univ Vet Med Hannover, Hannover, Germany.	klaus.schughart@helmholtz-hzi.de	Thomas, Paul G./H-1063-2018; Elbahesh, Husni/H-5161-2019; Webby, Richard J/N-5657-2018; Elbahesh, Husni/AAR-6880-2021	Thomas, Paul G./0000-0001-7955-0256; Elbahesh, Husni/0000-0003-1243-0967; Schughart, Klaus/0000-0002-6824-7523	UTHSC; Helmholtz-Association; HHS [HHSN266200700005C, HHSN272201400006C]; NIAID	UTHSC; Helmholtz-Association(Helmholtz Association); HHS(United States Department of Health & Human Services); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by start-up grants from UTHSC awarded to KS and HE and intramural grants from the Helmholtz-Association (Program Infection and Immunity) awarded to KS. The FLU09 influenza cohort was supported by HHS contracts HHSN266200700005C and HHSN272201400006C, the NIAID-funded St. Jude Center of Excellence for Influenza Research and Surveillance awarded to RW, supports RW and PT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Bagga B, 2013, ANTIVIR THER, V18, P785, DOI 10.3851/IMP2629; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berasain C, 2014, SEMIN CELL DEV BIOL, V28, P31, DOI 10.1016/j.semcdb.2014.01.005; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Brasier AR, 2011, J VIROL, V85, P11752, DOI 10.1128/JVI.05360-11; Cheung CY, 2012, J INFECT DIS, V206, P640, DOI 10.1093/infdis/jis423; Chi Y, 2013, J INFECT DIS, V208, P1962, DOI 10.1093/infdis/jit440; Choi S, 2014, PROTEOMICS, V14, P1933, DOI 10.1002/pmic.201400030; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Conze D, 2002, J EXP MED, V195, P811, DOI 10.1084/jem.20011508; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Crowley JJ, 2015, NAT GENET, V47, P353, DOI 10.1038/ng.3222; CRUIKSHANK WW, 1995, AM J RESP CELL MOL, V13, P738, DOI 10.1165/ajrcmb.13.6.7576712; CRUIKSHANK WW, 1994, P NATL ACAD SCI USA, V91, P5109, DOI 10.1073/pnas.91.11.5109; De Groote MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061002; Deng AM, 2005, J IMMUNOL, V174, P5243, DOI 10.4049/jimmunol.174.9.5243; Doyle William J., 1996, Rhinology (Utrecht), V34, P2; Dutta A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7374; Fauci AS, 2006, J INFECT DIS, V194, pS73, DOI 10.1086/507550; Fujita J, 2012, ALLERGY, V67, P744, DOI 10.1111/j.1398-9995.2012.02825.x; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gottfredsson M, 2008, P NATL ACAD SCI USA, V105, P1303, DOI 10.1073/pnas.0707659105; Govorkova EA, 2015, ANTIMICROB AGENTS CH, V59, P1495, DOI 10.1128/AAC.04431-14; GRAVESTEIN LA, 1995, INT IMMUNOL, V7, P551, DOI 10.1093/intimm/7.4.551; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Headland SE, 2015, SEMIN IMMUNOL, V27, P149, DOI 10.1016/j.smim.2015.03.014; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Horby P, 2010, EPIDEMIOL INFECT, V138, P1550, DOI 10.1017/S0950268810000518; Hu MCT, 1997, ONCOGENE, V15, P2277, DOI 10.1038/sj.onc.1201401; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Joo JH, 2008, J BIOL CHEM, V283, P16391, DOI 10.1074/jbc.M800945200; Kageyama T, 2013, EUROSURVEILLANCE, V18, P7; Karlsson EA, 2012, INFLUENZA OTHER RESP, V6, P449, DOI 10.1111/j.1750-2659.2012.00342.x; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Klenk HD, 2011, BIOESSAYS, V33, P180, DOI 10.1002/bies.201000118; Kollmus H, 2014, CURR OPIN VIROL, V6, P47, DOI 10.1016/j.coviro.2014.03.008; Kovner AV, 2013, B EXP BIOL MED+, V154, P476, DOI 10.1007/s10517-013-1981-z; Kraemer S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026332; Kroeker AL, 2012, J PROTEOME RES, V11, P4132, DOI 10.1021/pr300239r; Krug RM, 2006, SCIENCE, V311, P1562, DOI 10.1126/science.1125998; Larsson A, 2006, AMYLOID, V13, P78, DOI 10.1080/13506120600722530; Lietzen N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001340; Lin CH, 2015, EUR J PHARMACOL, V767, P135, DOI 10.1016/j.ejphar.2015.10.018; Liu C, 2012, J PROTEOME RES, V11, P5396, DOI 10.1021/pr3006342; Liu L, 2012, J PROTEOME RES, V11, P4091, DOI 10.1021/pr3001332; Liu N, 2008, PROTEOMICS, V8, P1851, DOI 10.1002/pmic.200700757; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; MacDonald J. W., 2022, AFFYCORETOOLS FUNCTI; Mancuso P, 2013, PULM PHARMACOL THER, V26, P412, DOI 10.1016/j.pupt.2012.04.006; Mehan MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035157; Moens U, 2013, GENES-BASEL, V4, P101, DOI 10.3390/genes4020101; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Nacken W, 2012, BIOL CHEM, V393, P525, DOI 10.1515/hsz-2011-0270; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; O'Brien KB, 2012, J INFECT DIS, V205, P252, DOI 10.1093/infdis/jir729; Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC; Oshansky CM, 2012, J LEUKOCYTE BIOL, V92, P83, DOI 10.1189/jlb.1011506; Petralki CD, 2006, BIOL CHEM, V387, P653, DOI 10.1515/BC.2006.084; Potapova OV, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/342686; Powell K, 2014, NAT MED, V20, P1082, DOI 10.1038/nm1014-1082; Qi WB, 2015, PROTEOMICS, V15, P1512, DOI 10.1002/pmic.201400309; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; R Core Team, 2013, R A LANGUAGE AND ENV; Rohloff JC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.49; Russell CJ, 2005, CELL, V123, P368, DOI 10.1016/j.cell.2005.10.019; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; SHOYAB M, 1989, SCIENCE, V243, P1074, DOI 10.1126/science.2466334; SKYTT A, 1995, BIOCHEM BIOPH RES CO, V211, P586, DOI 10.1006/bbrc.1995.1853; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spurlock CF, 2012, ARTHRITIS RHEUM-US, V64, P1780, DOI 10.1002/art.34342; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Vester D, 2009, PROTEOMICS, V9, P3316, DOI 10.1002/pmic.200800893; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Watanabe T, 2013, NATURE, V501, P551, DOI 10.1038/nature12392; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	87	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153674	10.1371/journal.pone.0153674	http://dx.doi.org/10.1371/journal.pone.0153674			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088501	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000040
J	Poulsen, JB; Lescai, F; Grove, J; Baekvad-Hansen, M; Christiansen, M; Hagen, CM; Maller, J; Stevens, C; Li, ST; Li, QB; Sun, JH; Wang, J; Nordentoft, M; Werge, TM; Mortensen, PB; Borglum, AD; Daly, M; Hougaard, DM; Bybjerg-Grauholm, J; Hollegaard, MV				Poulsen, Jesper Buchhave; Lescai, Francesco; Grove, Jakob; Baekvad-Hansen, Marie; Christiansen, Michael; Hagen, Christian Munch; Maller, Julian; Stevens, Christine; Li, Shenting; Li, Qibin; Sun, Jihua; Wang, Jun; Nordentoft, Merete; Werge, Thomas Mears; Mortensen, Preben Bo; Borglum, Anders Dupont; Daly, Mark; Hougaard, David Michael; Bybjerg-Grauholm, Jonas; Hollegaard, Mads Vilhelm			High-Quality Exome Sequencing of Whole-Genome Amplified Neonatal Dried Blood Spot DNA	PLOS ONE			English	Article							COMMON VARIANTS; NEWBORN; AMPLIFICATION; EXTRACTION; PROTEINS; CAPTURE; STORAGE	Stored neonatal dried blood spot (DBS) samples from neonatal screening programmes are a valuable diagnostic and research resource. Combined with information from national health registries they can be used in population-based studies of genetic diseases. DNA extracted from neonatal DBSs can be amplified to obtain micrograms of an otherwise limited resource, referred to as whole-genome amplified DNA (wgaDNA). Here we investigate the robustness of exome sequencing of wgaDNA of neonatal DBS samples. We conducted three pilot studies of seven, eight and seven subjects, respectively. For each subject we analysed a neonatal DBS sample and corresponding adult whole-blood (WB) reference sample. Different DNA sample types were prepared for each of the subjects. Pilot 1: wgaDNA of 2x3.2mm neonatal DBSs (DBS_ 2x3.2) and raw DNA extract of the WB reference sample (WB_ ref). Pilot 2: DBS_2x3.2, WB_ref and a WB_ref replica sharing DNA extract with the WB_ ref sample. Pilot 3: DBS_2x3.2, WB_ref, wgaDNA of 2x1.6 mm neonatal DBSs and wgaDNA of the WB reference sample. Following sequencing and data analysis, we compared pairwise variant calls to obtain a measure of similarity-the concordance rate. Concordance rates were slightly lower when comparing DBS vs WB sample types than for any two WB sample types of the same subject before filtering of the variant calls. The overall concordance rates were dependent on the variant type, with SNPs performing best. Post-filtering, the comparisons of DBS vs WB and WB vs WB sample types yielded similar concordance rates, with values close to 100%. WgaDNA of neonatal DBS samples performs with great accuracy and efficiency in exome sequencing. The wgaDNA performed similarly to matched high-quality reference-whole-blood DNA-based on concordance rates calculated from variant calls. No differences were observed substituting 2x3.2 with 2x1.6 mm discs, allowing for additional reduction of sample material in future projects.	[Poulsen, Jesper Buchhave; Baekvad-Hansen, Marie; Hougaard, David Michael; Bybjerg-Grauholm, Jonas; Hollegaard, Mads Vilhelm] Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Sect Neonatal Genet, DK-2300 Copenhagen, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Borglum, Anders Dupont] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Wang, Jun; Nordentoft, Merete; Werge, Thomas Mears; Mortensen, Preben Bo; Borglum, Anders Dupont] Aarhus Univ, iPSYCH Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Lescai, Francesco; Grove, Jakob; Li, Shenting; Wang, Jun; Borglum, Anders Dupont] Aarhus Univ, iSEQ Ctr Integrat Sequencing, Aarhus, Denmark; [Grove, Jakob] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark; [Christiansen, Michael; Hagen, Christian Munch] Statens Serum Inst, Dept Congenital Disorders, Mol Med, DK-2300 Copenhagen, Denmark; [Maller, Julian; Stevens, Christine; Daly, Mark] Stanley Ctr, Broad Inst, Cambridge, MA USA; [Li, Qibin; Wang, Jun] BGI Shenzhen, Shenzhen, Peoples R China; [Sun, Jihua] BGI Europe AS, Copenhagen, Denmark; [Nordentoft, Merete] Univ Copenhagen, Mental Hlth Ctr Copenhagen, Fac Hlth Sci, Copenhagen, Denmark; [Werge, Thomas Mears] Capital Reg Denmark, Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, Roskilde, Denmark; [Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Sch Business & Social Sci, Aarhus, Denmark; [Hougaard, David Michael; Hollegaard, Mads Vilhelm] Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Danish Neonatal Screening Biobank, DK-2300 Copenhagen, Denmark	Statens Serum Institut; Aarhus University; Aarhus University; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University; Statens Serum Institut; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Beijing Genomics Institute (BGI); University of Copenhagen; Aarhus University; Statens Serum Institut	Bybjerg-Grauholm, J (corresponding author), Statens Serum Inst, Dept Congenital Disorders, Danish Ctr Neonatal Screening, Sect Neonatal Genet, DK-2300 Copenhagen, Denmark.	jogr@ssi.dk	Bybjerg-Grauholm, Jonas/AAO-5447-2020; Daly, Mark J/B-2453-2017; Hougaard, David/AAD-6368-2019; Mortensen, Preben B/D-2358-2015; Nordentoft, Merete/AAH-3253-2019; Grove, Jakob/K-8112-2015	Bybjerg-Grauholm, Jonas/0000-0003-1705-4008; Daly, Mark J/0000-0002-0949-8752; Mortensen, Preben B/0000-0002-5230-9865; Baekvad-Hansen, Marie/0000-0002-5881-1776; Lescai, Francesco/0000-0002-6399-9101; Hagen, Christian/0000-0002-0513-7722; Nordentoft, Merete/0000-0003-4895-7023; Borglum, Anders/0000-0001-8627-7219; Grove, Jakob/0000-0003-2284-5744	Lundbeck Foundation; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden)	This work is part of the 'The Lundbeck Foundation Initiative for Integrative Psychiatric Research' - iPSYCH project (http://ipsych.au.dk/), which is funded by the Lundbeck Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Kikumaro, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P80; Asan, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r95; Bainbridge MN, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r62; Borglum AD, 2014, MOL PSYCHIATR, V19, P325, DOI 10.1038/mp.2013.2; Catsburg A, 2007, J IMMUNOL METHODS, V321, P135, DOI 10.1016/j.jim.2007.01.015; Clark MJ, 2011, NAT BIOTECHNOL, V29, P908, DOI 10.1038/nbt.1975; Feenstra B, 2012, NAT GENET, V44, P334, DOI 10.1038/ng.1067; Frank L, 2000, SCIENCE, V287, P2398, DOI 10.1126/science.287.5462.2398; Hamvas A, 2001, PEDIATR RES, V50, P666, DOI 10.1203/00006450-200111000-00021; Hannelius U, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032987; Hardin J, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-38; Hollegaard MV, 2007, CLIN CHEM, V53, P1161, DOI 10.1373/clinchem.2006.082313; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Hollegaard MV, 2013, HUM MUTAT, V34, P143, DOI 10.1002/humu.22173; Horikoshi M, 2013, NAT GENET, V45, P76, DOI 10.1038/ng.2477; Kahvejian A, 2008, NAT BIOTECHNOL, V26, P1125, DOI 10.1038/nbt1494; Lee S, 2014, AM J HUM GENET, V95, P5, DOI 10.1016/j.ajhg.2014.06.009; Lund AM, 2012, MOL GENET METAB, V107, P281, DOI 10.1016/j.ymgme.2012.06.006; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Norgaard-Pedersen B, 2007, J INHERIT METAB DIS, V30, P530, DOI 10.1007/s10545-007-0631-x; Norgaard-Pedersen B, 1999, ACTA PAEDIATR, V88, P106, DOI 10.1080/08035259950170736; Olney RS, 2006, J PEDIATR-US, V148, P618, DOI 10.1016/j.jpeds.2005.12.053; Parla JS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r97; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Steinberg S, 2014, MOL PSYCHIATR, V19, P108, DOI 10.1038/mp.2012.157; Tarini BA, 2012, ANNU REV GENOM HUM G, V13, P381, DOI 10.1146/annurev-genom-090711-163741; Therrell BL, 2007, J INHERIT METAB DIS, V30, P447, DOI 10.1007/s10545-007-0690-z; Webster Dianne, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P69; Wilcken B, 2008, PATHOLOGY, V40, P104, DOI 10.1080/00313020701813743	31	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153253	10.1371/journal.pone.0153253	http://dx.doi.org/10.1371/journal.pone.0153253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089011	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000014
J	Lier, R; Mork, PJ; Holtermann, A; Nilsen, TIL				Lier, Ragnhild; Mork, Paul Jarle; Holtermann, Andreas; Nilsen, Tom Ivar Lund			Familial Risk of Chronic Musculoskeletal Pain and the Importance of Physical Activity and Body Mass Index: Prospective Data from the HUNT Study, Norway	PLOS ONE			English	Article							LOW-BACK-PAIN; CHRONIC WIDESPREAD PAIN; NORD-TRONDELAG HEALTH; POPULATION-BASED HUNT; PARENTAL CHRONIC PAIN; UPPER-LIMB; SOCIOECONOMIC-STATUS; LONGITUDINAL DATA; SYMPTOMS; NECK	The main objectives of the current study was i) to prospectively examine if chronic musculoskeletal pain in parents is associated with risk of chronic musculoskeletal pain in their adult offspring, and ii) to assess if these parent-offspring associations are modified by offspring body mass index and leisure time physical activity. We used data on 4,742 adult offspring linked with their parents who participated in the population-based HUNT Study in Norway in 1995-97 and in 2006-08. Family relations were established through the national Family Registry. A Poisson regression model was used to estimate relative risk (RR) with 95% confidence interval (CI). In total, 1,674 offspring (35.3%) developed chronic musculoskeletal pain during the follow-up period of approximately 11 years. Both maternal (RR: 1.26, 95% CI: 1.03, 1.55) and paternal chronic musculoskeletal pain (RR: 1.29, 95% CI: 1.06, 1.57) was associated with increased risk of offspring chronic musculoskeletal pain. Compared to offspring of parents without chronic musculoskeletal pain, the adverse effect of parental pain was somewhat stronger among offspring who reported a low (RR: 1.82, 95% CI: 1.32, 2.52) versus high (RR: 1.32, 95% CI: 0.95, 1.84) level of leisure time physical activity. Offspring of parents with chronic musculoskeletal pain and who were classified as obese had more than twofold increased risk (RR: 2.33, 95% CI: 1.68, 3.24) of chronic musculoskeletal pain compared to normal weight offspring of parents without pain. In conclusion, parental chronic musculoskeletal pain is positively associated with risk of chronic musculoskeletal pain in their adult offspring. Maintenance of normal body weight may reduce the risk of chronic musculoskeletal pain in offspring of pain-afflicted parents.	[Lier, Ragnhild; Mork, Paul Jarle; Nilsen, Tom Ivar Lund] Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway; [Lier, Ragnhild] Cent Norway Reg Hlth Author RHA, Liaison Comm, Stjordal, Norway; [Lier, Ragnhild] Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway; [Holtermann, Andreas] Natl Res Ctr Working Environm, Copenhagen, Denmark	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); National Research Centre for the Working Environment	Lier, R (corresponding author), Norwegian Univ Sci & Technol, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway.; Lier, R (corresponding author), Cent Norway Reg Hlth Author RHA, Liaison Comm, Stjordal, Norway.; Lier, R (corresponding author), Norwegian Univ Sci & Technol, N-7034 Trondheim, Norway.	ragnhild.lier@ntnu.no			Liaison Committee [46054800]	Liaison Committee	This work was supported by a grant to Ragnhild Lier from the Liaison Committee between the Central Norway Regional Health Authority and the Norwegian University of Science and Technology (NTNU) (Grant number 46054800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], 1995, PHYS STAT US INT ANT; Arnold LM, 2004, ARTHRITIS RHEUM-US, V50, P944, DOI 10.1002/art.20042; Benjamin S, 2000, ARTHRITIS RHEUM-US, V43, P561, DOI 10.1002/1529-0131(200003)43:3<561::AID-ANR12>3.0.CO;2-O; Blangsted AK, 2008, SCAND J WORK ENV HEA, V34, P55, DOI 10.5271/sjweh.1192; Bradley LA, 2008, J CLIN PSYCHIAT, V69, P6; Bruehl S, 2005, PAIN, V115, P390, DOI 10.1016/j.pain.2005.03.017; Buskila Dan, 2005, Curr Pain Headache Rep, V9, P313; Cimmino MA, 2011, BEST PRACT RES CL RH, V25, P173, DOI 10.1016/j.berh.2010.01.012; D'Addio Anna Cristina, 2007, EMPLOYMENT MIGRATION, V52; Descatha A, 2007, SCAND J WORK ENV HEA, V33, P58, DOI 10.5271/sjweh.1065; Devereux JJ, 2002, OCCUP ENVIRON MED, V59, P269, DOI 10.1136/oem.59.4.269; EDWARDS PW, 1985, PAIN, V21, P379, DOI 10.1016/0304-3959(85)90166-6; Edwards RR, 2005, NEUROLOGY, V65, P437, DOI 10.1212/01.wnl.0000171862.17301.84; Evans Subhadra, 2010, Int J Disabil Hum Dev, V9, P11, DOI 10.1515/IJDHD.2010.003; Gerrits MMJG, 2015, J PSYCHOSOM RES, V78, P64, DOI 10.1016/j.jpsychores.2014.10.011; GOODMAN JE, 1991, PAIN, V46, P247, DOI 10.1016/0304-3959(91)90108-A; Hagen K, 2005, SCAND J PUBLIC HEALT, V33, P268, DOI 10.1080/14034940510005699; Henchoz Y, 2008, JOINT BONE SPINE, V75, P533, DOI 10.1016/j.jbspin.2008.03.003; Hocking LJ, 2012, EUR J PAIN, V16, P1053, DOI 10.1002/j.1532-2149.2011.00095.x; Hoftun GB, 2013, JAMA PEDIATR, V167, P61, DOI 10.1001/jamapediatrics.2013.422; Holliday KL, 2011, CURR RHEUMATOL REP, V13, P521, DOI 10.1007/s11926-011-0208-4; Holth HS, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-159; Jones GT, 2004, ANN RHEUM DIS, V63, P1152, DOI 10.1136/ard.2003.014670; Joud A, 2014, RHEUMATOL INT, V34, P1291, DOI 10.1007/s00296-014-3039-6; Kato K, 2006, ARTHRITIS RHEUM-US, V54, P1682, DOI 10.1002/art.21798; Kovacs FM, 2003, PAIN, V103, P259, DOI 10.1016/S0304-3959(02)00454-2; Krismer M, 2007, BEST PRACT RES CL RH, V21, P77, DOI 10.1016/j.berh.2006.08.004; Krokstad S, 2012, INT J EPIDEMIOL, V9, P9; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Landmark T, 2011, PAIN, V152, P2241, DOI 10.1016/j.pain.2011.04.029; Langhammer A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-143; Lawlor D, 2009, FAMILY MATTERS; Lier R, 2014, BMC PUBLIC HEALTH, V14, P1471; Linton SJ, 2001, SPINE, V26, P778, DOI 10.1097/00007632-200104010-00019; Livshits G, 2011, ANN RHEUM DIS, V70, P1740, DOI 10.1136/ard.2010.137836; Martin RM, 2004, EPIDEMIOLOGY, V15, P308, DOI 10.1097/01.ede.0000120042.16363.e3; Mogil JS, 2012, TRENDS GENET, V28, P258, DOI 10.1016/j.tig.2012.02.004; Mork PJ, 2013, EUR J PAIN, V17, P1252, DOI 10.1002/j.1532-2149.2013.00298.x; Mork PJ, 2012, ARTHRITIS RHEUM-US, V64, P281, DOI 10.1002/art.33346; Mork PJ, 2014, EUR J PUBLIC HEALTH, V24, P924, DOI 10.1093/eurpub/ckt198; Mustard CA, 2005, AM J EPIDEMIOL, V162, P779, DOI 10.1093/aje/kwi271; Nilsen TIL, 2011, AM J EPIDEMIOL, V174, P267, DOI 10.1093/aje/kwr087; Palmer K, 1999, OCCUP MED-OXFORD, V49, P171, DOI 10.1093/occmed/49.3.171; PAYNE B, 1986, PAIN, V26, P1, DOI 10.1016/0304-3959(86)90169-7; POLLARD CA, 1985, PSYCHOL REP, V57, P813, DOI 10.2466/pr0.1985.57.3.813; Pollard TCB, 2012, OSTEOARTHR CARTILAGE, V20, P368, DOI 10.1016/j.joca.2012.02.003; Ray L, 2011, PAIN, V152, P53, DOI 10.1016/j.pain.2010.08.043; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Saunders K, 2007, CLIN J PAIN, V23, P204, DOI 10.1097/AJP.0b013e31802d7807; Serbin LA, 2004, ANNU REV PSYCHOL, V55, P333, DOI 10.1146/annurev.psych.54.101601.145228; Sitthipornvorakul E, 2011, EUR SPINE J, V20, P677, DOI 10.1007/s00586-010-1630-4; van den Heuvel SG, 2005, PREV MED, V41, P260, DOI 10.1016/j.ypmed.2004.11.006; Vik KL, 2014, INT J EPIDEMIOL, V43, P760, DOI 10.1093/ije/dyt250; Vik KL, 2013, J EPIDEMIOL COMMUN H, V67, P564, DOI 10.1136/jech-2012-201634; VIOLON A, 1984, PAIN, V18, P199, DOI 10.1016/0304-3959(84)90887-X	57	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153828	10.1371/journal.pone.0153828	http://dx.doi.org/10.1371/journal.pone.0153828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082110	Green Published, gold, Green Submitted			2022-12-27	WOS:000374291800055
J	Rho, HS; Hanke, AT; Ottens, M; Gardeniers, H				Rho, Hoon Suk; Hanke, Alexander Thomas; Ottens, Marcel; Gardeniers, Han			Mapping of Enzyme Kinetics on a Microfluidic Device	PLOS ONE			English	Article							SOFT LITHOGRAPHY; GENE-EXPRESSION; GRADIENT; CHEMOMETRICS; CHEMOTAXIS; NETWORKS; SYSTEM; TIME	A microfluidic platform or "microfluidic mapper" is demonstrated, which in a single experiment performs 36 parallel biochemical reactions with 36 different combinations of two reagents in stepwise concentration gradients. The volume used in each individual reaction was 36 nl. With the microfluidic mapper, we obtained a 3D enzyme reaction plot of horseradish peroxidase (HRP) with Amplex Red (AR) and hydrogen peroxide (H2O2), for concentration ranges of 11.7 mu M to 100.0 mu M and 11.1 mu M to 66.7 mu M for AR and H2O2, respectively. This system and methodology could be used as a fast analytical tool to evaluate various chemical and biochemical reactions especially where two or more reagents interact with each other. The generation of dual concentration gradients in the present format has many advantages such as parallelization of reactions in a nanoliter-scale volume and the real-time monitoring of processes leading to quick concentration gradients. The microfluidic mapper could be applied to various problems in analytical chemistry such as revealing of binding kinetics, and optimization of reaction kinetics.	[Rho, Hoon Suk; Gardeniers, Han] Univ Twente, MESA Inst Nanotechnol, Mesoscale Chem Syst Grp, POB 217, NL-7500 AE Enschede, Netherlands; [Hanke, Alexander Thomas; Ottens, Marcel] Delft Univ Technol, Fac Sci Appl, Dept Biotechnol, BioProc Engn Grp, Delft, Netherlands	University of Twente; Delft University of Technology	Gardeniers, H (corresponding author), Univ Twente, MESA Inst Nanotechnol, Mesoscale Chem Syst Grp, POB 217, NL-7500 AE Enschede, Netherlands.	j.g.e.gardeniers@utwente.nl	Gardeniers, Johannes GE/B-6309-2013; Rho, Hoon Suk/AAK-5398-2021; Rho, Hoon Suk/G-2276-2018	Gardeniers, Johannes GE/0000-0003-0581-2668; Rho, Hoon Suk/0000-0002-5345-3965	BE-Basic foundation; Ministry of Economic Affairs of the Netherlands [FES0905];  [FS2.003.]	BE-Basic foundation; Ministry of Economic Affairs of the Netherlands(Ministry of Economic Affairs, Netherlands); 	This work was supported by the BE-Basic foundation (funded by the Ministry of Economic Affairs of the Netherlands, grant number: FES0905), a public private partnership of knowledge institutes, industry and academia, under the project nr. FS2.003. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold V.I., 1989, MATH METHODS CLASSIC; Bui MPN, 2011, ANAL CHEM, V83, P1603, DOI 10.1021/ac102472a; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Dai J, 2013, ANAL CHEM, V85, P5892, DOI 10.1021/ac400648z; Dertinger SKW, 2001, ANAL CHEM, V73, P1240, DOI 10.1021/ac001132d; Fraga CG, 2001, ANAL CHEM, V73, P675, DOI 10.1021/ac0010025; Frank T, 2013, LAB CHIP, V13, P1273, DOI 10.1039/c3lc41076e; Goulpeau J, 2005, J APPL PHYS, V98, DOI 10.1063/1.1947893; Hadd AG, 1997, ANAL CHEM, V69, P3407, DOI 10.1021/ac970192p; Hamon M, 2013, ANAL CHEM, V85, P5249, DOI 10.1021/ac400743w; Harvey D., 2000, MODERN ANAL CHEM; Hong JW, 2004, NAT BIOTECHNOL, V22, P435, DOI 10.1038/nbt951; Jambovane S, 2011, ANAL CHEM, V83, P3358, DOI 10.1021/ac103217p; Jambovane S, 2009, ANAL CHEM, V81, P3239, DOI 10.1021/ac8020938; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Khajeh M, 2010, ANAL CHEM, V82, P2102, DOI 10.1021/ac100110m; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Lineweaver H, 1934, J AM CHEM SOC, V56, P658, DOI 10.1021/ja01318a036; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Mehling M, 2015, LAB CHIP, V15, P1276, DOI 10.1039/c4lc01038h; Melin J, 2007, ANNU REV BIOPH BIOM, V36, P213, DOI 10.1146/annurev.biophys.36.040306.132646; Miller OJ, 2012, P NATL ACAD SCI USA, V109, P378, DOI 10.1073/pnas.1113324109; Neils C, 2004, LAB CHIP, V4, P342, DOI 10.1039/b314962e; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Price NC, 2001, BIOCH MOL BIOL ED, V29, P34; Saadi W, 2006, BIOMED MICRODEVICES, V8, P109, DOI 10.1007/s10544-006-7706-6; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Segel I.H., 1975, ENZYME KINETICS; Seong GH, 2003, ANAL CHEM, V75, P3161, DOI 10.1021/ac034155b; Shuler ML, 2002, BIOPROCESS ENG, V2a; Song H, 2003, ANGEW CHEM INT EDIT, V42, P768, DOI 10.1002/anie.200390203; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Wang JY, 2006, ANGEW CHEM INT EDIT, V45, P5276, DOI 10.1002/anie.200601677; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yang Y, 2015, LAB CHIP; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107958	37	15	15	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153437	10.1371/journal.pone.0153437	http://dx.doi.org/10.1371/journal.pone.0153437			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ6AH	27082243	Green Submitted, Green Published, gold			2022-12-27	WOS:000374291800020
J	Bonetti, M; Cirillo, P; Tanzi, PM; Trinchero, E				Bonetti, Marco; Cirillo, Pasquale; Tanzi, Paola Musile; Trinchero, Elisabetta			An Analysis of the Number of Medical Malpractice Claims and Their Amounts	PLOS ONE			English	Article							FREQUENCY; MODEL	Starting from an extensive database, pooling 9 years of data from the top three insurance brokers in Italy, and containing 38125 reported claims due to alleged cases of medical malpractice, we use an inhomogeneous Poisson process to model the number of medical malpractice claims in Italy. The intensity of the process is allowed to vary over time, and it depends on a set of covariates, like the size of the hospital, the medical department and the complexity of the medical operations performed. We choose the combination medical department by hospital as the unit of analysis. Together with the number of claims, we also model the associated amounts paid by insurance companies, using a two-stage regression model. In particular, we use logistic regression for the probability that a claim is closed with a zero payment, whereas, conditionally on the fact that an amount is strictly positive, we make use of lognormal regression to model it as a function of several covariates. The model produces estimates and forecasts that are relevant to both insurance companies and hospitals, for quality assurance, service improvement and cost reduction.	[Bonetti, Marco] Bocconi Univ, Milan, Italy; [Bonetti, Marco] Carlo F Dondena Ctr Res Social Dynam & Publ Polic, Milan, Italy; [Cirillo, Pasquale] Delft Univ Technol, Appl Probabil Grp, Delft, Netherlands; [Tanzi, Paola Musile; Trinchero, Elisabetta] SDA Bocconi Sch Management, Res Div C Dematte, Milan, Italy; [Tanzi, Paola Musile] Univ Perugia, Dept Econ, I-06100 Perugia, Italy	Bocconi University; Delft University of Technology; Bocconi University; University of Perugia	Cirillo, P (corresponding author), Delft Univ Technol, Appl Probabil Grp, Delft, Netherlands.	P.Cirillo@tudelft.nl		Trinchero, Elisabetta/0000-0002-9160-1084	European Union [PCIG13-GA-2013-618794];  [CIG PCIG13-GA-2013-618794]	European Union(European Commission); 	PC acknowledges the support of his Marie Curie CIG PCIG13-GA-2013-618794 under the Seventh Framework Programme (http://ec.europa.eu/research/mariecurieactions/funded-projects/how-to-manage/cig/index_en.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PC also acknowledges the support of the Marie Curie Career Integration Grant "Multivariate Shocks" (PCIG13-GA-2013-618794) from the European Union.	Baker Judith J, 2002, J Health Care Finance, V28, P1; Brusoni M, GESTIONE RITENZIONE; Cirillo P, 2013, PHYSICA A, V392, P5947, DOI 10.1016/j.physa.2013.07.061; Cirillo P, 2013, METHODOL COMPUT APPL, V15, P821, DOI 10.1007/s11009-012-9281-z; COOIL B, 1991, J AM STAT ASSOC, V86, P285, DOI 10.2307/2290560; Couturier DL, 2010, ANN APPL STAT, V4, P1824, DOI 10.1214/10-AOAS358; Craig CC, 1936, ANN MATH STAT, V7, P16, DOI 10.1214/aoms/1177732542; de Feijter JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031125; Embrechts P., 2003, MODELLING EXTREMAL E; Fattore Giovanni, 2006, Health Care Manag Sci, V9, P251, DOI 10.1007/s10729-006-9092-2; Fetter RB, 1980, MED CARE S, V18, P1; GIBBONS RD, 1994, J AM STAT ASSOC, V89, P760, DOI 10.2307/2290901; Hull J., 2015, RISK MANAGEMENT FINA, VFourth; Istituto Italiano di Statistica, CONS PRIC IND; Italian Ministry of Health, RAPP ANN SULL RIC OS; Jena AB, 2011, NEW ENGL J MED, V365, P629, DOI 10.1056/NEJMsa1012370; Johnson N., 1970, CONTINUOUS UNIVARIAT; Kleiber C., 2003, STAT SIZE DISTRIBUTI, DOI 10.1002/0471457175; LAWLESS JF, 1987, J AM STAT ASSOC, V82, P808, DOI 10.2307/2288790; LEE L, 1978, TECHNOMETRICS, V20, P41, DOI 10.2307/1268160; LINDGREN G, 1980, ANN PROBAB, V8, P775, DOI 10.1214/aop/1176994665; Nye BF, 1988, J RISK INSUR, V55, P150, DOI [10.2307/253287, DOI 10.2307/253287]; Randelli Mario, 2008, Chir Organi Mov, V91, P125, DOI 10.1007/s12306-007-0021-4; Rapp GC, 2006, NO ILLINOIS U LAW RE, V26, P439; Ritchey FJ, 2014, WILEY BLACKWELL ENCY, P1387; SLOAN FA, 1989, JAMA-J AM MED ASSOC, V262, P3291, DOI 10.1001/jama.262.23.3291; Tediosi F, 2009, HEALTH POLICY, V90, P303, DOI 10.1016/j.healthpol.2008.10.012; Traina F, 2009, CLIN ORTHOP RELAT R, V467, P434, DOI 10.1007/s11999-008-0582-z; van der Wijk J, 1939, INKOMENS EN VERMOGEN; Vargo E, 2010, J QUAL TECHNOL, V42, P276, DOI 10.1080/00224065.2010.11917824	30	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153362	10.1371/journal.pone.0153362	http://dx.doi.org/10.1371/journal.pone.0153362			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077661	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700044
J	Mohan, V; Gupta, S; Thomas, S; Mickey, H; Charakana, C; Chauhan, VS; Sharma, K; Kumar, R; Tyagi, K; Sarma, S; Gupta, SK; Kilambi, HV; Nongmaithem, S; Kumari, A; Gupta, P; Sreelakshmi, Y; Sharma, R				Mohan, Vijee; Gupta, Soni; Thomas, Sherinmol; Mickey, Hanjabam; Charakana, Chaitanya; Chauhan, Vineeta Singh; Sharma, Kapil; Kumar, Rakesh; Tyagi, Kamal; Sarma, Supriya; Gupta, Suresh Kumar; Kilambi, Himabindu Vasuki; Nongmaithem, Sapana; Kumari, Alka; Gupta, Prateek; Sreelakshmi, Yellamaraju; Sharma, Rameshwar			Tomato Fruits Show Wide Phenomic Diversity but Fruit Developmental Genes Show Low Genomic Diversity	PLOS ONE			English	Article							TILLING RESOURCE; ASSOCIATION; SHAPE; INTROGRESSION; REVEALS; TOOL; POLYMORPHISMS; SOFTWARE; NETWORK; COMPLEX	Domestication of tomato has resulted in large diversity in fruit phenotypes. An intensive phenotyping of 127 tomato accessions from 20 countries revealed extensive morphological diversity in fruit traits. The diversity in fruit traits clustered the accessions into nine classes and identified certain promising lines having desirable traits pertaining to total soluble salts (TSS), carotenoids, ripening index, weight and shape. Factor analysis of the morphometric data from Tomato Analyzer showed that the fruit shape is a complex trait shared by several factors. The 100% variance between round and flat fruit shapes was explained by one discriminant function having a canonical correlation of 0.874 by stepwise discriminant analysis. A set of 10 genes (ACS2, COP1, CYC-B, RIN, MSH2, NAC-NOR, PHOT1, PHYA, PHYB and PSY1) involved in various plant developmental processes were screened for SNP polymorphism by EcoTILLING. The genetic diversity in these genes revealed a total of 36 non-synonymous and 18 synonymous changes leading to the identification of 28 haplotypes. The average frequency of polymorphism across the genes was 0.038/Kb. Significant negative Tajima'D statistic in two of the genes, ACS2 and PHOT1 indicated the presence of rare alleles in low frequency. Our study indicates that while there is low polymorphic diversity in the genes regulating plant development, the population shows wider phenotype diversity. Nonetheless, morphological and genetic diversity of the present collection can be further exploited as potential resources in future.	[Mohan, Vijee; Gupta, Soni; Thomas, Sherinmol; Mickey, Hanjabam; Charakana, Chaitanya; Chauhan, Vineeta Singh; Sharma, Kapil; Kumar, Rakesh; Tyagi, Kamal; Sarma, Supriya; Gupta, Suresh Kumar; Kilambi, Himabindu Vasuki; Nongmaithem, Sapana; Kumari, Alka; Gupta, Prateek; Sreelakshmi, Yellamaraju; Sharma, Rameshwar] Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India; [Mohan, Vijee; Gupta, Suresh Kumar] Agr Res Org, Volcani Ctr, Inst Plant Sci, IL-50250 Bet Dagan, Israel; [Gupta, Soni] CSIR, Cent Inst Med & Aromat Plants, Dept Genet & Plant Breeding, Lucknow, Uttar Pradesh, India; [Chauhan, Vineeta Singh] Tierra Seed Sci Private Ltd, Hyderabad, Andhra Pradesh, India	University of Hyderabad; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Sharma, R (corresponding author), Univ Hyderabad, Dept Plant Sci, Repository Tomato Genom Resources, Hyderabad 500134, Andhra Pradesh, India.	syellamaraju@gmail.com; rameshwar.sharma@gmail.com	Gupta, Suresh/AFY-2970-2022; Mohan, Vijee/AAQ-4436-2021; Sharma, Kapil/AAM-5025-2021; Gupta, Prateek/AAM-6061-2021; Gupta, Soni/AAE-5055-2022	Mohan, Vijee/0000-0001-6472-0187; Sharma, Kapil/0000-0002-1847-4584; Gupta, Prateek/0000-0002-7296-8411; Gupta, Suresh Kumar/0000-0003-3972-6717; Sreelakshmi, Yellamaraju/0000-0003-3468-9136; Gupta, Soni/0000-0001-6857-5626; Thomas, Sherinmol/0000-0003-4068-0322; tygai, kamal/0000-0002-3706-5030; Kumar, Rakesh/0000-0001-5072-5673	Department of Biotechnology, India [BT/PR/5275/AGR/16/465/2004, BT/PR/7002/PBD/16/1009/2012]; University Grants Commission, India; Department of Science and Technology, India; Council of Scientific and Industrial Research, India; Indian Council of Medical Research, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India); Department of Science and Technology, India(Department of Science & Technology (India)); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research, India(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Biotechnology, India (grant no. BT/PR/5275/AGR/16/465/2004; BT/PR/7002/PBD/16/1009/2012) to RS and YS; University Grants Commission, India to YS and RS; Department of Science and Technology, India (Young Scientist grants to SG and VSC); Council of Scientific and Industrial Research, India (research fellowship to VM, HM, CC, RK, SKG, KT, SN, PG); University Grants Commission, India (research fellowship to ST, KS, SS, HVK) and Indian Council of Medical Research, India (research fellowship to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Azzi L, 2015, J EXP BOT, V66, P1075, DOI 10.1093/jxb/eru527; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barone Amalia, 2008, Int J Plant Genomics, V2008, P820274, DOI 10.1155/2008/820274; Bauchet G, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0279-2; Bauchet G, 2012, GENETIC DIVERSITY IN PLANTS, P133; Beecher GR, 1998, P SOC EXP BIOL MED, V218, P98, DOI 10.3181/00379727-218-44282a; Biehler E, 2010, J FOOD SCI, V75, pC55, DOI 10.1111/j.1750-3841.2009.01417.x; Blanca J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048198; Blomstedt CK, 2012, PLANT BIOTECHNOL J, V10, P54, DOI 10.1111/j.1467-7652.2011.00646.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Brewer MT, 2006, PLANT PHYSIOL, V141, P15, DOI 10.1104/pp.106.077867; CHARLESWORTH B, 1994, NATURE, V371, P215, DOI 10.1038/371215a0; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; Chitwood DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029570; Chusreeaeom K, 2014, MOL GENET GENOMICS, V289, P399, DOI 10.1007/s00438-014-0822-8; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Darrigues A, 2008, J AM SOC HORTIC SCI, V133, P579, DOI 10.21273/JASHS.133.4.579; DAVIES JN, 1981, CRC CR REV FOOD SCI, V15, P205, DOI 10.1080/10408398109527317; Frerichmann SLM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-52; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Gonzalez N, 2015, J EXP BOT, V66, P1045, DOI 10.1093/jxb/eru541; Grandillo S, 1999, THEOR APPL GENET, V99, P978, DOI 10.1007/s001220051405; Gupta SK, 2014, PLANT CELL ENVIRON, V37, P1688, DOI 10.1111/pce.12279; Ibiza VP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-631; Ichihashi Y, 2014, P NATL ACAD SCI USA, V111, pE2616, DOI 10.1073/pnas.1402835111; Ichihashi Y, 2014, CURR OPIN PLANT BIOL, V18, P9, DOI 10.1016/j.pbi.2013.12.004; Labate JA, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-133; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Liu LH, 2015, MOL PLANT, V8, P28, DOI 10.1016/j.molp.2014.11.006; Liu RH, 2004, J NUTR, V134, p3479S, DOI 10.1093/jn/134.12.3479S; Mazzucato A, 2008, THEOR APPL GENET, V116, P657, DOI 10.1007/s00122-007-0699-6; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Menda N, 2013, PLANT BIOTECHNOL-NAR, V30, P243, DOI 10.5511/plantbiotechnology.13.0904a; Mueller LA, 2005, PLANT PHYSIOL, V138, P1310, DOI 10.1104/pp.105.060707; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Nieto C, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-34; Ogura T, 2015, CURR OPIN PLANT BIOL, V23, P98, DOI 10.1016/j.pbi.2014.11.008; Okabe Y, 2011, PLANT CELL PHYSIOL, V52, P1994, DOI 10.1093/pcp/pcr134; Panthee DR, 2013, PLANT GENET RESOUR-C, V11, P106, DOI 10.1017/S1479262112000421; Perkel J, 2008, NAT METHODS, V5, P447, DOI 10.1038/nmeth0508-447; Quinet M, 2011, PHYSIOL PLANTARUM, V141, P166, DOI 10.1111/j.1399-3054.2010.01426.x; Rawat N, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-205; Rodriguez GR, 2010, JOVE-J VIS EXP, pe1856, DOI [DOI 10.3791/1856, 10.3791/1856]; Rodriguez GR, 2011, PLANT PHYSIOL, V156, P275, DOI 10.1104/pp.110.167577; Rodriguez-Amaya DB, 2004, HARVESTPLUS HANDBOOK; Rohlf FJ, 1992, APPLIED BIOSTATISTIC; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruggieri V, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0337-9; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; SADLER G, 1990, J FOOD SCI, V55, P1460, DOI 10.1111/j.1365-2621.1990.tb03958.x; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shakhatreh Y, 2010, GENET RESOUR CROP EV, V57, P131, DOI 10.1007/s10722-009-9457-8; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sreelakshmi Y, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-3; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Szymkowiak EJ, 2006, PLANTA, V223, P646, DOI 10.1007/s00425-005-0115-x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor NE, 2003, NUCLEIC ACIDS RES, V31, P3808, DOI 10.1093/nar/gkg574; van der Knaap E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00227; Vankadavath RN, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-18; Wang NA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-137; Xu JX, 2013, THEOR APPL GENET, V126, P567, DOI 10.1007/s00122-012-2002-8; Yu SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030765; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595	68	13	16	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152907	10.1371/journal.pone.0152907	http://dx.doi.org/10.1371/journal.pone.0152907			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077652	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700014
J	Reuscher, S; Kolter, A; Hoffmann, A; Pillen, K; Kramer, U				Reuscher, Stefan; Kolter, Andreas; Hoffmann, Astrid; Pillen, Klaus; Kraemer, Ute			Quantitative Trait Loci and Inter-Organ Partitioning for Essential Metal and Toxic Analogue Accumulation in Barley	PLOS ONE			English	Article							VULGARE SSP SPONTANEUM; INTROGRESSION LINES; DURUM-WHEAT; ZINC BIOFORTIFICATION; CADMIUM ACCUMULATION; GENE IDENTIFICATION; ALUMINUM TOLERANCE; IRON FORTIFICATION; GRAIN PROTEIN; QTL ANALYSIS	The concentrations of both essential nutrients and chemically similar toxic analogues accumulated in cereal grains have a major impact on the nutritional quality and safety of crops. Naturally occurring genetic diversity can be exploited for the breeding of improved varieties through introgression lines (ILs). In this study, multi-element analysis was conducted on vegetative leaves, senesced flag leaves and mature grains of a set of 54 ILs of the wild ancestral Hordeum vulgare ssp. spontaneum in the cultivated variety Hordeum vulgare ssp. vulgare cv. Scarlett. Plants were cultivated on an anthropogenically heavy metal-contaminated soil collected in an agricultural field, thus allowing simultaneous localization of quantitative trait loci (QTL) for the accumulation of both essential nutrients and toxic trace elements in barley as a model cereal crop. For accumulation of the micronutrients Fe and Zn and the interfering toxin Cd, we identified 25, 16 and 5 QTL, respectively. By examining the gene content of the introgressions, we associated QTL with candidate genes based on homology to known metal homeostasis genes of Arabidopsis and rice. Global comparative analyses suggested the preferential remobilization of Cu and Fe, over Cd, from the flag leaf to developing grains. Our data identifies grain micronutrient filling as a regulated and nutrient- specific process, which operates differently from vegetative micronutrient homoeostasis. In summary, this study provides novel QTL for micronutrient accumulation in the presence of toxic analogues and supports a higher degree of metal specificity of trace element partitioning during grain filling in barley than previously reported for other cereals.	[Reuscher, Stefan; Kolter, Andreas; Kraemer, Ute] Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, Bochum, Germany; [Hoffmann, Astrid; Pillen, Klaus] Univ Halle Wittenberg, Inst Agr & Nutr Sci, D-06108 Halle, Germany; [Reuscher, Stefan] Nagoya Univ, Biosci & Biotechnol Ctr, Furo Cho, Nagoya, Aichi 4648601, Japan; [Hoffmann, Astrid] Deutsch Saatveredelung DSV, Leutewitz 26, D-01665 Kabschutztal, Germany	Ruhr University Bochum; Martin Luther University Halle Wittenberg; Nagoya University	Kramer, U (corresponding author), Ruhr Univ Bochum, Dept Plant Physiol, Univ Str 150, Bochum, Germany.	ute.kraemer@ruhr-uni-bochum.de	Kraemer, Ute/C-5025-2008; Pillen, Klaus/I-6511-2012	Kraemer, Ute/0000-0001-7870-4508; Pillen, Klaus/0000-0003-4646-6351	Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata). [FOOD-CT2006-016253]; European Union [FOOD-CT-2006-016253]	Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).; European Union(European Commission)	This work was supported by FOOD-CT-2006-016253, https://ec.europa.eu/research/fp6/index_en.cfm, Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).; We thank Petra Duchting, Ruhr University Bochum, for technical support with sample digestion and multi-element analysis. We thank Erika Szakacs for plant cultivation and Michael J. Haydon for preparatory experiments. We thank Stephan Clemens, University of Bayreuth, for discussions and for sharing his calibration and measurement method for multi-element analysis as part of a standardization effort between our laboratories. We thank the LBEG (Hannover, Germany) for making available the soil. This work was funded by the European Union, FOOD-CT-2006-016253, https://ec.europa.eu/research/fp6/index_en.cfm, Integrated Project PHIME (Public health impact of long-term, low-level mixed element exposure in susceptible population strata).	Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Akesson A, 2006, ENVIRON HEALTH PERSP, V114, P830, DOI 10.1289/ehp.8763; Alloway B. J., 2005, ESSENTIALS MED GEOLO, P347; Arrivault S, 2006, PLANT J, V46, P861, DOI 10.1111/j.1365-313X.2006.02746.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bus A, 2008, THESIS R FRIEDRICH W; Clemens S, 2013, TRENDS PLANT SCI, V18, P92, DOI 10.1016/j.tplants.2012.08.003; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; Fan MS, 2008, J TRACE ELEM MED BIO, V22, P315, DOI 10.1016/j.jtemb.2008.07.002; Ferraro PM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-304; Fontecha G, 2007, THEOR APPL GENET, V114, P249, DOI 10.1007/s00122-006-0427-7; Gayomba SR, 2013, METALLOMICS, V5, P1262, DOI 10.1039/c3mt00111c; Greger M, 2004, CROP SCI, V44, P501, DOI 10.2135/cropsci2004.5010; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; Gu JF, 2012, J EXP BOT, V63, P455, DOI 10.1093/jxb/err292; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Harris NS, 2001, J EXP BOT, V52, P1473, DOI 10.1093/jexbot/52.360.1473; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Ishikawa S, 2005, NEW PHYTOL, V168, P345, DOI 10.1111/j.1469-8137.2005.01516.x; Ishikawa S, 2012, P NATL ACAD SCI USA, V109, P19166, DOI 10.1073/pnas.1211132109; Jarup L, 2004, BIOMETALS, V17, P505, DOI 10.1023/B:BIOM.0000045729.68774.a1; Knox RE, 2009, GENOME, V52, P741, DOI [10.1139/G09-042, 10.1139/g09-042]; Kobayashi T, 2012, ANNU REV PLANT BIOL, V63, P131, DOI 10.1146/annurev-arplant-042811-105522; Kraemer U, 2009, NEW PHYTOL, V181, P3, DOI 10.1111/j.1469-8137.2008.02699.x; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Lanquar V, 2010, PLANT PHYSIOL, V152, P1986, DOI 10.1104/pp.109.150946; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Leyva-Guerrero E, 2012, CURR OPIN BIOTECH, V23, P257, DOI 10.1016/j.copbio.2011.12.009; Mahone GS, 2012, CROP SCI, V52, P2198, DOI 10.2135/cropsci2011.06.0341; Maron LG, 2013, P NATL ACAD SCI USA, V110, P5241, DOI 10.1073/pnas.1220766110; Marschner P, 2012, MARSCHNER'S MINERAL NUTRITION OF HIGHER PLANTS, 3RD EDITION, P1; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Mayer KFX, 2011, PLANT CELL, V23, P1249, DOI 10.1105/tpc.110.082537; Murata Y, 2006, PLANT J, V46, P563, DOI 10.1111/j.1365-313X.2006.02714.x; Murray C.J.L., 2004, COMP QUANTIFICATION, V1, P257, DOI DOI 10.1007/S12263-011-0248-4; Newman RK, 2008, BARLEY FOOD HLTH SCI; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Pillen K, 2003, THEOR APPL GENET, V107, P340, DOI 10.1007/s00122-003-1253-9; Pure Earth Green Cross, 2015, WORLDS WORST POLL PR; Rawat N, 2011, GENOME, V54, P943, DOI [10.1139/G11-059, 10.1139/g11-059]; Rosado JL, 2009, J NUTR, V139, P1920, DOI 10.3945/jn.109.107755; Schmalenbach I, 2009, THEOR APPL GENET, V118, P483, DOI 10.1007/s00122-008-0915-z; Schmalenbach I, 2008, THEOR APPL GENET, V117, P1093, DOI 10.1007/s00122-008-0847-7; Schmalenbach I, 2011, G3-GENES GENOM GENET, V1, P187, DOI 10.1534/g3.111.000182; Schmalenbach I, 2009, THEOR APPL GENET, V118, P1411, DOI 10.1007/s00122-009-0991-8; Simic D, 2012, J HERED, V103, P47, DOI 10.1093/jhered/esr122; Sinclair SA, 2012, BBA-MOL CELL RES, V1823, P1553, DOI 10.1016/j.bbamcr.2012.05.016; Stoltzfus RJ., 2004, COMP QUANTIFICATION, pp. 163; Stomph TJ, 2009, TRENDS PLANT SCI, V14, P123, DOI 10.1016/j.tplants.2009.01.001; Sutton T, 2007, SCIENCE, V318, P1446, DOI 10.1126/science.1146853; Tezuka K, 2010, THEOR APPL GENET, V120, P1175, DOI 10.1007/s00122-009-1244-6; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tiwari VK, 2009, J HERED, V100, P771, DOI 10.1093/jhered/esp030; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Ueno D, 2009, J EXP BOT, V60, P3513, DOI 10.1093/jxb/erp191; Uraguchi S, 2013, CURR OPIN PLANT BIOL, V16, P328, DOI 10.1016/j.pbi.2013.03.012; Uraguchi S, 2011, P NATL ACAD SCI USA, V108, P20959, DOI 10.1073/pnas.1116531109; von Korff M, 2006, THEOR APPL GENET, V112, P1221, DOI 10.1007/s00122-006-0223-4; von Korff M, 2004, THEOR APPL GENET, V109, P1736, DOI 10.1007/s00122-004-1818-2; Wan Jian-Lin, 2003, Yi Chuan Xue Bao, V30, P893; Wang GW, 2010, THEOR APPL GENET, V120, P1559, DOI 10.1007/s00122-010-1276-y; Wu DZ, 2015, NEW PHYTOL, V208, P817, DOI 10.1111/nph.13512; Yordem BK, 2011, ANN BOT-LONDON, V108, P821, DOI 10.1093/aob/mcr200; Yuan L, 2013, J SCI FOOD AGR, V93, P254, DOI 10.1002/jsfa.5749; Zamir D, 2001, NAT REV GENET, V2, P983, DOI 10.1038/35103590	71	16	17	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153392	10.1371/journal.pone.0153392	http://dx.doi.org/10.1371/journal.pone.0153392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078500	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700049
J	Sutter, K; Nonnekes, J; Dibilio, V; Geurts, AC; Weerdesteyn, V				Sutter, Katrin; Nonnekes, Jorik; Dibilio, Valeria; Geurts, Alexander C.; Weerdesteyn, Vivian			Does the StartReact Effect Apply to First-Trial Reactive Movements?	PLOS ONE			English	Article							REACTION-TIME; 1ST TRIAL; STARTLE; HUMANS; HEALTHY; POSTURE; REFLEX	Introduction StartReact is the acceleration of reaction time by a startling acoustic stimulus (SAS). The SAS is thought to release a pre-prepared motor program. Here, we investigated whether the StartReact effect is applicable to the very first trial in a series of repeated unpractised single-joint movements. Methods Twenty healthy young subjects were instructed to perform a rapid ankle dorsiflexion movement in response to an imperative stimulus. Participants were divided in two groups of ten. Both groups performed 17 trials. In one group a SAS (116 dB) was given in the first trial, whereas the other group received a non-startling sound (70 dB) as the first imperative stimulus. In the remaining 16 trials, the SAS was given as the imperative stimulus in 25% of the trials in both groups. The same measurement was repeated one week later, but with the first-trial stimuli counterbalanced between groups. Results When a SAS was given in the very first trial, participants had significantly shorter onset latencies compared to first-trial responses to a non-startling stimulus. Succeeding trials were significantly faster compared to the first trial, both for trials with and without a SAS. However, the difference between the first and succeeding trials was significantly larger for responses to a non-startling stimulus compared to responses triggered by a SAS. SAS-induced acceleration in the first trial of the second session was similar to that in succeeding trials of session 1. Discussion The present results confirm that the StartReact phenomenon also applies to movements that have not yet been practiced in the experimental context. The excessive SAS-induced acceleration in the very first trial may be due to the absence of integration of novel context-specific information with the existing motor memory for movement execution. Our findings demonstrate that StartReact enables a rapid release of motor programs in the very first trial also without previous practice, which might provide a behavioural advantage in situations that require a rapid response to a potentially threatening environmental stimulus.	[Sutter, Katrin; Nonnekes, Jorik; Dibilio, Valeria; Geurts, Alexander C.; Weerdesteyn, Vivian] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Dibilio, Valeria] Univ Catania, Sect Neurosci, Dept GF Ingrassia, Catania, Italy; [Geurts, Alexander C.; Weerdesteyn, Vivian] Sint Maartensklin Res, Nijmegen, Netherlands	Radboud University Nijmegen; University of Catania; Sint Maartens Clinic	Weerdesteyn, V (corresponding author), Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands.	vivian.weerdesteyn@radboudumc.nl	Nonnekes, Jorik/P-6648-2015; Geurts, Alexander/H-8032-2014; Weerdesteyn, Vivian/A-9599-2014	Geurts, Alexander/0000-0001-7478-1119; Weerdesteyn, Vivian/0000-0003-4327-7600; Nonnekes, Jorik/0000-0003-2434-1427; Sutter, Katrin/0000-0002-5269-8573	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grant [916.10.106]	Radboud University Nijmegen Medical Centre Research Grant; Netherlands Organization for Scientific Research Veni Research Grant	This research was funded by a Radboud University Nijmegen Medical Centre Research Grant to Jorik Nonnekes, and a Netherlands Organization for Scientific Research Veni Research Grant (916.10.106) to Vivian Weerdesteyn (http://www.nwo.nl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN P, 1991, J NEUROL NEUROSUR PS, V54, P892, DOI 10.1136/jnnp.54.10.892; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Carlsen AN, 2004, J MOTOR BEHAV, V36, P253, DOI 10.3200/JMBR.36.3.253-264; Carlsen AN, 2012, CLIN NEUROPHYSIOL, V123, P21, DOI 10.1016/j.clinph.2011.04.028; Carlsen AN, 2011, NEUROSCI BIOBEHAV R, V35, P366, DOI 10.1016/j.neubiorev.2010.04.009; Delwaide PJ, 1995, ELECTROMYOGR MOTOR C, V97, P416, DOI 10.1016/0924-980X(95)00136-9; Hecht D, 2008, EXP BRAIN RES, V189, P133, DOI 10.1007/s00221-008-1410-0; Honeycutt CF, 2015, CLIN NEUROPHYSIOL, V126, P160, DOI 10.1016/j.clinph.2014.05.025; Iwanaga M, 2010, PSYCHOPHYSIOLOGY, V47, P281, DOI 10.1111/j.1469-8986.2009.00937.x; Maslovat D, 2011, BEHAV NEUROSCI, V125, P226, DOI 10.1037/a0022567; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Nonnekes J, 2015, NEUROSCI BIOBEHAV R, V53, P131, DOI 10.1016/j.neubiorev.2015.04.002; Nonnekes J, 2014, J NEUROSCI, V34, P275, DOI 10.1523/JNEUROSCI.2948-13.2014; Nonnekes J, 2013, J NEUROL, V260, P2387, DOI 10.1007/s00415-013-7002-3; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Shemmell J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00002; Valls-Sole J, 2005, EXP BRAIN RES, V165, P541, DOI 10.1007/s00221-005-2332-8; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; Wessel JR, 2012, J NEUROSCI, V32, P7528, DOI 10.1523/JNEUROSCI.6352-11.2012; Wu T, 2008, J PHYSIOL-LONDON, V586, P4295, DOI 10.1113/jphysiol.2008.153445	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153129	10.1371/journal.pone.0153129	http://dx.doi.org/10.1371/journal.pone.0153129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077654	Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700024
J	Val, S; Poley, M; Brown, K; Choi, R; Jeong, S; Colberg-Poley, A; Rose, MC; Panchapakesan, KC; Devaney, JC; Perez-Losada, M; Preciado, D				Val, Stephanie; Poley, Marian; Brown, Kristy; Choi, Rachel; Jeong, Stephanie; Colberg-Poley, Annie; Rose, Mary C.; Panchapakesan, Karuna C.; Devaney, Joe C.; Perez-Losada, Marcos; Preciado, Diego			Proteomic Characterization of Middle Ear Fluid Confirms Neutrophil Extracellular Traps as a Predominant Innate Immune Response in Chronic Otitis Media	PLOS ONE			English	Article							QUALITY-CONTROL; CHILDREN; EXPRESSION; EFFUSION; MUCOSA; MUCIN; ELASTASE; ADULTS; MUC5B	Background Chronic Otitis Media (COM) is characterized by middle ear effusion (MEE) and conductive hearing loss. MEE reflect mucus hypersecretion, but global proteomic profiling of the mucosal components are limited. Objective This study aimed at characterizing the proteome of MEEs from children with COM with the goal of elucidating important innate immune responses. Method MEEs were collected from children (n = 49) with COM undergoing myringotomy. Mass spectrometry was employed for proteomic profiling in nine samples. Independent samples were further analyzed by cytokine multiplex assay, immunoblotting, neutrophil elastase activity, next generation DNA sequencing, and/or immunofluorescence analysis. Results 109 unique and common proteins were identified by MS. A majority were innate immune molecules, along with typically intracellular proteins such as histones and actin. 19.5% percent of all mapped peptide counts were from proteins known to be released by neutrophils. Immunofluorescence and immunoblotting demonstrated the presence of neutrophil extracellular traps (NETs) in every MEE, along with MUC5B colocalization. DNA found in effusions revealed unfragmented DNA of human origin. Conclusion Proteomic analysis of MEEs revealed a predominantly neutrophilic innate mucosal response in which MUC5B is associated with NET DNA. NETs are a primary macromolecular constituent of human COM middle ear effusions.	[Val, Stephanie; Poley, Marian; Choi, Rachel; Jeong, Stephanie; Preciado, Diego] Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA; [Brown, Kristy; Colberg-Poley, Annie; Rose, Mary C.; Panchapakesan, Karuna C.; Devaney, Joe C.; Perez-Losada, Marcos] Childrens Natl Hlth Syst, Med Genet Res Ctr, Washington, DC USA; [Preciado, Diego] Childrens Natl Hlth Syst, Div Pediat Otolaryngol, Washington, DC USA	Children's National Health System; Children's National Health System; Children's National Health System	Preciado, D (corresponding author), Childrens Natl Hlth Syst, Sheikh Zayed Ctr Pediat Surg Innovat, Washington, DC USA.	dpreciad@cnmc.org	Perez-Losada, Marcos/I-4407-2013	Perez-Losada, Marcos/0000-0002-2585-4657	National Institute on Deafness and Communicative Diseases (NIDCD) [R01DC012377]; CRI; National Institute of Health (NIH) [P30HD040677]; NIH [2R24HD050846-06, NICHD 5P30HD040677, UL1TR000075]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677, R24HD050846] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC012377] Funding Source: NIH RePORTER	National Institute on Deafness and Communicative Diseases (NIDCD); CRI; National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by R01DC012377 from the National Institute on Deafness and Communicative Diseases (NIDCD) to DP. Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences).; Microscopic analysis was carried out at the Children's Research Institute (CRI) Light Microscopy and Image Analysis Core supported by CRI and National Institute of Health (NIH) grant P30HD040677. This work was partially supported by NIH core grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research), NICHD 5P30HD040677 (Intellectual and Developmental Disabilities Research Center) and UL1TR000075 (NIH National Center for Advancing Translational Sciences). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the National Center for Advancing Translational Sciences or the National Institutes of Health.	Ahmed S, 2014, LARYNGOSCOPE, V124, P301, DOI 10.1002/lary.24190; Alles R, 2001, PEDIAT ALLERG IMM-UK, V12, P102, DOI 10.1046/j.0905-6157.2000.00008.x; [Anonymous], 1969, BMJ-BRIT MED J, V4, P578; Bartlett JA, 2015, DIS MODEL MECH, V8, P501, DOI 10.1242/dmm.019646; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN DT, 1985, ARCH OTOLARYNGOL, V111, P688; CARRIE S, 1992, ACTA OTO-LARYNGOL, V112, P504, DOI 10.3109/00016489209137432; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Cherry Donald K, 2002, Adv Data, P1; Davis MPA, 2013, METHODS, V63, P41, DOI 10.1016/j.ymeth.2013.06.027; Dworski R, 2011, J ALLERGY CLIN IMMUN, V127, P1260, DOI 10.1016/j.jaci.2010.12.1103; Grabcanovic-Musija F, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0221-7; Grubb MS, 2010, CLIN PEDIATR, V49, P970, DOI 10.1177/0009922810370363; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hamaguchi S, 2014, EUR RESPIR J, V43, P1709, DOI 10.1183/09031936.00139813; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hong WZ, 2009, J INNATE IMMUN, V1, P215, DOI 10.1159/000205937; Hurst DS, 2002, ARCH OTOLARYNGOL, V128, P561, DOI 10.1001/archotol.128.5.561; Joo NS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116756; Juhn SK, 2008, CLIN EXP OTORHINOLAR, V1, P117, DOI 10.3342/ceo.2008.1.3.117; Juneau RA, 2011, INFECT IMMUN, V79, P431, DOI 10.1128/IAI.00660-10; Kawano H, 2002, ANN OTO RHINOL LARYN, V111, P415; Keshari RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048111; King LB, 2013, OTOLARYNGOLOGY, V3; Klein JO, 2000, VACCINE, V19, pS2, DOI 10.1016/S0264-410X(00)00271-1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee TH, 2013, ANN ALLERG ASTHMA IM, V111, P268, DOI 10.1016/j.anai.2013.06.028; LIM DJ, 1971, ANN OTO RHINOL LARYN, V80, P838, DOI 10.1177/000348947108000611; Lin JZ, 2003, JARO-J ASSOC RES OTO, V4, P384, DOI 10.1007/s10162-002-3023-9; Lin JZ, 2001, AM J PHYSIOL-LUNG C, V280, pL1157, DOI 10.1152/ajplung.2001.280.6.L1157; Liu Y, 2013, AM J PATHOL, V182, P1519, DOI 10.1016/j.ajpath.2013.01.050; Lous J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub2; Luo LT, 2014, AM J PHYSIOL-LUNG C, V307, pL586, DOI 10.1152/ajplung.00365.2013; Matkovic S, 2007, EUR ARCH OTO-RHINO-L, V264, P1283, DOI 10.1007/s00405-007-0373-2; NAKAJIMA K, 1979, J BIOL CHEM, V254, P4027; Neeli I, 2008, J IMMUNOL, V180, P1895, DOI 10.4049/jimmunol.180.3.1895; Ondrey FG, 1998, OTOLARYNG HEAD NECK, V119, P342, DOI 10.1016/S0194-5998(98)70075-0; Perez GF, 2015, PEDIAT ALLERG IMM-UK, V26, P145, DOI 10.1111/pai.12346; Peters-Hall JR, 2015, AM J RESP CELL MOL, V53, P22, DOI 10.1165/rcmb.2014-0256RC; Preciado D, 2010, PEDIATR RES, V68, P231, DOI 10.1203/00006450-201011001-00451; Rahman S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00378; Remijsen Q, 2011, CELL DEATH DIFFER, V18, P581, DOI 10.1038/cdd.2011.1; Rosenfeld RM, 2001, OTOLARYNG HEAD NECK, V125, P440, DOI 10.1067/mhn.2001.119326; Roy MG, 2014, NATURE, V505, P412, DOI 10.1038/nature12807; Ryan AF, 2005, ANN OTO RHINOL LARYN, V114, P42, DOI 10.1177/00034894051140S106; Sade J, 1996, ANN OTO RHINOL LARYN, V105, P643, DOI 10.1177/000348949610500810; Saffarzadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032366; Saieg A, 2015, PEDIATR RES, V77, P356, DOI 10.1038/pr.2014.187; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; SHAK S, 1990, P NATL ACAD SCI USA, V87, P9188, DOI 10.1073/pnas.87.23.9188; TEELE DW, 1984, PEDIATRICS, V74, P282; Thornton RB, 2014, PLOS ONE, V8; TOS M, 1977, ANN OTO RHINOL LARYN, V86, P209, DOI 10.1177/000348947708600212; Tseng CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041454; Ueki S, 2016, J ALLERGY CLIN IMMUN, V137, P258, DOI 10.1016/j.jaci.2015.04.041; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Val S, 2015, OTITIS MEDIA STATE A, P53; Wu XF, 2011, AM J RESP CELL MOL, V45, P525, DOI 10.1165/rcmb.2010-0133OC; Zhou J, 2013, MOL CELL BIOCHEM, V377, P75, DOI 10.1007/s11010-013-1572-3	59	29	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152865	10.1371/journal.pone.0152865	http://dx.doi.org/10.1371/journal.pone.0152865			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078692	gold, Green Published, Green Submitted			2022-12-27	WOS:000374131700010
J	Autier, P; Boniol, M; Smans, M; Sullivan, R; Boyle, P				Autier, Philippe; Boniol, Mathieu; Smans, Michel; Sullivan, Richard; Boyle, Peter			Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening	PLOS ONE			English	Article							AGE 40; FOLLOW-UP; MORTALITY; MAMMOGRAPHY; WOMEN; COUNTRIES; SURVIVAL; NIJMEGEN; PROGRAM	Background The role of breast screening in breast cancer mortality declines is debated. Screening impacts cancer mortality through decreasing the number of advanced cancers with poor diagnosis, while cancer treatment works through decreasing the case-fatality rate. Hence, reductions in cancer death rates thanks to screening should directly reflect reductions in advanced cancer rates. We verified whether in breast screening trials, the observed reductions in the risk of breast cancer death could be predicted from reductions of advanced breast cancer rates. Patients and Methods The Greater New York Health Insurance Plan trial (HIP) is the only breast screening trial that reported stage-specific cancer fatality for the screening and for the control group separately. The Swedish Two-County trial (TCT)) reported size-specific fatalities for cancer patients in both screening and control groups. We computed predicted numbers of breast cancer deaths, from which we calculated predicted relative risks (RR) and (95% confidence intervals). The Age trial in England performed its own calculations of predicted relative risk. Results The observed and predicted RR of breast cancer death were 0.72 (0.56-0.94) and 0.98 (0.77-1.24) in the HIP trial, and 0.79 (0.78-1.01) and 0.90 (0.80-1.01) in the Age trial. In the TCT, the observed RR was 0.73 (0.62-0.87), while the predicted RR was 0.89 (0.75-1.05) if overdiagnosis was assumed to be negligible and 0.83 (0.70-0.97) if extra cancers were excluded. Conclusions In breast screening trials, factors other than screening have contributed to reductions in the risk of breast cancer death most probably by reducing the fatality of advanced cancers in screening groups. These factors were the better management of breast cancer patients and the underreporting of breast cancer as the underlying cause of death. Breast screening trials should publish stage-specific fatalities observed in each group.	[Autier, Philippe; Boniol, Mathieu; Boyle, Peter] iPRI, Strathclyde Inst Global Publ Hlth, Lyon, France; [Autier, Philippe; Boniol, Mathieu; Smans, Michel; Boyle, Peter] Int Prevent Res Inst iPRI, Lyon, France; [Sullivan, Richard] Kings Hlth Partners Canc Ctr, Inst Canc Policy, Bermondsey Wing,Guys Campus, London, England	University of London; King's College London	Autier, P (corresponding author), iPRI, Strathclyde Inst Global Publ Hlth, Lyon, France.; Autier, P (corresponding author), Int Prevent Res Inst iPRI, Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Boniol, Mathieu/F-9623-2011; Boyle, Peter/A-4380-2014	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; Boyle, Peter/0000-0001-6251-0610; Sullivan, Richard/0000-0002-6435-1825	International Prevention Research Institute (iPRI)	International Prevention Research Institute (iPRI)	This work was supported by the International Prevention Research Institute (iPRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TJ, 2004, HUM PATHOL, V35, P1252, DOI 10.1016/j.humpath.2004.07.011; ANDERSSON I, 1988, BRIT MED J, V297, P943, DOI 10.1136/bmj.297.6654.943; Autier P, 2012, JNCI-J NATL CANCER I, V104, P1080, DOI 10.1093/jnci/djs272; Autier P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4411; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Biesheuvel C, 2011, CANCER EPIDEMIOL, V35, P545, DOI 10.1016/j.canep.2011.02.008; Birnbaum J, 2016, ANN INTERN MED, V164, P236, DOI 10.7326/M15-0754; Bjurstam N, 2003, CANCER-AM CANCER SOC, V97, P2387, DOI 10.1002/cncr.11361; Bleyer A, 2015, INT J CANC; Boniol M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008158; Broeders MJM, 2001, INT J CANCER, V92, P303, DOI 10.1002/1097-0215(200102)9999:9999&lt;::AID-IJC1186&gt;3.0.CO;2-B; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; DUFFY SW, 1991, BRIT J CANCER, V64, P1133, DOI 10.1038/bjc.1991.477; FINK R, 1968, PUBLIC HEALTH REP, V83, P479, DOI 10.2307/4593330; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Harding C, 2015, JAMA INT MED; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; International Agency for Research on Cancer, 2002, BREAST CANC SCREEN; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; LAARA E, 1987, LANCET, V1, P1247; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miller AB, 2001, LANCET, V358, P2164, DOI 10.1016/S0140-6736(01)07189-6; MILLER AB, 1976, INT J CANCER, V17, P602, DOI 10.1002/ijc.2910170508; Mook S, 2011, JNCI-J NATL CANCER I, V103, P585, DOI 10.1093/jnci/djr043; MORRISON AS, 1988, JNCI-J NATL CANCER I, V80, P1540, DOI 10.1093/jnci/80.19.1540; MORRISON AS, 1991, INT J EPIDEMIOL, V20, P642, DOI 10.1093/ije/20.3.642; Moss S, 2005, BRIT J CANCER, V92, P955, DOI 10.1038/sj.bjc.6602395; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Myers ER, 2015, JAMA-J AM MED ASSOC, V314, P1615, DOI 10.1001/jama.2015.13183; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Nystrom L, 1993, LANCET, P341; Ouakrim DA, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4970; PEER PGM, 1994, J NATL CANCER I, V86, P436, DOI 10.1093/jnci/86.6.436; Schoen RE, 2012, NEW ENGL J MED, V366, P2345, DOI 10.1056/NEJMoa1114635; SHAPIRO S, 1977, CANCER, V39, P2772, DOI 10.1002/1097-0142(197706)39:6<2772::AID-CNCR2820390665>3.0.CO;2-K; Shapiro S, 1985, Natl Cancer Inst Monogr, V67, P65; Shapiro S, 1987, SCREEN BREAST CANC, P3; Stang A, 2015, CANCER; TABAR L, 1992, RADIOL CLIN N AM, V30, P187; TABAR L, 1992, LANCET, V339, P412, DOI 10.1016/0140-6736(92)90090-P; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H	43	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0154113	10.1371/journal.pone.0154113	http://dx.doi.org/10.1371/journal.pone.0154113			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100174	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000374898500147
J	Ahmad, S; Mokaddas, E; Al-Mutairi, N; Eldeen, HS; Mohammadi, S				Ahmad, Suhail; Mokaddas, Eiman; Al-Mutairi, Noura; Eldeen, Hanaa S.; Mohammadi, Shirin			Discordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence Country	PLOS ONE			English	Article							EMBB CODON 306; MULTIDRUG-RESISTANT; RPOB MUTATIONS; MONORESISTANT TUBERCULOSIS; NUCLEOTIDE POLYMORPHISMS; STREPTOMYCIN RESISTANCE; MULTICENTER EVALUATION; RIFAMPICIN-RESISTANCE; ETHAMBUTOL RESISTANCE; CULTURE-SYSTEM	With increasing incidence of multidrug-resistant tuberculosis (MDR-TB), accurate drug susceptibility testing (DST) of Mycobacterium tuberculosis to first-line drugs has become crucial for proper patient management. We evaluated concordance of DST results for 70 M. tuberculosis isolates across two phenotypic and two molecular methods: BACTEC 460TB, MGIT 960 system, GenoType MTBDRplus and DNA sequencing of gene segments most commonly implicated in conferring resistance to anti-TB drugs. Most (84%) M. tuberculosis isolates were multidrug-resistant. Twenty-four isolates yielded discrepant DST results. For rifampicin, isoniazid and streptomycin, 96%, 97% and 93% of isolates, respectively, were susceptible or resistant by all four methods, whereas for ethambutol, this agreement was observed for only 76% of isolates (P < 0.05 for rifampicin or isoniazid or streptomycin versus ethambutol). Occurrence of rare mutations in three isolates that confer low-level resistance caused lower agreement for rifampicin among the four methods (kappa coefficient (kappa) range, 0.84 to 0.95). For isoniazid, there was perfect agreement among phenotypic methods and molecular methods (kappa, 1.00) but lower agreement between phenotypic and molecular methods. Three isolates were detected as polydrug-resistant by MGIT 960 system but as multidrug-resistant by DNA sequence-based method. The agreement was higher for streptomycin among the two phenotypic methods (kappa, 0.97) while targeted sequencing yielded lower agreement (kappa range, 0.86 to 0.89). The discrepancy for ethambutol resulted largely due to lower concordance of MGIT 960 results (kappa range, 0.53 to 0.64). The MGIT 960 system is an accurate method for DST of M. tuberculosis against isoniazid and streptomycin while the results of rifampicin susceptibility should be complemented with DNA sequencing-based method when the suspicion for resistance is high. The possibility of false susceptibility to ethambutol with MGIT 960 system suggests that molecular or other phenotypic methods may be more useful when accurate ethambutol susceptibility results are warranted.	[Ahmad, Suhail; Mokaddas, Eiman; Al-Mutairi, Noura; Mohammadi, Shirin] Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait; [Mokaddas, Eiman; Eldeen, Hanaa S.] Kuwait Natl TB Reference Lab, Shuwaikh, Kuwait	Kuwait University	Ahmad, S (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Safat, Kuwait.	Suhail_ah@hsc.edu.kw	Ahmad, Suhail/AAJ-5456-2021		Department of Microbiology, Faculty of Medicine; College of Graduate Studies, Kuwait University	Department of Microbiology, Faculty of Medicine; College of Graduate Studies, Kuwait University	The study was supported by internal departmental funding (Department of Microbiology, Faculty of Medicine) and in part by the College of Graduate Studies, Kuwait University.	Abal AT, 2002, MICROB DRUG RESIST, V8, P99, DOI 10.1089/107662902760190644; Ahmad S, 2007, TUBERCULOSIS, V87, P123, DOI 10.1016/j.tube.2006.05.004; Ahmad S, 2004, INT J ANTIMICROB AG, V23, P473, DOI 10.1016/j.ijantimicag.2003.10.004; Ahmad S, 2014, J INFECT PUBLIC HEAL, V7, P75, DOI 10.1016/j.jiph.2013.09.001; Ahmad S, 2012, INDIAN J MED RES, V135, P756; Ahmad S, 2009, RESP MED, V103, P1777, DOI 10.1016/j.rmed.2009.07.010; Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Al-Mutairi NM, 2011, INT J TUBERC LUNG D, V15, P110; Alonso M, 2011, J CLIN MICROBIOL, V49, P2688, DOI 10.1128/JCM.00659-11; Angr PK, 2012, J CLIN MICROBIOL, V50, P1233, DOI 10.1128/JCM.06479-11; [Anonymous], 2003, AM J RESP CRIT CARE, V167, P603; Banu S, 2014, J CLIN MICROBIOL, V52, P156, DOI 10.1128/JCM.02378-13; Becton Dickinson, BACTEC MGIT 960 SIRE; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Brown AC, 2015, J CLIN MICROBIOL, V53, P2230, DOI 10.1128/JCM.00486-15; Cambau E, 2015, J ANTIMICROB CHEMOTH, V70, P686, DOI 10.1093/jac/dku438; Campbell PJ, 2011, ANTIMICROB AGENTS CH, V55, P2032, DOI 10.1128/AAC.01550-10; Dalton T, 2012, LANCET, V380, P1406, DOI 10.1016/S0140-6736(12)60734-X; Drobniewski F, 2012, INT J TUBERC LUNG D, V16, P860, DOI 10.5588/ijtld.12.0180; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; Garrigo M, 2007, J CLIN MICROBIOL, V45, P1766, DOI 10.1128/JCM.02162-06; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hoffner S, 2012, LANCET, V380, P1367, DOI 10.1016/S0140-6736(12)61069-1; Jacobson KR, 2010, CLIN INFECT DIS, V51, P6, DOI 10.1086/653115; Jureen P, 2010, J CLIN MICROBIOL, V48, P1853, DOI 10.1128/JCM.00240-10; Koser CU, 2013, NEW ENGL J MED, V369, P290, DOI 10.1056/NEJMc1215305; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kurbatova EV, 2012, INT J TUBERC LUNG D, V16, P355, DOI 10.5588/ijtld.11.0542; Liu CH, 2012, J INFECTION, V65, P412, DOI 10.1016/j.jinf.2012.06.007; Machado D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034538; Madison B, 2002, J CLIN MICROBIOL, V40, P3976, DOI 10.1128/JCM.40.11.3976-3979.2002; Mokaddas E, 2008, INT J TUBERC LUNG D, V12, P319; Mokaddas E, 2007, JPN J INFECT DIS, V60, P140; Mokaddas E, 2015, J CLIN MICROBIOL, V53, P1351, DOI 10.1128/JCM.03412-14; Mukinda FK, 2012, INT J TUBERC LUNG D, V16, P196, DOI 10.5588/ijtld.11.0116; Ocheretina O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090569; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Palomino JC, 2008, J MICROBIOL METH, V75, P161, DOI 10.1016/j.mimet.2008.06.015; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Plinke C, 2011, ANTIMICROB AGENTS CH, V55, P2891, DOI 10.1128/AAC.00007-10; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Ramaswamy SV, 2003, ANTIMICROB AGENTS CH, V47, P1241, DOI 10.1128/AAC.47.4.1241-1250.2003; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Rigouts L, 2013, J CLIN MICROBIOL, V51, P2641, DOI 10.1128/JCM.02741-12; Safi H, 2008, ANTIMICROB AGENTS CH, V52, P2027, DOI 10.1128/AAC.01486-07; Scarparo C, 2004, J CLIN MICROBIOL, V42, P1109, DOI 10.1128/JCM.42.3.1109-1114.2004; Siddiqi SH, 1995, BACTEC 460TB SYSTEM; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Starks AM, 2009, ANTIMICROB AGENTS CH, V53, P1061, DOI 10.1128/AAC.01357-08; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Tortoli E, 2002, J CLIN MICROBIOL, V40, P607, DOI 10.1128/JCM.40.2.607-610.2002; Van Deun A, 2015, INT J TUBERC LUNG D, V19, P185, DOI 10.5588/ijtld.14.0651; Van Deun A, 2010, INT J TUBERC LUNG D, V14, P131; Van Deun A, 2009, J CLIN MICROBIOL, V47, P3501, DOI 10.1128/JCM.01209-09; Van Deun A, 2013, J CLIN MICROBIOL, V51, P2633, DOI 10.1128/JCM.00553-13; van Ingen J, 2011, INT J TUBERC LUNG D, V15, P990, DOI 10.5588/ijtld.10.0127; Velayati AA, 2014, AM J TROP MED HYG, V90, P99, DOI 10.4269/ajtmh.13-0057; Walker TM, 2015, LANCET INFECT DIS, V15, P1193, DOI 10.1016/S1473-3099(15)00062-6; WHO, 1998, INT J TUBERC LUNG D, V2, P71; WHO, 2014, WHOHQTB201412; Witney AA, 2015, J CLIN MICROBIOL, V53, P1473, DOI 10.1128/JCM.02993-14; World Health Organization, 2011, WHOHTMTB20112; World Health Organization, 2015, WHOHTMTB201522; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; Yakrus MA, 2014, J CLIN MICROBIOL, V52, P1932, DOI 10.1128/JCM.00417-14; Zhang HT, 2013, NAT GENET, V45, P1255, DOI 10.1038/ng.2735; Zhang Y, 2015, INT J TUBERC LUNG D, V19, P1276, DOI 10.5588/ijtld.15.0389; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320; Zignol M, 2013, DRUG RESIST UPDATE, V16, P108, DOI 10.1016/j.drup.2014.02.003	70	35	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153563	10.1371/journal.pone.0153563	http://dx.doi.org/10.1371/journal.pone.0153563			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096759	gold, Green Published, Green Submitted			2022-12-27	WOS:000374543600042
J	Echternach, M; Burk, F; Burdumy, M; Traser, L; Richter, B				Echternach, Matthias; Burk, Fabian; Burdumy, Michael; Traser, Louisa; Richter, Bernhard			Morphometric Differences of Vocal Tract Articulators in Different Loudness Conditions in Singing	PLOS ONE			English	Article							REAL-TIME MRI; INTENSITY VARIATION; RESONANCE; SINGERS; VOICE; CONFIGURATIONS; FORMANT; PHONATION; PRESSURE; REGISTER	Introduction Dynamic MRI analysis of phonation has gathered interest in voice and speech physiology. However, there are limited data addressing the extent to which articulation is dependent on loudness. Material and Methods 12 professional singer subjects of different voice classifications were analysed concerning the vocal tract profiles recorded with dynamic real-time MRI with 25fps in different pitch and loudness conditions. The subjects were asked to sing ascending scales on the vowel /a/in three loudness conditions (comfortable = mf, very soft = pp, very loud = ff, respectively). Furthermore, fundamental frequency and sound pressure level were analysed from the simultaneously recorded optical audio signal after noise cancellation. Results The data show articulatory differences with respect to changes of both pitch and loudness. Here, lip opening and pharynx width were increased. While the vertical larynx position was rising with pitch it was lower for greater loudness. Especially, the lip opening and pharynx width were more strongly correlated with the sound pressure level than with pitch. Conclusion For the vowel /a/loudness has an effect on articulation during singing which should be considered when articulatory vocal tract data are interpreted.	[Echternach, Matthias; Burk, Fabian; Burdumy, Michael; Traser, Louisa; Richter, Bernhard] Univ Freiburg, Med Ctr, Inst Musicians Med, Breisacher Str 60, D-79106 Freiburg, Germany; [Burdumy, Michael] Univ Freiburg, Med Ctr, Dept Med Phys, Radiol, Breisacher Str 60, D-79106 Freiburg, Germany; [Traser, Louisa] Univ Freiburg, Med Ctr, Dept Otorhinolaryngol, Kilianstr 5, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg	Echternach, M (corresponding author), Univ Freiburg, Med Ctr, Inst Musicians Med, Breisacher Str 60, D-79106 Freiburg, Germany.	matthias.echternach@uniklinik-freiburg.de	Burdumy, Michael/M-6212-2017	Burdumy, Michael/0000-0003-4577-5515; Echternach, Matthias/0000-0003-0095-5360	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study is funded by the Deutsche Forschungsgemeinschaft. The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ahmad M, 2009, J VOICE, V23, P235, DOI 10.1016/j.jvoice.2007.08.008; Bernardoni NH, 2014, J ACOUST SOC AM, V135, P491, DOI 10.1121/1.4836255; Bjorklund S, 2016, J VOICE, V30, P15, DOI 10.1016/j.jvoice.2015.03.006; BOUHUYS A, 1968, ANN NY ACAD SCI, V155, P165, DOI 10.1111/j.1749-6632.1968.tb56760.x; Bresch E, 2006, J ACOUST SOC AM, V120, P1791, DOI 10.1121/1.2335423; Bresch E, 2010, J ACOUST SOC AM, V128, pEL335, DOI 10.1121/1.3499700; Bunch M, 2000, J VOICE, V14, P363, DOI 10.1016/S0892-1997(00)80081-8; Burdumy M, 2015, J MAGN RESON IMAGING, V42, P925, DOI 10.1002/jmri.24857; Echternach M, 2008, LOGOP PHONIATR VOCO, V33, P67, DOI 10.1080/14015430701875653; Echternach M, 2015, J ACOUST SOC AM, V137, P2586, DOI 10.1121/1.4919356; Echternach M, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2014.01.011; Echternach M, 2014, J VOICE, V28, DOI 10.1016/j.jvoice.2013.10.009; Echternach M, 2012, CURR OPIN OTOLARYNGO, V20, P450, DOI 10.1097/MOO.0b013e3283585f87; Echternach M, 2011, J VOICE, V25, P670, DOI 10.1016/j.jvoice.2010.09.008; Echternach M, 2011, LOGOP PHONIATR VOCO, V36, P109, DOI 10.3109/14015439.2011.566576; Echternach M, 2010, FOLIA PHONIATR LOGO, V62, P278, DOI 10.1159/000312668; Echternach M, 2010, J VOICE, V24, P133, DOI 10.1016/j.jvoice.2008.06.004; ESTILL J, 1988, MED PROBL PERFORM AR, V3, P37; Fant G, 1960, ACOUSTIC THEORY SPEE, P51; Fu MJ, 2015, MAGN RESON MED, V73, P1820, DOI 10.1002/mrm.25302; Garnier M, 2010, J ACOUST SOC AM, V127, P3771, DOI 10.1121/1.3419907; Garnier M, 2010, J SPEECH LANG HEAR R, V53, P588, DOI 10.1044/1092-4388(2009/08-0138); Herbst CT, 2015, J VOICE, V29, P391, DOI 10.1016/j.jvoice.2014.08.009; HIRANO M, 1970, FOLIA PHONIATR, V22, P1, DOI 10.1159/000263363; Hirano M., 1988, J VOICE, V2, P51, DOI [10.1016/S0892-1997(88)80058-4, DOI 10.1016/S0892-1997(88)80058-4]; Horacek J, 2009, FOLIA PHONIATR LOGO, V61, P137, DOI 10.1159/000219949; Inouye JM, 2014, J ACOUST SOC AM, V135, P1019, DOI 10.1121/1.4864482; ISSHIKI N, 1964, J SPEECH HEAR RES, V7, P17, DOI 10.1044/jshr.0701.17; Joliveau E, 2004, NATURE, V427, P116, DOI 10.1038/427116a; Lombard E, 1911, ANN MALADIES OREILLE, P101; Luchsinger R, 1970, HDB STIMM SPRACHHEIL, P125; Mainka A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132241; NeuschaeferRube C, 1996, FOLIA PHONIATR LOGO, V48, P201, DOI 10.1159/000266409; Niebergall A, 2013, MAGN RESON MED, V69, P477, DOI 10.1002/mrm.24276; Nunthayanon K, 2015, OR SURG OR MED OR PA, V119, P684, DOI 10.1016/j.oooo.2015.03.003; Osborne C, 1979, HIFIDELITY, V29, P57; Proctor M, 2013, J ACOUST SOC AM, V133, P1043, DOI 10.1121/1.4773865; Raol N, 2015, ADV OTO-RHINO-LARYNG, V76, P27, DOI 10.1159/000368011; Roers F, 2009, J ACOUST SOC AM, V125, P503, DOI 10.1121/1.3026326; Rothenberg M, 1981, VOCAL FOLD PHYSL, P305; Shipp T, 1984, J RES SINGING, V7, P5; SONNINEN A A, 1956, Acta Otolaryngol Suppl, V130, P1; STATHOPOULOS ET, 1993, J SPEECH HEAR RES, V36, P64, DOI 10.1044/jshr.3601.64; SUNDBERG J, 1975, ACUSTICA, V32, P89; SUNDBERG J, 1974, J ACOUST SOC AM, V55, P838, DOI 10.1121/1.1914609; SUNDBERG J, 1993, J VOICE, V7, P301, DOI 10.1016/S0892-1997(05)80118-3; Sundberg J., 1979, FRONTIERS FRONTIERS, P301; Sundberg J., 1987, SCI SINGING VOICE; Sundberg J, 2011, PROFESSIONAL MALE SI; Sundberg J, 2013, J VOICE, V27, P278, DOI 10.1016/j.jvoice.2012.12.002; Sundberg J, 2009, J VOICE, V23, P546, DOI 10.1016/j.jvoice.2008.02.003; Titze IR, 2008, J ACOUST SOC AM, V123, P2733, DOI 10.1121/1.2832337; Titze IR, 2015, J ACOUST SOC AM, V137, P3005, DOI 10.1121/1.4919349; Titze IR, 1994, PRINCIPLES VOICE PRO; Traser L, 2013, J VOICE, V27, P141, DOI 10.1016/j.jvoice.2012.11.002; WEIN B, 1995, ROFO FORTSCHR RONTG, V162, P99, DOI 10.1055/s-2007-1015844; Woo Jonghye, 2014, J Speech Lang Hear Res, V57, pS626, DOI 10.1044/2014_JSLHR-S-12-0208; Xing FX, 2013, LECT NOTES COMPUT SC, V8151, P41, DOI 10.1007/978-3-642-40760-4_6; Zanartu M, 2014, J ACOUST SOC AM, V136, P3262, DOI 10.1121/1.4901714; Zanartu M, 2011, J ACOUST SOC AM, V129, P326, DOI 10.1121/1.3514536; Zvyagintsev M, 2010, J MAGN RESON IMAGING, V32, P705, DOI 10.1002/jmri.22285	61	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153792	10.1371/journal.pone.0153792	http://dx.doi.org/10.1371/journal.pone.0153792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096935	gold, Green Submitted, Green Published			2022-12-27	WOS:000374543600058
J	Gurkov, R; Strobl, R; Heinlin, N; Krause, E; Olzowy, B; Koppe, C; Grill, E				Guerkov, Robert; Strobl, Ralf; Heinlin, Nina; Krause, Eike; Olzowy, Bernhard; Koppe, Christina; Grill, Eva			Atmospheric Pressure and Onset of Episodes of Meniere's Disease - A Repeated Measures Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; SUBARACHNOID HEMORRHAGE; BAROMETRIC-PRESSURE; NATRIURETIC-PEPTIDE; ENDOLYMPHATIC SAC; HEARING-LOSS; LONG-TERM; EAR; PREVALENCE; WEATHER	Background External changes of air pressure are transmitted to the middle and inner ear and may be used therapeutically in Meniere's disease, one of the most common vertigo disorders. We analyzed the possible relationship of atmospheric pressure and other meteorological parameters with the onset of MD vertigo episodes in order to determine whether atmospheric pressure changes play a role in the occurrence of MD episodes. Methods Patients of a tertiary outpatient dizziness clinic diagnosed with MD were asked to keep a daily vertigo diary to document MD episodes (2004-2009). Local air pressure, absolute temperature and dew point temperature were acquired on an hourly basis. Change in meteorological parameters was conceptualized as the maximum difference in a 24 hour time frame preceding each day. Effects were estimated using additive mixed models with a random participant effect. We included lagged air parameters, age, sex, weekday and season in the model. Results A total of 56 persons (59% female) with mean age 54 years were included. Mean follow-up time was 267 days. Persons experienced on average 10.3 episodes during the observation period (median 8). Age and change in air pressure were significantly associated with vertigo onset risk (Odds Ratio = 0.979 and 1.010). We could not show an effect of sex, weekday, season, air temperature, and dew point temperature. Conclusions Change in air pressure was significantly associated with onset of MD episodes, suggesting a potential triggering mechanism in the inner ear. MD patients may possibly use air pressure changes as an early warning system for vertigo attacks in the future.	[Guerkov, Robert; Heinlin, Nina; Krause, Eike; Olzowy, Bernhard] Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany; [Guerkov, Robert; Strobl, Ralf; Grill, Eva] Univ Munich, German Ctr Vertigo & Balance Disorders, Marchioninistr 15, D-81377 Munich, Germany; [Strobl, Ralf; Grill, Eva] Univ Munich, Inst Med Informat Proc Biometr & Epidemiol IBE, Marchioninistr 17, D-81377 Munich, Germany; [Koppe, Christina] German Meteorol Serv, Frankfurter Str 135, D-63067 Offenbach, Germany	University of Munich; University of Munich; University of Munich; Deutscher Wetterdienst	Gurkov, R (corresponding author), Univ Munich, Dept Otorhinolaryngol Head & Neck Surg, Marchioninistr 15, D-81377 Munich, Germany.; Gurkov, R (corresponding author), Univ Munich, German Ctr Vertigo & Balance Disorders, Marchioninistr 15, D-81377 Munich, Germany.	robert.guerkov@med.uni-muenchen.de	Grill, Eva/AAF-8104-2020; Grill, Eva/D-1875-2010; Gürkov, Robert/K-3536-2013	Grill, Eva/0000-0002-0273-7984; Grill, Eva/0000-0002-0273-7984; Gürkov, Robert/0000-0002-4195-149X				Adrion C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6816; Anderson JP, 2001, OTOL NEUROTOL, V22, P888, DOI 10.1097/00129492-200111000-00030; AULICIEMS A, 1989, INT J BIOMETEOROL, V33, P215, DOI 10.1007/BF01051080; BROWN DH, 1988, LARYNGOSCOPE, V98, P599; Buxton N, 2001, J NEUROSURG, V95, P391, DOI 10.3171/jns.2001.95.3.0391; CARLBORG B, 1982, ANN OTO RHINOL LARYN, V91, P209, DOI 10.1177/000348948209100219; CELESTINO D, 1987, Acta Oto-Rhino-Laryngologica Belgica, V41, P951; Didyk LA, 2007, HEARING RES, V223, P20, DOI 10.1016/j.heares.2006.09.009; Dornhoffer JL, 2002, ARCH OTOLARYNGOL, V128, P379, DOI 10.1001/archotol.128.4.379; Duwel P, 2003, NEUROSCIENCE, V116, P963, DOI 10.1016/S0306-4522(02)00776-5; Gates GA, 2004, ARCH OTOLARYNGOL, V130, P718, DOI 10.1001/archotol.130.6.718; Grosse E., 1992, STAT MODELS S; Gurkov R, 2012, J LARYNGOL OTOL, V128, P356, DOI 10.1017/S0022215112000102; Harris JP, 2010, AUDIOL NEURO-OTOL, V15, P318, DOI 10.1159/000286213; Havia M, 2005, OTOLARYNG HEAD NECK, V133, P762, DOI 10.1016/j.otohns.2005.06.015; Hoffmann J, 2011, J NEUROL, V258, P596, DOI 10.1007/s00415-010-5798-7; Hofman R, 2008, EUR ARCH OTO-RHINO-L, V265, P153, DOI 10.1007/s00405-007-0424-8; JEHLE D, 1994, AM J EMERG MED, V12, P90, DOI 10.1016/0735-6757(94)90209-7; JONAS J, 1986, KLIN MONATSBL AUGENH, V189, P445, DOI 10.1055/s-2008-1050850; Kinney SE, 1997, AM J OTOL, V18, P67; Landers AT, 1997, BRIT J NEUROSURG, V11, P191, DOI 10.1080/02688699746230; Levo H, 2010, ANN OTO RHINOL LARYN, V119, P583, DOI 10.1177/000348941011900903; Luo Y, 2015, BIOMED REP, V3, P159, DOI 10.3892/br.2014.400; MIZUKOSHI K, 1995, ACTA OTO-LARYNGOL, P412; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P181, DOI 10.1016/S0194-5998(95)70102-8; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P768; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P360; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P938; Mygind SH, 1938, ANN OTO RHINOL LARYN, V47, P55; NAITO Y, 1988, ARCH OTO-RHINO-LARYN, V245, P321, DOI 10.1007/BF00464641; NISHIHARA S, 1992, AM J OTOL, V13, P364; Pereira AB, 2015, CHRONOBIOL INT, V32, P585, DOI 10.3109/07420528.2015.1014094; Preyer S, 1996, LARYNGO RHINO OTOL, V75, P443, DOI 10.1055/s-2007-997612; R Core Team, 2014, LANG ENV STAT COMP; Salt AN, 2004, HEARING RES, V191, P90, DOI 10.1016/j.heares.2003.12.018; SCHUKNECHT HAROLD F., 1963, LARYNGOSCOPE, V73, P651; Setzer M, 2007, SURG NEUROL, V67, P264, DOI 10.1016/j.surneu.2006.06.060; TONNDORF J, 1975, OTOLARYNG CLIN N AM, V8, P303; WLADISLAVOSKYWASERMAN P, 1984, LARYNGOSCOPE, V94, P1098; Yoon YJ, 2012, LARYNGOSCOPE, V122, P1605, DOI 10.1002/lary.23235; Zebenholzer K, 2011, CEPHALALGIA, V31, P391, DOI 10.1177/0333102410385580; ZECHNER G, 1980, LARYNG RHINOL OTOL V, V59, P829, DOI 10.1055/s-2007-1016415	42	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0152714	10.1371/journal.pone.0152714	http://dx.doi.org/10.1371/journal.pone.0152714			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096752	Green Published, gold, Green Submitted			2022-12-27	WOS:000374543600017
J	Jung, W; Campbell, RL; Gwak, Y; Kim, JI; Davies, PL; Jin, E				Jung, Woongsic; Campbell, Robert L.; Gwak, Yunho; Kim, Jong Im; Davies, Peter L.; Jin, EonSeon			New Cysteine-Rich Ice-Binding Protein Secreted from Antarctic Microalga, Chloromonas sp.	PLOS ONE			English	Article							HYPERACTIVE ANTIFREEZE PROTEIN; HORIZONTAL GENE-TRANSFER; SP-NOV VOLVOCALES; SEA-ICE; CONTINENTAL ANTARCTICA; ELECTRON-MICROSCOPY; WINDMILL ISLANDS; SNOW; EXPRESSION; CHLOROPHYCEAE	Many microorganisms in Antarctica survive in the cold environment there by producing ice-binding proteins (IBPs) to control the growth of ice around them. An IBP from the Antarctic freshwater microalga, Chloromonas sp., was identified and characterized. The length of the Chloromonas sp. IBP (ChloroIBP) gene was 3.2 kb with 12 exons, and the molecular weight of the protein deduced from the ChloroIBP cDNA was 34.0 kDa. Expression of the ChloroIBP gene was up-and down-regulated by freezing and warming conditions, respectively. Western blot analysis revealed that native ChloroIBP was secreted into the culture medium. This protein has fifteen cysteines and is extensively disulfide bonded as shown by in-gel mobility shifts between oxidizing and reducing conditions. The open-reading frame of ChloroIBP was cloned and over-expressed in Escherichia coli to investigate the IBP's biochemical characteristics. Recombinant ChloroIBP produced as a fusion protein with thioredoxin was purified by affinity chromatography and formed single ice crystals of a dendritic shape with a thermal hysteresis activity of 0.4 +/- 0.02 degrees C at a concentration of 5 mg/ml. In silico structural modeling indicated that the three-dimensional structure of ChloroIBP was that of a right-handed beta-helix. Site-directed mutagenesis of ChloroIBP showed that a conserved region of six parallel T-X-T motifs on the beta-2 face was the ice-binding region, as predicted from the model. In addition to disulfide bonding, hydrophobic interactions between inward-pointing residues on the beta-1 and beta-2 faces, in the region of ice-binding motifs, were crucial to maintaining the structural conformation of ice-binding site and the ice-binding activity of ChloroIBP.	[Jung, Woongsic; Gwak, Yunho; Jin, EonSeon] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Jong Im] Chungnam Natl Univ, Dept Biol, Daejeon, South Korea; [Campbell, Robert L.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Hanyang University; Chungnam National University; Queens University - Canada	Jin, E (corresponding author), Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea.; Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca; esjin@hanyang.ac.kr	Jin, EonSeon/AAW-6839-2020	Jin, EonSeon/0000-0001-5691-0124; Campbell, Robert/0000-0002-5473-5876	Korea CCS R&D Center (KCRC) of National Research Foundation [NRF-2014M1A8A1049273]; Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation - Korean government (Ministry of Science, ICT. & Future Planning) [NRF-2015M1A5A1037053]; CIHR	Korea CCS R&D Center (KCRC) of National Research Foundation; Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation - Korean government (Ministry of Science, ICT. & Future Planning)(Ministry of Science, ICT & Future Planning, Republic of Korea); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by funding to EJ, who holds Korea CCS R&D Center (KCRC) of National Research Foundation (NRF-2014M1A8A1049273) and by funding from the Basic Core Technology Development Program for the Oceans and the Polar Regions of National Research Foundation (NRF-2015M1A5A1037053) funded by the Korean government (Ministry of Science, ICT. & Future Planning). PLD, who holds a Canada Research Chair in Protein Engineering, acknowledges funding from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Austin BP, 2012, PROTEIN EXPRES PURIF, V82, P116, DOI 10.1016/j.pep.2011.11.015; Baardsnes J, 2002, BBA-PROTEINS PROTEOM, V1601, P49, DOI 10.1016/S1570-9639(02)00431-4; Basu K, 2015, P NATL ACAD SCI USA, V112, P737, DOI 10.1073/pnas.1422272112; Battaglia B, 1997, ANTARCTIC COMMUNITIE; Bayer-Giraldi M, 2010, ENVIRON MICROBIOL, V12, P1041, DOI 10.1111/j.1462-2920.2009.02149.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; Bowler C, 2010, ANNU REV MAR SCI, V2, P333, DOI 10.1146/annurev-marine-120308-081051; Chattopadhyay MK, 2001, POLAR BIOL, V24, P386; Cheng JL, 2006, PROTEINS, V62, P617, DOI 10.1002/prot.20787; Cockell Charles S., 2000, Environmental Reviews, V8, P1, DOI 10.1139/er-8-1-1; Davies PL, 2014, TRENDS BIOCHEM SCI, V39, P548, DOI 10.1016/j.tibs.2014.09.005; DeLano WL, 2002, THE PYMOL MOLECULAR; Deming JW, 2002, CURR OPIN MICROBIOL, V5, P301, DOI 10.1016/S1369-5274(02)00329-6; Ehn JK, 2013, LIMNOL OCEANOGR, V58, P893, DOI 10.4319/lo.2013.58.3.0893; Eicken H, 2000, COLD REG SCI TECHNOL, V31, P207, DOI 10.1016/S0165-232X(00)00016-1; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Friis DS, 2014, FEBS LETT, V588, P1767, DOI 10.1016/j.febslet.2014.03.032; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Garnham CP, 2008, BIOCHEM J, V411, P171, DOI 10.1042/BJ20071372; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gauthier SY, 1998, EUR J BIOCHEM, V258, P445, DOI 10.1046/j.1432-1327.1998.2580445.x; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Graether SP, 2004, EUR J BIOCHEM, V271, P3285, DOI 10.1111/j.1432-1033.2004.04256.x; Graether SP, 2003, J MOL BIOL, V327, P1155, DOI 10.1016/S0022-2836(03)00235-3; Graether SP, 2001, BIOPHYS J, V80, P1169, DOI 10.1016/S0006-3495(01)76093-6; Graham LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002616; Griffith M, 2004, TRENDS PLANT SCI, V9, P399, DOI 10.1016/j.tplants.2004.06.007; Gupta R., PREDICTION N G UNPUB; Gwak IG, 2010, MAR BIOTECHNOL, V12, P630, DOI 10.1007/s10126-009-9250-x; Gwak Y, 2014, FASEB J, V28, P4924, DOI 10.1096/fj.14-256388; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hoham RW, 2002, J PHYCOL, V38, P1051, DOI 10.1046/j.1529-8817.2002.t01-1-01227.x; Huang L, 2009, APPL MICROBIOL BIOT, V84, P301, DOI 10.1007/s00253-009-1982-z; Kajava AV, 2006, ADV PROTEIN CHEM, V73, P55, DOI 10.1016/S0065-3233(06)73003-0; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kondo H, 2012, P NATL ACAD SCI USA, V109, P9360, DOI 10.1073/pnas.1121607109; Kristiansen E, 2011, INSECT BIOCHEM MOLEC, V41, P109, DOI 10.1016/j.ibmb.2010.11.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee JH, 2012, J BIOL CHEM, V287, P11460, DOI 10.1074/jbc.M111.331835; Li HY, 2009, PROG NAT SCI-MATER, V19, P1059, DOI 10.1016/j.pnsc.2008.10.012; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Ling HU, 1998, POLAR BIOL, V20, P320, DOI 10.1007/s003000050309; LING HU, 1993, EUR J PHYCOL, V28, P77, DOI 10.1080/09670269300650131; Liou YC, 2000, NATURE, V406, P322, DOI 10.1038/35018604; Mao XF, 2011, CRYOBIOLOGY, V62, P91, DOI 10.1016/j.cryobiol.2011.01.001; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Marshall CB, 2002, FEBS LETT, V529, P261, DOI 10.1016/S0014-5793(02)03355-0; Matsuzaki R, 2014, PHYCOLOGIA, V53, P293, DOI 10.2216/14-3.1; Matsuzaki R, 2013, PHYCOLOGIA, V52, P239, DOI 10.2216/12-083.1; Middleton AJ, 2009, FEBS LETT, V583, P815, DOI 10.1016/j.febslet.2009.01.035; Mock T, 2005, ENVIRON MICROBIOL, V7, P605, DOI 10.1111/j.1462-2920.2005.00781.x; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PRIDDLE J, 1986, BIOL REV, V61, P199, DOI 10.1111/j.1469-185X.1986.tb00718.x; Proschold T, 2001, PROTIST, V152, P265, DOI 10.1078/1434-4610-00068; Qin WS, 2006, INSECT BIOCHEM MOLEC, V36, P210, DOI 10.1016/j.ibmb.2006.01.017; RAYMOND JA, 1989, P NATL ACAD SCI USA, V86, P881, DOI 10.1073/pnas.86.3.881; RAYMOND JA, 1994, POLAR BIOL, V14, P71; Raymond JA, 2000, POLAR BIOL, V23, P721, DOI 10.1007/s003000000147; Raymond JA, 2003, CRYOBIOLOGY, V46, P174, DOI 10.1016/S0011-2240(03)00023-3; Raymond JA, 2000, ANTARCT SCI, V12, P418; Raymond JA, 2014, EXTREMOPHILES, V18, P987, DOI 10.1007/s00792-014-0668-3; Raymond JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059186; Raymond JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035968; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; SAUNDERS GW, 1994, CAN J BOT, V72, P1250, DOI 10.1139/b94-153; SCHMIDT S, 1991, ANTARCT SCI, V3, P379, DOI 10.1017/S0954102091000482; Sechi S, 1998, ANAL CHEM, V70, P5150, DOI 10.1021/ac9806005; Smallwood M, 2002, PHILOS T R SOC B, V357, P831, DOI 10.1098/rstb.2002.1073; SONNICHSEN FD, 1995, PROTEIN SCI, V4, P460; Sorhannus U, 2011, EVOL BIOINFORM, V7, P279, DOI 10.4137/EBO.S8321; STEINER JJ, 1995, NUCLEIC ACIDS RES, V23, P2569, DOI 10.1093/nar/23.13.2569-a; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas DN, 2002, SCIENCE, V295, P641, DOI 10.1126/science.1063391; Uhlig C, 2011, CRYOBIOLOGY, V63, P220, DOI 10.1016/j.cryobiol.2011.08.005; Wilkins MR, 1997, ELECTROPHORESIS, V18, P403, DOI 10.1002/elps.1150180314	81	13	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0154056	10.1371/journal.pone.0154056	http://dx.doi.org/10.1371/journal.pone.0154056			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27097164	Green Published, Green Submitted, gold			2022-12-27	WOS:000374543600084
J	Koller, T; Kurze, D; Lange, M; Scherdin, M; Podbielski, A; Warnke, P				Koeller, Thomas; Kurze, Daniel; Lange, Mirjam; Scherdin, Martin; Podbielski, Andreas; Warnke, Philipp			Implementation and Evaluation of a Fully Automated Multiplex Real-Time PCR Assay on the BD Max Platform to Detect and Differentiate Herpesviridae from Cerebrospinal Fluids	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; VARICELLA-ZOSTER-VIRUS; POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; MOLLARETS MENINGITIS; CLINICAL-SAMPLES; NUCLEIC-ACID; NEUROLOGICAL DISEASE; VIRAL LOAD; HSV DNA	A fully automated multiplex real-time PCR assay-including a sample process control and a plasmid based positive control-for the detection and differentiation of herpes simplex virus 1 (HSV1), herpes simplex virus 2 (HSV2) and varicella-zoster virus (VZV) from cerebrospinal fluids (CSF) was developed on the BD Max platform. Performance was compared to an established accredited multiplex real time PCR protocol utilizing the easyMAG and the LightCycler 480/II, both very common devices in viral molecular diagnostics. For clinical validation, 123 CSF specimens and 40 reference samples from national interlaboratory comparisons were examined with both methods, resulting in 97.6% and 100% concordance for CSF and reference samples, respectively. Utilizing the BD Max platform revealed sensitivities of 173 (CI 95%, 88-258) copies/ml for HSV1, 171 (CI 95%, 148-194) copies/ml for HSV2 and 84 (CI 95%, 5-163) copies/ml for VZV. Cross reactivity could be excluded by checking 25 common viral, bacterial and fungal human pathogens. Workflow analyses displayed shorter test duration as well as remarkable fewer and easier preparation steps with the potential to reduce error rates occurring when manually assessing patient samples. This protocol allows for a fully automated PCR assay on the BD Max platform for the simultaneously detection of herpesviridae from CSF specimens. Singular or multiple infections due to HSV1, HSV2 and VZV can reliably be differentiated with good sensitivities. Control parameters are included within the assay, thereby rendering its suitability for current quality management requirements.	[Koeller, Thomas; Kurze, Daniel; Lange, Mirjam; Scherdin, Martin; Podbielski, Andreas; Warnke, Philipp] Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany	University of Rostock	Warnke, P (corresponding author), Rostock Univ Hosp, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	philipp.warnke@med.uni-rostock.de						Aberle SW, 2005, MED MICROBIOL IMMUN, V194, P7, DOI 10.1007/s00430-003-0202-1; Aberle SW, 2002, J CLIN VIROL, V25, pS79, DOI 10.1016/S1386-6532(02)00037-9; Bennett S, 2013, J VIROL METHODS, V189, P143, DOI 10.1016/j.jviromet.2012.08.020; BERGER JR, 1991, LANCET, V337, P1360, DOI 10.1016/0140-6736(91)93051-A; Binnicker MJ, 2014, J CLIN MICROBIOL, V52, P4361, DOI 10.1128/JCM.02623-14; Boutolleau D, 2003, J INFECT DIS, V187, P179, DOI 10.1086/367677; Buelow DR, 2013, J CLIN VIROL, V58, P84, DOI 10.1016/j.jcv.2013.05.008; Cardenas AM, 2014, J CLIN MICROBIOL, V52, P4375, DOI 10.1128/JCM.02237-14; Corey L, 2005, J MED VIROL, V76, P350, DOI 10.1002/jmv.20365; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; Enbom M, 2000, J MED VIROL, V62, P498, DOI 10.1002/1096-9071(200012)62:4&lt;498::AID-JMV15&gt;3.0.CO;2-B; Enbom M, 2001, SEX TRANSM DIS, V28, P300, DOI 10.1097/00007435-200105000-00013; Fan FN, 2014, FUTURE VIROL, V9, P721, DOI 10.2217/FVL.14.61; Fan FN, 2014, J CLIN MICROBIOL, V52, P3799, DOI 10.1128/JCM.02098-14; Farazmand P, 2011, INT J STD AIDS, V22, P306, DOI 10.1258/ijsa.2010.010405; Filen F, 2004, SEX TRANSM DIS, V31, P331, DOI 10.1097/00007435-200406000-00002; Heaton PR, 2015, DIAGN MICR INFEC DIS, V81, P169, DOI 10.1016/j.diagmicrobio.2014.11.012; Hobson-Peters J, 2007, MOL CELL PROBE, V21, P24, DOI 10.1016/j.mcp.2006.07.002; Hodgson J, 2007, J CLIN VIROL, V38, P217, DOI 10.1016/j.jcv.2006.12.014; Klapper Paul E., 1998, Clin Microbiol Infect, V4, P178, DOI 10.1111/j.1469-0691.1998.tb00665.x; Letertre C, 2003, MOL CELL PROBE, V17, P307, DOI 10.1016/j.mcp.2003.08.004; Leveque N, 2014, J CLIN MICROBIOL, V52, P212, DOI 10.1128/JCM.02270-13; Lundberg R, 2006, ANTICANCER RES, V26, P3627; Mengelle C, 2004, J MED VIROL, V74, P459, DOI 10.1002/jmv.20198; Mousavi-Jazi M, 2003, J CLIN VIROL, V26, P301, DOI 10.1016/S1386-6532(02)00046-X; Murphy RF, 2009, AM J CLIN PATHOL, V132, P687, DOI 10.1309/AJCP0KN1PCHEYSIK; Nakajima H, 1998, EUR NEUROL, V39, P163, DOI 10.1159/000007927; Petersen M, 2003, TRENDS BIOTECHNOL, V21, P74, DOI 10.1016/S0167-7799(02)00038-0; PICARD FJ, 1993, NEUROLOGY, V43, P1722, DOI 10.1212/WNL.43.9.1722; Pillet S, 2015, J CLIN MICROBIOL, V53, P1921, DOI 10.1128/JCM.03692-14; Poissy J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-356; Roizman B, 2001, Herpes, V8, P23; Rottenstreich A, 2014, DIAGN MICR INFEC DIS, V79, P174, DOI 10.1016/j.diagmicrobio.2014.02.015; Sankuntaw N, 2011, MOL CELL PROBE, V25, P114, DOI 10.1016/j.mcp.2011.03.004; Schloss L, 2003, J CLIN VIROL, V28, P175, DOI 10.1016/S1386-6532(03)00003-9; Schloss L, 2009, J MED VIROL, V81, P1432, DOI 10.1002/jmv.21563; Singh SK, 1998, CHEM COMMUN, P455, DOI 10.1039/a708608c; Stahl JP, 2012, EPIDEMIOL INFECT, V140, P372, DOI 10.1017/S0950268811000483; Steiner I, 2009, J NEUROVIROL; Steiner I, 2007, LANCET NEUROL, V6, P1015, DOI 10.1016/S1474-4422(07)70267-3; Sugita S, 2008, BRIT J OPHTHALMOL, V92, P928, DOI 10.1136/bjo.2007.133967; Sunden B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-220; Tan TY, 2013, DIAGN MOL PATHOL, V22, P245, DOI 10.1097/PDM.0b013e3182914291; Tang JW, 2010, J MED VIROL, V82, P1911, DOI 10.1002/jmv.21903; van Nierop GP, 2014, J NEUROVIROL, V20, P412, DOI 10.1007/s13365-014-0248-4; Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Ziyaeyan M, 2011, BRAZ J INFECT DIS, V15, P211, DOI [10.1590/S1413-86702011000300005, 10.1016/S1413-8670(11)70177-5]	48	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153991	10.1371/journal.pone.0153991	http://dx.doi.org/10.1371/journal.pone.0153991			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092772	Green Published, gold			2022-12-27	WOS:000374541200067
J	Massolt, ET; Effraimidis, G; Korevaar, TIM; Wiersinga, WM; Visser, WE; Peeters, RP; Drexhage, HA				Massolt, Elske T.; Effraimidis, Grigoris; Korevaar, Tim I. M.; Wiersinga, Wilmar M.; Visser, W. Edward; Peeters, Robin P.; Drexhage, Hemmo A.			Aberrant Levels of Hematopoietic/Neuronal Growth and Differentiation Factors in Euthyroid Women at Risk for Autoimmune Thyroid Disease	PLOS ONE			English	Article							BIPOLAR DISORDER; SIGNALING PATHWAYS; FEMALE RELATIVES; MOOD DISORDERS; HYPOTHYROIDISM; PREVALENCE; SCHIZOPHRENIA; EPIDEMIOLOGY; DEPRESSION; BIOMARKERS	Background Subjects at risk for major mood disorders have a higher risk to develop autoimmune thyroid disease (AITD) and vice-versa, implying a shared pathogenesis. In mood disorder patients, an abnormal profile of hematopoietic/neuronal growth factors is observed, suggesting that growth/differentiation abnormalities of these cell lineages may predispose to mood disorders. The first objective of our study was to investigate whether an aberrant profile of these hematopoietic/neuronal growth factors is also detectable in subjects at risk for AITD. A second objective was to study the inter relationship of these factors with previously determined and published growth factors/cytokines in the same subjects. Methods We studied 64 TPO-Ab-negative females with at least 1 first-or second-degree relative with AITD, 32 of whom did and 32 who did not seroconvert to TPO-Ab positivity in 5-year follow-up. Subjects were compared with 32 healthy controls (HCs). We measured serum levels of brain-derived neurotrophic factor (BDNF), Stem Cell Factor (SCF), Insulin-like Growth Factor-Binding Protein 2 (IGFBP-2), Epidermal Growth Factor (EGF) and IL-7 at baseline. Results BDNF was significantly lower (8.2 vs 18.9 ng/ml, P<0.001), while EGF (506.9 vs 307.6 pg/ml, P = 0.003) and IGFBP-2 (388.3 vs 188.5 ng/ml, P = 0.028) were significantly higher in relatives than in HCs. Relatives who seroconverted in the next 5 years had significantly higher levels of SCF than non-seroconverters (26.5 vs 16.7 pg/ml, P = 0.017). In a cluster analysis with the previously published growth factors/cytokines SCF clustered together with IL-1 beta, IL-6 and CCL-3, of which high levels also preceded seroconversion. Conclusion Relatives of AITD patients show aberrant serum levels of 4 hematopoietic/ neuronal growth factors similar to the aberrancies found in mood disorder patients, suggesting that shared growth and differentiation defects in both the hematopoietic and neuronal system may underlie thyroid autoimmunity and mood disorders. A distinct pattern of four inter correlating immune factors in the relatives preceded TPO-Ab seroconversion in the next 5 years.	[Massolt, Elske T.; Korevaar, Tim I. M.; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Dept Internal Med, Div Endocrinol, NL-3000 CA Rotterdam, Netherlands; [Massolt, Elske T.; Korevaar, Tim I. M.; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Dept Internal Med, Rotterdam Thyroid Ctr, NL-3000 CA Rotterdam, Netherlands; [Effraimidis, Grigoris] Nykobing Falster Hosp, Dept Internal Med, Endocrinol Sect, Fjordvej 15, DK-4800 Nykobing, Denmark; [Wiersinga, Wilmar M.] Univ Amsterdam, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands; [Drexhage, Hemmo A.] Erasmus MC, Dept Immunol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Erasmus University Rotterdam; Erasmus MC	Massolt, ET (corresponding author), Erasmus MC, Dept Internal Med, Div Endocrinol, NL-3000 CA Rotterdam, Netherlands.; Massolt, ET (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam Thyroid Ctr, NL-3000 CA Rotterdam, Netherlands.	e.massolt@erasmusmc.nl	Korevaar, Tim I.M./ABF-6688-2020; Visser, W. Edward/C-4062-2015	Peeters, Robin/0000-0001-7732-9371; Visser, W. Edward/0000-0002-5248-863X	PSYCHAID, seventh framework program, IAPP [286334]; Zon-MW TOP grant [91212044]; Erasmus MC MRACE grant	PSYCHAID, seventh framework program, IAPP; Zon-MW TOP grant; Erasmus MC MRACE grant	HAD was supported by: PSYCHAID, seventh framework program, IAPP, 286334. RPP was supported by: Zon-MW TOP grant ( number 91212044) and an Erasmus MC MRACE grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2004, J CLIN ENDOCR METAB, V89, P5496, DOI 10.1210/jc.2004-0977; Benros ME, 2013, JAMA PSYCHIAT, V70, P812, DOI 10.1001/jamapsychiatry.2013.1111; Beumer W, 2013, J CLIN ENDOCR METAB, V98, P2460, DOI 10.1210/jc.2012-4122; Brunoni AR, 2008, INT J NEUROPSYCHOPH, V11, P1169, DOI 10.1017/S1461145708009309; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Carta MG, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-25; Caturegli P, 2014, AUTOIMMUN REV, V13, P391, DOI 10.1016/j.autrev.2014.01.007; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Constant EL, 2001, J CLIN ENDOCR METAB, V86, P3864, DOI 10.1210/jc.86.8.3864; Domenici E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009166; Effraimidis G, 2009, J CLIN ENDOCR METAB, V94, P1324, DOI 10.1210/jc.2008-1548; Flynn RWV, 2004, J CLIN ENDOCR METAB, V89, P3879, DOI 10.1210/jc.2003-032089; Garcez RC, 2009, CELL MOL NEUROBIOL, V29, P1087, DOI 10.1007/s10571-009-9406-2; Herberth M, 2011, PROTEOMICS, V11, P94, DOI 10.1002/pmic.201000291; Hettmer S, 2005, HUM IMMUNOL, V66, P95, DOI 10.1016/j.humimm.2004.10.014; Hillegers MHJ, 2007, EUR NEUROPSYCHOPHARM, V17, P394, DOI 10.1016/j.euroneuro.2006.10.005; Kalia M, 2015, METABOLISM, V64, pS11, DOI 10.1016/j.metabol.2014.10.026; Klecha AJ, 2008, NEUROIMMUNOMODULAT, V15, P68, DOI 10.1159/000135626; Kupka RW, 2002, BIOL PSYCHIAT, V51, P305, DOI 10.1016/S0006-3223(01)01217-3; Laurberg P, 1998, J CLIN ENDOCR METAB, V83, P765, DOI 10.1210/jc.83.3.765; Ninan I, 2014, NEUROPHARMACOLOGY, V76, P684, DOI 10.1016/j.neuropharm.2013.04.011; Padmos RC, 2004, BIOL PSYCHIAT, V56, P476, DOI 10.1016/j.biopsych.2004.07.003; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Polacchini A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17989; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Rotondi M, 2013, J CLIN ENDOCR METAB, V98, P308, DOI 10.1210/jc.2012-2555; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; Schmohl M, 2012, METHODS MOL BIOL, V827, P271, DOI 10.1007/978-1-61779-442-1_18; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; Stezhammer V, 2013, EUR NEUROPSYCHOPHARM, V23, P1199, DOI 10.1016/j.euroneuro.2012.10.012; Strieder TGA, 2003, CLIN ENDOCRINOL, V59, P396, DOI 10.1046/j.1365-2265.2003.01862.x; Strieder TGA, 2008, ARCH INTERN MED, V168, P1657, DOI 10.1001/archinte.168.15.1657; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075562; VANDERPUMP MPJ, 1995, CLIN ENDOCRINOL, V43, P55, DOI 10.1111/j.1365-2265.1995.tb01894.x; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vonk R, 2007, BIOL PSYCHIAT, V62, P135, DOI 10.1016/j.biopsych.2006.08.041; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Zaiss DMW, 2013, IMMUNITY, V38, P275, DOI 10.1016/j.immuni.2012.09.023	40	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153892	10.1371/journal.pone.0153892	http://dx.doi.org/10.1371/journal.pone.0153892			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27092550	Green Published, Green Submitted, gold			2022-12-27	WOS:000374541200056
J	Shi, XF; Tian, P; Lin, RC; Huang, DY; Wang, JJ				Shi, Xiaofeng; Tian, Peng; Lin, Rongcheng; Huang, Dingyong; Wang, Jianjia			Characterization of the Complete Mitochondrial Genome Sequence of the Globose Head Whiptail Cetonurus globiceps (Gadiformes: Macrouridae) and Its Phylogenetic Analysis	PLOS ONE			English	Article							GRENADIER FISHES; EVOLUTION; PATTERNS; ASSEMBLAGES; PERSPECTIVE; ABUNDANCE; POSITION; PROGRAM; SPACER; GENES	The particular environmental characteristics of deep water such as its immense scale and high pressure systems, presents technological problems that have prevented research to broaden our knowledge of deep-sea fish. Here, we described the mitogenome sequence of a deep-sea fish, Cetonurus globiceps. The genome is 17,137 bp in length, with a standard set of 22 transfer RNA genes (tRNAs), two ribosomal RNA genes, 13 protein -coding genes, and two typical non -coding control regions. Additionally, a 70bp tRNAThr-tRNAPr intergenic spacer is present. The C. globiceps mitogenome exhibited strand-specific asymmetry in nucleotide composition. The AT-skew and GC-skew values in the whole genome of C. globiceps were 0 and -0.2877, respectively, revealing that the H-strand had equal amounts of A and T and that the overall nucleotide composition was C skewed. All of the tRNA genes could be folded into cloverleaf secondary structures, while the secondary structure of tRNAser(AGY) lacked a discernible dihydrouridine stem. By comparing this genom sequence with the recognition sites in teleost species, several conserved sequence blocks were identified in the control region. However, the GTGGG-box, the typical characteristic of conserved sequence block E (CSB-E), was absent. Notably, tandem repeats were identified in the 3' portion of the control region. No similar repetitive motifs are present in most of other gadiform species. Phylogenetic analysis based on 12 protein coding genes provided strong support that C. globiceps was the most derived in the Glade. Some relationships however, are in contrast with those presented in previous studies. This study enriches our knowledge of mitogenomes of the genus Cetonurus and provides valuable information on the evolution of Macrouridae mtDNA and deep-sea fish.	[Shi, Xiaofeng; Lin, Rongcheng; Huang, Dingyong; Wang, Jianjia] State Ocean Adm, Inst Oceanog 3, Lab Marine Biol & Ecol, Xiamen, Peoples R China; [Tian, Peng] Zhejiang Univ, Ocean Coll, Hangzhou 310003, Zhejiang, Peoples R China	State Oceanic Administration; Zhejiang University	Lin, RC (corresponding author), State Ocean Adm, Inst Oceanog 3, Lab Marine Biol & Ecol, Xiamen, Peoples R China.	linrongcheng@tio.org.cn			National Basic Research Program of China [2015CB755902]; China Ocean Mineral Resources Research and Development Association Program [DY125-22-QY-06, DY125-11-E-03]; NSFC [41406166]	National Basic Research Program of China(National Basic Research Program of China); China Ocean Mineral Resources Research and Development Association Program; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2015CB755902) granted to RL, China Ocean Mineral Resources Research and Development Association Program (Grant No. DY125-22-QY-06) granted to JW, China Ocean Mineral Resources Research and Development Association Program (Grant No. DY125-11-E-03) granted to RL, and project 41406166 supported by NSFC granted to XS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bakke I, 1999, MAR BIOTECHNOL, V1, P411, DOI 10.1007/PL00011797; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Breines R, 2008, POLAR BIOL, V31, P1245, DOI 10.1007/s00300-008-0463-7; Burland TG, 1999, DNASTARS LASERGENE S; Carr SM, 1999, CAN J ZOOL, V77, P19, DOI 10.1139/cjz-77-1-19; Chao QJ, 2014, GENET MOL RES, V13, P2739, DOI 10.4238/2014.April.14.3; Cheng J, 2012, GENE, V491, P210, DOI 10.1016/j.gene.2011.09.020; Endo Hiromitsu, 2002, Memoirs of the Graduate School of Fisheries Sciences Hokkaido University, V49, P75; Follesa MC, 2011, J APPL ICHTHYOL, V27, P129, DOI 10.1111/j.1439-0426.2010.01567.x; Fossen I, 2008, DEEP-SEA RES PT II, V55, P203, DOI 10.1016/j.dsr2.2007.09.004; Froese R, 2007, FISHBASE, V26, P27; Gao JF, 2014, GENE, V541, P92, DOI 10.1016/j.gene.2014.03.017; Hao WL, 2010, P NATL ACAD SCI USA, V107, P21576, DOI 10.1073/pnas.1016295107; Kriwet J, 2008, NATURWISSENSCHAFTEN, V95, P899, DOI 10.1007/s00114-008-0409-5; Labuschagne C, 2014, GENE, V534, P113, DOI 10.1016/j.gene.2013.09.057; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; LEE WJ, 1995, J MOL EVOL, V41, P54; Leviton AE, 1999, P CALIFORNIA ACAD SC, V51; Liu Y, 2009, MAR GENOM, V2, P133, DOI 10.1016/j.margen.2009.07.003; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; MASSUTI E, 1995, DEEP-SEA RES PT I, V42, P307, DOI 10.1016/0967-0637(95)00003-O; Menezes GM, 2009, DEEP-SEA RES PT II, V56, P2683, DOI 10.1016/j.dsr2.2008.12.028; Miya M, 2005, BIOL J LINN SOC, V85, P289, DOI 10.1111/j.1095-8312.2005.00483.x; Miya M, 2003, MOL PHYLOGENET EVOL, V26, P121, DOI 10.1016/S1055-7903(02)00332-9; Moller PR, 2002, POLAR BIOL, V25, P342, DOI 10.1007/s00300-001-0348-5; Moranta J, 2007, PROG OCEANOGR, V72, P63, DOI 10.1016/j.pocean.2006.09.003; Morita T, 1999, MOL PHYLOGENET EVOL, V13, P447, DOI 10.1006/mpev.1999.0661; MORITZ C, 1995, PHILOS T R SOC B, V349, P113, DOI 10.1098/rstb.1995.0097; Musick JA, 1999, AM FISH S S, V23, P1; Neat F, 2010, DEEP-SEA RES PT I, V57, P434, DOI 10.1016/j.dsr.2009.12.003; Palsson S, 2008, MAR BIOTECHNOL, V10, P270, DOI 10.1007/s10126-007-9058-5; Paramo J, 2012, FISH RES, V125, P87, DOI 10.1016/j.fishres.2012.02.011; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RAND DM, 1993, J MOL EVOL, V37, P281, DOI 10.1007/BF00175505; Roa-Varon A, 2009, MOL PHYLOGENET EVOL, V52, P688, DOI 10.1016/j.ympev.2009.03.020; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roques S, 2006, GENE, V383, P12, DOI 10.1016/j.gene.2006.06.018; Satoh TP, 2006, MOL PHYLOGENET EVOL, V40, P129, DOI 10.1016/j.ympev.2006.02.014; Schattner P, 2007, NUCLEIC ACIDS RES, V33, P686; Sima YH, 2013, GENE, V526, P309, DOI 10.1016/j.gene.2013.05.048; Speijer D, 2011, BIOESSAYS, V33, P344, DOI 10.1002/bies.201100010; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Wijk EM, 2000, CCAMLR SCI, V7, P171; Wu QL, 2014, GENE, V543, P76, DOI 10.1016/j.gene.2014.04.003; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Xia JH, 2008, MITOCHONDR DNA, V19, P385, DOI 10.1080/19401730802350998; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zardoya R, 1997, GENETICS, V146, P995; Zhang HL, 2013, GENE, V517, P89, DOI 10.1016/j.gene.2012.12.080; Zhang JB, 2011, BIOCHEM SYST ECOL, V39, P31, DOI 10.1016/j.bse.2010.12.017; Zhu BJ, 2013, GENE, V527, P283, DOI 10.1016/j.gene.2013.06.035; Zhuang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073561; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zwickl D. J, 2006, GENETIC ALGORITHM AP	57	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2016	11	4							e0153666	10.1371/journal.pone.0153666	http://dx.doi.org/10.1371/journal.pone.0153666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9NW	27093057	Green Submitted, Green Published, gold			2022-12-27	WOS:000374541200039
J	Amorim, JL; Simas, DLR; Pinheiro, MMG; Moreno, DSA; Alviano, CS; da Silva, AJR; Fernandes, PD				Amorim, Jorge Luis; Reis Simas, Daniel Luiz; Gomes Pinheiro, Mariana Martins; Alviano Moreno, Daniela Sales; Alviano, Celuta Sales; Ribeiro da Silva, Antonio Jorge; Fernandes, Patricia Dias			Anti-Inflammatory Properties and Chemical Characterization of the Essential Oils of Four Citrus Species	PLOS ONE			English	Article							D-LIMONENE; INFLAMMATION; TOXICITY; VOLATILE; RELEASE; LEMON	Citrus fruits have potential health-promoting properties and their essential oils have long been used in several applications. Due to biological effects described to some citrus species in this study our objectives were to analyze and compare the phytochemical composition and evaluate the anti-inflammatory effect of essential oils (EO) obtained from four different Citrus species. Mice were treated with EO obtained from C. limon, C. latifolia, C. aurantifolia or C. limonia (10 to 100 mg/kg, p.o.) and their anti-inflammatory effects were evaluated in chemical induced inflammation (formalin-induced licking response) and carrageenan-induced inflammation in the subcutaneous air pouch model. A possible antinociceptive effect was evaluated in the hot plate model. Phytochemical analyses indicated the presence of geranial, limonene, gamma-terpinene and others. EOs from C. limon, C. aurantifolia and C. limonia exhibited anti-inflammatory effects by reducing cell migration, cytokine production and protein extravasation induced by carrageenan. These effects were also obtained with similar amounts of pure limonene. It was also observed that C. aurantifolia induced myelotoxicity in mice. Anti-inflammatory effect of C. limon and C. limonia is probably due to their large quantities of limonene, while the myelotoxicity observed with C. aurantifolia is most likely due to the high concentration of citral. Our results indicate that these EOs from C. limon, C. aurantifolia and C. limonia have a significant anti-inflammatory effect; however, care should be taken with C. aurantifolia.	[Amorim, Jorge Luis; Gomes Pinheiro, Mariana Martins; Fernandes, Patricia Dias] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil; [Reis Simas, Daniel Luiz; Ribeiro da Silva, Antonio Jorge] Univ Fed Rio de Janeiro, Inst Pesquisa Prod Nat, Lab Anal Fitoquim, Rio De Janeiro, Brazil; [Alviano Moreno, Daniela Sales; Alviano, Celuta Sales] Univ Fed Rio de Janeiro, Inst Microbiol Paulo Goes, Lab Estruturas Superficie Microorganismos, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Fernandes, PD (corresponding author), Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Lab Farmacol Dor & Inflamacao, Rio De Janeiro, Brazil.	patricia.dias@icb.ufrj.br	da Silva, Antonio J R/C-4476-2013; Alviano, Celuta/V-3878-2019; Alviano, Daniela/U-1556-2019; da Silva, Antonio Jorge Ribeiro/N-4020-2019; Fernandes, Patricia Dias/W-1565-2019	da Silva, Antonio J R/0000-0002-7579-420X; Alviano, Celuta/0000-0002-0806-6712; da Silva, Antonio Jorge Ribeiro/0000-0002-7579-420X; Fernandes, Patricia Dias/0000-0001-6870-6745	Conselho Nacional de Pesquisa (CNPq) [303033/2013-4, 473106/2012-4]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/210.141/2014, E-26/010.002566/2014, E-26/203.018/2015]	Conselho Nacional de Pesquisa (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work received support from Conselho Nacional de Pesquisa (CNPq): 303033/2013-4 (fellowship) to PDF, 473106/2012-4 (grant) to PDF and from Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ): E-26/210.141/2014 (grant) to PDF, E-26/010.002566/2014 (grant) to PDF, E-26/203.018/2015 (fellowship) to PDF.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Amantea D, 2009, INT REV NEUROBIOL, V85, P389, DOI 10.1016/S0074-7742(09)85027-7; Arias BA, 2005, J ETHNOPHARMACOL, V97, P89, DOI 10.1016/j.jep.2004.10.019; BARTHOLOMEW B, 1984, FOOD CHEM TOXICOL, V22, P541, DOI 10.1016/0278-6915(84)90224-2; Belletti N, 2004, J AGR FOOD CHEM, V52, P6932, DOI 10.1021/jf049444v; Berliocchi L, 2009, INT REV NEUROBIOL, V85, P221, DOI 10.1016/S0074-7742(09)85017-4; Bisignano G, 2011, CITRUS OILS COMPOSIT; d'Alessio PA, 2013, LIFE SCI, V92, P1151, DOI 10.1016/j.lfs.2013.04.013; Gomes NM, 2007, J ETHNOPHARMACOL, V109, P486, DOI 10.1016/j.jep.2006.08.018; Gorinstein S, 2001, FOOD CHEM, V74, P309, DOI 10.1016/S0308-8146(01)00157-1; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hirota R, 2010, J FOOD SCI, V75, pH87, DOI 10.1111/j.1750-3841.2010.01541.x; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Kapoor S, 2013, HUM EXP TOXICOL, V32, P1228, DOI 10.1177/0960327113489053; Kummer R, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/859083; LORKE D, 1983, ARCH TOXICOL, V54, P275, DOI 10.1007/BF01234480; Lota ML, 2002, J AGR FOOD CHEM, V50, P796, DOI 10.1021/jf010924l; Matheus ME, 2005, J ETHNOPHARMACOL, V102, P377, DOI 10.1016/j.jep.2005.06.033; Mehl F, 2014, FOOD CHEM, V143, P325, DOI 10.1016/j.foodchem.2013.07.125; Misharina TA, 2008, APPL BIOCHEM MICRO+, V44, P438, DOI 10.1134/S0003683808040182; Moermans C, 2011, CYTOKINE, V56, P298, DOI 10.1016/j.cyto.2011.07.010; NOGUEIRA ACMA, 1995, TOXICOLOGY, V96, P105, DOI 10.1016/0300-483X(94)02915-H; Parada CA, 2001, NEUROSCIENCE, V102, P937, DOI 10.1016/S0306-4522(00)00523-6; Parodi A, 2010, TOXICOL LETT, V192, P101, DOI 10.1016/j.toxlet.2009.10.013; Pultrini ADM, 2006, LIFE SCI, V78, P1720, DOI 10.1016/j.lfs.2005.08.004; Raymundo LJRP, 2011, J ETHNOPHARMACOL, V134, P725, DOI 10.1016/j.jep.2011.01.027; Rehman MU, 2014, EXP BIOL MED, V239, P465, DOI 10.1177/1535370213520112; Ress NB, 2003, TOXICOL SCI, V71, P198, DOI 10.1093/toxsci/71.2.198; Romano L, 2005, J ANTIMICROB CHEMOTH, V55, P110, DOI 10.1093/jac/dkh503; Rouseff R, 2011, CITRUS FLAVOUR FLAVO; SAHLEY TL, 1979, PSYCHOPHARMACOLOGY, V65, P279, DOI 10.1007/BF00492216; SEDGWICK AD, 1984, J PHARM PHARMACOL, V36, P171, DOI 10.1111/j.2042-7158.1984.tb06933.x; Wehrli FW., 1979, PROGR CHEM ORGANIC N, P1	33	65	66	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153643	10.1371/journal.pone.0153643	http://dx.doi.org/10.1371/journal.pone.0153643			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088973	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000034
J	Combe, R; Mudgett, J; El Fertak, L; Champy, MF; Ayme-Dietrich, E; Petit-Demouliere, B; Sorg, T; Herault, Y; Madwed, JB; Monassier, L				Combe, Roy; Mudgett, John; El Fertak, Lahcen; Champy, Marie-france; Ayme-Dietrich, Estelle; Petit-Demouliere, Benoit; Sorg, Tania; Herault, Yann; Madwed, Jeffrey B.; Monassier, Laurent			How Does Circadian Rhythm Impact Salt Sensitivity of Blood Pressure in Mice? A Study in Two Close C57Bl/6 Substrains	PLOS ONE			English	Article							SYMPATHETIC-NERVE ACTIVITY; DAHL-S RATS; ANGIOTENSIN-II; DEOXYCORTICOSTERONE ACETATE; KNOCKOUT MICE; DIETARY SALT; HYPERTENSION; SODIUM; LACKING; RESPONSES	Background Mouse transgenesis has provided the unique opportunity to investigate mechanisms underlying sodium kidney reabsorption as well as end organ damage. However, understanding mouse background and the experimental conditions effects on phenotypic readouts of engineered mouse lines such as blood pressure presents a challenge. Despite the ability to generate high sodium and chloride plasma levels during high-salt diet, observed changes in blood pressure are not consistent between wild-type background strains and studies. Methods The present work was designed in an attempt to determine guidelines in the field of saltinduced hypertension by recording continuously blood pressure by telemetry in mice submitted to different sodium and potassium loaded diets and changing experimental conditions in both C57BL/6N and C57BL/6J mice strain (Normal salt vs. Low salt vs. High-salt/normal potassium vs. High salt/low potassium, standard vs. modified light cycle, Non-invasive tail cuff blood pressure vs. telemetry). Results In this study, we have shown that, despite a strong blood pressure (BP) basal difference between C57BL/6N and C57BL/6J mice, High salt/normal potassium diet increases BP and heart rate during the active phase only (dark period) in the same extent in both strains. On the other hand, while potassium level has no effect on salt-induced hypertension in C57BL/6N mice, high-salt/low potassium diet amplifies the effect of the high-salt challenge only in C57BL/6J mice. Indeed, in this condition, salt-induced hypertension can also be detected during light period even though this BP increase is lower compared to the one occurring during the dark period. Finally, from a methodological perspective, light cycle inversion has no effect on this circadian BP phenotype and tail-cuff method is less sensitive than telemetry to detect BP phenotypes due to salt challenges. Conclusions Therefore, to carry investigations on salt-induced hypertension in mice, chronic telemetry and studies in the active phase are essential prerequisites.	[Combe, Roy; El Fertak, Lahcen; Champy, Marie-france; Petit-Demouliere, Benoit; Sorg, Tania; Herault, Yann; Monassier, Laurent] Univ Strasbourg, Inst Clin Souris, Inst Genet & Biol Mol, Illkirch Graffenstaden, France; [Ayme-Dietrich, Estelle; Monassier, Laurent] Univ & Ctr Hosp Univ Strasbourg, Lab Neurobiol & Pharmacol Cardiovasc, Fac Med, Federat Med Translat, Strasbourg, France; [Mudgett, John; Madwed, Jeffrey B.] Merck Res Labs, Kenilworth, NJ USA; [Combe, Roy] Ecole Polytech Fed Lausanne, Ctr Phenogen, CH-1015 Lausanne, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Merck & Company; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Combe, R (corresponding author), Univ Strasbourg, Inst Clin Souris, Inst Genet & Biol Mol, Illkirch Graffenstaden, France.; Combe, R (corresponding author), Ecole Polytech Fed Lausanne, Ctr Phenogen, CH-1015 Lausanne, Switzerland.	roy.combe@epfl.ch	AYME, Estelle/AAC-8392-2022; Herault, Yann/B-5500-2012; Monassier, Laurent/AAE-4446-2022	AYME, Estelle/0000-0002-0613-3803; Herault, Yann/0000-0001-7049-6900; 	Mouse Clinical Institute (MCI); Merck Research Laboratories (MRL)	Mouse Clinical Institute (MCI); Merck Research Laboratories (MRL)(Merck & Company)	This work was financed by the Mouse Clinical Institute (MCI) in collaboration with Merck Research Laboratories (MRL). This study has been performed in the frame of a provision service by MCI for MRL. The billing of this specific service included part of the material resources that have been recruited to conduct this study. Apart from this financial support for MCI, MRL did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. It is noteworthy that MRL had to validate the study design and the manuscript before publication, but no revisions were asked by MRL. The specific roles of these authors are articulated in the 'author contributions' section.	Alfie ME, 1997, HYPERTENSION, V29, P483, DOI 10.1161/01.HYP.29.1.483; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Brochu I, 2002, CLIN SCI, V103, p380S, DOI 10.1042/CS103S380S; Carlson SH, 2002, HYPERTENSION, V39, P214, DOI 10.1161/hy0202.104267; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; Chen DA, 2010, AM J HYPERTENS, V23, P481, DOI 10.1038/ajh.2010.12; DiBona GF, 2003, ACTA PHYSIOL SCAND, V177, P285, DOI 10.1046/j.1365-201X.2003.01074.x; Esler M, 2006, HYPERTENSION, V48, P787, DOI 10.1161/01.HYP.0000242642.42177.49; Fujita M, 2005, HYPERTENSION, V45, P1165, DOI 10.1161/01.HYP.0000165690.85505.37; FUJITA T, 1980, AM J MED, V69, P334, DOI 10.1016/0002-9343(80)90002-9; Gross V, 2000, J HYPERTENS, V18, P955, DOI 10.1097/00004872-200018070-00018; Guild SJ, 2012, HYPERTENSION, V59, P614, DOI 10.1161/HYPERTENSIONAHA.111.180885; Handtrack C, 2007, J MOL MED-JMM, V85, P343, DOI 10.1007/s00109-007-0166-5; Hao XZ, 2011, PFLUG ARCH EUR J PHY, V461, P345, DOI 10.1007/s00424-011-0921-x; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Helkamaa T, 2003, J HYPERTENS, V21, P2365, DOI 10.1097/00004872-200312000-00026; Houghton BL, 2010, EXP PHYSIOL, V95, P282, DOI 10.1113/expphysiol.2009.049833; Huang BS, 1998, HYPERTENSION, V32, P1028, DOI 10.1161/01.HYP.32.6.1028; Huang BS, 2004, AM J PHYSIOL-HEART C, V287, pH1160, DOI 10.1152/ajpheart.00126.2004; Kennedy CRJ, 1999, NAT MED, V5, P217, DOI 10.1038/5583; KOEPKE JP, 1985, HYPERTENSION, V7, P357, DOI 10.1161/01.HYP.7.3_Pt_1.357; Koutnikova H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000591; KUROO M, 1995, CIRC RES, V76, P148, DOI 10.1161/01.RES.76.1.148; Makhanova N, 2008, HYPERTENSION, V51, P134, DOI 10.1161/HYPERTENSIONAHA.107.098897; Manolopoulou J, 2008, J ENDOCRINOL, V196, P215, DOI 10.1677/JOE-07-0134; McBryde FD, 2009, AM J PHYSIOL-REG I, V297, pR396, DOI 10.1152/ajpregu.90741.2008; Meneton P, 2000, AM J PHYSIOL-RENAL, V278, pF339, DOI 10.1152/ajprenal.2000.278.3.F339; Milia AF, 2001, HYPERTENSION, V37, P1473, DOI 10.1161/01.HYP.37.6.1473; Oliverio MI, 2000, HYPERTENSION, V35, P550, DOI 10.1161/01.HYP.35.2.550; Ono A, 1997, HYPERTENSION, V29, P808, DOI 10.1161/01.HYP.29.3.808; Osborn JW, 2010, EXP PHYSIOL, V95, P61, DOI 10.1113/expphysiol.2008.046326; Ruta LAM, 2010, AM J PHYSIOL-RENAL, V298, pF1384, DOI 10.1152/ajprenal.00049.2010; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Stocker SD, 2010, PHYSIOL BEHAV, V100, P519, DOI 10.1016/j.physbeh.2010.04.024; Strazzullo P, 2001, CLIN EXP HYPERTENS, V23, P25, DOI 10.1081/CEH-100001194; Van Huysse JW, 2011, AM J PHYSIOL-HEART C, V301, pH2147, DOI 10.1152/ajpheart.01216.2010; Wang Q, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017902.77985.84; Watanabe H, 2005, CIRC J, V69, P124, DOI 10.1253/circj.69.124; Wu XY, 1998, CLIN EXP HYPERTENS, V20, P795, DOI 10.3109/10641969809052120	40	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153472	10.1371/journal.pone.0153472	http://dx.doi.org/10.1371/journal.pone.0153472			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088730	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000022
J	Mulsow, K; Enzlein, T; Delebinski, C; Jaeger, S; Seifert, G; Melzig, MF				Mulsow, Katharina; Enzlein, Thomas; Delebinski, Catharina; Jaeger, Sebastian; Seifert, Georg; Melzig, Matthias F.			Impact of Mistletoe Triterpene Acids on the Uptake of Mistletoe Lectin by Cultured Tumor Cells	PLOS ONE			English	Article							VISCUM-ALBUM L; ACUTE LYMPHOBLASTIC-LEUKEMIA; IN-VITRO; INTRACELLULAR-TRANSPORT; MEMBRANE INTERACTIONS; HUMAN MONOCYTES; OLEANOLIC ACID; EXTRACT; APOPTOSIS; RICIN	Complementary treatment possibilities for the therapy of cancer are increasing in demand due to the severe side effects of the standard cytostatics used in the first-line therapy. A common approach as a complementary treatment is the use of aqueous extracts of Viscum album L. (Santalaceace). The therapeutic activity of these extracts is attributed to Mistletoe lectins which are Ribosome-inactivating proteins type II. Besides these main constituents the extract of Viscum album L. comprises also a mixture of lipophilic ingredients like triterpene acids of the oleanane, lupane and ursane type. However, these constituents are not contained in commercially available aqueous extracts due to their high lipophilicity and insolubility in aqueous extraction media. To understand the impact of the extract ingredients in cancer therapy, the intracellular uptake of the mistletoe lectin I (ML) by cultured tumor cells was investigated in relation to the mistletoe triterpene acids, mainly oleanolic acid. Firstly, these hydrophobic triterpene acids were solubilized using cyclodextrins ("TT" extract). Afterwards, the uptake of either single compounds (isolated ML and the aqueous "viscum" extract) or in combination with the TT extract (ML+TT, viscumTT), was analyzed. The uptake of ML was studied in THP-1-, HL-60-, 143B- and Ewing TC-71-cells and determined after 30, 60 and 120 minutes by an enzyme linked immunosorbent assay which quantifies the A-chain of the hololectin. It could be shown that the intracellular uptake after 120 minutes amounted to 20% in all cell lines after incubation with viscumTT. The studies further revealed that the uptake in THP-1-, HL-60- and Ewing TC-71-cells was independent of the addition of TT extract. Interestingly, the uptake of ML by 143B-cells could only be measured after addition of triterpenes pointing to resistance to mistletoe lectin.	[Mulsow, Katharina; Melzig, Matthias F.] Free Univ Berlin, Dept Pharmaceut Biol, Inst Pharm, Berlin, Germany; [Enzlein, Thomas] Mannheim Univ Appl Sci, Dept Biotechnol, Mannheim, Germany; [Delebinski, Catharina; Seifert, Georg] Charite, Dept Paediat, Div Oncol Haematol, Otto Heubner Ctr Paediat & Adolescent Med OHC, D-13353 Berlin, Germany; [Jaeger, Sebastian] Birken AG, Niefern Oeschelbronn, Germany	Free University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Melzig, MF (corresponding author), Free Univ Berlin, Dept Pharmaceut Biol, Inst Pharm, Berlin, Germany.	melzig@zedat.fu-berlin.de	Enzlein, Thomas/AFQ-4152-2022	Enzlein, Thomas/0000-0003-1789-4090; Delebinski, Catharina/0000-0003-2527-4385	Birken AG	Birken AG	Birken AG provided support in the form of salaries for authors SJ, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the 'author contributions' section.	Broniatowski M, 2014, BBA-BIOMEMBRANES, V1838, P2530, DOI 10.1016/j.bbamem.2014.05.027; Buessing A., 1996, APOPTOSIS, V1, P25; Delebinski CI, 2012, CELL PROLIFERAT, V45, P176, DOI 10.1111/j.1365-2184.2011.00801.x; Delebinski CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133892; Edlund U, 2000, ARZNEIMITTEL-FORSCH, V50, P645; Elsasser-Beile U, 2000, J CLIN LAB ANAL, V14, P255, DOI 10.1002/1098-2825(20001212)14:6<255::AID-JCLA1>3.0.CO;2-J; FRANZ H, 1986, ONCOLOGY, V43, P23, DOI 10.1159/000226417; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Fulda S, 2000, MED PEDIATR ONCOL, V35, P616, DOI 10.1002/1096-911X(20001201)35:6<616::AID-MPO27>3.0.CO;2-N; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Huber R, 2005, EUR J MED RES, V10, P411; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Laszczyk M, 2006, PLANTA MED, V72, P1389, DOI 10.1055/s-2006-951723; Laszczyk MN, 2009, PLANTA MED, V75, P1549, DOI 10.1055/s-0029-1186102; Lenartz D, 2000, ANTICANCER RES, V20, P2073; Li R, 2009, AAPS PHARMSCITECH, V10, P1137, DOI 10.1208/s12249-009-9317-z; Llorente A, 1998, FEBS LETT, V431, P200, DOI 10.1016/S0014-5793(98)00754-6; Manojlovic V, 2008, COLLOID SURFACE B, V64, P284, DOI 10.1016/j.colsurfb.2008.02.001; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; Moisenovich M, 2003, ARZNEIMITTEL-FORSCH, V53, P470; Moisenovich M, 2002, EUR J CELL BIOL, V81, P529, DOI 10.1078/0171-9335-00263; MUSIELSKI H, 1996, GRUNDLAGEN MISTELTHE, P95; Muthing J, 2004, BIOCHEMISTRY-US, V43, P2996, DOI 10.1021/bi0301892; OLSNES S, 1982, J BIOL CHEM, V257, P13263; Pohl P, 1998, BBA-BIOMEMBRANES, V1371, P11, DOI 10.1016/S0005-2736(98)00024-8; Prades J, 2011, BBA-BIOMEMBRANES, V1808, P752, DOI 10.1016/j.bbamem.2010.12.007; Rather MA, 2013, PHYTOMEDICINE, V21, P1, DOI 10.1016/j.phymed.2013.07.015; RibereauGayon G, 1996, CANCER LETT, V109, P33, DOI 10.1016/S0304-3835(96)04401-1; Robert Koch Institute, 2015, HLTH IN GERM; Rostock M, 2005, ANTICANCER RES, V25, P1969; Safayhi H, 1997, PLANTA MED, V63, P487, DOI 10.1055/s-2006-957748; Sairafianpour M, 2003, PLANTA MED, V69, P846, DOI 10.1055/s-2003-43212; SANDVIG K, 1994, FEBS LETT, V346, P99, DOI 10.1016/0014-5793(94)00281-9; Schaller G, 1996, PHYTOTHER RES, V10, P473, DOI 10.1002/(SICI)1099-1573(199609)10:6&lt;473::AID-PTR879&gt;3.0.CO;2-Q; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Struh CM, 2012, PHYTOTHER RES, V26, P1507, DOI 10.1002/ptr.4604; Struh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062168; Thies A, 2008, BRIT J CANCER, V98, P106, DOI 10.1038/sj.bjc.6604106; Tonevitsky AG, 2003, BIOCHEMISTRY-MOSCOW+, V68, P275, DOI 10.1023/A:1023050132342; Tsuchiya H, 2015, MOLECULES, V20, P18923, DOI 10.3390/molecules201018923; Urech K, 2005, J PHARM PHARMACOL, V57, P101, DOI 10.1211/0022357055083; Valentiner U, 2002, TOXICOLOGY, V171, P187, DOI 10.1016/S0300-483X(01)00581-9; Vervecken W, 2000, INT J BIOCHEM CELL B, V32, P317, DOI 10.1016/S1357-2725(99)00135-1; Wagner H, 2009, PHYTOMEDICINE, V16, P97, DOI 10.1016/j.phymed.2008.12.018; Williamson EM, 2001, PHYTOMEDICINE, V8, P401, DOI 10.1078/0944-7113-00060; Zhang WS, 2014, J CANCER RES THER, V10, P14, DOI 10.4103/0973-1482.139746; ZISKA P, 1981, EXPERIENTIA, V37, P219, DOI 10.1007/BF01991618	49	12	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153825	10.1371/journal.pone.0153825	http://dx.doi.org/10.1371/journal.pone.0153825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27088729	Green Published, Green Submitted, gold			2022-12-27	WOS:000374527000052
J	Oliveiros, B; Sanches, M; Quendera, B; Graca, B; Guelho, D; Gomes, L; Carrilho, F; Caseiro-Alves, F; Castelo-Branco, M				Oliveiros, Brbara; Sanches, Mafalda; Quendera, Bruno; Graca, Bruno; Guelho, Daniela; Gomes, Leonor; Carrilho, Francisco; Caseiro-Alves, Filipe; Castelo-Branco, Miguel			Relations between Cardiac and Visual Phenotypes in Diabetes: A Multivariate Approach	PLOS ONE			English	Article							VENTRICULAR DIASTOLIC DYSFUNCTION; OPTICAL COHERENCE TOMOGRAPHY; EJECTION FRACTION; HEART-FAILURE; RETINAL THICKNESS; COLOR-VISION; RETINOPATHY; MELLITUS; INFLAMMATION; ASSOCIATION	Cardiovascular disease and diabetes represent a major public health concern. The former is the most frequent cause of death and disability in patients with type 2 diabetes, where left ventricular dysfunction is highly prevalent. Moreover, diabetic retinopathy is becoming a dominant cause of visual impairment and blindness. The complex relation between cardiovascular disease and diabetic retinopathy as a function of ageing, obesity and hypertension remains to be clarified. Here, we investigated such relations in patients with diabetes type 2, in subjects with neither overt heart disease nor advanced proliferative diabetic retinopathy. We studied 47 patients and 50 controls, aged between 45 and 65 years, equally distributed according to gender. From the 36 measures regarding visual structure and function, and the 11 measures concerning left ventricle function, we performed data reduction to obtain eight new derived variables, seven of which related to the eye, adjusted for age, gender, body mass index and high blood pressure using both discriminant analysis (DA) and logistic regression (LR). We found moderate to strong correlation between left ventricle function and the eye constructs: minimum correlation was found for psychophysical motion thresholds (DA: 0.734; LR: 0.666), while the maximum correlation was achieved with structural volume density in the neural retina (DA: 0.786; LR: 0.788). Controlling the effect of pairwise correlated visual constructs, the parameters that were most correlated to left ventricle function were volume density in retina and thickness of the retinal nerve fiber layers (adjusted multiple R-2 is 0.819 and 0.730 for DA and LR), with additional contribution of psychophysical loss in achromatic contrast discrimination. We conclude that visual structural and functional changes in type 2 diabetes are related to heart dysfunction, when the effects of clinical, demographic and associated risk factors are taken into account, revealing a genuine relation between cardiac and retinal diabetic phenotypes.	[Oliveiros, Brbara; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Lab Biostat & Med Informat, Coimbra, Portugal; [Sanches, Mafalda; Quendera, Bruno; Castelo-Branco, Miguel] Univ Coimbra, Fac Med, Inst Nucl Sci Appl Hlth, Coimbra, Portugal; [Graca, Bruno; Caseiro-Alves, Filipe] Univ Ctr Hosp Coimbra, Dept Med Imaging, Coimbra, Portugal; [Guelho, Daniela; Gomes, Leonor; Carrilho, Francisco] Univ Ctr Hosp Coimbra, Endocrinol Diabet & Metab Dept, Coimbra, Portugal; [Oliveiros, Brbara; Castelo-Branco, Miguel] Univ Coimbra, Inst Biomed Imaging & Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade de Coimbra	Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Lab Biostat & Med Informat, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Fac Med, Inst Nucl Sci Appl Hlth, Coimbra, Portugal.; Castelo-Branco, M (corresponding author), Univ Coimbra, Inst Biomed Imaging & Life Sci, Coimbra, Portugal.	mcbranco@fmed.uc.pt	Castelo-Branco, Miguel/F-3866-2019; Alves, Filipe Caseiro/AAQ-1335-2020; Oliveiros, Bárbara/AAR-4529-2020; Oliveiros, Bárbara/AHD-0826-2022	Castelo-Branco, Miguel/0000-0003-4364-6373; Alves, Filipe Caseiro/0000-0001-9397-6149; Oliveiros, Bárbara/0000-0001-7836-8161; Graca, Bruno/0000-0002-3022-8116; Quendera, Bruno/0000-0002-1387-9953; Gomes, Leonor/0000-0001-6576-7104	FCT (Fundacao para a Ciencia e Tecnologia) [UID/NEU/04539/2013, POCI-01-0145-FEDER-007440];  [CENTRO-07-ST24-FEDER-00205]	FCT (Fundacao para a Ciencia e Tecnologia)(Portuguese Foundation for Science and Technology); 	This work was supported by CENTRO-07-ST24-FEDER-00205 From molecules to man: novel diagnostic imaging tools in neurological and psychiatric disorders, DoIT - Diamarker: a consortium for the discovery of novel biomarker in diabetes - QREN-COMPETE Genetic susceptibility of multisystemic complications of diabetes type 2: novel biomarkers for diagnosis and monitoring of therapy - PI FMUC - Faculdade de Medicina da Universidade de Coimbra, FCT (Fundacao para a Ciencia e Tecnologia) UID/NEU/04539/2013, Strategic Project and POCI-01-0145-FEDER-007440). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan A, 2011, GLOBAL STATUS REPORT ON NONCOMMUNICABLE DISEASES 2010, P9; Anderson TW., 2003, INTRO MULTIVARIATE S, V3; Andrade LCO, 2014, BMC OPHTHALMOL, V14, DOI 10.1186/1471-2415-14-104; Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009; Borlaug BA, 2011, EUR HEART J, V32, P670, DOI 10.1093/eurheartj/ehq426; Boyer JK, 2004, AM J CARDIOL, V93, P870, DOI 10.1016/j.amjcard.2003.12.026; Cheung N, 2008, J AM COLL CARDIOL, V51, P1573, DOI 10.1016/j.jacc.2007.11.076; Gardete Correia L., 2013, DIABETES FACTS NUMBE; Graca B, 2014, AM J ROENTGENOL, V202, P1207, DOI 10.2214/AJR.13.11325; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Karakosta A, 2012, AM J OPHTHALMOL, V153, P571, DOI 10.1016/j.ajo.2011.08.032; Kocur I., 2007, VISION 2020 RIGHT SI; Kurioka S, 2013, DIABETES RES CLIN PR, V99, P287, DOI 10.1016/j.diabres.2012.12.021; Lim MCC, 2005, INVEST OPHTH VIS SCI, V46, P974, DOI 10.1167/iovs.04-0828; Mathews DE, 1996, USING UNDERSTANDING; Mendis S, 2014, GLOBAL STATUS REPORT; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Reis A, 2014, DIABETES, V63, P3926, DOI 10.2337/db13-1673; ROY MS, 1986, ARCH OPHTHALMOL-CHIC, V104, P225; Sadda SR, 2006, OPHTHALMOLOGY, V113, P285, DOI 10.1016/j.ophtha.2005.10.005; Sharma S., 1996, APPL MULTIVARIATE TE; Suzman R, 2011, GLOBAL HLTH AGEING; Takeda Y, 2011, J CARD FAIL, V17, P556, DOI 10.1016/j.cardfail.2011.03.007; Walraven I, 2014, J DIABETES COMPLICAT, V28, P819, DOI 10.1016/j.jdiacomp.2014.06.010; Wolff BE, 2015, DOC OPHTHALMOL, V130, P131, DOI 10.1007/s10633-014-9476-4; Zabalgoitia M, 2001, AM J CARDIOL, V87, P320, DOI 10.1016/S0002-9149(00)01366-7	27	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2016	11	4							e0153772	10.1371/journal.pone.0153772	http://dx.doi.org/10.1371/journal.pone.0153772			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9IK	27089510	Green Published, gold, Green Submitted			2022-12-27	WOS:000374527000047
J	Che, YX; Ju, Y; Xuan, P; Long, R; Xing, F				Che, Yuxin; Ju, Ying; Xuan, Ping; Long, Ren; Xing, Fei			Identification of Multi-Functional Enzyme with Multi-Label Classifier	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; TUPLE NUCLEOTIDE COMPOSITION; SEQUENCE-BASED PREDICTOR; MODIFIED MAHALANOBIS DISCRIMINANT; NEURAL P SYSTEMS; PHYSICOCHEMICAL PROPERTIES; SUBCELLULAR-LOCALIZATION; MYCOBACTERIAL PROTEINS; PSEUDO; DNA	Enzymes are important and effective biological catalyst proteins participating in almost all active cell processes. Identification of multi-functional enzymes is essential in understanding the function of enzymes. Machine learning methods perform better in protein structure and function prediction than traditional biological wet experiments. Thus, in this study, we explore an efficient and effective machine learning method to categorize enzymes according to their function. Multi-functional enzymes are predicted with a special machine learning strategy, namely, multi-label classifier. Sequence features are extracted from a position-specific scoring matrix with autocross-covariance transformation. Experiment results show that the proposed method obtains an accuracy rate of 94.1% in classifying six main functional classes through five cross-validation tests and outperforms state-of-the-art methods. In addition, 91.25% accuracy is achieved in multi-functional enzyme prediction, which is often ignored in other enzyme function prediction studies. The online prediction server and datasets can be accessed from the link http://server.malab.cn/MEC/.	[Che, Yuxin; Ju, Ying] Xiamen Univ, Sch Informat Sci & Technol, Xiamen 361005, Fujian, Peoples R China; [Xuan, Ping] Heilongjiang Univ, Sch Comp Sci & Technol, Harbin 150080, Peoples R China; [Long, Ren] Harbin Inst Technol, Shenzhen Grad Sch, Sch Comp Sci & Technol, Shenzhen 518055, Guangdong, Peoples R China; [Xing, Fei] Xiamen Univ, Sch Aerosp Engn, Xiamen 361005, Fujian, Peoples R China	Xiamen University; Heilongjiang University; Harbin Institute of Technology; University Town of Shenzhen; Xiamen University	Xing, F (corresponding author), Xiamen Univ, Sch Aerosp Engn, Xiamen 361005, Fujian, Peoples R China.	f.xing@xmu.edu.cn		Che, Yuxin/0000-0001-9818-1003	Natural Science Foundation of China [61302139]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Natural Science Foundation of China (No. 61302139), http://www.nsfc.gov.cn/.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakaki AK, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-107; Brown P. F., 1992, Computational Linguistics, V18, P467; Cai SX, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/904267; Chen JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19062; Chen W, 2015, ANAL BIOCHEM, V490, P26, DOI 10.1016/j.ab.2015.08.021; Chen W, 2014, ANAL BIOCHEM, V462, P76, DOI 10.1016/j.ab.2014.06.022; Chen W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/623149; Chen W, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1450; Cheng WW, 2009, MACH LEARN, V76, P211, DOI 10.1007/s10994-009-5127-5; Cheng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038979; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Ding H, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/286419; Ding H, 2011, PROTEIN PEPTIDE LETT, V18, P58, DOI 10.2174/092986611794328708; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Dong QW, 2009, BIOINFORMATICS, V25, P2655, DOI 10.1093/bioinformatics/btp500; Feng P, 2015, INTERDISCIP SCI; Feng PM, 2013, ANAL BIOCHEM, V442, P118, DOI 10.1016/j.ab.2013.05.024; Feng PM, 2014, GENOMICS, V104, P229, DOI 10.1016/j.ygeno.2014.08.011; Feng PM, 2014, SCI WORLD J, DOI 10.1155/2014/740506; Feng PM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/935719; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goryanin I, 2012, ENZML MULTILABEL PRE, V13; Guo SH, 2014, BIOINFORMATICS, V30, P1522, DOI 10.1093/bioinformatics/btu083; Huang WL, 2007, BIOSYSTEMS, V90, P405, DOI 10.1016/j.biosystems.2006.10.004; Kumar N, 2012, BIOINFORMATICS, V28, P2687, DOI 10.1093/bioinformatics/bts510; Lin C, 2014, NEUROCOMPUTING, V123, P424, DOI 10.1016/j.neucom.2013.08.004; Lin C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056499, 10.1371/journal.pone.0080883, 10.1371/journal.pone.0065734, 10.1371/journal.pone.0070187]; Lin H, 2008, PROTEIN PEPTIDE LETT, V15, P739, DOI 10.2174/092986608785133681; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Lin H, 2014, NUCLEIC ACIDS RES, V42, P12961, DOI 10.1093/nar/gku1019; Lin H, 2012, J BIOMOL STRUCT DYN, V29, P643, DOI 10.1080/07391102.2011.672628; Liu B, 2017, BIOINFORMATICS, V33, P35, DOI [10.1093/bioinformatics/btv604, 10.1093/bioinformatics/btw539]; Liu B, 2015, BIOINFORMATICS, V31, P3492, DOI 10.1093/bioinformatics/btv413; Liu B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15479; Liu B, 2015, NUCLEIC ACIDS RES, V43, pW65, DOI 10.1093/nar/gkv458; Liu B, 2015, BIOINFORMATICS, V31, P1307, DOI 10.1093/bioinformatics/btu820; Liu B, 2015, MOL INFORM, V34, P8, DOI 10.1002/minf.201400025; Liu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106691; Liu B, 2014, BIOINFORMATICS, V30, P472, DOI 10.1093/bioinformatics/btt709; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046633; Liu J, 2015, J BIOMOL STRUCT DYN, V33, P7, DOI [10.1080/07391102.2015.1032552, 10.1080/07391102.2015.1014422]; Shen HB, 2007, BIOCHEM BIOPH RES CO, V364, P53, DOI 10.1016/j.bbrc.2007.09.098; Song L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-298; Song Tao P L, 2015, IEEE T NANOBIOSCIENC; Song Tao X J, 2016, NEUROCOMPUTING; Spyromitros E., 2008, P 5 HELL C ART INT; Tang H, 2016, MOL BIOSYSTEMS; Tian WD, 2004, NUCLEIC ACIDS RES, V32, P6226, DOI 10.1093/nar/gkh956; Wang CY, 2015, GENET MOL RES, V14, P123, DOI 10.4238/2015.January.15.15; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P649, DOI 10.1109/TNB.2015.2450233; Wei LY, 2015, IEEE T NANOBIOSCI, V14, P339, DOI 10.1109/TNB.2014.2352454; Wei LY, 2014, IEEE ACM T COMPUT BI, V11, P192, DOI 10.1109/TCBB.2013.146; Xu Chen, 2015, THEORETICAL COMPUTER; Yuan LF, 2013, TOXICOL IN VITRO, V27, P852, DOI 10.1016/j.tiv.2012.12.024; Zeng XX, 2017, IEEE ACM T COMPUT BI, V14, P687, DOI 10.1109/TCBB.2016.2520947; Zeng XX, 2016, BRIEF BIOINFORM, V17, P193, DOI 10.1093/bib/bbv033; Zeng XX, 2015, FRONT COMPUT SCI-CHI, V9, P643, DOI 10.1007/s11704-014-4089-3; Zeng XX, 2014, SCI CHINA INFORM SCI, V57, DOI 10.1007/s11432-013-4848-z; Zeng XX, 2014, NEURAL COMPUT, V26, P1340, DOI 10.1162/NECO_a_00605; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang Min-Ling, 2014, IEEE T KNOWL DATA EN, V26, P1; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P761, DOI 10.1109/TEVC.2014.2378512; Zhang XY, 2015, IEEE T NEUR NET LEAR, V26, P2816, DOI 10.1109/TNNLS.2015.2396940; Zhang XY, 2015, IEEE T EVOLUT COMPUT, V19, P201, DOI 10.1109/TEVC.2014.2308305; Zhang XY, 2014, INFORM SCIENCES, V278, P285, DOI 10.1016/j.ins.2014.03.053; Zhang XY, 2014, NEURAL COMPUT, V26, P974, DOI 10.1162/NECO_a_00580; Zhu PP, 2015, MOL BIOSYST, V11, P558, DOI 10.1039/c4mb00645c; Zou Q, 2016, BIG DATA RES; Zou Q, 2016, BRIEF FUNCT GENOMICS, V15, P55, DOI 10.1093/bfgp/elv024; Zou Q, 2016, NEUROCOMPUTING, V173, P346, DOI 10.1016/j.neucom.2014.12.123; Zou Q, 2015, BIOINFORMATICS, V31, P2475, DOI 10.1093/bioinformatics/btv177; Zou Q, 2014, BRIEF BIOINFORM, V15, P637, DOI 10.1093/bib/bbs088; Zou Q, 2013, BIOMED RES INT, V2013, DOI [10.1155/2013/686090, 10.1155/2013/608430]; Zou Q, 2013, J COMPUT THEOR NANOS, V10, P1038, DOI 10.1166/jctn.2013.2804	78	16	16	3	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153503	10.1371/journal.pone.0153503	http://dx.doi.org/10.1371/journal.pone.0153503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078147	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700068
J	Jing, ZB; Xu, HB; Chen, XH; Zhong, Q; Huang, JW; Zhang, Y; Guo, W; Yang, Z; Ding, S; Chen, P; Huang, ZG				Jing, Zhibin; Xu, Hongbo; Chen, Xiaohong; Zhong, Qi; Huang, Junwei; Zhang, Yang; Guo, Wei; Yang, Zheng; Ding, Shuo; Chen, Ping; Huang, Zhigang			The Proton-Sensing G-Protein Coupled Receptor GPR4 Promotes Angiogenesis in Head and Neck Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; FACTOR EXPRESSION; C-JUN; INTERLEUKIN-6; BEVACIZUMAB; RADIATION; SURVIVAL; DATABASE; THERAPY	Squamous cell carcinoma of the head and neck (SCCHN) is an aggressive disease with poor survival and is the sixth most common cancer worldwide. Gastroesophageal reflux is a common event in SCCHN patients. GPR4 is a proton-sensing G-protein coupled receptor, which can be activated by acidosis. The objective of this study was to explore the role of GPR4 in acid exposure and tumor angiogenesis in SCCHN. In this study, we confirmed that overexpressing GPR4 in SCCHN cells could increase the expression and secretion of IL6, IL8 and VEGFA at pH 5.9. This effect could be inhibited by SB203580 (a p38 inhibitor). Western blot analysis indicated that phosphorylation of p38 increased in GPR4 infected cells at pH 5.9, which could be inhibited by SB203580. In tube formation assay, HMEC-1 cells were incubated with conditioned medium (CM, pH 5.9, 6.5, 7.4) derived from control and GPR4 infected SCCHN cells. Tube length was significantly increased in HMEC-1 cells incubated with CM from GPR4 infected cells compared with control cells at pH5.9, which indicated the pro-angiogenic effect of GPR4 in acidic pH. The neutralizing antibodies of IL6, IL8 and VEGFA could inhibit tube formation of HMEC-1 cells. In vivo, the effect of GPR4 on angiogenesis was investigated with the chick chorioallantoic membrane (CAM) model. Control and GPR4 infected SCCHN cells were seeded onto the upper CAM surface (n = 5 in each group) and 5 mu L DMEM/F12 (pH 5.9, 6.5, 7.4) was added to the surface of the cell every 24 h. Four days later, the upper CAM were harvested and the ratio of the vascular area to the CAM area was quantified using Image-Pro Plus 6.0 software. GPR4 infected cells could recruit more vascular than control cells at pH5.9. In conclusion, we suggested that GPR4 induces angiogenesis via GPR4-induced p38-mediated IL6, IL8 and VEGFA secretion at acidic extracellular pH in SCCHN.	[Jing, Zhibin; Xu, Hongbo; Chen, Xiaohong; Zhong, Qi; Huang, Junwei; Zhang, Yang; Guo, Wei; Yang, Zheng; Ding, Shuo; Chen, Ping; Huang, Zhigang] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Huang, ZG (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	ent_huangzhigang@sina.com	xu, hong/GSD-8903-2022		Yangfan Program of Beijing Municipal Administration of Hospitals [XMLX201507]	Yangfan Program of Beijing Municipal Administration of Hospitals	This study was supported by grant from the Yangfan Program of Beijing Municipal Administration of Hospitals (no. XMLX201507). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Argiris A, 2013, ANN ONCOL, V24, P220, DOI 10.1093/annonc/mds245; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Cao S, 2011, ORAL ONCOL, V47, P459, DOI 10.1016/j.oraloncology.2011.04.001; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chen AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027586; Copper MP, 2000, LARYNGOSCOPE, V110, P1007, DOI 10.1097/00005537-200006000-00023; Dong LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061991; Duffy SA, 2008, CANCER-AM CANCER SOC, V113, P750, DOI 10.1002/cncr.23615; Eisma RJ, 1997, AM J SURG, V174, P513; Fury MG, 2012, CANCER-AM CANCER SOC, V118, P5008, DOI 10.1002/cncr.27498; Ge L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027529; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu HW, 2014, ORAL ONCOL, V50, P19, DOI 10.1016/j.oraloncology.2013.10.003; Im DS, 2005, ACTA PHARMACOL SIN, V26, P1435, DOI 10.1111/j.1745-7254.2005.00237.x; Justus CR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00354; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Kyzas PA, 2005, CLIN CANCER RES, V11, P1434, DOI 10.1158/1078-0432.CCR-04-1870; Kyzas PA, 2005, MODERN PATHOL, V18, P485, DOI 10.1038/modpathol.3800295; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Li T, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0236-4; Lingen MW, 1999, CRIT REV ORAL BIOL M, V10, P153, DOI 10.1177/10454411990100020301; Matossian M, 2014, INT J IMMUNOPATH PH, V27, P573, DOI 10.1177/039463201402700413; Papagerakis S, 2014, CANCER PREV RES, V7, P1258, DOI 10.1158/1940-6207.CAPR-14-0002; Pries R, 2006, EXPERT REV ANTICANC, V6, P1195, DOI 10.1586/14737140.6.9.1195; Ren J, 2014, CURR PHARM DESIGN, V20, P1904, DOI 10.2174/13816128113199990530; Riebe C, 2007, INT J MOL MED, V20, P883; Rofstad EK, 2006, CANCER RES, V66, P6699, DOI 10.1158/0008-5472.CAN-06-0983; Sato S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088831; Schmeck B, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-98; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Sin WC, 2004, ONCOGENE, V23, P6299, DOI 10.1038/sj.onc.1207838; Smit CF, 1998, LARYNGOSCOPE, V108, P299, DOI 10.1097/00005537-199802000-00027; Sturgis EM, 2004, SEMIN ONCOL, V31, P726, DOI 10.1053/j.seminoncol.2004.09.013; Tobo M, 2007, CELL SIGNAL, V19, P1745, DOI 10.1016/j.cellsig.2007.03.009; Toohill RJ, 1997, AM J MED, V103, p100S, DOI 10.1016/S0002-9343(97)00333-1; Van Tubergen E, 2011, CANCER-AM CANCER SOC, V117, P2677, DOI 10.1002/cncr.25859; Wan Q, 2015, DATABASE J BIOL DATA, V2015; Wang PZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10370; Wang PZ, 2015, NUCLEIC ACIDS RES, V43, pD1133, DOI 10.1093/nar/gku980; Wang PZ, 2011, MOL BIOL REP, V38, P3551, DOI 10.1007/s11033-010-0465-8; Xiao WH, 2004, CANCER BIOL THER, V3, P1007, DOI 10.4161/cbt.3.10.1141; Xu HB, 2013, BIOCHEM BIOPH RES CO, V436, P96, DOI 10.1016/j.bbrc.2013.05.065; Yang LV, 2007, MOL CELL BIOL, V27, P1334, DOI 10.1128/MCB.01909-06	45	40	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0152789	10.1371/journal.pone.0152789	http://dx.doi.org/10.1371/journal.pone.0152789			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078157	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131700008
J	Kowalska, A; Walczyk, A; Palyga, I; Gasior-Perczak, D; Gadawska-Juszczyk, K; Szymonek, M; Trybek, T; Lizis-Kolus, K; Szyska-Skrobot, D; Mikina, E; Hurej, S; Sluszniak, J; Mezyk, R; Gozdz, S				Kowalska, Aldona; Walczyk, Agnieszka; Palyga, Iwona; Gasior-Perczak, Danuta; Gadawska-Juszczyk, Klaudia; Szymonek, Monika; Trybek, Tomasz; Lizis-Kolus, Katarzyna; Szyska-Skrobot, Dorota; Mikina, Estera; Hurej, Stefan; Sluszniak, Janusz; Mezyk, Ryszard; Gozdz, Stanislaw			The Delayed Risk Stratification System in the Risk of Differentiated Thyroid Cancer Recurrence	PLOS ONE			English	Article							CARCINOMA PATIENTS; THERAPY; ASSOCIATION; PAPILLARY; ABLATION; INCREASE; OUTCOMES	Context There has been a marked increase in the detection of differentiated thyroid carcinoma (DTC) over the past few years, which has improved the prognosis. However, it is necessary to adjust treatment and monitoring strategies relative to the risk of an unfavourable disease course. Materials and Methods This retrospective study examined data from 916 patients with DTC who received treatment at a single centre between 2000 and 2013. The utility of the American Thyroid Association (ATA) and the European Thyroid Association (ETA) recommended systems for early assessment of the risk of recurrent/persistent disease was compared with that of the recently recommended delayed risk stratification (DRS) system. Results The PPV and NPV for the ATA (24.59% and 95.42%, respectively) and ETA (24.28% and 95.68%, respectively) were significantly lower than those for the DRS (56.76% and 98.5%, respectively) (p<0.0001). The proportion of variance for predicting the final outcome was 15.8% for ATA, 16.1% for ETA and 56.7% for the DRS. Recurrent disease was rare (1% of patients), and was nearly always identified in patients at intermediate/high risk according to the initial stratification (9/10 cases). Conclusions The DRS showed a better correlation with the risk of persistent disease than the early stratification systems and allows personalisation of follow-up. If clinicians plan to alter the intensity of surveillance, patients at intermediate/high risk according to the early stratification systems should remain within the specialized centers; however, low risk patients can be referred to endocrinologists or other appropriate practitioners for long-term follow-up, as these patients remained at low risk after risk re-stratification.	[Kowalska, Aldona; Walczyk, Agnieszka; Palyga, Iwona; Gasior-Perczak, Danuta; Gadawska-Juszczyk, Klaudia; Szymonek, Monika; Trybek, Tomasz; Lizis-Kolus, Katarzyna; Szyska-Skrobot, Dorota; Mikina, Estera; Hurej, Stefan] Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland; [Sluszniak, Janusz] Holycross Canc Ctr, Dept Surg Oncol, Kielce, Poland; [Mezyk, Ryszard] Holycross Canc Ctr, Dept Canc Epidemiol, Kielce, Poland; [Gozdz, Stanislaw] Holycross Canc Ctr, Dept Clin Oncol, Kielce, Poland; [Gozdz, Stanislaw] Jan Kochanowski Univ Humanities & Sci, Fac Hlth Sci, Kielce, Poland	Jan Kochanowski University	Kowalska, A (corresponding author), Holycross Canc Ctr, Dept Endocrinol, Kielce, Poland.	aldonako@onkol.kielce.pl	Gąsior-Perczak, Danuta/AAM-2668-2020; Kielce, SCO/O-6702-2016; Walczyk, Agnieszka/ABC-3334-2020; Gozdz, Stanislaw/D-3300-2013	Gąsior-Perczak, Danuta/0000-0003-0936-4890; Walczyk, Agnieszka/0000-0002-5083-659X; Gozdz, Stanislaw/0000-0001-6902-3807; Palyga, Iwona/0000-0001-5333-6112	Holycross Cancer Centre	Holycross Cancer Centre	The study was funded by Holycross Cancer Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschebrook-Kilfoy B, 2013, CANCER EPIDEM BIOMAR, V22, P1252, DOI 10.1158/1055-9965.EPI-13-0242; Brito JP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4706; Cano-Palomares A, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/591285; Castagna MG, 2011, EUR J ENDOCRINOL, V165, P441, DOI 10.1530/EJE-11-0466; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Cordioli MICV, 2009, ARQ BRAS ENDOCRINOL, V53, P453, DOI 10.1590/S0004-27302009000400011; Davies L, 2014, JAMA OTOLARYNGOL, V140, P317, DOI 10.1001/jamaoto.2014.1; Elisei R, 2010, J CLIN ENDOCR METAB, V95, P1516, DOI 10.1210/jc.2009-1536; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Greene FL, 2002, AJCC CANC STAGING HD; Han JM, 2012, THYROID, V22, P784, DOI 10.1089/thy.2011.0322; Hughes DT, 2011, THYROID, V21, P231, DOI 10.1089/thy.2010.0137; Ito Y, 2012, ENDOCR J, V59, P119, DOI 10.1507/endocrj.EJ11-0288; Jeon MJ, 2014, EUR J ENDOCRINOL, V170, P23, DOI 10.1530/EJE-13-0524; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Kowalska A, 2013, THYROID RES, V6, pA30, DOI DOI 10.1186/1756-6614-6-S2-A30; MAZZAFERRI EL, 1994, AM J MED, V97, P418, DOI 10.1016/0002-9343(94)90321-2; Momesso DP, 2014, ENDOCRIN METAB CLIN, V43, P401, DOI 10.1016/j.ecl.2014.02.010; Nascimento C, 2011, ENDOCR-RELAT CANCER, V18, pR29, DOI 10.1677/ERC-10-0292; Pacini F, 2006, EUR J ENDOCRINOL, V155, P385, DOI 10.1530/eje.1.02158e; Pitoia F, 2013, THYROID, V23, P1401, DOI 10.1089/thy.2013.0011; Scheffel RS, 2015, THYROID, V25, P883, DOI 10.1089/thy.2015.0077; Tuttle RM, 2010, THYROID, V20, P1341, DOI 10.1089/thy.2010.0178; Tuttle R Michael, 2008, Endocr Pract, V14, P764; Vaisman F, 2011, THYROID, V21, P1317, DOI 10.1089/thy.2011.0232	25	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153242	10.1371/journal.pone.0153242	http://dx.doi.org/10.1371/journal.pone.0153242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078258	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700029
J	Larsen, SC; Angquist, L; Moldovan, M; Huikari, V; Sebert, S; Cavadino, A; Ahluwalia, TS; Skaaby, T; Linneberg, A; Husemoen, LLN; Toft, U; Pedersen, O; Hansen, T; Herzig, KH; Jarvelin, MR; Power, C; Hypponen, E; Heitmann, BL; Sorensen, TIA				Larsen, Sofus C.; Angquist, Lars; Moldovan, Max; Huikari, Ville; Sebert, Sylvain; Cavadino, Alana; Ahluwalia, Tarunveer Singh; Skaaby, Tea; Linneberg, Allan; Husemoen, Lise Lotte N.; Toft, Ulla; Pedersen, Oluf; Hansen, Torben; Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta; Power, Chris; Hypponen, Elina; Heitmann, Berit L.; Sorensen, Thorkild I. A.			Serum 25-Hydroxyvitamin D Status and Longitudinal Changes in Weight and Waist Circumference: Influence of Genetic Predisposition to Adiposity	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; VITAMIN-D DEFICIENCY; BODY-MASS INDEX; BLOOD-PRESSURE; CONFER RISK; FTO GENE; OBESITY; VARIANTS; LOCI; AGE	Studies of the relationship between serum 25-hydroxyvitamin D (25(OH)D) and changes in measures of adiposity have shown inconsistent results, and interaction with genetic predisposition to obesity has rarely been examined. We examined whether 25(OH)D was associated with subsequent annual changes in body weight (Delta BW) or waist circumference (Delta WC), and whether the associations were modified by genetic predisposition to a high BMI, WC or waist-hip ratio adjusted for BMI (WHRBMI). The study was based on 10,898 individuals from the Danish Inter99, the 1958 British Birth Cohort and the Northern Finland Birth Cohort 1966. We combined 42 adiposity-associated Single Nucleotide Polymorphisms (SNPs) into four scores indicating genetic predisposition to BMI, WC and WHRBMI, or all three traits combined. Linear regression was used to examine the association between serum 25(OH)D and.BW or Delta WC, SNP-score x 25(OH)D interactions were examined, and results from the individual cohorts were meta-analyzed. In the meta-analyses, we found no evidence of an association between 25(OH)D and.BW (-9.4 gram/y per 10 nmol/L higher 25(OH)D [95% CI: -23.0, + 4.3; P = 0.18]) or Delta WC (-0.06 mm/y per 10 nmol/L higher 25(OH)D [95% CI: -0.17, + 0.06; P = 0.33]). Furthermore, we found no statistically significant interactions between the four SNP-scores and 25(OH) D in relation to Delta BW or Delta WC. Thus, in view of the narrow CIs, our results suggest that an association between 25(OH) D and changes in measures of adiposity is absent or marginal. Similarly, the study provided evidence that there is either no or very limited dependence on genetic predisposition to adiposity.	[Larsen, Sofus C.; Heitmann, Berit L.] Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Larsen, Sofus C.; Heitmann, Berit L.] Bispebjerg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark; [Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark; [Larsen, Sofus C.; Angquist, Lars; Heitmann, Berit L.; Sorensen, Thorkild I. A.] Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Moldovan, Max; Hypponen, Elina] Univ S Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA 5001, Australia; [Moldovan, Max; Hypponen, Elina] Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; [Huikari, Ville; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Fac Med, Ctr Life Course Hlth Res, POB 5000, FI-90014 Oulu, Finland; [Cavadino, Alana] Queen Mary Univ London, Barts & London Sch Med & Dent, Wolfson Inst Prevent Med, Ctr Environm & Prevent Med, London, England; [Cavadino, Alana; Power, Chris; Hypponen, Elina] UCL, UCL Inst Child Hlth, Populat Policy & Practice, London, England; [Ahluwalia, Tarunveer Singh; Pedersen, Oluf; Hansen, Torben; Sorensen, Thorkild I. A.] Univ Copenhagen, Fac Hlth & Med Sci, Sect Metab Genet, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Ahluwalia, Tarunveer Singh] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Skaaby, Tea; Linneberg, Allan; Husemoen, Lise Lotte N.; Toft, Ulla] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Clin Expt Res, Glostrup, Denmark; [Linneberg, Allan] Univ Copenhagen, Fac Hlth & Med Sci, Dept Clin Med, Copenhagen, Denmark; [Herzig, Karl-Heinz] Univ Oulu, Inst Biomed, Oulu, Finland; [Herzig, Karl-Heinz] Med Res Ctr Oulu, Oulu, Finland; [Herzig, Karl-Heinz] Oulu Univ Hosp, Oulu, Finland; [Herzig, Karl-Heinz; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, POB 5000,Aapistie 5A, FI-90014 Oulu, Finland; [Herzig, Karl-Heinz] Poznan Univ Med Sci, Dept Gastroenterol & Metab, Poznan, Poland; [Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, MRC PHE Ctr Environm & Hlth, Dept Epidemiol & Biostat, London, England; [Jarvelin, Marjo-Riitta] Oulu Univ Hosp, Unit Primary Care, Kajaanintie 50,POB 20, FI-90220 Oulu, Oys, Finland; [Hypponen, Elina] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia; [Heitmann, Berit L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Heitmann, Berit L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW 2006, Australia; [Sorensen, Thorkild I. A.] Univ Bristol, MRC Integrat Epidemiol Unit, Bristol, Avon, England	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Bispebjerg Hospital; University of South Australia; University of South Australia; University of Oulu; University of London; Queen Mary University London; University of London; University College London; Novo Nordisk Foundation; University of Copenhagen; Steno Diabetes Center; Rigshospitalet; University of Copenhagen; University of Oulu; University of Oulu; University of Oulu; Poznan University of Medical Sciences; Imperial College London; University of Oulu; South Australian Health & Medical Research Institute (SAHMRI); University of Southern Denmark; University of Sydney; University of Bristol	Larsen, SC (corresponding author), Frederiksberg Univ Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Larsen, SC (corresponding author), Bispebjerg Hosp, Parker Inst, Res Unit Dietary Studies, Frederiksberg, Denmark.; Larsen, SC (corresponding author), Bispebjerg Hosp, Inst Prevent Med, DK-2400 Copenhagen, Denmark.; Larsen, SC (corresponding author), Frederiksberg Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	sofus.christian.larsen@regionh.dk	Larsen, Sofus Christian/AAO-5894-2020; Hypponen, Elina/B-2596-2014; Cavadino, Alana/CAG-8915-2022; Pedersen, Oluf/Z-1731-2019; Ahluwalia, Tarunveer Singh/C-5549-2009; Toft, Ulla/AAH-2589-2020; Pedersen, Oluf/AAG-8015-2020; Moldovan, Max/H-7108-2014	Larsen, Sofus Christian/0000-0002-0838-9378; Hypponen, Elina/0000-0003-3670-9399; Cavadino, Alana/0000-0002-5709-367X; Pedersen, Oluf/0000-0002-3321-3972; Ahluwalia, Tarunveer Singh/0000-0002-7464-3354; Toft, Ulla/0000-0001-7770-8419; Moldovan, Max/0000-0001-9680-8474; Angquist, Lars/0000-0002-9516-4424; Skaaby, Tea/0000-0003-0031-5726; Heitmann, Berit Lilienthal/0000-0002-6809-4504; Linneberg, Allan/0000-0002-0994-0184; Jarvelin, Marjo-Riitta/0000-0002-2149-0630	Danish Council for Strategic Research [09-067111]; Danish Medical Research Council; Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk; Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Agustinus foundation; Ib Henriksen foundation; Becket foundation; Finnish Academy [139900]; MRC [G0000934]; Wellcome Trust [068545/Z/02, 076113]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; National Institute of Child Health and Human Development; Juvenile Diabetes Research Foundation International (JDRF); Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres');  [U01 DK062418]; Lundbeck Foundation [R219-2016-471] Funding Source: researchfish; Medical Research Council [G0000934, MR/N01104X/1, G1001799] Funding Source: researchfish; MRC [MR/N01104X/1, G1001799] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062418] Funding Source: NIH RePORTER	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Centre for Evaluation and Health Technology Assessment; Novo Nordisk(Novo Nordisk); Copenhagen County; Danish Heart Foundation; Danish Pharmaceutical Association; Agustinus foundation; Ib Henriksen foundation; Becket foundation; Finnish Academy(Academy of Finland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Juvenile Diabetes Research Foundation International (JDRF)(Juvenile Diabetes Research Foundation); Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC); Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres')(National Institute for Health Research (NIHR)); ; Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was carried out as part of the research program Gene-Diet Interactions in Obesity (GENDINOB), supported by the Danish Council for Strategic Research (grant 09-067111). Data collection in the Inter99 study was supported economically by The Danish Medical Research Council, The Danish Centre for Evaluation and Health Technology Assessment, Novo Nordisk, Copenhagen County, The Danish Heart Foundation, The Danish Pharmaceutical Association, Agustinus foundation, Ib Henriksen foundation and Becket foundation. The NFBC1966 was support in part by the grants from the Finnish Academy project 139900. In 1958BC, DNA collection was funded by MRC grant G0000934 and cell-line creation by Wellcome Trust grant 068545/Z/02. This research used resources provided by the Type 1 Diabetes Genetics Consortium, a collaborative clinical study sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute of Allergy and Infectious Diseases, National Human Genome Research Institute, National Institute of Child Health and Human Development, and Juvenile Diabetes Research Foundation International (JDRF) and supported by U01 DK062418. This study makes use of data generated by the Wellcome Trust Case-Control Consortium. A full list of investigators who contributed to generation of the data is available from the Wellcome Trust Case-Control Consortium website. Funding for the project was provided by the Wellcome Trust under the award 076113. The work was supported by the Department of Health Policy Research Programme through the Public Health Research Consortium (PHRC). The views expressed in the publication are those of the authors and not necessarily those of the Department of Health. Information about the wider programme of the PHRC is available from http://phrc.lshtm.ac.uk. Great Ormond Street Hospital/University College London, Institute of Child Health receives a proportion of funding from the Department of Health's National Institute for Health Research (NIHR) ('Biomedical Research Centres' funding).	Aadahl M, 2009, PREV MED, V48, P326, DOI 10.1016/j.ypmed.2009.01.015; Ankarfeldt MZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110890; Bender AM, 2012, EUR J PREV CARD 1211; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; Beydoun MA, 2010, J CLIN ENDOCR METAB, V95, P3814, DOI 10.1210/jc.2010-0410; Cheng S, 2010, DIABETES, V59, P242, DOI 10.2337/db09-1011; Christakos S, 2013, ANN NY ACAD SCI, V1287, P45, DOI 10.1111/nyas.12129; Cotsapas C, 2009, HUM MOL GENET, V18, P3502, DOI 10.1093/hmg/ddp292; Dhurandhar NV, 2014, INT J OBES LOND, DOI 10.1038/ijo.2014.199; Earthman CP, 2012, INT J OBESITY, V36, P387, DOI 10.1038/ijo.2011.119; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gilbert-Diamond D, 2010, AM J CLIN NUTR, V92, P1446, DOI 10.3945/ajcn.2010.29746; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Grandi NC, 2010, PREV MED, V51, P228, DOI 10.1016/j.ypmed.2010.06.013; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Huotari A, 2008, INT J CIRCUMPOL HEAL, V67, P164, DOI 10.3402/ijch.v67i2-3.18258; Hypponen E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010801; Hypponen E, 2007, J CLIN ENDOCR METAB, V92, P4615, DOI 10.1210/jc.2007-1279; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kremer R, 2009, J CLIN ENDOCR METAB, V94, P67, DOI 10.1210/jc.2008-1575; Larsen SC, 2014, AM J CLIN NUTR; Larsen SC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-43; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Liu YJ, 2008, HUM MOL GENET, V17, P1803, DOI 10.1093/hmg/ddn072; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Lourenco BH, 2013, DIABETES; Mai XM, 2012, AM J EPIDEMIOL, V175, P1029, DOI 10.1093/aje/kwr456; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Mutt SJ, 2012, FASEB J, V26, P4400, DOI 10.1096/fj.12-210880; Pathak K, 2014, OBES REV; Pilz S, 2013, CURR DIABETES REP, V13, P261, DOI 10.1007/s11892-012-0358-4; Pilz S, 2013, ANTI-CANCER AGENT ME, V13, P107, DOI 10.2174/187152013804487407; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rukh G, 2015, INT J OBES LOND 0916; Sandholt CH, 2014, OBESITY, V22, P901, DOI 10.1002/oby.20540; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tammelin T, 2004, INT J OBESITY, V28, P775, DOI 10.1038/sj.ijo.0802622; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Vimaleswaran KS, 2014, BMC GENET, V15, DOI 10.1186/1471-2156-15-37; Vimaleswaran KS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001383; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Young KA, 2009, J CLIN ENDOCR METAB, V94, P3306, DOI 10.1210/jc.2009-0079	54	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153611	10.1371/journal.pone.0153611	http://dx.doi.org/10.1371/journal.pone.0153611			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077659	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000374131700094
J	Neiweem, AE; Bussel, II; Schuman, JS; Brown, EN; Loewen, NA				Neiweem, Ashley E.; Bussel, Igor I.; Schuman, Joel S.; Brown, Eric N.; Loewen, Nils A.			Glaucoma Surgery Calculator: Limited Additive Effect of Phacoemulsification on Intraocular Pressure in Ab Interno Trabeculectomy	PLOS ONE			English	Article							LENS IMPLANTATION; CATARACT-EXTRACTION; OUTFLOW FACILITY; RISK-FACTORS; REDUCTION; TRABECTOME; EYES	Purpose To compare intraocular pressure (IOP) reduction and to develop a predictive surgery calculator based on the results between trabectome-mediated ab interno trabeculectomy in pseudophakic patients versus phacoemulsification combined with trabectome-mediated ab interno trabeculectomy in phakic patients. Methods This observational surgical cohort study analyzed pseudophakic patients who received trabectome-mediated ab interno trabeculectomy (AIT) or phacoemulsification combined with AIT (phaco-AIT). Follow up for less than 12 months or neovascular glaucoma led to exclusion. Missing data was imputed by generating 5 similar but non-identical datasets. Groups were matched using Coarsened Exact Matching based on age, gender, type of glaucoma, race, preoperative number of glaucoma medications and baseline intraocular pressure (IOP). Linear regression was used to examine the outcome measures consisting of IOP and medications. Results Of 949 cases, 587 were included consisting of 235 AIT and 352 phaco-AIT. Baseline IOP between groups was statistically significant (p <= 0.01) in linear regression models and was minimized after Coarsened Exact Matching. An increment of 1 mmHg in baseline IOP was associated with a 0.73 +/- 0.03 mmHg IOP reduction. Phaco-AIT had an IOP reduction thatwas only 0.73 +/- 0.32 mmHg greater than that of AIT. The resulting calculator to determine IOP reduction consisted of the formula -13.54+0.73 x (phacoemulsification yes: 1, no: 0) + 0.73 x (baseline IOP) + 0.59 x (secondary open angle glaucoma yes: 1, no: 0) + 0.03 x (age) + 0.09 x (medications). Conclusions This predictive calculator for minimally invasive glaucoma surgery can assist clinical decision making. Only a small additional IOP reduction was observed when phacoemulsification was added to AIT. Patients with a higher baseline IOP had a greater IOP reduction.	[Neiweem, Ashley E.] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Chicago, IL USA; [Bussel, Igor I.; Schuman, Joel S.; Brown, Eric N.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Brown, Eric N.] Vanderbilt Univ, Sch Med, Dept Ophthalmol, Nashville, TN 37212 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	Loewen.nils@gmail.com	Schuman, Joel S/K-7304-2012; Schuman, Joel S/M-2389-2019; Loewen, Nils/E-9946-2014; Brown, Eric N/A-1018-2010	Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Loewen, Nils/0000-0001-7167-1213; Brown, Eric N/0000-0002-2641-1890	Research to Prevent Blindness Departmental Grant; Department of Ophthalmology, University of Pittsburgh	Research to Prevent Blindness Departmental Grant(Research to Prevent Blindness (RPB)); Department of Ophthalmology, University of Pittsburgh(University of Pittsburgh)	This work was supported by Research to Prevent Blindness Departmental Grant and Individual Grant from Department of Ophthalmology, University of Pittsburgh. The sponsor or funding organization had no role in the design or conduct of this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bussel II, 2015, BRIT J OPHTHALMOL, V99, P914, DOI 10.1136/bjophthalmol-2014-305577; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P258, DOI 10.1136/bjophthalmol-2013-304717; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1014, DOI 10.1136/bjo.2006.091447; Honaker J, 2011, J STAT SOFTW, V45, P1; Iacus SM, 2012, POLIT ANAL, V20, P1, DOI 10.1093/pan/mpr013; Iacus SM, 2011, J AM STAT ASSOC, V106, P345, DOI 10.1198/jasa.2011.tm09599; Iordanous Y, 2014, J GLAUCOMA, V23, pE112, DOI 10.1097/IJG.0b013e31829d9bc7; Jacobi PC, 2002, OPHTHALMOLOGY, V109, P1597, DOI 10.1016/S0161-6420(02)01123-5; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Kee C, 2000, BRIT J OPHTHALMOL, V84, P987, DOI 10.1136/bjo.84.9.987; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P653, DOI 10.1001/archopht.116.5.653; Loewen R, 2016, PLOS ONE IN PRESS; Mansberger SL, 2012, OPHTHALMOLOGY, V119, P1826, DOI 10.1016/j.ophtha.2012.02.050; Meyer MA, 1997, OPHTHALMOLOGY, V104, P1221, DOI 10.1016/S0161-6420(97)30154-7; Mosaed S, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001045; O'Brien PD, 2007, CAN J OPHTHALMOL, V42, P51, DOI 10.3129/canjophthalmol.06-086; Parikh HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149384; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; R Core Team, 2013, R LANG ENV STAT COMP; ROSENQUIST R, 1989, CURR EYE RES, V8, P1233, DOI 10.3109/02713688909013902; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Schuman JS, 1999, INVEST OPHTH VIS SCI, V40, P1676; Shazly TA, 2011, CLIN OPHTHALMOL, V5, P377, DOI 10.2147/OPTH.S17237; Shingleton BJ, 2006, J GLAUCOMA, V15, P494, DOI 10.1097/01.ijg.0000212294.31411.92; Slabaugh MA, 2014, J CATARACT REFR SURG, V40, P538, DOI 10.1016/j.jcrs.2013.08.048; Tham CCY, 2009, OPHTHALMOLOGY, V116, P725, DOI 10.1016/j.ophtha.2008.12.054; Wang N, 2003, INVEST OPHTH VIS SCI, V44, P1977, DOI 10.1167/iovs.02-0631; Weiner Y, 2015, J CATARACT REFR SURG, V41, P2081, DOI 10.1016/j.jcrs.2015.10.048; Yang HS, 2013, AM J OPHTHALMOL, V156, P89, DOI 10.1016/j.ajo.2013.02.003	29	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153585	10.1371/journal.pone.0153585	http://dx.doi.org/10.1371/journal.pone.0153585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077914	Green Published, gold, Green Accepted			2022-12-27	WOS:000374131700086
J	Okabe, H; Kinoshita, H; Imai, K; Nakagawa, S; Higashi, T; Arima, K; Uchiyama, H; Ikegami, T; Harimoto, N; Itoh, S; Ishiko, T; Yoshizumi, T; Beppu, T; Monga, SPS; Baba, H; Maehara, Y				Okabe, Hirohisa; Kinoshita, Hiroki; Imai, Katsunori; Nakagawa, Shigeki; Higashi, Takaaki; Arima, Kota; Uchiyama, Hideaki; Ikegami, Toru; Harimoto, Norifumi; Itoh, Shinji; Ishiko, Takatoshi; Yoshizumi, Tomoharu; Beppu, Toru; Monga, Satdarshan P. S.; Baba, Hideo; Maehara, Yoshihiko			Diverse Basis of beta-Catenin Activation in Human Hepatocellular Carcinoma: Implications in Biology and Prognosis	PLOS ONE			English	Article							MUTATIONS; GROWTH; CANCER; CELLS; LIVER; METABOLISM; PATHWAY; TARGETS; AXIN2; GENE	Aim beta-catenin signaling is a major oncogenic pathway in hepatocellular carcinoma (HCC). Since beta-catenin phosphorylation by glycogen synthase kinase 3 beta (GSK3 beta) and casein kinase 1 epsilon (CK1 epsilon) results in its degradation, mutations affecting these phosphorylation sites cause beta-catenin stabilization. However, the relevance of missense mutations in non-phosphorylation sites in exon 3 remains unclear. The current study explores significance of such mutations in addition to addressing the clinical and biological implications of beta-catenin activation in human HCC. Methods Gene alteration in exon3 of CTNNB1, gene expression of beta-catenin targets such as glutamate synthetase (GS), axin2, lect2 and regucalcin (RGN), and protein expression of beta-catenin were examined in 125 human HCC tissues. Results Sixteen patients (12.8%) showed conventional missense mutations affecting codons 33, 37, 41, and 45. Fifteen additional patients (12.0%) had other missense mutations in codon 32, 34, and 35. Induction of exon3 mutation caused described beta-catenin target gene upregulation in HCC cell line. Interestingly, conventional and non-phosphorylation site mutations were equally associated with upregulation of beta-catenin target genes. Nuclear localization of beta-catenin was associated with poor overall survival (p = 0.0461). Of these patients with nuclear beta-catenin localization, loss of described beta-catenin target gene upregulation showed significant poorer overall survival than others (p = 0.0001). Conclusion This study suggests that both conventional and other missense mutations in exon 3 of CTNNB1 lead to beta-catenin activation in human HCC. Additionally, the mechanism of nuclear beta-catenin localization without upregulation of described beta-catenin target genes might be of clinical importance depending on distinct mechanism.	[Okabe, Hirohisa; Kinoshita, Hiroki; Imai, Katsunori; Nakagawa, Shigeki; Higashi, Takaaki; Arima, Kota; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Beppu, Toru] Kumamoto Univ Hosp, Dept Multidisciplinary Treatment Gastroenterol Ca, Kumamoto, Japan; [Okabe, Hirohisa; Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Monga, Satdarshan P. S.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Uchiyama, Hideaki; Ikegami, Toru; Harimoto, Norifumi; Itoh, Shinji; Yoshizumi, Tomoharu; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Kumamoto University; Kumamoto University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kyushu University	Baba, H (corresponding author), Kumamoto Univ, Grad Sch Life Sci, Dept Surg Gastroenterol, Kumamoto, Japan.	hdobaba@kumamoto-u.ac.jp	Harimoto, Norifumi/AAF-6070-2020; Ikegami, Toru/GRI-9889-2022	Monga, Satdarshan/0000-0002-8437-3378				Audard V, 2007, J PATHOL, V212, P345, DOI 10.1002/path.2169; Austinat M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-21; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cadoret A, 2002, ONCOGENE, V21, P8293, DOI 10.1038/sj.onc.1206118; Cieply B, 2009, HEPATOLOGY, V49, P821, DOI 10.1002/hep.22695; Dal Bello B, 2010, CLIN CANCER RES, V16, P2157, DOI 10.1158/1078-0432.CCR-09-1978; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Hsu HC, 2000, AM J PATHOL, V157, P763, DOI 10.1016/S0002-9440(10)64590-7; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lachenmayer A, 2012, CLIN CANCER RES, V18, P4997, DOI 10.1158/1078-0432.CCR-11-2322; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Lehwald N, 2011, GASTROENTEROLOGY, V141, P707, DOI 10.1053/j.gastro.2011.04.051; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Okabe H, 2012, INT J CANCER, V131, P2234, DOI 10.1002/ijc.27496; Polakis P, 2012, EMBO J, V31, P2737, DOI 10.1038/emboj.2012.126; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; Taniguchi K, 2002, ONCOGENE, V21, P4863, DOI 10.1038/sj.onc.1205591; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Wei W, 2010, INT J CANCER, V126, P2426, DOI 10.1002/ijc.24810; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zeng G, 2006, NEOPLASIA, V8, P279, DOI 10.1593/neo.05607; Zhang XF, 2010, HEPATOLOGY, V52, P954, DOI 10.1002/hep.23747	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2016	11	4							e0152695	10.1371/journal.pone.0152695	http://dx.doi.org/10.1371/journal.pone.0152695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK4OR	27100093	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000374898500014
J	Bourrelly, A; McIntyre, J; Morio, C; Despretz, P; Luyat, M				Bourrelly, Aurore; McIntyre, Joseph; Morio, Cedric; Despretz, Pascal; Luyat, Marion			Perception of Affordance during Short-Term Exposure to Weightlessness in Parabolic Flight	PLOS ONE			English	Article							PERCEIVING AFFORDANCES; EYE HEIGHT; PROLONGED WEIGHTLESSNESS; VISUAL INFORMATION; SCALED INFORMATION; SYMMETRY DETECTION; REFERENCE FRAMES; SIZE PERCEPTION; MICROGRAVITY; ORIENTATION	We investigated the role of the visual eye-height (VEH) in the perception of affordance during short-term exposure to weightlessness. Sixteen participants were tested during parabolic flight (0g) and on the ground (1g). Participants looked at a laptop showing a room in which a doorway-like aperture was presented. They were asked to adjust the opening of the virtual doorway until it was perceived to be just wide enough to pass through (i. e., the critical aperture). We manipulated VEH by raising the level of the floor in the visual room by 25 cm. The results showed effects of VEH and of gravity on the perceived critical aperture. When VEH was reduced (i. e., when the floor was raised), the critical aperture diminished, suggesting that widths relative to the body were perceived to be larger. The critical aperture was also lower in 0g, for a given VEH, suggesting that participants perceived apertures to be wider or themselves to be smaller in weightlessness, as compared to normal gravity. However, weightlessness also had an effect on the subjective level of the eyes projected into the visual scene. Thus, setting the critical aperture as a fixed percentage of the subjective visual eye-height remains a viable hypothesis to explain how human observers judge visual scenes in terms of potential for action or "affordances".	[Bourrelly, Aurore; Luyat, Marion] Univ Lille, EA 4072, PSITEC Psychol Interact Temps Emot, F-59000 Lille, France; [McIntyre, Joseph] Univ Paris 05, CNRS, UMR 8119, CNPP, F-75270 Paris, France; [McIntyre, Joseph] Tecnalia Hlth Res Labs, E-20009 San Sebastian, Spain; [McIntyre, Joseph] IKERBASQUE Res Fdn, E-48013 Bilbao, Spain; [Morio, Cedric] Decatlhon SportsLab, F-59650 Villeneuve Dascq, France; [Despretz, Pascal] INSERM CIC IT 807, F-5900 Lille, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Basque Foundation for Science; Institut National de la Sante et de la Recherche Medicale (Inserm)	Bourrelly, A (corresponding author), Univ Lille, EA 4072, PSITEC Psychol Interact Temps Emot, F-59000 Lille, France.	aurore.bourrelly@hotmail.fr	Luyat, Marion/HIR-3502-2022; Morio, Cédric/B-8489-2011; McIntyre, Dr Joseph/K-6395-2015	Luyat, Marion/0000-0002-5640-5002; Morio, Cédric/0000-0002-7695-0315; McIntyre, Dr Joseph/0000-0003-4974-4257	Centre National d'Etudes Spatiale (CNES); Centre National pour la Recherche Scientifique (CNRS); University of Caen	Centre National d'Etudes Spatiale (CNES); Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University of Caen	Aurore Bourrelly was supported by a postdoctoral research fellowship from the Centre National d'Etudes Spatiale (CNES). The authors are grateful to the Centre National d'Etudes Spatiale (CNES) and the Centre National pour la Recherche Scientifique (CNRS) for the financial support of this study. They also wish to thank the many people at CNES/CADMOS, Novespace, ESA and the University of Caen who have supported this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benson AJ, 1990, PERCEPTION CONTROL S; Bertamini M, 1998, PERCEPT PSYCHOPHYS, V60, P673, DOI 10.3758/BF03206054; Bourrelly A, 2015, COGN PROCESS, V16, pS171, DOI 10.1007/s10339-015-0692-y; CARELLO C, 1989, Ecological Psychology, V1, P27, DOI 10.1207/s15326969eco0101_3; Cheron G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082371; CHEUNG BSK, 1990, EXP BRAIN RES, V81, P391; CLEMENT G, 1989, AVIAT SPACE ENVIR MD, V60, P1194; Clement G., 2005, FUNDAMENTALS SPACE M; Clement G, 2007, GRAVIT SPACE RES, V20, P1; Clement G, 2008, ACTA ASTRONAUT, V63, P828, DOI 10.1016/j.actaastro.2008.01.002; Clement G, 2007, NEUROSCI LETT, V413, P150, DOI 10.1016/j.neulet.2006.11.047; Clement G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132317; Clement Gilles, 2013, Life-Basel, V3, P524, DOI 10.3390/life3040524; Clement G, 2012, NEUROSCI LETT, V507, P143, DOI 10.1016/j.neulet.2011.12.006; Clement G, 2009, ACTA ASTRONAUT, V64, P678, DOI 10.1016/j.actaastro.2009.01.001; Clement G, 2008, NEUROSCI LETT, V447, P179, DOI 10.1016/j.neulet.2008.10.012; Coelho T, 2014, IFIP ADV INF COMM TE, V425, P3; Davis TJ, 2010, PERCEPTION, V39, P1624, DOI 10.1068/p6712; De Saedeleer C, 2013, EXP BRAIN RES, V226, P95, DOI 10.1007/s00221-013-3414-7; Dixon MW, 2000, J EXP PSYCHOL HUMAN, V26, P582, DOI 10.1037/0096-1523.26.2.582; EBENHOLTZ SM, 1975, VISION RES, V15, P713, DOI 10.1016/0042-6989(75)90291-6; Fajen BJ, 2003, ADAPT BEHAV, V11, P276, DOI 10.1177/1059712303114004; Fath AJ, 2011, PERCEPTION, V40, P887, DOI 10.1068/p6917; FRIEDERICI AD, 1990, PERCEPT PSYCHOPHYS, V47, P253, DOI 10.3758/BF03205000; Gibson J.J., 1986, ECOLOGICAL APPROACH; Glasauer S, 1998, BRAIN RES REV, V28, P185, DOI 10.1016/S0165-0173(98)00038-1; GORDON C, 1986, AVIAT SPACE ENVIR MD, V57, P236; Harris LR, 2011, PROG BRAIN RES, V191, P133, DOI 10.1016/B978-0-444-53752-2.00008-4; Holmes Nicholas P, 2004, Cogn Process, V5, P94, DOI 10.1007/s10339-004-0013-3; Howard IP., 1986, HDB HUMAN PERCEPTION, P1; Jenkin HL, 2005, ACTA ASTRONAUT, V56, P1025, DOI 10.1016/j.actaastro.2005.01.030; JIANG Y, 1994, PERCEPT PSYCHOPHYS, V56, P691, DOI 10.3758/BF03208362; Kim JI, 2000, J VESTIBUL RES-EQUIL, V10, P291; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; Leone G, 1998, BRAIN RES REV, V28, P203, DOI 10.1016/S0165-0173(98)00040-X; Leone G, 1995, ACTA ASTRONAUT, V36, P743, DOI 10.1016/0094-5765(95)00165-4; LEONE G, 1995, SPATIAL VISION, V9, P127, DOI 10.1163/156856895X00142; Leone G, 1998, ACTA ASTRONAUT, V42, P281, DOI 10.1016/S0094-5765(98)00125-8; Lepecq JC, 2009, VIRTUAL REAL-LONDON, V13, P141, DOI 10.1007/s10055-009-0118-1; Lipshits M, 2005, PERCEPTION, V34, P545, DOI 10.1068/p5358; Luyat M, 2009, ANN PSYCHOL, V109, P297; Makowski AL, 2011, AVIAT SPACE ENVIR MD, V82, P683, DOI 10.3357/ASEM.2750.2011; Marcilly R., 2008, CURRENT PSYCHOL LETT, V24, P12; MARK LS, 1987, J EXP PSYCHOL HUMAN, V13, P361, DOI 10.1037/0096-1523.13.3.361; Massion J, 1997, EXP BRAIN RES, V114, P384, DOI 10.1007/PL00005647; MATIN L, 1995, J VESTIBUL RES-EQUIL, V5, P499, DOI 10.1016/0957-4271(95)02003-B; Michaels C.F., 1981, DIRECT PERCEPTION; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Oman CM, 2006, SPATIAL PROCESSING N, V2006, P1; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Ramenzoni VC, 2008, COGNITION, V106, P1059, DOI 10.1016/j.cognition.2007.04.008; Rand KM, 2011, PERCEPTION, V40, P143, DOI 10.1068/p6843; Regia-Corte T, 2013, VIRTUAL REAL-LONDON, V17, P17, DOI 10.1007/s10055-012-0216-3; Russomano T, 2005, SCI MED, V15, P124; Sedgwick H. A., 1980, PERCEPTION PICTURES, V1, P33; STOPER AE, 1989, PERCEPT PSYCHOPHYS, V46, P469, DOI 10.3758/BF03210862; Viel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010259; Villard E, 2005, NEUROREPORT, V16, P1395, DOI 10.1097/01.wnr.0000174060.34274.3e; Warren W.H., 2007, CLOSING GAP SCI WRIT, P253; WARREN WH, 1984, J EXP PSYCHOL HUMAN, V10, P683, DOI 10.1037/0096-1523.10.5.683; WARREN WH, 1987, J EXP PSYCHOL HUMAN, V13, P371, DOI 10.1037/0096-1523.13.3.371; White E, 2005, PERCEIVING PASS UNDE; Wraga M, 1999, J EXP PSYCHOL HUMAN, V25, P518, DOI 10.1037/0096-1523.25.2.518; Wraga M, 1999, PERCEPT PSYCHOPHYS, V61, P490, DOI 10.3758/BF03211968; YOUNG LR, 1986, EXP BRAIN RES, V64, P291	65	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153598	10.1371/journal.pone.0153598	http://dx.doi.org/10.1371/journal.pone.0153598			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27097218	Green Submitted, Green Published, gold			2022-12-27	WOS:000374543600045
J	Cassidy, AA; Saulnier, RJ; Lamarre, SG				Cassidy, Alicia A.; Saulnier, Roxanne J.; Lamarre, Simon G.			Adjustments of Protein Metabolism in Fasting Arctic Charr, Salvelinus alpinus	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; PROTEASOME-DEPENDENT PROTEOLYSIS; WOLFFISH ANARHICHAS-MINOR; EUROPEAN SEA BASS; RAINBOW-TROUT; FOOD-DEPRIVATION; 20S PROTEASOME; DICENTRARCHUS-LABRAX; SPAWNING MIGRATION; LOW-TEMPERATURE	Protein metabolism, including the interrelated processes of synthesis and degradation, mediates the growth of an animal. In ectothermic animals, protein metabolism is responsive to changes in both biotic and abiotic conditions. This study aimed to characterise responses of protein metabolism to food deprivation that occur in the coldwater salmonid, Arctic charr, Salvelinus alpinus. We compared two groups of Arctic charr: one fed continuously and the other deprived of food for 36 days. We measured the fractional rate of protein synthesis (K-S) in individuals from the fed and fasted groups using a flooding dose technique modified for the use of deuterium-labelled phenylalanine. The enzyme activities of the three major protein degradation pathways (ubiquitin proteasome, lysosomal cathepsins and the calpain systems) were measured in the same fish. This study is the first to measure both K-S and the enzymatic activity of protein degradation in the same fish, allowing us to examine the apparent contribution of different protein degradation pathways to protein turnover in various tissues (red and white muscle, liver, heart and gills). K-S was lower in the white muscle and in liver of the fasted fish compared to the fed fish. There were no observable effects of food deprivation on the protease activities in any of the tissues with the exception of liver, where the ubiquitin proteasome pathway seemed to be activated during fasting conditions. Lysosomal proteolysis appears to be the primary degradation pathway for muscle protein, while the ubiquitin proteasome pathway seems to predominate in the liver. We speculate that Arctic charr regulate protein metabolism during food deprivation to conserve proteins.	[Cassidy, Alicia A.; Saulnier, Roxanne J.; Lamarre, Simon G.] Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada	University of Moncton	Lamarre, SG (corresponding author), Univ Moncton, Dept Biol, Moncton, NB E1A 3E9, Canada.	simon.lamare@umoncton.ca	Lamarre, Simon/A-5674-2008	Lamarre, Simon/0000-0001-7038-4626	Natural Sciences and Engineering Research Council of Canada [435638-2013]; NSERC; Universite de Moncton; Natural Sciences and Engineering Research Council of Canada (NSERC) [435638-2013]; NSERC Canada; New Brunswick Innovation Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Universite de Moncton; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); New Brunswick Innovation Fund	This work was supported by the Natural Sciences and Engineering Research Council of Canada [435638-2013 to SGL]. AAC was supported by a postgraduate scholarship from NSERC and Universite de Moncton.; The authors are grateful to Andre Dumas and Claude Pelletier at the Coastal Zones Research Institute (Shippagan, NB, Canada) for providing the fish and to Dr Joy Stacey for the English revision of the manuscript. This research was funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grant to SGL [435638-2013], a NSERC Canada Graduate Scholarships-Master's grant to AAC and various grants from the New Brunswick Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar N., 2012, CHAPTER6 COMP PHYSL, DOI [10.1007/978-3-642-29056-5_6, DOI 10.1007/978-3-642-29056-5_6]; BLASCO J, 1992, J COMP PHYSIOL B, V162, P539; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caloin M, 2004, AM J PHYSIOL-ENDOC M, V287, pE790, DOI 10.1152/ajpendo.00414.2003; CARTER CG, 1994, J EXP BIOL, V189, P279; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; Cleveland BM, 2009, AM J PHYSIOL-REG I, V297, pR1332, DOI 10.1152/ajpregu.00272.2009; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Fraser KPP, 2007, ADV MAR BIOL, V52, P267, DOI 10.1016/S0065-2881(06)52003-6; Frick NT, 2008, COMP BIOCHEM PHYS A, V151, P85, DOI 10.1016/j.cbpa.2008.06.003; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Guderley H, 2003, COMP BIOCHEM PHYS A, V135, P347, DOI 10.1016/S1095-6433(03)00089-8; HERSHKO A, 1985, BIOCHEM BIOPH RES CO, V128, P1079, DOI 10.1016/0006-291X(85)91050-2; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; Houlihan D. F., 1991, ADV COMP ENV PHYSL, P1; HOULIHAN DF, 1988, CAN J FISH AQUAT SCI, V45, P951, DOI 10.1139/f88-117; HOULIHAN DF, 1986, PHYSIOL ZOOL, V59, P482, DOI 10.1086/physzool.59.4.30158601; HOULIHAN DF, 1989, AQUACULTURE, V79, P103, DOI 10.1016/0044-8486(89)90450-X; ILIAN MA, 1992, BIOCHEM J, V287, P163, DOI 10.1042/bj2870163; Johnston IA, 2011, J EXP BIOL, V214, P1617, DOI 10.1242/jeb.038620; Jorgensen EH, 2014, MAR GENOM, V14, P71, DOI 10.1016/j.margen.2013.10.005; Jorgensen EH, 2013, J EXP BIOL, V216, P3222, DOI 10.1242/jeb.088344; Khalilieh A, 2012, AM J PHYSIOL-REG I, V303, pR551, DOI 10.1152/ajpregu.00076.2012; Ladrat C, 2000, COMP BIOCHEM PHYS B, V125, P83, DOI 10.1016/S0305-0491(99)00157-1; Lamarre SG, 2015, COMP BIOCHEM PHYS B, V182, P1, DOI 10.1016/j.cbpb.2014.11.006; Lamarre SG, 2010, J FISH BIOL, V76, P1565, DOI 10.1111/j.1095-8649.2010.02581.x; Lamarre SG, 2012, AM J PHYSIOL-REG I, V303, pR427, DOI 10.1152/ajpregu.00077.2012; Lamarre SG, 2009, J EXP BIOL, V212, P1294, DOI 10.1242/jeb.028290; Lyndon AR, 1998, COMP BIOCHEM PHYS A, V119, P27, DOI 10.1016/S1095-6433(97)00409-1; Martin SAM, 2002, PFLUG ARCH EUR J PHY, V445, P257, DOI 10.1007/s00424-002-0916-8; Martin SAM, 2001, FISH PHYSIOL BIOCHEM, V24, P259, DOI 10.1023/A:1014015530045; McCue MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140053; McCue MD, 2010, COMP BIOCHEM PHYS A, V156, P1, DOI 10.1016/j.cbpa.2010.01.002; McKenzie DJ, 2014, J EXP BIOL, V217, P3283, DOI 10.1242/jeb.101857; MCMILLAN DN, 1988, PHYSIOL ZOOL, V61, P429, DOI 10.1086/physzool.61.5.30161265; MIGLAVS I, 1989, J FISH BIOL, V35, P1, DOI 10.1111/j.1095-8649.1989.tb03387.x; MOMMSEN TP, 1980, CAN J ZOOL, V58, P1785, DOI 10.1139/z80-246; Mommsen TP, 2004, COMP BIOCHEM PHYS B, V139, P383, DOI 10.1016/j.cbpc.2004.09.018; Mommsen TP, 2001, COMP BIOCHEM PHYS B, V129, P207, DOI 10.1016/S1096-4959(01)00312-8; MOON TW, 1983, CAN J ZOOL, V61, P802, DOI 10.1139/z83-106; Prinsen BHCMT, 2004, CLIN CHIM ACTA, V347, P1, DOI 10.1016/j.cccn.2004.04.005; Salem M, 2005, COMP BIOCHEM PHYS B, V140, P63, DOI 10.1016/j.cbpc.2004.09.007; Salem M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-328; Salmeron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075349; Seiliez I, 2008, J NUTR, V138, P487, DOI 10.1093/jn/138.3.487; Seiliez I, 2014, AM J PHYSIOL-REG I, V307, pR1330, DOI 10.1152/ajpregu.00370.2014; Seiliez I, 2013, ZEBRAFISH, V10, P237, DOI 10.1089/zeb.2012.0835; SHIBATANI T, 1995, ARCH BIOCHEM BIOPHYS, V321, P160, DOI 10.1006/abbi.1995.1381; Simon O., 1989, PROTEIN METABOLISM F, P273; Taylor RG, 1997, J MUSCLE RES CELL M, V18, P285, DOI 10.1023/A:1018665924412; Thompson VF, 2000, ANAL BIOCHEM, V279, P170, DOI 10.1006/abio.1999.4475; TOYOHARA H, 1989, COMP BIOCHEM PHYS B, V92, P577, DOI 10.1016/0305-0491(89)90134-X; Vijayan MM, 2006, TOXICOL SCI, V91, P431, DOI 10.1093/toxsci/kfj154; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; Wright, 1995, NITROGEN METABOLISM	56	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153364	10.1371/journal.pone.0153364	http://dx.doi.org/10.1371/journal.pone.0153364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096948	gold, Green Published			2022-12-27	WOS:000374543600034
J	Ozmen, O; Pullum, LL; Ramanathan, A; Nutaro, JJ				Ozmen, Ozgur; Pullum, Laura L.; Ramanathan, Arvind; Nutaro, James J.			Augmenting Epidemiological Models with Point-Of-Care Diagnostics Data	PLOS ONE			English	Article								Although adoption of newer Point-of-Care (POC) diagnostics is increasing, there is a significant challenge using POC diagnostics data to improve epidemiological models. In this work, we propose a method to process zip-code level POC datasets and apply these processed data to calibrate an epidemiological model. We specifically develop a calibration algorithm using simulated annealing and calibrate a parsimonious equation-based model of modified Susceptible-Infected-Recovered (SIR) dynamics. The results show that parsimonious models are remarkably effective in predicting the dynamics observed in the number of infected patients and our calibration algorithm is sufficiently capable of predicting peak loads observed in POC diagnostics data while staying within reasonable and empirical parameter ranges reported in the literature. Additionally, we explore the future use of the calibrated values by testing the correlation between peak load and population density from Census data. Our results show that linearity assumptions for the relationships among various factors can be misleading, therefore further data sources and analysis are needed to identify relationships between additional parameters and existing calibrated ones. Calibration approaches such as ours can determine the values of newly added parameters along with existing ones and enable policy-makers to make better multi-scale decisions.	[Pullum, Laura L.; Nutaro, James J.] Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA; [Ozmen, Ozgur; Ramanathan, Arvind] Oak Ridge Natl Lab, Hlth Data Sci Inst, Oak Ridge, TN USA; [Pullum, Laura L.] One Bethel Valley Rd,POB 2008, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory	Pullum, LL (corresponding author), Oak Ridge Natl Lab, Computat Sci & Engn Div, Oak Ridge, TN USA.; Pullum, LL (corresponding author), One Bethel Valley Rd,POB 2008, Oak Ridge, TN 37831 USA.	pullumll@ornl.gov		Pullum, Laura/0000-0001-6045-7668; Ramanathan, Arvind/0000-0002-1622-5488; Nutaro, James/0000-0001-7360-2836	DTRA (Defense Threat Reduction Agency) [2216-V387-11]; ORNL (Oak Ridge National Laboratory) [7280]; U.S. Department of Energy [DE-AC05-00OR22725]	DTRA (Defense Threat Reduction Agency)(United States Department of DefenseDefense Threat Reduction Agency); ORNL (Oak Ridge National Laboratory); U.S. Department of Energy(United States Department of Energy (DOE))	DTRA (Defense Threat Reduction Agency, contract no: 2216-V387-11) and ORNL (Oak Ridge National Laboratory, SEED project 7280) are the sources of funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank IMS Health Government Solutions, the Texas Department of Public Health, and the Knox County Public Health Department for the data used in this study. Data (used as part of this paper) can be requested through IMS Health Institute, the Texas Department of Public Health, and the Knox County Public Health Department. This manuscript has been authored by UT-Battelle, LLC under Contract No. DE-AC05-00OR22725 with the U.S. Department of Energy. The United States Government retains and the publisher, by accepting the article for publication, acknowledges that the United States Government retains a nonexclusive, paid-up, irrevocable, world-wide license to publish or reproduce the published form of this manuscript, or allow others to do so, for United States Government purposes. The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).	Breban R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000282; Clark M., 2013, GEN ADDITIVE MODELS; Dreo J., 2005, METAHEURISTICS HARD; EGLESE RW, 1990, EUR J OPER RES, V46, P271, DOI 10.1016/0377-2217(90)90001-R; Gog JR, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003635; Grubesic Tony H, 2006, Int J Health Geogr, V5, P58, DOI 10.1186/1476-072X-5-58; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Keeling M.J., 2011, MODELING INFECT DIS, DOI 10.1111/j.1541-0420.2008.01082-_}7.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Nutaro J.J., 2010, BUILDING SOFTWARE SI; Pullum LL, 2012, 2012 ASE INTERNATIONAL CONFERENCE ON BIOMEDICAL COMPUTING (BIOMEDCOM), P62, DOI 10.1109/BioMedCom.2012.17; Pullum LL, 2014, VERIFICATION VALIDAT; van Boven M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011442; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153769	10.1371/journal.pone.0153769	http://dx.doi.org/10.1371/journal.pone.0153769			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ9OU	27096162	gold, Green Published			2022-12-27	WOS:000374543600054
J	Vedhara, K; Dawe, K; Miles, JNV; Wetherell, MA; Cullum, N; Dayan, C; Drake, N; Price, P; Tarlton, J; Weinman, J; Day, A; Campbell, R; Reps, J; Soria, D				Vedhara, Kavita; Dawe, Karen; Miles, Jeremy N. V.; Wetherell, Mark A.; Cullum, Nicky; Dayan, Colin; Drake, Nicola; Price, Patricia; Tarlton, John; Weinman, John; Day, Andrew; Campbell, Rona; Reps, Jenna; Soria, Daniele			Illness Beliefs Predict Mortality in Patients with Diabetic Foot Ulcers	PLOS ONE			English	Article							GLYCEMIC CONTROL; DEPRESSION; PERCEPTION; SURVIVAL; ASSOCIATION; METAANALYSIS; OUTCOMES; COHORT; 1ST	Background Patients' illness beliefs have been associated with glycaemic control in diabetes and survival in other conditions. Objective We examined whether illness beliefs independently predicted survival in patients with diabetes and foot ulceration. Methods Patients (n = 169) were recruited between 2002 and 2007. Data on illness beliefs were collected at baseline. Data on survival were extracted on 1st November 2011. Number of days survived reflected the number of days from date of recruitment to 1st November 2011. Results Cox regressions examined the predictors of time to death and identified ischemia and identity beliefs (beliefs regarding symptoms associated with foot ulceration) as significant predictors of time to death. Conclusions Our data indicate that illness beliefs have a significant independent effect on survival in patients with diabetes and foot ulceration. These findings suggest that illness beliefs could improve our understanding of mortality risk in this patient group and could also be the basis for future therapeutic interventions to improve survival.	[Vedhara, Kavita] Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England; [Dawe, Karen; Campbell, Rona] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Miles, Jeremy N. V.] RAND Corp, Santa Monica, CA 90401 USA; [Wetherell, Mark A.] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Cullum, Nicky] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester M13 9PL, Lancs, England; [Dayan, Colin] Cardiff Univ, Inst Mol & Expt Med, Cardiff CF14 4XN, S Glam, Wales; [Drake, Nicola] Southmead Gen Hosp, Dept Podiatry, Bristol BS10 5NB, Avon, England; [Price, Patricia] Cardiff Univ, Sch Healthcare Studies, Cardiff CF14 4XN, S Glam, Wales; [Tarlton, John] Univ Bristol, Matrix Biol Res Grp, Bristol BS40 5DU, Avon, England; [Weinman, John] Kings Coll London, Inst Pharmaceut Sci, London SE1 9RT, England; [Day, Andrew] Univ Hosp Bristol, Dept Clin Biochem, Bristol BS1 3NU, Avon, England; [Reps, Jenna; Soria, Daniele] Univ Nottingham, Sch Comp Sci, Nottingham NG8 1BB, England; [Reps, Jenna; Soria, Daniele] Univ Nottingham, Adv Data Anal Ctr, Nottingham NG8 1BB, England	University of Nottingham; University of Bristol; RAND Corporation; Northumbria University; University of Manchester; Cardiff University; Southmead Hospital; Cardiff University; University of Bristol; University of London; King's College London; University of Bristol; University of Nottingham; University of Nottingham	Vedhara, K (corresponding author), Univ Nottingham, Div Primary Care, Nottingham NG7 2RD, England.	kavita.vedhara@nottingham.ac.uk	Cullum, Nicky/AAT-5888-2020; Cullum, Nicky A/F-2438-2011; Dayan, Colin/AAH-6242-2019	Cullum, Nicky/0000-0003-2631-123X; Cullum, Nicky A/0000-0003-2631-123X; Dayan, Colin/0000-0002-6557-3462; Wetherell, Mark/0000-0002-1026-2798; Dawe, Karen/0000-0003-2173-9851; Vedhara, Kavita/0000-0002-9940-7534; Weinman, John Alfred/0000-0002-6786-0166; Soria, Daniele/0000-0002-0164-8218; Tarlton, John/0000-0002-4886-6634	Medical Research Council, UK [MC_U145079313]; RAND Corporation; MRC [G0800047, MC_U145079313] Funding Source: UKRI; Medical Research Council [G0800047, MC_U145079313] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10111, NF-SI-0512-10028] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); RAND Corporation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The present study was funded by a programme grant from the Medical Research Council, UK (MC_U145079313). JNVM receives salary support from the RAND Corporation. This funder provided support in the form of salaries for the author (JNVM), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Alam R, 2009, PATIENT EDUC COUNS, V75, P25, DOI 10.1016/j.pec.2008.08.026; Baker N, 2005, DIABETIC FOOT, V8, P58; Batista GEAPA., 2002, SER FRONT ARTIF INTE, V87, P48; Beattie AM, 2014, HEALTH EXPECT, V17, P429, DOI 10.1111/j.1369-7625.2012.00768.x; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Broadbent E, 2015, PSYCHOL HEALTH, V30, P1361, DOI 10.1080/08870446.2015.1070851; Broadbent E, 2009, J PSYCHOSOM RES, V67, P17, DOI 10.1016/j.jpsychores.2008.12.001; Broadbent E, 2009, J PSYCHOSOM RES, V67, P11, DOI 10.1016/j.jpsychores.2008.11.006; Chen SL, 2011, INT J NURS STUD, V48, P235, DOI 10.1016/j.ijnurstu.2010.07.005; Chilcot J, 2011, AM J NEPHROL, V33, P358, DOI 10.1159/000326752; Crawshaw J, 2015, ANN BEHAV MED, V49, P769, DOI 10.1007/s12160-015-9695-2; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; French DP, 2006, J PSYCHOSOM RES, V61, P757, DOI 10.1016/j.jpsychores.2006.07.029; Gonzalez JS, 2010, DIABETOLOGIA, V53, P2241, DOI 10.1007/s00125-010-1821-x; Gonzalez JS, 2008, DIABETES CARE, V31, P2398, DOI 10.2337/dc08-1341; Hampson SE, 2000, BRIT J HEALTH PSYCH, V5, P27, DOI 10.1348/135910700168748; Ismail K, 2004, LANCET, V363, P1589, DOI 10.1016/S0140-6736(04)16202-8; Iversen MM, 2009, DIABETES CARE, V32, P2193, DOI 10.2337/dc09-0651; Jones CJ, 2015, J HLTH PSYCHOL; Leventhal H, 1984, HDB PSYCHOL HLTH, P219; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lustman PJ, 2000, DIABETES CARE, V23, P934, DOI 10.2337/diacare.23.7.934; Maindonald J, 2010, DATA ANAL GRAPHICS U; Markowitz SM, 2011, PSYCHOSOMATICS, V52, P1, DOI 10.1016/j.psym.2010.11.007; Mc Sharry J, 2011, DIABETIC MED, V28, P1300, DOI 10.1111/j.1464-5491.2011.03298.x; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Parfeni M, 2013, NEPHROL DIAL TRANSPL, V28, P2407, DOI 10.1093/ndt/gft194; Petrie KJ, 2012, BRIT J HEALTH PSYCH, V17, P74, DOI 10.1111/j.2044-8287.2011.02033.x; Rubin DB, 2004, MULTIPLE IMPUTATION; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Takahashi PY, 2009, OSTOMY WOUND MANAG, V55, P32; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; van Dijk S, 2009, NEPHROL DIAL TRANSPL, V24, P3183, DOI 10.1093/ndt/gfp184; Vedhara K, 2012, BEHAV RES THER, V50, P323, DOI 10.1016/j.brat.2012.02.013; Vedhara K, 2010, DIABETOLOGIA, V53, P1590, DOI 10.1007/s00125-010-1743-7; Vedhara K, 2014, DIABETES RES CLIN PR, V106, P67, DOI 10.1016/j.diabres.2014.07.018; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Winkley K, 2012, DIABETOLOGIA, V55, P303, DOI 10.1007/s00125-011-2359-2; Winkley K, 2007, J DIABETES COMPLICAT, V21, P341, DOI 10.1016/j.jdiacomp.2007.09.004; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	41	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2016	11	4							e0153315	10.1371/journal.pone.0153315	http://dx.doi.org/10.1371/journal.pone.0153315			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ9OU	27096609	Green Published, Green Accepted, gold			2022-12-27	WOS:000374543600032
J	Fukuma, M; Ganmyo, Y; Miura, O; Ohyama, T; Shimizu, N				Fukuma, Miki; Ganmyo, Yuto; Miura, Osamu; Ohyama, Takashi; Shimizu, Noriaki			Cloning and Characterization of a Human Genomic Sequence that Alleviates Repeat-Induced Gene Silencing	PLOS ONE			English	Article							REPLICATION INITIATION REGION; MATRIX ATTACHMENT REGIONS; MAMMALIAN-CELLS; TRANSGENE EXPRESSION; DNA; AMPLIFICATION; SITES; IDENTIFICATION; PLASMIDS; ELEMENTS	Plasmids bearing a mammalian replication initiation region (IR) and a nuclear matrix attachment region (MAR) are spontaneously amplified in transfected mammalian cells, and such amplification generates chromosomal homogeneously staining regions (HSRs) or extrachromosomal double minutes (DMs). This method provides a novel, efficient, and rapid way to establish cells that stably produce high levels of recombinant proteins. However, because IR/MAR plasmids are amplified as repeats, they are frequently targeted by repeat-induced gene silencing (RIGS), which silences a variety of repeated sequences in transgenes and the genome. To address this problem, we developed a novel screening system using the IR/MAR plasmid to isolate human genome sequences that alleviate RIGS. The screen identified a 3,271 bp sequence (B-3-31) that elevated transgene expression without affecting the amplification process. Neither non-B structure (i.e., the inverted repeats or bending) nor known epigenetic modifier elements such as MARs, insulators, UCOEs, or STARs could explain the anti-silencing activity of B-3-31. Instead, the activity was distributed throughout the entire B-3-31 sequence, which was extremely A/T-rich and CpG-poor. Because B-3-31 effectively and reproducibly alleviated RIGS of repeated genes, it could be used to increase recombinant protein production.	[Fukuma, Miki; Ganmyo, Yuto; Shimizu, Noriaki] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan; [Miura, Osamu; Ohyama, Takashi] Waseda Univ, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo, Japan	Hiroshima University; Waseda University	Shimizu, N (corresponding author), Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan.	shimizu@hiroshima-u.ac.jp			Japan Society for the Promotion of Science [23380203, 24658290, 26660293]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research (B) (23380203) and a Grant-in-Aid for Challenging Exploratory Research (24658290, 26660293), both from the Japan Society for the Promotion of Science (to NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Almeida R, 2005, TRENDS CELL BIOL, V15, P251, DOI 10.1016/j.tcb.2005.03.006; Araki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041787; Bansal M, 2014, CURR OPIN STRUC BIOL, V25, P77, DOI 10.1016/j.sbi.2014.01.007; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Dlakic M, 1998, BIOINFORMATICS, V14, P326, DOI 10.1093/bioinformatics/14.4.326; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; Geiger T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001090; GOUGH GW, 1986, EMBO J, V5, P191, DOI 10.1002/j.1460-2075.1986.tb04195.x; Harada S, 2011, NUCLEIC ACIDS RES, V39, P958, DOI 10.1093/nar/gkq882; Harada S, 2009, J BIOL CHEM, V284, P24320, DOI 10.1074/jbc.M109.008128; Harraghy N, 2011, J BIOTECHNOL, V154, P11, DOI 10.1016/j.jbiotec.2011.04.004; Hashizume T, 2007, J CELL BIOCHEM, V101, P552, DOI 10.1002/jcb.21210; Hyman E, 2002, CANCER RES, V62, P6240; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kobayashi T, 1998, BIOCHEM MOL BIOL INT, V44, P683; Kwaks THJ, 2003, NAT BIOTECHNOL, V21, P553, DOI 10.1038/nbt814; Majocchi S, 2014, NUCLEIC ACIDS RES, V42, P193, DOI 10.1093/nar/gkt880; Mariati, 2014, BIOENGINEERED, V5, P340, DOI 10.4161/bioe.32111; McBurney MW, 2002, EXP CELL RES, V274, P1, DOI 10.1006/excr.2001.5443; Mondello C, 2010, MUTAT RES-REV MUTAT, V704, P29, DOI 10.1016/j.mrrev.2010.01.008; MULLER UR, 1987, J BIOL CHEM, V262, P3730; Narayanan V, 2006, CELL, V125, P1283, DOI 10.1016/j.cell.2006.04.042; Noguchi C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052990; Ohyama T., 2005, DNA CONFORMATION TRA; Okada N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077350; Rudan MV, 2015, TRENDS GENET, V31, P651, DOI 10.1016/j.tig.2015.09.004; Saunders F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120096; Shimizu N, 2005, EXP CELL RES, V302, P233, DOI 10.1016/j.yexcr.2004.09.001; Shimizu N, 2004, J CELL SCI, V117, P5303, DOI 10.1242/jcs.01414; Shimizu N, 2003, CANCER RES, V63, P5281; Shimizu N, 2001, CANCER RES, V61, P6987; Shimizu N, 2007, J CELL BIOCHEM, V102, P515, DOI 10.1002/jcb.21313; Sumida N, 2006, FEBS J, V273, P5691, DOI 10.1111/j.1742-4658.2006.05557.x; Tanaka H, 2005, NAT GENET, V37, P320, DOI 10.1038/ng1515; Tanaka SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103439; Utani K, 2009, NUCLEIC ACIDS RES, V37, P393, DOI 10.1093/nar/gkn970; WAHL GM, 1989, CANCER RES, V49, P1333; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Williams S, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-17; Xiao S, 2014, CURR OPIN STRUC BIOL, V26, P32, DOI 10.1016/j.sbi.2014.03.005; Yoshimura H, 2011, PROTEIN EXPRES PURIF, V80, P41, DOI 10.1016/j.pep.2011.05.009; Yusufzai TM, 2004, P NATL ACAD SCI USA, V101, P8620, DOI 10.1073/pnas.0402938101; Zhang JH, 2014, BIOTECHNOL LETT, V36, P1937, DOI 10.1007/s10529-014-1563-9	47	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153338	10.1371/journal.pone.0153338	http://dx.doi.org/10.1371/journal.pone.0153338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078685	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700040
J	Kumar, J; Barhydt, T; Awasthi, A; Lithgow, GJ; Killilea, DW; Kapahi, P				Kumar, Jitendra; Barhydt, Tracy; Awasthi, Anjali; Lithgow, Gordon J.; Killilea, David W.; Kapahi, Pankaj			Zinc Levels Modulate Lifespan through Multiple Longevity Pathways in Caenorhabditis elegans	PLOS ONE			English	Article							PROTEIN HOMEOSTASIS; BEHAVIORAL DEFECTS; METALLOTHIONEIN; GENES; DAF-16; MUTATIONS; TOXICITY; KINASE; IDENTIFICATION; TRANSPORTERS	Zinc is an essential trace metal that has integral roles in numerous biological processes, including enzymatic function, protein structure, and cell signaling pathways. Both excess and deficiency of zinc can lead to detrimental effects on development and metabolism, resulting in abnormalities and disease. We altered the zinc balance within Caenorhabditis elegans to examine how changes in zinc burden affect longevity and healthspan in an invertebrate animal model. We found that increasing zinc levels in vivo with excess dietary zinc supplementation decreased the mean and maximum lifespan, whereas reducing zinc levels in vivo with a zinc-selective chelator increased the mean and maximum lifespan in C. elegans. We determined that the lifespan shortening effects of excess zinc required expression of DAF-16, HSF-1 and SKN-1 proteins, whereas the lifespan lengthening effects of the reduced zinc may be partially dependent upon this set of proteins. Furthermore, reducing zinc levels led to greater nuclear localization of DAF-16 and enhanced dauer formation compared to controls, suggesting that the lifespan effects of zinc are mediated in part by the insulin/IGF-1 pathway. Additionally, zinc status correlated with several markers of healthspan in worms, including proteostasis, locomotion and thermotolerance, with reduced zinc levels always associated with improvements in function. Taken together, these data support a role for zinc in regulating both development and lifespan in C. elegans, and that suggest that regulation of zinc homeostasis in the worm may be an example of antagonistic pleiotropy.	[Kumar, Jitendra; Barhydt, Tracy; Lithgow, Gordon J.; Kapahi, Pankaj] Buck Inst Res Aging, Novato, CA USA; [Awasthi, Anjali] Birla Inst Technol & Sci, Dept Biol Sci, Pilani, Rajasthan, India; [Killilea, David W.] Childrens Hosp Oakland, Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA; [Kumar, Jitendra] Univ Patna, Dept Bot Biotechnol, DBT PU IPLS Programme, Patna 800005, Bihar, India	Buck Institute for Research on Aging; Birla Institute of Technology & Science Pilani (BITS Pilani); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Patna University	Kumar, J; Kapahi, P (corresponding author), Buck Inst Res Aging, Novato, CA USA.; Killilea, DW (corresponding author), Childrens Hosp Oakland, Res Inst, Nutr & Metab Ctr, Oakland, CA 94609 USA.; Kumar, J (corresponding author), Univ Patna, Dept Bot Biotechnol, DBT PU IPLS Programme, Patna 800005, Bihar, India.	jitendratifr@gmail.com; dkillilea@chori.org; pkapahi@buckinstitute.org		Killilea, David/0000-0002-8929-6527	American Foundation for Aging Research Mid-Career Award; NIH/NIA [AG045835, AG038688]; DBT-PU-IPLS Programme, Govt. of India; DST [SB/YS/LS-166/2014]; NATIONAL INSTITUTE ON AGING [R56AG038688, R01AG045835, R01AG038688, R01AG029631] Funding Source: NIH RePORTER	American Foundation for Aging Research Mid-Career Award; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); DBT-PU-IPLS Programme, Govt. of India; DST(Department of Science & Technology (India)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, the authors thank DBT-PU-IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the members of the Kapahi and Lithgow labs for helpful advice and critical discussion. We thank Tai Holland from the CHORI Elemental Analysis Facility for technical assistance. This work was supported in part by an American Foundation for Aging Research Mid-Career Award and NIH/NIA Grants AG045835 and AG038688 (PK). Also, we thank to DBT-PU- IPLS Programme, Govt. of India and DST for young scientist award (SB/YS/LS-166/2014) for financial support.	Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Andrews M, 1999, Adv Wound Care, V12, P137; Apfeld J, 2004, GENE DEV, V18, P3004, DOI 10.1101/gad.1255404; BEDWAL RS, 1994, EXPERIENTIA, V50, P626, DOI 10.1007/BF01952862; Bofill R, 2009, FEBS J, V276, P7040, DOI 10.1111/j.1742-4658.2009.07417.x; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Bruinsma JJ, 2008, GENETICS, V179, P811, DOI 10.1534/genetics.107.084384; Bruinsma JJ, 2002, DEV CELL, V2, P567, DOI 10.1016/S1534-5807(02)00151-X; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Chen Y, 2001, EUR J BIOCHEM, V268, P3346, DOI 10.1046/j.1432-1327.2001.02250.x; Chi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124150; Colvin RA, 2010, METALLOMICS, V2, P306, DOI 10.1039/b926662c; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; Davis DE, 2009, GENETICS, V182, P1015, DOI 10.1534/genetics.109.103614; Douglas PM, 2010, J CELL BIOL, V190, P719, DOI 10.1083/jcb.201005144; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; FABIAN TJ, 1995, J GERONTOL A-BIOL, V50, pB245, DOI 10.1093/gerona/50A.5.B245; FAVIER AE, 1992, BIOL TRACE ELEM RES, V32, P363, DOI 10.1007/BF02784623; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Fraker PJ, 2004, ANNU REV NUTR, V24, P277, DOI 10.1146/annurev.nutr.24.012003.132454; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; FREEDMAN JH, 1993, J BIOL CHEM, V268, P2554; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Garigan D, 2002, GENETICS, V161, P1101; GOTTLIEB S, 1994, GENETICS, V137, P107; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Huang XD, 2000, J NUTR, V130, p1488S, DOI 10.1093/jn/130.5.1488S; Jacob C, 1998, P NATL ACAD SCI USA, V95, P3489, DOI 10.1073/pnas.95.7.3489; Jakubowski J, 1999, GENETICS, V153, P743; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kapahi Pankaj, 2004, Sci Aging Knowledge Environ, V2004, pPE34, DOI 10.1126/sageke.2004.36.pe34; Kikis EA, 2010, ADV EXP MED BIOL, V694, P138; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King JC, 2000, J NUTR, V130, p1360S, DOI 10.1093/jn/130.5.1360S; Koga H, 2011, AGEING RES REV, V10, P205, DOI 10.1016/j.arr.2010.02.001; Krebs NF, 2000, J NUTR, V130, p1374S, DOI 10.1093/jn/130.5.1374S; Kumar J, 2015, CNS NEUROL DISORD-DR, V14, P295, DOI 10.2174/1871527314666150116110212; Lansdown ABG, 2007, WOUND REPAIR REGEN, V15, P2, DOI 10.1111/j.1524-475X.2006.00179.x; Lee SJ, 2010, MOL BRAIN, V3, DOI 10.1186/1756-6606-3-30; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Leung MCK, 2008, TOXICOL SCI, V106, P5, DOI 10.1093/toxsci/kfn121; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin LC, 2006, INT J RADIAT ONCOL, V65, P745, DOI 10.1016/j.ijrobp.2006.01.015; Lynch CJ, 2001, AM J PHYSIOL-ENDOC M, V281, pE25, DOI 10.1152/ajpendo.2001.281.1.E25; Maret W, 2000, J NUTR, V130, p1455S, DOI 10.1093/jn/130.5.1455S; MCCLAIN C, 1980, GASTROENTEROLOGY, V78, P272; Murakami M, 2008, CANCER SCI, V99, P1515, DOI 10.1111/j.1349-7006.2008.00854.x; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Murphy JT, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002013; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Myung SJ, 1998, J GASTROENTEROL, V33, P876, DOI 10.1007/s005350050192; Nishi Y, 1996, J AM COLL NUTR, V15, P340; Olsen A, 2006, ANN NY ACAD SCI, V1067, P120, DOI 10.1196/annals.1354.015; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x; Prasad AS, 1996, NUTRITION, V12, P344, DOI 10.1016/S0899-9007(96)80058-X; Qu WB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-170; Rink L, 2000, P NUTR SOC, V59, P541, DOI 10.1017/S0029665100000781; ROGALSKI TM, 1995, GENETICS, V139, P159; Roh HC, 2012, CELL METAB, V15, P88, DOI 10.1016/j.cmet.2011.12.003; Rossi L, 2001, J NUTR, V131, P1142, DOI 10.1093/jn/131.4.1142; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shen LL, 2009, ENVIRON TOXICOL PHAR, V28, P125, DOI 10.1016/j.etap.2009.03.009; Sonani RR, 2014, AGE, V36, DOI 10.1007/s11357-014-9717-1; Takeda A, 2000, BRAIN RES REV, V34, P137, DOI 10.1016/S0165-0173(00)00044-8; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; UNDERWOOD EJ, 1981, J HUM NUTR, V35, P37; Uriu-Adams Janet Y., 2005, Molecular Aspects of Medicine, V26, P268, DOI 10.1016/j.mam.2005.07.015; VALLEE BL, 1990, BIOCHEMISTRY-US, V29, P5647, DOI 10.1021/bi00476a001; VALLEE BL, 1993, P NATL ACAD SCI USA, V90, P2715, DOI 10.1073/pnas.90.7.2715; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Yoder JH, 2004, EMBO J, V23, P111, DOI 10.1038/sj.emboj.7600025; Zeitoun-Ghandour S, 2010, FEBS J, V277, P2531, DOI 10.1111/j.1742-4658.2010.07667.x; Zhao JF, 2008, CELL CALCIUM, V44, P422, DOI 10.1016/j.ceca.2008.01.006	84	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153513	10.1371/journal.pone.0153513	http://dx.doi.org/10.1371/journal.pone.0153513			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27078872	Green Submitted, gold, Green Published			2022-12-27	WOS:000374131700072
J	Krendl, AC; Kensinger, EA				Krendl, Anne C.; Kensinger, Elizabeth A.			Does Older Adults' Cognitive Function Disrupt the Malleability of Their Attitudes toward Outgroup Members?: An fMRI Investigation	PLOS ONE			English	Article							AGE-DIFFERENCES; ATTRIBUTIONAL ANALYSIS; SOURCE MEMORY; EMPATHY; PREJUDICE; STIGMA; RESPONSES; IDEOLOGY; PAIN; DISSOCIATION	In the current study we examine how individual differences in older adults' global cognitive function impacts the extent to which their attitudes toward stigmatized individuals are malleable. Because prior research has elucidated the neural processes that are involved in evaluating stigmatized individuals who are responsible or not responsible for their condition, a cognitive neuroscience approach may be well-suited to answer this question. In the current study, 36 older and 17 young adults underwent functional magnetic resonance imaging while evaluating images of homeless people who were described as being responsible or not responsible for their condition. They also indicated how much pity they felt for each of the individuals in order to determine the extent to which their attitudes were malleable (e.g., more pity for not-responsible as compared to responsible individuals). Participants' cognitive function and baseline measure of their attitudes toward stigmatized individuals (including homeless individuals) were assessed. Results revealed that although older adults' attitudes were malleable, the extent to which this was true varied due to individual differences in their global cognitive function. Specifically, the difference in the magnitude of older adults' self-reported pity for not-responsible as compared to responsible homeless individuals was predicted by their global cognitive function. Moreover, the difference in pity that older adults expressed toward not-responsible as compared to responsible homeless individuals was related to activity in the left insula and the anterior cingulate cortex (regions implicated in empathy). These results suggest that attitude malleability is affected by individual differences in global cognitive function.	[Krendl, Anne C.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Kensinger, Elizabeth A.] Boston Coll, Dept Psychol, Chestnut Hills, MA USA	Indiana University System; Indiana University Bloomington	Krendl, AC (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	akrendl@indiana.edu		Kensinger, Elizabeth/0000-0003-1940-231X	Searle Foundation; Boston College; Ruth Kirschstein National Research Service Award from the National Institute on Aging [F32 AG034039-01A1]; NATIONAL INSTITUTE ON AGING [F32AG034039] Funding Source: NIH RePORTER	Searle Foundation; Boston College; Ruth Kirschstein National Research Service Award from the National Institute on Aging; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for this research was provided by the Searle Foundation and Boston College, as well as a Postdoctoral Fellowship from the Ruth Kirschstein National Research Service Award from the National Institute on Aging (F32 AG034039-01A1) to ACK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apfelbaum EP, 2010, J EXP SOC PSYCHOL, V46, P1074, DOI 10.1016/j.jesp.2010.07.017; Azevedo RT, 2014, NEUROIMAGE, V91, P109, DOI 10.1016/j.neuroimage.2013.11.041; Bailey PE, 2008, AGING MENT HEALTH, V12, P499, DOI 10.1080/13607860802224243; Bartholow BD, 2006, J PERS SOC PSYCHOL, V90, P272, DOI 10.1037/0022-3514.90.2.272; Bernhardt BC, 2012, ANNU REV NEUROSCI, V35, P1, DOI 10.1146/annurev-neuro-062111-150536; Blanchard-Fields F, 2005, J GERONTOL B-PSYCHOL, V60, pP19, DOI 10.1093/geronb/60.1.P19; BLANCHARDFIELDS F, 1994, J GERONTOL, V49, pP43, DOI 10.1093/geronj/49.2.P43; BlanchardFields F, 1996, APPL COGNITIVE PSYCH, V10, pS137; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Cheetham M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.029.2009; CRANDALL CS, 1995, BRIT J SOC PSYCHOL, V34, P67, DOI 10.1111/j.2044-8309.1995.tb01049.x; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Crandall CS, 1996, PERS SOC PSYCHOL B, V22, P1165, DOI 10.1177/01461672962211007; Decety J, 2006, CURR DIR PSYCHOL SCI, V15, P54, DOI 10.1111/j.0963-7214.2006.00406.x; Decety J, 2010, J COGNITIVE NEUROSCI, V22, P985, DOI 10.1162/jocn.2009.21266; DEVINE PG, 1989, J PERS SOC PSYCHOL, V56, P5, DOI 10.1037/0022-3514.56.1.5; Fehse K, 2015, SOC NEUROSCI-UK, V10, P243, DOI 10.1080/17470919.2014.980587; Finlay KA, 2000, J APPL SOC PSYCHOL, V30, P1720, DOI 10.1111/j.1559-1816.2000.tb02464.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GLISKY EL, 1995, NEUROPSYCHOLOGY, V9, P229, DOI 10.1037/0894-4105.9.2.229; Gonsalkorale K, SOCIAL PSYCHOL PERSO; Gonsalkorale K, 2009, J EXP SOC PSYCHOL, V45, P410, DOI 10.1016/j.jesp.2008.11.004; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Henry JD, 2013, PSYCHOL AGING, V28, P826, DOI 10.1037/a0030677; Hodson G, 2012, PSYCHOL SCI, V23, P187, DOI 10.1177/0956797611421206; Kramer AF, 1999, ACTA PSYCHOL, V101, P339, DOI 10.1016/S0001-6918(99)00011-6; Krendl AC, 2012, SOCIAL COGNITIVE AFF; Krendl AC, 2013, J GERONTOL B-PSYCHOL, V68, P333, DOI 10.1093/geronb/gbs070; Krendl AC, 2009, PSYCHOL AGING, V24, P530, DOI 10.1037/a0016065; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; Lawrence EJ, 2006, NEUROIMAGE, V29, P1173, DOI 10.1016/j.neuroimage.2005.09.001; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P488, DOI 10.1037/0022-3514.89.4.488; Radvansky GA, 2010, J EXP SOC PSYCHOL, V46, P51, DOI 10.1016/j.jesp.2009.09.010; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Stewart BD, 2009, PSYCHOL SCI, V20, P164, DOI 10.1111/j.1467-9280.2009.02274.x; Von Hippel W, 2000, PERSONALITY AND SOCI, P523; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; WEINER B, 1988, J PERS SOC PSYCHOL, V55, P738, DOI 10.1037/0022-3514.55.5.738; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; ZUCKER GS, 1993, J APPL SOC PSYCHOL, V23, P925, DOI 10.1111/j.1559-1816.1993.tb01014.x	43	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2016	11	4							e0152698	10.1371/journal.pone.0152698	http://dx.doi.org/10.1371/journal.pone.0152698			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UC	27074046	Green Submitted, Green Published, gold			2022-12-27	WOS:000374131200033
J	Cristobal-Narvaez, P; Sheinbaum, T; Ballespi, S; Mitjavila, M; Myin-Germeys, I; Kwapil, TR; Barrantes-Vidal, N				Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Ballespi, Sergi; Mitjavila, Merce; Myin-Germeys, Inez; Kwapil, Thomas R.; Barrantes-Vidal, Neus			Impact of Adverse Childhood Experiences on Psychotic-Like Symptoms and Stress Reactivity in Daily Life in Nonclinical Young Adults	PLOS ONE			English	Article							TRAUMA; SCHIZOTYPY; MECHANISMS; SCHIZOPHRENIA; METAANALYSIS; ASSOCIATION; NEGLECT; ABUSE; RISK; PSYCHOPATHOLOGY	Background There is increasing interest in elucidating the association of different childhood adversities with psychosis-spectrum symptoms as well as the mechanistic processes involved. This study used experience sampling methodology to examine (i) associations of a range of childhood adversities with psychosis symptom domains in daily life; (ii) whether associations of abuse and neglect with symptoms are consistent across self-report and interview methods of trauma assessment; and (iii) the role of different adversities in moderating affective, psychotic-like, and paranoid reactivity to situational and social stressors. Method A total of 206 nonclinical young adults were administered self-report and interview measures to assess childhood abuse, neglect, bullying, losses, and general traumatic events. Participants received personal digital assistants that signaled them randomly eight times daily for one week to complete questionnaires about current experiences, including symptoms, affect, and stress. Results Self-reported and interview-based abuse and neglect were associated with psychotic-like and paranoid symptoms, whereas only self-reported neglect was associated with negative-like symptoms. Bullying was associated with psychotic-like symptoms. Losses and general traumatic events were not directly associated with any of the symptom domains. All the childhood adversities were associated with stress reactivity in daily life. Interpersonal adversities (abuse, neglect, bullying, and losses) moderated psychotic-like and/or paranoid reactivity to situational and social stressors, whereas general traumatic events moderated psychotic-like reactivity to situational stress. Also, different interpersonal adversities exacerbated psychotic-like and/or paranoid symptoms in response to distinct social stressors. Discussion The present study provides a unique examination of how childhood adversities impact the expression of spectrum symptoms in the real world and lends support to the notion that stress reactivity is a mechanism implicated in the experience of reality distortion in individuals exposed to childhood trauma. Investigating the interplay between childhood experience and current context is relevant for uncovering potential pathways to the extended psychosis phenotype.	[Cristobal-Narvaez, Paula; Sheinbaum, Tamara; Ballespi, Sergi; Mitjavila, Merce; Barrantes-Vidal, Neus] Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain; [Myin-Germeys, Inez] Katholieke Univ Leuven, Dept Neurosci, Ctr Contextual Psychiat, Leuven, Belgium; [Kwapil, Thomas R.; Barrantes-Vidal, Neus] Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA; [Barrantes-Vidal, Neus] St Pere Claver Fundacio Sanitaria, Barcelona, Spain; [Barrantes-Vidal, Neus] Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain	Autonomous University of Barcelona; KU Leuven; University of North Carolina; University of North Carolina Greensboro; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III	Barrantes-Vidal, N (corresponding author), Univ Autonoma Barcelona, Dept Psicol Clin & Salut, E-08193 Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), Univ N Carolina, Dept Psychol, Greensboro, NC 27412 USA.; Barrantes-Vidal, N (corresponding author), St Pere Claver Fundacio Sanitaria, Barcelona, Spain.; Barrantes-Vidal, N (corresponding author), Inst Salud Carlos III, Ctr Biomed Res Network Mental Hlth CIBERSAM, Madrid, Spain.	neus.barrantes@uab.cat	Ballespí, Sergi/L-6492-2014; Myin Germeys, Inez/HIR-3364-2022; Myin-Germeys, Inez/L-5106-2014; Kwapil, Thomas/I-3163-2019; Sheinbaum, Tamara/A-8008-2016; Cristóbal-Narváez, Paula/K-3265-2017; Cristóbal-Narváez, Paula/AFU-7048-2022; Barrantes-Vidal, Neus/A-9578-2013; Mitjavila, Mercè/L-3760-2014; Kwapil, Thomas R./L-1127-2014	Ballespí, Sergi/0000-0002-6584-4138; Myin Germeys, Inez/0000-0002-3731-4930; Sheinbaum, Tamara/0000-0002-2268-7697; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Cristóbal-Narváez, Paula/0000-0001-8184-6347; Barrantes-Vidal, Neus/0000-0002-8671-1238; Mitjavila, Mercè/0000-0003-2390-3774; Kwapil, Thomas R./0000-0003-1116-5954	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D) [PSI2011-30321-C02-01, PSI2014-54009-R]; Red de Excelencia PROMOSAM [PSI2014-56303-REDT]; Fundacio La Marato de TV3 [091110]; Generalitat de Catalunya (Suport als Grups de Recerca) [2014SGR1070]; Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award	Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D); Red de Excelencia PROMOSAM; Fundacio La Marato de TV3; Generalitat de Catalunya (Suport als Grups de Recerca)(Generalitat de Catalunya); Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award(ICREA)	This work was supported by the Spanish Ministerio de Economia y Competitividad (Plan Nacional de I+D PSI2011-30321-C02-01 & PSI2014-54009-R and Red de Excelencia PROMOSAM PSI2014-56303-REDT), Fundacio La Marato de TV3 (091110), and Generalitat de Catalunya (Suport als Grups de Recerca 2014SGR1070). NBV is supported by the Institucio Catalana de Recerca i Estudis Avancats (ICREA), ICREA Academia Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntz A., 2010, INTERVIEW TRAUMATIC; Arseneault L, 2011, AM J PSYCHIAT, V168, P65, DOI 10.1176/appi.ajp.2010.10040567; Ashford CD, 2012, J EXP PSYCHOPATHOL, V3, P624, DOI 10.5127/jep.020611; Barrantes-Vidal N, 2015, SCHIZOPHRENIA BULL, V41, pS408, DOI 10.1093/schbul/sbu191; Barrantes-Vidal N, 2013, J ABNORM PSYCHOL, V122, P1077, DOI 10.1037/a0034793; Beards S, 2014, SOC PSYCH PSYCH EPID, V49, P1541, DOI 10.1007/s00127-014-0953-6; Bentall RP, 2008, SCHIZOPHRENIA BULL, V34, P1012, DOI 10.1093/schbul/sbn103; Bentall RP, 2014, SOC PSYCH PSYCH EPID, V49, P1011, DOI 10.1007/s00127-014-0914-0; Bentall RP, 2012, SCHIZOPHRENIA BULL, V38, P734, DOI 10.1093/schbul/sbs049; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; BIFULCO A, 1994, J CHILD PSYCHOL PSYC, V35, P1419, DOI 10.1111/j.1469-7610.1994.tb01284.x; Bifulco AT, 2013, UNDERSTANDING ADULT; Bowlby J., 1973, SEPARATION ANXIETY A, V2; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Brown AS, 2011, PROG NEUROBIOL, V93, P23, DOI 10.1016/j.pneurobio.2010.09.003; Chun CA, 2017, PERSONAL DISORD, V8, P64, DOI 10.1037/per0000141; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Conner TS, 2009, SOC PERSONAL PSYCHOL, V3, P292, DOI 10.1111/j.1751-9004.2009.00170.x; De Vries M, 1992, EXPERIENCE PSYCHOPAT; Debbane M, 2015, SCHIZOPHRENIA BULL, V41, pS386, DOI 10.1093/schbul/sbu175; Dohrenwend BP, 2006, PSYCHOL BULL, V132, P477, DOI 10.1037/0033-2909.132.3.477; Ettinger U, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00018; Fisher H, 2008, SOCIETY AND PSYCHOSIS, P95, DOI 10.1017/CBO9780511544064.007; Fisher HL, 2015, DEV PSYCHOPATHOL, V27, P1399, DOI 10.1017/S0954579415000838; Fisher HL, 2012, PSYCHIAT RES, V196, P323, DOI 10.1016/j.psychres.2011.12.004; Galletly C, 2011, SCHIZOPHR RES, V127, P76, DOI 10.1016/j.schres.2010.12.010; Glaser D, 2000, J CHILD PSYCHOL PSYC, V41, P97, DOI 10.1111/1469-7610.00551; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Heins M, 2011, AM J PSYCHIAT, V168, P1286, DOI 10.1176/appi.ajp.2011.10101531; Hektner JM, 2007, EXPERIENCE SAMPLING; Hildyard KL, 2002, CHILD ABUSE NEGLECT, V26, P679, DOI 10.1016/S0145-2134(02)00341-1; Kwapil TR, 2012, PSYCHOL MED, V42, P2555, DOI 10.1017/S0033291712000827; Kwapil TR, 2015, SCHIZOPHRENIA BULL, V41, pS366, DOI 10.1093/schbul/sbu186; Lardinois M, 2011, ACTA PSYCHIAT SCAND, V123, P28, DOI 10.1111/j.1600-0447.2010.01594.x; Lataster T, 2013, PSYCHOL MED, V43, P1389, DOI 10.1017/S0033291712002279; Lobbestael J, 2009, CHILD ABUSE NEGLECT, V33, P505, DOI 10.1016/j.chiabu.2009.03.002; Longden E, 2016, EPIDEMIOL PSYCH SCI, V25, P349, DOI 10.1017/S204579601500044X; March D, 2008, EPIDEMIOL REV, V30, P84, DOI 10.1093/epirev/mxn006; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; McCabe KL, 2012, J PSYCHIATR RES, V46, P600, DOI 10.1016/j.jpsychires.2012.01.023; Mikulincer M., 2007, ATTACHMENT ADULTHOOD; Monroe SM, 2008, ANNU REV CLIN PSYCHO, V4, P33, DOI 10.1146/annurev.clinpsy.4.022007.141207; Muthen B., 2010, MPLUS USERS GUIDE; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Nezlek J. B., 2011, MULTILEVEL MODELING; Oorschot M, 2009, PSYCHOL ASSESSMENT, V21, P498, DOI 10.1037/a0017077; Petersen AC, 2014, NEW DIRECTIONS IN CHILD ABUSE AND NEGLECT RESEARCH, P1; Ruby Eugene, 2014, Front Psychol Behav Sci, V3, P1; Schimmenti A, 2015, PSYCHIAT INVEST, V12, P415, DOI 10.4306/pi.2015.12.3.415; Sheinbaum T, 2015, ADV MENT HEALTH RES, P116; Sheinbaum T, 2014, PSYCHIAT RES, V220, P691, DOI 10.1016/j.psychres.2014.07.030; Simpson J. A., 2012, OXFORD HDB PERSONALI, P493; Spence R, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4085; Thompson JL, 2009, SCHIZOPHR RES, V108, P176, DOI 10.1016/j.schres.2008.12.005; van Dam DS, 2015, PSYCHOL MED, V45, P1363, DOI 10.1017/S0033291714001561; van Dam DS, 2012, PSYCHOL MED, V42, P2463, DOI 10.1017/S0033291712000360; van Nierop M, 2014, SCHIZOPHRENIA BULL, V40, pS123, DOI 10.1093/schbul/sbt150; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; van Winkel R, 2008, SCHIZOPHRENIA BULL, V34, P1095, DOI 10.1093/schbul/sbn101; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Velikonja T, 2015, PSYCHOL MED, V45, P947, DOI 10.1017/S0033291714002086; Wichers M, 2009, PSYCHOL MED, V39, P1077, DOI 10.1017/S0033291708004388	64	48	48	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2016	11	4							e0153557	10.1371/journal.pone.0153557	http://dx.doi.org/10.1371/journal.pone.0153557			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DJ6AH	27082442	gold, Green Published, Green Submitted			2022-12-27	WOS:000374291800030
J	Wu, HY; Li, P; Pan, DQ; Yin, ZX; Fang, QH; Wu, WS				Wu, Hanyu; Li, Ping; Pan, Duoqiang; Yin, Zhuoxin; Fang, Qiaohui; Wu, Wangsuo			Interactions between Silicon Oxide Nanoparticles (SONPs) and U(VI) Contaminations: Effects of pH, Temperature and Natural Organic Matters	PLOS ONE			English	Article							HUMIC-ACID; AQUEOUS-SOLUTIONS; IONIC-STRENGTH; SURFACE COMPLEXATION; SORPTION-DESORPTION; URANYL SORPTION; FULVIC-ACID; URANIUM(VI); ADSORPTION; REMOVAL	The interactions between contaminations of U(VI) and silicon oxide nanoparticles (SONPs), both of which have been widely used in modern industry and induced serious environmental challenge due to their high mobility, bioavailability, and toxicity, were studied under different environmental conditions such as pH, temperature, and natural organic matters (NOMs) by using both batch and spectroscopic approaches. The results showed that the accumulation process, i.e., sorption, of U(VI) on SONPs was strongly dependent on pH and ionic strength, demonstrating that possible outer- and/or inner-sphere complexes were controlling the sorption process of U(VI) on SONPs in the observed pH range. Humic acid (HA), one dominated component of NOMs, bounded SONPs can enhance U(VI) sorption below pH -4.5, whereas restrain at high pH range. The reversible sorption of U(VI) on SONPs possibly indicated that the outer-sphere complexes were prevalent at pH 5. However, an irreversible interaction of U(VI) was observed in the presence of HA (Fig 1). It was mainly due to the ternary SONPs-HA-U(VI) complexes (Type A Complexes). After SONPs adsorbed U(VI), the particle size in suspension was apparently increased from similar to 240 nm to similar to 350 nm. These results showed that toxicity of both SONPs and U(VI) will decrease to some extent after the interaction in the environment. These findings are key for providing useful information on the possible mutual interactions among different contaminants in the environment.	[Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China; [Fang, Qiaohui] Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China; [Li, Ping] China Acad Engn Phys, Inst Nucl Phys & Chem, Mianyang 621000, Sichuan, Peoples R China; [Wu, Hanyu; Pan, Duoqiang; Yin, Zhuoxin; Wu, Wangsuo] Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS; Chinese Academy of Engineering Physics	Wu, WS (corresponding author), Lanzhou Univ, Sch Nucl Sci & Technol, Radiochem Lab, Lanzhou 730000, Gansu, Peoples R China.; Fang, QH (corresponding author), Chinese Acad Sci, Inst Geol & Geophys, Gansu Prov CAS Key Lab Petr Resources Res, Key Lab Petr Resources, Lanzhou 730000, Gansu, Peoples R China.; Wu, WS (corresponding author), Minist Educ, Key Lab Special Funct Mat & Struct Design, Lanzhou 730000, Gansu, Peoples R China.	fanqh@lzb.ac.cn; wuws@lzu.edu.cn			Special Foundation for High Level Waste Disposal, China [[2012] 494]; National Natural Science Foundation of China [21327801, J1210001, 41573128]; Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University [Izujbky-2015-70]; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University [Izummm2015011]	Special Foundation for High Level Waste Disposal, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS; Basic Scientific Research Business Expenses of the Central University; Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University	The funding or sources of support received during this specific study (whether external or internal to the organization): 1) Special Foundation for High Level Waste Disposal, China ([2012] 494) http://www.sastind.gov.cn; 2) National Natural Science Foundation of China (21327801) http://www.nsfc.gov.cn/publish/portal1/; 3) National Natural Science Foundation of China (J1210001) http://www.nsfc.gov.cn/publish/portal1/; 4) National Natural Science Foundation of China (41573128) http://www.nsfc.gov.cn/publish/portal1/; 5) "100-Talent" Program from Chinese Academy of Sciences in Lanzhou Center for Oil and Gas Resources, Institute of Geology and Geophysics, CAS http://english.cas.cn; 6) The Basic Scientific Research Business Expenses of the Central University (Izujbky-2015-70) http://en.lzu.edu.cn; 7) Open Project of Key Laboratory for Magnetism and Magnetic Materials of the Ministry of Education, Lanzhou University (Izummm2015011) (http://en.lzu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARROW NJ, 1986, J SOIL SCI, V37, P295, DOI 10.1111/j.1365-2389.1986.tb00031.x; Batuk DN, 2011, ACTINIDE NANOPARTICL, P315, DOI [10.1007/978-3-642-11432-8_11, DOI 10.1007/978-3-642-11432-8_11]; Bhalara PD, 2014, J ENVIRON CHEM ENG, V2, P1621, DOI 10.1016/j.jece.2014.06.007; Campos B, 2013, APPL CLAY SCI, V85, P53, DOI 10.1016/j.clay.2013.08.046; Chisholm-Brause CJ, 2001, J COLLOID INTERF SCI, V233, P38, DOI 10.1006/jcis.2000.7227; Das D, 2010, J RADIOANAL NUCL CH, V285, P447, DOI 10.1007/s10967-010-0627-0; Dinesh R, 2012, GEODERMA, V173, P19, DOI 10.1016/j.geoderma.2011.12.018; Fan QH, 2014, ENVIRON SCI-PROC IMP, V16, P534, DOI 10.1039/c3em00324h; Fan QH, 2012, APPL RADIAT ISOTOPES, V70, P13, DOI 10.1016/j.apradiso.2011.07.004; Fan QH, 2009, ENVIRON SCI TECHNOL, V43, P5776, DOI 10.1021/es901241f; Fan QH, 2011, J HAZARD MATER, V192, P1851, DOI 10.1016/j.jhazmat.2011.07.022; Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001; Guo ZJ, 2009, RADIOCHIM ACTA, V97, P133, DOI 10.1524/ract.2009.1589; Ho YS, 1999, PROCESS BIOCHEM, V34, P451, DOI 10.1016/S0032-9592(98)00112-5; Ivanov P, 2012, J ENVIRON MONITOR, V14, P2968, DOI 10.1039/c2em30512g; Katsoyiannis IA, 2013, DESALIN WATER TREAT, V51, P2915, DOI 10.1080/19443994.2012.748300; Kavitha D, 2007, BIORESOURCE TECHNOL, V98, P14, DOI 10.1016/j.biortech.2005.12.008; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Krepelova A, 2008, J COLLOID INTERF SCI, V319, P40, DOI 10.1016/j.jcis.2007.11.010; Krepelova A, 2007, ENVIRON SCI TECHNOL, V41, P6142, DOI 10.1021/es070419q; Kushwaha S, 2013, J ENVIRON RADIOACTIV, V126, P115, DOI 10.1016/j.jenvrad.2013.07.021; Li P, 2014, ENVIRON SCI-PROC IMP, V16, P2278, DOI 10.1039/c4em00301b; Massey MS, 2014, ENVIRON SCI TECHNOL, V48, P8636, DOI 10.1021/es501064m; McCarthy J, 2012, CHEM RES TOXICOL, V25, P2227, DOI 10.1021/tx3002884; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nilchi A, 2013, DESALINATION, V321, P67, DOI 10.1016/j.desal.2012.06.022; Niu ZW, 2009, APPL RADIAT ISOTOPES, V67, P1582, DOI 10.1016/j.apradiso.2009.03.113; Okoturo-Evans O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072363; Olu-Owolabi BI, 2014, J ENVIRON MANAGE, V137, P1, DOI 10.1016/j.jenvman.2014.01.048; Ozer A, 2005, CHEM ENG J, V112, P181, DOI 10.1016/j.cej.2005.07.007; Payne TE, 2004, APPL CLAY SCI, V26, P151, DOI 10.1016/j.clay.2003.08.013; Rengaraj S, 2004, J COLLOID INTERF SCI, V273, P14, DOI 10.1016/j.jcis.2004.01.007; Rivera-Gil P, 2013, ACCOUNTS CHEM RES, V46, P743, DOI 10.1021/ar300039j; Sachs S, 2008, CHEMOSPHERE, V72, P1441, DOI 10.1016/j.chemosphere.2008.05.027; Sachs S, 2011, J RADIOANAL NUCL CH, V290, P17, DOI 10.1007/s10967-011-1084-0; Schafer T, 2012, APPL GEOCHEM, V27, P390, DOI 10.1016/j.apgeochem.2011.09.009; Schmeide K, 2003, INORG CHIM ACTA, V351, P133, DOI 10.1016/S0020-1693(03)00184-1; Sun YB, 2012, J ENVIRON RADIOACTIV, V105, P40, DOI 10.1016/j.jenvrad.2011.10.009; Tan XL, 2008, ENVIRON SCI TECHNOL, V42, P6532, DOI 10.1021/es8007062; Tan XL, 2010, MOLECULES, V15, P8431, DOI 10.3390/molecules15118431; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Tian G, 2011, J HAZARD MATER, V190, P442, DOI 10.1016/j.jhazmat.2011.03.066; Tipping Edward, 1993, Analytical Proceedings, V30, P186, DOI 10.1039/ap9933000186; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Weng LP, 2006, ENVIRON SCI TECHNOL, V40, P7494, DOI 10.1021/es060777d; Wu WS, 2007, APPL RADIAT ISOTOPES, V65, P1108, DOI 10.1016/j.apradiso.2007.05.009; Xu D, 2008, APPL CLAY SCI, V39, P133, DOI 10.1016/j.clay.2007.05.006; Yang SP, 2013, ENVIRON SCI TECHNOL, V47, P4718, DOI 10.1021/es3047334	48	32	37	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2016	11	3							e0149632	10.1371/journal.pone.0149632	http://dx.doi.org/10.1371/journal.pone.0149632			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF5ZW	26930197	Green Published, Green Submitted, gold			2022-12-27	WOS:000371434500036
J	Hu, JS; Wu, WB; Zhu, B; Wang, HT; Liu, RY; Zhang, X; Li, M; Yang, YB; Yan, J; Niu, FN; Tian, CS; Wang, K; Yu, HP; Chen, WB; Wan, SR; Sun, Y; Zhang, B				Hu, Jisu; Wu, Wenbo; Zhu, Bin; Wang, Huiting; Liu, Renyuan; Zhang, Xin; Li, Ming; Yang, Yongbo; Yan, Jing; Niu, Fengnan; Tian, Chuanshuai; Wang, Kun; Yu, Haiping; Chen, Weibo; Wan, Suiren; Sun, Yu; Zhang, Bing			Cerebral Glioma Grading Using Bayesian Network with Features Extracted from Multiple Modalities of Magnetic Resonance Imaging	PLOS ONE			English	Article							BRAIN-TUMORS; DIAGNOSIS; SPECTROSCOPY; PRINCIPLES; SPECTRA	Many modalities of magnetic resonance imaging (MRI) have been confirmed to be of great diagnostic value in glioma grading. Contrast enhanced T1-weighted imaging allows the recognition of blood-brain barrier breakdown. Perfusion weighted imaging and MR spectroscopic imaging enable the quantitative measurement of perfusion parameters and metabolic alterations respectively. These modalities can potentially improve the grading process in glioma if combined properly. In this study, Bayesian Network, which is a powerful and flexible method for probabilistic analysis under uncertainty, is used to combine features extracted from contrast enhanced T1-weighted imaging, perfusion weighted imaging and MR spectroscopic imaging. The networks were constructed using K2 algorithm along with manual determination and distribution parameters learned using maximum likelihood estimation. The grading performance was evaluated in a leave-one-out analysis, achieving an overall grading accuracy of 92.86% and an area under the curve of 0.9577 in the receiver operating characteristic analysis given all available features observed in the total 56 patients. Results and discussions show that Bayesian Network is promising in combining features from multiple modalities of MRI for improved grading performance.	[Hu, Jisu; Wan, Suiren; Sun, Yu] Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, Nanjing, Jiangsu, Peoples R China; [Hu, Jisu] Chinese Acad Sci, Suzhou Inst Biomed Engn & Technol, Suzhou, Jiangsu, Peoples R China; [Wu, Wenbo; Zhu, Bin; Wang, Huiting; Liu, Renyuan; Zhang, Xin; Li, Ming; Tian, Chuanshuai; Wang, Kun; Yu, Haiping; Zhang, Bing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing 210008, Jiangsu, Peoples R China; [Yang, Yongbo] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Neurosurg, Nanjing 210008, Jiangsu, Peoples R China; [Yan, Jing] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Oncol, Nanjing 210008, Jiangsu, Peoples R China; [Niu, Fengnan] Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Chen, Weibo] Philips Healthcare, Shanghai, Peoples R China	Southeast University - China; Chinese Academy of Sciences; Suzhou Institute of Biomedical Engineering & Technology, CAS; Nanjing University; Nanjing University; Nanjing University; Nanjing University; Philips; Philips Healthcare	Wan, SR; Sun, Y (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Lab Med Elect, Nanjing, Jiangsu, Peoples R China.; Zhang, B (corresponding author), Nanjing Univ, Sch Med, Affiliated Drum Tower Hosp, Dept Radiol, Nanjing 210008, Jiangsu, Peoples R China.	srwan@seu.edu.cn; yuyuly09@googlemail.com; zhangbing_nanjing@vip.163.com			National Natural Science Foundation of China [81571040, 81300925]; Provincial Natural Science Foundation of Jiangsu [BK20131085]; Key Project of Nanjing Health Bureau [ZKX14027]; Jiangsu Province Medical Key talented people; 12th five years plan for China development [RC2011013]; Philips Healthcare;  [1501076A];  [WSN-O50]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Jiangsu(Natural Science Foundation of Jiangsu Province); Key Project of Nanjing Health Bureau; Jiangsu Province Medical Key talented people; 12th five years plan for China development; Philips Healthcare; ; 	This work was supported by the National Natural Science Foundation of China (81571040, 81300925, B. Zhang), the Provincial Natural Science Foundation of Jiangsu (2014-2016, BK20131085, B. Zhang), the provincial postdoctoral project (1501076A, B. Zhang), the project of the sixth peak of talented people (WSN-O50, B. Zhang), the Key Project of Nanjing Health Bureau (ZKX14027 B. Zhang), and the Jiangsu Province Medical Key talented people and "the 12th five years plan for China development" (2011-2016, RC2011013, B. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philips Healthcare provided support in the form of salary for author Weibo Chen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2001, COMPUTING SCI STAT, V33; Barbier EL, 2001, J MAGN RESON IMAGING, V13, P496, DOI 10.1002/jmri.1073; Callot V, 2008, EUR J RADIOL, V67, P268, DOI 10.1016/j.ejrad.2008.02.036; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Cruz-Ramirez N, 2007, COMPUT BIOL MED, V37, P1553, DOI 10.1016/j.compbiomed.2007.02.003; Daly R, 2011, KNOWL ENG REV, V26, P99, DOI 10.1017/S0269888910000251; DKN F, 2009, PROBABILISTIC GRAPHI; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Hakyemez B, 2005, CLIN RADIOL, V60, P493, DOI 10.1016/j.crad.2004.09.009; Law M, 2003, AM J NEURORADIOL, V24, P1989; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Ludemann L, 2001, EUR RADIOL, V11, P1231; Mani S, 2005, APPL INTELL, V22, P93, DOI 10.1007/s10489-005-5599-3; Ostergaard L, 2005, J MAGN RESON IMAGING, V22, P710, DOI 10.1002/jmri.20460; Posse S, 2013, J MAGN RESON IMAGING, V37, P1301, DOI 10.1002/jmri.23945; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Qiang Ning CM, 2015, THR 23 ISMRM ANN M; Reynolds GM, 2007, BMC MED INFORM DECIS, V7, DOI 10.1186/1472-6947-7-27; Seixas FL, 2014, COMPUT BIOL MED, V51, P140, DOI 10.1016/j.compbiomed.2014.04.010; Senturk S, 2009, DIAGN INTERV RADIOL, V15, P3; Sibtain NA, 2007, CLIN RADIOL, V62, P109, DOI 10.1016/j.crad.2006.09.012; Stadlbauer A, 2004, NEUROIMAGE, V23, P454, DOI 10.1016/j.neuroimage.2004.06.022; Wang XH, 1999, INT J MED INFORM, V54, P115, DOI 10.1016/S1386-5056(98)00174-9	24	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2016	11	4							e0153369	10.1371/journal.pone.0153369	http://dx.doi.org/10.1371/journal.pone.0153369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ3UH	27077923	Green Published, gold, Green Submitted			2022-12-27	WOS:000374131700046
